{"meta":{"query_hash":"aa5babbbc3fc","filters":{"venue":"Breast Cancer Research and Treatment"},"cohort_total":814,"direct_labels_cover":3,"predictions_cover":814,"exported":814,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/aa5babbbc3fc","api":"https://metacan.xera.ac/api/v1/cohort?venue=Breast+Cancer+Research+and+Treatment"},"results":[{"id":"W1447575175","doi":"10.1007/s10549-015-3547-4","title":"Octreotide LAR and tamoxifen versus tamoxifen in phase III randomize early breast cancer trials: NCIC CTG MA.14 and NSABP B-29","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Sunnybrook Health Science Centre; University of Toronto; Jewish General Hospital; McGill University; Queen's University","funders":"National Cancer Institute; Canadian Cancer Society Research Institute","keywords":"Medicine; Internal medicine; Breast cancer; Tamoxifen; Hazard ratio; Cancer; Oncology; Gastroenterology; Gynecology; Confidence interval","score_opus":0.18917399873553203,"score_gpt":0.4822184187308608,"score_spread":0.29304441999532876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1447575175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9641675,0.02085544,0.0000026115333,0.01015513,0.00030595742,0.002410994,0.0013003044,0.000045496796,0.00075659424],"genre_scores_gemma":[0.975111,0.019439617,0.000030960116,0.00010143597,0.0007204221,0.0018830145,0.000043696808,0.000051315117,0.002618501],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99647623,0.0005846805,0.000559091,0.00082930084,0.0006019907,0.0009486809],"domain_scores_gemma":[0.9974327,0.00071393204,0.00013520163,0.0003003181,0.00028699674,0.001130824],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013955825,0.00046272308,0.0013474878,0.00041219316,0.0001901549,0.00010098678,0.000094554416,0.0001593402,0.0005901286],"category_scores_gemma":[0.0000662099,0.00030901155,0.00011883988,0.00038874874,0.00051060144,0.00022949028,0.00011997522,0.00030645318,0.000015170905],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.43893838,0.0029675113,0.13062689,0.0001396791,0.0026494234,0.0012404753,0.002501198,0.000003257615,0.0023331386,0.000116265524,0.0048259217,0.41365784],"study_design_scores_gemma":[0.8095943,0.007287674,0.16282475,0.00061646145,0.0014045193,0.00075934525,0.0005823838,0.00010843259,0.0022843955,0.0004762007,0.013388473,0.00067310926],"about_ca_topic_score_codex":0.027637934,"about_ca_topic_score_gemma":0.0073076882,"teacher_disagreement_score":0.41298476,"about_ca_system_score_codex":0.0013819203,"about_ca_system_score_gemma":0.0010031245,"threshold_uncertainty_score":0.9999362},"labels":[],"label_agreement":null},{"id":"W1526044470","doi":"10.1007/s10549-015-3462-8","title":"Benefits and risks of contralateral prophylactic mastectomy in women undergoing treatment for sporadic unilateral breast cancer: a decision analysis","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; BC Cancer Agency; National Institutes of Health","keywords":"Medicine; Breast cancer; Life expectancy; Stage (stratigraphy); Mastectomy; Quality of life (healthcare); Cancer; Gynecology; Cohort; Oncology; Univariate analysis; Surgery; Internal medicine; Demography; Multivariate analysis; Population; Environmental health","score_opus":0.08617029810907283,"score_gpt":0.3818282270115268,"score_spread":0.29565792890245396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1526044470","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98854417,0.0082189115,0.000013002225,0.00074618444,0.000044450997,0.000897949,0.0015079632,0.000008900632,0.000018448449],"genre_scores_gemma":[0.99004465,0.007770601,0.00013703636,0.000015590893,0.00012287669,0.0017124749,0.00007545735,0.00003061826,0.000090684516],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979399,0.00009447462,0.00030679128,0.00068926584,0.0002774501,0.00069213455],"domain_scores_gemma":[0.9988742,0.00008495405,0.00010498059,0.0002927541,0.00029181057,0.00035130896],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002192192,0.00033946527,0.000574133,0.0003399692,0.00014163734,0.00005368974,0.00009350162,0.00009487596,0.000014982257],"category_scores_gemma":[0.00001085383,0.00024671605,0.00009187769,0.00043996013,0.00022551935,0.000022007916,0.00009611263,0.00006068199,5.436717e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015657973,0.000980062,0.7531668,0.000060020593,0.0025847936,0.000018845192,0.00090324495,0.000747813,0.00065750146,0.00003679214,0.000016561436,0.22516958],"study_design_scores_gemma":[0.014994196,0.0040234043,0.97716975,0.00014210219,0.0003842689,0.00008181,0.00055366225,0.0001297513,0.0018282261,0.00021747712,0.00018797848,0.00028736115],"about_ca_topic_score_codex":0.01805673,"about_ca_topic_score_gemma":0.016234767,"teacher_disagreement_score":0.22488223,"about_ca_system_score_codex":0.0011605703,"about_ca_system_score_gemma":0.0005316567,"threshold_uncertainty_score":0.9999985},"labels":[],"label_agreement":null},{"id":"W1531458427","doi":"10.1007/s10549-015-3464-6","title":"A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":235,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; Thunder Bay Regional Health Sciences Centre; Mount Sinai Hospital; Kingston General Hospital; Juravinski Hospital; London Health Sciences Centre; Health Sciences North; University of Toronto; Ottawa Hospital; Health Sciences Centre; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"Canadian Cancer Society Research Institute; Institute for Clinical Evaluative Sciences; Ontario Ministry of Health and Long-Term Care; Genomic Health","keywords":"Medicine; Ductal carcinoma; Breast cancer; Hazard ratio; Internal medicine; Cohort; Breast-conserving surgery; Population; Oncology; Proportional hazards model; Mastectomy; Gynecology; Cancer; Confidence interval","score_opus":0.06391129614555653,"score_gpt":0.3411308198548659,"score_spread":0.27721952370930936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1531458427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959771,0.0014741995,0.0000018137749,0.00046505456,0.000052738862,0.00084202574,0.0011615857,0.000010191125,0.00001529411],"genre_scores_gemma":[0.99871105,0.0003039249,0.000012411091,0.000009338477,0.00006574383,0.00062891946,0.00022340943,0.00002049575,0.000024712359],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978332,0.0005202171,0.00031317715,0.0004927823,0.00047106692,0.0003695862],"domain_scores_gemma":[0.9988797,0.00015432863,0.00017519809,0.00038556635,0.00027181432,0.00013343974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056188036,0.00021964057,0.00030433835,0.00013916264,0.00021671837,0.000036726662,0.0001363261,0.00007532773,0.000009942155],"category_scores_gemma":[0.00009537375,0.00015243386,0.000056618363,0.00047527222,0.0001132503,0.00001416833,0.00012886646,0.00010775295,6.959939e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051904214,0.0011282592,0.98019016,0.000013699661,0.00022469655,0.0000024756762,0.0003572932,0.00009455983,0.00017653513,4.9104415e-7,0.00023071698,0.017062044],"study_design_scores_gemma":[0.0031688088,0.00038697684,0.9916601,0.00013599535,0.00006509298,0.000016559832,0.00054088817,0.000041665087,0.0038188684,0.000022080209,0.000020590656,0.00012236861],"about_ca_topic_score_codex":0.07796453,"about_ca_topic_score_gemma":0.010933967,"teacher_disagreement_score":0.067030564,"about_ca_system_score_codex":0.0003196642,"about_ca_system_score_gemma":0.00034836223,"threshold_uncertainty_score":0.9281754},"labels":[],"label_agreement":null},{"id":"W1831196039","doi":"10.1007/s10549-015-3612-z","title":"Predictive value and clinical utility of centrally assessed ER, PgR, and Ki-67 to select adjuvant endocrine therapy for premenopausal women with hormone receptor-positive, HER2-negative early breast cancer: TEXT and SOFT trials","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services","funders":"National Cancer Institute; Susan G. Komen for the Cure; Pfizer; Ipsen Fund; Canadian Cancer Society Research Institute; Ipsen; National Institute for Health and Care Research; Cancer Research UK; National Health and Medical Research Council; Breast Cancer Research Foundation; Schweizerische Arbeitsgemeinschaft für Klinische Krebsforschung; Oncosuisse","keywords":"Exemestane; Breast cancer; Medicine; Tamoxifen; Internal medicine; Progesterone receptor; Oncology; Estrogen receptor; Population; Cancer; Hormone receptor; Gynecology; Endocrinology","score_opus":0.06265246098170117,"score_gpt":0.3926188715416153,"score_spread":0.3299664105599141,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1831196039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9814765,0.008250099,0.00006454023,0.0017148039,0.00004249448,0.0025556271,0.0058463938,0.000013816806,0.00003572701],"genre_scores_gemma":[0.977132,0.020012476,0.0004152399,0.00004521703,0.00024679376,0.001972297,0.000060396364,0.000039775787,0.00007579852],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99704105,0.0004988963,0.00042376958,0.0009504154,0.0003827737,0.0007031085],"domain_scores_gemma":[0.99780995,0.0003461174,0.00016907578,0.0002502392,0.0007706878,0.0006539266],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008633411,0.00040512675,0.0008318414,0.000081211176,0.00021370353,0.00007024229,0.000095963405,0.00011256996,0.000012433058],"category_scores_gemma":[0.00008800057,0.0002750633,0.000048372283,0.00016871428,0.00068765425,0.00003045326,0.00016093811,0.00012755545,2.867033e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14377971,0.0019262783,0.55474305,0.00007948885,0.0056511825,0.000013342712,0.0018353164,0.000006191773,0.008606164,0.000027507409,0.0008152746,0.2825165],"study_design_scores_gemma":[0.017912135,0.01678553,0.9561191,0.00011328998,0.00016482869,0.000061497274,0.00054999103,0.00002110393,0.0073796613,0.00009140944,0.00053446123,0.00026698184],"about_ca_topic_score_codex":0.009496143,"about_ca_topic_score_gemma":0.001358933,"teacher_disagreement_score":0.4013761,"about_ca_system_score_codex":0.00026500272,"about_ca_system_score_gemma":0.0007263441,"threshold_uncertainty_score":0.99997014},"labels":[],"label_agreement":null},{"id":"W1857523518","doi":"10.1007/s10549-015-3382-7","title":"Hepatitis B virus screening before adjuvant chemotherapy in patients with early-stage breast cancer: a cost-effectiveness analysis","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Sunnybrook Health Science Centre; University of Toronto; St. Michael's Hospital; Toronto Public Health","funders":"Canadian Cancer Society; Gilead Sciences; Sanofi","keywords":"Medicine; Entecavir; Lamivudine; Hepatitis B virus; Breast cancer; Internal medicine; Oncology; Hepatitis B; Chemotherapy; Cost effectiveness; Cost-effectiveness analysis; Adjuvant; Cancer; Immunology; Virus","score_opus":0.057641937622267644,"score_gpt":0.3721125597162981,"score_spread":0.3144706220940304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1857523518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936186,0.0009459747,0.000030131168,0.0008503864,0.00002629335,0.0020534599,0.0023418446,0.00003744174,0.00009583306],"genre_scores_gemma":[0.99439096,0.0028888993,0.00007870819,0.000052028063,0.000092090486,0.0020857295,0.00010163152,0.00004762999,0.00026232481],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972387,0.00020561504,0.00024319855,0.0006171275,0.00093086297,0.0007644893],"domain_scores_gemma":[0.9982473,0.00006849512,0.00007195482,0.00034307555,0.0007175222,0.00055162207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034825786,0.00032408026,0.00077300856,0.0005298029,0.00018774658,0.000059463047,0.00008350481,0.00006681852,0.0001506806],"category_scores_gemma":[0.0000122483425,0.00022149814,0.00007677202,0.0012798302,0.00027090654,0.00016781123,0.00007622687,0.00022422735,0.000007813517],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007411867,0.0010014423,0.85175425,0.000041865074,0.0020004625,0.00013166656,0.0007817009,0.00004444017,0.0000075869934,0.000008208905,0.000027084734,0.13678944],"study_design_scores_gemma":[0.012294809,0.0031503036,0.9830802,0.00035553443,0.00027812284,0.000011289747,0.000059290946,0.0001537491,0.000112240865,0.0000084672065,0.00030737472,0.00018858102],"about_ca_topic_score_codex":0.6164112,"about_ca_topic_score_gemma":0.42441434,"teacher_disagreement_score":0.19199684,"about_ca_system_score_codex":0.002058561,"about_ca_system_score_gemma":0.0004625247,"threshold_uncertainty_score":0.9032432},"labels":[],"label_agreement":null},{"id":"W1905072147","doi":"10.1007/s10549-015-3596-8","title":"Does the age of breast cancer diagnosis in first-degree relatives impact on the risk of breast cancer in BRCA1 and BRCA2 mutation carriers?","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University Health Network; University of Toronto; Women's College Hospital","funders":"","keywords":"Breast cancer; Medicine; BRCA mutation; Cancer; First-degree relatives; Oncology; Family history; Relative risk; Internal medicine; Germline mutation; Risk factor; Gynecology; Obstetrics; Mutation; Genetics; Biology","score_opus":0.044369779793213236,"score_gpt":0.35989029603212774,"score_spread":0.31552051623891453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1905072147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9809276,0.0062849377,0.000001972699,0.0064917635,0.00006927819,0.0007239406,0.0054086894,0.000003257607,0.00008859441],"genre_scores_gemma":[0.98078233,0.017114788,0.00001096266,0.000026173937,0.0001307096,0.0017882538,0.000028660666,0.000024719544,0.00009339548],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99817544,0.00034987737,0.00028115627,0.0004446686,0.0003664607,0.00038238632],"domain_scores_gemma":[0.99885565,0.00020434016,0.00014451533,0.00038556955,0.00028272354,0.00012718486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005345149,0.00023540751,0.00027220428,0.00014619155,0.00013853441,0.000035606627,0.00018494907,0.00011355579,0.00010535173],"category_scores_gemma":[0.000040981482,0.0001103879,0.000072682626,0.00039969446,0.00062310335,0.00001935464,0.00010854606,0.00020332923,5.7658775e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020364877,0.0002989709,0.9168116,0.000038652746,0.00054245675,0.000014012425,0.003384698,0.0018138874,0.0012743096,0.000032885062,0.00053376064,0.07321829],"study_design_scores_gemma":[0.0021803633,0.0003895603,0.98955727,0.0001941907,0.000049980285,0.000031381875,0.0014895477,0.00011529163,0.00532227,0.00027395322,0.00026027448,0.00013594652],"about_ca_topic_score_codex":0.08598059,"about_ca_topic_score_gemma":0.0844599,"teacher_disagreement_score":0.07308234,"about_ca_system_score_codex":0.00080342276,"about_ca_system_score_gemma":0.00077038945,"threshold_uncertainty_score":0.9322463},"labels":[],"label_agreement":null},{"id":"W1945994099","doi":"10.1007/s10549-015-3622-x","title":"Digital versus screen-film mammography: impact of mammographic density and hormone therapy on breast cancer detection","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Digital Radiography and Breast Imaging","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; University of Toronto; University Health Network; Cancer Care Ontario; Women's College Hospital; Public Health Ontario","funders":"Canadian Institutes of Health Research; Canadian Breast Cancer Research Alliance; Breast Cancer Alliance; Association Canadienne des Radiologistes; Cancer Research Institute","keywords":"Mammography; Medicine; Breast cancer; Digital mammography; Gynecology; Hormone therapy; Confidence interval; Breast cancer screening; Logistic regression; Cancer; Obstetrics; Oncology; Internal medicine","score_opus":0.062020918554932705,"score_gpt":0.36262297298133245,"score_spread":0.30060205442639976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1945994099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912841,0.0052244137,0.0000045502466,0.0006285015,0.000060389393,0.00060094777,0.001114857,0.000047286892,0.0010349872],"genre_scores_gemma":[0.9944168,0.0051162406,0.000009998074,0.000014408983,0.00016419223,0.00012203485,0.000036985533,0.00003160143,0.00008777408],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99804586,0.00005130909,0.00019967584,0.00048156196,0.0006524028,0.0005691607],"domain_scores_gemma":[0.9983809,0.00006928624,0.000067709916,0.00029478167,0.0004238882,0.00076344266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018529895,0.0003088863,0.00040864345,0.00069385866,0.00014619142,0.00014160754,0.00006807813,0.00008050412,0.000019924257],"category_scores_gemma":[0.000007841438,0.00020824294,0.00023093926,0.00091416866,0.00056083157,0.00033540986,0.000044268403,0.0002057018,0.0000024607666],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028544301,0.00082305755,0.38095638,0.000015334963,0.0010428007,0.000059289763,0.000092667724,0.000003179938,0.0006550152,0.00002011057,0.000110434536,0.5876774],"study_design_scores_gemma":[0.011173249,0.0074396892,0.9789532,0.00014829033,0.00008037077,0.0006768365,0.00015639648,0.000045723245,0.0008855059,0.00011781153,0.00013479931,0.00018813617],"about_ca_topic_score_codex":0.012034151,"about_ca_topic_score_gemma":0.00047981789,"teacher_disagreement_score":0.59799683,"about_ca_system_score_codex":0.0003337398,"about_ca_system_score_gemma":0.00029367348,"threshold_uncertainty_score":0.9945448},"labels":[],"label_agreement":null},{"id":"W1964124861","doi":"10.1007/s10549-005-9076-9","title":"Nitric oxide attenuates resistance to doxorubicin in three-dimensional aggregates of human breast carcinoma cells","year":2005,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Nitric Oxide and Endothelin Effects","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Canadian Institutes of Health Research","keywords":"Doxorubicin; Nitric oxide; Human breast; Breast cancer; Breast carcinoma; Cancer research; Medicine; Internal medicine; Carcinoma; Oncology; Chemistry; Cancer; Chemotherapy","score_opus":0.03540775068055349,"score_gpt":0.3362510553822657,"score_spread":0.30084330470171217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964124861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908895,0.0045680664,0.0000011177975,0.003148654,0.000014676511,0.0008592003,0.00020319382,0.000019604764,0.0002959814],"genre_scores_gemma":[0.99772817,0.00017353112,0.00028125025,0.0000762075,0.00018973101,0.00024176048,0.000015933088,0.00003047498,0.00126293],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979635,0.000073560994,0.00031153907,0.00046297442,0.0005559619,0.0006324561],"domain_scores_gemma":[0.99878114,0.00020385609,0.000055408247,0.00033369486,0.00023854217,0.00038733694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003212336,0.00023038677,0.00045912067,0.0005187226,0.00012246257,0.000018977331,0.00009554406,0.00007193907,0.000100178746],"category_scores_gemma":[0.000012197287,0.0001701555,0.00007169585,0.0006590628,0.00015820119,0.000069775415,0.000072171504,0.0001870124,0.00004880636],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006013301,0.0044571804,0.7282519,0.00029976055,0.0003219343,0.0006308608,0.00024959337,0.000050621344,0.18602514,0.000184372,0.0012321688,0.07228322],"study_design_scores_gemma":[0.01039559,0.00073994894,0.88566613,0.0007098842,0.00006169202,0.00020218303,0.00006148516,0.00007914119,0.10125837,0.00024918732,0.00037683334,0.00019954784],"about_ca_topic_score_codex":0.013695502,"about_ca_topic_score_gemma":0.018656861,"teacher_disagreement_score":0.15741429,"about_ca_system_score_codex":0.0005936121,"about_ca_system_score_gemma":0.00023639375,"threshold_uncertainty_score":0.9992501},"labels":[],"label_agreement":null},{"id":"W1964246208","doi":"10.1007/s10549-006-9315-8","title":"Expression of protein elongation factor eEF1A2 predicts favorable outcome in breast cancer","year":2006,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"RNA and protein synthesis mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":71,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia; BC Cancer Agency; University of Ottawa","funders":"National Cancer Institute; Canadian Breast Cancer Research Alliance; Canada Research Chairs; Breast Cancer Alliance","keywords":"Breast cancer; Carcinogenesis; Malignancy; Oncology; Lymph node; Mammary gland; Internal medicine; Cancer research; Biology; Messenger RNA; Cancer; Medicine; Gene; Genetics","score_opus":0.033912338862238045,"score_gpt":0.32761106539204504,"score_spread":0.293698726529807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964246208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99583566,0.0018685041,0.00004029329,0.00060162734,0.000029298944,0.00075509615,0.00067773234,0.0000071941954,0.00018457226],"genre_scores_gemma":[0.99686956,0.00069985626,0.00011521644,0.0000073701176,0.00015708857,0.0009003922,0.000048083082,0.000019530056,0.0011828908],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986368,0.00012197248,0.00022854228,0.00036584926,0.00028896326,0.00035789766],"domain_scores_gemma":[0.99946344,0.000012340556,0.00007010088,0.00022707376,0.00013128726,0.00009575779],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016722226,0.00015835853,0.0001901392,0.00009920792,0.00009123008,0.000025730957,0.0000986362,0.000118077216,0.00012451765],"category_scores_gemma":[0.000005845487,0.000118549535,0.00004401045,0.00012905002,0.00008196067,0.000011485517,0.00006007333,0.00006773622,0.0000022692002],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065165194,0.00029288718,0.12640297,0.000048121834,0.00002350892,0.000005556652,0.00002693846,0.000023113496,0.84773797,0.000053510375,0.00005667455,0.024677087],"study_design_scores_gemma":[0.0011768542,0.0002654317,0.21588646,0.00015129367,0.0000052173727,0.000010408452,0.00003160793,0.00001019836,0.7816331,0.0002207495,0.000495891,0.000112836206],"about_ca_topic_score_codex":0.010086412,"about_ca_topic_score_gemma":0.0012509475,"teacher_disagreement_score":0.08948349,"about_ca_system_score_codex":0.0001315567,"about_ca_system_score_gemma":0.0001815675,"threshold_uncertainty_score":0.9965055},"labels":[],"label_agreement":null},{"id":"W1964291161","doi":"10.1007/s10549-013-2561-7","title":"Evolution of sites of recurrence after early breast cancer over the last 20 years: implications for patient care and future research","year":2013,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":97,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Ottawa; Princess Margaret Cancer Centre; Ottawa Hospital; McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Lumpectomy; Breast cancer; Mastectomy; Radiation therapy; Chemotherapy; Clinical trial; Randomized controlled trial; Cancer; Regimen; Internal medicine; Oncology; Surgery","score_opus":0.0528082912743622,"score_gpt":0.3990265585996078,"score_spread":0.3462182673252456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964291161","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.041433595,0.9398069,8.198243e-7,0.00031983922,0.00006203534,0.0023287358,0.016012,0.0000040972573,0.00003197772],"genre_scores_gemma":[0.08172665,0.90726495,0.000037316375,0.0000035287374,0.00054831064,0.010083939,0.0002488762,0.000038507038,0.000047904432],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99773806,0.00026241606,0.0003576514,0.0007078191,0.00038679986,0.00054727757],"domain_scores_gemma":[0.9977395,0.000140699,0.00018117961,0.0005864507,0.0012030794,0.00014909836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018939505,0.0003547162,0.000648866,0.00018903142,0.00024978793,0.000046607594,0.000219596,0.00024264213,0.00003140351],"category_scores_gemma":[0.000010195669,0.00022043967,0.00020061914,0.00037936243,0.0007146865,0.000013567642,0.0003162132,0.00021690952,0.000001701657],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032080794,0.00020624233,0.014134445,0.0017980424,0.00078526174,8.278619e-7,0.00044088153,2.1316139e-7,0.000045408822,0.00008978483,0.00084265764,0.9813354],"study_design_scores_gemma":[0.0014855624,0.001979213,0.40924582,0.0033678834,0.0006577913,0.000075436976,0.00084890967,4.5239494e-7,0.00009475267,0.00010903322,0.58171314,0.00042200836],"about_ca_topic_score_codex":0.005172906,"about_ca_topic_score_gemma":0.0026938792,"teacher_disagreement_score":0.9809134,"about_ca_system_score_codex":0.0005340348,"about_ca_system_score_gemma":0.0008579209,"threshold_uncertainty_score":0.8989269},"labels":[],"label_agreement":null},{"id":"W1964349843","doi":"10.1007/s10549-011-1941-0","title":"Long-term follow-up of Jewish women with a BRCA1 and BRCA2 mutation who underwent population genetic screening","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":83,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Oophorectomy; Prophylactic Mastectomy; Prophylactic Surgery; Breast cancer; Population; Genetic testing; BRCA mutation; Ovarian cancer; Gynecology; Distress; Mastectomy; Psychosocial; Obstetrics; Cancer; Oncology; Internal medicine; Hysterectomy; Surgery; Psychiatry","score_opus":0.034217249389368445,"score_gpt":0.33473027357828633,"score_spread":0.3005130241889179,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964349843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99281645,0.0060345223,0.00044471628,0.00016234606,0.000035905752,0.00037952984,0.00007851343,0.000005591176,0.000042445783],"genre_scores_gemma":[0.9976044,0.0010508224,0.0004413545,0.000015821493,0.00015896559,0.00034924186,0.00008079413,0.000022994587,0.0002755873],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99887556,0.00007065735,0.00013902139,0.00028972336,0.0002412727,0.0003837534],"domain_scores_gemma":[0.99940395,0.000015971887,0.000060572387,0.0001963341,0.00014359108,0.00017955447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014810792,0.00013542522,0.00014110268,0.00008727386,0.000132366,0.000035336998,0.000051941694,0.00006502441,0.000030286297],"category_scores_gemma":[0.000005764925,0.00010925781,0.000019599778,0.00013180141,0.0001376797,0.000015421103,0.00005812379,0.000049573246,6.991413e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008992135,0.00013857475,0.6925594,0.000051950356,0.0003326308,0.0000040980644,0.00066834333,0.00006664347,0.005234194,0.000021939228,0.00003586957,0.29998714],"study_design_scores_gemma":[0.0021844017,0.00082957983,0.9888203,0.000055436747,0.000032674645,0.00010282958,0.0002025132,0.000022975653,0.007460136,0.00004596678,0.0001226963,0.000120459794],"about_ca_topic_score_codex":0.0006992899,"about_ca_topic_score_gemma":0.00081930123,"teacher_disagreement_score":0.29986668,"about_ca_system_score_codex":0.0002913688,"about_ca_system_score_gemma":0.0001332744,"threshold_uncertainty_score":0.4455404},"labels":[],"label_agreement":null},{"id":"W1964407943","doi":"10.1007/s10549-012-2369-x","title":"A randomized phase II study of lapatinib + pazopanib versus lapatinib in patients with HER2+ inflammatory breast cancer","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"National Center for Research Resources; GlaxoSmithKline","keywords":"Lapatinib; Pazopanib; Medicine; Clinical endpoint; Internal medicine; Cohort; Adverse effect; Breast cancer; Oncology; Cancer; Pharmacology; Randomized controlled trial; Trastuzumab; Sunitinib","score_opus":0.07212824753998884,"score_gpt":0.4215965446262711,"score_spread":0.34946829708628224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964407943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910557,0.0012479842,3.9042726e-7,0.0006971372,0.00013318862,0.0057515483,0.0006614042,0.000033202883,0.00041942566],"genre_scores_gemma":[0.99345374,0.0008223451,0.000024191457,0.000018369581,0.0002839321,0.0049802074,0.000049418784,0.000073419935,0.0002943899],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9950516,0.000680329,0.0006250026,0.00060465635,0.001788938,0.0012494635],"domain_scores_gemma":[0.9972669,0.00040477386,0.0001632711,0.0006030006,0.00078540196,0.0007766821],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013116446,0.00040588478,0.0011510033,0.0005222717,0.00023868245,0.000035476318,0.00017307514,0.000113578244,0.0009247999],"category_scores_gemma":[0.00006626198,0.00026691146,0.00009671812,0.00078963436,0.0005466706,0.00023242421,0.00018707874,0.00047569355,0.0000109695875],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.36702946,0.0141592175,0.54697275,0.00013435358,0.00075718446,0.000037677997,0.0031995568,0.0000038522217,0.000028208393,0.000021064614,0.00010616671,0.06755051],"study_design_scores_gemma":[0.5046924,0.009641299,0.48342982,0.00042944448,0.00017118976,0.000013526861,0.0009822639,0.000023618835,0.00015784896,0.0000039719507,0.00025728898,0.00019733871],"about_ca_topic_score_codex":0.023163283,"about_ca_topic_score_gemma":0.006663854,"teacher_disagreement_score":0.13766292,"about_ca_system_score_codex":0.0014437253,"about_ca_system_score_gemma":0.0010979082,"threshold_uncertainty_score":0.9999885},"labels":[],"label_agreement":null},{"id":"W1964423199","doi":"10.1007/s10549-010-0763-9","title":"Metformin and rapamycin have distinct effects on the AKT pathway and proliferation in breast cancer cells","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":212,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"Canadian Breast Cancer Research Alliance","keywords":"AMPK; PI3K/AKT/mTOR pathway; Metformin; Protein kinase B; Phosphorylation; RPTOR; Cell growth; Signal transduction; Cancer research; mTORC1; Protein kinase A; Chemistry; Cell biology; Endocrinology; Biology; Biochemistry; Insulin","score_opus":0.020428991629397448,"score_gpt":0.31669560324967083,"score_spread":0.2962666116202734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964423199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99451226,0.0020139688,0.0000034715674,0.0021232634,0.00008992953,0.0007509101,0.0003626139,0.0000062000704,0.00013739777],"genre_scores_gemma":[0.9966885,0.0014640046,0.000023455234,0.00009237993,0.00037227356,0.0010217899,0.000023432669,0.000023471848,0.00029070905],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99863106,0.0001284377,0.00013214268,0.00048622492,0.00022899141,0.00039316097],"domain_scores_gemma":[0.99933684,0.00010024327,0.000040748237,0.000257914,0.00009489742,0.00016934663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034801278,0.00020903817,0.00016959712,0.00006973582,0.00020568391,0.000090873764,0.000087797736,0.0001175855,0.000038872786],"category_scores_gemma":[0.000015727286,0.00013059285,0.00002776786,0.00008861848,0.0002335784,0.000009799555,0.00008368898,0.00021726386,0.0000016939973],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014553872,0.0002499571,0.097860806,0.0000842194,0.0001376848,0.00003126506,0.00025884958,0.0000064686815,0.67926836,0.00016565065,0.00040874016,0.22007263],"study_design_scores_gemma":[0.0028117725,0.0010109042,0.16384634,0.00012973491,0.000027375552,0.00012285713,0.000074846226,0.00013368973,0.8280462,0.00019547481,0.003327275,0.00027351192],"about_ca_topic_score_codex":0.002487734,"about_ca_topic_score_gemma":0.0065739467,"teacher_disagreement_score":0.21979912,"about_ca_system_score_codex":0.00010390421,"about_ca_system_score_gemma":0.00022381262,"threshold_uncertainty_score":0.53254217},"labels":[],"label_agreement":null},{"id":"W1964988865","doi":"10.1007/s10549-012-2215-1","title":"Improving size, lymph node metastatic rate, breast conservation, and mortality of invasive breast cancer in Rhode Island women, a well-screened population","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"National Center for Chronic Disease Prevention and Health Promotion","keywords":"Medicine; Breast cancer; Mammography; Cancer; Mortality rate; Population; Internal medicine; Cancer registry; Demography; Oncology; Gynecology; Environmental health","score_opus":0.09048571225189866,"score_gpt":0.39106305328487073,"score_spread":0.30057734103297207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964988865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99339557,0.0024559442,0.00001630425,0.0018766376,0.00004380585,0.0007909409,0.0012837194,0.000017075381,0.00012002008],"genre_scores_gemma":[0.99691856,0.0017766925,0.00014383142,0.00018872535,0.00015099622,0.0005772129,0.00005312742,0.0000252174,0.00016562386],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99753267,0.00021868348,0.00044121625,0.00043832322,0.0005573164,0.0008117724],"domain_scores_gemma":[0.998433,0.0002411808,0.00016137524,0.00027586363,0.00040882317,0.0004797807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083534565,0.00027157692,0.0005671304,0.00021117377,0.00016636188,0.000049883318,0.00007179961,0.000078352874,0.00034597432],"category_scores_gemma":[0.00005740457,0.00021189154,0.000050406266,0.0005301238,0.00022904304,0.0004381669,0.000081194274,0.00015278348,0.0000024029193],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025176648,0.00033814088,0.9733414,0.0002900768,0.0002948901,0.0000345486,0.00065583206,0.00001986734,0.0016707286,0.0000826173,0.000049569466,0.020704675],"study_design_scores_gemma":[0.0047491235,0.0001968385,0.9919459,0.0005063955,0.00012623162,0.0004353935,0.0010823519,0.00023868571,0.00037693902,0.00015384777,0.00001622379,0.00017205323],"about_ca_topic_score_codex":0.22330357,"about_ca_topic_score_gemma":0.0273555,"teacher_disagreement_score":0.19594808,"about_ca_system_score_codex":0.001294195,"about_ca_system_score_gemma":0.00064958446,"threshold_uncertainty_score":0.99039274},"labels":[],"label_agreement":null},{"id":"W1965727743","doi":"10.1007/s10549-004-8693-z","title":"The potential role of breast conservation surgery and adjuvant breast radiation for adenoid cystic carcinoma of the breast","year":2004,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Salivary Gland Tumors Diagnosis and Treatment","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; McMaster University; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Lumpectomy; Breast cancer; Adenoid cystic carcinoma; Radiation therapy; Mastectomy; Surgery; Male breast cancer; Breast carcinoma; Lymph node; Breast surgery; Cancer; Carcinoma; Internal medicine","score_opus":0.025312484445296175,"score_gpt":0.3033161825256824,"score_spread":0.2780036980803862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965727743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97970325,0.007256715,0.0000063970074,0.009840077,0.000078959834,0.0013317442,0.0017451434,0.0000102794465,0.000027407326],"genre_scores_gemma":[0.99686414,0.0022215475,0.000021430436,0.00002711332,0.00017853477,0.0005173252,0.00008597207,0.000024021641,0.00005991567],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983075,0.000109386754,0.00035785732,0.00033023534,0.00048295368,0.00041204545],"domain_scores_gemma":[0.9985006,0.00039979725,0.00015428742,0.00033378458,0.00041192456,0.00019962498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033662174,0.00021184422,0.0004060726,0.00011948076,0.00039329194,0.000040210496,0.0000773096,0.000065897184,0.000018367522],"category_scores_gemma":[0.000020264222,0.00011137697,0.00015533579,0.00024939227,0.0003991869,0.00008021958,0.000053903077,0.000093470095,0.0000010796807],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003335177,0.0011018785,0.89596474,0.000113734684,0.0004214819,0.000021631386,0.00020597284,0.0000126235755,0.00062879093,0.000979998,0.00011032223,0.097103655],"study_design_scores_gemma":[0.004877914,0.000521672,0.98722225,0.00028438342,0.0002563286,0.0031865374,0.0003205458,0.00008620241,0.0022256488,0.0008611702,0.000066837616,0.000090530244],"about_ca_topic_score_codex":0.011668506,"about_ca_topic_score_gemma":0.0007288722,"teacher_disagreement_score":0.09701313,"about_ca_system_score_codex":0.00034098967,"about_ca_system_score_gemma":0.000650029,"threshold_uncertainty_score":0.99491286},"labels":[],"label_agreement":null},{"id":"W1965788714","doi":"10.1007/s10549-004-3779-1","title":"Complementary and alternative medicine use is associated with an increased perception of breast cancer risk and death","year":2005,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Complementary and Alternative Medicine Studies","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Cancer Care Ontario; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; Hospital Anxiety and Depression Scale; Anxiety; Psychosocial; Depression (economics); Cancer; Internal medicine; Distress; Ambulatory; Oncology; Psychiatry; Clinical psychology","score_opus":0.11682865259918873,"score_gpt":0.4211137130642144,"score_spread":0.3042850604650257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965788714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902723,0.0014581216,0.0000061427263,0.0046616714,0.000016656559,0.00072824955,0.0027727492,0.000015264866,0.000068864545],"genre_scores_gemma":[0.9857613,0.013121403,0.00011346916,0.00017029946,0.00037618884,0.00014409995,0.0001436589,0.000018827195,0.0001507482],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998233,0.0001745855,0.00023937096,0.00045362883,0.00053812406,0.00036129585],"domain_scores_gemma":[0.9987864,0.00022151234,0.000108023225,0.00016238511,0.00036734962,0.00035432004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028327308,0.00024751297,0.00048714355,0.00020349123,0.00029296026,0.000017765711,0.000046003213,0.000016553537,0.0008067176],"category_scores_gemma":[0.000015286872,0.00015019508,0.000022482036,0.00016468098,0.0005847444,0.00020476907,0.00007720119,0.00016371187,4.5726404e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028503982,0.0005147458,0.86778927,0.000034671255,0.0010980788,0.0000359086,0.0024375971,8.943844e-7,0.00048518938,0.0000419073,0.00014239222,0.124568954],"study_design_scores_gemma":[0.011425997,0.0049975724,0.97858876,0.0006389465,0.00041542848,0.00016527686,0.0026818363,0.0003268945,0.00015713532,0.000059087917,0.00041696607,0.00012608866],"about_ca_topic_score_codex":0.1298003,"about_ca_topic_score_gemma":0.013474015,"teacher_disagreement_score":0.12444287,"about_ca_system_score_codex":0.00042187588,"about_ca_system_score_gemma":0.00009147175,"threshold_uncertainty_score":0.8832992},"labels":[],"label_agreement":null},{"id":"W1965830162","doi":"10.1007/s10549-012-2170-x","title":"Metformin and breast cancer risk: a meta-analysis and critical literature review","year":2012,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":217,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Metformin; Breast cancer; Meta-analysis; Cochrane Library; Internal medicine; Observational study; Cohort study; Cohort; Odds ratio; Oncology; Hazard ratio; Cancer; Confidence interval; Insulin","score_opus":0.11443133663161735,"score_gpt":0.4424164480234159,"score_spread":0.32798511139179853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965830162","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006935853,0.9872053,0.0000028404354,0.0002298795,0.000058477468,0.0010041606,0.01137771,0.0000080138325,0.000044253753],"genre_scores_gemma":[0.0001293653,0.9946733,0.000060859427,0.00011255676,0.00065092574,0.003307973,0.00042691838,0.000060508584,0.00057758426],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963857,0.00069824164,0.0004825292,0.0011311765,0.0004421111,0.0008602238],"domain_scores_gemma":[0.9979736,0.0001142435,0.0001761666,0.00066644675,0.000364883,0.00070461724],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00082802365,0.0007121228,0.0028768152,0.00027672006,0.00027557174,0.00018871791,0.00018709691,0.00037703058,0.0005520694],"category_scores_gemma":[0.000030803098,0.00042674053,0.00096102944,0.0006946118,0.000411059,0.000022345608,0.0002536316,0.00040834842,0.0000045739084],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046998426,0.00012233647,0.00012377955,0.009340652,0.047379885,0.000013621294,0.00002139979,2.5242826e-8,0.0000010638472,0.000037431564,0.0004766325,0.94243616],"study_design_scores_gemma":[0.00029067163,0.00011310531,0.00019026591,0.0019243185,0.16987133,0.00028214476,0.0000057514935,4.054485e-7,0.000009370894,0.000019567191,0.82692605,0.0003670182],"about_ca_topic_score_codex":0.0013062124,"about_ca_topic_score_gemma":0.0009402759,"teacher_disagreement_score":0.9420692,"about_ca_system_score_codex":0.00012009607,"about_ca_system_score_gemma":0.00040931857,"threshold_uncertainty_score":0.99981844},"labels":[],"label_agreement":null},{"id":"W1965959593","doi":"10.1007/s10549-015-3355-x","title":"Prognostic associations of 25 hydroxy vitamin D in NCIC CTG MA.21, a phase III adjuvant randomized clinical trial of three chemotherapy regimens in high-risk breast cancer","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Sunnybrook Health Science Centre; University of Ottawa; Ontario Clinical Oncology Group; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; Saint John Regional Hospital; London Health Sciences Centre; McMaster University; Queen's University; University of Toronto","funders":"National Cancer Institute; Canadian Cancer Society Research Institute","keywords":"Medicine; Breast cancer; Internal medicine; Oncology; Vitamin D and neurology; Population; Proportional hazards model; Gastroenterology; Cancer","score_opus":0.10448639879685911,"score_gpt":0.44953964984056544,"score_spread":0.3450532510437063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965959593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98433936,0.0030776758,0.000008669292,0.0055786623,0.000101385944,0.0055416464,0.0012138502,0.000016655844,0.00012209303],"genre_scores_gemma":[0.983271,0.012874701,0.00009640451,0.000015450189,0.00026894483,0.0030325986,0.000047439342,0.00003466359,0.0003587998],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9950052,0.0011730646,0.0011457207,0.00059040403,0.0012916252,0.0007939852],"domain_scores_gemma":[0.99619764,0.0017692811,0.00035054368,0.00043747338,0.00078551593,0.00045957387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004887626,0.00030149502,0.0019701244,0.000584763,0.00008510568,0.000017309474,0.0001471149,0.00016963354,0.00008020799],"category_scores_gemma":[0.0010404247,0.00020301211,0.00023074084,0.0008615067,0.0009711405,0.000094734365,0.00012157008,0.0005031759,0.000003228069],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.46304354,0.008649938,0.4502809,0.00008675454,0.0013936542,0.000113006434,0.0009690433,0.000008093774,0.000080968704,0.000057236408,0.0003682559,0.07494859],"study_design_scores_gemma":[0.5563766,0.002816387,0.43922058,0.00042218925,0.00017135957,0.000013525099,0.000234493,0.00030941708,0.00011277301,0.00019937492,0.000023060622,0.00010027029],"about_ca_topic_score_codex":0.059170563,"about_ca_topic_score_gemma":0.020733153,"teacher_disagreement_score":0.093333036,"about_ca_system_score_codex":0.0014175293,"about_ca_system_score_gemma":0.0020372234,"threshold_uncertainty_score":0.99713594},"labels":[],"label_agreement":null},{"id":"W1966037324","doi":"10.1007/s10549-015-3307-5","title":"Evidence for biological effects of metformin in operable breast cancer: biomarker analysis in a pre-operative window of opportunity randomized trial","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":93,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Mount Sinai Hospital; University Health Network; Ontario Institute for Cancer Research","funders":"Breast Cancer Research Trust; National Institute for Health and Care Research","keywords":"Metformin; Medicine; Breast cancer; Biomarker; Insulin; Internal medicine; Oncology; Cancer; Endocrinology; Biology","score_opus":0.14630624488955238,"score_gpt":0.4327590834056447,"score_spread":0.28645283851609227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966037324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85986376,0.13733514,0.00003103845,0.00007995294,0.000051111674,0.002194334,0.00042503682,0.0000018978919,0.000017763605],"genre_scores_gemma":[0.89013016,0.10620548,0.000072145616,0.000015595799,0.00007823364,0.0033524523,0.000052162683,0.000009031184,0.00008472],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9978069,0.0006880805,0.0004144498,0.00044204545,0.0002544596,0.00039405306],"domain_scores_gemma":[0.99872065,0.00030750583,0.00011515728,0.00025255245,0.00037377363,0.00023037555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016566949,0.00019157626,0.00090264366,0.0002678397,0.00003736744,0.000016882821,0.00014515428,0.00013007617,0.000045612953],"category_scores_gemma":[0.00031335998,0.00012479005,0.0001889625,0.00053094997,0.00033830578,0.000017520102,0.0000794315,0.00007388417,1.577511e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.74313,0.0010932818,0.032333918,0.00012091637,0.0016912165,0.000007516731,0.00044271373,0.000106772066,0.010402521,0.00003655771,0.00007785365,0.21055669],"study_design_scores_gemma":[0.82955164,0.0035061557,0.07004842,0.0004554186,0.00061253353,0.000008612538,0.0002819765,0.0006549054,0.09356368,0.0002133869,0.00070927443,0.00039397622],"about_ca_topic_score_codex":0.017367397,"about_ca_topic_score_gemma":0.0053240256,"teacher_disagreement_score":0.2101627,"about_ca_system_score_codex":0.00016853929,"about_ca_system_score_gemma":0.00096947065,"threshold_uncertainty_score":0.98917603},"labels":[],"label_agreement":null},{"id":"W1966205301","doi":"10.1007/s10549-010-1025-6","title":"Amplification of the prolactin receptor gene in mammary lobular neoplasia","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Lesions and Carcinomas","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; McMaster University; Ontario Institute for Cancer Research","funders":"","keywords":"Lobular carcinoma; Breast cancer; Ductal carcinoma; Immunohistochemistry; Biology; Comparative genomic hybridization; Pathology; Gene duplication; Mammary gland; Invasive lobular carcinoma; Prolactin receptor; Progesterone receptor; Cancer; Prolactin; Cancer research; Estrogen receptor; Gene; Medicine; Endocrinology; Hormone; Genetics; Invasive ductal carcinoma; Genome","score_opus":0.038361203222155624,"score_gpt":0.33377232164607096,"score_spread":0.2954111184239153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966205301","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988994,0.00043351567,0.0000036440306,0.009533471,0.00005432342,0.0006106846,0.000048107417,0.000007433378,0.00031480598],"genre_scores_gemma":[0.9983904,0.00032312117,0.00022215724,0.00002464857,0.0000907084,0.0002474795,0.000010714548,0.000009903537,0.0006808956],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991067,0.00005438241,0.00013104848,0.00021356044,0.00026582857,0.00022845343],"domain_scores_gemma":[0.99930364,0.000030710195,0.00003191591,0.0003718571,0.00013521721,0.00012666162],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019876297,0.000085773405,0.00014263592,0.00009806315,0.0000785143,0.00001424667,0.00007696653,0.000061855186,0.00012442478],"category_scores_gemma":[0.000011172246,0.000049478356,0.000038786064,0.0002845877,0.0001316357,0.00004074078,0.000047155583,0.0002189925,0.0000065536424],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017603696,0.0011898088,0.49550617,0.00006717681,0.00008177623,0.000025389145,0.00033799486,6.1784783e-7,0.2569,0.0015990413,0.00029192233,0.24223971],"study_design_scores_gemma":[0.0014001991,0.00018701704,0.97416943,0.000052293366,0.000012599018,0.00019020306,0.00005918884,0.000022124921,0.021883894,0.0001068113,0.0018755235,0.00004071575],"about_ca_topic_score_codex":0.0019897555,"about_ca_topic_score_gemma":0.0007280757,"teacher_disagreement_score":0.47866327,"about_ca_system_score_codex":0.00014079893,"about_ca_system_score_gemma":0.00038757303,"threshold_uncertainty_score":0.30079284},"labels":[],"label_agreement":null},{"id":"W1966365049","doi":"10.1023/b:brea.0000036897.92513.72","title":"Enumeration of Circulating Tumor Cells in the Blood of Breast Cancer Patients After Filtration Enrichment: Correlation with Disease Stage","year":2004,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"University of Toronto","keywords":"Circulating tumor cell; Breast cancer; Medicine; Population; Immunostaining; Incidence (geometry); Pathology; Internal medicine; Cancer; Blood sampling; Cytokeratin; Oncology; Immunohistochemistry; Metastasis","score_opus":0.02083046803186057,"score_gpt":0.30442768584026025,"score_spread":0.2835972178083997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966365049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962338,0.00076655974,0.000024043571,0.0006434943,0.000024817988,0.0010117955,0.0012250281,0.000003929864,0.000066500426],"genre_scores_gemma":[0.99867254,0.00052564207,0.000046884135,0.0000292031,0.00005385387,0.0005202556,0.00007842182,0.000012059232,0.00006116234],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987133,0.00006566414,0.00022956822,0.00023192164,0.00053933804,0.00022016926],"domain_scores_gemma":[0.9993278,0.000034673314,0.00010298872,0.00017277616,0.00024566712,0.00011613544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001472655,0.00012391256,0.00019425162,0.00012660347,0.00006263323,0.000018122504,0.00003450486,0.000019061725,0.000119174016],"category_scores_gemma":[0.00000371607,0.00007513959,0.000039985596,0.00031133095,0.000099480785,0.00010555963,0.000012265546,0.00008906802,6.9474845e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059122955,0.0035157616,0.95782083,0.0004096764,0.0002279668,0.000096972086,0.0022804374,0.0015504439,0.0047532376,0.0001264338,0.000009555768,0.023296375],"study_design_scores_gemma":[0.006234623,0.00078602147,0.9859583,0.00045741853,0.00019011108,0.000014681471,0.00022365013,0.000056432946,0.0059361206,0.000025486832,0.000042141488,0.000075020966],"about_ca_topic_score_codex":0.011126524,"about_ca_topic_score_gemma":0.0017067367,"teacher_disagreement_score":0.028137447,"about_ca_system_score_codex":0.00030579153,"about_ca_system_score_gemma":0.00043686552,"threshold_uncertainty_score":0.9954585},"labels":[],"label_agreement":null},{"id":"W1966382361","doi":"10.1023/a:1024417331304","title":"Breast Cancer Diagnosis by Scintimammography: A Meta-analysis and Review of the Literature","year":2003,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Breast Lesions and Carcinomas","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital du Sacré-Cœur de Montréal; McGill University; Montreal General Hospital","funders":"","keywords":"Scintimammography; Medicine; Breast cancer; Mammography; Radiology; Cancer; Meta-analysis; Medical physics; Nuclear medicine; Internal medicine","score_opus":0.11885321628177652,"score_gpt":0.42283689946956643,"score_spread":0.3039836831877899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966382361","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006648118,0.9787323,2.5207552e-7,0.0040422673,0.000032070853,0.0022978003,0.014714943,0.000010386232,0.00010352607],"genre_scores_gemma":[0.00032022537,0.99012,0.000019589495,0.00018587528,0.00008289902,0.00740414,0.00017906209,0.00005409178,0.0016341476],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962496,0.0006726214,0.0006379616,0.00093553704,0.00090231234,0.0006019362],"domain_scores_gemma":[0.997404,0.000179389,0.000296439,0.0010130228,0.0006070643,0.00050011446],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005764562,0.00066748494,0.0042882953,0.0005789733,0.00026265878,0.00008488183,0.00021195346,0.00024353822,0.0017005737],"category_scores_gemma":[0.000009214735,0.00030383168,0.0027677019,0.0038494382,0.00048661671,0.000064641645,0.00014731676,0.0005630849,0.0000024922897],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057620215,0.00053555635,0.0030100492,0.044699695,0.115016215,0.000039050108,0.00003033942,1.5753741e-8,2.5695283e-7,0.000027371625,0.0067861807,0.8297976],"study_design_scores_gemma":[0.00060943526,0.00015749222,0.004673289,0.040572003,0.36185426,0.0014635136,0.000009554892,2.1979874e-7,0.0000025928034,0.000008431631,0.59037554,0.00027368145],"about_ca_topic_score_codex":0.004806432,"about_ca_topic_score_gemma":0.00036396488,"teacher_disagreement_score":0.829524,"about_ca_system_score_codex":0.00039685427,"about_ca_system_score_gemma":0.0009281805,"threshold_uncertainty_score":0.9999414},"labels":[],"label_agreement":null},{"id":"W1966385883","doi":"10.1007/s10549-014-3221-2","title":"Weekly paclitaxel and concurrent pazopanib following doxorubicin and cyclophosphamide as neoadjuvant therapy for HER-negative locally advanced breast cancer: NSABP Foundation FB-6, a phase II study","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Saint-Sacrement; Ottawa Regional Cancer Foundation; Montreal General Hospital; Ottawa Hospital; Centre Hospitalier de l’Université de Montréal","funders":"NSABP Foundation; GlaxoSmithKline","keywords":"Pazopanib; Medicine; Cyclophosphamide; Oncology; Breast cancer; Paclitaxel; Doxorubicin; Internal medicine; Neoadjuvant therapy; Chemotherapy; Cancer","score_opus":0.048088481825683545,"score_gpt":0.43952695847675566,"score_spread":0.3914384766510721,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966385883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9777007,0.00957532,0.00003202394,0.0066421577,0.00024189,0.0051695816,0.00047119992,0.000053214255,0.000113889524],"genre_scores_gemma":[0.9803448,0.013599237,0.00006583873,0.00020453575,0.0003522366,0.004468222,0.000064377506,0.00005487577,0.0008459052],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99727714,0.00019990845,0.0003676276,0.0009186029,0.00046756244,0.0007691809],"domain_scores_gemma":[0.99834037,0.0003825084,0.000118628544,0.0002532693,0.00031764485,0.0005875946],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042332042,0.00046217383,0.0007506667,0.0001869428,0.0007292218,0.00009751117,0.00007710624,0.00008743512,0.00016653116],"category_scores_gemma":[0.000020416917,0.0003377354,0.000109794695,0.00025516318,0.00030589034,0.00020697991,0.00009104652,0.00021221547,0.0000035573987],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018790703,0.0049527823,0.041664477,0.00007475819,0.0014213506,0.00007333678,0.0023334688,0.0000038309668,0.003876387,0.00011650735,0.00017522967,0.9265172],"study_design_scores_gemma":[0.3151426,0.13281912,0.5107216,0.0011877113,0.001649003,0.0006059997,0.005436554,0.0010480412,0.008361682,0.0013806582,0.020408938,0.0012380361],"about_ca_topic_score_codex":0.011816245,"about_ca_topic_score_gemma":0.0030385766,"teacher_disagreement_score":0.92527914,"about_ca_system_score_codex":0.0007837396,"about_ca_system_score_gemma":0.0005274719,"threshold_uncertainty_score":0.9999075},"labels":[],"label_agreement":null},{"id":"W1966738468","doi":"10.1007/s10549-011-1529-8","title":"Insulin-like growth factor receptor (IGF-1R) in breast cancer subtypes","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":138,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia; McGill University; Vancouver Hospital and Health Sciences Centre; Jewish General Hospital; BC Cancer Agency","funders":"Sanofi","keywords":"Breast cancer; Insulin-like growth factor; Internal medicine; Oestrogen receptor; Endocrinology; Receptor; Cancer; Medicine; Mammary gland; Oncology; Growth factor; Cancer research; Biology","score_opus":0.07488335036378008,"score_gpt":0.33336262611638967,"score_spread":0.2584792757526096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966738468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877687,0.0045547946,0.0000014151955,0.0034231166,0.0002511352,0.0010279185,0.00107097,0.000079724996,0.0018222376],"genre_scores_gemma":[0.9785135,0.018768406,0.00008204415,0.00019595426,0.00036707375,0.0007279984,0.000053225423,0.00007091428,0.0012208918],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967431,0.00014841073,0.00044681845,0.0008150413,0.0007083793,0.0011382384],"domain_scores_gemma":[0.99810135,0.000089216905,0.00008254043,0.0004329148,0.0004866441,0.00080731034],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00023709075,0.00044738365,0.00062934496,0.0005704095,0.00021847458,0.000053744952,0.00018482908,0.00021831876,0.0022655262],"category_scores_gemma":[0.000019471585,0.00032443597,0.00012918869,0.00079895265,0.00034918057,0.00028332436,0.0001171279,0.0004942769,0.00014558804],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052399933,0.0017683666,0.9290471,0.00012148106,0.00038611353,0.00019682242,0.002116034,1.2344657e-7,0.0019271424,0.00022231905,0.0018571058,0.057117384],"study_design_scores_gemma":[0.0051703295,0.0010477885,0.9857776,0.00026068883,0.000061015202,0.00015807658,0.00033846,0.00000997721,0.004265008,0.0001630559,0.0024324793,0.00031549387],"about_ca_topic_score_codex":0.050173696,"about_ca_topic_score_gemma":0.0022676045,"teacher_disagreement_score":0.05680189,"about_ca_system_score_codex":0.0012334903,"about_ca_system_score_gemma":0.000887854,"threshold_uncertainty_score":0.9999208},"labels":[],"label_agreement":null},{"id":"W1966774810","doi":"10.1007/s10549-006-9257-1","title":"Quality of Life Analyses in a Clinical Trial of DPPE (tesmilifene) Plus Doxorubicin Versus Doxorubicin in Patients with Advanced or Metastatic Breast Cancer: NCIC CTG Trial MA.19","year":2006,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Nausea and vomiting management","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Ontario Institute for Cancer Research","funders":"","keywords":"Doxorubicin; Medicine; Breast cancer; Oncology; Internal medicine; Clinical trial; Metastatic breast cancer; Quality of life (healthcare); Cancer; Chemotherapy","score_opus":0.2719247156265156,"score_gpt":0.523883179990982,"score_spread":0.2519584643644664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966774810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99336267,0.00075809273,0.000003930973,0.000917328,0.00015039575,0.004081039,0.00055837387,0.000016380713,0.00015182272],"genre_scores_gemma":[0.99752754,0.0010059399,0.0001670972,0.00002959708,0.00022804602,0.00074462703,0.00008072363,0.00003219301,0.00018425463],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99504375,0.000775926,0.0015469574,0.00070518855,0.0012252365,0.0007029228],"domain_scores_gemma":[0.9974195,0.0009093361,0.0004293373,0.0005142207,0.00037454505,0.00035309637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014521204,0.00034043807,0.0015633676,0.0006284748,0.000074459174,0.00002151899,0.0001496167,0.00009524403,0.00014672863],"category_scores_gemma":[0.000226635,0.00021664031,0.000179373,0.0011230139,0.0003884535,0.00011232599,0.000092912225,0.00029361626,0.0000018214605],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.71069956,0.006274586,0.2565923,0.00023478406,0.0005871511,0.00004904398,0.00007120592,0.00014418096,0.000047351332,0.00004532555,0.00005450133,0.025200024],"study_design_scores_gemma":[0.470254,0.010169263,0.5185407,0.00029792605,0.00018597969,0.0000014414289,0.00023507875,0.000035060493,0.000093820054,0.000021612188,0.000035532586,0.00012959664],"about_ca_topic_score_codex":0.10052742,"about_ca_topic_score_gemma":0.041334398,"teacher_disagreement_score":0.26194838,"about_ca_system_score_codex":0.0011084942,"about_ca_system_score_gemma":0.0018349646,"threshold_uncertainty_score":0.97615874},"labels":[],"label_agreement":null},{"id":"W1966799993","doi":"10.1007/s10549-008-9987-3","title":"Predictors of follow-up exercise behavior 6 months after a randomized trial of exercise training during breast cancer chemotherapy","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer survivorship and care","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Athabasca University; Ottawa Hospital; BC Cancer Agency; University of Ottawa; Alberta Cancer Foundation; University of Alberta","funders":"","keywords":"Medicine; Breast cancer; Aerobic exercise; Physical therapy; Randomized controlled trial; Guideline; Internal medicine; Body mass index; Psychosocial; Cancer; Pathology","score_opus":0.03904323051247313,"score_gpt":0.3323640962548608,"score_spread":0.2933208657423877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966799993","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98687315,0.0075580147,0.0000011339029,0.00043440738,0.00031945753,0.003693727,0.0009646099,0.000032807304,0.00012266886],"genre_scores_gemma":[0.9586217,0.031682175,0.00001249022,0.000008030931,0.00030590093,0.0075364565,0.000020116995,0.000055656466,0.0017574652],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99728245,0.000119537995,0.0005518772,0.0005056981,0.00093540445,0.00060506153],"domain_scores_gemma":[0.998471,0.00009313136,0.00014994305,0.0004180059,0.00044274548,0.0004251682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034447855,0.0003314227,0.0013963531,0.0003211262,0.00014173199,0.000015282507,0.00010650981,0.00013744397,0.0006993407],"category_scores_gemma":[0.000009470857,0.00023909273,0.00041914047,0.00039545374,0.00064826134,0.000107991094,0.000047803944,0.00019372109,0.000001348385],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.85165983,0.0011087969,0.07582364,0.00025193754,0.00055857765,0.0001448262,0.009065829,0.0000016726044,0.00043412647,0.0000015462504,0.000047153702,0.060902048],"study_design_scores_gemma":[0.75806504,0.0008048629,0.23238832,0.0016051474,0.00074627093,0.00017029361,0.00091804506,0.0000103780085,0.0050112377,0.000008150845,0.000051680272,0.00022055686],"about_ca_topic_score_codex":0.034293674,"about_ca_topic_score_gemma":0.0025337143,"teacher_disagreement_score":0.15656467,"about_ca_system_score_codex":0.00041735213,"about_ca_system_score_gemma":0.0008299949,"threshold_uncertainty_score":0.97499186},"labels":[],"label_agreement":null},{"id":"W1966927770","doi":"10.1023/b:brea.0000032978.67677.9f","title":"The Addition of Manual Lymph Drainage to Compression Therapy For Breast Cancer Related Lymphedema: a Randomized Controlled Trial","year":2004,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Lymphatic System and Diseases","field":"Medicine","cited_by":284,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Lymphedema; Medicine; Massage; Randomized controlled trial; Breast cancer; Surgery; Physical therapy; Cancer; Internal medicine; Pathology","score_opus":0.03319399409630322,"score_gpt":0.3849892178740019,"score_spread":0.3517952237776987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966927770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9522862,0.0107268235,0.000032452444,0.011925394,0.00028943166,0.02248517,0.0013656814,0.00005966883,0.0008291815],"genre_scores_gemma":[0.97658014,0.0037012303,0.000033825672,0.00007262803,0.00036823022,0.018283488,0.000042558426,0.000025924162,0.000891973],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9976775,0.00034931008,0.00054085185,0.00035177954,0.0006279526,0.0004526026],"domain_scores_gemma":[0.9976468,0.0010592695,0.00016041817,0.00028373132,0.0004895589,0.00036019538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008671368,0.00022913254,0.0010970465,0.00014369193,0.0003975698,0.00005583916,0.000088674075,0.000080629,0.00018494955],"category_scores_gemma":[0.00008131322,0.00010802089,0.00034543866,0.00020856512,0.00024848038,0.000059075355,0.00002935721,0.000015537045,0.0000048170655],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95393634,0.0014894772,0.00018265522,0.00006350234,0.0014749083,0.000015315092,0.00045328724,0.000013252613,0.00025935174,0.0010197079,0.00024663936,0.040845577],"study_design_scores_gemma":[0.98856515,0.0012550307,0.006846073,0.000618637,0.00033194027,0.000081738865,0.00029163287,0.00007479199,0.00039017858,0.0012393771,0.0001998164,0.00010561392],"about_ca_topic_score_codex":0.0031648995,"about_ca_topic_score_gemma":0.00009190689,"teacher_disagreement_score":0.040739965,"about_ca_system_score_codex":0.0008385996,"about_ca_system_score_gemma":0.0012635578,"threshold_uncertainty_score":0.47844025},"labels":[],"label_agreement":null},{"id":"W1966934989","doi":"10.1007/s10549-012-2229-8","title":"GSK3β and cyclin D1 expression predicts outcome in early breast cancer patients","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Cyclin D1; Breast cancer; Cancer research; Cyclin D; GSK-3; Biology; Cyclin B; Protein kinase B; Tissue microarray; Cancer; PI3K/AKT/mTOR pathway; Cyclin; Kinase; Cell cycle; Phosphorylation; Signal transduction; Genetics","score_opus":0.050114836549128884,"score_gpt":0.36570891294081825,"score_spread":0.31559407639168935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966934989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904102,0.005886126,0.0000021897147,0.0013031291,0.0002124512,0.0011527726,0.0006883694,0.00003575117,0.00030901667],"genre_scores_gemma":[0.9951628,0.0030596594,0.00003700163,0.00006226834,0.00029193313,0.0007708323,0.000042290558,0.00004775893,0.0005254939],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975255,0.00011568151,0.00030644276,0.00048340484,0.0006667409,0.0009022395],"domain_scores_gemma":[0.99863684,0.000055969776,0.00006134789,0.00030211709,0.00018143008,0.0007622694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024367645,0.00027057002,0.00039041578,0.0002932749,0.00014755737,0.000041163083,0.00006610452,0.00015407955,0.00018521717],"category_scores_gemma":[0.000017332912,0.0001993266,0.000056389817,0.00031425364,0.00018900736,0.00020406434,0.00012869766,0.00034527766,0.000018567855],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016526625,0.0011405079,0.93285346,0.0000720398,0.00010330211,0.000045423618,0.0007093029,0.0000019198112,0.0018114228,0.000012813183,0.00028476157,0.06131236],"study_design_scores_gemma":[0.007951198,0.00058864546,0.98778445,0.00054031314,0.0000591401,0.00010341861,0.00006484554,0.000019273944,0.0017962111,0.000015806276,0.0009115268,0.000165188],"about_ca_topic_score_codex":0.0117492415,"about_ca_topic_score_gemma":0.0008174999,"teacher_disagreement_score":0.061147172,"about_ca_system_score_codex":0.0011108454,"about_ca_system_score_gemma":0.0002388245,"threshold_uncertainty_score":0.9948316},"labels":[],"label_agreement":null},{"id":"W1967224938","doi":"10.1023/b:brea.0000032983.87966.4e","title":"Health-Related Quality of Life in Axillary Node-Negative, Estrogen Receptor-Negative Breast Cancer Patients Undergoing AC Versus CMF Chemotherapy: Findings from the National Surgical Adjuvant Breast and Bowel Project B-23","year":2004,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":64,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arthritis Research Centre of Canada; University of British Columbia","funders":"National Cancer Institute","keywords":"Medicine; Breast cancer; Internal medicine; Tamoxifen; Oncology; Quality of life (healthcare); Cyclophosphamide; Population; Placebo; Cancer; Chemotherapy; Pathology","score_opus":0.0513906635509203,"score_gpt":0.36493863860264397,"score_spread":0.31354797505172366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967224938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97747844,0.0044068685,7.531823e-7,0.009619014,0.00007590497,0.00092880323,0.007414262,0.000012642724,0.00006332248],"genre_scores_gemma":[0.9882852,0.010463721,0.00008055082,0.00010467267,0.00015074774,0.00050609437,0.0003412099,0.000037438243,0.000030360672],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99712616,0.00034297272,0.00050459907,0.0007739408,0.00064947124,0.00060282444],"domain_scores_gemma":[0.9986131,0.00033324104,0.00021002325,0.00021332502,0.00041680393,0.0002134612],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036151905,0.00037582894,0.00053250504,0.00010437704,0.0003632274,0.00004532949,0.0001629146,0.00014800164,0.0000414909],"category_scores_gemma":[0.000059541548,0.00026478892,0.00010194457,0.0003572687,0.0006016952,0.00003035759,0.00018730042,0.00020208712,0.0000024896633],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019352341,0.0016265409,0.9567572,0.00007168096,0.0021803428,0.0000067166325,0.0022142911,0.000067109744,0.00042276227,0.00013454846,0.00038859362,0.016777879],"study_design_scores_gemma":[0.022667522,0.00059206755,0.97424334,0.000263278,0.00002650216,0.000026102314,0.0006819642,0.0000050402136,0.0009828073,0.00018868447,0.00007594484,0.00024672423],"about_ca_topic_score_codex":0.096729405,"about_ca_topic_score_gemma":0.01739898,"teacher_disagreement_score":0.07933042,"about_ca_system_score_codex":0.0011727092,"about_ca_system_score_gemma":0.0016509062,"threshold_uncertainty_score":0.99998045},"labels":[],"label_agreement":null},{"id":"W1967912275","doi":"10.1007/s10549-007-9503-1","title":"Quantitative exploration of possible reasons for the recent improvement in breast cancer survival","year":2007,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National de Santé Publique du Québec; Université Laval; Centre hospitalier universitaire de Québec; Hôpital du Saint-Sacrement","funders":"","keywords":"Breast cancer; Medicine; Relative survival; Relative risk; Cancer; Internal medicine; Oncology; Gynecology; Cancer registry; Confidence interval","score_opus":0.11461337665519251,"score_gpt":0.41978686506358315,"score_spread":0.30517348840839065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967912275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9580435,0.013757523,0.00071082317,0.021158908,0.00031511585,0.0024969517,0.0032072223,0.000013905515,0.00029602865],"genre_scores_gemma":[0.97078145,0.026711853,0.00015191613,0.000040758212,0.00021938392,0.0017897763,0.00007693463,0.000025744635,0.0002021677],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99841803,0.00006309269,0.00025517587,0.00044110266,0.00029654187,0.00052603823],"domain_scores_gemma":[0.9988928,0.00016184882,0.00008828367,0.00027264954,0.0004779213,0.00010652459],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056840066,0.00020689158,0.00022963532,0.0001039682,0.00023154859,0.000025433861,0.00011917324,0.000069433794,0.000027372507],"category_scores_gemma":[0.000017226845,0.00013517844,0.000065501765,0.00028362416,0.00025935256,0.000017986755,0.0000921446,0.00007332881,9.1608257e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023219163,0.0022555273,0.19696678,0.000118676326,0.001886644,0.000012528685,0.0016646069,0.0001692318,0.04607977,0.002316132,0.0012357591,0.7240752],"study_design_scores_gemma":[0.00823545,0.0024778089,0.91272223,0.00018329227,0.00013308153,0.000024300616,0.0057351124,0.000056485685,0.06329375,0.0005460103,0.006219492,0.00037297883],"about_ca_topic_score_codex":0.011654673,"about_ca_topic_score_gemma":0.028790433,"teacher_disagreement_score":0.7237022,"about_ca_system_score_codex":0.0003919144,"about_ca_system_score_gemma":0.00031762107,"threshold_uncertainty_score":0.9949268},"labels":[],"label_agreement":null},{"id":"W1967929812","doi":"10.1007/s10549-004-0594-7","title":"A population-based study of the impact of delaying radiotherapy after conservative surgery for breast cancer","year":2004,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":68,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Charles-Le Moyne; McGill University Health Centre; Hôpital du Saint-Sacrement; Université Laval; Université de Montréal; Institut National de Santé Publique du Québec","funders":"Canadian Breast Cancer Research Alliance; Breast Cancer Alliance","keywords":"Medicine; Radiation therapy; Breast cancer; Hazard ratio; Confidence interval; Proportional hazards model; Surgery; Population; Mastectomy; Cohort; Survival analysis; Multivariate analysis; Cancer; Oncology; Internal medicine","score_opus":0.044198950670300045,"score_gpt":0.38333009864972706,"score_spread":0.339131147979427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967929812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99285513,0.0025211833,0.000019163863,0.00085842144,0.00003854136,0.0011132027,0.002586863,0.0000041486037,0.0000033355159],"genre_scores_gemma":[0.99750674,0.00043026934,0.000038445487,0.000022539205,0.00010278806,0.0018266558,0.000026950027,0.000025839103,0.000019766172],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99876213,0.00010211736,0.00022829029,0.00034650424,0.00023595014,0.00032503478],"domain_scores_gemma":[0.9990192,0.00009893293,0.000121098485,0.0003035737,0.00037683157,0.00008038094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013332594,0.00021066272,0.00033835732,0.0000838925,0.00016966512,0.000013602018,0.00009006333,0.00005538269,0.000027748307],"category_scores_gemma":[0.000009518268,0.00012528343,0.00019391181,0.00021972449,0.00015861366,0.000007237146,0.000041959338,0.000046077632,9.266823e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053018555,0.0014036242,0.97894484,0.000032790558,0.0013824905,0.0000020658185,0.0003650657,0.0009758111,0.0015478646,0.000004543225,0.00003632091,0.010002745],"study_design_scores_gemma":[0.0044430997,0.0008122651,0.9912371,0.00011020798,0.00006340922,0.000010847331,0.00020807837,0.000011713719,0.0029518635,0.000034923134,0.000008629692,0.000107837805],"about_ca_topic_score_codex":0.06593508,"about_ca_topic_score_gemma":0.008486019,"teacher_disagreement_score":0.05744906,"about_ca_system_score_codex":0.0005324283,"about_ca_system_score_gemma":0.00076845515,"threshold_uncertainty_score":0.94028497},"labels":[],"label_agreement":null},{"id":"W1968061919","doi":"10.1007/s10549-012-2198-y","title":"Local estrogen therapy and risk of breast cancer recurrence among hormone-treated patients: a nested case–control study","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":171,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Jewish General Hospital","keywords":"Medicine; Tamoxifen; Breast cancer; Cohort; Internal medicine; Cohort study; Gynecology; Obstetrics; Estrogen; Cancer; Aromatase inhibitor; Case-control study; Oncology","score_opus":0.01707642250554791,"score_gpt":0.31094180846286945,"score_spread":0.29386538595732153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968061919","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9706561,0.026706712,0.0000060176817,0.000040427618,0.000036193596,0.0012656021,0.0012601818,0.000009975307,0.000018807068],"genre_scores_gemma":[0.98051333,0.01871269,0.0000069160847,0.000005362391,0.00010824818,0.0005499124,0.000033730877,0.000027857812,0.00004191956],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99814355,0.0003987465,0.0002090347,0.0004228411,0.0002527479,0.0005730548],"domain_scores_gemma":[0.9989355,0.00004490736,0.000099389305,0.000277714,0.00026341822,0.00037904934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028145645,0.00026881587,0.00028036177,0.00008904287,0.00023128199,0.000029856925,0.00008215816,0.00014688769,0.00001768834],"category_scores_gemma":[0.0000078578605,0.00018319616,0.00006443916,0.00019628103,0.00035728214,0.000019957686,0.00007167259,0.00016742221,0.0000014708885],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022619537,0.001517345,0.8525675,0.000008371475,0.001178275,0.000043632765,0.00024110096,0.0000074882496,0.001785487,0.0000029191813,0.000045960456,0.14033996],"study_design_scores_gemma":[0.006867302,0.0032178566,0.98479253,0.000030844276,0.00018118396,0.00033479842,0.00032789513,0.00005019769,0.0039569396,0.000002595153,0.000049575807,0.00018828185],"about_ca_topic_score_codex":0.01763618,"about_ca_topic_score_gemma":0.00068447285,"teacher_disagreement_score":0.14015168,"about_ca_system_score_codex":0.00009906648,"about_ca_system_score_gemma":0.00010792849,"threshold_uncertainty_score":0.9889055},"labels":[],"label_agreement":null},{"id":"W1968765579","doi":"10.1007/s10549-011-1894-3","title":"Progression of ductal carcinoma in situ to invasive breast cancer is associated with gene expression programs of EMT and myoepithelia","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia","funders":"","keywords":"Myoepithelial cell; Ductal carcinoma; Breast cancer; Biology; Pathology; Stromal cell; Cancer research; Carcinoma in situ; Stroma; Tumor progression; Cancer; Carcinoma; Medicine; Immunohistochemistry; Genetics","score_opus":0.07384498753671576,"score_gpt":0.34841275109072956,"score_spread":0.2745677635540138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968765579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994489,0.0027777255,0.0000010121527,0.00056010135,0.000020260371,0.0013405277,0.0006209959,0.000008862167,0.00018149002],"genre_scores_gemma":[0.9966428,0.0021397856,0.0003242486,0.000019055926,0.000043290853,0.0006508006,0.000025652456,0.000025910937,0.00012843039],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998306,0.000072789524,0.0002468085,0.00042883249,0.0005133087,0.0004322761],"domain_scores_gemma":[0.9988743,0.000030949715,0.00010715553,0.00022891215,0.0004001106,0.00035856364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018640026,0.00020146328,0.00047721653,0.00022981493,0.000061155595,0.000011327552,0.000060170056,0.00007100461,0.00015098097],"category_scores_gemma":[0.0000073295164,0.00012598363,0.000044814373,0.0004367321,0.000253311,0.000070428716,0.0000866693,0.000117344716,6.818003e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070169307,0.0016839511,0.7509977,0.00021286614,0.0002502154,0.00021156929,0.004114682,3.9168435e-7,0.09622547,0.000005069565,0.00006711054,0.13921401],"study_design_scores_gemma":[0.0038026974,0.0024277589,0.64739096,0.0014080305,0.000082616716,0.00013400665,0.0005148791,0.0000016436404,0.34411207,0.000011628744,0.000017625583,0.00009606617],"about_ca_topic_score_codex":0.02300249,"about_ca_topic_score_gemma":0.0073623136,"teacher_disagreement_score":0.2478866,"about_ca_system_score_codex":0.00034014034,"about_ca_system_score_gemma":0.00054201635,"threshold_uncertainty_score":0.9835034},"labels":[],"label_agreement":null},{"id":"W1968846760","doi":"10.1007/s10549-015-3378-3","title":"CYP19A1 polymorphisms and clinical outcomes in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1–98 trial","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"National Cancer Institute; National Institutes of Health; National Institute of General Medical Sciences; Breast Cancer Research Foundation","keywords":"Letrozole; Breast cancer; Tamoxifen; Medicine; Internal medicine; Oncology; Aromatase; Proportional hazards model; Adverse effect; Cancer; Gynecology","score_opus":0.03524408952665578,"score_gpt":0.35707696325956345,"score_spread":0.3218328737329077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968846760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907337,0.005085298,4.5522248e-7,0.0026826197,0.00007407527,0.0009503384,0.00031901756,0.0000051815405,0.00014934999],"genre_scores_gemma":[0.9918196,0.006783178,0.000011262438,0.0000819933,0.00028790341,0.00070233305,0.000036518908,0.0000214358,0.00025576857],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99799556,0.00042449028,0.0002261854,0.00047978043,0.00031236894,0.00056164],"domain_scores_gemma":[0.9992432,0.000079309626,0.000049235754,0.00022874137,0.0000942059,0.0003053218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006752671,0.00022506887,0.000308729,0.000100268335,0.000093192866,0.0000577693,0.00012417875,0.00017366586,0.000009441471],"category_scores_gemma":[0.000013429668,0.00012293298,0.000031703898,0.00021773108,0.00034963133,0.000009927779,0.00008977266,0.00026844713,0.000003525578],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.24555682,0.0036805365,0.5428479,0.000012397246,0.0013898079,0.0003641617,0.0018203128,0.000011209049,0.008890226,0.000064466425,0.00063341775,0.19472878],"study_design_scores_gemma":[0.05711305,0.016097762,0.9241714,0.00005703548,0.000044273933,0.00022557001,0.0009305617,0.000007624862,0.00058727874,0.000045426572,0.00043882508,0.0002812233],"about_ca_topic_score_codex":0.007539712,"about_ca_topic_score_gemma":0.0018804177,"teacher_disagreement_score":0.3813235,"about_ca_system_score_codex":0.00026336662,"about_ca_system_score_gemma":0.00053123763,"threshold_uncertainty_score":0.99906915},"labels":[],"label_agreement":null},{"id":"W1968847679","doi":"10.1023/a:1022133219353","title":"Estradiol Promotes Growth and Angiogenesis in Polyoma Middle T Transgenic Mouse Mammary Tumor Explants","year":2003,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":61,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Angiogenesis; Estrogen; Carcinogenesis; Biology; Breast cancer; Mammary gland; Cancer research; Genetically modified mouse; In vivo; Transgene; Mammary tumor; Cancer; Neovascularization; Internal medicine; Endocrinology; Medicine; Genetics; Gene","score_opus":0.02715513530787614,"score_gpt":0.285743818448838,"score_spread":0.25858868314096184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968847679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847098,0.01437222,0.0000044138046,0.00018278496,0.000015888725,0.0004029699,0.00007803049,0.000007852739,0.00022602876],"genre_scores_gemma":[0.99051845,0.008820347,0.00009052569,0.000013872939,0.000035463818,0.00022806042,0.000027467062,0.000018932487,0.00024687639],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99883354,0.00013741934,0.00010944451,0.00038350179,0.00012569368,0.00041039736],"domain_scores_gemma":[0.999574,0.000016806895,0.000016816042,0.00015792379,0.000029076042,0.00020535094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011714066,0.00016379303,0.00014732624,0.000096695,0.00010064011,0.000033729877,0.00006390421,0.00009199679,0.000008529162],"category_scores_gemma":[0.0000072871735,0.00012591152,0.000042978147,0.00012813919,0.00010278645,0.000007768927,0.000023997078,0.000060562696,0.0000017145553],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010966456,0.0010074704,0.11465345,0.00012205745,0.0005063681,0.00028005033,0.00029908618,0.0000024610238,0.8552953,0.0004544104,0.00008321765,0.026199488],"study_design_scores_gemma":[0.0028087692,0.0013761839,0.038180597,0.000043703614,0.000022667035,0.00050131103,0.00008593809,0.000008623586,0.95645773,0.000095076066,0.00019713787,0.0002222865],"about_ca_topic_score_codex":0.00063763675,"about_ca_topic_score_gemma":0.00013817444,"teacher_disagreement_score":0.10116242,"about_ca_system_score_codex":0.000040764153,"about_ca_system_score_gemma":0.0001523853,"threshold_uncertainty_score":0.5134523},"labels":[],"label_agreement":null},{"id":"W1969103199","doi":"10.1007/s10549-012-2077-6","title":"Adjuvant bisphosphonate treatment for breast cancer: Why did something so elegant become so complicated?","year":2012,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Bone health and treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Adjuvant; Bisphosphonate; Oncology; Breast cancer; Adjuvant therapy; Internal medicine; Clinical trial; Randomized controlled trial; Cancer; Osteoporosis","score_opus":0.2034249712387361,"score_gpt":0.475218991803003,"score_spread":0.2717940205642669,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969103199","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006787555,0.9630507,0.0000060154784,0.0046252375,0.00042597667,0.009672341,0.021283744,0.00015499903,0.00010218906],"genre_scores_gemma":[0.003437119,0.9716225,0.00017959691,0.00021084055,0.0006588392,0.018275365,0.0017030439,0.00031526914,0.0035973815],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.992602,0.0003328296,0.0012167246,0.0018207674,0.0010340884,0.002993574],"domain_scores_gemma":[0.9947131,0.00054660393,0.00047943674,0.0011710578,0.0005848644,0.0025049075],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0005183484,0.0015933729,0.0043111374,0.00078865903,0.0015171852,0.0002826251,0.00028891073,0.000623567,0.0005517385],"category_scores_gemma":[0.000010278024,0.0009998183,0.0010009017,0.0008436552,0.0006057332,0.00021340036,0.00017903051,0.00072089426,0.00015299792],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0017302172,0.0034358639,0.0022455582,0.008364705,0.0042901277,0.0002371936,0.00021620218,2.865833e-7,0.0000018385467,0.00012285996,0.0006007116,0.97875446],"study_design_scores_gemma":[0.00908794,0.0025945767,0.005293928,0.00952275,0.0050446717,0.0025796937,0.00003728152,0.0000122402125,0.000022251877,0.000056756995,0.96501213,0.0007357777],"about_ca_topic_score_codex":0.100788325,"about_ca_topic_score_gemma":0.0097119985,"teacher_disagreement_score":0.97801864,"about_ca_system_score_codex":0.0071819923,"about_ca_system_score_gemma":0.005846749,"threshold_uncertainty_score":0.9997892},"labels":[],"label_agreement":null},{"id":"W1969287659","doi":"10.1007/s10549-012-2303-2","title":"Insulin-like growth factor-1, insulin-like growth factor-binding protein-3, growth hormone, and mammographic density in the Nurses’ Health Studies","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute","keywords":"Medicine; Body mass index; MAMMOGRAPHIC DENSITY; Overweight; Confounding; Insulin-like growth factor; Breast cancer; Internal medicine; Endocrinology; Nurses' Health Study; Oncology; Mammography; Growth factor; Cancer; Epidemiology; Receptor","score_opus":0.07731476026916892,"score_gpt":0.36455894828575985,"score_spread":0.2872441880165909,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969287659","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9482262,0.04125108,0.000003775765,0.0060653067,0.00029402334,0.003492714,0.00037995548,0.00010650134,0.00018044023],"genre_scores_gemma":[0.9465868,0.051123332,0.00009259297,0.00041899204,0.00044303725,0.00094472396,0.00007900397,0.00009269505,0.00021885875],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9933684,0.0008007732,0.00085105095,0.001106431,0.0015642742,0.002309084],"domain_scores_gemma":[0.99663705,0.0004697322,0.00024939908,0.00063523324,0.0007322229,0.0012763453],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012510599,0.0008794039,0.0012778211,0.0011045255,0.0010526015,0.00018089538,0.000320217,0.00029379126,0.000025435142],"category_scores_gemma":[0.00017116909,0.00056672737,0.0002123847,0.0017430743,0.0009346692,0.00069381157,0.00027343718,0.0011388903,0.000027453161],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002745335,0.0028613345,0.9534916,0.00064861745,0.001138328,0.00021398655,0.013907169,4.8092076e-8,0.0018132488,0.001722385,0.0012685886,0.02018933],"study_design_scores_gemma":[0.0067676674,0.0031094411,0.98170143,0.00039365306,0.000115523064,0.00041029602,0.004209142,0.0000039815704,0.0013862038,0.0005494522,0.00080414745,0.00054908113],"about_ca_topic_score_codex":0.011372066,"about_ca_topic_score_gemma":0.0009883307,"teacher_disagreement_score":0.028209783,"about_ca_system_score_codex":0.001368758,"about_ca_system_score_gemma":0.00062558515,"threshold_uncertainty_score":0.99967843},"labels":[],"label_agreement":null},{"id":"W1969405269","doi":"10.1023/a:1012564620853","title":"Cytotoxicity induced by manipulation of signal transduction pathways is associated with down-regulation of Bcl-2 but not Mcl-1 in MCF-7 human breast cancer","year":2001,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital","funders":"","keywords":"MCF-7; Signal transduction; Breast cancer; Cytotoxicity; Human breast; Cancer research; Cancer; Biology; Oncology; Internal medicine; Medicine; Chemistry; Cell biology; In vitro; Genetics","score_opus":0.04192190424934354,"score_gpt":0.3113636838953381,"score_spread":0.26944177964599453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969405269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982688,0.0005012446,0.000042186715,0.00018978989,0.000011265429,0.0003529225,0.0005404594,0.000005252668,0.00008809352],"genre_scores_gemma":[0.99851114,0.00081181945,0.000006701296,0.000008835979,0.00006670702,0.00015437139,0.00023884609,0.00001715214,0.0001844192],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99870133,0.00010276556,0.0002426535,0.0003451167,0.00033780103,0.0002703088],"domain_scores_gemma":[0.99935424,0.000012452729,0.00011841356,0.00015186238,0.0002866039,0.000076432356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018077611,0.00015805227,0.00021282873,0.000092310605,0.00009885276,0.000014685782,0.000074930475,0.00015023799,0.000120465105],"category_scores_gemma":[0.0000032414787,0.0001259524,0.000041602147,0.00023784624,0.00014270564,0.000015739657,0.000018665443,0.00009078765,2.6942053e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011024557,0.0004316036,0.055289958,0.000042248226,0.00012745261,0.0000024769768,0.00015587472,0.00006890713,0.9325141,0.000015973736,0.00002761591,0.010221381],"study_design_scores_gemma":[0.0019178994,0.00065135845,0.23184913,0.00010517506,0.00002316523,0.000020702291,0.00008057401,0.00006336818,0.76509964,0.00005834105,0.000020750917,0.00010988718],"about_ca_topic_score_codex":0.00601542,"about_ca_topic_score_gemma":0.0016869027,"teacher_disagreement_score":0.17655918,"about_ca_system_score_codex":0.00024244827,"about_ca_system_score_gemma":0.00021864705,"threshold_uncertainty_score":0.9093555},"labels":[],"label_agreement":null},{"id":"W1969405636","doi":"10.1007/s10549-009-0559-y","title":"Density of tumour stroma is correlated to outcome after adoptive transfer of CD4+ and CD8+ T cells in a murine mammary carcinoma model","year":2009,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Victoria; BC Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"Adoptive cell transfer; CD8; Stroma; Pathology; Cytotoxic T cell; Infiltration (HVAC); Ovalbumin; Lymph node; Immunotherapy; Stromal cell; Cancer research; T cell; Breast cancer; Biology; Medicine; Immunology; Cancer; Immune system; Immunohistochemistry; Internal medicine; In vitro","score_opus":0.04772655796454484,"score_gpt":0.34449636715946963,"score_spread":0.2967698091949248,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969405636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99547243,0.0007303549,0.000032368658,0.0020530943,0.000008958898,0.0011514063,0.0003043399,0.000007633039,0.00023940032],"genre_scores_gemma":[0.99719197,0.00065314944,0.00017182183,0.00007193715,0.000020976879,0.000108957865,0.0000071677514,0.000017246171,0.0017567986],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99817324,0.00008041677,0.00030468838,0.0004054091,0.0005550503,0.00048120975],"domain_scores_gemma":[0.9989583,0.000054686796,0.00001930253,0.0002932705,0.00029159442,0.0003828625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023898564,0.00019309425,0.000516971,0.00040138524,0.000033527696,0.000012875204,0.000073060706,0.000082902276,0.0002415791],"category_scores_gemma":[0.0000049349746,0.00014933667,0.00007352482,0.0003801733,0.00014732682,0.00006130863,0.000055202734,0.00023177895,0.0000022234362],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029466787,0.002196038,0.57599044,0.00027350808,0.00026524172,0.00087712205,0.004111624,0.000047324374,0.33005768,0.000068985806,0.00007344502,0.05657182],"study_design_scores_gemma":[0.0062083276,0.003455913,0.90992254,0.0001523625,0.000044165627,0.0000879097,0.00013871408,0.0012072952,0.07857025,0.00008295962,0.000015291056,0.00011428941],"about_ca_topic_score_codex":0.0045677563,"about_ca_topic_score_gemma":0.00067491224,"teacher_disagreement_score":0.3339321,"about_ca_system_score_codex":0.00038909397,"about_ca_system_score_gemma":0.0002942937,"threshold_uncertainty_score":0.69051117},"labels":[],"label_agreement":null},{"id":"W1969932910","doi":"10.1007/s10549-014-3231-0","title":"No effect of scalp cooling on survival among women with breast cancer","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National de Santé Publique du Québec; Université Laval; Hôpital du Saint-Sacrement","funders":"","keywords":"Medicine; Scalp; Breast cancer; Hazard ratio; Proportional hazards model; Chemotherapy; Internal medicine; Confidence interval; Cancer; Oncology; Surgery","score_opus":0.01676497524236144,"score_gpt":0.32749751872038146,"score_spread":0.31073254347802004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969932910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942128,0.00024328164,0.0000041907474,0.0006024842,0.000046824636,0.0006394851,0.00015876748,0.00002594715,0.004066222],"genre_scores_gemma":[0.9977876,0.00040899185,0.0000066238817,0.00003389581,0.0002291804,0.0006368543,0.000011900585,0.000030117082,0.00085484167],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981172,0.0001524482,0.00014282098,0.00036644013,0.00058345747,0.0006376103],"domain_scores_gemma":[0.9987445,0.00019234097,0.000039926894,0.00025990274,0.00023635635,0.0005270075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038167395,0.00021510648,0.00044343658,0.00016022248,0.00013458371,0.000024541994,0.00006124777,0.00006130499,0.00032567116],"category_scores_gemma":[0.00001894204,0.00012417206,0.000042661315,0.00025685868,0.0003223451,0.00005573671,0.000027970533,0.00016225401,0.000020203885],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028638111,0.00051403744,0.80406517,0.00029969861,0.00038714666,0.000029523568,0.00024593153,0.000022663862,0.0002843115,0.00005817449,0.000119729375,0.16533548],"study_design_scores_gemma":[0.010706554,0.009436285,0.97700304,0.0005790626,0.00006691532,0.000042592474,0.00013216825,0.00014983899,0.0010677116,0.000012148689,0.00065616413,0.00014754695],"about_ca_topic_score_codex":0.013457529,"about_ca_topic_score_gemma":0.0014083821,"teacher_disagreement_score":0.17293783,"about_ca_system_score_codex":0.00043055546,"about_ca_system_score_gemma":0.0002607638,"threshold_uncertainty_score":0.99311197},"labels":[],"label_agreement":null},{"id":"W1971110586","doi":"10.1007/s10549-010-0893-0","title":"Recording of hormone therapy and breast density in breast screening programs: summary and recommendations of the International Cancer Screening Network","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario","funders":"National Cancer Institute","keywords":"Breast cancer; Breast density; Medicine; Mammography; Breast cancer screening; Gynecology; Hormone replacement therapy (female-to-male); Mammography screening; Oncology; Hormone therapy; Internal medicine; Cancer; Obstetrics","score_opus":0.12247844376528955,"score_gpt":0.39445871199187826,"score_spread":0.2719802682265887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971110586","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9808012,0.004072526,0.000018541292,0.014033053,0.000082159706,0.0006171471,0.00020411868,0.000010860419,0.00016034424],"genre_scores_gemma":[0.9880953,0.010080381,0.0012571582,0.000064377695,0.00023201943,0.00015332643,0.000020395199,0.000015594507,0.00008147471],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984757,0.000077696204,0.00028710888,0.0003437702,0.00043627867,0.00037948723],"domain_scores_gemma":[0.99905044,0.00010447169,0.000120104516,0.00021295309,0.00033024498,0.00018178736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005752708,0.00016631771,0.00031493587,0.00013596848,0.00021265801,0.00004861411,0.00011743577,0.00007788423,0.00003529014],"category_scores_gemma":[0.000012960268,0.000114040806,0.00005332829,0.00039498488,0.000373837,0.00016640249,0.00017312296,0.00034782357,1.2157982e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013396558,0.000095336996,0.5733012,0.000011620912,0.0001385019,0.0000061473525,0.00014739149,0.0000047106664,0.0014814893,0.000097191456,0.0002215219,0.42315525],"study_design_scores_gemma":[0.0028327052,0.00026464544,0.993252,0.0008281076,0.00003706481,0.0005484316,0.0005160113,0.0004273131,0.0003093052,0.00013000601,0.000753062,0.00010136979],"about_ca_topic_score_codex":0.04624922,"about_ca_topic_score_gemma":0.012401168,"teacher_disagreement_score":0.4230539,"about_ca_system_score_codex":0.00012181524,"about_ca_system_score_gemma":0.00020918399,"threshold_uncertainty_score":0.9601019},"labels":[],"label_agreement":null},{"id":"W1971156035","doi":"10.1007/s10549-007-9865-4","title":"The thrombin inhibitor Argatroban reduces breast cancer malignancy and metastasis via osteopontin-dependent and osteopontin-independent mechanisms","year":2007,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Bone and Dental Protein Studies","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre","funders":"London Health Sciences Centre","keywords":"Osteopontin; Argatroban; Cancer research; Metastasis; Thrombin; Metastatic breast cancer; Medicine; Breast cancer; Tissue factor; Cancer; Chemistry; Immunology; Internal medicine","score_opus":0.03295216863307312,"score_gpt":0.3426368816376451,"score_spread":0.309684713004572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971156035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9544766,0.034325164,0.000024800338,0.008203936,0.00020878878,0.0017717807,0.00033783348,0.000048905145,0.0006021997],"genre_scores_gemma":[0.9790147,0.017644832,0.0001284062,0.00007733412,0.00033552927,0.0005626073,0.000009675967,0.000046497982,0.002180449],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9967033,0.00012883346,0.00040903746,0.00078073895,0.0009615397,0.0010165004],"domain_scores_gemma":[0.99849635,0.00016772597,0.00011174752,0.00034211003,0.00031100615,0.00057104323],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000987719,0.00041189216,0.00056011317,0.00018121107,0.0010845505,0.00021649673,0.00010043902,0.00012034459,0.00010899956],"category_scores_gemma":[0.000011979756,0.00024791775,0.000089873254,0.00026923744,0.0006071232,0.00017245066,0.0003231667,0.0003152987,0.000010705837],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006225373,0.000914822,0.027943587,0.00019568691,0.001862868,0.00075077184,0.0011812674,2.5265356e-7,0.05470905,0.0012626385,0.00065051246,0.9043032],"study_design_scores_gemma":[0.014649738,0.0039297454,0.7676873,0.0010084616,0.0008784161,0.007814669,0.009243056,0.0000125186025,0.18847714,0.0036361164,0.0018275024,0.0008353049],"about_ca_topic_score_codex":0.011299062,"about_ca_topic_score_gemma":0.009609782,"teacher_disagreement_score":0.9034679,"about_ca_system_score_codex":0.00047474357,"about_ca_system_score_gemma":0.00019941415,"threshold_uncertainty_score":0.9999973},"labels":[],"label_agreement":null},{"id":"W1971387210","doi":"10.1023/a:1006470206271","title":"Management of familial breast cancer risk","year":2000,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Breast cancer; Medicine; Psychosocial; Family history; Prophylactic Surgery; Quality of life (healthcare); Genetic testing; Cancer; Gynecology; Family medicine; Intensive care medicine; Surgery; Internal medicine; Nursing; Psychiatry","score_opus":0.051487458461725734,"score_gpt":0.40341821352556717,"score_spread":0.3519307550638414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971387210","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012896392,0.9860667,0.000003053208,0.00009477706,0.00014142781,0.0011905276,0.01032227,0.000009645993,0.000881938],"genre_scores_gemma":[0.0013057413,0.991823,0.00008588466,0.00000594759,0.0005743373,0.0027549816,0.0003331606,0.00007655365,0.0030403736],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974744,0.00023289681,0.00041694875,0.00087090273,0.00042811886,0.00057676487],"domain_scores_gemma":[0.9987305,0.000025111965,0.00017753587,0.00067657285,0.00018504892,0.00020523333],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020520636,0.00045220676,0.00077114283,0.00018895429,0.00019123916,0.000040329007,0.00030836224,0.00026792815,0.00043015138],"category_scores_gemma":[0.0000014719923,0.00034307438,0.00028402277,0.0003555025,0.00034008035,0.00000475873,0.00020238811,0.00021867122,0.000020587446],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025235506,0.00024326204,0.00017988915,0.0019484124,0.0020334038,0.000023211542,0.000021025935,0.000010131675,0.000004335829,0.000018911862,0.0011463844,0.9941187],"study_design_scores_gemma":[0.0010116246,0.00029176287,0.001208395,0.0030589765,0.0007981525,0.00014369331,0.00004126841,0.0000015450262,0.00006203429,0.000029644289,0.99301445,0.0003384638],"about_ca_topic_score_codex":0.0033879958,"about_ca_topic_score_gemma":0.0005303908,"teacher_disagreement_score":0.9937802,"about_ca_system_score_codex":0.0007619984,"about_ca_system_score_gemma":0.0011534976,"threshold_uncertainty_score":0.9999021},"labels":[],"label_agreement":null},{"id":"W1972287988","doi":"10.1007/s10549-009-0595-7","title":"The Leu33Pro polymorphism in the ITGB3 gene does not modify BRCA1/2-associated breast or ovarian cancer risks: results from a multicenter study among 15,542 BRCA1 and BRCA2 mutation carriers","year":2009,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Canadian Institutes of Health Research; U.S. Public Health Service; Cancer Research UK","keywords":"Ovarian cancer; Breast cancer; Oncology; Hazard ratio; Biology; Internal medicine; Genotype; Proportional hazards model; Allele; Genetics; Cancer; Medicine; Gene; Confidence interval","score_opus":0.06402901765703548,"score_gpt":0.38023421231836935,"score_spread":0.3162051946613339,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972287988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97366786,0.0017489947,0.0000016906329,0.01916415,0.00006193476,0.003473711,0.0017540869,0.00003406179,0.00009350954],"genre_scores_gemma":[0.9935213,0.0035726097,0.000020481039,0.00020490574,0.00022510286,0.0009942298,0.00011595286,0.000040593273,0.0013048413],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99499416,0.00092243723,0.0005367177,0.0009601993,0.0015386547,0.0010478465],"domain_scores_gemma":[0.997476,0.0007812418,0.0001402562,0.0007051365,0.00040300566,0.0004943572],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012973675,0.0003882354,0.00047567903,0.000283055,0.00076693064,0.00032880704,0.00029451324,0.00015215947,0.000111233356],"category_scores_gemma":[0.00020054616,0.00018254513,0.00008565306,0.0006737812,0.0004767779,0.0001498986,0.00012790454,0.0006400897,0.0000071003506],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05405869,0.0058181346,0.35349724,0.00003730665,0.001960423,0.00391132,0.022147153,0.000048744125,0.007857387,0.0000172646,0.00068512437,0.5499612],"study_design_scores_gemma":[0.019838499,0.0014882836,0.9702288,0.00017733508,0.00014994669,0.000072692106,0.005224888,0.0010140892,0.0014342709,0.00005824924,0.000114176655,0.00019878165],"about_ca_topic_score_codex":0.23606198,"about_ca_topic_score_gemma":0.09593764,"teacher_disagreement_score":0.6167315,"about_ca_system_score_codex":0.0013961678,"about_ca_system_score_gemma":0.0006733064,"threshold_uncertainty_score":0.92055917},"labels":[],"label_agreement":null},{"id":"W1972332868","doi":"10.1007/s10549-011-1739-0","title":"Are genetic and environmental components of variance in mammographic density measures that predict breast cancer risk independent of within-twin pair differences in body mass index?","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Digital Radiography and Breast Imaging","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario","funders":"National Medical Research Council; National Health and Medical Research Council","keywords":"Statistics; Correlation; Covariance; Twin study; Body mass index; Bivariate analysis; Breast cancer; Mathematics; Variance (accounting); Risk factors for breast cancer; Heritability; Cancer; Medicine; Biology; Internal medicine; Genetics","score_opus":0.050608320636071034,"score_gpt":0.2719646859470027,"score_spread":0.22135636531093164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972332868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947734,0.0032354298,0.000009277387,0.00015378113,0.000031922453,0.0006515671,0.001091902,0.000009558116,0.000043181277],"genre_scores_gemma":[0.9957937,0.0039154007,0.000048343514,0.000008735995,0.00002357736,0.00016547725,0.0000112766775,0.000018029206,0.00001548465],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99784464,0.00017347204,0.00034937775,0.00047820376,0.0007060499,0.00044828176],"domain_scores_gemma":[0.9991693,0.000053337586,0.00021087792,0.0002424925,0.0000580391,0.00026595066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003028225,0.00025501198,0.0005477774,0.00057792995,0.00006223524,0.000020273455,0.00010924251,0.000087685396,0.00003432724],"category_scores_gemma":[0.0000051736697,0.00019147799,0.000075346186,0.00037204023,0.00084147573,0.00014571092,0.00008142229,0.00026817666,2.9525864e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030505734,0.0015100391,0.9721601,0.00011325354,0.00035888355,0.00018768535,0.00063539227,0.000004106386,0.0006933469,0.0000075689177,0.00000201275,0.021277025],"study_design_scores_gemma":[0.0039090025,0.00039899573,0.99204105,0.0007297975,0.00008058757,0.00023336524,0.0009039709,0.0001901814,0.0011574477,0.0002146186,0.0000017870341,0.0001392056],"about_ca_topic_score_codex":0.03823751,"about_ca_topic_score_gemma":0.0048018377,"teacher_disagreement_score":0.033435673,"about_ca_system_score_codex":0.00020181708,"about_ca_system_score_gemma":0.00009937404,"threshold_uncertainty_score":0.96816695},"labels":[],"label_agreement":null},{"id":"W1972688314","doi":"10.1007/s10549-004-1368-y","title":"Prognostic factors affecting the natural history of node-negative breast cancer","year":2005,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; St. Michael's Hospital; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Health Sciences Centre; University Health Network; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Breast cancer; Natural history; Oncology; Medicine; Internal medicine; Cancer; Gynecology","score_opus":0.03288019039236431,"score_gpt":0.32847918109117213,"score_spread":0.2955989906988078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972688314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9770813,0.018091619,0.0000020642392,0.0030398436,0.00018441457,0.00060439704,0.000636368,0.000015678072,0.00034429488],"genre_scores_gemma":[0.99495435,0.0028713176,0.000039019833,0.000053199346,0.0004981137,0.00045834607,0.00003353401,0.00003154713,0.0010605557],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998306,0.0001389465,0.00018540918,0.00049354794,0.0003443608,0.0005317794],"domain_scores_gemma":[0.9990087,0.00014283115,0.00009725474,0.00030829225,0.0003121063,0.00013079116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014044567,0.00028793112,0.00026114297,0.00007550592,0.0002461552,0.000021008036,0.00016367986,0.00007341055,0.00008972609],"category_scores_gemma":[0.00002428773,0.00017190984,0.00010410532,0.00014457281,0.0005859817,0.000014035787,0.000155378,0.00015486892,0.0000035173068],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025722836,0.0012214455,0.78956014,0.0000984487,0.0026167687,0.00001302908,0.0048226486,0.00009200788,0.01409192,0.000075758435,0.004730859,0.1801047],"study_design_scores_gemma":[0.0019729834,0.00029316306,0.9792122,0.00011077855,0.00011596478,0.0000817332,0.0009307363,0.000023424605,0.013252121,0.0000150952155,0.0037615222,0.00023024157],"about_ca_topic_score_codex":0.011763858,"about_ca_topic_score_gemma":0.0068314793,"teacher_disagreement_score":0.18965212,"about_ca_system_score_codex":0.0011722086,"about_ca_system_score_gemma":0.00054933975,"threshold_uncertainty_score":0.9948169},"labels":[],"label_agreement":null},{"id":"W1973041508","doi":"10.1007/s10549-011-1708-7","title":"Lifecourse predictors of mammographic density: the Newcastle Thousand Families cohort Study","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Menarche; Body mass index; Demography; Breast cancer; Logistic regression; Odds ratio; Family history; Cohort study; Obstetrics; Gynecology; Cancer; Internal medicine","score_opus":0.0842099793428427,"score_gpt":0.3648000963490076,"score_spread":0.28059011700616493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973041508","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99555904,0.0013646847,0.0000012109896,0.00030115907,0.00008530391,0.0015188584,0.00010690806,0.000022143548,0.0010407041],"genre_scores_gemma":[0.99469066,0.004264301,0.0000080828095,0.000015659436,0.00014642027,0.00034690218,0.0000054196485,0.00001934641,0.0005032128],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985725,0.00008784523,0.00017997444,0.0003056578,0.0005087635,0.00034523034],"domain_scores_gemma":[0.99905884,0.000059305352,0.000046247325,0.00039346816,0.00021268833,0.00022941861],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032063574,0.00015777638,0.00031979225,0.00018179086,0.00018406581,0.000018322608,0.0000790437,0.00004307439,0.00020110622],"category_scores_gemma":[0.0000076254946,0.000084406434,0.00007780651,0.0003259391,0.00043246016,0.000044472585,0.000062487576,0.00015237194,0.0000042464985],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012951317,0.0012557032,0.96977717,0.000018797893,0.0007900645,0.00005684195,0.0022479743,1.999573e-7,0.000043514392,0.00002344821,0.00029154736,0.024199618],"study_design_scores_gemma":[0.001965046,0.0023524046,0.99142134,0.00004645126,0.0002582024,0.000060333095,0.0027797406,0.0000037642237,0.00043962838,0.000033956356,0.0005720412,0.000067117],"about_ca_topic_score_codex":0.052047625,"about_ca_topic_score_gemma":0.008684565,"teacher_disagreement_score":0.04336306,"about_ca_system_score_codex":0.00013025543,"about_ca_system_score_gemma":0.0002467371,"threshold_uncertainty_score":0.9542649},"labels":[],"label_agreement":null},{"id":"W1973137836","doi":"10.1007/s10549-011-1649-1","title":"A SEER-Medicare population-based study of lymphedema-related claims incidence following breast cancer in men","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Male Breast Health Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario","funders":"","keywords":"Lymphedema; Medicine; Breast cancer; Incidence (geometry); Population; Cohort; Cumulative incidence; Epidemiology; Cancer; Surgery; Internal medicine","score_opus":0.06917526963028543,"score_gpt":0.40258284184004367,"score_spread":0.33340757220975825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973137836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931767,0.0018913442,7.8958226e-7,0.0020489513,0.000071332805,0.002078263,0.00020200359,0.000038035578,0.0004925675],"genre_scores_gemma":[0.9977816,0.00037741486,0.00003565893,0.000036992908,0.00007035204,0.0014071768,0.000018777955,0.00003373309,0.0002383435],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99694115,0.00023417668,0.0005621369,0.000587195,0.000970784,0.00070455996],"domain_scores_gemma":[0.9985874,0.00014880474,0.00012313371,0.00038672748,0.0003311367,0.0004227453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054989924,0.0002773529,0.0006826181,0.00043640775,0.00021856936,0.000011734448,0.00011892833,0.000108015716,0.00053147646],"category_scores_gemma":[0.0000241496,0.00020521128,0.00008136513,0.00077867036,0.000121232086,0.00009674494,0.00009267361,0.00016549783,0.0000053932713],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020046094,0.0021723043,0.95132565,0.00018188184,0.00044988585,0.00027858064,0.003891133,0.000013438938,0.000030232235,0.000016902508,0.00002834609,0.039607037],"study_design_scores_gemma":[0.0093543045,0.001134895,0.9847835,0.0009393303,0.00013734378,0.00006943031,0.0030840004,0.0002652908,0.00003111161,0.00005285033,0.0000063656553,0.00014158386],"about_ca_topic_score_codex":0.23637497,"about_ca_topic_score_gemma":0.02785039,"teacher_disagreement_score":0.20852458,"about_ca_system_score_codex":0.0015028727,"about_ca_system_score_gemma":0.0009928624,"threshold_uncertainty_score":0.9898888},"labels":[],"label_agreement":null},{"id":"W1973550734","doi":"10.1007/s10549-005-1409-1","title":"Breast cancer predisposing alleles in Poland","year":2005,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":126,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Coalition for Research in Women's Health; University of Toronto","funders":"","keywords":"Breast cancer; CHEK2; Missense mutation; Allele; Genetics; Population; Odds ratio; Biology; Mutation; Cancer; Oncology; Internal medicine; Medicine; Gene; Germline mutation","score_opus":0.02986733416414252,"score_gpt":0.3628503013709281,"score_spread":0.3329829672067856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973550734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9819341,0.010467632,0.000010098041,0.005962107,0.00005657442,0.00034922443,0.0007065974,0.000009582633,0.00050413585],"genre_scores_gemma":[0.9893028,0.008179314,0.0001496439,0.00006338798,0.0007111116,0.00056527177,0.000052133993,0.000025373169,0.00095096225],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986593,0.000066899236,0.00014936237,0.0004444942,0.00021600786,0.00046395048],"domain_scores_gemma":[0.9994469,0.000014231468,0.000027876047,0.00023467839,0.00012783891,0.00014846081],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014093056,0.00015988995,0.00013510576,0.00011323244,0.00014058693,0.000054559507,0.00010768996,0.00008921728,0.00015074201],"category_scores_gemma":[0.0000030537803,0.00013254293,0.000035898942,0.00016937828,0.0001564094,0.0000108107,0.00008333292,0.00009783183,0.0000068287964],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014619165,0.0006252588,0.24475488,0.000032707663,0.0003107172,0.000019571065,0.00047295788,0.00075629144,0.042081315,0.000079381956,0.003076234,0.70632875],"study_design_scores_gemma":[0.005462348,0.0005168887,0.8960476,0.0001708633,0.00003809269,0.00046971458,0.00036456916,0.00033250853,0.035585027,0.00011433779,0.060410116,0.00048794725],"about_ca_topic_score_codex":0.004347494,"about_ca_topic_score_gemma":0.018119149,"teacher_disagreement_score":0.7058408,"about_ca_system_score_codex":0.00063037546,"about_ca_system_score_gemma":0.0005181237,"threshold_uncertainty_score":0.99979764},"labels":[],"label_agreement":null},{"id":"W1973729526","doi":"10.1007/s10549-008-0267-z","title":"Immunohistochemical validation of multiple phospho-specific epitopes for estrogen receptor α (ERα) in tissue microarrays of ERα positive human breast carcinomas","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"Canadian Institutes of Health Research; CancerCare Manitoba Foundation; National Cancer Institute; University of Manitoba; Manitoba Health Research Council","keywords":"Immunohistochemistry; Estrogen receptor; Breast cancer; Tissue microarray; Cancer research; Estrogen receptor alpha; Estrogen receptor beta; Antibody; Phosphorylation; Estrogen; Biology; Epitope; Cancer; Internal medicine; Pathology; Medicine; Immunology; Cell biology","score_opus":0.0845461179765854,"score_gpt":0.39014807308163685,"score_spread":0.30560195510505145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973729526","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98899406,0.0060032033,0.000011639512,0.0008579389,0.00003897026,0.0022120404,0.0016391327,0.000013057309,0.0002299676],"genre_scores_gemma":[0.99520504,0.0021773537,0.0006043093,0.0000049766495,0.0001574245,0.0009743561,0.00029592722,0.000045120538,0.00053550577],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99757063,0.0001285289,0.00047317197,0.00054148794,0.00065758446,0.0006286091],"domain_scores_gemma":[0.9982545,0.00023048918,0.00009982926,0.00041744567,0.000723239,0.00027450873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036832324,0.00023065672,0.000578622,0.00032651186,0.00017710989,0.000013011039,0.00015566943,0.00012889632,0.00030252026],"category_scores_gemma":[0.000030024763,0.00019735484,0.00010964239,0.00041044748,0.0006902449,0.000075752214,0.00007843433,0.00023507331,0.000008383932],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059662974,0.0014992909,0.17559558,0.00023742422,0.00019808579,0.00005355488,0.0014471759,0.0000030673768,0.78220063,0.00011034696,0.0009790151,0.031709522],"study_design_scores_gemma":[0.0065548564,0.0019863127,0.14688326,0.0003937734,0.000025999809,0.00024753818,0.00026358332,0.0000104006185,0.8415578,0.000030904674,0.0018998177,0.00014574693],"about_ca_topic_score_codex":0.018188758,"about_ca_topic_score_gemma":0.00017808679,"teacher_disagreement_score":0.05935716,"about_ca_system_score_codex":0.0012492856,"about_ca_system_score_gemma":0.00069194107,"threshold_uncertainty_score":0.9883492},"labels":[],"label_agreement":null},{"id":"W1974605217","doi":"10.1007/s10549-012-2364-2","title":"Association between BRIP1 (BACH1) polymorphisms and breast cancer risk: a meta-analysis","year":2012,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Ministry of the Environment, Conservation and Parks","funders":"","keywords":"Breast cancer; Meta-analysis; Oncology; Medicine; Cancer; Internal medicine","score_opus":0.1438262219065846,"score_gpt":0.4211886928827429,"score_spread":0.2773624709761583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974605217","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010094943,0.977886,0.00001252947,0.0007385776,0.00007084783,0.00089898607,0.019289635,0.000013412844,0.00008050242],"genre_scores_gemma":[0.0095099965,0.98146117,0.00007534797,0.000017857472,0.0010792284,0.002958581,0.0008968905,0.000078556914,0.003922382],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99634653,0.0006832949,0.00048213368,0.0010467577,0.0005961326,0.0008451281],"domain_scores_gemma":[0.998018,0.00014219689,0.00042998182,0.00064178405,0.0003408743,0.00042712],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00077355874,0.0005934766,0.0019339396,0.0003943045,0.00037529488,0.00015650579,0.00023007827,0.0004253091,0.0005640461],"category_scores_gemma":[0.000014411281,0.00042663587,0.0008638022,0.0007586366,0.00019263859,0.000014731241,0.00024733323,0.0003488649,0.000016925327],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049141207,0.00014898674,0.012913469,0.0003284076,0.24291754,0.0000030847675,0.000043953452,0.0000025826714,0.0000064971814,0.000004364436,0.0005553595,0.7430266],"study_design_scores_gemma":[0.0005515127,0.00023816875,0.017108705,0.00010324383,0.328313,0.000060914936,0.0000131386,0.0000013822346,0.00003989854,0.000015347072,0.65303713,0.0005175298],"about_ca_topic_score_codex":0.013462478,"about_ca_topic_score_gemma":0.004887208,"teacher_disagreement_score":0.74250907,"about_ca_system_score_codex":0.0016289207,"about_ca_system_score_gemma":0.0010146673,"threshold_uncertainty_score":0.99981856},"labels":[],"label_agreement":null},{"id":"W1974795335","doi":"10.1007/s10549-014-2900-3","title":"Experiences and attitudes toward risk of recurrence testing in women with breast cancer: a systematic review","year":2014,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics; South Health Campus","funders":"","keywords":"Breast cancer; Medicine; Oncology; Gynecology; Cancer; Internal medicine; Obstetrics","score_opus":0.07104179607564236,"score_gpt":0.40652804225889766,"score_spread":0.3354862461832553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974795335","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0073608956,0.989897,0.000002552124,0.000069331734,0.000027940734,0.0019569837,0.00065586035,0.0000049860064,0.000024418401],"genre_scores_gemma":[0.016627496,0.96976554,0.000088766705,0.0000119428705,0.00009010158,0.013316575,0.000021381304,0.00003211088,0.000046092304],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99751616,0.00047801077,0.0005142263,0.0007046245,0.00033136513,0.00045561342],"domain_scores_gemma":[0.99860364,0.00014259783,0.00036185505,0.00043466006,0.0002868279,0.00017042208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006709499,0.00036853115,0.0014723808,0.00014246823,0.000103442224,0.000044803037,0.00022912386,0.00012255923,0.00002144076],"category_scores_gemma":[0.00007870235,0.00022795286,0.00006243027,0.0004653873,0.00038658825,0.000008187564,0.0001398223,0.00017876933,0.0000010391491],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010294239,0.00011281997,0.002056221,0.38827023,0.00057101407,0.000006966495,0.0004458859,0.0000016058978,0.0000027422227,0.0000018774215,0.000038902872,0.6083888],"study_design_scores_gemma":[0.0012854632,0.0018327526,0.002997317,0.9738946,0.0011890715,0.00083665055,0.00086656155,0.000005429739,0.000029001496,0.000012645283,0.016279068,0.0007714686],"about_ca_topic_score_codex":0.0016309702,"about_ca_topic_score_gemma":0.0006616616,"teacher_disagreement_score":0.6076173,"about_ca_system_score_codex":0.00059953873,"about_ca_system_score_gemma":0.0013952636,"threshold_uncertainty_score":0.9295648},"labels":[],"label_agreement":null},{"id":"W1975324908","doi":"10.1007/s10549-012-1998-4","title":"Evaluation of RAD51C as cancer susceptibility gene in a large breast-ovarian cancer patient population referred for genetic testing","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Ovarian cancer; Breast cancer; Germline mutation; Genetic testing; Genetics; Biology; Genetic predisposition; Population; Germline; Mutation; Allele; Cancer; Gene; Oncology; Medicine","score_opus":0.10591137902812836,"score_gpt":0.42233003686826603,"score_spread":0.3164186578401377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975324908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861728,0.010190502,0.00003812798,0.00035597009,0.0001558108,0.0015580774,0.001468596,0.000006360531,0.000053766245],"genre_scores_gemma":[0.99372137,0.0008184874,0.00077776937,0.000022929187,0.00037842535,0.0040016295,0.00019783109,0.000031598036,0.000049950002],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99773383,0.0002853743,0.00032376192,0.000487931,0.0005764282,0.0005926539],"domain_scores_gemma":[0.998346,0.00004370772,0.00012184648,0.00033135226,0.0009956129,0.00016152544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010269942,0.00018970587,0.00020811835,0.00013065593,0.00015302097,0.000021267111,0.00008766078,0.0001216393,0.0001308327],"category_scores_gemma":[0.00008870991,0.00016861391,0.000053738186,0.00029867957,0.00008008543,0.000017816128,0.000074298085,0.000075308,0.0000010704719],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006647018,0.0005525171,0.5710502,0.00004786593,0.00019687155,5.350813e-7,0.0003785096,0.0011116198,0.041360307,0.000017974227,0.000070228736,0.38454863],"study_design_scores_gemma":[0.003440337,0.0004653948,0.96793425,0.00007958892,0.00012610713,0.00002839326,0.00016549874,0.0012280272,0.025740271,0.00024500358,0.00035660333,0.0001905529],"about_ca_topic_score_codex":0.024524514,"about_ca_topic_score_gemma":0.018457526,"teacher_disagreement_score":0.396884,"about_ca_system_score_codex":0.0015692336,"about_ca_system_score_gemma":0.0011242711,"threshold_uncertainty_score":0.99945307},"labels":[],"label_agreement":null},{"id":"W1975678666","doi":"10.1007/s10549-010-0970-4","title":"DNA methylation profiling of phyllodes and fibroadenoma tumours of the breast","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Lesions and Carcinomas","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Ottawa Mental Health Centre","funders":"Peter MacCallum Cancer Centre; Cancer Institute NSW","keywords":"CDKN2A; Methylation; DNA methylation; Phyllodes tumor; Cancer research; Biology; Fibroadenoma; Epigenetics; Breast cancer; Pathology; CDH1; Cancer; Medicine; Gene; Genetics; Gene expression","score_opus":0.04022654585722239,"score_gpt":0.34706439247897075,"score_spread":0.30683784662174834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975678666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99611396,0.0008790889,0.0000015439646,0.0019848729,0.000031553107,0.0004522707,0.00017320603,0.000006286522,0.0003572198],"genre_scores_gemma":[0.99928766,0.00016447352,0.00015346802,0.0000055006744,0.00008936474,0.00006184814,0.0000057738034,0.000011565135,0.00022034052],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99906206,0.000053656404,0.0001540264,0.00020137623,0.00031539466,0.00021347802],"domain_scores_gemma":[0.9992669,0.000059476122,0.000053996002,0.0002482591,0.0002286308,0.00014268991],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020572149,0.00010438685,0.0002114543,0.00009739938,0.00011513649,0.000011924848,0.000053518736,0.000054777505,0.00006286791],"category_scores_gemma":[0.000009846821,0.000058561778,0.000053081025,0.00020618836,0.0003770776,0.000045704048,0.00006190629,0.00015894242,6.383846e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008197814,0.00032270688,0.5883954,0.00012171149,0.00007805968,0.0000055350824,0.00020077337,5.3199716e-7,0.309812,0.000687708,0.000017156479,0.09953865],"study_design_scores_gemma":[0.0012118053,0.00023772118,0.8989751,0.000114256276,0.000052870404,0.00046328714,0.0001930719,0.00003842274,0.09847723,0.00015907513,0.000034518205,0.000042648055],"about_ca_topic_score_codex":0.001515588,"about_ca_topic_score_gemma":0.00022536215,"teacher_disagreement_score":0.31057972,"about_ca_system_score_codex":0.000050842318,"about_ca_system_score_gemma":0.00024920475,"threshold_uncertainty_score":0.238808},"labels":[],"label_agreement":null},{"id":"W1975696113","doi":"10.1023/a:1023926401227","title":"Risk Factors for Colorectal Cancer Following Breast Cancer","year":2003,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; University of Calgary","funders":"National Cancer Institute","keywords":"Medicine; Breast cancer; Colorectal cancer; Family history; Cancer; Oncology; Internal medicine; Odds ratio; Gynecology; Cancer registry; Population; Epidemiology; Epidemiology of cancer; Body mass index","score_opus":0.05558737688816778,"score_gpt":0.3786550019926228,"score_spread":0.323067625104455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975696113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9840408,0.0065989406,0.000011094195,0.0017253219,0.00039323085,0.0017513736,0.0045849467,0.000051182036,0.00084313395],"genre_scores_gemma":[0.9839949,0.010412937,0.00009229059,0.000110117675,0.0003492502,0.0028398621,0.00007439788,0.00006423074,0.00206199],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99740237,0.00012261611,0.00026870632,0.00070072524,0.0005232388,0.0009823492],"domain_scores_gemma":[0.9985092,0.0002514739,0.00007701486,0.00026024692,0.00027194293,0.0006300943],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00028233466,0.00035606272,0.0005597939,0.00020425674,0.0005785689,0.00007249045,0.00009025518,0.0001290832,0.001549202],"category_scores_gemma":[0.000029759365,0.00025522412,0.00025993295,0.00032447546,0.00019005379,0.00016638718,0.000032188636,0.0002770053,0.000006154914],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035229546,0.00052676635,0.84804696,0.0001182236,0.0018517907,0.00006047818,0.00082714844,0.00003112224,0.0022927988,0.000114052775,0.0019483207,0.14065938],"study_design_scores_gemma":[0.01545111,0.0015167284,0.9358333,0.00030277748,0.00060955714,0.00015563147,0.0010323817,0.00019539736,0.010890053,0.00013340231,0.033351857,0.00052781345],"about_ca_topic_score_codex":0.033420973,"about_ca_topic_score_gemma":0.005762062,"teacher_disagreement_score":0.14013158,"about_ca_system_score_codex":0.002204754,"about_ca_system_score_gemma":0.0017985713,"threshold_uncertainty_score":0.99999},"labels":[],"label_agreement":null},{"id":"W1975803034","doi":"10.1007/s10549-015-3312-8","title":"The prevalence of BRCA1 and BRCA2 mutations among young Mexican women with triple-negative breast cancer","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":86,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"National Cancer Institute; Breast Cancer Research Foundation; National Institutes of Health; American Cancer Society","keywords":"Breast cancer; Triple-negative breast cancer; Medicine; Founder effect; BRCA mutation; Mutation; Cancer; Oncology; Internal medicine; Genetics; Haplotype; Genotype; Biology; Gene","score_opus":0.02954017966565936,"score_gpt":0.3382651798742503,"score_spread":0.30872500020859095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975803034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99177325,0.0044264724,0.000015526106,0.0015920908,0.000050310995,0.00059224904,0.0011892603,0.0000069575726,0.00035388028],"genre_scores_gemma":[0.9900955,0.005559032,0.00007336939,0.000017876133,0.00012789553,0.0015930518,0.000013147338,0.00002093511,0.0024991941],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985549,0.0001327164,0.00015823591,0.0004116495,0.00033880395,0.00040368343],"domain_scores_gemma":[0.998739,0.000054899592,0.00008116145,0.00029983517,0.0005145809,0.00031054826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003067547,0.00016400486,0.00014737587,0.00005979817,0.00030704797,0.00006226048,0.00014153752,0.000058150574,0.000025166466],"category_scores_gemma":[0.000026905745,0.00010309269,0.000020721824,0.0002302879,0.0010282536,0.000012823461,0.00009263875,0.00008978228,6.754773e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00862848,0.0006208087,0.76890516,0.00025835997,0.0022932556,0.000025494312,0.010057588,0.00036888046,0.0067880363,0.00037767054,0.0020343272,0.19964191],"study_design_scores_gemma":[0.0040720343,0.0014643768,0.97744155,0.00008721596,0.00007953485,0.00019839911,0.0046143434,0.00007833559,0.009915603,0.0003249354,0.0014813261,0.00024233235],"about_ca_topic_score_codex":0.008273473,"about_ca_topic_score_gemma":0.007345575,"teacher_disagreement_score":0.20853639,"about_ca_system_score_codex":0.00057941244,"about_ca_system_score_gemma":0.001230702,"threshold_uncertainty_score":0.99833053},"labels":[],"label_agreement":null},{"id":"W1975881851","doi":"10.1007/s10549-007-9583-y","title":"A phase II trial evaluating the palliative benefit of second-line oral ibandronate in breast cancer patients with either a skeletal related event (SRE) or progressive bone metastases (BM) despite standard bisphosphonate (BP) therapy","year":2007,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Bone health and treatments","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Bisphosphonate; Bone pain; Breast cancer; Palliative care; Regimen; Metastatic breast cancer; Progressive disease; Internal medicine; Cancer; N-terminal telopeptide; Bone disease; Surgery; Oncology; Urology; Chemotherapy; Osteoporosis","score_opus":0.08039643999595886,"score_gpt":0.45607334339596967,"score_spread":0.3756769034000108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975881851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98230875,0.0069948332,0.0000019501842,0.0013753895,0.00007235999,0.005898805,0.0032986163,0.000023420575,0.000025897209],"genre_scores_gemma":[0.9950083,0.0018619788,0.000116882664,0.00008648427,0.000043958415,0.0018377247,0.00016189707,0.000061437044,0.0008213393],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9960318,0.00023945325,0.0007464469,0.00065709086,0.0012907124,0.0010344863],"domain_scores_gemma":[0.99771506,0.00023376268,0.00036678553,0.00033956204,0.0008683068,0.00047653232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011065372,0.00045490786,0.0008420032,0.0002913301,0.0004049174,0.00003362998,0.00009713581,0.00011503957,0.0008989017],"category_scores_gemma":[0.000020845038,0.00022088297,0.0001232346,0.0008630219,0.00039897076,0.00014225492,0.00006672354,0.00038482243,0.000002682149],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.480322,0.009967889,0.05145677,0.00006943465,0.0014611124,0.0002810363,0.0013605567,0.00000912875,0.000057066125,0.000012990826,0.000020241372,0.45498174],"study_design_scores_gemma":[0.5101494,0.11658485,0.36769906,0.0012510207,0.0004389496,0.0001268193,0.0003815313,0.00010936488,0.0021824283,0.00011557521,0.0005969706,0.00036403385],"about_ca_topic_score_codex":0.012052484,"about_ca_topic_score_gemma":0.0152133815,"teacher_disagreement_score":0.4546177,"about_ca_system_score_codex":0.0012308314,"about_ca_system_score_gemma":0.0015311284,"threshold_uncertainty_score":0.9945263},"labels":[],"label_agreement":null},{"id":"W1976191178","doi":"10.1007/s10549-008-0137-8","title":"Fulvestrant for systemic therapy of locally advanced or metastatic breast cancer in postmenopausal women: a systematic review","year":2008,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Cancer Care Ontario; Kingston General Hospital; Queen's University","funders":"","keywords":"Anastrozole; Fulvestrant; Medicine; Exemestane; Oncology; Breast cancer; Internal medicine; Metastatic breast cancer; Clinical trial; Adjuvant therapy; Hormonal therapy; Systemic therapy; Cancer; Tamoxifen; Gynecology","score_opus":0.04683582102131132,"score_gpt":0.39792989292549813,"score_spread":0.3510940719041868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976191178","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020806857,0.986036,0.0000028471613,0.0000873455,0.000044097833,0.009911295,0.0018227465,0.000008513337,0.000006446097],"genre_scores_gemma":[0.0013915511,0.9773061,0.000023792993,0.000027089274,0.00007488411,0.020592265,0.00018109278,0.000086693166,0.00031648934],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9965968,0.00059199985,0.0009106876,0.00074398395,0.0003771812,0.0007793236],"domain_scores_gemma":[0.9983609,0.00015425816,0.0003780501,0.00053308497,0.0002988198,0.0002748851],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00044122516,0.00061316846,0.0026274852,0.00021473844,0.00010507488,0.000022725722,0.00027708473,0.00024339465,0.000024768007],"category_scores_gemma":[0.00002278513,0.00034371222,0.0003098441,0.00042837163,0.00019300067,0.000008480097,0.000055871547,0.0002256629,0.000003236614],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019655903,0.00076881406,0.000005663583,0.57256526,0.00318835,0.00018623332,0.00007464874,0.000004398455,0.00032420346,0.000009084506,0.00008918333,0.42081857],"study_design_scores_gemma":[0.007903253,0.010080901,0.00001952641,0.94574136,0.0013213528,0.013701974,0.00015868768,0.000007219867,0.00019014941,0.000009529211,0.019846665,0.0010193668],"about_ca_topic_score_codex":0.00027977306,"about_ca_topic_score_gemma":0.00006284731,"teacher_disagreement_score":0.4197992,"about_ca_system_score_codex":0.0006164083,"about_ca_system_score_gemma":0.002227916,"threshold_uncertainty_score":0.9999015},"labels":[],"label_agreement":null},{"id":"W1976684510","doi":"10.1007/s10549-008-9938-z","title":"Germline RAP80 mutations and susceptibility to breast cancer","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Women's College Hospital; University of Toronto","funders":"McGill University","keywords":"Breast cancer; Medicine; Oncology; Germline mutation; Germline; Cancer; Internal medicine; Mutation; Biology; Genetics; Gene","score_opus":0.04105073879634214,"score_gpt":0.3579217438125442,"score_spread":0.3168710050162021,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976684510","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945549,0.0013660035,0.000028482345,0.0025031941,0.00003926521,0.00048974773,0.00087487925,0.000015167402,0.00012835427],"genre_scores_gemma":[0.9941754,0.0028988929,0.00021256995,0.000080415804,0.00021591838,0.0005191639,0.000060402323,0.000020136249,0.0018171353],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986803,0.00007059014,0.00012350234,0.0005201017,0.00021556635,0.00038996738],"domain_scores_gemma":[0.9991103,0.000015910016,0.000020918384,0.00028769698,0.00022258029,0.00034260974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013369143,0.00015505734,0.00014443693,0.00007174624,0.0002757773,0.00002705679,0.00007541798,0.00006964797,0.000132003],"category_scores_gemma":[0.000009140577,0.00012521728,0.000038523292,0.0001454598,0.00020587341,0.0000066014936,0.00011662212,0.0000647099,0.000008329398],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026147643,0.0012597675,0.28637016,0.00006524648,0.0005720867,0.000120503304,0.00081798865,0.00006489941,0.51003605,0.00021211803,0.0029135358,0.19495292],"study_design_scores_gemma":[0.0032090347,0.0015859307,0.88349783,0.000051072377,0.00004144763,0.000922572,0.00022689889,0.000063223255,0.10197382,0.00021531424,0.007809816,0.00040302117],"about_ca_topic_score_codex":0.003827391,"about_ca_topic_score_gemma":0.0034884939,"teacher_disagreement_score":0.59712774,"about_ca_system_score_codex":0.00013788746,"about_ca_system_score_gemma":0.00028647197,"threshold_uncertainty_score":0.57858956},"labels":[],"label_agreement":null},{"id":"W1977541054","doi":"10.1007/s10549-006-9433-3","title":"Influence of young age at diagnosis and family history of breast or ovarian cancer on breast cancer outcomes in a population-based cohort study","year":2006,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":64,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Statistics Canada; Lunenfeld-Tanenbaum Research Institute; Cancer Care Ontario; Mount Sinai Hospital","funders":"","keywords":"Breast cancer; Medicine; Family history; Lymphovascular invasion; Internal medicine; Oncology; Population; Cancer; Gynecology; Cohort; Ovarian cancer; Metastasis","score_opus":0.02923286623180769,"score_gpt":0.34057521312709343,"score_spread":0.3113423468952857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977541054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99367976,0.002907181,8.928274e-7,0.00041454626,0.00006511716,0.0010861488,0.0017681853,0.0000062019258,0.000071943985],"genre_scores_gemma":[0.9946688,0.0015061386,0.000022306273,0.00004018028,0.00007525762,0.0028400556,0.000074548756,0.00003054648,0.0007421702],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981298,0.00014028013,0.000356257,0.0005857141,0.0004332152,0.00035476286],"domain_scores_gemma":[0.99906737,0.00006516638,0.00013411572,0.00036926242,0.0002563892,0.00010768993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020039914,0.00024571083,0.0003831538,0.00021449708,0.00008756227,0.000014483853,0.00012555059,0.00010005309,0.000088896144],"category_scores_gemma":[0.000009705863,0.00019132646,0.00005232816,0.00022342904,0.00025659287,0.0000121570265,0.000085413136,0.00008920993,4.9508236e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015769736,0.0010662149,0.98319715,0.000049826976,0.00024537978,0.000021712203,0.00015476419,0.0031065773,0.0038508722,0.0000075760104,0.00018882401,0.0065341434],"study_design_scores_gemma":[0.0028252185,0.00046044713,0.9950847,0.000108306245,0.000060501985,0.000015749332,0.000067190944,0.000037170972,0.0009948722,0.000008727259,0.00016312639,0.00017397746],"about_ca_topic_score_codex":0.26891142,"about_ca_topic_score_gemma":0.1781522,"teacher_disagreement_score":0.09075921,"about_ca_system_score_codex":0.0024700658,"about_ca_system_score_gemma":0.00088529836,"threshold_uncertainty_score":0.8368444},"labels":[],"label_agreement":null},{"id":"W1977543422","doi":"10.1023/a:1024549729256","title":"Inhibition of Invasion and Metastasis by Glypican-3 in a Syngeneic Breast Cancer Model","year":2003,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Proteoglycans and glycosaminoglycans research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":92,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Glypican 3; Metastasis; Cancer research; Transfection; Biology; Mammary tumor; Apoptosis; Tumor progression; Cancer; Cell; Cell culture; Breast cancer; Cell biology","score_opus":0.04035635674864079,"score_gpt":0.34279847778590916,"score_spread":0.30244212103726836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977543422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98798573,0.008881962,0.00005002139,0.0007325437,0.000010551796,0.00052113825,0.0015990491,0.0000034525222,0.00021555969],"genre_scores_gemma":[0.9797742,0.019046549,0.000106014384,0.000023812912,0.000027439182,0.0006166506,0.000057079287,0.000020315232,0.00032793995],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99834776,0.00016344333,0.00019432268,0.0004995588,0.00031283597,0.000482086],"domain_scores_gemma":[0.9993116,0.000017016177,0.00003978927,0.0002347226,0.00017107563,0.0002257884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000307014,0.00018221224,0.00022760849,0.00016074497,0.00010846682,0.000032243697,0.00007066123,0.00010593742,0.000051878756],"category_scores_gemma":[0.000012453914,0.00014443544,0.000040032843,0.00024605685,0.000261637,0.000013072433,0.00008708575,0.00011773751,7.191662e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017593557,0.00079735357,0.030654706,0.000117158714,0.00021381327,0.00002049088,0.00013934479,0.00010748967,0.84602,0.00029245488,0.0006417568,0.11923607],"study_design_scores_gemma":[0.0080496855,0.001779351,0.035828184,0.0002771263,0.00005694801,0.00024196079,0.00037490326,0.00080821477,0.94889057,0.0008097128,0.0023518791,0.00053148693],"about_ca_topic_score_codex":0.007818248,"about_ca_topic_score_gemma":0.004435653,"teacher_disagreement_score":0.11870458,"about_ca_system_score_codex":0.0001650512,"about_ca_system_score_gemma":0.0004380923,"threshold_uncertainty_score":0.9987888},"labels":[],"label_agreement":null},{"id":"W1977677856","doi":"10.1007/s10549-014-3018-3","title":"Effect of multifocality and multicentricity on outcome in early stage breast cancer: a systematic review and meta-analysis","year":2014,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":94,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Hazard ratio; Internal medicine; Meta-analysis; Breast cancer; Oncology; Stage (stratigraphy); Odds ratio; Disease; Confidence interval; Cancer","score_opus":0.09569241060622743,"score_gpt":0.44817271916201196,"score_spread":0.3524803085557845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977677856","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0033347222,0.98592544,0.0000013348587,0.0002481024,0.00001481751,0.0042096428,0.0062474813,0.000007684273,0.000010753221],"genre_scores_gemma":[0.049025208,0.9452085,0.00000728815,0.000033551692,0.00003721611,0.0053379517,0.00010333568,0.000044208697,0.00020277752],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9950433,0.001808467,0.00091798656,0.0011799922,0.00046338158,0.00058689516],"domain_scores_gemma":[0.99777836,0.00050859706,0.00046636548,0.00077366777,0.00019145846,0.0002815677],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012585339,0.00081696967,0.006884807,0.00036058077,0.00013968236,0.00005188855,0.00019298845,0.0002025895,0.000033266984],"category_scores_gemma":[0.000072749084,0.00046274756,0.00077519915,0.00058338686,0.00034158718,0.000008804433,0.00026470528,0.00024562332,0.0000023488494],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000674134,0.00067369133,0.016531473,0.75614333,0.17083284,0.00003392929,0.000052778498,0.000002680819,0.0000011314003,0.000013251016,0.000015405976,0.055025365],"study_design_scores_gemma":[0.004291042,0.0032037243,0.02004987,0.035372797,0.9324547,0.00013953166,0.000020577703,0.000009540468,0.00003623853,0.0000025139032,0.0033105856,0.001108875],"about_ca_topic_score_codex":0.018115703,"about_ca_topic_score_gemma":0.0032975033,"teacher_disagreement_score":0.7616219,"about_ca_system_score_codex":0.00040192917,"about_ca_system_score_gemma":0.00015142803,"threshold_uncertainty_score":0.99978244},"labels":[],"label_agreement":null},{"id":"W1978388294","doi":"10.1007/s10549-012-2387-8","title":"Adherence to adjuvant hormone therapy in low-income women with breast cancer: the role of provider–patient communication","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":144,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Cancer Institute; American Cancer Society","keywords":"Medicine; Breast cancer; Tamoxifen; Patient satisfaction; Internal medicine; Population; Logistic regression; Multivariate analysis; Odds ratio; Hormone therapy; Cancer; Gynecology; Physical therapy; Surgery","score_opus":0.04881053203288777,"score_gpt":0.3616095271244036,"score_spread":0.3127989950915158,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978388294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98034644,0.012913089,0.0000022973347,0.0047680438,0.000012234691,0.0014415289,0.00008925769,0.000011602432,0.00041551623],"genre_scores_gemma":[0.9869578,0.0083820755,0.00004846816,0.00014054585,0.000053809857,0.0040992466,0.0000069252064,0.0000137033785,0.00029744554],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9984431,0.00012412755,0.000217075,0.00021558432,0.00050405273,0.00049602],"domain_scores_gemma":[0.99872714,0.00007024891,0.0000788787,0.0005055948,0.00026075993,0.0003573719],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029998546,0.0001429594,0.0002588243,0.00010560946,0.000118081356,0.000017759989,0.00015552565,0.000034890047,0.0003437364],"category_scores_gemma":[0.000006064416,0.00007653786,0.0000185349,0.0004453042,0.00021453584,0.000107866515,0.000059531194,0.00016391683,0.000028210265],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004071435,0.0009927849,0.32516688,0.000032738342,0.00010300859,0.0000028492166,0.0048796264,0.000004729459,0.0013632809,0.00010329209,0.00009742092,0.66318196],"study_design_scores_gemma":[0.0026149682,0.0027048725,0.9868972,0.00062305236,0.000010436185,0.00006750925,0.0035386088,0.00003833787,0.0016068844,0.00009155511,0.001706532,0.00010008482],"about_ca_topic_score_codex":0.010915014,"about_ca_topic_score_gemma":0.000564149,"teacher_disagreement_score":0.6630819,"about_ca_system_score_codex":0.00056464405,"about_ca_system_score_gemma":0.00045343058,"threshold_uncertainty_score":0.9956714},"labels":[],"label_agreement":null},{"id":"W1978585547","doi":"10.1007/s10549-005-9051-5","title":"Influence of selected lifestyle factors on breast and ovarian cancer risk in BRCA1 mutation carriers from Poland","year":2005,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":105,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Coalition for Research in Women's Health; Women's College Hospital","funders":"","keywords":"Breast cancer; Menarche; Medicine; Ovarian cancer; Gynecology; Obstetrics; Case-control study; Oncology; Population; Cancer; Oophorectomy; Internal medicine; Environmental health; Surgery; Hysterectomy","score_opus":0.014589228730126419,"score_gpt":0.31765784969409117,"score_spread":0.30306862096396475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978585547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99477667,0.0021163824,0.0000036450704,0.0005539422,0.000019544188,0.0002994628,0.0021885387,0.0000056749973,0.00003616766],"genre_scores_gemma":[0.99642736,0.0029549517,0.00006002491,0.000021510074,0.00014259016,0.00018623372,0.000118714495,0.000018420349,0.000070195565],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987909,0.00011760696,0.0001696118,0.00042021382,0.00020994962,0.00029172405],"domain_scores_gemma":[0.9993426,0.000047939055,0.000066542765,0.00020023268,0.00019746576,0.00014521752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010482769,0.00015932937,0.00015862916,0.00012581075,0.00011160468,0.000026973388,0.000072918265,0.00010205086,0.00003497423],"category_scores_gemma":[0.000024039722,0.00013272287,0.000021693379,0.00024451513,0.0001765439,0.000012581108,0.000040943738,0.00011630837,0.0000010944459],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010115544,0.00018153038,0.8970083,0.000012525653,0.00030512648,0.000005862047,0.0011181287,0.004169989,0.03138139,0.000012381094,0.00009151479,0.06470171],"study_design_scores_gemma":[0.001967377,0.00032080783,0.95213014,0.000049038874,0.000023677352,0.000014754464,0.00017782838,0.0000945474,0.044592418,0.00003471654,0.00047188753,0.00012281621],"about_ca_topic_score_codex":0.047938965,"about_ca_topic_score_gemma":0.02672414,"teacher_disagreement_score":0.0645789,"about_ca_system_score_codex":0.0003833568,"about_ca_system_score_gemma":0.0005004668,"threshold_uncertainty_score":0.9910356},"labels":[],"label_agreement":null},{"id":"W1978859321","doi":"10.1007/s10549-009-0356-7","title":"Defining the therapeutic window of vertebral photodynamic therapy in a murine pre-clinical model of breast cancer metastasis using the photosensitizer BPD-MA (Verteporfin)","year":2009,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Sunnybrook Health Science Centre","funders":"","keywords":"Verteporfin; Photodynamic therapy; Medicine; Photosensitizer; Bioluminescence imaging; Breast cancer; Radiation therapy; Cancer research; Pathology; Cancer; Oncology; Internal medicine; Macular degeneration; Luciferase; Ophthalmology; Transfection; Biology; Chemistry","score_opus":0.08337442915615176,"score_gpt":0.42766954862418294,"score_spread":0.34429511946803115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978859321","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9809922,0.011676035,0.0000125263805,0.0046268194,0.00003525686,0.0019128672,0.0006471437,0.000016145512,0.00008100997],"genre_scores_gemma":[0.9801027,0.019004794,0.00007051875,0.00024473376,0.000065932814,0.00031961012,0.000010224749,0.000036152443,0.00014531481],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.996467,0.0005055173,0.0006590414,0.00053431524,0.0010073883,0.00082673156],"domain_scores_gemma":[0.99805504,0.0004562373,0.00018453252,0.00066646596,0.00044722797,0.00019048229],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012776515,0.00035359498,0.0008839672,0.00026486156,0.0002612727,0.00003246435,0.0002685017,0.000097795484,0.0001143336],"category_scores_gemma":[0.000025302943,0.00017751822,0.00024634524,0.000707002,0.0010193376,0.00010188046,0.000104475264,0.00052957784,8.441646e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.036290493,0.0052306275,0.0750912,0.00015766593,0.0056508677,0.00013295327,0.004670561,0.0017806174,0.24697165,0.00047266006,0.00007774174,0.623473],"study_design_scores_gemma":[0.013476945,0.0028584865,0.915577,0.0006230055,0.00027755895,0.00033447292,0.00089248875,0.044872798,0.019960731,0.00081806723,0.000031524556,0.0002769168],"about_ca_topic_score_codex":0.017801737,"about_ca_topic_score_gemma":0.002612242,"teacher_disagreement_score":0.8404858,"about_ca_system_score_codex":0.0005619821,"about_ca_system_score_gemma":0.0011083324,"threshold_uncertainty_score":0.9887388},"labels":[],"label_agreement":null},{"id":"W1979391857","doi":"10.1023/a:1006480504790","title":"Liarozole Fumarate (R85246): In the Treatment of ER Negative, Tamoxifen Refractory or Chemotherapy Resistant Postmenopausal Metastatic Breast Cancer","year":2000,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; Princess Margaret Cancer Centre; Kingston General Hospital; Mount Sinai Hospital; Credit Valley Hospital; Ottawa Regional Cancer Foundation","funders":"","keywords":"Medicine; Internal medicine; Tamoxifen; Tolerability; Breast cancer; Chemotherapy; Refractory (planetary science); Oncology; Endocrinology; Estrogen receptor; Gastroenterology; Cancer; Adverse effect; Biology","score_opus":0.07173302003090129,"score_gpt":0.420558018104273,"score_spread":0.34882499807337175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979391857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9763915,0.007422057,1.6111429e-7,0.010825792,0.00006141573,0.0022581501,0.0015996939,0.000025214533,0.0014160485],"genre_scores_gemma":[0.91859823,0.06817428,0.00005497425,0.0003034105,0.00028308996,0.0023859825,0.00005447132,0.000049387592,0.010096185],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9971635,0.00037557542,0.00044008243,0.000614516,0.00059950264,0.0008068423],"domain_scores_gemma":[0.99860793,0.0003406128,0.00010165843,0.00045205164,0.00019305875,0.0003046789],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00025291689,0.00044063147,0.00074881606,0.00026719042,0.00021564016,0.000044865916,0.00014563349,0.0000871596,0.008757533],"category_scores_gemma":[0.0000024723372,0.00023164238,0.00012458357,0.0006892588,0.0004537527,0.00012873705,0.000015657388,0.00019648169,0.00002573364],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12060711,0.023957683,0.03806363,0.00020068776,0.0035137732,0.0015528263,0.01049865,0.000020127804,0.008240387,0.00005672139,0.002739895,0.7905485],"study_design_scores_gemma":[0.045198582,0.028535577,0.8612804,0.0004136865,0.00090023084,0.00076059904,0.00127563,0.0000778065,0.0054873386,0.00023363707,0.055354882,0.00048163396],"about_ca_topic_score_codex":0.03624864,"about_ca_topic_score_gemma":0.011644433,"teacher_disagreement_score":0.82321674,"about_ca_system_score_codex":0.0018695021,"about_ca_system_score_gemma":0.0010621897,"threshold_uncertainty_score":0.9921486},"labels":[],"label_agreement":null},{"id":"W1979560051","doi":"10.1007/s10549-014-3063-y","title":"Mammography screening and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a prospective study","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; BC Cancer Agency; McGill University; McGill Genome Centre; McGill University Health Centre; Public Health Ontario; University of Toronto","funders":"Canada Research Chairs","keywords":"Breast cancer; Medicine; Mammography; Hazard ratio; Cancer; Oncology; Internal medicine; Gynecology; Obstetrics; Confidence interval","score_opus":0.016129579865925288,"score_gpt":0.32847137247388386,"score_spread":0.3123417926079586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979560051","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922749,0.0054897317,0.000049233517,0.00070231565,0.000022910412,0.00097345334,0.00041516745,0.000003925582,0.000068357156],"genre_scores_gemma":[0.9952438,0.0035349932,0.00007301835,0.000013531258,0.00010187853,0.0009652239,0.000008520742,0.000015863927,0.000043192063],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986375,0.00030540695,0.00016078561,0.0004334114,0.00021425656,0.00024866677],"domain_scores_gemma":[0.9993639,0.00006772572,0.00007041966,0.00021625511,0.00019189926,0.00008980905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053577294,0.00014600823,0.00019259777,0.000121529505,0.00019314766,0.000047140904,0.0000710241,0.00005430531,0.000010828334],"category_scores_gemma":[0.000021363603,0.00009774899,0.000033435306,0.000243796,0.00055175787,0.000009760807,0.000092345625,0.00010867954,1.356115e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002052727,0.00018357848,0.839062,0.000020397405,0.00056585507,0.0000030502033,0.0020105166,0.0001123853,0.0007867424,0.000070559494,0.000021679301,0.15511055],"study_design_scores_gemma":[0.0072036427,0.0006396266,0.98763925,0.00004246196,0.000077234086,0.00004623264,0.0022398934,0.00023470588,0.0013538788,0.00031281635,0.000103095364,0.000107137836],"about_ca_topic_score_codex":0.016312473,"about_ca_topic_score_gemma":0.014042286,"teacher_disagreement_score":0.15500341,"about_ca_system_score_codex":0.00011033325,"about_ca_system_score_gemma":0.00014623512,"threshold_uncertainty_score":0.990238},"labels":[],"label_agreement":null},{"id":"W1980050427","doi":"10.1007/s10549-005-9121-8","title":"The role of CXCR4 receptor expression in breast cancer: a large tissue microarray study","year":2005,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":221,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Hôpital du Saint-Sacrement; McGill University","funders":"Canadian Breast Cancer Research Alliance; Fondation du cancer du sein du Québec; Breast Cancer Alliance; Cancer Research Institute","keywords":"Breast cancer; Tissue microarray; CA 15-3; Progesterone receptor; Pathology; Ductal carcinoma; Oncology; Breast carcinoma; CA15-3; Cancer; Medicine; Breast disease; Hormone receptor; Internal medicine; Cancer research; Biology; Estrogen receptor","score_opus":0.022639050688655554,"score_gpt":0.3620899242659409,"score_spread":0.3394508735772853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980050427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98161554,0.012227199,7.285376e-7,0.004607597,0.000034815883,0.000997477,0.00026168357,0.00001306327,0.00024190694],"genre_scores_gemma":[0.99181783,0.0061649554,0.000041500385,0.000013987376,0.0003940269,0.00053828774,0.000011475584,0.000023129136,0.0009948235],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99829465,0.00011309967,0.0002630663,0.00034201975,0.00046297995,0.00052416226],"domain_scores_gemma":[0.99918824,0.00009080693,0.000053835014,0.00026829864,0.00018490246,0.00021394095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040798416,0.00016948163,0.00031884448,0.00012546428,0.0002202564,0.00003268752,0.000094688476,0.000056939512,0.0006430775],"category_scores_gemma":[0.0000064443357,0.00009756684,0.000047608602,0.00028646525,0.00010087482,0.000059293292,0.000076481236,0.00019757498,0.00000923206],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002470352,0.0028166461,0.40633765,0.00003033907,0.0001469103,0.000013697511,0.0019027428,0.0000037962907,0.13043718,0.000015138716,0.0006691693,0.45515636],"study_design_scores_gemma":[0.017777108,0.0020703017,0.35755584,0.0011376699,0.000104749786,0.00016620707,0.009536014,0.0001429916,0.46614587,0.00005207904,0.14495815,0.00035302434],"about_ca_topic_score_codex":0.006792729,"about_ca_topic_score_gemma":0.0037295348,"teacher_disagreement_score":0.45480335,"about_ca_system_score_codex":0.00059821527,"about_ca_system_score_gemma":0.00028610826,"threshold_uncertainty_score":0.9998211},"labels":[],"label_agreement":null},{"id":"W1980168308","doi":"10.1007/s10549-007-9656-y","title":"HER2/neu in systemic therapy for women with breast cancer: a systematic review","year":2007,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Hospital; Cancer Care Ontario; McMaster University; Mount Sinai Hospital; Sunnybrook Health Science Centre; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Taxane; Oncology; Internal medicine; Anthracycline; Breast cancer; Hazard ratio; Meta-analysis; Adjuvant therapy; Confidence interval; Regimen; Relative risk; Cochrane Library; Clinical trial; Randomized controlled trial; Cancer; Gynecology","score_opus":0.17333335732310998,"score_gpt":0.5007484195405519,"score_spread":0.327415062217442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980168308","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001540021,0.9648531,0.0000018438694,0.0010838109,0.00007773079,0.031109218,0.0024494894,0.00006129554,0.00020951836],"genre_scores_gemma":[0.000338089,0.89988697,0.000018859173,0.00011809979,0.00045254148,0.09579606,0.000098704644,0.00024337345,0.0030472775],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99204427,0.00082439504,0.0014323806,0.0015069977,0.0018766907,0.0023152456],"domain_scores_gemma":[0.99543124,0.0007663171,0.00039270954,0.0013326148,0.0009751321,0.0011020089],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0031471315,0.0010589412,0.006181797,0.0010702542,0.00023004107,0.00014038236,0.0004811685,0.00039154897,0.00037209675],"category_scores_gemma":[0.00004805762,0.00059656904,0.00038228446,0.0019651805,0.00037690531,0.00010453413,0.000112933085,0.0009723306,0.00004244979],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.001182572,0.0004283852,0.00015797604,0.5376742,0.0012198853,0.0002986959,0.00010792277,1.03208194e-7,3.863731e-7,0.000011088657,0.0003017987,0.458617],"study_design_scores_gemma":[0.0042464496,0.0024036951,0.00016769061,0.836479,0.00086253206,0.005277406,0.00016221337,0.0000023587422,0.0000011766011,0.000007797032,0.14989357,0.00049611984],"about_ca_topic_score_codex":0.006638586,"about_ca_topic_score_gemma":0.0016457177,"teacher_disagreement_score":0.45812088,"about_ca_system_score_codex":0.013001779,"about_ca_system_score_gemma":0.007352615,"threshold_uncertainty_score":0.9999763},"labels":[],"label_agreement":null},{"id":"W1980674859","doi":"10.1007/s10549-006-9471-x","title":"Insulin receptor is an independent predictor of a favorable outcome in early stage breast cancer","year":2007,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":97,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Diabetes Canada; Statistics Canada; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Breast cancer; Medicine; Internal medicine; Oncology; Hazard ratio; Tissue microarray; Stage (stratigraphy); Biomarker; Cancer; Proportional hazards model; Insulin; Cohort; Progesterone receptor; Multivariate analysis; Clinical significance; Estrogen receptor; Biology; Confidence interval","score_opus":0.04349744498317911,"score_gpt":0.3569988510324634,"score_spread":0.31350140604928434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980674859","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9472952,0.04900438,0.000007790719,0.00013116782,0.00011254645,0.00048377147,0.0028271005,0.000007938509,0.00013011493],"genre_scores_gemma":[0.94532675,0.0527989,0.000041785755,0.00007720603,0.00035083696,0.00028187493,0.000061640094,0.000032702545,0.0010283189],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99774575,0.000105954474,0.0003661375,0.00059045985,0.00047947987,0.0007121906],"domain_scores_gemma":[0.9988555,0.000016482154,0.000090229645,0.0004047499,0.00026718347,0.00036589245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005959068,0.00023532887,0.00032964305,0.00018301657,0.00009018469,0.000040336785,0.00019631059,0.0001714931,0.0004822991],"category_scores_gemma":[0.0000076130095,0.0001903555,0.00006997984,0.00026706114,0.00018790223,0.000021304688,0.00010029915,0.00016877065,0.000005666086],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023749324,0.0008648882,0.73328996,0.0000734249,0.00021662246,0.000012765658,0.0006034529,0.000010887562,0.014814144,0.000055687808,0.00024690304,0.24743636],"study_design_scores_gemma":[0.0047351597,0.0010284735,0.8990523,0.000083776664,0.000027258036,0.000010356925,0.0004228209,0.000012034575,0.062041197,0.000044519693,0.03224687,0.00029519762],"about_ca_topic_score_codex":0.023307364,"about_ca_topic_score_gemma":0.009861565,"teacher_disagreement_score":0.24714117,"about_ca_system_score_codex":0.0002675077,"about_ca_system_score_gemma":0.00045098327,"threshold_uncertainty_score":0.9831965},"labels":[],"label_agreement":null},{"id":"W1980909734","doi":"10.1023/a:1013095329825","title":"Osteopontin(OPN)-induced increase in human mammary epithelial cell invasiveness is urokinase (uPA)-dependent","year":2001,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Bone and Dental Protein Studies","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation; London Health Sciences Centre; Western University","funders":"","keywords":"Urokinase receptor; Transfection; Matrigel; Osteopontin; Cell migration; Antibody; Biology; Cancer research; Plasminogen activator; Cell culture; Gentamicin protection assay; Vitronectin; Cell; Chemistry; Molecular biology; Cell biology; Immunology; Endocrinology; Fibronectin; Cancer; Metastasis; Angiogenesis; Biochemistry","score_opus":0.06318551601446971,"score_gpt":0.3640298236820039,"score_spread":0.30084430766753417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980909734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98871696,0.0026943146,0.0000014925458,0.00286197,0.000042065843,0.00115313,0.00013030019,0.00003130108,0.0043684803],"genre_scores_gemma":[0.99108917,0.0035215179,0.000020073328,0.00017870491,0.00020578595,0.0006750515,0.000026712763,0.000027821032,0.004255167],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99783796,0.00013331532,0.0002591231,0.00055047846,0.00057583756,0.00064327114],"domain_scores_gemma":[0.99895465,0.00005819293,0.000044826884,0.00038538454,0.00016584151,0.00039110743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027839426,0.00025550346,0.00041680434,0.00029475725,0.00028905144,0.000060745908,0.00010081044,0.00009461815,0.00024334936],"category_scores_gemma":[0.0000101236565,0.00019539877,0.00007726606,0.00034141433,0.0001321615,0.00013542181,0.0002179997,0.00025768444,0.000049505717],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013845591,0.007605198,0.5797857,0.00043410077,0.00056591723,0.018987548,0.002088862,9.0317e-7,0.13099594,0.00022457626,0.00095520477,0.24451044],"study_design_scores_gemma":[0.024036625,0.004017263,0.82611537,0.0005476477,0.00012637775,0.0013045543,0.0013992658,0.000011268517,0.1380047,0.00073230633,0.003208399,0.0004962397],"about_ca_topic_score_codex":0.04523253,"about_ca_topic_score_gemma":0.004853731,"teacher_disagreement_score":0.24632964,"about_ca_system_score_codex":0.0005754246,"about_ca_system_score_gemma":0.00028719087,"threshold_uncertainty_score":0.9611254},"labels":[],"label_agreement":null},{"id":"W1981065236","doi":"10.1007/s10549-011-1695-8","title":"Final overall survival results and effect of prolonged (≥1 year) first-line bevacizumab-containing therapy for metastatic breast cancer in the ATHENA trial","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Institute of Cancer Research","funders":"","keywords":"Bevacizumab; Metastatic breast cancer; Breast cancer; Medicine; Oncology; Internal medicine; Cancer; Surgery; Chemotherapy","score_opus":0.1811653887197427,"score_gpt":0.43949079744762376,"score_spread":0.25832540872788107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981065236","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885917,0.0027776998,0.0000010655638,0.0030309286,0.00009415328,0.004064699,0.0012291137,0.0000107450805,0.00019992236],"genre_scores_gemma":[0.9902234,0.005735765,0.000027235801,0.00003407715,0.0002770524,0.003383732,0.0000435566,0.000022436148,0.00025275338],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9982202,0.00030549636,0.00029114023,0.0003978799,0.00031675084,0.00046851864],"domain_scores_gemma":[0.998759,0.0006785983,0.00008763849,0.00020615138,0.00012978626,0.00013887932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009164378,0.00023567025,0.00053571444,0.00015465498,0.00014349901,0.00002027306,0.00008577507,0.00005734033,0.00015250483],"category_scores_gemma":[0.000019101351,0.00012840584,0.00009744597,0.00017825945,0.0002102381,0.000062504914,0.00002911289,0.00016621005,9.57565e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.797305,0.0019038034,0.067257,0.0001509614,0.0009769629,0.000090012276,0.003608569,0.0000023166301,0.00017825,0.00008400473,0.00013884161,0.1283043],"study_design_scores_gemma":[0.43198943,0.04794725,0.51586187,0.000275019,0.0005218111,0.00017944386,0.00024298907,0.00009739399,0.0015187277,0.00028797064,0.00086669414,0.00021137754],"about_ca_topic_score_codex":0.013706965,"about_ca_topic_score_gemma":0.0058794944,"teacher_disagreement_score":0.44860488,"about_ca_system_score_codex":0.0002716253,"about_ca_system_score_gemma":0.00030461,"threshold_uncertainty_score":0.99286085},"labels":[],"label_agreement":null},{"id":"W1981231327","doi":"10.1007/s10549-013-2429-x","title":"Should all BRCA1 mutation carriers with stage I breast cancer receive chemotherapy?","year":2013,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University; Centre Hospitalier de l’Université de Montréal; BC Cancer Agency; University of Toronto; Women's College Hospital","funders":"","keywords":"Breast cancer; Medicine; Chemotherapy; Internal medicine; Hazard ratio; Oncology; Stage (stratigraphy); Cancer; Estrogen receptor; Gynecology; Biology","score_opus":0.038989030391196805,"score_gpt":0.35569087951047423,"score_spread":0.31670184911927746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981231327","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863306,0.002397741,0.00005047186,0.008411374,0.00007687231,0.0010279814,0.0010513761,0.000022038419,0.00063151476],"genre_scores_gemma":[0.98594487,0.005622493,0.00023301817,0.00034091214,0.00034105303,0.0024889521,0.00016098864,0.00005930751,0.004808405],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99820834,0.000085654014,0.00015711189,0.0006194442,0.00037295543,0.0005564759],"domain_scores_gemma":[0.99879754,0.000018659362,0.00006168482,0.00036917158,0.0004760387,0.0002769255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001192803,0.00025271063,0.00018007492,0.000095983145,0.00020627456,0.00011376251,0.00014064038,0.00012504203,0.0007574258],"category_scores_gemma":[0.0000037486186,0.00018707929,0.00004699927,0.0002110305,0.00031079462,0.000021657992,0.000051760268,0.00013149132,0.000023636601],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042208633,0.0008958374,0.09922789,0.000134553,0.0036317839,0.000071447204,0.0025783612,0.0012413738,0.1193397,0.00011165915,0.022857212,0.74568933],"study_design_scores_gemma":[0.016538415,0.0042784456,0.6420615,0.0002608791,0.00022192788,0.0008330152,0.003937291,0.00050544646,0.21231072,0.0003601821,0.11703759,0.001654649],"about_ca_topic_score_codex":0.015226652,"about_ca_topic_score_gemma":0.0054603745,"teacher_disagreement_score":0.74403465,"about_ca_system_score_codex":0.00070858357,"about_ca_system_score_gemma":0.00075899856,"threshold_uncertainty_score":0.99133104},"labels":[],"label_agreement":null},{"id":"W1981831148","doi":"10.1007/s10549-009-0590-z","title":"Expression of TGF-β signaling factors in invasive breast cancers: relationships with age at diagnosis and tumor characteristics","year":2009,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary","funders":"National Institutes of Health","keywords":"Transforming growth factor; Breast cancer; Carcinogenesis; Immunohistochemistry; Biology; Cancer research; Tumor progression; Internal medicine; Oncology; Transforming growth factor beta; Medicine; Cancer; Pathology","score_opus":0.05042146044234101,"score_gpt":0.3176550100840627,"score_spread":0.2672335496417217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981831148","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99744624,0.0016558899,0.0000029590303,0.000108228494,0.000008711873,0.0003125483,0.000437895,0.0000053683434,0.000022167898],"genre_scores_gemma":[0.99847853,0.0010197936,0.000065494656,0.000011479745,0.000059365917,0.00016481697,0.0001370593,0.000014017224,0.0000494436],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989043,0.00010567858,0.00016515952,0.00034680706,0.00020186424,0.00027621756],"domain_scores_gemma":[0.9993856,0.000086682616,0.0000708912,0.00017653339,0.00010156058,0.00017872038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009968309,0.00015917429,0.00018474269,0.000094679184,0.00015772096,0.000027642162,0.00006716386,0.00005817656,0.000021692704],"category_scores_gemma":[0.000029776797,0.00011705067,0.000024218321,0.00010988225,0.00017844842,0.000009614925,0.000055272943,0.00008590051,4.561152e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010829478,0.00025265172,0.8519361,0.000038270042,0.000045137454,0.000050907795,0.00029747517,0.00003048134,0.14337772,0.0000060486614,0.000038462007,0.0028438135],"study_design_scores_gemma":[0.000857476,0.0005349799,0.73125046,0.00029888182,0.000015695812,0.000022174496,0.0001789644,0.000002279355,0.2666397,0.000019126928,0.00007137475,0.00010885567],"about_ca_topic_score_codex":0.0008355915,"about_ca_topic_score_gemma":0.0015904522,"teacher_disagreement_score":0.123262,"about_ca_system_score_codex":0.00020318419,"about_ca_system_score_gemma":0.00025185346,"threshold_uncertainty_score":0.4773188},"labels":[],"label_agreement":null},{"id":"W1981987902","doi":"10.1007/s10549-005-9026-6","title":"cDNA microarray analysis of isogenic paclitaxel- and doxorubicin-resistant breast tumor cell lines reveals distinct drug-specific genetic signatures of resistance","year":2005,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Gene expression and cancer classification","field":"Biochemistry, Genetics and Molecular Biology","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; Laurentian University; Sudbury Regional Hospital","funders":"","keywords":"Paclitaxel; Doxorubicin; Breast cancer; Microarray; Drug resistance; Biology; Complementary DNA; Microarray analysis techniques; Cancer research; Gene expression; Gene expression profiling; Gene; Cancer; Chemotherapy; Genetics","score_opus":0.018142472858571426,"score_gpt":0.3005116334721571,"score_spread":0.2823691606135857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981987902","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9518263,0.04585438,0.000028651448,0.00069907395,0.000020751073,0.00031787733,0.0010660976,0.000005212573,0.0001817046],"genre_scores_gemma":[0.989477,0.007969128,0.00032205088,0.00001860477,0.00014448959,0.00012401675,0.00009381186,0.000020900736,0.0018300007],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99817044,0.00016314726,0.00038739436,0.0006096665,0.0003220499,0.0003472885],"domain_scores_gemma":[0.9987443,0.000042532745,0.00018769756,0.00050301047,0.0003277467,0.00019469377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022108355,0.00022128838,0.00037597705,0.00026242924,0.0001314147,0.00002957573,0.00015967805,0.00007926561,0.000070864524],"category_scores_gemma":[0.000007369149,0.00017063248,0.00013201132,0.0004983128,0.00032547882,0.000007028569,0.00007807605,0.000081376136,9.62906e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001542732,0.00036472493,0.018104099,0.000083530635,0.00042813428,0.00000343717,0.00014182094,0.000039199873,0.96604395,0.000032607077,0.001559044,0.011656691],"study_design_scores_gemma":[0.0014949768,0.00030767836,0.55882466,0.00009284069,0.00024852325,0.000009971636,0.0003241146,0.000023837147,0.4282169,0.000037904083,0.010189566,0.00022900377],"about_ca_topic_score_codex":0.00034310218,"about_ca_topic_score_gemma":0.0015417103,"teacher_disagreement_score":0.5407206,"about_ca_system_score_codex":0.00008856886,"about_ca_system_score_gemma":0.0001452293,"threshold_uncertainty_score":0.6958191},"labels":[],"label_agreement":null},{"id":"W1982207478","doi":"10.1007/s10549-007-9537-4","title":"BARD1 and breast cancer in Poland","year":2007,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Coalition for Research in Women's Health","funders":"","keywords":"Breast cancer; CHEK2; Medicine; Oncology; Internal medicine; Cancer; Allele; Mutation; Germline mutation; Genetics; Biology; Gene","score_opus":0.027706546212335214,"score_gpt":0.37339352001416376,"score_spread":0.34568697380182856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982207478","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870841,0.009283123,0.000017018803,0.002136144,0.00006597899,0.00030948027,0.00064416905,0.0000060340203,0.00045398794],"genre_scores_gemma":[0.9929131,0.0058370805,0.00006128455,0.000055941713,0.00031141998,0.00018326034,0.000026625998,0.000020043924,0.0005912198],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99875546,0.000042154472,0.00013402896,0.00041720303,0.00018989274,0.0004612605],"domain_scores_gemma":[0.99944973,0.0000222934,0.000022478234,0.00019951143,0.000119588876,0.0001864193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027879042,0.00014329742,0.00012710848,0.00012748186,0.000121817364,0.000039884293,0.00007001117,0.00009152347,0.000114737515],"category_scores_gemma":[0.0000044198173,0.00011716538,0.000023008837,0.00017857549,0.00020281959,0.000006680014,0.00008487243,0.00009327358,0.0000026815253],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012754345,0.00022254382,0.62375575,0.000024037434,0.00017223466,0.000032046562,0.00019623645,0.000021257867,0.022285892,0.00008610814,0.0005966727,0.3513318],"study_design_scores_gemma":[0.0019336869,0.00019014989,0.9836694,0.000036215148,0.000011090248,0.00011364155,0.00014835632,0.00001019774,0.005855329,0.00008636926,0.007799563,0.0001460111],"about_ca_topic_score_codex":0.0050385636,"about_ca_topic_score_gemma":0.014534117,"teacher_disagreement_score":0.35991365,"about_ca_system_score_codex":0.00035376602,"about_ca_system_score_gemma":0.00032961933,"threshold_uncertainty_score":0.81103784},"labels":[],"label_agreement":null},{"id":"W1982234365","doi":"10.1007/s10549-013-2814-5","title":"Everolimus plus exemestane as first-line therapy in HR+, HER2− advanced breast cancer in BOLERO-2","year":2013,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Cancer Institute","keywords":"Exemestane; Everolimus; Medicine; Hazard ratio; Breast cancer; Aromatase inhibitor; Internal medicine; Oncology; Clinical endpoint; Cancer; Discontinuation; Randomized controlled trial; Aromatase; Confidence interval","score_opus":0.04306472712332436,"score_gpt":0.37923311203474724,"score_spread":0.33616838491142287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982234365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9582352,0.017123027,0.000005770353,0.020751903,0.00012053884,0.0029264921,0.00031956992,0.00007970315,0.0004377954],"genre_scores_gemma":[0.9519284,0.039322812,0.000120286386,0.00036523968,0.00031596282,0.005701724,0.000030822244,0.00010306595,0.0021116848],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9960511,0.00013699649,0.0005227815,0.0009925616,0.0008387579,0.0014578489],"domain_scores_gemma":[0.9980678,0.00015138976,0.000101921345,0.0006216341,0.0004464838,0.0006108033],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002437991,0.0005544001,0.0008547506,0.0005607702,0.00018647916,0.00007703256,0.00020763592,0.0001722094,0.0026984208],"category_scores_gemma":[0.000013207205,0.00041958116,0.000103894,0.0010105869,0.00040007354,0.00045828888,0.000101367434,0.0005294255,0.00008859225],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01259774,0.0014234479,0.12633033,0.00010074438,0.0002642671,0.0003860451,0.0011002474,0.00041914516,0.002371127,0.00006846062,0.00006158234,0.8548769],"study_design_scores_gemma":[0.029489515,0.0021968368,0.9574912,0.0011834204,0.000025187666,0.00076018396,0.00077221193,0.0003588604,0.0015442495,0.0010404993,0.004639955,0.0004978422],"about_ca_topic_score_codex":0.07359025,"about_ca_topic_score_gemma":0.019564226,"teacher_disagreement_score":0.854379,"about_ca_system_score_codex":0.0037585446,"about_ca_system_score_gemma":0.0010310241,"threshold_uncertainty_score":0.9998256},"labels":[],"label_agreement":null},{"id":"W1982980985","doi":"10.1007/s10549-009-0342-0","title":"Incidence of scalp metastases in breast cancer: a retrospective cohort study in women who were offered scalp cooling","year":2009,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Hôpital du Saint-Sacrement; Université Laval","funders":"Mach-Gaensslen Foundation of Canada","keywords":"Scalp; Medicine; Incidence (geometry); Breast cancer; Retrospective cohort study; Surgery; Cohort; Chemotherapy; Internal medicine; Cancer","score_opus":0.03366203268161049,"score_gpt":0.37550479586299856,"score_spread":0.34184276318138807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982980985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98845977,0.0043405183,3.313084e-7,0.0032001254,0.000034082335,0.0029292693,0.00084546674,0.000020719603,0.00016971557],"genre_scores_gemma":[0.98492426,0.011823604,0.000015645877,0.00006662462,0.00009845002,0.0028732978,0.000019168614,0.000025821677,0.00015310208],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99660426,0.0002074593,0.0005246521,0.00084058236,0.0009448829,0.00087816996],"domain_scores_gemma":[0.9985508,0.0001233383,0.00011168078,0.0004540666,0.000349108,0.00041105162],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00064964057,0.0003563072,0.0011604638,0.00058657,0.00011791857,0.000050574705,0.00012096918,0.00007972545,0.00034073787],"category_scores_gemma":[0.000019679177,0.00026824625,0.000088016975,0.0010089928,0.00020661637,0.00015461184,0.00007711821,0.00029615618,0.000004791257],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006529171,0.006499893,0.91541326,0.000047783495,0.0004933542,0.0004937068,0.0013644346,0.000019669094,0.00010771022,0.000040783845,0.00012191892,0.06886833],"study_design_scores_gemma":[0.010561905,0.0034267744,0.98294985,0.0010572069,0.00012245947,0.00010266477,0.0009911563,0.00005275562,0.000407924,0.00010578533,0.0000362788,0.00018524818],"about_ca_topic_score_codex":0.082422994,"about_ca_topic_score_gemma":0.024486307,"teacher_disagreement_score":0.06868308,"about_ca_system_score_codex":0.006358669,"about_ca_system_score_gemma":0.0008005414,"threshold_uncertainty_score":0.999977},"labels":[],"label_agreement":null},{"id":"W1982994560","doi":"10.1007/s10549-009-0621-9","title":"Cyclin D1 is a direct target of JAG1-mediated Notch signaling in breast cancer","year":2009,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":161,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Cyclin D1; Cancer research; Cyclin D; JAG1; Cyclin B; Cyclin A2; Notch signaling pathway; Biology; Breast cancer; Cell cycle; Cyclin A; Cyclin; Cancer; Signal transduction; Cell biology; Genetics","score_opus":0.02505003455872102,"score_gpt":0.347420285084259,"score_spread":0.32237025052553797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982994560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98819214,0.008316355,0.0000033474264,0.0014260862,0.000037667145,0.0003412841,0.0014899418,0.000012001841,0.00018118156],"genre_scores_gemma":[0.996559,0.002407452,0.0000763119,0.000112297275,0.00020603463,0.00020479722,0.00011866848,0.000022002407,0.00029340587],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998264,0.00011062648,0.00025856143,0.0005105822,0.00033132828,0.0005248872],"domain_scores_gemma":[0.9991741,0.000041439074,0.00006550292,0.00027926415,0.0002068355,0.00023285922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019192926,0.0002144228,0.00027419836,0.0001438764,0.00009270385,0.000029363626,0.00015141256,0.00011398592,0.00022234536],"category_scores_gemma":[0.00001623289,0.00017696332,0.000076168886,0.00027153117,0.00014512382,0.000007906302,0.000056543657,0.00010314397,0.000004935442],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030141713,0.0016686581,0.22101422,0.0000672881,0.00034522888,0.000059292994,0.00035583196,0.00026540627,0.7278716,0.000006605542,0.0013282871,0.044003397],"study_design_scores_gemma":[0.0039011985,0.0008536416,0.41640735,0.00033955186,0.000042216114,0.00003235827,0.00012576862,0.0001183574,0.57452136,0.00010086281,0.0031715673,0.00038576906],"about_ca_topic_score_codex":0.0035992574,"about_ca_topic_score_gemma":0.00042639696,"teacher_disagreement_score":0.19539315,"about_ca_system_score_codex":0.00016154944,"about_ca_system_score_gemma":0.00049732084,"threshold_uncertainty_score":0.7216355},"labels":[],"label_agreement":null},{"id":"W1985698558","doi":"10.1023/a:1026394718897","title":"Consensus on Medical Treatment of Metastatic Breast Cancer","year":2003,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"","keywords":"Breast cancer; Medicine; Metastatic breast cancer; Oncology; Cancer; Internal medicine","score_opus":0.11568431217018388,"score_gpt":0.4625313005886781,"score_spread":0.3468469884184942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985698558","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96849304,0.009213438,9.60616e-7,0.0156184,0.00021166634,0.001437228,0.0013799928,0.000037570913,0.003607698],"genre_scores_gemma":[0.97503895,0.019273575,0.00005526936,0.00014631252,0.00021643909,0.0012239661,0.00003290848,0.000038197162,0.003974411],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9973527,0.00025705644,0.00033148486,0.0005491773,0.0008141072,0.00069545256],"domain_scores_gemma":[0.99821126,0.00034885106,0.00007637966,0.000321063,0.00027232987,0.00077009934],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021249,0.00034551593,0.00070256455,0.0002769416,0.00017317865,0.000017263095,0.000061400955,0.000097562996,0.0057774703],"category_scores_gemma":[0.000014786361,0.0002210221,0.00015387767,0.00036308364,0.00051037496,0.000026590433,0.000017860193,0.00014518881,0.000034421842],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022525072,0.028571071,0.25612673,0.00031904166,0.008051134,0.0030430479,0.0013094313,0.000020734245,0.002656243,0.0037114997,0.0060900813,0.6675759],"study_design_scores_gemma":[0.13912591,0.055115305,0.58578056,0.0016476653,0.0040229564,0.012409051,0.0013351138,0.00023737097,0.058006607,0.0010807116,0.13989587,0.0013428766],"about_ca_topic_score_codex":0.010181015,"about_ca_topic_score_gemma":0.0018006378,"teacher_disagreement_score":0.66623306,"about_ca_system_score_codex":0.0014997593,"about_ca_system_score_gemma":0.0017339841,"threshold_uncertainty_score":0.99641025},"labels":[],"label_agreement":null},{"id":"W1986014640","doi":"10.1007/s10549-008-0099-x","title":"Columnar cell lesions, mammographic density and breast cancer risk","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Digital Radiography and Breast Imaging","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Occupational Cancer Research Centre","funders":"Canadian Institutes of Health Research; Canada Research Chairs","keywords":"Breast cancer; Breast tissue; Medicine; Pathology; Ductal carcinoma; Mammography; Mammary gland; MAMMOGRAPHIC DENSITY; Mastectomy; Cancer; Internal medicine","score_opus":0.03611311614348632,"score_gpt":0.3186660573304242,"score_spread":0.28255294118693786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986014640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98594797,0.00860015,0.0000035410833,0.0027993873,0.000046480698,0.00061249244,0.000895049,0.000059887956,0.0010350328],"genre_scores_gemma":[0.954376,0.043875802,0.00006934958,0.00007343519,0.00019206913,0.00023155213,0.000021149204,0.000030064126,0.0011305843],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979162,0.00009027458,0.00019165101,0.00058153307,0.00052869745,0.0006915996],"domain_scores_gemma":[0.9985583,0.00008332186,0.000054596378,0.0003005278,0.0002690839,0.0007341873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018255835,0.00026697086,0.00037785812,0.00038813715,0.0006926684,0.00007721534,0.000068981804,0.000077585195,0.00012480924],"category_scores_gemma":[0.000004840094,0.0002005074,0.00012186383,0.0006370254,0.00077142956,0.00018975478,0.00007990869,0.000284569,0.000010148574],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011838325,0.00075901113,0.82088536,0.00006290599,0.00024508874,0.00043531045,0.00015969272,6.11652e-7,0.00025107618,0.000027441763,0.000915189,0.17507446],"study_design_scores_gemma":[0.0033783184,0.0005270327,0.9885388,0.00018786057,0.00013786677,0.00475977,0.00016732012,0.00002962998,0.00055343163,0.00011791861,0.0014128922,0.00018918283],"about_ca_topic_score_codex":0.01928717,"about_ca_topic_score_gemma":0.0010109756,"teacher_disagreement_score":0.17488527,"about_ca_system_score_codex":0.0002181088,"about_ca_system_score_gemma":0.00035856245,"threshold_uncertainty_score":0.9872435},"labels":[],"label_agreement":null},{"id":"W1986150776","doi":"10.1007/s10549-008-9960-1","title":"Increased racial differences on breast cancer care and survival in America: historical evidence consistent with a health insurance hypothesis, 1975–2001","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University; University of Toronto; Windsor Regional Hospital; Ontario Tech University; Sunnybrook Health Science Centre; Western University; University of Windsor","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Breast cancer; Medicine; Socioeconomic status; Demography; Ethnic group; Gerontology; Disease; Health care; African american; Cancer; Race (biology); Health equity; Cancer registry; Public health; Environmental health; Population; Internal medicine; Pathology; Biology","score_opus":0.23468526276644805,"score_gpt":0.39945608154670104,"score_spread":0.164770818780253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986150776","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9656187,0.025035802,0.0000018441573,0.007894664,0.000053522934,0.0008044111,0.00037687432,0.000028986316,0.00018518837],"genre_scores_gemma":[0.95901287,0.039563674,0.00012277627,0.00031741927,0.0002090949,0.0005788414,0.000007898101,0.000022202368,0.00016521958],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968752,0.0002580547,0.00030080587,0.00072642823,0.0010055975,0.0008338864],"domain_scores_gemma":[0.99829805,0.00030530323,0.000099927885,0.00027735223,0.0003123414,0.0007069973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002106859,0.0003224077,0.0007366524,0.00023094869,0.0004126561,0.000038264934,0.00010002958,0.00007184949,0.00007011938],"category_scores_gemma":[0.00003779706,0.00021640942,0.00005662676,0.000540251,0.0005153303,0.00013701899,0.000049979557,0.0003212289,0.000003586442],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008809087,0.0003599361,0.8482817,0.00011411256,0.000098557066,0.00048248272,0.0012217587,0.0000038971302,0.00003959151,0.000008595021,0.0003082835,0.14027199],"study_design_scores_gemma":[0.0035960483,0.0035621498,0.98874754,0.0017720426,0.000026441585,0.0006886434,0.00082613074,0.000014998228,0.00003335594,0.0000053807157,0.00052500283,0.00020224162],"about_ca_topic_score_codex":0.23556207,"about_ca_topic_score_gemma":0.034635495,"teacher_disagreement_score":0.20092657,"about_ca_system_score_codex":0.0038797276,"about_ca_system_score_gemma":0.0019987174,"threshold_uncertainty_score":0.9999442},"labels":[],"label_agreement":null},{"id":"W1986794350","doi":"10.1007/s10549-012-2294-z","title":"Lipid concentrations in postmenopausal women on letrozole after 5 years of tamoxifen: an NCIC CTG MA.17 sub-study","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; Queen's University; University of British Columbia","funders":"National Cancer Institute; Avon Foundation for Women","keywords":"Letrozole; Medicine; Tamoxifen; Internal medicine; Cholesterol; Lipid profile; Placebo; Endocrinology; Breast cancer; Cancer","score_opus":0.017774811491571584,"score_gpt":0.32614693511733583,"score_spread":0.30837212362576427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986794350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972213,0.0019123605,2.9658065e-7,0.00007107373,0.0000410769,0.00049139553,0.00009774159,0.00000411284,0.00016063961],"genre_scores_gemma":[0.99845546,0.0006290714,0.0000064895153,0.000022123879,0.00016252599,0.00046972957,0.000041368556,0.000014823319,0.00019837354],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99885315,0.000147841,0.00011904342,0.0002361536,0.00018103528,0.00046275256],"domain_scores_gemma":[0.99946797,0.000014951636,0.000023938366,0.00021689216,0.000045707016,0.00023055503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019866262,0.00011614768,0.00013321148,0.00007875227,0.000051800445,0.000016101656,0.000061005212,0.00007849363,0.000035086698],"category_scores_gemma":[0.00000468417,0.00009437915,0.000021851874,0.00011472878,0.00009999801,0.000009949957,0.000041924795,0.00009839288,0.00000767964],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006312014,0.0086769555,0.68691576,0.000021029227,0.00043495235,0.00008097711,0.0026550833,0.000025694288,0.25628763,0.000067390494,0.00024714333,0.038275376],"study_design_scores_gemma":[0.0030288815,0.009499829,0.9319305,0.000026782707,0.000019289604,0.000026675849,0.00060065585,0.00000531321,0.05371984,0.000009338309,0.00097323715,0.00015967843],"about_ca_topic_score_codex":0.00046672483,"about_ca_topic_score_gemma":0.0001978937,"teacher_disagreement_score":0.24501474,"about_ca_system_score_codex":0.00014560767,"about_ca_system_score_gemma":0.000113056136,"threshold_uncertainty_score":0.384867},"labels":[],"label_agreement":null},{"id":"W1986975696","doi":"10.1007/s10549-007-9764-8","title":"Polymorphisms in manganese superoxide dismutase, myeloperoxidase and glutathione-S-transferase and survival after treatment for metastatic breast cancer","year":2007,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Glutathione Transferases and Polymorphisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; Sudbury Regional Hospital","funders":"","keywords":"GSTP1; Internal medicine; Breast cancer; Hazard ratio; Oncology; Medicine; SOD2; Genotype; Metastatic breast cancer; Single-nucleotide polymorphism; Cancer; Gastroenterology; Immunology; Biology; Confidence interval; Superoxide dismutase; Genetics","score_opus":0.033955207029171826,"score_gpt":0.34253263078740903,"score_spread":0.3085774237582372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986975696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97713774,0.014805101,0.00010121976,0.002348614,0.00006580777,0.0011027416,0.0044074967,0.000011548201,0.000019709521],"genre_scores_gemma":[0.9824501,0.015313237,0.00012855753,0.00009162365,0.00018601543,0.0012263978,0.00017240159,0.00005129079,0.00038034315],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99768156,0.00011118731,0.00031352186,0.0007828882,0.0002506326,0.0008602322],"domain_scores_gemma":[0.9989826,0.00010149678,0.000025059464,0.00026110015,0.00011034662,0.00051936106],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00037586433,0.00041713307,0.00039465394,0.00019491823,0.00022912315,0.00008293235,0.000071801085,0.00011947582,0.000056081113],"category_scores_gemma":[0.0000047350595,0.00031259458,0.000092116825,0.00017205082,0.00033971525,0.000025093508,0.000046710386,0.00010438164,0.0000014988956],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.038127717,0.0037630866,0.32088622,0.00032071205,0.0017020963,0.0013629425,0.0027087934,0.000037459653,0.21913898,0.0005910817,0.00008483843,0.41127607],"study_design_scores_gemma":[0.023646181,0.0047823125,0.91333455,0.0002558969,0.00035744067,0.0012280598,0.0011485723,0.00006880711,0.050543584,0.00021894365,0.003327451,0.001088226],"about_ca_topic_score_codex":0.01152474,"about_ca_topic_score_gemma":0.028487137,"teacher_disagreement_score":0.5924483,"about_ca_system_score_codex":0.00020127471,"about_ca_system_score_gemma":0.00021446505,"threshold_uncertainty_score":0.9999326},"labels":[],"label_agreement":null},{"id":"W1987598375","doi":"10.1007/s10549-006-9229-5","title":"Assessment of multiple different estrogen receptor-β antibodies for their ability to immunoprecipitate under chromatin immunoprecipitation conditions","year":2006,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Canadian Institutes of Health Research; CancerCare Manitoba Foundation; Manitoba Health Research Council","keywords":"Chromatin immunoprecipitation; Immunoprecipitation; Polyclonal antibodies; Gene isoform; Immunohistochemistry; Western blot; Monoclonal antibody; Estrogen receptor; Antibody; Molecular biology; Biology; Blot; Estrogen; Estrogen receptor alpha; Estrogen receptor beta; Endocrinology; Immunology; Breast cancer; Gene expression; Cancer; Biochemistry; Promoter; Genetics; Gene","score_opus":0.02177698084999967,"score_gpt":0.3525843592866273,"score_spread":0.3308073784366276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987598375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952837,0.0015975464,0.0002076932,0.0004371225,0.000059301015,0.0011271335,0.0011876049,0.000009976078,0.0000898761],"genre_scores_gemma":[0.9967114,0.00071456446,0.00051966286,0.0000061807973,0.00008682952,0.0009643266,0.0007816242,0.000019506271,0.0001959151],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99886155,0.00011574076,0.00021154531,0.00033449064,0.00015341358,0.00032324693],"domain_scores_gemma":[0.99926704,0.00010252765,0.00005690427,0.00024519488,0.00023585334,0.00009246201],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016871945,0.00017384652,0.00020223123,0.00007361094,0.00021628957,0.000030126132,0.00008257034,0.00008718908,0.000016111579],"category_scores_gemma":[0.00001044495,0.0001235575,0.00009531457,0.00008623732,0.00015568509,0.000006543713,0.00006309782,0.000061864215,0.0000016607617],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041495272,0.00063995423,0.03361345,0.000037441292,0.00026399587,3.6125294e-7,0.000060217408,0.0002099461,0.958491,0.0004520025,0.00020340228,0.0056132656],"study_design_scores_gemma":[0.0019612315,0.001912712,0.5753332,0.000055648692,0.000028216491,0.000006186863,0.00018778376,0.00012916722,0.41945207,0.0005184369,0.00026735335,0.00014800012],"about_ca_topic_score_codex":0.0010393327,"about_ca_topic_score_gemma":0.00017438846,"teacher_disagreement_score":0.54171973,"about_ca_system_score_codex":0.00015934164,"about_ca_system_score_gemma":0.00012470096,"threshold_uncertainty_score":0.5038529},"labels":[],"label_agreement":null},{"id":"W1987656036","doi":"10.1007/s10549-007-9616-6","title":"Breast cancer in pregnancy: a literature review","year":2007,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston General Hospital; Queen's University","funders":"","keywords":"Medicine; Pregnancy; Breast cancer; Cancer; Disease; MEDLINE; Obstetrics; Gynecology; Intensive care medicine; Oncology; Internal medicine","score_opus":0.1276499342256845,"score_gpt":0.4842009717356825,"score_spread":0.356551037509998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987656036","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000017243025,0.98845077,1.9951226e-7,0.0014177534,0.00014525309,0.004230351,0.00514457,0.000036179128,0.0005576596],"genre_scores_gemma":[0.000044493067,0.9915868,0.000008917137,0.00008355538,0.00064618443,0.0040030284,0.00027721748,0.00010835152,0.0032414296],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961076,0.00019266557,0.0007055034,0.0010632848,0.00080719334,0.001123779],"domain_scores_gemma":[0.9979951,0.00012113595,0.00017161379,0.00068888324,0.00034527396,0.00067803543],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003791382,0.0007461197,0.0026467403,0.00074215856,0.00012896449,0.00009216507,0.00018012422,0.00040134147,0.00093096215],"category_scores_gemma":[0.0000079859865,0.00045886904,0.00047205418,0.0018085733,0.00021418052,0.00010640396,0.00011582382,0.0010930275,0.000032272023],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002379818,0.00044353682,0.0008872407,0.0670197,0.00048548105,0.0011795883,0.000077713965,2.8575391e-8,1.0277912e-7,0.000022108385,0.0012460954,0.9284004],"study_design_scores_gemma":[0.0010673646,0.00019885738,0.0022635933,0.41904846,0.0005326994,0.002130593,0.0000057611205,2.8720345e-7,2.53078e-7,0.0000057130087,0.5745068,0.0002396053],"about_ca_topic_score_codex":0.007324115,"about_ca_topic_score_gemma":0.0037127496,"teacher_disagreement_score":0.9281608,"about_ca_system_score_codex":0.0032370188,"about_ca_system_score_gemma":0.0024165139,"threshold_uncertainty_score":0.9999823},"labels":[],"label_agreement":null},{"id":"W1987764512","doi":"10.1007/s10549-008-0064-8","title":"No association of TGFB1 L10P genotypes and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a multi-center cohort study","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Cancer Care Ontario; Lunenfeld-Tanenbaum Research Institute; Centre hospitalier universitaire de Québec; Université Laval","funders":"National Cancer Institute; National Institutes of Health; Cancer Research UK","keywords":"Breast cancer; Medicine; Genotype; Oncology; Mutation; Internal medicine; Allele; Cancer; Population; Genetics; Biology; Gene","score_opus":0.021839199231650036,"score_gpt":0.33036640146881474,"score_spread":0.3085272022371647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987764512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946982,0.003636948,0.0000032617363,0.00007881168,0.000026191157,0.00065896905,0.0008728728,0.000005365075,0.0000193833],"genre_scores_gemma":[0.993931,0.0052377423,0.00003570908,0.0000088096895,0.0000884347,0.00034818874,0.00005374158,0.000016125756,0.0002802452],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987131,0.0001746972,0.00017342567,0.00040914174,0.00025876585,0.0002708984],"domain_scores_gemma":[0.99934137,0.000031618165,0.00008397825,0.0001487937,0.0002556198,0.00013861882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022571192,0.00014394427,0.000190852,0.00008455091,0.0001507079,0.00002457835,0.0000498649,0.00007643141,0.000019988287],"category_scores_gemma":[0.000032310723,0.000121918594,0.000025299129,0.00009293474,0.00013298634,0.000011188352,0.000066005814,0.00007585963,0.0000010556117],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068304915,0.0009474862,0.986935,0.00002381328,0.00040261872,0.000018103201,0.0005542385,0.000016206117,0.0031219996,3.9938834e-7,0.000066521345,0.0072305575],"study_design_scores_gemma":[0.0046432964,0.00040876944,0.9922259,0.000034487344,0.00004740155,0.000031021213,0.00018568295,0.000058964808,0.0020995706,0.0000030290587,0.00015484731,0.00010704518],"about_ca_topic_score_codex":0.015368973,"about_ca_topic_score_gemma":0.008400196,"teacher_disagreement_score":0.0071235127,"about_ca_system_score_codex":0.00023700867,"about_ca_system_score_gemma":0.00022247546,"threshold_uncertainty_score":0.99118775},"labels":[],"label_agreement":null},{"id":"W1988243755","doi":"10.1007/s10549-011-1938-8","title":"The KL-VS sequence variant of Klotho and cancer risk in BRCA1 and BRCA2 mutation carriers","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Parathyroid Disorders and Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute for Health and Care Research; Canadian Institutes of Health Research; National Cancer Institute; Cancer Research UK; National Institutes of Health; ZonMw","keywords":"Breast cancer; Ovarian cancer; Internal medicine; Medicine; Oncology; Cancer; Mutation; BRCA2 Protein; BRCA mutation; Germline mutation; Cancer research; Biology; Genetics; Gene","score_opus":0.054248114749286626,"score_gpt":0.39405635770966085,"score_spread":0.3398082429603742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988243755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92325366,0.074462555,0.0000022545903,0.0012505406,0.000029413544,0.0005595904,0.00023498126,0.000005639138,0.0002013713],"genre_scores_gemma":[0.94338727,0.055897295,0.000034756045,0.000016422937,0.000044573342,0.00035592561,0.000008525981,0.000011256093,0.00024399652],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99884003,0.000105537685,0.0001498436,0.00023596142,0.00025052502,0.00041807524],"domain_scores_gemma":[0.99930996,0.00012830048,0.000050909064,0.00015632602,0.000083863015,0.00027066976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028498692,0.00013611911,0.00021702121,0.00009043134,0.00022069125,0.000027933938,0.000029770361,0.000046754023,0.000011769469],"category_scores_gemma":[0.00002068314,0.00008049637,0.000021428257,0.00018025083,0.00032658337,0.00010219396,0.000032720935,0.00010645788,0.0000012843423],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012938137,0.00033131652,0.85923713,0.000023115646,0.00029993628,0.000060102408,0.001882536,0.0000028942432,0.0003003657,0.00025785185,0.00009513278,0.13621578],"study_design_scores_gemma":[0.005390721,0.00061078457,0.9910377,0.000061632716,0.00010152087,0.00018379895,0.00072513043,0.00012554978,0.0005695655,0.00028108276,0.0008324001,0.00008005779],"about_ca_topic_score_codex":0.042606264,"about_ca_topic_score_gemma":0.0044839396,"teacher_disagreement_score":0.13613573,"about_ca_system_score_codex":0.00030222896,"about_ca_system_score_gemma":0.00022460667,"threshold_uncertainty_score":0.9637691},"labels":[],"label_agreement":null},{"id":"W1988337574","doi":"10.1023/a:1014993006190","title":"Expression of Ets-related Transcription Factors and Matrix Metalloproteinase Genes in Human Breast Cancer Cells","year":2002,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster University Medical Centre; Hamilton Regional Laboratory Medicine Program; Cancer Care Ontario","funders":"","keywords":"Cell culture; Matrix metalloproteinase; Messenger RNA; Gene expression; Cancer research; Biology; Molecular biology; Breast cancer; Gene; Cell; Transcription factor; Cancer; Genetics","score_opus":0.03330726156533099,"score_gpt":0.31611025138801857,"score_spread":0.2828029898226876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988337574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864573,0.012346479,0.0000043324017,0.00021503304,0.000029872383,0.00049465743,0.00040066976,0.000005864768,0.000045783054],"genre_scores_gemma":[0.99099284,0.008161102,0.000024089612,0.00000528941,0.000057649508,0.00025655318,0.000033447475,0.000017452076,0.0004515478],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99886453,0.000098112796,0.00018185748,0.00036246088,0.00019595293,0.00029710133],"domain_scores_gemma":[0.99956185,0.0000053937274,0.000045366058,0.00016861537,0.000075570104,0.0001432307],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000108675624,0.00017055676,0.00019346678,0.00010716973,0.00011493726,0.000020735848,0.000063182095,0.00012367478,0.0002214285],"category_scores_gemma":[0.0000013336488,0.00012459654,0.000050218605,0.0001081637,0.000112534966,0.000013280479,0.000044405766,0.000083141815,9.692246e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019649409,0.00029950304,0.00429182,0.000039083105,0.000055393426,0.000008744842,0.00014778934,0.000005576612,0.9866908,0.00002690432,0.00004932506,0.008188547],"study_design_scores_gemma":[0.0015997381,0.00047474762,0.007097846,0.000099059376,0.000018418781,0.000017625833,0.00009640843,0.000023418188,0.99012697,0.00007311532,0.00025019754,0.00012247765],"about_ca_topic_score_codex":0.004311017,"about_ca_topic_score_gemma":0.0005652687,"teacher_disagreement_score":0.008066069,"about_ca_system_score_codex":0.00007095478,"about_ca_system_score_gemma":0.00003846857,"threshold_uncertainty_score":0.6516997},"labels":[],"label_agreement":null},{"id":"W1988434980","doi":"10.1007/s10549-006-9172-5","title":"Diabetes mellitus and breast cancer: a retrospective population-based cohort study","year":2006,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":100,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Sunnybrook Health Science Centre; Mount Sinai Hospital; Institute for Clinical Evaluative Sciences","funders":"","keywords":"Medicine; Breast cancer; Diabetes mellitus; Hyperinsulinemia; Population; Hazard ratio; Incidence (geometry); Internal medicine; Cancer; Retrospective cohort study; Type 2 diabetes; Cohort study; Insulin resistance; Gynecology; Obstetrics; Confidence interval; Endocrinology; Environmental health","score_opus":0.012875956593008143,"score_gpt":0.30655907241789215,"score_spread":0.293683115824884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988434980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.885826,0.11190754,0.0000016116206,0.00019464348,0.000066796274,0.0008497367,0.001045348,0.000013937318,0.000094419476],"genre_scores_gemma":[0.97289556,0.024702623,0.000014033506,0.00004340754,0.00055957073,0.0013403827,0.00016043994,0.00003052428,0.0002534518],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99805886,0.0001385305,0.00018829138,0.0006922388,0.0003786023,0.00054349937],"domain_scores_gemma":[0.9991679,0.000020740821,0.000056532386,0.0003126251,0.00024909794,0.0001930727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024763902,0.0002458839,0.00030758043,0.000094729214,0.00028330612,0.00009336958,0.00008947999,0.00008704216,0.000070367634],"category_scores_gemma":[0.0000052476385,0.00019518418,0.000053798572,0.00018332402,0.00015458374,0.00000982827,0.000058973317,0.00009407959,0.000003516046],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002318879,0.0004989236,0.92720956,0.00001667134,0.00023218099,0.00000398916,0.000018852925,0.000019898107,0.0007064113,0.00003719634,0.00029867672,0.07072573],"study_design_scores_gemma":[0.0020956022,0.00048681442,0.9922337,0.000026440859,0.00007574026,0.000004427718,0.000048777354,0.000036374593,0.002178717,0.0001374119,0.0024738645,0.00020214022],"about_ca_topic_score_codex":0.040383697,"about_ca_topic_score_gemma":0.010367045,"teacher_disagreement_score":0.08720492,"about_ca_system_score_codex":0.00027699897,"about_ca_system_score_gemma":0.00021673238,"threshold_uncertainty_score":0.96600646},"labels":[],"label_agreement":null},{"id":"W1988499760","doi":"10.1023/b:brea.0000003956.11376.5b","title":"MR Imaging-guided Focused Ultrasound Surgery of Breast Cancer: Correlation of Dynamic Contrast-enhanced MRI with Histopathologic Findings","year":2003,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"MRI in cancer diagnosis","field":"Medicine","cited_by":146,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Saint-Luc","funders":"","keywords":"Magnetic resonance imaging; Medicine; Breast cancer; Ultrasound; Histopathology; Receiver operating characteristic; Radiology; Breast tumor; Cutoff; Dynamic contrast; Dynamic contrast-enhanced MRI; Breast MRI; Nuclear medicine; Contrast-enhanced ultrasound; Cancer; Mammography; Pathology; Internal medicine","score_opus":0.0339412082897941,"score_gpt":0.33782703545551884,"score_spread":0.30388582716572476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988499760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899494,0.0042727664,0.0001779884,0.002959774,0.000120885874,0.00119384,0.00081443123,0.00003551102,0.0004753853],"genre_scores_gemma":[0.98641604,0.012025843,0.00024087881,0.000036795333,0.0000424162,0.0007771438,0.000043637716,0.00004432438,0.00037291678],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974288,0.00017867608,0.00047586925,0.0005799513,0.00071815366,0.00061854796],"domain_scores_gemma":[0.9976822,0.00065366476,0.00021760773,0.00041478855,0.00074801134,0.00028369616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004995051,0.00030098716,0.000768016,0.00037702502,0.00011997894,0.000021816548,0.00008334735,0.00009044475,0.000591214],"category_scores_gemma":[0.000046761084,0.00022049487,0.00011813,0.00061547256,0.00063493446,0.00013057126,0.000019597193,0.00020381882,0.0000034080235],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00304511,0.0010859286,0.94574296,0.00030579255,0.0003701396,0.00009934985,0.000517919,0.000055754692,0.019405652,0.00014690624,0.0011736989,0.028050765],"study_design_scores_gemma":[0.0073294127,0.0009144605,0.9551595,0.0012941969,0.000332754,0.0010878639,0.0002696806,0.00010987984,0.032703333,0.00015650774,0.00035074685,0.00029168467],"about_ca_topic_score_codex":0.007119335,"about_ca_topic_score_gemma":0.0012868779,"teacher_disagreement_score":0.02775908,"about_ca_system_score_codex":0.0016623928,"about_ca_system_score_gemma":0.0012125606,"threshold_uncertainty_score":0.99949235},"labels":[],"label_agreement":null},{"id":"W1989466967","doi":"10.1007/s10549-010-1322-0","title":"A randomized, placebo-controlled trial (NCIC CTG MAP.2) examining the effects of exemestane on mammographic breast density, bone density, markers of bone metabolism and serum lipid levels in postmenopausal women","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Medical Imaging Techniques and Applications","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Pfizer","keywords":"Medicine; Bone remodeling; Bone mineral; Internal medicine; Femoral neck; Endocrinology; Exemestane; N-terminal telopeptide; Bone density; Placebo; Bone resorption; Breast cancer; Osteoporosis; Osteocalcin; Urology; Aromatase; Cancer; Alkaline phosphatase; Biology","score_opus":0.041634602959741585,"score_gpt":0.3285250110864677,"score_spread":0.2868904081267261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989466967","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907096,0.0012031307,0.000012070821,0.0016911116,0.0000494596,0.006097128,0.000061633174,0.00002580883,0.00015004932],"genre_scores_gemma":[0.9944778,0.001767503,0.0002761177,0.000060036342,0.00009215115,0.0030660965,0.0000058784285,0.00002448847,0.00022994576],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99742216,0.00053150073,0.00051627663,0.00040575047,0.00060450705,0.00051979517],"domain_scores_gemma":[0.9979028,0.0009922513,0.00017532319,0.0004022984,0.00019465208,0.00033266537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021059,0.00025375577,0.0013265316,0.00041028037,0.00011105956,0.00001902085,0.00009204654,0.00009378838,0.0000684763],"category_scores_gemma":[0.00012788479,0.00014644024,0.000100815654,0.00035382903,0.000818062,0.000045745892,0.000130661,0.00028281365,9.816677e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96208525,0.001588287,0.0029135665,0.00025766474,0.00066711,0.00013002058,0.00092934264,4.8933e-8,0.003710366,0.0005630765,0.00006553311,0.027089754],"study_design_scores_gemma":[0.8717782,0.003450641,0.118937686,0.00068373076,0.0004305289,0.00037720826,0.0002746653,0.000049847906,0.0030282333,0.0008162858,0.000021690807,0.00015128111],"about_ca_topic_score_codex":0.0034804665,"about_ca_topic_score_gemma":0.00017066147,"teacher_disagreement_score":0.116024114,"about_ca_system_score_codex":0.00014471848,"about_ca_system_score_gemma":0.00022610812,"threshold_uncertainty_score":0.597166},"labels":[],"label_agreement":null},{"id":"W1989960002","doi":"10.1007/s10549-011-1351-3","title":"Aromatase inhibitor therapy: toxicities and management strategies in the treatment of postmenopausal women with hormone-sensitive early breast cancer","year":2011,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":90,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; Ottawa Hospital; Pfizer (Canada); University of Ottawa","funders":"Pfizer","keywords":"Medicine; Tamoxifen; Aromatase; Breast cancer; Aromatase inhibitor; Adjuvant; Adjuvant therapy; Hormonal therapy; Internal medicine; Oncology; Cancer; Anastrozole; Gynecology","score_opus":0.03316697567197469,"score_gpt":0.3340144727176574,"score_spread":0.3008474970456827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989960002","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.30050877,0.6964777,1.5375976e-7,0.00004075231,0.000016396178,0.0015581901,0.0012358117,0.00000486439,0.00015734401],"genre_scores_gemma":[0.085696764,0.91098696,0.000009727032,0.000006997367,0.00013044379,0.0028316649,0.00013300739,0.00004404409,0.00016037261],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997971,0.00031749607,0.00026627904,0.0006032059,0.00025432467,0.00058772566],"domain_scores_gemma":[0.99921644,0.000041477746,0.00012103237,0.00037834226,0.00008074378,0.00016198975],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016112899,0.0005179509,0.0007399744,0.00018420753,0.00014117992,0.000085150015,0.0001380632,0.00021011742,0.000008732454],"category_scores_gemma":[4.369511e-7,0.00025881568,0.00007943576,0.00021649733,0.00045036082,0.000013716435,0.000059989412,0.00014608727,0.0000017746926],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040580737,0.0014418478,0.00012363204,0.00081968063,0.0030497902,0.00029196986,0.0020480617,6.796142e-7,0.00023514954,0.00014761348,0.00005633543,0.98772717],"study_design_scores_gemma":[0.036383275,0.1767242,0.068346046,0.017239189,0.0036818413,0.005441588,0.022173751,0.0000030925132,0.0038772207,0.00027748905,0.6614889,0.004363438],"about_ca_topic_score_codex":0.0030352916,"about_ca_topic_score_gemma":0.000357101,"teacher_disagreement_score":0.98336375,"about_ca_system_score_codex":0.0002983705,"about_ca_system_score_gemma":0.0003840178,"threshold_uncertainty_score":0.9999864},"labels":[],"label_agreement":null},{"id":"W1990195000","doi":"10.1007/s10549-011-1756-z","title":"Inhibition of EGFR phosphorylation in a panel of human breast cancer cells correlates with synergistic interactions between gefitinib and 5′-DFUR, the bioactive metabolite of Xeloda®","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital; Royal Victoria Regional Health Centre","funders":"Canadian Institutes of Health Research","keywords":"Gefitinib; Metabolite; Breast cancer; Phosphorylation; Cancer research; Pharmacology; Chemistry; Medicine; Internal medicine; Cancer; Epidermal growth factor receptor; Biochemistry","score_opus":0.11291987091672188,"score_gpt":0.3855439548003682,"score_spread":0.2726240838836463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990195000","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955231,0.0018529326,0.0000027226927,0.00036366459,0.000027479713,0.0007184317,0.0011274761,0.000005387264,0.0003788388],"genre_scores_gemma":[0.99716634,0.0022208295,0.000019745703,0.000006214491,0.000048349266,0.00032779734,0.000044399138,0.00001409429,0.0001522179],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99895906,0.00009576925,0.00027538507,0.0002335828,0.00021188386,0.00022434116],"domain_scores_gemma":[0.9991568,0.00016610147,0.00016394402,0.00013590913,0.0002751809,0.00010207406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001352335,0.00015079741,0.00039633524,0.00022695938,0.000078177036,0.0000052518662,0.00003394635,0.00004698251,0.00025444652],"category_scores_gemma":[0.000002324369,0.00009100675,0.00004287441,0.0003167166,0.00052150805,0.000082593535,0.00003040011,0.00014644938,5.390496e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0072251223,0.001911234,0.8624419,0.00021432516,0.0014585536,0.000027693692,0.006573013,0.0000060123125,0.08020066,0.00034674825,0.00002744308,0.039567325],"study_design_scores_gemma":[0.004257847,0.0012853554,0.8325141,0.0003689219,0.00051104464,0.000031939868,0.0008714864,0.000016299806,0.1598862,0.000170257,0.00001633385,0.000070202004],"about_ca_topic_score_codex":0.06729486,"about_ca_topic_score_gemma":0.004562729,"teacher_disagreement_score":0.07968553,"about_ca_system_score_codex":0.0002483328,"about_ca_system_score_gemma":0.00020799953,"threshold_uncertainty_score":0.9389161},"labels":[],"label_agreement":null},{"id":"W1990549321","doi":"10.1007/s10549-010-0849-4","title":"Role of ferritin alterations in human breast cancer cells","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":215,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Lethbridge","funders":"","keywords":"Ferritin; Breast cancer; Transferrin receptor; Ectopic expression; Cancer; Cancer research; Cancer cell; Biology; Ferroportin; Phenotype; Transferrin; Cell biology; Chemistry; Hepcidin; Immunology; Endocrinology; Biochemistry; Gene; Genetics","score_opus":0.024313338801978192,"score_gpt":0.3542347627396116,"score_spread":0.3299214239376334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990549321","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99632055,0.0011175966,0.0000026704868,0.0007234928,0.000034488996,0.00025620108,0.0008372004,0.000003409817,0.0007043879],"genre_scores_gemma":[0.99667716,0.0015884837,0.000036550002,0.0000140312695,0.00020762575,0.00058776117,0.000054889504,0.000013549439,0.0008199674],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991161,0.000040154795,0.00014588596,0.0002914619,0.00014127803,0.00026511517],"domain_scores_gemma":[0.9994176,0.0000071547565,0.00003276313,0.00026519434,0.00016510376,0.00011217477],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010683706,0.00010534309,0.000114875635,0.000084124214,0.00013398739,0.000030309086,0.00009866188,0.000073740775,0.00023878424],"category_scores_gemma":[0.0000015435066,0.000087655826,0.00003514381,0.00012344935,0.0001619777,0.0000063571733,0.000044119788,0.000109439876,0.0000020704167],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012228587,0.00032172687,0.020630619,0.000007920296,0.000040331113,0.0000012701191,0.00006867818,0.000020014619,0.94417506,0.00046612535,0.00017544102,0.03397051],"study_design_scores_gemma":[0.0016520811,0.00030001256,0.40197003,0.000044742337,0.000015008801,0.00003433371,0.00022520784,0.000056863988,0.5880872,0.00028109265,0.007145939,0.00018751297],"about_ca_topic_score_codex":0.012929424,"about_ca_topic_score_gemma":0.02083378,"teacher_disagreement_score":0.3813394,"about_ca_system_score_codex":0.000061032064,"about_ca_system_score_gemma":0.00022569469,"threshold_uncertainty_score":0.9970335},"labels":[],"label_agreement":null},{"id":"W1990635160","doi":"10.1007/s10549-009-0566-z","title":"Prognosis of BRCA-associated breast cancer: a summary of evidence","year":2009,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":135,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; McMaster University; Mount Sinai Hospital; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Breast cancer; Oncology; Internal medicine; BRCA mutation; Prospective cohort study; Cancer; Cohort study; Gynecology","score_opus":0.16344018365029997,"score_gpt":0.44749654594798965,"score_spread":0.2840563622976897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990635160","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019609549,0.9911858,0.0000010794794,0.00040262332,0.00006812667,0.0012804735,0.00500192,0.000008415193,0.000090612506],"genre_scores_gemma":[0.00996014,0.9869574,0.000045901033,0.000009549069,0.00023739539,0.0016540713,0.00025548125,0.00005261433,0.0008274987],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972538,0.000345414,0.0005821355,0.00075091684,0.00053205993,0.00053569535],"domain_scores_gemma":[0.99803734,0.000106782805,0.0003955609,0.0005430227,0.0007286708,0.00018860328],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039298148,0.00042018158,0.0011405764,0.00023935265,0.000110667395,0.000028895944,0.00035430427,0.00034899914,0.00007994709],"category_scores_gemma":[0.000036735444,0.0002942003,0.00033762265,0.00060247275,0.00040331882,0.0000093119925,0.00017954882,0.0002000032,0.0000021359867],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022021832,0.0005139641,0.0013438327,0.002429296,0.0012260305,0.0000072231223,0.000034892044,0.0000031127063,0.00020197713,0.00000719644,0.0018536014,0.99215865],"study_design_scores_gemma":[0.0031568075,0.0041018226,0.012880874,0.067343846,0.0028613526,0.00040091152,0.00009930277,0.000006868804,0.0044001844,0.000083796906,0.9033198,0.0013444875],"about_ca_topic_score_codex":0.0037321514,"about_ca_topic_score_gemma":0.0013542767,"teacher_disagreement_score":0.99081415,"about_ca_system_score_codex":0.0009799334,"about_ca_system_score_gemma":0.0037487089,"threshold_uncertainty_score":0.999951},"labels":[],"label_agreement":null},{"id":"W1990685855","doi":"10.1007/s10549-006-9381-y","title":"The effects of atamestane and toremifene alone and in combination compared with letrozole on bone, serum lipids and the uterus in an ovariectomized rat model","year":2006,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Mount Sinai Hospital","funders":"Canadian Institutes of Health Research","keywords":"Ovariectomized rat; Toremifene; Letrozole; Endocrinology; Uterus; Medicine; Internal medicine; Antiestrogen; Urology; Breast cancer; Tamoxifen; Estrogen; Cancer","score_opus":0.008242784768469388,"score_gpt":0.27686911209751175,"score_spread":0.26862632732904235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990685855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905384,0.008282886,0.0000045690776,0.00051961525,0.0000104759565,0.00059493224,0.000017018958,0.0000022460638,0.00002985333],"genre_scores_gemma":[0.9946986,0.004989018,0.000022582,0.000010670807,0.00001925709,0.00013981125,0.000022135308,0.000008800756,0.00008911736],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9991686,0.00018406223,0.00010377182,0.00022185134,0.000121303325,0.00020042036],"domain_scores_gemma":[0.9996293,0.00010744655,0.000029858254,0.00013634209,0.00003955392,0.000057493915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023357166,0.00011297034,0.0001735183,0.000048250226,0.00011461319,0.00003990661,0.000036225832,0.000058657515,2.0752822e-7],"category_scores_gemma":[0.000006623589,0.000057010304,0.00001105613,0.00008138284,0.0003730898,0.000007071167,0.000041749317,0.00008948735,4.2870486e-8],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14196223,0.003520297,0.33507845,0.00044617997,0.0005976123,0.00022720297,0.0012924069,0.0012359374,0.40171126,0.004331845,0.0002638664,0.10933271],"study_design_scores_gemma":[0.116267696,0.009356896,0.6314239,0.00047044683,0.00010169156,0.00023960281,0.00026235,0.022966135,0.21713692,0.001189519,0.00013234206,0.0004524794],"about_ca_topic_score_codex":0.0016282293,"about_ca_topic_score_gemma":0.0025032163,"teacher_disagreement_score":0.29634547,"about_ca_system_score_codex":0.00003882736,"about_ca_system_score_gemma":0.00005524589,"threshold_uncertainty_score":0.24614064},"labels":[],"label_agreement":null},{"id":"W1990710094","doi":"10.1007/s10549-009-0540-9","title":"Evaluation of variants in the CHEK2, BRIP1 and PALB2 genes in an Irish breast cancer cohort","year":2009,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"National Institute for Health and Care Research","keywords":"CHEK2; PALB2; Breast cancer; Medicine; Population; Internal medicine; Oncology; Cohort; Cancer; Germline mutation; Mutation; Genetics; Biology; Gene; Environmental health","score_opus":0.06853346983228717,"score_gpt":0.41524389056027156,"score_spread":0.3467104207279844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990710094","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884891,0.008658388,0.0000022078884,0.0017227817,0.000026211404,0.0006491458,0.00024121217,0.0000020232515,0.00020892295],"genre_scores_gemma":[0.992609,0.006524628,0.000032991575,0.00006204455,0.00013250607,0.00055264705,0.00004306779,0.000008937305,0.000034166053],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9984186,0.00031596664,0.00016512556,0.00037469066,0.00045600036,0.0002695751],"domain_scores_gemma":[0.99929243,0.000014868875,0.000038969283,0.0002657989,0.00032103958,0.00006688412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001081484,0.0001210938,0.00013634078,0.0000987259,0.00007100704,0.00003670016,0.00011165601,0.000076127544,0.00004349279],"category_scores_gemma":[0.000008651286,0.000088403234,0.00001920189,0.00022642298,0.0001317773,0.0000126635305,0.0000293829,0.000074502124,3.8938686e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038553373,0.0004881538,0.3896015,0.00001094154,0.00009243469,0.0000063945513,0.0005199228,0.00025893608,0.0213793,0.0000193227,0.00019011486,0.58704746],"study_design_scores_gemma":[0.0017935197,0.00032071327,0.99332136,0.00003347126,0.000039500985,0.000051439292,0.00026696917,0.00035848614,0.0033558176,0.00019684508,0.00017267995,0.00008922182],"about_ca_topic_score_codex":0.0061045648,"about_ca_topic_score_gemma":0.011290569,"teacher_disagreement_score":0.60371983,"about_ca_system_score_codex":0.00032792313,"about_ca_system_score_gemma":0.0006313392,"threshold_uncertainty_score":0.92283165},"labels":[],"label_agreement":null},{"id":"W1990719422","doi":"10.1007/s10549-012-2157-7","title":"Risk of rash with the anti-HER2 dimerization antibody pertuzumab: a meta-analysis","year":2012,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pertuzumab; Medicine; Rash; Internal medicine; Oncology; Trastuzumab; Incidence (geometry); Breast cancer; Docetaxel; Clinical trial; Cancer","score_opus":0.271116512031164,"score_gpt":0.5036414260120149,"score_spread":0.2325249139808509,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990719422","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004046652,0.9932876,0.000029234092,0.00085071754,0.000022928109,0.003087877,0.001923586,0.0000229103,0.00037045014],"genre_scores_gemma":[0.015699783,0.9792815,0.00004861939,0.000011013481,0.00024670974,0.002208925,0.00040525733,0.000098438264,0.0019997426],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9945008,0.0013460491,0.00055528485,0.0008158607,0.0018274388,0.00095455965],"domain_scores_gemma":[0.99651384,0.0006349859,0.00035940242,0.001277997,0.0006945991,0.00051916717],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015030971,0.0005994469,0.0039724135,0.00083887106,0.00033921414,0.00009045327,0.0003077816,0.00018700291,0.0015597007],"category_scores_gemma":[0.000028955565,0.00025475663,0.0012368012,0.002829462,0.00077429845,0.000082790284,0.0001605486,0.00075030525,0.00003430229],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003186727,0.0010116197,0.0058444343,0.0047391327,0.33286646,0.00006593847,0.00021488414,0.0000037467385,0.000003827044,0.00003797571,0.00017946473,0.6547138],"study_design_scores_gemma":[0.00094159174,0.0016302326,0.0060059032,0.00089083234,0.45516133,0.00020918097,0.00008934411,0.000012491355,0.000013358241,0.0000042194483,0.5347413,0.00030021268],"about_ca_topic_score_codex":0.017310511,"about_ca_topic_score_gemma":0.001423074,"teacher_disagreement_score":0.65441364,"about_ca_system_score_codex":0.00088790304,"about_ca_system_score_gemma":0.00209834,"threshold_uncertainty_score":0.99999046},"labels":[],"label_agreement":null},{"id":"W1991519982","doi":"10.1007/s10549-009-0662-0","title":"A randomized, placebo-controlled trial (NCIC CTG MAP1) examining the effects of letrozole on mammographic breast density and other end organs in postmenopausal women","year":2009,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Digital Radiography and Breast Imaging","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Health Sciences Centre; Sunnybrook Health Science Centre; Niagara Health System; Ontario Institute for Cancer Research","funders":"","keywords":"Letrozole; Medicine; Breast cancer; Aromatase inhibitor; Placebo; Tamoxifen; Internal medicine; Bone mineral; Hormone replacement therapy (female-to-male); Bone density; Clinical endpoint; Randomized controlled trial; Urology; Gynecology; Endocrinology; Oncology; Cancer; Osteoporosis; Testosterone (patch)","score_opus":0.018448964902709336,"score_gpt":0.3055030780993978,"score_spread":0.2870541131966885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991519982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916046,0.0014880766,0.0000015355413,0.0014849374,0.00004957596,0.004162703,0.000050954546,0.00002279246,0.001134794],"genre_scores_gemma":[0.99808633,0.00045893225,0.000009269831,0.00017469385,0.0001396771,0.00090840063,0.000004841226,0.000020812704,0.00019701688],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9976355,0.00041225587,0.00033124047,0.00042637752,0.0005428603,0.00065179804],"domain_scores_gemma":[0.9982332,0.0010221313,0.00008863451,0.0002752865,0.00009255299,0.00028817295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010592883,0.00028666816,0.00095807743,0.0005727238,0.00014636193,0.00007861235,0.0000829135,0.000068206944,0.000035303714],"category_scores_gemma":[0.000068979614,0.00015999915,0.00011802272,0.0005507709,0.00052811037,0.00009412789,0.00003188008,0.00025037563,0.0000017168474],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.88549143,0.0014674697,0.012588287,0.00006249377,0.00060640555,0.000166138,0.0007657928,5.551257e-7,0.00076147483,0.00026558217,0.000011580988,0.09781277],"study_design_scores_gemma":[0.8703075,0.006244792,0.12102831,0.00042525612,0.00015847046,0.00057035696,0.00029234806,0.000019582316,0.0003866676,0.00040783588,0.000021449649,0.000137416],"about_ca_topic_score_codex":0.0011696238,"about_ca_topic_score_gemma":0.00011859414,"teacher_disagreement_score":0.10844003,"about_ca_system_score_codex":0.00022318467,"about_ca_system_score_gemma":0.00018124789,"threshold_uncertainty_score":0.6524576},"labels":[],"label_agreement":null},{"id":"W1991742579","doi":"10.1007/s10549-013-2800-y","title":"Identifying molecular features that distinguish fluvastatin-sensitive breast tumor cells","year":2013,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":63,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Princess Margaret Cancer Centre; Institute of Cancer Research; Ontario Institute for Cancer Research; University of Toronto; University Health Network","funders":"Canada Research Chairs; Ontario Institute for Cancer Research; University of Pennsylvania","keywords":"Fluvastatin; Breast cancer; Cancer research; Cancer; Estrogen receptor; Oncogene; Biology; Molecular medicine; Medicine; Pharmacology; Internal medicine; Cell cycle; Simvastatin","score_opus":0.025579619097234024,"score_gpt":0.31896972401594903,"score_spread":0.293390104918715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991742579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884995,0.005857705,0.00008104285,0.00091520377,0.001361348,0.00095675857,0.0010670514,0.000027962471,0.0012333938],"genre_scores_gemma":[0.99074215,0.0019409779,0.00022561089,0.00014019052,0.0038226866,0.00051842997,0.00014302928,0.00004800809,0.0024189153],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997964,0.00014135134,0.0001587924,0.00065139896,0.00038216918,0.0007022657],"domain_scores_gemma":[0.9988289,0.000028317396,0.00006222019,0.00036236364,0.00035675237,0.00036148008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015562508,0.00028006957,0.00025638394,0.00009653869,0.0002792268,0.00020833881,0.00013950763,0.0000812485,0.00011144704],"category_scores_gemma":[0.000013024319,0.00022604894,0.00010926137,0.00013775767,0.00026571346,0.000014515028,0.00016538755,0.00015148286,0.000032033717],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005783834,0.0003893054,0.0043932237,0.000070483926,0.00050226983,0.000019621944,0.000422312,0.000011492163,0.8265386,0.00021062553,0.033315383,0.13354826],"study_design_scores_gemma":[0.0050184885,0.00082251977,0.33447406,0.00023683917,0.00013783116,0.0012508722,0.0021466562,0.000024590589,0.5721676,0.0005308775,0.08220766,0.0009820483],"about_ca_topic_score_codex":0.009314902,"about_ca_topic_score_gemma":0.00084990467,"teacher_disagreement_score":0.33008084,"about_ca_system_score_codex":0.00011725115,"about_ca_system_score_gemma":0.00022054583,"threshold_uncertainty_score":0.99728215},"labels":[],"label_agreement":null},{"id":"W1991822158","doi":"10.1007/s10549-008-0271-3","title":"A novel doxorubicin-mitomycin C co-encapsulated nanoparticle formulation exhibits anti-cancer synergy in multidrug resistant human breast cancer cells","year":2009,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":117,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Doxorubicin; Cancer; Mitomycin C; Multiple drug resistance; Human breast; Cancer research; Breast cancer; Medicine; Biology; Chemotherapy; Drug resistance; Internal medicine; Microbiology; Surgery","score_opus":0.03710128094177855,"score_gpt":0.3397939369125332,"score_spread":0.3026926559707546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991822158","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99416053,0.000954677,0.0000050273907,0.0021892842,0.000107708605,0.0009870861,0.0014345038,0.00009906163,0.00006209823],"genre_scores_gemma":[0.9980736,0.0006351704,0.00007387634,0.00009209426,0.00018334805,0.0004942655,0.000026164493,0.000042241478,0.00037924785],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9959261,0.00022856059,0.0005963826,0.0009715956,0.0009130961,0.0013643049],"domain_scores_gemma":[0.9984055,0.000106507934,0.00015297442,0.00050017337,0.00036877344,0.00046605797],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006194731,0.0004102052,0.00051130017,0.00036076465,0.00052495697,0.00024608528,0.00025755158,0.00012584841,0.0006458476],"category_scores_gemma":[0.000008619755,0.00033208745,0.000076357916,0.0007955006,0.00022427243,0.0005762156,0.00008059567,0.00020607926,0.000056515066],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001410174,0.0016207745,0.007523594,0.000032268577,0.000039608985,0.0000865506,0.00041932234,0.0016796706,0.9787288,0.00018972598,0.00015120208,0.008118364],"study_design_scores_gemma":[0.0049593346,0.00036507848,0.17477602,0.00027698863,0.000029009145,0.00002639812,0.00010646731,0.0014065392,0.8175881,0.000065892746,0.00008082262,0.0003193911],"about_ca_topic_score_codex":0.05509786,"about_ca_topic_score_gemma":0.010526765,"teacher_disagreement_score":0.16725242,"about_ca_system_score_codex":0.0017200247,"about_ca_system_score_gemma":0.00047081272,"threshold_uncertainty_score":0.9999131},"labels":[],"label_agreement":null},{"id":"W1992069532","doi":"10.1023/a:1014965726663","title":"Purging of Contaminating Breast Cancer Cells From Hematopoietic Progenitor Cell Preparations Using Activation Enhanced Cell Death","year":2002,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Arthritis Research Centre of Canada; Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Econazole; Progenitor cell; Cancer research; Cancer cell; Breast cancer; Haematopoiesis; Biology; Immunology; Cancer; Stem cell; Internal medicine; Medicine; Cell biology","score_opus":0.07928790543226419,"score_gpt":0.3651955292932847,"score_spread":0.28590762386102053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992069532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935746,0.0029225498,0.00014369539,0.00040796914,0.00008314693,0.0011442621,0.0008269845,0.000025561883,0.0008712214],"genre_scores_gemma":[0.9947146,0.0026482437,0.0007736456,0.000019409086,0.00029750203,0.00046382434,0.000027642029,0.000038946742,0.001016147],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99804294,0.00008428236,0.00033362594,0.0004983344,0.00053444545,0.000506341],"domain_scores_gemma":[0.99875885,0.000112056485,0.00015993799,0.00030288278,0.00037152864,0.00029475475],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00011893598,0.00024304983,0.000430685,0.00018289131,0.00025349265,0.00005257684,0.00006948027,0.000078242374,0.0011076573],"category_scores_gemma":[0.0000036727056,0.0001986006,0.00010408176,0.00033613504,0.00011367811,0.00015150024,0.000050302104,0.00016222351,0.000008232069],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006287766,0.0015289593,0.008393153,0.0003178533,0.0002541589,0.000022195067,0.0019091436,0.00009745525,0.92662275,0.000010387749,0.000114677314,0.0601005],"study_design_scores_gemma":[0.003859196,0.00033616577,0.008679298,0.0005155045,0.0002636211,0.000036661066,0.00072203594,0.0014888904,0.9836163,0.000016006472,0.000277507,0.0001888028],"about_ca_topic_score_codex":0.017512055,"about_ca_topic_score_gemma":0.00032542698,"teacher_disagreement_score":0.059911698,"about_ca_system_score_codex":0.00088121515,"about_ca_system_score_gemma":0.00033304782,"threshold_uncertainty_score":0.99980545},"labels":[],"label_agreement":null},{"id":"W1992180550","doi":"10.1007/s10549-006-9286-9","title":"Lewis x Antigen Mediates Adhesion of Human Breast Carcinoma Cells to Activated Endothelium. Possible Involvement of the Endothelial Scavenger Receptor C-type Lectin","year":2006,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"Consejo Nacional de Investigaciones Científicas y Técnicas; Agencia Nacional de Promoción Científica y Tecnológica; Directorate for Biological Sciences; Fundación Sales; Wellcome Trust","keywords":"Molecular biology; Monoclonal antibody; Chemistry; Antigen; Cancer cell; Endothelium; Biology; Cell biology; Cancer research; Antibody; Immunology; Cancer","score_opus":0.028687858565122862,"score_gpt":0.31403052753793553,"score_spread":0.2853426689728127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992180550","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973425,0.0005209699,0.0000018083546,0.0005358339,0.00007940671,0.0008225969,0.00042563397,0.000005129261,0.00026610366],"genre_scores_gemma":[0.99646235,0.00032841903,0.00004478289,0.000011678648,0.00018239902,0.00012228823,0.00007203026,0.000023098833,0.0027529697],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99830997,0.00018429074,0.00024178546,0.00036427737,0.00049333496,0.00040634614],"domain_scores_gemma":[0.9989342,0.00002478508,0.00007802495,0.0003645636,0.0004554623,0.00014296298],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024632856,0.00016732755,0.0001971181,0.00014694143,0.00020855693,0.00002617592,0.00020360475,0.00008900864,0.00014201793],"category_scores_gemma":[0.000011831318,0.00011179894,0.00007755409,0.00035787415,0.00019938697,0.0000070171013,0.00017691494,0.00009341996,0.000007176947],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008999681,0.0008655601,0.038963012,0.000033565542,0.00006940689,0.0000015710519,0.000082689716,0.000009172264,0.95380193,0.00003102622,0.0009788693,0.0042632204],"study_design_scores_gemma":[0.0020445127,0.0010478304,0.08114361,0.00004628847,0.000007088683,0.000008350409,0.00007064744,0.0000033610013,0.91346943,0.000029845703,0.002036457,0.00009258089],"about_ca_topic_score_codex":0.015346555,"about_ca_topic_score_gemma":0.0018969935,"teacher_disagreement_score":0.0421806,"about_ca_system_score_codex":0.00012561181,"about_ca_system_score_gemma":0.0003135237,"threshold_uncertainty_score":0.99121034},"labels":[],"label_agreement":null},{"id":"W1992261227","doi":"10.1007/s10549-008-0295-8","title":"Patterns of recurrence in the basal and non-basal subtypes of triple-negative breast cancers","year":2009,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":122,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Breast cancer; Basal (medicine); Cytokeratin; Estrogen receptor; Progesterone receptor; Medicine; Internal medicine; Oncology; Estrogen; Triple-negative breast cancer; Cancer; Immunohistochemistry; Pathology","score_opus":0.02613883904658297,"score_gpt":0.33701894609479943,"score_spread":0.31088010704821645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992261227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99383014,0.0025940032,0.000005762062,0.001884845,0.000033660323,0.0004595983,0.001015579,0.0000021528342,0.0001742733],"genre_scores_gemma":[0.9937715,0.0058077574,0.000030413998,0.000048603208,0.00008771922,0.00017115784,0.000027926999,0.000008618504,0.000046321034],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987106,0.00012103517,0.00019726726,0.00036982403,0.00026382573,0.00033750045],"domain_scores_gemma":[0.9993701,0.00006690359,0.000076675766,0.00024317666,0.00016471675,0.000078434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020173208,0.00018770013,0.000262093,0.00009150856,0.00009053932,0.0000146955435,0.00013281539,0.000060230686,0.000012408084],"category_scores_gemma":[0.000012695482,0.00012217289,0.000046766465,0.00019306033,0.00026359427,0.000008852814,0.000053917727,0.000088251916,3.4963057e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004378137,0.0008868027,0.8410383,0.00007922786,0.0004007032,0.000023535315,0.0021685713,0.000013439646,0.0048177987,0.00011988859,0.00040426126,0.14566933],"study_design_scores_gemma":[0.0025837817,0.001181058,0.9809127,0.00012974859,0.000027698177,0.000031622512,0.0008223734,0.000007715607,0.013931262,0.00021266936,0.000050833438,0.000108525506],"about_ca_topic_score_codex":0.015987784,"about_ca_topic_score_gemma":0.006945002,"teacher_disagreement_score":0.1455608,"about_ca_system_score_codex":0.0001324726,"about_ca_system_score_gemma":0.00027080296,"threshold_uncertainty_score":0.9905648},"labels":[],"label_agreement":null},{"id":"W1992316696","doi":"10.1007/s10549-014-2855-4","title":"Assessment of microtubule-associated protein (MAP)-Tau expression as a predictive and prognostic marker in TACT; a trial assessing substitution of sequential docetaxel for FEC as adjuvant chemotherapy for early breast cancer","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"Research England; Cancer Research UK; National Institute for Health and Care Research; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research","keywords":"Docetaxel; Tact; Taxane; Oncology; Breast cancer; Medicine; Tau protein; Internal medicine; Population; Immunohistochemistry; Tissue microarray; Cancer; Psychology","score_opus":0.02646158200281549,"score_gpt":0.3715063833433568,"score_spread":0.3450448013405413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992316696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916771,0.0012414431,0.0002663279,0.00053439185,0.000068367095,0.0044786856,0.0016901998,0.000008792385,0.000034680626],"genre_scores_gemma":[0.99100053,0.00062980416,0.000362542,0.000011955166,0.00019213518,0.007483919,0.00018844582,0.000036408914,0.00009426353],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9979761,0.0002029303,0.0003626718,0.00063107605,0.00032803704,0.00049915543],"domain_scores_gemma":[0.9988088,0.000116242074,0.00024498074,0.00020771363,0.0004897631,0.00013250655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045818446,0.00029565892,0.000501217,0.00013467333,0.00019169853,0.000049906943,0.00009582427,0.00016667096,0.000013222863],"category_scores_gemma":[0.000049800634,0.0002322621,0.000113786184,0.00013788362,0.00031542344,0.000029981973,0.00007841582,0.000090602654,1.4280158e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14614849,0.0047650244,0.34581694,0.000822739,0.0022581075,0.0000070213428,0.0005764645,0.00003632256,0.4350355,0.00023284685,0.000097147415,0.06420342],"study_design_scores_gemma":[0.084474586,0.0063226596,0.7937861,0.0013207362,0.000190992,0.000021216085,0.00016331417,0.00020306231,0.11266242,0.00036084006,0.0001904553,0.0003035868],"about_ca_topic_score_codex":0.005734917,"about_ca_topic_score_gemma":0.00094980875,"teacher_disagreement_score":0.4479692,"about_ca_system_score_codex":0.00042111747,"about_ca_system_score_gemma":0.00076371414,"threshold_uncertainty_score":0.94713736},"labels":[],"label_agreement":null},{"id":"W1992360936","doi":"10.1007/s10549-009-0473-3","title":"Cytotoxicity and mechanism of action of a new ROS-generating microsphere formulation for circumventing multidrug resistance in breast cancer cells","year":2009,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto","funders":"University of Toronto","keywords":"Multiple drug resistance; Microsphere; Cytotoxicity; Mechanism of action; Breast cancer; Mechanism (biology); Cancer research; Cancer cell; Medicine; Pharmacology; Cancer; Drug resistance; Chemistry; Biology; In vitro; Internal medicine; Genetics; Physics; Biochemistry","score_opus":0.050553072486108866,"score_gpt":0.3565520283039898,"score_spread":0.30599895581788095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992360936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952782,0.0016294786,0.0006146547,0.0009650652,0.000034774264,0.0010899116,0.0003387644,0.00001157395,0.0000375903],"genre_scores_gemma":[0.99489534,0.001685879,0.0024570131,0.000015201991,0.00010169983,0.000108215994,0.000020956386,0.000016522372,0.0006991798],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986902,0.000025983756,0.0003222711,0.00032606552,0.00028634974,0.00034912035],"domain_scores_gemma":[0.9993476,0.000035724475,0.00012359169,0.00013769885,0.00020214039,0.00015320328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023809975,0.00015896765,0.00036724962,0.00011833732,0.00011949856,0.000016436383,0.000038707687,0.00008281589,0.000026436974],"category_scores_gemma":[0.0000034351574,0.00012790748,0.00006607624,0.000217667,0.000040074967,0.000108581626,0.000009387469,0.00009770157,1.191783e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030824067,0.00042743044,0.010668294,0.00044769756,0.00008095978,0.000009429603,0.00083241134,0.000029595678,0.93952817,0.0010898194,0.00002312316,0.043780643],"study_design_scores_gemma":[0.007854268,0.00047966884,0.20464851,0.0014025419,0.0000926203,0.000020711823,0.00049459474,0.0011718011,0.7819377,0.0016792326,0.00004697099,0.00017135793],"about_ca_topic_score_codex":0.0043004183,"about_ca_topic_score_gemma":0.008735753,"teacher_disagreement_score":0.19398022,"about_ca_system_score_codex":0.00030073916,"about_ca_system_score_gemma":0.0002800733,"threshold_uncertainty_score":0.6500975},"labels":[],"label_agreement":null},{"id":"W1992858366","doi":"10.1007/s10549-010-0793-3","title":"Effect of air travel on lymphedema risk in women with history of breast cancer","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Lymphatic System and Diseases","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of British Columbia","funders":"","keywords":"Breast cancer; Medicine; Lymphedema; Cancer; Population; Air travel; Gynecology; Demography; Obstetrics; Surgery; Internal medicine; Environmental health","score_opus":0.017535173679999072,"score_gpt":0.32432764275137044,"score_spread":0.30679246907137137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992858366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949769,0.0017012906,2.5369326e-7,0.00029755748,0.00006106525,0.0007525749,0.00046613053,0.000008405131,0.0017358484],"genre_scores_gemma":[0.9974298,0.00064187066,0.0000051630755,0.000019004023,0.000107014974,0.0008702389,0.000004587159,0.000017831975,0.0009044901],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984799,0.00014919048,0.00020348083,0.0002916178,0.0005050909,0.00037073967],"domain_scores_gemma":[0.9989179,0.00021609961,0.00008604523,0.00030012304,0.0001485321,0.00033129303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036028036,0.00017531129,0.00048768288,0.00022123042,0.00003228176,0.0000035595954,0.000059400776,0.000060298866,0.00037678704],"category_scores_gemma":[0.000016574017,0.00010017313,0.000045093413,0.00017257991,0.00031201448,0.000038917726,0.000017159296,0.000035389705,0.0000033754823],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.035073135,0.0015975202,0.7557112,0.0007992369,0.00041259726,0.00009414626,0.0011146023,0.0000053839394,0.0036923557,0.00004284014,0.0003277848,0.20112923],"study_design_scores_gemma":[0.012024948,0.004163844,0.97942746,0.00062249467,0.00009818278,0.000116269264,0.00018424976,0.000017832786,0.0031045848,0.000009289828,0.00014429308,0.00008657257],"about_ca_topic_score_codex":0.030925388,"about_ca_topic_score_gemma":0.0016663679,"teacher_disagreement_score":0.22371626,"about_ca_system_score_codex":0.0017678057,"about_ca_system_score_gemma":0.0013727839,"threshold_uncertainty_score":0.97552776},"labels":[],"label_agreement":null},{"id":"W1993584752","doi":"10.1007/s10549-011-1816-4","title":"IGFBP7 reduces breast tumor growth by induction of senescence and apoptosis pathways","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research","keywords":"Senescence; Breast cancer; Apoptosis; Cancer research; Breast tumor; Signal transduction; Cellular senescence; Mammary gland; Medicine; Internal medicine; Oncology; Biology; Cancer; Cell biology; Genetics; Gene; Phenotype","score_opus":0.08185198898811565,"score_gpt":0.3178326369158198,"score_spread":0.23598064792770418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993584752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956221,0.002094681,0.0000034445397,0.0008449919,0.00005351153,0.00045513784,0.0003778421,0.000031737567,0.0005165587],"genre_scores_gemma":[0.9942755,0.004986639,0.00013944077,0.000026085541,0.00011066497,0.00014379705,0.000022064924,0.000021431197,0.00027435645],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9983457,0.00007842852,0.00022966304,0.00046580393,0.00042891383,0.00045149645],"domain_scores_gemma":[0.9989426,0.000045100103,0.00006880333,0.00022451558,0.00031550697,0.00040343215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001912453,0.0002057111,0.00034047483,0.00019721246,0.00017417844,0.000023721532,0.000071740964,0.00006656702,0.00013284269],"category_scores_gemma":[0.0000147297005,0.00014952439,0.00004407291,0.00033329372,0.000531866,0.0001465206,0.000053875036,0.00015243597,0.0000050503627],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043333396,0.00254446,0.29343995,0.00039188238,0.00041504466,0.000098917975,0.0032496566,4.111849e-8,0.26168248,0.00050282624,0.0011002222,0.43224117],"study_design_scores_gemma":[0.0023609037,0.0017544039,0.5509204,0.00041716459,0.00009625137,0.0011589394,0.0015477415,0.0000086191785,0.44108284,0.00024276471,0.00017956017,0.00023034941],"about_ca_topic_score_codex":0.011792843,"about_ca_topic_score_gemma":0.00009426792,"teacher_disagreement_score":0.4320108,"about_ca_system_score_codex":0.0001773912,"about_ca_system_score_gemma":0.0002434845,"threshold_uncertainty_score":0.9947877},"labels":[],"label_agreement":null},{"id":"W1993747196","doi":"10.1007/s10549-012-2073-x","title":"Body size and breast cancer prognosis in relation to hormone receptor and menopausal status: a meta-analysis","year":2012,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":188,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Princess Margaret Cancer Centre; Mount Sinai Hospital","funders":"University of Toronto","keywords":"Medicine; Breast cancer; Internal medicine; Hazard ratio; Meta-analysis; Oncology; Obesity; Gynecology; Estrogen receptor; Estrogen; Hormone receptor; Cancer; Endocrinology; Confidence interval","score_opus":0.19044661725629475,"score_gpt":0.4518748275884921,"score_spread":0.2614282103321974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993747196","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008661084,0.9813074,6.9669215e-7,0.0016852038,0.000034123437,0.0030600408,0.0051713865,0.000022411048,0.00005766361],"genre_scores_gemma":[0.041432437,0.95160705,0.000072384544,0.000022906377,0.00023676766,0.005506535,0.00018232349,0.00006875749,0.0008708642],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99644154,0.00028714194,0.0005920185,0.001008792,0.0006994406,0.00097109325],"domain_scores_gemma":[0.9978592,0.00027856353,0.00017267473,0.0003683854,0.00021195995,0.0011092641],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005249413,0.00062341016,0.0031302175,0.0008492474,0.00017234935,0.00012708691,0.00007187749,0.00022036002,0.0008627569],"category_scores_gemma":[0.000015846936,0.0003901048,0.00029941043,0.0014676062,0.00018861986,0.00015791306,0.00014370948,0.00045250132,0.00001025093],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011562163,0.000721986,0.016923936,0.0018786072,0.06634494,0.00003869063,0.00046269968,4.3381624e-7,0.0000145150225,0.000018292378,0.00022896813,0.9122107],"study_design_scores_gemma":[0.0028068137,0.0026489997,0.32489964,0.001429738,0.24189208,0.00024014775,0.00012735178,0.0000044453727,0.0000030398735,0.000010502644,0.4252105,0.00072673714],"about_ca_topic_score_codex":0.05288686,"about_ca_topic_score_gemma":0.0074955723,"teacher_disagreement_score":0.911484,"about_ca_system_score_codex":0.0017768927,"about_ca_system_score_gemma":0.000736988,"threshold_uncertainty_score":0.9998551},"labels":[],"label_agreement":null},{"id":"W1994219760","doi":"10.1007/s10549-012-1991-y","title":"Which prediction models best identify additional axillary disease after a positive sentinel node biopsy for breast cancer?","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Island Health; University of Victoria; BC Cancer Agency","funders":"Fonds De La Recherche Scientifique - FNRS; Memorial Sloan-Kettering Cancer Center","keywords":"Breast cancer; Sentinel node; Medicine; Biopsy; Oncology; Breast disease; Axillary nodes; Internal medicine; Cancer","score_opus":0.033391358338302535,"score_gpt":0.34224878293590105,"score_spread":0.3088574245975985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994219760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7584889,0.013423775,0.00016050052,0.006373104,0.00030770453,0.0013476532,0.21962403,0.00003839189,0.00023595786],"genre_scores_gemma":[0.9820595,0.0040507177,0.00009819963,0.00009841259,0.0016823316,0.008344468,0.003153412,0.00005732386,0.00045565527],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997706,0.00008551296,0.00021556612,0.0006910526,0.00041587002,0.000886002],"domain_scores_gemma":[0.99835205,0.00004976239,0.0000662103,0.00032196566,0.00065344607,0.0005565786],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012895421,0.00036357302,0.00024767092,0.00012156167,0.00045167512,0.00007532562,0.00010307742,0.00011947724,0.0003656501],"category_scores_gemma":[0.0000100164625,0.00029973075,0.00013572891,0.0002086349,0.00023060304,0.000057695626,0.0001647213,0.000095630996,0.0000141176115],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034349374,0.0064875395,0.880952,0.0003304929,0.0052596265,0.00006486616,0.0006591355,0.000222935,0.0052413014,0.00035294212,0.020117253,0.04596251],"study_design_scores_gemma":[0.0027895214,0.0001584691,0.993422,0.00020598173,0.00025753927,0.0002647602,0.00013924015,0.00015023169,0.0006372923,0.00016403323,0.0015030485,0.00030788305],"about_ca_topic_score_codex":0.0013036325,"about_ca_topic_score_gemma":0.00042796612,"teacher_disagreement_score":0.2235706,"about_ca_system_score_codex":0.00046543762,"about_ca_system_score_gemma":0.00038972177,"threshold_uncertainty_score":0.99994546},"labels":[],"label_agreement":null},{"id":"W1994262858","doi":"10.1007/s10549-014-3026-3","title":"Duration of tamoxifen use and the risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Women's College Hospital; Cancer Care Ontario; McGill University; University of Toronto; BC Cancer Agency; University of Alberta; Université de Montréal","funders":"National Cancer Institute","keywords":"Breast cancer; Tamoxifen; Medicine; Oncology; Internal medicine; Duration (music); Mutation; Cancer; Gynecology; Biology; Genetics; Gene","score_opus":0.017140606873584603,"score_gpt":0.31306727539047224,"score_spread":0.29592666851688765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994262858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99561435,0.0022538458,0.00002698982,0.00096610613,0.000027944385,0.000390293,0.0006978634,0.0000018249219,0.000020771953],"genre_scores_gemma":[0.9932999,0.0062638335,0.000046302714,0.000016444319,0.00006473757,0.0002127378,0.000025535915,0.000010333751,0.000060183433],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99900705,0.0002219179,0.000189326,0.000252659,0.00014814852,0.00018087492],"domain_scores_gemma":[0.99941134,0.000072885014,0.00009052801,0.0001629094,0.00019512666,0.00006718674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003328674,0.00010521854,0.00016698422,0.000066065935,0.00008513749,0.000031539665,0.00004696489,0.000062946456,0.000012547807],"category_scores_gemma":[0.00003137839,0.00007070594,0.00002546728,0.00010089423,0.0005176151,0.0000149236885,0.00004216872,0.000062896164,9.5246385e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043011256,0.0001323851,0.8041048,0.00007884512,0.0005694207,0.000002730543,0.0020729173,0.00054097,0.03451139,0.00041541236,0.000092720526,0.15317726],"study_design_scores_gemma":[0.0052193864,0.00025683452,0.97456056,0.000047077305,0.00005205598,0.000045603785,0.00019477734,0.0007849082,0.01829155,0.00030980137,0.00015234578,0.00008510671],"about_ca_topic_score_codex":0.016766137,"about_ca_topic_score_gemma":0.007902171,"teacher_disagreement_score":0.17045574,"about_ca_system_score_codex":0.000104131395,"about_ca_system_score_gemma":0.00017025144,"threshold_uncertainty_score":0.9897813},"labels":[],"label_agreement":null},{"id":"W1994685129","doi":"10.1007/s10549-012-2288-x","title":"Pooled analysis of individual patient data from capecitabine monotherapy clinical trials in locally advanced or metastatic breast cancer","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Capecitabine; Medicine; Metastatic breast cancer; Internal medicine; Regimen; Adverse effect; Breast cancer; Oncology; Odds ratio; Cancer; Progression-free survival; Gastroenterology; Surgery; Chemotherapy; Colorectal cancer","score_opus":0.3623807112931028,"score_gpt":0.5579478726196762,"score_spread":0.19556716132657337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994685129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96088064,0.016454263,0.000011810765,0.0028822818,0.00018263826,0.0017279321,0.0178033,0.000016756374,0.00004038798],"genre_scores_gemma":[0.9745741,0.022111567,0.00030640484,0.00021785736,0.0003694915,0.0009747774,0.0012094587,0.00003297084,0.00020336435],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9954032,0.0012536614,0.0011950497,0.0006918755,0.0007195945,0.0007366614],"domain_scores_gemma":[0.99642396,0.0017656024,0.00031310183,0.0006760199,0.00022858189,0.00059271406],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0023915577,0.00032439834,0.0019354825,0.0006325386,0.00007850384,0.000028885312,0.00022457975,0.00010456096,0.0049107876],"category_scores_gemma":[0.000088394605,0.00020037455,0.00023833783,0.0012064527,0.00027053704,0.0002232115,0.00016545194,0.00026135775,0.0000075331163],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029291477,0.006052672,0.4141712,0.000028038598,0.020240992,0.00007514891,0.0006922922,0.000028573077,0.0005126228,0.000006982949,0.00064661255,0.5282534],"study_design_scores_gemma":[0.02594896,0.002191589,0.9582316,0.0001683511,0.0098326225,0.000029131827,0.00048816117,0.00050693116,0.0005040367,0.000019042773,0.0018683819,0.0002111679],"about_ca_topic_score_codex":0.02452852,"about_ca_topic_score_gemma":0.017494142,"teacher_disagreement_score":0.5440604,"about_ca_system_score_codex":0.0006263703,"about_ca_system_score_gemma":0.0009746712,"threshold_uncertainty_score":0.99599886},"labels":[],"label_agreement":null},{"id":"W1994760694","doi":"10.1007/s10549-004-2622-z","title":"PEA3, AP-1, and a unique repetitive sequence all are involved in transcriptional regulation of the breast cancer-associated gene, mammaglobin","year":2005,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster University Medical Centre","funders":"","keywords":"Mammaglobin; Breast cancer; Gene; Biology; Sequence (biology); Cancer; Genetics; Cancer research; Computational biology","score_opus":0.04839983044940402,"score_gpt":0.33050966087985434,"score_spread":0.28210983043045035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994760694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895259,0.0026578198,0.0000060565158,0.006051777,0.000017303173,0.00037567917,0.001289359,0.0000038134174,0.00007227735],"genre_scores_gemma":[0.99159986,0.007165665,0.000036145102,0.0000592291,0.00008327836,0.00038175503,0.0000780905,0.000011081395,0.00058488076],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9989458,0.00013242956,0.00015991491,0.0003286619,0.00019672145,0.00023652452],"domain_scores_gemma":[0.99941033,0.000010888984,0.0000728625,0.00019913742,0.00022619202,0.0000805911],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017493848,0.00011861288,0.00012512233,0.000053748616,0.00010575577,0.000021528449,0.000088661924,0.00008470704,0.000035538767],"category_scores_gemma":[0.0000058592623,0.000086707776,0.00003911217,0.00016742403,0.00022888424,0.000011979759,0.000037775426,0.00008105808,3.578215e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00095940713,0.0006119988,0.23150016,0.000032075703,0.0002509143,0.0000031338595,0.0004217396,0.0003075297,0.7267792,0.0007586674,0.00031064896,0.038064472],"study_design_scores_gemma":[0.0013061048,0.00011047755,0.95598966,0.000101700025,0.000017458215,0.000023897517,0.00013350579,0.00014085016,0.040357415,0.00013251483,0.0015844837,0.00010192017],"about_ca_topic_score_codex":0.005904232,"about_ca_topic_score_gemma":0.022909952,"teacher_disagreement_score":0.7244895,"about_ca_system_score_codex":0.00035667943,"about_ca_system_score_gemma":0.00031559117,"threshold_uncertainty_score":0.9949194},"labels":[],"label_agreement":null},{"id":"W1995517580","doi":"10.1007/s10549-011-1896-1","title":"TIMP-1 in combination with HER2 and TOP2A for prediction of benefit from adjuvant anthracyclines in high-risk breast cancer patients","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Sunnybrook Health Science Centre; St. Michael's Hospital; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Breast cancer; Adjuvant; Medicine; Oncology; Internal medicine; Cancer","score_opus":0.056476571669289696,"score_gpt":0.3589421221986461,"score_spread":0.30246555052935636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995517580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990145,0.0012016258,0.0000062494014,0.0008291324,0.00005210655,0.0018295044,0.005858105,0.000012176535,0.00006608882],"genre_scores_gemma":[0.9909719,0.006911681,0.00020247935,0.000009949349,0.000087254084,0.0015100493,0.00016745066,0.000031304786,0.00010788491],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998112,0.00008198858,0.00031847498,0.00048390136,0.0005369628,0.0004666305],"domain_scores_gemma":[0.9988751,0.00012617258,0.0000844849,0.0002206832,0.00047044817,0.0002231158],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027768774,0.0001866095,0.0004076652,0.00034574317,0.00008175214,0.000018182413,0.00006781179,0.00009526148,0.00015372508],"category_scores_gemma":[0.000018152574,0.00013304329,0.000027434322,0.00035161892,0.0002401073,0.00014271986,0.000050557344,0.00020048644,0.000001052982],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006326378,0.0017912871,0.7757727,0.000107910535,0.0001057902,0.000013817111,0.0007156539,0.0000028564302,0.00007266298,0.000041392643,0.000037487625,0.21501204],"study_design_scores_gemma":[0.014827419,0.00374133,0.9781704,0.0007728058,0.000053036805,0.000010308643,0.00020412111,0.00029799587,0.0012815368,0.00047708658,0.00006837908,0.00009557799],"about_ca_topic_score_codex":0.21937238,"about_ca_topic_score_gemma":0.04468502,"teacher_disagreement_score":0.21491647,"about_ca_system_score_codex":0.00078244455,"about_ca_system_score_gemma":0.0003376086,"threshold_uncertainty_score":0.97274697},"labels":[],"label_agreement":null},{"id":"W1995791488","doi":"10.1007/s10549-015-3268-8","title":"Germ line knockout of IGFBP-3 reveals influences of the gene on mammary gland neoplasia","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre; Jewish General Hospital","funders":"","keywords":"Knockout mouse; Endocrinology; Internal medicine; Gene knockout; Biology; Carcinogenesis; Mammary gland; Metastasis; Mammary tumor; DMBA; Cancer research; Cancer; Breast cancer; Receptor; Gene; Medicine; Genetics","score_opus":0.09393618233507531,"score_gpt":0.36794795206356307,"score_spread":0.27401176972848773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995791488","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925221,0.0029406825,0.0000010115538,0.0025068463,0.000060710572,0.00052273343,0.00017410071,0.00000959917,0.0012621899],"genre_scores_gemma":[0.9971116,0.0016124072,0.000046297806,0.00006201981,0.00012576587,0.00007301328,0.0000121941075,0.000012537406,0.00094416825],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99844414,0.000092225695,0.00027579616,0.00024209953,0.000635314,0.00031042326],"domain_scores_gemma":[0.9987556,0.00008467288,0.00009157214,0.00039117053,0.00037591037,0.0003010747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002608208,0.00015191219,0.00034697598,0.00014479454,0.000070527756,0.0000123041045,0.00012476409,0.000074003976,0.000020972342],"category_scores_gemma":[0.000046261845,0.000081037964,0.00007440169,0.0003368778,0.00024821394,0.00006378934,0.00008175991,0.00014658495,0.0000052697897],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052073086,0.0015580581,0.87790275,0.00022790635,0.0006652273,0.00009233469,0.0014526345,0.000012871851,0.013158473,0.0004786435,0.0020713983,0.09717237],"study_design_scores_gemma":[0.0039200364,0.0030187815,0.940147,0.00028494923,0.000068045105,0.000108925735,0.00013831467,0.000014484673,0.050630312,0.0004433485,0.0011391205,0.000086727494],"about_ca_topic_score_codex":0.0027865332,"about_ca_topic_score_gemma":0.00010240178,"teacher_disagreement_score":0.09708565,"about_ca_system_score_codex":0.00017748527,"about_ca_system_score_gemma":0.00059297186,"threshold_uncertainty_score":0.42124233},"labels":[],"label_agreement":null},{"id":"W1996044800","doi":"10.1007/s10549-011-1533-z","title":"Effects of music therapy on pain among female breast cancer patients after radical mastectomy: results from a randomized controlled trial","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Music Therapy and Health","field":"Psychology","cited_by":147,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Randomized controlled trial; Mastectomy; Physical therapy; McGill Pain Questionnaire; Anxiety; Modified Radical Mastectomy; Radical mastectomy; Music therapy; Breast surgery; Cancer; Surgery; Internal medicine; Visual analogue scale","score_opus":0.057789338278717926,"score_gpt":0.35697362497440327,"score_spread":0.29918428669568536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996044800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98551345,0.0025252397,0.000003923716,0.0003543016,0.0005675338,0.0091124335,0.0011503928,0.000030495872,0.0007422108],"genre_scores_gemma":[0.98299253,0.0013563492,0.000010589984,0.00020491176,0.0005663072,0.01414815,0.000030433413,0.000041700776,0.00064904045],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9940124,0.0032714913,0.0006823335,0.00071629963,0.0005813458,0.00073608954],"domain_scores_gemma":[0.99639,0.0023349668,0.0002632555,0.0004259287,0.00019453761,0.00039134876],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017299589,0.00036133663,0.0014842696,0.00024341019,0.0001620296,0.000028436147,0.0001629633,0.00019959823,0.004483776],"category_scores_gemma":[0.000051091574,0.00021464315,0.00031306446,0.000200583,0.0005705003,0.000060714745,0.00003066187,0.00028691022,0.000019510018],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8380613,0.0045605055,0.0075244717,0.000021244521,0.0016064883,0.00005328323,0.0078037865,1.3379261e-7,0.000010216576,0.00008363272,0.0002340475,0.1400409],"study_design_scores_gemma":[0.724507,0.0039097085,0.27077913,0.0002020763,0.00007533578,9.28763e-7,0.00006163085,0.0000061073424,0.000067593435,0.00013977855,0.000113154376,0.00013755269],"about_ca_topic_score_codex":0.071679704,"about_ca_topic_score_gemma":0.0024122212,"teacher_disagreement_score":0.26325467,"about_ca_system_score_codex":0.00028941754,"about_ca_system_score_gemma":0.00027092898,"threshold_uncertainty_score":0.9964263},"labels":[],"label_agreement":null},{"id":"W1996079450","doi":"10.1007/s10549-006-9208-x","title":"Pre-menopausal breast cancer and aromatase inhibitors: treating a new generation of women","year":2006,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Aromatase; Breast cancer; Medicine; Cancer; Internal medicine; Oncology; Gynecology; Endocrine system; Aromatase inhibitor; Menopause; Population; Anastrozole; Hormone","score_opus":0.03804621043606593,"score_gpt":0.3665825666742077,"score_spread":0.32853635623814176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996079450","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.121449135,0.8759856,0.0000011387642,0.000058948648,0.0000470491,0.00085763267,0.0015519311,0.000008116976,0.000040429975],"genre_scores_gemma":[0.008785282,0.9872167,0.00003004946,0.0000037223242,0.001077663,0.0009237572,0.000819546,0.000054554846,0.0010887248],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99797,0.00017745978,0.0003561763,0.0006451232,0.00025556723,0.0005956919],"domain_scores_gemma":[0.9990412,0.000028837247,0.00016972779,0.00029253244,0.000092114205,0.00037561162],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020488043,0.00040985463,0.00074041105,0.00015132816,0.00016013885,0.000066877255,0.00009552071,0.00033782472,0.00002206699],"category_scores_gemma":[0.0000055681107,0.00028579283,0.000091733826,0.0001944602,0.00017235363,0.000008876029,0.0001248927,0.00018527571,0.0000019343624],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021492077,0.00023968623,0.00025660946,0.0013333216,0.00078148703,0.00002226068,0.00007030681,0.0000034943125,0.0026359903,0.000008982534,0.0013992513,0.9930337],"study_design_scores_gemma":[0.009764484,0.009624208,0.002312513,0.015419641,0.0022208719,0.0028135006,0.00012196073,0.00005655411,0.009377228,0.00005603951,0.94605786,0.0021751232],"about_ca_topic_score_codex":0.007739442,"about_ca_topic_score_gemma":0.0003397189,"teacher_disagreement_score":0.99085855,"about_ca_system_score_codex":0.00048371218,"about_ca_system_score_gemma":0.001066311,"threshold_uncertainty_score":0.9999594},"labels":[],"label_agreement":null},{"id":"W1996146233","doi":"10.1023/a:1017371013487","title":"Effects of Bcl-2 modulation with G3139 antisense oligonucleotide on human breast cancer cells are independent of inherent Bcl-2 protein expression","year":2000,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":67,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Cytotoxic T cell; Apoptosis; Biology; Programmed cell death; Cytotoxicity; Cancer cell; Cell culture; In vitro; Sense (electronics); Cancer research; Estrogen receptor; Molecular biology; Cell biology; Cancer; Chemistry; Biochemistry; Breast cancer","score_opus":0.01924259500436479,"score_gpt":0.3053459202519247,"score_spread":0.2861033252475599,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996146233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977211,0.00082793843,0.000015685213,0.00010371289,0.000020122437,0.0010385773,0.00018986875,0.0000061192536,0.00007690168],"genre_scores_gemma":[0.9967547,0.001752355,0.000041208223,0.000005085554,0.0001025281,0.0002906529,0.000043026765,0.000025522166,0.0009849156],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986477,0.000108454784,0.00019150086,0.00039773408,0.0003839694,0.00027063282],"domain_scores_gemma":[0.9993379,0.000009651069,0.000114792245,0.0002499707,0.00016137173,0.0001262944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009071603,0.00018946549,0.00022211156,0.00008757372,0.00012784581,0.000017160173,0.00006903717,0.00010738051,0.00011262632],"category_scores_gemma":[9.624014e-7,0.00012786558,0.00005317299,0.00010407769,0.0001080841,0.0000084104995,0.000035550827,0.00007245324,0.000001544168],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001770491,0.0006954485,0.0020783278,0.00016174366,0.00010109797,0.000012856266,0.000058857506,0.0005594997,0.91568846,0.00002504644,0.000035355788,0.07881283],"study_design_scores_gemma":[0.0022548377,0.0011834835,0.16608723,0.00057349476,0.000022032114,0.000013725286,0.000027319318,0.000055531033,0.8294918,0.00003165377,0.00013959469,0.000119304896],"about_ca_topic_score_codex":0.0020535735,"about_ca_topic_score_gemma":0.0004991152,"teacher_disagreement_score":0.16400889,"about_ca_system_score_codex":0.00009631339,"about_ca_system_score_gemma":0.00008438081,"threshold_uncertainty_score":0.5214207},"labels":[],"label_agreement":null},{"id":"W1996457137","doi":"10.1007/s10549-007-9600-1","title":"Response to neo-adjuvant chemotherapy in women with BRCA1-positive breast cancers","year":2007,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":139,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Docetaxel; Medicine; Oncology; Taxane; Breast cancer; Internal medicine; Chemotherapy; Adjuvant; Anthracycline; Doxorubicin; Cancer","score_opus":0.015603138609867487,"score_gpt":0.3381825811488379,"score_spread":0.3225794425389704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996457137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921111,0.00093857234,0.00009696835,0.005487416,0.00003912148,0.00065554795,0.00036762937,0.000008127751,0.0002955046],"genre_scores_gemma":[0.9967681,0.00060898205,0.00023739765,0.0004371045,0.0001833377,0.0006740074,0.000018482584,0.000038935847,0.0010336316],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9978714,0.00013873227,0.00019017045,0.00063461816,0.00038667212,0.0007784003],"domain_scores_gemma":[0.99887544,0.00006285674,0.000038051447,0.00038122432,0.0002754996,0.0003669065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008826402,0.00021342386,0.00020336422,0.0002487142,0.00013693319,0.00005500424,0.00015515494,0.00008934977,0.00007108505],"category_scores_gemma":[0.000012763473,0.00016538144,0.000025080799,0.00051839533,0.00020557703,0.000008055306,0.000071652605,0.00011140231,0.0000077820205],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14103068,0.000590027,0.04074805,0.000014831483,0.00055458327,0.00020761347,0.004121366,0.0005353418,0.1318075,0.000029351597,0.0019153506,0.6784453],"study_design_scores_gemma":[0.0055243014,0.003563482,0.913825,0.0000853898,0.000007836671,0.00030176644,0.0017362691,0.00000704038,0.05109012,0.00005487339,0.023478288,0.0003256739],"about_ca_topic_score_codex":0.003239255,"about_ca_topic_score_gemma":0.008265576,"teacher_disagreement_score":0.8730769,"about_ca_system_score_codex":0.002965694,"about_ca_system_score_gemma":0.0011815296,"threshold_uncertainty_score":0.77551866},"labels":[],"label_agreement":null},{"id":"W1996524730","doi":"10.1007/s10549-008-9892-9","title":"Early radiation exposures and BRCA1-associated breast cancer in young women from Poland","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Breast cancer; Medicine; Odds ratio; Risk factor; Oncology; Cancer; Internal medicine; Confidence interval; Gynecology","score_opus":0.021728225115792536,"score_gpt":0.31387175186650146,"score_spread":0.2921435267507089,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996524730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98896515,0.0075152083,0.0000020043817,0.0007789157,0.00006905779,0.0002970466,0.0022665702,0.000009037639,0.000097024815],"genre_scores_gemma":[0.98146737,0.016980397,0.00001564155,0.000028679973,0.00025133765,0.0006570783,0.00011738347,0.000023509963,0.00045858792],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985789,0.0001137318,0.00015890763,0.00046284782,0.00023581792,0.0004498011],"domain_scores_gemma":[0.9994412,0.000025308218,0.00004563617,0.00018936438,0.00012657717,0.0001718795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013385959,0.00016586701,0.00017315353,0.000109195506,0.00020729355,0.000048113874,0.00007798458,0.000119046425,0.00010209309],"category_scores_gemma":[0.0000095708765,0.00014579332,0.000023027846,0.0001853308,0.00019350104,0.000014379298,0.0000652736,0.000099947385,0.000002532424],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000614996,0.00018154275,0.93334275,0.000005206043,0.00024405803,0.000018515197,0.0014811835,0.000022180717,0.012930566,0.0000041377903,0.00031789675,0.050836947],"study_design_scores_gemma":[0.0027228997,0.00028090534,0.9934336,0.000026918506,0.0000099374465,0.00005550618,0.00018035927,0.000019921834,0.0026406788,0.00006634036,0.00041583137,0.00014709249],"about_ca_topic_score_codex":0.03555972,"about_ca_topic_score_gemma":0.015074535,"teacher_disagreement_score":0.06009084,"about_ca_system_score_codex":0.00084883155,"about_ca_system_score_gemma":0.00046013662,"threshold_uncertainty_score":0.97086257},"labels":[],"label_agreement":null},{"id":"W1996713943","doi":"10.1007/s10549-012-2223-1","title":"Metformin in early breast cancer: a prospective window of opportunity neoadjuvant study","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":241,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network; Statistics Canada; Ontario Institute for Cancer Research; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"Canadian Institutes of Health Research; Susan G. Komen","keywords":"Metformin; Medicine; Breast cancer; Internal medicine; Endocrinology; Leptin; Gastroenterology; Insulin; Cancer; Oncology; Obesity","score_opus":0.04864406748858407,"score_gpt":0.3631630840645098,"score_spread":0.31451901657592574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996713943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90622765,0.09174928,8.4892486e-7,0.00006403796,0.0000809558,0.00093742536,0.00068271614,0.00000524539,0.00025182628],"genre_scores_gemma":[0.9652576,0.032860927,0.000012951485,0.000019255907,0.00035367566,0.0012048245,0.00001991784,0.000023756926,0.00024711713],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981381,0.00017511612,0.0002414581,0.00040022103,0.00035887692,0.0006862183],"domain_scores_gemma":[0.99894464,0.000017149898,0.00007445858,0.00033325623,0.00023912302,0.0003913508],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048482566,0.00021977107,0.00034876887,0.00013404117,0.000101090896,0.000023952434,0.00013769743,0.000085415006,0.00012980163],"category_scores_gemma":[0.000011269012,0.00016642147,0.00006394944,0.00025395642,0.00018136555,0.00002270663,0.000120959805,0.0001347003,0.000002675753],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009407798,0.0017022184,0.6562525,0.000020843818,0.00026644315,0.000007396137,0.00078093575,0.0000019764068,0.002293214,0.000034116667,0.00006647169,0.3376331],"study_design_scores_gemma":[0.0037442641,0.0011177991,0.9715066,0.000048484788,0.000054188942,0.000029252295,0.0009263778,0.0000017781283,0.018586092,0.00005020956,0.0037361663,0.0001988049],"about_ca_topic_score_codex":0.017969003,"about_ca_topic_score_gemma":0.0047461363,"teacher_disagreement_score":0.3374343,"about_ca_system_score_codex":0.00022687868,"about_ca_system_score_gemma":0.0004952231,"threshold_uncertainty_score":0.98857045},"labels":[],"label_agreement":null},{"id":"W1996813547","doi":"10.1007/s10549-008-0039-9","title":"A pilot genome-wide association study of early-onset breast cancer","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; University of Toronto","funders":"National Cancer Institute; Cancer Care Ontario; Deutsches Krebsforschungszentrum","keywords":"Single-nucleotide polymorphism; Breast cancer; Genome-wide association study; Biology; Multiple comparisons problem; Genetics; Bonferroni correction; Haplotype; False discovery rate; Population; Genetic association; Genotype; Oncology; Cancer; Gene; Medicine","score_opus":0.04908902431718378,"score_gpt":0.3512812746081813,"score_spread":0.30219225029099755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996813547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99539393,0.001866062,0.000004064355,0.000859529,0.00007593566,0.0006673562,0.0010015661,0.000009326362,0.00012223829],"genre_scores_gemma":[0.9929232,0.003824013,0.00002450975,0.000041464362,0.00024553898,0.0009635788,0.000046093108,0.000027836171,0.0019037726],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99831635,0.00015804742,0.00021165948,0.0004522256,0.00044682465,0.00041489294],"domain_scores_gemma":[0.9989044,0.000055989218,0.00009708557,0.00032834974,0.00046583446,0.00014834701],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020496295,0.00017294512,0.00020548125,0.00011114548,0.0002582525,0.00002373563,0.0001359022,0.000062598556,0.0001804321],"category_scores_gemma":[0.00001926633,0.00014847556,0.00004665783,0.00025155596,0.00013455427,0.000008627659,0.00010441202,0.000103943144,0.000007823608],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011107732,0.0013673446,0.98626167,0.000011621765,0.00061268033,0.000013744603,0.0008525681,0.000060136485,0.004338517,8.701964e-7,0.0019094215,0.0034606457],"study_design_scores_gemma":[0.002645293,0.002398674,0.9903005,0.000015778092,0.000039158935,0.000041927215,0.0003598423,0.0000029572548,0.0029415914,0.000016374252,0.0010977122,0.0001401959],"about_ca_topic_score_codex":0.012815512,"about_ca_topic_score_gemma":0.0060002077,"teacher_disagreement_score":0.006815304,"about_ca_system_score_codex":0.00087584386,"about_ca_system_score_gemma":0.00074093207,"threshold_uncertainty_score":0.99375826},"labels":[],"label_agreement":null},{"id":"W1997376045","doi":"10.1007/s10549-011-1517-z","title":"Common genetic variation in adiponectin, leptin, and leptin receptor and association with breast cancer subtypes","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Adipokines, Inflammation, and Metabolic Diseases","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Institute of Environmental Health Sciences; National Cancer Institute","keywords":"Breast cancer; Single-nucleotide polymorphism; Adiponectin; Leptin receptor; Odds ratio; Internal medicine; Adipokine; Haplotype; Biology; Endocrinology; Population; Case-control study; Leptin; Oncology; Medicine; Genotype; Cancer; Genetics; Obesity; Insulin resistance; Gene","score_opus":0.03271795817379406,"score_gpt":0.31027126334338884,"score_spread":0.27755330516959476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997376045","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993192,0.003979511,0.0000033338874,0.0014275197,0.00003610833,0.0006642787,0.00021505453,0.000023772822,0.0004583801],"genre_scores_gemma":[0.9895837,0.008696889,0.00014662751,0.00003956651,0.00019282397,0.000424211,0.000027039894,0.000021594868,0.0008675863],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99866176,0.000112826376,0.00019124981,0.00034323585,0.0003372123,0.00035373576],"domain_scores_gemma":[0.9991633,0.00006778192,0.00008663211,0.00014012368,0.00027438716,0.000267763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002446919,0.00017016692,0.00028225436,0.00018410949,0.00014578417,0.000041613708,0.000030260644,0.00007745058,0.00044345346],"category_scores_gemma":[0.000019225057,0.000121791105,0.000018867755,0.00022610239,0.00010834452,0.00014172246,0.00002472174,0.00011471822,0.0000052371147],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019364665,0.00031374797,0.90095186,0.00006887759,0.00021019019,0.0000162124,0.001354511,0.0000016261272,0.0005224859,0.000082418606,0.00011709342,0.09442453],"study_design_scores_gemma":[0.003460128,0.0003913989,0.9942019,0.00016857035,0.00016049798,0.000092069895,0.00020554302,0.000041527117,0.00029779848,0.000064771746,0.0007974572,0.00011834756],"about_ca_topic_score_codex":0.036335804,"about_ca_topic_score_gemma":0.01300872,"teacher_disagreement_score":0.094306186,"about_ca_system_score_codex":0.0004645504,"about_ca_system_score_gemma":0.00029059322,"threshold_uncertainty_score":0.9700813},"labels":[],"label_agreement":null},{"id":"W1997404594","doi":"10.1007/s10549-008-0255-3","title":"Family history of breast cancer and all-cause mortality after breast cancer diagnosis in the Breast Cancer Family Registry","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Cancer Care Ontario; Mount Sinai Hospital","funders":"National Cancer Institute","keywords":"Breast cancer; Medicine; Family history; Oncology; Internal medicine; Cancer; Mammary gland; Epidemiology of cancer","score_opus":0.07866127971220313,"score_gpt":0.3612386082702602,"score_spread":0.28257732855805706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997404594","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.916202,0.06363966,0.0000024060257,0.005346625,0.0002830178,0.0008546333,0.013387669,0.000015929849,0.00026805297],"genre_scores_gemma":[0.85032153,0.13944858,0.000022157688,0.0005364083,0.00057824503,0.0080704605,0.0000791024,0.000066425106,0.00087707455],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962687,0.0002955185,0.0005134782,0.0011610661,0.00080759096,0.00095366506],"domain_scores_gemma":[0.9979083,0.00006968887,0.00019610015,0.0009290334,0.000549367,0.00034752866],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003770878,0.000542568,0.00051896204,0.00020010993,0.00023080812,0.000053516636,0.00042495146,0.00028256106,0.0003230159],"category_scores_gemma":[0.000007398473,0.00041058488,0.00015233959,0.0003972952,0.0013562884,0.00004744452,0.00024285974,0.00036435007,0.0000031505356],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002381848,0.000999677,0.9096415,0.00017120117,0.001976992,0.00017896437,0.0012418989,0.00009960476,0.0085352715,0.000018636692,0.029494759,0.045259632],"study_design_scores_gemma":[0.0024555472,0.00016340897,0.98361856,0.00022546126,0.00026108103,0.00068963855,0.00042838816,0.000021864735,0.0006351856,0.000026052672,0.011041579,0.00043325304],"about_ca_topic_score_codex":0.121823415,"about_ca_topic_score_gemma":0.031917404,"teacher_disagreement_score":0.08990601,"about_ca_system_score_codex":0.0026133258,"about_ca_system_score_gemma":0.0029236306,"threshold_uncertainty_score":0.9998346},"labels":[],"label_agreement":null},{"id":"W1997695524","doi":"10.1007/s10549-009-0501-3","title":"An integrative genomic and transcriptomic analysis reveals molecular pathways and networks regulated by copy number aberrations in basal-like, HER2 and luminal cancers","year":2009,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Gene expression and cancer classification","field":"Biochemistry, Genetics and Molecular Biology","cited_by":153,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"Cancer Research UK","keywords":"Biology; Transcriptome; Gene; Copy number analysis; Breast cancer; Copy-number variation; Microarray; Gene expression profiling; Gene expression; Cancer research; Cancer; Genetics; Genome","score_opus":0.015352931415507658,"score_gpt":0.32121499504678835,"score_spread":0.3058620636312807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997695524","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99140656,0.0070799277,0.00029218252,0.0006235387,0.000016217085,0.00033738225,0.00014433432,0.0000060707007,0.00009378683],"genre_scores_gemma":[0.9874991,0.011682938,0.00007853971,0.00011716237,0.000039486058,0.00015887173,0.00018924671,0.000011824346,0.00022280125],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99869025,0.00016554158,0.00017031777,0.0005611542,0.00012316613,0.00028956012],"domain_scores_gemma":[0.9994219,0.000009261515,0.000042877702,0.00020756976,0.00007842514,0.00023995548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014959571,0.00018460512,0.00021884852,0.00011382004,0.00015147429,0.00008106209,0.00005768191,0.00011622814,0.000018321536],"category_scores_gemma":[0.0000023267735,0.00015171719,0.000030770345,0.00027963397,0.00018693325,0.000015418647,0.000018274442,0.00010382828,1.8421701e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010165044,0.00022867465,0.06424078,0.000011210461,0.00039379467,0.000011256964,0.00069130375,0.00020759727,0.88931614,0.00010850947,0.0013171426,0.04245705],"study_design_scores_gemma":[0.0044578873,0.0017978117,0.94450563,0.00010237246,0.00026998707,0.000052694413,0.0014502231,0.004242866,0.040423255,0.00052502914,0.0016158426,0.00055637787],"about_ca_topic_score_codex":0.0018590085,"about_ca_topic_score_gemma":0.0026246726,"teacher_disagreement_score":0.8802649,"about_ca_system_score_codex":0.00015083296,"about_ca_system_score_gemma":0.00012434603,"threshold_uncertainty_score":0.61868477},"labels":[],"label_agreement":null},{"id":"W1997716402","doi":"10.1023/a:1010615124301","title":"Characterization of bipotent mammary epithelial progenitor cells in normal adult human breast tissue","year":2001,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":369,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"National Cancer Institute","keywords":"Myoepithelial cell; Progenitor cell; Biology; Cell biology; Keratin; Progenitor; Epithelial cell adhesion molecule; Population; Stem cell; Epithelium; Immunology; Cell adhesion molecule; Immunohistochemistry; Medicine; Genetics","score_opus":0.033298330805041326,"score_gpt":0.33878690125845745,"score_spread":0.30548857045341615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997716402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960488,0.00038204997,0.000014311528,0.001620474,0.00006864021,0.00089595024,0.00067356025,0.000014769302,0.0002814132],"genre_scores_gemma":[0.99218,0.0053406586,0.000060514165,0.000025671263,0.00034660258,0.00032101537,0.000113131915,0.000021615844,0.0015907983],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99852085,0.00006314961,0.000259896,0.0003225431,0.00040520894,0.0004283263],"domain_scores_gemma":[0.9991661,0.000012929733,0.00005749314,0.00023435969,0.0002736098,0.00025554426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013986659,0.00016163377,0.00031163922,0.00025978236,0.00008561078,0.000025296915,0.00006373806,0.00006169384,0.0002556571],"category_scores_gemma":[0.0000017528625,0.00012407228,0.000053526423,0.00035237314,0.000112118454,0.000103314705,0.00005028251,0.000116531824,0.000010155148],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014707744,0.001147871,0.037937604,0.00011356712,0.00011021478,0.00022850017,0.00021988172,6.9254594e-7,0.5936021,0.00006497804,0.000022292148,0.36508152],"study_design_scores_gemma":[0.0064553674,0.0015987211,0.5708045,0.0003040669,0.000075372765,0.0006084338,0.00009150533,0.000017931667,0.41383576,0.00002182977,0.0060129496,0.00017361084],"about_ca_topic_score_codex":0.008721484,"about_ca_topic_score_gemma":0.0013593922,"teacher_disagreement_score":0.53286684,"about_ca_system_score_codex":0.000365392,"about_ca_system_score_gemma":0.00026497248,"threshold_uncertainty_score":0.9978795},"labels":[],"label_agreement":null},{"id":"W1997802902","doi":"10.1007/s10549-014-3179-0","title":"Methylation of the BRCA1 promoter in peripheral blood DNA is associated with triple-negative and medullary breast cancer","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"DNA methylation; Breast cancer; Peripheral blood; Methylation; Triple-negative breast cancer; Cancer research; Medullary cavity; Biology; Promoter; Cancer; DNA; Medicine; Oncology; Pathology; Genetics; Internal medicine; Gene; Gene expression","score_opus":0.020562067851148447,"score_gpt":0.316476736448199,"score_spread":0.29591466859705057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997802902","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948902,0.001312858,0.000007953542,0.0026341146,0.000032050895,0.00049574586,0.00048784734,0.00000331469,0.00013587618],"genre_scores_gemma":[0.99801546,0.0008713477,0.00004269544,0.000060175233,0.00008654428,0.00038654823,0.000020977664,0.000018426117,0.0004977991],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99877834,0.00021336706,0.00014155218,0.00035217992,0.00025110974,0.00026343437],"domain_scores_gemma":[0.99937636,0.00003371951,0.00007183789,0.00021333981,0.00023054502,0.00007417429],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023255346,0.00014406258,0.00016734489,0.000056864574,0.00012000518,0.000025883151,0.000087329296,0.000088221204,0.000055284305],"category_scores_gemma":[0.000020119463,0.00009031631,0.00003091412,0.0002363157,0.00029816298,0.000009126689,0.00007040136,0.00009584831,1.9538965e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026180546,0.0011599603,0.6748647,0.00009937069,0.0019828058,0.00000872888,0.003559193,0.00015780947,0.11382677,0.00009019148,0.00053341885,0.20109901],"study_design_scores_gemma":[0.0052767955,0.00078016624,0.8701639,0.00016805896,0.00008156303,0.000058438807,0.00019711284,0.00021801006,0.122297786,0.00021562685,0.00036353336,0.00017900986],"about_ca_topic_score_codex":0.0029301746,"about_ca_topic_score_gemma":0.00844909,"teacher_disagreement_score":0.20092,"about_ca_system_score_codex":0.0002396262,"about_ca_system_score_gemma":0.00040486632,"threshold_uncertainty_score":0.47147903},"labels":[],"label_agreement":null},{"id":"W1999461982","doi":"10.1007/s10549-008-0033-2","title":"Changes over time of extracellular domain of HER2 (ECD/HER2) serum levels have prognostic value in metastatic breast cancer","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; University of Calgary; Western University; Cancer Care Ontario","funders":"","keywords":"Medicine; Breast cancer; Internal medicine; Metastatic breast cancer; Multivariate analysis; Oncology; Univariate analysis; Cancer; Proportional hazards model; Prognostic variable","score_opus":0.11164049616071636,"score_gpt":0.4002757301324612,"score_spread":0.28863523397174484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999461982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97902215,0.01022196,0.0000056109184,0.0048664687,0.00004398999,0.002291633,0.0032059138,0.000022663347,0.00031959105],"genre_scores_gemma":[0.98899007,0.0061445837,0.00023683885,0.000031886564,0.00017235923,0.0011358879,0.000024377157,0.000076864075,0.0031871109],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99552757,0.0004341138,0.0005539657,0.00070867175,0.0016448605,0.0011308069],"domain_scores_gemma":[0.99784374,0.00033830456,0.0001437945,0.0005773458,0.00055524777,0.00054158457],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00089733285,0.00037654352,0.00095408375,0.00061801367,0.00013772937,0.000020858073,0.00021001925,0.00012810282,0.0028303869],"category_scores_gemma":[0.000043211283,0.0002887025,0.00012542821,0.00081381085,0.000892776,0.00010988593,0.00014525527,0.0004108649,0.000022109205],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004611985,0.004147132,0.85718924,0.0016630515,0.0013708671,0.002014697,0.004111076,0.000082072285,0.021111663,0.00015753711,0.0007302447,0.10281041],"study_design_scores_gemma":[0.0077893506,0.002190933,0.9709188,0.0017486588,0.00012685875,0.00084442564,0.00045022572,0.0004214478,0.014208588,0.00020171588,0.0008167173,0.00028233006],"about_ca_topic_score_codex":0.03679738,"about_ca_topic_score_gemma":0.0053202673,"teacher_disagreement_score":0.11372949,"about_ca_system_score_codex":0.0013321498,"about_ca_system_score_gemma":0.002073121,"threshold_uncertainty_score":0.9999565},"labels":[],"label_agreement":null},{"id":"W1999636411","doi":"10.1007/s10549-014-3011-x","title":"Double heterozygosity for germline mutations in BRCA1 and p53 in a woman with early onset breast cancer","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre; Juravinski Hospital","funders":"","keywords":"Multiplex ligation-dependent probe amplification; Loss of heterozygosity; Breast cancer; Germline mutation; Germline; Biology; Genetic testing; Genetics; Exon; Cancer research; Cancer; Mutation; Medicine; Gene; Allele","score_opus":0.03100624167884535,"score_gpt":0.35346964939144404,"score_spread":0.3224634077125987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999636411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994814,0.001220065,0.00006054846,0.0023760416,0.000024326875,0.00071996317,0.00072133116,0.00000586673,0.000057870093],"genre_scores_gemma":[0.9961694,0.0007503896,0.00023363964,0.000058816608,0.000119767916,0.0022311392,0.00009202238,0.000023870483,0.00032098035],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987472,0.00006564984,0.00014810759,0.00048287504,0.00014996015,0.00040614879],"domain_scores_gemma":[0.9994317,0.000033647466,0.000034285564,0.00021675476,0.000149194,0.00013439608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019684271,0.00015963739,0.00017148023,0.00014445256,0.00013242841,0.000056623183,0.00007758011,0.00007747954,0.000019137406],"category_scores_gemma":[0.000004385731,0.00012866012,0.000023895429,0.00019892622,0.00020599485,0.000012227904,0.000053776657,0.000088384986,8.9482035e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066016517,0.00071267533,0.8946488,0.00009557695,0.0002634004,0.000017815695,0.0008194387,0.00046376357,0.0064587984,0.00010661753,0.0003906235,0.089420825],"study_design_scores_gemma":[0.0088554565,0.0009828708,0.98137945,0.000099078614,0.000022816204,0.00012326341,0.00011574038,0.0002192696,0.005703962,0.00017838566,0.0020978511,0.00022184725],"about_ca_topic_score_codex":0.014607217,"about_ca_topic_score_gemma":0.07083287,"teacher_disagreement_score":0.08919898,"about_ca_system_score_codex":0.00033608437,"about_ca_system_score_gemma":0.00034435248,"threshold_uncertainty_score":0.9919546},"labels":[],"label_agreement":null},{"id":"W2000057619","doi":"10.1007/s10549-007-9607-7","title":"Cost-effectiveness of letrozole versus tamoxifen as initial adjuvant therapy in postmenopausal women with hormone-receptor positive early breast cancer from a Canadian perspective","year":2007,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Letrozole; Tamoxifen; Medicine; Breast cancer; Oncology; Gynecology; Population; Internal medicine; Antiestrogen; Quality-adjusted life year; Adjuvant therapy; Hormone therapy; Cancer; Cost effectiveness","score_opus":0.03176024745410351,"score_gpt":0.36129349442144953,"score_spread":0.32953324696734604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000057619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853076,0.005517313,0.0000032549392,0.0006198374,0.00008355263,0.001336491,0.0066609816,0.000009387491,0.00046163486],"genre_scores_gemma":[0.99475586,0.0030597243,0.000022585618,0.000038192877,0.00026664883,0.0016062129,0.0001718372,0.00005078462,0.000028152612],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9973935,0.00022005306,0.00020486426,0.0007601997,0.00040413323,0.0010172474],"domain_scores_gemma":[0.99841076,0.0001444218,0.00007469918,0.00028655195,0.0005838025,0.0004997654],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000286255,0.00039065577,0.00044232304,0.00025790537,0.00020964994,0.00004040771,0.00015834262,0.00014523312,0.00009307739],"category_scores_gemma":[0.000009059465,0.0003009769,0.000048449332,0.0003693631,0.0004747382,0.000025612855,0.000079463505,0.00017662077,0.000006025462],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3907445,0.0028893345,0.3570536,0.000028313982,0.0070428383,0.0005254537,0.010796799,0.00003759618,0.07318648,0.0002740463,0.000083076746,0.15733796],"study_design_scores_gemma":[0.014390334,0.006798254,0.94997346,0.00011948758,0.000039935432,0.000040062292,0.0031769378,6.0216223e-7,0.024965547,0.00006720611,0.00012650533,0.00030163542],"about_ca_topic_score_codex":0.8216814,"about_ca_topic_score_gemma":0.3739794,"teacher_disagreement_score":0.5929199,"about_ca_system_score_codex":0.0034573914,"about_ca_system_score_gemma":0.0015231331,"threshold_uncertainty_score":0.9999442},"labels":[],"label_agreement":null},{"id":"W2000536166","doi":"10.1007/s10549-009-0318-0","title":"Progesterone receptor is a significant factor associated with clinical outcomes and effect of adjuvant tamoxifen therapy in breast cancer patients","year":2009,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":122,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia; Vancouver General Hospital","funders":"National Cancer Institute; Canadian Breast Cancer Research Alliance; Breast Cancer Alliance","keywords":"Breast cancer; Medicine; Oncology; Tamoxifen; Internal medicine; Lymphovascular invasion; Proportional hazards model; Estrogen receptor; Progesterone receptor; Adjuvant therapy; Cohort; Population; Hormonal therapy; Cancer; Tissue microarray; Gynecology; Metastasis","score_opus":0.0242336923018934,"score_gpt":0.35889228611744545,"score_spread":0.3346585938155521,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000536166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957228,0.0019323869,1.5798345e-7,0.00069611095,0.000025939984,0.0009390457,0.0006651329,0.000006295279,0.000012179348],"genre_scores_gemma":[0.99115914,0.008354886,0.0000055087917,0.00004140903,0.00004523707,0.00019374222,0.00007012579,0.00001758008,0.000112397975],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99842715,0.00028076392,0.00022783804,0.0004316876,0.0002532322,0.0003793541],"domain_scores_gemma":[0.99935186,0.00006833459,0.000085328626,0.00016670048,0.00013219492,0.00019555312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000221752,0.00022454803,0.0003901425,0.000067417546,0.000064616695,0.000022427634,0.000073410345,0.00016957727,0.000018400322],"category_scores_gemma":[0.000012160389,0.00012665476,0.000062170155,0.00013162648,0.00018967333,0.000007859231,0.000031635413,0.00015127465,8.2396986e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038444009,0.00093237456,0.8749456,0.000010191958,0.00040918993,0.0000069596335,0.00008489144,5.172719e-7,0.008699536,6.1049593e-7,0.00009703678,0.1109687],"study_design_scores_gemma":[0.0077298204,0.010356368,0.9611085,0.0001187324,0.000023797176,0.0000047204862,0.000008803285,0.000004224275,0.020452667,0.0000027863434,0.00005548353,0.00013408583],"about_ca_topic_score_codex":0.0008509809,"about_ca_topic_score_gemma":0.000116614574,"teacher_disagreement_score":0.11083461,"about_ca_system_score_codex":0.00009467694,"about_ca_system_score_gemma":0.00014695183,"threshold_uncertainty_score":0.5164831},"labels":[],"label_agreement":null},{"id":"W2000550559","doi":"10.1007/s10549-006-9207-y","title":"Duration of letrozole treatment and outcomes in the placebo-controlled NCIC CTG MA.17 extended adjuvant therapy trial","year":2006,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":92,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Letrozole; Medicine; Placebo; Breast cancer; Adjuvant; Adjuvant therapy; Duration (music); Internal medicine; Randomized controlled trial; Oncology; Clinical trial; Cancer; Tamoxifen; Alternative medicine","score_opus":0.02032681081597929,"score_gpt":0.3338940062184454,"score_spread":0.3135671954024661,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000550559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98689985,0.010238788,0.0000015246965,0.000782535,0.000029160088,0.001657777,0.000051910938,0.000003847229,0.00033463276],"genre_scores_gemma":[0.99176216,0.0062414533,0.000010034263,0.000013581936,0.00011808076,0.0008937383,0.00005593006,0.000010409866,0.0008945851],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99884504,0.00023896617,0.00020537674,0.00026712025,0.0001748757,0.00026861593],"domain_scores_gemma":[0.99957883,0.000070219096,0.000056200028,0.00019443572,0.00004721402,0.000053086962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026204262,0.00016614245,0.00027636846,0.00007565933,0.00011208366,0.000033112352,0.000060995535,0.000092478294,0.0000096001495],"category_scores_gemma":[0.000006382794,0.0000840969,0.00008202329,0.000079498386,0.0001243682,0.000005080685,0.000018536062,0.00006257508,8.6652983e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5268169,0.0074165277,0.050511047,0.000028632163,0.0017386784,0.00010597777,0.0007004039,0.00007160748,0.21716966,0.0004776176,0.00061556336,0.19434735],"study_design_scores_gemma":[0.60131603,0.02477648,0.23072475,0.000056154502,0.00015740254,0.00013958724,0.00048268566,0.0001585667,0.13823667,0.0004021952,0.0031126814,0.00043677658],"about_ca_topic_score_codex":0.0024387583,"about_ca_topic_score_gemma":0.0007874257,"teacher_disagreement_score":0.19391058,"about_ca_system_score_codex":0.00007803234,"about_ca_system_score_gemma":0.00012500724,"threshold_uncertainty_score":0.36866894},"labels":[],"label_agreement":null},{"id":"W2000765979","doi":"10.1007/s10549-008-9974-8","title":"Genetic contribution to all cancers: the first demonstration using the model of breast cancers from Poland stratified by age at diagnosis and tumour pathology","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Coalition for Research in Women's Health; University of Toronto","funders":"","keywords":"Breast cancer; CDKN2A; CHEK2; Genetic predisposition; Oncology; Medicine; Cancer; Internal medicine; Population; Pathology; Biology; Disease; Germline mutation; Gene; Genetics","score_opus":0.050699307951924864,"score_gpt":0.329127639426374,"score_spread":0.2784283314744492,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000765979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875203,0.0062514907,0.00030703307,0.0024406197,0.000036297406,0.000658505,0.0027682718,0.0000037441866,0.000013737126],"genre_scores_gemma":[0.99140394,0.007338303,0.00015228493,0.00017291802,0.0001253241,0.00063759973,0.000110950125,0.000015635498,0.00004306357],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987971,0.00010206223,0.0001788833,0.00039046738,0.0002123719,0.00031912193],"domain_scores_gemma":[0.9993539,0.00005018171,0.00006711512,0.0002608347,0.00015239224,0.00011561883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011384078,0.00015905287,0.00015680533,0.000035175948,0.00047585115,0.000030883886,0.00011870768,0.00008510072,0.000015341495],"category_scores_gemma":[0.000008701794,0.00010277552,0.000035119618,0.00010787815,0.0004471754,0.000007479111,0.00009307745,0.00007518577,4.9083064e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023156332,0.0002477602,0.20562041,0.000026973099,0.0009173958,0.00004570658,0.0023630874,0.02157096,0.74305075,0.000049109374,0.007376575,0.016415657],"study_design_scores_gemma":[0.0066740643,0.0018541352,0.73329365,0.0001485676,0.00038076856,0.0010033665,0.00088493153,0.013857345,0.23481354,0.000391671,0.005915644,0.0007822759],"about_ca_topic_score_codex":0.018585714,"about_ca_topic_score_gemma":0.032081775,"teacher_disagreement_score":0.5276733,"about_ca_system_score_codex":0.0008007646,"about_ca_system_score_gemma":0.00058373774,"threshold_uncertainty_score":0.9879496},"labels":[],"label_agreement":null},{"id":"W2000970249","doi":"10.1007/s10549-014-3126-0","title":"Development of prediction tools for diarrhea and rash in breast cancer patients receiving lapatinib in combination with capecitabine","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"GlaxoSmithKline","keywords":"Capecitabine; Lapatinib; Rash; Medicine; Breast cancer; Oncology; Internal medicine; Diarrhea; Cancer; Trastuzumab; Colorectal cancer","score_opus":0.03625959730007277,"score_gpt":0.3316780500213907,"score_spread":0.29541845272131795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000970249","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963137,0.00046962782,0.000006845719,0.0010771435,0.00003208616,0.0014245901,0.000556537,0.0000077361565,0.00011171859],"genre_scores_gemma":[0.99574035,0.0006925546,0.00021136475,0.0000122919355,0.000033771597,0.0031301077,0.00009256067,0.000014809626,0.00007218255],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99878275,0.000052038824,0.00024289389,0.0003090431,0.0003142996,0.00029899276],"domain_scores_gemma":[0.99939054,0.00012103257,0.000058998598,0.00008156121,0.00025174007,0.00009610141],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023613237,0.0001459162,0.00032286905,0.00021005595,0.00014936594,0.000019597006,0.000025654746,0.00003266727,0.000012770045],"category_scores_gemma":[0.0000134440415,0.0001023403,0.000016791313,0.000239935,0.00008455291,0.00009437167,0.000041309857,0.00008023323,1.5388683e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024074442,0.0009632766,0.6771301,0.00009149673,0.0000945373,0.0000016720631,0.0011480014,0.000004297271,0.00007271159,0.000019489706,0.000018938057,0.31804806],"study_design_scores_gemma":[0.0140453335,0.0014708546,0.98283654,0.0004401846,0.00002930532,0.000009091875,0.0002865262,0.00017924106,0.00032218473,0.00002900429,0.0002715625,0.00008017351],"about_ca_topic_score_codex":0.002558997,"about_ca_topic_score_gemma":0.013022661,"teacher_disagreement_score":0.3179679,"about_ca_system_score_codex":0.0010469328,"about_ca_system_score_gemma":0.00024579887,"threshold_uncertainty_score":0.72669506},"labels":[],"label_agreement":null},{"id":"W2001223590","doi":"10.1007/s10549-006-9189-9","title":"Telomerase immortalization of human mammary epithelial cells derived from a BRCA2 mutation carrier","year":2006,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Telomerase; Mammary gland; Cancer research; BRCA2 Protein; Breast cancer; Human breast; Mutation; Biology; Medicine; Cancer; Gene; Genetics; Germline mutation","score_opus":0.031848657849421855,"score_gpt":0.3337428080592382,"score_spread":0.30189415020981636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001223590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99645287,0.0013448659,0.000063624,0.00044388656,0.000052806492,0.00056454615,0.0007827685,0.00003227295,0.00026235482],"genre_scores_gemma":[0.9975962,0.00071157166,0.00014762864,0.000024243984,0.00026624204,0.00013242809,0.00041867074,0.0000231515,0.00067985966],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984348,0.00008568723,0.00027750945,0.0003792581,0.00047700337,0.00034576564],"domain_scores_gemma":[0.9991183,0.000055031483,0.000073705334,0.00027700182,0.00027685147,0.00019910805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000102406004,0.00017567152,0.00030868145,0.000207243,0.00017649838,0.000035228262,0.00006244268,0.00007686311,0.00021247975],"category_scores_gemma":[0.0000058205605,0.00013925883,0.00006403414,0.00027685447,0.00020285763,0.00010904,0.000030823,0.0000934655,0.0000066573307],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012090032,0.0011917439,0.104734555,0.00011140827,0.00030251022,0.00050092017,0.0007962576,0.000012862077,0.815112,0.00039899093,0.00029807555,0.07533168],"study_design_scores_gemma":[0.003653343,0.00062732823,0.6160162,0.00011188799,0.000080685095,0.00004867845,0.00017126549,0.00007639819,0.3782905,0.00048667993,0.00030217826,0.00013483409],"about_ca_topic_score_codex":0.057932734,"about_ca_topic_score_gemma":0.0026572705,"teacher_disagreement_score":0.51128167,"about_ca_system_score_codex":0.00026019829,"about_ca_system_score_gemma":0.00027640397,"threshold_uncertainty_score":0.9483406},"labels":[],"label_agreement":null},{"id":"W2001366190","doi":"10.1007/s10549-007-9502-2","title":"Decreased levels of hypoxic cells in gefitinib treated ER+ HER-2 overexpressing MCF-7 breast cancer tumors are associated with hyperactivation of the mTOR pathway: therapeutic implications for combination therapy with rapamycin","year":2007,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"University of Pennsylvania","keywords":"Gefitinib; Breast cancer; In vivo; Medicine; Cancer research; PI3K/AKT/mTOR pathway; Epidermal growth factor receptor; MCF-7; EGFR inhibitors; Cancer; Protein kinase B; Pharmacology; Oncology; Internal medicine; Biology; Signal transduction","score_opus":0.05867916153529029,"score_gpt":0.33964189797129685,"score_spread":0.28096273643600655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001366190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952826,0.00087071414,0.000093113944,0.0004932072,0.000016872917,0.0011373662,0.0020691736,0.000007326827,0.0000296577],"genre_scores_gemma":[0.9988626,0.00022133444,0.000042560485,0.0000344351,0.000047967136,0.0005888207,0.00007444078,0.000037261576,0.00009055255],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99859226,0.00013721334,0.00025497953,0.00037065515,0.00027647175,0.0003684043],"domain_scores_gemma":[0.9985768,0.00015929657,0.00028474958,0.0002901479,0.00060450076,0.0000844941],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003171796,0.00020370167,0.0002542155,0.00010850742,0.00015743534,0.00002249339,0.00013192475,0.00010249994,0.000017710103],"category_scores_gemma":[0.000012526432,0.0001270461,0.000056580317,0.0003907597,0.00022457476,0.000016695141,0.000021046328,0.00009213658,6.293873e-8],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034477324,0.0008588956,0.20007433,0.000025963769,0.00030818567,0.0000010971363,0.00011508708,0.00011902421,0.7646988,0.00004278421,0.000010253015,0.03029783],"study_design_scores_gemma":[0.0035490107,0.0005977311,0.55463177,0.0002642613,0.00001862624,0.000007841381,0.00006690205,0.00002110385,0.44066814,0.00004496334,0.000035770234,0.00009390075],"about_ca_topic_score_codex":0.0022476863,"about_ca_topic_score_gemma":0.002890414,"teacher_disagreement_score":0.3545574,"about_ca_system_score_codex":0.00037582743,"about_ca_system_score_gemma":0.00057923404,"threshold_uncertainty_score":0.518079},"labels":[],"label_agreement":null},{"id":"W2002401135","doi":"10.1007/s10549-007-9608-6","title":"Germline TP53 mutations in BRCA1 and BRCA2 mutation-negative French Canadian breast cancer families","year":2007,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Montreal General Hospital; Jewish General Hospital; University of Toronto; Hôtel-Dieu de Montréal; McGill University; Centre Hospitalier de l’Université de Montréal; Women's College Hospital; Hôpital Notre-Dame; Université de Montréal; McGill University Health Centre","funders":"","keywords":"Germline mutation; Breast cancer; Germline; Mutation; Genetics; Oncology; BRCA2 Protein; Medicine; Cancer; Biology; Internal medicine; Gene","score_opus":0.025190900524258555,"score_gpt":0.35051350757310173,"score_spread":0.3253226070488432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002401135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890625,0.003955224,0.000033665056,0.0034087363,0.00009325951,0.0005796273,0.0020472968,0.000009664537,0.000810044],"genre_scores_gemma":[0.99466336,0.0030825434,0.000259474,0.000117840325,0.00027410928,0.00056076463,0.00018265523,0.000029893286,0.00082933746],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9981955,0.00007625637,0.00024181238,0.00057714176,0.00025145913,0.0006577873],"domain_scores_gemma":[0.9988802,0.00007217279,0.000047779205,0.00023898765,0.00036577458,0.00039505027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002966143,0.00022136084,0.00018215693,0.0003807704,0.00031814116,0.00007101313,0.00010671812,0.00013326724,0.00015054434],"category_scores_gemma":[0.000023353645,0.00020170613,0.00003537804,0.0004447517,0.00040220725,0.000017983586,0.000057189067,0.0001495242,0.0000054151183],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005249828,0.0004714574,0.3763721,0.000069954964,0.0007344199,0.00023089584,0.0041295425,0.00072812644,0.007249298,0.00022052537,0.0017311515,0.60753757],"study_design_scores_gemma":[0.002006443,0.00022568039,0.9877739,0.000055964698,0.000027832382,0.000206584,0.0010984984,0.00009282031,0.005003963,0.00031889262,0.0029426597,0.00024673712],"about_ca_topic_score_codex":0.5298802,"about_ca_topic_score_gemma":0.88633186,"teacher_disagreement_score":0.61140186,"about_ca_system_score_codex":0.0011532856,"about_ca_system_score_gemma":0.0016502464,"threshold_uncertainty_score":0.8225337},"labels":[],"label_agreement":null},{"id":"W2002541650","doi":"10.1007/s10549-013-2519-9","title":"Fasting blood glucose and long-term prognosis of non-metastatic breast cancer: a cohort study","year":2013,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"National Cancer Institute","keywords":"Medicine; Breast cancer; Hazard ratio; Body mass index; Internal medicine; Proportional hazards model; Confidence interval; Cancer; Oncology; Metastasis; Cohort; Cohort study; Gastroenterology","score_opus":0.04558825852869533,"score_gpt":0.37693081841342935,"score_spread":0.33134255988473404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002541650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914735,0.0031161637,0.0000019499398,0.0010465031,0.000038392387,0.003797982,0.00043302757,0.000022969867,0.00006953903],"genre_scores_gemma":[0.99066126,0.0056989933,0.00003393331,0.000015982185,0.00013822658,0.0031360106,0.000016995587,0.000036232326,0.00026234795],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99783003,0.000073144365,0.0003260891,0.00056507403,0.00061555917,0.000590116],"domain_scores_gemma":[0.99860823,0.000089169735,0.00009622987,0.00029302994,0.00041542415,0.0004979202],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022440247,0.00027451653,0.00059762865,0.00022712389,0.00019090327,0.00008467184,0.000074895586,0.00004404568,0.00052943325],"category_scores_gemma":[0.000007882165,0.0001886328,0.00006732396,0.00035584994,0.00027740272,0.00013614986,0.00010471985,0.00018546176,0.0000060505145],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043954808,0.0023377375,0.7697145,0.00018958829,0.0010634925,0.000083968735,0.00051764655,6.2868935e-7,0.0008724015,0.0000013228671,0.00003851604,0.2247407],"study_design_scores_gemma":[0.00606958,0.0022912582,0.9887693,0.00042997877,0.0005718455,0.0003131096,0.00049204484,0.000053534273,0.00084455346,0.0000062872145,0.00000883533,0.00014968307],"about_ca_topic_score_codex":0.08913382,"about_ca_topic_score_gemma":0.0047838725,"teacher_disagreement_score":0.22459102,"about_ca_system_score_codex":0.00031545298,"about_ca_system_score_gemma":0.0003920986,"threshold_uncertainty_score":0.9169317},"labels":[],"label_agreement":null},{"id":"W2002873340","doi":"10.1007/s10549-015-3293-7","title":"Prevalence of BRCA1 and BRCA2 germline mutations in patients with triple-negative breast cancer","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":130,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"National Medical Research Council; Cancer Institute NSW; National Breast Cancer Foundation; National Health and Medical Research Council; Hunter Cancer Research Alliance","keywords":"Triple-negative breast cancer; Breast cancer; Germline mutation; Medicine; Oncology; BRCA mutation; Mutation; Ovarian cancer; Internal medicine; Genetic testing; Cancer; Cancer research; Genetics; Biology; Gene","score_opus":0.03149279560625292,"score_gpt":0.3441734918046504,"score_spread":0.3126806961983975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002873340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944517,0.002250626,0.000010032484,0.00069985643,0.000034601853,0.0006090313,0.0018347072,0.000004043344,0.00010537954],"genre_scores_gemma":[0.9972266,0.0014439252,0.00019610036,0.000017662509,0.00007310037,0.0005260369,0.000054853856,0.000018400324,0.0004433206],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99875695,0.000090317095,0.00016840371,0.00040751038,0.00029425952,0.00028258513],"domain_scores_gemma":[0.9989645,0.000025150168,0.000063635875,0.00021449747,0.00055468915,0.00017753245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001479099,0.00014965764,0.00015805976,0.000114389215,0.00007076823,0.0000212698,0.00008337506,0.00006238783,0.000039173403],"category_scores_gemma":[0.000017576614,0.00011376854,0.000018612098,0.00023698034,0.0003642928,0.000014941309,0.00007109549,0.00007650272,9.187303e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002457773,0.0005797156,0.94930637,0.00007565024,0.00023092674,0.0000042573647,0.000706284,0.00018864348,0.00065675576,0.000029764933,0.00024070934,0.045523122],"study_design_scores_gemma":[0.0059089093,0.00090969255,0.9883452,0.00009195972,0.000032591244,0.000017633647,0.00020389185,0.000037616675,0.004069996,0.000089365785,0.00015939705,0.00013371733],"about_ca_topic_score_codex":0.0036523524,"about_ca_topic_score_gemma":0.0025630686,"teacher_disagreement_score":0.045389406,"about_ca_system_score_codex":0.0003651779,"about_ca_system_score_gemma":0.00077940733,"threshold_uncertainty_score":0.55212885},"labels":[],"label_agreement":null},{"id":"W2003490109","doi":"10.1023/a:1020552501345","title":"Mega-Dose Vitamins and Minerals in the Treatment of Non-Metastatic Breast Cancer: An Historical Cohort Study","year":2002,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Antioxidant Activity and Oxidative Stress","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"QUAD Engineering (Canada); Institute for Clinical Evaluative Sciences; University of Waterloo; BC Cancer Agency; University of Victoria","funders":"","keywords":"Medicine; Breast cancer; Internal medicine; Hazard ratio; Proportional hazards model; Cancer; Cohort; Oncology; Vitamin; Surgery; Gastroenterology; Confidence interval","score_opus":0.09230364693574779,"score_gpt":0.39290898740478786,"score_spread":0.3006053404690401,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003490109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99117124,0.003325397,0.0000016211999,0.002789679,0.000030832463,0.002036547,0.00037575056,0.000009301556,0.0002596558],"genre_scores_gemma":[0.9852383,0.012026887,0.000023573406,0.000019280154,0.00012600541,0.0010465547,0.000013898696,0.000017855831,0.001487625],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979795,0.00029400445,0.00025415857,0.00048280254,0.000557543,0.00043198458],"domain_scores_gemma":[0.99901736,0.00018555415,0.000063514475,0.0003428117,0.00014120356,0.00024955734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002617025,0.00025187078,0.0005779982,0.00023206348,0.00017701976,0.000034748336,0.00007988755,0.000040600775,0.0002180688],"category_scores_gemma":[0.0000060775046,0.00014395955,0.000059023176,0.00037534523,0.0002438173,0.00014215574,0.000023002221,0.0001284923,0.0000018893237],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001138053,0.01667109,0.8235854,0.0000464121,0.00044986684,0.00036739666,0.0043382756,0.0000019399217,0.0008336357,0.0000140367765,0.00018363634,0.15237029],"study_design_scores_gemma":[0.006837068,0.0073315226,0.9824038,0.00008729925,0.0002342091,0.00024450885,0.0017427849,0.00020055947,0.00021291246,0.000009878791,0.00057486683,0.00012059615],"about_ca_topic_score_codex":0.048251163,"about_ca_topic_score_gemma":0.010862397,"teacher_disagreement_score":0.15881842,"about_ca_system_score_codex":0.0012290463,"about_ca_system_score_gemma":0.0001084171,"threshold_uncertainty_score":0.9580866},"labels":[],"label_agreement":null},{"id":"W2003626943","doi":"10.1007/s10549-008-0265-1","title":"Does multicentric/multifocal breast cancer differ from unifocal breast cancer? An analysis of survival and contralateral breast cancer incidence","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":90,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Island Health; BC Cancer Agency","funders":"","keywords":"Breast cancer; Medicine; Internal medicine; Cancer; Incidence (geometry); Oncology; Cumulative incidence; Univariate analysis; Breast disease; Stage (stratigraphy); Gynecology; Multivariate analysis; Cohort","score_opus":0.028317651783944173,"score_gpt":0.33704377711293665,"score_spread":0.30872612532899246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003626943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93323106,0.005915706,0.00001708525,0.0039364654,0.000291561,0.00072296953,0.055829763,0.000039728835,0.000015667469],"genre_scores_gemma":[0.95778716,0.039102376,0.00005289473,0.00009253744,0.0009201116,0.0011468652,0.0005404606,0.000085351436,0.000272256],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9947927,0.00041000085,0.000650587,0.0017846001,0.0009651758,0.0013969557],"domain_scores_gemma":[0.99695206,0.00013957714,0.00026750195,0.0007947279,0.0009612292,0.0008849263],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021175235,0.0008688631,0.0013125053,0.00038168975,0.0007195441,0.00011152666,0.00040180102,0.0003231437,0.0006111675],"category_scores_gemma":[0.0000092185865,0.0005718815,0.00029336443,0.00082717824,0.0014685807,0.000088584806,0.00040682606,0.00031029442,0.0000027742592],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061575053,0.0012640232,0.9289676,0.000047765316,0.0067376625,0.000092039554,0.0007920651,0.0002563039,0.007833763,0.000016286827,0.000107291504,0.047727678],"study_design_scores_gemma":[0.0060388916,0.00024012597,0.9869924,0.00017723718,0.0013972656,0.00022897165,0.0004901094,0.0008769518,0.0027652045,0.000015026429,0.00013525867,0.0006425619],"about_ca_topic_score_codex":0.3284519,"about_ca_topic_score_gemma":0.111462384,"teacher_disagreement_score":0.2169895,"about_ca_system_score_codex":0.0010044797,"about_ca_system_score_gemma":0.0008321213,"threshold_uncertainty_score":0.99967325},"labels":[],"label_agreement":null},{"id":"W2004009193","doi":"10.1007/s10549-012-2056-y","title":"Risk factors for uncommon histologic subtypes of breast cancer using centralized pathology review in the Breast Cancer Family Registry","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Cancer Care Ontario; Public Health Ontario; University of Toronto","funders":"National Health and Medical Research Council; National Institutes of Health; National Cancer Institute; Medical Research Council; Cancer Care Ontario","keywords":"Medicine; Breast cancer; Odds ratio; Menarche; Population; Cancer registry; Family history; Internal medicine; Cancer; Not Otherwise Specified; Mucinous carcinoma; Oncology; Confidence interval; Gynecology; Pathology; Adenocarcinoma","score_opus":0.07866602275306618,"score_gpt":0.3852750301401786,"score_spread":0.30660900738711244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004009193","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8342575,0.15339103,0.000007785549,0.0029419446,0.00017585792,0.0011610135,0.008001548,0.000010010796,0.000053337408],"genre_scores_gemma":[0.8382329,0.15961841,0.000051036608,0.00014188855,0.00031179446,0.0014238172,0.000129246,0.000035765745,0.0000551625],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99715304,0.0004547567,0.00040132625,0.000616743,0.00035307996,0.0010210342],"domain_scores_gemma":[0.99853164,0.00014249027,0.0002604619,0.00055245915,0.00031770323,0.000195236],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00051354954,0.0004289402,0.00064151536,0.000104436906,0.00032154325,0.000022650629,0.00029036452,0.00017447429,0.000059110982],"category_scores_gemma":[0.000025724956,0.0002666968,0.00019163868,0.0003265056,0.00050702185,0.000023593104,0.00013478281,0.00018886215,9.251271e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017935216,0.0008804798,0.9649807,0.00036523808,0.00059351156,0.000010404485,0.00041485752,0.000021376845,0.0031566296,0.000048191247,0.0016931891,0.026041867],"study_design_scores_gemma":[0.0027304098,0.00023820231,0.99052864,0.0005757144,0.0003784019,0.00035327414,0.0006470921,0.0000065167164,0.0010306713,0.00005342286,0.0031475706,0.00031008144],"about_ca_topic_score_codex":0.04138633,"about_ca_topic_score_gemma":0.0052909562,"teacher_disagreement_score":0.036095373,"about_ca_system_score_codex":0.0007112978,"about_ca_system_score_gemma":0.00043111164,"threshold_uncertainty_score":0.99997854},"labels":[],"label_agreement":null},{"id":"W2006033910","doi":"10.1007/s10549-004-1250-y","title":"The 3020insC allele of NOD2 predisposes to early-onset breast cancer","year":2005,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Coalition for Research in Women's Health; University of Toronto","funders":"Warszawski Uniwersytet Medyczny","keywords":"Breast cancer; Allele; Medicine; Oncology; Cancer; Internal medicine; Genetics; Biology; Gene","score_opus":0.046368982688401096,"score_gpt":0.3790881616826772,"score_spread":0.3327191789942761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006033910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9716891,0.00494059,0.0000017598737,0.02026054,0.000097034484,0.0011500316,0.0010931394,0.000025696638,0.0007420757],"genre_scores_gemma":[0.98960084,0.0053857393,0.00011321271,0.00011661134,0.0004668984,0.001125397,0.000010168912,0.00003485041,0.0031462593],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9977978,0.00008010115,0.00025712812,0.0004281559,0.00074952096,0.00068733166],"domain_scores_gemma":[0.9984051,0.0001626573,0.000049480055,0.00044442381,0.0004474857,0.0004908254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023178157,0.00022250603,0.0003167672,0.00012512507,0.00027356396,0.000049796407,0.00016852161,0.00007406081,0.0006755139],"category_scores_gemma":[0.0000192995,0.00013278794,0.00008090183,0.00035687254,0.00035411262,0.000054203927,0.00012409971,0.00018223922,0.00003419794],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0074558677,0.0007524561,0.42402604,0.00006943051,0.0006271004,0.000023294902,0.0010790764,0.00005103739,0.0029308489,0.000046678288,0.009291631,0.55364656],"study_design_scores_gemma":[0.002251507,0.0015733881,0.95975095,0.0001680703,0.000073572795,0.00018858847,0.00019176195,0.00003529719,0.009407267,0.000038830723,0.02617797,0.00014278054],"about_ca_topic_score_codex":0.011368051,"about_ca_topic_score_gemma":0.009139716,"teacher_disagreement_score":0.55350375,"about_ca_system_score_codex":0.0008952525,"about_ca_system_score_gemma":0.0007117114,"threshold_uncertainty_score":0.99521536},"labels":[],"label_agreement":null},{"id":"W2006325063","doi":"10.1023/a:1023338718974","title":"SR Protein Expression and CD44 Splicing Pattern in Human Breast Tumours","year":2003,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Medical Research and Materiel Command; Canadian Institutes of Health Research","keywords":"RNA splicing; CD44; Breast cancer; Protein expression; Alternative splicing; Biology; Cancer research; Expression (computer science); Human breast; Oncology; Medicine; Internal medicine; Pathology; Exon; Genetics; Gene; Cancer; Computer science; Cell","score_opus":0.027548543326596318,"score_gpt":0.3413254758276895,"score_spread":0.3137769325010932,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006325063","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99722564,0.0014588718,0.000017352319,0.00036498174,0.000008959522,0.00053255673,0.000056548895,0.000005822926,0.00032926115],"genre_scores_gemma":[0.9972658,0.0007369583,0.0000336852,0.00001539356,0.00007991379,0.00035912468,0.00002334456,0.000021707267,0.0014640847],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983544,0.0001821435,0.0001403358,0.00047861115,0.00025512427,0.0005893989],"domain_scores_gemma":[0.99937654,0.000012342993,0.000025217085,0.00023371389,0.00007693577,0.0002752769],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032594183,0.00016572115,0.00015599963,0.00012450678,0.00023926447,0.00007283722,0.000080723345,0.00007849608,0.00004285282],"category_scores_gemma":[0.000011805879,0.00012816105,0.000028154876,0.000117483236,0.00014338862,0.000009672108,0.00009491018,0.00014518712,0.000002347584],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019726375,0.00019835687,0.17077613,0.000029972454,0.000024270472,0.000048385406,0.000054107844,0.0000025286802,0.7943991,0.000060258193,0.00006523089,0.034144424],"study_design_scores_gemma":[0.006154371,0.0017828067,0.36282977,0.00050377694,0.000009530263,0.0004788652,0.0005591913,0.00003648435,0.62553304,0.00026568855,0.0013945856,0.00045186354],"about_ca_topic_score_codex":0.003390703,"about_ca_topic_score_gemma":0.0018482399,"teacher_disagreement_score":0.19205365,"about_ca_system_score_codex":0.00010803238,"about_ca_system_score_gemma":0.00012435715,"threshold_uncertainty_score":0.5226256},"labels":[],"label_agreement":null},{"id":"W2006789505","doi":"10.1007/s10549-014-2840-y","title":"Pure anti-tumor effect of zoledronic acid in naïve bone-only metastatic and locally advanced breast cancer: proof from the “biological window therapy”","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Bone health and treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Laurentian University","funders":"","keywords":"Zoledronic acid; Breast cancer; Medicine; Metastatic breast cancer; Internal medicine; In vivo; Metastasis; Oncology; Cancer; Bone metastasis; Cancer research; Biology","score_opus":0.0327818350417973,"score_gpt":0.3671359964887995,"score_spread":0.33435416144700225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006789505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9671274,0.024767566,0.0000023891128,0.004912274,0.000039669212,0.0024398386,0.00064851186,0.000018632833,0.000043745204],"genre_scores_gemma":[0.9884208,0.009944928,0.000034115124,0.0001654023,0.000078729936,0.0012249947,0.000051056555,0.00002781109,0.000052178064],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99742794,0.0004945508,0.00033775927,0.0005729045,0.00044636952,0.000720487],"domain_scores_gemma":[0.99856967,0.00044297508,0.00010548165,0.00035989427,0.00013448515,0.00038748642],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005007652,0.00033180742,0.00080126594,0.00011020864,0.00018722464,0.000028947554,0.00009498769,0.00007763094,0.000094204945],"category_scores_gemma":[0.00002851185,0.0001638704,0.00008155209,0.00029209323,0.0004119776,0.00008047417,0.00006193171,0.00030455302,0.00000462674],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071142465,0.0006015113,0.5270197,0.00009610254,0.00031707305,0.0001251974,0.00016981034,0.000002733702,0.0012468785,0.000023214168,0.000017966946,0.46326557],"study_design_scores_gemma":[0.02015095,0.0053030173,0.9678949,0.0005655189,0.00010174543,0.00051610783,0.000084393934,0.00004709151,0.004743888,0.00015507505,0.00029681862,0.00014049216],"about_ca_topic_score_codex":0.014924704,"about_ca_topic_score_gemma":0.0052483645,"teacher_disagreement_score":0.46312508,"about_ca_system_score_codex":0.00037236654,"about_ca_system_score_gemma":0.0006131109,"threshold_uncertainty_score":0.991635},"labels":[],"label_agreement":null},{"id":"W2007270591","doi":"10.1007/s10549-013-2637-4","title":"Tumour diploidy and survival in breast cancer patients with BRCA2 mutations","year":2013,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Breast cancer; Oncology; Internal medicine; Hazard ratio; BRCA2 Protein; Medicine; Cancer; Aneuploidy; Proportional hazards model; BRCA mutation; Mutation; Biology; Germline mutation; Genetics; Confidence interval; Chromosome","score_opus":0.018803501404523058,"score_gpt":0.31632309282025073,"score_spread":0.29751959141572765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007270591","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951686,0.0013421739,0.0000069709254,0.0020497262,0.00004448152,0.00063364924,0.0005652436,0.0000072267026,0.00018188592],"genre_scores_gemma":[0.9962115,0.001517862,0.00008581479,0.000038209615,0.00011999883,0.0015434551,0.00010959428,0.000027735965,0.00034581777],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987062,0.00007853628,0.00013483745,0.00045479013,0.0002241173,0.00040149502],"domain_scores_gemma":[0.99925154,0.00002332595,0.000033995388,0.00018375661,0.0003262688,0.0001810852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000080857186,0.00017225,0.00014604548,0.00010570897,0.00015973652,0.00007971738,0.0000806011,0.00006475337,0.0001507445],"category_scores_gemma":[0.00000455238,0.00012860363,0.00001925677,0.00020309108,0.00024371567,0.000017920622,0.00007966084,0.0000924235,0.0000070013534],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004070404,0.00050015963,0.9192813,0.00002205745,0.00019620117,0.000004371141,0.00020901726,0.00005693921,0.0071965517,0.00003655278,0.00038771718,0.07170206],"study_design_scores_gemma":[0.0025527782,0.00032948848,0.99436444,0.000038939896,0.000015260679,0.000018954785,0.0001769133,0.000029184204,0.0016278098,0.00008343749,0.0006053597,0.0001574473],"about_ca_topic_score_codex":0.011268377,"about_ca_topic_score_gemma":0.005882247,"teacher_disagreement_score":0.07508309,"about_ca_system_score_codex":0.00031403362,"about_ca_system_score_gemma":0.0003815172,"threshold_uncertainty_score":0.9953157},"labels":[],"label_agreement":null},{"id":"W2007353846","doi":"10.1007/s10549-009-0336-y","title":"Family-based genetic association study of insulin-like growth factor I microsatellite markers and premenopausal breast cancer risk","year":2009,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Ontario Institute for Cancer Research; Hospital for Sick Children; Public Health Ontario; University of Toronto","funders":"National Institutes of Health; National Cancer Institute; Cancer Care Ontario","keywords":"Breast cancer; Allele; Risk factor; Internal medicine; Oncology; Genotype; Medicine; Endocrinology; Cancer; Biology; Genetics; Gene","score_opus":0.030105275037020537,"score_gpt":0.31913652509318136,"score_spread":0.2890312500561608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007353846","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907893,0.0050049718,0.0000032289904,0.0010227121,0.000076501485,0.0016650624,0.0013028341,0.000038975544,0.00009642796],"genre_scores_gemma":[0.9873177,0.011875568,0.000072353454,0.000103799764,0.00014713744,0.00021251243,0.000032168537,0.00003434182,0.0002044359],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99700594,0.0002659306,0.00045765907,0.0006523252,0.00090208213,0.0007160522],"domain_scores_gemma":[0.998215,0.00014518727,0.00020502385,0.00031478622,0.0006304061,0.00048956135],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031308204,0.0003631874,0.00058228424,0.0003515138,0.00026176425,0.000070211114,0.0000981671,0.00015118385,0.00006856795],"category_scores_gemma":[0.00002376714,0.0002760672,0.000069755886,0.00049943186,0.00013141306,0.00012327726,0.000043767686,0.00032202093,0.0000046677274],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004209666,0.002540912,0.8962987,0.00007132264,0.00061924045,0.000044321932,0.00073565467,0.0000029478629,0.0065978253,0.0000025295672,0.00021131964,0.08866555],"study_design_scores_gemma":[0.00945935,0.0060462574,0.9818934,0.000121266436,0.00029771272,0.000020324418,0.0003632549,0.00005746665,0.0013294752,0.00003335681,0.00016395669,0.0002141782],"about_ca_topic_score_codex":0.02129031,"about_ca_topic_score_gemma":0.00063623587,"teacher_disagreement_score":0.08845138,"about_ca_system_score_codex":0.0010817513,"about_ca_system_score_gemma":0.00049074774,"threshold_uncertainty_score":0.9999691},"labels":[],"label_agreement":null},{"id":"W2007894844","doi":"10.1007/s10549-013-2795-4","title":"Prospective associations of depression with survival: a population-based cohort study in patients with newly diagnosed breast cancer","year":2013,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer survivorship and care","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; BC Cancer Agency; University of British Columbia","funders":"BC Cancer Agency; Canadian Institutes of Health Research","keywords":"Breast cancer; Medicine; Depression (economics); Prospective cohort study; Oncology; Internal medicine; Cohort study; Cancer survival; Population; Cancer; Environmental health","score_opus":0.02339133766689157,"score_gpt":0.3337348880804718,"score_spread":0.31034355041358025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007894844","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99429536,0.0001400409,0.0000018766827,0.00046483905,0.000032460917,0.0042985873,0.00062593777,0.000020630037,0.00012026439],"genre_scores_gemma":[0.9952427,0.0000444283,0.000015182682,0.00001535953,0.000049452046,0.004382522,0.000120142075,0.00003094606,0.000099233665],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99794215,0.00013306027,0.00020636585,0.00044294176,0.0009046004,0.00037086188],"domain_scores_gemma":[0.9984292,0.00011695258,0.00009354954,0.0002743145,0.0008728373,0.00021316376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014949928,0.00019739632,0.0004189268,0.00020999687,0.00012675229,0.000037178408,0.000053780794,0.00005201036,0.00022676063],"category_scores_gemma":[0.000008488781,0.00012092125,0.000031810807,0.0005882198,0.000078795296,0.00012497237,0.00002329469,0.00015271793,0.0000017747892],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027342392,0.0029682042,0.9815729,0.000032351534,0.000348506,0.000012186613,0.00057130767,0.00005604365,0.0000034677919,0.0000039464685,0.000018189372,0.011678618],"study_design_scores_gemma":[0.013131075,0.0015879574,0.9841688,0.00029145813,0.00010817965,0.0000016004758,0.00052752637,0.000027033557,0.000022646629,0.000008061409,0.0000025791521,0.00012307032],"about_ca_topic_score_codex":0.49082497,"about_ca_topic_score_gemma":0.2819617,"teacher_disagreement_score":0.20886324,"about_ca_system_score_codex":0.001392262,"about_ca_system_score_gemma":0.00052611646,"threshold_uncertainty_score":0.7311406},"labels":[],"label_agreement":null},{"id":"W2008478049","doi":"10.1007/s10549-012-2255-6","title":"Evaluation of chromosome 6p22 as a breast cancer risk modifier locus in a follow-up study of BRCA2 mutation carriers","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec; University of Toronto; Cancer Care Ontario","funders":"National Cancer Institute; Canadian Institutes of Health Research; National Institutes of Health; Cancer Research UK","keywords":"Breast cancer; Germline mutation; Ovarian cancer; Oncology; Medicine; Population; BRCA2 Protein; Mutation; Cancer; Internal medicine; Genetics; Hazard ratio; Confidence interval; Biology; Gene","score_opus":0.05697026537657951,"score_gpt":0.3964929683591961,"score_spread":0.3395227029826166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008478049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919099,0.005793629,0.000006022781,0.0001298063,0.0001266938,0.0011753398,0.00071269635,0.0000035360476,0.00014232734],"genre_scores_gemma":[0.9967088,0.0012728379,0.000014740101,0.0000053809404,0.00016341088,0.0016511607,0.000044022672,0.000023968641,0.0001156765],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99764496,0.00045397962,0.00028389026,0.00037720206,0.0008462709,0.00039370352],"domain_scores_gemma":[0.9985208,0.000027119964,0.00013754587,0.0003378371,0.000827855,0.00014884995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010547704,0.00017155996,0.00022934715,0.00019305784,0.00009570318,0.0000140172315,0.00010508055,0.00009769428,0.00015120582],"category_scores_gemma":[0.000041495343,0.00014766036,0.000053114596,0.0003626499,0.00015859074,0.000020073607,0.000069349524,0.00009750512,0.0000020207392],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002884896,0.00321641,0.5132912,0.00006650932,0.0017463556,0.0000060513594,0.008756199,0.0045094206,0.03507494,0.000024825255,0.0001774009,0.4302458],"study_design_scores_gemma":[0.018600767,0.0026535855,0.90333915,0.00012226088,0.00062080595,0.00009812953,0.0074203364,0.00078256096,0.06551975,0.00024916918,0.00021913892,0.00037434656],"about_ca_topic_score_codex":0.037238885,"about_ca_topic_score_gemma":0.016287088,"teacher_disagreement_score":0.42987144,"about_ca_system_score_codex":0.00092006224,"about_ca_system_score_gemma":0.0011744584,"threshold_uncertainty_score":0.96917224},"labels":[],"label_agreement":null},{"id":"W2009929157","doi":"10.1007/s10549-012-2247-6","title":"Impact of biomarkers on clinical trial risk in breast cancer","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; University of Toronto","funders":"","keywords":"Taxane; Medicine; Anthracycline; Breast cancer; Oncology; Internal medicine; Clinical trial; Biomarker; Context (archaeology); Ixabepilone; Trastuzumab; Metastatic breast cancer; Cancer","score_opus":0.6218604223864977,"score_gpt":0.5987315367021722,"score_spread":0.023128885684325584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009929157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9812999,0.003762906,0.0000035478365,0.0077436143,0.0003649695,0.0011688425,0.0049725515,0.000010786327,0.0006729223],"genre_scores_gemma":[0.99128807,0.0069133863,0.000043414435,0.00012776219,0.0008213147,0.0006222787,0.00001659059,0.000025351332,0.00014184469],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99559844,0.00078540633,0.0021760466,0.0005002554,0.00016602158,0.0007738624],"domain_scores_gemma":[0.99706614,0.0011340049,0.0008055462,0.00041058724,0.00008561412,0.0004981278],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.012711255,0.00020150583,0.0009171124,0.0004996777,0.00013567961,0.000039348066,0.00014281973,0.0001451502,0.0009952314],"category_scores_gemma":[0.00030200218,0.00017835021,0.0002051688,0.00031849177,0.0002102777,0.00026595974,0.000045647037,0.00023382601,0.00020085995],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009169438,0.0015110562,0.9689844,0.000034408255,0.00045816269,0.0000010437793,0.00036349712,0.000020328855,6.1667447e-7,0.001103481,0.002760128,0.015593393],"study_design_scores_gemma":[0.019879928,0.0010771821,0.9769989,0.000088660134,0.000009350533,0.000006439593,0.00013578714,0.00013407588,0.0000015726417,0.00046339026,0.0010534467,0.00015121857],"about_ca_topic_score_codex":0.103427626,"about_ca_topic_score_gemma":0.0019173325,"teacher_disagreement_score":0.101510294,"about_ca_system_score_codex":0.002432491,"about_ca_system_score_gemma":0.000552691,"threshold_uncertainty_score":0.999918},"labels":[],"label_agreement":null},{"id":"W2010239645","doi":"10.1023/a:1012942910375","title":"The polymorphic CAG repeat of the androgen receptor gene: a potential role in breast cancer in women over 40","year":2001,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Sexual Differentiation and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; John Abbott College; Jewish General Hospital","funders":"","keywords":"Androgen receptor; Biology; Androgen; Allele; Population; Endocrinology; Internal medicine; Breast cancer; Estrogen receptor; Estrogen; Trinucleotide repeat expansion; Cancer; Genetics; Gene; Prostate cancer; Medicine; Hormone","score_opus":0.013941638964458068,"score_gpt":0.3009653057125309,"score_spread":0.28702366674807284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010239645","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99210453,0.0051748394,6.578831e-7,0.001943432,0.000057883655,0.00031319767,0.00029067023,0.0000024378026,0.00011237141],"genre_scores_gemma":[0.9898109,0.008748741,0.0000012331128,0.0000624335,0.000083355146,0.00037308678,0.000023285613,0.000012298975,0.00088470837],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987933,0.0001360311,0.00015855941,0.00028076337,0.00022739009,0.0004039466],"domain_scores_gemma":[0.9995275,0.000011973135,0.000040941668,0.00026091406,0.00006578123,0.00009289646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014918622,0.000120841156,0.00011860772,0.000059180013,0.00012927296,0.000031806056,0.00014414727,0.000070506554,0.00019008871],"category_scores_gemma":[0.000006042823,0.00007048602,0.000041857704,0.00023006287,0.00015717601,0.000005550674,0.00009761148,0.000080453014,0.0000014588443],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053171436,0.00068785605,0.7594088,0.000013185038,0.00021819635,0.00000930668,0.000541632,0.00009191777,0.10295752,0.00003734899,0.00044816843,0.13026895],"study_design_scores_gemma":[0.002774272,0.0001599562,0.9840675,0.00002807795,0.000007109074,0.000033178025,0.0006701486,0.000054450666,0.008848754,0.000098792145,0.0031474032,0.00011032907],"about_ca_topic_score_codex":0.012167325,"about_ca_topic_score_gemma":0.010964811,"teacher_disagreement_score":0.22465874,"about_ca_system_score_codex":0.00019286304,"about_ca_system_score_gemma":0.0002298525,"threshold_uncertainty_score":0.99441075},"labels":[],"label_agreement":null},{"id":"W2010561252","doi":"10.1007/s10549-009-0421-2","title":"Breast-conserving therapy after previous irradiation for lymphoma","year":2009,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec; Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Breast cancer; Lymphoma; Radiation therapy; Mammary gland; Oncology; Internal medicine; Cancer","score_opus":0.031898760510876444,"score_gpt":0.3440546179234882,"score_spread":0.31215585741261176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010561252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9755344,0.017337851,0.000025804953,0.0051899008,0.000062874155,0.0009827992,0.0006659245,0.000023505369,0.00017698966],"genre_scores_gemma":[0.9882086,0.008792261,0.00013754296,0.0002253521,0.0004907953,0.0016679823,0.000102580234,0.000024729154,0.0003501491],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99857026,0.00006133309,0.0001451626,0.00052190945,0.00019225362,0.00050910754],"domain_scores_gemma":[0.9992567,0.00003154556,0.00004021499,0.00029829075,0.00021598345,0.00015729426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011979441,0.00023756578,0.00019674482,0.00007676551,0.00025843192,0.000063910324,0.000094972005,0.00008620002,0.00002737097],"category_scores_gemma":[0.000004793473,0.00018148744,0.0000894953,0.00011282364,0.000106396794,0.000010704726,0.000037996953,0.000031947948,0.000004525234],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063114963,0.0008136223,0.03118269,0.000015628091,0.00044475598,0.000011616983,0.00021985019,0.0000036650836,0.004530508,0.00007531965,0.0008373267,0.95555353],"study_design_scores_gemma":[0.0060124756,0.0015536115,0.97660565,0.000049835155,0.000038280225,0.0002626398,0.000072670984,0.000013603435,0.0055382806,0.00046796075,0.009135587,0.00024941724],"about_ca_topic_score_codex":0.00075375766,"about_ca_topic_score_gemma":0.00037190868,"teacher_disagreement_score":0.9553041,"about_ca_system_score_codex":0.00023536208,"about_ca_system_score_gemma":0.00019593684,"threshold_uncertainty_score":0.74008435},"labels":[],"label_agreement":null},{"id":"W2011219564","doi":"10.1007/s10549-009-0373-6","title":"Breast cancer-related preferences among women with and without BRCA mutations","year":2009,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; BRCA mutation; Mammography; Logistic regression; Cancer; Demography; Health care; Life expectancy; Genetic testing; Gynecology; Magnetic resonance imaging; Ovarian cancer; Oncology; Obstetrics; Internal medicine; Environmental health; Radiology; Population","score_opus":0.023421966442109792,"score_gpt":0.3335802362583102,"score_spread":0.31015826981620037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011219564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99447167,0.0023868787,0.000009768926,0.0017762394,0.000027413593,0.0004546491,0.00032296634,0.000022935717,0.00052747707],"genre_scores_gemma":[0.9944095,0.00353957,0.00015306385,0.000034850083,0.00011254038,0.00080096716,0.000047345813,0.000019131137,0.00088304066],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986064,0.00007308787,0.00013726631,0.0005082141,0.00021552337,0.00045954617],"domain_scores_gemma":[0.9992231,0.000012501677,0.000049064252,0.0002333581,0.0002300402,0.0002519416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011487953,0.00019545207,0.0001650944,0.00009366316,0.00028907548,0.00009201021,0.000095936935,0.00009113322,0.00009592763],"category_scores_gemma":[0.0000026512676,0.00014214996,0.00001785334,0.00022062795,0.00034494358,0.000016345492,0.000040599865,0.00010497582,0.000002181045],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017990593,0.00061883975,0.39072037,0.000032336153,0.0010067075,0.00001216283,0.0021131004,0.00016164585,0.00792701,0.000107786174,0.0003596581,0.5951413],"study_design_scores_gemma":[0.0025904197,0.0016401102,0.9893985,0.00007369923,0.000051857452,0.00026778103,0.00055775687,0.000067322966,0.003475526,0.00047598596,0.0011419364,0.00025911327],"about_ca_topic_score_codex":0.0016735189,"about_ca_topic_score_gemma":0.0017906362,"teacher_disagreement_score":0.5986781,"about_ca_system_score_codex":0.00038262043,"about_ca_system_score_gemma":0.0005971906,"threshold_uncertainty_score":0.5796707},"labels":[],"label_agreement":null},{"id":"W2012493093","doi":"10.1007/s10549-008-0221-0","title":"Reactive oxygen species induce phosphorylation of serine 118 and 167 on estrogen receptor alpha","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Canadian Institutes of Health Research","keywords":"Phosphorylation; Protein kinase B; Wortmannin; Estrogen receptor; Kinase; Serine; LY294002; Signal transduction; Reactive oxygen species; Chemistry; Endocrinology; Internal medicine; Biology; Cell biology; Medicine; Cancer; Breast cancer","score_opus":0.03430026739182796,"score_gpt":0.3098260020718944,"score_spread":0.27552573468006647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012493093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945242,0.0040112915,0.000001169516,0.00031581995,0.000025314526,0.0002942137,0.00011197634,0.0000052471964,0.00071076275],"genre_scores_gemma":[0.9879883,0.010621091,0.000049028073,0.0000092618475,0.00011292839,0.00007626138,0.00008666171,0.000013958073,0.001042492],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991688,0.00005855436,0.00009742507,0.00028403345,0.00016965087,0.00022154761],"domain_scores_gemma":[0.9995557,0.000020163468,0.000037351158,0.00015413454,0.000101866906,0.0001307689],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007953726,0.0001273166,0.0001350931,0.000055295444,0.00014898434,0.000008979587,0.000044633958,0.00009617801,0.00002221582],"category_scores_gemma":[0.000008632115,0.00009506583,0.000033737724,0.00009198071,0.0002113568,0.0000054314173,0.000049408627,0.000087196786,0.0000040269665],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034056543,0.00056092173,0.036253087,0.00002385399,0.0005414964,0.000033670793,0.0003198034,0.000008540923,0.92286336,0.0002686436,0.0008501502,0.034870796],"study_design_scores_gemma":[0.001603568,0.0029519345,0.116201445,0.000038856982,0.000017406202,0.000115208735,0.00010320493,0.0000065364993,0.8734439,0.000026224252,0.0053668357,0.00012488135],"about_ca_topic_score_codex":0.00054439466,"about_ca_topic_score_gemma":0.000019774334,"teacher_disagreement_score":0.07994835,"about_ca_system_score_codex":0.00006865369,"about_ca_system_score_gemma":0.00012615492,"threshold_uncertainty_score":0.38766718},"labels":[],"label_agreement":null},{"id":"W2012604818","doi":"10.1007/s10549-009-0667-8","title":"Breast cancer cell CD200 expression regulates immune response to EMT6 tumor cells in mice","year":2009,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":63,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Immune system; Breast cancer; Cancer; Biology; Cancer research; Immunology; Medicine; Internal medicine","score_opus":0.01741225436293152,"score_gpt":0.3089028144996538,"score_spread":0.29149056013672225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012604818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95328003,0.041029017,0.000001124319,0.0037293036,0.00020110265,0.000848596,0.0007085487,0.00004772106,0.00015452896],"genre_scores_gemma":[0.9815388,0.006539577,0.000026205496,0.00014624721,0.000051862782,0.00042285162,0.000029162129,0.00003400233,0.0112113245],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967752,0.00092813134,0.00040928106,0.00065214967,0.00014166866,0.0010935314],"domain_scores_gemma":[0.99884593,0.0003079249,0.00008194108,0.0004763002,0.00017371756,0.00011420861],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006564579,0.00037927748,0.0004876906,0.0003628604,0.0004407365,0.00006953,0.00030171248,0.00018493099,0.0014072335],"category_scores_gemma":[0.000009889519,0.0002891627,0.000101051024,0.00043827825,0.00023123235,0.00020041142,0.00010199874,0.0003301579,0.00017016196],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.050568353,0.0010129978,0.00056091684,0.000012434228,0.00008313269,0.000057932728,0.0012255933,0.000013801974,0.8874763,0.000009458484,0.0009494398,0.0580296],"study_design_scores_gemma":[0.0047121504,0.0013299164,0.21844149,0.00032670159,0.000014826989,0.0002660024,0.0005411799,0.0000014121056,0.76476073,0.000031011583,0.009288428,0.00028615553],"about_ca_topic_score_codex":0.012336332,"about_ca_topic_score_gemma":0.0004070788,"teacher_disagreement_score":0.21788058,"about_ca_system_score_codex":0.0008481569,"about_ca_system_score_gemma":0.00044257776,"threshold_uncertainty_score":0.9999561},"labels":[],"label_agreement":null},{"id":"W2013195626","doi":"10.1007/s10549-014-2911-0","title":"Fatal breast cancer risk in relation to use of unopposed estrogen and combined hormone therapy","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Ministry of Health, Saskatchewan; University of Washington","keywords":"Breast cancer; Medicine; Odds ratio; Cancer; Gynecology; Population; Incidence (geometry); Confidence interval; Internal medicine; Hormone therapy; Estrogen; Oncology","score_opus":0.022704338020877856,"score_gpt":0.30986566470017063,"score_spread":0.2871613266792928,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013195626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99499816,0.0036186818,0.00001080841,0.0005124359,0.000018852192,0.0004956631,0.0003092012,0.000005380645,0.000030792573],"genre_scores_gemma":[0.98171,0.017808484,0.000061429884,0.000017328966,0.000054090167,0.0001671459,0.00005332901,0.000018029552,0.00011014269],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989111,0.00016471898,0.00014195371,0.00033058377,0.00016008294,0.00029156363],"domain_scores_gemma":[0.9994399,0.0000383346,0.000044228902,0.00019479379,0.000095231684,0.00018750686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017668455,0.00014688467,0.00017323288,0.00010117119,0.00008829145,0.00002796995,0.000054386892,0.000114602895,0.0000071192026],"category_scores_gemma":[0.000010564939,0.00010908061,0.0000337164,0.00015508264,0.000114978786,0.000009777457,0.000056035246,0.00010456323,0.0000015394547],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007741146,0.0005289844,0.38729545,0.000015561161,0.0003920436,0.000009331919,0.00021470188,0.00012952449,0.3798937,0.00011394765,0.00020063843,0.22346498],"study_design_scores_gemma":[0.0052362992,0.0028008695,0.9350212,0.000052287513,0.00002336961,0.00003735824,0.000024621419,0.00021018836,0.055483997,0.000051592317,0.00089229044,0.0001658938],"about_ca_topic_score_codex":0.0070334715,"about_ca_topic_score_gemma":0.0003147067,"teacher_disagreement_score":0.5477258,"about_ca_system_score_codex":0.000066805835,"about_ca_system_score_gemma":0.00009318864,"threshold_uncertainty_score":0.9995788},"labels":[],"label_agreement":null},{"id":"W2013307908","doi":"10.1007/s10549-013-2729-1","title":"The impact of pregnancy on breast cancer survival in women who carry a BRCA1 or BRCA2 mutation","year":2013,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McGill University; Women's College Hospital; Cancer Care Ontario; Université de Montréal; Princess Margaret Cancer Centre; BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health","keywords":"Breast cancer; Medicine; Hazard ratio; BRCA mutation; Pregnancy; Cancer; Obstetrics; Proportional hazards model; Gynecology; Oncology; Cohort; Survival rate; Internal medicine; Cohort study; Confidence interval; Genetics; Biology","score_opus":0.06689507586734411,"score_gpt":0.41182794638977055,"score_spread":0.34493287052242644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013307908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99189055,0.0025704198,3.143184e-7,0.0029504367,0.00005861507,0.0013090577,0.0008275397,0.000013155353,0.00037992472],"genre_scores_gemma":[0.9857292,0.010601694,0.0000015814544,0.000015553805,0.00012821582,0.0019386718,0.000012546129,0.000023001028,0.0015494941],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9980946,0.00010770751,0.00025481862,0.00034984417,0.0005067075,0.0006863292],"domain_scores_gemma":[0.998812,0.00017934317,0.0000707101,0.00031588238,0.0002850812,0.0003369526],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018318612,0.00021658104,0.00038922456,0.00018159336,0.00015764378,0.00006415578,0.00008740295,0.00006796697,0.0009800699],"category_scores_gemma":[0.000012881827,0.00010616983,0.00008762614,0.00041850586,0.00022308543,0.00010936062,0.000037714985,0.00020332371,0.0000121160465],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0074326894,0.0007204372,0.2937186,0.000074672746,0.00051105,0.00007067052,0.0020078782,0.000042660828,0.0002680099,0.00002818511,0.0008314498,0.6942937],"study_design_scores_gemma":[0.004551658,0.002019535,0.9912363,0.000724478,0.00001834147,0.0000700358,0.00077331474,0.00008844371,0.00015963147,0.00007874754,0.00017299097,0.00010648985],"about_ca_topic_score_codex":0.231931,"about_ca_topic_score_gemma":0.013095146,"teacher_disagreement_score":0.69751775,"about_ca_system_score_codex":0.002526363,"about_ca_system_score_gemma":0.001108569,"threshold_uncertainty_score":0.9999332},"labels":[],"label_agreement":null},{"id":"W2013794829","doi":"10.1007/s10549-011-1490-6","title":"Trends in improving survival in breast cancer: two steps forward but one step back?","year":2011,"lang":"en","type":"letter","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Breast cancer; Medicine; Oncology; Internal medicine; Cancer","score_opus":0.05238118297557423,"score_gpt":0.3373133746683679,"score_spread":0.2849321916927937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013794829","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3666364,0.047458265,0.000023776147,0.5348076,0.0017273054,0.004839782,0.03690913,0.00012491309,0.007472799],"genre_scores_gemma":[0.8840705,0.051670097,0.0003824773,0.015324424,0.012250488,0.0112248715,0.005735937,0.0007098665,0.018631333],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9946176,0.00040415203,0.00058000383,0.0018045781,0.0007434391,0.0018502523],"domain_scores_gemma":[0.9983042,0.00007180811,0.00019142528,0.0008652206,0.00029243858,0.0002748974],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00034246227,0.0009232701,0.0010693332,0.00083446497,0.00020556957,0.00010701155,0.00043749585,0.0006683972,0.00047312613],"category_scores_gemma":[0.000005990875,0.00079903577,0.00022955817,0.0006029792,0.00046591723,0.00002402447,0.00050574564,0.001021425,0.00002218919],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063202814,0.0020909812,0.30105442,0.00047824267,0.0028398312,0.0011495182,0.00042865358,0.000012867777,0.0015977457,0.000024189549,0.07914204,0.60486126],"study_design_scores_gemma":[0.02921795,0.0020600571,0.82164216,0.0015573218,0.0004909578,0.0005634292,0.0005095981,0.000030025714,0.0027694828,0.00013019018,0.13824965,0.0027791793],"about_ca_topic_score_codex":0.18129377,"about_ca_topic_score_gemma":0.09219181,"teacher_disagreement_score":0.6020821,"about_ca_system_score_codex":0.0018024904,"about_ca_system_score_gemma":0.0007704467,"threshold_uncertainty_score":0.99944603},"labels":[],"label_agreement":null},{"id":"W2013923368","doi":"10.1007/s10549-010-0828-9","title":"Targeting trastuzumab-resistant breast cancer cells with a lentivirus engineered to bind antibodies that recognize HER-2","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"BC Cancer Agency; Terry Fox Foundation","keywords":"Trastuzumab; Cancer research; Breast cancer; Lentivirus; Cancer; Cancer cell; Medicine; Metastatic breast cancer; Biology; Virology; Immunology; Virus; Internal medicine; Viral disease","score_opus":0.028904149008519522,"score_gpt":0.32780717820901434,"score_spread":0.29890302920049483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013923368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932286,0.0022152686,0.000016744005,0.0016140934,0.000107199456,0.00092921796,0.0017428704,0.00002395441,0.000122062294],"genre_scores_gemma":[0.9929535,0.0039348155,0.00019839087,0.000057474277,0.00044310925,0.00080740737,0.00007384667,0.00007867886,0.0014527849],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972458,0.00010987653,0.00018692385,0.0008372865,0.0005836222,0.0010365177],"domain_scores_gemma":[0.99856025,0.000040215305,0.000047744896,0.0004659294,0.0003739352,0.00051193294],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00037399153,0.00036860514,0.00030417767,0.00019895843,0.0003624087,0.00015561936,0.00025608306,0.00013800415,0.00035370432],"category_scores_gemma":[0.000007713561,0.00026697054,0.00007424144,0.00031528657,0.00027848987,0.000015269336,0.00014088859,0.00029936436,0.000023983732],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012103875,0.00037629757,0.0071403384,0.000035263412,0.00045304606,0.00004505802,0.00015669798,0.00006365466,0.92247397,0.0000038797984,0.0007550432,0.05639285],"study_design_scores_gemma":[0.0033710704,0.0047716033,0.027264489,0.00011597635,0.00004176056,0.00008314571,0.000301802,0.000039187034,0.95825887,0.000016372866,0.005219161,0.00051657594],"about_ca_topic_score_codex":0.0040557827,"about_ca_topic_score_gemma":0.016528571,"teacher_disagreement_score":0.055876274,"about_ca_system_score_codex":0.00018497699,"about_ca_system_score_gemma":0.0005409607,"threshold_uncertainty_score":0.99997824},"labels":[],"label_agreement":null},{"id":"W2014321261","doi":"10.1007/s10549-015-3374-7","title":"Factors associated with genetic counseling and BRCA testing in a population-based sample of young Black women with breast cancer","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":99,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"National Cancer Institute; Moffitt Cancer Center; American Cancer Society","keywords":"Medicine; Referral; Breast cancer; Genetic counseling; Population; Socioeconomic status; Family medicine; Genetic testing; Cancer registry; Health equity; Health care; Cancer screening; Cancer; Demography; Gerontology; Public health; Environmental health; Internal medicine; Nursing","score_opus":0.06674894701991176,"score_gpt":0.3347987882895532,"score_spread":0.26804984126964143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014321261","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997876,0.00078818295,0.000035797875,0.00014720658,0.000013601122,0.00034719156,0.000765813,0.00000681341,0.000019393907],"genre_scores_gemma":[0.99912614,0.00013153689,0.0002195151,0.000012891738,0.00004759601,0.00031458423,0.00008579553,0.000027484119,0.00003444999],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987118,0.00008092164,0.00015517925,0.00036780446,0.00030781145,0.00037648776],"domain_scores_gemma":[0.99905217,0.000079264435,0.000078400335,0.00016616074,0.0004439269,0.00018009407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018567915,0.00017018183,0.0001940624,0.000104919025,0.00008425289,0.00003681662,0.00006243089,0.00006625446,0.000013631878],"category_scores_gemma":[0.000038070615,0.000120034434,0.0000107073965,0.00033078354,0.00019364296,0.000008479533,0.000027053968,0.00007165794,1.0913526e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068514195,0.00013927293,0.9872047,0.000020908357,0.00016037183,0.0000036974154,0.0006886377,0.003926772,0.0010608018,0.000001264735,0.000011933328,0.006096514],"study_design_scores_gemma":[0.0027551802,0.0008393845,0.9936427,0.00013997154,0.000023387698,0.000011225118,0.0007224006,0.0006345208,0.0010263048,0.000030931446,0.000021364325,0.0001526658],"about_ca_topic_score_codex":0.02250324,"about_ca_topic_score_gemma":0.021511013,"teacher_disagreement_score":0.006437979,"about_ca_system_score_codex":0.0008550767,"about_ca_system_score_gemma":0.0010133247,"threshold_uncertainty_score":0.99634385},"labels":[],"label_agreement":null},{"id":"W2014331129","doi":"10.1007/s10549-008-0087-1","title":"Expression profiling of familial breast cancers demonstrates higher expression of FGFR2 in BRCA2-associated tumors","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"National Cancer Institute","keywords":"Breast cancer; BRCA2 Protein; Oncology; Gene expression profiling; Medicine; Internal medicine; Cancer research; Pathology; Biology; Gene expression; Cancer; Mutation; Gene; Genetics; Germline mutation","score_opus":0.03850682409171169,"score_gpt":0.32766626291087814,"score_spread":0.28915943881916645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014331129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975205,0.0011762044,0.0000020461212,0.000074163625,0.000028728788,0.0004710602,0.00047768265,0.0000069183407,0.00024269527],"genre_scores_gemma":[0.9979921,0.0012344349,0.00011456308,0.0000026750731,0.000069259215,0.0001844831,0.000099673176,0.000027269289,0.00027554546],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979422,0.00021514622,0.00031473226,0.00046453526,0.0005142571,0.0005491199],"domain_scores_gemma":[0.99911046,0.000048363014,0.00010131226,0.00027052136,0.0002823355,0.00018701138],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021440782,0.00020077405,0.0003077766,0.00019071558,0.000120235214,0.0000095465575,0.00016897792,0.00015200378,0.000062321604],"category_scores_gemma":[0.000023321198,0.00015686422,0.00006932305,0.00030331986,0.00047428565,0.000014413267,0.00016137374,0.0001635275,0.0000012993232],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014160406,0.00033140418,0.25719923,0.000050420505,0.000043489315,0.000020465217,0.0000849259,0.00004219492,0.7394492,0.0000058637033,0.00016365192,0.0011931208],"study_design_scores_gemma":[0.0017627855,0.00063113455,0.28437513,0.00029591745,0.0000036450713,0.000030047162,0.00011348225,0.000017783823,0.71262264,0.000012949317,0.00002848738,0.000106021645],"about_ca_topic_score_codex":0.0061577447,"about_ca_topic_score_gemma":0.0006180988,"teacher_disagreement_score":0.027175916,"about_ca_system_score_codex":0.00028416634,"about_ca_system_score_gemma":0.00067926216,"threshold_uncertainty_score":0.93087095},"labels":[],"label_agreement":null},{"id":"W2015001695","doi":"10.1007/s10549-007-9617-5","title":"Melatonin, environmental light, and breast cancer","year":2007,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Circadian rhythm and melatonin","field":"Neuroscience","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"The Scarborough Hospital","funders":"","keywords":"Melatonin; Breast cancer; Endocrinology; Internal medicine; Cancer; Antiestrogen; Pineal gland; Estrogen; Estrogen receptor; Cancer cell; Cancer research; Medicine; Biology","score_opus":0.11612045912851582,"score_gpt":0.40314067199142356,"score_spread":0.28702021286290774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015001695","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025937445,0.99037397,3.4869552e-7,0.0004758818,0.00017775739,0.0014275194,0.0038767753,0.000044234523,0.0010297905],"genre_scores_gemma":[0.0049363454,0.98915064,0.0000051324882,0.000046548095,0.00056347955,0.0011032799,0.000022278316,0.00010188405,0.0040704175],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959605,0.00026599262,0.0004251572,0.0013814584,0.00074414106,0.0012227593],"domain_scores_gemma":[0.9981877,0.00029068507,0.00014124553,0.0004809209,0.000026498523,0.0008729132],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002715001,0.0006745411,0.0011454782,0.0004608329,0.00054335827,0.00019190663,0.00022591735,0.00032447575,0.0006941795],"category_scores_gemma":[0.000007004859,0.00047805908,0.00021501952,0.00043532392,0.00050164474,0.00016798798,0.00024225446,0.00060480775,0.00018529757],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008406675,0.00025919348,0.00048238388,0.0008027058,0.00012976617,0.000406171,0.00010925857,7.4472204e-8,0.00006161869,0.00064586557,0.0002283282,0.9967906],"study_design_scores_gemma":[0.00091715046,0.0001669723,0.0022121707,0.0027380243,0.00023399136,0.0042522964,0.000024367248,0.0000018402218,0.0004831237,0.000022332837,0.9884761,0.0004716439],"about_ca_topic_score_codex":0.00088104635,"about_ca_topic_score_gemma":0.00017276064,"teacher_disagreement_score":0.99631894,"about_ca_system_score_codex":0.0014524434,"about_ca_system_score_gemma":0.0006083662,"threshold_uncertainty_score":0.9997671},"labels":[],"label_agreement":null},{"id":"W2015413901","doi":"10.1007/s10549-008-0102-6","title":"Tumor size is an unreliable predictor of prognosis in basal-like breast cancers and does not correlate closely with lymph node status","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":104,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Breast cancer; Medicine; Oncology; Internal medicine; Lymph node; Lymph; Correlation; Cancer; Pathology","score_opus":0.02333632885157947,"score_gpt":0.29120852132197145,"score_spread":0.26787219247039196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015413901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99276096,0.0027197793,0.0000013088994,0.0007673846,0.000055775974,0.00062152016,0.002915878,0.000014804584,0.00014257322],"genre_scores_gemma":[0.9867961,0.011474226,0.0002052428,0.00010090834,0.000103775914,0.00084599725,0.000060622537,0.000045897585,0.00036722652],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976511,0.00009819062,0.00025593242,0.00080961507,0.0004160757,0.00076910533],"domain_scores_gemma":[0.99888974,0.000060416143,0.000093398936,0.00033848966,0.00027057642,0.000347369],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011620094,0.00035141114,0.0004051983,0.00011252863,0.0002461048,0.000028569884,0.000112455506,0.00009279183,0.00003997419],"category_scores_gemma":[0.000008989286,0.00023077808,0.00004623719,0.00024896377,0.0007344607,0.000027037036,0.00012180708,0.00010453551,0.0000012851201],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068338555,0.0007692987,0.98048985,0.0000787904,0.00058867043,0.00010742038,0.00082754774,0.000030017496,0.0028002737,0.000011804608,0.00020165816,0.007260806],"study_design_scores_gemma":[0.00664184,0.0013113944,0.976318,0.000178692,0.0000706208,0.00034473647,0.00046026724,0.000032504016,0.014012259,0.00002621818,0.00033273603,0.00027073812],"about_ca_topic_score_codex":0.038551405,"about_ca_topic_score_gemma":0.005929252,"teacher_disagreement_score":0.032622155,"about_ca_system_score_codex":0.0004656486,"about_ca_system_score_gemma":0.0009037698,"threshold_uncertainty_score":0.967851},"labels":[],"label_agreement":null},{"id":"W2015564512","doi":"10.1007/s10549-010-1241-0","title":"Expression of Abl interactor 1 and its prognostic significance in breast cancer: a tissue-array-based investigation","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Ontario Institute for Cancer Research; University of Manitoba","funders":"Canadian Institutes of Health Research","keywords":"Tissue microarray; Immunohistochemistry; Breast cancer; Protein kinase B; Cancer research; Biology; Cancer; Pathology; Oncology; Medicine; Internal medicine; Signal transduction; Genetics","score_opus":0.042785451384319106,"score_gpt":0.36029989975908927,"score_spread":0.31751444837477016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015564512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99265695,0.0016810533,0.0000017345111,0.0034955866,0.000066635694,0.0015294541,0.00047541343,0.00002364434,0.00006954413],"genre_scores_gemma":[0.99687415,0.0010612713,0.00022795735,0.000030450943,0.00012764572,0.0013523039,0.00005101457,0.000030121204,0.00024506933],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99818283,0.00009503308,0.00028395536,0.0005206662,0.0004592757,0.0004582403],"domain_scores_gemma":[0.99875945,0.00019974959,0.00009428252,0.00027039245,0.00026402008,0.00041211353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018921238,0.00024043626,0.00038236828,0.00027410802,0.00009191494,0.000030304935,0.00007353579,0.000112285816,0.00036240113],"category_scores_gemma":[0.000037594597,0.00017586158,0.00003168856,0.0003337531,0.00025940087,0.00013276744,0.000040050734,0.0003175183,0.000005943516],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019727848,0.0006689936,0.45898443,0.00032062762,0.00007094243,0.000077606055,0.00048571263,0.000005698576,0.4949542,0.000017970122,0.00007442386,0.042366605],"study_design_scores_gemma":[0.0077681066,0.00085276103,0.6934063,0.0014410481,0.000063904,0.00014785788,0.00008559917,0.00030253458,0.2954372,0.00004429708,0.000294917,0.00015551824],"about_ca_topic_score_codex":0.010335864,"about_ca_topic_score_gemma":0.0029679756,"teacher_disagreement_score":0.23442185,"about_ca_system_score_codex":0.0009737824,"about_ca_system_score_gemma":0.0014286424,"threshold_uncertainty_score":0.9962544},"labels":[],"label_agreement":null},{"id":"W2015996473","doi":"10.1007/s10549-009-0510-2","title":"Patterns of relapse in breast cancer: changes over time","year":2009,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Anthracycline; Cumulative incidence; Internal medicine; Oncology; Chemotherapy; Cohort; Tamoxifen; Incidence (geometry); Metastasis; Cancer","score_opus":0.022743885802643027,"score_gpt":0.33342011629744,"score_spread":0.310676230494797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015996473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844948,0.0054211505,9.869182e-7,0.0076013803,0.00004003985,0.00037969984,0.0018487504,0.000010795388,0.00020237654],"genre_scores_gemma":[0.9816507,0.01693952,0.000014274888,0.00010144755,0.00025673278,0.0003286501,0.000073016614,0.000021082386,0.0006145839],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983985,0.00008116772,0.00017774239,0.00051874487,0.00028691813,0.00053696305],"domain_scores_gemma":[0.99930173,0.000021693028,0.000060246075,0.00031742765,0.00014561893,0.00015328634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012032306,0.00024953537,0.00030959217,0.0001518262,0.00009819747,0.000020401405,0.00012472713,0.000100787576,0.00017140503],"category_scores_gemma":[0.0000035062205,0.00019593287,0.000059208713,0.0001977027,0.00011336765,0.000008533456,0.000090503774,0.000090445545,0.0000050997737],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028990353,0.0013475339,0.7346943,0.0000447345,0.00045360075,0.00005298873,0.00032717976,0.000014424016,0.029870108,0.00008229166,0.0011187071,0.2290951],"study_design_scores_gemma":[0.0029857769,0.00067967543,0.9841151,0.00016071713,0.00003165542,0.000070020535,0.00006817177,0.0000066282655,0.010424509,0.00006295382,0.0012097363,0.00018503792],"about_ca_topic_score_codex":0.009755205,"about_ca_topic_score_gemma":0.0051191607,"teacher_disagreement_score":0.24942082,"about_ca_system_score_codex":0.0002874144,"about_ca_system_score_gemma":0.00017312917,"threshold_uncertainty_score":0.9968389},"labels":[],"label_agreement":null},{"id":"W2016583530","doi":"10.1007/s10549-006-9223-y","title":"Cosmetic outcomes following breast conservation therapy: in search of a reliable scale","year":2006,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Implant and Reconstruction","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Health Sciences Centre Foundation","keywords":"Cosmesis; Kappa; Confidence interval; Reliability (semiconductor); Medicine; Scale (ratio); Cohen's kappa; Statistics; Physical therapy; Surgery; Mathematics; Internal medicine","score_opus":0.0471245885774082,"score_gpt":0.3521505025220145,"score_spread":0.3050259139446063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016583530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950624,0.00087923015,0.0000028416243,0.0027704453,0.000056383215,0.0006154595,0.0000984779,0.000017418075,0.000497336],"genre_scores_gemma":[0.9983229,0.00031235965,0.00013986553,0.000011350882,0.00006161102,0.00012242411,0.000039063347,0.000014795006,0.0009756266],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986954,0.00006451383,0.00023303293,0.00024749426,0.00038744148,0.00037216954],"domain_scores_gemma":[0.9994795,0.00007378824,0.000032372114,0.00015559066,0.00015162697,0.0001071404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028455278,0.00012919499,0.00032835058,0.00031192484,0.00009541943,0.0000222394,0.00003748793,0.000070049784,0.00006922559],"category_scores_gemma":[0.000001423492,0.000088282985,0.00007471674,0.00038410668,0.00016114619,0.00008351507,0.000019859755,0.00012958875,0.000005092627],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007639672,0.00049621053,0.8362972,0.000033146396,0.00008887192,0.000032496668,0.00007038366,0.000002633332,0.001126495,0.00008138928,0.0000572487,0.16094993],"study_design_scores_gemma":[0.0053151334,0.00037128362,0.98907405,0.00021335798,0.000023504092,0.002412665,0.00018441299,0.00006217358,0.0019681805,0.00024505632,0.00005550668,0.00007468469],"about_ca_topic_score_codex":0.0474876,"about_ca_topic_score_gemma":0.0025867717,"teacher_disagreement_score":0.16087525,"about_ca_system_score_codex":0.00028996397,"about_ca_system_score_gemma":0.00030018343,"threshold_uncertainty_score":0.9588553},"labels":[],"label_agreement":null},{"id":"W2016905991","doi":"10.1007/s10549-010-1101-y","title":"Commentary on: “Effect of obesity on survival in women with breast cancer: systematic review and meta-analysis” (Melinda Protani, Michael Coory, Jennifer H. Martin)","year":2010,"lang":"en","type":"letter","venue":"Breast Cancer Research and Treatment","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Breast cancer; Meta-analysis; Obesity; Medicine; Gerontology; Cancer; Oncology; Internal medicine; Gynecology","score_opus":0.045910721086821565,"score_gpt":0.357944472115379,"score_spread":0.31203375102855746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016905991","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21327652,0.055250015,3.9882502e-7,0.70463556,0.00008258721,0.016806828,0.009811181,0.000035283025,0.00010163517],"genre_scores_gemma":[0.6639502,0.067601144,0.000016145294,0.21634367,0.0016243198,0.04504316,0.000867761,0.00035205254,0.004201518],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9952631,0.0008441974,0.00069802895,0.0010049762,0.0013085658,0.00088110793],"domain_scores_gemma":[0.99761033,0.00041017742,0.00034379167,0.0009514754,0.0002931351,0.00039108848],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011648249,0.0007735448,0.0051343595,0.000570287,0.00013818587,0.000056205132,0.00018422656,0.00040016367,0.0009670591],"category_scores_gemma":[0.000012552752,0.0004070082,0.00041411867,0.0006886076,0.0003759731,0.00005900533,0.0000876455,0.0020177593,0.0000052217324],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02334498,0.002866926,0.09742353,0.3970368,0.35707784,0.0024387047,0.0007252141,0.000006559203,0.00002332761,0.000005120136,0.11530074,0.0037502635],"study_design_scores_gemma":[0.02149836,0.025310213,0.13641435,0.05350286,0.7444004,0.0008272776,0.00022128291,0.000025900297,0.0002808708,0.00001816637,0.015347865,0.002152484],"about_ca_topic_score_codex":0.038287185,"about_ca_topic_score_gemma":0.0102741765,"teacher_disagreement_score":0.4882919,"about_ca_system_score_codex":0.0014868223,"about_ca_system_score_gemma":0.00037996442,"threshold_uncertainty_score":0.9999462},"labels":[],"label_agreement":null},{"id":"W2016981231","doi":"10.1007/s10549-005-9009-7","title":"Gene expression patterns for doxorubicin (Adriamycin) and cyclophosphamide (Cytoxan) (AC) response and resistance","year":2005,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":128,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Ottawa Mental Health Centre; Institute of Cancer Research","funders":"National Cancer Institute","keywords":"Docetaxel; Biology; Breast cancer; Doxorubicin; Gene expression; Cancer research; Cyclophosphamide; Gene expression profiling; Chemotherapy regimen; Oncology; Internal medicine; Cancer; Gene; Medicine; Chemotherapy; Genetics","score_opus":0.025910436644172457,"score_gpt":0.3337307440364717,"score_spread":0.3078203073922992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016981231","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9739936,0.019383417,0.000051782477,0.0048166364,0.000036546116,0.0006753424,0.00097336224,0.000015085138,0.000054257605],"genre_scores_gemma":[0.9796393,0.016040923,0.0014232448,0.00009148808,0.00036205488,0.0010517554,0.00006461283,0.000036827038,0.0012897877],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9982524,0.000119307304,0.00017882777,0.0007225048,0.0002031875,0.0005237799],"domain_scores_gemma":[0.9991283,0.00011936906,0.00005011283,0.00031050446,0.00014632934,0.00024538077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000263687,0.00028131128,0.00025722838,0.000078077115,0.0004110153,0.00006313854,0.000077762226,0.000100353085,0.000014246368],"category_scores_gemma":[0.000025965393,0.00021505253,0.00004552212,0.00007128438,0.0002409312,0.000015331329,0.00016698371,0.000068120935,0.0000014806625],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.066437185,0.0010933182,0.2484729,0.00023150252,0.0010389902,0.00007659019,0.0014474982,0.000008501189,0.46289816,0.00023110902,0.003625904,0.21443835],"study_design_scores_gemma":[0.007952416,0.0011088818,0.57173234,0.00019485255,0.00007217189,0.000141028,0.00035371902,0.000006191721,0.38674214,0.00022770018,0.031071303,0.0003972427],"about_ca_topic_score_codex":0.00045771647,"about_ca_topic_score_gemma":0.0023495886,"teacher_disagreement_score":0.32325947,"about_ca_system_score_codex":0.00018445085,"about_ca_system_score_gemma":0.0001187973,"threshold_uncertainty_score":0.8769587},"labels":[],"label_agreement":null},{"id":"W2016999745","doi":"10.1007/s10549-014-3088-2","title":"Digital compared to screen-film mammography: breast cancer prognostic features in an organized screening program","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Digital Radiography and Breast Imaging","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; University Health Network; Sunnybrook Health Science Centre; Cancer Care Ontario","funders":"Canadian Institutes of Health Research; Canadian Breast Cancer Research Alliance; Association Canadienne des Radiologistes; Cancer Care Ontario; Breast Cancer Alliance; Cancer Research Institute","keywords":"Medicine; Mammography; Confidence interval; Breast cancer; Odds ratio; Radiography; Computed radiography; Radiology; Logistic regression; Stage (stratigraphy); Cancer; Internal medicine","score_opus":0.033356529873166625,"score_gpt":0.3583288994832844,"score_spread":0.3249723696101178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016999745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98835146,0.0008384948,0.000031679283,0.0050135357,0.000047791247,0.0025132361,0.0010983992,0.00021718892,0.0018882232],"genre_scores_gemma":[0.99703443,0.00012504956,0.00056499674,0.00013335401,0.00032644538,0.0012249346,0.00021101453,0.00006725817,0.00031254537],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.996836,0.00010077058,0.00030685496,0.00084050035,0.00076931424,0.0011465307],"domain_scores_gemma":[0.9978634,0.000104973835,0.00005172462,0.0004188932,0.00041406997,0.0011469156],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002474496,0.00041125846,0.00058103405,0.0008903925,0.00024013703,0.000594909,0.00019118788,0.000085790125,0.0000919397],"category_scores_gemma":[0.000022761258,0.00030902852,0.00013242582,0.0017575232,0.00033551335,0.0005297025,0.00010939309,0.00031739456,0.000010785877],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022556055,0.0013028246,0.4957479,0.000039806895,0.00016670502,0.00007903984,0.0001243728,0.000010433317,0.00010335773,0.00004326801,0.00014990923,0.49997678],"study_design_scores_gemma":[0.005280028,0.0018275266,0.9887496,0.0007895122,0.000074202144,0.00074769836,0.00032346952,0.00027488454,0.00012809494,0.00006574101,0.0014215857,0.00031766226],"about_ca_topic_score_codex":0.005503631,"about_ca_topic_score_gemma":0.0029100552,"teacher_disagreement_score":0.49965912,"about_ca_system_score_codex":0.00025236479,"about_ca_system_score_gemma":0.00023691406,"threshold_uncertainty_score":0.99993616},"labels":[],"label_agreement":null},{"id":"W2017317192","doi":"10.1007/s10549-011-1796-4","title":"The BRCA2 c.9004G&gt;A (E2003K) variant is likely pathogenic and recurs in breast and/or ovarian cancer families of French Canadian descent","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Jewish General Hospital; Women's College Hospital; University of Toronto; Université de Montréal; McGill University Health Centre; McGill University; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Breast cancer; Ovarian cancer; Cancer; Medicine; Population; Family history; Oncology; Internal medicine; Gynecology","score_opus":0.04129349429592028,"score_gpt":0.31189680347168575,"score_spread":0.27060330917576547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017317192","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97527146,0.019141765,0.000005550499,0.0027484782,0.00010108687,0.0006198741,0.0015776014,0.000004472177,0.0005297269],"genre_scores_gemma":[0.9566234,0.04208891,0.00016039204,0.000082236635,0.00008737775,0.00041208736,0.000019738258,0.000023103663,0.0005027759],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9984324,0.00011608612,0.00021830751,0.0004898452,0.00019526029,0.0005481195],"domain_scores_gemma":[0.9990785,0.000029308829,0.000053017717,0.00033464542,0.0002042457,0.00030027144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028198108,0.00019900303,0.00018601547,0.00014243624,0.00025863634,0.000047759397,0.00014518837,0.00012104852,0.000101865415],"category_scores_gemma":[0.000011756493,0.0001345137,0.000033249296,0.00024287126,0.0004473994,0.000009774927,0.00010165667,0.00011209708,0.0000012073399],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019051082,0.00040013698,0.2600579,0.0000894055,0.00078037655,0.00011819367,0.004381461,0.0000066598964,0.008367178,0.00046528006,0.002247788,0.7211805],"study_design_scores_gemma":[0.002402206,0.0007215494,0.97287554,0.0001363223,0.000058615668,0.00039230275,0.00083913654,0.000054241013,0.0074034617,0.00031419733,0.0145074,0.00029500326],"about_ca_topic_score_codex":0.43742234,"about_ca_topic_score_gemma":0.6620677,"teacher_disagreement_score":0.7208855,"about_ca_system_score_codex":0.00041575634,"about_ca_system_score_gemma":0.0017623899,"threshold_uncertainty_score":0.56632394},"labels":[],"label_agreement":null},{"id":"W2017319820","doi":"10.1007/s10549-010-1036-3","title":"International distribution and age estimation of the Portuguese BRCA2 c.156_157insAlu founder mutation","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre; Jewish General Hospital; Women's College Hospital; University of Toronto","funders":"Ministério da Saúde; Ministerio de Ciencia e Innovación; Jewish General Hospital; Liga Portuguesa Contra o Cancro; Hospital de Clínicas de Porto Alegre; Conselho Nacional de Desenvolvimento Científico e Tecnológico; Coordenação de Aperfeiçoamento de Pessoal de Nível Superior; Susan G. Komen for the Cure","keywords":"Founder effect; Breast cancer; Portuguese; Estimation; Mutation; Genetics; Medicine; Biology; Oncology; Demography; Cancer; Gene; Genotype; Haplotype; Sociology","score_opus":0.025640022634346133,"score_gpt":0.35582678334332835,"score_spread":0.33018676070898223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017319820","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968557,0.00037913388,0.00027131368,0.0014678357,0.00018547576,0.00024869383,0.00032654355,0.0000038267817,0.00026151372],"genre_scores_gemma":[0.99826413,0.0006556442,0.00020596024,0.000014311489,0.00013788139,0.00013351649,0.00026779613,0.000007710202,0.0003130319],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9993416,0.000034882712,0.00010225268,0.00020204758,0.00019520504,0.00012399281],"domain_scores_gemma":[0.9995487,0.000015169128,0.000043738444,0.00017414303,0.0001675294,0.000050736875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001353229,0.000073562616,0.000059450056,0.000029687086,0.00010245383,0.000025595169,0.00007516917,0.000058968144,0.000032472326],"category_scores_gemma":[0.000029154338,0.000052000833,0.000024000354,0.000079603145,0.00025343412,0.00000849343,0.00006933528,0.000073209165,8.1282474e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037454872,0.00029612647,0.01884617,0.00002581684,0.00026519058,0.00000697017,0.00027138097,0.00024204739,0.12971428,0.001576496,0.0008642315,0.8475168],"study_design_scores_gemma":[0.0016755365,0.00029211416,0.9050131,0.000027187947,0.000032633696,0.00017300225,0.00012755074,0.000969508,0.082718074,0.0015357331,0.007299523,0.00013604554],"about_ca_topic_score_codex":0.0005479508,"about_ca_topic_score_gemma":0.00082132046,"teacher_disagreement_score":0.88616693,"about_ca_system_score_codex":0.000101697726,"about_ca_system_score_gemma":0.00017148188,"threshold_uncertainty_score":0.21205324},"labels":[],"label_agreement":null},{"id":"W2017794382","doi":"10.1007/s10549-009-0531-x","title":"Association of low tumor RNA integrity with response to chemotherapy in breast cancer patients","year":2009,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Health Sciences Centre; Queen's University; University Health Network; University of Toronto; Laurentian University; Sunnybrook Health Science Centre; Sudbury Regional Hospital","funders":"Sanofi","keywords":"Breast cancer; Oncology; Medicine; Chemotherapy; Internal medicine; Cancer; Cancer research","score_opus":0.013046307017853465,"score_gpt":0.32830068417394237,"score_spread":0.3152543771560889,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017794382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922787,0.00018669381,0.0000030818987,0.0066913962,0.000010675431,0.00046383686,0.00030570867,0.0000036163012,0.0000562818],"genre_scores_gemma":[0.9977809,0.0007541832,0.000035885834,0.00013233833,0.00006303778,0.0001567238,0.00001809865,0.000011834353,0.0010469804],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99852896,0.00015600216,0.00014151182,0.0003241134,0.0003973578,0.00045206308],"domain_scores_gemma":[0.99917716,0.000028422332,0.000046313326,0.00017729995,0.0003638008,0.00020698206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004008443,0.000131412,0.00017449072,0.00013531695,0.000068650115,0.000028878972,0.00010081828,0.000061247,0.000036577596],"category_scores_gemma":[0.00002599953,0.00009407492,0.000030547166,0.00026536806,0.000047832124,0.000008360311,0.00003065987,0.00012772459,0.0000017059119],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028758667,0.0011472994,0.58962506,0.000018816047,0.00013531739,0.0000130954295,0.00014312519,0.00001944031,0.2975386,0.0000050527387,0.00073534535,0.0818602],"study_design_scores_gemma":[0.0034132726,0.002287577,0.93633115,0.00011520729,0.0000039934966,0.0000056617305,0.000052230345,0.000015542848,0.057355914,0.0000112436355,0.00030604008,0.00010216634],"about_ca_topic_score_codex":0.0040250355,"about_ca_topic_score_gemma":0.0023300524,"teacher_disagreement_score":0.34670612,"about_ca_system_score_codex":0.00052789325,"about_ca_system_score_gemma":0.0003712004,"threshold_uncertainty_score":0.6084677},"labels":[],"label_agreement":null},{"id":"W2018257514","doi":"10.1007/s10549-005-9092-9","title":"Genomic instability in invasive breast carcinoma measured by inter-Simple Sequence Repeat PCR","year":2005,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital","funders":"National Cancer Institute; American Cancer Society","keywords":"Genome instability; Breast cancer; Microsatellite instability; Biology; genomic DNA; Colorectal cancer; Breast carcinoma; Cancer; Pathology; Oncology; Internal medicine; Medicine; DNA; Gene; Genetics; DNA damage; Microsatellite","score_opus":0.04410918952510025,"score_gpt":0.3206292564878869,"score_spread":0.2765200669627867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018257514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99212277,0.0037195256,0.000008200292,0.0015130453,0.000036486883,0.00049425865,0.0018027421,0.000007249962,0.00029575155],"genre_scores_gemma":[0.9937107,0.0050942446,0.000052155236,0.00010685619,0.00024825358,0.00033287436,0.00023168007,0.000026582256,0.00019665707],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99823433,0.00009476916,0.00024357098,0.00066555035,0.00019985044,0.0005619341],"domain_scores_gemma":[0.99900126,0.000046878748,0.000046199282,0.00045806778,0.00018140291,0.0002661713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025976019,0.00022189203,0.00022011907,0.00008467486,0.00013084819,0.000066625966,0.00017744611,0.00010861405,0.000059936898],"category_scores_gemma":[0.000032630516,0.00019826258,0.000060914495,0.00014003675,0.00023669361,0.000010709671,0.00019461058,0.00013229995,0.000009789819],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015918568,0.0007716422,0.5010654,0.00003830389,0.0001329071,0.000040008246,0.00030546205,0.000053600143,0.29898918,0.00005394255,0.0030037644,0.19395393],"study_design_scores_gemma":[0.00875315,0.0022607225,0.73932856,0.00010470703,0.00004965516,0.0005801742,0.00058303593,0.00014492586,0.18343958,0.0004145341,0.06341282,0.0009281287],"about_ca_topic_score_codex":0.01286164,"about_ca_topic_score_gemma":0.03421766,"teacher_disagreement_score":0.23826317,"about_ca_system_score_codex":0.00090229936,"about_ca_system_score_gemma":0.0006543205,"threshold_uncertainty_score":0.99371177},"labels":[],"label_agreement":null},{"id":"W2018303837","doi":"10.1023/a:1024529119454","title":"Expedition Inspiration Fund for Breast Cancer Research Meeting 2003","year":2003,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Breast cancer; Gerontology; Library science; Cancer; Medical school; Medicine; Medical education; Internal medicine","score_opus":0.2251703269098286,"score_gpt":0.4809634851581347,"score_spread":0.25579315824830606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018303837","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00046308772,0.9849634,0.0000120890145,0.0005106554,0.0003477326,0.0034747445,0.009587152,0.000024857623,0.0006162915],"genre_scores_gemma":[0.00095494644,0.9727181,0.00009986116,0.000029581057,0.002277347,0.020187592,0.0012477265,0.00015782038,0.00232699],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949022,0.0007165399,0.00056558696,0.0015750823,0.0008021578,0.0014384469],"domain_scores_gemma":[0.99675,0.00017815712,0.00021624463,0.0006807079,0.0017868145,0.00038807662],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009328335,0.0007612797,0.0011340334,0.00044173497,0.001140152,0.00019814241,0.00027892395,0.00051235274,0.00012597526],"category_scores_gemma":[0.000051448158,0.00058636727,0.00028918657,0.0008945627,0.00052064535,0.000023398716,0.00022912378,0.0003949249,0.000021532991],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005701514,0.00053801696,0.00024563118,0.002315667,0.0014298699,0.000013404274,0.00007575862,0.0000018548432,0.00007432549,0.00012972909,0.010357436,0.98424816],"study_design_scores_gemma":[0.002051307,0.0007254957,0.00043132209,0.0036760794,0.00044606123,0.00021611541,0.00015585992,0.0000015257758,0.00020451278,0.000059409307,0.99147606,0.0005562583],"about_ca_topic_score_codex":0.0035476638,"about_ca_topic_score_gemma":0.0025148275,"teacher_disagreement_score":0.9836919,"about_ca_system_score_codex":0.0017232806,"about_ca_system_score_gemma":0.0023305917,"threshold_uncertainty_score":0.99965876},"labels":[],"label_agreement":null},{"id":"W2018588434","doi":"10.1007/s10549-012-2113-6","title":"Incidence of invasive breast cancer in the presence of competing mortality: the Canadian National Breast Screening Study","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto Metropolitan University; Public Health Ontario; University of Toronto","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Health Canada","keywords":"Breast cancer; Medicine; Mammography; Incidence (geometry); Cancer; Population; Internal medicine; Oncology; Gynecology; Obstetrics","score_opus":0.19767025833083124,"score_gpt":0.4425919888036684,"score_spread":0.24492173047283716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018588434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896374,0.0022044135,0.0000015369609,0.005287108,0.00003889979,0.0012461757,0.00082635175,0.0000054243083,0.0007527267],"genre_scores_gemma":[0.9987106,0.0003775395,0.000025005516,0.00013180754,0.00024427925,0.000455348,0.000010142549,0.000012287229,0.000033043303],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967038,0.0003548944,0.00036151294,0.00029236908,0.001597165,0.00069023704],"domain_scores_gemma":[0.99798375,0.0004435996,0.0001301257,0.0003292233,0.0008029337,0.0003103902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002033083,0.0001868243,0.0003373475,0.00022392908,0.00037096898,0.00004569764,0.00029330922,0.00005474787,0.00015146966],"category_scores_gemma":[0.00007973101,0.00010594999,0.000063003645,0.0007903357,0.00048077092,0.00023797948,0.00010467144,0.00031482245,0.0000017713621],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004439622,0.00038554438,0.9791034,0.00004367057,0.00022545664,0.000038753693,0.004528167,0.0000817442,0.0001149701,0.0002914843,0.000089875146,0.014652956],"study_design_scores_gemma":[0.0011726345,0.0002636281,0.986655,0.00054010545,0.00007509085,0.0004986022,0.010417784,0.0000903441,0.00011356963,0.000043123247,0.000043447853,0.000086668704],"about_ca_topic_score_codex":0.8379855,"about_ca_topic_score_gemma":0.79485774,"teacher_disagreement_score":0.04312778,"about_ca_system_score_codex":0.0008207783,"about_ca_system_score_gemma":0.0020857025,"threshold_uncertainty_score":0.43205154},"labels":[],"label_agreement":null},{"id":"W2019063845","doi":"10.1007/s10549-014-3150-0","title":"Tamoxifen-associated skin reactions in breast cancer patients: from case report to literature review","year":2014,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Chemotherapy-related skin toxicity","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Tamoxifen; Breast cancer; Medicine; Oncology; Antiestrogen; Mammary gland; Cancer; Gynecology; Internal medicine","score_opus":0.04883813600671446,"score_gpt":0.42225619526383873,"score_spread":0.3734180592571243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019063845","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026876936,0.9808778,4.2778137e-7,0.0031626448,0.0001652015,0.004737767,0.008098016,0.000059896982,0.00021051658],"genre_scores_gemma":[0.0006798565,0.9903898,0.000028805089,0.00029127343,0.0004940895,0.0038447168,0.0020565756,0.00014422703,0.002070646],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99499875,0.0006042069,0.0011895765,0.0013879895,0.0008917971,0.00092765514],"domain_scores_gemma":[0.9965405,0.0003199604,0.00043085538,0.0010130205,0.00082046085,0.0008752255],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006934123,0.00079496205,0.0028200739,0.00061134883,0.00021260112,0.00010242158,0.00016955216,0.0005980857,0.00075034495],"category_scores_gemma":[0.00014062626,0.00055609737,0.0004488793,0.0019976764,0.00012483734,0.000107332184,0.00012142823,0.0012878847,0.00005097086],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028922825,0.0020436656,0.0016103765,0.011412535,0.0015242328,0.02449533,0.0001793687,1.9288984e-7,9.604146e-7,0.0000025750521,0.008466158,0.9499754],"study_design_scores_gemma":[0.0027945344,0.0003369195,0.0039718365,0.27615693,0.0011256225,0.023960771,0.000008556739,0.0000013346388,0.0000026319642,0.000012755239,0.69115764,0.00047045597],"about_ca_topic_score_codex":0.040065996,"about_ca_topic_score_gemma":0.0084286975,"teacher_disagreement_score":0.9495049,"about_ca_system_score_codex":0.006025784,"about_ca_system_score_gemma":0.0013799494,"threshold_uncertainty_score":0.99968904},"labels":[],"label_agreement":null},{"id":"W2019395174","doi":"10.1007/s10549-009-0326-0","title":"Correlates of existential well-being and their association with health-related quality of life in breast cancer survivors compared with the general population","year":2009,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer survivorship and care","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"McGill University","keywords":"Quality of life (healthcare); Medicine; Population; Breast cancer; Logistic regression; Distress; Cancer; Gerontology; Demography; Clinical psychology; Internal medicine; Environmental health","score_opus":0.039179824033028436,"score_gpt":0.34855917412847703,"score_spread":0.3093793500954486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019395174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98738986,0.0024749706,0.00000300463,0.009158426,0.00003252121,0.0006052584,0.00018692529,0.000010794797,0.00013822639],"genre_scores_gemma":[0.9985864,0.00097368844,0.000005839204,0.0000542974,0.000053181644,0.000071667535,0.000059499613,0.000011949809,0.00018347372],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983427,0.0002818692,0.00033995768,0.00025754218,0.00046173742,0.00031620864],"domain_scores_gemma":[0.9990589,0.000111583984,0.00023235928,0.00016288672,0.00027694512,0.00015733298],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055759354,0.00015672162,0.0005090478,0.00011933988,0.00011931999,0.000019323525,0.00004254886,0.00006264861,0.000038736936],"category_scores_gemma":[0.0000047047574,0.00008453591,0.000038150123,0.00039910976,0.000119693876,0.00006619042,0.0000149727375,0.0001711527,1.6291985e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055927606,0.00026855263,0.9752238,0.00009218326,0.00025378165,0.0000027474164,0.0034336913,0.000093155264,0.00012203422,0.00015540353,0.000025058871,0.014736839],"study_design_scores_gemma":[0.00374212,0.0007077044,0.9930321,0.00032571988,0.000034372813,0.000022323955,0.0016723933,0.00019532924,0.00011784359,0.000056814013,0.000012864329,0.00008044107],"about_ca_topic_score_codex":0.4249798,"about_ca_topic_score_gemma":0.215631,"teacher_disagreement_score":0.20934883,"about_ca_system_score_codex":0.0006414671,"about_ca_system_score_gemma":0.0003463998,"threshold_uncertainty_score":0.7986817},"labels":[],"label_agreement":null},{"id":"W2019417464","doi":"10.1023/a:1006334132303","title":"Is ICI 182,780 an antiprogestin in addition to being an antiestrogen?","year":2000,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Antiestrogen; Mifepristone; Progesterone receptor; Endocrinology; Internal medicine; Progestin; Estrogen; Transfection; Estrogen receptor; Biology; Medicine; Chemistry; Cell culture; Breast cancer; Cancer","score_opus":0.026281251553891726,"score_gpt":0.3560375136717094,"score_spread":0.32975626211781767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019417464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974258,0.0009840572,0.0000015019099,0.00042290526,0.000017286395,0.0004215991,0.00017626707,0.0000130416975,0.00053753733],"genre_scores_gemma":[0.99660254,0.0019818002,0.00010571912,0.00007919596,0.00017559469,0.00020696224,0.00023590768,0.000023118764,0.0005891714],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986173,0.00012866227,0.00012244387,0.00048432196,0.00018335403,0.00046393104],"domain_scores_gemma":[0.9993079,0.000007672443,0.000013615259,0.0002671344,0.00007303287,0.00033064824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014717395,0.00015918828,0.00013424446,0.000100578334,0.00015732573,0.000057028556,0.00009528877,0.000118808595,0.00018233465],"category_scores_gemma":[0.000003682034,0.00013109755,0.000029844812,0.00021696706,0.000081970335,0.000014790629,0.00003133087,0.00010806867,0.000026444919],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025874022,0.0015199097,0.078740075,0.00002068164,0.0001781801,0.00017742727,0.0005786736,0.00007695661,0.15701987,0.00008401739,0.0007001666,0.75831664],"study_design_scores_gemma":[0.0069612036,0.017881649,0.33762974,0.00027633543,0.00006418374,0.0005894691,0.00047159835,0.0004444791,0.6095902,0.0003248801,0.024837488,0.0009287832],"about_ca_topic_score_codex":0.0020051647,"about_ca_topic_score_gemma":0.00039844157,"teacher_disagreement_score":0.7573879,"about_ca_system_score_codex":0.00008017924,"about_ca_system_score_gemma":0.00014131192,"threshold_uncertainty_score":0.5346003},"labels":[],"label_agreement":null},{"id":"W2019934381","doi":"10.1007/s10549-007-9803-5","title":"The development of a predictive model to estimate cardiotoxic risk for patients with metastatic breast cancer receiving anthracyclines","year":2007,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Regional Municipality of Durham; Cancer Care Ontario; BC Cancer Agency; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Discontinuation; Metastatic breast cancer; Internal medicine; Breast cancer; Cardiac toxicity; Heart failure; Toxicity; Chemotherapy; Area under the curve; Oncology; Cancer; Surgery","score_opus":0.04501115047012002,"score_gpt":0.39700351303797365,"score_spread":0.35199236256785366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019934381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99122065,0.00036207814,0.004355876,0.0006751295,0.000032234922,0.0024140696,0.0008591299,0.000018155863,0.00006265648],"genre_scores_gemma":[0.9939854,0.00052162533,0.0040098084,0.0000165123,0.00008514093,0.0011883517,0.00002770749,0.000030117957,0.00013530794],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.998301,0.000042050997,0.00027774074,0.00033477158,0.0005574025,0.00048699087],"domain_scores_gemma":[0.9984782,0.00023445871,0.0000933031,0.00020950654,0.00071075384,0.00027378308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006332771,0.00018606329,0.00033042853,0.00012562075,0.00045760933,0.00002832875,0.000061141116,0.00004007872,0.0000045278266],"category_scores_gemma":[0.000028339216,0.000106582746,0.00006654888,0.0002614076,0.00015075007,0.00007155606,0.000028810728,0.00011057491,5.292938e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016779562,0.00090015115,0.19734545,0.00017041789,0.002113754,0.000004871551,0.0033167235,0.0010015449,0.0044008032,0.000027131317,0.000055496315,0.7738841],"study_design_scores_gemma":[0.0076737623,0.0013076485,0.9368162,0.0006339178,0.0002863725,0.000027610464,0.00051576685,0.0016940713,0.05056575,0.000109706685,0.00018513137,0.00018403736],"about_ca_topic_score_codex":0.00069830904,"about_ca_topic_score_gemma":0.002485754,"teacher_disagreement_score":0.77370006,"about_ca_system_score_codex":0.0007767685,"about_ca_system_score_gemma":0.00066703185,"threshold_uncertainty_score":0.43463182},"labels":[],"label_agreement":null},{"id":"W2020372142","doi":"10.1007/s10549-009-0325-1","title":"Estrogen receptor: is it predictive for response to cytotoxic as well as hormonal therapy?","year":2009,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Estrogen; Estrogen receptor; Cytotoxic T cell; Medicine; Breast cancer; Hormone; Hormonal therapy; Internal medicine; Oncology; Endocrinology; Biology; Cancer","score_opus":0.02540817436267295,"score_gpt":0.36298349340947766,"score_spread":0.3375753190468047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020372142","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832402,0.006127191,0.000012179444,0.007993614,0.000034395878,0.0012977204,0.0003358936,0.000012357616,0.0009464706],"genre_scores_gemma":[0.98551023,0.0060698222,0.00010338627,0.00055392255,0.00026643282,0.0006961987,0.00008320485,0.000025253097,0.006691578],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99846524,0.00013555674,0.0001248142,0.0005100026,0.0002523528,0.0005120204],"domain_scores_gemma":[0.99911785,0.00004654775,0.000026692984,0.00026071334,0.00016384339,0.0003843596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026989548,0.00020683742,0.00015951612,0.000090093155,0.00023042472,0.0000490609,0.00012447064,0.00016367467,0.00013876628],"category_scores_gemma":[0.000020227977,0.00015420615,0.000101628975,0.00013117692,0.00008838604,0.0000058816245,0.00004158238,0.00010017525,0.00013841546],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05823293,0.0006200652,0.00050800224,0.000004815751,0.0004811868,0.000023305194,0.00031252656,0.000009988361,0.85190713,0.00006686796,0.01782393,0.070009276],"study_design_scores_gemma":[0.004001996,0.030776152,0.0048723184,0.000039916467,0.000025044485,0.00012320811,0.00017034706,0.000013985728,0.7700093,0.00025695548,0.18946464,0.00024618744],"about_ca_topic_score_codex":0.00020318927,"about_ca_topic_score_gemma":0.0000070451697,"teacher_disagreement_score":0.17164071,"about_ca_system_score_codex":0.00015153432,"about_ca_system_score_gemma":0.00040499363,"threshold_uncertainty_score":0.6288344},"labels":[],"label_agreement":null},{"id":"W2020563819","doi":"10.1007/s10549-008-9967-7","title":"Validation of the Tenon breast cancer score for predicting non-sentinel lymph node status in breast cancer patients with sentinel lymph node metastasis: a prospective multicenter study","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":63,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre d'expertise et de recherche en infrastructures urbaines","funders":"","keywords":"Medicine; Breast cancer; Receiver operating characteristic; Confidence interval; Prospective cohort study; Axillary Lymph Node Dissection; Sentinel lymph node; Internal medicine; Cut-off; Positive predicative value; Area under the curve; Predictive value of tests; Oncology; Cancer; Predictive value","score_opus":0.025347054671272237,"score_gpt":0.3123230993911312,"score_spread":0.28697604471985894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020563819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887455,0.00095265475,0.0000087028075,0.00087544566,0.00010394099,0.0026516526,0.006609431,0.000016317515,0.000036359048],"genre_scores_gemma":[0.99207616,0.0014314997,0.00004220284,0.000048384405,0.00025210093,0.0057877074,0.00015988664,0.00008141459,0.00012062389],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99656034,0.00017842196,0.00046155776,0.0010582783,0.0007424851,0.0009989402],"domain_scores_gemma":[0.9978342,0.000050711322,0.00027978278,0.0005186242,0.0011046295,0.00021205319],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019007105,0.000531788,0.0005504748,0.00017702117,0.00056369667,0.00005043113,0.0002313492,0.00010420589,0.000026684647],"category_scores_gemma":[0.000013476229,0.0003401397,0.0001445347,0.0005034088,0.00041438418,0.00004588525,0.00028096847,0.00012988978,9.655673e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068460926,0.004093271,0.9815806,0.00011642083,0.0017831442,0.000009110659,0.0010349284,0.00027596438,0.0009186243,0.0000011050215,0.000043459513,0.0032972554],"study_design_scores_gemma":[0.019783998,0.0001492634,0.9746479,0.00038218978,0.00031427757,0.00003673037,0.00075762195,0.00009059966,0.0035220147,0.0000031639213,0.000010766088,0.0003014818],"about_ca_topic_score_codex":0.029750807,"about_ca_topic_score_gemma":0.0016475455,"teacher_disagreement_score":0.028103262,"about_ca_system_score_codex":0.001085302,"about_ca_system_score_gemma":0.00082769437,"threshold_uncertainty_score":0.99990505},"labels":[],"label_agreement":null},{"id":"W2020658618","doi":"10.1023/a:1021853302033","title":"A Comparison of Risk Perception and Psychological Morbidity in Women with Ductal Carcinoma in situ and Early Invasive Breast Cancer","year":2003,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer survivorship and care","field":"Medicine","cited_by":170,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Breast cancer; Medicine; Ductal carcinoma; Anxiety; Distress; Internal medicine; Cancer; Depression (economics); Oncology; Gynecology; Obstetrics; Clinical psychology; Psychiatry","score_opus":0.07948844193845597,"score_gpt":0.39191328070559156,"score_spread":0.31242483876713556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020658618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959852,0.0026246093,4.9490046e-7,0.00043529927,0.000022674094,0.0005265356,0.00020270278,0.000006310857,0.00019614128],"genre_scores_gemma":[0.99504125,0.004419863,0.000013879428,0.000013566598,0.000042906828,0.00042294725,0.000004179276,0.000012649367,0.00002876008],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99849105,0.00018436476,0.00018614002,0.00043260478,0.00029953002,0.00040628944],"domain_scores_gemma":[0.9993463,0.000075845324,0.000047542744,0.00015250471,0.00011595284,0.0002618231],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022555423,0.00016852716,0.00042034016,0.00020390066,0.00006625339,0.000024124578,0.000030879262,0.00008036104,0.000104022576],"category_scores_gemma":[0.000009692057,0.00011677436,0.000017802762,0.00031877062,0.00032972725,0.00007522109,0.000027150934,0.00025541708,5.8171776e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054139476,0.0007017476,0.9445434,0.00007222209,0.00004911233,0.0000913193,0.00867347,0.0000018641939,0.0008532829,0.000016472439,0.000011263648,0.03957187],"study_design_scores_gemma":[0.0052231248,0.0018867807,0.9858145,0.00019683987,0.000026111897,0.00025215387,0.0061399266,0.0000055365267,0.00027097328,0.00005894358,0.000018988932,0.00010610019],"about_ca_topic_score_codex":0.08793379,"about_ca_topic_score_gemma":0.12275988,"teacher_disagreement_score":0.04127109,"about_ca_system_score_codex":0.0006378805,"about_ca_system_score_gemma":0.00020298251,"threshold_uncertainty_score":0.91813976},"labels":[],"label_agreement":null},{"id":"W2021343669","doi":"10.1007/s10549-010-1043-4","title":"Comparative effectiveness of screening and prevention strategies among BRCA1/2-affected mutation carriers","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":116,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"Medicine; Prophylactic Mastectomy; Breast cancer; Mammography; Cohort; Quality-adjusted life year; BRCA mutation; Medicaid; Psychological intervention; Cost effectiveness; Gynecology; Oncology; Mastectomy; Internal medicine; Health care; Cancer","score_opus":0.03267088001044264,"score_gpt":0.3829762191240329,"score_spread":0.35030533911359024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021343669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979484,0.0008175892,0.00038358025,0.000032434593,0.000041686373,0.0004927888,0.00009300837,0.0000056855856,0.00018483459],"genre_scores_gemma":[0.9989177,0.00019901952,0.00033843768,0.0000010401194,0.00005944881,0.00032733253,0.00009054267,0.000009679925,0.000056813886],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99914443,0.00017359543,0.00009374696,0.00027756827,0.00013982429,0.00017085277],"domain_scores_gemma":[0.99946976,0.0000459305,0.000044057615,0.0001336774,0.00022574674,0.000080817335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024253913,0.000105033054,0.00013794465,0.00007114673,0.00012949454,0.000040990424,0.00004363715,0.000073471325,0.0000132626765],"category_scores_gemma":[0.000010111507,0.00008971552,0.000026597687,0.00011618934,0.0003819568,0.00001457471,0.00003885306,0.000087057044,2.8440354e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014049322,0.00021748131,0.05175221,0.00014220258,0.00070588646,0.000006662338,0.00081903033,0.00034923022,0.85028607,0.0003872357,0.000039126833,0.09388994],"study_design_scores_gemma":[0.0016117899,0.000797082,0.73046684,0.00006139652,0.00002403516,0.000027086413,0.0007907234,0.000095150506,0.2655883,0.00034942463,0.00009243326,0.000095707765],"about_ca_topic_score_codex":0.0014312176,"about_ca_topic_score_gemma":0.003015353,"teacher_disagreement_score":0.67871463,"about_ca_system_score_codex":0.000053773078,"about_ca_system_score_gemma":0.00030405974,"threshold_uncertainty_score":0.36584926},"labels":[],"label_agreement":null},{"id":"W2021349245","doi":"10.1007/s10549-012-2276-1","title":"Smoking and survival after breast cancer diagnosis: a prospective observational study and systematic review","year":2012,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brock University","funders":"National Cancer Institute","keywords":"Medicine; Breast cancer; Hazard ratio; Cancer; Prospective cohort study; Cohort study; Internal medicine; Epidemiology; Epidemiology of cancer; Oncology; Confidence interval; Observational study; Gynecology","score_opus":0.24884560950274656,"score_gpt":0.4741760083714476,"score_spread":0.22533039886870102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021349245","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0033866784,0.9830476,1.2522253e-7,0.0005492321,0.00010479648,0.010368291,0.0024906052,0.000024583142,0.000028090064],"genre_scores_gemma":[0.0203501,0.928156,0.0000029609464,0.000043000993,0.00044556352,0.050564982,0.000050899373,0.00007227391,0.00031421412],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9965621,0.00039647392,0.0006489496,0.000849429,0.0008829447,0.0006601059],"domain_scores_gemma":[0.9981139,0.00029310383,0.00022727506,0.0004338111,0.00035406533,0.0005778472],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00071271777,0.00062785094,0.0029270384,0.00023712516,0.00023141572,0.00012524921,0.000085553045,0.00015075348,0.0003418262],"category_scores_gemma":[0.00002193186,0.00037424854,0.00019115946,0.00045149948,0.00021830601,0.00015258348,0.00017300133,0.00044383545,0.0000049787645],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019388358,0.00073384476,0.2668141,0.39990872,0.0026785224,0.00008682286,0.00027461114,4.146498e-9,1.12955325e-8,0.000013948813,0.000052523883,0.329243],"study_design_scores_gemma":[0.0022030117,0.0006577855,0.4257464,0.5345722,0.01370567,0.000840636,0.0001992901,4.9834136e-7,7.197177e-8,0.00000848733,0.021613693,0.000452242],"about_ca_topic_score_codex":0.009043383,"about_ca_topic_score_gemma":0.0022394948,"teacher_disagreement_score":0.32879078,"about_ca_system_score_codex":0.0016327178,"about_ca_system_score_gemma":0.0007973203,"threshold_uncertainty_score":0.99987096},"labels":[],"label_agreement":null},{"id":"W2021616811","doi":"10.1007/s10549-007-9546-3","title":"Stromal mast cells in invasive breast cancer are a marker of favourable prognosis: a study of 4,444 cases","year":2007,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":221,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"Canadian Institutes of Health Research; Canadian Breast Cancer Research Alliance; Sanofi","keywords":"Breast cancer; Medicine; Oncology; Internal medicine; Hazard ratio; Tissue microarray; Stromal cell; Lymph node; Survival analysis; Confidence interval; Pathology; Cancer","score_opus":0.042426689733371735,"score_gpt":0.3213423895869035,"score_spread":0.27891569985353176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021616811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99200225,0.00472724,3.1497353e-7,0.00021055265,0.00007330523,0.0010688095,0.0016579146,0.000008476036,0.00025112228],"genre_scores_gemma":[0.99667364,0.0014348712,0.0000073836645,0.0000056236026,0.000029348854,0.00039225537,0.00001914773,0.000018072118,0.0014196631],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99823,0.00018486379,0.00039341135,0.0004145807,0.00014141575,0.00063573144],"domain_scores_gemma":[0.99903834,0.00020538348,0.00015662983,0.00023223954,0.00028831448,0.00007912149],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003638668,0.00021601669,0.0004986973,0.00033187907,0.00012866198,0.000012969647,0.00013685435,0.00010962983,0.0010153252],"category_scores_gemma":[0.0000070213264,0.00016288961,0.00005439087,0.00035173242,0.0003356382,0.000065135595,0.00010551514,0.0001963557,0.000007597663],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006719892,0.0076795043,0.8989788,0.00020414451,0.0007328094,0.0003440481,0.0022844153,0.000009856773,0.05492188,0.00002779269,0.00037041388,0.027726438],"study_design_scores_gemma":[0.0063368543,0.0021739956,0.9509665,0.00033853983,0.00006593269,0.00017820216,0.009415529,8.902827e-7,0.029979544,0.000006666506,0.00038822068,0.00014914981],"about_ca_topic_score_codex":0.083206184,"about_ca_topic_score_gemma":0.13621818,"teacher_disagreement_score":0.053011987,"about_ca_system_score_codex":0.00027412857,"about_ca_system_score_gemma":0.00028244324,"threshold_uncertainty_score":0.9998979},"labels":[],"label_agreement":null},{"id":"W2021717793","doi":"10.1007/s10549-006-9382-x","title":"CDKN2A-positive breast cancers in young women from Poland","year":2006,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Coalition for Research in Women's Health","funders":"","keywords":"CDKN2A; Breast cancer; Oncology; Medicine; Odds ratio; Population; Cancer; Internal medicine; Estrogen receptor; Gynecology","score_opus":0.014236543515193885,"score_gpt":0.31414302533981653,"score_spread":0.29990648182462265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021717793","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99178296,0.003503394,0.000011125556,0.00076227327,0.000074682335,0.000318678,0.0021843065,0.000007751396,0.0013548312],"genre_scores_gemma":[0.99596864,0.0014618124,0.000066242625,0.00002959502,0.0004996249,0.00072721246,0.00029142894,0.00002475715,0.0009306791],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984837,0.00008453966,0.00015165146,0.0005080432,0.00022696985,0.0005450857],"domain_scores_gemma":[0.9994432,0.000020917676,0.000032260436,0.000244278,0.00012489228,0.00013449247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001211526,0.00017387528,0.0001578174,0.00010712734,0.00013576867,0.00006008167,0.000103436294,0.000092471986,0.00012432443],"category_scores_gemma":[0.0000028301547,0.0001519653,0.000031959815,0.00019798202,0.00019395867,0.000008225302,0.0000749342,0.00009655203,0.000007756673],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033038768,0.00068801973,0.79619414,0.000019401754,0.00055273133,0.00009348182,0.0011046294,0.0004362673,0.08753894,0.00013627711,0.0031801674,0.106752075],"study_design_scores_gemma":[0.0029559033,0.0003949602,0.9787989,0.000045306148,0.000012472249,0.00010535749,0.0005134526,0.000037091035,0.013351686,0.00048323916,0.003060173,0.00024140856],"about_ca_topic_score_codex":0.115518376,"about_ca_topic_score_gemma":0.06982584,"teacher_disagreement_score":0.18260482,"about_ca_system_score_codex":0.0019774963,"about_ca_system_score_gemma":0.00067579816,"threshold_uncertainty_score":0.9471474},"labels":[],"label_agreement":null},{"id":"W2021833052","doi":"10.1007/s10549-010-1156-9","title":"A high prevalence of BRCA1 mutations among breast cancer patients from the Bahamas","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":73,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Breast cancer; Cancer; Ovarian cancer; Medicine; Genetic counseling; Oncology; Population; Mutation; Family history; Incidence (geometry); Internal medicine; Genetic testing; Gynecology; Genetics; Gene; Biology","score_opus":0.01819576058975373,"score_gpt":0.32152399937327747,"score_spread":0.3033282387835237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021833052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99056673,0.0010474504,0.000008218546,0.0015720287,0.00019818885,0.0004894564,0.006041878,0.000006550398,0.000069474205],"genre_scores_gemma":[0.9963153,0.0017076143,0.000100272075,0.00003766367,0.00038401558,0.00083487,0.00016288724,0.000022771916,0.00043461303],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99866897,0.00008592825,0.00018074106,0.00042778143,0.00032401644,0.0003125496],"domain_scores_gemma":[0.99881554,0.00006486044,0.00007792347,0.00043722944,0.00047401187,0.0001304614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012458279,0.00015782657,0.00012941977,0.000044228662,0.0002403827,0.00004172643,0.00022705694,0.000097025084,0.0004391877],"category_scores_gemma":[0.000019754212,0.00010725038,0.00005414984,0.0001689925,0.00057065155,0.000011221173,0.00011964836,0.00015477721,0.0000045288707],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038758406,0.0005065427,0.8953084,0.000030449644,0.00039811863,0.0000021351807,0.00041385507,0.000056925182,0.03204279,0.000099412675,0.0013689145,0.06938488],"study_design_scores_gemma":[0.0012454482,0.00018648281,0.97381306,0.00004034144,0.00005136185,0.000006822821,0.00007111791,0.000017326332,0.023197535,0.0001846842,0.0010737431,0.00011208339],"about_ca_topic_score_codex":0.019182947,"about_ca_topic_score_gemma":0.0117159495,"teacher_disagreement_score":0.07850466,"about_ca_system_score_codex":0.0001374229,"about_ca_system_score_gemma":0.0005079236,"threshold_uncertainty_score":0.9873484},"labels":[],"label_agreement":null},{"id":"W2021977870","doi":"10.1007/s10549-013-2659-y","title":"The impact of endocrine therapy on sexual dysfunction in postmenopausal women with early stage breast cancer: encouraging results from a prospective study","year":2013,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Sexual function and dysfunction studies","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa; Carleton University; Centre de Santé et de Services Sociaux de Chicoutimi","funders":"","keywords":"Medicine; Distress; Breast cancer; Sexual function; Sexual dysfunction; Gynecology; Prospective cohort study; Sex organ; Endocrine system; Libido; Cancer; Obstetrics; Internal medicine; Clinical psychology; Hormone","score_opus":0.04819211191692865,"score_gpt":0.3726339190914514,"score_spread":0.32444180717452276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021977870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948683,0.00051228417,6.581376e-7,0.0011694386,0.00006355501,0.0024055284,0.0006379033,0.000031885913,0.0003104873],"genre_scores_gemma":[0.9942069,0.0010127889,0.0000026251746,0.000024133547,0.00018374035,0.002626692,0.00001426124,0.000025020638,0.0019038199],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978495,0.00015454755,0.0002816837,0.0005217432,0.0006407649,0.00055171066],"domain_scores_gemma":[0.99854755,0.0002809703,0.00009409004,0.0003283443,0.00051906897,0.00022997492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002541618,0.00026342037,0.00037833853,0.00021616454,0.00030706,0.0000800829,0.000056343546,0.000031397944,0.00031783126],"category_scores_gemma":[0.000014578181,0.00012543854,0.000025479954,0.00047978855,0.00019794164,0.00013738453,0.000038398055,0.00025288027,0.000012516516],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.080791354,0.002568618,0.812207,0.0000052787586,0.0014814235,0.000048181984,0.006392786,0.000035547608,0.0010093156,0.0000068969516,0.0001689904,0.09528461],"study_design_scores_gemma":[0.017486714,0.030286139,0.9377678,0.000053698233,0.000020596812,0.00003176037,0.014036783,0.000024441586,0.00010453736,0.000019458059,0.00006466955,0.00010342128],"about_ca_topic_score_codex":0.33715934,"about_ca_topic_score_gemma":0.0047421004,"teacher_disagreement_score":0.33241725,"about_ca_system_score_codex":0.001647316,"about_ca_system_score_gemma":0.0003911532,"threshold_uncertainty_score":0.66725457},"labels":[],"label_agreement":null},{"id":"W2022309076","doi":"10.1007/s10549-012-2188-0","title":"Cross-platform pathway-based analysis identifies markers of response to the PARP inhibitor olaparib","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Office of Science; Breast Cancer Research Foundation; Pfizer; National Cancer Institute; National Institutes of Health; Cancer Research UK; Belgian American Educational Foundation; Stand Up To Cancer; U.S. Department of Energy","keywords":"Olaparib; Synthetic lethality; Biology; DNA repair; PARP inhibitor; Homologous recombination; Cancer research; Gene; Genetics; DNA damage; Molecular biology; Poly ADP ribose polymerase; DNA; Polymerase","score_opus":0.07377723545298644,"score_gpt":0.41215573030947594,"score_spread":0.3383784948564895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022309076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905894,0.0019638934,0.000036856363,0.005488701,0.0001058283,0.0008164859,0.000704773,0.00002358358,0.00027049426],"genre_scores_gemma":[0.99664354,0.00023967621,0.00007621341,0.00016534819,0.000271597,0.00082188006,0.000035961955,0.000020871596,0.0017249223],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99783665,0.00018961793,0.0002945979,0.00030392673,0.0007706767,0.0006045203],"domain_scores_gemma":[0.99819624,0.00036222648,0.00007146928,0.00053278246,0.00037523053,0.00046205916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014012866,0.00018186597,0.00035988312,0.00046335245,0.00026907542,0.000066653265,0.000100647376,0.000067624795,0.0007557016],"category_scores_gemma":[0.000046011217,0.00011114965,0.00017108953,0.0011344033,0.0003620664,0.0001293928,0.000048279122,0.00014482028,0.00003395522],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09567325,0.0017725215,0.8083462,0.00012414149,0.0036574386,0.000042642718,0.0021872332,0.0001465639,0.026038261,0.00012834379,0.0028064293,0.05907695],"study_design_scores_gemma":[0.0044623455,0.0012437068,0.8994439,0.00013480743,0.0002643635,0.000028172526,0.0004109532,0.00004800861,0.07731643,0.000025087527,0.016483301,0.00013892354],"about_ca_topic_score_codex":0.0024153988,"about_ca_topic_score_gemma":0.0005631603,"teacher_disagreement_score":0.0912109,"about_ca_system_score_codex":0.00075332477,"about_ca_system_score_gemma":0.0004883702,"threshold_uncertainty_score":0.82744026},"labels":[],"label_agreement":null},{"id":"W2022667742","doi":"10.1007/s10549-014-3212-3","title":"Stearidonic acid-enriched flax oil reduces the growth of human breast cancer in vitro and in vivo","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Innovates; University of Saskatchewan; University of Alberta","funders":"Alberta Innovates; Shandong Academy of Sciences; Canada Research Chairs; Government of Alberta","keywords":"Docosapentaenoic acid; Apoptosis; Polyunsaturated fatty acid; In vivo; Arachidonic acid; Phospholipid; In vitro; Eicosapentaenoic acid; Fatty acid; Docosahexaenoic acid; Biochemistry; Biology; Chemistry; Cancer research; Membrane; Enzyme; Biotechnology","score_opus":0.018887495915533993,"score_gpt":0.31822417438425127,"score_spread":0.29933667846871725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022667742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98747104,0.010021011,7.807394e-7,0.0014023122,0.00022127893,0.0001983824,0.00033372646,0.000003497293,0.00034795195],"genre_scores_gemma":[0.9821332,0.015210193,0.0000072142097,0.00003495259,0.0014766682,0.0003630218,0.000013890207,0.000017988472,0.00074286544],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985509,0.0001801117,0.00020097109,0.000413442,0.00021724492,0.00043732018],"domain_scores_gemma":[0.9994298,0.000026153932,0.00005241585,0.00024655898,0.00011721579,0.00012784745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036010804,0.00017451837,0.00026397067,0.00011786274,0.0001156345,0.00003511895,0.00013948766,0.00008842514,0.00004497985],"category_scores_gemma":[0.000010785099,0.000118431555,0.000043936983,0.00019631321,0.0003182252,0.000009296605,0.00010986441,0.00012844104,4.940169e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013823851,0.00022080676,0.015033248,0.000048440786,0.00009229443,5.6192215e-7,0.0002801635,0.0000050135227,0.89850676,0.000104778424,0.0005606504,0.08376492],"study_design_scores_gemma":[0.008143835,0.00062458334,0.41510135,0.00016320865,0.00005510156,0.00007709748,0.0005389651,0.000056738478,0.5598461,0.00029259155,0.014692658,0.00040778343],"about_ca_topic_score_codex":0.020753609,"about_ca_topic_score_gemma":0.014456669,"teacher_disagreement_score":0.40006807,"about_ca_system_score_codex":0.00012369467,"about_ca_system_score_gemma":0.00025555867,"threshold_uncertainty_score":0.9857673},"labels":[],"label_agreement":null},{"id":"W2023466774","doi":"10.1007/s10549-014-2880-3","title":"Dermcidin expression is associated with disease progression and survival among breast cancer patients","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute; National Institutes of Health","keywords":"Breast cancer; Medicine; Oncology; Internal medicine; Disease; Cancer","score_opus":0.025981955336902555,"score_gpt":0.33915990255071304,"score_spread":0.3131779472138105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023466774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964899,0.00077912176,0.0000032025232,0.0015719474,0.000034765337,0.0006306715,0.00032641922,0.000031206408,0.00013277921],"genre_scores_gemma":[0.9979697,0.0008649881,0.000013780995,0.000032578046,0.00018526772,0.00034903278,0.00008664057,0.0000335676,0.0004644327],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981307,0.00010941006,0.00014747007,0.00046357955,0.0006813181,0.00046751628],"domain_scores_gemma":[0.9986628,0.000077850025,0.00006314504,0.00016924216,0.00032731963,0.0006996403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017846614,0.00021801688,0.00031007308,0.00009813422,0.00028690897,0.00006522102,0.000041495223,0.000068015186,0.00024085556],"category_scores_gemma":[0.00001768694,0.00012824663,0.00003973351,0.00018558942,0.00020484532,0.00009879231,0.000066517976,0.00015137599,0.0000015011893],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019996301,0.00077485695,0.91013765,0.00006134383,0.00012733608,0.000021138,0.00017871683,7.2838e-7,0.00055348594,0.0000041255307,0.00030211013,0.08583887],"study_design_scores_gemma":[0.0059782756,0.0006166024,0.9877706,0.0015916302,0.00009547574,0.000011019965,0.000044483208,0.00022509324,0.00322187,0.00001974357,0.00027271538,0.00015244454],"about_ca_topic_score_codex":0.0015076699,"about_ca_topic_score_gemma":0.00031331778,"teacher_disagreement_score":0.08568643,"about_ca_system_score_codex":0.00037010852,"about_ca_system_score_gemma":0.00018581082,"threshold_uncertainty_score":0.52297455},"labels":[],"label_agreement":null},{"id":"W2023484110","doi":"10.1007/s10549-014-2865-2","title":"Survival from breast cancer in patients with CHEK2 mutations","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"CHEK2; Breast cancer; Medicine; Internal medicine; Hazard ratio; Oncology; Proportional hazards model; Cancer; Survival analysis; Mutation; Gynecology; Biology; Genetics; Germline mutation; Confidence interval; Gene","score_opus":0.019214568044670345,"score_gpt":0.3208714521491739,"score_spread":0.30165688410450353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023484110","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99530333,0.0006069117,0.000038316557,0.0012458418,0.000082315266,0.0003627652,0.0020416235,0.000007898176,0.00031097763],"genre_scores_gemma":[0.99783826,0.00045809394,0.0001204317,0.00003596224,0.00025932584,0.00062395533,0.0003578271,0.000028038476,0.0002781251],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986657,0.00011090022,0.00012940263,0.00047142495,0.00025643766,0.00036615154],"domain_scores_gemma":[0.9992494,0.000030725492,0.00003543896,0.00028329942,0.000256583,0.00014452758],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000109990506,0.00016299007,0.00015023799,0.00008540683,0.00013534151,0.00004542845,0.00010664864,0.00007428667,0.00017786302],"category_scores_gemma":[0.0000063388748,0.00012506869,0.000025717763,0.00019773107,0.00018487476,0.000008998676,0.00006168202,0.000090454974,0.0000071346008],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010108381,0.00041614872,0.84850514,0.000007412393,0.00021203367,0.0000017682511,0.000131633,0.00020546748,0.0013741411,0.0000409157,0.00016436478,0.14793016],"study_design_scores_gemma":[0.0035111778,0.00036391514,0.99111485,0.000037861748,0.000019467103,0.0000030444633,0.00006438446,0.000045882418,0.0015317712,0.00010104139,0.0030497594,0.00015682442],"about_ca_topic_score_codex":0.0090371985,"about_ca_topic_score_gemma":0.01244764,"teacher_disagreement_score":0.14777334,"about_ca_system_score_codex":0.0003860232,"about_ca_system_score_gemma":0.0003836924,"threshold_uncertainty_score":0.9975617},"labels":[],"label_agreement":null},{"id":"W2023760479","doi":"10.1007/s10549-012-2065-x","title":"Tumour characteristics among women with very low-risk breast cancer","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Women's College Hospital; University of Toronto","funders":"","keywords":"Overdiagnosis; Medicine; Breast cancer; Oncology; Internal medicine; Cancer; Lymph node; Mammography; Immunohistochemistry; Gynecology","score_opus":0.016654471103451172,"score_gpt":0.29816142628799386,"score_spread":0.28150695518454266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023760479","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926889,0.0030697712,0.0000058878054,0.00063075405,0.0001249391,0.0004518568,0.002809904,0.000026464415,0.0001915147],"genre_scores_gemma":[0.98638934,0.009615181,0.000028029855,0.000052600913,0.0012119687,0.0020875868,0.00009177403,0.00006522589,0.00045828382],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974008,0.00012929775,0.00019839758,0.0005944132,0.00040733584,0.001269711],"domain_scores_gemma":[0.99859524,0.000034055734,0.00010720107,0.00039860347,0.00027397633,0.00059094786],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021504366,0.0004077293,0.00036062027,0.000103563994,0.0004447253,0.0000750915,0.00014574133,0.00011464643,0.00018355554],"category_scores_gemma":[0.0000073104306,0.00028457268,0.000055715023,0.00021794227,0.00048251107,0.000030081097,0.0001791446,0.00017433753,0.000018520965],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030474188,0.0007798198,0.9443392,0.00003844203,0.0010267068,0.000019609332,0.0005546554,0.0000036315498,0.0017221206,0.0000142926965,0.0003120496,0.048142053],"study_design_scores_gemma":[0.0023261942,0.0005013634,0.990935,0.00009745245,0.00008813327,0.00015903299,0.0004248636,0.0000028244485,0.0033154537,0.000010513038,0.001826495,0.00031264723],"about_ca_topic_score_codex":0.0061999867,"about_ca_topic_score_gemma":0.0013254964,"teacher_disagreement_score":0.047829404,"about_ca_system_score_codex":0.00077053555,"about_ca_system_score_gemma":0.00031324258,"threshold_uncertainty_score":0.99996066},"labels":[],"label_agreement":null},{"id":"W2024302667","doi":"10.1007/s10549-007-9610-z","title":"Gemcitabine in the management of metastatic breast cancer: a systematic review","year":2007,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; McMaster University; Ottawa Hospital","funders":"","keywords":"Gemcitabine; Docetaxel; Medicine; Oncology; Taxane; Metastatic breast cancer; Internal medicine; Breast cancer; Capecitabine; Clinical trial; Randomized controlled trial; Chemotherapy; Anthracycline; Cancer; Colorectal cancer","score_opus":0.20374862271191702,"score_gpt":0.5221446010040509,"score_spread":0.3183959782921339,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024302667","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000039276747,0.9844312,4.3387737e-7,0.0015979299,0.000073296855,0.011900805,0.0012565982,0.0000148458175,0.0006856319],"genre_scores_gemma":[0.00022833883,0.984049,0.000024642917,0.00013183327,0.0001294294,0.013834676,0.00015756351,0.000054219145,0.001390279],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9959501,0.00063104444,0.0010805489,0.0006388726,0.0009216101,0.00077780255],"domain_scores_gemma":[0.9980979,0.0003964603,0.0003405821,0.00070026016,0.00021679889,0.0002480082],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013767746,0.00060061127,0.0036519913,0.00053707795,0.000105705796,0.000028201912,0.00029526473,0.00010402522,0.00049594004],"category_scores_gemma":[0.0000039863708,0.0003016078,0.00046017056,0.0014177394,0.00024506403,0.00004801498,0.000101376216,0.00041854076,0.000024990906],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001973648,0.0011178261,0.000048297454,0.60377556,0.0036969755,0.0007297525,0.000059241323,5.314487e-8,6.5891655e-8,0.00011561225,0.0003901679,0.3898691],"study_design_scores_gemma":[0.0036366314,0.0007938428,0.0005893264,0.8465413,0.024752382,0.0029526367,0.00014033602,0.0000011221823,6.1802876e-7,0.000019584266,0.12029022,0.00028202077],"about_ca_topic_score_codex":0.0040831445,"about_ca_topic_score_gemma":0.00069042377,"teacher_disagreement_score":0.38958707,"about_ca_system_score_codex":0.001789393,"about_ca_system_score_gemma":0.0008983198,"threshold_uncertainty_score":0.9999436},"labels":[],"label_agreement":null},{"id":"W2024879187","doi":"10.1007/s10549-008-9900-0","title":"25-Hydroxyvitamin D3 is a natural chemopreventive agent against carcinogen induced precancerous lesions in mouse mammary gland organ culture","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Shriners Hospitals for Children - Canada","funders":"National Cancer Institute; National Institutes of Health","keywords":"Mammary gland; Autocrine signalling; Paracrine signalling; Organ culture; Endocrinology; Internal medicine; Vitamin D and neurology; Carcinogen; Hormone; Biology; Prohormone; In vivo; Cancer research; Breast cancer; Cancer; Medicine; Receptor; In vitro; Biochemistry","score_opus":0.059275673196970045,"score_gpt":0.35501026543766057,"score_spread":0.29573459224069054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024879187","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9837535,0.009890057,8.040865e-7,0.003631731,0.000052196585,0.0017140862,0.00030521106,0.00004578726,0.00060661713],"genre_scores_gemma":[0.9585729,0.026607525,0.000076989425,0.0001180969,0.00020128972,0.0010046976,0.00007763386,0.00004059539,0.013300233],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967496,0.00018310206,0.00028873252,0.00076650816,0.0009767882,0.001035275],"domain_scores_gemma":[0.99843997,0.0000809871,0.000052093877,0.00048211598,0.00041310274,0.00053172035],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022590513,0.00037030337,0.0005740216,0.00029807433,0.0004933223,0.000043216383,0.0001862062,0.00014489029,0.000062594016],"category_scores_gemma":[0.000056163753,0.00025338162,0.000114369854,0.0007185484,0.00036108113,0.00016204857,0.0003219221,0.00062811753,0.000022964978],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016313714,0.0047228415,0.6059942,0.00049036066,0.0024503875,0.0071384036,0.027732925,0.0000032995874,0.07952546,0.000025208532,0.011892908,0.2583926],"study_design_scores_gemma":[0.0091138175,0.0014197626,0.9450666,0.0003944133,0.000044622793,0.0005345349,0.0011604598,0.00006659783,0.040300757,0.000025958983,0.0015653789,0.00030711482],"about_ca_topic_score_codex":0.0066286246,"about_ca_topic_score_gemma":0.0030737675,"teacher_disagreement_score":0.33907235,"about_ca_system_score_codex":0.0020692083,"about_ca_system_score_gemma":0.0007595618,"threshold_uncertainty_score":0.99999183},"labels":[],"label_agreement":null},{"id":"W2024981400","doi":"10.1007/s10549-010-1183-6","title":"Biomarker alterations with metronomic use of low-dose zoledronic acid for breast cancer patients with bone metastases and potential clinical significance","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Bone health and treatments","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of British Columbia","funders":"","keywords":"Zoledronic acid; Medicine; Breast cancer; Regimen; Internal medicine; Clinical endpoint; Oncology; N-terminal telopeptide; Biomarker; Urology; Cancer; Metastatic breast cancer; Bone remodeling; Gastroenterology; Randomized controlled trial; Osteocalcin; Alkaline phosphatase","score_opus":0.0648832606274134,"score_gpt":0.3964893727552942,"score_spread":0.3316061121278808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024981400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895813,0.0007008414,0.000034215158,0.001603993,0.00007020074,0.0023624026,0.005623373,0.000016798142,0.00000686189],"genre_scores_gemma":[0.9960481,0.000949038,0.0010342964,0.0000499132,0.000084567844,0.0013990435,0.0001895818,0.000041150106,0.00020434572],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99799156,0.00008945535,0.0003748119,0.000578803,0.0003747544,0.0005906199],"domain_scores_gemma":[0.99819046,0.00016399831,0.00014004938,0.00032749525,0.0005376224,0.0006403901],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002108773,0.00027108294,0.00054516754,0.00018970635,0.00026320078,0.00005894965,0.000044236123,0.0000824865,0.00011599326],"category_scores_gemma":[0.000011111025,0.0001626505,0.000072196744,0.0002051859,0.0005571497,0.00021107092,0.00003384236,0.00020393354,0.000002044348],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025459263,0.0039788666,0.78652203,0.00018439112,0.0014772885,0.000038439426,0.00004766424,0.0000035845778,0.0007033759,0.000043812717,0.00015067733,0.1813906],"study_design_scores_gemma":[0.019614283,0.0034846556,0.9747262,0.00017935084,0.00049152866,0.00011341444,0.000022438418,0.00013959158,0.00068467757,0.000010145296,0.0003814924,0.00015222322],"about_ca_topic_score_codex":0.006547105,"about_ca_topic_score_gemma":0.0069639585,"teacher_disagreement_score":0.18820417,"about_ca_system_score_codex":0.00022137955,"about_ca_system_score_gemma":0.0011029576,"threshold_uncertainty_score":0.9897308},"labels":[],"label_agreement":null},{"id":"W2024991157","doi":"10.1007/s10549-006-9261-5","title":"Direct-to-patient BRCA1 testing: the Twoj Styl experience","year":2006,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Coalition for Research in Women's Health","funders":"","keywords":"Genetic testing; Genetic counseling; Breast cancer; Medicine; BRCA mutation; Family medicine; Population; Test (biology); Cancer; Gynecology; Family history; Breast cancer screening; Demography; Oncology; Mammography; Internal medicine; Genetics; Environmental health; Biology","score_opus":0.04806330212111851,"score_gpt":0.35334629772245674,"score_spread":0.3052829956013382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024991157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907119,0.0025454203,0.000023005226,0.0017083421,0.0000763868,0.00047863397,0.00013505534,0.000012246184,0.0043089855],"genre_scores_gemma":[0.99651265,0.0001951534,0.00024380788,0.000101545054,0.00034098854,0.0012214598,0.000020618898,0.000018006063,0.0013457724],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987581,0.00006664788,0.00012030238,0.0004151157,0.00025886716,0.00038096655],"domain_scores_gemma":[0.99925023,0.000039571278,0.000025488227,0.00036118744,0.00020950992,0.000114029266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010116363,0.00013177763,0.000087786626,0.00004689812,0.00032203356,0.00006905948,0.00013860196,0.000041554897,0.00003767864],"category_scores_gemma":[0.000021245909,0.00008615306,0.000028750575,0.00025774707,0.00020141664,0.0000035706462,0.00012442056,0.00005448758,0.000012979779],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009409894,0.0010366213,0.0849199,0.000021729706,0.00028167744,0.00004636516,0.0017527611,0.0016986838,0.34765807,0.0003620385,0.027083296,0.53419787],"study_design_scores_gemma":[0.0015397368,0.0021851354,0.229151,0.00005561931,0.000026928641,0.00015979796,0.00091491704,0.00007489942,0.41272953,0.00020802884,0.3525198,0.00043459848],"about_ca_topic_score_codex":0.0046595703,"about_ca_topic_score_gemma":0.0013374117,"teacher_disagreement_score":0.5337633,"about_ca_system_score_codex":0.0002551549,"about_ca_system_score_gemma":0.00027857398,"threshold_uncertainty_score":0.70439076},"labels":[],"label_agreement":null},{"id":"W2025322874","doi":"10.1007/s10549-007-9498-7","title":"Alcohol metabolism, alcohol intake, and breast cancer risk: a sister-set analysis using the Breast Cancer Family Registry","year":2007,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Alcohol Consumption and Health Effects","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Cancer Care Ontario; Mount Sinai Hospital","funders":"National Institute of Environmental Health Sciences; National Cancer Institute","keywords":"Breast cancer; ADH1B; Acetaldehyde; Alcohol; Medicine; Cancer; Internal medicine; Alcohol dehydrogenase; Oncology; Physiology; Ethanol; Biology; Biochemistry; Enzyme","score_opus":0.18628811876911067,"score_gpt":0.4670998357307335,"score_spread":0.2808117169616228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025322874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9637631,0.021839023,0.000055794975,0.008095277,0.00016095677,0.0016608081,0.0041064145,0.000066170454,0.00025242718],"genre_scores_gemma":[0.9698393,0.026977489,0.00008466715,0.0007524636,0.0007863317,0.00068222964,0.000057039924,0.00006336292,0.0007571259],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99562114,0.00035903524,0.0005619109,0.0010130137,0.0010710384,0.0013738626],"domain_scores_gemma":[0.9968461,0.0003041502,0.00026463548,0.0007755817,0.0006678182,0.0011417224],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013584963,0.0005262123,0.0009351007,0.0006515969,0.0010581942,0.00018577062,0.00018851331,0.0002221143,0.00052539806],"category_scores_gemma":[0.000019180532,0.00033499594,0.00025311863,0.0015385263,0.0007754328,0.00019023145,0.00016293231,0.0007071667,0.000011066817],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050573754,0.00046378165,0.8076593,0.00022621034,0.004303135,0.00020545463,0.00088279176,0.00003591955,0.0012542238,0.00006106636,0.0008292602,0.17902143],"study_design_scores_gemma":[0.0054455227,0.0001402829,0.98554593,0.00032440975,0.0027632357,0.0010852593,0.0007673061,0.000569465,0.00013316062,0.000019871262,0.0028988859,0.00030667393],"about_ca_topic_score_codex":0.12514794,"about_ca_topic_score_gemma":0.022865552,"teacher_disagreement_score":0.17871475,"about_ca_system_score_codex":0.00146678,"about_ca_system_score_gemma":0.0011043337,"threshold_uncertainty_score":0.99991024},"labels":[],"label_agreement":null},{"id":"W2025598781","doi":"10.1007/s10549-007-9654-0","title":"The impact of diabetes on survival following breast cancer","year":2007,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":179,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; University of Toronto; Cancer Care Ontario; Institute for Clinical Evaluative Sciences","funders":"","keywords":"Medicine; Breast cancer; Diabetes mellitus; Hyperinsulinemia; Hazard ratio; Comorbidity; Internal medicine; Cancer; Population; Proportional hazards model; Type 2 diabetes; Oncology; Gynecology; Confidence interval; Insulin resistance; Endocrinology","score_opus":0.03054989329367037,"score_gpt":0.37886227572146386,"score_spread":0.3483123824277935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025598781","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8998897,0.09859652,0.0000017488434,0.0001458176,0.000195051,0.00025629392,0.00049561844,0.00000545015,0.00041379468],"genre_scores_gemma":[0.94990355,0.04896928,0.0000040065174,0.000021102614,0.0005721065,0.0001616442,0.000023122455,0.000024856483,0.00032034604],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.998264,0.000098696604,0.00018558452,0.0003590074,0.00036524565,0.0007274347],"domain_scores_gemma":[0.9991014,0.00008419787,0.00005674526,0.00034578904,0.00018115119,0.00023069062],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006163436,0.00020395161,0.00023046261,0.000063513304,0.00027815552,0.00004769511,0.0001639854,0.000083496925,0.00006250088],"category_scores_gemma":[0.000012460842,0.00011680905,0.00019472638,0.00017520036,0.0002100587,0.0000061153974,0.00006840051,0.00010190158,0.0000029560192],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001023308,0.0003062262,0.18331468,0.000014415354,0.0009986458,0.0000047504,0.00006096011,0.000026808,0.020247646,0.000087905544,0.00085892907,0.7930557],"study_design_scores_gemma":[0.0030319318,0.0014895798,0.90213776,0.00010768105,0.000066528344,0.000005248526,0.00019302912,0.000016234611,0.07093117,0.00015730354,0.02155187,0.00031167967],"about_ca_topic_score_codex":0.0037652683,"about_ca_topic_score_gemma":0.0017745049,"teacher_disagreement_score":0.79274404,"about_ca_system_score_codex":0.00019718101,"about_ca_system_score_gemma":0.00033730452,"threshold_uncertainty_score":0.5691984},"labels":[],"label_agreement":null},{"id":"W2026055570","doi":"10.1023/a:1023979226714","title":"2. Survival Impact of HER-2/Neu, Cox-2, Urokinase Plasminogen Activator (upa), Cytokeratin 17/5,6 and other Markers with Long-Term Outcome of Early Breast Cancer. Report from the British Columbia Tissue Micro-Array Project (BCTMAP)","year":2003,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Cytokeratin; Breast cancer; Immunohistochemistry; Internal medicine; Oncology; Medicine; Pathology; Urokinase receptor; Biology; Cancer; Plasminogen activator","score_opus":0.047285448596771855,"score_gpt":0.36464497862614403,"score_spread":0.31735953002937217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026055570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862582,0.0033294554,0.000004215343,0.00025942855,0.000059736987,0.0017725256,0.007848399,0.00001464321,0.0004533627],"genre_scores_gemma":[0.9946401,0.0014961485,0.00012629022,0.000027334214,0.00013546819,0.0003965053,0.000056357116,0.00006541517,0.0030563504],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973174,0.00023795223,0.00046893404,0.0006588902,0.0007008016,0.00061602803],"domain_scores_gemma":[0.9983024,0.00016831867,0.00024567073,0.000540484,0.00036782637,0.00037530332],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00042790495,0.00030180518,0.0007895296,0.000071350696,0.00029173566,0.00025291851,0.00011127255,0.000096196585,0.0010395324],"category_scores_gemma":[0.000019281939,0.00022675208,0.00013887869,0.00037126726,0.00058946013,0.000105326755,0.000044163742,0.00023771459,9.4323286e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005069073,0.00067519967,0.9502283,0.00013092453,0.0016879119,0.0006106391,0.00027387321,0.0000010550607,0.011495339,6.103728e-7,0.001232824,0.028594298],"study_design_scores_gemma":[0.0059322435,0.0017006833,0.9794133,0.00051767525,0.00033312212,0.0021557654,0.00021351088,5.058151e-7,0.00830471,0.0000029663222,0.0012156258,0.0002098957],"about_ca_topic_score_codex":0.74078393,"about_ca_topic_score_gemma":0.26810592,"teacher_disagreement_score":0.472678,"about_ca_system_score_codex":0.0005959489,"about_ca_system_score_gemma":0.0015398569,"threshold_uncertainty_score":0.99987364},"labels":[],"label_agreement":null},{"id":"W2026727525","doi":"10.1007/s10549-006-9441-3","title":"Age at first birth and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers","year":2007,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Western University; University of British Columbia; Université de Montréal; McGill University; Centre Hospitalier de l’Université de Montréal; London Health Sciences Centre; Women's College Hospital; Université du Québec à Montréal; Princess Margaret Cancer Centre; BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health","keywords":"Breast cancer; Medicine; BRCA mutation; Obstetrics; Childbirth; Pregnancy; Ovarian cancer; Gynecology; Population; Genetic counseling; Oncology; Cancer; Internal medicine; Genetics; Biology","score_opus":0.02720911644467028,"score_gpt":0.3515969487490057,"score_spread":0.32438783230433543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026727525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855874,0.009799527,0.0000022759762,0.0027150908,0.00003794569,0.0007536992,0.00089216157,0.000008750555,0.00020313491],"genre_scores_gemma":[0.9680222,0.03126063,0.000008315417,0.000028155107,0.00010217861,0.00014545818,0.000009962146,0.00001735345,0.00040571744],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986293,0.00006724629,0.0002167566,0.00033251237,0.00035132543,0.00040290097],"domain_scores_gemma":[0.99915814,0.00020725671,0.00006954945,0.00018439183,0.00010613338,0.00027450544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051316054,0.00016330427,0.00033357608,0.00018543663,0.00022202024,0.000028056089,0.000038664457,0.00006354229,0.00013789795],"category_scores_gemma":[0.000013502373,0.00009530844,0.000044306926,0.00027849228,0.0007354339,0.000057513855,0.000060439623,0.00017150588,7.6997776e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007265253,0.00011842745,0.81266177,0.000098588156,0.0002736144,0.00012716226,0.0031587745,0.00000947448,0.00011707243,0.00007253552,0.00006839208,0.17602892],"study_design_scores_gemma":[0.009926639,0.00029280776,0.98675984,0.00016516547,0.00008873001,0.00023321668,0.00083018234,0.00007751945,0.00030166935,0.00008496769,0.0011534108,0.000085841115],"about_ca_topic_score_codex":0.17384268,"about_ca_topic_score_gemma":0.1608435,"teacher_disagreement_score":0.17594308,"about_ca_system_score_codex":0.0007287656,"about_ca_system_score_gemma":0.00017441245,"threshold_uncertainty_score":0.85446894},"labels":[],"label_agreement":null},{"id":"W2026828661","doi":"10.1007/s10549-011-1380-y","title":"EMSY and CCND1 amplification in familial breast cancer: from the Ontario site of the Breast Cancer Family Registry","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; St. Michael's Hospital; Hamilton Health Sciences; University of Toronto; McMaster University","funders":"National Cancer Institute","keywords":"Breast cancer; Gene duplication; Cyclin D1; Cancer research; Tissue microarray; Oncogene; Cancer; Biology; Immunohistochemistry; Fluorescence in situ hybridization; Oncology; Internal medicine; Medicine; Gene; Genetics; Chromosome; Cell cycle","score_opus":0.05200347077717383,"score_gpt":0.32036979620263584,"score_spread":0.268366325425462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026828661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854447,0.006367572,0.0000053142435,0.0025128413,0.00015252428,0.00056891,0.00467206,0.0000054785296,0.00027057156],"genre_scores_gemma":[0.99067885,0.0073717474,0.000041826534,0.000117035575,0.0002857011,0.0007841643,0.00006517167,0.000025498679,0.0006299824],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983204,0.00014596584,0.00024982254,0.00057518267,0.0003152389,0.0003933719],"domain_scores_gemma":[0.9988562,0.00003302306,0.000114076836,0.0006309776,0.00024842354,0.00011733553],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018540707,0.00022238829,0.0002022283,0.00004879182,0.00023689985,0.000042288848,0.00026864195,0.00013412593,0.00012706924],"category_scores_gemma":[0.000005179978,0.00013936558,0.0000641519,0.00022605679,0.00055401004,0.000014326732,0.00019412769,0.00020453296,0.0000018180366],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013635221,0.00026384566,0.89252824,0.000018043598,0.0002715995,0.000003698028,0.0021318637,0.000027349775,0.027760986,0.00003645631,0.0011195098,0.07447486],"study_design_scores_gemma":[0.0014164036,0.00009546785,0.9904672,0.00010222975,0.00004941031,0.000050769177,0.0004477182,0.000011495963,0.0047824592,0.00014142154,0.002289851,0.00014558731],"about_ca_topic_score_codex":0.629541,"about_ca_topic_score_gemma":0.538992,"teacher_disagreement_score":0.097938925,"about_ca_system_score_codex":0.0007792487,"about_ca_system_score_gemma":0.0013267111,"threshold_uncertainty_score":0.5683164},"labels":[],"label_agreement":null},{"id":"W2026880258","doi":"10.1007/s10549-008-0019-0","title":"High insulin levels in newly diagnosed breast cancer patients reflect underlying insulin resistance and are associated with components of the insulin resistance syndrome","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Sunnybrook Health Science Centre; Fluidigm (Canada); Grand River Hospital; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"","keywords":"Hyperinsulinemia; Insulin resistance; Breast cancer; Medicine; Internal medicine; Insulin; Endocrinology; Cancer; Hyperinsulinism","score_opus":0.09092112607861139,"score_gpt":0.34092410055802186,"score_spread":0.25000297447941044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026880258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873758,0.005795182,7.324287e-7,0.0025120038,0.00006781598,0.0013542062,0.0027853595,0.000025602358,0.00008328177],"genre_scores_gemma":[0.99032724,0.008318719,0.000028614671,0.00007237401,0.000039850525,0.0004228538,0.00005299128,0.000052829175,0.00068449834],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996855,0.00024735497,0.0004879861,0.00068818155,0.0010104838,0.0007109551],"domain_scores_gemma":[0.99825245,0.00022795984,0.00028434195,0.0004255745,0.00048304483,0.00032664195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023316301,0.00037366583,0.0007705691,0.00026188605,0.00041590576,0.00003633836,0.00016402046,0.00014587969,0.00005669917],"category_scores_gemma":[0.000052187217,0.00024224188,0.00007139161,0.0010797835,0.0006306289,0.00015371147,0.00010341551,0.00043972625,0.0000013628242],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059740786,0.0016399296,0.9842379,0.00015995452,0.00040044045,0.0003722652,0.00091528945,0.000020997706,0.0002124768,0.000026982107,0.00017666175,0.0058629997],"study_design_scores_gemma":[0.015802987,0.00050456607,0.97999454,0.0027716868,0.00006436131,0.000060629303,0.00014306925,0.000008221397,0.0001602863,0.00005295884,0.00020919928,0.00022747662],"about_ca_topic_score_codex":0.03204117,"about_ca_topic_score_gemma":0.079207025,"teacher_disagreement_score":0.047165856,"about_ca_system_score_codex":0.0015909803,"about_ca_system_score_gemma":0.00068864314,"threshold_uncertainty_score":0.98783374},"labels":[],"label_agreement":null},{"id":"W2027262675","doi":"10.1007/s10549-006-9309-6","title":"The decision-making experience among women diagnosed with stage I and II breast cancer","year":2006,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Patient-Provider Communication in Healthcare","field":"Health Professions","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Capital District Health Authority; Cancer Care Nova Scotia; Dalhousie University","funders":"","keywords":"Regret; Breast cancer; Logistic regression; Medicine; Family medicine; Cancer; Disease; Patient participation; Patient satisfaction; Health care; Gynecology; Nursing; Internal medicine","score_opus":0.1281766421984513,"score_gpt":0.47077575486975515,"score_spread":0.34259911267130383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027262675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98473924,0.008503264,0.000004424845,0.00408303,0.00009190668,0.0016499298,0.0005132072,0.00004808608,0.00036688807],"genre_scores_gemma":[0.9816556,0.005085884,0.000078267294,0.000090679234,0.00016003674,0.011587634,0.0000073360807,0.000032386666,0.0013021845],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969293,0.0005321103,0.00037175612,0.00047627985,0.0006111406,0.0010794105],"domain_scores_gemma":[0.99652743,0.0017981514,0.00015659392,0.00069739134,0.0004900762,0.00033035633],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.00030997602,0.00021645078,0.00024116815,0.00011273721,0.005253874,0.000075973105,0.00027087744,0.00008985683,0.0002619967],"category_scores_gemma":[0.00003414406,0.00012418035,0.000019911675,0.00037061443,0.0006377345,0.0002151474,0.00039027474,0.00043304102,0.0000073560973],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011099026,0.00015171779,0.8781138,0.00005602476,0.000044370794,0.000018818813,0.016528407,0.000011615291,0.00000697232,0.00032321046,0.00035240655,0.10328277],"study_design_scores_gemma":[0.0018774223,0.0002970756,0.9633184,0.0007923044,0.000006470218,0.000010651931,0.027453024,0.000100360754,0.000005220658,0.00037410736,0.005619067,0.00014591186],"about_ca_topic_score_codex":0.07810611,"about_ca_topic_score_gemma":0.06939264,"teacher_disagreement_score":0.10313686,"about_ca_system_score_codex":0.0017799698,"about_ca_system_score_gemma":0.00086308236,"threshold_uncertainty_score":0.9960412},"labels":[],"label_agreement":null},{"id":"W2027341444","doi":"10.1007/s10549-013-2692-x","title":"Clinical characteristics of breast cancer in patients with an NBS1 mutation","year":2013,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Breast cancer; Medicine; Mutation; Internal medicine; Nijmegen breakage syndrome; Cancer; Mutation rate; Oncology; Proportional hazards model; Stage (stratigraphy); Genetics; Biology; Gene; Population; DNA; DNA damage","score_opus":0.02856917325298508,"score_gpt":0.37048999503713004,"score_spread":0.34192082178414496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027341444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978989,0.00022107134,0.000008650596,0.0004174112,0.000052217765,0.0005318494,0.0008224483,0.0000036358595,0.000043823344],"genre_scores_gemma":[0.9980735,0.0007470155,0.00013860915,0.000027731372,0.00015939219,0.00054475147,0.00017646674,0.00002012004,0.00011237298],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99879676,0.00011011147,0.00023699409,0.00035975626,0.00022654679,0.0002698172],"domain_scores_gemma":[0.9990187,0.000017781265,0.0000742989,0.00024964073,0.00049875356,0.00014080634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013565886,0.00012569886,0.00017353854,0.00007734922,0.00005817585,0.000027913855,0.00008759483,0.000083725354,0.00016851896],"category_scores_gemma":[0.0000062522695,0.00009343104,0.000025409541,0.0001419546,0.00022507997,0.000015794154,0.00004304707,0.000082462655,0.000003939182],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008584767,0.000576642,0.7425449,0.000012795555,0.00009318813,0.0000017130773,0.000057188856,0.00001304659,0.0004987423,0.000006961376,0.00007310646,0.25526324],"study_design_scores_gemma":[0.0024362945,0.0012037148,0.9951909,0.0000400347,0.000013617156,0.0000063515618,0.00006028512,0.00003817999,0.000715761,0.000026881655,0.00016757994,0.00010036953],"about_ca_topic_score_codex":0.003884588,"about_ca_topic_score_gemma":0.0016531005,"teacher_disagreement_score":0.25516286,"about_ca_system_score_codex":0.00019840409,"about_ca_system_score_gemma":0.00041427027,"threshold_uncertainty_score":0.5872361},"labels":[],"label_agreement":null},{"id":"W2027584166","doi":"10.1007/s10549-011-1753-2","title":"Role of Src in breast cancer cell migration and invasion in a breast cell/bone-derived cell microenvironment","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Bone health and treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Cancer research; Proto-oncogene tyrosine-protein kinase Src; Breast cancer; Cancer cell; Cell migration; Bone metastasis; Cell culture; Cell; Chemistry; Cancer; Biology; Cell biology; Internal medicine; Medicine; Kinase; Biochemistry","score_opus":0.03846310560150481,"score_gpt":0.30697270034432383,"score_spread":0.26850959474281905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027584166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856965,0.010159568,2.8991317e-7,0.0013152733,0.000023793735,0.0013123725,0.00048218228,0.000011362969,0.0009986555],"genre_scores_gemma":[0.96762514,0.031086296,0.00011309816,0.00006638155,0.000033052525,0.0006660356,0.00004516745,0.00003475306,0.00033005772],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99774605,0.00013649325,0.0004117091,0.0006038286,0.0003988965,0.00070303975],"domain_scores_gemma":[0.99897075,0.000039649,0.0001091098,0.0003035145,0.000080708334,0.0004962874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020060263,0.00030066547,0.00048732015,0.00023598692,0.00010196495,0.000016045851,0.000059315407,0.00013319305,0.00028294267],"category_scores_gemma":[9.724139e-7,0.00023377879,0.00005409986,0.00025322035,0.00018381047,0.00014086394,0.00007982023,0.00020921128,0.000012206829],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046045347,0.0048755985,0.88817936,0.0003179516,0.00004850593,0.00014665404,0.0021610898,0.0000017163707,0.060665395,0.000004428169,0.00005273379,0.03894201],"study_design_scores_gemma":[0.010071403,0.00081918086,0.9417943,0.00034695663,0.000061824714,0.0001750776,0.00092045416,0.000051507228,0.045437533,0.000054791628,0.00011001291,0.00015699083],"about_ca_topic_score_codex":0.21051815,"about_ca_topic_score_gemma":0.036010373,"teacher_disagreement_score":0.17450777,"about_ca_system_score_codex":0.0011592642,"about_ca_system_score_gemma":0.00042706475,"threshold_uncertainty_score":0.9815799},"labels":[],"label_agreement":null},{"id":"W2027797732","doi":"10.1007/s10549-004-7260-y","title":"Metaplastic breast carcinoma: clinical–pathologic characteristics and HER2/neu expression","year":2005,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Lesions and Carcinomas","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nova Scotia Hospital; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Metaplastic carcinoma; Adenosquamous carcinoma; Carcinosarcoma; Medicine; Sarcomatoid carcinoma; Pathology; Cytokeratin; Carcinoma; Adenocarcinoma; Breast cancer; Spindle cell carcinoma; Immunohistochemistry; Cancer; Oncology; Internal medicine","score_opus":0.09494441713047135,"score_gpt":0.3988335281646542,"score_spread":0.30388911103418287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027797732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905548,0.0030137228,0.000011296378,0.004967662,0.0000770444,0.00056739576,0.0003857213,0.000046210072,0.00037613156],"genre_scores_gemma":[0.994063,0.003016764,0.00032967338,0.0001285408,0.00077661604,0.00022688082,0.000045404147,0.00003345624,0.0013796696],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99770033,0.00019549651,0.00038226054,0.0006638463,0.00043144464,0.00062663713],"domain_scores_gemma":[0.99833333,0.00018300561,0.000073073184,0.0004150306,0.00024821926,0.0007473588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044489565,0.0002822131,0.00055021804,0.00017789632,0.00031546984,0.000071630035,0.0000791148,0.00015422463,0.00034437163],"category_scores_gemma":[0.000024385956,0.00018334301,0.00010201916,0.00019735476,0.00043337353,0.00010934753,0.00014856395,0.00034810277,0.000047952115],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017380519,0.0013212995,0.55827945,0.000068282796,0.00010658761,0.0005242847,0.00012755762,2.7555632e-7,0.0020299917,0.00010161275,0.0004227078,0.43527988],"study_design_scores_gemma":[0.0035417434,0.0011008814,0.9869825,0.00015806285,0.00014227998,0.004382818,0.00010915684,0.00012999124,0.00031734424,0.00003236952,0.00294059,0.00016224045],"about_ca_topic_score_codex":0.00063006766,"about_ca_topic_score_gemma":0.00011478958,"teacher_disagreement_score":0.43511763,"about_ca_system_score_codex":0.00025775572,"about_ca_system_score_gemma":0.00027844304,"threshold_uncertainty_score":0.7476511},"labels":[],"label_agreement":null},{"id":"W2028064456","doi":"10.1007/s10549-015-3290-x","title":"Quetiapine inhibits osteoclastogenesis and prevents human breast cancer-induced bone loss through suppression of the RANKL-mediated MAPK and NF-κB signaling pathways","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Bone Metabolism and Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Key Research and Development Program of China; National Natural Science Foundation of China","keywords":"Osteoclast; RANKL; Cancer research; Bone resorption; Osteolysis; Bone metastasis; Breast cancer; MAPK/ERK pathway; In vivo; Medicine; Cancer; Internal medicine; Signal transduction; Biology; Activator (genetics); Cell biology; Receptor","score_opus":0.0613645076142955,"score_gpt":0.33678396590846427,"score_spread":0.27541945829416875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028064456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9823538,0.015261795,0.0000016889056,0.00058914814,0.000047141133,0.00048583734,0.0012222568,0.00000946644,0.000028880211],"genre_scores_gemma":[0.99604785,0.0033190695,0.000016591512,0.000031735355,0.0001741998,0.00019736764,0.000073398725,0.000028418892,0.0001113909],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99842906,0.00019764918,0.00020665556,0.00045567026,0.00034533322,0.00036565054],"domain_scores_gemma":[0.9991026,0.000020352221,0.00008456829,0.00027728238,0.00021567973,0.00029954858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018656775,0.00021888052,0.00026627345,0.000047503672,0.00023020645,0.00003959503,0.00009667176,0.00010915575,0.000012499866],"category_scores_gemma":[0.000016199181,0.00014141056,0.000051155646,0.00014150752,0.00028742524,0.000014895313,0.0002742838,0.00007622379,5.557746e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015811555,0.00044232514,0.07939606,0.00011132221,0.00019131109,0.00001085794,0.00033079737,0.0000053194062,0.89908385,0.00004790529,0.00024496968,0.018554132],"study_design_scores_gemma":[0.0070088864,0.0006302477,0.15113707,0.0002920239,0.00012563916,0.00013150372,0.00026957996,0.0000086032505,0.8389461,0.00025757856,0.00092253066,0.0002702242],"about_ca_topic_score_codex":0.0055087344,"about_ca_topic_score_gemma":0.0007955347,"teacher_disagreement_score":0.07174101,"about_ca_system_score_codex":0.000050731862,"about_ca_system_score_gemma":0.0003211605,"threshold_uncertainty_score":0.8327595},"labels":[],"label_agreement":null},{"id":"W2028616390","doi":"10.1023/a:1026118602273","title":"A Novel Pure SERM Achieves Complete Regression of the Majority of Human Breast Cancer Tumors in Nude Mice","year":2003,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Tamoxifen; Breast cancer; Estrogen; Estrogen receptor; Cancer; Selective estrogen receptor modulator; Medicine; Mammary gland; Internal medicine; Antiestrogen; Cancer research; Oncology","score_opus":0.02919191251859132,"score_gpt":0.3384126851941826,"score_spread":0.3092207726755913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028616390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942263,0.004226305,9.570894e-7,0.00041443293,0.000030726347,0.00036435333,0.0004800195,0.0000022252425,0.00025472825],"genre_scores_gemma":[0.99820787,0.0012944598,0.00002050256,0.0000095705145,0.00004030972,0.00009706624,0.000018744846,0.000013461463,0.0002979969],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99889195,0.00015463133,0.00016954435,0.00027540606,0.00021650805,0.000291951],"domain_scores_gemma":[0.9994545,0.000016429518,0.0000759307,0.00024855358,0.00011138356,0.00009317593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016960483,0.0001490608,0.00020285173,0.000055242366,0.000117359414,0.000008062721,0.00012866063,0.00010560363,0.0000184103],"category_scores_gemma":[0.0000068288427,0.00008530492,0.000071762384,0.00019306461,0.0002602466,0.000004293063,0.000079994825,0.00014939769,4.5742865e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005136629,0.00058612996,0.10511708,0.00006379171,0.00014332762,0.0000060268435,0.000097062555,0.000015964957,0.88866186,0.00024172723,0.00008674421,0.004466608],"study_design_scores_gemma":[0.0028990107,0.0005573222,0.5604659,0.00037719557,0.000030202222,0.00015230064,0.00013542952,0.000011253338,0.43494043,0.00007516569,0.00022102454,0.00013478183],"about_ca_topic_score_codex":0.0048540477,"about_ca_topic_score_gemma":0.0016296026,"teacher_disagreement_score":0.4553488,"about_ca_system_score_codex":0.00008661597,"about_ca_system_score_gemma":0.00022442223,"threshold_uncertainty_score":0.73379004},"labels":[],"label_agreement":null},{"id":"W2028943787","doi":"10.1007/s10549-014-3181-6","title":"Differences in expression of proliferation-associated genes and RANKL across the menstrual cycle in estrogen receptor-positive primary breast cancer","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"National Institute for Health and Care Research","keywords":"Menstrual cycle; Estrogen; RANKL; Breast cancer; Internal medicine; Endocrinology; Biology; Gene expression; Estrogen receptor; Gene; Cancer research; Cancer; Medicine; Hormone; Genetics","score_opus":0.012007515480124005,"score_gpt":0.3039143559152082,"score_spread":0.2919068404350842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028943787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938154,0.004860355,0.000001202534,0.0005332942,0.000023018472,0.00042566747,0.00029952894,0.0000031009968,0.000038438146],"genre_scores_gemma":[0.99360824,0.005864072,0.000010874086,0.000013347391,0.000066841174,0.0003143545,0.000056624496,0.000010635502,0.000054989316],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987787,0.000276616,0.000152032,0.00029585927,0.00017840773,0.00031838665],"domain_scores_gemma":[0.9996106,0.00005185079,0.000050410737,0.0001212649,0.00008397669,0.000081864615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026969955,0.000136624,0.00018940317,0.00004103528,0.0001376863,0.000029695477,0.000074885545,0.000119650766,0.000006622745],"category_scores_gemma":[0.000008266432,0.00008272139,0.000027486636,0.00012117117,0.00023099348,0.000008890495,0.00008917784,0.00011295384,4.0857987e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001316273,0.00035438396,0.6817137,0.000024319623,0.0001233379,0.0000036282006,0.00062096823,0.000024972833,0.2629127,0.000025504783,0.000020991256,0.05285924],"study_design_scores_gemma":[0.0030557094,0.00060821284,0.8088568,0.00018989203,0.000012561373,0.000024131037,0.0002496949,0.00012427336,0.18668638,0.000035714584,0.000028571048,0.00012806262],"about_ca_topic_score_codex":0.0023783185,"about_ca_topic_score_gemma":0.0010276954,"teacher_disagreement_score":0.12714311,"about_ca_system_score_codex":0.00009767197,"about_ca_system_score_gemma":0.00012792312,"threshold_uncertainty_score":0.3595322},"labels":[],"label_agreement":null},{"id":"W2029231174","doi":"10.1007/s10549-012-2197-z","title":"Diagnostic values of GHSR DNA methylation pattern in breast cancer","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University and Génome Québec Innovation Centre","funders":"Bundesministerium für Bildung und Forschung","keywords":"DNA methylation; Breast cancer; Epigenetics; Methylation; Cancer; Biology; Bisulfite sequencing; Cancer research; Tissue microarray; Oncology; Pathology; Internal medicine; Medicine; Genetics; DNA; Gene; Gene expression","score_opus":0.040028576653925375,"score_gpt":0.3690601095094921,"score_spread":0.3290315328555667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029231174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98365766,0.014931093,0.000051483774,0.000578824,0.00006696675,0.00027835259,0.00031527452,0.0000030974718,0.000117227726],"genre_scores_gemma":[0.98417956,0.015052867,0.000024198374,0.000010887183,0.00030141673,0.00024091586,0.00006163097,0.000015934542,0.00011261782],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99888915,0.00013197106,0.00016991634,0.00023440774,0.00021168252,0.0003629036],"domain_scores_gemma":[0.9994249,0.00006805428,0.00004963698,0.00017991642,0.00013616707,0.00014132698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030205614,0.00012356238,0.00014442037,0.00009816691,0.00006049372,0.000014937894,0.000060012353,0.000081853206,0.000069682974],"category_scores_gemma":[0.000018137218,0.00009942241,0.000037142938,0.00013465947,0.00009330236,0.00000968439,0.000057446163,0.000057763355,0.000002579603],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012689506,0.00031087422,0.7274677,0.000024498935,0.00006636385,0.0000013756102,0.00016371356,0.000036396268,0.08240334,0.000015868429,0.000032566444,0.18935041],"study_design_scores_gemma":[0.00076907396,0.00018880799,0.8631927,0.000047670048,0.000015938527,0.000004757932,0.000056373196,0.000022477674,0.13500464,0.00010228437,0.00049979147,0.00009550136],"about_ca_topic_score_codex":0.004850103,"about_ca_topic_score_gemma":0.0010408484,"teacher_disagreement_score":0.18925491,"about_ca_system_score_codex":0.000107504515,"about_ca_system_score_gemma":0.000101768404,"threshold_uncertainty_score":0.73319376},"labels":[],"label_agreement":null},{"id":"W2029338166","doi":"10.1007/s10549-004-5780-0","title":"Detection of genetic instability at HER-2/neu and p53 loci in breast cancer cells sing Comet–FISH","year":2005,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Animal Genetics and Reproduction","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"U.S. Department of Defense","keywords":"Breast cancer; Fish <Actinopterygii>; Comet assay; Biology; Microsatellite instability; Comet; Cancer; Oncology; Genetics; Gene; Cancer research; Medicine; DNA damage; DNA; Fishery; Microsatellite; Allele","score_opus":0.023698229468976616,"score_gpt":0.31240054757294294,"score_spread":0.28870231810396635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029338166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931461,0.005381401,0.00001054823,0.00087638665,0.000036772017,0.0003149646,0.00018552324,0.0000038349635,0.000044466775],"genre_scores_gemma":[0.9853711,0.013955255,0.000054434375,0.000019237967,0.00023145865,0.00009749253,0.000010753062,0.000015369054,0.0002448956],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987761,0.000078048724,0.00018434752,0.000490529,0.00016999921,0.0003009714],"domain_scores_gemma":[0.99946535,0.000008590596,0.000048049234,0.00021342126,0.00014370738,0.00012089433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016289741,0.00013940963,0.00016002993,0.00007636837,0.00013393907,0.000019616984,0.00004978652,0.00009193703,0.000033820124],"category_scores_gemma":[0.000003156999,0.00011495028,0.00003481091,0.0001429685,0.00024239744,0.0000059492463,0.000109685956,0.00007439844,0.000001005759],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071860116,0.00027185658,0.094845094,0.00004088169,0.00005905279,0.0000021694666,0.0000817597,0.00016203194,0.6769928,0.000001271269,0.000029944065,0.22679456],"study_design_scores_gemma":[0.0009978531,0.00044521026,0.6582547,0.000023715642,0.000015588967,0.00006518911,0.00006808711,0.0001036907,0.3371173,0.000011027922,0.002780978,0.00011669891],"about_ca_topic_score_codex":0.0042852797,"about_ca_topic_score_gemma":0.011180744,"teacher_disagreement_score":0.56340957,"about_ca_system_score_codex":0.00025670463,"about_ca_system_score_gemma":0.00008990479,"threshold_uncertainty_score":0.64780897},"labels":[],"label_agreement":null},{"id":"W2029440783","doi":"10.1007/s10549-006-9371-0","title":"Diet quality and BRCA-associated breast cancer risk","year":2006,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Nutritional Studies and Diet","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôtel-Dieu de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"National Cancer Institute","keywords":"Medicine; Mediterranean diet; Odds ratio; Logistic regression; Breast cancer; Demography; Confidence interval; Cohort; Lower risk; Cancer; Internal medicine; Oncology","score_opus":0.06965200471431934,"score_gpt":0.4053019056244485,"score_spread":0.33564990091012914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029440783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96521056,0.010907489,6.325937e-7,0.01690155,0.000038488884,0.0005008535,0.0047427793,0.000035127232,0.0016625265],"genre_scores_gemma":[0.97612536,0.021021802,0.00001763186,0.000083113664,0.00042892015,0.00041668434,0.00008207457,0.000017119968,0.00180727],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983556,0.00010094109,0.00019535678,0.00038721508,0.00046393517,0.0004969526],"domain_scores_gemma":[0.9991148,0.00012125231,0.000053093117,0.00014230625,0.00031557307,0.0002529531],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025541498,0.00017645229,0.00034153005,0.00007100865,0.00044760804,0.00004580763,0.000031825424,0.00006569157,0.00031088802],"category_scores_gemma":[0.000011937065,0.00012300424,0.00006264408,0.00020501864,0.00026674272,0.000049602273,0.00006433813,0.00015293,0.000007277986],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034478838,0.0014384162,0.9504316,0.00006230329,0.0004916066,0.000051976025,0.000045994722,9.83234e-7,0.00013003607,0.0004513672,0.007134452,0.036313385],"study_design_scores_gemma":[0.0052184816,0.00062213687,0.98775,0.00012686654,0.00009311798,0.000055764256,0.00010813408,0.0000092288365,0.00004661175,0.0011084526,0.004744334,0.000116902665],"about_ca_topic_score_codex":0.18994555,"about_ca_topic_score_gemma":0.017127505,"teacher_disagreement_score":0.17281805,"about_ca_system_score_codex":0.0006909416,"about_ca_system_score_gemma":0.00014685902,"threshold_uncertainty_score":0.95575494},"labels":[],"label_agreement":null},{"id":"W2029461912","doi":"10.1007/s10549-015-3345-z","title":"Erratum to: Platinum-based chemotherapy in triple-negative advanced breast cancer","year":2015,"lang":"en","type":"erratum","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Health Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; University of Ottawa; Ottawa Hospital","funders":"","keywords":"Breast cancer; Triple-negative breast cancer; Oncology; Chemotherapy; Medicine; Internal medicine; Triple negative; Platinum; Cancer; Biology","score_opus":0.06377048360085881,"score_gpt":0.42867668471138654,"score_spread":0.36490620111052774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029461912","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2916198,0.12581863,0.000009224615,0.3059999,0.035199948,0.045595814,0.060829528,0.0008647688,0.13406238],"genre_scores_gemma":[0.20328364,0.047854077,0.0003280619,0.0028752396,0.008206975,0.023233872,0.0025619813,0.00058209896,0.71107405],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.995128,0.00024717048,0.0005454239,0.0014245512,0.0011490986,0.0015057662],"domain_scores_gemma":[0.996962,0.00017575853,0.00017674713,0.0006030234,0.00083373644,0.001248738],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00035360098,0.00090841274,0.0015433689,0.0009989054,0.00021494683,0.00008497671,0.00023280078,0.00056103646,0.0021135425],"category_scores_gemma":[0.000021133408,0.0007010808,0.00020785355,0.0012486945,0.00036406747,0.00012132418,0.00009627068,0.0012828978,0.000056837758],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.02939053,0.0027972984,0.009340457,0.00027967786,0.0011602578,0.0006149151,0.00092310744,0.000032782693,0.0002622753,0.000007816967,0.7685311,0.18665978],"study_design_scores_gemma":[0.10741247,0.011690291,0.25464782,0.0051012416,0.000843235,0.00050360034,0.0006086933,0.00040019728,0.0014690035,0.00043386852,0.6150313,0.0018583044],"about_ca_topic_score_codex":0.026836287,"about_ca_topic_score_gemma":0.022101602,"teacher_disagreement_score":0.57701164,"about_ca_system_score_codex":0.0073506925,"about_ca_system_score_gemma":0.0071065594,"threshold_uncertainty_score":0.999544},"labels":[],"label_agreement":null},{"id":"W2029865157","doi":"10.1007/s10549-006-9171-6","title":"Effect of adjuvant breast cancer chemotherapy on cognitive function from the older patient’s perspective","year":2006,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"National Institute on Aging; American Society of Clinical Oncology","keywords":"Breast cancer; Medicine; Cognition; Prospective cohort study; Chemotherapy; Cancer; Internal medicine; Oncology; Psychiatry","score_opus":0.017949360312446833,"score_gpt":0.34688876033058025,"score_spread":0.32893940001813343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029865157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9772948,0.008283949,0.0000041849785,0.007931754,0.0001285272,0.0022920268,0.002635019,0.000033662393,0.0013960452],"genre_scores_gemma":[0.9939105,0.003331684,0.0000014175757,0.00020965423,0.00054690376,0.0014311217,0.000060095772,0.000036481295,0.00047216995],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9979459,0.00022360052,0.00019940584,0.0005201805,0.00065580546,0.00045511543],"domain_scores_gemma":[0.998277,0.00060956884,0.00009153281,0.0001936695,0.0007031522,0.0001250574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001588906,0.0002987141,0.00043404364,0.00012454203,0.00029116927,0.000025551666,0.000045805486,0.00007313114,0.00063460675],"category_scores_gemma":[0.000016039128,0.00016524937,0.00012373342,0.00032859467,0.00046373735,0.00006099445,0.000039599923,0.00025220434,0.000016603643],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.056009803,0.0022547266,0.26733136,0.000072467265,0.0035588874,0.00005270277,0.0019147957,0.000007853946,0.0008423651,0.00008875838,0.0038556668,0.6640106],"study_design_scores_gemma":[0.01346846,0.008017986,0.9658356,0.0012395823,0.0006068912,0.000041990363,0.001596341,0.000016260277,0.008627916,0.00012101924,0.00027371693,0.0001542449],"about_ca_topic_score_codex":0.06598503,"about_ca_topic_score_gemma":0.0021575869,"teacher_disagreement_score":0.6985042,"about_ca_system_score_codex":0.0012415219,"about_ca_system_score_gemma":0.00023079035,"threshold_uncertainty_score":0.94023466},"labels":[],"label_agreement":null},{"id":"W2029938510","doi":"10.1023/b:brea.0000004377.12288.3c","title":"Ineffectiveness of Doxorubicin Treatment on Solitary Dormant Mammary Carcinoma Cells or Late-developing Metastases","year":2003,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":307,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation; Western University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Cancer research; Metastasis; Doxorubicin; Chemotherapy; Metastatic breast cancer; Cytotoxic T cell; Population; Breast cancer; Cancer cell; Cancer; Circulating tumor cell; Internal medicine; Biology; In vitro","score_opus":0.08703821062688523,"score_gpt":0.37438539857049397,"score_spread":0.28734718794360875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029938510","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99045855,0.005238714,0.00003214761,0.0008731172,0.00012074811,0.0014062629,0.00047192257,0.000026773056,0.0013717484],"genre_scores_gemma":[0.9857341,0.011064439,0.00049852947,0.0000630122,0.00008219097,0.00057594926,0.000036431364,0.000035321682,0.0019100154],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978416,0.00024647135,0.00029225374,0.00053187914,0.00046804998,0.00061972224],"domain_scores_gemma":[0.99871653,0.00022196292,0.00006589293,0.0004300836,0.00021117009,0.00035436868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030396145,0.00033219208,0.0006677034,0.0003310711,0.0001666006,0.000026239235,0.000066929155,0.00006511688,0.00018183756],"category_scores_gemma":[0.000010786618,0.0001966821,0.00013816597,0.00041702087,0.00016162095,0.00008101333,0.000040679293,0.00011704316,0.000011793029],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025973648,0.017427128,0.035134465,0.0015381592,0.004556158,0.0034877474,0.0016234793,0.00006019796,0.040471464,0.0044252495,0.0009599377,0.8643424],"study_design_scores_gemma":[0.025210245,0.011481246,0.047774836,0.0005989699,0.0004429085,0.0004275723,0.0004872808,0.000019521054,0.8913297,0.00016097767,0.021688536,0.0003782228],"about_ca_topic_score_codex":0.008939374,"about_ca_topic_score_gemma":0.00078041106,"teacher_disagreement_score":0.86396414,"about_ca_system_score_codex":0.0013806246,"about_ca_system_score_gemma":0.0012527175,"threshold_uncertainty_score":0.99766016},"labels":[],"label_agreement":null},{"id":"W2030373227","doi":"10.1007/s10549-008-0034-1","title":"Cost-effectiveness analysis of adjuvant docetaxel, doxorubicin, and cyclophosphamide (TAC) for node-positive breast cancer: modeling the downstream effects","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Queen Elizabeth II Health Sciences Centre; University of Alberta","funders":"","keywords":"Medicine; Docetaxel; Breast cancer; Oncology; Internal medicine; Cyclophosphamide; Quality-adjusted life year; Cohort; Doxorubicin; Cost effectiveness; Gynecology; Cancer; Chemotherapy","score_opus":0.045291526933460904,"score_gpt":0.3582560225071904,"score_spread":0.3129644955737295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030373227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97345173,0.019185526,0.0003492562,0.00095961045,0.00006316301,0.0018382649,0.004094549,0.00001304914,0.000044830467],"genre_scores_gemma":[0.9719956,0.023771148,0.00006519326,0.00004742085,0.00015585672,0.0036787242,0.00019791823,0.000034789573,0.000053371987],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977841,0.00019983553,0.00025516603,0.0007843168,0.00034107958,0.00063551945],"domain_scores_gemma":[0.9984359,0.00029156508,0.00010089453,0.0004087087,0.00055621314,0.00020672676],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025292495,0.00038612707,0.0006506512,0.00018442184,0.00065921893,0.000032393946,0.0001480616,0.00011291934,0.000009611685],"category_scores_gemma":[0.000017209473,0.0002493615,0.00020805217,0.0005096228,0.0006006933,0.000016249842,0.00016923287,0.000105984844,5.780916e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013717919,0.0016216576,0.75573283,0.00033468264,0.021989781,0.00006139218,0.0013089466,0.00705204,0.017805759,0.0001500749,0.0001716405,0.18005328],"study_design_scores_gemma":[0.0060653966,0.0007816584,0.9540592,0.00019767105,0.0017265873,0.00019268741,0.0002620119,0.0018954969,0.03425358,0.00005820271,0.0001583399,0.00034916718],"about_ca_topic_score_codex":0.017006272,"about_ca_topic_score_gemma":0.0024353673,"teacher_disagreement_score":0.19832638,"about_ca_system_score_codex":0.00032564037,"about_ca_system_score_gemma":0.00028652977,"threshold_uncertainty_score":0.9999959},"labels":[],"label_agreement":null},{"id":"W2030812135","doi":"10.1007/s10549-007-9805-3","title":"JAG1 expression is associated with a basal phenotype and recurrence in lymph node-negative breast cancer","year":2007,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":147,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; SickKids Foundation; University Health Network; University of Toronto; Discovery Centre","funders":"","keywords":"Breast cancer; Lymph node; Phenotype; Medicine; Basal (medicine); Oncology; Cancer; Internal medicine; Biology; Pathology; Gene; Genetics","score_opus":0.026894653847062598,"score_gpt":0.34112431678307203,"score_spread":0.31422966293600946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030812135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952506,0.0032347895,0.000015356509,0.0003577615,0.000022712862,0.0002934168,0.00068419706,0.000008739549,0.00013245379],"genre_scores_gemma":[0.9981804,0.0010610609,0.00007003538,0.00006486266,0.00010897316,0.00020713624,0.000048040463,0.000022056185,0.00023745422],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99847716,0.00008830482,0.00014092529,0.0005100843,0.00029142434,0.0004920985],"domain_scores_gemma":[0.9992449,0.00006359089,0.00005289032,0.00018546874,0.00021130043,0.00024184892],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002188381,0.00019242847,0.0001700602,0.000089021836,0.00015511161,0.000042181302,0.00008893748,0.00009761803,0.00007138709],"category_scores_gemma":[0.000023291932,0.00014011613,0.000022773236,0.0001998802,0.0002476928,0.000010785131,0.00009049902,0.000091338996,0.0000016145596],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007322284,0.0010902331,0.85427636,0.000051117942,0.00033246327,0.00010335067,0.00080051227,0.000022169894,0.04670123,0.000008643843,0.00045379976,0.08883783],"study_design_scores_gemma":[0.0032357527,0.000319988,0.9188827,0.00045198124,0.0000207121,0.000022004162,0.00018392515,0.000024414747,0.07643081,0.00004898324,0.00016522032,0.00021348176],"about_ca_topic_score_codex":0.0039991788,"about_ca_topic_score_gemma":0.003276157,"teacher_disagreement_score":0.08862435,"about_ca_system_score_codex":0.00025556295,"about_ca_system_score_gemma":0.00041097024,"threshold_uncertainty_score":0.6045588},"labels":[],"label_agreement":null},{"id":"W2030865526","doi":"10.1007/s10549-011-1453-y","title":"Breast cancer scalp metastasis as first metastatic site after scalp cooling: Two cases of occurrence after 7- and 9-year follow-up","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; The Quebec Population Health Research Network; Hôpital du Saint-Sacrement","funders":"","keywords":"Scalp; Medicine; Breast cancer; Metastasis; Chemotherapy; Metastatic breast cancer; Cancer; Surgery; Internal medicine","score_opus":0.08529247172079103,"score_gpt":0.3766334539889901,"score_spread":0.2913409822681991,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030865526","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96977603,0.019888112,0.0000022152833,0.0012937505,0.00011535032,0.001221472,0.00745394,0.000028767476,0.00022033902],"genre_scores_gemma":[0.9788046,0.016722145,0.00017194617,0.00008602573,0.00012178097,0.0035599372,0.000048626105,0.0000436905,0.00044123243],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99707484,0.000116853575,0.00042130114,0.0008442203,0.0007280894,0.00081466814],"domain_scores_gemma":[0.997933,0.00020004256,0.000111690075,0.0005119697,0.00047395166,0.00076938217],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00023770826,0.00046614642,0.000815141,0.00033109123,0.0001998878,0.0000710213,0.00008902518,0.00006601077,0.0027605365],"category_scores_gemma":[0.000015446778,0.0003257988,0.00020131412,0.00044436063,0.00059332035,0.00019541243,0.00015239902,0.00019070537,0.0000404038],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022761485,0.0025709951,0.84435683,0.00045973255,0.0023205339,0.0016404653,0.001852025,0.0000014255731,0.00003909455,0.0000752786,0.000636766,0.123285376],"study_design_scores_gemma":[0.014450735,0.002661085,0.971724,0.0013670786,0.0019562899,0.0020687126,0.0004323082,0.000021181464,0.0029357271,0.00011017686,0.0018399237,0.00043281403],"about_ca_topic_score_codex":0.07294833,"about_ca_topic_score_gemma":0.02418664,"teacher_disagreement_score":0.12736714,"about_ca_system_score_codex":0.00059492985,"about_ca_system_score_gemma":0.0005210631,"threshold_uncertainty_score":0.9999194},"labels":[],"label_agreement":null},{"id":"W2030904903","doi":"10.1007/s10549-007-9500-4","title":"CYP1B1 and predisposition to breast cancer in Poland","year":2007,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Glutathione Transferases and Polymorphisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Haplotype; Breast cancer; CYP1B1; Single-nucleotide polymorphism; Genotype; Case-control study; Biology; Genetics; Cancer; Oncology; SNP; Internal medicine; Gene; Medicine; Cytochrome P450","score_opus":0.019012723710637936,"score_gpt":0.3436053615714442,"score_spread":0.3245926378608063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030904903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927172,0.003277873,0.000041582032,0.0025893732,0.0000372568,0.00034066124,0.0008468273,0.000004894029,0.00014430542],"genre_scores_gemma":[0.99545854,0.0037387984,0.000025118086,0.00008390963,0.00021436022,0.00013316423,0.000035785815,0.000013912293,0.000296433],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989727,0.00003241454,0.00011158966,0.00033106987,0.00014598695,0.00040622446],"domain_scores_gemma":[0.9995266,0.000012526045,0.000010172162,0.00012312747,0.000064091255,0.00026348254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017174435,0.00012666859,0.000110760666,0.000103615566,0.00010112528,0.000032691813,0.000044942244,0.000069584996,0.00005088255],"category_scores_gemma":[0.0000014289851,0.000100544305,0.000022278327,0.00012943616,0.00007572718,0.00000571517,0.000037524074,0.00006536549,0.000002504178],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056352657,0.000507049,0.38962317,0.00004166056,0.00015710009,0.00009685092,0.00047566247,0.000029034478,0.25990322,0.00018828738,0.00032822738,0.34301448],"study_design_scores_gemma":[0.0018452747,0.00069333095,0.9803224,0.00006554231,0.000012466995,0.00019157899,0.00009064114,0.000008681708,0.014631329,0.000037463666,0.001956535,0.00014473165],"about_ca_topic_score_codex":0.009087294,"about_ca_topic_score_gemma":0.0142956525,"teacher_disagreement_score":0.59069926,"about_ca_system_score_codex":0.000094172115,"about_ca_system_score_gemma":0.00009145796,"threshold_uncertainty_score":0.99751127},"labels":[],"label_agreement":null},{"id":"W2031260154","doi":"10.1007/s10549-006-9448-9","title":"Clinical and pathological correlations in male breast cancer: intratumoral aromatase expression via tissue microarray","year":2007,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Male Breast Health Studies","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Nova Scotia; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Tissue microarray; Breast cancer; Immunohistochemistry; Internal medicine; Lymphovascular invasion; Aromatase; Cancer; Pathology; Oncology; Estrogen receptor; Metastasis","score_opus":0.08044941361650544,"score_gpt":0.4548057215700024,"score_spread":0.37435630795349695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031260154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9827454,0.006108566,0.00003117864,0.008929064,0.00011349269,0.0011146571,0.0006257669,0.000033510136,0.00029835748],"genre_scores_gemma":[0.99141103,0.0063400837,0.000449814,0.00012175322,0.0004527034,0.0003645286,0.000051813815,0.000020973992,0.00078728545],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99749076,0.00018652611,0.0005141026,0.00063343777,0.00038204557,0.00079314027],"domain_scores_gemma":[0.99853194,0.00025861044,0.000071371745,0.00026846203,0.00017500782,0.0006945859],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092280505,0.00023996277,0.0005280136,0.00022727139,0.00028111335,0.000028210026,0.00006215094,0.00016378824,0.0003730491],"category_scores_gemma":[0.000027775635,0.00016705645,0.000041752133,0.0003147253,0.0005791883,0.000084121326,0.00012529292,0.000466969,0.000017866816],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002856494,0.00091655005,0.7809197,0.00008963938,0.00003405311,0.0009900654,0.00021795154,5.4991665e-7,0.0013594043,0.000028450584,0.00076821464,0.21181896],"study_design_scores_gemma":[0.0043389476,0.00077530596,0.98891693,0.00039443708,0.000034625642,0.0033460942,0.00024551354,0.000028502935,0.00029171756,0.000064836786,0.0014262304,0.00013682984],"about_ca_topic_score_codex":0.0072371573,"about_ca_topic_score_gemma":0.0043371096,"teacher_disagreement_score":0.21168213,"about_ca_system_score_codex":0.000495204,"about_ca_system_score_gemma":0.0003218389,"threshold_uncertainty_score":0.99937373},"labels":[],"label_agreement":null},{"id":"W2031705055","doi":"10.1007/s10549-014-2990-y","title":"Expression of membrane transporters and metabolic enzymes involved in estrone-3-sulphate disposition in human breast tumour tissues","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Breast cancer; Abcg2; Estrone; Biology; Stroma; Transporter; Efflux; Cancer research; Cancer; Cancer cell; Internal medicine; Hormone; Endocrinology; Medicine; Pathology; ATP-binding cassette transporter; Biochemistry; Immunohistochemistry; Gene","score_opus":0.025182883007751875,"score_gpt":0.3226950226792409,"score_spread":0.297512139671489,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031705055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995122,0.0033187808,0.000014237017,0.0007879912,0.000017802491,0.00053163513,0.00010367949,0.000013695033,0.00009015505],"genre_scores_gemma":[0.99672496,0.0026896088,0.000080265745,0.000008087093,0.000053057924,0.00016904373,0.00008083342,0.000019773328,0.00017438659],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998575,0.00008413553,0.00027530803,0.0003504888,0.00033971405,0.000375402],"domain_scores_gemma":[0.9995106,0.000026853937,0.000043418666,0.00015644927,0.000058917863,0.00020378345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029161532,0.00017980706,0.0004593921,0.00032471432,0.000073575364,0.000015286509,0.000048776554,0.000067668894,0.000049935174],"category_scores_gemma":[0.0000013546476,0.00012815723,0.00004200189,0.00022202333,0.00017431428,0.00010698978,0.000010951436,0.00013569887,5.837139e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043571945,0.0016660414,0.3997208,0.0005404563,0.00009949407,0.00022036256,0.0021456503,0.000011893666,0.54387087,0.0019403565,0.000006268464,0.045420617],"study_design_scores_gemma":[0.005559447,0.0003941172,0.7589702,0.0008682387,0.000046944668,0.000031106123,0.00041518145,0.000027622478,0.2333058,0.00020217733,0.00007539441,0.000103792656],"about_ca_topic_score_codex":0.0052646054,"about_ca_topic_score_gemma":0.006287405,"teacher_disagreement_score":0.35924938,"about_ca_system_score_codex":0.00009321066,"about_ca_system_score_gemma":0.000067802415,"threshold_uncertainty_score":0.7958544},"labels":[],"label_agreement":null},{"id":"W2032132964","doi":"10.1007/s10549-010-1259-3","title":"Role of CD200 expression in regulation of metastasis of EMT6 tumor cells in mice","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Inflammation biomarkers and pathways","field":"Immunology and Microbiology","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre; Toronto General Hospital; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Biology; Metastasis; Lymph; Cytotoxic T cell; Immune system; Cancer research; Ectopic expression; Nod; Tumor progression; Genetically modified mouse; Breast cancer; Mammary tumor; Immunology; Cell culture; Transgene; Cancer; Pathology; Endocrinology; Medicine; In vitro; Gene","score_opus":0.020645975451165748,"score_gpt":0.2931483030660704,"score_spread":0.27250232761490467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032132964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99819684,0.00079770345,6.2260233e-7,0.00004982753,0.000033592292,0.00023622457,0.00033787088,0.0000015985187,0.0003457459],"genre_scores_gemma":[0.999593,0.00013370615,0.000079468184,8.8919364e-7,0.0000058841324,0.0000434857,0.00003107734,0.0000038470525,0.00010860092],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99921644,0.00015506413,0.00027766134,0.00013491097,0.000058550082,0.00015737789],"domain_scores_gemma":[0.99955267,0.00008515691,0.000103207596,0.00013021666,0.00011336629,0.000015406576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003714959,0.00006724475,0.0002067627,0.00022419168,0.000024611592,0.0000021321289,0.000057713252,0.00006807776,0.0003707114],"category_scores_gemma":[0.0000082514725,0.00004930762,0.000029957451,0.00016271854,0.00016185356,0.000042584634,0.000027796987,0.000090204616,0.0000032512125],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009102691,0.00027683325,0.028330743,0.000027618258,0.000029922348,0.00000115572,0.00050727895,0.0000043369523,0.9473582,0.00018664691,0.000026542482,0.022340488],"study_design_scores_gemma":[0.0011421905,0.00012900755,0.24864696,0.00005438987,0.0000037834504,0.0000052030628,0.0002025297,0.0000057541297,0.74937487,0.00015172658,0.00025633228,0.000027265538],"about_ca_topic_score_codex":0.0041773194,"about_ca_topic_score_gemma":0.002436195,"teacher_disagreement_score":0.22031622,"about_ca_system_score_codex":0.000034348825,"about_ca_system_score_gemma":0.00009274613,"threshold_uncertainty_score":0.6314885},"labels":[],"label_agreement":null},{"id":"W2032304812","doi":"10.1023/b:brea.0000021048.52430.c0","title":"Selective Cytotoxicity of a Red Grape Wine Flavonoid Fraction Against MCF-7 Cells","year":2004,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Phytochemicals and Antioxidant Activities","field":"Medicine","cited_by":146,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"MCF-7; Flavonoid; Wine; Cytotoxicity; Naringenin; Cancer cell; Biochemistry; Polyphenol; Flavanone; Chemistry; Quercetin; Biology; Cancer; Food science; In vitro; Human breast; Antioxidant","score_opus":0.03569384585860146,"score_gpt":0.34103724005528224,"score_spread":0.3053433941966808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032304812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99618834,0.000405485,0.000020034322,0.0015160094,0.000018638686,0.0005334986,0.0001359822,0.000023214114,0.0011587905],"genre_scores_gemma":[0.9973839,0.0018070253,0.00009677229,0.00002831464,0.0002015027,0.00015816039,0.000017633009,0.000014618104,0.00029205842],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99891067,0.00003185486,0.00014689635,0.00027048343,0.00031851386,0.00032160865],"domain_scores_gemma":[0.9993603,0.000045069813,0.000049719685,0.00015158804,0.000213439,0.00017983346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008975434,0.00013743862,0.00029621914,0.00013716608,0.00011304918,0.000018235976,0.000033466746,0.000060657316,0.000027803117],"category_scores_gemma":[0.000008506528,0.000101375204,0.0000717989,0.00027045436,0.00018899387,0.00012476598,0.000024435558,0.00016216873,0.0000031458885],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018738653,0.0012400713,0.0039765756,0.000080346865,0.0002252953,0.000033029686,0.00012718796,0.000006843817,0.9840261,0.00005215425,0.00011467831,0.008243857],"study_design_scores_gemma":[0.003410836,0.0010597779,0.08015439,0.00024892233,0.000032291264,0.00003148662,0.00013232726,0.000010530582,0.91416156,0.0005119405,0.00016218208,0.00008375188],"about_ca_topic_score_codex":0.0018774465,"about_ca_topic_score_gemma":0.00007924667,"teacher_disagreement_score":0.07617781,"about_ca_system_score_codex":0.00053811807,"about_ca_system_score_gemma":0.00027772534,"threshold_uncertainty_score":0.4133961},"labels":[],"label_agreement":null},{"id":"W2032931935","doi":"10.1007/s10549-013-2534-x","title":"Association between sex hormones, glucose homeostasis, adipokines, and inflammatory markers and mammographic density among postmenopausal women","year":2013,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Digital Radiography and Breast Imaging","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; Alberta Cancer Foundation; University of British Columbia; Sunnybrook Hospital; University of British Columbia, Okanagan Campus; Ontario Institute for Cancer Research; University of Alberta; Dalhousie University","funders":"Canadian Institutes of Health Research","keywords":"Internal medicine; Endocrinology; Adiponectin; Estrone; Leptin; Adipokine; Body mass index; Breast cancer; Adipose tissue; Medicine; Waist; Sex hormone-binding globulin; Hormone; Obesity; Cancer; Insulin resistance","score_opus":0.013551181937667264,"score_gpt":0.2707518839931218,"score_spread":0.25720070205545453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032931935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99053526,0.0064680916,6.665089e-7,0.0015070892,0.000018013126,0.0009016379,0.00018018034,0.00005031009,0.00033872493],"genre_scores_gemma":[0.9918648,0.007030314,0.000024697487,0.00004091421,0.00013443144,0.00038125526,0.00005241186,0.000025925097,0.00044525467],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980283,0.00009518632,0.00020642103,0.00045237047,0.00049157604,0.00072614796],"domain_scores_gemma":[0.998637,0.00014917082,0.00007028341,0.00019039412,0.00021559888,0.0007375612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039113252,0.00025078104,0.00037763896,0.00042371103,0.00025780904,0.00024056238,0.000046647245,0.00010337217,0.000042229374],"category_scores_gemma":[0.000016226435,0.00019581422,0.00004243579,0.00037626654,0.00035492206,0.00041320187,0.00008803615,0.00020959649,0.0000049397736],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002654529,0.000121443605,0.70707107,0.00006031643,0.00076456653,0.000041894098,0.00016771548,2.080432e-8,0.00021412924,0.000011345547,0.00019080914,0.29109123],"study_design_scores_gemma":[0.0023940722,0.000951571,0.99463767,0.00010563772,0.00014359874,0.00015946434,0.00035969535,0.0000083629375,0.00024068309,0.00032451475,0.0005038851,0.00017084587],"about_ca_topic_score_codex":0.00490657,"about_ca_topic_score_gemma":0.00019866141,"teacher_disagreement_score":0.29092038,"about_ca_system_score_codex":0.00050666527,"about_ca_system_score_gemma":0.000116454685,"threshold_uncertainty_score":0.7985072},"labels":[],"label_agreement":null},{"id":"W2033334824","doi":"10.1007/s10549-014-3052-1","title":"Prevalence of women with early-stage breast cancer receiving active management using electronic health records from oncology clinics in the United States","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"Amgen","keywords":"Medicine; Breast cancer; Stage (stratigraphy); Internal medicine; Medical record; Triple-negative breast cancer; Oncology; Estrogen receptor; Cancer; Chemotherapy; Disease; Gynecology","score_opus":0.03378045138910681,"score_gpt":0.37574872362221473,"score_spread":0.34196827223310794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033334824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946393,0.001581106,0.000038603663,0.0018103542,0.000037832207,0.00070938235,0.0011139621,0.0000074988347,0.00006196512],"genre_scores_gemma":[0.9623331,0.03617884,0.00011677877,0.00015041245,0.0001288624,0.00088489335,0.000076965865,0.00002844961,0.00010173965],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972917,0.0005654566,0.00027024152,0.0006051943,0.00033248513,0.00093490916],"domain_scores_gemma":[0.9989603,0.00013862115,0.00017397405,0.00040042846,0.00017568089,0.00015096205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062123983,0.00026239955,0.0003527606,0.00014662232,0.00022225571,0.00002799098,0.00021786129,0.000075226104,0.00004125364],"category_scores_gemma":[0.0000057234306,0.0001710886,0.000036151258,0.00038270568,0.00030898376,0.000013364008,0.00013671466,0.00018823612,7.7707426e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0128621105,0.0015676856,0.66031337,0.000262486,0.002077158,0.00002232549,0.0065630195,0.00071541,0.00029050183,0.00013742218,0.00007125912,0.31511724],"study_design_scores_gemma":[0.0037183126,0.0029645017,0.98542595,0.00026402765,0.000069564645,0.000023337772,0.0032121495,0.00012161604,0.00038816957,0.00013878621,0.0034682036,0.0002053786],"about_ca_topic_score_codex":0.07941396,"about_ca_topic_score_gemma":0.01592528,"teacher_disagreement_score":0.32511258,"about_ca_system_score_codex":0.0020331487,"about_ca_system_score_gemma":0.0005891253,"threshold_uncertainty_score":0.9267163},"labels":[],"label_agreement":null},{"id":"W2033894890","doi":"10.1023/a:1010635328299","title":"Are medical oncologists biased in their treatment of the large woman with breast cancer?","year":2001,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Breast cancer; Medicine; Oncology; Cancer; Gynecology; Internal medicine","score_opus":0.08736655512268195,"score_gpt":0.4045667950867029,"score_spread":0.31720023996402097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033894890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9780186,0.0027831309,9.582628e-7,0.016789498,0.00005506251,0.0010133617,0.0010108744,0.00001942266,0.00030909776],"genre_scores_gemma":[0.98558766,0.012583419,0.0000035826704,0.000134471,0.00021115699,0.00077800447,0.000014096768,0.000025875182,0.0006617669],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99780923,0.00011969279,0.00024255502,0.00043039993,0.0007290409,0.0006690783],"domain_scores_gemma":[0.99878776,0.00010183473,0.00010831564,0.00040622219,0.00017455676,0.00042133254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001799216,0.0002609026,0.00053121604,0.00016569968,0.00016203968,0.000020624213,0.0001185458,0.000111860165,0.00078382815],"category_scores_gemma":[0.000009114325,0.00011816634,0.000099863624,0.00059457304,0.00041695155,0.000046996778,0.000051438583,0.00018372893,0.0000026406142],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041957293,0.0026045307,0.86421424,0.000032312906,0.00026768478,0.0004622363,0.00051512703,0.0000040716636,0.000045070887,0.00002062272,0.00017850884,0.12745984],"study_design_scores_gemma":[0.010777145,0.0016427833,0.9772052,0.00056956324,0.000056562872,0.00058002566,0.00075112743,0.000055213546,0.00038850182,0.000015028569,0.007845464,0.000113352275],"about_ca_topic_score_codex":0.05829697,"about_ca_topic_score_gemma":0.15621842,"teacher_disagreement_score":0.12734649,"about_ca_system_score_codex":0.0021144063,"about_ca_system_score_gemma":0.0012331808,"threshold_uncertainty_score":0.9479739},"labels":[],"label_agreement":null},{"id":"W2034401336","doi":"10.1007/s10549-004-4259-3","title":"Should oral bisphosphonates be standard of care in women with early breast cancer?","year":2005,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Bone health and treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Zoledronic acid; Breast cancer; Oncology; Adjuvant; Internal medicine; Cancer; Randomized controlled trial; Gynecology","score_opus":0.10254552758640122,"score_gpt":0.4515989075656492,"score_spread":0.34905337997924796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034401336","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01889228,0.96767384,6.266919e-8,0.0012584539,0.000044621498,0.0030528186,0.008842465,0.000029972241,0.00020547005],"genre_scores_gemma":[0.026542362,0.967467,0.00005423404,0.000039488707,0.0000973982,0.0046736295,0.00016718415,0.00010863227,0.00085004396],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959848,0.00017482102,0.0006122965,0.0008582369,0.0010404804,0.0013293975],"domain_scores_gemma":[0.9977658,0.00010847353,0.00019621683,0.0005195507,0.00047900784,0.000930991],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022909879,0.0006851928,0.0026967726,0.0005800176,0.00015437802,0.00004494994,0.00013990657,0.0003113206,0.00042456976],"category_scores_gemma":[0.0000041442886,0.0004098966,0.00015940407,0.0009115663,0.00034733486,0.0000982931,0.000080726364,0.0005936782,0.000008601035],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.012493935,0.00069087517,0.013555333,0.0076379846,0.0010650128,0.00039333166,0.00067287276,4.3964712e-7,7.852364e-8,0.000013639318,0.00008656038,0.96338993],"study_design_scores_gemma":[0.016288182,0.013642597,0.06660158,0.039014626,0.0012318735,0.0009524625,0.0005854404,7.855468e-7,0.000010445663,0.000011945375,0.8610232,0.0006368993],"about_ca_topic_score_codex":0.058726978,"about_ca_topic_score_gemma":0.02907436,"teacher_disagreement_score":0.96275306,"about_ca_system_score_codex":0.0068428568,"about_ca_system_score_gemma":0.00580278,"threshold_uncertainty_score":0.9998353},"labels":[],"label_agreement":null},{"id":"W2034849620","doi":"10.1007/s10549-014-3033-4","title":"Platinum-based chemotherapy in triple-negative advanced breast cancer","year":2014,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Health Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Chemotherapy; Metastatic breast cancer; Internal medicine; Oncology; Breast cancer; Triple-negative breast cancer; Cancer","score_opus":0.04969153023903283,"score_gpt":0.4083813426675538,"score_spread":0.358689812428521,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034849620","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014657533,0.99027044,0.0000054189095,0.001001917,0.0001669165,0.002301783,0.0045285346,0.000028390043,0.00023082278],"genre_scores_gemma":[0.006173539,0.98386025,0.000089370384,0.00008189381,0.0006898334,0.007780609,0.00044850897,0.0001535343,0.00072245894],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958887,0.00041921553,0.000580848,0.0014971457,0.00049992674,0.0011141625],"domain_scores_gemma":[0.9982234,0.00018445733,0.0002662462,0.0007171515,0.0002800883,0.00032863687],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000280932,0.0009706001,0.0018200732,0.0003765671,0.0002747587,0.00007727636,0.0003327442,0.00041875977,0.00017986665],"category_scores_gemma":[0.00001933165,0.00071000255,0.00037512448,0.0005887184,0.00046137432,0.000011838595,0.00016268525,0.00037494782,0.000019194758],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001437761,0.00059390214,0.0014023797,0.0013355946,0.001044486,0.000026656504,0.00006290366,0.000010487654,0.000014498931,0.000014273084,0.00048401835,0.993573],"study_design_scores_gemma":[0.018272184,0.0012903006,0.0152403815,0.011927699,0.0005685805,0.00024479456,0.00010862243,0.000015589701,0.00031714272,0.00007305728,0.950372,0.0015696926],"about_ca_topic_score_codex":0.005076647,"about_ca_topic_score_gemma":0.005559677,"teacher_disagreement_score":0.9920033,"about_ca_system_score_codex":0.0014294895,"about_ca_system_score_gemma":0.0015847397,"threshold_uncertainty_score":0.9995351},"labels":[],"label_agreement":null},{"id":"W2034897616","doi":"10.1007/s10549-013-2511-4","title":"CYP3A4 and seasonal variation in vitamin D status in addition to CYP2D6 contribute to therapeutic endoxifen level during tamoxifen therapy","year":2013,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":78,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"Ontario Institute for Cancer Research; Cancer Care Ontario","keywords":"Tamoxifen; CYP2D6; Breast cancer; Pharmacogenetics; Medicine; Oncology; Internal medicine; Pharmacogenomics; Pharmacology; CYP3A5; Selective estrogen receptor modulator; Genotype; Prospective cohort study; Cancer; Bioinformatics; Biology; Genetics; Cytochrome P450","score_opus":0.16394551591650738,"score_gpt":0.4609639978878481,"score_spread":0.29701848197134073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034897616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98843765,0.0024597587,0.0000130284825,0.005373416,0.00012314986,0.0022265501,0.0012287496,0.000015111769,0.00012258878],"genre_scores_gemma":[0.9888468,0.006920136,0.000064418615,0.0006548752,0.0001948237,0.002981123,0.00003283149,0.00002185006,0.00028315416],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9976583,0.0005020961,0.00025790642,0.0004565635,0.00026929632,0.0008558337],"domain_scores_gemma":[0.99881256,0.00024135549,0.000038846683,0.00012792794,0.00016150306,0.000617781],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054106745,0.00022360092,0.0002765485,0.00036920854,0.00018094118,0.00007224624,0.0000991917,0.00011967626,0.00078762847],"category_scores_gemma":[0.000017932423,0.00018877789,0.000027445078,0.0004071285,0.000076512675,0.00013703658,0.00008658259,0.0003102395,0.000052177333],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003839233,0.0011592876,0.14482532,0.000028917011,0.00029172833,0.00008186488,0.004479188,0.00035033945,0.23540348,0.00027184898,0.0003444337,0.6089243],"study_design_scores_gemma":[0.007947214,0.00029859034,0.96698785,0.00003155367,0.000016327405,0.000021321524,0.00010281576,0.00052645203,0.01642065,0.000548832,0.00689976,0.00019865736],"about_ca_topic_score_codex":0.0045575546,"about_ca_topic_score_gemma":0.001431144,"teacher_disagreement_score":0.8221625,"about_ca_system_score_codex":0.000479439,"about_ca_system_score_gemma":0.00019365849,"threshold_uncertainty_score":0.8623979},"labels":[],"label_agreement":null},{"id":"W2035182098","doi":"10.1007/s10549-007-9869-0","title":"Familial association of laryngeal, lung, stomach and early-onset breast cancer","year":2007,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Larynx; Cancer; Stomach; Stomach cancer; Incidence (geometry); Lung cancer; Internal medicine; Population; Mammary gland; Laryngeal Neoplasm; Oncology; Gastroenterology; Surgery","score_opus":0.020202317185290003,"score_gpt":0.35458650552474436,"score_spread":0.3343841883394544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035182098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99144334,0.0054500555,0.000021039954,0.0010696901,0.00009292975,0.00034239478,0.0013337462,0.000007629212,0.00023915239],"genre_scores_gemma":[0.992211,0.005815194,0.00006661787,0.000033311186,0.00032625717,0.00018271916,0.000044826797,0.000021438864,0.0012986661],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985801,0.00007536444,0.00018816549,0.00038449134,0.00033900447,0.00043285676],"domain_scores_gemma":[0.9991594,0.000042825654,0.00008091581,0.00020645116,0.0003436857,0.00016674493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043039594,0.00015042633,0.00017196112,0.00010661383,0.00015747461,0.00003168977,0.00008365011,0.00013791688,0.000055926677],"category_scores_gemma":[0.000011554483,0.00013083895,0.000043089105,0.0001742673,0.00016879663,0.000009106765,0.0000877769,0.000099050514,0.0000014399743],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001021543,0.00021213556,0.90349734,0.00003820803,0.0004297273,0.000007407411,0.00022579831,0.000007936908,0.020482756,0.000021072769,0.002985207,0.07107089],"study_design_scores_gemma":[0.0017503328,0.00036366016,0.97117406,0.000033547487,0.00004593913,0.00005101252,0.00012337964,0.000015019799,0.02279404,0.000037429483,0.0034735887,0.00013800742],"about_ca_topic_score_codex":0.007173211,"about_ca_topic_score_gemma":0.0050030323,"teacher_disagreement_score":0.07093288,"about_ca_system_score_codex":0.00065797404,"about_ca_system_score_gemma":0.00041891562,"threshold_uncertainty_score":0.9994381},"labels":[],"label_agreement":null},{"id":"W2035431183","doi":"10.1007/s10549-009-0557-0","title":"Learning to predict relapse in invasive ductal carcinomas based on the subcellular localization of junctional proteins","year":2009,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Machine Learning in Bioinformatics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Athabasca University; University of Saskatchewan; University of Alberta","funders":"","keywords":"Classifier (UML); Breast cancer; Subcellular localization; Decision tree; Machine learning; PTEN; Artificial intelligence; Biology; Decision tree learning; Bioinformatics; Computer science; Cancer; Cytoplasm; Signal transduction; PI3K/AKT/mTOR pathway","score_opus":0.018101540308751243,"score_gpt":0.2895833958624085,"score_spread":0.2714818555536573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035431183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99633795,0.00012052626,0.00030633557,0.0020648784,0.000014294802,0.00058380474,0.000027130318,0.000004577292,0.00054051983],"genre_scores_gemma":[0.9992342,0.00008707085,0.00009472755,0.00007838695,0.000059163285,0.0001175007,0.00006502631,0.0000069026814,0.0002570191],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991414,0.00012534212,0.00012566599,0.00017138316,0.00024697106,0.00018926352],"domain_scores_gemma":[0.9996017,0.00003211666,0.000034642228,0.00015672074,0.00010360069,0.000071170194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024245527,0.00009176647,0.00008268422,0.00009209559,0.000107718064,0.000016404874,0.00006837752,0.000049412472,0.000026160717],"category_scores_gemma":[0.00009206852,0.00006114888,0.000025055793,0.00016725755,0.00006512591,0.0000033196143,0.000027755734,0.00011836706,0.0000026371686],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055841305,0.0015091189,0.73979616,0.00012491981,0.00015125866,0.000047953094,0.0015657527,0.14487348,0.07037723,0.00091134885,0.0010359444,0.034022696],"study_design_scores_gemma":[0.0053999047,0.023479814,0.7776491,0.00043533513,0.000030507577,0.0000693127,0.0008526922,0.045648463,0.13930453,0.00021244689,0.0064752544,0.00044264793],"about_ca_topic_score_codex":0.00046430057,"about_ca_topic_score_gemma":0.00024013298,"teacher_disagreement_score":0.099225014,"about_ca_system_score_codex":0.00009567605,"about_ca_system_score_gemma":0.00020300134,"threshold_uncertainty_score":0.24935788},"labels":[],"label_agreement":null},{"id":"W2035520465","doi":"10.1007/s10549-007-9727-0","title":"Lymphedema in women with breast cancer: characteristics of patients screened for a randomized trial","year":2007,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Lymphatic System and Diseases","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Population Health Research Institute; Western University; Sunnybrook Health Science Centre; Juravinski Cancer Centre; University of Toronto; Ottawa Regional Cancer Foundation; Ontario Clinical Oncology Group; McMaster University","funders":"","keywords":"Breast cancer; Lymphedema; Medicine; Randomized controlled trial; Oncology; Internal medicine; Cancer; Gynecology","score_opus":0.030042860662349118,"score_gpt":0.35358589370514637,"score_spread":0.32354303304279725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035520465","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928213,0.0005231595,0.000019624596,0.00046662206,0.000052016298,0.0046520904,0.0013105934,0.000011502783,0.00014312749],"genre_scores_gemma":[0.995304,0.0005553536,0.000043885477,0.00004009388,0.00024632868,0.0035096412,0.00005238991,0.000022603179,0.00022571915],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9981046,0.00009650931,0.00042944727,0.000300537,0.0005082684,0.0005606364],"domain_scores_gemma":[0.9984389,0.0003850423,0.0001242597,0.00019066618,0.00046542022,0.00039572973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071094214,0.00018096027,0.0008335309,0.00022707693,0.00007318849,0.000020397,0.000051891788,0.000056806843,0.00010967081],"category_scores_gemma":[0.0000470189,0.000107018146,0.000071705574,0.00024378124,0.00022718622,0.000055256576,0.000021457552,0.00001263233,0.0000010162381],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.75661767,0.0015919062,0.14078388,0.00018853098,0.00034318664,0.000021353,0.00029373378,1.7193446e-7,0.000017596554,0.000030741896,0.000023040144,0.10008822],"study_design_scores_gemma":[0.56847346,0.0014425939,0.42922956,0.0003430841,0.000088128625,0.000013978918,0.00019436704,0.0000105735935,0.0000680503,0.000022598528,0.000043938293,0.00006967517],"about_ca_topic_score_codex":0.0052776486,"about_ca_topic_score_gemma":0.00045625572,"teacher_disagreement_score":0.28844568,"about_ca_system_score_codex":0.0010019212,"about_ca_system_score_gemma":0.0008659934,"threshold_uncertainty_score":0.7978261},"labels":[],"label_agreement":null},{"id":"W2035582761","doi":"10.1023/a:1020820103126","title":"Satisfaction and Anxiety for Women During Investigation of an Abnormal Screening Mammogram","year":2002,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Island Health; Vancouver Hospital and Health Sciences Centre; University of British Columbia; Providence Health Care; BC Cancer Agency","funders":"","keywords":"Anxiety; Medicine; Referral; Patient satisfaction; Mammography; Breast cancer; Family medicine; Physical therapy; Psychiatry; Cancer; Nursing; Internal medicine","score_opus":0.12926372579539006,"score_gpt":0.3800738350420897,"score_spread":0.25081010924669966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035582761","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99794513,0.000792918,0.000018550378,0.0005385618,0.000012009831,0.0005019016,0.00008126915,0.000018122073,0.00009152412],"genre_scores_gemma":[0.9971494,0.0012871742,0.0007042285,0.000019599831,0.000117732925,0.0004941794,0.000010732134,0.000010470851,0.0002064818],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989761,0.00003223923,0.0001343896,0.00024251099,0.0002766215,0.00033813622],"domain_scores_gemma":[0.9993654,0.000025386586,0.00003745505,0.00011673749,0.00015325741,0.00030178743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019585046,0.000098155564,0.00017013629,0.00010883428,0.00019237793,0.00003170275,0.00002051539,0.000046004974,0.000077917364],"category_scores_gemma":[0.0000082554325,0.00007939041,0.000023854363,0.00015218976,0.00013587065,0.00021094296,0.000020233912,0.000075313896,5.295723e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011621672,0.000042444728,0.6041156,0.0000997586,0.000075651114,0.000007863356,0.00071602396,0.0000066062616,0.0026154506,0.000037160735,0.000022072292,0.3910992],"study_design_scores_gemma":[0.002847099,0.0015565365,0.98994404,0.00013172484,0.000023734738,0.00021264468,0.0007584815,0.0007279169,0.0034230705,0.00013077965,0.00017325787,0.00007072391],"about_ca_topic_score_codex":0.004105531,"about_ca_topic_score_gemma":0.00064630527,"teacher_disagreement_score":0.39102846,"about_ca_system_score_codex":0.00027331026,"about_ca_system_score_gemma":0.000043442335,"threshold_uncertainty_score":0.6206362},"labels":[],"label_agreement":null},{"id":"W2035680293","doi":"10.1023/a:1025476722493","title":"Necrosis and Hypoxia in Invasive Breast Carcinoma","year":2003,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":112,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Manitoba","funders":"Medical Research and Materiel Command; Canadian Institutes of Health Research; Bayer Corporation","keywords":"Hypoxia (environmental); Necrosis; Stromal cell; Pathology; Biology; Breast cancer; Ductal carcinoma; Immunohistochemistry; Tumor hypoxia; Cancer research; Medicine; Internal medicine; Cancer; Chemistry","score_opus":0.029285284114546187,"score_gpt":0.30727222591627046,"score_spread":0.2779869418017243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035680293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9811352,0.0169347,0.0000017578711,0.00039504273,0.00011651948,0.00034855327,0.00024487416,0.0000046095292,0.0008187553],"genre_scores_gemma":[0.9809713,0.017104333,0.000048174817,0.000052349536,0.0003130633,0.00029386196,0.000027357351,0.000020579231,0.0011689946],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986029,0.00011587225,0.00013275632,0.00048870605,0.00017136474,0.0004883525],"domain_scores_gemma":[0.99935263,0.000023165954,0.000025292917,0.00024156935,0.00010437719,0.0002529808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017214364,0.00018072459,0.00019575613,0.00010840299,0.00013313828,0.00005397335,0.000067307614,0.00009556414,0.000048675414],"category_scores_gemma":[0.000016889207,0.00015012792,0.000040527615,0.00016153922,0.00020857705,0.00000794974,0.00006658127,0.00009248592,0.0000036420627],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002014235,0.0010525358,0.38653737,0.00010463925,0.00035277507,0.000059282862,0.00079262437,0.000009792663,0.32818595,0.001106269,0.0035056246,0.2762789],"study_design_scores_gemma":[0.0055359486,0.0006910792,0.89048743,0.000054163913,0.000034126744,0.00070174003,0.00040482724,0.0000037549498,0.04372216,0.00040103128,0.057613067,0.000350642],"about_ca_topic_score_codex":0.005103232,"about_ca_topic_score_gemma":0.0060621495,"teacher_disagreement_score":0.5039501,"about_ca_system_score_codex":0.000097230455,"about_ca_system_score_gemma":0.00038327216,"threshold_uncertainty_score":0.7714594},"labels":[],"label_agreement":null},{"id":"W2035758649","doi":"10.1007/s10549-010-0863-6","title":"Meta-analysis of two ERCC2 (XPD) polymorphisms, Asp312Asn and Lys751Gln, in breast cancer","year":2010,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Hospital for Sick Children; Princess Margaret Cancer Centre; Ministry of the Environment, Conservation and Parks; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"ERCC2; Breast cancer; Oncology; Genotype; Medicine; Biology; Genetics; Internal medicine; Cancer; Gene; Single-nucleotide polymorphism","score_opus":0.13125206721973165,"score_gpt":0.42374773907280827,"score_spread":0.2924956718530766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035758649","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004620764,0.98806554,0.0000023904283,0.00028499644,0.000050404436,0.0009308876,0.0059373947,0.000008210834,0.00009942926],"genre_scores_gemma":[0.007185551,0.9890243,0.0000881291,0.000020966629,0.00015629783,0.0018594654,0.00038272003,0.000067172296,0.0012154136],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967301,0.0004112685,0.00057290174,0.0011353381,0.00048175565,0.0006686549],"domain_scores_gemma":[0.99828506,0.000072950446,0.00024274904,0.0008346829,0.00022632127,0.00033826666],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005831796,0.00058876973,0.0025999127,0.0007086926,0.00009975136,0.000060490263,0.00029352165,0.00040679757,0.00045964806],"category_scores_gemma":[0.000007924305,0.00040213176,0.0009768232,0.0008140611,0.0003148228,0.000008599528,0.00031276117,0.00035653665,0.000003367255],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019980257,0.00050522265,0.00074414816,0.00083083543,0.11420879,0.000057401827,0.000040553306,0.0000033975139,0.0011451839,0.0001540753,0.00008514295,0.8820255],"study_design_scores_gemma":[0.0041471217,0.0012205362,0.0037317895,0.0013257056,0.38718167,0.000850482,0.0000637911,0.000039088736,0.002775749,0.00019653297,0.5964765,0.001991005],"about_ca_topic_score_codex":0.01589622,"about_ca_topic_score_gemma":0.0140024675,"teacher_disagreement_score":0.88003445,"about_ca_system_score_codex":0.00021852576,"about_ca_system_score_gemma":0.0008330632,"threshold_uncertainty_score":0.99984306},"labels":[],"label_agreement":null},{"id":"W2035903801","doi":"10.1007/s10549-007-9887-y","title":"New cutpoints to identify increased HER2 copy number: analysis of a large, population-based cohort with long-term follow-up","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Canadian Breast Cancer Research Alliance; Sanofi; Breast Cancer Alliance","keywords":"Breast cancer; Immunohistochemistry; Internal medicine; Oncology; Fluorescence in situ hybridization; Population; Cancer; Medicine; Cohort; Trastuzumab; Fish <Actinopterygii>; Pathology; Biology; Gene; Genetics","score_opus":0.05632076209097779,"score_gpt":0.43925768052665604,"score_spread":0.38293691843567823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035903801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99536276,0.00036570325,0.00017901548,0.0012902144,0.00003582804,0.0017634113,0.00057235576,0.00004128481,0.00038943553],"genre_scores_gemma":[0.9951441,0.0005390083,0.00039282948,0.0000968208,0.00012666178,0.0006201213,0.00039722107,0.000051638366,0.0026315914],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99592924,0.00019620471,0.0003914387,0.0007373308,0.0018745053,0.0008712536],"domain_scores_gemma":[0.9970303,0.00018866395,0.00008117336,0.00073857716,0.0007313478,0.0012299345],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00048812092,0.00029255054,0.0008348611,0.0008493446,0.0002773301,0.000049590853,0.0001708639,0.000101429825,0.0028975164],"category_scores_gemma":[0.000048102298,0.00021712316,0.00018952509,0.002642064,0.00015868443,0.00008817285,0.00007506814,0.0002352664,0.00005573132],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006066364,0.00074681366,0.97977835,0.00010138272,0.0032535095,0.0004868909,0.00020603486,0.000023311479,0.00016357252,0.000016092532,0.00118118,0.0079765245],"study_design_scores_gemma":[0.007433429,0.0011437131,0.9879902,0.00031665928,0.00081980973,0.0001069598,0.000033592696,0.00008769151,0.0016649592,0.0000068643285,0.00021729432,0.00017884815],"about_ca_topic_score_codex":0.13935672,"about_ca_topic_score_gemma":0.030685391,"teacher_disagreement_score":0.10867132,"about_ca_system_score_codex":0.0014743191,"about_ca_system_score_gemma":0.0022494777,"threshold_uncertainty_score":0.998014},"labels":[],"label_agreement":null},{"id":"W2035948281","doi":"10.1007/s10549-008-9895-6","title":"Polymorphisms in folate metabolizing enzymes and transport proteins and the risk of breast cancer","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; University Health Network; Women's College Hospital; University of Toronto","funders":"","keywords":"MTRR; Breast cancer; Methylenetetrahydrofolate reductase; Single-nucleotide polymorphism; Genotype; Case-control study; Biology; Genetics; Cancer; Internal medicine; Medicine; Oncology; Gene; Bioinformatics; Physiology","score_opus":0.045041733796689756,"score_gpt":0.3396557810745558,"score_spread":0.29461404727786605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035948281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9560207,0.038044505,0.0000012715614,0.0041053724,0.000012370848,0.0012058546,0.0004169308,0.000009569822,0.00018341452],"genre_scores_gemma":[0.89745665,0.101160035,0.00003064679,0.000018727213,0.00007844969,0.00051177666,0.0000056150725,0.000019191728,0.0007189129],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981891,0.0001683405,0.00023767246,0.0003738923,0.0005183314,0.0005126891],"domain_scores_gemma":[0.9991854,0.000118305616,0.000046516703,0.00022552891,0.0001594793,0.00026477416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050246296,0.00018884265,0.0004759007,0.0002610504,0.0002663774,0.000017430795,0.000064666994,0.0000700155,0.000096424024],"category_scores_gemma":[0.000010474478,0.00010221772,0.00006081252,0.00038091277,0.0010219618,0.00010362671,0.000052270592,0.00029235796,0.0000011718835],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007344603,0.0004539646,0.8805862,0.00009938935,0.00061822933,0.00024940193,0.0020317459,0.000001470842,0.002051264,0.0003285154,0.000028996013,0.10620619],"study_design_scores_gemma":[0.009934846,0.00048704655,0.98527366,0.00019450433,0.00011480643,0.0007251935,0.0001895936,0.0000937268,0.0025183433,0.00010656981,0.00026725593,0.00009443824],"about_ca_topic_score_codex":0.10557328,"about_ca_topic_score_gemma":0.0063547655,"teacher_disagreement_score":0.10611176,"about_ca_system_score_codex":0.00013454187,"about_ca_system_score_gemma":0.0004083786,"threshold_uncertainty_score":0.90038276},"labels":[],"label_agreement":null},{"id":"W2036335583","doi":"10.1023/a:1006320122711","title":"Liarozole fumarate (R85246): a novel imidazole in the treatment of receptor positive postmenopausal metastatic breast cancer","year":2000,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation; Princess Margaret Cancer Centre; Alberta Cancer Foundation; Toronto General Hospital","funders":"","keywords":"Metastatic breast cancer; Medicine; Breast cancer; Oncology; Internal medicine; Cancer; Postmenopausal women; Estrogen receptor; Cancer research","score_opus":0.06413388611206063,"score_gpt":0.41164285071278633,"score_spread":0.3475089646007257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036335583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9709468,0.0075733704,5.268965e-7,0.0137025695,0.00007861857,0.0022029616,0.004148801,0.000021456997,0.0013249326],"genre_scores_gemma":[0.9637543,0.029488593,0.00005467503,0.00019760632,0.0002940404,0.0025576444,0.00014777387,0.000039107676,0.0034662765],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9974881,0.00022753216,0.00037551275,0.0005752255,0.00053070456,0.0008029699],"domain_scores_gemma":[0.9988043,0.00025644113,0.000077254845,0.00034694848,0.00020836585,0.00030669337],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020894896,0.0003997664,0.00065563933,0.00025948064,0.00020870053,0.000042384454,0.00012402731,0.000076588854,0.0044422583],"category_scores_gemma":[0.000001623061,0.0002359957,0.0001312837,0.00062030554,0.0003792995,0.0001171453,0.000020116784,0.00017711619,0.000047208876],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.042255558,0.040341064,0.06427204,0.00017577123,0.004445504,0.0007459644,0.011672338,0.000081689024,0.022911977,0.0002238531,0.0019454497,0.81092876],"study_design_scores_gemma":[0.04148285,0.023073917,0.8958871,0.0006326445,0.0014848686,0.0017509152,0.001418559,0.00026130467,0.011089277,0.0001011302,0.022223571,0.00059389655],"about_ca_topic_score_codex":0.042761758,"about_ca_topic_score_gemma":0.004836309,"teacher_disagreement_score":0.83161503,"about_ca_system_score_codex":0.001629246,"about_ca_system_score_gemma":0.00070710166,"threshold_uncertainty_score":0.9964678},"labels":[],"label_agreement":null},{"id":"W2036650093","doi":"10.1007/s10549-014-3015-6","title":"Randomised, phase II, placebo-controlled, trial of fulvestrant plus vandetanib in postmenopausal women with bone only or bone predominant, hormone-receptor-positive metastatic breast cancer (MBC): the OCOG ZAMBONEY study","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Bone health and treatments","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nova Scotia Cancer Centre; Queen Elizabeth II Health Sciences Centre; Centre Hospitalier de l’Université de Montréal; University of Toronto; Sunnybrook Health Science Centre; Grand River Hospital; McMaster University; Ontario Clinical Oncology Group; Princess Margaret Cancer Centre; BC Cancer Agency; Ottawa Hospital; University of Ottawa","funders":"AstraZeneca","keywords":"Medicine; Vandetanib; Internal medicine; Fulvestrant; Breast cancer; Placebo; Oncology; Metastatic breast cancer; Gastroenterology; Cancer; Endocrinology; Estrogen receptor; Pathology; Receptor","score_opus":0.030848549326914144,"score_gpt":0.3687571923549521,"score_spread":0.3379086430280379,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036650093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97123367,0.0022790565,0.0000056318268,0.0024860406,0.00008911039,0.022395814,0.0012946908,0.00002872838,0.00018729168],"genre_scores_gemma":[0.97898304,0.0019211675,0.00005197904,0.000068042085,0.00017162801,0.016978571,0.000052376537,0.00007023202,0.0017029755],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9945909,0.00092437654,0.000979444,0.0008757749,0.0012469352,0.0013825622],"domain_scores_gemma":[0.99698424,0.0007801311,0.00033384628,0.0006001235,0.00040923516,0.000892443],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016322398,0.00064089155,0.0021269487,0.00040093355,0.0005198268,0.00006321653,0.00014231614,0.00010114737,0.00035622274],"category_scores_gemma":[0.00004480376,0.0003128389,0.00012482873,0.0006407858,0.000489082,0.00016561325,0.00008312483,0.00043306404,0.000007767188],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9034288,0.022192258,0.0019023296,0.00009012783,0.0028222974,0.0006886205,0.003374116,0.0000088979095,0.0003549145,0.0000141962855,0.000084966414,0.065038465],"study_design_scores_gemma":[0.8909003,0.08985581,0.014342422,0.00032246852,0.0010162833,0.0009136168,0.0020046462,0.00016415588,0.00010751925,0.000018688286,0.0000882772,0.00026577295],"about_ca_topic_score_codex":0.024694035,"about_ca_topic_score_gemma":0.011068838,"teacher_disagreement_score":0.06766356,"about_ca_system_score_codex":0.0018631512,"about_ca_system_score_gemma":0.0031243484,"threshold_uncertainty_score":0.99993235},"labels":[],"label_agreement":null},{"id":"W2036971299","doi":"10.1007/s10549-006-9181-4","title":"Prognostic significance of circulating tumour cells enumerated after filtration enrichment in early and metastatic breast cancer patients","year":2006,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; Health Sciences Centre","funders":"","keywords":"Breast cancer; Medicine; Oncology; Cancer; Internal medicine; Metastatic breast cancer; Mammary gland; Pathology; Cancer research","score_opus":0.027501155498999393,"score_gpt":0.3145756197281938,"score_spread":0.2870744642291944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036971299","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942542,0.0028201165,0.000007760674,0.00041503916,0.00004304825,0.0014776941,0.00089319295,0.000011018717,0.00007796431],"genre_scores_gemma":[0.99716014,0.0010702544,0.00013033567,0.000018337112,0.00008402246,0.0012536356,0.00004731095,0.000025063477,0.0002108972],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99809134,0.000111429246,0.00036775938,0.0004531459,0.0005007662,0.0004755521],"domain_scores_gemma":[0.99915355,0.00008575829,0.00009991178,0.00014678792,0.0003212126,0.00019278727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018608116,0.0002194168,0.00039671556,0.00022654845,0.00007885256,0.0000471103,0.000036363515,0.000040395473,0.0001557658],"category_scores_gemma":[0.000005625427,0.00016959767,0.000047743073,0.00043588656,0.0001481721,0.000112007656,0.000030396808,0.00013329687,0.0000023334155],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016242831,0.0016988339,0.91392726,0.0003421913,0.00017675335,0.00009948897,0.00042657155,0.00005108122,0.027476002,0.000017734288,0.00004591948,0.05411389],"study_design_scores_gemma":[0.003997582,0.00062773994,0.9840515,0.00038122,0.00014400721,0.000029492168,0.00007000527,0.000084318424,0.010354376,0.000041889492,0.00007868649,0.00013915378],"about_ca_topic_score_codex":0.04533471,"about_ca_topic_score_gemma":0.0035171153,"teacher_disagreement_score":0.07012428,"about_ca_system_score_codex":0.00052361406,"about_ca_system_score_gemma":0.00033130325,"threshold_uncertainty_score":0.9610225},"labels":[],"label_agreement":null},{"id":"W2037273883","doi":"10.1007/s10549-010-0889-9","title":"Interactions between breast cancer cells and bone marrow derived cells in vitro define a role for osteopontin in affecting breast cancer cell migration","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Bone and Dental Protein Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Osteopontin; Homing (biology); Cancer research; Bone marrow; Breast cancer; Bone metastasis; Tumor microenvironment; Cancer cell; Cancer; In vitro; Chemistry; Medicine; Biology; Pathology; Immunology; Internal medicine; Biochemistry","score_opus":0.027739022219463717,"score_gpt":0.3390864961475258,"score_spread":0.31134747392806206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037273883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98701525,0.0036744291,0.0000028081906,0.0046585253,0.00012394419,0.0019053294,0.0024260792,0.000023577588,0.00017004543],"genre_scores_gemma":[0.99327934,0.0030237737,0.00017566592,0.00004128485,0.00040137046,0.0023201224,0.000050210714,0.000041620693,0.00066660246],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99803674,0.00006990221,0.00033326627,0.00058265514,0.0002950509,0.0006823921],"domain_scores_gemma":[0.99901253,0.00020305852,0.0000929873,0.00020261742,0.00020606717,0.0002827507],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027713476,0.00030014545,0.00053964165,0.00026068932,0.00025078066,0.00007608551,0.000054587872,0.00011309911,0.00014348146],"category_scores_gemma":[0.0000056387175,0.00024093622,0.00007703303,0.00030855046,0.00016657345,0.0002123508,0.000097778284,0.0004015604,0.0000046592336],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033831308,0.00063475384,0.19361953,0.00020136975,0.00013250134,0.00003827656,0.0009288103,0.0000032180578,0.68072057,0.0000027157114,0.00014013506,0.12019501],"study_design_scores_gemma":[0.008272445,0.00035924904,0.72032434,0.00046165395,0.00013889532,0.00019085639,0.0018152704,0.00016353682,0.26737076,0.000055988447,0.00056302396,0.00028397466],"about_ca_topic_score_codex":0.20474395,"about_ca_topic_score_gemma":0.29991263,"teacher_disagreement_score":0.5267048,"about_ca_system_score_codex":0.00070006325,"about_ca_system_score_gemma":0.00022933338,"threshold_uncertainty_score":0.9825094},"labels":[],"label_agreement":null},{"id":"W2037503359","doi":"10.1007/s10549-015-3271-0","title":"Meta-analyses of etiologic studies should account for the underlying biologic mechanisms","year":2015,"lang":"en","type":"letter","venue":"Breast Cancer Research and Treatment","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services","funders":"","keywords":"Breast cancer; Medicine; MEDLINE; Biology; Bioinformatics; Computational biology; Internal medicine; Cancer","score_opus":0.8604205539923171,"score_gpt":0.5845997363599873,"score_spread":0.2758208176323298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037503359","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0040559596,0.22698735,0.00012906066,0.7606869,0.0003109901,0.00400707,0.0036599108,0.000044915305,0.000117854215],"genre_scores_gemma":[0.6265614,0.20943685,0.0008229125,0.11704557,0.005552313,0.02305796,0.0012181465,0.0002691021,0.016035724],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99758434,0.00016545322,0.00036197217,0.00058101624,0.00071356853,0.0005936401],"domain_scores_gemma":[0.9972195,0.0010514762,0.00018363881,0.0005079638,0.00092817156,0.000109270535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077454356,0.0004069107,0.0014477585,0.00023242843,0.00025214936,0.00004188058,0.00017264648,0.00033173917,0.00017677495],"category_scores_gemma":[0.000058720423,0.00016323735,0.0005191421,0.00022917007,0.0005346851,0.000033804357,0.00011046437,0.0005883824,0.0000032497119],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029131332,0.0004688836,0.0006920413,0.0010760155,0.15300749,0.00026359348,0.00067558617,0.00003162234,0.0009844189,0.00031098977,0.78647935,0.053096853],"study_design_scores_gemma":[0.00834727,0.013833638,0.004366851,0.00049205613,0.072985195,0.00035994902,0.0044025574,0.000080693106,0.0024437942,0.02200662,0.8697228,0.00095858355],"about_ca_topic_score_codex":0.008631639,"about_ca_topic_score_gemma":0.00061865186,"teacher_disagreement_score":0.64364135,"about_ca_system_score_codex":0.0008716316,"about_ca_system_score_gemma":0.00059803727,"threshold_uncertainty_score":0.99797},"labels":[],"label_agreement":null},{"id":"W2037750236","doi":"10.1007/s10549-013-2727-3","title":"Preference weights for chemotherapy side effects from the perspective of women with breast cancer","year":2013,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":99,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Ottawa Hospital; Royal Victoria Hospital; University of Ottawa","funders":"","keywords":"Nausea; Breast cancer; Medicine; Vomiting; Chemotherapy; Side effect (computer science); Quality of life (healthcare); Cancer; Internal medicine; Oncology; Surgery","score_opus":0.24794265711861302,"score_gpt":0.4349916345598271,"score_spread":0.18704897744121407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037750236","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92751724,0.0043403087,0.000080362704,0.062043164,0.000065427295,0.002664397,0.0028543596,0.00001445246,0.00042031414],"genre_scores_gemma":[0.9893495,0.001779285,0.00025973428,0.00074294617,0.00034452384,0.0071052974,0.000011655248,0.00002622858,0.00038086032],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978573,0.00017806736,0.00067599915,0.0005447547,0.00013735166,0.0006065817],"domain_scores_gemma":[0.99724984,0.0013794247,0.0004031552,0.00038225667,0.00033247797,0.00025286418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016135888,0.00018984446,0.0006220247,0.00011165221,0.00026302622,0.00009190312,0.00019249019,0.00006579144,0.00055176613],"category_scores_gemma":[0.000072632094,0.00012953389,0.000048822727,0.00015974739,0.00022836606,0.0002511286,0.0000297293,0.00010293188,0.00006522791],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004464088,0.0021329867,0.6962696,0.00091144704,0.004879219,0.0000032986063,0.052087143,0.00006627003,0.00014675371,0.11827095,0.010576648,0.11019164],"study_design_scores_gemma":[0.0037699929,0.0006787602,0.9538257,0.00022119857,0.000011560174,0.0000059570957,0.003083943,0.0002955086,0.00011282956,0.035039145,0.00274605,0.00020932828],"about_ca_topic_score_codex":0.16468054,"about_ca_topic_score_gemma":0.0040255194,"teacher_disagreement_score":0.25755617,"about_ca_system_score_codex":0.0027625,"about_ca_system_score_gemma":0.00043733313,"threshold_uncertainty_score":0.84088194},"labels":[],"label_agreement":null},{"id":"W2037989702","doi":"10.1007/s10549-012-2392-y","title":"Elevated expression of podocalyxin is associated with lymphatic invasion, basal-like phenotype, and clinical outcome in axillary lymph node-negative breast cancer","year":2013,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Renal Diseases and Glomerulopathies","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Public Health Ontario; St. Michael's Hospital; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"Canadian Institutes of Health Research; University Health Network; University of Michigan","keywords":"Breast cancer; Lymphatic system; Medicine; Lymphovascular invasion; Lymph node; Oncology; Basal (medicine); Phenotype; Pathology; Internal medicine; Axilla; Cancer; Biology; Metastasis; Gene","score_opus":0.05086456171990781,"score_gpt":0.3682715124770857,"score_spread":0.3174069507571779,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037989702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929068,0.0026378105,0.0000016222673,0.002828592,0.000029391178,0.00093020586,0.0005582134,0.000018347411,0.000089002235],"genre_scores_gemma":[0.99198294,0.0068175173,0.000079790894,0.00026155883,0.000054923337,0.0003890764,0.00003622575,0.00003180329,0.00034614015],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976232,0.0002425836,0.0004920549,0.00051866035,0.0006168927,0.00050662144],"domain_scores_gemma":[0.99820346,0.0003176809,0.00013969379,0.00027022054,0.00056992826,0.00049902155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028639828,0.00026567077,0.00066918536,0.00022170681,0.00011582549,0.00004220264,0.000069423266,0.00012583207,0.00044394308],"category_scores_gemma":[0.0000685787,0.00015901934,0.00007652511,0.00050084246,0.00045138836,0.00016742526,0.000093966984,0.0001467832,0.000007833479],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027283567,0.0012290404,0.971481,0.00016489491,0.0003553614,0.000090332345,0.00022867392,0.0000021902333,0.00077091955,0.00000998684,0.00020212801,0.022737103],"study_design_scores_gemma":[0.008425725,0.0005982772,0.987682,0.0016647234,0.00012621138,0.000042108513,0.00029417826,0.00021517026,0.00055215525,0.00023260155,0.000009892774,0.00015698692],"about_ca_topic_score_codex":0.029350474,"about_ca_topic_score_gemma":0.0007536881,"teacher_disagreement_score":0.028596787,"about_ca_system_score_codex":0.00048365333,"about_ca_system_score_gemma":0.0005712519,"threshold_uncertainty_score":0.9771132},"labels":[],"label_agreement":null},{"id":"W2038284593","doi":"10.1007/s10549-012-2146-x","title":"Beyond radiation therapy: photodynamic therapy maintains structural integrity of irradiated healthy and metastatically involved vertebrae in a pre-clinical in vivo model","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto; Sunnybrook Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Photodynamic therapy; Breast cancer; Bone metastasis; Metastasis; Radiation therapy; In vivo; Cancer; Pathology; Thoracic vertebrae; Lumbar vertebrae; Radiology; Urology; Internal medicine; Lumbar; Biology","score_opus":0.09382280355459754,"score_gpt":0.432882584476253,"score_spread":0.33905978092165545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038284593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99130064,0.004849358,0.000010531525,0.001695832,0.000029348048,0.0018084575,0.00021328453,0.000011011421,0.00008155893],"genre_scores_gemma":[0.98767745,0.011192048,0.0004167854,0.00023524468,0.000030177116,0.0003220604,0.00004818954,0.000019991574,0.00005805561],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99779594,0.00042205636,0.00047135056,0.00033843005,0.00044000472,0.0005321929],"domain_scores_gemma":[0.99896497,0.00018875592,0.00007838245,0.00023944254,0.00008959478,0.0004388306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011132042,0.00019541314,0.0005007101,0.0003502554,0.0000463301,0.0000196614,0.00006277659,0.000068271205,0.0001624533],"category_scores_gemma":[0.00004606852,0.00013877894,0.00005532911,0.00031499274,0.00024026047,0.00015704411,0.000038434067,0.00028336392,8.683365e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017550627,0.003141339,0.80723053,0.00015307678,0.00045662365,0.000030240086,0.0019951335,0.000023006654,0.0006470076,0.0010541576,0.000074871925,0.1676434],"study_design_scores_gemma":[0.014649789,0.0013310176,0.9587182,0.00006074422,0.000033837623,0.0000060785546,0.0002580235,0.023332482,0.000072987365,0.0014128243,0.000024343739,0.00009970258],"about_ca_topic_score_codex":0.006937883,"about_ca_topic_score_gemma":0.002361997,"teacher_disagreement_score":0.16754371,"about_ca_system_score_codex":0.00041264127,"about_ca_system_score_gemma":0.00045273532,"threshold_uncertainty_score":0.999675},"labels":[],"label_agreement":null},{"id":"W2038304935","doi":"10.1007/s10549-013-2714-8","title":"Do alternative methods of measuring tumor size, including consideration of multicentric/multifocal disease, enhance prognostic information beyond TNM staging in women with early stage breast cancer: an analysis of the NCIC CTG MA.5 and MA.12 clinical trials","year":2013,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Sunnybrook Health Science Centre; Juravinski Cancer Centre; University of British Columbia; University of Toronto; Mount Sinai Hospital; BC Cancer Agency; Ottawa Hospital; McMaster University; Queen's University; University of Ottawa","funders":"","keywords":"Medicine; Stage (stratigraphy); Breast cancer; Oncology; Internal medicine; Disease; Cancer; Mammary gland; Gynecology","score_opus":0.09370750888913441,"score_gpt":0.4498117588831009,"score_spread":0.35610424999396645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038304935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959119,0.0010461637,0.00013251252,0.00030376855,0.000029075345,0.0012296751,0.0013315066,0.0000038932803,0.00001150343],"genre_scores_gemma":[0.99693507,0.001487434,0.0005960989,0.000017979759,0.000043059932,0.000872387,0.000023255327,0.000013268914,0.000011430238],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99702317,0.001055972,0.000726059,0.0004035643,0.0004284441,0.0003628079],"domain_scores_gemma":[0.9977826,0.0005969137,0.0005174983,0.00030367248,0.0006012433,0.00019810289],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014737134,0.0002253311,0.0006780158,0.00021251982,0.00013101374,0.000052524883,0.000118469055,0.000054831697,0.000029761295],"category_scores_gemma":[0.00031881276,0.00014369345,0.00008477658,0.00041603955,0.0004429943,0.000080685604,0.00016610765,0.00011106587,1.3163782e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00466674,0.0004523335,0.9032174,0.00011751993,0.0020916208,0.0000024302187,0.0016174559,0.00056497764,0.0036892898,0.000018585,0.0000019962808,0.0835597],"study_design_scores_gemma":[0.0030218859,0.00042460725,0.981059,0.00018721957,0.0003800214,0.0000028970603,0.0013457537,0.0009276197,0.012484779,0.0000349307,0.0000055741657,0.00012568841],"about_ca_topic_score_codex":0.01852691,"about_ca_topic_score_gemma":0.0026807857,"teacher_disagreement_score":0.083434016,"about_ca_system_score_codex":0.00029687022,"about_ca_system_score_gemma":0.0004060393,"threshold_uncertainty_score":0.9880088},"labels":[],"label_agreement":null},{"id":"W2038343200","doi":"10.1007/s10549-006-9470-y","title":"Aromatase inhibitors and cardiac toxicity: getting to the heart of the matter","year":2007,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Tamoxifen; Medicine; Aromatase; Breast cancer; Context (archaeology); Cardiac toxicity; Adjuvant; Internal medicine; Toxicity; Oncology; Pharmacology; Gynecology; Bioinformatics; Cancer; Biology","score_opus":0.034722581199259965,"score_gpt":0.3740143037781945,"score_spread":0.33929172257893453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038343200","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.034654133,0.9630637,2.6663182e-7,0.0006120045,0.000082151986,0.0010753667,0.0004176476,0.0000022584243,0.00009247495],"genre_scores_gemma":[0.0055318163,0.9931916,0.000010220535,0.000045372803,0.0003328761,0.0002643833,0.000047644713,0.0000274495,0.00054865103],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99867326,0.00024292216,0.00018540736,0.00034655194,0.0002127137,0.00033914397],"domain_scores_gemma":[0.99930596,0.00005520299,0.000054862518,0.00038733968,0.000049507515,0.0001471208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036859413,0.00021635182,0.00040052383,0.000059935035,0.00019968093,0.00003486798,0.0001278877,0.00017784865,0.0000060298216],"category_scores_gemma":[0.000008802984,0.00009819751,0.0001789891,0.00017529464,0.00018314042,0.0000017285003,0.00026395734,0.00019682363,0.000009626352],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008015252,0.00009349848,0.001211923,0.0008981946,0.0006198902,0.0000068013896,0.000050809263,5.2819183e-7,0.00072250434,0.000009474774,0.0077077,0.9885985],"study_design_scores_gemma":[0.0001945174,0.00031692276,0.00081636,0.001484738,0.00016666204,0.00010293356,0.00002550396,1.5698174e-7,0.0029605238,0.0000027782205,0.99379337,0.00013550682],"about_ca_topic_score_codex":0.00045250534,"about_ca_topic_score_gemma":0.000036344405,"teacher_disagreement_score":0.98846304,"about_ca_system_score_codex":0.00006787301,"about_ca_system_score_gemma":0.00019673821,"threshold_uncertainty_score":0.40043783},"labels":[],"label_agreement":null},{"id":"W2039267747","doi":"10.1007/s10549-014-2953-3","title":"Adolescent dietary fiber, vegetable fat, vegetable protein, and nut intakes and breast cancer risk","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Nutritional Studies and Diet","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; Public Health Ontario; University of Toronto","funders":"National Cancer Institute","keywords":"Medicine; Breast cancer; Odds ratio; Population; Confidence interval; Cancer; Case-control study; Logistic regression; Environmental health; Internal medicine","score_opus":0.038499536076881564,"score_gpt":0.33020529806905197,"score_spread":0.2917057619921704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039267747","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93104583,0.05549009,0.0000019419444,0.010040709,0.000047240403,0.0013373725,0.00085168035,0.000037480415,0.0011476312],"genre_scores_gemma":[0.9551229,0.041225377,0.000118169446,0.00010720341,0.0005587222,0.00090182264,0.00002475466,0.000027575028,0.0019134955],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99819267,0.00008577017,0.00017940396,0.00053001597,0.0004115672,0.00060056505],"domain_scores_gemma":[0.99897534,0.000063806336,0.000047339516,0.00020449172,0.00023226204,0.00047677444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020014212,0.00025120346,0.00041049148,0.00009567036,0.00052552985,0.00007264843,0.0000441829,0.000069432805,0.00017950514],"category_scores_gemma":[0.000011309074,0.00017429874,0.000047766316,0.00015117718,0.00035001364,0.000100515506,0.00012151391,0.00022487623,0.000011970289],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037873078,0.0014419488,0.65218437,0.00080844236,0.00070048025,0.000057196958,0.00015439364,0.000002997291,0.0009914411,0.00020832825,0.0031945347,0.33646858],"study_design_scores_gemma":[0.0057803793,0.0011376874,0.9576406,0.00093552197,0.00015550399,0.00021712549,0.000112232825,0.00008093267,0.00062771945,0.0006007291,0.032503657,0.00020794875],"about_ca_topic_score_codex":0.0212285,"about_ca_topic_score_gemma":0.0018253891,"teacher_disagreement_score":0.33626062,"about_ca_system_score_codex":0.0002873344,"about_ca_system_score_gemma":0.00010769869,"threshold_uncertainty_score":0.9852892},"labels":[],"label_agreement":null},{"id":"W2039755267","doi":"10.1023/a:1006314010958","title":"Effect of social housing condition on heat shock protein (HSP) expression in the Shionogi mouse mammary carcinoma (SC115)","year":2000,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; National Institute on Alcohol Abuse and Alcoholism; National Institutes of Health","keywords":"Heat shock protein; Downregulation and upregulation; Endocrinology; Internal medicine; Biology; In vivo; In vitro; Medicine; Gene; Biochemistry; Genetics","score_opus":0.02155190910100523,"score_gpt":0.3448273884151004,"score_spread":0.32327547931409517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039755267","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964895,0.00044755297,0.0000043262244,0.00080086564,0.0000055423825,0.0014647493,0.000116824514,0.000005536945,0.00066510367],"genre_scores_gemma":[0.9977894,0.0002967221,0.000016166834,0.000019471583,0.00013572111,0.0011163456,0.00008268138,0.000018232964,0.00052528316],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99776363,0.00083043566,0.0001520848,0.0003766871,0.00043952392,0.00043763334],"domain_scores_gemma":[0.9994821,0.000045811496,0.00001526584,0.00030339486,0.00006215108,0.00009127713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005807899,0.00016294442,0.00017491124,0.000104221544,0.00024418032,0.00004694904,0.00017879586,0.00011951903,0.00009810554],"category_scores_gemma":[0.000013726877,0.000100989666,0.000056957168,0.00016937952,0.00015856477,0.000010195065,0.00006749689,0.00017822036,0.0000067612023],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006333987,0.0006491662,0.004496547,0.00011995973,0.000051573246,0.00007262163,0.00030795162,0.0000311114,0.8026595,0.00004147663,0.00034592397,0.18489015],"study_design_scores_gemma":[0.0025617592,0.0046510086,0.018376531,0.00007968223,0.0000049389837,0.00002084461,0.00005689749,0.00003485278,0.97286034,0.000018065277,0.0012190609,0.00011600891],"about_ca_topic_score_codex":0.0011706662,"about_ca_topic_score_gemma":0.00022201697,"teacher_disagreement_score":0.18477415,"about_ca_system_score_codex":0.00017666661,"about_ca_system_score_gemma":0.0001690805,"threshold_uncertainty_score":0.41182393},"labels":[],"label_agreement":null},{"id":"W2039874815","doi":"10.1007/s10549-011-1761-2","title":"Non-existence of caveolin-1 gene mutations in human breast cancer","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Caveolin-1 and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Breast cancer; Biology; Microdissection; Cancer research; Gene; Mutation; Germline mutation; Cancer; Caveolae; Genetics; Cell","score_opus":0.052825803208286316,"score_gpt":0.3515259007903604,"score_spread":0.29870009758207405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039874815","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956012,0.0024777036,0.000012466694,0.0001382872,0.000027448597,0.00026287872,0.00047747034,0.000004061508,0.0009984821],"genre_scores_gemma":[0.9954528,0.002994656,0.000054005468,0.000014151518,0.00012175426,0.00032532614,0.00007062488,0.000016977912,0.00094965607],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99890846,0.000029752804,0.00018092344,0.00035716157,0.00017608519,0.00034759493],"domain_scores_gemma":[0.9993414,0.000006213867,0.000047709873,0.00023179007,0.00023415757,0.00013869134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001139824,0.00014195967,0.00016681927,0.0001042435,0.00011307979,0.000013665434,0.00012405732,0.00007766231,0.00015573596],"category_scores_gemma":[0.0000024880053,0.00011810647,0.000047135753,0.00018080384,0.0002571421,0.0000069325565,0.00007850352,0.00007499732,0.0000026611349],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011525772,0.0016140651,0.31177545,0.00015627705,0.0003236625,0.00008818142,0.0013103143,0.000025490135,0.64287,0.00025445694,0.00012388591,0.040305633],"study_design_scores_gemma":[0.0020586601,0.00061569404,0.37944275,0.00009093504,0.00003268008,0.00013272784,0.00034587402,0.000016471433,0.61634743,0.0003662519,0.00033381776,0.000216665],"about_ca_topic_score_codex":0.02055021,"about_ca_topic_score_gemma":0.007457666,"teacher_disagreement_score":0.067667305,"about_ca_system_score_codex":0.000082880666,"about_ca_system_score_gemma":0.0003165094,"threshold_uncertainty_score":0.98597205},"labels":[],"label_agreement":null},{"id":"W2039952097","doi":"10.1007/s10549-014-3046-z","title":"Breast cancer and bone metastases: the association of axial skeleton MRI findings with skeletal-related events and survival","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Medical Imaging Techniques and Applications","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Breast cancer; Hazard ratio; Axial skeleton; Confidence interval; Skeleton (computer programming); Vertebra; Bone marrow; Odds ratio; Internal medicine; Proportional hazards model; Metastasis; Metastatic breast cancer; Cancer; Oncology; Bone metastasis; Radiology; Surgery; Anatomy","score_opus":0.0223751291011141,"score_gpt":0.35027601802357217,"score_spread":0.32790088892245806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039952097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96171314,0.0006269789,0.00004995952,0.03635836,0.000016397566,0.0007113577,0.00032683037,0.000026036452,0.00017091594],"genre_scores_gemma":[0.9949308,0.0035832534,0.0001757825,0.000041786745,0.00007940703,0.0003608853,0.000030610234,0.000015328718,0.00078211655],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986899,0.00009785874,0.0001681797,0.00027594485,0.00047848333,0.0002896529],"domain_scores_gemma":[0.9991773,0.00016437878,0.000071491166,0.00017715934,0.00019006396,0.00021962545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006053588,0.00013190882,0.00027701864,0.00007454706,0.0001870304,0.00002557282,0.000044240514,0.00005619725,0.000069043475],"category_scores_gemma":[0.00001701728,0.0000722262,0.00002830791,0.00021231273,0.00025814766,0.000048592734,0.000051665604,0.00017531923,0.0000010942239],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00141304,0.0010957296,0.6507705,0.00028316124,0.0013219251,0.000017297869,0.0006009859,0.0000016392931,0.0033224071,0.0038492004,0.0032065872,0.33411756],"study_design_scores_gemma":[0.007442376,0.0011086083,0.9783316,0.00053207955,0.00048932974,0.000387014,0.0001627473,0.00050834555,0.0012199807,0.0007009235,0.008923147,0.00019380805],"about_ca_topic_score_codex":0.0063703335,"about_ca_topic_score_gemma":0.00046784998,"teacher_disagreement_score":0.33392376,"about_ca_system_score_codex":0.0002127599,"about_ca_system_score_gemma":0.00013028995,"threshold_uncertainty_score":0.9630081},"labels":[],"label_agreement":null},{"id":"W2040775711","doi":"10.1023/a:1026389427983","title":"Psychosocial Support for Women with Advanced Breast Cancer","year":2003,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer survivorship and care","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"","keywords":"Psychosocial; Psychological intervention; Coping (psychology); Breast cancer; Distress; Anxiety; Social support; Clinical psychology; Medicine; Mood; Cognitive behavioral therapy; Randomized controlled trial; Psychology; Psychiatry; Psychotherapist; Cancer; Internal medicine","score_opus":0.03623766347127115,"score_gpt":0.3806411013339931,"score_spread":0.34440343786272193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040775711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9792717,0.0021351012,0.000021965367,0.007229737,0.00028653955,0.0021680226,0.002347174,0.00006732279,0.0064724097],"genre_scores_gemma":[0.982176,0.0025203205,0.00006715768,0.00018887669,0.00036350908,0.0061399485,0.000029536366,0.000053246604,0.008461423],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9978524,0.000054549982,0.00016031406,0.0005363107,0.00049883634,0.0008975809],"domain_scores_gemma":[0.9986147,0.000054913617,0.000042090232,0.0002753437,0.0004448494,0.0005680959],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002098627,0.0002459486,0.00037866624,0.00012673481,0.00026722168,0.00005030107,0.000062268795,0.000077891396,0.0013150586],"category_scores_gemma":[0.000004773932,0.00016916369,0.00006313074,0.0003407641,0.0002053258,0.0000935234,0.000015078395,0.00014979056,0.000008066917],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03325156,0.0015101014,0.15778668,0.00039756607,0.001225495,0.00012728156,0.0037443687,0.0000051933653,0.0007968383,0.0011970117,0.0030609998,0.7968969],"study_design_scores_gemma":[0.036230154,0.011801169,0.5283007,0.00057107443,0.00026845103,0.001277709,0.0067086276,0.000008633189,0.0023669316,0.00089067995,0.41072577,0.0008500613],"about_ca_topic_score_codex":0.003507187,"about_ca_topic_score_gemma":0.00803369,"teacher_disagreement_score":0.79604685,"about_ca_system_score_codex":0.00140297,"about_ca_system_score_gemma":0.0012305395,"threshold_uncertainty_score":0.99959785},"labels":[],"label_agreement":null},{"id":"W2040952105","doi":"10.1007/s10549-006-9390-x","title":"Estrogen receptor-β regulates psoriasin (S100A7) in human breast cancer","year":2006,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"S100 Proteins and Annexins","field":"Biochemistry, Genetics and Molecular Biology","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Estrogen receptor; In vivo; Biology; Internal medicine; Estrogen; Cancer research; Agonist; Endocrinology; Estrogen receptor alpha; Breast cancer; Receptor; Cancer; Medicine","score_opus":0.022942941050483088,"score_gpt":0.335898476955694,"score_spread":0.3129555359052109,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040952105","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923619,0.004712562,0.000001559203,0.0012973335,0.00004605001,0.00040446533,0.0006384674,0.000012906206,0.0005247432],"genre_scores_gemma":[0.9941206,0.0016145088,0.000042120897,0.000021875068,0.00065698934,0.0005710016,0.00019286042,0.00003125893,0.0027487965],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984306,0.000084462336,0.00018627835,0.00052472466,0.00019981479,0.00057410676],"domain_scores_gemma":[0.99940014,0.00000804315,0.00003898617,0.00027796018,0.00012969109,0.00014520882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015348941,0.00021048581,0.00018633656,0.00010973516,0.00020807842,0.000067002664,0.00012532005,0.0001226951,0.00023714527],"category_scores_gemma":[0.0000021981145,0.00016888816,0.0000618741,0.00018988283,0.00018845825,0.000008809567,0.000089013076,0.00010321412,0.000007394277],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012308182,0.0012634387,0.30644548,0.00004209683,0.00022794305,0.00004071821,0.00007090528,0.00007663059,0.5818594,0.0018480447,0.004844193,0.10205032],"study_design_scores_gemma":[0.0054965545,0.0011532882,0.6427455,0.00020019946,0.000027777325,0.00014526735,0.00017069509,0.0000224486,0.306295,0.0008726182,0.042285442,0.0005852075],"about_ca_topic_score_codex":0.040869202,"about_ca_topic_score_gemma":0.009253461,"teacher_disagreement_score":0.33630005,"about_ca_system_score_codex":0.00021747158,"about_ca_system_score_gemma":0.00020256583,"threshold_uncertainty_score":0.96551776},"labels":[],"label_agreement":null},{"id":"W2041398470","doi":"10.1023/a:1023951616696","title":"Hormone Replacement Therapy after Treatment for Breast Cancer: Physicians' Attitudes towards Randomized Trials","year":2003,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Menopause: Health Impacts and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"College of Family Physicians of Canada","keywords":"Medicine; Randomized controlled trial; Hormone replacement therapy (female-to-male); Breast cancer; Hormone therapy; Internal medicine; Gynecology; Clinical trial; Cancer","score_opus":0.16751463954046367,"score_gpt":0.4715420834103193,"score_spread":0.3040274438698556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041398470","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88371944,0.07835092,0.000034740642,0.014579252,0.00030834062,0.017163843,0.00500972,0.000098793265,0.0007349702],"genre_scores_gemma":[0.8636041,0.106831126,0.0003223983,0.00033710117,0.0005099983,0.02423058,0.000089288835,0.00008270279,0.0039926963],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9952118,0.0008850096,0.00083939853,0.0009452817,0.0007839801,0.0013345383],"domain_scores_gemma":[0.9970878,0.0006793285,0.00024225687,0.000631063,0.0004946325,0.00086491654],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019750805,0.00065237045,0.002315339,0.0002812282,0.0004666024,0.00013408673,0.00007260744,0.000145334,0.0010227117],"category_scores_gemma":[0.000079433274,0.00036949126,0.00022809244,0.0003049792,0.00031692395,0.00013906183,0.00002408255,0.00014248693,0.00001759228],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5355944,0.005334517,0.0079772575,0.0001602356,0.006249818,0.00009966122,0.00059634814,0.0000017780344,0.0010250169,0.00022160832,0.00092895655,0.44181037],"study_design_scores_gemma":[0.84222203,0.025220456,0.1008876,0.00065899733,0.0016796279,0.00032306244,0.00015691305,0.000027398208,0.005191003,0.00043159074,0.022641085,0.00056021597],"about_ca_topic_score_codex":0.01198099,"about_ca_topic_score_gemma":0.0006039499,"teacher_disagreement_score":0.44125018,"about_ca_system_score_codex":0.0026381374,"about_ca_system_score_gemma":0.001531189,"threshold_uncertainty_score":0.9998905},"labels":[],"label_agreement":null},{"id":"W2041693178","doi":"10.1007/s10549-009-0418-x","title":"Treatment-related symptoms among underserved women with breast cancer: the impact of physician–patient communication","year":2009,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer survivorship and care","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Cancer Institute; American Cancer Society","keywords":"Medicine; Nausea; Depression (economics); Breast cancer; Ethnic group; Psychological intervention; Logistic regression; Family medicine; Psychiatry; Internal medicine; Cancer","score_opus":0.02747994388320609,"score_gpt":0.3393087514497406,"score_spread":0.3118288075665345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041693178","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905037,0.0030131335,5.8055485e-7,0.003718024,0.000021023765,0.0011083067,0.0004888348,0.00003570016,0.001110649],"genre_scores_gemma":[0.9946379,0.004038087,0.0000024412582,0.000042940806,0.00006114774,0.0007222398,0.00005590254,0.00002636219,0.00041296755],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9982048,0.00016765794,0.0002311633,0.00034376988,0.00046797027,0.0005846196],"domain_scores_gemma":[0.99847543,0.00007497482,0.00011962958,0.00065679895,0.00035535722,0.0003177897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010588352,0.0002870959,0.000438661,0.00013186093,0.00028299246,0.00004948915,0.0001241921,0.00007168266,0.00018544692],"category_scores_gemma":[0.0000014491982,0.00014388848,0.000122019126,0.00057268626,0.0004294483,0.00012364569,0.000031235177,0.00017733466,0.0000031635839],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009650115,0.0024252813,0.24986881,0.000033812226,0.0025082415,0.000040437106,0.010325493,0.00015039874,0.0005354611,0.00014042851,0.00014587016,0.72417563],"study_design_scores_gemma":[0.005476546,0.008515694,0.9813881,0.00033174548,0.00015825528,0.00011931341,0.0030128977,0.00013130544,0.00044392786,0.00015922941,0.000102773556,0.00016023463],"about_ca_topic_score_codex":0.10159146,"about_ca_topic_score_gemma":0.0077136587,"teacher_disagreement_score":0.7315193,"about_ca_system_score_codex":0.003157918,"about_ca_system_score_gemma":0.00070557743,"threshold_uncertainty_score":0.9043911},"labels":[],"label_agreement":null},{"id":"W2041865709","doi":"10.1007/s10549-012-2278-z","title":"Aromatase inhibitors in obese breast cancer patients are not associated with increased plasma estradiol levels","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec; Hôpital du Saint-Sacrement","funders":"","keywords":"Breast cancer; Medicine; Aromatase; Internal medicine; Body mass index; Endocrinology; Lean body mass; Obesity; Estrogen; Postmenopausal women; Cancer; Menopause; Body weight","score_opus":0.06283885054474149,"score_gpt":0.3479244630373585,"score_spread":0.28508561249261705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041865709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98965096,0.0008168937,1.8414082e-7,0.0010363273,0.00009442102,0.001116467,0.0071444917,0.0000398329,0.000100410405],"genre_scores_gemma":[0.9976672,0.00070214196,0.000007402156,0.00007192195,0.00028907057,0.00082215224,0.00021224948,0.00005358412,0.00017429843],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99717957,0.00013099956,0.00029822323,0.00048665653,0.00082487863,0.0010796869],"domain_scores_gemma":[0.9983146,0.00012005342,0.00011828759,0.00028574272,0.00026078455,0.0009005007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000260128,0.0003559344,0.0005404674,0.00032180827,0.00018747617,0.0000546096,0.000080213795,0.00013647295,0.0003273802],"category_scores_gemma":[0.000025490088,0.00024027555,0.00006999135,0.00057440554,0.00024127205,0.00025556548,0.000053308217,0.00033932275,0.000012858816],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031833088,0.0030189196,0.95642364,0.000052775493,0.00033547066,0.00010444273,0.0004447531,0.0000033162407,0.00017300896,0.000006851324,0.00044040513,0.03581312],"study_design_scores_gemma":[0.011141099,0.0007255691,0.98483217,0.00094718323,0.00009981868,0.00008841493,0.00021891095,0.000031546082,0.0013344812,0.0000035278354,0.00033186402,0.0002454322],"about_ca_topic_score_codex":0.05416424,"about_ca_topic_score_gemma":0.012440994,"teacher_disagreement_score":0.041723244,"about_ca_system_score_codex":0.002620802,"about_ca_system_score_gemma":0.0006059913,"threshold_uncertainty_score":0.97981524},"labels":[],"label_agreement":null},{"id":"W2041940241","doi":"10.1007/s10549-011-1786-6","title":"Is knowledge translation adequate? A quality assurance study of staging investigations in early stage breast cancer patients","year":2011,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Medicine; Stage (stratigraphy); Breast cancer; Radiological weapon; Cancer; Cohort; Disease; Retrospective cohort study; Surgery; Internal medicine","score_opus":0.712849734848584,"score_gpt":0.6218271399634635,"score_spread":0.09102259488512054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041940241","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.27008823,0.71680915,0.0000043104483,0.00055255997,0.00012402063,0.0068773804,0.005398046,0.000024514806,0.00012181458],"genre_scores_gemma":[0.16752124,0.82925004,0.000045300614,0.000014250687,0.000119389566,0.0024709885,0.00021757964,0.00005574703,0.00030547738],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9952088,0.0010414176,0.0017558024,0.0007811815,0.00070359453,0.0005091852],"domain_scores_gemma":[0.996609,0.001129834,0.0005932485,0.0004857468,0.0008389317,0.00034323696],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012149571,0.0004087831,0.0014404705,0.0005411661,0.00012936172,0.000040326908,0.00013414826,0.00016467612,0.00040043582],"category_scores_gemma":[0.00012730705,0.00031272118,0.00017359761,0.00095764495,0.00017452118,0.00026757686,0.00007178476,0.00053032616,0.00001477545],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045902462,0.004133169,0.24653372,0.0030649595,0.0005858701,0.000007711882,0.0040956405,3.255246e-7,3.1471313e-7,0.000014915179,0.000044681154,0.74105966],"study_design_scores_gemma":[0.011233562,0.0022385034,0.9297263,0.010743008,0.0014303488,0.000010941148,0.0014994234,0.000013491355,0.0000023037298,0.00003137057,0.042656206,0.0004145328],"about_ca_topic_score_codex":0.123316474,"about_ca_topic_score_gemma":0.029067736,"teacher_disagreement_score":0.7406451,"about_ca_system_score_codex":0.001213089,"about_ca_system_score_gemma":0.0020993243,"threshold_uncertainty_score":0.99993247},"labels":[],"label_agreement":null},{"id":"W2042133498","doi":"10.1007/s10549-009-0447-5","title":"Validity of self-reports of breast cancer treatment in low-income, medically underserved women with breast cancer","year":2009,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Patient-Provider Communication in Healthcare","field":"Health Professions","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Cancer Institute; U.S. Public Health Service; American Cancer Society","keywords":"Medicine; Kappa; Breast cancer; Cohen's kappa; Radiation therapy; Medical record; Internal medicine; Cancer; Chemotherapy; Oncology","score_opus":0.17785279513291283,"score_gpt":0.45649015420389366,"score_spread":0.27863735907098086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042133498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9756065,0.002640524,0.00000165655,0.015994858,0.00014028908,0.002962297,0.0023074525,0.0000665747,0.0002798676],"genre_scores_gemma":[0.9848502,0.009296981,0.000100452904,0.0001329045,0.00015256823,0.0051224916,0.000043653898,0.00004529418,0.0002554091],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99427956,0.0012613378,0.0012035616,0.0007429719,0.0011387835,0.0013737616],"domain_scores_gemma":[0.9956721,0.0005173738,0.0006283927,0.0011340554,0.0012496517,0.00079844054],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00062049786,0.00043595998,0.00095403206,0.00042523025,0.0005296121,0.000015484928,0.00032043573,0.00024615586,0.0009880491],"category_scores_gemma":[0.000019621233,0.00030148,0.00007832518,0.0009252721,0.00037582873,0.00021935531,0.00015285393,0.000535267,0.0000048599713],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0033893166,0.0024981957,0.95015705,0.00067451765,0.00037504217,0.00007021506,0.0097178,0.00005105397,0.00008715413,0.000084789775,0.000096403994,0.032798495],"study_design_scores_gemma":[0.0056355214,0.0015295191,0.98545635,0.002312403,0.00006161348,0.00007216589,0.004064449,0.00007192299,0.000102427926,0.00026762462,0.00018401419,0.00024201577],"about_ca_topic_score_codex":0.15719648,"about_ca_topic_score_gemma":0.06832193,"teacher_disagreement_score":0.08887455,"about_ca_system_score_codex":0.007762178,"about_ca_system_score_gemma":0.006429703,"threshold_uncertainty_score":0.99994373},"labels":[],"label_agreement":null},{"id":"W2042193506","doi":"10.1023/a:1016089215070","title":"Delay in adjuvant radiation treatment and outcomes of breast cancer – a review","year":2002,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Charles-Le Moyne; Hôpital du Saint-Sacrement; McGill University Health Centre; Institut National de Santé Publique du Québec","funders":"National Cancer Institute","keywords":"Medicine; Radiation therapy; Breast cancer; Randomized controlled trial; Chemotherapy; Oncology; Observational study; Systemic therapy; Retrospective cohort study; Cancer; Internal medicine; Dose fractionation; Surgery","score_opus":0.07252365505762283,"score_gpt":0.41555783561019716,"score_spread":0.34303418055257434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042193506","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001352728,0.9906715,3.4018245e-7,0.00096165633,0.00007143524,0.0020787742,0.0047736284,0.000010118516,0.00007981079],"genre_scores_gemma":[0.002927457,0.9910678,0.00001516188,0.000036144545,0.00019532851,0.0048720124,0.00032425535,0.00007432669,0.00048751512],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99694407,0.0003245115,0.0006584098,0.0010438318,0.0003363163,0.00069287425],"domain_scores_gemma":[0.9986111,0.00010171547,0.00027937128,0.0005677496,0.00018161596,0.0002584671],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019909427,0.00077565154,0.002178876,0.00029147082,0.00014314566,0.000031263513,0.00016463648,0.0002552373,0.000106732514],"category_scores_gemma":[0.0000123530635,0.00050484785,0.00032183155,0.0003905826,0.00031249714,0.000012621348,0.00017299714,0.00015587738,0.0000063494767],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013085626,0.0006702182,0.01442368,0.0043161334,0.0017568854,0.000029744151,0.00005898986,4.8473265e-7,0.0000026974633,0.000009495035,0.0003734386,0.9782274],"study_design_scores_gemma":[0.0051448,0.0012232765,0.060457874,0.02639278,0.0023000904,0.0007368703,0.000044391647,0.0000017373503,0.000036083555,0.000013064191,0.90277714,0.0008718724],"about_ca_topic_score_codex":0.0092480555,"about_ca_topic_score_gemma":0.0034651195,"teacher_disagreement_score":0.9773555,"about_ca_system_score_codex":0.0011035175,"about_ca_system_score_gemma":0.00059911463,"threshold_uncertainty_score":0.9997403},"labels":[],"label_agreement":null},{"id":"W2044015759","doi":"10.1007/s10549-014-2963-1","title":"Tamoxifen-associated hot flash severity is inversely correlated with endoxifen concentration and CYP3A4*22","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Hot flash; Tamoxifen; Medicine; CYP2D6; Internal medicine; Oncology; Breast cancer; Prospective cohort study; Odds ratio; Genotype; Cohort study; Cancer; Biology; Genetics","score_opus":0.013932030625085075,"score_gpt":0.2812390889153647,"score_spread":0.2673070582902796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044015759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99693865,0.0013039826,0.000009412124,0.00044354357,0.00003161622,0.00038939374,0.000104700484,0.000016067626,0.0007626652],"genre_scores_gemma":[0.99559206,0.0030077146,0.000025552512,0.00008870753,0.00007135113,0.000092068236,0.00014498533,0.000018844888,0.00095874525],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987555,0.00015841224,0.000104134546,0.00039320462,0.00020915514,0.0003795998],"domain_scores_gemma":[0.99938005,0.00002724579,0.00004490128,0.00016624921,0.00014193512,0.00023959506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016819795,0.00017454378,0.00016143755,0.000027052934,0.00021970087,0.00005519949,0.00005420665,0.00016630358,0.000027118893],"category_scores_gemma":[0.000013459076,0.00012475792,0.000028891176,0.00012356527,0.00023475058,0.0000090051535,0.00004970824,0.00013878077,0.000008644949],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011949693,0.002025157,0.4729417,0.00011936406,0.003735245,0.00015327084,0.0015859365,0.000048008966,0.31400615,0.00047709895,0.0144115845,0.17854679],"study_design_scores_gemma":[0.031625703,0.018112829,0.491557,0.00039694735,0.0004243219,0.000751704,0.0003294073,0.003424726,0.41938788,0.00034083397,0.032231852,0.0014168009],"about_ca_topic_score_codex":0.0008455613,"about_ca_topic_score_gemma":0.00023996226,"teacher_disagreement_score":0.17713,"about_ca_system_score_codex":0.00009579265,"about_ca_system_score_gemma":0.00015009021,"threshold_uncertainty_score":0.508748},"labels":[],"label_agreement":null},{"id":"W2044057692","doi":"10.1007/s10549-010-0981-1","title":"Prognostic factors for skeletal complications from metastatic bone disease in breast cancer","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Bone health and treatments","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"Cancer Research UK","keywords":"Medicine; Zoledronic acid; Internal medicine; Breast cancer; Oncology; Multivariate analysis; Pathologic fracture; Proportional hazards model; Spinal cord compression; Bone metastasis; Radiation therapy; Univariate analysis; Palliative care; Cancer; Surgery","score_opus":0.08067297305541712,"score_gpt":0.4229164110805938,"score_spread":0.34224343802517665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044057692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97192025,0.0015781466,0.0000061624114,0.01486722,0.00008605726,0.0026680187,0.008798215,0.000033106422,0.000042827247],"genre_scores_gemma":[0.9922539,0.00078204763,0.00022735712,0.00008286318,0.000102484984,0.0056001213,0.00059229974,0.000035345478,0.0003235541],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99816,0.000049706647,0.00025314232,0.00052080373,0.0003441169,0.0006722034],"domain_scores_gemma":[0.9980812,0.0003145707,0.00005097702,0.0003316433,0.00022069231,0.001000926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009920202,0.00023697065,0.00037047177,0.00020334448,0.00025430068,0.00004151303,0.000058916456,0.000051583233,0.00028228087],"category_scores_gemma":[0.000028614693,0.00016470412,0.00008271378,0.00025487508,0.0002012414,0.00008840712,0.000030994266,0.0002317634,0.000015836544],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001466421,0.0023775138,0.9432032,0.0001038399,0.0002566798,0.00007452927,0.00016468806,0.0000011787046,0.00028097394,0.00018112648,0.00013797868,0.05175186],"study_design_scores_gemma":[0.0057660416,0.00029337592,0.99157983,0.00015208196,0.0002102054,0.000037432004,0.0000624469,0.00018141081,0.00005599555,0.00051989884,0.0010198279,0.000121449535],"about_ca_topic_score_codex":0.05391589,"about_ca_topic_score_gemma":0.018355643,"teacher_disagreement_score":0.051630408,"about_ca_system_score_codex":0.00043175716,"about_ca_system_score_gemma":0.0009677696,"threshold_uncertainty_score":0.9995568},"labels":[],"label_agreement":null},{"id":"W2044166564","doi":"10.1007/s10549-011-1692-y","title":"Inhibition of aldehyde dehydrogenase (ALDH) activity reduces chemotherapy and radiation resistance of stem-like ALDHhiCD44+ human breast cancer cells","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":328,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Ontario Ministry of Research and Innovation; Canadian Institutes of Health Research","keywords":"Aldehyde dehydrogenase; Breast cancer; Cancer stem cell; Cancer; Chemotherapy; Cancer research; Medicine; Stem cell; Oncology; Internal medicine; Biology; Enzyme; Biochemistry; Genetics","score_opus":0.06497320140829642,"score_gpt":0.3488083949856305,"score_spread":0.28383519357733406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044166564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909209,0.00590777,0.000003693898,0.0007439846,0.000047547084,0.0007750744,0.0011221904,0.000014933312,0.00046391398],"genre_scores_gemma":[0.9785093,0.020161286,0.00008197944,0.000027078167,0.000112228765,0.0002390069,0.000016365188,0.000029953728,0.00082276535],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983419,0.00010418159,0.00028178171,0.00044753015,0.00044840307,0.000376208],"domain_scores_gemma":[0.9989207,0.00003834429,0.00017978612,0.00028713158,0.00028837402,0.0002856993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026546622,0.00021920633,0.00047522385,0.00020997065,0.00014225776,0.000015187553,0.000049743325,0.000084666695,0.0003472775],"category_scores_gemma":[0.0000012513419,0.00017324182,0.00008577087,0.0002995207,0.00039118738,0.00013863514,0.000034089284,0.00012654897,9.943097e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006975969,0.0017188751,0.013989076,0.0005522151,0.00065449486,0.00003368484,0.0018248572,0.0000012410856,0.69457024,0.00010049264,0.00056492834,0.27901393],"study_design_scores_gemma":[0.0043372773,0.0006584951,0.1248027,0.00041938788,0.0001477962,0.000036477028,0.00022171179,0.000005091355,0.8684943,0.00006276844,0.0006771666,0.00013684845],"about_ca_topic_score_codex":0.019751364,"about_ca_topic_score_gemma":0.0032761567,"teacher_disagreement_score":0.27887708,"about_ca_system_score_codex":0.00039875967,"about_ca_system_score_gemma":0.0003566204,"threshold_uncertainty_score":0.9867762},"labels":[],"label_agreement":null},{"id":"W2044891501","doi":"10.1007/s10549-008-0296-7","title":"A high-resolution integrated analysis of genetic and expression profiles of breast cancer cell lines","year":2009,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Gene expression and cancer classification","field":"Biochemistry, Genetics and Molecular Biology","cited_by":63,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"Cancer Research UK","keywords":"Breast cancer; Cancer; Biology; Oncology; Computational biology; Medicine; Cancer research; Genetics","score_opus":0.024530577804032686,"score_gpt":0.3270845703817999,"score_spread":0.3025539925777672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044891501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903833,0.008111891,0.00010417372,0.0004339716,0.000020952917,0.00024591575,0.00065419945,0.0000046707273,0.00004092636],"genre_scores_gemma":[0.9850233,0.014136401,0.00024250663,0.000011678401,0.00006853906,0.0001361536,0.000115054085,0.000007894073,0.00025845953],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9989342,0.00008817569,0.00021159244,0.0003552312,0.00020908812,0.00020171207],"domain_scores_gemma":[0.9992135,0.000009482757,0.000106929314,0.00023841306,0.0003153877,0.00011624273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000085352316,0.00013552401,0.00022885221,0.00016427088,0.00007470788,0.000014955754,0.00007672975,0.00008946556,0.00007302101],"category_scores_gemma":[0.0000035403618,0.000096145646,0.000057780777,0.00035738197,0.00012973676,0.000007042397,0.00003920142,0.00004431108,1.8678935e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087655225,0.0003450309,0.024615914,0.00002761355,0.00020654255,7.795198e-7,0.0000764658,0.00016599627,0.9109798,0.000019597781,0.0002842615,0.062401425],"study_design_scores_gemma":[0.00084221276,0.00045429228,0.5653624,0.00006605523,0.00013529552,0.000004084309,0.00015677015,0.00027168752,0.4323273,0.000023171406,0.00026881823,0.00008789986],"about_ca_topic_score_codex":0.0037561199,"about_ca_topic_score_gemma":0.0006030996,"teacher_disagreement_score":0.5407465,"about_ca_system_score_codex":0.00006725564,"about_ca_system_score_gemma":0.00016365918,"threshold_uncertainty_score":0.5678155},"labels":[],"label_agreement":null},{"id":"W2045150799","doi":"10.1007/s10549-014-3171-8","title":"Upper extremity bioimpedance before and after treadmill testing in women post breast cancer treatment","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Lymphatic System and Diseases","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Center for Advancing Translational Sciences; National Center for Research Resources; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Nursing Research","keywords":"Medicine; Treadmill; Repeated measures design; Lymphedema; Physical therapy; Cardiorespiratory fitness; Breast cancer; Internal medicine; Cancer; Mathematics","score_opus":0.035137598675195204,"score_gpt":0.34228229533642335,"score_spread":0.3071446966612281,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045150799","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99008936,0.004148566,6.824905e-7,0.0033274665,0.00005156669,0.0009517734,0.0008989307,0.000042407508,0.00048926356],"genre_scores_gemma":[0.994012,0.0014288141,0.000048049114,0.00017189952,0.00037548397,0.0027097363,0.000019241488,0.000039463313,0.0011953347],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99755377,0.00014490016,0.00029195068,0.00068794144,0.0004306783,0.0008907412],"domain_scores_gemma":[0.99829733,0.00020856012,0.000056184745,0.00036746523,0.00025604718,0.00081440614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002371787,0.00035760112,0.000551747,0.00025857936,0.00017674344,0.00008018238,0.000059484035,0.00008901475,0.00030992465],"category_scores_gemma":[0.000041347274,0.00022744903,0.00006227805,0.00034296938,0.00025868812,0.0001323987,0.00006401741,0.00004479482,0.000014881349],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020565407,0.00065967103,0.6527958,0.000120756835,0.00012113599,0.00010406965,0.00087066734,5.4572615e-7,0.00015049976,0.000011821226,0.000022262171,0.34308627],"study_design_scores_gemma":[0.007267192,0.0014485589,0.98830426,0.0007884061,0.00008199091,0.0005214161,0.0006044755,0.00013476126,0.000094157935,0.000083518695,0.00048368945,0.00018757183],"about_ca_topic_score_codex":0.026602242,"about_ca_topic_score_gemma":0.006206184,"teacher_disagreement_score":0.3428987,"about_ca_system_score_codex":0.0022738506,"about_ca_system_score_gemma":0.0006641665,"threshold_uncertainty_score":0.9798797},"labels":[],"label_agreement":null},{"id":"W2045403268","doi":"10.1007/s10549-010-1123-5","title":"The CYP17A1 −34T &gt; C polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"Cancer Research UK; Canadian Institutes of Health Research; Deutsches Krebsforschungszentrum","keywords":"Breast cancer; Oncology; Medicine; Internal medicine; BRCA2 Protein; Mutation; Cancer; Germline mutation; Biology; Genetics; Gene","score_opus":0.014901733678744578,"score_gpt":0.3240505956699931,"score_spread":0.3091488619912485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045403268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9801853,0.014644774,0.0000031318398,0.0037173743,0.00014007725,0.00045187492,0.00072173984,0.000007152708,0.00012857886],"genre_scores_gemma":[0.9687066,0.029802643,0.000048509082,0.000041554347,0.00028665116,0.00065998064,0.000028375305,0.000025531523,0.00040016093],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99853355,0.00011290844,0.0001616704,0.00052087125,0.00022616862,0.00044482315],"domain_scores_gemma":[0.99921316,0.000057815127,0.000056277735,0.00030073716,0.00015894536,0.00021304043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032488743,0.00018982311,0.00013921823,0.00009103347,0.0004764455,0.0001248357,0.00010515132,0.00012781228,0.00003847171],"category_scores_gemma":[0.000022264838,0.0001349285,0.000028396871,0.00016980445,0.00060760387,0.000013309882,0.000109288034,0.00022390364,0.0000015262356],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010065482,0.00012944275,0.1969841,0.000016340538,0.00031050618,0.000022697315,0.00064589607,0.000023625731,0.04547831,0.00015636532,0.00066625455,0.75455993],"study_design_scores_gemma":[0.0037109791,0.00034950938,0.9654856,0.000030220526,0.000035223497,0.0004312085,0.0004774917,0.00014087492,0.014053069,0.0004303237,0.014588434,0.0002670742],"about_ca_topic_score_codex":0.013368383,"about_ca_topic_score_gemma":0.032639466,"teacher_disagreement_score":0.7685015,"about_ca_system_score_codex":0.00020064622,"about_ca_system_score_gemma":0.0004944892,"threshold_uncertainty_score":0.9932017},"labels":[],"label_agreement":null},{"id":"W2045484627","doi":"10.1007/s10549-009-0479-x","title":"Co-amplification of CCND1 and EMSY is associated with an adverse outcome in ER-positive tamoxifen-treated breast cancers","year":2009,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; BC Cancer Agency","funders":"Canadian Institutes of Health Research; Michael Smith Health Research BC; McGill University","keywords":"Tamoxifen; Breast cancer; Oncology; Medicine; Internal medicine; Adverse effect; Mammary gland; Cyclin D1; Cancer","score_opus":0.02925380219239061,"score_gpt":0.3459557256285886,"score_spread":0.316701923436198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045484627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977526,0.00031291216,0.000007857622,0.00032361306,0.0000070403735,0.00047665156,0.0008926298,0.00000986751,0.0002168468],"genre_scores_gemma":[0.99873644,0.00046481309,0.000058217076,0.000047529316,0.000026176938,0.00010199671,0.00025758537,0.00001542309,0.0002918445],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986921,0.000111526366,0.0001721861,0.00044989932,0.00023269221,0.0003415761],"domain_scores_gemma":[0.99929166,0.000014845291,0.00007174982,0.00023911452,0.0002009055,0.00018171141],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017836828,0.00017367581,0.00021624958,0.000107507185,0.000084234896,0.00001924616,0.000073177674,0.00010411171,0.000020448962],"category_scores_gemma":[0.000007051253,0.00013632367,0.000027548223,0.00018662163,0.00016295047,0.000014132032,0.0000175908,0.00007603571,8.760691e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007011502,0.0018564544,0.56385916,0.000030327521,0.00063228235,0.00010140722,0.0009779658,0.00003677695,0.35687035,0.00019415695,0.00012001562,0.068309605],"study_design_scores_gemma":[0.0038545083,0.0036957536,0.86168176,0.00009096466,0.00003721666,0.00008712617,0.00029323046,0.00007368375,0.12985228,0.000082712606,0.000049309983,0.00020146479],"about_ca_topic_score_codex":0.0047647916,"about_ca_topic_score_gemma":0.0027652006,"teacher_disagreement_score":0.29782262,"about_ca_system_score_codex":0.00033145217,"about_ca_system_score_gemma":0.00020435335,"threshold_uncertainty_score":0.72029716},"labels":[],"label_agreement":null},{"id":"W2046248898","doi":"10.1007/s10549-010-1162-y","title":"Concurrent use of tamoxifen with CYP2D6 inhibitors and the risk of breast cancer recurrence","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Tamoxifen; Breast cancer; Medicine; Oncology; Internal medicine; Population; CYP2D6; Cancer; Cohort; Cohort study; Gynecology","score_opus":0.01617350504155061,"score_gpt":0.3061668766328374,"score_spread":0.2899933715912868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046248898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99316764,0.0051456387,0.0000028741838,0.0004320929,0.00006292512,0.00045315537,0.00069889904,0.0000026668479,0.000034099583],"genre_scores_gemma":[0.9818514,0.017739171,0.000022391889,0.0000051747415,0.00009791758,0.00016376577,0.00001585989,0.000011755369,0.00009256557],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990124,0.00013314298,0.00013737204,0.00027170428,0.00020553629,0.00023983009],"domain_scores_gemma":[0.9992486,0.000071984425,0.00009568319,0.00022667198,0.00022244085,0.00013457671],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020661246,0.00014257063,0.0001913029,0.00004196939,0.000112823654,0.000022212678,0.000075813005,0.00009112182,0.00001336723],"category_scores_gemma":[0.000014497095,0.00007184758,0.000046177556,0.00011496066,0.0010376881,0.0000073574074,0.00008002201,0.00020417265,3.8424753e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007043822,0.00072882447,0.53231,0.00011515217,0.0016343335,0.000013591069,0.00060202926,0.00003595206,0.14687368,0.0005138501,0.0007009364,0.30942783],"study_design_scores_gemma":[0.01650861,0.0037322314,0.58352065,0.00048323403,0.00045934698,0.00060605624,0.00024217286,0.00022401918,0.3902202,0.00010945599,0.0034051952,0.0004888124],"about_ca_topic_score_codex":0.008140663,"about_ca_topic_score_gemma":0.0013914324,"teacher_disagreement_score":0.308939,"about_ca_system_score_codex":0.00001957587,"about_ca_system_score_gemma":0.00021043708,"threshold_uncertainty_score":0.9984642},"labels":[],"label_agreement":null},{"id":"W2046425053","doi":"10.1007/s10549-010-0829-8","title":"Among women who experience a recurrence after postmastectomy radiation therapy irradiation is not associated with more aggressive local recurrence or reduced survival","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; BC Cancer Agency; University of British Columbia","funders":"National Center for Research Resources; National Cancer Institute","keywords":"Medicine; Mastectomy; Breast cancer; Radiation therapy; Internal medicine; Randomized controlled trial; Cancer; Oncology; Proportional hazards model; Survival analysis; Clinical trial; Surgery","score_opus":0.028204354898924925,"score_gpt":0.3374733766171007,"score_spread":0.3092690217181758,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046425053","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99635804,0.0011659467,0.00000906443,0.0009911571,0.00013056224,0.0006795391,0.00060290383,0.000019501842,0.000043311626],"genre_scores_gemma":[0.9921176,0.0038357715,0.000021654545,0.00008971635,0.00020699373,0.003288596,0.000104340004,0.00003320315,0.00030215684],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99766016,0.00014416763,0.00019982594,0.0007989659,0.000506395,0.0006904818],"domain_scores_gemma":[0.9986693,0.00007147418,0.00016972199,0.0003918316,0.0004148203,0.00028283455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018375726,0.00034160353,0.00028990593,0.00010233276,0.00031750393,0.000092892486,0.00016121901,0.00015694428,0.00013640763],"category_scores_gemma":[0.000057064586,0.00022879976,0.00004816238,0.000350184,0.000637497,0.000036659647,0.00008140893,0.00021293151,0.0000033201056],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01854649,0.00093095074,0.50069046,0.00002031612,0.00092932873,0.000101416874,0.010752084,0.000006272497,0.006214229,0.000010030291,0.00024844112,0.46154997],"study_design_scores_gemma":[0.003926828,0.001518438,0.97368485,0.000114661314,0.00001898874,0.00004116482,0.00081795314,0.00003405448,0.018762385,0.000011464037,0.0007629218,0.00030629363],"about_ca_topic_score_codex":0.0015698279,"about_ca_topic_score_gemma":0.002436571,"teacher_disagreement_score":0.47299436,"about_ca_system_score_codex":0.00039973302,"about_ca_system_score_gemma":0.0004652218,"threshold_uncertainty_score":0.9330183},"labels":[],"label_agreement":null},{"id":"W2047044229","doi":"10.1007/s10549-005-6941-5","title":"Celecoxib Inhibits Urokinase-Type Plasminogen Activator (uPA) Production in MDA-MB-231 Breast Cancer Cells","year":2005,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia","funders":"National Cancer Institute; Pfizer Canada; University of British Columbia; Pfizer","keywords":"Plasminogen activator; Urokinase; Celecoxib; Breast cancer; Cancer research; Metastatic breast cancer; Medicine; Internal medicine; Activator (genetics); Oncology; Endocrinology; Cancer; Receptor","score_opus":0.03470165394724399,"score_gpt":0.3392442076448864,"score_spread":0.3045425536976424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047044229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902973,0.0018970106,2.1064568e-7,0.005549025,0.00030838564,0.0014601414,0.0001930863,0.000050674364,0.0002441228],"genre_scores_gemma":[0.9917752,0.0035569647,0.000035354366,0.00008238869,0.0017140544,0.0007624039,0.00002933105,0.00005445683,0.0019898543],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997346,0.000141315,0.00028263393,0.0006871584,0.00065112987,0.00089175574],"domain_scores_gemma":[0.99867815,0.000067760535,0.00006832963,0.00034797384,0.0003037526,0.00053402607],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003640942,0.00032454383,0.000430717,0.00038073218,0.00021072729,0.000044856246,0.00007989996,0.00014884649,0.00053606776],"category_scores_gemma":[0.000018093504,0.00024697714,0.000066231376,0.00059599447,0.00017580678,0.00022033892,0.000058190384,0.0003718575,0.00009676778],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016161807,0.003227924,0.20204605,0.0005076738,0.0005193882,0.000517623,0.0017147947,0.00010769601,0.22108008,0.000038178416,0.008269661,0.54580915],"study_design_scores_gemma":[0.0066749146,0.0011178071,0.40485114,0.0006310593,0.00009342142,0.0005102923,0.0001738197,0.00013151244,0.5723044,0.000015471447,0.013118822,0.00037727645],"about_ca_topic_score_codex":0.004264623,"about_ca_topic_score_gemma":0.0030751103,"teacher_disagreement_score":0.54543185,"about_ca_system_score_codex":0.0018386764,"about_ca_system_score_gemma":0.0009432343,"threshold_uncertainty_score":0.9999983},"labels":[],"label_agreement":null},{"id":"W2047045989","doi":"10.1007/s10549-006-9299-4","title":"Cost-utility of adjuvant hormone therapies for breast cancer in post-menopausal women: sequential tamoxifen-exemestane and upfront anastrozole","year":2006,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Nova Scotia; Dalhousie University","funders":"","keywords":"Exemestane; Anastrozole; Medicine; Tamoxifen; Breast cancer; Gynecology; Quality-adjusted life year; Oncology; Cost effectiveness; Internal medicine; Cancer; Risk analysis (engineering)","score_opus":0.01945983161690895,"score_gpt":0.32450126921322836,"score_spread":0.3050414375963194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047045989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.973827,0.021715479,0.000015718646,0.00080519094,0.00003449402,0.0009386203,0.0026073921,0.000006842217,0.000049273774],"genre_scores_gemma":[0.99227434,0.006252789,0.000051323274,0.000015482774,0.0001421149,0.00085992034,0.00013867879,0.000023249411,0.00024209061],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99846405,0.00009740837,0.00021753095,0.00043734215,0.00019708267,0.00058661227],"domain_scores_gemma":[0.99935716,0.000022274915,0.000058450343,0.00019243563,0.0002010169,0.00016862931],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002415341,0.00021485295,0.0002764801,0.000091755894,0.00012255104,0.000030046807,0.00007896163,0.00013147443,0.000040549432],"category_scores_gemma":[0.0000033282888,0.0001617528,0.000035088255,0.000111384994,0.00031671478,0.000011210266,0.000073393916,0.00010491372,4.5355884e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009131877,0.0010074716,0.028716026,0.00007817938,0.00054459873,0.000032039836,0.00031821313,0.000030876177,0.77274346,0.000053650147,0.00047586008,0.18686777],"study_design_scores_gemma":[0.009603974,0.006006214,0.9055802,0.00008223818,0.00007103912,0.00017612267,0.0005432218,0.00021991032,0.07524034,0.00020642992,0.0018909697,0.00037931767],"about_ca_topic_score_codex":0.006907325,"about_ca_topic_score_gemma":0.0020095934,"teacher_disagreement_score":0.8768642,"about_ca_system_score_codex":0.00017085984,"about_ca_system_score_gemma":0.00028743598,"threshold_uncertainty_score":0.9997058},"labels":[],"label_agreement":null},{"id":"W2048250189","doi":"10.1007/s10549-011-1840-4","title":"Chromosome 17 centromere (CEP17) duplication as a predictor of anthracycline response: evidence from the NCIC Clinical Trials Group (NCIC CTG) MA.5 Trial","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; BC Cancer Agency; University of British Columbia; McMaster University; Queen's University; St. Michael's Hospital; Hamilton Health Sciences; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Gene duplication; Oncology; Internal medicine; Anthracycline; Medicine; Breast cancer; Biology; Chromosome; Genetics; Cancer; Gene","score_opus":0.4511763596314084,"score_gpt":0.5504747129697497,"score_spread":0.0992983533383413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048250189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9692452,0.011862638,0.00001748004,0.011941474,0.00028996955,0.00540149,0.0010120774,0.000051577146,0.00017810521],"genre_scores_gemma":[0.9695594,0.024760652,0.00020163275,0.000096806594,0.0018127551,0.002151734,0.00007945633,0.00005795957,0.0012796074],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9905265,0.004250976,0.001438279,0.0010265562,0.0018555536,0.00090215984],"domain_scores_gemma":[0.9896905,0.007057765,0.0003791566,0.0013945668,0.0006494135,0.0008285957],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.011311777,0.00034722523,0.0012108074,0.00022193509,0.00029351545,0.00007122278,0.00047961337,0.00026228846,0.0041124034],"category_scores_gemma":[0.0040184674,0.00020497787,0.00035221517,0.0006627478,0.0011937043,0.00018590606,0.00024047578,0.00070539303,0.0001042572],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6918171,0.003842662,0.09308809,0.00011438648,0.0012486494,0.00020711204,0.0013794658,2.7524905e-7,0.00833957,0.00008431332,0.005952237,0.19392611],"study_design_scores_gemma":[0.06329102,0.017705966,0.90340817,0.0016357326,0.00043852802,0.00010645801,0.00041140753,0.000087810935,0.004704538,0.00045659384,0.007515563,0.00023820008],"about_ca_topic_score_codex":0.024980664,"about_ca_topic_score_gemma":0.0007941213,"teacher_disagreement_score":0.8103201,"about_ca_system_score_codex":0.0009922807,"about_ca_system_score_gemma":0.0026092685,"threshold_uncertainty_score":0.996798},"labels":[],"label_agreement":null},{"id":"W2048287458","doi":"10.1023/a:1024435101619","title":"Pain and Quality of Life after Surgery for Breast Cancer","year":2003,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Pain Management and Opioid Use","field":"Medicine","cited_by":190,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Quality of life (healthcare); Modified Radical Mastectomy; Mastectomy; McGill Pain Questionnaire; Disease; Surgery; Incidence (geometry); Distress; Cancer; Internal medicine","score_opus":0.09943990230683844,"score_gpt":0.39526729723299675,"score_spread":0.2958273949261583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048287458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869542,0.007096522,0.000038395523,0.0041199373,0.000040417046,0.0009126501,0.0006161207,0.000014673088,0.00020708045],"genre_scores_gemma":[0.99241966,0.004657821,0.00007524372,0.00019475984,0.0001226247,0.0010597232,0.000012522945,0.000017417156,0.0014402168],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99853766,0.00023450298,0.0002235826,0.00030504717,0.00029953074,0.0003996729],"domain_scores_gemma":[0.9987718,0.00047363515,0.000047159054,0.00020051988,0.00019836996,0.0003085194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013804317,0.00014310009,0.00037292854,0.00015028789,0.00009088006,0.000023900153,0.000026873578,0.000048203743,0.00030998164],"category_scores_gemma":[0.000088562665,0.000101871265,0.000077622746,0.00016591305,0.00017407697,0.00005173587,0.000022900904,0.00006436483,0.0000013488001],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030355125,0.0003545855,0.90795165,0.00048275,0.00031278285,0.000009144253,0.000110337416,3.1819482e-7,0.00008527277,0.0002790524,0.0012428765,0.08613572],"study_design_scores_gemma":[0.0024494298,0.00022639662,0.99178964,0.00017663634,0.000052289233,0.0000038799485,0.00016730666,0.000022346718,0.00010650972,0.00013646348,0.004770777,0.00009835177],"about_ca_topic_score_codex":0.0041348524,"about_ca_topic_score_gemma":0.0010662838,"teacher_disagreement_score":0.08603737,"about_ca_system_score_codex":0.00016852062,"about_ca_system_score_gemma":0.00034354217,"threshold_uncertainty_score":0.6250688},"labels":[],"label_agreement":null},{"id":"W2048556868","doi":"10.1007/s10549-004-4023-8","title":"The CHEK2 c.1100delC germline mutation rarely contributes to breast cancer development in the Czech Republic","year":2005,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"lékařská fakulta Univerzity Karlovy; Terry Fox Foundation","keywords":"CHEK2; Breast cancer; Germline mutation; Germline; Czech; Mutation; Oncology; Medicine; Internal medicine; Cancer; Biology; Cancer research; Genetics; Gene","score_opus":0.034267851845965085,"score_gpt":0.3631714933122224,"score_spread":0.32890364146625733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048556868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92577666,0.010266476,0.000066195666,0.0621905,0.00008911748,0.0010741445,0.00029313986,0.000011203238,0.00023256638],"genre_scores_gemma":[0.99161124,0.0027597144,0.00015761111,0.0005117138,0.00040858422,0.0032804313,0.00008249535,0.000021496646,0.0011667093],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982203,0.00016009642,0.0002592952,0.00045515265,0.0003600322,0.0005450746],"domain_scores_gemma":[0.99900156,0.00007359265,0.000048510476,0.00037906977,0.00037861418,0.00011867802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006845805,0.00018391106,0.00013391294,0.00010676569,0.0005023214,0.00016861848,0.00027370773,0.00008215166,0.000045830737],"category_scores_gemma":[0.000027289336,0.000108110224,0.000038754406,0.00041692433,0.00016408067,0.000011723261,0.00010995531,0.00013363549,0.000012037766],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011314615,0.00038210378,0.013065382,0.000013533899,0.00033648833,0.000013174847,0.0010177558,0.0005518793,0.0048993626,0.00030949689,0.009194017,0.96908534],"study_design_scores_gemma":[0.0029028277,0.00029525606,0.46870673,0.00007029767,0.000026427277,0.00018188797,0.00073386496,0.00012287614,0.029667106,0.00013029756,0.49688017,0.0002822737],"about_ca_topic_score_codex":0.0015265762,"about_ca_topic_score_gemma":0.017359639,"teacher_disagreement_score":0.96880305,"about_ca_system_score_codex":0.00095112034,"about_ca_system_score_gemma":0.0010871829,"threshold_uncertainty_score":0.9687086},"labels":[],"label_agreement":null},{"id":"W2048687800","doi":"10.1007/s10549-015-3309-3","title":"Cost-effectiveness of prophylactic granulocyte colony-stimulating factor for febrile neutropenia in breast cancer patients receiving FEC-D","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Public Health; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Febrile neutropenia; Filgrastim; Epirubicin; Pegfilgrastim; Breast cancer; Internal medicine; Cost effectiveness; Granulocyte colony-stimulating factor; Quality-adjusted life year; Neutropenia; Oncology; Surgery; Chemotherapy; Cancer","score_opus":0.14494848483956724,"score_gpt":0.4282421451940865,"score_spread":0.28329366035451925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048687800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927567,0.0004592388,0.000009663382,0.00054622407,0.0001723882,0.0046221837,0.001146763,0.000024152601,0.00026263422],"genre_scores_gemma":[0.99459153,0.00027761064,0.000038179365,0.000016850337,0.00014909003,0.004638657,0.0000395887,0.000043429533,0.0002050592],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99795705,0.00022262352,0.00029047002,0.0004893323,0.0004562488,0.00058426],"domain_scores_gemma":[0.9981048,0.00026563625,0.00009598368,0.0002306591,0.00090949907,0.00039341472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003495148,0.00023725364,0.0005416263,0.0002504961,0.00017180486,0.000046541805,0.00007579901,0.000079950165,0.00008311069],"category_scores_gemma":[0.000035671324,0.00018056553,0.00008299857,0.00048416402,0.00016042103,0.00017995888,0.00006205456,0.00019745469,0.000004139539],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011329727,0.00121672,0.91279894,0.0004478474,0.00016527818,0.00001548536,0.00033326552,0.00015588109,0.002821799,0.000024298586,0.00005286104,0.07063788],"study_design_scores_gemma":[0.0143775195,0.002312449,0.9783374,0.0006317638,0.0000836575,0.00004583751,0.000079089936,0.00014319821,0.0034478356,0.00004222005,0.00033838185,0.00016061756],"about_ca_topic_score_codex":0.016645646,"about_ca_topic_score_gemma":0.0026622072,"teacher_disagreement_score":0.07047726,"about_ca_system_score_codex":0.002236524,"about_ca_system_score_gemma":0.0009663111,"threshold_uncertainty_score":0.9899026},"labels":[],"label_agreement":null},{"id":"W2049142360","doi":"10.1007/s10549-010-1318-9","title":"Age of diagnosis, tumor size, and survival after breast cancer: implications for mammographic screening","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Women's College Hospital","funders":"","keywords":"Medicine; Breast cancer; Mammography; Cohort; Cancer; Oncology; Survival rate; Internal medicine; Breast cancer screening; Cohort study; Gynecology","score_opus":0.16070610030501684,"score_gpt":0.40739271373478164,"score_spread":0.2466866134297648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049142360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9841136,0.008542201,0.000047104804,0.003273346,0.00003859264,0.0011895301,0.002455205,0.000026166374,0.00031428467],"genre_scores_gemma":[0.98831,0.0066020074,0.0007112845,0.00009039364,0.00016004457,0.003957366,0.000022230288,0.000025249723,0.00012147395],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99844646,0.00004714073,0.00023668194,0.00043886236,0.00029524305,0.00053560006],"domain_scores_gemma":[0.998716,0.0001673933,0.000062628234,0.00027284282,0.00038591385,0.0003952177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024488525,0.00019568008,0.0003776206,0.000156408,0.00019377777,0.00003103651,0.00008317124,0.00005529223,0.00021062956],"category_scores_gemma":[0.000017099963,0.00014917177,0.00009694496,0.0003338214,0.00036710678,0.000115184455,0.000069825786,0.000116128336,7.9094355e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032348384,0.0002518218,0.8989444,0.0001055568,0.00027212905,0.000045172805,0.00022213107,2.7721165e-7,0.00029050058,0.0003070691,0.000094292525,0.09623183],"study_design_scores_gemma":[0.0024292048,0.0007755613,0.9941328,0.000404127,0.0001637445,0.0001938223,0.0002387548,0.000004263075,0.00040638846,0.00037410788,0.00075049227,0.00012674123],"about_ca_topic_score_codex":0.027497103,"about_ca_topic_score_gemma":0.0060831117,"teacher_disagreement_score":0.09610509,"about_ca_system_score_codex":0.0001570772,"about_ca_system_score_gemma":0.00022925787,"threshold_uncertainty_score":0.9789789},"labels":[],"label_agreement":null},{"id":"W2049167941","doi":"10.1007/s10549-014-3050-3","title":"ERβ splice variant expression in four large cohorts of human breast cancer patient tumors","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"National Institutes of Health","keywords":"Breast cancer; Estrogen receptor; Cancer research; Biomarker; Gene knockdown; Context (archaeology); Oncology; Cancer; RNA splicing; Medicine; Alternative splicing; splice; Triple-negative breast cancer; Immunohistochemistry; Biology; Internal medicine; Gene isoform; Genetics; Gene; RNA","score_opus":0.014128819075056729,"score_gpt":0.3131417675354952,"score_spread":0.29901294846043847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049167941","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965356,0.0021754694,0.0000066538555,0.00022590283,0.000038213348,0.00041756377,0.00025497848,0.0000059290073,0.00033971336],"genre_scores_gemma":[0.99751943,0.0017769466,0.000022724467,0.000019478095,0.00012089487,0.00030878853,0.000048819733,0.00002191317,0.00016100532],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985021,0.00018201357,0.00019508426,0.0004087264,0.00025037894,0.00046171143],"domain_scores_gemma":[0.9993417,0.000018350449,0.00006388448,0.00026987566,0.00011346661,0.00019271395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022587118,0.0001739391,0.00022607077,0.000093971714,0.00013899487,0.0000140109405,0.00009172662,0.0001241402,0.00005134355],"category_scores_gemma":[0.000005274012,0.0001252918,0.000054915206,0.00012950304,0.0000998411,0.000006025442,0.00012179056,0.00012956402,0.0000023984594],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019741408,0.0016817799,0.21999946,0.00012016412,0.0003035831,0.00014583443,0.0003840298,0.000076429,0.71120197,0.00026086753,0.00079960056,0.06305214],"study_design_scores_gemma":[0.007067737,0.0036729898,0.570367,0.0007449248,0.000054883043,0.00039352942,0.0002039238,0.00019253204,0.41425374,0.00015169944,0.002416408,0.0004806263],"about_ca_topic_score_codex":0.0031743124,"about_ca_topic_score_gemma":0.00077706063,"teacher_disagreement_score":0.35036755,"about_ca_system_score_codex":0.00010619035,"about_ca_system_score_gemma":0.00012785874,"threshold_uncertainty_score":0.5109252},"labels":[],"label_agreement":null},{"id":"W2049627106","doi":"10.1007/s10549-011-1506-2","title":"The use of atypical antipsychotics and the risk of breast cancer","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Breast cancer; Medicine; Olanzapine; Risperidone; Internal medicine; Retrospective cohort study; Relative risk; Atypical antipsychotic; Antipsychotic; Cohort; Population; Cohort study; Oncology; Cancer; Pediatrics; Obstetrics; Gynecology; Psychiatry; Confidence interval; Schizophrenia (object-oriented programming)","score_opus":0.1340612527554656,"score_gpt":0.377450515793547,"score_spread":0.2433892630380814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049627106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986433,0.007012724,0.0000036238307,0.004642768,0.000038326012,0.0010334897,0.0007552773,0.000008656913,0.00007207744],"genre_scores_gemma":[0.9346673,0.06441175,0.00020283398,0.00001308833,0.00007576308,0.000303164,0.0000042142283,0.000016576601,0.0003053368],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99814713,0.00027642286,0.00025317012,0.00028545878,0.00057161093,0.0004661906],"domain_scores_gemma":[0.998104,0.00061756576,0.00008873826,0.0004627025,0.00041135034,0.00031564297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041566073,0.00017314553,0.00035791588,0.00009501005,0.00031630349,0.00003532138,0.000104167346,0.00005633687,0.00013240875],"category_scores_gemma":[0.000044187287,0.0000717351,0.0001027178,0.00025925724,0.0018143347,0.00006140095,0.000092179456,0.00022517129,0.0000030470298],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20655155,0.0009809643,0.5454663,0.00005156759,0.0017685116,0.000040643845,0.0005572004,8.686897e-7,0.0000543699,0.0036802182,0.00035137447,0.24049646],"study_design_scores_gemma":[0.0108398395,0.0008635681,0.9854061,0.00013414882,0.00023918718,0.00018964866,0.00015700448,0.0001080015,0.00063882954,0.00093166507,0.00043252177,0.000059470705],"about_ca_topic_score_codex":0.018756106,"about_ca_topic_score_gemma":0.004523038,"teacher_disagreement_score":0.43993983,"about_ca_system_score_codex":0.0001364142,"about_ca_system_score_gemma":0.00041421308,"threshold_uncertainty_score":0.98777807},"labels":[],"label_agreement":null},{"id":"W2049786577","doi":"10.1023/a:1021112121782","title":"Polymorphisms in Steroid Hormone Pathway Genes and Mammographic Density","year":2003,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Digital Radiography and Breast Imaging","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"National Cancer Institute; Centers for Disease Control and Prevention","keywords":"Breast cancer; Genotype; Internal medicine; Endocrinology; Risk factors for breast cancer; Menopause; Allele; Medicine; Hormone; Breast density; Biology; Oncology; Gene; Mammography; Genetics; Cancer","score_opus":0.03640984360185148,"score_gpt":0.3104847936234778,"score_spread":0.2740749500216263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049786577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97513527,0.021904444,0.0000026521195,0.0011174765,0.00001980791,0.00039056863,0.00005958818,0.000020378633,0.0013498082],"genre_scores_gemma":[0.9929791,0.00639913,0.00006883093,0.000044316468,0.000042884192,0.00011702278,0.000008323015,0.00001547543,0.0003249361],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986638,0.00006809332,0.00013611752,0.0003628593,0.0002847982,0.00048435287],"domain_scores_gemma":[0.9993352,0.00004222795,0.00001895819,0.0001813962,0.00007546373,0.00034670986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020630663,0.0001659331,0.000247586,0.0004314732,0.000117671385,0.00007045509,0.00003107063,0.00004540568,0.000023613678],"category_scores_gemma":[0.0000057306133,0.000122028585,0.00005185348,0.0005530807,0.0002899016,0.00012560142,0.000027296624,0.00012747369,0.0000029599207],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006463453,0.0005390558,0.6122568,0.000020576745,0.00011504831,0.00039598107,0.000114780065,1.0342793e-7,0.0028547826,0.00058817654,0.000023877405,0.38244447],"study_design_scores_gemma":[0.003616819,0.0008629777,0.9882353,0.00010559112,0.000025746767,0.0017045635,0.00015619642,0.000006108479,0.003140827,0.00061385933,0.0014012336,0.00013076239],"about_ca_topic_score_codex":0.0019472496,"about_ca_topic_score_gemma":0.00051088614,"teacher_disagreement_score":0.3823137,"about_ca_system_score_codex":0.000114501076,"about_ca_system_score_gemma":0.00013125231,"threshold_uncertainty_score":0.49761814},"labels":[],"label_agreement":null},{"id":"W2050416584","doi":"10.1007/s10549-007-9532-9","title":"Quantitative detection of circulating epithelial cells by Q-RT-PCR","year":2007,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Circulating tumor cell; Mammaglobin; Serial dilution; Cytokeratin; RNA extraction; Reverse transcriptase; Breast cancer; Real-time polymerase chain reaction; Biology; Molecular biology; Cancer; Cancer research; Medicine; RNA; Pathology; Internal medicine; Metastasis; Immunology; Gene; Immunohistochemistry","score_opus":0.07077639996544038,"score_gpt":0.39660214206040895,"score_spread":0.32582574209496856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050416584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947234,0.0029454809,0.00043071504,0.00027985315,0.00007519307,0.0004540993,0.0003224117,0.00001292402,0.0007559204],"genre_scores_gemma":[0.99741787,0.0016172688,0.00021811899,0.00001449524,0.000113089685,0.000050042574,0.000011431969,0.000015888307,0.00054178206],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987894,0.00003898411,0.00018931588,0.0002514001,0.00036833077,0.00036252514],"domain_scores_gemma":[0.9992555,0.00011221048,0.00005327415,0.00014005351,0.00021762116,0.00022138024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038511897,0.00011289622,0.00023449812,0.00014261995,0.00011174863,0.000012610608,0.000027136943,0.000044391792,0.00010857931],"category_scores_gemma":[0.000009147626,0.00008437875,0.0000625885,0.0002596695,0.00015421878,0.000041355644,0.000020265998,0.00010665114,0.0000069873336],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018862374,0.0003139147,0.0021661234,0.00006030783,0.00016907837,0.000032039934,0.00028843983,0.0000015443529,0.6540124,0.000054583306,0.00006362663,0.34095174],"study_design_scores_gemma":[0.0031533325,0.002132514,0.020572577,0.0000965496,0.00008540135,0.0000735959,0.00074236304,0.000034864002,0.96881187,0.000059737107,0.0041431813,0.00009399405],"about_ca_topic_score_codex":0.012018537,"about_ca_topic_score_gemma":0.0012375945,"teacher_disagreement_score":0.34085774,"about_ca_system_score_codex":0.00038664092,"about_ca_system_score_gemma":0.00014579622,"threshold_uncertainty_score":0.99456054},"labels":[],"label_agreement":null},{"id":"W2050939151","doi":"10.1007/s10549-008-0042-1","title":"Mutations of the MYH gene do not substantially contribute to the risk of breast cancer","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Genetic Syndromes and Imprinting","field":"Biochemistry, Genetics and Molecular Biology","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Women's College Hospital; University of Toronto","funders":"","keywords":"Breast cancer; Gene; Medicine; Oncology; Cancer; Genetics; Mutation; Biology; Internal medicine; Cancer research","score_opus":0.02861996030288757,"score_gpt":0.31702780802881747,"score_spread":0.2884078477259299,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050939151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931235,0.0020895435,0.000041999647,0.0021947282,0.00005505944,0.0004299477,0.0019853786,0.0000018071378,0.00007806401],"genre_scores_gemma":[0.99416655,0.004957976,0.000073266376,0.000028040651,0.000110764275,0.00015270927,0.000008714238,0.000011337301,0.0004906484],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99893796,0.00010473474,0.0001713838,0.00023570914,0.00026762192,0.00028260026],"domain_scores_gemma":[0.9991099,0.000026974103,0.000078424375,0.0003485349,0.0003394613,0.00009670093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001787533,0.000108342494,0.00014420919,0.000032694203,0.00026636705,0.000012710174,0.00017875864,0.000044215212,0.00006154032],"category_scores_gemma":[0.000017635813,0.000058537455,0.00008212632,0.00018637777,0.00024056778,0.0000022612905,0.00013186055,0.000062203835,0.0000013548027],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006003537,0.00044194033,0.5534496,0.00003328662,0.0010832279,0.000006066586,0.0009022627,0.00084202434,0.36524612,0.000092629954,0.0011663751,0.07613614],"study_design_scores_gemma":[0.0008441469,0.0002302423,0.86309445,0.000027179663,0.00003870111,0.00012987497,0.00009508318,0.00001970988,0.13382798,0.000016827596,0.0016119335,0.00006385768],"about_ca_topic_score_codex":0.007168092,"about_ca_topic_score_gemma":0.0017516294,"teacher_disagreement_score":0.30964488,"about_ca_system_score_codex":0.00004363282,"about_ca_system_score_gemma":0.0003275221,"threshold_uncertainty_score":0.99944323},"labels":[],"label_agreement":null},{"id":"W2051557651","doi":"10.1007/s10549-012-1960-5","title":"Willingness to use tamoxifen to prevent breast cancer among diverse women","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Center for Research Resources; National Institute on Aging; Agency for Healthcare Research and Quality","keywords":"Tamoxifen; Breast cancer; Medicine; Ethnic group; Logistic regression; Family medicine; Oncology; Cancer; Demography; Gynecology; Gerontology; Internal medicine","score_opus":0.04352565877806177,"score_gpt":0.3600465472212384,"score_spread":0.31652088844317666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051557651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949964,0.00081266294,0.000047986934,0.0016138719,0.00020415662,0.0008638377,0.0013540823,0.000014579953,0.00009239434],"genre_scores_gemma":[0.99123293,0.0010437743,0.0001668497,0.00021337741,0.000717937,0.0032967257,0.00003729902,0.000042196443,0.0032488825],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99791133,0.000096768934,0.00016127713,0.0005321911,0.00035278095,0.00094562303],"domain_scores_gemma":[0.9983725,0.000020699827,0.000034307723,0.0004253908,0.0002749674,0.0008721427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024548607,0.00023367925,0.00018705483,0.00011096576,0.0002502917,0.000091485934,0.00017675075,0.00009414528,0.00027883876],"category_scores_gemma":[0.00001372258,0.0001946679,0.000049122948,0.00030869961,0.00013145384,0.000027519398,0.0002865068,0.0000874778,0.000035780322],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001927888,0.0013533226,0.76835495,0.000046457535,0.0008019394,0.000017378714,0.0046869777,0.0006635554,0.026764158,0.00004384959,0.0085182125,0.18682131],"study_design_scores_gemma":[0.0009908543,0.0005374128,0.9227712,0.00007095962,0.00003384691,0.00005809265,0.0005189459,0.000008009045,0.020788647,0.00001555861,0.05384886,0.00035761463],"about_ca_topic_score_codex":0.0073139803,"about_ca_topic_score_gemma":0.0025337078,"teacher_disagreement_score":0.1864637,"about_ca_system_score_codex":0.0013141513,"about_ca_system_score_gemma":0.00037338003,"threshold_uncertainty_score":0.9992964},"labels":[],"label_agreement":null},{"id":"W2051714896","doi":"10.1007/s10549-009-0477-z","title":"Psychological distress and physical health in the year after diagnosis of DCIS or invasive breast cancer","year":2009,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer survivorship and care","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Université de Montréal; Hôpital Notre-Dame; Centre hospitalier universitaire de Québec; Hôpital du Saint-Sacrement","funders":"Canadian Institutes of Health Research","keywords":"Breast cancer; Medicine; Ductal carcinoma; Quality of life (healthcare); Distress; Internal medicine; Disease; Psychological distress; Gynecology; Cancer; Oncology; Mental health; Clinical psychology; Psychiatry","score_opus":0.06613567858472585,"score_gpt":0.4247944006821579,"score_spread":0.35865872209743205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051714896","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9597097,0.0036442943,2.542543e-7,0.034735538,0.000026676953,0.00060180435,0.0011378201,0.0000074619375,0.00013642096],"genre_scores_gemma":[0.97868294,0.019596113,0.000005299714,0.00053008134,0.0002133395,0.00085093937,0.000015086116,0.000008643139,0.00009758725],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986278,0.00013917421,0.00014757174,0.00034855303,0.00035167756,0.0003852701],"domain_scores_gemma":[0.9992543,0.00017138413,0.000033771885,0.00023186485,0.00009006203,0.0002186444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014487248,0.00015033426,0.0003356438,0.00008480665,0.000071611736,0.000027979519,0.00007209799,0.000046104018,0.00022078179],"category_scores_gemma":[0.0000080310765,0.000076563665,0.000052635543,0.0003167687,0.00023149261,0.000044837452,0.00002822284,0.0001767597,0.0000017813027],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006154756,0.001903212,0.4420431,0.000098139244,0.00008308529,0.00012812437,0.0039607766,3.5351704e-7,0.000014553373,0.000105358755,0.0008367283,0.54467183],"study_design_scores_gemma":[0.0022324943,0.0021113756,0.99356264,0.0003660926,0.000033852837,0.00011062943,0.0009447008,0.0000024614956,0.00005813064,0.00017395092,0.00032766414,0.0000760325],"about_ca_topic_score_codex":0.015439731,"about_ca_topic_score_gemma":0.033598457,"teacher_disagreement_score":0.5515195,"about_ca_system_score_codex":0.00023237045,"about_ca_system_score_gemma":0.00020639415,"threshold_uncertainty_score":0.9911165},"labels":[],"label_agreement":null},{"id":"W2051771186","doi":"10.1007/s10549-006-9439-x","title":"Provider’s volume and quality of breast cancer detection and treatment","year":2006,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Institut National de Santé Publique du Québec; Hôpital Charles-Le Moyne","funders":"","keywords":"Medicine; Mammography; Breast cancer; Psychological intervention; Breast cancer screening; Medical physics; Cancer; Gynecology; Family medicine; Oncology; Internal medicine; Nursing","score_opus":0.3010050145181978,"score_gpt":0.4954629894190316,"score_spread":0.19445797490083383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051771186","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01566859,0.97912097,0.0000026478008,0.00051141216,0.00005754843,0.002165149,0.0022001765,0.00002996481,0.00024351875],"genre_scores_gemma":[0.027755532,0.9681301,0.000031581676,0.000012622621,0.00041840496,0.001644481,0.00007303772,0.000047949525,0.0018863013],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968842,0.00026484023,0.0006317792,0.0008906439,0.00066875725,0.0006597441],"domain_scores_gemma":[0.99839413,0.0001326811,0.00026186203,0.0003932575,0.0003440725,0.00047402256],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00037619635,0.0005621195,0.0018889209,0.00030870005,0.00025600084,0.000085055384,0.00007256964,0.00026378184,0.00009492643],"category_scores_gemma":[0.0000118048865,0.0003687438,0.00022203308,0.00038513922,0.00046188923,0.00012781557,0.000093530296,0.00027037828,0.000003722367],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080955855,0.00028172604,0.012871122,0.004713727,0.0007100344,0.00004941585,0.00006910256,2.8874152e-7,0.00001294234,0.000020000372,0.00009337715,0.98036873],"study_design_scores_gemma":[0.008079117,0.0052089696,0.2419338,0.022845343,0.003477455,0.0028243437,0.0002861948,0.000029123563,0.00006429124,0.00006471078,0.71424663,0.0009400433],"about_ca_topic_score_codex":0.16390717,"about_ca_topic_score_gemma":0.021130746,"teacher_disagreement_score":0.97942865,"about_ca_system_score_codex":0.0022298198,"about_ca_system_score_gemma":0.0012566659,"threshold_uncertainty_score":0.99987644},"labels":[],"label_agreement":null},{"id":"W2051838333","doi":"10.1007/s10549-006-9320-y","title":"A deletion in CHEK2 of 5,395 bp predisposes to breast cancer in Poland","year":2006,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":115,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Coalition for Research in Women's Health","funders":"","keywords":"Breast cancer; CHEK2; Oncology; Internal medicine; Medicine; Cancer; Cancer research; Biology; Genetics; Gene; Mutation","score_opus":0.020181245418625888,"score_gpt":0.3487212990047873,"score_spread":0.32854005358616145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051838333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99307436,0.0031669585,0.00000926799,0.0019742192,0.00003819027,0.0004533727,0.00096834457,0.0000035878952,0.00031167772],"genre_scores_gemma":[0.9970697,0.001503034,0.000072789626,0.000026738115,0.00019617744,0.0007024596,0.00005410728,0.000016517686,0.00035848655],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99883336,0.00006284555,0.00019074058,0.00036665756,0.00019579186,0.00035058183],"domain_scores_gemma":[0.9995397,0.000013031399,0.00003140246,0.00019195721,0.00014081979,0.0000831226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014430305,0.00012851851,0.00014999372,0.00018980826,0.000042214757,0.000018324547,0.00008571808,0.000078562836,0.00006361537],"category_scores_gemma":[0.000004351631,0.000110251676,0.000028858469,0.00032254143,0.00009714086,0.0000064474,0.000063428044,0.00006559037,0.0000019060271],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019521201,0.000726296,0.78185546,0.000053371376,0.000082670296,0.00001713068,0.00022144159,0.0014253361,0.11412487,0.000092741546,0.0010962416,0.09835234],"study_design_scores_gemma":[0.0018399324,0.00029965132,0.9644701,0.00009725992,0.0000076876895,0.00003279293,0.00008825491,0.000039529506,0.03091712,0.00012295965,0.0019614706,0.00012322512],"about_ca_topic_score_codex":0.035750095,"about_ca_topic_score_gemma":0.06412878,"teacher_disagreement_score":0.18261468,"about_ca_system_score_codex":0.00050917844,"about_ca_system_score_gemma":0.0004382665,"threshold_uncertainty_score":0.97067094},"labels":[],"label_agreement":null},{"id":"W2052100668","doi":"10.1007/s10549-011-1854-y","title":"Local treatment of mixed osteolytic/osteoblastic spinal metastases: is photodynamic therapy effective?","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Ontario Institute for Cancer Research; Sunnybrook Hospital; Sunnybrook Health Science Centre","funders":"Ontario Institute for Cancer Research","keywords":"Medicine; Photodynamic therapy; Osteolysis; Cancer; Pathology; Breast cancer; Prostate cancer; Internal medicine; Surgery","score_opus":0.0696665296868817,"score_gpt":0.3696950802209022,"score_spread":0.3000285505340205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052100668","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895366,0.0050032074,0.00017355372,0.000428085,0.000061459294,0.0030697456,0.0005620084,0.000034831664,0.0011305236],"genre_scores_gemma":[0.9936825,0.0030499217,0.00022533175,0.000040929608,0.000042860793,0.0020246373,0.00003500463,0.000039593313,0.0008592171],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9975982,0.00025191266,0.00031264033,0.0005725757,0.0006723712,0.0005923184],"domain_scores_gemma":[0.9985398,0.00012352662,0.00008625498,0.0005108639,0.00023699565,0.00050258165],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027614026,0.00035111114,0.0006262272,0.00034905417,0.000117568605,0.000021543086,0.000088997826,0.000050652878,0.0016754474],"category_scores_gemma":[0.000011493224,0.00023086464,0.00018910262,0.00032887663,0.00049729616,0.00007762712,0.000047349902,0.000080699545,0.0000464203],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029372964,0.009412844,0.013096083,0.0003314207,0.003434051,0.0007073729,0.0012889054,0.0000013807619,0.0014823198,0.00035299617,0.00017643659,0.9403432],"study_design_scores_gemma":[0.04802289,0.06951783,0.77879655,0.0006986214,0.0019295134,0.00033010892,0.0023702157,0.00057091843,0.09281448,0.0006804141,0.0036864022,0.0005820438],"about_ca_topic_score_codex":0.0063336105,"about_ca_topic_score_gemma":0.00025900317,"teacher_disagreement_score":0.93976116,"about_ca_system_score_codex":0.000671964,"about_ca_system_score_gemma":0.00031301356,"threshold_uncertainty_score":0.9992372},"labels":[],"label_agreement":null},{"id":"W2052566490","doi":"10.1007/s10549-014-2973-z","title":"Associations between anthropometric characteristics, physical activity, and breast cancer risk in a Canadian cohort","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Waterloo; University of Calgary; University of Alberta; Cancer Care Ontario; Public Health Ontario; University of Toronto","funders":"","keywords":"Breast cancer; Medicine; Hazard ratio; Anthropometry; Cohort; Metabolic equivalent; Prospective cohort study; Cohort study; Obesity; Cancer; Proportional hazards model; Body mass index; Internal medicine; Confidence interval; Demography; Gynecology; Physical therapy; Physical activity","score_opus":0.04429318119086831,"score_gpt":0.3915358403306941,"score_spread":0.34724265913982577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052566490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867515,0.00030622544,0.000001834034,0.0039617755,0.000049401235,0.000614131,0.008070343,0.000015647045,0.00022913626],"genre_scores_gemma":[0.9933979,0.005460878,0.0000037944262,0.000019466353,0.0005950738,0.00023241749,0.00007569662,0.000025485799,0.00018929497],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99821335,0.000108567656,0.00014057214,0.00044012608,0.0003882965,0.00070911186],"domain_scores_gemma":[0.99858713,0.00015827561,0.000063951964,0.0002008663,0.00016536168,0.00082441553],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029268235,0.00019468156,0.0005110331,0.0005505064,0.00028925255,0.000072898234,0.000049613143,0.0000864779,0.00010982639],"category_scores_gemma":[0.000030342566,0.00015249413,0.000049652717,0.0006384486,0.00023104332,0.000088691624,0.000041912965,0.00031429037,0.0000071661993],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000105132254,0.00027379193,0.71937376,0.000012779471,0.00017631431,0.000011532976,0.00015639611,2.4612297e-7,0.000020249907,0.00002115236,0.000070283975,0.27977836],"study_design_scores_gemma":[0.0017759769,0.00034903424,0.99622405,0.00007249132,0.00013048414,0.000018844468,0.000027250537,0.00016806177,0.000047687456,0.000037437763,0.0010131992,0.0001354939],"about_ca_topic_score_codex":0.9590577,"about_ca_topic_score_gemma":0.6396933,"teacher_disagreement_score":0.3193644,"about_ca_system_score_codex":0.0024419825,"about_ca_system_score_gemma":0.000823848,"threshold_uncertainty_score":0.6385699},"labels":[],"label_agreement":null},{"id":"W2053810161","doi":"10.1007/s10549-010-0943-7","title":"DEAD box 1: a novel and independent prognostic marker for early recurrence in breast cancer","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Wnt/β-catenin signaling in development and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":70,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Alberta Cancer Foundation; Cancer Research Institute","keywords":"Breast cancer; Medicine; Oncology; Cancer; Internal medicine","score_opus":0.03230631072071268,"score_gpt":0.3349686635094247,"score_spread":0.30266235278871206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053810161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99506396,0.0020159024,0.000027356322,0.0012969694,0.0001436737,0.000795009,0.0005620328,0.000007588648,0.0000875055],"genre_scores_gemma":[0.9938644,0.0024216815,0.00029405198,0.000039620412,0.00027144217,0.0023041626,0.000046330428,0.000026438222,0.0007318368],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99842554,0.00003178891,0.00017541139,0.0005808221,0.00024090444,0.00054555817],"domain_scores_gemma":[0.99929667,0.000040546864,0.00004321682,0.00018392374,0.00022931876,0.0002063351],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003020175,0.00020888679,0.00017671159,0.000100591955,0.00015471075,0.00008572607,0.00012978006,0.00014450273,0.00006264707],"category_scores_gemma":[0.00001563408,0.00016725252,0.000037465255,0.0001418846,0.00020573399,0.000012461753,0.0001113265,0.00018029213,0.0000017799362],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015604219,0.00032744196,0.8305127,0.000051280746,0.00014955414,0.0000075826847,0.00014248388,0.000002251948,0.088355035,0.00004068012,0.0005391791,0.0783114],"study_design_scores_gemma":[0.0030270694,0.00034069174,0.9791568,0.0001189646,0.000021998214,0.00009153137,0.000046700676,0.000032007345,0.011423879,0.00008055438,0.0054024816,0.00025734666],"about_ca_topic_score_codex":0.0026301825,"about_ca_topic_score_gemma":0.005199722,"teacher_disagreement_score":0.14864407,"about_ca_system_score_codex":0.00009723332,"about_ca_system_score_gemma":0.00045817287,"threshold_uncertainty_score":0.68203604},"labels":[],"label_agreement":null},{"id":"W2053822585","doi":"10.1023/a:1010665603732","title":"Incidence of Second Primary Breast Cancer Among Women with a First Primary in Manitoba, Canada","year":2001,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Research Manitoba; Manitoba Health; Health Canada; University of Ottawa","funders":"Social Sciences and Humanities Research Council of Canada; Canadian Institutes of Health Research; Health Canada","keywords":"Breast cancer; Medicine; Incidence (geometry); Cancer; Population; Epidemiology; Gynecology; Obstetrics; Internal medicine; Oncology; Environmental health","score_opus":0.016294957436057675,"score_gpt":0.27401527607006454,"score_spread":0.25772031863400685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053822585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949472,0.0021463113,0.0000028130826,0.00079818,0.00003678366,0.0004304412,0.00094179163,0.0000040487776,0.0006924085],"genre_scores_gemma":[0.99441844,0.0032779402,0.000036518253,0.00008636628,0.00013346429,0.0011458786,0.000053580086,0.00002640836,0.00082141825],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983913,0.000046899822,0.00019654742,0.00046461006,0.0003709183,0.00052972644],"domain_scores_gemma":[0.9991657,0.000031846936,0.00006749401,0.00031931687,0.00022474726,0.00019090214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001274373,0.00019108925,0.00022580898,0.000099473036,0.00011642142,0.000032108415,0.00016555503,0.00007163113,0.00021761627],"category_scores_gemma":[0.0000036344256,0.00015379132,0.000019285733,0.00030834854,0.0002825323,0.000017439352,0.00011349693,0.00011247317,7.394784e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021282102,0.00024137773,0.9555095,0.0001234315,0.00023888954,0.000104563165,0.00028839312,0.000180869,0.0035424063,0.0000029369296,0.0009661398,0.036673278],"study_design_scores_gemma":[0.0016667756,0.00034617155,0.99005395,0.00012839293,0.000009390435,0.00018237064,0.00038251065,0.0000057455572,0.0017373658,0.00001156089,0.005303219,0.00017253477],"about_ca_topic_score_codex":0.49844578,"about_ca_topic_score_gemma":0.9714482,"teacher_disagreement_score":0.4730024,"about_ca_system_score_codex":0.0029722615,"about_ca_system_score_gemma":0.003941769,"threshold_uncertainty_score":0.77723604},"labels":[],"label_agreement":null},{"id":"W2053852384","doi":"10.1007/s10549-011-1847-x","title":"A plea for the biopsy marker: how, why and why not clipping after breast biopsy?","year":2011,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Breast Lesions and Carcinomas","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Biopsy; Radiology; Breast cancer; Mammography; Breast MRI; CLIPS; Mastectomy; Breast biopsy; Percutaneous; Breast imaging; Magnetic resonance imaging; Sentinel lymph node; Breast ultrasound; Neoadjuvant therapy; Surgery; Cancer; Internal medicine","score_opus":0.1500653269298619,"score_gpt":0.390934296911341,"score_spread":0.2408689699814791,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053852384","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00057194714,0.98598623,0.000023181541,0.0060835877,0.00012869376,0.0037422602,0.0032375648,0.000038004495,0.00018850302],"genre_scores_gemma":[0.0049665123,0.9847679,0.00012104005,0.00015510015,0.0008285642,0.006744907,0.00012116524,0.00012434121,0.0021704587],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99681187,0.00022325112,0.00040250976,0.0010312092,0.0004834056,0.0010477332],"domain_scores_gemma":[0.9976081,0.00040207122,0.0001445811,0.0008401003,0.00034411423,0.00066099316],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005968031,0.0007037904,0.0014808219,0.00040060794,0.0005381471,0.00022484669,0.0002070958,0.00033206693,0.0003701706],"category_scores_gemma":[0.000015084528,0.0003669953,0.0004904917,0.00044698344,0.0006313642,0.00009907586,0.00024028882,0.0004928752,0.000017214194],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018400316,0.000317181,0.00079151295,0.0047619557,0.0012389545,0.00018089428,0.000093332324,3.2971086e-9,0.0000026984376,0.00014186128,0.0013092804,0.9893223],"study_design_scores_gemma":[0.0023757934,0.0006053299,0.03245045,0.008746425,0.0019715535,0.014115489,0.0001356322,0.0000073618303,0.0000010623761,0.000031489843,0.93916875,0.0003906803],"about_ca_topic_score_codex":0.0033882644,"about_ca_topic_score_gemma":0.00028991431,"teacher_disagreement_score":0.9889316,"about_ca_system_score_codex":0.0005255718,"about_ca_system_score_gemma":0.0007962183,"threshold_uncertainty_score":0.9998782},"labels":[],"label_agreement":null},{"id":"W2054327739","doi":"10.1007/s10549-010-1264-6","title":"Acquisition of metastatic tissue from patients with bone metastases from breast cancer","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ottawa Hospital; Princess Margaret Cancer Centre; University of Ottawa","funders":"","keywords":"Medicine; Trephine; Biopsy; Bone marrow; Iliac crest; Bone metastasis; Metastasis; Breast cancer; Cancer; Radiology; Metastatic breast cancer; Pathology; Surgery; Internal medicine","score_opus":0.030765640557984617,"score_gpt":0.35374861379259953,"score_spread":0.3229829732346149,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054327739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9651392,0.0035676307,0.000004791449,0.0029622363,0.0000981648,0.0010835538,0.027051967,0.00002365911,0.00006880142],"genre_scores_gemma":[0.99463457,0.0021881065,0.0005051704,0.0000580975,0.00025177668,0.0011642401,0.0010351631,0.000042094376,0.00012079659],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978163,0.00007272836,0.00028389684,0.0005891343,0.0007791642,0.0004587497],"domain_scores_gemma":[0.9983071,0.00018350806,0.00011733636,0.00045304728,0.000503263,0.0004357076],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00009219345,0.00030448666,0.0006205372,0.00017599022,0.00014715536,0.000050821614,0.00006875676,0.00005858925,0.0035772056],"category_scores_gemma":[0.000004113361,0.00019146655,0.00007752879,0.0002741998,0.00029288363,0.00014040378,0.000053857857,0.00018693654,0.000017263968],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005514859,0.0050075892,0.66146505,0.000056924328,0.0024597398,0.00015640075,0.0002955894,0.0000027658816,0.004864143,0.00006479028,0.0005573625,0.31955478],"study_design_scores_gemma":[0.011135857,0.0015097184,0.9686772,0.00035920096,0.00092433847,0.00003518775,0.000097549,0.000009547107,0.015478472,0.00015738339,0.0014368353,0.0001786738],"about_ca_topic_score_codex":0.15862562,"about_ca_topic_score_gemma":0.020001475,"teacher_disagreement_score":0.31937608,"about_ca_system_score_codex":0.000412929,"about_ca_system_score_gemma":0.0004082581,"threshold_uncertainty_score":0.99788094},"labels":[],"label_agreement":null},{"id":"W2054350484","doi":"10.1007/s10549-013-2490-5","title":"MicroSPECT/CT imaging of co-expressed HER2 and EGFR on subcutaneous human tumor xenografts in athymic mice using 111In-labeled bispecific radioimmunoconjugates","year":2013,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Medicine; Cancer research; Chimera (genetics); Pathology; Biology; Gene","score_opus":0.0593012011594051,"score_gpt":0.39596892794450966,"score_spread":0.3366677267851046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054350484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874088,0.008668786,3.7409183e-7,0.0011433301,0.000039230315,0.002126633,0.0001715313,0.00003272168,0.00040860364],"genre_scores_gemma":[0.9956384,0.0031071603,0.00014986566,0.000045970177,0.00013599181,0.00045976308,0.000024994022,0.00007334497,0.00036454413],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9967439,0.000209736,0.00046621318,0.0007704538,0.00074733404,0.0010623632],"domain_scores_gemma":[0.99850094,0.00021823269,0.00009291286,0.00045017933,0.00031859227,0.00041912287],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004373642,0.00035585105,0.00066437427,0.00063664006,0.00028971405,0.00016153244,0.00017651843,0.00003398431,0.0005098577],"category_scores_gemma":[0.00002251563,0.00028702794,0.00007283968,0.0005163312,0.0007560341,0.00013090727,0.000105607134,0.00045802002,0.000029529314],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021220478,0.0013513414,0.22860308,0.00037696693,0.000244747,0.0028244336,0.00055837637,0.000006122607,0.73477966,0.00006662345,0.00045739443,0.028609185],"study_design_scores_gemma":[0.029630145,0.0074059935,0.4882652,0.0049201143,0.00015422994,0.0108602885,0.0025224814,0.0011361763,0.4499131,0.0006185346,0.0034589162,0.0011148298],"about_ca_topic_score_codex":0.05594511,"about_ca_topic_score_gemma":0.00089974276,"teacher_disagreement_score":0.28486657,"about_ca_system_score_codex":0.0016540914,"about_ca_system_score_gemma":0.00046629645,"threshold_uncertainty_score":0.99995816},"labels":[],"label_agreement":null},{"id":"W2054386542","doi":"10.1023/a:1006356502820","title":"Shorter CAG repeat length in the androgen receptor gene is associated with more aggressive forms of breast cancer","year":2000,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Sexual Differentiation and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":92,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Androgen receptor; Allele; Breast cancer; Biology; Prostate cancer; Trinucleotide repeat expansion; Internal medicine; Cancer; Androgen; Genetics; Gene; Cancer research; Oncology; Endocrinology; Medicine; Hormone","score_opus":0.025064109010404317,"score_gpt":0.327860753974465,"score_spread":0.30279664496406067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054386542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99465096,0.0020850196,7.5599206e-7,0.0013532136,0.000010421621,0.00036828683,0.0012219595,0.0000036029542,0.000305774],"genre_scores_gemma":[0.9940859,0.0041918163,0.000003802597,0.0001668011,0.0000475618,0.0003230133,0.00035782863,0.000014527666,0.0008087484],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99889123,0.00008089148,0.00013227273,0.0003099849,0.00027559508,0.00031001115],"domain_scores_gemma":[0.99949694,0.000014600555,0.00005424065,0.00022195338,0.00012761053,0.00008466941],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009647159,0.00014485566,0.00015262104,0.000049649025,0.00009720209,0.00002724004,0.000107863554,0.00007673036,0.0005678897],"category_scores_gemma":[0.0000042545694,0.00008104664,0.00003893474,0.00016990337,0.00015675943,0.000007560021,0.000022301003,0.00006940143,0.000001863795],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006295816,0.0023830717,0.5757198,0.000041960782,0.0015980715,0.00006694467,0.0039205016,0.00005938529,0.011119369,0.000027404161,0.0042767036,0.39449102],"study_design_scores_gemma":[0.007312607,0.001585265,0.9540608,0.00017849097,0.00008259159,0.00016122889,0.0019037554,0.00007622313,0.03142075,0.00005675234,0.002779729,0.00038184054],"about_ca_topic_score_codex":0.0029231347,"about_ca_topic_score_gemma":0.003988868,"teacher_disagreement_score":0.3941092,"about_ca_system_score_codex":0.000085135674,"about_ca_system_score_gemma":0.00014464825,"threshold_uncertainty_score":0.6217994},"labels":[],"label_agreement":null},{"id":"W2054541910","doi":"10.1007/s10549-010-1232-1","title":"The PI3 kinase/mTOR blocker NVP-BEZ235 overrides resistance against irreversible ErbB inhibitors in breast cancer cells","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"PI3K/AKT/mTOR pathway; ErbB; Lapatinib; Protein kinase B; Erlotinib; Cancer research; Gefitinib; Breast cancer; Pharmacology; EGFR inhibitors; Drug resistance; Medicine; Cancer; Phosphorylation; Biology; Signal transduction; Internal medicine; Epidermal growth factor receptor; Trastuzumab; Cell biology","score_opus":0.016603159093930408,"score_gpt":0.31025268447063814,"score_spread":0.29364952537670774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054541910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98403287,0.00863258,0.0000015142177,0.004216881,0.00060153,0.000631118,0.0010375971,0.00001936098,0.00082652975],"genre_scores_gemma":[0.9837567,0.010374981,0.00006243923,0.0001219489,0.0010732498,0.0005726744,0.000037843853,0.000056574416,0.0039435765],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99726504,0.00014111387,0.00030152092,0.0008063494,0.0005235186,0.0009624337],"domain_scores_gemma":[0.99852335,0.000090380076,0.00009556456,0.00066227675,0.0002986216,0.00032979317],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004717942,0.00034959006,0.00025905596,0.00011796629,0.00051147275,0.00015519372,0.00036143351,0.00021500405,0.00011590226],"category_scores_gemma":[0.000019016576,0.00025162514,0.00010764733,0.00034934006,0.00057652115,0.000018941431,0.00019804391,0.00041655355,0.000014206086],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026616706,0.0005209546,0.057637516,0.00006896216,0.00034651096,0.00008361593,0.00019789863,0.00006448933,0.8516596,0.00010941601,0.030307457,0.05634193],"study_design_scores_gemma":[0.004953567,0.0004602794,0.07495138,0.00039818932,0.000055800712,0.000050915794,0.00039356964,0.000057208243,0.5888725,0.00020506476,0.3287606,0.000840949],"about_ca_topic_score_codex":0.004780147,"about_ca_topic_score_gemma":0.031070426,"teacher_disagreement_score":0.29845315,"about_ca_system_score_codex":0.0004562194,"about_ca_system_score_gemma":0.00084420043,"threshold_uncertainty_score":0.9999936},"labels":[],"label_agreement":null},{"id":"W2055726268","doi":"10.1023/a:1006425809069","title":"p53 Protein Accumulation in Non-Invasive Lesions Surrounding p53 Mutation Positive Invasive Breast Cancers","year":2001,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"National Cancer Institute","keywords":"Pathology; Biology; Invasive lobular carcinoma; Carcinogenesis; Missense mutation; Ductal carcinoma; Breast cancer; Carcinoma; Cancer research; Staining; Hyperplasia; Immunohistochemistry; Mutation; Cancer; Medicine; Invasive ductal carcinoma; Gene; Genetics","score_opus":0.07248034722259618,"score_gpt":0.38080819312264935,"score_spread":0.3083278459000532,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055726268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913113,0.001036368,0.00007049444,0.0031729357,0.00007213753,0.0030118953,0.00033659057,0.000040262243,0.00094797893],"genre_scores_gemma":[0.9953679,0.0019888093,0.00009144321,0.00005324121,0.00020452142,0.0014370228,0.0002008888,0.000050504783,0.0006056601],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99745274,0.00017333466,0.00031167906,0.0006589166,0.00066077797,0.0007425385],"domain_scores_gemma":[0.9985343,0.00017626754,0.00009684394,0.00029985968,0.00048230714,0.00041040138],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026739374,0.00029397832,0.00037860285,0.0005909443,0.00030416352,0.00007594746,0.00007720136,0.00015320885,0.00014220347],"category_scores_gemma":[0.000062464314,0.00025742798,0.00008784945,0.00095596636,0.00019538819,0.0002477808,0.00006178997,0.00035572224,0.000029952547],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022256838,0.0034955149,0.19511227,0.00051618303,0.0019807962,0.011437706,0.009647412,0.003423383,0.2183096,0.0008182212,0.00049198413,0.5325101],"study_design_scores_gemma":[0.017648507,0.0028635222,0.9257092,0.00420736,0.00020077881,0.0035359971,0.0025227098,0.0010867612,0.041014176,0.0003973128,0.00021921095,0.0005944804],"about_ca_topic_score_codex":0.04578433,"about_ca_topic_score_gemma":0.036292434,"teacher_disagreement_score":0.7305969,"about_ca_system_score_codex":0.0060409503,"about_ca_system_score_gemma":0.0021713777,"threshold_uncertainty_score":0.9999878},"labels":[],"label_agreement":null},{"id":"W2056242601","doi":"10.1007/s10549-011-1482-6","title":"FOXA1 is an independent prognostic marker for ER-positive breast cancer","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"FOXO transcription factor regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":133,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Sanofi","keywords":"FOXA1; Breast cancer; Oncology; Estrogen receptor; Internal medicine; Medicine; Tamoxifen; Population; Cancer; Survival analysis","score_opus":0.06705456540238168,"score_gpt":0.34609874910648863,"score_spread":0.27904418370410694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056242601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99380374,0.0009880133,0.0001301938,0.00067255204,0.00007974662,0.0011162647,0.0029317478,0.000014092526,0.00026363446],"genre_scores_gemma":[0.99643695,0.0007184559,0.00012237178,0.00005685253,0.000202049,0.0012955918,0.00022623807,0.00003176158,0.0009097107],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985921,0.00007710219,0.00013684873,0.00052505924,0.0002404297,0.00042847745],"domain_scores_gemma":[0.9991162,0.000011166944,0.00003728939,0.00024213988,0.00034819066,0.0002450526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013297884,0.00018729593,0.00013616633,0.00007405578,0.00018697603,0.000045253364,0.00010063495,0.000114252194,0.0003172027],"category_scores_gemma":[0.0000030347665,0.00015096387,0.00006639238,0.00008500627,0.00015001239,0.000018428756,0.00003590296,0.00006451828,0.0000053050867],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011539792,0.0023618839,0.54982865,0.00011222886,0.0013453423,0.00002572745,0.0018550738,0.00000856228,0.13661213,0.0003937718,0.0012646784,0.29465213],"study_design_scores_gemma":[0.0020700085,0.0013125679,0.95582294,0.00004527261,0.000055338736,0.00009203394,0.00013559827,0.000054029115,0.038485337,0.00015612296,0.0015670314,0.00020370042],"about_ca_topic_score_codex":0.0037772488,"about_ca_topic_score_gemma":0.0018752615,"teacher_disagreement_score":0.4059943,"about_ca_system_score_codex":0.00016489085,"about_ca_system_score_gemma":0.00021781777,"threshold_uncertainty_score":0.6156128},"labels":[],"label_agreement":null},{"id":"W2056416478","doi":"10.1007/s10549-009-0586-8","title":"Evidence for a tumor promoting effect of high-fat diet independent of insulin resistance in HER2/Neu mammary carcinogenesis","year":2009,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; University Health Network; University of Toronto; McGill University","funders":"Canadian Institutes of Health Research","keywords":"Internal medicine; Endocrinology; Hyperinsulinemia; Insulin resistance; Mammary gland; Mammary tumor; Insulin; Biology; Carcinogenesis; Protein kinase B; Breast cancer; Basal (medicine); Cancer; Medicine; Phosphorylation","score_opus":0.035314030834319284,"score_gpt":0.34088451383687596,"score_spread":0.3055704830025567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056416478","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.78077775,0.2181905,0.000008759934,0.00011618151,0.000025269277,0.00070408673,0.00015063932,0.0000027532838,0.000024058478],"genre_scores_gemma":[0.9616544,0.037425183,0.00012605518,0.000017802244,0.000119810546,0.00054332835,0.000020048954,0.00001292757,0.0000804367],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984556,0.0001822959,0.0002600949,0.0004346699,0.0002788306,0.0003885109],"domain_scores_gemma":[0.9992233,0.00007043571,0.000095224364,0.00031561716,0.00018475416,0.00011070447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004948914,0.00016967084,0.0003556579,0.00009979673,0.000054232925,0.000015180378,0.00016118443,0.00007059478,0.000009252153],"category_scores_gemma":[0.00006622854,0.0001311366,0.00007903005,0.00018595291,0.000092853305,0.000011132357,0.000057787238,0.00006155994,3.0923206e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01822761,0.00077406986,0.064932145,0.0009847882,0.000262796,0.000028432189,0.00034631573,0.00001885599,0.16223308,0.00025592002,0.00021428935,0.7517217],"study_design_scores_gemma":[0.0044647274,0.0057430547,0.2289014,0.0006328434,0.000047405116,0.0000054306274,0.000028895502,0.000013356966,0.75849694,0.0004278647,0.0010477479,0.00019034199],"about_ca_topic_score_codex":0.001256239,"about_ca_topic_score_gemma":0.0015744026,"teacher_disagreement_score":0.75153136,"about_ca_system_score_codex":0.0001059928,"about_ca_system_score_gemma":0.00022112673,"threshold_uncertainty_score":0.5347596},"labels":[],"label_agreement":null},{"id":"W2057247490","doi":"10.1023/a:1006326432340","title":"Mammographic density changes in perimenopausal and postmenopausal women: is effect of hormone replacement therapy predictable?","year":2000,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Digital Radiography and Breast Imaging","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Hormone replacement therapy (female-to-male); Medicine; MAMMOGRAPHIC DENSITY; Menopause; Breast cancer; Postmenopausal women; Breast density; Bone density; Gynecology; Mammography; Internal medicine; Obstetrics; Cancer; Osteoporosis","score_opus":0.017901321356885193,"score_gpt":0.316782695086249,"score_spread":0.2988813737293638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057247490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9849379,0.011626282,1.2003756e-7,0.0015467207,0.000012163416,0.00096978655,0.00016365552,0.000022777278,0.00072060316],"genre_scores_gemma":[0.9802647,0.01870914,0.000012066051,0.000070294314,0.000057163645,0.00044707622,0.000015933763,0.000020034558,0.00040356212],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982167,0.000105610474,0.00017851799,0.00044825271,0.00044257782,0.00060838024],"domain_scores_gemma":[0.99923706,0.00007944551,0.000030967858,0.00024567416,0.00007383121,0.0003330164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041721013,0.00023754625,0.00044310032,0.00041127214,0.000103075596,0.000046543588,0.000050061793,0.000056370736,0.00023426072],"category_scores_gemma":[0.000003082315,0.00016278095,0.00003432177,0.0005339417,0.00035703578,0.0001091371,0.000032093292,0.00014445596,0.0000020438292],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0255024,0.0010404203,0.5389635,0.000087150125,0.0004662425,0.00013516474,0.00096841005,2.2463168e-7,0.006890992,0.000015547175,0.00010385666,0.42582607],"study_design_scores_gemma":[0.012821292,0.030879045,0.94462395,0.00018422453,0.000046650886,0.00058041373,0.00016777664,0.000019868403,0.009605824,0.00008338527,0.00082404766,0.00016351006],"about_ca_topic_score_codex":0.0020379643,"about_ca_topic_score_gemma":0.00011825577,"teacher_disagreement_score":0.42566258,"about_ca_system_score_codex":0.0002111322,"about_ca_system_score_gemma":0.000090026035,"threshold_uncertainty_score":0.6638015},"labels":[],"label_agreement":null},{"id":"W2058298653","doi":"10.1007/s10549-011-1929-9","title":"Mammographic density, parity and age at first birth, and risk of breast cancer: an analysis of four case–control studies","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Digital Radiography and Breast Imaging","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; Sunnybrook Health Science Centre; Dalhousie University","funders":"National Cancer Institute; U.S. Department of Health and Human Services","keywords":"Parity (physics); Breast cancer; Medicine; Obstetrics; Odds ratio; Logistic regression; Gynecology; Case-control study; Body mass index; Demography; Cancer; Internal medicine","score_opus":0.051893235375858174,"score_gpt":0.3585277819972429,"score_spread":0.30663454662138473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058298653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9719737,0.023941508,0.000002550191,0.00058434234,0.000022289365,0.00042425367,0.0029888724,0.000015215141,0.000047269008],"genre_scores_gemma":[0.9684783,0.03120735,0.0000325314,0.000012312934,0.00008206497,0.0001066336,0.000013466002,0.000015578185,0.000051716317],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982731,0.0001390174,0.00026733518,0.00038640058,0.00039770934,0.0005364434],"domain_scores_gemma":[0.99847335,0.00023214924,0.000120341094,0.0002930861,0.0003182203,0.000562842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048674643,0.00023884546,0.00080701767,0.00075395306,0.00029411083,0.000034612625,0.000044981396,0.000057090907,0.000031971784],"category_scores_gemma":[0.00001439262,0.00016677298,0.00016044201,0.0009134632,0.00091564114,0.00023963916,0.00010221886,0.00012526503,2.1969555e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015549401,0.0006204142,0.8928071,0.00022320465,0.010023617,0.00032531426,0.00071740226,0.0000034764491,0.00007302918,0.000043171876,0.000013179429,0.0935951],"study_design_scores_gemma":[0.0028357697,0.0005348532,0.9879509,0.00014785792,0.004336205,0.0030319607,0.00070386525,0.00012463774,0.000112235255,0.000056689438,0.00003636836,0.00012864186],"about_ca_topic_score_codex":0.035171818,"about_ca_topic_score_gemma":0.03782467,"teacher_disagreement_score":0.095143765,"about_ca_system_score_codex":0.00016552817,"about_ca_system_score_gemma":0.000058262878,"threshold_uncertainty_score":0.9797325},"labels":[],"label_agreement":null},{"id":"W2058771273","doi":"10.1023/a:1015229630260","title":"Phase III Randomized Trial of Droloxifene and Tamoxifen As First-Line Endocrine Treatment of ER/PgR-Positive Advanced Breast Cancer","year":2002,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":67,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Tamoxifen; Medicine; Breast cancer; Hazard ratio; Internal medicine; Oncology; Hormonal therapy; Cancer; Gynecology; Confidence interval","score_opus":0.018635356274463413,"score_gpt":0.3463511523647948,"score_spread":0.3277157960903314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058771273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9704083,0.025073618,0.0000050767294,0.0010871963,0.00006634301,0.0021404792,0.00089474587,0.000008471523,0.00031572612],"genre_scores_gemma":[0.8880955,0.10939759,0.000028879485,0.000010546758,0.00020233741,0.0010410071,0.00009117975,0.000026135922,0.0011068553],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9981221,0.0002180903,0.00038780883,0.00051919825,0.0002862903,0.00046648897],"domain_scores_gemma":[0.9989161,0.000119602104,0.00015836829,0.00029421438,0.00022843253,0.0002832988],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016063981,0.00031864148,0.0007783361,0.000121935744,0.00015463882,0.000017765737,0.00008371966,0.00013377955,0.00013661495],"category_scores_gemma":[0.00001594933,0.00021467761,0.00019046963,0.00016166594,0.0005444915,0.000011367361,0.000066890076,0.00008400019,0.000002057049],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7384357,0.0053390805,0.0002577559,0.00004391964,0.0019340216,0.00006286422,0.00030942223,0.000039410923,0.055315908,0.000051051855,0.00006282292,0.19814804],"study_design_scores_gemma":[0.78893644,0.015689736,0.0002184668,0.00010117787,0.00028010405,0.00019793074,0.000040935887,0.00020144651,0.19358554,0.00004685346,0.00050248735,0.00019890294],"about_ca_topic_score_codex":0.0039618216,"about_ca_topic_score_gemma":0.00023515694,"teacher_disagreement_score":0.19794914,"about_ca_system_score_codex":0.00013806915,"about_ca_system_score_gemma":0.00013350134,"threshold_uncertainty_score":0.87542987},"labels":[],"label_agreement":null},{"id":"W2058947545","doi":"10.1007/s10549-007-9711-8","title":"Anti-estrogenic mechanism of unliganded progesterone receptor isoform B in breast cancer cells","year":2007,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Genetics; University of Illinois at Urbana-Champaign","keywords":"Progesterone receptor; Breast cancer; Internal medicine; Endocrinology; Gene isoform; Mechanism (biology); Oestrogen receptor; Estrogen receptor; Receptor; Cancer; Medicine; Biology; Cancer research; Physics; Gene; Biochemistry","score_opus":0.016519584736764042,"score_gpt":0.31877682925233586,"score_spread":0.3022572445155718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058947545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99448115,0.0039175353,0.000009761156,0.00044557246,0.00008043854,0.00060489104,0.00034163316,0.00000857311,0.000110456924],"genre_scores_gemma":[0.989495,0.00975049,0.00006188872,0.000016371165,0.00014044822,0.00016051199,0.00005181431,0.000028687733,0.00029482454],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99836427,0.00006222043,0.00024350452,0.00042620592,0.00026529835,0.00063851615],"domain_scores_gemma":[0.9992941,0.000018971099,0.00006581482,0.00024314318,0.00014225834,0.00023568513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034916567,0.00021065328,0.00025792522,0.00014858332,0.00008963098,0.000019161485,0.00011958651,0.00019960276,0.00005659656],"category_scores_gemma":[0.0000022749675,0.00016039272,0.000072640265,0.00025275513,0.00016984677,0.000008281645,0.00008874163,0.0001537481,0.000005777788],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014589017,0.0006521813,0.024088627,0.000046079113,0.00027814592,0.00003238221,0.00009261533,0.0000068122554,0.94213885,0.0001413077,0.00012211666,0.03094197],"study_design_scores_gemma":[0.0026540393,0.0009460154,0.036074355,0.000109119654,0.0000263969,0.00010618213,0.00011375393,0.000010528949,0.95941275,0.00004131339,0.00033124237,0.00017429046],"about_ca_topic_score_codex":0.0027037764,"about_ca_topic_score_gemma":0.00063421705,"teacher_disagreement_score":0.03076768,"about_ca_system_score_codex":0.0001876469,"about_ca_system_score_gemma":0.00027805846,"threshold_uncertainty_score":0.6540625},"labels":[],"label_agreement":null},{"id":"W2059179380","doi":"10.1007/s10549-014-2906-x","title":"A phase II, multicentre trial evaluating the efficacy of de-escalated bisphosphonate therapy in metastatic breast cancer patients at low-risk of skeletal-related events","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Bone health and treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto; Princess Margaret Cancer Centre; University of Ottawa; Ottawa Hospital","funders":"Government of Ontario; Ontario Institute for Cancer Research","keywords":"Medicine; N-terminal telopeptide; Internal medicine; Clinical endpoint; Population; Bone sialoprotein; Breast cancer; Bisphosphonate; Gastroenterology; Bone pain; Cancer; Oncology; Surgery; Randomized controlled trial; Alkaline phosphatase; Osteocalcin; Osteoporosis","score_opus":0.053121955901301435,"score_gpt":0.4272503795736377,"score_spread":0.3741284236723363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059179380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931799,0.001555246,4.943484e-7,0.00062882795,0.00009068923,0.0037794774,0.0007318706,0.000014124931,0.00001938076],"genre_scores_gemma":[0.9947992,0.0039097345,0.000031350453,0.000027011567,0.000022953762,0.00078193407,0.0000894861,0.000036369736,0.00030197794],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9966358,0.00067859323,0.0006722892,0.00045096347,0.0008254892,0.00073688105],"domain_scores_gemma":[0.99801004,0.00048818652,0.0003267533,0.00036762928,0.00042144608,0.0003859556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008673039,0.0002938255,0.00065431313,0.00020437702,0.00028718886,0.000008782454,0.00010463873,0.000090491354,0.00033627142],"category_scores_gemma":[0.00009308118,0.00017035069,0.00015094613,0.0005266334,0.0002198722,0.00005978809,0.000074399795,0.0002585363,0.000006230998],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15008596,0.017749663,0.28264308,0.000102039856,0.0011393352,0.000011107996,0.0016760756,0.000031702828,0.00038794475,0.0000039063493,0.000018320477,0.54615086],"study_design_scores_gemma":[0.30204642,0.016198356,0.67753017,0.00046791058,0.00030322676,0.000016841264,0.00005089236,0.0021253363,0.001075716,0.000048854938,0.000026625665,0.00010965069],"about_ca_topic_score_codex":0.041625973,"about_ca_topic_score_gemma":0.0020067003,"teacher_disagreement_score":0.54604125,"about_ca_system_score_codex":0.0009680756,"about_ca_system_score_gemma":0.00071559893,"threshold_uncertainty_score":0.96475595},"labels":[],"label_agreement":null},{"id":"W2059715164","doi":"10.1023/a:1026548320063","title":"Utilization of Professional Supportive Care Services by Women with Breast Cancer","year":2000,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer survivorship and care","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"Cancer Care Ontario","keywords":"Breast cancer; Medicine; Family medicine; Service (business); Social work; Nursing; Cancer; Internal medicine; Business","score_opus":0.027532835504544946,"score_gpt":0.36447422792504186,"score_spread":0.3369413924204969,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059715164","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98906237,0.0044936687,4.4612744e-7,0.0016673006,0.00004093012,0.0006351136,0.0030879667,0.000021746757,0.0009904528],"genre_scores_gemma":[0.9902733,0.003989921,0.000003977586,0.000075200456,0.00011789046,0.0010438672,0.00018497463,0.000025256486,0.0042856364],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99835813,0.00006260954,0.0001586718,0.00036244476,0.00060302584,0.00045509436],"domain_scores_gemma":[0.99890465,0.000022403454,0.000045218116,0.0001989174,0.00050860236,0.00032022162],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00007528946,0.00017916242,0.0002880321,0.00008957183,0.00014749718,0.000020929798,0.00006118084,0.00006607646,0.0044294577],"category_scores_gemma":[4.1746287e-7,0.00011329763,0.00002943772,0.0003309625,0.00018336937,0.00010319119,0.00002265363,0.0001178021,0.0000056378826],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01356912,0.00076604786,0.30321386,0.0006682781,0.00040422424,0.000040356004,0.013350077,0.0000041065205,0.00037512634,0.000016176464,0.0004940401,0.6670986],"study_design_scores_gemma":[0.0067544966,0.0025164883,0.95058936,0.0012504894,0.00012481355,0.00018428211,0.021990355,0.00002169297,0.004005015,0.000027437069,0.012276181,0.0002593673],"about_ca_topic_score_codex":0.034162734,"about_ca_topic_score_gemma":0.0115806265,"teacher_disagreement_score":0.66683924,"about_ca_system_score_codex":0.000775202,"about_ca_system_score_gemma":0.00071512436,"threshold_uncertainty_score":0.99648064},"labels":[],"label_agreement":null},{"id":"W2059844610","doi":"10.1007/s10549-013-2596-9","title":"Moderate-to-vigorous intensity physical activity across the life course and risk of pre- and post-menopausal breast cancer","year":2013,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Physical Activity and Health","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Queen's University","funders":"Canadian Institutes of Health Research","keywords":"Breast cancer; Medicine; Metabolic equivalent; Demography; Cancer; Logistic regression; Odds ratio; Mammography; Gerontology; Physical activity; Gynecology; Internal medicine; Physical therapy","score_opus":0.04756663479404434,"score_gpt":0.4050079688395043,"score_spread":0.35744133404545997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059844610","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9794087,0.00054429687,0.0000026170553,0.017370498,0.000022413376,0.0011778731,0.0014286123,0.000016358028,0.000028624198],"genre_scores_gemma":[0.9965874,0.002383867,0.000007954587,0.00013231032,0.00027371378,0.00042761906,0.000004556998,0.00001773294,0.00016487356],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9983759,0.00013512987,0.00010949732,0.00042483452,0.000392889,0.00056175614],"domain_scores_gemma":[0.9983025,0.00020538371,0.000058261954,0.00025776323,0.00044993352,0.00072614284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018539724,0.0002051692,0.0005124701,0.00003510633,0.0004275758,0.000069098,0.000056734316,0.00005790642,0.000027521957],"category_scores_gemma":[0.000018588642,0.00011642139,0.000032994045,0.0001550047,0.0005867253,0.00018056855,0.00016313339,0.0003665426,0.0000055323585],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025169292,0.00960398,0.17728645,0.0003887259,0.0019961803,0.00002900901,0.00700437,0.000022797507,0.025376597,0.00014887849,0.0005066704,0.75246704],"study_design_scores_gemma":[0.0019480383,0.0021967476,0.99190813,0.00010038084,0.00016279225,0.00009423731,0.0003281769,0.00095953385,0.0020020471,0.00017068311,0.000026444239,0.000102814825],"about_ca_topic_score_codex":0.14834796,"about_ca_topic_score_gemma":0.0036076857,"teacher_disagreement_score":0.8146217,"about_ca_system_score_codex":0.00017987774,"about_ca_system_score_gemma":0.0004219011,"threshold_uncertainty_score":0.8573233},"labels":[],"label_agreement":null},{"id":"W2059896643","doi":"10.1023/a:1006359308505","title":"Resection margin status in lumpectomy specimens of infiltrating lobular carcinoma","year":2000,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Lumpectomy; Margin (machine learning); Lobular carcinoma; Medicine; Carcinoma; Invasive lobular carcinoma; Breast cancer; Resection; Mastectomy; Radiology; Pathology; Oncology; Cancer; Internal medicine; Surgery; Ductal carcinoma; Invasive ductal carcinoma","score_opus":0.028683931229322526,"score_gpt":0.32702396156524727,"score_spread":0.29834003033592477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059896643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99297935,0.00402925,9.667243e-7,0.00033653263,0.000025368434,0.00035653642,0.0002452066,0.00000625467,0.0020205274],"genre_scores_gemma":[0.9937669,0.005074387,0.00007296456,0.000010636523,0.00016879494,0.00027700237,0.00006137653,0.000019323705,0.00054862484],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985083,0.00010626651,0.00019740853,0.00042720124,0.00024092555,0.00051994424],"domain_scores_gemma":[0.999448,0.000025594332,0.00003461451,0.00025875718,0.00010740427,0.00012562847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012456434,0.0001780035,0.00021199245,0.00012163546,0.000118729404,0.00001962659,0.000066521985,0.00006991471,0.00026985328],"category_scores_gemma":[0.00000706915,0.00014920959,0.000046281577,0.00024622056,0.00019932042,0.000008321182,0.0000508152,0.00008516378,0.000005869691],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004119558,0.0008752369,0.83640456,0.00005581599,0.00034763067,0.000059876194,0.0006364129,0.000079685706,0.04453895,0.00007174343,0.00030682265,0.11250373],"study_design_scores_gemma":[0.00308713,0.00086797524,0.96306735,0.000055806475,0.000015948895,0.000045466073,0.00029145225,0.000012457404,0.029218875,0.00005734307,0.0031452414,0.00013492395],"about_ca_topic_score_codex":0.015500829,"about_ca_topic_score_gemma":0.0074050776,"teacher_disagreement_score":0.12666284,"about_ca_system_score_codex":0.00029081438,"about_ca_system_score_gemma":0.00019352934,"threshold_uncertainty_score":0.991055},"labels":[],"label_agreement":null},{"id":"W2060064180","doi":"10.1007/s10549-009-0681-x","title":"Dietary lignan intakes in relation to survival among women with breast cancer: the Western New York Exposures and Breast Cancer (WEB) Study","year":2009,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Phytoestrogen effects and research","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute","keywords":"Breast cancer; Medicine; Hazard ratio; Lignan; Confounding; Proportional hazards model; Body mass index; Quartile; Internal medicine; Cancer; Lower risk; Confidence interval; Physiology; Biology","score_opus":0.05102093157981926,"score_gpt":0.35936822730773255,"score_spread":0.3083472957279133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060064180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9768025,0.0033104245,4.79343e-7,0.016896527,0.00004634191,0.0025106797,0.000290704,0.000032533597,0.00010975995],"genre_scores_gemma":[0.9946944,0.002321614,0.000006783508,0.00010773724,0.0005062733,0.0012658049,0.000009475203,0.000037946284,0.001049973],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967847,0.00030357626,0.00026944623,0.00070434966,0.0009435282,0.0009944004],"domain_scores_gemma":[0.9983628,0.00012297793,0.000055727487,0.0004055388,0.00020236036,0.00085063215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005669657,0.00035147395,0.00052539824,0.00030433465,0.00034761315,0.00016019975,0.00015728502,0.00008312236,0.00009519036],"category_scores_gemma":[0.000005835554,0.00018807601,0.000037685826,0.0007367571,0.00025784035,0.00017756218,0.000086319225,0.0004293022,0.0000039933043],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067065563,0.0009386464,0.73152536,0.000033450448,0.0003224183,0.00017735652,0.0034674588,0.000039981398,0.0005579185,0.000003146751,0.00017530112,0.25605237],"study_design_scores_gemma":[0.0054772934,0.0047071828,0.9863254,0.000567041,0.00006857176,0.0002280521,0.002153506,0.000033819862,0.000088055654,0.000018676488,0.0001355065,0.00019693928],"about_ca_topic_score_codex":0.08960689,"about_ca_topic_score_gemma":0.06115476,"teacher_disagreement_score":0.25585544,"about_ca_system_score_codex":0.0010914062,"about_ca_system_score_gemma":0.00096959365,"threshold_uncertainty_score":0.9559767},"labels":[],"label_agreement":null},{"id":"W2060708771","doi":"10.1007/s10549-014-2950-6","title":"Cost-effectiveness analysis of extended adjuvant endocrine therapy in the treatment of post-menopausal women with hormone receptor positive breast cancer","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Tamoxifen; Quality-adjusted life year; Cost effectiveness; Oncology; Letrozole; Gynecology; Internal medicine; Cancer","score_opus":0.019094182184641956,"score_gpt":0.3353691531732998,"score_spread":0.31627497098865787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060708771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902028,0.007114839,0.0000064253304,0.0003272076,0.000014943956,0.0011753036,0.001101396,0.000003835871,0.00005325379],"genre_scores_gemma":[0.9737087,0.02429072,0.000012400669,0.000014384066,0.00005983161,0.0016685943,0.00017139368,0.000019488085,0.000054484728],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99812865,0.0005019684,0.00018928818,0.00042113758,0.00029888772,0.00046008313],"domain_scores_gemma":[0.9990508,0.00011131796,0.00008774448,0.00033108366,0.00028415243,0.00013488095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002779247,0.00024693922,0.0004653859,0.00020645089,0.00009198604,0.00001729851,0.000119964476,0.00007853869,0.00003169251],"category_scores_gemma":[0.000003278877,0.00012958811,0.0000646317,0.0005526968,0.00027892407,0.000007633173,0.000025360687,0.00007869786,6.668432e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02988826,0.0039824103,0.034534674,0.000024352497,0.0070813037,0.000027826918,0.0014546383,0.000204362,0.5510164,0.00004793443,0.000011145325,0.3717267],"study_design_scores_gemma":[0.0068561095,0.03076265,0.8510286,0.000050648327,0.00028107245,0.0000487912,0.00038669666,0.000040164916,0.110063106,0.0000087756935,0.00030177837,0.00017160151],"about_ca_topic_score_codex":0.007922486,"about_ca_topic_score_gemma":0.0007484361,"teacher_disagreement_score":0.8164939,"about_ca_system_score_codex":0.0003007367,"about_ca_system_score_gemma":0.00019604641,"threshold_uncertainty_score":0.99868387},"labels":[],"label_agreement":null},{"id":"W2060804848","doi":"10.1007/s10549-009-0441-y","title":"Is red meat intake a risk factor for breast cancer among premenopausal women?","year":2009,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Nutritional Studies and Diet","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Breast cancer; Medicine; Risk factor; Red meat; Gynecology; Oncology; Cancer; Internal medicine; Obstetrics; Physiology; Pathology","score_opus":0.13200443142069018,"score_gpt":0.435175200862149,"score_spread":0.3031707694414588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060804848","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014769844,0.945973,7.439957e-7,0.0018071015,0.00009091434,0.004358545,0.04597732,0.000041222138,0.00027419502],"genre_scores_gemma":[0.0022367982,0.984598,0.00003737702,0.000056829824,0.0012205113,0.0087395,0.00017389163,0.00008033839,0.0028567843],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965169,0.0001252295,0.00049295917,0.0009511751,0.00076762715,0.0011461542],"domain_scores_gemma":[0.99795437,0.00019337102,0.00018939118,0.00040612638,0.00052541745,0.0007313186],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021015367,0.00064193265,0.0019192994,0.00027424394,0.00050600787,0.00009128053,0.00013705138,0.0002464963,0.0013667975],"category_scores_gemma":[0.000016093609,0.0004093286,0.00036336447,0.00039114375,0.00025222343,0.000073414354,0.00009883684,0.00041902292,0.000014514036],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016760848,0.0008681974,0.0025962677,0.004845475,0.0026786332,0.000053207208,0.00015913807,4.258166e-8,7.010108e-7,0.000015434964,0.0048006284,0.9823062],"study_design_scores_gemma":[0.004641085,0.0024926295,0.06917962,0.010443662,0.0011880184,0.00020235936,0.00008349999,0.0000015065197,0.000002596287,0.00011978291,0.9112548,0.00039040393],"about_ca_topic_score_codex":0.0049173897,"about_ca_topic_score_gemma":0.0012944501,"teacher_disagreement_score":0.9819158,"about_ca_system_score_codex":0.0031541327,"about_ca_system_score_gemma":0.00095740886,"threshold_uncertainty_score":0.99983585},"labels":[],"label_agreement":null},{"id":"W2060950189","doi":"10.1007/s10549-013-2694-8","title":"Post-surgical highly sensitive C-reactive protein and prognosis in early-stage breast cancer","year":2013,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Lunenfeld-Tanenbaum Research Institute; Custom Security Industries (Canada); Mount Sinai Hospital","funders":"","keywords":"Medicine; Breast cancer; Internal medicine; Hazard ratio; C-reactive protein; Body mass index; Oncology; Confidence interval; Proportional hazards model; Cancer; Gastroenterology; Estrogen receptor; Leptin; Obesity; Inflammation","score_opus":0.025754107686817043,"score_gpt":0.3313247333024965,"score_spread":0.3055706256156795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060950189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9827193,0.0010129538,1.6815493e-7,0.0106056575,0.000026771928,0.0040041488,0.0010605102,0.000049607224,0.00052086235],"genre_scores_gemma":[0.9907375,0.0005892914,0.00007076644,0.000048735277,0.00017858611,0.0072636264,0.000026576208,0.000044140932,0.0010407837],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973313,0.00022082446,0.00027187463,0.0007313176,0.00061430165,0.00083036465],"domain_scores_gemma":[0.99823356,0.000106623316,0.00006367427,0.00023632142,0.00066368224,0.00069613056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024277538,0.00033495354,0.00043981234,0.0003313183,0.00019611148,0.00012190828,0.00006670714,0.00014612319,0.00032336125],"category_scores_gemma":[0.000014197848,0.00024398112,0.00007618689,0.0003638019,0.0005522902,0.00027266092,0.0001325011,0.00030209476,0.000038035876],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00664685,0.0012703941,0.8858983,0.00020238748,0.0006649357,0.0016985061,0.0008109336,2.5783825e-7,0.004830104,0.00012020437,0.00007966659,0.09777745],"study_design_scores_gemma":[0.005149252,0.00076044956,0.9834234,0.00060068007,0.00007313509,0.0004436354,0.0005400687,0.0000603339,0.00840187,0.00003974644,0.00027180024,0.00023562521],"about_ca_topic_score_codex":0.039711215,"about_ca_topic_score_gemma":0.0010651328,"teacher_disagreement_score":0.097541824,"about_ca_system_score_codex":0.0009917973,"about_ca_system_score_gemma":0.0005235784,"threshold_uncertainty_score":0.99492615},"labels":[],"label_agreement":null},{"id":"W2061054340","doi":"10.1007/s10549-005-2116-7","title":"The importance of temporal effects in evaluating the prognostic impact of joint ERPR expression in premenopausal women with node-positive breast cancer","year":2005,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Ontario Institute for Cancer Research; Queen's University","funders":"","keywords":"Breast cancer; Medicine; Estrogen receptor; Internal medicine; Oncology; Progesterone receptor; Cancer; Clinical significance; Phenotype; Estrogen; Stage (stratigraphy); Gynecology; Biology; Gene","score_opus":0.018504170252758894,"score_gpt":0.3556940460050919,"score_spread":0.337189875752333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061054340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99227864,0.0062089646,0.0000016130919,0.00035621115,0.000009539435,0.0010089595,0.00009560665,0.0000021177973,0.000038352275],"genre_scores_gemma":[0.99782157,0.0011283914,0.00003476626,0.000005683996,0.00005600466,0.0008892867,0.000011880267,0.00001552328,0.000036887548],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985154,0.00027767668,0.00021134132,0.000273683,0.00028708292,0.00043477496],"domain_scores_gemma":[0.99935335,0.00009845525,0.0001053857,0.00021974713,0.00013202142,0.000091037145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005228606,0.00016140447,0.00019787083,0.00005436552,0.00010755796,0.0000174704,0.00010309969,0.00006882724,0.0000075685384],"category_scores_gemma":[0.000018019571,0.00007311355,0.000033733566,0.00019899072,0.00024151738,0.000009282101,0.00007381201,0.00015594288,2.9223887e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061319955,0.00045152777,0.69026583,0.000044172266,0.00025014638,0.000014100886,0.0005612911,0.0007808291,0.2664367,0.00000533358,0.000019767387,0.035038285],"study_design_scores_gemma":[0.0025174355,0.004153596,0.92943466,0.0004216387,0.000016869062,0.00004345797,0.00013877924,0.00030624404,0.06285427,0.000018719109,0.0000032950404,0.00009104958],"about_ca_topic_score_codex":0.0023289223,"about_ca_topic_score_gemma":0.0014986122,"teacher_disagreement_score":0.23916881,"about_ca_system_score_codex":0.00035232474,"about_ca_system_score_gemma":0.00051732745,"threshold_uncertainty_score":0.35206494},"labels":[],"label_agreement":null},{"id":"W2061224075","doi":"10.1007/s10549-008-9977-5","title":"Smoking and the risk of breast cancer in BRCA1 and BRCA2 carriers: an update","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; Princess Margaret Cancer Centre; BC Cancer Agency; Université de Montréal; University of Toronto; University Health Network; McGill University; Centre Hospitalier de l’Université de Montréal","funders":"National Cancer Institute","keywords":"Medicine; Breast cancer; BRCA mutation; Case-control study; Odds ratio; Oncology; Internal medicine; Gynecology; Cancer; Family history; Risk factor; Obstetrics","score_opus":0.027397824379992157,"score_gpt":0.3371516323105158,"score_spread":0.30975380793052365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061224075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9803395,0.016918158,0.0000049804776,0.001383044,0.000033720225,0.0003395141,0.00090556365,0.0000036372935,0.0000718823],"genre_scores_gemma":[0.94374746,0.055626344,0.000038872622,0.000037824546,0.00013021624,0.00029814028,0.000018176803,0.00001696094,0.000086002234],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998728,0.0001988356,0.0001588912,0.00041087167,0.00019908296,0.00030435243],"domain_scores_gemma":[0.9993593,0.00003367542,0.000056795358,0.0002770208,0.00013927896,0.00013393065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003190503,0.00014781661,0.00018913855,0.00008051081,0.00024643866,0.000029083096,0.00009490677,0.00007829863,0.00003556694],"category_scores_gemma":[0.000010148104,0.00009920674,0.000029081435,0.00015521087,0.0009011698,0.000012480884,0.000108421445,0.00012033484,2.5353887e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030014822,0.00021368742,0.7879671,0.000041964162,0.0007080575,0.000025240253,0.0021960756,0.00018612239,0.005280493,0.0001737847,0.0002522477,0.19995378],"study_design_scores_gemma":[0.0065657794,0.00032741233,0.9822716,0.00005629197,0.00006760191,0.00038995937,0.0006790312,0.00019194593,0.007352597,0.00027645388,0.0016318788,0.00018942011],"about_ca_topic_score_codex":0.016745158,"about_ca_topic_score_gemma":0.008242183,"teacher_disagreement_score":0.19976436,"about_ca_system_score_codex":0.00016922793,"about_ca_system_score_gemma":0.00037697758,"threshold_uncertainty_score":0.9898024},"labels":[],"label_agreement":null},{"id":"W2062097521","doi":"10.1007/s10549-009-0712-7","title":"Beyond bisphosphonates: photodynamic therapy structurally augments metastatically involved vertebrae and destroys tumor tissue","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Ontario Institute for Cancer Research","keywords":"Medicine; Breast cancer; Photodynamic therapy; Metastasis; Bone metastasis; Cancer; Metastatic breast cancer; Pathology; Oncology; Internal medicine","score_opus":0.030440550754109237,"score_gpt":0.35544167378601343,"score_spread":0.3250011230319042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062097521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932777,0.0019019155,0.000008927783,0.002218785,0.0000966639,0.001647275,0.00032038955,0.000044938,0.0004833981],"genre_scores_gemma":[0.99427366,0.0016011996,0.0018420247,0.00033277334,0.000054286953,0.0005243234,0.00009438767,0.000044363762,0.0012330001],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.997704,0.000086222106,0.0002601943,0.0005862003,0.0007394753,0.0006238618],"domain_scores_gemma":[0.9984777,0.00010432446,0.000056810408,0.00040864837,0.0002139667,0.00073854724],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000297325,0.00031019343,0.00041079914,0.0002124632,0.0002151249,0.00013370304,0.000114695606,0.00004592551,0.0013745128],"category_scores_gemma":[0.00003205975,0.00021434172,0.00005259427,0.00023491148,0.0004275511,0.00013680808,0.00007672115,0.0002760768,0.000023587436],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0081167035,0.0026219676,0.07167262,0.00040159424,0.0025009448,0.0014284534,0.0007668345,0.000001290947,0.10627303,0.0027005083,0.0010328542,0.8024832],"study_design_scores_gemma":[0.025110168,0.0040616128,0.93403643,0.000177687,0.00048259634,0.000334389,0.00065806555,0.00070180546,0.02213725,0.0062285885,0.005508562,0.00056285795],"about_ca_topic_score_codex":0.0026049293,"about_ca_topic_score_gemma":0.0012231073,"teacher_disagreement_score":0.8623638,"about_ca_system_score_codex":0.00016125482,"about_ca_system_score_gemma":0.0003536796,"threshold_uncertainty_score":0.99953836},"labels":[],"label_agreement":null},{"id":"W2062165579","doi":"10.1007/s10549-013-2626-7","title":"Exosomal pMHC-I complex targets T cell-based vaccine to directly stimulate CTL responses leading to antitumor immunity in transgenic FVBneuN and HLA-A2/HER2 mice and eradicating trastuzumab-resistant tumor in athymic nude mice","year":2013,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Saskatchewan Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"CTL*; HER2/neu; Biology; Immunology; Cytotoxic T cell; Immune system; Cancer research; CD8; Trastuzumab; Immunotherapy; Cancer; Breast cancer","score_opus":0.03457243733282276,"score_gpt":0.32486445629961336,"score_spread":0.2902920189667906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062165579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97559506,0.020402836,0.000008920883,0.0019443989,0.000049566584,0.0016829096,0.00024576677,0.000035143155,0.000035382083],"genre_scores_gemma":[0.9969148,0.0013726797,0.0002108064,0.00018405897,0.000016256643,0.0006248639,0.000037238977,0.00004480291,0.00059451483],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9965214,0.0010882446,0.0005103096,0.0007020735,0.00011690049,0.0010610643],"domain_scores_gemma":[0.99851054,0.00081490446,0.000077449455,0.00032334295,0.00011031523,0.00016343525],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006605669,0.0004141981,0.0006599222,0.00072650594,0.00050560996,0.00010779958,0.00023166375,0.00011955438,0.00027488777],"category_scores_gemma":[0.00005720061,0.0003500822,0.00005898109,0.0005298169,0.00023988495,0.00016967308,0.00010255078,0.0004192915,0.000049530532],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016924849,0.0007241226,0.021768758,0.00007781458,0.00013581176,0.000056296187,0.0023072662,0.000039095128,0.9411622,0.000008499169,0.00006752501,0.016727723],"study_design_scores_gemma":[0.008440287,0.0023794093,0.7939799,0.00036981885,0.000026277214,0.00012151128,0.0007906319,0.00005053643,0.19184296,0.000015680249,0.0015830158,0.000399977],"about_ca_topic_score_codex":0.031890392,"about_ca_topic_score_gemma":0.005243677,"teacher_disagreement_score":0.77221113,"about_ca_system_score_codex":0.00046786127,"about_ca_system_score_gemma":0.00030376436,"threshold_uncertainty_score":0.9998951},"labels":[],"label_agreement":null},{"id":"W2062390900","doi":"10.1007/s10549-004-5168-1","title":"Accuracy of breast screening among women with and without a family history of breast and/or ovarian cancer","year":2005,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital; Cancer Care Ontario","funders":"Cancer Care Ontario","keywords":"Family history; Medicine; Breast cancer; Gynecology; Mammography; Obstetrics; Confidence interval; Breast cancer screening; Cancer; Population; Confounding; Ovarian cancer; Demography; Internal medicine","score_opus":0.03561525537177414,"score_gpt":0.33144724538063564,"score_spread":0.2958319900088615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062390900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98798406,0.010056136,0.000048053662,0.0005909291,0.000022903696,0.00039010102,0.0006604958,0.0000066545817,0.00024064622],"genre_scores_gemma":[0.9923275,0.0050363634,0.0006453705,0.000035473564,0.0001693969,0.00049848127,0.000018430865,0.000031401367,0.001237599],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99859387,0.00007248378,0.00020574567,0.0004610851,0.00027189357,0.00039492638],"domain_scores_gemma":[0.99906015,0.000027575701,0.00012037398,0.0002829017,0.00028198454,0.0002270106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001859355,0.00020437714,0.00027064444,0.0001198515,0.00008955999,0.00002072923,0.00009854984,0.000087544446,0.000083822335],"category_scores_gemma":[0.000006299589,0.00014791502,0.000023767998,0.00013155598,0.0007147666,0.000022940885,0.00011290005,0.00009416887,2.689133e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008170472,0.0003593983,0.28070748,0.00014456396,0.0009306856,0.000007754202,0.0017792137,0.00008964976,0.051360033,0.000026035334,0.0005618187,0.65586287],"study_design_scores_gemma":[0.0051581077,0.0012380828,0.97877705,0.00026612633,0.00007648872,0.0004515216,0.0009828366,0.00013409871,0.0050275344,0.0000113832475,0.0075939563,0.00028278923],"about_ca_topic_score_codex":0.008436789,"about_ca_topic_score_gemma":0.004096678,"teacher_disagreement_score":0.6980696,"about_ca_system_score_codex":0.00061166205,"about_ca_system_score_gemma":0.0011058382,"threshold_uncertainty_score":0.99816614},"labels":[],"label_agreement":null},{"id":"W2063692243","doi":"10.1007/s10549-012-2338-4","title":"Molecularly targeted gold nanoparticles enhance the radiation response of breast cancer cells and tumor xenografts to X-radiation","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Radiation Therapy and Dosimetry","field":"Medicine","cited_by":157,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Breast cancer; Radiation; Cancer research; Medicine; Radiation therapy; Cancer; Colloidal gold; Oncology; Breast tumor; Nanoparticle; Internal medicine; Materials science; Nanotechnology; Optics; Physics","score_opus":0.022541539130855888,"score_gpt":0.34813490992427665,"score_spread":0.32559337079342077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063692243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9776617,0.015124071,0.0000108132945,0.005923659,0.00008102545,0.0008209905,0.00034118333,0.000016493199,0.000020060299],"genre_scores_gemma":[0.995943,0.0027781166,0.00004919166,0.00026116884,0.00024078465,0.00040286433,0.000008746939,0.00001908312,0.0002970566],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99847764,0.00026665692,0.00020118973,0.00023699933,0.00039809692,0.00041941443],"domain_scores_gemma":[0.9989767,0.00017775412,0.0000694747,0.00022947398,0.00016368995,0.00038289707],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058089494,0.00014500454,0.00020687838,0.00018477111,0.00015194558,0.000039415158,0.00005296114,0.000043759064,0.00010457445],"category_scores_gemma":[0.000023762475,0.000095064024,0.000039340404,0.0004693171,0.00013237019,0.00016084172,0.000023108218,0.00009371151,0.000010035067],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011293888,0.00066390436,0.10610791,0.000050216342,0.0003034002,0.000009593716,0.0025042414,0.000028333989,0.6606131,0.000073727,0.00100603,0.21734561],"study_design_scores_gemma":[0.0012929483,0.0004905847,0.6821139,0.000050043294,0.00004666476,0.000037052276,0.0001384662,0.00005884733,0.31412223,0.0000091374,0.0015655886,0.00007452737],"about_ca_topic_score_codex":0.0022411477,"about_ca_topic_score_gemma":0.00006240821,"teacher_disagreement_score":0.576006,"about_ca_system_score_codex":0.0003149241,"about_ca_system_score_gemma":0.00021686296,"threshold_uncertainty_score":0.38765985},"labels":[],"label_agreement":null},{"id":"W2064182120","doi":"10.1007/s10549-006-9452-0","title":"Type of TP53 mutation and ERBB2 amplification affects survival in node-negative breast cancer","year":2007,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Missense mutation; Breast cancer; Mutation; Oncology; Exon; Medicine; Internal medicine; Cancer; Disease; Cancer research; Biology; Genetics; Gene","score_opus":0.06260978444270525,"score_gpt":0.39554597439757233,"score_spread":0.33293618995486707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064182120","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941991,0.0023455995,0.00004433323,0.0015291194,0.00008186244,0.0009224287,0.0002400383,0.000017002041,0.00062052836],"genre_scores_gemma":[0.99689454,0.0025518304,0.00008751274,0.000018367906,0.000096943855,0.00014435487,0.000037381822,0.00002386597,0.0001451985],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9985643,0.00008090375,0.00019048696,0.0003641638,0.0004179954,0.00038215917],"domain_scores_gemma":[0.99906397,0.00013949307,0.000066032095,0.0001892511,0.0003221454,0.00021909193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039282723,0.000153651,0.00027229096,0.00029290476,0.00007206536,0.00001684842,0.000036107853,0.00009137445,0.00007537836],"category_scores_gemma":[0.000025382236,0.00012625658,0.00002946038,0.0005716331,0.0002102857,0.000060340295,0.00002997634,0.00017418014,0.0000038383137],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014308022,0.0014483074,0.33290377,0.00039005346,0.0006298291,0.0004621187,0.0026706927,0.00008421234,0.055465236,0.0008686469,0.000153402,0.5906157],"study_design_scores_gemma":[0.004784629,0.0006620044,0.9769727,0.0003835537,0.00006328078,0.00022030655,0.00035977652,0.000117976866,0.016097682,0.00010907938,0.00011686631,0.0001121481],"about_ca_topic_score_codex":0.022079272,"about_ca_topic_score_gemma":0.011007263,"teacher_disagreement_score":0.6440689,"about_ca_system_score_codex":0.0009066948,"about_ca_system_score_gemma":0.0004409145,"threshold_uncertainty_score":0.98443276},"labels":[],"label_agreement":null},{"id":"W2064366286","doi":"10.1007/s10549-012-2120-7","title":"Feasibility of a randomized controlled trial of vitamin D vs. placebo in women with recently diagnosed breast cancer","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Breast cancer; Medicine; Placebo; Randomized controlled trial; Internal medicine; Oncology; Cancer; Vitamin D and neurology; Gynecology; Alternative medicine; Pathology","score_opus":0.04200335594353122,"score_gpt":0.37890104902178684,"score_spread":0.3368976930782556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064366286","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9810045,0.0031639207,9.727047e-7,0.002909947,0.000060891703,0.012101963,0.00037444662,0.000012900667,0.00037049793],"genre_scores_gemma":[0.9711237,0.011714967,0.000030705465,0.000013839558,0.00018130075,0.01636867,0.000006545393,0.000026441034,0.0005338089],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9956159,0.0009927931,0.00069375866,0.00041547825,0.001219005,0.0010630669],"domain_scores_gemma":[0.99654937,0.0016285179,0.00020464524,0.00040290103,0.000692533,0.00052205793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035041738,0.0003007428,0.0026279122,0.00042596576,0.000091338254,0.000015511809,0.00010396219,0.000090649424,0.00035151833],"category_scores_gemma":[0.0003989419,0.00016275137,0.00017431911,0.0005561269,0.001126232,0.00012297367,0.0001014312,0.00026075734,0.0000019712872],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.81530046,0.0046899966,0.16365016,0.00024027066,0.0017118236,0.000033131568,0.0016497064,0.0000016227391,0.00026770704,0.00001894744,0.00008015447,0.01235599],"study_design_scores_gemma":[0.673183,0.0019182217,0.32323545,0.00045488146,0.0001455156,0.000024273784,0.00063405436,0.000010509204,0.00027594506,0.000012480538,0.00001684782,0.00008883451],"about_ca_topic_score_codex":0.009851604,"about_ca_topic_score_gemma":0.0015121402,"teacher_disagreement_score":0.15958528,"about_ca_system_score_codex":0.0016224151,"about_ca_system_score_gemma":0.001000491,"threshold_uncertainty_score":0.9967419},"labels":[],"label_agreement":null},{"id":"W2064546724","doi":"10.1007/s10549-008-0292-y","title":"Breast cancer risk in relation to the joint effect of BRCA mutations and diet diversity","year":2009,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôtel-Dieu de Québec; Centre Hospitalier de l’Université de Montréal; Hotel Dieu Hospital; Occupational Cancer Research Centre; Hôtel-Dieu de Montréal; Coalition for Research in Women's Health","funders":"","keywords":"Breast cancer; Odds ratio; Confidence interval; Oncology; Quartile; BRCA mutation; Body mass index; Medicine; Internal medicine; Demography; Logistic regression; Cancer; Diversity (politics); Genetics; Biology","score_opus":0.02305968930899543,"score_gpt":0.3335742201694428,"score_spread":0.3105145308604474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064546724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992782,0.0019274789,0.000019213054,0.003960332,0.00003164784,0.0005308393,0.0006520654,0.0000034668326,0.00009297687],"genre_scores_gemma":[0.99671394,0.002794809,0.000034564204,0.000029077435,0.000089214824,0.00019491756,0.000026660675,0.0000065706,0.00011027453],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99905723,0.00015570666,0.00011263489,0.0002846125,0.00017786151,0.00021193954],"domain_scores_gemma":[0.9995318,0.000035361118,0.00003940297,0.00019308498,0.00010972663,0.00009063381],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028042987,0.00010678541,0.00012191067,0.00008622327,0.00026635165,0.000019873632,0.000070032416,0.000053485404,0.000020881827],"category_scores_gemma":[0.000014402714,0.0000721848,0.00003053292,0.00020847184,0.00012121942,0.0000070646097,0.00011313258,0.00008408261,0.0000014850186],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035398516,0.0002595241,0.5831574,0.00003002074,0.00023565923,0.000007178474,0.0015006489,0.001747663,0.011337586,0.000065155655,0.00097554474,0.39714378],"study_design_scores_gemma":[0.0012847877,0.0012139397,0.9893297,0.000036274025,0.000034286786,0.000021534785,0.00008625001,0.000059011014,0.0073868562,0.000111330824,0.00035889083,0.00007716035],"about_ca_topic_score_codex":0.0066613993,"about_ca_topic_score_gemma":0.0048441854,"teacher_disagreement_score":0.40617228,"about_ca_system_score_codex":0.00026036482,"about_ca_system_score_gemma":0.00013687204,"threshold_uncertainty_score":0.9999533},"labels":[],"label_agreement":null},{"id":"W2065019417","doi":"10.1007/s10549-005-2415-z","title":"Mechanisms of omega-3 fatty acid-induced growth inhibition in MDA-MB-231 human breast cancer cells","year":2005,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Fatty Acid Research and Health","field":"Nursing","cited_by":196,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph; University of Alberta","funders":"","keywords":"Docosahexaenoic acid; Cell growth; Eicosapentaenoic acid; Omega 3 fatty acid; Apoptosis; Protein kinase B; Biology; Linoleic acid; DNA fragmentation; Fatty acid; Endocrinology; Biochemistry; Internal medicine; Cancer research; Molecular biology; Programmed cell death; Polyunsaturated fatty acid; Medicine","score_opus":0.059033834624936346,"score_gpt":0.37828050893314547,"score_spread":0.31924667430820913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065019417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97876227,0.0008820549,0.000034250745,0.017364575,0.00012591961,0.0012992752,0.0010631415,0.000050479204,0.00041803092],"genre_scores_gemma":[0.99707335,0.0013569557,0.0002737809,0.00012829261,0.00030833314,0.00066869176,0.000044608656,0.000051666888,0.000094299794],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99608994,0.00035365295,0.00047016403,0.0006940873,0.001022921,0.0013692537],"domain_scores_gemma":[0.99840105,0.00008949866,0.00010785064,0.00036245477,0.00042224972,0.0006169262],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00065897644,0.0003288122,0.00049307506,0.00066436187,0.00046979208,0.00009389502,0.00016200742,0.00017767034,0.0004674381],"category_scores_gemma":[0.000009587304,0.0002695151,0.0000975616,0.00073300896,0.0002490089,0.00034125565,0.00011394779,0.0005132533,0.000038270693],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003380889,0.0019953377,0.0064950236,0.00031627656,0.00011220794,0.00007972192,0.0009694881,0.000017455619,0.8671864,0.0012660496,0.00064546295,0.117535666],"study_design_scores_gemma":[0.005596975,0.0014262716,0.107955605,0.0004899946,0.000020855563,0.000072291565,0.00031895543,0.00012862637,0.88201576,0.0016222988,0.00008681379,0.00026554803],"about_ca_topic_score_codex":0.054084036,"about_ca_topic_score_gemma":0.03512077,"teacher_disagreement_score":0.11727012,"about_ca_system_score_codex":0.002416107,"about_ca_system_score_gemma":0.0004455628,"threshold_uncertainty_score":0.9999757},"labels":[],"label_agreement":null},{"id":"W2065331919","doi":"10.1007/s10549-010-1138-y","title":"Bone mineral density and risk of postmenopausal breast cancer","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Manitoba Health; University of Saskatchewan; University of Manitoba; CancerCare Manitoba","funders":"CancerCare Manitoba Foundation","keywords":"Medicine; Breast cancer; Bone mineral; Quartile; Femoral neck; Osteoporosis; Internal medicine; Hazard ratio; Proportional hazards model; Gynecology; Cancer; Oncology; Urology; Confidence interval","score_opus":0.028851675810217674,"score_gpt":0.35618031905782804,"score_spread":0.32732864324761035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065331919","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99312687,0.0021984943,7.2174885e-7,0.002261672,0.000109570436,0.0005112353,0.0015973867,0.000018778825,0.00017524413],"genre_scores_gemma":[0.98669827,0.011989981,0.000060104976,0.00002726567,0.00036814078,0.00014269019,0.000019071584,0.000023687857,0.0006708088],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99850154,0.000045423938,0.00019068366,0.00040248132,0.00040498038,0.0004548834],"domain_scores_gemma":[0.99880755,0.000060702034,0.00006743414,0.00028230125,0.00030533498,0.0004767014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019326361,0.00020151149,0.0003970992,0.00015506365,0.00017488837,0.00003109644,0.000043581138,0.00009407625,0.0004280927],"category_scores_gemma":[0.0000091817365,0.0001371905,0.00005272347,0.00018791812,0.0004464494,0.000072085044,0.00007048668,0.00033702614,0.000003459454],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002754195,0.00047572493,0.8116673,0.000056282282,0.00038324343,0.000076301374,0.00024724545,4.0939364e-7,0.02263971,0.000088316374,0.00034777162,0.16126348],"study_design_scores_gemma":[0.0036151605,0.0008457922,0.99018437,0.000072307404,0.00019357142,0.00082882144,0.00007175482,0.000029104973,0.0027812468,0.00006751463,0.0011893122,0.000121030986],"about_ca_topic_score_codex":0.09938002,"about_ca_topic_score_gemma":0.022294683,"teacher_disagreement_score":0.17851707,"about_ca_system_score_codex":0.0002060675,"about_ca_system_score_gemma":0.0003910315,"threshold_uncertainty_score":0.99554586},"labels":[],"label_agreement":null},{"id":"W2065386366","doi":"10.1007/s10549-013-2799-0","title":"Osteolysis and pain due to experimental bone metastases are improved by treatment with rapamycin","year":2013,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Bone health and treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Shriners Hospitals for Children - Canada; McGill University","funders":"","keywords":"Osteolysis; Medicine; Breast cancer; Intractable pain; Oncology; Surgery; Cancer; Internal medicine","score_opus":0.03547872215611514,"score_gpt":0.35286030306586497,"score_spread":0.3173815809097498,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065386366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9750438,0.012104288,0.0000045738225,0.0091382135,0.000016097101,0.0030329667,0.0005174731,0.000044458284,0.000098135875],"genre_scores_gemma":[0.98913854,0.0013627043,0.00035903713,0.00031558942,0.000052402174,0.005715089,0.0000904729,0.000044537428,0.0029216385],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99771863,0.00017594965,0.0002293647,0.0006807974,0.00038653705,0.0008087447],"domain_scores_gemma":[0.9979636,0.00011970022,0.000055894485,0.00034770143,0.00016427514,0.0013488258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017312285,0.00037835093,0.0006223496,0.00020976462,0.00032240868,0.00009390134,0.000036409612,0.000066401066,0.00034947554],"category_scores_gemma":[0.0000075668513,0.0002225067,0.00005808731,0.00027759475,0.00017360956,0.000116892705,0.000044009594,0.00009268875,0.0000395966],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007551201,0.0066555496,0.110064775,0.00012151184,0.001958139,0.00082204776,0.0010497805,4.774282e-7,0.011639639,0.000012084656,0.0036695101,0.85645527],"study_design_scores_gemma":[0.10962237,0.1556427,0.52625436,0.0013391913,0.0016440059,0.004880112,0.013179903,0.00048059892,0.14884445,0.00008298067,0.036072284,0.001957033],"about_ca_topic_score_codex":0.053068727,"about_ca_topic_score_gemma":0.0025276793,"teacher_disagreement_score":0.85449827,"about_ca_system_score_codex":0.0009519354,"about_ca_system_score_gemma":0.00024766958,"threshold_uncertainty_score":0.953237},"labels":[],"label_agreement":null},{"id":"W2065705923","doi":"10.1007/s10549-012-1989-5","title":"Cost-utility of the 21-gene recurrence score assay in node-negative and node-positive breast cancer","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":60,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Medicine; Breast cancer; Cohort; Oncology; Internal medicine; Population; Quality-adjusted life year; Gynecology; Disease; Cancer; Cost effectiveness; Environmental health","score_opus":0.05948690056745847,"score_gpt":0.3615667509758435,"score_spread":0.30207985040838503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065705923","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98139054,0.010389033,0.0000071863697,0.0025800297,0.000117760086,0.0009116971,0.004201654,0.0000058291134,0.00039630005],"genre_scores_gemma":[0.99264693,0.005987198,0.00005111839,0.00007023975,0.00018679729,0.00089989055,0.000037951657,0.000020826346,0.00009906748],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99797916,0.00028691976,0.00021444136,0.0005296015,0.0003291245,0.00066076306],"domain_scores_gemma":[0.99893504,0.0000963379,0.00009132121,0.000371446,0.00029457465,0.00021125907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033843535,0.0002862727,0.00030949488,0.00006934384,0.0002441683,0.000023303175,0.00014841775,0.00010658797,0.00004932058],"category_scores_gemma":[0.000028133583,0.00018792094,0.00006805818,0.00028822396,0.0007617026,0.000021653892,0.00030737507,0.00016108714,0.000001561301],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013853539,0.000655024,0.9339095,0.000036935086,0.0003561141,0.0000028982615,0.00077388587,0.0000040311006,0.0035574834,0.0000275498,0.00020065712,0.05909057],"study_design_scores_gemma":[0.0018853204,0.00010760263,0.9540365,0.00017275847,0.00004984562,0.00006996339,0.0002788124,0.000011060552,0.042973068,0.000044154775,0.00020978533,0.00016118126],"about_ca_topic_score_codex":0.014467711,"about_ca_topic_score_gemma":0.0051168334,"teacher_disagreement_score":0.058929387,"about_ca_system_score_codex":0.00031290468,"about_ca_system_score_gemma":0.0003137573,"threshold_uncertainty_score":0.99209505},"labels":[],"label_agreement":null},{"id":"W2065838490","doi":"10.1007/s10549-008-9986-4","title":"Outcomes of surveillance mammography after treatment of primary breast cancer: a population-based case series","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Dalhousie University; Cancer Care Ontario; Institute for Clinical Evaluative Sciences; University of Toronto","funders":"","keywords":"Mammography; Breast cancer; Medicine; Series (stratigraphy); Population; Gynecology; Mammography screening; Oncology; Cancer; Obstetrics; Internal medicine; Environmental health; Biology","score_opus":0.027138275832885785,"score_gpt":0.31410798431997733,"score_spread":0.2869697084870915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065838490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832623,0.008753786,0.0000029895566,0.0010519186,0.00006154128,0.0005775117,0.006223703,0.000014571899,0.000051689865],"genre_scores_gemma":[0.9878554,0.010121474,0.000135049,0.000022802324,0.00012155497,0.0013095668,0.000192913,0.000037190523,0.00020408974],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99809873,0.00012873353,0.0003457797,0.0005724424,0.00036521355,0.00048912846],"domain_scores_gemma":[0.9987612,0.0000647836,0.00013618999,0.00048179354,0.00037126368,0.0001847893],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0000778663,0.0003761682,0.00062494056,0.00019166473,0.00023520952,0.000011758405,0.000081051236,0.00010264074,0.00006536485],"category_scores_gemma":[0.000004075591,0.0002722869,0.00021292943,0.00029365227,0.00052681786,0.000014707531,0.00006157213,0.000044854634,9.378781e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039731404,0.0012599642,0.9736144,0.000074018775,0.0010927175,0.00031292115,0.0001760844,0.000028973587,0.0006416623,0.0000091607935,0.00003873535,0.018778225],"study_design_scores_gemma":[0.0036236215,0.0010677695,0.9895139,0.00004423398,0.000073440046,0.0014641394,0.00008417942,0.0000023332834,0.0036068088,0.000011730379,0.00029548476,0.00021236138],"about_ca_topic_score_codex":0.029974815,"about_ca_topic_score_gemma":0.011869576,"teacher_disagreement_score":0.018565865,"about_ca_system_score_codex":0.00037735532,"about_ca_system_score_gemma":0.0004195417,"threshold_uncertainty_score":0.99997294},"labels":[],"label_agreement":null},{"id":"W2065931400","doi":"10.1007/s10549-014-3216-z","title":"Effects of the BEAT Cancer physical activity behavior change intervention on physical activity, aerobic fitness, and quality of life in breast cancer survivors: a multicenter randomized controlled trial","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer survivorship and care","field":"Medicine","cited_by":195,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute; Canada Research Chairs; National Comprehensive Cancer Network; University of Alabama at Birmingham","keywords":"Medicine; Breast cancer; Randomized controlled trial; Physical therapy; Aerobic exercise; Confidence interval; Cancer; Odds ratio; Physical fitness; Quality of life (healthcare); Internal medicine","score_opus":0.060612306172521155,"score_gpt":0.4042363232032189,"score_spread":0.3436240170306977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065931400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884235,0.0006949455,0.0000021795051,0.0017326334,0.0002871372,0.008523232,0.00030400723,0.00001247015,0.000019853873],"genre_scores_gemma":[0.980376,0.0009462725,5.1607816e-7,0.000024520394,0.0005446241,0.017963931,0.000004942172,0.000026997763,0.00011218301],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99623626,0.0017572966,0.00031130915,0.00050422724,0.00076915114,0.00042173313],"domain_scores_gemma":[0.99764365,0.0012714539,0.0002799437,0.00032435387,0.00025297815,0.00022764312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080716255,0.0003226499,0.001973673,0.00015634033,0.000093240735,0.000026945168,0.00010256796,0.00009936189,0.000033669436],"category_scores_gemma":[0.00009318435,0.00018353826,0.00051306543,0.00028150354,0.0005539167,0.00012017654,0.00011529655,0.0003206312,4.960636e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8172984,0.008774498,0.061329544,0.00074079115,0.0005550883,0.000002978535,0.0012009819,0.0000016237503,0.003429876,0.000051882227,0.0000042618894,0.106610045],"study_design_scores_gemma":[0.501084,0.00067108154,0.4923588,0.0008210133,0.00037276992,0.0000014462115,0.00005707296,0.00029668142,0.0042131497,0.000009685213,0.000004495005,0.00010976692],"about_ca_topic_score_codex":0.27525142,"about_ca_topic_score_gemma":0.06465261,"teacher_disagreement_score":0.43102926,"about_ca_system_score_codex":0.0004890972,"about_ca_system_score_gemma":0.00022534655,"threshold_uncertainty_score":0.95241505},"labels":[],"label_agreement":null},{"id":"W2066327505","doi":"10.1007/s10549-006-9262-4","title":"Cost-Effectiveness of Letrozole in the Extended Adjuvant Treatment of Women with Early Breast Cancer","year":2006,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada)","funders":"U.S. Army Medical Command; Novartis Pharma","keywords":"Letrozole; Medicine; Breast cancer; Tamoxifen; Oncology; Cost effectiveness; Adjuvant therapy; Quality-adjusted life year; Internal medicine; Clinical trial; Gynecology; Cancer","score_opus":0.03358527494242729,"score_gpt":0.345306888839836,"score_spread":0.3117216138974087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066327505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99118197,0.0057384414,0.000005480108,0.0004340924,0.000025004207,0.0012218937,0.0011992969,0.000005777474,0.00018807242],"genre_scores_gemma":[0.9921759,0.0031149262,0.000017271977,0.000006733511,0.0001296367,0.004379314,0.000056296507,0.000027517744,0.00009245539],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979092,0.00029673494,0.00023753432,0.00050118385,0.00038654078,0.000668806],"domain_scores_gemma":[0.99905366,0.00008664877,0.000097285716,0.00040474662,0.00025480406,0.00010283802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026619583,0.00030586007,0.000468231,0.00012799437,0.0001238099,0.000021484417,0.00014666248,0.00007379928,0.000029438785],"category_scores_gemma":[0.0000023545922,0.00017269157,0.000068318586,0.0003310012,0.00048200067,0.000011458675,0.0000518996,0.00005972697,9.4711424e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019032974,0.0050091185,0.8521146,0.0001340279,0.0011871243,0.00006357763,0.0013381076,0.00016281534,0.015191802,0.00021489954,0.000042096464,0.105508834],"study_design_scores_gemma":[0.0067171394,0.002998579,0.96782583,0.00013214952,0.000061085026,0.000087588895,0.00057110604,0.0000027155845,0.020946087,0.00007745468,0.0004246879,0.00015554907],"about_ca_topic_score_codex":0.056435157,"about_ca_topic_score_gemma":0.0088637695,"teacher_disagreement_score":0.115711235,"about_ca_system_score_codex":0.0009563162,"about_ca_system_score_gemma":0.0003847063,"threshold_uncertainty_score":0.9498481},"labels":[],"label_agreement":null},{"id":"W2066548418","doi":"10.1007/s10549-010-0795-1","title":"High levels of uPA and PAI-1 predict a good response to anthracyclines","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Breast cancer; Internal medicine; Medicine; Oncology; Cancer research; Biology; Cancer","score_opus":0.02394331461331799,"score_gpt":0.3460215584750042,"score_spread":0.3220782438616862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066548418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99702805,0.0011092139,0.000020181573,0.0010528624,0.000053522188,0.0002515527,0.00037609655,0.000005355504,0.00010315329],"genre_scores_gemma":[0.9972054,0.0011847276,0.00028284395,0.000017879007,0.00019285496,0.00013701087,0.000014228993,0.000014286822,0.0009507638],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990175,0.000080504455,0.000129373,0.00033364192,0.00017923859,0.0002597855],"domain_scores_gemma":[0.99930674,0.000047915444,0.000029064064,0.00024842008,0.00017477424,0.00019309802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003151524,0.00012263234,0.00014256209,0.000063882864,0.00010284172,0.00002764883,0.00009242242,0.000092545844,0.00004181014],"category_scores_gemma":[0.00006415949,0.00009033443,0.000026171878,0.00009910782,0.00024436254,0.0000044537533,0.000105890584,0.000087829234,0.000001638543],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032092892,0.00016345696,0.018603938,0.00003329881,0.000080371785,0.000013232816,0.000078119534,0.0000017583084,0.91351336,0.0000774866,0.00012531244,0.064100385],"study_design_scores_gemma":[0.0015249862,0.0018968004,0.1500165,0.00003910738,0.000016399134,0.000090978196,0.0000787003,0.0000049326604,0.837529,0.00019452251,0.008478151,0.00012990447],"about_ca_topic_score_codex":0.00052963383,"about_ca_topic_score_gemma":0.000254408,"teacher_disagreement_score":0.13141257,"about_ca_system_score_codex":0.000020195934,"about_ca_system_score_gemma":0.00025124816,"threshold_uncertainty_score":0.36837313},"labels":[],"label_agreement":null},{"id":"W2067265379","doi":"10.1007/s10549-005-9151-2","title":"XPD Common Variants and their Association with Melanoma and Breast Cancer Risk","year":2006,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Coalition for Research in Women's Health; University of Toronto","funders":"","keywords":"Breast cancer; Melanoma; Oncology; Internal medicine; Cancer; Genotype; Medicine; Single-nucleotide polymorphism; Haplotype; Genotyping; Linkage disequilibrium; Biology; Genetics; Cancer research; Gene","score_opus":0.013805190121544127,"score_gpt":0.2998355213465374,"score_spread":0.2860303312249933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067265379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98924696,0.0064611556,0.000017645993,0.0018222488,0.000032538464,0.00031125502,0.0017691439,0.000008745922,0.00033033115],"genre_scores_gemma":[0.9910132,0.007378777,0.000065444714,0.000029635681,0.00028314826,0.00034727066,0.000072342744,0.000022746635,0.0007874203],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99884224,0.00010965339,0.00011179161,0.00041621734,0.0001792647,0.00034084346],"domain_scores_gemma":[0.9994285,0.000036753117,0.000069675254,0.00018356592,0.0001689078,0.00011258622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018511343,0.00017248926,0.00015796792,0.000056663102,0.00028382067,0.00008737536,0.000053376458,0.00010091164,0.000031503034],"category_scores_gemma":[0.0000034327986,0.00011943334,0.000019291727,0.0001137826,0.000154808,0.000010383734,0.00006821362,0.00009656856,0.0000010806347],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006896151,0.00017259117,0.88256156,0.00001745632,0.0004190625,0.0000069455423,0.00012832765,0.00003416055,0.0075289565,0.000055033663,0.0011095299,0.10727676],"study_design_scores_gemma":[0.0022179657,0.00046329075,0.98266,0.00003602622,0.000050522445,0.00015495051,0.00012987346,0.00006844207,0.009890252,0.00024812575,0.003903679,0.00017689327],"about_ca_topic_score_codex":0.018512143,"about_ca_topic_score_gemma":0.016709045,"teacher_disagreement_score":0.10709987,"about_ca_system_score_codex":0.0004050719,"about_ca_system_score_gemma":0.0002477086,"threshold_uncertainty_score":0.9880237},"labels":[],"label_agreement":null},{"id":"W2067271684","doi":"10.1007/s10549-011-1479-1","title":"The impact of contralateral mastectomy on mortality in BRCA1 and BRCA2 mutation carriers with breast cancer","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Breast cancer; Medicine; Mastectomy; Prophylactic Mastectomy; Cancer; Oncology; Gynecology; Surgery; Internal medicine","score_opus":0.041524861021020106,"score_gpt":0.36445259441525335,"score_spread":0.32292773339423325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067271684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971606,0.0013593931,0.0000027937967,0.00022325921,0.000022834367,0.00041758807,0.0005739298,0.0000032077753,0.0002363973],"genre_scores_gemma":[0.99779224,0.0015855712,0.000016126523,0.000008740569,0.000054256023,0.00040693663,0.00001898862,0.000015569973,0.000101571495],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989619,0.00009123926,0.00013546586,0.00031447664,0.00017604308,0.00032086845],"domain_scores_gemma":[0.9994142,0.000019878116,0.000051092677,0.0002272924,0.00017217915,0.00011535132],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015976843,0.0001464677,0.00013858217,0.00006114108,0.00012322521,0.000028118424,0.000074979034,0.00005803253,0.00004149127],"category_scores_gemma":[0.0000037644656,0.00008340466,0.000034966608,0.00013509598,0.00037324938,0.000009175015,0.000031884683,0.0000811411,4.4573306e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004624786,0.0002367467,0.9189131,0.000019867102,0.00084055716,0.000024985942,0.0009437638,0.00021176097,0.005869971,0.00006137214,0.00009096963,0.06816207],"study_design_scores_gemma":[0.0021333622,0.0010315642,0.9849968,0.00004099065,0.00001930835,0.00007638556,0.00020424527,0.00004285539,0.011231444,0.00008466042,0.000042858377,0.00009553532],"about_ca_topic_score_codex":0.029666634,"about_ca_topic_score_gemma":0.012825017,"teacher_disagreement_score":0.06806653,"about_ca_system_score_codex":0.0003734038,"about_ca_system_score_gemma":0.00051410386,"threshold_uncertainty_score":0.9767949},"labels":[],"label_agreement":null},{"id":"W2067527491","doi":"10.1007/s10549-013-2593-z","title":"ROCK: a resource for integrative breast cancer data analysis","year":2013,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Breast cancer; Resource (disambiguation); Computational biology; Computer science; Annotation; microRNA; Cancer; Bioinformatics; Biology; Data mining; Gene; Genetics","score_opus":0.06464139213229035,"score_gpt":0.3899111970555987,"score_spread":0.3252698049233083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067527491","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9341573,0.016645698,0.0036949394,0.018529082,0.000088535,0.0029654945,0.022756958,0.000034484998,0.0011274884],"genre_scores_gemma":[0.98556775,0.004244001,0.00016416493,0.000077578145,0.00034029118,0.003091752,0.0010088147,0.000021705166,0.0054839216],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99850124,0.000067687,0.00014871477,0.0006858507,0.00018827037,0.00040824222],"domain_scores_gemma":[0.99856925,0.00002714984,0.000047473553,0.00076851813,0.0003855548,0.00020204693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015306385,0.00017442123,0.00020061938,0.0001204366,0.00026474227,0.000110108005,0.00029213273,0.000064474225,0.00033958192],"category_scores_gemma":[0.000008253721,0.00011989347,0.0000681189,0.00033903698,0.00010896066,0.000015768517,0.00017024725,0.00006996324,0.000008740925],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025581252,0.0015587524,0.06172912,0.00006283742,0.008531783,0.000004684525,0.00037988022,0.0003858212,0.05623722,0.0005055666,0.084891915,0.7831543],"study_design_scores_gemma":[0.0069854488,0.0030814295,0.58954066,0.00015304705,0.0014451195,0.000098970544,0.0026682876,0.009118167,0.017775584,0.0005581734,0.36733034,0.0012447798],"about_ca_topic_score_codex":0.01324475,"about_ca_topic_score_gemma":0.0053816224,"teacher_disagreement_score":0.7819095,"about_ca_system_score_codex":0.00014841472,"about_ca_system_score_gemma":0.00027859802,"threshold_uncertainty_score":0.9933261},"labels":[],"label_agreement":null},{"id":"W2067661283","doi":"10.1007/s10549-007-9606-8","title":"Overcoming endocrine resistance in breast cancer—are signal transduction inhibitors the answer?","year":2007,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Breast cancer; Endocrine system; Hormone; Estrogen receptor; Crosstalk; Signal transduction; Medicine; Hormone receptor; Cancer research; Cancer; Internal medicine; Endocrinology; Bioinformatics; Biology; Cell biology","score_opus":0.041716346678753666,"score_gpt":0.37427800902160474,"score_spread":0.33256166234285106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067661283","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0074389717,0.98976356,0.0000017039106,0.0006282764,0.00014808822,0.0011445164,0.00070444273,0.000010858604,0.00015958016],"genre_scores_gemma":[0.012583188,0.9845732,0.000008498553,0.000013678649,0.0009304118,0.0008690794,0.00013777956,0.000060085687,0.00082406553],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99744344,0.00033393645,0.00037274367,0.0007333556,0.00036986353,0.000746662],"domain_scores_gemma":[0.9991193,0.00006706158,0.00013123527,0.000362147,0.000114269846,0.00020599725],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00037694938,0.00045224294,0.00064990734,0.00020975174,0.0002783199,0.00006585242,0.00020822682,0.0003271635,0.0000508626],"category_scores_gemma":[0.0000037678833,0.00027640516,0.00024406359,0.00047022593,0.0002753694,0.000008767645,0.00008030383,0.00054414955,0.0000048329493],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072942465,0.00027813503,0.0006527661,0.001371567,0.0005686399,0.000165699,0.000057662004,0.0000037649809,0.0003075306,0.000025442794,0.0008370551,0.9950023],"study_design_scores_gemma":[0.0016063944,0.0003152522,0.0012064239,0.006935269,0.00027497372,0.0006421514,0.00008550927,0.0000015908139,0.0009831546,0.000018219922,0.98746574,0.00046533195],"about_ca_topic_score_codex":0.002152023,"about_ca_topic_score_gemma":0.0029529633,"teacher_disagreement_score":0.994537,"about_ca_system_score_codex":0.0005816075,"about_ca_system_score_gemma":0.00059138867,"threshold_uncertainty_score":0.9999688},"labels":[],"label_agreement":null},{"id":"W2067928417","doi":"10.1007/s10549-008-0114-2","title":"Cognitive impairments associated with breast cancer treatments: results from a longitudinal study","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":182,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Canadian Institutes of Health Research; Fondation du cancer du sein du Québec","keywords":"Breast cancer; Medicine; Verbal fluency test; Radiation therapy; Chemotherapy; Cognition; Cancer; Oncology; Verbal memory; Chemotherapy regimen; Internal medicine; Neuropsychology; Verbal learning; Psychiatry","score_opus":0.10710883099612725,"score_gpt":0.39662519745529545,"score_spread":0.28951636645916823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067928417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9785744,0.0014998575,0.000001953764,0.0025005462,0.00008640361,0.0038317158,0.012813112,0.00012468189,0.00056734635],"genre_scores_gemma":[0.9879345,0.0045676646,0.000013164243,0.000072897565,0.00034635817,0.003310099,0.00040311477,0.00007684691,0.0032753234],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954559,0.00027103478,0.00045569887,0.0012966936,0.0013827609,0.0011378727],"domain_scores_gemma":[0.99704945,0.0004543795,0.00018015355,0.00036727756,0.0012976298,0.00065108534],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023948107,0.00061799405,0.0008681778,0.00034416554,0.00096317055,0.000060840437,0.000096965756,0.0001187018,0.00045714327],"category_scores_gemma":[0.00005858586,0.00041184048,0.00012091175,0.00085981627,0.0007611225,0.0002297197,0.00013737023,0.00039933115,0.000041344058],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03635899,0.01204082,0.9084509,0.000011173162,0.011752503,0.0031849926,0.0031383669,0.0000028693953,0.000030075675,7.1849587e-7,0.00066522264,0.024363387],"study_design_scores_gemma":[0.053217344,0.00984368,0.9307526,0.0011001811,0.0013961521,0.0007327065,0.0024343412,0.000017294036,0.00011544567,0.0000118621765,0.00003819908,0.0003402435],"about_ca_topic_score_codex":0.060669065,"about_ca_topic_score_gemma":0.011262326,"teacher_disagreement_score":0.04940674,"about_ca_system_score_codex":0.0033201114,"about_ca_system_score_gemma":0.001024208,"threshold_uncertainty_score":0.99983335},"labels":[],"label_agreement":null},{"id":"W2068553049","doi":"10.1007/s10549-007-9673-x","title":"Prediction of metastatic relapse in node-positive breast cancer: establishment of a clinicogenomic model after FEC100 adjuvant regimen","year":2007,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; National Institutes of Health; Institut National Du Cancer; National Cancer Institute; Ligue Contre le Cancer; Pfizer","keywords":"Breast cancer; Oncology; Internal medicine; Epirubicin; Medicine; Cancer; Proportional hazards model; Regimen","score_opus":0.03870086731612015,"score_gpt":0.34284658746365215,"score_spread":0.304145720147532,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068553049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98402315,0.008207147,0.00008304801,0.0006593521,0.000058187587,0.00077051594,0.006013883,0.0000071838863,0.00017753155],"genre_scores_gemma":[0.98935324,0.009212881,0.00028367902,0.000026708087,0.000097399556,0.0007187609,0.000112487534,0.000033741588,0.0001610883],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977718,0.00011693894,0.00051404414,0.0006200079,0.0003905753,0.00058666395],"domain_scores_gemma":[0.9988469,0.00006728159,0.00016607088,0.0003797349,0.00035384262,0.0001861554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052648614,0.00028870392,0.00046924918,0.00024184604,0.000081244194,0.000013645656,0.00012234958,0.000099496676,0.000030429037],"category_scores_gemma":[0.000009339071,0.00023401006,0.00011159901,0.00027580312,0.0003932881,0.000019393005,0.00015895221,0.00012153145,0.0000012325216],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030768652,0.0041814656,0.79653615,0.00026456438,0.0025763481,0.000109348846,0.0021423977,0.0011590665,0.034747656,0.000098003395,0.00032517372,0.12709118],"study_design_scores_gemma":[0.006946548,0.0011101682,0.95477885,0.00039691347,0.00022406079,0.00010187917,0.0005750007,0.00026041127,0.03512437,0.00013866264,0.00010366741,0.0002394463],"about_ca_topic_score_codex":0.009297018,"about_ca_topic_score_gemma":0.004935131,"teacher_disagreement_score":0.15824273,"about_ca_system_score_codex":0.00061352854,"about_ca_system_score_gemma":0.00048249392,"threshold_uncertainty_score":0.99730015},"labels":[],"label_agreement":null},{"id":"W2068803310","doi":"10.1007/s10549-011-1740-7","title":"Vascular proliferation is increased in basal-like breast cancer","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Universitetet i Bergen; Susan G. Komen","keywords":"Angiogenesis; Breast cancer; Basal (medicine); Cytokeratin; Immunohistochemistry; Cancer; Proliferation index; Pathology; Neovascularization; Vascular endothelial growth factor; Biology; Cancer research; Medicine; Internal medicine; VEGF receptors","score_opus":0.04833121284198428,"score_gpt":0.33150556991343805,"score_spread":0.2831743570714538,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068803310","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99073815,0.0069069564,0.000016615097,0.0006813933,0.000069369846,0.0005317597,0.00054811535,0.000009590676,0.0004980665],"genre_scores_gemma":[0.9851523,0.012470643,0.000058762595,0.00025115375,0.000324712,0.0011074247,0.000056620607,0.000031137737,0.00054725417],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99843234,0.000104567254,0.00017604655,0.0005423305,0.00026303384,0.0004816732],"domain_scores_gemma":[0.99923086,0.0000071805966,0.0000373475,0.00031468173,0.00020250355,0.00020744003],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021233296,0.00020522089,0.00018738778,0.000110203284,0.00014249243,0.00003489562,0.00011696915,0.0001274103,0.0005559626],"category_scores_gemma":[0.0000026304617,0.00016080309,0.000084468724,0.00019165108,0.00013774916,0.000012033935,0.000080000915,0.00007746387,0.000010671244],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024067336,0.0010751275,0.8819981,0.00005760421,0.000566426,0.00003527143,0.0005479358,0.000007901791,0.028259521,0.00010788901,0.0035861556,0.081351295],"study_design_scores_gemma":[0.0029381295,0.0005645834,0.93943673,0.00009196523,0.000043648295,0.000045817163,0.0001332134,0.0000667927,0.046624266,0.000112557995,0.009611729,0.00033055944],"about_ca_topic_score_codex":0.020688102,"about_ca_topic_score_gemma":0.005110822,"teacher_disagreement_score":0.081020735,"about_ca_system_score_codex":0.00020795385,"about_ca_system_score_gemma":0.0003986323,"threshold_uncertainty_score":0.9858332},"labels":[],"label_agreement":null},{"id":"W2069659635","doi":"10.1007/s10549-013-2416-2","title":"PAM50 proliferation score as a predictor of weekly paclitaxel benefit in breast cancer","year":2013,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"BC Cancer Agency; U.S. Public Health Service; Universitat de Barcelona; Universitat Autònoma de Barcelona; National Cancer Institute; National Institutes of Health; Sociedad Española de Oncología Médica; Vancouver Coastal Health Research Institute; Breast Cancer Research Foundation","keywords":"Medicine; Paclitaxel; Internal medicine; Oncology; Breast cancer; Anthracycline; Clinical endpoint; Chemotherapy; Proportional hazards model; Adjuvant; Clinical trial; Randomized controlled trial; Cancer","score_opus":0.028572442873062938,"score_gpt":0.32695856392894357,"score_spread":0.29838612105588064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069659635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98644,0.004617061,0.0000018508144,0.006315831,0.00005828428,0.0010585344,0.0012105139,0.000012224426,0.0002856913],"genre_scores_gemma":[0.9883366,0.006890912,0.000034556513,0.00006076382,0.0003051263,0.0035275777,0.000100918616,0.000032957843,0.0007105606],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998109,0.00007539751,0.00027785977,0.0005922096,0.00037071214,0.000574849],"domain_scores_gemma":[0.9989201,0.00002746035,0.00007810508,0.00033563952,0.0004262633,0.00021245431],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011499172,0.00027971546,0.00031257013,0.00014700613,0.00014250661,0.00004813142,0.00012708807,0.00012358217,0.0002625855],"category_scores_gemma":[0.0000089799205,0.00021225696,0.00007042756,0.00024276631,0.00027175,0.000024352334,0.00013312118,0.000102609825,0.000014945202],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001549358,0.00094248937,0.91913056,0.00007422494,0.0004978445,0.000010343973,0.00033521614,0.00002440027,0.011725393,0.0001779918,0.0009857804,0.06454638],"study_design_scores_gemma":[0.0032523517,0.00065842835,0.986198,0.00018149232,0.00003520068,0.00007549133,0.00026173037,0.000020841619,0.008292956,0.00041627954,0.00041458453,0.00019261248],"about_ca_topic_score_codex":0.03506443,"about_ca_topic_score_gemma":0.0064476235,"teacher_disagreement_score":0.067067444,"about_ca_system_score_codex":0.00035144642,"about_ca_system_score_gemma":0.0003918872,"threshold_uncertainty_score":0.97136116},"labels":[],"label_agreement":null},{"id":"W2070086300","doi":"10.1007/s10549-008-0086-2","title":"Pattern of metastatic spread in triple-negative breast cancer","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Bone health and treatments","field":"Medicine","cited_by":558,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Breast cancer; Medicine; Triple-negative breast cancer; Internal medicine; Cancer; Progesterone receptor; Oncology; Estrogen receptor; Hazard ratio; Incidence (geometry); Metastasis; Cohort; Metastatic breast cancer; Gynecology; Confidence interval","score_opus":0.10863370371260445,"score_gpt":0.4209652545074436,"score_spread":0.31233155079483915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070086300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896487,0.0029819524,0.000002477201,0.004147301,0.000052886186,0.0013863759,0.0013526395,0.000017161145,0.0004104775],"genre_scores_gemma":[0.987743,0.009520806,0.00006592702,0.000082739345,0.000054453543,0.0010457442,0.00002952696,0.000026843554,0.0014309535],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99790424,0.00013391834,0.00033875537,0.00042470265,0.00053496077,0.0006634187],"domain_scores_gemma":[0.99878854,0.0001343101,0.000076727105,0.00026669557,0.0002527659,0.00048096234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015400801,0.00023260301,0.0005697775,0.00032504057,0.00014297693,0.000008226096,0.000055889857,0.000056208995,0.00045637606],"category_scores_gemma":[0.000009962634,0.0001607959,0.00007418666,0.0004798951,0.0003143249,0.000091145106,0.000037159527,0.00019579561,0.000019388066],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031639033,0.0022008072,0.7718068,0.00016690991,0.0004569433,0.00066663144,0.0010768016,0.0000019357558,0.000077826255,0.000014228243,0.00024834217,0.22011891],"study_design_scores_gemma":[0.012857143,0.00108205,0.98308474,0.00038511795,0.000084307685,0.0008845496,0.00019639259,0.000047745634,0.0010613276,0.00007263926,0.00013392803,0.000110050016],"about_ca_topic_score_codex":0.19704278,"about_ca_topic_score_gemma":0.016133655,"teacher_disagreement_score":0.22000886,"about_ca_system_score_codex":0.0008339084,"about_ca_system_score_gemma":0.0010243667,"threshold_uncertainty_score":0.90029585},"labels":[],"label_agreement":null},{"id":"W2070618523","doi":"10.1007/s10549-009-0352-y","title":"Effect of denosumab on bone mineral density in women receiving adjuvant aromatase inhibitors for non-metastatic breast cancer: subgroup analyses of a phase 3 study","year":2009,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Bone health and treatments","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Essar Steel Algoma (Canada)","funders":"AstraZeneca; Amgen","keywords":"Denosumab; Medicine; Femoral neck; Bone mineral; Breast cancer; Placebo; Internal medicine; Aromatase inhibitor; Subgroup analysis; Oncology; Osteoporosis; Tamoxifen; Urology; Cancer; Meta-analysis; Pathology","score_opus":0.054963915460917084,"score_gpt":0.450782485112127,"score_spread":0.3958185696512099,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070618523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99334997,0.0010772473,9.617833e-7,0.0006172817,0.000033694578,0.0036155223,0.0012824599,0.000012109842,0.000010723845],"genre_scores_gemma":[0.9976903,0.00059689855,0.000037290585,0.00002683152,0.00005209122,0.0014493243,0.0000672538,0.000022447442,0.000057515263],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99738044,0.00026368035,0.00052934414,0.0005133071,0.00056882657,0.00074440084],"domain_scores_gemma":[0.9984753,0.0003386891,0.00016111498,0.00034705858,0.00019230999,0.00048548856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007049861,0.00031514323,0.0010946913,0.0005413015,0.00012149859,0.000014768358,0.000058171987,0.00005238019,0.000029984443],"category_scores_gemma":[0.00003666305,0.00021079321,0.000108361,0.00052569824,0.00011525639,0.00007843803,0.000025172892,0.00015188084,0.0000013777213],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08742281,0.021467648,0.339628,0.0007197617,0.0009463038,0.0006481577,0.0013508929,0.000010593444,0.0055681164,0.0000022118106,0.00012872007,0.54210675],"study_design_scores_gemma":[0.06353095,0.05704857,0.8642466,0.0010178314,0.00043551344,0.00016829449,0.00036499012,0.0001503063,0.012838664,0.000025875057,0.0000067340375,0.00016567379],"about_ca_topic_score_codex":0.024292056,"about_ca_topic_score_gemma":0.0023127336,"teacher_disagreement_score":0.5419411,"about_ca_system_score_codex":0.0012388851,"about_ca_system_score_gemma":0.00045434939,"threshold_uncertainty_score":0.9822053},"labels":[],"label_agreement":null},{"id":"W2070651249","doi":"10.1007/s10549-010-0774-6","title":"Past recreational physical activity, body size, and all-cause mortality following breast cancer diagnosis: results from the breast cancer family registry","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Public Health Ontario; University of Toronto; Cancer Care Ontario; Mount Sinai Hospital","funders":"National Cancer Institute","keywords":"Medicine; Breast cancer; Body mass index; Hazard ratio; Overweight; Internal medicine; Cancer; Proportional hazards model; Cancer registry; Population; National Death Index; Confidence interval; Demography; Oncology; Environmental health","score_opus":0.08919298459098243,"score_gpt":0.41875437041422353,"score_spread":0.3295613858232411,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070651249","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94351166,0.0016579474,7.439541e-7,0.027932096,0.00032668118,0.0010632932,0.025170764,0.000059289323,0.00027751896],"genre_scores_gemma":[0.9794569,0.014140288,0.000013630254,0.00020749439,0.0026320934,0.0028423802,0.00015412309,0.000064127256,0.0004889394],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963543,0.00015816739,0.00031610197,0.0011268769,0.0011607225,0.00088384317],"domain_scores_gemma":[0.99718964,0.0007521925,0.00015509145,0.0008091871,0.00032063716,0.00077325327],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00034377698,0.00050238153,0.00064533035,0.00008405572,0.0005879792,0.00024582114,0.00021072688,0.00019210741,0.00029452107],"category_scores_gemma":[0.000039760645,0.00031881724,0.0002176907,0.00035982826,0.0006207064,0.00029262382,0.00020247359,0.0008411114,0.000006858409],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051998394,0.0015558407,0.8514555,0.000038297687,0.0038792694,0.00017261051,0.0006757564,0.0000032550474,0.005222615,0.000052009545,0.006209849,0.12553516],"study_design_scores_gemma":[0.0061221104,0.00019406657,0.9877689,0.00044054873,0.0009393918,0.00015824105,0.00027179025,0.00007666971,0.00039992915,0.00011586849,0.0032005792,0.000311893],"about_ca_topic_score_codex":0.31403095,"about_ca_topic_score_gemma":0.037941672,"teacher_disagreement_score":0.27608928,"about_ca_system_score_codex":0.0008157904,"about_ca_system_score_gemma":0.0010512733,"threshold_uncertainty_score":0.9999264},"labels":[],"label_agreement":null},{"id":"W2071102398","doi":"10.1023/a:1017938608460","title":"Loss of androgen receptor associated protein 70 (ARA70) expression in a subset of HER2-positive breast cancers","year":2001,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada; Health Sciences Centre; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; Women's College Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"Medical Research Council","keywords":"Androgen receptor; Cancer research; Biology; Transactivation; Breast cancer; Endocrinology; Internal medicine; Cancer; Gene expression; Medicine; Prostate cancer; Gene","score_opus":0.052325602305618654,"score_gpt":0.3874648457897417,"score_spread":0.33513924348412305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071102398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906717,0.0023838212,0.0000019126026,0.002191689,0.000028061666,0.0021202774,0.0017887339,0.00001851431,0.00079527363],"genre_scores_gemma":[0.992991,0.0045410614,0.00006379188,0.000012287413,0.00009163093,0.0010042492,0.0001025578,0.00004348908,0.0011499544],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99657995,0.00037735052,0.000455003,0.0005559814,0.0011746587,0.00085705915],"domain_scores_gemma":[0.99817383,0.0001323164,0.00013241499,0.00039719648,0.00072050147,0.00044375166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007084361,0.00025777667,0.0006658206,0.00043719987,0.00009852584,0.000020138657,0.00015800243,0.00016663654,0.00069545023],"category_scores_gemma":[0.000053011576,0.00019963815,0.0000973492,0.0010784632,0.000566729,0.000103567174,0.00010984948,0.00035863245,0.000009065486],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0187628,0.0034650615,0.8024711,0.00045665924,0.00063926267,0.0006238405,0.001801819,0.000016804359,0.07443839,0.00004589046,0.0010895431,0.096188806],"study_design_scores_gemma":[0.017948905,0.0061660316,0.6837769,0.0075531686,0.0000776449,0.0004847808,0.0011935077,0.00010711816,0.2802229,0.00016167494,0.001877481,0.0004298937],"about_ca_topic_score_codex":0.046160974,"about_ca_topic_score_gemma":0.004938389,"teacher_disagreement_score":0.2057845,"about_ca_system_score_codex":0.002947015,"about_ca_system_score_gemma":0.00202163,"threshold_uncertainty_score":0.9601907},"labels":[],"label_agreement":null},{"id":"W2071523786","doi":"10.1007/s10549-013-2591-1","title":"Clinical–pathologic significance of cancer stem cell marker expression in familial breast cancers","year":2013,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; University of Guelph; Juravinski Hospital; McMaster University; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Juravinski Cancer Centre","funders":"National Institutes of Health; Ontario Institute for Cancer Research; National Cancer Institute; Cancer Care Ontario","keywords":"Breast cancer; CD24; CD44; Medicine; Oncology; Cancer stem cell; Cancer; Pathology; Internal medicine; Cancer research; Biology; Cell; Genetics","score_opus":0.07837988311216067,"score_gpt":0.3962498067276852,"score_spread":0.3178699236155246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071523786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9822591,0.012422423,0.0000046958003,0.0014042355,0.00019100186,0.0017724613,0.0006682884,0.000021735143,0.0012560753],"genre_scores_gemma":[0.96060896,0.03390757,0.00017289829,0.00008130314,0.0002595156,0.0019681088,0.000013685689,0.00003472696,0.0029532597],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9971116,0.00025439812,0.0005773018,0.00073010474,0.00058529485,0.00074126077],"domain_scores_gemma":[0.9983791,0.00015124398,0.00014634538,0.00045687048,0.00037177562,0.0004946379],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00047350797,0.00028720073,0.00071499037,0.00023690934,0.00009875736,0.000031306074,0.00013180968,0.0001459616,0.0013461921],"category_scores_gemma":[0.00000485364,0.00019786246,0.00015050491,0.00046337204,0.0005391216,0.00012348723,0.0000989926,0.00033597767,0.000022284386],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002254159,0.00090483483,0.4374247,0.00022154293,0.00010253488,0.00010072739,0.00020894995,0.000018977393,0.017420547,0.000006321065,0.0011112776,0.54022545],"study_design_scores_gemma":[0.007495961,0.0011747448,0.9730736,0.0006522044,0.000090532,0.00006417531,0.000812441,0.000059740923,0.013089386,0.000047993242,0.0031977016,0.0002415372],"about_ca_topic_score_codex":0.06945789,"about_ca_topic_score_gemma":0.0042602504,"teacher_disagreement_score":0.5399839,"about_ca_system_score_codex":0.0011037865,"about_ca_system_score_gemma":0.0011143635,"threshold_uncertainty_score":0.99956673},"labels":[],"label_agreement":null},{"id":"W2071551172","doi":"10.1007/s10549-012-2342-8","title":"Total energy intake and breast cancer risk in sisters: the Breast Cancer Family Registry","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Nutritional Studies and Diet","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Public Health Ontario; University of Toronto; Mount Sinai Hospital","funders":"National Cancer Institute; National Institutes of Health; Susan G. Komen; Georgetown University","keywords":"Breast cancer; Medicine; Body mass index; Quartile; Odds ratio; Cancer; Confidence interval; Cohort study; Internal medicine; Prospective cohort study; Cohort; Demography; Logistic regression; European Prospective Investigation into Cancer and Nutrition; Oncology; Gynecology","score_opus":0.047433011367195306,"score_gpt":0.3498053930371468,"score_spread":0.3023723816699515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071551172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9164977,0.054505657,0.0000011156244,0.023205813,0.00014457513,0.00048652804,0.0041669314,0.00002107186,0.00097058236],"genre_scores_gemma":[0.92654616,0.0698376,0.0000114962695,0.00027123216,0.0010426344,0.0012428976,0.000027087775,0.000027541726,0.0009933416],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99788296,0.00011197671,0.00022751701,0.00042805215,0.00052140927,0.0008280775],"domain_scores_gemma":[0.9988797,0.00012093053,0.00006581904,0.00027281974,0.00020325292,0.00045749205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024191095,0.00027232265,0.00037446545,0.000109516186,0.00040276232,0.0000620662,0.00007673139,0.000088452136,0.0002331913],"category_scores_gemma":[0.000005853475,0.00016349663,0.00007703983,0.0003070865,0.00045695837,0.00013426878,0.00014299962,0.00026645913,0.000004291147],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032142275,0.0009346095,0.80020934,0.000084190855,0.0005170452,0.00005357495,0.00032180606,0.0000032249693,0.00016248607,0.00030315446,0.0058779838,0.18831836],"study_design_scores_gemma":[0.0038163543,0.00020712917,0.9847283,0.00036205133,0.00011087932,0.0009132039,0.0011603612,0.00001753674,0.000032064527,0.00010577261,0.008381301,0.0001650723],"about_ca_topic_score_codex":0.18643227,"about_ca_topic_score_gemma":0.015051611,"teacher_disagreement_score":0.18815328,"about_ca_system_score_codex":0.00095874147,"about_ca_system_score_gemma":0.00027223348,"threshold_uncertainty_score":0.8399152},"labels":[],"label_agreement":null},{"id":"W2071635593","doi":"10.1007/s10549-008-0009-2","title":"RETRACTED ARTICLE: Glypican-3 regulates migration, adhesion and actin cytoskeleton organization in mammary tumor cells through Wnt signaling modulation","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Wnt/β-catenin signaling in development and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":81,"is_retracted":true,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Wnt signaling pathway; Glypican 3; Cancer research; Biology; Cell biology; Actin cytoskeleton; Cell migration; Signal transduction; Metastasis; LRP5; Cell growth; Cell; Cancer; Cytoskeleton","score_opus":0.026058663316471838,"score_gpt":0.28695819469347694,"score_spread":0.2608995313770051,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071635593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99797285,0.00090268615,0.00006164653,0.00068605144,0.00003257043,0.00028956166,0.00001654183,0.000014075552,0.000024045656],"genre_scores_gemma":[0.99524194,0.0036660896,0.00040426746,0.000033748664,0.00012738677,0.00007679944,0.00013906226,0.000019630077,0.00029104925],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988555,0.00008291488,0.00018494458,0.0003857817,0.0002203407,0.00027053145],"domain_scores_gemma":[0.9994683,0.000021400858,0.00005181312,0.0001355273,0.00023830817,0.00008459547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001393283,0.0001429065,0.00012721075,0.00007071169,0.00021703023,0.000043121152,0.000059247577,0.00007087364,0.000028315444],"category_scores_gemma":[0.000019255785,0.00012268825,0.000015232592,0.00034673273,0.00009589542,0.000029510533,0.000052895015,0.00009272597,0.0000022941044],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030160823,0.00014217015,0.10703294,0.00001775524,0.00004461133,0.000031710504,0.0003115598,0.00010872692,0.8860283,0.000022901064,0.00035022752,0.0056075067],"study_design_scores_gemma":[0.0009446659,0.00019837725,0.22623405,0.00004297377,0.0000059898057,0.00007867874,0.00006372322,0.0001333278,0.7716107,0.000107309155,0.0004512807,0.00012894406],"about_ca_topic_score_codex":0.0010267268,"about_ca_topic_score_gemma":0.0003264094,"teacher_disagreement_score":0.11920111,"about_ca_system_score_codex":0.00014167726,"about_ca_system_score_gemma":0.0002217395,"threshold_uncertainty_score":0.5003081},"labels":[],"label_agreement":null},{"id":"W2071788805","doi":"10.1007/s10549-010-0909-9","title":"Identification of a novel BRCA1 nucleotide 4803delCC/c.4684delCC mutation and a nucleotide 249T&gt;A/c.130T&gt;A (p.Cys44Ser) mutation in two Greenlandic Inuit families: implications for genetic screening of Greenlandic Inuit families with high risk for breast and/or ovarian cancer","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Frameshift mutation; Mutation; Genetics; Biology; Founder effect; BRCA2 Protein; Single-nucleotide polymorphism; Ovarian cancer; Nonsense mutation; Cancer; Population; Germline mutation; Gene; Medicine; Haplotype; Missense mutation; Genotype","score_opus":0.024354477158658,"score_gpt":0.33440656325665474,"score_spread":0.3100520860979967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071788805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.982438,0.0006915327,0.0054119583,0.00071800855,0.00004686806,0.002133568,0.00854401,0.000012043566,0.0000039644656],"genre_scores_gemma":[0.9870799,0.0021292327,0.007518318,0.000017234925,0.00014666651,0.0027183814,0.00025693385,0.00005764758,0.000075692304],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9980125,0.00008021415,0.0005075273,0.0007287179,0.0002498399,0.00042119005],"domain_scores_gemma":[0.9982446,0.00017466898,0.0003519691,0.00039692008,0.0006757531,0.00015608336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004296528,0.00028483605,0.00035445776,0.0003807284,0.00027963147,0.0000687091,0.00015495796,0.00012874843,0.00001255889],"category_scores_gemma":[0.000061286526,0.000237307,0.000058998812,0.00041169318,0.000493663,0.00004315101,0.000073792056,0.00013424964,2.1649811e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054698423,0.0005667888,0.21254858,0.0004207803,0.0007281625,0.000004551583,0.0033547587,0.0016815485,0.2578274,0.000532216,0.000038679682,0.5168267],"study_design_scores_gemma":[0.009584093,0.0011585234,0.97022367,0.00016502355,0.00022692714,0.00018931412,0.00094544794,0.0034577851,0.013082554,0.00052572537,0.00013074615,0.00031021773],"about_ca_topic_score_codex":0.017821332,"about_ca_topic_score_gemma":0.16476461,"teacher_disagreement_score":0.75767505,"about_ca_system_score_codex":0.00021419178,"about_ca_system_score_gemma":0.0007998431,"threshold_uncertainty_score":0.9887191},"labels":[],"label_agreement":null},{"id":"W2071831087","doi":"10.1007/s10549-004-3778-2","title":"Pathology of breast cancer in women with constitutional CHEK2 mutations","year":2005,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Coalition for Research in Women's Health; University of Toronto","funders":"","keywords":"CHEK2; Breast cancer; Missense mutation; Medicine; Male breast cancer; Oncology; Histology; Pathology; Cancer; Internal medicine; Mutation; Germline mutation; Biology; Gene; Genetics","score_opus":0.02212291869023115,"score_gpt":0.34282543578039465,"score_spread":0.3207025170901635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071831087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920163,0.002778559,0.00005378924,0.0031776011,0.000026942469,0.00029740034,0.0012347908,0.000004588499,0.00041000656],"genre_scores_gemma":[0.99572575,0.0023021093,0.00026894096,0.000052198837,0.00016391976,0.0011577732,0.00003884956,0.000010930169,0.00027950323],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9989645,0.000060138147,0.00014633732,0.00032339315,0.00016135711,0.0003442623],"domain_scores_gemma":[0.99942636,0.000017697934,0.000039275277,0.0001763519,0.0002322376,0.00010805445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001282886,0.00011938373,0.00014004447,0.00011808262,0.000089983034,0.000012915577,0.00007738807,0.00006839282,0.0002537818],"category_scores_gemma":[0.000003959384,0.000093822375,0.000017813207,0.00020473635,0.00085331727,0.000008387484,0.000043906235,0.000075891105,0.0000031404331],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057118665,0.0016455345,0.16917914,0.0000639547,0.00073280424,0.000053531054,0.0015510321,0.0053326855,0.106389195,0.0019377383,0.0005593307,0.7068432],"study_design_scores_gemma":[0.00687821,0.0011582716,0.94510245,0.00012008919,0.00003292035,0.00078552996,0.00077978446,0.00010404736,0.028125944,0.00026404907,0.016304007,0.00034471264],"about_ca_topic_score_codex":0.0006683856,"about_ca_topic_score_gemma":0.0026211683,"teacher_disagreement_score":0.7759233,"about_ca_system_score_codex":0.00063151284,"about_ca_system_score_gemma":0.0012290499,"threshold_uncertainty_score":0.38259655},"labels":[],"label_agreement":null},{"id":"W2072319283","doi":"10.1023/b:brea.0000019951.32001.93","title":"BAG-1 Expression Correlates with Bcl-2, p53, Differentiation, Estrogen and Progesterone Receptors in Invasive Breast Carcinoma","year":2004,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Manitoba; Memorial University of Newfoundland; McGill University","funders":"Sylvester Comprehensive Cancer Center, University of Miami Health Systems; National Cancer Institute; Health Research Board; Canadian Institutes of Health Research; University of Miami","keywords":"Carcinogenesis; Breast cancer; Estrogen receptor; Cancer research; Progesterone receptor; Estrogen; Cancer; Biology; Internal medicine; Oncology; CA15-3; Medicine","score_opus":0.020179549061222404,"score_gpt":0.29708731940540034,"score_spread":0.27690777034417796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072319283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955698,0.0023231572,0.000014802761,0.00094981707,0.000015053622,0.00097326474,0.00010511166,0.000008251501,0.000040706516],"genre_scores_gemma":[0.9965864,0.0019681526,0.00013482462,0.000008742315,0.000079977355,0.0008299161,0.00011189483,0.000029281104,0.0002508424],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99825567,0.00013794079,0.0001570893,0.00057171367,0.00033899784,0.000538576],"domain_scores_gemma":[0.99920714,0.000022359016,0.00003094994,0.00026811083,0.00017176272,0.00029968272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014870251,0.00020704567,0.00018441028,0.00014496352,0.0001849196,0.000073136594,0.00010156435,0.00012132374,0.000029771581],"category_scores_gemma":[0.00001406098,0.0001451378,0.000022534585,0.00018388209,0.0002447372,0.000016739707,0.00016166821,0.00015874532,0.0000045095207],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023442328,0.0007663285,0.753628,0.00008302274,0.00013181982,0.00008412278,0.00046207805,0.000039269024,0.20672637,0.00005412424,0.000044964992,0.035635654],"study_design_scores_gemma":[0.008534127,0.0032432133,0.5332731,0.00038142377,0.00001731098,0.0005617009,0.00046474172,0.000011679736,0.45267174,0.00013754267,0.00037159168,0.00033183978],"about_ca_topic_score_codex":0.002768924,"about_ca_topic_score_gemma":0.003010557,"teacher_disagreement_score":0.24594536,"about_ca_system_score_codex":0.00027483766,"about_ca_system_score_gemma":0.00051529123,"threshold_uncertainty_score":0.5918548},"labels":[],"label_agreement":null},{"id":"W2073204385","doi":"10.1007/s10549-012-2216-0","title":"Mammary differentiation induces expression of Tristetraprolin, a tumor suppressor AU-rich mRNA-binding protein","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Tristetraprolin; Breast cancer; Immunostaining; Prolactin; Cancer research; Biology; Messenger RNA; Cancer; Mammary gland; Gene expression; Mammary tumor; Internal medicine; Endocrinology; Immunohistochemistry; Medicine; Hormone; RNA-binding protein; Gene; Immunology; Genetics","score_opus":0.03688845181477152,"score_gpt":0.33323685891707167,"score_spread":0.29634840710230015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073204385","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996761,0.0021518134,0.000026473721,0.00017835203,0.000036289857,0.00058989844,0.00009984223,0.000006419317,0.00014989944],"genre_scores_gemma":[0.99739224,0.00039908514,0.000124748,0.0000035162461,0.00021381621,0.00049649173,0.0000634095,0.000016613487,0.0012900956],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984207,0.00015795048,0.00016925958,0.00028085176,0.00036499402,0.0006062577],"domain_scores_gemma":[0.9992397,0.000023843471,0.000061545295,0.00025338808,0.0001423984,0.0002791145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030086745,0.00014441289,0.00016601059,0.00013444314,0.00018979037,0.00003817047,0.00013278626,0.00007696454,0.000026614076],"category_scores_gemma":[0.000032221764,0.00010425355,0.000049390186,0.00014139024,0.00009601657,0.000023648548,0.00014594125,0.00010942203,0.0000026834248],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052391575,0.0004002133,0.032361273,0.000058733476,0.00006839987,0.0000043520026,0.00009948774,4.112003e-7,0.9558724,0.00003909431,0.000069166905,0.010502565],"study_design_scores_gemma":[0.0012388177,0.0005876,0.061210994,0.000085346044,0.000007672369,0.000019744753,0.000114463626,0.000008420644,0.93638045,0.000019000752,0.00022723345,0.00010026413],"about_ca_topic_score_codex":0.00062053197,"about_ca_topic_score_gemma":0.0000611836,"teacher_disagreement_score":0.028849721,"about_ca_system_score_codex":0.00012709489,"about_ca_system_score_gemma":0.00021123175,"threshold_uncertainty_score":0.42513365},"labels":[],"label_agreement":null},{"id":"W2073212579","doi":"10.1007/s10549-014-2908-8","title":"Microsatellite genotyping reveals a signature in breast cancer exomes","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"McMaster University; National Science Foundation","keywords":"Breast cancer; Microsatellite; Genotyping; Biology; Exome; Microsatellite instability; Genetics; Exome sequencing; Cancer; Genotype; Allele; Gene; Mutation","score_opus":0.041833705064124316,"score_gpt":0.36168945988465556,"score_spread":0.31985575482053125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073212579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9766839,0.013150145,0.0000036693934,0.007964806,0.00013874979,0.0009395867,0.0003319747,0.000035787027,0.00075138017],"genre_scores_gemma":[0.98783296,0.009008948,0.00014341544,0.00026627313,0.00042651972,0.0007726255,0.000018848496,0.000045434812,0.0014849514],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976095,0.00015212568,0.0002589833,0.00063854,0.0005127859,0.0008280716],"domain_scores_gemma":[0.99879986,0.00013849753,0.000049248025,0.00035687818,0.00026774642,0.00038779844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037093568,0.0002794816,0.00045367834,0.00029474814,0.00014891378,0.000060705363,0.000112500544,0.00015995477,0.000668797],"category_scores_gemma":[0.000016313985,0.00020554336,0.000071699105,0.0004943224,0.00023907467,0.00006342159,0.00008681755,0.00036816305,0.00002210245],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031744493,0.00050057523,0.52191305,0.00024565595,0.00025648618,0.000096676595,0.0007888578,0.00002517618,0.063380904,0.00009158995,0.00096342474,0.40856314],"study_design_scores_gemma":[0.003934068,0.000610535,0.9804749,0.0007273264,0.000054119908,0.00034632933,0.00011255654,0.000071123424,0.006210163,0.00039446633,0.0068106013,0.00025383904],"about_ca_topic_score_codex":0.00780833,"about_ca_topic_score_gemma":0.0023922932,"teacher_disagreement_score":0.45856184,"about_ca_system_score_codex":0.0013627597,"about_ca_system_score_gemma":0.00044393324,"threshold_uncertainty_score":0.9987988},"labels":[],"label_agreement":null},{"id":"W2073550420","doi":"10.1007/s10549-008-0260-6","title":"Trastuzumab mediated cardiotoxicity in the setting of adjuvant chemotherapy for breast cancer: a retrospective study","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":154,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; St. Boniface Hospital; University of Manitoba","funders":"","keywords":"Trastuzumab; Medicine; Cardiotoxicity; Breast cancer; Internal medicine; Cardiomyopathy; Cardiology; Asymptomatic; Ejection fraction; Oncology; Coronary artery disease; Population; Ventricle; Cancer; Heart failure; Chemotherapy","score_opus":0.052527934148644206,"score_gpt":0.3703070964892654,"score_spread":0.3177791623406212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073550420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901368,0.0008368239,0.000008963613,0.0042308834,0.00002915474,0.0036643113,0.0009489856,0.00002008144,0.00012398558],"genre_scores_gemma":[0.9949157,0.0028223451,0.000023999717,0.00009533764,0.0002599255,0.0017694468,0.000024260396,0.000027990356,0.000060943938],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979814,0.00018086586,0.00027668674,0.00043093727,0.00067666674,0.00045342505],"domain_scores_gemma":[0.9989865,0.00015858539,0.0000771978,0.00029239967,0.00035231543,0.00013303579],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063630653,0.0002112875,0.0005847001,0.00017506914,0.0002479842,0.000016371167,0.00009722732,0.00008405146,0.00003919686],"category_scores_gemma":[0.000019022586,0.00013661804,0.00013906168,0.0005557619,0.00020989834,0.00007040832,0.000017376893,0.00023471181,6.077802e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00575977,0.003397094,0.8462323,0.00010806711,0.0011993904,0.000094146846,0.01942072,0.000010403903,0.026723957,0.000024273759,0.00021766644,0.09681219],"study_design_scores_gemma":[0.011508039,0.0017407461,0.9696101,0.00013432973,0.000067665336,0.00039722657,0.0029240106,0.0000658247,0.013333496,0.00004419663,0.00006081499,0.00011356875],"about_ca_topic_score_codex":0.009794276,"about_ca_topic_score_gemma":0.0026588566,"teacher_disagreement_score":0.12337776,"about_ca_system_score_codex":0.0011537622,"about_ca_system_score_gemma":0.0005471804,"threshold_uncertainty_score":0.9967996},"labels":[],"label_agreement":null},{"id":"W2073596729","doi":"10.1007/s10549-004-0780-7","title":"Association between the T27C polymorphism in the cytochrome P450 c17? (CYP17) gene and risk factors for breast cancer","year":2004,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Children’s Health Research Institute; BC Research (Canada); Ontario Institute for Cancer Research","funders":"Health Canada","keywords":"Breast cancer; Genotype; Internal medicine; Endocrinology; Risk factors for breast cancer; Medicine; Dehydroepiandrosterone sulfate; Allele; Sex hormone-binding globulin; Hormone; Risk factor; Oncology; Cancer; Biology; Gene; Genetics; Androgen","score_opus":0.060778559392772255,"score_gpt":0.37335458773814423,"score_spread":0.31257602834537196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073596729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96713203,0.003198371,0.000009130504,0.023439616,0.0000435672,0.0016345393,0.004484386,0.000016912405,0.000041461622],"genre_scores_gemma":[0.98511887,0.012797472,0.000012347904,0.00008162663,0.00060383644,0.00096039154,0.000054777385,0.000028240425,0.00034244187],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99804157,0.000113401045,0.00022369693,0.00040567623,0.0005809159,0.0006347334],"domain_scores_gemma":[0.9988867,0.00037358797,0.0000999423,0.0002760287,0.00014981492,0.00021393926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005111412,0.00023439438,0.0003480474,0.00013951959,0.00047587065,0.000101408936,0.000113728405,0.00011132055,0.00007885507],"category_scores_gemma":[0.000022697832,0.000117753414,0.00009394211,0.0003291576,0.0001800329,0.00009231458,0.000044139648,0.00030776794,0.0000025950667],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065476354,0.00024615467,0.9305374,0.000028391572,0.0006927986,0.000013243728,0.0019952806,0.000011959992,0.00031568028,0.000041159907,0.00031115577,0.06515201],"study_design_scores_gemma":[0.0048882873,0.0005172937,0.991133,0.000084584746,0.00028541684,0.000047304664,0.0005122383,0.0000078109915,0.00043283074,0.00032560225,0.0016445646,0.00012107867],"about_ca_topic_score_codex":0.16150407,"about_ca_topic_score_gemma":0.016610077,"teacher_disagreement_score":0.14489399,"about_ca_system_score_codex":0.0020569859,"about_ca_system_score_gemma":0.0004587455,"threshold_uncertainty_score":0.9268812},"labels":[],"label_agreement":null},{"id":"W2074667852","doi":"10.1007/s10549-013-2823-4","title":"Timing of oral contraceptive use and the risk of breast cancer in BRCA1 mutation carriers","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Reproductive Health and Contraception","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Alberta; Université de Montréal; University of Toronto; BC Cancer Agency; Women's College Hospital","funders":"National Cancer Institute","keywords":"Medicine; Breast cancer; Odds ratio; Gynecology; Cancer; Obstetrics; Pill; Case-control study; Population; BRCA mutation; Confidence interval; Internal medicine; Oncology","score_opus":0.05342391175251379,"score_gpt":0.3844997849542203,"score_spread":0.3310758732017065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074667852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928584,0.0018434095,0.000019278337,0.0039736195,0.000025798807,0.0009385525,0.0002746386,0.0000043275854,0.00006194616],"genre_scores_gemma":[0.9947546,0.0047217617,0.000030863892,0.000020148538,0.00008895964,0.00026725893,0.0000059176905,0.000009066486,0.000101427126],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986985,0.00031065228,0.0002107507,0.0002585174,0.0002670753,0.00025450336],"domain_scores_gemma":[0.9989887,0.000221629,0.00010275751,0.00016716047,0.0003847326,0.00013502521],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007032575,0.000101367135,0.00031939166,0.000117205636,0.000091957336,0.000013040388,0.00002534885,0.00004314636,0.000050367842],"category_scores_gemma":[0.00008328961,0.00005902571,0.000035375,0.00017748582,0.00051425723,0.000098221586,0.000015588626,0.00014020847,4.7302547e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011014875,0.00019401775,0.5259464,0.00009832072,0.00021991701,0.0000054061547,0.0021511917,0.000038456477,0.0008144698,0.00028055886,0.0000229219,0.4592135],"study_design_scores_gemma":[0.009174439,0.00045619847,0.98736405,0.00017419306,0.00009468985,0.0000521268,0.0007296874,0.0010278927,0.00063583313,0.00018035294,0.00006517665,0.00004537142],"about_ca_topic_score_codex":0.08915362,"about_ca_topic_score_gemma":0.006646674,"teacher_disagreement_score":0.46141768,"about_ca_system_score_codex":0.00022954588,"about_ca_system_score_gemma":0.00023181053,"threshold_uncertainty_score":0.9169118},"labels":[],"label_agreement":null},{"id":"W2074695616","doi":"10.1007/s10549-012-2236-9","title":"Management of small HER2 overexpressing tumours","year":2012,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Trastuzumab; Medicine; Oncology; Internal medicine; Breast cancer; Hazard ratio; Odds ratio; Chemotherapy; Cancer; Gynecology; Confidence interval","score_opus":0.29971512262007144,"score_gpt":0.4988222990774509,"score_spread":0.19910717645737946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074695616","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022939402,0.9902469,0.0000022556856,0.00022258091,0.00010432796,0.0028842322,0.00054633507,0.000032719952,0.0057312767],"genre_scores_gemma":[0.0008183095,0.9902547,0.00032960408,0.0000054746265,0.00049925596,0.0021172075,0.00010199281,0.00012629168,0.0057471544],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958081,0.00032485026,0.0005828262,0.0007658761,0.0012232742,0.0012950323],"domain_scores_gemma":[0.99767506,0.00017896228,0.0001701546,0.0008737866,0.00028496177,0.0008170634],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00074014394,0.0005389326,0.0018135777,0.0005503127,0.0001736798,0.000069491,0.000267325,0.00024625243,0.0007213858],"category_scores_gemma":[0.0000059768604,0.00036664883,0.00036194394,0.0006771763,0.00044677654,0.000059709004,0.00036178651,0.000636182,0.00007856559],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023408768,0.0007555787,0.00051860657,0.037319418,0.0012565067,0.0003979323,0.00006246133,8.7504255e-8,0.0000012001321,0.00019037981,0.0002500585,0.9590137],"study_design_scores_gemma":[0.0015242208,0.00071039447,0.0015605259,0.054465935,0.0014972739,0.00054104166,0.000085264815,0.0000014003313,0.000028955079,0.000031575684,0.93926245,0.00029098842],"about_ca_topic_score_codex":0.0028598255,"about_ca_topic_score_gemma":0.000091326016,"teacher_disagreement_score":0.9587227,"about_ca_system_score_codex":0.0022818004,"about_ca_system_score_gemma":0.0013137115,"threshold_uncertainty_score":0.9998785},"labels":[],"label_agreement":null},{"id":"W2074876140","doi":"10.1007/s10549-010-1224-1","title":"Evaluation of metformin in early breast cancer: a modification of the traditional paradigm for clinical testing of anti-cancer agents","year":2010,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":176,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; Juravinski Cancer Centre; Sunnybrook Health Science Centre; University of British Columbia; Queen's University; Université Laval; BC Cancer Agency; Centre hospitalier universitaire de Québec; University of Toronto; University Health Network; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; Ontario Institute for Cancer Research","funders":"","keywords":"Metformin; Medicine; Breast cancer; Cancer; Oncology; Adjuvant; Drug; Clinical trial; Internal medicine; Diabetes mellitus; Intensive care medicine; Pharmacology; Endocrinology; Insulin","score_opus":0.4426397235164595,"score_gpt":0.510092707747534,"score_spread":0.06745298423107449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074876140","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18925875,0.8029872,0.0000019907038,0.000025379692,0.00013004414,0.0016011556,0.005975402,0.0000012415281,0.000018805596],"genre_scores_gemma":[0.06048101,0.9357961,0.000039779774,0.000003881926,0.00035694454,0.003117507,0.00015064697,0.000027121689,0.000027024844],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99732876,0.00044952764,0.0007455249,0.00047975883,0.0006889132,0.00030749067],"domain_scores_gemma":[0.9979847,0.00012898407,0.00055843237,0.00040366463,0.00082872144,0.00009546104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017656044,0.000240701,0.000871353,0.00012829783,0.00006667473,0.000011867002,0.0002548284,0.000273954,0.00004110936],"category_scores_gemma":[0.00008362096,0.00015857628,0.00030461376,0.00030933786,0.00033854763,0.000009762767,0.000054631728,0.0001914976,2.1914559e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011458153,0.00041052228,0.0048265015,0.0010886793,0.00042647347,1.0903244e-7,0.000026722135,0.00001242648,0.00017417314,0.000048123915,0.00005419901,0.99281746],"study_design_scores_gemma":[0.01714672,0.0022181235,0.3791931,0.018318268,0.007205396,0.00006369534,0.00008486611,0.00077380054,0.012788438,0.0012756261,0.559595,0.0013369498],"about_ca_topic_score_codex":0.0019205547,"about_ca_topic_score_gemma":0.0006063548,"teacher_disagreement_score":0.9914805,"about_ca_system_score_codex":0.00019000727,"about_ca_system_score_gemma":0.0027677007,"threshold_uncertainty_score":0.6466553},"labels":[],"label_agreement":null},{"id":"W2075080356","doi":"10.1007/s10549-013-2540-z","title":"Survival of patients with BRCA1-associated breast cancer diagnosed in an MRI-based surveillance program","year":2013,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Medicine; Breast cancer; Mammography; Oncology; Cancer; Internal medicine; Context (archaeology); Population; Mastectomy; Breast MRI; Cancer registry; Gynecology","score_opus":0.021376112061846485,"score_gpt":0.33337332323491636,"score_spread":0.3119972111730699,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075080356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99596745,0.0004993334,0.000004073098,0.00064127997,0.000048642214,0.0012686624,0.0015067183,0.000013784996,0.000050057777],"genre_scores_gemma":[0.99599147,0.0004452645,0.000093501694,0.000022978795,0.00007252774,0.0028384982,0.00043000796,0.000034803044,0.00007096509],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981978,0.0002034079,0.00020478157,0.0005081862,0.00038307623,0.0005027596],"domain_scores_gemma":[0.9985876,0.000038468013,0.000083891755,0.00033720816,0.00077062164,0.00018221662],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016922702,0.00020583211,0.0002405527,0.00010827015,0.00009204612,0.000051542964,0.00014941214,0.00010555843,0.00014988106],"category_scores_gemma":[0.000010044371,0.00015645614,0.000036298017,0.00035272076,0.00026592496,0.000016064298,0.00004815423,0.00009506583,0.0000021794694],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074836175,0.0017951875,0.9307019,0.000020393461,0.0001451953,0.0000034171649,0.000054477325,0.0002213191,0.0008526492,0.0000032301512,0.0001590796,0.06529478],"study_design_scores_gemma":[0.004587899,0.0013274722,0.9917999,0.000050347022,0.000009512033,0.0000012096242,0.00006015763,0.00010602636,0.0015878929,0.000008436676,0.00028749308,0.00017364578],"about_ca_topic_score_codex":0.014272238,"about_ca_topic_score_gemma":0.04267326,"teacher_disagreement_score":0.06512114,"about_ca_system_score_codex":0.00047138036,"about_ca_system_score_gemma":0.00083929795,"threshold_uncertainty_score":0.9922918},"labels":[],"label_agreement":null},{"id":"W2075174350","doi":"10.1023/a:1024513815374","title":"Lignans and Tamoxifen, Alone or in Combination, Reduce Human Breast Cancer Cell Adhesion, Invasion and Migration in vitro","year":2003,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Phytoestrogen effects and research","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Natural Sciences and Engineering Research Council of Canada; University of Toronto","keywords":"Tamoxifen; Matrigel; Cell adhesion; Metastasis; Enterolactone; Breast cancer; Cancer research; Fibronectin; Estrogen receptor; Cell migration; Antiestrogen; Cell; Cancer; Internal medicine; Chemistry; Medicine; Endocrinology; Biology; Estrogen; Phytoestrogens; Biochemistry; Angiogenesis","score_opus":0.05410302657519845,"score_gpt":0.37480094583414425,"score_spread":0.3206979192589458,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075174350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885997,0.005916812,5.157442e-7,0.0039927284,0.000020145315,0.0011696614,0.00009531262,0.000010568798,0.00019454045],"genre_scores_gemma":[0.984217,0.0142214345,0.00003435856,0.000036872643,0.00005516027,0.00057424535,0.00003287113,0.000022892738,0.0008052021],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99804324,0.00026957263,0.00023980754,0.0004921932,0.00043502307,0.000520162],"domain_scores_gemma":[0.9991318,0.00011282325,0.000038912138,0.00018116926,0.00018656136,0.00034872085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048846635,0.00019554945,0.00033627733,0.00029826164,0.00021562888,0.00006188838,0.000042226606,0.00009808406,0.0001027883],"category_scores_gemma":[0.000020450516,0.00012915306,0.000022515947,0.0004246846,0.00021401684,0.00015670803,0.000044848835,0.00022448722,0.000001784729],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006263582,0.0041931807,0.44852012,0.0005277397,0.00010755133,0.0005386134,0.0017148085,0.0000025365975,0.4622367,0.00019576355,0.00058545114,0.07511397],"study_design_scores_gemma":[0.013056671,0.0017864112,0.8259838,0.000644835,0.000034157587,0.00042286507,0.00059142883,0.00010114147,0.15648004,0.000270167,0.00042749534,0.00020097272],"about_ca_topic_score_codex":0.03072949,"about_ca_topic_score_gemma":0.021862995,"teacher_disagreement_score":0.3774637,"about_ca_system_score_codex":0.00069347664,"about_ca_system_score_gemma":0.00041729957,"threshold_uncertainty_score":0.99598545},"labels":[],"label_agreement":null},{"id":"W2075196112","doi":"10.1007/s10549-013-2818-1","title":"Utility of 3-dimensional echocardiography, global longitudinal strain, and exercise stress echocardiography to detect cardiac dysfunction in breast cancer patients treated with doxorubicin-containing adjuvant therapy","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia, Okanagan Campus; University of British Columbia","funders":"National Cancer Institute","keywords":"Medicine; Ejection fraction; Cardiology; Internal medicine; Breast cancer; Asymptomatic; Anthracycline; Stress Echocardiography; Subclinical infection; Cardiac function curve; Speckle tracking echocardiography; Chemotherapy; Heart failure; Cancer; Stress testing (software); Doxorubicin; Coronary artery disease","score_opus":0.02323094352406039,"score_gpt":0.3036683898335081,"score_spread":0.28043744630944767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075196112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941939,0.0016569659,0.000019304129,0.0003137907,0.000047612553,0.0016221874,0.0020022895,0.000032293698,0.000111672016],"genre_scores_gemma":[0.9957652,0.0034727,0.000054891123,0.000037131682,0.00011093377,0.00043156155,0.00009368924,0.00002726084,0.0000066111825],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974724,0.00019709367,0.00029542507,0.00071723934,0.0007523526,0.0005654907],"domain_scores_gemma":[0.9985774,0.00006485104,0.000076099044,0.00032034586,0.0005310876,0.00043020843],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036854378,0.0003483798,0.00079099264,0.0004151355,0.00016523773,0.000041180174,0.000059200116,0.00013249936,0.000025598902],"category_scores_gemma":[0.0000047752883,0.00025180154,0.00019657143,0.0010042428,0.00026701696,0.00012522622,0.000036807658,0.0001956219,5.3314574e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008682546,0.0002982335,0.6737085,0.000048446596,0.00059014617,0.000010266142,0.0001119997,0.000028653605,0.0021282202,0.000003980783,0.000017854763,0.31437117],"study_design_scores_gemma":[0.008462389,0.0023245162,0.97316855,0.00074397697,0.00014060373,0.000025999752,0.00015536687,0.000044215387,0.014663363,0.000039470102,0.000028227632,0.00020333113],"about_ca_topic_score_codex":0.015040187,"about_ca_topic_score_gemma":0.0009509599,"teacher_disagreement_score":0.31416786,"about_ca_system_score_codex":0.00034333867,"about_ca_system_score_gemma":0.00020892073,"threshold_uncertainty_score":0.99999344},"labels":[],"label_agreement":null},{"id":"W2075804585","doi":"10.1007/s10549-006-9401-y","title":"Identifying menopause in breast cancer patients: considerations and implications","year":2006,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Comprehensive Cancer Network","keywords":"Tamoxifen; Medicine; Breast cancer; Menopause; Oncology; Aromatase; Internal medicine; Cancer; Gynecology; Hormone therapy; Adjuvant therapy; Etiology; Disease","score_opus":0.05255167148494908,"score_gpt":0.4018540546695704,"score_spread":0.3493023831846213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075804585","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009951308,0.98632497,7.2473927e-7,0.00033845616,0.00004410805,0.0011063498,0.0020767108,0.000008413883,0.00014896152],"genre_scores_gemma":[0.014347922,0.9826246,0.000016678752,0.000012121804,0.00015777825,0.0018745358,0.0006078053,0.00004186263,0.0003167332],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983119,0.0001803001,0.00029802453,0.00061495014,0.0001558733,0.00043899132],"domain_scores_gemma":[0.9992532,0.000052136205,0.00008791976,0.00026981125,0.00015213534,0.00018480027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000117569354,0.00031427853,0.00048629858,0.00020357194,0.00026802215,0.00011044027,0.000075783144,0.00026432023,0.000023627124],"category_scores_gemma":[0.000005889407,0.00023389798,0.000078481564,0.00020981664,0.00018423187,0.000009142258,0.00012559655,0.00022851929,0.000004881198],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007917495,0.0008631158,0.008374696,0.0013216542,0.000759671,0.000029477147,0.00004717425,0.000002126632,0.00022780511,0.00024061983,0.0025586514,0.9854958],"study_design_scores_gemma":[0.008810634,0.0017628111,0.09310401,0.01167513,0.0017910963,0.0016887871,0.00007335298,0.000006520676,0.00031173605,0.0006783916,0.87794447,0.0021530648],"about_ca_topic_score_codex":0.0033160166,"about_ca_topic_score_gemma":0.0015279334,"teacher_disagreement_score":0.98334277,"about_ca_system_score_codex":0.0002883072,"about_ca_system_score_gemma":0.00052998064,"threshold_uncertainty_score":0.9538083},"labels":[],"label_agreement":null},{"id":"W2076003089","doi":"10.1023/a:1016075709022","title":"Insulin-like growth factor binding proteins 1 and 3 and breast cancer outcomes","year":2002,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; Women's College Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; Quartile; Hazard ratio; Internal medicine; Insulin; Oncology; Insulin-like growth factor; Proportional hazards model; Endocrinology; Estrogen receptor; Cancer; Growth factor; Receptor; Confidence interval","score_opus":0.07211867368566989,"score_gpt":0.3393362038699912,"score_spread":0.2672175301843213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076003089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97893506,0.008298263,0.000001498271,0.009837229,0.00008849261,0.0012698617,0.001096665,0.00006692717,0.00040598537],"genre_scores_gemma":[0.9697053,0.027038049,0.000059635295,0.00016008365,0.00020717633,0.000584396,0.000018296801,0.000052632826,0.002174434],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974191,0.00008467111,0.00030544287,0.00071972294,0.0006159238,0.00085514516],"domain_scores_gemma":[0.99842316,0.000110320114,0.0000677341,0.00027998857,0.00026601448,0.0008528102],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014139502,0.00041235416,0.0005852232,0.0003966692,0.00044939856,0.00013685835,0.000078478355,0.00015445933,0.0004985635],"category_scores_gemma":[0.000021391561,0.00027954776,0.000074053256,0.00039363911,0.0004059943,0.00026728286,0.0001312347,0.00034826144,0.00002512472],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006541648,0.0006546822,0.8674972,0.00017950377,0.00052812626,0.0001609917,0.0009977957,6.1763544e-8,0.0016406857,0.00011406729,0.0005512178,0.12702148],"study_design_scores_gemma":[0.005690293,0.0009632664,0.98928076,0.00021107239,0.00010647333,0.0005730958,0.00022972294,0.00005288471,0.00079516217,0.000059557573,0.0017445632,0.00029313547],"about_ca_topic_score_codex":0.009560151,"about_ca_topic_score_gemma":0.00042436246,"teacher_disagreement_score":0.12672834,"about_ca_system_score_codex":0.0004775018,"about_ca_system_score_gemma":0.00015158074,"threshold_uncertainty_score":0.99996567},"labels":[],"label_agreement":null},{"id":"W2079053066","doi":"10.1007/s10549-015-3347-x","title":"Prevalence of PALB2 mutations in the Creighton University Breast Cancer Family Registry","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Women's College Hospital; University of Toronto","funders":"","keywords":"PALB2; Breast cancer; Proband; Medicine; Cancer; Oncology; Family history; Internal medicine; Mutation; Germline mutation; Genetics; Gene; Biology","score_opus":0.05991812753315464,"score_gpt":0.35036966988727936,"score_spread":0.29045154235412474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079053066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904383,0.004263489,0.00001645225,0.0023828542,0.00004453213,0.00034467716,0.0013519033,0.000003922962,0.0011538636],"genre_scores_gemma":[0.9937863,0.0047124145,0.0000622942,0.00003017449,0.000103937724,0.00011526347,0.00003382879,0.000009124607,0.0011466655],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989106,0.00016415099,0.000108382126,0.0003015529,0.00027200018,0.00024330491],"domain_scores_gemma":[0.99921596,0.00002827534,0.000045969653,0.0003206098,0.00028835185,0.00010085137],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023773451,0.00010612861,0.00009633769,0.00007423168,0.00010119117,0.000018425846,0.0002066084,0.00006576615,0.000025233714],"category_scores_gemma":[0.000009200992,0.000078243625,0.00003291382,0.00026174492,0.00032232952,0.000009115171,0.00006843938,0.000086203305,0.0000018943225],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041593513,0.0018197384,0.82105577,0.00031434122,0.00065339974,0.00012706793,0.0044648913,0.001486212,0.031690024,0.0011932481,0.016630627,0.116405316],"study_design_scores_gemma":[0.00291719,0.00054602366,0.9756314,0.000108857326,0.00006258025,0.00013260313,0.0038536768,0.00005409436,0.0053781127,0.00031993378,0.010791454,0.00020407538],"about_ca_topic_score_codex":0.0077058394,"about_ca_topic_score_gemma":0.0024152265,"teacher_disagreement_score":0.15457562,"about_ca_system_score_codex":0.00039021525,"about_ca_system_score_gemma":0.0010502249,"threshold_uncertainty_score":0.9989019},"labels":[],"label_agreement":null},{"id":"W2079157714","doi":"10.1007/s10549-008-0153-8","title":"BRCA1 and BRCA2 mutation carriers in the Breast Cancer Family Registry: an open resource for collaborative research","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":63,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Cancer Care Ontario; Mount Sinai Hospital","funders":"National Institute of Environmental Health Sciences; National Cancer Institute","keywords":"Proband; Breast cancer; Germline mutation; Mutation; Genetics; BRCA2 Protein; Medicine; Genetic counseling; Genetic testing; Germline; Cancer; Oncology; Biology; Gene","score_opus":0.10173353503980541,"score_gpt":0.4220222914369063,"score_spread":0.32028875639710086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079157714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9814087,0.006299051,0.000011517561,0.0068742535,0.00003868954,0.002247201,0.0023124693,0.0000063439784,0.00080177974],"genre_scores_gemma":[0.9881296,0.005399712,0.0001831991,0.0001601233,0.00031036406,0.004812169,0.00022154019,0.00003511568,0.00074814004],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9974731,0.0005446188,0.00019202591,0.00075259904,0.0004543312,0.00058328663],"domain_scores_gemma":[0.99845654,0.00011815581,0.00005313991,0.0004977355,0.0006800235,0.00019439383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010370302,0.00019077654,0.00019325502,0.00014594544,0.000854979,0.0002007606,0.00041311074,0.00012917088,0.000012720117],"category_scores_gemma":[0.000037081292,0.00014139072,0.000024520528,0.00058791426,0.0007975935,0.000030901305,0.00018709345,0.00019361752,9.253988e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029077599,0.0031511562,0.1548643,0.0002862544,0.0018981068,0.0004615121,0.03846971,0.0010859646,0.08684327,0.0021579266,0.15076448,0.5309397],"study_design_scores_gemma":[0.015351975,0.006184777,0.729497,0.00022237822,0.000076794255,0.001422514,0.041642826,0.0002706937,0.012655533,0.0014994615,0.19028421,0.00089179823],"about_ca_topic_score_codex":0.012868031,"about_ca_topic_score_gemma":0.01400342,"teacher_disagreement_score":0.57463276,"about_ca_system_score_codex":0.0006243684,"about_ca_system_score_gemma":0.0019215243,"threshold_uncertainty_score":0.9937054},"labels":[],"label_agreement":null},{"id":"W2079238552","doi":"10.1007/s10549-004-9454-8","title":"Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ?","year":2004,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Ductal carcinoma; Breast cancer; Surgical pathology; Carcinoma in situ; Anatomical pathology; Pathology; Carcinoma; Radiology; Cancer; Internal medicine","score_opus":0.040566080942962636,"score_gpt":0.3755033972629834,"score_spread":0.3349373163200207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079238552","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97643435,0.009960846,0.000090544905,0.01120503,0.0000903934,0.001118479,0.00067991065,0.0000067521582,0.0004136784],"genre_scores_gemma":[0.9888414,0.008246363,0.00041547758,0.00008260031,0.00015830695,0.0020769215,0.00005929174,0.000023655723,0.000095939526],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99849063,0.000050163904,0.0002031986,0.0005229265,0.00024318277,0.0004898842],"domain_scores_gemma":[0.99930704,0.000034259127,0.000051553892,0.00037932824,0.00013960892,0.000088187466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017256392,0.00022270076,0.00023384173,0.000079702346,0.00020056308,0.000020687463,0.0001656936,0.00007244408,0.000019749505],"category_scores_gemma":[0.000001178486,0.00014769426,0.00008920851,0.00015938017,0.0003132708,0.0000077322675,0.00019256359,0.000069702815,0.0000012223525],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012654684,0.00861138,0.47695374,0.0006178735,0.007517272,0.0010411532,0.0044864113,0.00034749636,0.05404642,0.005957909,0.0029606323,0.42480502],"study_design_scores_gemma":[0.007480201,0.0008182099,0.97084695,0.00009298635,0.00007331934,0.000404573,0.0019047868,0.0000061836713,0.016869875,0.00045543446,0.0008580743,0.0001894147],"about_ca_topic_score_codex":0.0030825082,"about_ca_topic_score_gemma":0.001186147,"teacher_disagreement_score":0.4938932,"about_ca_system_score_codex":0.00033994732,"about_ca_system_score_gemma":0.00020269598,"threshold_uncertainty_score":0.60227966},"labels":[],"label_agreement":null},{"id":"W2079242442","doi":"10.1007/s10549-007-9634-4","title":"Ovarian cysts and breast cancer: results from the Women’s Contraceptive and Reproductive Experiences Study","year":2007,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Cancer Institute; Centers for Disease Control and Prevention","keywords":"Medicine; Breast cancer; Odds ratio; Ovarian cancer; Gynecology; Confidence interval; Population; Epidemiology; Case-control study; Obstetrics; Cancer; Demography; Oncology; Internal medicine","score_opus":0.04891227199401871,"score_gpt":0.37506724685075754,"score_spread":0.32615497485673883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079242442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96732426,0.0077347546,0.0000011753318,0.020808091,0.0001178368,0.0021671923,0.0015437013,0.00002953298,0.00027343398],"genre_scores_gemma":[0.9891436,0.0067452653,0.00003022492,0.00011779123,0.000765817,0.0027808195,0.000019177869,0.000026661366,0.0003706466],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99696636,0.00016944224,0.00033634022,0.0011816995,0.0005929341,0.0007531938],"domain_scores_gemma":[0.9979943,0.00051434484,0.000097771735,0.0005329874,0.00030399693,0.0005566142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087807834,0.00033052586,0.00049155974,0.00011321731,0.00057992927,0.0001501124,0.0000852656,0.00007325994,0.00017807832],"category_scores_gemma":[0.000035071633,0.00018857853,0.0000387643,0.0003027108,0.0006531067,0.00014090433,0.000119169825,0.00022294093,0.0000034931286],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015813174,0.0025106913,0.50670534,0.000014231035,0.0017154982,0.00051625754,0.08912957,5.2041105e-7,0.00008297576,0.00011575593,0.00033908503,0.38305688],"study_design_scores_gemma":[0.0121054575,0.0023420393,0.91555583,0.00015754426,0.00015575648,0.00023198241,0.06796833,0.000004176701,0.00029015343,0.00016181722,0.0008626894,0.00016420886],"about_ca_topic_score_codex":0.0711235,"about_ca_topic_score_gemma":0.009570184,"teacher_disagreement_score":0.4088505,"about_ca_system_score_codex":0.0011941612,"about_ca_system_score_gemma":0.00035145628,"threshold_uncertainty_score":0.935062},"labels":[],"label_agreement":null},{"id":"W2079272606","doi":"10.1023/a:1010686118469","title":"Health System Costs of Metastatic Breast Cancer","year":2001,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Confidence interval; Christian ministry; Demography; Cancer; Psychological intervention; Gynecology; Gerontology; Internal medicine; Nursing","score_opus":0.08661251427354645,"score_gpt":0.3504204916679984,"score_spread":0.26380797739445194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079272606","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88948137,0.06344105,0.00021600598,0.020745443,0.0005361967,0.0015148062,0.011183467,0.00007425892,0.01280742],"genre_scores_gemma":[0.97424453,0.023842389,0.000055221397,0.00009649063,0.00022133286,0.00037087433,0.000013826671,0.000034345812,0.0011209968],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979573,0.00004443062,0.0006247377,0.0005192552,0.000099894765,0.00075440673],"domain_scores_gemma":[0.9987358,0.00006225138,0.000314816,0.00033952264,0.00014787815,0.00039975563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005676115,0.00022857173,0.00077997224,0.00032414796,0.00023138193,0.00007333345,0.00017126593,0.00005800545,0.0005030582],"category_scores_gemma":[0.000007481107,0.00021023287,0.00010115497,0.0003629818,0.0002174253,0.00025410342,0.0000592091,0.00013535508,0.00008991219],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010647887,0.00080940174,0.46299326,0.00025821372,0.0007282949,0.00004451729,0.0006238361,0.00007797337,0.000014234672,0.15806448,0.002331729,0.37298927],"study_design_scores_gemma":[0.006663353,0.0012336355,0.9475351,0.00078885094,0.00003728924,0.0005370464,0.00080944557,0.0007369952,0.0000799243,0.003957552,0.036948543,0.0006722937],"about_ca_topic_score_codex":0.09914063,"about_ca_topic_score_gemma":0.0052620685,"teacher_disagreement_score":0.4845418,"about_ca_system_score_codex":0.0025456112,"about_ca_system_score_gemma":0.0003960369,"threshold_uncertainty_score":0.90685827},"labels":[],"label_agreement":null},{"id":"W2079398602","doi":"10.1007/s10549-005-2414-0","title":"Somatostatin receptors in primary human breast cancer: quantitative analysis of mRNA for subtypes 1–5 and correlation with receptor protein expression and tumor pathology","year":2005,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; McGill University; Royal Victoria Hospital","funders":"","keywords":"Somatostatin receptor 2; Somatostatin receptor 1; Somatostatin receptor; Immunocytochemistry; Biology; Receptor; Somatostatin; Somatostatin receptor 3; Pathology; Endocrinology; Internal medicine; Breast cancer; Receptor expression; Cancer; Medicine","score_opus":0.03204289049299733,"score_gpt":0.3734229866046056,"score_spread":0.34138009611160824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079398602","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99278957,0.0020847057,0.000010817431,0.00260144,0.000008047802,0.001846186,0.000607965,0.000014556957,0.000036715537],"genre_scores_gemma":[0.99443805,0.0016564705,0.0019009684,0.000018767176,0.00003650079,0.0015063375,0.00008943217,0.000025916414,0.0003275795],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99821144,0.0001770232,0.00027040788,0.00051968073,0.00038018601,0.00044127522],"domain_scores_gemma":[0.99898946,0.00021004598,0.00011577833,0.00016606759,0.00028687395,0.00023174171],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022442163,0.00019152457,0.00052028464,0.0006278758,0.00015320322,0.000024564897,0.000045889217,0.000018097118,0.00008338269],"category_scores_gemma":[0.000028964636,0.0001317262,0.000035382327,0.000556277,0.0004440003,0.00018429651,0.0000538095,0.00016568995,5.5738445e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0154976,0.0009591941,0.8327605,0.0004485211,0.00055914005,0.00019493364,0.00088804413,0.00006155773,0.08299241,0.00024038718,0.00010182028,0.065295905],"study_design_scores_gemma":[0.010086611,0.005146467,0.9565017,0.0008748836,0.00026713332,0.00042576186,0.0010393785,0.0005982246,0.024310116,0.00009580437,0.0004192262,0.00023469866],"about_ca_topic_score_codex":0.0023113692,"about_ca_topic_score_gemma":0.004478481,"teacher_disagreement_score":0.12374121,"about_ca_system_score_codex":0.00035827924,"about_ca_system_score_gemma":0.00024084034,"threshold_uncertainty_score":0.5371639},"labels":[],"label_agreement":null},{"id":"W2079507174","doi":"10.1007/s10549-011-1785-7","title":"Vascular proliferation is a prognostic factor in breast cancer","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Hôpital du Sacré-Cœur de Montréal; Jewish General Hospital","funders":"Norges Forskningsråd; Jewish General Hospital; Helse Vest","keywords":"Angiogenesis; Breast cancer; Medicine; Immunohistochemistry; Context (archaeology); Cancer; Pathology; Vascular endothelial growth factor; Univariate analysis; Oncology; Breast carcinoma; Internal medicine; Cancer research; Biology; Multivariate analysis","score_opus":0.059831929706923116,"score_gpt":0.3416120181856098,"score_spread":0.2817800884786867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079507174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919058,0.0060076527,0.000014932733,0.00065198395,0.00004887979,0.0005851604,0.0005764468,0.0000080086675,0.00020112889],"genre_scores_gemma":[0.9878964,0.009926111,0.000044938486,0.0000906178,0.0002668406,0.0013171965,0.00003073492,0.000025212366,0.00040195612],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986441,0.000069503294,0.00014889849,0.00047450673,0.00022528214,0.0004377057],"domain_scores_gemma":[0.999384,0.0000067172887,0.000031553063,0.00023372853,0.0001806621,0.00016336935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001044762,0.00017878256,0.00015757131,0.00008843965,0.00011461513,0.00003346872,0.00009505519,0.00010541751,0.00045867672],"category_scores_gemma":[0.0000031134882,0.00013481978,0.00006958363,0.00015747131,0.00010658056,0.000009898841,0.00006398459,0.00006734681,0.00000903779],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005893239,0.00048241616,0.92857516,0.000031214153,0.00023804118,0.000013401452,0.00041638024,0.000002415732,0.010133073,0.000040674055,0.0005267683,0.05895116],"study_design_scores_gemma":[0.0013833207,0.00043172008,0.9713028,0.00007214264,0.000023803685,0.000037576414,0.00008028873,0.000029742294,0.022524444,0.000049033948,0.0038636012,0.00020150152],"about_ca_topic_score_codex":0.0054840376,"about_ca_topic_score_gemma":0.0020870462,"teacher_disagreement_score":0.05874966,"about_ca_system_score_codex":0.00016587733,"about_ca_system_score_gemma":0.00032786175,"threshold_uncertainty_score":0.8290261},"labels":[],"label_agreement":null},{"id":"W2079689268","doi":"10.1007/s10549-013-2530-1","title":"Determination of clinically therapeutic endoxifen concentrations based on efficacy from human MCF7 breast cancer xenografts","year":2013,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Tamoxifen; Pharmacokinetics; In vivo; Breast cancer; CYP2D6; Active metabolite; Medicine; Estrogen receptor; Pharmacology; Pharmacodynamics; Cancer; Oncology; Internal medicine; Biology; Metabolism; Cytochrome P450","score_opus":0.03416581233443016,"score_gpt":0.3727183254085206,"score_spread":0.33855251307409046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079689268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99604785,0.0012251402,0.000034466364,0.0012752581,0.000049701226,0.0007001686,0.0004166376,0.000009770637,0.00024102247],"genre_scores_gemma":[0.9977393,0.0011384581,0.00006665462,0.0000793589,0.00019907622,0.00042691457,0.00017482147,0.000019073726,0.00015632145],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987354,0.00015862897,0.00022499218,0.00035016055,0.00022947615,0.00030132977],"domain_scores_gemma":[0.99921024,0.0000822646,0.00007570811,0.00026059145,0.0001961653,0.00017503755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001051738,0.00015715894,0.00016764128,0.00005771912,0.00016967658,0.000039852486,0.00010227992,0.00013224423,0.00018647786],"category_scores_gemma":[0.000006602626,0.00011347312,0.00007817001,0.00009491755,0.00021446707,0.0000071408067,0.000030374162,0.00011449478,0.000010110329],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016238146,0.0022659558,0.12105095,0.000026165953,0.00053592306,0.000012885569,0.00014428612,0.00008312954,0.50527316,0.00008546366,0.00040082532,0.3684974],"study_design_scores_gemma":[0.009456713,0.004891731,0.8149981,0.0002483684,0.00015088572,0.000025193725,0.00008170688,0.0013405547,0.16737252,0.00016085271,0.0008736003,0.0003997876],"about_ca_topic_score_codex":0.004290104,"about_ca_topic_score_gemma":0.00019892943,"teacher_disagreement_score":0.69394714,"about_ca_system_score_codex":0.00008129971,"about_ca_system_score_gemma":0.00020116576,"threshold_uncertainty_score":0.64853823},"labels":[],"label_agreement":null},{"id":"W2080076833","doi":"10.1007/s10549-009-0452-8","title":"Predicting benefit from fulvestrant in pretreated metastatic breast cancer patients","year":2009,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Saskatoon Medical Imaging; Saskatchewan Cancer Agency; Ottawa Hospital; BC Cancer Agency; Princess Margaret Cancer Centre","funders":"","keywords":"Fulvestrant; Medicine; Breast cancer; Oncology; Internal medicine; Tamoxifen; Aromatase inhibitor; Chemotherapy; Metastatic breast cancer; Cancer","score_opus":0.017167887203761827,"score_gpt":0.31473533753378274,"score_spread":0.2975674503300209,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080076833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99225277,0.005291191,9.637979e-7,0.00055159867,0.0000442537,0.00053041364,0.001164165,0.000013503607,0.0001511408],"genre_scores_gemma":[0.994344,0.0047987886,0.000027184831,0.000032099262,0.00012612506,0.00019131922,0.000270637,0.000019777532,0.00019007064],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99841076,0.000089933295,0.00019537956,0.000509781,0.00026363324,0.0005305262],"domain_scores_gemma":[0.999362,0.000022567643,0.000045414283,0.00020701316,0.00012604622,0.00023695079],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009595265,0.00022475426,0.00021531024,0.000100433565,0.00013338242,0.000047352136,0.00010172955,0.00011186883,0.000048821108],"category_scores_gemma":[0.0000055855103,0.00016671984,0.00005602187,0.00020479664,0.000084004925,0.000011357617,0.000041563242,0.00015962114,0.000004583012],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002502068,0.0017670583,0.7574608,0.00001843132,0.00054655515,0.000078258374,0.00023502878,0.00011213291,0.03748371,0.000021585314,0.00011993231,0.19965447],"study_design_scores_gemma":[0.0043629003,0.0016122115,0.97430885,0.00016450285,0.000059450012,0.00003292339,0.000052427768,0.00014361234,0.018831465,0.00012943307,0.000097113516,0.00020508867],"about_ca_topic_score_codex":0.009301018,"about_ca_topic_score_gemma":0.0012831612,"teacher_disagreement_score":0.2168481,"about_ca_system_score_codex":0.00018821968,"about_ca_system_score_gemma":0.0001500516,"threshold_uncertainty_score":0.99729615},"labels":[],"label_agreement":null},{"id":"W2080558042","doi":"10.1007/s10549-013-2559-1","title":"Multigene assays and molecular markers in breast cancer: systematic review of health economic analyses","year":2013,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; Dalhousie University; Genomic Health","keywords":"Breast cancer; Medicine; Cochrane Library; Oncology; Adjuvant chemotherapy; Systematic review; MEDLINE; Medical prescription; Intensive care medicine; Internal medicine; Cancer; Bioinformatics; Gynecology; Meta-analysis; Biology; Pharmacology","score_opus":0.557476561669923,"score_gpt":0.5714956463608163,"score_spread":0.014019084690893302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080558042","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020353399,0.9791278,0.0000064558235,0.0071296454,0.000105105144,0.0067557273,0.006545366,0.000013629353,0.00011273198],"genre_scores_gemma":[0.00037622513,0.9921349,0.00009347398,0.00047752538,0.00009122387,0.0064632357,0.00012584441,0.00007422114,0.00016332953],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9893246,0.0022433444,0.006240052,0.001133524,0.00021076541,0.0008476647],"domain_scores_gemma":[0.99400645,0.0009857169,0.0035800221,0.000824364,0.00013041127,0.00047303765],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.013268199,0.0005817748,0.0076625217,0.0010438259,0.00017120747,0.0001070901,0.00032839007,0.00021869908,0.0005336763],"category_scores_gemma":[0.00020130619,0.00051961344,0.0003520814,0.00040496208,0.00020955138,0.0002341049,0.00012951734,0.00029742095,0.00017786105],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011834073,0.00016785662,0.00071304716,0.92274624,0.0011786385,0.0000046055693,0.000106860054,0.0000037231405,5.954814e-8,0.00078637764,0.0014310745,0.072849676],"study_design_scores_gemma":[0.0016805305,0.0002891116,0.0026005965,0.95466113,0.00045967032,0.00017930774,0.00030960012,0.00024658756,2.9665816e-7,0.00034955554,0.03829453,0.00092907104],"about_ca_topic_score_codex":0.08489595,"about_ca_topic_score_gemma":0.0015485531,"teacher_disagreement_score":0.0833474,"about_ca_system_score_codex":0.00587341,"about_ca_system_score_gemma":0.0020678728,"threshold_uncertainty_score":0.9997255},"labels":[],"label_agreement":null},{"id":"W2081066309","doi":"10.1007/s10549-012-2205-3","title":"A randomized double-blind placebo-controlled cross-over trial of the impact on quality of life of continuing dexamethasone beyond 24 h following adjuvant chemotherapy for breast cancer","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Nausea and vomiting management","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Ottawa Hospital; Princess Margaret Cancer Centre; McMaster University; University of Toronto","funders":"European Society for Medical Oncology","keywords":"Medicine; Nausea; Vomiting; Breast cancer; Placebo; Epirubicin; Dexamethasone; Granisetron; Chemotherapy; Antiemetic; Internal medicine; Regimen; Anesthesia; Cancer; Surgery","score_opus":0.10521611853387895,"score_gpt":0.46507074438100804,"score_spread":0.3598546258471291,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081066309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866301,0.0022324808,0.000015177846,0.0011057465,0.0002024543,0.009027806,0.00054342125,0.00000956053,0.00023329252],"genre_scores_gemma":[0.9962749,0.0005865133,0.000042754775,0.00002952243,0.00037973278,0.0020455082,0.000008733208,0.000033139608,0.0005991814],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99706733,0.00041777873,0.0008010455,0.00030687702,0.000820603,0.0005863827],"domain_scores_gemma":[0.99701893,0.0014440991,0.00049757276,0.00041689607,0.00034812832,0.00027438172],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037289378,0.0002772719,0.0018509518,0.00019054077,0.00010664177,0.000027761133,0.00012396912,0.000095338175,0.00017661469],"category_scores_gemma":[0.00017906324,0.00014058588,0.000873283,0.00026210662,0.00033713545,0.000090179376,0.000054392072,0.00015127222,3.7069103e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9293157,0.0019090069,0.041916516,0.00020151876,0.0040923683,7.594305e-7,0.0006519391,0.000015150219,0.0015948701,0.00016953454,0.00006977022,0.02006287],"study_design_scores_gemma":[0.9036827,0.0009637151,0.08958685,0.00040750462,0.0004784191,0.0000025959907,0.00011831106,0.000063873136,0.0045185997,0.000052058145,0.000017972303,0.00010736661],"about_ca_topic_score_codex":0.010389547,"about_ca_topic_score_gemma":0.00015900706,"teacher_disagreement_score":0.04767033,"about_ca_system_score_codex":0.00037738375,"about_ca_system_score_gemma":0.00041798432,"threshold_uncertainty_score":0.9962004},"labels":[],"label_agreement":null},{"id":"W2081673104","doi":"10.1007/s10549-011-1375-8","title":"Biomarkers of PARP inhibitor sensitivity","year":2011,"lang":"en","type":"letter","venue":"Breast Cancer Research and Treatment","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Breast cancer; Sensitivity (control systems); Medicine; PARP inhibitor; Biomarker; Oncology; Internal medicine; Poly ADP ribose polymerase; Biology; Cancer; Genetics; DNA","score_opus":0.10794391362082746,"score_gpt":0.38517812548318286,"score_spread":0.2772342118623554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081673104","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.112659514,0.008936142,0.0000118351845,0.8600612,0.0006202428,0.0034990176,0.0061358274,0.0001289581,0.0079472335],"genre_scores_gemma":[0.7941328,0.03467988,0.0006433711,0.1244339,0.019328242,0.004164225,0.0017460893,0.000536449,0.020335024],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972454,0.0002807028,0.00032143272,0.000641433,0.0008301614,0.0006808927],"domain_scores_gemma":[0.99834555,0.00020440582,0.00013366633,0.000564632,0.0005007358,0.00025099158],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00035122657,0.00036401945,0.00070987985,0.00043119505,0.00011605536,0.00002237099,0.0000623557,0.0004523404,0.00074403314],"category_scores_gemma":[0.000009966933,0.00027363864,0.0001767355,0.00029677115,0.0007549511,0.00005559344,0.000060563383,0.000773411,0.00003515856],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041610077,0.0007091168,0.009114906,0.00069744984,0.002537695,0.002783336,0.0003019326,1.02181545e-7,0.003039777,0.000023726468,0.9049845,0.07164649],"study_design_scores_gemma":[0.0113611715,0.0039405143,0.036108322,0.0029126627,0.00046926684,0.002126779,0.00010053636,0.000008364488,0.041066986,0.00045420273,0.90077907,0.0006721509],"about_ca_topic_score_codex":0.008189018,"about_ca_topic_score_gemma":0.00020125725,"teacher_disagreement_score":0.73562735,"about_ca_system_score_codex":0.0009966881,"about_ca_system_score_gemma":0.00090726424,"threshold_uncertainty_score":0.99997157},"labels":[],"label_agreement":null},{"id":"W2081731272","doi":"10.1023/a:1006402323445","title":"Alcohol and Breast Cancer Mortality in a Cohort Study","year":2000,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Alcohol Consumption and Health Effects","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; Centre for Addiction and Mental Health; Ontario Tobacco Research Unit; University of Toronto; Toronto Public Health","funders":"Medical Research Council Canada; U.S. Department of Agriculture","keywords":"Breast cancer; Medicine; Epidemiology; Hazard ratio; Cohort study; Cohort; Prospective cohort study; Cancer; National Death Index; Internal medicine; Lower risk; Gynecology; Oncology; Demography; Confidence interval","score_opus":0.1773226861026055,"score_gpt":0.49535624972747466,"score_spread":0.3180335636248692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081731272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903526,0.0021180667,8.6608864e-8,0.0038098379,0.000026125063,0.0026645788,0.00020144643,0.00002903492,0.00079827633],"genre_scores_gemma":[0.98564965,0.010571513,0.0000045750676,0.00016800046,0.00012898166,0.0019266903,0.0000111149575,0.00001859019,0.0015208626],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99805903,0.00017431747,0.0002179192,0.00052252796,0.00048099362,0.0005451822],"domain_scores_gemma":[0.9990215,0.000062036466,0.00002321925,0.00026860702,0.0001149956,0.00050967647],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004936647,0.00018624072,0.00039283262,0.00017239264,0.00019078699,0.00004016876,0.00004056117,0.000064304775,0.0023125317],"category_scores_gemma":[0.0000041462918,0.00013564013,0.000029474624,0.0002788105,0.00018964362,0.000075985015,0.00003087684,0.00023216513,0.00003218584],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014312969,0.001200344,0.83665574,0.00006849302,0.0002023119,0.00020228226,0.00035405022,8.661488e-7,0.000023422326,0.000011169779,0.00009945853,0.15975057],"study_design_scores_gemma":[0.0068143867,0.0006332175,0.99116683,0.0001616906,0.00008245251,0.00024622143,0.00014099712,0.000056520457,0.000010867789,0.000015646494,0.00056714204,0.00010405268],"about_ca_topic_score_codex":0.070749395,"about_ca_topic_score_gemma":0.017786462,"teacher_disagreement_score":0.15964651,"about_ca_system_score_codex":0.00066196086,"about_ca_system_score_gemma":0.00042218078,"threshold_uncertainty_score":0.99859947},"labels":[],"label_agreement":null},{"id":"W2082075144","doi":"10.1007/s10549-005-6654-9","title":"Serum Lipids and Outcome of Early-stage Breast Cancer: Results of a Prospective Cohort Study","year":2005,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":83,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; University of Toronto; Health Sciences Centre; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; Institute for Clinical Evaluative Sciences","funders":"","keywords":"Medicine; Breast cancer; Internal medicine; Dyslipidemia; Body mass index; Cancer; Prospective cohort study; Insulin resistance; Diabetes mellitus; Oncology; Proportional hazards model; Breast disease; Cohort; Obesity; Endocrinology","score_opus":0.02649220764887728,"score_gpt":0.3534696719480105,"score_spread":0.3269774642991332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082075144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99080914,0.0034340841,0.000001796934,0.00047760474,0.00025967817,0.0012143952,0.0034670883,0.0000070000165,0.0003292029],"genre_scores_gemma":[0.9880253,0.00664714,0.000027117578,0.0000119467395,0.0021758808,0.00048511356,0.000019903006,0.00002308528,0.002584499],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99821806,0.00010085758,0.00034577583,0.0005709114,0.0003630234,0.00040137235],"domain_scores_gemma":[0.9989249,0.000019861287,0.00011370271,0.00038634238,0.00034786054,0.00020733789],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036048447,0.00021503339,0.0004091813,0.00010664425,0.00010831063,0.000023754003,0.000115464376,0.000085231964,0.00003967288],"category_scores_gemma":[0.000011135556,0.00016696588,0.00006779091,0.00017029596,0.00030328232,0.000012407668,0.00014428531,0.00010148552,9.693844e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003493138,0.0008427201,0.9543832,0.000039607792,0.00050155126,5.969482e-7,0.00047506098,0.000011753218,0.005058431,0.00003811661,0.0003605589,0.0347953],"study_design_scores_gemma":[0.005587817,0.0013327077,0.9773091,0.000033296827,0.000073753516,0.000020359696,0.00032668127,0.000005603659,0.006053529,0.000008380394,0.009101372,0.00014739146],"about_ca_topic_score_codex":0.024261229,"about_ca_topic_score_gemma":0.013195335,"teacher_disagreement_score":0.034647908,"about_ca_system_score_codex":0.0001350497,"about_ca_system_score_gemma":0.0002718704,"threshold_uncertainty_score":0.9822363},"labels":[],"label_agreement":null},{"id":"W2082187680","doi":"10.1007/s10549-005-9098-3","title":"Energy balance and breast cancer risk: a prospective cohort study","year":2005,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Breast cancer; Medicine; Body mass index; Cohort; Cohort study; Cancer; Prospective cohort study; Internal medicine; Incidence (geometry); Demography; Gynecology; Oncology","score_opus":0.024759019839051835,"score_gpt":0.3628984870352481,"score_spread":0.33813946719619625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082187680","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875543,0.006323276,0.000003881376,0.0029436753,0.000051990817,0.0014525282,0.00094598497,0.000045405755,0.0006789589],"genre_scores_gemma":[0.972854,0.022353899,0.000020297663,0.000056097924,0.00064840366,0.002048902,0.000011204412,0.000034978875,0.0019721952],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978318,0.00008611273,0.00020165302,0.00071036746,0.00057305145,0.0005969763],"domain_scores_gemma":[0.99880236,0.000052148996,0.000059956816,0.00031865994,0.0002705968,0.0004962583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021279177,0.00027192407,0.0004534965,0.00016154519,0.00032643107,0.00007500044,0.00006089661,0.000065032975,0.00049305503],"category_scores_gemma":[0.0000043178648,0.00018760459,0.00005438238,0.00030231246,0.00025531155,0.00012126099,0.00007824705,0.00023072278,0.00000748629],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001636836,0.0010629313,0.7590782,0.0000125880015,0.0005676213,0.000045693163,0.00048060357,0.0000024365863,0.000034339675,0.000031431973,0.00041576568,0.23663157],"study_design_scores_gemma":[0.0056056892,0.0011415352,0.9877537,0.00008664685,0.00018887596,0.000239788,0.0003483503,0.00015298615,0.00012993084,0.000036844413,0.004144207,0.00017148042],"about_ca_topic_score_codex":0.12782475,"about_ca_topic_score_gemma":0.030715244,"teacher_disagreement_score":0.23646009,"about_ca_system_score_codex":0.0013201828,"about_ca_system_score_gemma":0.00040362278,"threshold_uncertainty_score":0.9869717},"labels":[],"label_agreement":null},{"id":"W2082486482","doi":"10.1023/b:brea.0000021046.29834.12","title":"Cross-Resistance Studies of Isogenic Drug-Resistant Breast Tumor Cell Lines Support Recent Clinical Evidence Suggesting that Sensitivity to Paclitaxel may be Strongly Compromised by Prior Doxorubicin Exposure","year":2004,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Laurentian University; University of Sudbury; Northeast Cancer Centre","funders":"","keywords":"Paclitaxel; Doxorubicin; Docetaxel; Breast cancer; Chemotherapy; Medicine; Drug resistance; Pharmacology; Metastatic breast cancer; Crossover study; Cross-resistance; Internal medicine; Cancer research; Oncology; Cancer; Biology; Pathology; Microbiology","score_opus":0.13174036259987493,"score_gpt":0.42953747230335687,"score_spread":0.29779710970348194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082486482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9702325,0.012049441,0.0000263886,0.013509713,0.0001642222,0.002057672,0.0018125997,0.000064256004,0.00008322715],"genre_scores_gemma":[0.9863796,0.008198231,0.0009383273,0.00011766637,0.00021484036,0.00031989702,0.000063065934,0.00006236085,0.0037059942],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99526465,0.00028667698,0.00091421837,0.0011278449,0.0013101766,0.001096445],"domain_scores_gemma":[0.99646896,0.0005585731,0.00025760793,0.0006733169,0.0011855187,0.00085604494],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018797335,0.0005208072,0.0012141916,0.00018431548,0.0004432656,0.000074919626,0.00017718688,0.00011781751,0.00009485827],"category_scores_gemma":[0.000097531185,0.000373611,0.0002495417,0.0005064591,0.0008417135,0.00017449705,0.00011310242,0.0003981061,0.000009562341],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07848382,0.011010027,0.6209679,0.004538881,0.0025138513,0.004354856,0.0044852346,0.00012679343,0.22772561,0.00021097722,0.0026291467,0.042952888],"study_design_scores_gemma":[0.022405319,0.0052231504,0.7418601,0.006112318,0.0006341804,0.000314406,0.004737622,0.0000073541846,0.21462443,0.00010786895,0.0030720604,0.0009011709],"about_ca_topic_score_codex":0.0018801078,"about_ca_topic_score_gemma":0.006149409,"teacher_disagreement_score":0.120892204,"about_ca_system_score_codex":0.0009352818,"about_ca_system_score_gemma":0.0013048376,"threshold_uncertainty_score":0.9998716},"labels":[],"label_agreement":null},{"id":"W2082717337","doi":"10.1023/a:1006481228794","title":"Characterization of a novel silencer element in the human aromatase gene PII promoter","year":2000,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Genomics and Chromatin Dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto","funders":"","keywords":"Aromatase; Promoter; Biology; Transcription factor; Transfection; Silencer; Gene; Cancer research; Ovarian cancer; Breast cancer; Gene expression; Molecular biology; Cancer; Genetics","score_opus":0.026163024633267286,"score_gpt":0.3177103270013942,"score_spread":0.29154730236812687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082717337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99851036,0.00013434827,0.000008177589,0.00034667805,0.0000061130313,0.0003713897,0.0005208062,0.0000013338573,0.00010080979],"genre_scores_gemma":[0.99814975,0.00083323126,0.000045382632,0.000027456634,0.00006370415,0.00022670132,0.00041066675,0.000007917022,0.00023519926],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9993104,0.00003896741,0.00012737892,0.00019514232,0.0001352371,0.00019288488],"domain_scores_gemma":[0.9996897,0.000003347833,0.000025976191,0.00020344273,0.000038530543,0.00003901394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001428931,0.00008343007,0.00007920761,0.000032265823,0.000076032076,0.000022218743,0.000096002324,0.000036173224,0.00008546312],"category_scores_gemma":[8.163256e-7,0.00005533796,0.00002233513,0.00007075025,0.000069002504,0.0000028379475,0.000028045664,0.00003741649,0.0000013516084],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011377846,0.00073765736,0.0051014316,0.000016569807,0.00003866992,0.0000040364025,0.00025239983,0.000014919312,0.9678069,0.000045929948,0.000014073031,0.025853679],"study_design_scores_gemma":[0.0057071196,0.0024256962,0.6897045,0.000084921085,0.000034502234,0.00012255806,0.00024518772,0.00077752967,0.29512504,0.00014538501,0.0052979565,0.0003296342],"about_ca_topic_score_codex":0.0006179596,"about_ca_topic_score_gemma":0.00037192038,"teacher_disagreement_score":0.68460304,"about_ca_system_score_codex":0.000042322292,"about_ca_system_score_gemma":0.000058919242,"threshold_uncertainty_score":0.22566165},"labels":[],"label_agreement":null},{"id":"W2082724230","doi":"10.1007/s10549-007-9736-z","title":"Automated quantitative analysis of estrogen receptor expression in breast carcinoma does not differ from expert pathologist scoring: a tissue microarray study of 3,484 cases","year":2007,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":109,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia; Vancouver Coastal Health Research Institute; Vancouver Coastal Health","funders":"Michael Smith Health Research BC; Sanofi","keywords":"Concordance; Medicine; Kappa; Tissue microarray; Breast cancer; Estrogen receptor; Immunohistochemistry; Internal medicine; Oncology; Pathology; Breast carcinoma; Carcinoma; Tamoxifen; Cancer","score_opus":0.05338137941385647,"score_gpt":0.3904327876159716,"score_spread":0.33705140820211515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082724230","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932093,0.0031162205,0.000010212954,0.00015761564,0.00005283004,0.00058355334,0.002842374,0.000016060443,0.0000118126645],"genre_scores_gemma":[0.99813557,0.00086193805,0.00032168286,0.0000066788853,0.00007127448,0.00031075932,0.00023660532,0.000023207456,0.000032302312],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99785465,0.0002186899,0.0004142179,0.00070458266,0.00035354513,0.0004542873],"domain_scores_gemma":[0.9988499,0.00016091674,0.00015152908,0.00043877636,0.0002574403,0.00014141621],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022934712,0.00029175106,0.00059816707,0.00037841924,0.00011903086,0.0000171042,0.00014954506,0.000104864084,0.000042918862],"category_scores_gemma":[0.000022047134,0.00019462567,0.00009533405,0.00053403084,0.00033314552,0.000009664484,0.00017814868,0.000077003344,9.1078124e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004105171,0.0021201265,0.575862,0.000011586012,0.0012709543,0.00008570728,0.0020041796,0.00001089907,0.40995526,0.000002882284,0.000029598157,0.004541671],"study_design_scores_gemma":[0.0022409386,0.0010964266,0.66869813,0.000050910916,0.00016057692,0.00001242884,0.004752622,0.000009746681,0.3228225,0.0000019273336,0.00002580552,0.00012798647],"about_ca_topic_score_codex":0.05835516,"about_ca_topic_score_gemma":0.014584931,"teacher_disagreement_score":0.092836164,"about_ca_system_score_codex":0.00023455232,"about_ca_system_score_gemma":0.000107349566,"threshold_uncertainty_score":0.9479153},"labels":[],"label_agreement":null},{"id":"W2082946674","doi":"10.1007/s10549-011-1856-9","title":"A comparative biomarker study of 514 matched cases of male and female breast cancer reveals gender-specific biological differences","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Male Breast Health Studies","field":"Medicine","cited_by":130,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"National Institute for Health and Care Research","keywords":"Breast cancer; Biomarker; Internal medicine; Oncology; Medicine; Cancer; Male breast cancer; Incidence (geometry); Basal (medicine); Lymph node; Biology; Genetics","score_opus":0.4643675474027231,"score_gpt":0.45863468818183734,"score_spread":0.005732859220885789,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082946674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874255,0.009065153,7.854919e-7,0.00034979748,0.000031889806,0.0016888024,0.0008666386,0.00001490243,0.0005565142],"genre_scores_gemma":[0.991185,0.007625937,0.00007098568,0.000010273741,0.000060863546,0.00078162836,0.0000066627895,0.000013090809,0.00024554675],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977939,0.00027078835,0.00043862063,0.000542239,0.00044493025,0.0005095156],"domain_scores_gemma":[0.9985276,0.00024021704,0.00015286311,0.00028885136,0.00045755878,0.0003329399],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028866337,0.00027207722,0.0009800157,0.00021435355,0.00018228455,0.000010891774,0.00008437153,0.00007466445,0.0008794101],"category_scores_gemma":[0.000007819107,0.0001651487,0.000052800504,0.00031879425,0.0007906831,0.000050069022,0.00014401051,0.00013031097,0.000002754415],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066066263,0.0036675248,0.9639358,0.00029069427,0.0008102467,0.00014452514,0.007946531,5.1861317e-8,0.0009465428,0.000053524476,0.00012251265,0.015475401],"study_design_scores_gemma":[0.0037481468,0.0032111604,0.97900295,0.0002478414,0.00009368296,0.00069314404,0.0124878455,0.000004204683,0.00032405424,0.000045587316,0.000020136715,0.00012121679],"about_ca_topic_score_codex":0.025122838,"about_ca_topic_score_gemma":0.0020627382,"teacher_disagreement_score":0.023060098,"about_ca_system_score_codex":0.00018254755,"about_ca_system_score_gemma":0.00019050395,"threshold_uncertainty_score":0.98136896},"labels":[],"label_agreement":null},{"id":"W2083364219","doi":"10.1007/s10549-004-2230-y","title":"Cyclin I is expressed in human breast cancer and closely associated with VEGF and KDR expression","year":2005,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Angiogenesis; Breast cancer; Cancer research; Cyclin; Cyclin D; Cyclin E; Cyclin A; Pathological; Cyclin D1; Biology; Cancer; Cell cycle; Oncology; Internal medicine; Medicine","score_opus":0.04087508064572197,"score_gpt":0.3566847473930762,"score_spread":0.3158096667473542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083364219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98534685,0.0069953282,0.0000016882734,0.0057095597,0.000016793623,0.00087546697,0.0006657229,0.000038600072,0.00034996288],"genre_scores_gemma":[0.99243075,0.005857714,0.00004949717,0.0001225486,0.00015619589,0.0005872418,0.000042100786,0.00005005539,0.00070388574],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978197,0.00010053383,0.00024050807,0.00067349407,0.00053664943,0.0006291003],"domain_scores_gemma":[0.9989661,0.00006197485,0.00006987265,0.00027717545,0.00017621006,0.00044868933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020936497,0.00028598824,0.00043070538,0.0002652806,0.00023316902,0.00006843939,0.00005704787,0.00015542415,0.0001683614],"category_scores_gemma":[0.000008577282,0.00020768195,0.000035408462,0.00030577934,0.00029678864,0.00013065909,0.000083509316,0.00034291,0.0000026124112],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008927603,0.0031551775,0.42578354,0.00024229892,0.0010412178,0.00078827026,0.0042897165,0.00003427312,0.2240576,0.00007932344,0.002449203,0.32915178],"study_design_scores_gemma":[0.02155649,0.0013929068,0.9280512,0.0026464965,0.00015358553,0.0003801259,0.0002824386,0.00019158136,0.04273478,0.00006773281,0.002157319,0.00038539607],"about_ca_topic_score_codex":0.0074622594,"about_ca_topic_score_gemma":0.0073959925,"teacher_disagreement_score":0.5022676,"about_ca_system_score_codex":0.0009560705,"about_ca_system_score_gemma":0.00034371196,"threshold_uncertainty_score":0.9991471},"labels":[],"label_agreement":null},{"id":"W2083471536","doi":"10.1007/s10549-009-0523-x","title":"A randomized trial exploring the biomarker effects of neoadjuvant sequential treatment with exemestane and anastrozole in post-menopausal women with hormone receptor-positive breast cancer","year":2009,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Sunnybrook Health Science Centre; University of Toronto; Princess Margaret Cancer Centre","funders":"Pfizer Canada; Pfizer","keywords":"Exemestane; Anastrozole; Medicine; Breast cancer; Internal medicine; Aromatase inhibitor; Aromatase; Oncology; Biomarker; Tamoxifen; Letrozole; Cancer; Gynecology; Biology","score_opus":0.016152535485918867,"score_gpt":0.2933112284903494,"score_spread":0.2771586930044305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083471536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887326,0.007654466,0.0000053512604,0.0009160029,0.00003459189,0.0024263388,0.00018216805,0.000008094357,0.00004040335],"genre_scores_gemma":[0.98129195,0.01598429,0.00003272898,0.000019135918,0.00011706253,0.002367468,0.00005106851,0.000024813111,0.000111459725],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9980244,0.0003826937,0.00021597082,0.0004910544,0.00029292746,0.00059292425],"domain_scores_gemma":[0.99921024,0.000093001014,0.00008598531,0.00023210472,0.00014735601,0.00023131874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028161463,0.00032455652,0.0005094485,0.00011878037,0.00016376704,0.000048862796,0.000080652986,0.00008704954,0.000008255566],"category_scores_gemma":[0.0000051724487,0.00016124395,0.000039588638,0.0002242619,0.00045145387,0.000019920677,0.000042193158,0.00012464717,4.8901626e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6973274,0.0006660513,0.0002897692,0.0000150920205,0.0011393533,0.00009656232,0.00059187616,0.000009663017,0.18022333,0.00001309391,0.00000931913,0.11961853],"study_design_scores_gemma":[0.82119787,0.055581577,0.04502487,0.0003394105,0.00030205998,0.00036879804,0.00048317705,0.0000317404,0.07617288,0.00001598449,0.00008667997,0.00039496247],"about_ca_topic_score_codex":0.0037012317,"about_ca_topic_score_gemma":0.00034864503,"teacher_disagreement_score":0.12387049,"about_ca_system_score_codex":0.00032426638,"about_ca_system_score_gemma":0.00035299378,"threshold_uncertainty_score":0.65753376},"labels":[],"label_agreement":null},{"id":"W2083509136","doi":"10.1007/s10549-012-2137-y","title":"111In-Bn-DTPA-nimotuzumab with/without modification with nuclear translocation sequence (NLS) peptides: an Auger electron-emitting radioimmunotherapeutic agent for EGFR-positive and trastuzumab (Herceptin)-resistant breast cancer","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Aptose Biosciences (Canada); University of Toronto","funders":"","keywords":"Nimotuzumab; Cancer research; Trastuzumab; Chemistry; Monoclonal antibody; Molecular biology; Epidermal growth factor receptor; Receptor; Cancer; Medicine; Breast cancer; Immunology; Antibody; Internal medicine; Biology; Biochemistry","score_opus":0.090223480004224,"score_gpt":0.40598910964189566,"score_spread":0.31576562963767163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083509136","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874325,0.0050416337,0.00007024086,0.0039772866,0.000018696244,0.0021681294,0.001100352,0.000049419294,0.00014176917],"genre_scores_gemma":[0.99118036,0.005442073,0.00054789294,0.00011387926,0.00031327974,0.0013485819,0.00021930084,0.00009054297,0.00074411754],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9969515,0.00018150764,0.00029023696,0.0006695885,0.0007673217,0.0011398023],"domain_scores_gemma":[0.99836606,0.00013925438,0.000097484204,0.0003155221,0.0005154825,0.00056619605],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042127023,0.00039813234,0.0004760496,0.00020683417,0.0006878338,0.00013312991,0.00011828619,0.00008842686,0.00018651671],"category_scores_gemma":[0.000003934797,0.00025689675,0.00007030857,0.00031820734,0.00047556448,0.00037062424,0.000021918446,0.00031810626,0.000007662206],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0698338,0.0028942558,0.07581523,0.0008021855,0.002414727,0.00006557337,0.010800641,0.000040722538,0.15352571,0.00110437,0.00010910477,0.68259364],"study_design_scores_gemma":[0.015084743,0.013038371,0.9392879,0.0023171536,0.0006620228,0.0030797308,0.00378454,0.0030829345,0.01424309,0.00007166009,0.004334014,0.0010138699],"about_ca_topic_score_codex":0.011438702,"about_ca_topic_score_gemma":0.001227987,"teacher_disagreement_score":0.86347264,"about_ca_system_score_codex":0.001517494,"about_ca_system_score_gemma":0.0007106557,"threshold_uncertainty_score":0.9999883},"labels":[],"label_agreement":null},{"id":"W2083569128","doi":"10.1007/s10549-007-9718-1","title":"Distribution and significance of caveolin 2 expression in normal breast and invasive breast cancer: an immunofluorescence and immunohistochemical analysis","year":2007,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Caveolin-1 and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":70,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health Research Institute; University of British Columbia; BC Cancer Agency","funders":"Sanofi","keywords":"Myoepithelial cell; Cytokeratin; Breast cancer; Immunohistochemistry; Pathology; Biology; Progesterone receptor; Cancer; Estrogen receptor; Cancer research; Medicine","score_opus":0.013952919273980915,"score_gpt":0.31327416252898177,"score_spread":0.29932124325500087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083569128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9848728,0.013331323,0.00008100743,0.0001539674,0.000012662446,0.00027672655,0.0012506727,0.0000043845944,0.000016431053],"genre_scores_gemma":[0.98272324,0.01670398,0.000034044548,0.0000079997935,0.00007758007,0.00010315726,0.0002854388,0.000012499745,0.000052084815],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99848855,0.0000683133,0.00025172476,0.00055540004,0.00022091037,0.00041508448],"domain_scores_gemma":[0.9991934,0.00004060697,0.00007940832,0.00022399217,0.00021978687,0.00024285476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031479698,0.00020557025,0.00028412562,0.00012959515,0.00015270583,0.000042237032,0.000089600006,0.00011792742,0.000017380435],"category_scores_gemma":[0.000009990735,0.00017266363,0.000034391254,0.00030395182,0.0005381887,0.000025633422,0.00014629084,0.00012647524,1.4129863e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025599052,0.00031817946,0.22584012,0.00008564278,0.00017342524,0.000018687006,0.00018052048,0.000005770246,0.7302945,0.000018278293,0.000010742113,0.04049421],"study_design_scores_gemma":[0.0014743698,0.0004887632,0.66426766,0.000104186896,0.000084922256,0.00023166364,0.00034551247,0.000037466543,0.33268312,0.000033100758,0.00005440026,0.00019485105],"about_ca_topic_score_codex":0.009164449,"about_ca_topic_score_gemma":0.004935392,"teacher_disagreement_score":0.4384275,"about_ca_system_score_codex":0.000121312594,"about_ca_system_score_gemma":0.0002063388,"threshold_uncertainty_score":0.9974336},"labels":[],"label_agreement":null},{"id":"W2083583664","doi":"10.1023/a:1026114501364","title":"Ligand-Induced Regulation of ERα and ERβ is Indicative of Human Breast Cancer Cell Proliferation","year":2003,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":64,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Antiestrogen; Estrogen receptor; Tamoxifen; Cell growth; Genistein; Cancer research; Estrogen receptor alpha; Breast cancer; Estrogen; Estrogen receptor beta; Biology; Cell; Selective estrogen receptor modulator; Internal medicine; Endocrinology; Cell culture; MCF-7; Cancer; Medicine; Human breast; Biochemistry","score_opus":0.022777619496728088,"score_gpt":0.3351458927874194,"score_spread":0.31236827329069133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083583664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99525774,0.003523858,0.000002017155,0.00017369432,0.000013189776,0.00039957656,0.00015204534,0.0000025580966,0.00047530307],"genre_scores_gemma":[0.9962786,0.0031616595,0.000016748982,0.0000076050997,0.0000432317,0.00012551331,0.00003276087,0.000011714591,0.00032215996],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991618,0.00009439452,0.00013935294,0.0002561663,0.00016471335,0.00018359271],"domain_scores_gemma":[0.9994444,0.000009584524,0.00012474523,0.00014617883,0.00017644344,0.00009863928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012700558,0.000112994945,0.0001443581,0.00005363952,0.00011012367,0.000011647118,0.000036937792,0.00011543861,0.000030178322],"category_scores_gemma":[0.000004078181,0.00008547147,0.000031238607,0.00009902004,0.00012373393,0.000007556328,0.000025095309,0.0000599094,4.6807986e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035232824,0.0002836991,0.046752278,0.000051217292,0.00017335349,0.0000010158641,0.0003690117,0.0000020045213,0.9422634,0.00014420591,0.00009308676,0.009514366],"study_design_scores_gemma":[0.0013091977,0.00089853135,0.11469793,0.000045319845,0.000029598363,0.000021250577,0.00009145271,0.0000082513,0.88271207,0.00006868087,0.000045710116,0.00007203219],"about_ca_topic_score_codex":0.0014615399,"about_ca_topic_score_gemma":0.00018332872,"teacher_disagreement_score":0.06794566,"about_ca_system_score_codex":0.000061928935,"about_ca_system_score_gemma":0.00017940634,"threshold_uncertainty_score":0.3485425},"labels":[],"label_agreement":null},{"id":"W2083718162","doi":"10.1007/s10549-010-1102-x","title":"Phase II study evaluating the efficacy and safety of sagopilone (ZK-EPO) in patients with metastatic breast cancer that has progressed following chemotherapy","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Université Laval","funders":"Bayer HealthCare","keywords":"Medicine; Breast cancer; Chemotherapy; Oncology; Metastatic breast cancer; Internal medicine; Cancer; Mammary gland; Phases of clinical research","score_opus":0.10599594354823769,"score_gpt":0.46746760014198563,"score_spread":0.3614716565937479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083718162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99009085,0.0011785112,4.0178742e-7,0.0040177046,0.00007547939,0.0043597505,0.0002294455,0.000015114167,0.000032772186],"genre_scores_gemma":[0.99781907,0.00038702338,0.00006204032,0.00004170082,0.00008664917,0.0013634962,0.00003023917,0.000033944627,0.00017583158],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979021,0.00018119632,0.00026901282,0.00047201125,0.0006777019,0.00049798394],"domain_scores_gemma":[0.99897444,0.00021362996,0.00010633605,0.00029223654,0.0001976284,0.00021575113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050634606,0.0002747448,0.0005274855,0.00016892042,0.0004044847,0.000044122706,0.000085753694,0.000040956067,0.0003232928],"category_scores_gemma":[0.000008346259,0.00014874483,0.000051775594,0.00037828964,0.0003608374,0.00009848935,0.000064027794,0.00028805283,6.295607e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030073158,0.016106164,0.65005064,0.00004483257,0.0014433617,0.0000429766,0.0026665074,0.0000021636401,0.0013033903,0.000003244008,0.000024128487,0.29823947],"study_design_scores_gemma":[0.10734071,0.023314893,0.8673678,0.00019435966,0.0005282818,0.000030163,0.00035881076,0.000055111363,0.0005746311,0.000009343063,0.00009700712,0.00012886547],"about_ca_topic_score_codex":0.007308177,"about_ca_topic_score_gemma":0.0045833588,"teacher_disagreement_score":0.2981106,"about_ca_system_score_codex":0.00030809696,"about_ca_system_score_gemma":0.0005529768,"threshold_uncertainty_score":0.99930227},"labels":[],"label_agreement":null},{"id":"W2084174108","doi":"10.1023/a:1019685829799","title":"The Characteristics of Cyclical and Non-Cyclical Mastalgia: A Prospective Study using a Modified McGill Pain Questionnaire","year":2002,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute of Neurological Disorders and Stroke","keywords":"Medicine; McGill Pain Questionnaire; Visual analogue scale; Breast cancer; Breast pain; Physical therapy; Rheumatoid arthritis; Quality of life (healthcare); Schmidt sting pain index; Arthritis; Internal medicine; Cancer","score_opus":0.04096538500900489,"score_gpt":0.33361484989696283,"score_spread":0.29264946488795796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084174108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960039,0.0019095207,0.000022664322,0.0008117101,0.000026776288,0.00084410375,0.00028778322,0.0000073560286,0.00008618695],"genre_scores_gemma":[0.99685955,0.0022943837,0.00003006551,0.00001311922,0.0001282915,0.0005430297,0.0000069830744,0.000020217369,0.00010436433],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99852043,0.0002041249,0.0001982562,0.00044862228,0.00025332932,0.00037525754],"domain_scores_gemma":[0.99927026,0.00006862963,0.00006057273,0.00026486831,0.00019295656,0.00014268514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023571769,0.00020381603,0.00024198873,0.000044888468,0.00054539484,0.00003550866,0.000080277896,0.000067054796,0.00000620661],"category_scores_gemma":[0.000039692175,0.00013081859,0.000044636166,0.00012331754,0.00045519357,0.000006201563,0.00016371315,0.000096477066,8.585251e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003047015,0.003903731,0.7221977,0.00006244795,0.001739999,0.000081897306,0.0010301591,0.0000050323833,0.0066139405,0.00018950396,0.00017112166,0.26095745],"study_design_scores_gemma":[0.0033435104,0.0022822649,0.9910105,0.00008571874,0.000095845266,0.000106771375,0.0007474605,0.00036692093,0.0014679836,0.0001164975,0.00018542891,0.00019112176],"about_ca_topic_score_codex":0.001882824,"about_ca_topic_score_gemma":0.00076161104,"teacher_disagreement_score":0.26881278,"about_ca_system_score_codex":0.00015635701,"about_ca_system_score_gemma":0.000036554262,"threshold_uncertainty_score":0.5334627},"labels":[],"label_agreement":null},{"id":"W2084312945","doi":"10.1007/s10549-010-0733-2","title":"Differential subcellular expression of protein kinase C betaII in breast cancer: correlation with breast cancer subtypes","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes; University of British Columbia","funders":"School of Medicine, Indiana University; Eli Lilly and Company","keywords":"Breast cancer; Protein kinase C; Tissue microarray; Estrogen receptor; Cancer research; Cancer; Immunohistochemistry; Medicine; Internal medicine; Pathology; Biology; Oncology; Endocrinology; Kinase; Cell biology","score_opus":0.031178596612747553,"score_gpt":0.35196370857803233,"score_spread":0.32078511196528475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084312945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863301,0.001578705,0.000010461665,0.0073141926,0.00013204566,0.002436783,0.001974405,0.000041367904,0.0001819731],"genre_scores_gemma":[0.9921915,0.0028441395,0.00006759018,0.00001482601,0.0005075246,0.002875283,0.00007826292,0.000084092,0.0013367779],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958528,0.00021417228,0.00045075855,0.00088417006,0.0015213585,0.0010766875],"domain_scores_gemma":[0.997641,0.00008754314,0.00014342717,0.0006509365,0.00079852453,0.0006785213],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003630901,0.0004249027,0.00067889545,0.00054031925,0.0002416795,0.0000762453,0.00022068112,0.00024088145,0.0033897029],"category_scores_gemma":[0.000010533742,0.00028925427,0.00009463074,0.0007999075,0.0006814051,0.00021270252,0.00014475486,0.0009383435,0.000012011709],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010997131,0.0014694278,0.7310394,0.00050747837,0.00017019075,0.00020863011,0.0003558027,0.000020338623,0.17242505,0.000076784345,0.00017524936,0.08255453],"study_design_scores_gemma":[0.008395454,0.0008848382,0.9165532,0.0020977512,0.00010238768,0.0003474309,0.0001592966,0.0003705991,0.07009527,0.000047733465,0.00062474236,0.00032131604],"about_ca_topic_score_codex":0.069047935,"about_ca_topic_score_gemma":0.0165603,"teacher_disagreement_score":0.1855138,"about_ca_system_score_codex":0.0011405316,"about_ca_system_score_gemma":0.0019849339,"threshold_uncertainty_score":0.99995595},"labels":[],"label_agreement":null},{"id":"W2084522014","doi":"10.1007/s10549-013-2489-y","title":"Phosphorylation of AKT pathway proteins is not predictive of benefit of taxane therapy in early breast cancer","year":2013,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; Ontario Institute for Cancer Research","funders":"National Institute for Health and Care Research; Cancer Research UK; Ontario Institute for Cancer Research","keywords":"Taxane; Tact; Docetaxel; Epirubicin; Oncology; Medicine; Breast cancer; Anthracycline; Internal medicine; Chemotherapy; Cancer; Psychology","score_opus":0.027267808827154478,"score_gpt":0.3107653741352789,"score_spread":0.2834975653081244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084522014","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99258345,0.0037665614,0.000010840254,0.0003912273,0.000030308682,0.001023002,0.0020961682,0.0000033282186,0.00009513848],"genre_scores_gemma":[0.9948938,0.0035801851,0.00005550765,0.000015481382,0.00008949848,0.00106493,0.000027177179,0.000022461978,0.00025098646],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985807,0.00006209254,0.00029332627,0.00036845898,0.00037831833,0.0003170901],"domain_scores_gemma":[0.99881816,0.000022493987,0.00016330733,0.0002988017,0.0005950123,0.00010220931],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015315578,0.00017111434,0.00027756684,0.00010952097,0.00003883585,0.0000110148985,0.00013649288,0.00012378003,0.00024432773],"category_scores_gemma":[0.000005497833,0.00013467521,0.000068953246,0.0002097141,0.00025732318,0.000014256667,0.00005892497,0.000086928696,0.0000011608686],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002940251,0.00060970464,0.17317319,0.00006997078,0.00035390633,0.0000017011208,0.00062227837,0.0000938609,0.6831467,0.000029911767,0.00008100252,0.13887748],"study_design_scores_gemma":[0.0016800448,0.0016026627,0.33758393,0.00013067713,0.0000075935445,0.0000039367833,0.00005825044,0.00003194968,0.65865445,0.00006616899,0.00009717943,0.00008315209],"about_ca_topic_score_codex":0.04889971,"about_ca_topic_score_gemma":0.0011107656,"teacher_disagreement_score":0.16441074,"about_ca_system_score_codex":0.0001652433,"about_ca_system_score_gemma":0.0003994479,"threshold_uncertainty_score":0.95743376},"labels":[],"label_agreement":null},{"id":"W2084718649","doi":"10.1023/a:1006344200094","title":"Role of specific apoptotic pathways in the restoration of paclitaxel-induced apoptosis by valspodar in doxorubicin-resistant MCF-7 breast cancer cells","year":2000,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Laurentian University; University of Calgary; Northeast Cancer Centre","funders":"Northern Ontario Heritage Fund Corporation; Cancer Care Ontario","keywords":"Paclitaxel; Apoptosis; MCF-7; Doxorubicin; P-glycoprotein; Cytotoxicity; Pharmacology; Cancer cell; Cancer research; Necrosis; Biology; Drug resistance; Multiple drug resistance; Chemotherapy; Cancer; In vitro; Biochemistry","score_opus":0.03590449380046536,"score_gpt":0.30382672201746364,"score_spread":0.2679222282169983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084718649","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993161,0.0026869404,8.5380015e-7,0.0015091021,0.00003196255,0.0010768344,0.0010158437,0.000008923103,0.0005085029],"genre_scores_gemma":[0.9919217,0.0072455257,0.000031105024,0.000017957524,0.00007283551,0.00034253046,0.000047697813,0.00002450949,0.00029613735],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9975772,0.00018241092,0.00049448234,0.00042360715,0.0007819769,0.0005403051],"domain_scores_gemma":[0.9991214,0.00008290339,0.00008648056,0.00039488668,0.00015461062,0.00015969203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053421373,0.0002377762,0.0005185171,0.00025962712,0.0000875381,0.000019697896,0.00014401978,0.00010907819,0.00052083057],"category_scores_gemma":[0.0000019394686,0.00015057146,0.00009240477,0.0007107973,0.0001832829,0.000084454055,0.00001141648,0.00023276244,0.0000058969276],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071483245,0.0025723393,0.01336368,0.00018875739,0.00012248439,0.000044240518,0.0027790656,0.000022408378,0.90130556,0.00043548422,0.00017156168,0.071846075],"study_design_scores_gemma":[0.0073973625,0.0015543036,0.5225494,0.0012554304,0.0001029295,0.00002479096,0.003760219,0.000044078315,0.4615768,0.00048059493,0.0009733984,0.0002807329],"about_ca_topic_score_codex":0.01962338,"about_ca_topic_score_gemma":0.0057619456,"teacher_disagreement_score":0.50918573,"about_ca_system_score_codex":0.00050736486,"about_ca_system_score_gemma":0.00033478995,"threshold_uncertainty_score":0.98690504},"labels":[],"label_agreement":null},{"id":"W2084941037","doi":"10.1007/s10549-010-1022-9","title":"Results of a phase II study comparing three dosing regimens of fulvestrant in postmenopausal women with advanced breast cancer (FINDER2)","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":89,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Regional Municipality of Durham; Jewish General Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"AstraZeneca","keywords":"Fulvestrant; Tolerability; Medicine; Discontinuation; Dosing; Breast cancer; Internal medicine; Clinical endpoint; Hazard ratio; Cancer; Pharmacokinetics; Aromatase inhibitor; Oncology; Gastroenterology; Urology; Confidence interval; Adverse effect; Randomized controlled trial; Tamoxifen","score_opus":0.020623715873909182,"score_gpt":0.3414630079312039,"score_spread":0.32083929205729467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084941037","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99755275,0.0009437513,0.0000010902008,0.00019133309,0.000031110834,0.00081591133,0.00032698878,0.0000054684324,0.00013159127],"genre_scores_gemma":[0.9990186,0.0004867516,0.000049216877,0.000003021607,0.000052703734,0.00029278785,0.000024266386,0.000021576092,0.00005104227],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984777,0.000072156225,0.0002612604,0.0004373915,0.0002761717,0.00047532184],"domain_scores_gemma":[0.99920726,0.000021964766,0.000103937986,0.0003267474,0.00015572523,0.00018437803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002675027,0.00020077669,0.00032337336,0.00012391027,0.0001200645,0.0000135680875,0.00011657931,0.00009382293,0.000009430715],"category_scores_gemma":[0.0000048336883,0.00013931976,0.00002497949,0.00022639969,0.00025731616,0.000009210982,0.0000962127,0.00022422416,2.5609114e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.035167374,0.006139343,0.055282798,0.000044869495,0.0006334563,0.0000719005,0.0011936177,0.000110779794,0.82612175,0.000019555127,0.000010004011,0.075204566],"study_design_scores_gemma":[0.0874632,0.07280749,0.5492436,0.0005273546,0.0001524293,0.0004265424,0.0023408162,0.00016947619,0.28600565,0.000054376775,0.00017653513,0.00063254486],"about_ca_topic_score_codex":0.0048829615,"about_ca_topic_score_gemma":0.0059950054,"teacher_disagreement_score":0.54011613,"about_ca_system_score_codex":0.00009849351,"about_ca_system_score_gemma":0.00034820882,"threshold_uncertainty_score":0.73816097},"labels":[],"label_agreement":null},{"id":"W2085412553","doi":"10.1007/s10549-010-1135-1","title":"The association between biological subtype and locoregional recurrence in newly diagnosed breast cancer","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":86,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Breast cancer; Internal medicine; Oncology; Estrogen receptor; Proportional hazards model; Progesterone receptor; Multivariate analysis; Lymph node; Cancer; Univariate analysis; Mastectomy; Hormonal therapy; Gynecology; Gastroenterology","score_opus":0.04115896596853534,"score_gpt":0.3489456782147958,"score_spread":0.3077867122462604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085412553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866232,0.0037625777,0.0000011058179,0.008290716,0.00011370539,0.00038885232,0.0007080982,0.000008804158,0.00010291745],"genre_scores_gemma":[0.97705823,0.021224067,0.000019192956,0.0000371067,0.0005574139,0.0008333735,0.00006482589,0.0000138716205,0.00019194359],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99838877,0.00012772346,0.00016464984,0.0005068537,0.00026166582,0.00055034686],"domain_scores_gemma":[0.99911374,0.00023540907,0.000071452465,0.00021147288,0.00020003793,0.00016788367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032597408,0.00020763301,0.00020057475,0.00005422117,0.0003906232,0.00007527604,0.00012881977,0.00015726106,0.000022965556],"category_scores_gemma":[0.000046034038,0.00012819549,0.00004124087,0.00017573104,0.0003880909,0.000009678426,0.00014516676,0.0002287023,0.0000042151996],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046337713,0.00012731516,0.8684403,0.000004270712,0.00019348192,0.0000068902696,0.000060690054,6.136137e-7,0.0010877515,0.00013232556,0.0003799005,0.12910312],"study_design_scores_gemma":[0.0018701368,0.00019790922,0.99064785,0.000027457849,0.000020732325,0.000027896267,0.00006836834,0.0000026114633,0.0005841971,0.0001972673,0.0062217307,0.00013383992],"about_ca_topic_score_codex":0.0077132145,"about_ca_topic_score_gemma":0.021301094,"teacher_disagreement_score":0.12896928,"about_ca_system_score_codex":0.00027038617,"about_ca_system_score_gemma":0.00026561168,"threshold_uncertainty_score":0.9988945},"labels":[],"label_agreement":null},{"id":"W2085835360","doi":"10.1007/s10549-014-3259-1","title":"Prognostic and predictive investigation of PAM50 intrinsic subtypes in the NCIC CTG MA.21 phase III chemotherapy trial","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Juravinski Cancer Centre; Sunnybrook Health Science Centre; University of Toronto; Ontario Clinical Oncology Group; Saint John Regional Hospital; McMaster University; Queen's University; Vancouver Coastal Health; Vancouver Coastal Health Research Institute; University of British Columbia","funders":"National Cancer Institute; Plexxikon; Susan G. Komen; Bristol-Myers Squibb; Amgen; Pfizer; Sanofi; Cancer Research Institute; BC Cancer Agency; Susan G. Komen for the Cure","keywords":"Epirubicin; Medicine; Internal medicine; Oncology; Cyclophosphamide; Breast cancer; Proportional hazards model; Chemotherapy; Hazard ratio; Paclitaxel; Multivariate analysis; Cancer; Confidence interval","score_opus":0.02964056418049475,"score_gpt":0.33766392108995746,"score_spread":0.3080233569094627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085835360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949004,0.0021208855,0.000016131296,0.0017333073,0.000030064342,0.0009875237,0.00012086533,0.0000045115503,0.0000863222],"genre_scores_gemma":[0.99609464,0.0026220614,0.000031105494,0.000053446085,0.00023887635,0.0008412301,0.00006917107,0.000012537999,0.000036929923],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988084,0.00020429083,0.00016379142,0.00034333213,0.00021833107,0.00026187286],"domain_scores_gemma":[0.9994535,0.000098117576,0.000057358022,0.0002059771,0.000107598404,0.0000774893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030707195,0.0001580925,0.00020112784,0.00007507701,0.000116226016,0.000022131555,0.00007592955,0.000062793435,0.0000073807605],"category_scores_gemma":[0.000026800142,0.000099945246,0.000031551714,0.0001589158,0.00039103563,0.000007514559,0.000048759168,0.000071659255,6.065457e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20250595,0.002659974,0.40152553,0.0001314886,0.0011555969,0.000016775077,0.004748009,0.000009789402,0.0092887655,0.00054728,0.0005933485,0.3768175],"study_design_scores_gemma":[0.08476301,0.0070319143,0.89046067,0.00010469994,0.00009380069,0.000044174914,0.0005795544,0.000044375854,0.014838944,0.0006415981,0.0012092851,0.0001879603],"about_ca_topic_score_codex":0.0012466571,"about_ca_topic_score_gemma":0.0007301703,"teacher_disagreement_score":0.48893514,"about_ca_system_score_codex":0.000074450574,"about_ca_system_score_gemma":0.00013704908,"threshold_uncertainty_score":0.4075649},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"split"},{"id":"W2086036058","doi":"10.1007/s10549-010-1152-0","title":"Phase II, double-blind, randomized trial of capecitabine plus enzastaurin versus capecitabine plus placebo in patients with metastatic or recurrent breast cancer after prior anthracycline and taxane therapy","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Eli Lilly (Canada); University of Alberta; Ottawa Hospital","funders":"Eli Lilly and Company","keywords":"Capecitabine; Medicine; Internal medicine; Metastatic breast cancer; Placebo; Hazard ratio; Breast cancer; Taxane; Oncology; Anthracycline; Cancer; Colorectal cancer; Confidence interval","score_opus":0.07088188007729243,"score_gpt":0.42360677427515525,"score_spread":0.3527248941978628,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086036058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98239625,0.0033531685,0.0000014282772,0.0027302438,0.00045564037,0.00952273,0.0014578288,0.000023458324,0.000059235455],"genre_scores_gemma":[0.98165303,0.008948794,0.00012070732,0.00003321262,0.0004353681,0.00782367,0.00020334114,0.00005940062,0.0007224668],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9966747,0.00024645307,0.0006887964,0.00078495726,0.00079237414,0.0008127286],"domain_scores_gemma":[0.99785787,0.00048586613,0.00024257538,0.0003893472,0.00046918608,0.0005551626],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00055117474,0.00055029214,0.0015894471,0.0005127019,0.00018994126,0.00004420232,0.00011007432,0.000120162025,0.0025065339],"category_scores_gemma":[0.000021784226,0.00031694188,0.00013623618,0.0005359762,0.00080484175,0.00018185332,0.0000950739,0.00048543775,0.0000023358784],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8422863,0.012525837,0.0028060137,0.00009784547,0.0015761175,0.00015015232,0.0007971101,0.000003989877,0.0002081112,0.000008734042,0.00006336169,0.13947643],"study_design_scores_gemma":[0.96607435,0.022898823,0.008323055,0.0002168545,0.0006714927,0.0000631485,0.00010792615,0.000120422905,0.0006440203,0.0000056731237,0.00059203134,0.0002821901],"about_ca_topic_score_codex":0.010491389,"about_ca_topic_score_gemma":0.019039344,"teacher_disagreement_score":0.13919424,"about_ca_system_score_codex":0.00086543727,"about_ca_system_score_gemma":0.0015014341,"threshold_uncertainty_score":0.9999283},"labels":[],"label_agreement":null},{"id":"W2086104261","doi":"10.1007/s10549-006-9249-1","title":"Economic Analysis of Psychosocial Group Therapy in Women with Metastatic Breast Cancer","year":2006,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer survivorship and care","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Statistics Canada; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Psychosocial; Breast cancer; Psychological intervention; Metastatic breast cancer; Randomized controlled trial; Physical therapy; Mood; Anxiety; Health care; Cancer; Internal medicine; Psychiatry","score_opus":0.03046380162424772,"score_gpt":0.35835915039785327,"score_spread":0.32789534877360554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086104261","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930437,0.0026492402,0.0000023555444,0.0021619364,0.0000381843,0.000488529,0.0011865688,0.000011804136,0.0004176472],"genre_scores_gemma":[0.9938736,0.0044483566,0.000010981784,0.0000466732,0.00015432466,0.0011151815,0.000041606654,0.000021940788,0.00028731325],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984613,0.00008463673,0.00022776441,0.00038836533,0.00034485868,0.0004930892],"domain_scores_gemma":[0.99936414,0.000051360497,0.000062595325,0.00022974862,0.00011604491,0.00017612024],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020204841,0.00018378132,0.000561142,0.00052249065,0.000067814464,0.000028628248,0.00006305086,0.00004021141,0.0009294241],"category_scores_gemma":[4.4262723e-7,0.00012490356,0.00008153607,0.0008515032,0.00019849194,0.00006793795,0.000015378235,0.00011052487,0.0000021475948],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014302357,0.0012628526,0.76788425,0.00005438707,0.0036524923,0.000059682992,0.0014733352,0.00012723535,0.00025851562,0.00018324508,0.00013716858,0.21060447],"study_design_scores_gemma":[0.005511528,0.0010361379,0.9912544,0.00008086621,0.00026785157,0.000024107836,0.0007407321,0.000053181862,0.00009667892,0.000095997646,0.00071796944,0.00012054712],"about_ca_topic_score_codex":0.29451743,"about_ca_topic_score_gemma":0.29431883,"teacher_disagreement_score":0.22337015,"about_ca_system_score_codex":0.0016599344,"about_ca_system_score_gemma":0.00043698144,"threshold_uncertainty_score":0.99998385},"labels":[],"label_agreement":null},{"id":"W2086775915","doi":"10.1007/s10549-008-0060-z","title":"A common Greenlandic Inuit BRCA1 RING domain founder mutation","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ovarian cancer; Genetics; Founder effect; Mutation; Biology; Population; Breast cancer; Single-nucleotide polymorphism; Cancer; Haplotype; Medicine; Gene; Genotype","score_opus":0.04891071369308564,"score_gpt":0.3563522990661232,"score_spread":0.30744158537303756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086775915","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99579936,0.0022197415,0.00011550037,0.0007091788,0.000053474057,0.00032491607,0.00012810837,0.00001196453,0.00063775043],"genre_scores_gemma":[0.9959774,0.0017953077,0.00034604242,0.00004900935,0.00028050793,0.0004050543,0.00007710205,0.000022173035,0.0010473795],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99884754,0.000088141365,0.00012486258,0.00035928245,0.00024565085,0.00033451561],"domain_scores_gemma":[0.9994472,0.000020129055,0.000031184645,0.0002494922,0.00011990537,0.00013205508],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013040185,0.00013313789,0.00011822715,0.00008935084,0.0003461258,0.00003067632,0.00008617303,0.000075991185,0.00007450343],"category_scores_gemma":[0.000004647392,0.00011309867,0.000039954328,0.00015167253,0.00023806481,0.0000068527534,0.00007184693,0.00007972265,0.000014692802],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029442215,0.001226075,0.4117171,0.00009443584,0.0014308172,0.00056389405,0.006154527,0.00041006022,0.06221668,0.0007718186,0.003983212,0.50848716],"study_design_scores_gemma":[0.009865551,0.0028591722,0.89737815,0.00010176505,0.000059550628,0.0022348242,0.0011019389,0.0001843367,0.048949067,0.003527179,0.032987665,0.00075082434],"about_ca_topic_score_codex":0.0026639893,"about_ca_topic_score_gemma":0.0059855725,"teacher_disagreement_score":0.5077363,"about_ca_system_score_codex":0.00049410434,"about_ca_system_score_gemma":0.00046456073,"threshold_uncertainty_score":0.461203},"labels":[],"label_agreement":null},{"id":"W2087029919","doi":"10.1007/s10549-007-9770-x","title":"Adjuvant chemotherapy for breast cancer: a cost-utility analysis of FEC-D vs. FEC 100","year":2007,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Dalhousie University","funders":"","keywords":"Medicine; Breast cancer; Epirubicin; Docetaxel; Oncology; Internal medicine; Gynecology; Cancer","score_opus":0.0409900207940185,"score_gpt":0.39054020280051116,"score_spread":0.3495501820064927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087029919","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9768912,0.008053237,0.00025016168,0.0033739859,0.00009157532,0.0014987134,0.009591192,0.000022112456,0.00022777653],"genre_scores_gemma":[0.9898536,0.007836182,0.00012326172,0.00010163211,0.00026317252,0.0011555136,0.00026315672,0.000038891776,0.0003645522],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9975292,0.00007252989,0.00034860917,0.00080961396,0.00039887897,0.00084117573],"domain_scores_gemma":[0.9983468,0.00010292906,0.00012763009,0.00052468583,0.00059676694,0.0003012077],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00048128096,0.00035649023,0.00063605217,0.0002872357,0.0002919607,0.000032632244,0.00018251169,0.00014419357,0.00017734877],"category_scores_gemma":[0.000010776867,0.00027664157,0.00029997624,0.0006754744,0.00043791853,0.000010213031,0.000106634994,0.000088059285,0.0000015037933],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01274379,0.0013562114,0.42412356,0.00007579479,0.008664066,0.000010127017,0.00028486893,0.0000261301,0.0051512187,0.00006282767,0.0009541751,0.54654723],"study_design_scores_gemma":[0.0049302476,0.0007045388,0.96525335,0.000046774392,0.00071583403,0.000028445094,0.00020346184,0.00006814392,0.021406949,0.000046060777,0.0063385214,0.00025766593],"about_ca_topic_score_codex":0.013200749,"about_ca_topic_score_gemma":0.017432075,"teacher_disagreement_score":0.54628956,"about_ca_system_score_codex":0.0004587626,"about_ca_system_score_gemma":0.00037037788,"threshold_uncertainty_score":0.9999686},"labels":[],"label_agreement":null},{"id":"W2087438360","doi":"10.1007/s10549-007-9649-x","title":"Effectiveness of a self-administered, home-based exercise rehabilitation program for women following a modified radical mastectomy and axillary node dissection: a preliminary study","year":2007,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Lymphatic System and Diseases","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Concordia University","funders":"Concordia University","keywords":"Medicine; Rehabilitation; Physical therapy; Range of motion; Modified Radical Mastectomy; Breast cancer; Mastectomy; Surgery; Cancer; Internal medicine","score_opus":0.02840656120162417,"score_gpt":0.3797113513189866,"score_spread":0.35130479011736243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087438360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905803,0.0015981905,0.000048091613,0.00010951693,0.000040256855,0.0074801687,0.000048035796,0.000056721437,0.000038689093],"genre_scores_gemma":[0.9909554,0.00002543759,0.00038976973,0.0000025163993,0.000045691366,0.008505862,0.000014045502,0.000022511707,0.000038775015],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99833214,0.00017746411,0.00025291633,0.00040871842,0.0004303926,0.0003983672],"domain_scores_gemma":[0.9982752,0.00088243186,0.000046214394,0.00021911264,0.00018807274,0.00038894895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010290272,0.00017091015,0.0004347622,0.00022784887,0.00015943253,0.00003315276,0.000035854955,0.000058239624,0.000005374666],"category_scores_gemma":[0.000047036523,0.00012183955,0.000090949434,0.0002660454,0.00012218798,0.00006455388,0.000027023769,0.000023776893,3.1469656e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07592249,0.012833144,0.7823457,0.0047612116,0.00066809385,0.00022389127,0.0029182192,0.0000032059513,0.00021904288,0.000011979262,0.0000054345965,0.12008757],"study_design_scores_gemma":[0.024981862,0.025012344,0.9436137,0.0011543707,0.0002606204,0.000076164404,0.004100373,0.00022158226,0.00039100993,0.000056279598,0.00001659094,0.00011508766],"about_ca_topic_score_codex":0.00033652308,"about_ca_topic_score_gemma":0.000023936096,"teacher_disagreement_score":0.161268,"about_ca_system_score_codex":0.0006491436,"about_ca_system_score_gemma":0.0004182189,"threshold_uncertainty_score":0.49684724},"labels":[],"label_agreement":null},{"id":"W2088394534","doi":"10.1007/s10549-006-9312-y","title":"Coordinated steroid hormone-dependent and independent expression of multiple kallikreins in breast cancer cell lines","year":2006,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Dihydrotestosterone; Hormone; Steroid hormone; Biology; Kallikrein; Endocrinology; Internal medicine; Cancer research; Androgen; Medicine","score_opus":0.029394531098471642,"score_gpt":0.3197050283149824,"score_spread":0.29031049721651075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088394534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.976713,0.020562455,0.000005236003,0.0012085484,0.000043014163,0.0007414413,0.0004908441,0.000026366552,0.00020906972],"genre_scores_gemma":[0.9894718,0.008594545,0.000034654568,0.000017370212,0.0001818664,0.0002702858,0.00006108231,0.000031563926,0.001336829],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980895,0.000075369004,0.00035820046,0.00047485056,0.00051129307,0.0004907727],"domain_scores_gemma":[0.99909234,0.00008805011,0.0000917523,0.00023123877,0.00024995016,0.00024667926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018321995,0.00024420445,0.0004144772,0.00020745833,0.00013079992,0.000039310748,0.00006753733,0.000115800314,0.00014522146],"category_scores_gemma":[0.0000040788423,0.00018138246,0.000056220968,0.00022416725,0.0001659494,0.00014464607,0.00009260245,0.00014014845,0.0000022723077],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036923052,0.0016714924,0.9018333,0.00013936267,0.000073211544,0.00009825755,0.00040238135,0.000052639538,0.062364664,0.000028125305,0.00029557484,0.029348679],"study_design_scores_gemma":[0.008877039,0.0005561464,0.9481972,0.00033773232,0.000046518762,0.00010411606,0.00030822572,0.0003383004,0.040816437,0.000063876636,0.00019477346,0.00015965942],"about_ca_topic_score_codex":0.107142754,"about_ca_topic_score_gemma":0.017301599,"teacher_disagreement_score":0.08984116,"about_ca_system_score_codex":0.00046701307,"about_ca_system_score_gemma":0.0002477202,"threshold_uncertainty_score":0.96546984},"labels":[],"label_agreement":null},{"id":"W2088524487","doi":"10.1023/a:1019915101457","title":"Mitogenic Properties of Insulin-Like Growth Factors I and II, Insulin-Like Growth Factor Binding Protein-3 and Epidermal Growth Factor on Human Breast Epithelial Cells in Primary Culture","year":2002,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Epidermal growth factor; Growth factor receptor inhibitor; Internal medicine; Endocrinology; Growth factor; Insulin-like growth factor-binding protein; Primary culture; Insulin; Insulin-like growth factor; Biology; Cancer research; Cell culture; Chemistry; Cell biology; Medicine; Receptor; Genetics","score_opus":0.06239063904561519,"score_gpt":0.29298113534931547,"score_spread":0.23059049630370027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088524487","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893957,0.0046558133,7.335325e-7,0.0009856418,0.00013228523,0.0026877408,0.0018229954,0.000081741426,0.00023735304],"genre_scores_gemma":[0.9900956,0.008038137,0.00005020779,0.000090369256,0.0002532594,0.00037106956,0.000086631815,0.000114250994,0.00090043736],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99481624,0.00033804285,0.0009207239,0.0013256914,0.0012126461,0.0013866761],"domain_scores_gemma":[0.9976208,0.0001352251,0.00025621153,0.00045838428,0.0005471832,0.0009821524],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002734582,0.0009607159,0.0013423709,0.001017712,0.00070337125,0.00013273887,0.0002471057,0.00043563955,0.000124594],"category_scores_gemma":[0.00006338792,0.00064772693,0.00020661592,0.0007882467,0.0008757975,0.00052104745,0.0003211687,0.00091705075,0.000012572569],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004325063,0.0045804763,0.48198205,0.0016056456,0.0009714567,0.00027879034,0.009165507,2.7486533e-7,0.485025,0.00021531772,0.0003287608,0.011521668],"study_design_scores_gemma":[0.0126597155,0.0065421495,0.7612735,0.0011485621,0.00015959059,0.00029209518,0.00071403076,0.00001999219,0.21592338,0.00010471612,0.00027315423,0.00088912906],"about_ca_topic_score_codex":0.005898733,"about_ca_topic_score_gemma":0.00023892094,"teacher_disagreement_score":0.27929142,"about_ca_system_score_codex":0.0009200001,"about_ca_system_score_gemma":0.00027491973,"threshold_uncertainty_score":0.9995974},"labels":[],"label_agreement":null},{"id":"W2088694463","doi":"10.1007/s10549-008-0146-7","title":"Association between IGF1 CA microsatellites and mammographic density, anthropometric measures, and circulating IGF-I levels in premenopausal Caucasian women","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Cancer Care Ontario; Hospital for Sick Children; Public Health Ontario; University of Toronto","funders":"","keywords":"Allele; Internal medicine; Breast cancer; Endocrinology; Anthropometry; Genotype; MAMMOGRAPHIC DENSITY; Biology; Body mass index; Polymorphism (computer science); Medicine; Genetics; Mammography; Cancer; Gene","score_opus":0.09331046260386545,"score_gpt":0.34329457739254654,"score_spread":0.2499841147886811,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088694463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99209195,0.0060021817,0.0000016693135,0.00094795536,0.000021452988,0.00061728124,0.00015968452,0.000022190514,0.00013561602],"genre_scores_gemma":[0.99057996,0.008849949,0.000046739697,0.000020560747,0.00012207156,0.000103166814,0.000029759074,0.000024421426,0.000223354],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977501,0.00013823985,0.0002898176,0.0004814629,0.0005987773,0.0007415837],"domain_scores_gemma":[0.9989097,0.00019278089,0.00007121769,0.00015861854,0.00021587119,0.00045180038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005311713,0.00022831198,0.00045620187,0.00078480406,0.00037918563,0.000062476596,0.00004152954,0.00014096498,0.000029521283],"category_scores_gemma":[0.00006992698,0.00018708222,0.00002834197,0.00094879046,0.00025917508,0.00014815705,0.000072166826,0.00027510975,0.0000030517845],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018255689,0.00023304056,0.96422726,0.000065466935,0.0003487209,0.00015310741,0.0014621179,9.260411e-8,0.0025369416,0.00000516308,0.000040264607,0.030745298],"study_design_scores_gemma":[0.0030196763,0.0011312123,0.9930947,0.00008681813,0.000061117076,0.0002685395,0.0003190562,0.000006337304,0.0014750296,0.00009252793,0.00029043446,0.00015458252],"about_ca_topic_score_codex":0.012184438,"about_ca_topic_score_gemma":0.0010628267,"teacher_disagreement_score":0.030590715,"about_ca_system_score_codex":0.0011658139,"about_ca_system_score_gemma":0.00026163575,"threshold_uncertainty_score":0.9943935},"labels":[],"label_agreement":null},{"id":"W2088871749","doi":"10.1007/s10549-014-3058-8","title":"Cardiac glycosides and the risk of breast cancer in women with chronic heart failure and supraventricular arrhythmia","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Breast cancer; Internal medicine; Odds ratio; Heart failure; Cumulative dose; Cohort; Confidence interval; Population; Cardiology; Cohort study; Cancer; Oncology","score_opus":0.009894111536922922,"score_gpt":0.28435067043964346,"score_spread":0.2744565589027205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088871749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9625655,0.007300899,0.0000036803817,0.028370872,0.000016625103,0.001470862,0.00018485842,0.000013889835,0.00007284243],"genre_scores_gemma":[0.98459303,0.013610307,0.000094447794,0.00003404077,0.00019905892,0.0011748408,0.0000054406605,0.00002057514,0.00026822762],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99821824,0.0002597916,0.000181485,0.00040458108,0.0003905034,0.00054538035],"domain_scores_gemma":[0.99911124,0.00016862877,0.00004835641,0.00028196778,0.00011151575,0.0002783001],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058591174,0.00022610805,0.00054065476,0.00017260175,0.00016656968,0.00004709121,0.000036458638,0.00005403203,0.00009027102],"category_scores_gemma":[0.000008374828,0.000114708106,0.000042391363,0.0002789918,0.00053324725,0.00007321828,0.00007240246,0.00016913956,0.00000226911],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00880062,0.00030376826,0.74044013,0.00032265155,0.0016884183,0.00008614695,0.0010960033,0.000027621632,0.00021465536,0.0007491606,0.00064483687,0.24562599],"study_design_scores_gemma":[0.014913834,0.0015197983,0.9561692,0.00042525763,0.00026935549,0.00021991046,0.00050360116,0.00014228438,0.00021338684,0.00012274366,0.02535508,0.00014554943],"about_ca_topic_score_codex":0.022270458,"about_ca_topic_score_gemma":0.0052243746,"teacher_disagreement_score":0.24548045,"about_ca_system_score_codex":0.00054921897,"about_ca_system_score_gemma":0.00022520733,"threshold_uncertainty_score":0.98424035},"labels":[],"label_agreement":null},{"id":"W2088949718","doi":"10.1007/s10549-014-2883-0","title":"Effects of exercise dose and type on sleep quality in breast cancer patients receiving chemotherapy: a multicenter randomized trial","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer survivorship and care","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital; BC Cancer Agency; Alberta Health Services; University of British Columbia; University of Alberta","funders":"Alberta Innovates; Canadian Breast Cancer Research Alliance; Alberta Cancer Foundation; Canada Research Chairs; Breast Cancer Alliance","keywords":"Medicine; Pittsburgh Sleep Quality Index; Aerobic exercise; Breast cancer; Randomized controlled trial; Internal medicine; Physical therapy; Sleep quality; Cancer; Insomnia","score_opus":0.02446893150285202,"score_gpt":0.362233175836529,"score_spread":0.33776424433367697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088949718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99421424,0.0014670851,8.422158e-7,0.0012077894,0.0002053985,0.002663633,0.00007635439,0.0000131741945,0.000151513],"genre_scores_gemma":[0.9921842,0.006393509,0.0000072486496,0.000078131714,0.00014908228,0.0009916058,0.000013178699,0.000025338659,0.00015770052],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9980127,0.00042093365,0.00030369742,0.0004125388,0.00047514826,0.0003749704],"domain_scores_gemma":[0.99867874,0.0005285758,0.00008475957,0.0002132665,0.0002544747,0.00024018182],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006490626,0.0002098416,0.00078085624,0.0001859207,0.000064809785,0.000025970234,0.0000510389,0.000084493346,0.000088125315],"category_scores_gemma":[0.00006045986,0.00014139783,0.000089568326,0.00023994173,0.00020443129,0.000052822146,0.00003685548,0.00016214457,0.0000020846276],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6927783,0.0012818162,0.09680089,0.00034554402,0.00015115153,0.0000047036656,0.0010651706,6.2588344e-7,0.00013231035,0.000014774817,0.00002304001,0.20740166],"study_design_scores_gemma":[0.5297834,0.0010890354,0.46734354,0.0008952972,0.000075301476,0.0000017875817,0.00004940009,0.00005468777,0.00052128226,0.000026411255,0.000062763866,0.00009707265],"about_ca_topic_score_codex":0.032815333,"about_ca_topic_score_gemma":0.0033840165,"teacher_disagreement_score":0.37054265,"about_ca_system_score_codex":0.00039073927,"about_ca_system_score_gemma":0.00012893495,"threshold_uncertainty_score":0.97362524},"labels":[],"label_agreement":null},{"id":"W2089685822","doi":"10.1007/s10549-010-0927-7","title":"Associations between mammographic density and serum and dietary cholesterol","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Digital Radiography and Breast Imaging","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Calgary; Sunnybrook Health Science Centre; Sunnybrook Hospital; Ontario Institute for Cancer Research; Alberta Health Services","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Breast cancer; Internal medicine; Cholesterol; MAMMOGRAPHIC DENSITY; High-density lipoprotein; Endocrinology; Alcohol consumption; Cancer; Risk factor; Cross-sectional study; Estrogen; Physiology; Mammography; Alcohol; Biology","score_opus":0.04650573720300648,"score_gpt":0.3522955712805874,"score_spread":0.3057898340775809,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089685822","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924096,0.00056876394,7.8839537e-7,0.005659489,0.000025947087,0.00032380928,0.0004989058,0.000028963066,0.00048376463],"genre_scores_gemma":[0.9986851,0.00076953974,0.000054298805,0.00005204223,0.0001672638,0.000044338292,0.00004089516,0.0000125109555,0.00017398882],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989467,0.000029446195,0.00011071213,0.0003079825,0.00025060456,0.00035452127],"domain_scores_gemma":[0.99921256,0.00008210126,0.000024676146,0.00015309815,0.00010716322,0.00042038495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018586617,0.00013530494,0.00023304753,0.00022573803,0.00026242936,0.00011728067,0.00002966922,0.000060111728,0.000013401212],"category_scores_gemma":[0.0000086865275,0.00010115393,0.000043370535,0.0002432011,0.00035449959,0.00016040508,0.000054266584,0.0002482062,0.0000017609248],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006825364,0.00011864686,0.7412248,0.000015447677,0.00018698294,0.000020238014,0.00008623841,6.7221055e-9,0.00025006098,0.00004273105,0.000023990995,0.25796255],"study_design_scores_gemma":[0.0015006022,0.0003495918,0.9965898,0.00004997833,0.000094779556,0.00028123893,0.000043192376,0.000005176826,0.00024741155,0.00044049157,0.0003156016,0.00008213135],"about_ca_topic_score_codex":0.0017724504,"about_ca_topic_score_gemma":0.0011174878,"teacher_disagreement_score":0.25788042,"about_ca_system_score_codex":0.000039743867,"about_ca_system_score_gemma":0.000058765985,"threshold_uncertainty_score":0.41249374},"labels":[],"label_agreement":null},{"id":"W2089959409","doi":"10.1007/s10549-013-2713-9","title":"Blood levels of vitamin D and early stage breast cancer prognosis: a systematic review and meta-analysis","year":2013,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McGill University; Statistics Canada; University of Toronto; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"","keywords":"Breast cancer; Medicine; Oncology; Internal medicine; Hazard ratio; Meta-analysis; Vitamin D and neurology; Cancer; Observational study; Confidence interval","score_opus":0.2261282930899937,"score_gpt":0.4560924891580444,"score_spread":0.2299641960680507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089959409","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00041665445,0.9780858,3.7136752e-7,0.001500045,0.000007722948,0.011955235,0.00797625,0.000022010057,0.000035889196],"genre_scores_gemma":[0.0031576236,0.9630676,0.00004188953,0.000021610836,0.000051150648,0.027580768,0.000027688471,0.00007361794,0.0059780353],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9943723,0.0009678736,0.0011885988,0.0011660602,0.0013738974,0.00093128975],"domain_scores_gemma":[0.9962994,0.0005348859,0.0005056023,0.0008572343,0.0010506501,0.0007522469],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012694371,0.0008722358,0.01070874,0.0009391812,0.00024445957,0.00014011397,0.000216165,0.00017921416,0.0006777698],"category_scores_gemma":[0.00009067123,0.00044847667,0.0010043943,0.0014782462,0.0007690347,0.00014124566,0.0004077616,0.00049529364,0.000008344308],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021080377,0.00053210114,0.0005789183,0.6587267,0.30744812,0.000093331095,0.00008505042,1.4723099e-8,9.232086e-7,0.000012029925,0.00007302615,0.03242874],"study_design_scores_gemma":[0.0010787575,0.0011880114,0.006704417,0.103859656,0.8846154,0.0005377318,0.00008639789,8.130648e-7,0.0000035592361,0.0000030709975,0.0015418635,0.0003803148],"about_ca_topic_score_codex":0.010202571,"about_ca_topic_score_gemma":0.0007650743,"teacher_disagreement_score":0.5771673,"about_ca_system_score_codex":0.0004373925,"about_ca_system_score_gemma":0.00080791046,"threshold_uncertainty_score":0.9997967},"labels":[],"label_agreement":null},{"id":"W2090886420","doi":"10.1007/s10549-013-2455-8","title":"Can we select individuals with low risk ductal carcinoma in situ (DCIS)? A population-based outcomes analysis","year":2013,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":63,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Hospital; London Health Sciences Centre; University of Toronto; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre; Kingston General Hospital; Canada Research Chairs; Occupational Cancer Research Centre; Thunder Bay Regional Health Sciences Centre; Health Sciences Centre","funders":"Institute for Clinical Evaluative Sciences","keywords":"Medicine; Radiation therapy; Ductal carcinoma; Breast cancer; Breast-conserving surgery; Population; Oncology; Cohort; Mastectomy; Internal medicine; Randomized controlled trial; Stage (stratigraphy); Cancer; Gynecology","score_opus":0.015223175261930755,"score_gpt":0.30284059766761573,"score_spread":0.287617422405685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090886420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99417347,0.0013046244,0.0000051542756,0.0031472142,0.000014311288,0.0006602309,0.00062231184,0.000012614224,0.000060076163],"genre_scores_gemma":[0.9972474,0.00058037654,0.00012363933,0.000041545856,0.0000701278,0.0014175605,0.0003517306,0.000027136954,0.00014047154],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99801946,0.0001657858,0.00019924447,0.00064837566,0.0003667663,0.00060035725],"domain_scores_gemma":[0.9991067,0.00006393559,0.00007550372,0.00036471972,0.00018414202,0.000204996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011421003,0.00030499237,0.00039331152,0.00034598613,0.0002312238,0.00007662459,0.000111595866,0.00007253416,0.00007234121],"category_scores_gemma":[0.000011703418,0.00020620483,0.000090151065,0.0006713104,0.00013975028,0.000010887376,0.00006633013,0.00011051471,0.0000059476993],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003076244,0.0004885484,0.98888385,0.000012336045,0.0017331636,0.000017833117,0.00013269049,0.00024296703,0.00030282413,0.000005672842,0.000051027633,0.007821476],"study_design_scores_gemma":[0.0027881449,0.0007204047,0.9937984,0.000022109656,0.00024288787,0.000012138897,0.00013797963,0.000043920427,0.0019346456,0.000059177088,0.000031491014,0.00020872397],"about_ca_topic_score_codex":0.113852255,"about_ca_topic_score_gemma":0.113780625,"teacher_disagreement_score":0.007612752,"about_ca_system_score_codex":0.0003949468,"about_ca_system_score_gemma":0.00029087364,"threshold_uncertainty_score":0.90239054},"labels":[],"label_agreement":null},{"id":"W2090888216","doi":"10.1007/s10549-007-9595-7","title":"Decision making in adjuvant trials in breast cancer: the NCIC CTG MA.17 trial as an example","year":2007,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Interim; Interim analysis; Medicine; Hazard ratio; Breast cancer; Confidence interval; Internal medicine; Placebo; Sample size determination; Letrozole; Oncology; Clinical endpoint; Relative risk; Absolute risk reduction; Clinical trial; Adjuvant; Cancer; Statistics; Mathematics; Tamoxifen; Alternative medicine; Pathology","score_opus":0.742129627608868,"score_gpt":0.6636178839131149,"score_spread":0.07851174369575309,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090888216","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988875,0.0009604122,0.0012742655,0.0023633076,0.0006051452,0.004508384,0.0007950051,0.000044164888,0.0005743245],"genre_scores_gemma":[0.971668,0.0020926017,0.022940412,0.000111081885,0.0013397143,0.0015565129,0.0000043787445,0.00006550415,0.00022179332],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99134624,0.003726256,0.0017669426,0.00086503325,0.0011798553,0.0011156593],"domain_scores_gemma":[0.92414355,0.074349076,0.000276285,0.00068778975,0.00019600095,0.0003472949],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.031307768,0.00033280096,0.0013620021,0.0003756709,0.0002317165,0.00016468865,0.00038035633,0.00021589517,0.0011930519],"category_scores_gemma":[0.008870003,0.00019486535,0.00016111693,0.00076383445,0.0003381107,0.0001235336,0.00017788698,0.00053494633,0.0000145250715],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.110777095,0.0015906155,0.0076706936,0.000036364345,0.00011928988,0.00023863013,0.00055818126,0.0000055352775,0.000042328556,0.0074758297,0.00040220245,0.87108326],"study_design_scores_gemma":[0.07143636,0.0018750211,0.16649215,0.0011746826,0.00012111867,0.00011487304,0.00077826576,0.00012884753,0.00025392833,0.75641465,0.00080482033,0.0004052762],"about_ca_topic_score_codex":0.026462015,"about_ca_topic_score_gemma":0.029843295,"teacher_disagreement_score":0.87067795,"about_ca_system_score_codex":0.0012666704,"about_ca_system_score_gemma":0.00057124376,"threshold_uncertainty_score":0.99972},"labels":[],"label_agreement":null},{"id":"W2091640600","doi":"10.1007/s10549-014-3125-1","title":"Breast cancer in young women: have the prognostic implications of breast cancer subtypes changed over time?","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":81,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Breast cancer; Oncology; Cancer; Medicine; Internal medicine; Gynecology","score_opus":0.020546513869174967,"score_gpt":0.32647086114877677,"score_spread":0.3059243472796018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091640600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97659975,0.0043376484,0.000004063203,0.012378786,0.00008177432,0.0009861037,0.0052568666,0.00001754959,0.00033748217],"genre_scores_gemma":[0.9872043,0.0062185884,0.000008493784,0.00007935165,0.0004983961,0.0052485703,0.00007166657,0.000049199403,0.00062139786],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975401,0.00020950689,0.00029476473,0.0007170919,0.00036867498,0.00086987234],"domain_scores_gemma":[0.998614,0.000092571005,0.00012472288,0.0005621255,0.00038559138,0.00022100411],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003036419,0.00036555534,0.00040347554,0.00014701852,0.00032616247,0.00005345124,0.00026545706,0.0001236641,0.00035694084],"category_scores_gemma":[0.000011620433,0.00024449572,0.00008979001,0.0003589908,0.00052620086,0.00001837379,0.000217517,0.00015528112,0.000007896546],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013874479,0.0006908898,0.9203803,0.000056368634,0.00070911826,0.000003069925,0.0007298694,0.00003704908,0.0072055813,0.000084132545,0.00067772646,0.06803847],"study_design_scores_gemma":[0.0022600559,0.00023526358,0.99457836,0.00013369042,0.000071929004,0.000145328,0.00021543473,0.000042209118,0.0013477743,0.00011361369,0.0006225821,0.00023375869],"about_ca_topic_score_codex":0.02407708,"about_ca_topic_score_gemma":0.03137032,"teacher_disagreement_score":0.07419808,"about_ca_system_score_codex":0.00070026284,"about_ca_system_score_gemma":0.0004136273,"threshold_uncertainty_score":0.99702466},"labels":[],"label_agreement":null},{"id":"W2091820323","doi":"10.1007/s10549-007-9602-z","title":"Effects of a combined aerobic and resistance exercise program in breast cancer survivors: a randomized controlled trial","year":2007,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer survivorship and care","field":"Medicine","cited_by":273,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Breast cancer; Medicine; Aerobic exercise; Randomized controlled trial; Quality of life (healthcare); Clinical endpoint; Physical therapy; Anxiety; Repeated measures design; Cancer; Internal medicine; Analysis of variance","score_opus":0.016608958403642037,"score_gpt":0.343406487212894,"score_spread":0.326797528809252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091820323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9626322,0.020542607,0.000003350417,0.0017109041,0.00019982243,0.014421934,0.000078422425,0.000042421852,0.00036837134],"genre_scores_gemma":[0.97224385,0.014990132,0.000035990462,0.00002483192,0.00018033695,0.011362819,0.0000125613105,0.00003426122,0.001115248],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9970603,0.000366439,0.00060968264,0.0005415086,0.0006885809,0.0007335184],"domain_scores_gemma":[0.9977162,0.0010538282,0.00014571233,0.00027129092,0.00038700443,0.00042598968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016105681,0.00032662455,0.0019850368,0.0004233773,0.000105115905,0.000047228157,0.00007884515,0.00013674934,0.000067981695],"category_scores_gemma":[0.000051620438,0.0002165139,0.00022937793,0.0006117374,0.0005589252,0.00007559651,0.000051680425,0.00024007587,9.609529e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9365312,0.002024934,0.008732414,0.0005872043,0.00051242014,0.0001754001,0.00089042104,1.9803409e-7,0.00027145166,0.00015981105,0.00003817915,0.05007641],"study_design_scores_gemma":[0.9474595,0.0012451942,0.047810715,0.0016601187,0.00038967843,0.00002430996,0.00026576538,0.000015638807,0.0006630237,0.00015733112,0.00012670421,0.0001819848],"about_ca_topic_score_codex":0.05463065,"about_ca_topic_score_gemma":0.08919889,"teacher_disagreement_score":0.049894426,"about_ca_system_score_codex":0.00051461,"about_ca_system_score_gemma":0.0004986813,"threshold_uncertainty_score":0.9516646},"labels":[],"label_agreement":null},{"id":"W2092759243","doi":"10.1007/s10549-013-2636-5","title":"Rates and predictors of consideration for adjuvant radiotherapy among high-risk breast cancer patients: a cohort study","year":2013,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research","keywords":"Medicine; Odds ratio; Breast cancer; Confidence interval; Referral; Cohort; Cohort study; Internal medicine; Odds; Generalized estimating equation; Radiation therapy; Prospective cohort study; Cancer; Demography; Logistic regression; Family medicine","score_opus":0.013858885278677784,"score_gpt":0.31187570722963065,"score_spread":0.29801682195095286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092759243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911143,0.0029197698,0.000009989589,0.00049968244,0.00008269903,0.003081555,0.0022721693,0.000010572026,0.000009273463],"genre_scores_gemma":[0.9852885,0.008340966,0.00005425871,0.000017920183,0.00022291596,0.0058153607,0.00012287941,0.000033236687,0.00010399144],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983792,0.0001330859,0.00024800922,0.0005856146,0.00026422922,0.00038991723],"domain_scores_gemma":[0.9987914,0.00007097351,0.00011921916,0.0002427861,0.0006066443,0.00016900159],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014895521,0.000265222,0.00036175048,0.00008670058,0.0002881341,0.000059160386,0.00006749748,0.000077389566,0.000060905946],"category_scores_gemma":[0.000013905919,0.00019056804,0.0000515095,0.00009947027,0.00036676167,0.000022824892,0.0000692825,0.00006071689,6.1546103e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009055788,0.0010776487,0.9678973,0.000025274352,0.0016603993,9.0142913e-7,0.00034228567,0.000008621214,0.0006389117,0.000006479042,0.00066333957,0.026773278],"study_design_scores_gemma":[0.0061570434,0.0019924303,0.98874253,0.000040286606,0.00014775226,0.00000654312,0.00036486835,0.000022806009,0.0022472185,0.000038645565,0.00007997223,0.00015991392],"about_ca_topic_score_codex":0.05466838,"about_ca_topic_score_gemma":0.0073825684,"teacher_disagreement_score":0.047285814,"about_ca_system_score_codex":0.0001989765,"about_ca_system_score_gemma":0.00015387105,"threshold_uncertainty_score":0.95162666},"labels":[],"label_agreement":null},{"id":"W2092763841","doi":"10.1007/s10549-005-6932-6","title":"How Should We Inform Women at Higher Risk of Breast Cancer About Tamoxifen? An Approach with a Decision Guide","year":2005,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Health Sciences Centre","funders":"","keywords":"Tamoxifen; Breast cancer; Medicine; Incidence (geometry); Family medicine; Gynecology; Oncology; Obstetrics; Cancer; Internal medicine","score_opus":0.024815015835870178,"score_gpt":0.3277590837720367,"score_spread":0.3029440679361665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092763841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98881173,0.008379179,0.000021340426,0.001010552,0.00002538523,0.00049764826,0.0005919859,0.000012557752,0.00064964907],"genre_scores_gemma":[0.9728823,0.020240631,0.00044243355,0.000028687613,0.00030801605,0.000607923,0.00007574449,0.000037346254,0.005376974],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99818,0.0000867627,0.0001726121,0.0005040284,0.0004447106,0.0006119316],"domain_scores_gemma":[0.99883497,0.00002069722,0.00008844927,0.00042304807,0.00022119813,0.0004116394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000221309,0.0002658909,0.00026261766,0.00009879962,0.00021830428,0.000063798885,0.0001602979,0.00019813469,0.000069615715],"category_scores_gemma":[0.0000036056815,0.00016101563,0.00006348896,0.00018580846,0.00025809155,0.000023712102,0.00013039722,0.00016495021,0.0000032134885],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013442883,0.0017084366,0.095964536,0.00009661069,0.0018424991,0.000029786908,0.00083533,0.00050951715,0.042684216,0.00008941317,0.0024227342,0.84037405],"study_design_scores_gemma":[0.0264872,0.012856654,0.62815183,0.00055783504,0.0004430363,0.001197088,0.0011327412,0.00078452966,0.15096517,0.00015345227,0.1755899,0.0016805396],"about_ca_topic_score_codex":0.0017753344,"about_ca_topic_score_gemma":0.0008812072,"teacher_disagreement_score":0.8386935,"about_ca_system_score_codex":0.00045292528,"about_ca_system_score_gemma":0.00032974198,"threshold_uncertainty_score":0.6566027},"labels":[],"label_agreement":null},{"id":"W2093130510","doi":"10.1007/s10549-012-2393-x","title":"A systematic review of elastography, electrical impedance scanning, and digital infrared thermography for breast cancer screening and diagnosis","year":2013,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Infrared Thermography in Medicine","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes; University of British Columbia","funders":"","keywords":"Medicine; Breast cancer; Cochrane Library; Medical physics; Elastography; Meta-analysis; CINAHL; Systematic review; MEDLINE; Radiology; Cancer; Ultrasound; Internal medicine; Psychological intervention","score_opus":0.055286157672320285,"score_gpt":0.3976112877043384,"score_spread":0.34232513003201814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093130510","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00065646286,0.98398167,0.000011068037,0.00035375843,0.000038000115,0.010892519,0.003946121,0.00004115081,0.00007925674],"genre_scores_gemma":[0.00068658084,0.9765172,0.00013871743,0.00006867242,0.00023056085,0.021976257,0.00011901644,0.000117106894,0.0001458798],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99591637,0.00026262546,0.001111957,0.0009240004,0.000860753,0.0009242964],"domain_scores_gemma":[0.9964236,0.0009673899,0.00054984,0.0006119682,0.00075561274,0.0006915787],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006178397,0.0008027074,0.004037089,0.0011292018,0.00023639233,0.00011626781,0.00019915965,0.00027651872,0.00009125987],"category_scores_gemma":[0.000115377115,0.0004933883,0.00067737035,0.0014946021,0.00083681487,0.00017472911,0.0001244393,0.00049353606,9.925452e-7],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014456318,0.00017138846,0.0024826084,0.43608826,0.002734521,0.000016441025,0.000056807065,6.1710734e-9,7.055774e-7,0.000021176395,0.0002997483,0.55798376],"study_design_scores_gemma":[0.002654129,0.0017872258,0.0033491813,0.9706057,0.0071158786,0.0014709858,0.000070999355,0.000008178023,0.0000024209312,0.000067045614,0.012376496,0.0004918157],"about_ca_topic_score_codex":0.0006768058,"about_ca_topic_score_gemma":0.000013419751,"teacher_disagreement_score":0.55749196,"about_ca_system_score_codex":0.00024269069,"about_ca_system_score_gemma":0.0005335508,"threshold_uncertainty_score":0.99975175},"labels":[],"label_agreement":null},{"id":"W2093508849","doi":"10.1007/s10549-008-9904-9","title":"Effect of a low-fat, high-carbohydrate dietary intervention on change in mammographic density over menopause","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; BC Cancer Agency; University of Toronto; Ontario Institute for Cancer Research","funders":"Canadian Breast Cancer Research Alliance; Breast Cancer Alliance; American Institute for Cancer Research; Cancer Research Institute","keywords":"Medicine; Breast cancer; Menopause; Postmenopausal women; MAMMOGRAPHIC DENSITY; Post-hoc analysis; Mammography; Internal medicine; Endocrinology; Physiology; Cancer","score_opus":0.05220611703871131,"score_gpt":0.3760366224076801,"score_spread":0.3238305053689688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093508849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968585,0.0015986405,2.002332e-7,0.00039109745,0.00006686276,0.00092460855,0.00011358804,0.000014227766,0.000032324493],"genre_scores_gemma":[0.9927066,0.0065334477,0.0000022189329,0.000019840787,0.0001652691,0.00044139804,0.000031289306,0.000017070655,0.000082843624],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99866253,0.00014414913,0.00017278538,0.00031128843,0.00037138272,0.000337868],"domain_scores_gemma":[0.9994172,0.00006833455,0.000041671476,0.00022587558,0.00006302491,0.00018391316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002068143,0.0001682556,0.0003685915,0.00038317873,0.00007365692,0.0000075788244,0.00003874863,0.00005970151,0.00008954626],"category_scores_gemma":[0.0000058160817,0.00011361439,0.00008818795,0.0003737565,0.00023894163,0.00006356073,0.00003844703,0.00016647203,0.000004394603],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013200892,0.001380927,0.83091664,0.0002951857,0.0002745474,0.00059477135,0.00044130895,0.0000013998662,0.0027586971,0.000020502128,0.000055955938,0.15005916],"study_design_scores_gemma":[0.0065078703,0.008123374,0.97541404,0.00058605644,0.000048423455,0.00003787039,0.000010876667,0.00002776826,0.009109862,0.000017236542,0.000035629564,0.00008098247],"about_ca_topic_score_codex":0.10542784,"about_ca_topic_score_gemma":0.00744224,"teacher_disagreement_score":0.14997818,"about_ca_system_score_codex":0.00037834846,"about_ca_system_score_gemma":0.000047609363,"threshold_uncertainty_score":0.9005292},"labels":[],"label_agreement":null},{"id":"W2094397571","doi":"10.1007/s10549-011-1518-y","title":"Mutational characterization of individual breast tumors: TP53 and PI3K pathway genes are frequently and distinctively mutated in different subtypes","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":79,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut National Du Cancer","keywords":"PTEN; Breast cancer; Gene; Biology; CDH1; Cancer research; Mutation; Genetics; Phenotype; Cancer; PI3K/AKT/mTOR pathway; Signal transduction; Cadherin; Cell","score_opus":0.048569846495085674,"score_gpt":0.29848441245210394,"score_spread":0.24991456595701828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094397571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99652433,0.0011991486,0.000015136918,0.00011242515,0.000021337453,0.00027921656,0.001816601,0.0000048582297,0.000026954402],"genre_scores_gemma":[0.9986268,0.00069268025,0.00003152442,0.000009934809,0.00008749198,0.00018476562,0.0003059141,0.000016191452,0.000044659104],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989117,0.00009402126,0.00016940119,0.0003717453,0.0002093108,0.00024382689],"domain_scores_gemma":[0.99952227,0.000019988074,0.00008169514,0.000109341076,0.00014742023,0.000119272554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011780068,0.00016224466,0.00018133482,0.000098207594,0.000075806216,0.000028571641,0.0000662305,0.00007023031,0.000035844743],"category_scores_gemma":[0.00000784054,0.00012535483,0.000020235238,0.000089327536,0.00025780222,0.000011902022,0.0000837009,0.00006282159,3.9604927e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001083209,0.00040231107,0.661473,0.000060026046,0.00018413596,0.00003074215,0.00052759284,9.330578e-7,0.29083234,0.000060213843,0.0000040898885,0.04534144],"study_design_scores_gemma":[0.0011605067,0.0004815046,0.89329857,0.0000839234,0.000014601434,0.00009050168,0.00011607386,0.000013973961,0.104496025,0.00011215627,0.00002328373,0.000108902044],"about_ca_topic_score_codex":0.0010095079,"about_ca_topic_score_gemma":0.0005650577,"teacher_disagreement_score":0.23182558,"about_ca_system_score_codex":0.000066708366,"about_ca_system_score_gemma":0.00013224405,"threshold_uncertainty_score":0.5111822},"labels":[],"label_agreement":null},{"id":"W2094523134","doi":"10.1007/s10549-014-3100-x","title":"Pathologic complete response to neoadjuvant cisplatin in BRCA1-positive breast cancer patients","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":269,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Breast cancer; Medicine; Chemotherapy; Oncology; Internal medicine; Cisplatin; Cancer; Stage (stratigraphy); Mastectomy; Neoadjuvant therapy; BRCA mutation; Biology","score_opus":0.02920730775215029,"score_gpt":0.34596991043679276,"score_spread":0.31676260268464246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094523134","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919122,0.0005390378,0.00004484024,0.004125319,0.00010114697,0.00071288075,0.0023325763,0.000008753728,0.00022324955],"genre_scores_gemma":[0.9972371,0.0004151726,0.00015842418,0.0002862883,0.00021381858,0.0010332142,0.00011708774,0.000031638003,0.0005072717],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99747145,0.000522574,0.00025868454,0.0007516324,0.0003951324,0.00060055405],"domain_scores_gemma":[0.99874175,0.000103279934,0.000058319754,0.00040820293,0.00041798144,0.00027048663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005830945,0.00023783615,0.00024931904,0.00021483487,0.00019032267,0.00006733445,0.00019753155,0.000113877184,0.000089571215],"category_scores_gemma":[0.000061982755,0.00019258438,0.00005276789,0.00034646605,0.0001772202,0.000008702021,0.00020844972,0.00013153645,0.000025729896],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016981605,0.0013275495,0.39635155,0.000026600706,0.00026002986,0.000065130786,0.0013470644,0.00088003156,0.10808766,0.00007612394,0.003405663,0.471191],"study_design_scores_gemma":[0.0031209625,0.001580808,0.9828293,0.00007254294,0.000012348528,0.00005146816,0.00011074989,0.000072312025,0.0057275174,0.00011331297,0.0060671484,0.00024158212],"about_ca_topic_score_codex":0.002408371,"about_ca_topic_score_gemma":0.0029509044,"teacher_disagreement_score":0.5864777,"about_ca_system_score_codex":0.00078742555,"about_ca_system_score_gemma":0.00036186946,"threshold_uncertainty_score":0.7853363},"labels":[],"label_agreement":null},{"id":"W2094763732","doi":"10.1007/s10549-005-9094-7","title":"Can bone markers guide more effective treatment of bone metastases from breast cancer?","year":2005,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Bone health and treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; N-terminal telopeptide; Oncology; Cancer; Internal medicine; Bone disease; Bone resorption; Bone remodeling; Osteoporosis; Osteocalcin; Alkaline phosphatase","score_opus":0.08487442535280759,"score_gpt":0.4586146276175355,"score_spread":0.3737402022647279,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094763732","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0032711367,0.9331997,3.121908e-7,0.0026034492,0.00014242531,0.007014489,0.05347499,0.00006525335,0.00022825265],"genre_scores_gemma":[0.0028478994,0.97962064,0.00016228501,0.000044756558,0.00066884607,0.0108976085,0.002450709,0.00018461145,0.0031226627],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9938984,0.00057670014,0.0012354841,0.0015742193,0.001152935,0.0015622948],"domain_scores_gemma":[0.9956464,0.0006219932,0.0005256002,0.0010948181,0.00048155652,0.0016296303],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0002894497,0.0013405936,0.0048757847,0.0008148721,0.0003589765,0.000059311427,0.00013839094,0.0004256365,0.0007808056],"category_scores_gemma":[0.000017353514,0.00085036526,0.00090298796,0.0008010209,0.00058125966,0.0000975741,0.00010848044,0.00040118393,0.00004191853],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002960048,0.0038085359,0.0027106055,0.0033603327,0.0076465057,0.0012035487,0.00017891453,5.125408e-7,0.0000025408704,0.000010204848,0.0008578729,0.97726035],"study_design_scores_gemma":[0.015779108,0.0054905512,0.029189914,0.019497897,0.011102666,0.0025119656,0.00015775666,0.0000058564797,0.000038085258,0.000021451331,0.9154269,0.00077786733],"about_ca_topic_score_codex":0.2569954,"about_ca_topic_score_gemma":0.016443716,"teacher_disagreement_score":0.9764825,"about_ca_system_score_codex":0.008826226,"about_ca_system_score_gemma":0.0044802832,"threshold_uncertainty_score":0.9999345},"labels":[],"label_agreement":null},{"id":"W2095038393","doi":"10.1007/s10549-013-2426-0","title":"Expression of key oestrogen-regulated genes differs substantially across the menstrual cycle in oestrogen receptor-positive primary breast cancer","year":2013,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"National Institute for Health and Care Research","keywords":"Menstrual cycle; Breast cancer; Progesterone receptor; Immunohistochemistry; Gene expression; Endocrinology; Internal medicine; Estrogen; Biology; Estrogen receptor; Cancer; Gene; Medicine; Hormone; Genetics","score_opus":0.010962770137574147,"score_gpt":0.2985710787581959,"score_spread":0.28760830862062176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095038393","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989552,0.00789328,0.0000020207333,0.0007721441,0.000059550384,0.0008757125,0.00076424057,0.000009986611,0.000071053626],"genre_scores_gemma":[0.99210167,0.006791592,0.0000415141,0.000021058342,0.00014277152,0.0005465679,0.00014290963,0.00003454557,0.0001773986],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979748,0.00024588095,0.00025639194,0.0005004685,0.00034702822,0.00067541085],"domain_scores_gemma":[0.999084,0.00003923711,0.0000884862,0.00033518558,0.00023813144,0.0002149923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018123307,0.0002709931,0.000275669,0.000061350525,0.00024084901,0.000056914585,0.00020309427,0.00020665894,0.000080118785],"category_scores_gemma":[0.0000036601286,0.0001664697,0.00009808553,0.00022279598,0.00046561132,0.000018716846,0.00018164693,0.0001835971,0.000006995435],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014332115,0.00038368258,0.07726735,0.000025690322,0.00033343222,0.000013333194,0.0003646569,0.00008359802,0.8710912,0.000015494534,0.00015374263,0.04883463],"study_design_scores_gemma":[0.002622275,0.00060209224,0.36176398,0.00014862986,0.000027675494,0.000098010234,0.00034008408,0.00003991401,0.6340181,0.000026408663,0.00010322687,0.00020959678],"about_ca_topic_score_codex":0.005482554,"about_ca_topic_score_gemma":0.00030059702,"teacher_disagreement_score":0.28449664,"about_ca_system_score_codex":0.00019582368,"about_ca_system_score_gemma":0.00027690685,"threshold_uncertainty_score":0.8288018},"labels":[],"label_agreement":null},{"id":"W2095137807","doi":"10.1007/s10549-006-9302-0","title":"The management of ductal carcinoma in situ of the breast: a screened population-based analysis","year":2006,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":65,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Newborn Screening Ontario; University of Toronto; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre; Health Sciences Centre","funders":"","keywords":"Medicine; Mastectomy; Ductal carcinoma; Breast cancer; Logistic regression; Population; Gynecology; Radiation therapy; Radiology; Obstetrics; Surgery; Cancer; Internal medicine","score_opus":0.015609847065663329,"score_gpt":0.302609252514653,"score_spread":0.28699940544898966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095137807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99532986,0.00248104,0.0000053388612,0.0011669018,0.000018417117,0.0003681827,0.00031929804,0.0000023637112,0.00030861615],"genre_scores_gemma":[0.99911094,0.0003372901,0.00004102805,0.0000053170616,0.000045309236,0.00023956764,0.00007214933,0.000009868469,0.0001385572],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99878794,0.000101214355,0.00021920538,0.0002916223,0.00031049465,0.00028954906],"domain_scores_gemma":[0.999316,0.00003373896,0.00008238604,0.0003976176,0.00013153134,0.000038753355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014523942,0.00014288758,0.00019604347,0.00009859687,0.00018543225,0.000014378966,0.00014899732,0.000033969787,0.00000772237],"category_scores_gemma":[0.000001544588,0.00008014219,0.00011372311,0.00056700315,0.00023240536,0.000003287395,0.00011052284,0.000041009145,2.6781314e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093340816,0.0004370136,0.98856294,0.000025566695,0.0010380821,0.0000072983817,0.000017184198,0.00042409144,0.0014978397,0.00030006707,0.000029314513,0.0067272196],"study_design_scores_gemma":[0.0014154948,0.00014604536,0.99114925,0.000030095905,0.00019449134,0.000010530942,0.00011340544,0.000030014988,0.006721954,0.000088241366,0.00003471817,0.000065750355],"about_ca_topic_score_codex":0.035291612,"about_ca_topic_score_gemma":0.032195587,"teacher_disagreement_score":0.0066614696,"about_ca_system_score_codex":0.00016126566,"about_ca_system_score_gemma":0.00009302283,"threshold_uncertainty_score":0.98546433},"labels":[],"label_agreement":null},{"id":"W2095438644","doi":"10.1007/s10549-015-3323-5","title":"The association between diabetes and breast cancer stage at diagnosis: a population-based study","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":84,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; Women's College Hospital; University of Toronto","funders":"Canadian Institutes of Health Research; Ontario Ministry of Health and Long-Term Care; Ontario Institute for Cancer Research; Cancer Care Ontario","keywords":"Medicine; Breast cancer; Diabetes mellitus; Odds ratio; Stage (stratigraphy); Population; Internal medicine; Cancer; Cancer registry; Incidence (geometry); Confidence interval; Gynecology; Oncology; Obstetrics; Endocrinology","score_opus":0.04400181140581558,"score_gpt":0.3521214667572862,"score_spread":0.30811965535147057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095438644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9099992,0.08741454,4.177139e-7,0.000685559,0.0000783626,0.000600603,0.0011849593,0.000009251948,0.000027132552],"genre_scores_gemma":[0.9739797,0.022589969,0.0000034699128,0.000056280922,0.0005143206,0.0019574177,0.00010347203,0.000023145618,0.00077219814],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981768,0.0002599959,0.0001710801,0.00042471327,0.00046007827,0.0005073398],"domain_scores_gemma":[0.9989687,0.00010365053,0.0000840896,0.0002637652,0.00028424727,0.0002955378],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057167304,0.00018514019,0.00021171961,0.000048745787,0.00042641305,0.0001270797,0.00010594791,0.00008639483,0.00003361905],"category_scores_gemma":[0.0000325846,0.00012266735,0.000041487667,0.00013054843,0.00007128099,0.000010245432,0.00010554874,0.000083082545,0.0000031483398],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001626704,0.00015461097,0.85665417,0.000009280827,0.00032167786,9.351313e-7,0.000082557475,0.000010720651,0.000049874965,0.000004733818,0.0006612017,0.14188755],"study_design_scores_gemma":[0.0024372556,0.000461878,0.96559715,0.000021916585,0.00008864104,4.998583e-7,0.0002152595,0.0000165003,0.0012039463,0.00003102108,0.029774357,0.0001515982],"about_ca_topic_score_codex":0.0052395505,"about_ca_topic_score_gemma":0.009281064,"teacher_disagreement_score":0.14173596,"about_ca_system_score_codex":0.00059437985,"about_ca_system_score_gemma":0.00027567308,"threshold_uncertainty_score":0.79206675},"labels":[],"label_agreement":null},{"id":"W2097066287","doi":"10.1007/s10549-007-9873-4","title":"Macroautophagy inhibition sensitizes tamoxifen-resistant breast cancer cells and enhances mitochondrial depolarization","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Autophagy in Disease and Therapy","field":"Medicine","cited_by":271,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Tamoxifen; Autophagy; Cancer research; ATG5; Gene knockdown; Breast cancer; Antiestrogen; Biology; Estrogen receptor; Programmed cell death; Viability assay; Cancer cell; Cancer; Apoptosis; Medicine; Internal medicine","score_opus":0.030837105704221483,"score_gpt":0.3310155380438172,"score_spread":0.30017843233959574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097066287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989291,0.006715167,0.000024968675,0.0018858095,0.00013420002,0.00076352723,0.0009633574,0.000056607514,0.0001653554],"genre_scores_gemma":[0.9743198,0.023203734,0.00011936818,0.0001293544,0.0007203699,0.00033985244,0.00007140766,0.00003317306,0.0010629433],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981353,0.00010535635,0.00022390299,0.0005135647,0.0005178707,0.00050396967],"domain_scores_gemma":[0.9989783,0.000060166956,0.00006138131,0.00021683745,0.00025412062,0.00042919742],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007535085,0.0002506179,0.00033777856,0.00017127178,0.00049783423,0.000057707628,0.000035024095,0.00010732109,0.0003857515],"category_scores_gemma":[0.0000033727952,0.00018837108,0.00006631149,0.00025359323,0.00041554333,0.0001575696,0.000040048846,0.00015174008,0.000010387991],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011473902,0.0013852696,0.013003924,0.0001835602,0.0007441184,0.0015852612,0.001229934,0.0000071758927,0.8789818,0.0002306195,0.0006721996,0.09050218],"study_design_scores_gemma":[0.009990189,0.0011471641,0.46672803,0.00042325398,0.00018765022,0.0016755573,0.00017358096,0.00018177083,0.51802605,0.00024437843,0.00086806976,0.00035433285],"about_ca_topic_score_codex":0.0051043886,"about_ca_topic_score_gemma":0.00051317044,"teacher_disagreement_score":0.45372412,"about_ca_system_score_codex":0.00035048614,"about_ca_system_score_gemma":0.00047887056,"threshold_uncertainty_score":0.7716342},"labels":[],"label_agreement":null},{"id":"W2097409839","doi":"10.1007/s10549-011-1511-5","title":"Topoisomerase II alpha protein and responsiveness of breast cancer to adjuvant chemotherapy with CEF compared to CMF in the NCIC CTG randomized MA.5 adjuvant trial","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; University of Calgary; University of British Columbia; McMaster University; BC Cancer Agency; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Topoisomerase; Breast cancer; Medicine; Anthracycline; Internal medicine; Chemotherapy; Adjuvant; Oncology; Immunohistochemistry; Cancer; Tissue microarray; Randomized controlled trial; Endocrinology; Biology; Enzyme","score_opus":0.04826573960736869,"score_gpt":0.3435125010807395,"score_spread":0.2952467614733708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097409839","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902031,0.0022132646,0.000052905354,0.0030331477,0.000044327182,0.003944991,0.0004406774,0.00000479846,0.00006281668],"genre_scores_gemma":[0.99351275,0.0017152984,0.00015543727,0.00028552572,0.00013147289,0.0037989954,0.000016646409,0.000028767676,0.00035513623],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.998146,0.00029846324,0.00026128074,0.00050759566,0.00033128652,0.00045537515],"domain_scores_gemma":[0.9990666,0.000035695324,0.000069859794,0.00037820172,0.00021723444,0.0002323948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006200653,0.0002502374,0.00051372394,0.00014112183,0.00015032587,0.000031187017,0.00018864844,0.0000728308,0.00007459274],"category_scores_gemma":[0.0000073290194,0.00014757743,0.0000680271,0.0002557427,0.00019360411,0.0000073878796,0.000098628036,0.00009322325,7.937129e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8229376,0.0007420634,0.0004002949,0.000028599485,0.00033253815,0.00002217288,0.0023398395,0.0000061572027,0.11667224,0.0001672905,0.000054280354,0.056296933],"study_design_scores_gemma":[0.6039192,0.0129258465,0.0368736,0.0005354708,0.00015886872,0.00016742863,0.0016408659,0.00003492553,0.33591244,0.0004086829,0.006718119,0.0007045346],"about_ca_topic_score_codex":0.011341856,"about_ca_topic_score_gemma":0.0059146485,"teacher_disagreement_score":0.2192402,"about_ca_system_score_codex":0.0001145363,"about_ca_system_score_gemma":0.00039323056,"threshold_uncertainty_score":0.9952417},"labels":[],"label_agreement":null},{"id":"W2098050195","doi":"10.1007/s10549-014-3235-9","title":"Thyroid hormone receptor α in breast cancer: prognostic and therapeutic implications","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Thyroid Disorders and Treatments","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Women's College Hospital; Toronto Public Health; Juravinski Cancer Centre; Canada Research Chairs; Public Health Ontario; University of Toronto","funders":"Hamilton Health Sciences","keywords":"Breast cancer; Medicine; Hormone receptor; Thyroid; Oncology; Hormone; Internal medicine; Cancer; Endocrinology","score_opus":0.03680280726859021,"score_gpt":0.3528988021443068,"score_spread":0.3160959948757166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098050195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95373255,0.019717151,0.0000037618292,0.024433011,0.000022692462,0.001147135,0.00041088645,0.00003594955,0.0004968846],"genre_scores_gemma":[0.9778749,0.019611228,0.0000413213,0.00011189784,0.00010955128,0.0016933372,0.000042055533,0.000030041676,0.00048571228],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99846274,0.000084594605,0.00017906085,0.0004825618,0.00025253455,0.00053850247],"domain_scores_gemma":[0.99909323,0.00010345584,0.0000359887,0.00027870966,0.00013653068,0.0003520774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013836088,0.00021779038,0.00031086276,0.00019466165,0.00020934509,0.000052282096,0.000056938872,0.00007000444,0.00009090737],"category_scores_gemma":[0.000006699188,0.00015187565,0.000039398245,0.00033013258,0.00021357615,0.00006001852,0.000046644185,0.00014636344,0.000018853914],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010047813,0.0011906613,0.67514825,0.000027618082,0.0002193261,0.000009779434,0.00022040294,9.681028e-7,0.0020245737,0.00054434093,0.00033486725,0.31927443],"study_design_scores_gemma":[0.0062496113,0.0011007208,0.98969764,0.00009306495,0.000085122534,0.0001715605,0.000116460775,0.000051675324,0.00008257803,0.0006398273,0.0015832599,0.00012850543],"about_ca_topic_score_codex":0.007958053,"about_ca_topic_score_gemma":0.0013192302,"teacher_disagreement_score":0.31914592,"about_ca_system_score_codex":0.00041721528,"about_ca_system_score_gemma":0.00022924133,"threshold_uncertainty_score":0.99864805},"labels":[],"label_agreement":null},{"id":"W2098968548","doi":"10.1007/s10549-006-9396-4","title":"Nuclear morphometric features in benign breast tissue and risk of subsequent breast cancer","year":2006,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Morphological variations and asymmetry","field":"Mathematics","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Breast cancer; Quartile; Odds ratio; Medicine; Risk factor; Breast disease; Confidence interval; Oncology; Case-control study; Cancer; Internal medicine","score_opus":0.04479521697167549,"score_gpt":0.3490025195667125,"score_spread":0.30420730259503703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098968548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914328,0.0032086058,0.000015605592,0.0012811963,0.000030979347,0.0005572174,0.0028450675,0.000025627936,0.00060290884],"genre_scores_gemma":[0.9933541,0.0050693005,0.0005767893,0.000007939553,0.00013943804,0.00018638752,0.000015985945,0.000029205965,0.00062088686],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99806654,0.00018516277,0.0003154381,0.0004580662,0.00045410148,0.0005206945],"domain_scores_gemma":[0.99895227,0.00028083634,0.000118153046,0.00027552486,0.00018518223,0.00018804967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039448362,0.00023383652,0.00041162642,0.00048617634,0.00019379854,0.00007472346,0.0001224658,0.00012246522,0.00060356857],"category_scores_gemma":[0.00001983257,0.00016310018,0.00005336025,0.0009359503,0.0002240262,0.00009557947,0.000103438535,0.00023781531,0.0000048493953],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010008711,0.0036571214,0.72876334,0.00023175783,0.000473306,0.00020574356,0.0002781994,0.000045679484,0.0020028662,0.03761617,0.0046786284,0.22104633],"study_design_scores_gemma":[0.0018297138,0.00022670541,0.99135315,0.00010710137,0.000055702512,0.00029043478,0.00012516609,0.000049119357,0.00038017295,0.004985537,0.00042594472,0.00017125867],"about_ca_topic_score_codex":0.08705835,"about_ca_topic_score_gemma":0.006085285,"teacher_disagreement_score":0.2625898,"about_ca_system_score_codex":0.0004036367,"about_ca_system_score_gemma":0.00010052467,"threshold_uncertainty_score":0.919021},"labels":[],"label_agreement":null},{"id":"W2102299301","doi":"10.1023/b:brea.0000036783.88387.47","title":"HER-2/neu as a Predictive Marker in a Population of Advanced Breast Cancer Patients Randomly Treated Either with Single-agent Doxorubicin or Single-agent Docetaxel","year":2004,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":138,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Sacré-Cœur de Montréal","funders":"Amis de l'Institut Bordet","keywords":"Docetaxel; Medicine; Internal medicine; Breast cancer; Oncology; Doxorubicin; Population; Odds ratio; Cancer; Cohort; Chemotherapy","score_opus":0.049143343182379784,"score_gpt":0.3644664732989722,"score_spread":0.3153231301165924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102299301","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897237,0.0014478129,0.0000057860398,0.002652736,0.00007106007,0.0043671955,0.0010052497,0.000054906814,0.00067154586],"genre_scores_gemma":[0.99360114,0.0018002155,0.0000888497,0.000069247486,0.0001368745,0.0024975212,0.00012128659,0.00011210965,0.0015727264],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99506253,0.0002562019,0.0006504389,0.0010197763,0.0017967166,0.001214312],"domain_scores_gemma":[0.99750733,0.00014965086,0.00019368439,0.00054270943,0.0009276834,0.00067895843],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00040390927,0.00053258403,0.00092583295,0.00066245615,0.0001866476,0.000069600384,0.00016885894,0.00017495094,0.00076821446],"category_scores_gemma":[0.000051039933,0.00033909787,0.0001213649,0.0013340748,0.0004335856,0.00024860172,0.00010535852,0.0004105605,0.000014792544],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13717486,0.009372644,0.6993963,0.0003833756,0.0009291383,0.00052094174,0.0013518359,0.0004658784,0.0045482954,0.000016830669,0.00008850069,0.14575137],"study_design_scores_gemma":[0.054889232,0.013476274,0.919961,0.003153642,0.0001881227,0.00026194705,0.00040658255,0.00005810584,0.0067802803,0.00006389258,0.00040149203,0.0003594475],"about_ca_topic_score_codex":0.0667501,"about_ca_topic_score_gemma":0.019265411,"teacher_disagreement_score":0.22056465,"about_ca_system_score_codex":0.006329662,"about_ca_system_score_gemma":0.0013168551,"threshold_uncertainty_score":0.9999061},"labels":[],"label_agreement":null},{"id":"W2104730114","doi":"10.1023/a:1006380306781","title":"The diagnostic and prognostic utility of prostate-specific antigen for diseases of the breast","year":2000,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Urologic and reproductive health conditions","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Medicine; Breast cancer; Prostate-specific antigen; Prostate cancer; Prostate; Oncology; Disease; Breast disease; Internal medicine; Cancer; Gynecology","score_opus":0.12464749783058238,"score_gpt":0.4302585597617317,"score_spread":0.30561106193114934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104730114","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0039055592,0.9812118,3.8834503e-7,0.0014085821,0.000053976408,0.0067877765,0.0065635093,0.000007846927,0.000060571674],"genre_scores_gemma":[0.03912032,0.95738024,0.0000049890004,0.000004399758,0.0001555535,0.0028826857,0.00009106812,0.000020445228,0.0003403005],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981535,0.0002584999,0.000392949,0.00046895683,0.000322812,0.0004032948],"domain_scores_gemma":[0.9970572,0.001758982,0.0001499709,0.0005037296,0.00033343714,0.00019667961],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029617784,0.00023010383,0.00080509065,0.000079713405,0.00046194033,0.000018003035,0.0001057059,0.000087058215,0.000052493877],"category_scores_gemma":[0.0001339256,0.00009365711,0.00019540267,0.0002776235,0.0013778809,0.000021601885,0.000067089466,0.00018935978,0.0000012337703],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061822275,0.000647651,0.024655249,0.005320842,0.00036096285,0.0000060102398,0.000057538247,3.8820243e-8,1.5904531e-7,0.0000917842,0.00046671712,0.9677748],"study_design_scores_gemma":[0.0010445948,0.0011895691,0.4281096,0.0052879234,0.0008625443,0.00032731213,0.000058523765,0.0000013999565,0.0000021361802,0.00035203807,0.56266254,0.00010183032],"about_ca_topic_score_codex":0.00037071633,"about_ca_topic_score_gemma":0.0000492717,"teacher_disagreement_score":0.967673,"about_ca_system_score_codex":0.000109190325,"about_ca_system_score_gemma":0.0012312826,"threshold_uncertainty_score":0.50768596},"labels":[],"label_agreement":null},{"id":"W2105613608","doi":"10.1007/s10549-006-9161-8","title":"Diet, lifestyle and BRCA-related breast cancer risk among French-Canadians","year":2006,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":123,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; University of Toronto; Women's College Hospital; Centre Hospitalier de l’Université de Montréal; Hôtel-Dieu de Montréal","funders":"National Cancer Institute","keywords":"Medicine; Breast cancer; Odds ratio; Body mass index; Confidence interval; Demography; Cohort; Logistic regression; Cancer; Family history; Internal medicine; Lower risk; Gerontology","score_opus":0.018299713241905064,"score_gpt":0.31514005445934523,"score_spread":0.2968403412174402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105613608","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98179644,0.008958553,0.0000013673019,0.003987503,0.00010074907,0.0007455571,0.0027494878,0.000053613567,0.0016067001],"genre_scores_gemma":[0.98090994,0.012864225,0.000012267264,0.000042016858,0.00046579886,0.0004295044,0.0000623329,0.000046395304,0.0051675085],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977555,0.00007879627,0.00026618852,0.000615138,0.0004631401,0.0008212389],"domain_scores_gemma":[0.99859667,0.000073840696,0.00007546411,0.0003134326,0.00020152077,0.0007390559],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017085343,0.00030229357,0.00041886469,0.0002511451,0.00042323422,0.00009741835,0.00006787656,0.00013833393,0.0008334899],"category_scores_gemma":[0.000005638508,0.0002220425,0.000086375134,0.00039580427,0.0005388742,0.00012184079,0.00005449248,0.00034597656,0.000014249613],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005388357,0.00031068103,0.8987019,0.000036809735,0.0003312504,0.00015438121,0.0002566836,0.000011301706,0.00005910588,0.000057606558,0.0031649559,0.09637647],"study_design_scores_gemma":[0.0038510296,0.00060862896,0.98884994,0.00020060962,0.0001814821,0.00020896079,0.0001282594,0.000115365336,0.00007464566,0.00016853648,0.0054017045,0.0002108251],"about_ca_topic_score_codex":0.83206326,"about_ca_topic_score_gemma":0.3238978,"teacher_disagreement_score":0.5081655,"about_ca_system_score_codex":0.0010214831,"about_ca_system_score_gemma":0.0005953243,"threshold_uncertainty_score":0.912613},"labels":[],"label_agreement":null},{"id":"W2105982533","doi":"10.1007/s10549-009-0372-7","title":"NIP1/DUOXA1 expression in epithelial breast cancer cells: regulation of cell adhesion and actin dynamics","year":2009,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"S100 Proteins and Annexins","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research; Canada Research Chairs; Ontario Genomics Institute; Genome Canada","keywords":"Breast cancer; Dynamics (music); Cell adhesion; Epithelium; Cell biology; Cancer research; Adhesion; Biology; Cell; Cancer; Medicine; Internal medicine; Chemistry; Pathology; Genetics","score_opus":0.018021987757504004,"score_gpt":0.31374011776798444,"score_spread":0.2957181300104804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105982533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968009,0.0016324788,0.000014585196,0.00063269655,0.000024886784,0.0003184017,0.000414201,0.0000041286,0.00015772709],"genre_scores_gemma":[0.99379456,0.0053540613,0.000104058476,0.000014666142,0.00012941434,0.00007308611,0.000047502715,0.0000116733645,0.00047095958],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989901,0.00007071367,0.00014656327,0.00034288436,0.00017555527,0.00027415532],"domain_scores_gemma":[0.9995538,0.000010446311,0.00005288712,0.00017543393,0.00009439747,0.00011301815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011586604,0.00013724549,0.0001477888,0.00008680069,0.00008912512,0.000022164955,0.00006107063,0.00010649935,0.000038959886],"category_scores_gemma":[0.0000023006787,0.00010540384,0.000031900938,0.0001045861,0.00008485814,0.000010212378,0.00005157764,0.00007498624,7.1287343e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010423795,0.0003095644,0.0065393406,0.000023210287,0.000011231009,0.000003845059,0.000059347243,0.000019658513,0.8856675,0.000016324326,0.00006205717,0.10624553],"study_design_scores_gemma":[0.0015205977,0.00065083976,0.19481163,0.00011736982,0.0000071180175,0.0000144164715,0.00010059569,0.00018540805,0.80210793,0.000099339224,0.000275404,0.00010936824],"about_ca_topic_score_codex":0.001982575,"about_ca_topic_score_gemma":0.0011865349,"teacher_disagreement_score":0.1882723,"about_ca_system_score_codex":0.000113287,"about_ca_system_score_gemma":0.00010230663,"threshold_uncertainty_score":0.42982438},"labels":[],"label_agreement":null},{"id":"W2107315098","doi":"10.1007/s10549-010-1269-1","title":"Variation in genes coding for AMP-activated protein kinase (AMPK) and breast cancer risk in the European Prospective Investigation on Cancer (EPIC)","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"AMPK; European Prospective Investigation into Cancer and Nutrition; Single-nucleotide polymorphism; Breast cancer; Protein kinase A; Genome-wide association study; Biology; AMP-activated protein kinase; Bioinformatics; Medicine; Prospective cohort study; Endocrinology; Internal medicine; Cancer; Gene; Cancer research; Genetics; Kinase; Genotype","score_opus":0.03844368521690159,"score_gpt":0.32411872676188347,"score_spread":0.28567504154498186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107315098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98582727,0.011156311,0.000006995747,0.0005720753,0.00006924582,0.001496112,0.0007891068,0.000006076967,0.000076801574],"genre_scores_gemma":[0.9732041,0.022668974,0.000046630154,0.000059340015,0.00047111878,0.003394379,0.000050756888,0.000025304262,0.000079431695],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9984738,0.00031556486,0.000162528,0.0004884861,0.00019356952,0.00036599903],"domain_scores_gemma":[0.99941087,0.000035923073,0.000077581106,0.00021230949,0.00015837738,0.0001049205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006167299,0.00018305896,0.00016052596,0.00010442754,0.00019388598,0.00007734,0.00009761944,0.000080559534,0.000026805108],"category_scores_gemma":[0.000029258203,0.00012680005,0.000029013143,0.00020620784,0.00015207386,0.000017329381,0.00003761612,0.00020020168,8.116949e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013698094,0.00029685104,0.15620565,0.000059362526,0.000120492856,0.0000040925984,0.0011590625,0.000047081856,0.35489687,0.00031576815,0.000073665906,0.48545128],"study_design_scores_gemma":[0.0032809728,0.00028626743,0.91965693,0.00011632287,0.000026564909,0.00000599484,0.000106307714,0.000053615924,0.07005367,0.00049132254,0.005719713,0.00020231452],"about_ca_topic_score_codex":0.015859542,"about_ca_topic_score_gemma":0.03417727,"teacher_disagreement_score":0.7634513,"about_ca_system_score_codex":0.00015396276,"about_ca_system_score_gemma":0.00023159072,"threshold_uncertainty_score":0.9906939},"labels":[],"label_agreement":null},{"id":"W2107723446","doi":"10.1007/s10549-012-2076-7","title":"Expression of activated type I receptor tyrosine kinases in early breast cancer","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"AstraZeneca","keywords":"Breast cancer; Medicine; Tissue microarray; Immunohistochemistry; Internal medicine; Oncology; Cancer; Cohort; Receptor","score_opus":0.09947066223487866,"score_gpt":0.42730410465319474,"score_spread":0.3278334424183161,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107723446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879607,0.007193711,4.05439e-7,0.00273391,0.00013346337,0.0009371338,0.00056283653,0.000027822034,0.0004500509],"genre_scores_gemma":[0.9891377,0.00832388,0.000065651744,0.000023849449,0.00045065585,0.0006189058,0.000033378597,0.000049737617,0.0012962293],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99718374,0.00019636513,0.0002924763,0.0004152286,0.0009001286,0.0010120373],"domain_scores_gemma":[0.99825245,0.00013385626,0.00006270313,0.0004001138,0.00052258524,0.00062827975],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000427613,0.0002386408,0.000456737,0.0004099414,0.00011163259,0.00002887074,0.00012060174,0.00013273531,0.0019799678],"category_scores_gemma":[0.000034700624,0.00016965263,0.00005641518,0.0009485614,0.00031438016,0.00020924886,0.00012325657,0.00035725202,0.000037901376],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066429623,0.0016514256,0.68817383,0.00020599744,0.00010918534,0.00002830651,0.0006574725,0.0000018616715,0.2238373,0.000033509827,0.0017840397,0.0768741],"study_design_scores_gemma":[0.00331183,0.0009367399,0.7763776,0.0012124226,0.000024590554,0.000072881405,0.00018520842,0.00000465021,0.21465686,0.0000118153275,0.003059983,0.00014537203],"about_ca_topic_score_codex":0.035118803,"about_ca_topic_score_gemma":0.0006759597,"teacher_disagreement_score":0.0882038,"about_ca_system_score_codex":0.0014317585,"about_ca_system_score_gemma":0.0008121266,"threshold_uncertainty_score":0.99893236},"labels":[],"label_agreement":null},{"id":"W2109875937","doi":"10.1023/a:1015261111605","title":"The Role of Dietary Long-Chain N-3 Fatty Acids in Anti-Cancer Immune Defense and R3230AC Mammary Tumor Growth in Rats: Influence of Diet Fat Composition","year":2002,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Fatty Acid Research and Health","field":"Nursing","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Polyunsaturated fatty acid; Biology; Endocrinology; Population; Immune system; Fatty acid; Internal medicine; Mammary tumor; Phosphatidylcholine; Food science; Phospholipid; Biochemistry; Cancer; Immunology; Breast cancer; Medicine","score_opus":0.028876246275501217,"score_gpt":0.3226141468359388,"score_spread":0.2937379005604376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109875937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9644639,0.030707654,0.0000011460043,0.003726413,0.000023556326,0.0007921909,0.00020305213,0.000009316813,0.00007276698],"genre_scores_gemma":[0.9688393,0.030728558,0.000046809044,0.00002526527,0.000032048938,0.00028557974,0.000011569456,0.000016646729,0.000014258862],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975877,0.00040769472,0.00040366917,0.00036325306,0.00050772884,0.00072995265],"domain_scores_gemma":[0.998955,0.00028336543,0.00008921885,0.00026999664,0.00019877093,0.00020361252],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004981983,0.00018999403,0.00038314154,0.00030120756,0.00024783277,0.0000480212,0.00017767186,0.00006457771,0.00001965422],"category_scores_gemma":[0.00002441599,0.0001333627,0.000046452627,0.00052040356,0.00059295126,0.00023438242,0.00012846214,0.00033235946,0.0000018680795],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067259204,0.0011370177,0.8677463,0.00034583246,0.0000855496,0.00008367476,0.0013100489,0.00008171063,0.057686344,0.00019576555,0.000024576295,0.06457726],"study_design_scores_gemma":[0.0024858897,0.001460947,0.93517053,0.0005144256,0.000008243536,0.000021768663,0.0003242972,0.00081089494,0.05851896,0.0005479723,0.000018984538,0.000117079944],"about_ca_topic_score_codex":0.027195895,"about_ca_topic_score_gemma":0.0057325973,"teacher_disagreement_score":0.06742424,"about_ca_system_score_codex":0.0004462675,"about_ca_system_score_gemma":0.000085399945,"threshold_uncertainty_score":0.9792821},"labels":[],"label_agreement":null},{"id":"W2112343680","doi":"10.1023/a:1006304518750","title":"Differential steroid hormone regulation of human glandular kallikrein (hK2) and prostate-specific antigen (PSA) in breast cancer cell lines","year":2000,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":61,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Kallikrein; Breast cancer; Prostate; Antigen; Cancer; Hormone; Prostate-specific antigen; Mammary gland; Steroid; Steroid hormone; Medicine; Cancer research; Internal medicine; Human breast; Oncology; Biology; Endocrinology; Immunology","score_opus":0.01630859523654967,"score_gpt":0.2966485263118235,"score_spread":0.28033993107527383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112343680","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98181355,0.017001228,8.294789e-7,0.0002598901,0.000018244971,0.00048272798,0.00029019677,0.000006184426,0.00012712498],"genre_scores_gemma":[0.94678324,0.051972713,0.000008983911,0.0000034372415,0.00015064307,0.00013207148,0.000166071,0.00002183164,0.0007610025],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987323,0.00010056772,0.00019801331,0.00040741166,0.0002032409,0.0003584095],"domain_scores_gemma":[0.99952257,0.000008398985,0.0000435487,0.00019649269,0.00008348214,0.00014549063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008510484,0.00018913564,0.00021237475,0.000069214635,0.00012795452,0.00003679576,0.00006954734,0.00014201633,0.00018815568],"category_scores_gemma":[4.8667215e-7,0.00014381637,0.000041713593,0.00011019985,0.00017776541,0.000011881011,0.000047705893,0.000097380165,0.0000016456742],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022193338,0.00045163318,0.039300945,0.000034131597,0.00011385666,0.000010952584,0.000176829,0.000024675557,0.9169544,0.000009865275,0.00016749394,0.040535863],"study_design_scores_gemma":[0.0045686094,0.0014722374,0.7614539,0.00009356577,0.00002327293,0.000042026277,0.000057234916,0.00005248387,0.23119676,0.000034763925,0.0007994523,0.00020569142],"about_ca_topic_score_codex":0.004991801,"about_ca_topic_score_gemma":0.0006498491,"teacher_disagreement_score":0.72215295,"about_ca_system_score_codex":0.00008130225,"about_ca_system_score_gemma":0.000071118986,"threshold_uncertainty_score":0.7546143},"labels":[],"label_agreement":null},{"id":"W2112886099","doi":"10.1007/s10549-010-0921-0","title":"Insulin like growth factor binding protein-7 reduces growth of human breast cancer cells and xenografted tumors","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research; Canadian Breast Cancer Research Alliance; Breast Cancer Alliance","keywords":"Cancer research; Breast cancer; Insulin-like growth factor-binding protein; Growth factor; Cancer; Biology; Triple-negative breast cancer; Insulin-like growth factor 2; Immunohistochemistry; Medicine; Internal medicine; Insulin-like growth factor; Receptor","score_opus":0.03724598397401263,"score_gpt":0.3295307949135737,"score_spread":0.29228481093956105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112886099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936598,0.000890438,3.4165282e-7,0.0019347762,0.00011548998,0.0015253746,0.0015202819,0.000064317384,0.0002892065],"genre_scores_gemma":[0.99645185,0.0018111315,0.000090306894,0.00003173248,0.0003261634,0.00058447284,0.00005235608,0.00007044739,0.0005815365],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99692965,0.000108659704,0.0004981374,0.00076635333,0.00078686484,0.0009103456],"domain_scores_gemma":[0.99784845,0.000079119265,0.00016347549,0.00035345287,0.00070515566,0.00085032394],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026785888,0.0004582376,0.0007048533,0.0006331697,0.00042494023,0.000093316405,0.00017104596,0.00021180497,0.000336575],"category_scores_gemma":[0.000021443302,0.00033332972,0.00011850606,0.0007096268,0.0007259303,0.0002531811,0.00014306908,0.000638665,0.0000106073],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015405958,0.0010789904,0.17391482,0.00034025332,0.00044904754,0.00009681641,0.0008227527,3.252075e-8,0.804199,0.00031636914,0.00027028838,0.016971042],"study_design_scores_gemma":[0.004606635,0.0017427192,0.5585987,0.00046961723,0.00010996894,0.00019711646,0.0002884687,0.000007153185,0.43336117,0.00012463254,0.00015073645,0.000343072],"about_ca_topic_score_codex":0.017702408,"about_ca_topic_score_gemma":0.0007292965,"teacher_disagreement_score":0.38468388,"about_ca_system_score_codex":0.00029901552,"about_ca_system_score_gemma":0.0005623811,"threshold_uncertainty_score":0.99991184},"labels":[],"label_agreement":null},{"id":"W2114153887","doi":"10.1007/s10549-010-1336-7","title":"Risk of ipsilateral breast cancer in BRCA1 and BRCA2 mutation carriers","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":78,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; Sunnybrook Health Science Centre; McGill University; Centre Hospitalier de l’Université de Montréal; BC Cancer Agency; University Health Network; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Breast cancer; Medicine; Oophorectomy; Oncology; Internal medicine; Cancer; Mastectomy; Radiation therapy; BRCA mutation; Chemotherapy; Gynecology; Surgery; Hysterectomy","score_opus":0.03170857351183815,"score_gpt":0.3349142384364258,"score_spread":0.30320566492458767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114153887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939474,0.0039184173,0.000008652319,0.0002779005,0.00007042365,0.00031393272,0.001224351,0.000004476148,0.0002344496],"genre_scores_gemma":[0.9919615,0.0072211367,0.0001223284,0.000014198361,0.00010945212,0.00034163296,0.000027223912,0.000019027762,0.00018351828],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99884975,0.00010437376,0.00017124639,0.00039347835,0.00016899817,0.00031213905],"domain_scores_gemma":[0.9994128,0.000013389168,0.000060061226,0.00020739662,0.00017403669,0.00013235067],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017771263,0.0001431804,0.0001539259,0.00012394175,0.00009374749,0.000017489172,0.00007626741,0.000089906454,0.00012738723],"category_scores_gemma":[0.000006709392,0.00012035673,0.000032586337,0.00016421569,0.00028728816,0.000010771314,0.00006588111,0.000089277404,0.0000010810277],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017393759,0.00027450558,0.7620995,0.000047874575,0.0004994382,0.000024859653,0.00228549,0.00008988966,0.012888013,0.00006132165,0.0002020404,0.21978769],"study_design_scores_gemma":[0.0020319477,0.00041106355,0.96813285,0.000046596895,0.000037584305,0.000104281266,0.00042657193,0.00006380621,0.028012242,0.00024247721,0.0003451531,0.00014542117],"about_ca_topic_score_codex":0.02124841,"about_ca_topic_score_gemma":0.009324409,"teacher_disagreement_score":0.21964227,"about_ca_system_score_codex":0.000264272,"about_ca_system_score_gemma":0.00036776072,"threshold_uncertainty_score":0.9852692},"labels":[],"label_agreement":null},{"id":"W2116214608","doi":"10.1007/s10549-005-0320-0","title":"The benefit of participating to clinical research","year":2005,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Charles-Le Moyne; Université de Sherbrooke; Hôpital du Saint-Sacrement; Institut National de Santé Publique du Québec","funders":"Health Canada","keywords":"Hazard ratio; Medicine; Confidence interval; Breast cancer; Clinical trial; Internal medicine; Oncology; Cancer; Gynecology","score_opus":0.8161875323808384,"score_gpt":0.7275529777051931,"score_spread":0.0886345546756453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116214608","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90172386,0.0017555581,0.0000023789123,0.09208176,0.000050896226,0.0010349915,0.000049090402,0.00001474983,0.0032866914],"genre_scores_gemma":[0.97843224,0.010824928,0.00040916668,0.000113278256,0.00082136894,0.0009636398,0.0000022334343,0.00002420343,0.008408919],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99482524,0.0004831443,0.0006462621,0.00054693327,0.002411793,0.0010865971],"domain_scores_gemma":[0.9788118,0.017153503,0.000043393524,0.0007670226,0.0022994527,0.00092480466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015553865,0.000120933415,0.00034161302,0.00018614024,0.0006429473,0.0000768539,0.00026901747,0.00017719391,0.00022061702],"category_scores_gemma":[0.0043520126,0.00006858273,0.00010006066,0.00067670376,0.0014148958,0.000044244865,0.0004046073,0.001578816,0.00012149333],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033431796,0.0012533808,0.18976107,0.000061877916,0.00023343606,0.000029938745,0.00042385247,0.0000070822307,0.00021098199,0.013325149,0.0010648096,0.7902852],"study_design_scores_gemma":[0.005073713,0.010824939,0.8824329,0.0009584542,0.000050294526,0.000053373235,0.0011742302,0.00032578956,0.004757514,0.01467519,0.07948739,0.00018622473],"about_ca_topic_score_codex":0.0030685738,"about_ca_topic_score_gemma":0.010964382,"teacher_disagreement_score":0.790099,"about_ca_system_score_codex":0.00049927406,"about_ca_system_score_gemma":0.0011993566,"threshold_uncertainty_score":0.6859257},"labels":[],"label_agreement":null},{"id":"W2116267931","doi":"10.1023/a:1022931403825","title":"The Prognostic Value of the Human Kallikrein Gene 9 (KLK9) in Breast Cancer","year":2003,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Kallikrein; Breast cancer; Gene; Internal medicine; Oncology; Value (mathematics); Cancer; Mammary gland; Medicine; Biology; Cancer research; Genetics; Enzyme; Biochemistry; Mathematics","score_opus":0.04765376970994101,"score_gpt":0.363989513318913,"score_spread":0.316335743608972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116267931","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98111165,0.010373146,6.760122e-7,0.006702525,0.000078067365,0.0009777119,0.00013394431,0.00001216262,0.0006101197],"genre_scores_gemma":[0.9940122,0.0031061817,0.000011001879,0.0000506242,0.00013593622,0.00046995663,0.0000073411074,0.000022307277,0.0021844995],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99824584,0.00018082974,0.00025876448,0.00029968112,0.00050499314,0.0005099164],"domain_scores_gemma":[0.9990578,0.00015623837,0.000063987856,0.0003552567,0.00019525911,0.00017139927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036446739,0.00017070356,0.00024767703,0.000085148866,0.0004091466,0.000038115104,0.000113956376,0.000057015917,0.00015910417],"category_scores_gemma":[0.000023110408,0.0000877926,0.00008654345,0.00041153826,0.00037597245,0.000045692304,0.000045132692,0.00015127701,0.0000033479328],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002875474,0.00048285158,0.9557623,0.000042777254,0.00018389118,0.00002039902,0.00036752256,0.000019838712,0.0011721534,0.0040565925,0.00023831274,0.037365776],"study_design_scores_gemma":[0.0023860198,0.00019073671,0.9907547,0.00026594312,0.000060479964,0.00013185316,0.00014028548,0.00006021314,0.0034811595,0.00063647074,0.0018062993,0.0000857935],"about_ca_topic_score_codex":0.015360102,"about_ca_topic_score_gemma":0.0045540053,"teacher_disagreement_score":0.037279982,"about_ca_system_score_codex":0.00041425417,"about_ca_system_score_gemma":0.00063086394,"threshold_uncertainty_score":0.9911967},"labels":[],"label_agreement":null},{"id":"W2120324973","doi":"10.1023/b:brea.0000003969.21267.81","title":"Potent Killing of Paclitaxel- and Doxorubicin-resistant Breast Cancer Cells by Calphostin C Accompanied by Cytoplasmic Vacuolization","year":2003,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Laurentian University; Northeast Cancer Centre","funders":"Canadian Institutes of Health Research; Cancer Care Ontario","keywords":"Calphostin C; Paclitaxel; Doxorubicin; Vacuolization; Cancer cell; Cancer research; Cell culture; Biology; Pharmacology; Chemistry; Cell biology; Cancer; Endocrinology; Chemotherapy; Protein kinase C; Signal transduction","score_opus":0.024381472443263826,"score_gpt":0.31186049900210017,"score_spread":0.28747902655883634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120324973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97815573,0.016034387,0.00012113246,0.0017339052,0.00009457598,0.00092519564,0.002617812,0.000030285853,0.00028695515],"genre_scores_gemma":[0.9784507,0.019490609,0.000110874804,0.00004728001,0.00005031264,0.00018644547,0.00009570648,0.000042046096,0.0015259926],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977792,0.00008688332,0.00035206435,0.0005464712,0.00059935317,0.000636014],"domain_scores_gemma":[0.9988605,0.00006259306,0.000092711314,0.00025125194,0.0002759283,0.0004570125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025591833,0.00029645892,0.0005133238,0.00015153478,0.00023234186,0.00003907961,0.00006538134,0.000111741676,0.00022759433],"category_scores_gemma":[0.0000036991646,0.00021167375,0.00007109885,0.0003191828,0.00022580873,0.00007602927,0.000018855088,0.00017273423,0.0000029722257],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006029119,0.0023300408,0.051083382,0.0006947452,0.00083663594,0.00014180884,0.00087737606,0.000023799892,0.88070834,0.0008089319,0.0034003411,0.053065464],"study_design_scores_gemma":[0.016766153,0.0018822261,0.10715887,0.0017162305,0.00064294145,0.00028973963,0.0019290285,0.00021012887,0.85483676,0.00037749272,0.013410399,0.0007800433],"about_ca_topic_score_codex":0.0060632257,"about_ca_topic_score_gemma":0.00072895817,"teacher_disagreement_score":0.05607549,"about_ca_system_score_codex":0.00045035183,"about_ca_system_score_gemma":0.00033113512,"threshold_uncertainty_score":0.91658235},"labels":[],"label_agreement":null},{"id":"W2120386009","doi":"10.1007/s10549-015-3342-2","title":"Overall survival (OS) endpoint: an incomplete evaluation of metastatic breast cancer (MBC) treatment outcome","year":2015,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Internal medicine; Metastatic breast cancer; Clinical trial; Oncology; Progression-free survival; Breast cancer; Chemotherapy; Clinical endpoint; Cancer; Randomized controlled trial","score_opus":0.5563596854227307,"score_gpt":0.5889062232591702,"score_spread":0.03254653783643946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120386009","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007655107,0.9712751,7.6932173e-7,0.00078212534,0.00041943425,0.006072688,0.013036819,0.000053168333,0.00070479873],"genre_scores_gemma":[0.008573545,0.97968125,0.000051511746,0.000023134386,0.00085809093,0.0071260235,0.0016991739,0.00014267417,0.0018446144],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99302006,0.0015423098,0.0010958997,0.00125382,0.0020148337,0.0010730925],"domain_scores_gemma":[0.99590707,0.00029377034,0.0004712824,0.00086816435,0.0013786,0.0010811232],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015549026,0.0010529541,0.003764723,0.0007639128,0.00022298326,0.00007204782,0.00022716199,0.00025410697,0.003173001],"category_scores_gemma":[0.000013346953,0.0006780957,0.0006042205,0.0006001817,0.00040365203,0.0001900833,0.00012748106,0.00039045565,0.000048834867],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0020039254,0.0042426726,0.002493601,0.0030213525,0.005751782,0.00015605491,0.00028093669,0.0000073933975,0.000006541751,0.00007639031,0.00033023482,0.98162913],"study_design_scores_gemma":[0.037826847,0.011458678,0.015748614,0.0058627343,0.03865169,0.0016767061,0.000206246,0.00020501022,0.00002778067,0.00032165743,0.8867623,0.0012517311],"about_ca_topic_score_codex":0.03184845,"about_ca_topic_score_gemma":0.0066665183,"teacher_disagreement_score":0.9803774,"about_ca_system_score_codex":0.011147164,"about_ca_system_score_gemma":0.0068868957,"threshold_uncertainty_score":0.99956703},"labels":[],"label_agreement":null},{"id":"W2120389505","doi":"10.1007/s10549-006-9378-6","title":"Prevalence of BRCA1 and BRCA2 mutations in breast cancer patients from Brazil","year":2006,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":88,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Coalition for Research in Women's Health; University of Toronto","funders":"","keywords":"Breast cancer; BRCA2 Protein; Cancer; Mutation; Medicine; Family history; Founder effect; Oncology; Incidence (geometry); Internal medicine; Genetic testing; Genetics; Gynecology; Genotype; Germline mutation; Biology; Gene; Haplotype","score_opus":0.017170806608212838,"score_gpt":0.33225531254116697,"score_spread":0.3150845059329541,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120389505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888443,0.005733733,0.0000054159314,0.0009788674,0.00004499452,0.0003508839,0.0038642213,0.000004461991,0.00017311847],"genre_scores_gemma":[0.9945105,0.0042508487,0.000093712384,0.000026074307,0.00014198359,0.0004333197,0.0001524908,0.000018098535,0.00037298756],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99875903,0.0000722401,0.00019914337,0.00044704336,0.00023183302,0.00029069645],"domain_scores_gemma":[0.9993794,0.000030926323,0.00005567391,0.00021109247,0.00023569941,0.00008720082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000081872604,0.0001434631,0.0001404742,0.00010049458,0.000096870535,0.000027675977,0.00009220093,0.000102546146,0.000111217174],"category_scores_gemma":[0.0000054588068,0.00012629047,0.000028337085,0.0001717031,0.00028327238,0.000011480217,0.00008222643,0.00008758405,0.00000162846],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003443056,0.0005022656,0.94598854,0.000050304632,0.0000990445,0.000003297667,0.00014244462,0.00010050652,0.013370003,0.000038936883,0.00053603353,0.038824324],"study_design_scores_gemma":[0.0019867655,0.00017632489,0.9839035,0.00007091473,0.00002390721,0.000008420128,0.000048576352,0.00003474478,0.012894268,0.0002606804,0.00047457393,0.0001173069],"about_ca_topic_score_codex":0.024647312,"about_ca_topic_score_gemma":0.006463834,"teacher_disagreement_score":0.038707018,"about_ca_system_score_codex":0.00028418415,"about_ca_system_score_gemma":0.00035130873,"threshold_uncertainty_score":0.98184764},"labels":[],"label_agreement":null},{"id":"W2120981144","doi":"10.1007/s10549-006-9359-9","title":"Evaluating the organization and delivery of breast cancer services: use of performance measures to identify knowledge gaps","year":2006,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Breast cancer; Medicine; Cancer; Oncology; Internal medicine","score_opus":0.39924198548159723,"score_gpt":0.5202326145872245,"score_spread":0.12099062910562725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120981144","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13223642,0.86529106,0.0000024970072,0.0001343886,0.00004963489,0.0014055881,0.0008215691,0.0000117847485,0.000047063673],"genre_scores_gemma":[0.0808233,0.918128,0.00004965533,0.000016449356,0.00023290355,0.00035661654,0.000077628756,0.000041898064,0.00027356],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99743193,0.00023635497,0.00054470415,0.00049946643,0.00085735606,0.00043016946],"domain_scores_gemma":[0.99726367,0.00020504162,0.00023353675,0.00040093184,0.0016771349,0.00021968172],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005891048,0.00034321702,0.0010521155,0.00028237482,0.00023905392,0.00007668691,0.00017019731,0.00013947864,0.00007244562],"category_scores_gemma":[0.00002232408,0.00020313117,0.00010881559,0.0010485852,0.0002068215,0.00017218139,0.00018690206,0.00022995508,0.000004970002],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034485204,0.00013957676,0.0143542,0.009956713,0.0004436456,0.000007574276,0.00030411195,0.000018111536,0.00005379585,0.00001251438,0.00011741785,0.9742475],"study_design_scores_gemma":[0.0055867326,0.004937275,0.39837974,0.20609511,0.00823655,0.002542369,0.0007632419,0.00035948755,0.00048283942,0.000018893828,0.37131906,0.0012787214],"about_ca_topic_score_codex":0.021177681,"about_ca_topic_score_gemma":0.002813361,"teacher_disagreement_score":0.97296876,"about_ca_system_score_codex":0.00073838816,"about_ca_system_score_gemma":0.0016076672,"threshold_uncertainty_score":0.98534036},"labels":[],"label_agreement":null},{"id":"W2123712628","doi":"10.1023/a:1014405730585","title":"Chemopreventive and adjuvant therapeutic potential of pomegranate (Punica granatum) for human breast cancer","year":2002,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Pomegranate: compositions and health benefits","field":"Nursing","cited_by":445,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Office of the Chief Scientist, Ministry of Health; Virginia Commonwealth University","keywords":"Punica; Polyphenol; Chemistry; Food science; Fermentation; Biochemistry; Traditional medicine; Antioxidant; Medicine","score_opus":0.07885890565532098,"score_gpt":0.3944234224275364,"score_spread":0.3155645167722154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123712628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9472326,0.03283733,0.000027153024,0.014792185,0.00018872881,0.0016689351,0.0029425155,0.0000416584,0.0002688769],"genre_scores_gemma":[0.99168,0.0070503647,0.00005764256,0.000079325015,0.00016367946,0.0005927844,0.0000271743,0.000037529906,0.0003114531],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9980368,0.0001048672,0.0003005855,0.00048478608,0.00035769888,0.0007152547],"domain_scores_gemma":[0.9989043,0.00007759838,0.000099222794,0.00025848066,0.00034772314,0.0003126781],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019656986,0.0002461029,0.00041983792,0.00028164932,0.0008345314,0.00006391823,0.00012964757,0.00009453701,0.00027259972],"category_scores_gemma":[0.000001737015,0.00019229691,0.0001064949,0.00028647424,0.0003433346,0.0001201531,0.000049642433,0.0001728251,0.000002434734],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029585718,0.0016769399,0.008860496,0.0003272173,0.0006141565,0.00002439899,0.0009527541,0.000013798861,0.010428163,0.0015823751,0.0004760742,0.97208506],"study_design_scores_gemma":[0.020822974,0.004556885,0.9438928,0.0011718053,0.00064322876,0.0004978016,0.00050321186,0.0025857573,0.009863592,0.011511074,0.0030820076,0.0008688896],"about_ca_topic_score_codex":0.013395762,"about_ca_topic_score_gemma":0.0028231577,"teacher_disagreement_score":0.97121614,"about_ca_system_score_codex":0.00039397323,"about_ca_system_score_gemma":0.000058977337,"threshold_uncertainty_score":0.99317414},"labels":[],"label_agreement":null},{"id":"W2126386849","doi":"10.1007/s10549-007-9584-x","title":"A Phase 2 study of perifosine in advanced or metastatic breast cancer","year":2007,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"National Cancer Institute","keywords":"Medicine; Metastatic breast cancer; Internal medicine; Chemotherapy; Breast cancer; Nausea; Neutropenia; Regimen; Anthracycline; Gastroenterology; Progressive disease; Oncology; Toxicity; Performance status; Surgery; Cancer","score_opus":0.11632199615301068,"score_gpt":0.5141281501004372,"score_spread":0.3978061539474265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126386849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923108,0.0031566683,0.0000017309609,0.0014795369,0.00007753056,0.0022542311,0.00047479826,0.000019802585,0.00022488883],"genre_scores_gemma":[0.9939991,0.003042598,0.000045527908,0.000045433564,0.00014011461,0.0011589439,0.000021016196,0.000029616758,0.0015176506],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9979238,0.000099659104,0.00037855704,0.0004714371,0.00046374902,0.0006628161],"domain_scores_gemma":[0.9989074,0.00016313593,0.00007465177,0.00024514995,0.00025181504,0.0003578786],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00034770934,0.00025226473,0.0005985069,0.00045505032,0.000103134866,0.000013919349,0.000070686765,0.00004283587,0.0014107877],"category_scores_gemma":[0.0000061596984,0.00016328176,0.000055954748,0.00076699397,0.00018074489,0.00009132615,0.000047508038,0.0001850494,0.0000042723527],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08869792,0.053507354,0.24499385,0.0001863167,0.0013598029,0.0021286253,0.0032944295,0.000010388841,0.005921259,0.000027611099,0.00020729605,0.59966516],"study_design_scores_gemma":[0.14244202,0.0340783,0.8095869,0.0003826069,0.00063649355,0.00086579856,0.005136412,0.00007541336,0.0047867703,0.000027213036,0.0016873016,0.00029481135],"about_ca_topic_score_codex":0.023102198,"about_ca_topic_score_gemma":0.030269315,"teacher_disagreement_score":0.59937036,"about_ca_system_score_codex":0.0010396405,"about_ca_system_score_gemma":0.00060959713,"threshold_uncertainty_score":0.99950206},"labels":[],"label_agreement":null},{"id":"W2126839072","doi":"10.1007/s10549-006-9182-3","title":"BRCA1-positive breast cancers in young women from Poland","year":2006,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Coalition for Research in Women's Health; University of Toronto","funders":"","keywords":"Breast cancer; Medicine; Medullary cavity; Family history; Oncology; Ovarian cancer; Cancer; Internal medicine; Histology; Gynecology; Mammography","score_opus":0.01443610435021696,"score_gpt":0.31350085885929235,"score_spread":0.2990647545090754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126839072","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99141467,0.0036519968,0.00001327317,0.00097494357,0.0000799543,0.0003259671,0.0022238947,0.000006969413,0.0013083194],"genre_scores_gemma":[0.9960833,0.0013061836,0.000059467817,0.00003196682,0.000559502,0.00066231325,0.00026567193,0.000025749297,0.0010057995],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99827206,0.00011222666,0.00018399389,0.0005753121,0.000295827,0.00056058104],"domain_scores_gemma":[0.999323,0.000030221103,0.000040110383,0.00029803425,0.00016385331,0.00014475475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017532954,0.00018230721,0.00017840198,0.00012738137,0.00013779085,0.000078096265,0.0001280472,0.000099656936,0.000111097346],"category_scores_gemma":[0.000004998446,0.00015624061,0.000036730868,0.00023874386,0.00019835473,0.000009002464,0.00008799884,0.00010288218,0.000008820956],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023829818,0.0005341225,0.8524062,0.000012250712,0.0004577765,0.00007085423,0.000803096,0.00044124454,0.053966917,0.00012259903,0.0032249098,0.08557705],"study_design_scores_gemma":[0.0025665385,0.000328855,0.9829894,0.00003333186,0.000010139843,0.00008943446,0.0004407111,0.000032402393,0.0096611865,0.0007157717,0.0029262758,0.00020598853],"about_ca_topic_score_codex":0.096255146,"about_ca_topic_score_gemma":0.085191,"teacher_disagreement_score":0.13058317,"about_ca_system_score_codex":0.0020879738,"about_ca_system_score_gemma":0.0006979805,"threshold_uncertainty_score":0.93150187},"labels":[],"label_agreement":null},{"id":"W2128719333","doi":"10.1007/s10549-012-2104-7","title":"Specific transcriptional response of four blockers of estrogen receptors on estradiol-modulated genes in the mouse mammary gland","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Theratechnologies (Canada); Université Laval","funders":"","keywords":"Fulvestrant; Antiestrogen; Tamoxifen; Raloxifene; Estrogen receptor; Mammary gland; Estrogen; Endocrinology; Selective estrogen receptor modulator; Internal medicine; Breast cancer; Endocrine system; Biology; Medicine; Cancer research; Cancer; Hormone","score_opus":0.036560865280086674,"score_gpt":0.3069586897008745,"score_spread":0.2703978244207878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128719333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98830557,0.01074628,0.0000030109709,0.00044451604,0.00003815189,0.00031144454,0.00010096999,0.0000025172344,0.00004753106],"genre_scores_gemma":[0.99436903,0.005210449,0.00006525569,0.000006774193,0.00009288076,0.00007267014,0.000050961844,0.000010975353,0.00012100857],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988351,0.00032172413,0.00014548986,0.00018239759,0.00022555425,0.00028972418],"domain_scores_gemma":[0.9995504,0.00005142067,0.000034641507,0.00021386308,0.00005162805,0.00009803515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044070062,0.00011962833,0.00013340735,0.00009482836,0.00005362644,0.00000832638,0.00010866749,0.0000999547,0.00001057195],"category_scores_gemma":[0.0000055891296,0.00007538945,0.00006378474,0.00014396282,0.00013145946,0.0000056042104,0.000016980954,0.00009166305,0.0000012718565],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012294303,0.0011712619,0.06976375,0.000026500407,0.0003660194,0.0000218643,0.00044398574,0.00006428827,0.8958688,0.00029744065,0.0004620065,0.019219788],"study_design_scores_gemma":[0.0035526676,0.0034022212,0.20054036,0.000055187138,0.000028358494,0.00019765821,0.00019537467,0.00001920939,0.7857308,0.000028521397,0.0060750903,0.00017458672],"about_ca_topic_score_codex":0.00022387588,"about_ca_topic_score_gemma":0.000009210621,"teacher_disagreement_score":0.13077661,"about_ca_system_score_codex":0.000050296814,"about_ca_system_score_gemma":0.00010342928,"threshold_uncertainty_score":0.30742925},"labels":[],"label_agreement":null},{"id":"W2131928438","doi":"10.1023/a:1006459613498","title":"Breast cancer prognostic significance of a single nucleotide polymorphism in the proximal androgen response element of the prostate specific antigen gene promoter","year":2000,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre; Mount Sinai Hospital","funders":"","keywords":"Genotype; Breast cancer; Single-nucleotide polymorphism; Internal medicine; Oncology; Prostate cancer; Biology; Medicine; Breast carcinoma; Cancer research; Cancer; Gene; Genetics","score_opus":0.04569737626745415,"score_gpt":0.3270604888343454,"score_spread":0.2813631125668913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131928438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9753138,0.006809482,2.876988e-7,0.011127248,0.00003386935,0.0051783146,0.0013040444,0.000013196948,0.00021977568],"genre_scores_gemma":[0.98982304,0.0066311187,0.000041631934,0.00003553482,0.00013446658,0.0019237833,0.000022603399,0.00003952938,0.0013483036],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996432,0.0005557079,0.0004715792,0.0005729567,0.0011100168,0.0008577256],"domain_scores_gemma":[0.99855983,0.00017047653,0.00011450056,0.0006268577,0.00032313893,0.0002051816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084305636,0.00030874068,0.00047377642,0.00021602624,0.00022068027,0.000050234838,0.00028053793,0.00007274852,0.0005370085],"category_scores_gemma":[0.000009032676,0.00015197888,0.00013235779,0.0009314678,0.0008585334,0.00010141809,0.00008125297,0.00026405338,0.000006554601],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.058185574,0.006027696,0.51223487,0.00030977535,0.00056796474,0.00038859434,0.0044492413,0.000015076447,0.22534001,0.000028540167,0.00032503498,0.19212762],"study_design_scores_gemma":[0.0073031858,0.0029837838,0.8694104,0.00077171257,0.000087870765,0.0003644067,0.00043779294,0.000025341882,0.11620274,0.00010226754,0.002125219,0.0001853127],"about_ca_topic_score_codex":0.004653643,"about_ca_topic_score_gemma":0.00045155463,"teacher_disagreement_score":0.3571755,"about_ca_system_score_codex":0.00075266545,"about_ca_system_score_gemma":0.0011095764,"threshold_uncertainty_score":0.7034947},"labels":[],"label_agreement":null},{"id":"W2133154503","doi":"10.1007/s10549-009-0364-7","title":"Both t-Darpp and DARPP-32 can cause resistance to trastuzumab in breast cancer cells and are frequently expressed in primary breast cancers","year":2009,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Trastuzumab; Breast cancer; Cancer research; Gene silencing; Medicine; Oncology; Cancer; Internal medicine; Biology; Gene; Genetics","score_opus":0.047857390762481605,"score_gpt":0.3666355244360162,"score_spread":0.3187781336735346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133154503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9456804,0.009880857,0.0000016829085,0.035664152,0.00007765836,0.0026803182,0.0050807823,0.000051722574,0.00088244595],"genre_scores_gemma":[0.97448635,0.021557204,0.00012009777,0.0006518372,0.0002848825,0.0014953214,0.000038796603,0.000084217754,0.0012812791],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.994394,0.00030668685,0.00059061416,0.0015440648,0.0013310541,0.0018335523],"domain_scores_gemma":[0.9972363,0.00016632333,0.000103133985,0.0007011922,0.0003243557,0.0014686708],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00066310714,0.0006102115,0.0010195317,0.00090256624,0.00027820363,0.00020353538,0.00024659073,0.00021443563,0.00019960225],"category_scores_gemma":[0.000017711758,0.0005224708,0.000065736866,0.0012352857,0.0005377112,0.00023471357,0.00016129686,0.00077382347,0.0000051493025],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019063253,0.0019714925,0.65057707,0.0011648656,0.00044793307,0.0038178428,0.0048809047,0.00008467848,0.03225752,0.00010591883,0.0066941837,0.27893436],"study_design_scores_gemma":[0.009084326,0.00081415416,0.980904,0.002642503,0.00005705675,0.00045020715,0.000884222,0.000033367174,0.0019685857,0.00011924601,0.0025423209,0.0005000034],"about_ca_topic_score_codex":0.07185091,"about_ca_topic_score_gemma":0.122850925,"teacher_disagreement_score":0.33032694,"about_ca_system_score_codex":0.008712465,"about_ca_system_score_gemma":0.0029647343,"threshold_uncertainty_score":0.99972266},"labels":[],"label_agreement":null},{"id":"W2134155956","doi":"10.1007/s10549-011-1559-2","title":"Associations of objectively assessed physical activity and sedentary time with biomarkers of breast cancer risk in postmenopausal women: findings from NHANES (2003–2006)","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Physical Activity and Health","field":"Medicine","cited_by":116,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Athabasca University; Alberta Health Services","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Waist; Breast cancer; Body mass index; National Health and Nutrition Examination Survey; Internal medicine; Anthropometry; Confounding; Biomarker; Quartile; Population; Oncology; Sedentary lifestyle; Cancer; Physiology; Endocrinology; Obesity; Environmental health; Biology","score_opus":0.05180185396028153,"score_gpt":0.35842318079120106,"score_spread":0.3066213268309195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134155956","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923442,0.00011952699,8.1462986e-7,0.0004558737,0.000010782342,0.0005621909,0.006326368,0.000009955177,0.00017031588],"genre_scores_gemma":[0.999071,0.0005251847,0.00003656062,0.000010063156,0.000056350767,0.0002014467,0.000028284141,0.00001555203,0.00005556358],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985395,0.00015060106,0.0001341872,0.0003504611,0.0004074137,0.0004178434],"domain_scores_gemma":[0.99902594,0.00020251368,0.00011038549,0.00014379031,0.00025673825,0.00026063275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017138786,0.00017181259,0.0005663245,0.0001643109,0.00010549328,0.000009646984,0.00004530424,0.000061858984,0.0001271727],"category_scores_gemma":[0.000012872839,0.0001221681,0.000026541229,0.00050803245,0.00031839998,0.00017796154,0.000041781066,0.00021434185,0.0000014953328],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013001057,0.012166504,0.89878577,0.00010070752,0.0014981275,0.00003988595,0.0041345023,7.2426207e-7,0.03873088,0.000032636726,0.00003803378,0.0314712],"study_design_scores_gemma":[0.0036329988,0.0026649951,0.9810416,0.0001794664,0.00010716879,0.000013229802,0.00032252393,0.00006965231,0.011651002,0.00021817435,0.0000024295573,0.000096769996],"about_ca_topic_score_codex":0.22172593,"about_ca_topic_score_gemma":0.005531786,"teacher_disagreement_score":0.21619414,"about_ca_system_score_codex":0.00085724756,"about_ca_system_score_gemma":0.00077409996,"threshold_uncertainty_score":0.7834567},"labels":[],"label_agreement":null},{"id":"W2134267892","doi":"10.1007/s10549-012-2012-x","title":"25-Hydroxy vitamin-D, obesity, and associated variables as predictors of breast cancer risk and tamoxifen benefit in NSABP-P1","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute; U.S. Department of Health and Human Services","keywords":"Medicine; Breast cancer; Internal medicine; Body mass index; Tamoxifen; Adipokine; Vitamin D and neurology; Oncology; Population; Insulin resistance; Cancer; Odds ratio; Leptin; Endocrinology; Obesity","score_opus":0.025767386734002917,"score_gpt":0.3377148942639271,"score_spread":0.3119475075299242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134267892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9819528,0.0130832065,3.4409248e-7,0.0013770134,0.000056474568,0.0012201295,0.0017158297,0.000024430923,0.00056975684],"genre_scores_gemma":[0.9473428,0.050682824,0.00002016697,0.000015549054,0.00021632432,0.00069258566,0.00002106117,0.000034354143,0.0009743406],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99704933,0.00020336226,0.00031408173,0.0005027242,0.0008592005,0.0010712954],"domain_scores_gemma":[0.99823624,0.0003603426,0.000098915116,0.00027191796,0.00032561703,0.00070696295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008694077,0.00031213296,0.00066220853,0.00039340305,0.00028357081,0.000042219563,0.00008833617,0.0001541687,0.00016514838],"category_scores_gemma":[0.000115245995,0.00022388251,0.000051470903,0.00052378216,0.00068185513,0.00021703372,0.00032041367,0.00036203754,0.0000037915313],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005438709,0.0013742005,0.9717017,0.0001931384,0.0009040814,0.00004440706,0.0012515422,0.000002182044,0.00050447957,0.000096198826,0.00018817776,0.023196058],"study_design_scores_gemma":[0.0053681824,0.00083155447,0.9912509,0.00058753794,0.00019159114,0.00013057311,0.0005019141,0.000050056122,0.00053338276,0.00015535657,0.00023268054,0.0001662688],"about_ca_topic_score_codex":0.055513974,"about_ca_topic_score_gemma":0.006816996,"teacher_disagreement_score":0.048696976,"about_ca_system_score_codex":0.00090577843,"about_ca_system_score_gemma":0.00032568694,"threshold_uncertainty_score":0.95077544},"labels":[],"label_agreement":null},{"id":"W2134570780","doi":"10.1007/s10549-013-2478-1","title":"The influence of adjuvant therapy on cardiorespiratory fitness in early-stage breast cancer seven years after diagnosis: the Cooper Center Longitudinal Study","year":2013,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer survivorship and care","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Okanagan University College; University of British Columbia, Okanagan Campus; University of British Columbia","funders":"National Cancer Institute","keywords":"Medicine; Breast cancer; Cardiorespiratory fitness; Asymptomatic; Internal medicine; Adjuvant therapy; Cancer; Stage (stratigraphy); Adjuvant; Regimen; Oncology; Surgery","score_opus":0.046486842979138895,"score_gpt":0.3561632772116143,"score_spread":0.3096764342324754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134570780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98881996,0.005756226,5.6618436e-8,0.0027020085,0.000086478154,0.0020864415,0.0004904812,0.00001070964,0.000047647387],"genre_scores_gemma":[0.9834795,0.0068924325,2.8887814e-7,0.00015415823,0.00015925466,0.008848879,0.0000028984598,0.00002919235,0.0004333765],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977625,0.00028344366,0.00025208326,0.00042167498,0.00073664496,0.0005436354],"domain_scores_gemma":[0.9986411,0.00017935967,0.000052922238,0.0005574499,0.0003768696,0.00019229739],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003653442,0.0002293713,0.0003483933,0.0001143286,0.00016909884,0.000087760774,0.0001859397,0.000056105026,0.00027099464],"category_scores_gemma":[0.0000063153166,0.000113369504,0.00008951126,0.0003706823,0.0003809089,0.00010872981,0.0000894655,0.00029492314,0.00001586573],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002642446,0.0007957512,0.92009187,0.000019985528,0.00031186518,0.0000957557,0.003275037,0.000031187443,0.000014523901,0.0000064579067,0.00016427491,0.07255087],"study_design_scores_gemma":[0.0033809373,0.0009348029,0.9914373,0.00026439314,0.000029590134,0.00001702264,0.0013682864,0.0000024596116,0.00006620021,0.000006562877,0.0023822265,0.000110229],"about_ca_topic_score_codex":0.13810018,"about_ca_topic_score_gemma":0.059675522,"teacher_disagreement_score":0.07842465,"about_ca_system_score_codex":0.0004659315,"about_ca_system_score_gemma":0.00032663657,"threshold_uncertainty_score":0.95748293},"labels":[],"label_agreement":null},{"id":"W2136107801","doi":"10.1007/s10549-008-0257-1","title":"No evidence that GATA3 rs570613 SNP modifies breast cancer risk","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Metastasis and carcinoma case studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research and Materiel Command; National Cancer Institute; Medical Research Council; Cancer Council Tasmania; National Institutes of Health; Sahlgrenska Universitetssjukhuset; Fox Chase Cancer Center; Lunds Universitet; Uppsala Universitet; Cancerfonden; Radboud Universiteit; Akademiska Sjukhuset; Helsingin ja Uudenmaan Sairaanhoitopiiri; Robert Bosch Stiftung; Vrije Universiteit Amsterdam; National Breast Cancer Foundation; Huntsman Cancer Institute; Breast Cancer Research Foundation; Cancer Care Ontario; Bundesministerium für Bildung und Forschung; Universiteit Leiden; National Health and Medical Research Council; Cancer Research UK","keywords":"Breast cancer; Single-nucleotide polymorphism; Allele; GATA3; Estrogen receptor; Oncology; SNP; Internal medicine; Medicine; Linkage disequilibrium; Cancer; Genotype; Biology; Genetics; Transcription factor; Gene","score_opus":0.238466334642105,"score_gpt":0.4103213373174322,"score_spread":0.1718550026753272,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136107801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94261926,0.048214674,0.0000049662435,0.0049123247,0.00013609228,0.0008487588,0.0015760384,0.000049904796,0.0016379656],"genre_scores_gemma":[0.82194966,0.17100926,0.000049256196,0.000077034834,0.00052044867,0.0008476864,0.000013193346,0.000029094272,0.0055043637],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971382,0.00017491698,0.00023562301,0.00067440246,0.000971583,0.0008052777],"domain_scores_gemma":[0.99809057,0.00018696576,0.00009638917,0.00049981533,0.0005989576,0.0005272949],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003311769,0.000333432,0.0005666979,0.00018576405,0.00078693865,0.000053473053,0.00010669009,0.00007072797,0.001310635],"category_scores_gemma":[0.000040034545,0.00021511318,0.0001491568,0.0003140735,0.0006305102,0.00019328661,0.00014089521,0.0002878139,0.000112603964],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004610108,0.0007335062,0.80253357,0.00019282037,0.0010760158,0.001040184,0.00078442926,0.00000443673,0.00049260096,0.00007930765,0.01178456,0.17666847],"study_design_scores_gemma":[0.0029199154,0.0010052841,0.9824318,0.00060043664,0.00024637656,0.0021254385,0.00039801872,0.000052150306,0.0011118297,0.000036158937,0.008828671,0.00024390075],"about_ca_topic_score_codex":0.038962413,"about_ca_topic_score_gemma":0.0015754282,"teacher_disagreement_score":0.17989826,"about_ca_system_score_codex":0.00063384266,"about_ca_system_score_gemma":0.000613834,"threshold_uncertainty_score":0.9996023},"labels":[],"label_agreement":null},{"id":"W2136957569","doi":"10.1007/s10549-008-0104-4","title":"Autoimmune hypothyroidism and breast cancer in the elderly","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Thyroid Disorders and Treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; St. Michael's Hospital; Women's College Hospital; University of Toronto","funders":"","keywords":"Breast cancer; Medicine; Cancer; Oncology; Internal medicine","score_opus":0.05152938137277015,"score_gpt":0.35092351975025915,"score_spread":0.299394138377489,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136957569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9543209,0.027804295,5.020215e-7,0.015752291,0.000031216183,0.0008347038,0.00032361152,0.000022414717,0.000910066],"genre_scores_gemma":[0.96395034,0.033389024,0.000016642889,0.00009972358,0.00009879067,0.0007731586,0.000016582702,0.00002307682,0.0016326687],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99828756,0.00009842835,0.00017994698,0.00041787632,0.00044716266,0.0005690036],"domain_scores_gemma":[0.9992707,0.00008371375,0.000030735067,0.00030738054,0.000096156145,0.00021136348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014679665,0.00022823292,0.00031355995,0.0001699695,0.00038669488,0.000042834283,0.000080896854,0.00006940081,0.00015668271],"category_scores_gemma":[0.0000043171676,0.000129989,0.000053544616,0.00034026412,0.00037637592,0.00009503335,0.000047265406,0.00020918132,0.000013761132],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021961262,0.0025595075,0.5976391,0.000040682015,0.00043540014,0.0012958454,0.0026735833,0.0000022934726,0.0005804646,0.00027875052,0.0014784305,0.39081985],"study_design_scores_gemma":[0.007402338,0.0011048334,0.9864412,0.000082253195,0.000054587876,0.0023877397,0.00051302527,0.000018674013,0.00005441865,0.00019275515,0.001632488,0.00011569252],"about_ca_topic_score_codex":0.026213376,"about_ca_topic_score_gemma":0.0025011345,"teacher_disagreement_score":0.39070415,"about_ca_system_score_codex":0.0003234322,"about_ca_system_score_gemma":0.00033908614,"threshold_uncertainty_score":0.98027116},"labels":[],"label_agreement":null},{"id":"W2137506740","doi":"10.1007/s10549-012-2258-3","title":"Further evidence for a role of tumor CD200 expression in breast cancer metastasis: decreased metastasis in CD200R1KO mice or using CD200-silenced EMT6","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Neuroinflammation and Neurodegeneration Mechanisms","field":"Neuroscience","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; University of Toronto; Toronto General Hospital; University Health Network","funders":"","keywords":"Metastasis; Cancer research; Biology; Adoptive cell transfer; Mammary tumor; Breast cancer; Tumor progression; Nod; Immune system; NOD mice; Cancer; Immunology; T cell; In vivo","score_opus":0.2216355359345644,"score_gpt":0.42818234218950724,"score_spread":0.20654680625494284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137506740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942847,0.002163609,0.000061888524,0.00086121156,0.000102695514,0.0016060413,0.00087718765,0.00002832331,0.000014344343],"genre_scores_gemma":[0.9956017,0.0018897452,0.0005973656,0.00011813864,0.00011657213,0.0014996143,0.0000041712283,0.00004645596,0.00012623574],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99644893,0.0006813279,0.00053127063,0.000727282,0.00070291327,0.0009082854],"domain_scores_gemma":[0.9983058,0.00059389917,0.00018942065,0.00034691865,0.00018273488,0.0003812043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006730354,0.0003238908,0.00045345156,0.00057356746,0.00020811317,0.00008234319,0.00023988356,0.000061270264,0.00047691134],"category_scores_gemma":[0.00016733067,0.000238567,0.00009137861,0.0009645887,0.00014802479,0.00074227527,0.00009810607,0.00017441425,0.000005976759],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039591826,0.00077850977,0.008387446,0.00008222635,0.000018338804,0.000029661585,0.0006899584,0.0002208082,0.967293,0.00016203117,0.000023710661,0.018355131],"study_design_scores_gemma":[0.00301155,0.00025264258,0.013809961,0.0005166898,0.00004261585,0.0001610683,0.0004737688,0.0019564691,0.97927696,0.00009541072,0.00015436727,0.00024849208],"about_ca_topic_score_codex":0.0029868174,"about_ca_topic_score_gemma":0.0014368481,"teacher_disagreement_score":0.01810664,"about_ca_system_score_codex":0.00047127972,"about_ca_system_score_gemma":0.00056442263,"threshold_uncertainty_score":0.972848},"labels":[],"label_agreement":null},{"id":"W2139782977","doi":"10.1007/s10549-006-9400-z","title":"MR-determined metabolic phenotype of breast cancer in prediction of lymphatic spread, grade, and hormone status","year":2006,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"MRI in cancer diagnosis","field":"Medicine","cited_by":130,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston Health Sciences Centre","funders":"","keywords":"Breast cancer; Multivariate statistics; Multivariate analysis; Internal medicine; Principal component analysis; Oncology; Magnetic resonance imaging; Medicine; Cancer; Radiology; Artificial intelligence; Mathematics; Statistics; Computer science","score_opus":0.04010344188028359,"score_gpt":0.34671713889438177,"score_spread":0.3066136970140982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139782977","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9650395,0.029393623,0.0000020258428,0.0016771858,0.00004590798,0.00090445543,0.002699013,0.0000159054,0.00022240142],"genre_scores_gemma":[0.9463056,0.05252374,0.00007490359,0.0000109698985,0.00016853194,0.0006600096,0.00003700946,0.00002765205,0.00019159219],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99804556,0.000089005356,0.00039190246,0.0004010796,0.0005525718,0.0005198886],"domain_scores_gemma":[0.9989953,0.00012083375,0.00010810144,0.00028013595,0.0002626937,0.00023292423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019269294,0.00020946751,0.00055780663,0.0003866676,0.000054391694,0.000015369893,0.000055270317,0.00007944116,0.00015881461],"category_scores_gemma":[0.000006591548,0.0001624466,0.00005200808,0.00052867795,0.00034377098,0.00011229764,0.000049615297,0.000096527154,0.0000010787443],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026140497,0.0014045241,0.88100153,0.00030029856,0.00030927607,0.000035703117,0.0003532052,0.000027310161,0.013508729,0.00015430502,0.00038956036,0.0999015],"study_design_scores_gemma":[0.007360603,0.00073370745,0.983702,0.00038252666,0.00019047706,0.00007321091,0.00011403642,0.00016494856,0.0066846567,0.00017791105,0.00032120213,0.00009473426],"about_ca_topic_score_codex":0.11025771,"about_ca_topic_score_gemma":0.006447841,"teacher_disagreement_score":0.10380986,"about_ca_system_score_codex":0.0005928855,"about_ca_system_score_gemma":0.0005299335,"threshold_uncertainty_score":0.89566714},"labels":[],"label_agreement":null},{"id":"W2140503098","doi":"10.1007/s10549-011-1934-z","title":"Molecular insights on basal-like breast cancer","year":2012,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":85,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Breast cancer; Oncology; Internal medicine; Basal (medicine); Medicine; Progesterone receptor; Epidermal growth factor receptor; Triple-negative breast cancer; Epigenetics; Estrogen receptor; Metastasis; Cancer; Cancer research; Biology; Genetics; Gene","score_opus":0.08133697763086953,"score_gpt":0.3989915856751402,"score_spread":0.3176546080442707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140503098","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013114903,0.9916105,0.0000015300824,0.0005787746,0.00036808185,0.0014521307,0.0040161554,0.000033451557,0.00062788],"genre_scores_gemma":[0.010208417,0.98104954,0.000014371937,0.00011701353,0.0014871411,0.005413437,0.0005944844,0.00019340037,0.00092221913],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956436,0.00039708766,0.0004547485,0.0014706817,0.00070383423,0.0013300307],"domain_scores_gemma":[0.99778146,0.000077767974,0.00019702324,0.0010038909,0.00030828512,0.0006315827],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001669906,0.0011072461,0.0014386686,0.00033941134,0.0004430726,0.00010616969,0.0003743757,0.00049583276,0.00018348107],"category_scores_gemma":[0.000005085836,0.0007600369,0.00047180572,0.00043755517,0.00044789835,0.000013509013,0.00040706157,0.000401498,0.00010172548],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004978852,0.0009479449,0.0003855103,0.0012824485,0.0031170475,0.000086336346,0.00006853378,0.0000020252976,0.000030230342,0.00012392459,0.0014055428,0.99205256],"study_design_scores_gemma":[0.0015783886,0.0005184915,0.0021098899,0.0031972064,0.0011196568,0.0003210597,0.00003262248,4.1915672e-7,0.00016655406,0.000031355343,0.9901327,0.0007916386],"about_ca_topic_score_codex":0.003079542,"about_ca_topic_score_gemma":0.0009833807,"teacher_disagreement_score":0.99126095,"about_ca_system_score_codex":0.0011667425,"about_ca_system_score_gemma":0.001042114,"threshold_uncertainty_score":0.9994851},"labels":[],"label_agreement":null},{"id":"W2141418796","doi":"10.1007/s10549-013-2735-3","title":"Cure of metastatic growth of EMT6 tumor cells in mice following manipulation of CD200:CD200R signaling","year":2013,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; University Health Network","funders":"","keywords":"Metastasis; Lung; Lymph; Adoptive cell transfer; Medicine; CD8; Active immunization; Cancer research; Pathology; Immunology; Biology; Cancer; Immune system; Immunization; Internal medicine; T cell","score_opus":0.039157447656365384,"score_gpt":0.314476812896867,"score_spread":0.27531936524050166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141418796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997244,0.0018675149,0.000013706779,0.00010620016,0.0001840534,0.00036526914,0.000027239757,0.000004228239,0.0001877688],"genre_scores_gemma":[0.99884135,0.00022953523,0.000037556285,0.0000051268103,0.0000067467913,0.00007341002,0.00003270611,0.000007684938,0.00076588435],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991093,0.00016566087,0.00030484202,0.0001513198,0.00006643979,0.0002023924],"domain_scores_gemma":[0.9994633,0.00011944411,0.00011434462,0.00009086887,0.00019435908,0.000017664415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017658681,0.00009314491,0.00025234142,0.00023138337,0.000044492215,0.000005398553,0.00005234884,0.00004037526,0.0007257431],"category_scores_gemma":[0.000009890562,0.00007283418,0.00006544623,0.00018423973,0.00008836274,0.0001203945,0.000022606499,0.00010252125,0.000020356247],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004607361,0.0004535463,0.014318517,0.000085330495,0.0002634357,0.0000025898185,0.00044838915,0.000023004235,0.98032874,0.00009153002,0.00021588505,0.0033083216],"study_design_scores_gemma":[0.0021465118,0.00061010325,0.043655645,0.000201987,0.00004305224,0.000017724135,0.00090143504,0.000035235975,0.9520684,0.000121563084,0.00012866184,0.00006967861],"about_ca_topic_score_codex":0.017580595,"about_ca_topic_score_gemma":0.0001593536,"teacher_disagreement_score":0.029337129,"about_ca_system_score_codex":0.000099959805,"about_ca_system_score_gemma":0.000069893096,"threshold_uncertainty_score":0.9889614},"labels":[],"label_agreement":null},{"id":"W2142361869","doi":"10.1007/s10549-008-0134-y","title":"Analysis of the genes coding for the BRCA1-interacting proteins, RAP80 and Abraxas (CCDC98), in high-risk, non-BRCA1/2, multiethnic breast cancer cases","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Jewish General Hospital; McGill University","funders":"","keywords":"Breast cancer; DNA repair; Genetics; Missense mutation; Gene; Biology; Single-nucleotide polymorphism; Mutation; Genotype; Cancer","score_opus":0.04864518897385026,"score_gpt":0.36562058845410506,"score_spread":0.31697539948025477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142361869","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98637456,0.009543377,0.00006766433,0.0015047101,0.00008559755,0.0010817271,0.0013282524,0.0000038854523,0.000010258672],"genre_scores_gemma":[0.9800189,0.017678969,0.00010940879,0.000029311797,0.00018461097,0.0016500198,0.00003239626,0.0000228699,0.0002734966],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985358,0.00014067543,0.00024395785,0.00046607247,0.0002380007,0.00037550952],"domain_scores_gemma":[0.998881,0.00024511205,0.00013964639,0.00039452617,0.00026045786,0.00007926252],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030352807,0.00018751921,0.00025582287,0.0001515851,0.00051457225,0.000034976696,0.00018305772,0.00008099048,0.00002890054],"category_scores_gemma":[0.00004700555,0.0001128179,0.000120603574,0.0005145715,0.00036234307,0.000012090022,0.00014585353,0.000132483,2.7364118e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014431702,0.00030503247,0.8132944,0.00006776331,0.003075137,0.000012208896,0.0011200951,0.003229018,0.02721879,0.000011141705,0.00031478313,0.14990842],"study_design_scores_gemma":[0.0024637145,0.00026464876,0.95574033,0.00009011431,0.00039594847,0.00011750645,0.00068563136,0.0021992584,0.03698816,0.000009674859,0.0008589928,0.00018603694],"about_ca_topic_score_codex":0.041031722,"about_ca_topic_score_gemma":0.048571844,"teacher_disagreement_score":0.14972238,"about_ca_system_score_codex":0.00029983695,"about_ca_system_score_gemma":0.00047682013,"threshold_uncertainty_score":0.9687892},"labels":[],"label_agreement":null},{"id":"W2143129903","doi":"10.1023/a:1016387020854","title":"The Long Island Breast Cancer Study Project: Description of a Multi-Institutional Collaboration to Identify Environmental Risk Factors for Breast Cancer","year":2002,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":219,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Massachusetts Institute of Technology; Brown University; York University; National Institute of Environmental Health Sciences; University of Southern California","keywords":"Breast cancer; Medicine; Demography; Family history; Population; Cancer; Case-control study; Cancer registry; Environmental health; Gynecology; Gerontology; Internal medicine","score_opus":0.09411122753734119,"score_gpt":0.40240609512593933,"score_spread":0.30829486758859814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143129903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9689112,0.0028104284,0.00005218385,0.0016875755,0.00022489234,0.00445933,0.021820005,0.000020376689,0.00001402813],"genre_scores_gemma":[0.9859145,0.009183779,0.00001768903,0.000017130733,0.00033840386,0.0033345728,0.00006415995,0.000034848836,0.0010948604],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976198,0.00011605745,0.0003585645,0.00057362893,0.0007597693,0.00057216093],"domain_scores_gemma":[0.9988532,0.00010259419,0.0001358546,0.0002990382,0.00030943818,0.00029989152],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025849105,0.0003128083,0.0003916043,0.00022316705,0.0008494675,0.00013899493,0.000110403664,0.00008093932,0.00040554212],"category_scores_gemma":[0.000012819216,0.00018689262,0.0001113719,0.00044169987,0.00029888446,0.00021831652,0.00006348587,0.00018185464,0.0000051768557],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003013343,0.0021121276,0.8767446,0.000048501566,0.00071855134,0.0000120982595,0.0031743478,0.00008847333,0.0010036589,0.000006042337,0.0008102661,0.11226797],"study_design_scores_gemma":[0.006108295,0.0009556558,0.9870675,0.00014259515,0.00026691234,0.00006678452,0.0032255638,0.0006175779,0.0003152609,0.0000042607776,0.0010512322,0.00017837013],"about_ca_topic_score_codex":0.08983937,"about_ca_topic_score_gemma":0.1037958,"teacher_disagreement_score":0.112089604,"about_ca_system_score_codex":0.0021776075,"about_ca_system_score_gemma":0.00046382518,"threshold_uncertainty_score":0.9162215},"labels":[],"label_agreement":null},{"id":"W2143331437","doi":"10.1007/s10549-012-2360-6","title":"Which nomogram is best for predicting non-sentinel lymph node metastasis in breast cancer patients? A meta-analysis","year":2013,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":60,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Natural Science Foundation of China; Memorial Sloan-Kettering Cancer Center","keywords":"Nomogram; Medicine; Micrometastasis; Sentinel lymph node; Breast cancer; Meta-analysis; Oncology; Odds ratio; Cancer; Internal medicine","score_opus":0.11466147524745779,"score_gpt":0.41129963411860365,"score_spread":0.29663815887114586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143331437","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002610343,0.96559227,0.000010344702,0.0010662277,0.00008693277,0.0031500377,0.02735865,0.000017745639,0.000107473046],"genre_scores_gemma":[0.013820382,0.9498307,0.0001247505,0.00005347587,0.000427191,0.032884292,0.0019488888,0.0001512639,0.000759073],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9945981,0.00031038647,0.0009243236,0.0020486116,0.00068658823,0.0014320049],"domain_scores_gemma":[0.9968943,0.00016420413,0.00043762848,0.0009392231,0.0011373713,0.00042728015],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003861398,0.0012017705,0.0036571412,0.0007595896,0.00042904145,0.00021117614,0.00043275254,0.0003713842,0.00032553266],"category_scores_gemma":[0.000019863714,0.00082006137,0.0017941765,0.001593506,0.00024020275,0.000026280146,0.00044629592,0.00025871873,0.000020122308],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054698944,0.0036151416,0.08603282,0.0033882675,0.35812548,0.000009662127,0.00012414053,0.000019244679,0.000004119224,0.000004055978,0.00095968513,0.5471704],"study_design_scores_gemma":[0.012471028,0.0012467246,0.07865714,0.0027301915,0.6593306,0.00015065231,0.00030926563,0.000105261424,0.00009854983,0.000026399932,0.24155344,0.0033207345],"about_ca_topic_score_codex":0.03016864,"about_ca_topic_score_gemma":0.0057901046,"teacher_disagreement_score":0.54384965,"about_ca_system_score_codex":0.000990302,"about_ca_system_score_gemma":0.0009447889,"threshold_uncertainty_score":0.999425},"labels":[],"label_agreement":null},{"id":"W2146717458","doi":"10.1007/s10549-008-0128-9","title":"Response to neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":339,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Breast cancer; Medicine; Oncology; Chemotherapy; Internal medicine; Mastectomy; Cisplatin; Neoadjuvant therapy; Cancer; Clinical trial","score_opus":0.027426526070608685,"score_gpt":0.33845533326892663,"score_spread":0.31102880719831794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146717458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99236,0.0013563138,0.000010295889,0.0041014184,0.000045464385,0.00081048213,0.0011921676,0.000006815402,0.000117058364],"genre_scores_gemma":[0.9944615,0.0027841034,0.000113725284,0.00021397184,0.000136827,0.0012550208,0.000063139545,0.00003688344,0.00093484874],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979688,0.00023797991,0.0001896059,0.0006410832,0.00044745687,0.00051506906],"domain_scores_gemma":[0.9988597,0.000051410465,0.00004445416,0.00034108607,0.00045922515,0.00024414898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023175443,0.0002251262,0.00020333966,0.00019664314,0.00022318796,0.000036455793,0.00014747963,0.00008572272,0.00008432934],"category_scores_gemma":[0.0000124492935,0.00016331281,0.00003695847,0.00041789093,0.00021376593,0.000010619046,0.00008603358,0.00011001998,0.000009443344],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.047731113,0.001563794,0.71576005,0.000007674966,0.00041611036,0.00012899,0.0019622133,0.00054699165,0.033040453,0.0000099928675,0.0031304138,0.1957022],"study_design_scores_gemma":[0.0048301932,0.00229114,0.96753186,0.00005999447,0.0000057413217,0.00012213147,0.00010504622,0.0000088337565,0.020172535,0.0000116159545,0.0046502394,0.00021064217],"about_ca_topic_score_codex":0.004018172,"about_ca_topic_score_gemma":0.0036775167,"teacher_disagreement_score":0.2517718,"about_ca_system_score_codex":0.0007603445,"about_ca_system_score_gemma":0.0009373673,"threshold_uncertainty_score":0.6659703},"labels":[],"label_agreement":null},{"id":"W2147908679","doi":"10.1007/s10549-011-1895-2","title":"Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":376,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Terry Fox Foundation; American College of Radiology Imaging Network; Breast Cancer Research Foundation","keywords":"Breast cancer; Oncology; Medicine; Chemotherapy; Internal medicine; Biomarker; Neoadjuvant therapy; Cancer; Biology","score_opus":0.08937757815703253,"score_gpt":0.3586874118529415,"score_spread":0.269309833695909,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147908679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97549903,0.0044029336,0.0000018811113,0.009417767,0.00025396157,0.001364791,0.008676854,0.000021144648,0.00036163838],"genre_scores_gemma":[0.9843021,0.0126985805,0.000065320746,0.00013833577,0.0005170036,0.001717281,0.00016339528,0.000055390192,0.00034258625],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.996336,0.0006646396,0.00041224167,0.0011944034,0.0005393397,0.0008534085],"domain_scores_gemma":[0.9981486,0.00033175646,0.0001226264,0.0009325479,0.0001902012,0.0002742694],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00080837,0.0005010816,0.00045228042,0.00013945863,0.00035451335,0.00008059214,0.0003896245,0.00020073111,0.0001370365],"category_scores_gemma":[0.000081253354,0.0003190441,0.00010409002,0.000320884,0.00059310097,0.00001999713,0.0003168529,0.00024927937,0.000007630108],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6118323,0.0016085004,0.07391382,0.00001154122,0.00093780644,0.00008701387,0.0017283993,0.0000012014542,0.0023012548,0.00003795952,0.0026537825,0.3048864],"study_design_scores_gemma":[0.06313116,0.0018119196,0.9247781,0.00020949263,0.000054995246,0.000049766422,0.00060851127,0.000009446114,0.0059868256,0.0001719865,0.0028146592,0.0003731484],"about_ca_topic_score_codex":0.043414056,"about_ca_topic_score_gemma":0.016597804,"teacher_disagreement_score":0.8508643,"about_ca_system_score_codex":0.00039940374,"about_ca_system_score_gemma":0.0004923274,"threshold_uncertainty_score":0.99992615},"labels":[],"label_agreement":null},{"id":"W2151962431","doi":"10.1007/s10549-014-3141-1","title":"Differential effects of metformin on breast cancer proliferation according to markers of insulin resistance and tumor subtype in a randomized presurgical trial","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Canadian Cancer Society Research Institute; Ministero della Salute; Associazione Italiana per la Ricerca sul Cancro; Bundesministerium für Bildung und Forschung; Robert Bosch Stiftung","keywords":"Metformin; Medicine; Breast cancer; Internal medicine; Insulin resistance; Placebo; Quartile; Oncology; Endocrinology; Cancer; Insulin; Pathology","score_opus":0.014054582202154919,"score_gpt":0.31136286197566954,"score_spread":0.2973082797735146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151962431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98160416,0.016420884,0.000017564384,0.00010621957,0.00009359283,0.0015384676,0.00014711366,0.0000028042004,0.00006919177],"genre_scores_gemma":[0.9790411,0.01922029,0.000029862911,0.000020878852,0.00024697618,0.0013232585,0.000016263633,0.000014907234,0.0000864454],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9983346,0.00040527337,0.00029469936,0.00038262978,0.00028069696,0.00030209418],"domain_scores_gemma":[0.9992654,0.00016367999,0.000095822325,0.00019117212,0.0001348505,0.00014912886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045544328,0.00016999115,0.0005627745,0.00013587989,0.000051170624,0.000022198596,0.00007748227,0.0000711997,0.000022611213],"category_scores_gemma":[0.00010594914,0.00012066118,0.000075428325,0.00014384429,0.00015911448,0.0000078988705,0.00005667069,0.00007452502,3.1215563e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.76867986,0.00049672707,0.0037073612,0.0002424399,0.00024736565,0.0000031766308,0.00010359316,0.000011862069,0.014027004,0.00022982263,0.00006666965,0.21218413],"study_design_scores_gemma":[0.6583547,0.0039110547,0.049960997,0.000896972,0.00018278495,0.000010324128,0.00007893301,0.00018988783,0.28296578,0.00027378,0.0027373063,0.00043750356],"about_ca_topic_score_codex":0.0010710859,"about_ca_topic_score_gemma":0.0009641274,"teacher_disagreement_score":0.26893878,"about_ca_system_score_codex":0.00006806531,"about_ca_system_score_gemma":0.00017901896,"threshold_uncertainty_score":0.492042},"labels":[],"label_agreement":null},{"id":"W2154436990","doi":"10.1007/s10549-012-2295-y","title":"The HOXB13 p.Gly84Glu mutation is not associated with the risk of breast cancer","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Public Health Ontario; Women's College Hospital; University of Toronto","funders":"Medical School, University of Michigan; University of Michigan","keywords":"Breast cancer; Medicine; Oncology; Internal medicine; Germline mutation; Cancer; Mutation; Family history; Tamoxifen; Prostate cancer; Gene; Genetics; Biology","score_opus":0.04792564922707676,"score_gpt":0.3595563921409384,"score_spread":0.3116307429138616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154436990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9795188,0.0048586666,0.0000025319575,0.013283517,0.0000963668,0.0008946722,0.0009558033,0.000015880758,0.00037377595],"genre_scores_gemma":[0.992857,0.0045000957,0.000011696594,0.00009965653,0.00023681369,0.00080934935,0.000010131247,0.000028139137,0.0014471444],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979639,0.00020197041,0.00016707701,0.000243793,0.0008082711,0.0006150013],"domain_scores_gemma":[0.99836177,0.00044069433,0.00012010865,0.00032914913,0.00051163515,0.00023667216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052936753,0.00018613409,0.00023793835,0.00006330519,0.00045021996,0.000038775288,0.000107074804,0.000068953996,0.0003060836],"category_scores_gemma":[0.000032213142,0.00008057409,0.000064371976,0.00038062947,0.00054338557,0.00006263272,0.00005119185,0.00024348982,0.0000072774415],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052615,0.000635767,0.77139735,0.000037282374,0.0019404899,0.000010140333,0.0027502645,0.000019099825,0.0009714784,0.000056807414,0.003466893,0.21345294],"study_design_scores_gemma":[0.0022678198,0.0007797007,0.9883772,0.00012016903,0.00026230898,0.00009127319,0.00053449534,0.00005170644,0.0056889155,0.000027274173,0.0017065167,0.0000926222],"about_ca_topic_score_codex":0.011954636,"about_ca_topic_score_gemma":0.004014971,"teacher_disagreement_score":0.21697986,"about_ca_system_score_codex":0.00082594313,"about_ca_system_score_gemma":0.00049847324,"threshold_uncertainty_score":0.99462485},"labels":[],"label_agreement":null},{"id":"W2155602686","doi":"10.1023/a:1006422302173","title":"Steroid hormone activity of flavonoids and related compounds","year":2000,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Phytoestrogen effects and research","field":"Medicine","cited_by":215,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Phytoestrogens; Naringenin; Genistein; Biochanin A; Dihydrotestosterone; Isoflavones; Apigenin; Endocrinology; Estrogen; Chemistry; Internal medicine; Progestin; Steroid; Luteolin; Androgen; Hormone; Steroid hormone; Pharmacology; Daidzein; Flavonoid; Biology; Medicine; Biochemistry","score_opus":0.03810150840844816,"score_gpt":0.36778092560004333,"score_spread":0.32967941719159516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155602686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896043,0.0044727977,2.4263846e-7,0.0016112033,0.000009629158,0.0005354142,0.000091824164,0.000014800805,0.0036597955],"genre_scores_gemma":[0.988465,0.007921331,0.00001614299,0.0000062230697,0.000052125117,0.00009066536,0.0000096048725,0.0000145465,0.0034243409],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99870414,0.00011052049,0.00012131211,0.0002787622,0.0003942411,0.00039104512],"domain_scores_gemma":[0.9992487,0.00008582939,0.000018782184,0.00020764399,0.00010715633,0.00033191504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024366262,0.00012461297,0.0002983871,0.00012509862,0.000144629,0.000023943508,0.000039083396,0.00006530143,0.0003395919],"category_scores_gemma":[0.00000420969,0.00008091658,0.000043079686,0.00022226336,0.00041106975,0.00006405941,0.000037635466,0.00019488575,0.0000108934555],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006985286,0.0016488284,0.029139362,0.0001303549,0.0005883097,0.00017299526,0.00026501942,0.0000011950356,0.12804294,0.00005074909,0.00030228062,0.83267266],"study_design_scores_gemma":[0.007506718,0.0056234743,0.96653926,0.00014278533,0.000054482887,0.00046296138,0.00005334323,0.00020521662,0.018203415,0.00014980177,0.000943712,0.000114796414],"about_ca_topic_score_codex":0.0027090982,"about_ca_topic_score_gemma":0.00006709192,"teacher_disagreement_score":0.9373999,"about_ca_system_score_codex":0.00017583762,"about_ca_system_score_gemma":0.00018376973,"threshold_uncertainty_score":0.4095364},"labels":[],"label_agreement":null},{"id":"W2156003012","doi":"10.1007/s10549-010-0902-3","title":"Cytochrome P450 2D6 and outcomes of adjuvant tamoxifen therapy: results of a meta-analysis","year":2010,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Tamoxifen; CYP2D6; Breast cancer; Medicine; Oncology; Internal medicine; Genotype; Hazard ratio; Meta-analysis; Adjuvant therapy; Cancer; Pharmacology; Confidence interval; Biology; Cytochrome P450; Genetics","score_opus":0.5229333359174899,"score_gpt":0.5894168278163905,"score_spread":0.06648349189890057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156003012","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006217097,0.9778647,5.041813e-7,0.00040754225,0.00008997757,0.0015405394,0.013512984,0.000012717991,0.000353936],"genre_scores_gemma":[0.017580613,0.98001444,0.000048282,0.000044507804,0.000118164804,0.0009694454,0.0001414589,0.0000451442,0.0010379283],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958511,0.0012027452,0.0010114117,0.0007692223,0.0005191053,0.00064642844],"domain_scores_gemma":[0.99690455,0.0010731064,0.00056293735,0.00056830974,0.00036935453,0.0005217608],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001552362,0.0006253958,0.004639549,0.0008034114,0.00018368107,0.000028401197,0.0003603606,0.00043818797,0.0008141427],"category_scores_gemma":[0.000027413911,0.00036792568,0.0012378314,0.00081963517,0.0007766098,0.000048989023,0.0002180363,0.0008670084,0.0000069790026],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065533066,0.0011210587,0.00016852618,0.0007690351,0.18164197,0.000032024345,0.00021336722,0.000004218701,0.00029326245,0.00008331079,0.00010558929,0.8149123],"study_design_scores_gemma":[0.0029135372,0.00049341295,0.0020867607,0.000059852864,0.16086493,0.000033659104,0.00001195967,0.000009797177,0.0004850885,0.00010064357,0.83263564,0.00030473134],"about_ca_topic_score_codex":0.0016775051,"about_ca_topic_score_gemma":0.00032113382,"teacher_disagreement_score":0.83253,"about_ca_system_score_codex":0.00008304232,"about_ca_system_score_gemma":0.0005767357,"threshold_uncertainty_score":0.9998773},"labels":[],"label_agreement":null},{"id":"W2157259618","doi":"10.1007/s10549-005-9031-9","title":"The latest is the greatest? Results of a structured lecture about aromatase inhibitor use for breast cancer","year":2005,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Tamoxifen; Medicine; Breast cancer; Aromatase inhibitor; Gynecology; Cancer; Aromatase; Oncology; Endocrine system; Internal medicine; Hormone","score_opus":0.01952636858013055,"score_gpt":0.32304236876057013,"score_spread":0.30351600018043956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157259618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96230745,0.015910314,0.0000024937617,0.0122876195,0.00007318263,0.0010783473,0.008290269,0.000009024742,0.000041300482],"genre_scores_gemma":[0.9864413,0.01149378,0.00003861954,0.00007996359,0.00049973605,0.00047579207,0.0001305202,0.000026052083,0.0008142526],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998634,0.000095859854,0.00019866951,0.00038048063,0.00022250063,0.0004684898],"domain_scores_gemma":[0.99898535,0.000123847,0.00007920644,0.0004150288,0.00024481726,0.00015176831],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020097759,0.00020678468,0.00015917327,0.000035087967,0.00047649193,0.000094644936,0.0001662309,0.0001466683,0.000011592448],"category_scores_gemma":[0.000022828071,0.00009858692,0.000101471815,0.00013845778,0.00033736145,0.000009548867,0.00007503234,0.000141474,0.0000017990391],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02635002,0.0007449042,0.010992347,0.000097326774,0.0026436877,0.000023739385,0.0009796243,0.00045406356,0.20452805,0.0001567527,0.047655806,0.7053737],"study_design_scores_gemma":[0.015203212,0.0033081463,0.14378305,0.00031856415,0.000309825,0.0005532569,0.00018776604,0.00040757188,0.62135017,0.00027463675,0.21366596,0.00063781656],"about_ca_topic_score_codex":0.0020581966,"about_ca_topic_score_gemma":0.0018724815,"teacher_disagreement_score":0.7047359,"about_ca_system_score_codex":0.00009718502,"about_ca_system_score_gemma":0.00025767385,"threshold_uncertainty_score":0.4020258},"labels":[],"label_agreement":null},{"id":"W2157392918","doi":"10.1007/s10549-006-9255-3","title":"Cigarette smoking and breast cancer risk: update of a prospective cohort study","year":2006,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Relative risk; Obstetrics; Prospective cohort study; Confidence interval; Cohort study; Population; Gynecology; Cohort; Pregnancy; Proportional hazards model; Cancer; Internal medicine; Demography; Environmental health","score_opus":0.02387445449442558,"score_gpt":0.35374507178532394,"score_spread":0.32987061729089834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157392918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99101007,0.0041906144,0.0000017647526,0.0010324947,0.000048603673,0.0019395598,0.0013588505,0.000026217438,0.00039181046],"genre_scores_gemma":[0.99332356,0.0049964422,0.0000072928415,0.0000140192815,0.00026878493,0.000920606,0.000018244356,0.00003037357,0.0004206513],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99801767,0.00007707417,0.00024853658,0.00055955973,0.00062536,0.00047179795],"domain_scores_gemma":[0.9990271,0.00004474005,0.000094489245,0.0002794586,0.00032210173,0.00023212067],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028851043,0.00022967155,0.00047797948,0.00018956132,0.00023199992,0.00004722706,0.00005185759,0.000060486465,0.00026432105],"category_scores_gemma":[0.0000039286138,0.00016023967,0.0000580976,0.00032353378,0.00029590927,0.00008335701,0.0000732047,0.00023911211,0.000001199235],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001687153,0.0010084921,0.9453709,0.00003527657,0.000974132,0.00006394567,0.0003317702,0.0000037781979,0.00006495603,0.000045136083,0.00024906246,0.05016537],"study_design_scores_gemma":[0.005205337,0.00088613015,0.99194306,0.00013946988,0.0004386613,0.000115494804,0.00033679683,0.000022044007,0.00035746576,0.000106598156,0.00031503697,0.00013390672],"about_ca_topic_score_codex":0.21139611,"about_ca_topic_score_gemma":0.016427778,"teacher_disagreement_score":0.19496833,"about_ca_system_score_codex":0.0007742357,"about_ca_system_score_gemma":0.00031673734,"threshold_uncertainty_score":0.9167085},"labels":[],"label_agreement":null},{"id":"W2157650294","doi":"10.1007/s10549-008-0231-y","title":"Tamoxifen and ICI 182,780 increase Bcl-2 levels and inhibit growth of breast carcinoma cells by modulating PI3K/AKT, ERK and IGF-1R pathways independent of ERα","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Alberta","funders":"Lawrence Berkeley National Laboratory","keywords":"Antiestrogen; Tamoxifen; MCF-7; Cancer research; Protein kinase B; PI3K/AKT/mTOR pathway; MAPK/ERK pathway; Biology; Cell growth; Estrogen receptor; Cell culture; Endocrinology; Cell biology; Signal transduction; Internal medicine; Chemistry; Cancer cell; Breast cancer; Medicine; Cancer; Biochemistry","score_opus":0.02392100430216138,"score_gpt":0.2696324204286137,"score_spread":0.2457114161264523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157650294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844652,0.013944848,0.0000047512335,0.00010681449,0.000013402231,0.0004202347,0.0008836782,0.0000054725047,0.00015559739],"genre_scores_gemma":[0.9949351,0.004653604,0.000059321115,0.000010940825,0.000060667007,0.000055543675,0.00005844574,0.000025279167,0.0001411161],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984651,0.00013694953,0.00024525932,0.00048954866,0.00027650007,0.00038663571],"domain_scores_gemma":[0.99914014,0.00004673527,0.00009463427,0.00019937631,0.00018275231,0.00033633332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019556051,0.00024125248,0.00031970735,0.00009654277,0.00020016964,0.000021746537,0.00006761305,0.00017963612,0.0000058511387],"category_scores_gemma":[0.000011323056,0.00018812506,0.000040977033,0.000118503216,0.0004907568,0.00001413211,0.00020309967,0.00014492862,4.323334e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011429428,0.00069844985,0.12974034,0.00017419577,0.00029716437,0.0000758601,0.00039247048,0.0000016689266,0.8556598,0.00003379702,0.0002031299,0.011580224],"study_design_scores_gemma":[0.00778932,0.002215077,0.23727345,0.0001365518,0.000073531955,0.0011811785,0.00014435778,0.000094710675,0.7506873,0.000075532356,0.0000401402,0.00028882065],"about_ca_topic_score_codex":0.005058087,"about_ca_topic_score_gemma":0.00007437744,"teacher_disagreement_score":0.10753313,"about_ca_system_score_codex":0.00004888504,"about_ca_system_score_gemma":0.00020120996,"threshold_uncertainty_score":0.7671518},"labels":[],"label_agreement":null},{"id":"W2162794483","doi":"10.1007/s10549-015-3269-7","title":"The prognostic and predictive value of Tregs and tumor immune subtypes in postmenopausal, hormone receptor-positive breast cancer patients treated with adjuvant endocrine therapy: a Dutch TEAM study analysis","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Exemestane; Breast cancer; Internal medicine; Oncology; Tamoxifen; Adjuvant; Immune system; Endocrine system; FOXP3; Hormone; Hormone receptor; Cancer; Gastroenterology; Immunology","score_opus":0.019819838874036568,"score_gpt":0.31346079668735405,"score_spread":0.2936409578133175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162794483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97049856,0.02463632,2.665889e-7,0.0008464553,0.000015018959,0.0028643298,0.001072781,0.000014305338,0.000051951272],"genre_scores_gemma":[0.9839968,0.014512981,0.0000075253306,0.000013660539,0.000036445097,0.0011909734,0.0000732952,0.000028670607,0.0001396672],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99774295,0.00029446415,0.00034063726,0.00052780414,0.0006054999,0.00048866845],"domain_scores_gemma":[0.99857306,0.00018676296,0.00013049565,0.00026294307,0.00057376764,0.00027297786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003689321,0.00031055245,0.00062999234,0.00032131036,0.00020302973,0.00005831403,0.00007516514,0.000034815974,0.00001675607],"category_scores_gemma":[0.000012630795,0.00016290102,0.000042608233,0.0009978904,0.0005731219,0.00010922499,0.000060542527,0.00016572338,3.500767e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08502907,0.0033746134,0.8684005,0.000016177188,0.0046114083,0.00004983245,0.002059792,0.0000029715125,0.00100586,0.0000025545844,0.000026886546,0.03542029],"study_design_scores_gemma":[0.019741103,0.027384188,0.9481418,0.00017792168,0.0006516486,0.00006950229,0.0029679576,0.000060457864,0.0006232877,0.000005313142,0.000029472134,0.00014733917],"about_ca_topic_score_codex":0.063344784,"about_ca_topic_score_gemma":0.004749545,"teacher_disagreement_score":0.07974127,"about_ca_system_score_codex":0.00063327944,"about_ca_system_score_gemma":0.00042335177,"threshold_uncertainty_score":0.9428925},"labels":[],"label_agreement":null},{"id":"W2165845535","doi":"10.1007/s10549-006-9166-3","title":"Increased prevalence of prior breast cancer in women with newly diagnosed diabetes","year":2006,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":73,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Institute for Clinical Evaluative Sciences","funders":"","keywords":"Medicine; Breast cancer; Hyperinsulinemia; Diabetes mellitus; Odds ratio; Internal medicine; Type 2 diabetes; Cancer; Population; Insulin resistance; Confidence interval; Gynecology; Oncology; Endocrinology; Environmental health","score_opus":0.011130720312564433,"score_gpt":0.28465780371699356,"score_spread":0.2735270834044291,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165845535","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8994176,0.09850442,0.0000011116424,0.00016020786,0.000026779719,0.0004681787,0.0013208375,0.000006952464,0.000093954],"genre_scores_gemma":[0.9305,0.06723267,0.000026144759,0.00004305962,0.0002610131,0.0015453928,0.00002424453,0.000028011096,0.00033947034],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99806863,0.00012784408,0.00022205697,0.0005246659,0.00034155746,0.00071524817],"domain_scores_gemma":[0.99914867,0.000035258847,0.000075652366,0.0003267206,0.00021463328,0.00019905677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023177837,0.00023234231,0.00030363293,0.000120386954,0.00008697843,0.000032788113,0.00015736106,0.00009120149,0.00023388781],"category_scores_gemma":[0.0000063673187,0.00016947078,0.000037471003,0.00026273928,0.00030138815,0.000013381802,0.000068498695,0.00009194965,0.0000016340438],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002384652,0.0008438908,0.5928379,0.00025533195,0.00021453,0.000015594323,0.0001233779,0.00008224456,0.024762733,0.000028083517,0.0003908094,0.3780608],"study_design_scores_gemma":[0.0048639094,0.0006861862,0.9566503,0.00021437331,0.00003370043,0.000007784333,0.000080100566,0.00001422722,0.032335527,0.00006284386,0.004822141,0.00022891337],"about_ca_topic_score_codex":0.011538054,"about_ca_topic_score_gemma":0.004573927,"teacher_disagreement_score":0.37783188,"about_ca_system_score_codex":0.00023840938,"about_ca_system_score_gemma":0.00053653395,"threshold_uncertainty_score":0.9950442},"labels":[],"label_agreement":null},{"id":"W2170328295","doi":"10.1007/s10549-007-9638-0","title":"Progressive resistance training in breast cancer: a systematic review of clinical trials","year":2007,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Lymphatic System and Diseases","field":"Medicine","cited_by":177,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Victoria","funders":"","keywords":"Medicine; Breast cancer; Clinical trial; Randomized controlled trial; Adverse effect; Systematic review; Physical therapy; Quality of life (healthcare); Cancer; Psychological intervention; Lymphedema; MEDLINE; Surgery; Internal medicine","score_opus":0.4985946663743232,"score_gpt":0.6131461718920764,"score_spread":0.11455150551775323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170328295","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000029505925,0.9843148,4.1161886e-7,0.00052629615,0.00013181558,0.012231981,0.0022434487,0.000022651651,0.00049911864],"genre_scores_gemma":[0.00028973137,0.9884087,0.000023403321,0.00005194574,0.0006289677,0.009556362,0.00010065178,0.000065112916,0.00087512046],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9889091,0.0037165852,0.0043770843,0.00089173065,0.0013133131,0.0007921607],"domain_scores_gemma":[0.9927845,0.0033747081,0.0016365485,0.00078575005,0.00065223884,0.0007662498],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.010700913,0.00059787685,0.011289313,0.00053894386,0.000085141364,0.000040462957,0.00022084915,0.0003120099,0.00028595232],"category_scores_gemma":[0.001204581,0.00033079815,0.001122729,0.0010142892,0.00036257328,0.00006378535,0.00007150309,0.00017875504,0.000012711085],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050952355,0.0004487153,0.00027500928,0.5958479,0.0011945154,0.0005074544,0.000065760745,4.1077852e-9,1.9018076e-8,0.000031661537,0.00023919319,0.40088025],"study_design_scores_gemma":[0.003111671,0.00025555765,0.00038883789,0.97333103,0.0054991525,0.0009803568,0.00018589874,4.6840412e-7,2.4639868e-7,0.0000114995855,0.016005076,0.00023020549],"about_ca_topic_score_codex":0.0009620849,"about_ca_topic_score_gemma":0.00025808925,"teacher_disagreement_score":0.40065002,"about_ca_system_score_codex":0.0013711173,"about_ca_system_score_gemma":0.0087138135,"threshold_uncertainty_score":0.9999144},"labels":[],"label_agreement":null},{"id":"W2171924126","doi":"10.1007/s10549-009-0601-0","title":"Pooled analysis indicates that the GSTT1 deletion, GSTM1 deletion, and GSTP1 Ile105Val polymorphisms do not modify breast cancer risk in BRCA1 and BRCA2 mutation carriers","year":2009,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Glutathione Transferases and Polymorphisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"National Cancer Institute; Canadian Institutes of Health Research; Cancer Research UK","keywords":"GSTP1; Breast cancer; Genetics; Oncology; Biology; Proportional hazards model; Mutation; Population; Cancer; Genotype; Internal medicine; Gene; Medicine; Environmental health","score_opus":0.01754987491979572,"score_gpt":0.30051705018732433,"score_spread":0.2829671752675286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171924126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9767871,0.0130923595,0.00008941648,0.008212173,0.000027591323,0.00047725326,0.0012793371,0.000010783486,0.000024019748],"genre_scores_gemma":[0.975218,0.023915786,0.000028696932,0.0001961511,0.00013159952,0.00023452297,0.0001658947,0.00001918017,0.00009019699],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997971,0.00023606422,0.0002397909,0.00067346403,0.000350216,0.000529487],"domain_scores_gemma":[0.99916863,0.00004494751,0.00007690434,0.00027975993,0.00014568339,0.0002840612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003472603,0.00028640794,0.00029598715,0.0002588591,0.00045211441,0.0001470846,0.00011962189,0.00015696025,0.0000770697],"category_scores_gemma":[0.000008556637,0.00020070584,0.000092851464,0.0004475943,0.0003514834,0.00002213565,0.00004457565,0.00019431463,0.0000012987871],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003932461,0.0005567253,0.5673699,0.000031346382,0.003074486,0.000083687286,0.002071003,0.00077891466,0.02860096,0.00044830516,0.0002529847,0.39279926],"study_design_scores_gemma":[0.0028385138,0.00054511864,0.98672175,0.000034908575,0.00052728935,0.00018632485,0.00037496662,0.00037031723,0.007490143,0.00031952056,0.00031475365,0.00027638348],"about_ca_topic_score_codex":0.019366458,"about_ca_topic_score_gemma":0.0066216914,"teacher_disagreement_score":0.4193519,"about_ca_system_score_codex":0.0001420138,"about_ca_system_score_gemma":0.00018986347,"threshold_uncertainty_score":0.98716366},"labels":[],"label_agreement":null},{"id":"W2174423882","doi":"10.1007/s10549-015-3643-5","title":"Correlation between progression-free survival and overall survival in metastatic breast cancer patients receiving anthracyclines, taxanes, or targeted therapies: a trial-level meta-analysis","year":2015,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"National Cancer Institute","keywords":"Medicine; Internal medicine; Hazard ratio; Metastatic breast cancer; Oncology; Breast cancer; Progression-free survival; Randomized controlled trial; Clinical trial; Meta-analysis; Cancer; Overall survival; Confidence interval","score_opus":0.3655082059876479,"score_gpt":0.5081216217604009,"score_spread":0.142613415772753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2174423882","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006154077,0.9711132,0.0000031789707,0.0012411913,0.0002909236,0.0067812023,0.0143079655,0.00004362248,0.000064657404],"genre_scores_gemma":[0.010927355,0.9771853,0.00009186485,0.000015560981,0.0005241415,0.0065722642,0.0024915251,0.00011518766,0.0020767765],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99319506,0.0017093999,0.0012348428,0.0013579159,0.0015010071,0.0010017921],"domain_scores_gemma":[0.99595916,0.0013050797,0.00063800084,0.00067019946,0.0006945771,0.0007329952],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001525147,0.0010191388,0.0061392942,0.0012143067,0.000259822,0.00013569323,0.00022117973,0.00029286646,0.0012242007],"category_scores_gemma":[0.00007695355,0.0005738579,0.00080200535,0.0018119651,0.00032467415,0.00021953021,0.0002261682,0.00065108796,0.000006799866],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02469307,0.00370095,0.03466239,0.0021969127,0.16481526,0.00018400566,0.0002883394,0.000003070931,2.5354902e-7,0.000008090458,0.00048491315,0.76896274],"study_design_scores_gemma":[0.1427883,0.009544821,0.13069504,0.0033842716,0.5642329,0.00014145266,0.000170889,0.000052934924,0.0000012787898,0.00012978716,0.14727843,0.0015799106],"about_ca_topic_score_codex":0.024972081,"about_ca_topic_score_gemma":0.018143449,"teacher_disagreement_score":0.76738286,"about_ca_system_score_codex":0.0021718666,"about_ca_system_score_gemma":0.0026349074,"threshold_uncertainty_score":0.99977285},"labels":[],"label_agreement":null},{"id":"W2175453042","doi":"10.1007/s10549-015-3633-7","title":"Health-related quality of life in patients with locally advanced or metastatic breast cancer treated with eribulin mesylate or capecitabine in an open-label randomized phase 3 trial","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"National Cancer Institute; Medical Research Council; Eisai; Celgene","keywords":"Capecitabine; Medicine; Eribulin; Metastatic breast cancer; Internal medicine; Nausea; Breast cancer; Quality of life (healthcare); Randomized controlled trial; Oncology; Cancer; Surgery; Nursing","score_opus":0.1701282498210228,"score_gpt":0.486875781200225,"score_spread":0.3167475313792022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2175453042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98264474,0.0016742283,0.0000026164112,0.003377606,0.00005272502,0.010677757,0.0014961994,0.000026404792,0.000047741654],"genre_scores_gemma":[0.9922891,0.00133617,0.00022562568,0.00010700582,0.000049503706,0.0048051113,0.00041211364,0.000058993577,0.0007163657],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9951771,0.0013015511,0.0011262066,0.0007750119,0.0007803199,0.0008398286],"domain_scores_gemma":[0.99713224,0.0003498573,0.0003941934,0.0003761529,0.0007221677,0.0010253898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012940458,0.0004667398,0.0025114175,0.00043337644,0.00009663305,0.00004662913,0.00017219079,0.000086494154,0.0006234852],"category_scores_gemma":[0.000056215475,0.00023926172,0.000042719916,0.0012212034,0.00048445247,0.00033001965,0.00007063529,0.00028882688,0.0000025363238],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8580164,0.024132835,0.06592083,0.00012340807,0.0012443179,0.00021323982,0.0007134143,0.000056304994,0.000029762292,0.000010294074,0.000055235745,0.049483966],"study_design_scores_gemma":[0.8900327,0.043679215,0.06474781,0.0005063728,0.0002522218,0.00003513648,0.00022463029,0.00019356469,0.000046241857,0.000014795595,0.000030271958,0.00023701446],"about_ca_topic_score_codex":0.12224705,"about_ca_topic_score_gemma":0.12047834,"teacher_disagreement_score":0.049246952,"about_ca_system_score_codex":0.0019424135,"about_ca_system_score_gemma":0.0055193314,"threshold_uncertainty_score":0.9791057},"labels":[],"label_agreement":null},{"id":"W2181389880","doi":"10.1007/s10549-015-3588-8","title":"Paclitaxel-induced transcriptional regulation of Fas signaling pathway is antagonized by dexamethasone","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor","funders":"Natural Sciences and Engineering Research Council of Canada; Windsor Cancer Centre Foundation; Breast Cancer Society of Canada","keywords":"Paclitaxel; Dexamethasone; Breast cancer; Medicine; Chemotherapy; Cancer; Cancer research; Internal medicine; Triple-negative breast cancer; Apoptosis; Oncology; Pharmacology; Endocrinology; Biology","score_opus":0.0753521041421698,"score_gpt":0.3392089924453275,"score_spread":0.2638568883031577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2181389880","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944018,0.0038336683,0.00041241825,0.0006006857,0.000046714336,0.00028939615,0.00029881572,0.0000054480706,0.00011106239],"genre_scores_gemma":[0.99750394,0.00059769186,0.00024730983,0.000018570445,0.00011974801,0.00007173126,0.00023335232,0.000013732722,0.0011938997],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99895763,0.00008435133,0.00014877858,0.00028259872,0.00030067598,0.00022596373],"domain_scores_gemma":[0.9993769,0.000011212361,0.000044484197,0.00015243638,0.00025296226,0.00016198591],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026665686,0.00011277843,0.00013343184,0.0000541047,0.00008150578,0.00001992682,0.000047341047,0.00009927747,0.000065062246],"category_scores_gemma":[0.000005880056,0.0000883238,0.00004914098,0.000097727774,0.00006723967,0.000007040702,0.000021629749,0.000043358265,0.0000016655118],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006365018,0.00017436767,0.00064709765,0.000011344032,0.00008243027,0.0000010386501,0.00013292032,0.000010634985,0.9433515,0.00016667208,0.0002832077,0.05450225],"study_design_scores_gemma":[0.0027422041,0.0011742429,0.005049708,0.000028705645,0.000017455925,0.000019173227,0.00020765647,0.00011913159,0.9842576,0.00050297024,0.0057632695,0.000117919815],"about_ca_topic_score_codex":0.0007307476,"about_ca_topic_score_gemma":0.00006571611,"teacher_disagreement_score":0.05438433,"about_ca_system_score_codex":0.000080080616,"about_ca_system_score_gemma":0.00019235749,"threshold_uncertainty_score":0.360174},"labels":[],"label_agreement":null},{"id":"W2189664995","doi":"10.1007/s10549-015-3646-2","title":"A randomized, double-blind, phase II, exploratory trial evaluating the palliative benefit of either continuing pamidronate or switching to zoledronic acid in patients with high-risk bone metastases from breast cancer","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Bone health and treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Canadian Cancer Society; American Society of Clinical Oncology; Amgen","keywords":"Medicine; Zoledronic acid; Breast cancer; Randomized controlled trial; Internal medicine; Bisphosphonate; Palliative care; Quality of life (healthcare); Oncology; Surgery; Cancer; Gastroenterology; Osteoporosis","score_opus":0.14392511978413938,"score_gpt":0.4395517459207426,"score_spread":0.2956266261366032,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2189664995","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851785,0.0035637375,0.0000075179714,0.0014901197,0.00009770976,0.0074088923,0.002218567,0.000021662192,0.000013299183],"genre_scores_gemma":[0.99227405,0.0008147198,0.00016591701,0.000057800135,0.00014367179,0.006211807,0.00013416019,0.000052180967,0.00014572205],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99620163,0.000543504,0.00065310753,0.0006360651,0.0011950365,0.000770641],"domain_scores_gemma":[0.99749136,0.00039300966,0.0003278699,0.00041533762,0.0007024063,0.00067002885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014203282,0.0003971642,0.001193932,0.00028029492,0.0002659475,0.000050181032,0.0001073202,0.00008043752,0.00015817807],"category_scores_gemma":[0.0000656355,0.00019526918,0.00010042378,0.0005334759,0.0001848221,0.00019363768,0.0001128428,0.00033209426,0.000005915935],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8110494,0.0029445007,0.042855054,0.000024716497,0.0012311991,0.00004084414,0.0035624222,0.000038690323,0.00001875417,0.000012231306,0.000011572728,0.13821061],"study_design_scores_gemma":[0.95512986,0.013616956,0.028122505,0.0008496027,0.00078687514,0.0000069304147,0.0007550652,0.00011232544,0.0003077081,0.00010017122,0.000024826017,0.00018716513],"about_ca_topic_score_codex":0.09922591,"about_ca_topic_score_gemma":0.025801336,"teacher_disagreement_score":0.14408046,"about_ca_system_score_codex":0.0011808396,"about_ca_system_score_gemma":0.0012827138,"threshold_uncertainty_score":0.99197525},"labels":[],"label_agreement":null},{"id":"W2196791823","doi":"10.1007/s10549-015-3634-6","title":"ESR1 and ESR2 polymorphisms in the BIG 1-98 trial comparing adjuvant letrozole versus tamoxifen or their sequence for early breast cancer","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Institute of Mining, Metallurgy and Petroleum","funders":"Novartis Pharma; National Cancer Institute; National Institutes of Health; National Institute of General Medical Sciences; Cancer Research Institute; Breast Cancer Research Foundation; Susan G. Komen for the Cure; Foundation for the National Institutes of Health","keywords":"Letrozole; Tamoxifen; Breast cancer; Single-nucleotide polymorphism; Internal medicine; Estrogen receptor alpha; Medicine; Estrogen receptor; Oncology; Selective estrogen receptor modulator; Genotype; Endocrinology; Cancer; Gynecology; Biology; Genetics; Gene","score_opus":0.15924388192302238,"score_gpt":0.3876460268976765,"score_spread":0.22840214497465414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2196791823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99020207,0.006780749,0.000004326999,0.0013021429,0.00016501456,0.0010664735,0.0003370652,0.000007459448,0.00013467202],"genre_scores_gemma":[0.9956539,0.0024874662,0.00001845267,0.000030391288,0.0005001635,0.0009793432,0.000048285267,0.000021004565,0.00026099393],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99856335,0.00015425326,0.00015061947,0.0004048987,0.00022507361,0.00050182693],"domain_scores_gemma":[0.9993193,0.0000722358,0.000042339267,0.00023637025,0.000104514955,0.00022521656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003498309,0.00020300683,0.00023043394,0.00006918751,0.000175781,0.00008564661,0.0001589488,0.0001204735,0.00000586052],"category_scores_gemma":[0.000013973603,0.00011123177,0.000050076633,0.00015421741,0.00023002489,0.000010162371,0.00009086634,0.00014733891,0.0000018360467],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.48937443,0.0015892527,0.0710683,0.00007410652,0.001466744,0.00019473185,0.0024106866,0.000090634145,0.04847697,0.0002380135,0.0020831486,0.382933],"study_design_scores_gemma":[0.55041426,0.048574932,0.288147,0.00070929277,0.00053144677,0.0016810527,0.003928445,0.0015215522,0.08450709,0.0006056554,0.017125841,0.0022534207],"about_ca_topic_score_codex":0.008719491,"about_ca_topic_score_gemma":0.0027296634,"teacher_disagreement_score":0.38067955,"about_ca_system_score_codex":0.00016191923,"about_ca_system_score_gemma":0.0004895989,"threshold_uncertainty_score":0.99788153},"labels":[],"label_agreement":null},{"id":"W2203649236","doi":"10.1007/s10549-015-3666-y","title":"The relationship between local recurrence and death in early-stage breast cancer","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Women's College Hospital","funders":"","keywords":"Breast cancer; Medicine; Stage (stratigraphy); Lymphovascular invasion; Cancer; Oncology; Tamoxifen; Internal medicine; Radiation therapy; Survival rate; Gynecology; Metastasis","score_opus":0.12112372019513062,"score_gpt":0.3945836573270137,"score_spread":0.2734599371318831,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2203649236","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9825758,0.011678328,0.000015386742,0.0042482396,0.00005732501,0.0004131955,0.0008188409,0.000009864515,0.00018307316],"genre_scores_gemma":[0.99316823,0.0051489626,0.000020003989,0.000018447376,0.00026085018,0.00071597967,0.00003762275,0.000021582367,0.00060832937],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99827194,0.0001713369,0.00018100231,0.00051350094,0.00030739477,0.0005548211],"domain_scores_gemma":[0.9990092,0.00017070594,0.00004608032,0.00029006883,0.00018503351,0.00029891546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033712454,0.0002251324,0.00019660725,0.000073912306,0.00037367173,0.00008161782,0.00012847986,0.0000962464,0.00000550283],"category_scores_gemma":[0.000030767984,0.0001489672,0.000032863616,0.0002089248,0.0004271525,0.000015164903,0.0001858768,0.00016237976,0.000005050795],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000687489,0.00008395488,0.9513525,0.00000954286,0.000118939766,0.000010487674,0.0002289081,0.0000072452217,0.000011552521,0.00028855292,0.00019442147,0.047006436],"study_design_scores_gemma":[0.0020196247,0.000271835,0.9937607,0.00006638349,0.00002384352,0.00003950585,0.00031621393,0.000006137267,0.00019067731,0.0003838519,0.0027737347,0.0001474704],"about_ca_topic_score_codex":0.02025549,"about_ca_topic_score_gemma":0.011996906,"teacher_disagreement_score":0.046858966,"about_ca_system_score_codex":0.00042637403,"about_ca_system_score_gemma":0.00040396256,"threshold_uncertainty_score":0.9862687},"labels":[],"label_agreement":null},{"id":"W2228540097","doi":"10.1007/s10549-015-3669-8","title":"Choice of study endpoint significantly impacts the results of breast cancer trials evaluating chemotherapy-induced nausea and vomiting","year":2016,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Nausea and vomiting management","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Statistics Canada; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Breast cancer; Nausea; Medicine; Vomiting; Chemotherapy; Oncology; Chemotherapy-induced nausea and vomiting; Internal medicine; Cancer; Antiemetic","score_opus":0.2714342835148381,"score_gpt":0.4988262448922453,"score_spread":0.2273919613774072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2228540097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862209,0.0007699381,0.0000018736588,0.00949733,0.000048088088,0.0025896188,0.0006151345,0.00001771044,0.00023939234],"genre_scores_gemma":[0.9968316,0.0017113787,0.000025210787,0.00003157291,0.00032992873,0.00039594324,0.000003589427,0.000029642373,0.00064116204],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99676234,0.0006419306,0.00071551965,0.00049899454,0.0008615199,0.00051970803],"domain_scores_gemma":[0.9968193,0.0016120278,0.00036529524,0.00045485038,0.0004997777,0.00024873528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042227944,0.00024141332,0.0007354587,0.0002005165,0.0001703531,0.00003913471,0.0001142666,0.000053198488,0.00009376153],"category_scores_gemma":[0.0004182288,0.00011237501,0.00009504918,0.00030930212,0.00022822725,0.00008075591,0.00010418317,0.0001306931,0.000001197005],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021767803,0.0016349937,0.18580769,0.00022206322,0.0019686348,0.000024976278,0.0020017382,0.0000010371961,0.13504821,0.000033177872,0.00026532632,0.6512244],"study_design_scores_gemma":[0.026314264,0.0042541814,0.94185007,0.0009425301,0.00035946775,0.000026909933,0.001412006,0.000026726075,0.024533538,0.000043967586,0.00010316312,0.00013316478],"about_ca_topic_score_codex":0.014092396,"about_ca_topic_score_gemma":0.0012783292,"teacher_disagreement_score":0.75604236,"about_ca_system_score_codex":0.00045544485,"about_ca_system_score_gemma":0.0005394795,"threshold_uncertainty_score":0.9924728},"labels":[],"label_agreement":null},{"id":"W2262040041","doi":"10.1007/s10549-016-3704-4","title":"Associations of sex steroid hormones with mortality in women with breast cancer","year":2016,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Center for Research Resources; National Institute of Child Health and Human Development; National Cancer Institute; National Institutes of Health; University of New Mexico","keywords":"Breast cancer; Sex hormone-binding globulin; Medicine; Estrone; Hazard ratio; Internal medicine; Proportional hazards model; Cancer; Oncology; Testosterone (patch); Body mass index; Prospective cohort study; Confidence interval; Odds ratio; Gynecology; Estrogen; Hormone; Androgen","score_opus":0.021406792836156447,"score_gpt":0.32370327539041377,"score_spread":0.30229648255425734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2262040041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99678683,0.0013010633,0.0000036877711,0.00062524434,0.0000082786455,0.00030184924,0.0008326191,0.0000048679635,0.00013555492],"genre_scores_gemma":[0.99579364,0.003294678,0.000010820967,0.000009760525,0.000054480384,0.00041733566,0.0000150393225,0.000015861453,0.0003883577],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989138,0.00008171177,0.000111949324,0.0002913134,0.00022057761,0.00038064376],"domain_scores_gemma":[0.9994697,0.000019183735,0.00004860084,0.00018936726,0.00013166021,0.00014147647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013993791,0.00013423589,0.00017924499,0.00006064934,0.00006844322,0.000013493965,0.000064352,0.00007864644,0.000023049628],"category_scores_gemma":[0.0000019212166,0.000067155954,0.000018238614,0.00014660739,0.00019536716,0.00000860799,0.000037317826,0.000060396913,0.0000010681875],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027859327,0.0004970624,0.83249116,0.000018227198,0.00078085106,0.00002562467,0.00023768246,0.00001154297,0.09353806,0.000016446402,0.00005661353,0.06954079],"study_design_scores_gemma":[0.0031721164,0.0015899292,0.96209645,0.00009914962,0.000022167837,0.000043536038,0.0001287198,0.0000017689733,0.03259481,0.000018434424,0.00011167405,0.000121234196],"about_ca_topic_score_codex":0.0038132293,"about_ca_topic_score_gemma":0.0024316462,"teacher_disagreement_score":0.1296053,"about_ca_system_score_codex":0.00024172672,"about_ca_system_score_gemma":0.00029689394,"threshold_uncertainty_score":0.57644874},"labels":[],"label_agreement":null},{"id":"W227417487","doi":"10.1007/s10549-015-3419-y","title":"Second primary breast cancer in BRCA1 and BRCA2 mutation carriers: 10-year cumulative incidence in the Breast Cancer Family Registry","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute","funders":"National Cancer Institute","keywords":"Breast cancer; Medicine; Cancer; Oncology; Incidence (geometry); Internal medicine; Cumulative incidence; Cancer registry; Family history; Gynecology; Cohort","score_opus":0.04440823097639967,"score_gpt":0.3617064162398202,"score_spread":0.3172981852634205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W227417487","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9807768,0.010783197,0.0000050968597,0.003840387,0.00009735373,0.00078876736,0.002872125,0.000009210099,0.00082710496],"genre_scores_gemma":[0.9929807,0.004061403,0.000051341794,0.00023564596,0.0003447593,0.0014359185,0.00011135386,0.000036407797,0.0007424707],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99747366,0.0003090039,0.00030259558,0.00078883057,0.0005280361,0.0005978902],"domain_scores_gemma":[0.99872863,0.00006084389,0.00010302234,0.00044044846,0.00042046362,0.00024659478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000590455,0.00029935336,0.00027724268,0.00017853522,0.00016635765,0.00012376979,0.000254596,0.000178509,0.000140892],"category_scores_gemma":[0.000019783995,0.0002308063,0.0000445478,0.0004881158,0.00048065407,0.000049110367,0.00016060223,0.00026110577,0.0000041748494],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008285594,0.0010170569,0.68299085,0.00029270374,0.0008619607,0.000369135,0.011603752,0.0022871676,0.018973013,0.0001758316,0.013819552,0.2593234],"study_design_scores_gemma":[0.004667475,0.0003336646,0.98494846,0.00020498532,0.00003648699,0.000542599,0.0041936794,0.0001356699,0.0011219471,0.0003121408,0.0031366928,0.00036617732],"about_ca_topic_score_codex":0.018655727,"about_ca_topic_score_gemma":0.03313723,"teacher_disagreement_score":0.30195764,"about_ca_system_score_codex":0.0017006561,"about_ca_system_score_gemma":0.002187095,"threshold_uncertainty_score":0.98787916},"labels":[],"label_agreement":null},{"id":"W2277921451","doi":"10.1007/s10549-016-3685-3","title":"Hormone replacement therapy after menopause and risk of breast cancer in BRCA1 mutation carriers: a case–control study","year":2016,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":105,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McGill University; University Health Network; University of Toronto; Women's College Hospital","funders":"National Cancer Institute; Canadian Cancer Society Research Institute; Canada Research Chairs; Cancer Research Institute","keywords":"Menopause; Medicine; Surgical Menopause; Hormone replacement therapy (female-to-male); Breast cancer; Odds ratio; Ovarian cancer; Oophorectomy; Gynecology; Logistic regression; Internal medicine; Confidence interval; Family history; Obstetrics; Oncology; Cancer; Hysterectomy; Surgery","score_opus":0.018124525384541207,"score_gpt":0.33559999904502064,"score_spread":0.31747547366047946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2277921451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98246807,0.012578503,0.000021967138,0.00069666683,0.000032316508,0.0011163754,0.0030667686,0.0000047786316,0.000014579836],"genre_scores_gemma":[0.9782306,0.019188024,0.00002355064,0.00001529921,0.00011026245,0.0022387297,0.000005182172,0.000023767969,0.00016459406],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983822,0.00026769668,0.0002311905,0.00053261995,0.00024673415,0.00033956088],"domain_scores_gemma":[0.9991815,0.000046625817,0.00007844242,0.00033173268,0.00022520986,0.00013648988],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003904739,0.00018755058,0.0002058178,0.00013259983,0.00010235671,0.000027338325,0.0000630197,0.00007051084,0.000101446436],"category_scores_gemma":[0.000009956866,0.00012205886,0.000029040486,0.00015217181,0.00020466436,0.000013975955,0.000056138513,0.000064640444,8.3520916e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012343881,0.000815744,0.5310516,0.000014489014,0.001455213,0.00024613066,0.0013672871,0.00003278202,0.034065742,0.0000036985512,0.00008863045,0.41851482],"study_design_scores_gemma":[0.017781194,0.0034060983,0.9683178,0.000052345844,0.00009701662,0.0004691786,0.0010729324,0.000019443729,0.008277493,0.000047274116,0.00025541027,0.00020381097],"about_ca_topic_score_codex":0.011378905,"about_ca_topic_score_gemma":0.015446858,"teacher_disagreement_score":0.43726623,"about_ca_system_score_codex":0.00043658025,"about_ca_system_score_gemma":0.00033410944,"threshold_uncertainty_score":0.9952044},"labels":[],"label_agreement":null},{"id":"W227897036","doi":"10.1007/s10549-015-3393-4","title":"Prospective evaluation of alcohol consumption and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Cancer Care Ontario; Women's College Hospital; University of Toronto","funders":"National Institutes of Health; Canada Research Chairs; National Cancer Institute; Cancer Care Ontario","keywords":"Medicine; Breast cancer; Prospective cohort study; Relative risk; BRCA mutation; Proportional hazards model; Population; Internal medicine; Cohort study; Risk factor; Cancer; Oncology; Cohort; Confidence interval; Gynecology; Environmental health","score_opus":0.06334716366910739,"score_gpt":0.39776043693364155,"score_spread":0.3344132732645342,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W227897036","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98554516,0.0122547755,0.00000765993,0.00053558126,0.000032733282,0.0008916807,0.000647517,0.0000017740119,0.00008313519],"genre_scores_gemma":[0.9924159,0.0067235013,0.000032242886,0.0000056102954,0.000051657,0.0007119341,0.00002060913,0.000009262523,0.000029301063],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987496,0.00031331278,0.00016133989,0.00028105578,0.00034129078,0.00015340961],"domain_scores_gemma":[0.99900895,0.000039824292,0.000094755575,0.00015500448,0.0006230459,0.00007840193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009858174,0.00010000228,0.00014887216,0.00008151928,0.000068985384,0.00001674623,0.00004299257,0.000060848113,0.00001555072],"category_scores_gemma":[0.000047299713,0.00006940411,0.000020322897,0.00012885223,0.00061505137,0.000010738504,0.000047906004,0.00006480168,2.1311159e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038112123,0.00014916735,0.8125606,0.000050283877,0.00056370615,0.000001386247,0.0030283784,0.0010478378,0.0061631356,0.00016512818,0.000077618155,0.17238155],"study_design_scores_gemma":[0.010727552,0.00028085426,0.97191936,0.000053513613,0.0001437296,0.00005384809,0.0010510274,0.0011894848,0.013423474,0.0010371353,0.000034785808,0.00008522412],"about_ca_topic_score_codex":0.009254302,"about_ca_topic_score_gemma":0.0062520024,"teacher_disagreement_score":0.17229633,"about_ca_system_score_codex":0.00038180102,"about_ca_system_score_gemma":0.00063559535,"threshold_uncertainty_score":0.9973432},"labels":[],"label_agreement":null},{"id":"W2282118044","doi":"10.1007/s10549-016-3720-4","title":"Transcriptomic analyses identify association between mitotic kinases, PDZ-binding kinase and BUB1, and clinical outcome in breast cancer","year":2016,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Instituto de Salud Carlos III; Ministerio de Economía y Competitividad; CRIS Cancer Foundation; Fundación Científica Asociación Española Contra el Cáncer; Astellas Pharma; European Commission","keywords":"Kinase; BUB1; Biology; Cancer research; Breast cancer; Gene; Basal (medicine); Downregulation and upregulation; Cancer; Genetics; Endocrinology; Kinetochore","score_opus":0.08931231672172761,"score_gpt":0.44262706188919215,"score_spread":0.35331474516746453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2282118044","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930354,0.0031078428,0.0000132094565,0.0022423347,0.00006169691,0.0003118902,0.0012067,0.0000064443307,0.000014508706],"genre_scores_gemma":[0.97377276,0.025152542,0.000017551401,0.00003208382,0.00026219527,0.000106746,0.000049119022,0.000020388761,0.00058662036],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99826264,0.00019022703,0.00032324475,0.0005574502,0.00019933887,0.0004670869],"domain_scores_gemma":[0.99930644,0.00009586326,0.00007777761,0.0001834059,0.00010227552,0.00023423543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004211841,0.00019530849,0.0003134405,0.00013499612,0.00013085145,0.00007209028,0.00008134123,0.00018505675,0.000026224021],"category_scores_gemma":[0.000023210392,0.00013547693,0.00007185063,0.00011943105,0.00016049102,0.000017883658,0.00008325882,0.000118706645,0.0000026692069],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023059965,0.0001274332,0.8808562,0.00002471817,0.00033118128,0.000010791706,0.00002250137,2.880062e-7,0.07120089,0.0000044161825,0.00010818728,0.047082752],"study_design_scores_gemma":[0.0030049894,0.00022977058,0.9895059,0.00011144224,0.00012490012,0.00002123193,0.00004823137,0.0000069453536,0.0061892397,0.000029782048,0.0005563946,0.00017118407],"about_ca_topic_score_codex":0.0046702004,"about_ca_topic_score_gemma":0.006135191,"teacher_disagreement_score":0.10864965,"about_ca_system_score_codex":0.00034811677,"about_ca_system_score_gemma":0.00014142506,"threshold_uncertainty_score":0.7059977},"labels":[],"label_agreement":null},{"id":"W2305750879","doi":"10.1007/s10549-016-3749-4","title":"The impact of oophorectomy on survival after breast cancer in BRCA1-positive breast cancer patients","year":2016,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Medicine; Breast cancer; Oophorectomy; Ovarian cancer; Internal medicine; Cancer; Oncology; Hazard ratio; Gynecology; Proportional hazards model; Cancer registry; Cohort; Cause of death; Survival analysis; Stage (stratigraphy); Survival rate; Obstetrics; Surgery; Hysterectomy; Disease; Confidence interval","score_opus":0.01758640418892278,"score_gpt":0.35312736952695595,"score_spread":0.3355409653380332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2305750879","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98061633,0.0024614872,0.0000021703813,0.0029379916,0.00017086542,0.0006380075,0.012976099,0.00000514568,0.00019192055],"genre_scores_gemma":[0.9881351,0.0091665685,0.0000035747341,0.000024105826,0.00035882764,0.0015952195,0.000030353382,0.000043688913,0.0006425715],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99750155,0.0002681958,0.00030810016,0.0006699757,0.00054011727,0.00071203156],"domain_scores_gemma":[0.99834025,0.00012863478,0.000110610796,0.00048161537,0.00071783754,0.00022107926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002847953,0.00031279915,0.00028459978,0.00014737394,0.00018272203,0.000056995075,0.00024686006,0.00013036697,0.00032486225],"category_scores_gemma":[0.000015406606,0.00016230145,0.00014452782,0.00033831963,0.0004646288,0.000016651795,0.0001522311,0.00012886587,0.000007834638],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0074888524,0.0006572306,0.7016498,0.000010303882,0.0006613263,0.000008716736,0.00014839608,0.00007286163,0.008018919,0.000016502634,0.00082399306,0.28044313],"study_design_scores_gemma":[0.00320608,0.0007170649,0.9866853,0.000181379,0.000021370724,0.000021159034,0.000048193382,0.000006444452,0.0084582465,0.00006542802,0.00038965096,0.00019968118],"about_ca_topic_score_codex":0.017534167,"about_ca_topic_score_gemma":0.013294923,"teacher_disagreement_score":0.28503555,"about_ca_system_score_codex":0.0018600406,"about_ca_system_score_gemma":0.0011435122,"threshold_uncertainty_score":0.9890082},"labels":[],"label_agreement":null},{"id":"W2307665013","doi":"10.1007/s10549-016-3689-z","title":"Molecular subtype profiling of invasive breast cancers weakly positive for estrogen receptor","year":2016,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; St. Paul's Hospital; Lions Gate Hospital; University of Ottawa; BC Cancer Agency; Ottawa Hospital; University of British Columbia","funders":"Canadian Cancer Society","keywords":"Breast cancer; Immunohistochemistry; Medicine; Estrogen receptor; Oncology; Internal medicine; Estrogen; Progesterone receptor; Cohort; Biomarker; Pathology; Cancer; Biology","score_opus":0.026931708745231913,"score_gpt":0.3289429712399911,"score_spread":0.3020112624947592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2307665013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858473,0.0046061985,0.00010010231,0.0022890756,0.00007590579,0.001069748,0.0058578346,0.000012368533,0.00014148014],"genre_scores_gemma":[0.99387485,0.0036332184,0.00044822355,0.000029087849,0.00022699828,0.001393519,0.00013774353,0.00004344185,0.00021289776],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982742,0.00008252732,0.00020263979,0.0006127802,0.00025846093,0.00056940684],"domain_scores_gemma":[0.9987136,0.00009826552,0.000093428884,0.00030690274,0.0005902067,0.00019758895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013082747,0.0002667163,0.00029074145,0.00009291177,0.00016823925,0.00001815728,0.00013540917,0.000098812605,0.000028375061],"category_scores_gemma":[0.000029648643,0.00017595282,0.00011931102,0.00014262926,0.00040038492,0.000011270728,0.00011692102,0.000043434295,0.000004356924],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005855518,0.00035861935,0.050143987,0.0000677347,0.0017440724,0.000011472359,0.00014183857,0.000009839362,0.8582177,0.0008528142,0.0004105001,0.08218591],"study_design_scores_gemma":[0.0039140647,0.0015969124,0.023970066,0.00022530148,0.0000921537,0.00008151809,0.00023342686,0.0000017145434,0.9688294,0.000229478,0.00056810345,0.00025789658],"about_ca_topic_score_codex":0.0026066264,"about_ca_topic_score_gemma":0.0005350707,"teacher_disagreement_score":0.11061167,"about_ca_system_score_codex":0.0005188913,"about_ca_system_score_gemma":0.00080947345,"threshold_uncertainty_score":0.7175148},"labels":[],"label_agreement":null},{"id":"W2327324661","doi":"10.1023/a:1006350913243","title":"RT-PCR amplification of CK19 mRNA in the blood of breast cancer patients: correlation with established prognostic parameters","year":2000,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Women's College Hospital; Sunnybrook Health Science Centre","funders":"University of Toronto","keywords":"Breast cancer; Cytokeratin; Medicine; Circulating tumor cell; Internal medicine; Cancer; Oncology; Pathology; Stage (stratigraphy); Breast disease; Reverse transcriptase; Metastatic breast cancer; Polymerase chain reaction; Metastasis; Biology; Immunohistochemistry; Gene","score_opus":0.03399913235122605,"score_gpt":0.31841257874557444,"score_spread":0.2844134463943484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327324661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99559176,0.0009815084,0.0000040366244,0.0011559322,0.000018646659,0.0013254978,0.0005570755,0.0000062207846,0.00035929572],"genre_scores_gemma":[0.9955345,0.0033937523,0.000090766145,0.000024692688,0.00003413749,0.0006323041,0.00007768813,0.000015040852,0.00019714801],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99850076,0.000102852326,0.00026209594,0.0002836954,0.000555877,0.00029470708],"domain_scores_gemma":[0.9990951,0.000121164834,0.00009150476,0.00025754172,0.00032360415,0.00011111423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021260383,0.0001414028,0.00028162115,0.00015725299,0.00006238964,0.000021638545,0.00007115596,0.000036537087,0.00032260935],"category_scores_gemma":[0.000009140571,0.000080555714,0.000043709533,0.0005786954,0.00022127706,0.000095507006,0.000010172048,0.00012333873,0.0000017879651],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039928295,0.002625274,0.73388207,0.00014629659,0.00025511993,0.000012677871,0.0009502693,0.00011254306,0.0003370866,0.000042172265,0.00007634614,0.25756732],"study_design_scores_gemma":[0.0058664167,0.0015485979,0.9900793,0.00043665178,0.00027718226,0.00006095216,0.00028297844,0.000047969803,0.0010700049,0.000024158919,0.00022490029,0.000080900274],"about_ca_topic_score_codex":0.025800604,"about_ca_topic_score_gemma":0.0020864,"teacher_disagreement_score":0.2574864,"about_ca_system_score_codex":0.00021464517,"about_ca_system_score_gemma":0.00033777862,"threshold_uncertainty_score":0.98068666},"labels":[],"label_agreement":null},{"id":"W2330347335","doi":"10.1007/s10549-016-3761-8","title":"Competing risks of death in women treated with adjuvant aromatase inhibitors for early breast cancer on NCIC CTG MA.27","year":2016,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Hamilton Health Sciences; University of Toronto; Juravinski Cancer Centre; Sunnybrook Health Science Centre; Robarts Clinical Trials; McMaster University; Queen's University","funders":"National Institute of General Medical Sciences; National Cancer Institute; Pfizer; Canadian Cancer Society Research Institute; Avon Foundation for Women","keywords":"Medicine; Exemestane; Internal medicine; Breast cancer; Letrozole; Anastrozole; Cancer; Oncology; Cause of death; Placebo; Aromatase inhibitor; Tamoxifen; Gynecology; Disease; Pathology","score_opus":0.04899130155347559,"score_gpt":0.3543085091021927,"score_spread":0.3053172075487171,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2330347335","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99132854,0.0016599157,0.0000062909044,0.0013566685,0.000038317106,0.00091299077,0.00459092,0.000014583779,0.00009175863],"genre_scores_gemma":[0.994186,0.002708215,0.0000460977,0.000027833665,0.00020263212,0.0025110105,0.000063198,0.00005160742,0.00020339625],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99770665,0.000113943264,0.000279265,0.00073289574,0.00033320967,0.00083401025],"domain_scores_gemma":[0.9989083,0.000104882325,0.000115798015,0.0003691135,0.0002551816,0.00024673744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020324969,0.00036701397,0.00044386275,0.0001878353,0.00016282649,0.00002576816,0.00013229836,0.00010467241,0.000043844215],"category_scores_gemma":[0.000010599536,0.00021368838,0.00007116794,0.00021815428,0.0003006819,0.000014811898,0.00009089801,0.000077024335,0.0000035838023],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021564674,0.0011584673,0.82764894,0.00007684072,0.0009032661,0.000041754185,0.0004187245,0.00002112543,0.009852261,0.00004053548,0.00014649524,0.13812692],"study_design_scores_gemma":[0.011228444,0.002951918,0.9499521,0.00069351145,0.000060876126,0.000058301895,0.00037075722,0.0000048033844,0.03371507,0.00004806512,0.0005977334,0.00031839573],"about_ca_topic_score_codex":0.01190667,"about_ca_topic_score_gemma":0.0034331353,"teacher_disagreement_score":0.13780852,"about_ca_system_score_codex":0.00081499055,"about_ca_system_score_gemma":0.00027860154,"threshold_uncertainty_score":0.99467313},"labels":[],"label_agreement":null},{"id":"W2335924678","doi":"10.1007/s10549-016-3782-3","title":"The incidence of bone metastasis after early-stage breast cancer in Canada","year":2016,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Bone health and treatments","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto General Hospital; Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Bone metastasis; Cumulative incidence; Incidence (geometry); Cancer; Oncology; Stage (stratigraphy); Metastasis; Tamoxifen; Cohort; Internal medicine; Cancer registry","score_opus":0.038783140537013865,"score_gpt":0.36327808745015955,"score_spread":0.3244949469131457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2335924678","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9742238,0.0072133415,5.2101217e-7,0.015481082,0.000057953454,0.00073504745,0.0021814532,0.0000066826087,0.000100149184],"genre_scores_gemma":[0.98305035,0.013343181,0.000011765783,0.00006483881,0.00004265612,0.0012239142,0.00000272658,0.000020072934,0.002240481],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99779963,0.000112880676,0.00031646524,0.00035910582,0.0006508429,0.00076107774],"domain_scores_gemma":[0.9986319,0.0002173017,0.000070399125,0.00036451625,0.00023815694,0.00047774788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002509362,0.00019273003,0.00037210356,0.00012111038,0.00014991323,0.00001627874,0.00006827676,0.000041367894,0.0004052402],"category_scores_gemma":[0.000012200108,0.00009001488,0.000049218357,0.00031121488,0.00023619884,0.00008691325,0.000061483974,0.00012347345,0.000007405088],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032122585,0.00018231437,0.7273302,0.000043959713,0.0001742745,0.0003274178,0.000068421934,3.1211414e-7,0.00008289242,0.000030869498,0.000094319366,0.26845276],"study_design_scores_gemma":[0.0036947948,0.00030140585,0.9930301,0.00039762122,0.000046582154,0.00012115813,0.000087810615,0.000003856974,0.0006972459,0.0000339374,0.0015041139,0.00008139668],"about_ca_topic_score_codex":0.98471606,"about_ca_topic_score_gemma":0.9857623,"teacher_disagreement_score":0.26837134,"about_ca_system_score_codex":0.002813796,"about_ca_system_score_gemma":0.0042175646,"threshold_uncertainty_score":0.7481779},"labels":[],"label_agreement":null},{"id":"W2343566398","doi":"10.1007/s10549-016-3808-x","title":"Phase II clinical study of eribulin monotherapy in Japanese patients with metastatic breast cancer who had well-defined taxane resistance","year":2016,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Eisai Canada; Eisai; Ministry of Health, Labour and Welfare; Japan Agency for Medical Research and Development","keywords":"Medicine; Eribulin; Taxane; Internal medicine; Metastatic breast cancer; Tolerability; Breast cancer; Neutropenia; Febrile neutropenia; Clinical endpoint; Gastroenterology; Progressive disease; Adverse effect; Oncology; Surgery; Chemotherapy; Cancer; Clinical trial","score_opus":0.07258553034229742,"score_gpt":0.4487050927202439,"score_spread":0.37611956237794647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343566398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98957014,0.0015856604,8.387522e-7,0.004581274,0.00006952933,0.0027075582,0.0013067637,0.000020889931,0.0001573523],"genre_scores_gemma":[0.98907745,0.004769369,0.000031208212,0.00006615107,0.00013264222,0.0017078964,0.000030373203,0.000044554126,0.0041403277],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971246,0.00032073565,0.0005719797,0.00071902893,0.0006268868,0.0006367431],"domain_scores_gemma":[0.9983099,0.00026747517,0.00017810475,0.00040615068,0.00044339866,0.00039493677],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00033483392,0.00034264746,0.00088855333,0.00027026449,0.00015486164,0.00001527889,0.00011412074,0.000068532034,0.0011779307],"category_scores_gemma":[0.000009335334,0.00018546826,0.000073616044,0.0005393193,0.00038857144,0.00011986457,0.00005608335,0.00018230098,0.000006878767],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08933979,0.052485406,0.6967527,0.00007206508,0.0016810949,0.00022860868,0.0013655251,0.0000018464951,0.0003368385,0.00000960597,0.0009793817,0.15674709],"study_design_scores_gemma":[0.18368076,0.030819839,0.7817797,0.000552695,0.00036961166,0.000024711277,0.00040771614,0.000006972338,0.00029888155,0.0000146920265,0.0018101641,0.00023427587],"about_ca_topic_score_codex":0.012558293,"about_ca_topic_score_gemma":0.019394252,"teacher_disagreement_score":0.15651281,"about_ca_system_score_codex":0.0007989737,"about_ca_system_score_gemma":0.00057060167,"threshold_uncertainty_score":0.9997351},"labels":[],"label_agreement":null},{"id":"W2343845543","doi":"10.1007/s10549-016-3812-1","title":"Canadian Cancer Trials Group IND197: a phase II study of foretinib in patients with estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2-negative recurrent or metastatic breast cancer","year":2016,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University; Hôpital Charles-Le Moyne; Juravinski Cancer Centre; University Health Network; Hamilton Health Sciences; Princess Margaret Cancer Centre; Kingston General Hospital; Interior Health; Ottawa Hospital; BC Cancer Agency; Queen Elizabeth II Health Sciences Centre","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Ipsen; AstraZeneca; Celgene; Genomic Health; Cancer Care Ontario; Pfizer; Cancer Research Institute","keywords":"Medicine; Internal medicine; PTEN; Cancer; Breast cancer; Oncology; Response Evaluation Criteria in Solid Tumors; Progressive disease; Metastatic breast cancer; Triple-negative breast cancer; Estrogen receptor; Clinical endpoint; Adverse effect; Clinical trial; Disease; Biology; PI3K/AKT/mTOR pathway","score_opus":0.12762285403095874,"score_gpt":0.4400756633405633,"score_spread":0.31245280930960456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343845543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9699857,0.0012245558,9.642941e-7,0.0049915677,0.00013152452,0.008871657,0.0147420745,0.000028297172,0.000023622923],"genre_scores_gemma":[0.98702204,0.0032490292,0.00013661258,0.00003342523,0.0002385433,0.00857873,0.00013106246,0.00011597564,0.00049455307],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9929707,0.0013433492,0.0010954667,0.0013039592,0.0016550021,0.001631541],"domain_scores_gemma":[0.99567777,0.00055721926,0.00037789563,0.0005508632,0.0011932792,0.0016429849],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013816219,0.000674206,0.0016748,0.0009543069,0.0004669993,0.000081982296,0.0002619687,0.00015489584,0.0039845253],"category_scores_gemma":[0.00020723902,0.00037297455,0.000099915844,0.0010144943,0.00067566545,0.00033413369,0.0001884327,0.0004918258,0.000007406356],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026637692,0.006821732,0.5959875,0.00026309508,0.001418397,0.000046519235,0.002815307,2.1703819e-7,0.0007413381,0.00002745867,0.0007006662,0.36454007],"study_design_scores_gemma":[0.12310858,0.07292167,0.78897256,0.005066504,0.0004926612,0.00004534132,0.0022487591,0.000004951173,0.0043579345,0.000052178682,0.0018025406,0.0009263007],"about_ca_topic_score_codex":0.47958815,"about_ca_topic_score_gemma":0.48549688,"teacher_disagreement_score":0.36361375,"about_ca_system_score_codex":0.005713955,"about_ca_system_score_gemma":0.0036539382,"threshold_uncertainty_score":0.9998722},"labels":[],"label_agreement":null},{"id":"W2344554404","doi":"10.1007/s10549-016-3805-0","title":"An international survey of surveillance schemes for unaffected BRCA1 and BRCA2 mutation carriers","year":2016,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Medicine; BRCA mutation; Breast cancer; Prophylactic Mastectomy; Ovarian cancer; Gynecology; Breast imaging; Genetic testing; Obstetrics; Oncology; Mammography; Cancer; Family medicine; Mastectomy; Internal medicine","score_opus":0.040423436684606615,"score_gpt":0.3855187853069151,"score_spread":0.34509534862230845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344554404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950394,0.00088240375,0.00040812689,0.0006056566,0.000067337976,0.00032034755,0.0026408238,0.000005044182,0.000030826995],"genre_scores_gemma":[0.99751455,0.0014963921,0.0002546061,0.000008752114,0.00009192544,0.00026532388,0.0002187346,0.000013935184,0.00013575856],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999146,0.00010278676,0.00010753335,0.00031927656,0.0001442566,0.00018018261],"domain_scores_gemma":[0.9990578,0.00007948381,0.000041128777,0.0002287929,0.00050067506,0.00009208325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002961634,0.0000901216,0.00009972763,0.00006172693,0.0000741222,0.00002210054,0.000103942504,0.000055304776,0.000018837642],"category_scores_gemma":[0.00009253407,0.00006363022,0.000018739747,0.000078103,0.00020563546,0.000010774306,0.000042013395,0.000019451492,2.847227e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021497353,0.00018279134,0.42382586,0.000027346723,0.0004900782,0.0000019457004,0.00011295406,0.000009030209,0.19761099,0.0001751276,0.00046310393,0.37495103],"study_design_scores_gemma":[0.0032782084,0.00092703546,0.87593096,0.000022846352,0.0000075549424,0.000019364572,0.000046700112,0.000050645165,0.116446346,0.00013638815,0.0030214828,0.00011243267],"about_ca_topic_score_codex":0.0014731872,"about_ca_topic_score_gemma":0.0034509026,"teacher_disagreement_score":0.45210513,"about_ca_system_score_codex":0.00014837044,"about_ca_system_score_gemma":0.00027474464,"threshold_uncertainty_score":0.2594765},"labels":[],"label_agreement":null},{"id":"W2344570909","doi":"10.1007/s10549-016-3806-z","title":"Relapse-free survival of statistically standardized continuous RT-PCR estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2): NCIC CTG MA.14","year":2016,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; McGill University; Queen's University","funders":"Novartis Pharmaceuticals Canada; Canadian Cancer Society Research Institute; Avon Foundation for Women","keywords":"Breast cancer; Medicine; Progesterone receptor; Internal medicine; Estrogen receptor; Biomarker; Tamoxifen; Oncology; Univariate analysis; Proportional hazards model; Population; Gynecology; Cancer; Multivariate analysis; Biology","score_opus":0.024570992455228778,"score_gpt":0.332665148771888,"score_spread":0.30809415631665926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344570909","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9841265,0.0013694996,0.0012998283,0.0030117854,0.000054958397,0.0013005274,0.008587598,0.00003954565,0.00020976218],"genre_scores_gemma":[0.98688656,0.0052103032,0.00448951,0.000034552282,0.00021097923,0.001095756,0.0004800035,0.00006565982,0.0015266986],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975904,0.0003088088,0.0003902478,0.0007600234,0.00034235782,0.00060813146],"domain_scores_gemma":[0.9983787,0.00008353676,0.00013832234,0.00058688485,0.00045519968,0.0003573683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037155452,0.00031519638,0.00043438023,0.00008145568,0.00023453466,0.00004065559,0.00025749297,0.00024174034,0.00032377327],"category_scores_gemma":[0.00009514941,0.00021590565,0.000089381596,0.00011352461,0.00072336145,0.000011536941,0.00027236238,0.00012937345,0.000008460504],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018039899,0.0004826705,0.034165982,0.000056510613,0.00045275583,0.000006939647,0.000042011576,4.0846437e-8,0.8905416,0.003660329,0.0059015974,0.06288554],"study_design_scores_gemma":[0.010401052,0.0082576955,0.04657439,0.00023282877,0.000107619606,0.000078907,0.00010890196,0.0000010988938,0.84160256,0.0013570951,0.090451345,0.00082647067],"about_ca_topic_score_codex":0.00071784965,"about_ca_topic_score_gemma":0.0002384549,"teacher_disagreement_score":0.08454975,"about_ca_system_score_codex":0.00014980305,"about_ca_system_score_gemma":0.00024097216,"threshold_uncertainty_score":0.8804377},"labels":[],"label_agreement":null},{"id":"W2344988130","doi":"10.1007/s10549-016-3784-1","title":"Germline RECQL mutations in high risk Chinese breast cancer patients","year":2016,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Public Health Ontario; Women's College Hospital","funders":"","keywords":"Breast cancer; Nonsense mutation; Germline mutation; Cancer; Mutation; Genetics; Biology; Cancer research; Oncology; Gene mutation; Genome instability; Internal medicine; Medicine; Gene; Missense mutation; DNA; DNA damage","score_opus":0.013604870086532739,"score_gpt":0.3217027717941388,"score_spread":0.3080979017076061,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344988130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946889,0.0005256177,0.000012019145,0.0013249276,0.000083619445,0.0004237524,0.0028567088,0.000011982007,0.00007247342],"genre_scores_gemma":[0.99320203,0.00439211,0.00006276247,0.000021534644,0.00021041553,0.00074878987,0.00009974231,0.000027052465,0.0012355793],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998529,0.00012785432,0.00016768427,0.00048425174,0.00024789016,0.00044329657],"domain_scores_gemma":[0.9992266,0.00003002918,0.000050766022,0.00027937,0.00021836482,0.00019484728],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014908485,0.00018093771,0.00015808368,0.000108891756,0.00012505183,0.000024335282,0.00010630114,0.00008904021,0.0001909342],"category_scores_gemma":[0.00002178256,0.00010842795,0.000047339447,0.00018191128,0.00012226123,0.000010627054,0.00010130435,0.000070728915,0.000015293504],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000820451,0.00070255937,0.7725469,0.000009450155,0.00014489074,0.000012878723,0.00005327547,0.0000074164077,0.023002809,0.00003880892,0.00019373123,0.20246682],"study_design_scores_gemma":[0.00439367,0.00059955096,0.9828257,0.00006571565,0.000016466312,0.000020643216,0.000016466294,0.000010294912,0.01068481,0.0004888059,0.00070646504,0.00017139604],"about_ca_topic_score_codex":0.00950878,"about_ca_topic_score_gemma":0.007955196,"teacher_disagreement_score":0.21027881,"about_ca_system_score_codex":0.000278194,"about_ca_system_score_gemma":0.00020302819,"threshold_uncertainty_score":0.997087},"labels":[],"label_agreement":null},{"id":"W2396057381","doi":"10.1007/s10549-016-3834-8","title":"A longitudinal analysis of chronic arm morbidity following breast cancer surgery","year":2016,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer survivorship and care","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Horizon Health Network; University of Ottawa; Research Institute in Oncology and Hematology; BC Cancer Agency; University of Manitoba; McGill University; Dalhousie University; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Affect (linguistics); Medicine; Mood; Breast cancer; Quality of life (healthcare); Physical therapy; Range of motion; Longitudinal study; Physical medicine and rehabilitation; Internal medicine; Cancer; Psychology; Clinical psychology; Nursing","score_opus":0.0830894033442911,"score_gpt":0.386151076837384,"score_spread":0.3030616734930929,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2396057381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9857352,0.0072388914,0.00002083218,0.0046765283,0.00019163272,0.00033737754,0.0015712044,0.000029154526,0.00019919162],"genre_scores_gemma":[0.9896402,0.008467145,0.0000028989493,0.000017633316,0.0003850462,0.00044347745,0.000027763028,0.000024577115,0.0009912576],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976987,0.000096361495,0.0002809353,0.0005430454,0.0007366695,0.000644269],"domain_scores_gemma":[0.9985025,0.00025955058,0.00007492064,0.00042897277,0.0003279554,0.00040609512],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003606838,0.00022725039,0.00074350275,0.00059241924,0.0001403648,0.000025967418,0.00007775993,0.00007876696,0.0016804592],"category_scores_gemma":[0.000010443455,0.00013599325,0.00045643514,0.0012147257,0.00023230692,0.000108720145,0.00006418365,0.00010907644,0.000007068889],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011164129,0.00049685064,0.77669215,0.000076806806,0.0041193743,0.00013068785,0.00012002389,0.0000025554978,0.0008516538,0.000032023137,0.00028035964,0.2160811],"study_design_scores_gemma":[0.0017251085,0.00030295845,0.99336785,0.00052419025,0.0014881875,0.00006838795,0.00008786796,0.00003215601,0.0012850818,0.000022012988,0.00094146776,0.00015472125],"about_ca_topic_score_codex":0.091986746,"about_ca_topic_score_gemma":0.07234422,"teacher_disagreement_score":0.2166757,"about_ca_system_score_codex":0.0018368397,"about_ca_system_score_gemma":0.001150455,"threshold_uncertainty_score":0.9992321},"labels":[],"label_agreement":null},{"id":"W2408550433","doi":"10.1007/s10549-016-3842-8","title":"Long-term consequences of ovarian ablation for premenopausal breast cancer","year":2016,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Tamoxifen; Medicine; Breast cancer; Goserelin; Oncology; Gynecology; Population; Internal medicine; Cancer","score_opus":0.04934624895585982,"score_gpt":0.37719600023267064,"score_spread":0.3278497512768108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2408550433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98863196,0.0022038028,0.00048304978,0.0046307263,0.000113271984,0.000772092,0.0030454434,0.000008275144,0.000111392976],"genre_scores_gemma":[0.99458396,0.0027247884,0.00016292179,0.000018791126,0.00033424524,0.0011993122,0.00005112401,0.000019886476,0.0009049513],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9988632,0.00005642328,0.00016777928,0.00038564228,0.00019980222,0.00032712548],"domain_scores_gemma":[0.9991379,0.000039623614,0.000067209345,0.00023492846,0.00040916394,0.00011117978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016419427,0.0001351,0.00013923571,0.00007025838,0.00012918693,0.000023132336,0.0001047885,0.000079129175,0.00017240632],"category_scores_gemma":[0.000009475975,0.00008872581,0.0000397274,0.000096019496,0.00040262807,0.0000106027655,0.000048327754,0.000028269249,0.0000018878825],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00183427,0.00020455747,0.16298811,0.0000594858,0.00043730554,0.00000285956,0.000064227395,0.000012015098,0.59745574,0.00034794587,0.0006026338,0.23599082],"study_design_scores_gemma":[0.003923167,0.0011490299,0.5800867,0.00018835276,0.00006302002,0.00009588873,0.000034668843,0.0000060593675,0.4116372,0.00045269693,0.0021421737,0.00022108053],"about_ca_topic_score_codex":0.0012309174,"about_ca_topic_score_gemma":0.0015822604,"teacher_disagreement_score":0.41709855,"about_ca_system_score_codex":0.00032005654,"about_ca_system_score_gemma":0.0007803542,"threshold_uncertainty_score":0.36181334},"labels":[],"label_agreement":null},{"id":"W2415764626","doi":"10.1007/s10549-016-3823-y","title":"Long-term cardiovascular outcomes and overall survival of early-stage breast cancer patients with early discontinuation of trastuzumab: a population-based study","year":2016,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; BC Cancer Agency; Cancer Care Ontario; Ontario Institute for Cancer Research; Public Health Ontario; Toronto Public Health; Sunnybrook Health Science Centre; St. Michael's Hospital; Institute for Clinical Evaluative Sciences; Health Sciences Centre; University Health Network; University of Toronto","funders":"Canadian Cancer Society","keywords":"Medicine; Hazard ratio; Trastuzumab; Discontinuation; Internal medicine; Breast cancer; Population; Myocardial infarction; Clinical endpoint; Proportional hazards model; Cardiotoxicity; Cancer; Retrospective cohort study; Confidence interval; Oncology; Chemotherapy; Randomized controlled trial","score_opus":0.033026724685220006,"score_gpt":0.3275058798334186,"score_spread":0.2944791551481986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2415764626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971926,0.00021114493,0.000027845545,0.0002792305,0.000023555453,0.0015150141,0.00072862447,0.0000112855,0.000010702517],"genre_scores_gemma":[0.9993587,0.00015108069,0.000009239023,0.0000045886623,0.000046888443,0.00023233981,0.00003113265,0.000023803012,0.00014221574],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99822503,0.0001238028,0.00023220021,0.0003438875,0.0008243913,0.00025068314],"domain_scores_gemma":[0.99902236,0.000079056925,0.00009163395,0.00027992675,0.00037427837,0.00015271733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021224648,0.00018196808,0.0005311313,0.00014912144,0.00007867733,0.000020210899,0.000040340474,0.00005214706,0.000042815114],"category_scores_gemma":[0.0000065392187,0.00010359238,0.00011570686,0.00014133035,0.000116326795,0.00013743203,0.00001803528,0.000064604385,3.1246427e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024027252,0.0012043887,0.93520224,0.000064399566,0.0014629373,0.000007413137,0.0003905645,0.0000046797077,0.0008829221,0.000008586633,4.334202e-7,0.05836869],"study_design_scores_gemma":[0.014296489,0.0019435746,0.98079824,0.00032045698,0.00022683223,0.0000025854852,0.00005285304,0.0000019366314,0.0022481985,0.00000461537,0.0000012969884,0.000102913866],"about_ca_topic_score_codex":0.021851031,"about_ca_topic_score_gemma":0.00247413,"teacher_disagreement_score":0.058265775,"about_ca_system_score_codex":0.00037554651,"about_ca_system_score_gemma":0.00019595608,"threshold_uncertainty_score":0.98466253},"labels":[],"label_agreement":null},{"id":"W2466624478","doi":"10.1007/s10549-016-3901-1","title":"A novel approach to breast cancer prevention: reducing excessive ovarian androgen production in elderly women","year":2016,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Breast cancer; Medicine; Aromatase; Estrogen; Oncology; Internal medicine; Testosterone (patch); Androgen; Population; Endocrinology; Cancer; Gynecology; Hormone","score_opus":0.03942102929699136,"score_gpt":0.345996508115373,"score_spread":0.30657547881838165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2466624478","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912632,0.0010159909,0.0003097453,0.005531239,0.00012064219,0.00091077056,0.00053584314,0.000010943062,0.0003016237],"genre_scores_gemma":[0.9897456,0.0011855892,0.0004983877,0.000027023181,0.0006106302,0.00441963,0.000024267556,0.000029679379,0.0034591954],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9981659,0.00008422504,0.00018435843,0.00076384697,0.00025603047,0.00054566324],"domain_scores_gemma":[0.99916375,0.000009624806,0.000047165362,0.00034665817,0.00021535427,0.0002174787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028132394,0.00018174232,0.00016636934,0.00016390497,0.00015412371,0.00004710242,0.00012906049,0.00009153159,0.0000772589],"category_scores_gemma":[0.000013550982,0.00012931938,0.000035061716,0.0003513613,0.00012528352,0.000019225403,0.0000996964,0.000069291855,0.000004626799],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019351885,0.001098371,0.012607693,0.000049832437,0.00037806647,0.0000065281224,0.0012916854,0.00026069087,0.28210455,0.000044517088,0.0011632991,0.6990596],"study_design_scores_gemma":[0.019565128,0.004710683,0.6501939,0.0013727888,0.00011095611,0.0021778666,0.0036177256,0.000053953176,0.28948942,0.0009939161,0.025928158,0.0017854882],"about_ca_topic_score_codex":0.0020469427,"about_ca_topic_score_gemma":0.0014014235,"teacher_disagreement_score":0.6972741,"about_ca_system_score_codex":0.0014109857,"about_ca_system_score_gemma":0.0008769021,"threshold_uncertainty_score":0.5273491},"labels":[],"label_agreement":null},{"id":"W2472613475","doi":"10.1007/s10549-016-3900-2","title":"Impact of resistance and aerobic exercise on sarcopenia and dynapenia in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial","year":2016,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":169,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; BC Cancer Agency; Alberta Health Services; University of British Columbia; Ottawa Regional Cancer Foundation; University of Alberta","funders":"Canadian Institutes of Health Research; Canadian Breast Cancer Research Alliance","keywords":"Sarcopenia; Medicine; Breast cancer; Internal medicine; Chemotherapy; Randomized controlled trial; Oncology; Quality of life (healthcare); Cancer; Aerobic exercise; Confidence interval; Anemia; Physical therapy","score_opus":0.028778245990266595,"score_gpt":0.38867798910665935,"score_spread":0.3598997431163928,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2472613475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98424566,0.0035338767,6.252308e-7,0.0061537297,0.000049785023,0.0057263887,0.00019362207,0.000010968444,0.00008535229],"genre_scores_gemma":[0.9643059,0.03312954,0.000036391586,0.000058315753,0.00007351076,0.0018433541,0.000005626381,0.000023474997,0.0005238887],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9980125,0.00028194618,0.00047123336,0.00041197895,0.00036243934,0.00045992492],"domain_scores_gemma":[0.99863255,0.00048252053,0.00013931311,0.00017022906,0.00023706362,0.00033832577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064593856,0.00022655216,0.0012860869,0.00028735274,0.000102902246,0.00002807237,0.000040544513,0.000070365786,0.0002496773],"category_scores_gemma":[0.000042476328,0.00011565159,0.00011190478,0.0001469039,0.00029842393,0.000083665225,0.000028451024,0.00012934813,0.0000015905741],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.83196247,0.0010994124,0.109650046,0.000116601885,0.0002177027,0.00001200604,0.00029147544,7.955937e-8,0.00048275842,0.000007053226,0.000097283206,0.056063116],"study_design_scores_gemma":[0.64872295,0.0006736064,0.34777918,0.0025312249,0.000053065854,0.000005855924,0.000019737066,0.00001918833,0.00007549897,0.00002827172,0.000017852646,0.00007357851],"about_ca_topic_score_codex":0.0028903622,"about_ca_topic_score_gemma":0.001018421,"teacher_disagreement_score":0.23812912,"about_ca_system_score_codex":0.00071097404,"about_ca_system_score_gemma":0.00028656225,"threshold_uncertainty_score":0.4716135},"labels":[],"label_agreement":null},{"id":"W2475233440","doi":"10.1007/s10549-016-3894-9","title":"Impact of a prior diagnosis of DCIS on survival from invasive breast cancer","year":2016,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Lumpectomy; Ductal carcinoma; Mastectomy; Oncology; Stage (stratigraphy); Cancer; Radiation therapy; Internal medicine; Gynecology","score_opus":0.04430641448041019,"score_gpt":0.3713990514306787,"score_spread":0.3270926369502685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2475233440","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9802124,0.0029667893,0.0000019898202,0.0015781744,0.000068512294,0.00039801814,0.014666819,0.0000067774567,0.00010055319],"genre_scores_gemma":[0.9780286,0.020581327,0.000021002113,0.000010929763,0.00027831542,0.00086514803,0.00004766101,0.00003174795,0.0001352752],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982044,0.00012483625,0.00024009775,0.00057668117,0.0003856571,0.00046833217],"domain_scores_gemma":[0.9986051,0.00022323,0.00012409786,0.00043901635,0.00040327478,0.00020532763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009569111,0.00029286082,0.00042446345,0.000111820926,0.00010617281,0.000012464515,0.00015858695,0.000100759746,0.00034727115],"category_scores_gemma":[0.000025615078,0.00016624936,0.00018620006,0.00016731834,0.00042391813,0.000009965421,0.00015273472,0.000053394655,0.0000056387253],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004065953,0.0009257019,0.8095156,0.000018409262,0.001898876,0.000008719124,0.00012398868,0.0000036665206,0.019357711,0.00001956773,0.0005006511,0.1635612],"study_design_scores_gemma":[0.0037989793,0.0014779004,0.9205973,0.00029762366,0.000077366436,0.000011103919,0.000054483477,3.3097876e-7,0.07332141,0.00006750396,0.00014036878,0.00015563463],"about_ca_topic_score_codex":0.042936306,"about_ca_topic_score_gemma":0.0071368725,"teacher_disagreement_score":0.16340555,"about_ca_system_score_codex":0.00038200105,"about_ca_system_score_gemma":0.0005803288,"threshold_uncertainty_score":0.96343684},"labels":[],"label_agreement":null},{"id":"W2478042827","doi":"10.1007/s10549-016-3906-9","title":"Endocrine treatment-associated cognitive impairment in breast cancer survivors: evidence from published studies","year":2016,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre; Women's College Hospital; University of Toronto; Health Sciences Centre; University of British Columbia","funders":"Ontario Institute for Cancer Research; Cancer Care Ontario","keywords":"Breast cancer; Medicine; Neuropsychology; Cognition; Endocrine system; Randomized controlled trial; Oncology; Cognitive decline; Effects of sleep deprivation on cognitive performance; Internal medicine; Cancer; Dementia; Disease; Psychiatry; Hormone","score_opus":0.16665830214822366,"score_gpt":0.4708245507537167,"score_spread":0.304166248605493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2478042827","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0130033335,0.95376873,3.4490748e-7,0.0061463127,0.00042557597,0.007511411,0.018858459,0.00013253716,0.00015332401],"genre_scores_gemma":[0.011902768,0.96288943,0.0000045816782,0.000048615344,0.0010256848,0.020054545,0.00047369848,0.00018162081,0.003419075],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99180406,0.0010881145,0.0012804703,0.002295017,0.001416957,0.0021153868],"domain_scores_gemma":[0.99304056,0.003226834,0.00053620077,0.00067284715,0.0017249784,0.000798589],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00064734835,0.0016239347,0.004725697,0.0012519427,0.0004630606,0.00018812814,0.00025416628,0.00038706936,0.0014389234],"category_scores_gemma":[0.0002829542,0.00095761573,0.0006837956,0.0016021688,0.0010083652,0.00048027415,0.0004542623,0.00075406063,0.00012376666],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003216608,0.0029610826,0.03462929,0.0022976685,0.017386522,0.0010075768,0.00085180893,1.2010877e-7,0.0000020177943,0.000003222253,0.0010900754,0.936554],"study_design_scores_gemma":[0.041493513,0.010061952,0.19389369,0.58353037,0.013808555,0.001055712,0.0027588431,0.0000055594937,0.000046973328,0.0001610682,0.15046741,0.0027163965],"about_ca_topic_score_codex":0.09727286,"about_ca_topic_score_gemma":0.042537607,"teacher_disagreement_score":0.9338376,"about_ca_system_score_codex":0.020930152,"about_ca_system_score_gemma":0.0035870513,"threshold_uncertainty_score":0.99965084},"labels":[],"label_agreement":null},{"id":"W2487059482","doi":"10.1007/s10549-016-3870-4","title":"A Survey of BRCA1, BRCA2, and PALB2 mutations in women with breast cancer in Trinidad and Tobago","year":2016,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Women's College Hospital; University of Toronto","funders":"Susan G. Komen; Susan G. Komen for the Cure","keywords":"PALB2; Breast cancer; Medicine; Cancer; Oncology; Mutation; Gynecology; Genetics; Gene; Internal medicine; Demography; Germline mutation; Biology","score_opus":0.03170213214605699,"score_gpt":0.3447986936998417,"score_spread":0.3130965615537847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2487059482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928187,0.0035193563,0.0000062411123,0.0016766104,0.00001442398,0.00035482636,0.0015488932,0.000002666814,0.000058294285],"genre_scores_gemma":[0.9912562,0.007659237,0.000030146342,0.000020441006,0.000033103188,0.000770763,0.000014587717,0.000016889677,0.00019866363],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987438,0.00013902906,0.00017074795,0.00042323204,0.0001623424,0.0003608813],"domain_scores_gemma":[0.99935246,0.00007313698,0.00004201895,0.00018666367,0.00018096356,0.00016476706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030417438,0.00014183368,0.00019341169,0.00015479737,0.000054863154,0.000022346161,0.00006195056,0.00006952102,0.00005217227],"category_scores_gemma":[0.000020559028,0.00009279257,0.0000094126035,0.00027330793,0.00036812754,0.000012137732,0.00007028564,0.000056222834,4.6651562e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020709238,0.00019176114,0.68553984,0.00002588489,0.00012269741,0.000009616362,0.00039201003,0.00001493645,0.008082053,0.000015045643,0.000042151045,0.3034931],"study_design_scores_gemma":[0.004026417,0.00049132004,0.99192196,0.00011792809,0.000006632055,0.00004694859,0.00021896746,0.000008984486,0.00275996,0.000050098966,0.00023309387,0.00011769855],"about_ca_topic_score_codex":0.018086914,"about_ca_topic_score_gemma":0.07758502,"teacher_disagreement_score":0.30638212,"about_ca_system_score_codex":0.00038454522,"about_ca_system_score_gemma":0.0007140391,"threshold_uncertainty_score":0.9884517},"labels":[],"label_agreement":null},{"id":"W2487431344","doi":"10.1007/s10549-016-3908-7","title":"Standardized measures of lobular involution and subsequent breast cancer risk among women with benign breast disease: a nested case–control study","year":2016,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Lesions and Carcinomas","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Cancer Institute; National Institutes of Health; Susan G. Komen; Mayo Clinic","keywords":"Quartile; Breast cancer; Medicine; Breast disease; Involution (esoterism); Odds ratio; Logistic regression; Confidence interval; Internal medicine; Cancer; Biology","score_opus":0.0329526719419565,"score_gpt":0.3106430970803345,"score_spread":0.277690425138378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2487431344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98324865,0.0038463357,0.000058821843,0.0019495048,0.000026111402,0.0023334702,0.008475824,0.00004437848,0.000016917915],"genre_scores_gemma":[0.99587274,0.0018710808,0.000013929574,0.000013282638,0.00016580886,0.0017954918,0.00000767297,0.000054342552,0.00020568275],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964191,0.00049748406,0.0003684007,0.00078828895,0.0010715802,0.00085514964],"domain_scores_gemma":[0.9970538,0.00012258133,0.00015217635,0.000570989,0.00089724944,0.0012032262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000757245,0.00040776702,0.0007309712,0.00030978746,0.00040352036,0.00006197804,0.00008609933,0.00008666303,0.00029013527],"category_scores_gemma":[0.000015175899,0.00021906749,0.00007737552,0.0004244144,0.00073138135,0.00019834425,0.00007295514,0.00019108056,0.0000017316825],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024955746,0.001362877,0.80696636,0.000080478065,0.0014191772,0.0017305695,0.00059665326,0.0000062163176,0.000529973,0.000025404257,0.00002448905,0.16230206],"study_design_scores_gemma":[0.021651307,0.0022117565,0.96916723,0.0005704114,0.00063828606,0.0038355957,0.001503012,0.000044504643,0.000054724016,0.000047433234,0.000039013798,0.00023670404],"about_ca_topic_score_codex":0.028597578,"about_ca_topic_score_gemma":0.007640697,"teacher_disagreement_score":0.1622009,"about_ca_system_score_codex":0.0015651715,"about_ca_system_score_gemma":0.0010679346,"threshold_uncertainty_score":0.97787106},"labels":[],"label_agreement":null},{"id":"W2504552842","doi":"10.1007/s10549-016-3897-6","title":"Polygenic risk score is associated with increased disease risk in 52 Finnish breast cancer families","year":2016,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Orionin Tutkimussäätiö; Academy of Finland; European Commission; Cancer Research UK; Government of Canada; Canadian Institutes of Health Research; Suomen Kulttuurirahasto; Genome Canada; Nordic Cancer Union","keywords":"Breast cancer; Family history; Medicine; Odds ratio; Breast disease; Cancer; Population; Case-control study; Oncology; Disease; Internal medicine; Gynecology; Obstetrics; Environmental health","score_opus":0.020783999500772303,"score_gpt":0.31245218066802705,"score_spread":0.29166818116725474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2504552842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97944117,0.0050453744,0.000011630239,0.0018965701,0.000045935114,0.00054963474,0.012915581,0.000017485856,0.000076611876],"genre_scores_gemma":[0.97226727,0.025257505,0.00002180659,0.00007894516,0.00020493318,0.0012296282,0.00009677621,0.000047833753,0.0007953305],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976565,0.00027132762,0.00020929774,0.00078054285,0.0004096232,0.0006726805],"domain_scores_gemma":[0.998628,0.00007557209,0.00011058143,0.0004983925,0.00031315105,0.0003742951],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025857543,0.00029152443,0.00024114287,0.00016626017,0.00027645493,0.000056481007,0.00017836013,0.00012002444,0.00023549663],"category_scores_gemma":[0.000051392606,0.00018470759,0.00007397868,0.00037178348,0.0004360659,0.000017062117,0.000114385,0.00014432146,0.000009521747],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024112428,0.00037040497,0.8981162,0.000011186831,0.00053917296,0.00003206777,0.000112365015,0.000020270314,0.0027302986,0.0000051741704,0.001221381,0.09443027],"study_design_scores_gemma":[0.0048473123,0.0003874819,0.9887909,0.00021705318,0.00009832439,0.00002023163,0.00009381735,0.000023584547,0.003903211,0.000113781934,0.0012296272,0.00027462674],"about_ca_topic_score_codex":0.025298802,"about_ca_topic_score_gemma":0.02980649,"teacher_disagreement_score":0.09415564,"about_ca_system_score_codex":0.0010109956,"about_ca_system_score_gemma":0.0014992337,"threshold_uncertainty_score":0.98789704},"labels":[],"label_agreement":null},{"id":"W2513382862","doi":"10.1007/s10549-016-3954-1","title":"Cost-effectiveness of febrile neutropenia prevention with primary versus secondary G-CSF prophylaxis for adjuvant chemotherapy in breast cancer: a systematic review","year":2016,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Pegfilgrastim; Medicine; Febrile neutropenia; Breast cancer; Internal medicine; Filgrastim; Granulocyte colony-stimulating factor; Oncology; Neutropenia; Cost effectiveness; Chemotherapy; Adjuvant; Surgery; Cancer","score_opus":0.10589650524727208,"score_gpt":0.4418618303045254,"score_spread":0.33596532505725335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2513382862","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00034772223,0.9675666,0.000006495559,0.00032013736,0.00011256819,0.028643524,0.0028045357,0.000025125195,0.00017325644],"genre_scores_gemma":[0.0007433739,0.93784153,0.000016722875,0.000020100091,0.00016367686,0.060381945,0.0001904404,0.00010613896,0.0005360932],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.996484,0.0007129694,0.00077159837,0.00084168726,0.00055056094,0.00063919096],"domain_scores_gemma":[0.9975504,0.0005018394,0.00041589234,0.0006423402,0.0006059204,0.0002835601],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00079990976,0.00059232494,0.0038829143,0.00038964796,0.00013683556,0.00003987843,0.00017271264,0.0001793895,0.0002225278],"category_scores_gemma":[0.000012126597,0.0003222758,0.00044151046,0.00071258604,0.00023549754,0.00015219761,0.00005957544,0.00035622725,0.0000086319415],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00454078,0.0005155838,0.00011765422,0.51410365,0.0012267873,0.000024322988,0.000012025379,8.829671e-8,0.000007788867,0.000013453399,0.00006221707,0.47937566],"study_design_scores_gemma":[0.014690997,0.0048897746,0.002393175,0.9401277,0.003029064,0.0007769703,0.000014020176,3.014338e-7,0.000034354456,0.000011437999,0.033653058,0.000379194],"about_ca_topic_score_codex":0.0014302033,"about_ca_topic_score_gemma":0.0005145294,"teacher_disagreement_score":0.47899646,"about_ca_system_score_codex":0.0037291187,"about_ca_system_score_gemma":0.0044133742,"threshold_uncertainty_score":0.99992293},"labels":[],"label_agreement":null},{"id":"W2514212828","doi":"10.1007/s10549-016-3945-2","title":"Effects of a multicomponent physical activity behavior change intervention on breast cancer survivor health status outcomes in a randomized controlled trial","year":2016,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer survivorship and care","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; National Institutes of Health; Canada Research Chairs","keywords":"Medicine; Breast cancer; Randomized controlled trial; Physical therapy; Quality of life (healthcare); Body mass index; WOMAC; Confidence interval; Cancer; Cancer survivor; Internal medicine; Osteoarthritis","score_opus":0.06251246346930821,"score_gpt":0.42510687709911643,"score_spread":0.3625944136298082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2514212828","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.979551,0.0012211534,0.0000040442415,0.004684068,0.0003109235,0.013521826,0.00067171425,0.000022392469,0.000012882716],"genre_scores_gemma":[0.95996684,0.0031213143,0.0000017133389,0.000028059207,0.00024380902,0.036295418,0.000008260146,0.000026481013,0.00030808354],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99681383,0.0010203574,0.000367522,0.00046226924,0.00069501944,0.00064100046],"domain_scores_gemma":[0.9978363,0.0011750119,0.00018718658,0.00024262087,0.00017907226,0.00037980458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006957636,0.00028824978,0.0021058742,0.00033440848,0.00006989083,0.000018495957,0.00005673582,0.00006668011,0.00007587845],"category_scores_gemma":[0.000050375544,0.00014594985,0.00048748494,0.000187557,0.00022865091,0.00008637425,0.000046722143,0.00016227091,0.000003050311],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6496429,0.0073750955,0.022011757,0.00017330844,0.00043338985,0.000023623388,0.0006122687,6.92179e-8,0.0005001722,0.000026275491,0.0000035194641,0.31919762],"study_design_scores_gemma":[0.63860726,0.0019893164,0.35749376,0.0008936773,0.00015207204,0.0000044415883,0.000049230428,0.00001840476,0.0006825961,0.0000077718005,0.000014029855,0.00008745272],"about_ca_topic_score_codex":0.18940623,"about_ca_topic_score_gemma":0.030323764,"teacher_disagreement_score":0.335482,"about_ca_system_score_codex":0.0016540987,"about_ca_system_score_gemma":0.00037936133,"threshold_uncertainty_score":0.9873703},"labels":[],"label_agreement":null},{"id":"W2517811060","doi":"10.1007/s10549-016-3960-3","title":"The relationship between time to initiation of adjuvant chemotherapy and survival in breast cancer: a systematic review and meta-analysis","year":2016,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":143,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; University of Toronto","funders":"","keywords":"Funnel plot; Medicine; Meta-analysis; Publication bias; Breast cancer; Oncology; Internal medicine; MEDLINE; Systematic review; Random effects model; Statistic; Adjuvant chemotherapy; Cancer; Surgery; Statistics","score_opus":0.13472492853919252,"score_gpt":0.4264882852874373,"score_spread":0.29176335674824483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2517811060","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022872395,0.9890905,0.0000017124892,0.0038142032,0.000007339389,0.002404214,0.0044245566,0.0000045565,0.00002417404],"genre_scores_gemma":[0.007205723,0.98772615,0.0000070488272,0.00003222884,0.00006631388,0.004304189,0.00011898123,0.000035521258,0.0005038706],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9972727,0.0007124336,0.00063887273,0.0006605697,0.00032901167,0.0003864649],"domain_scores_gemma":[0.9981473,0.00065776985,0.0002985856,0.0005059628,0.00021617925,0.00017420255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078076584,0.0004419462,0.003050392,0.00023349545,0.00020216563,0.000046654397,0.00015977651,0.00012193353,0.00004867261],"category_scores_gemma":[0.000050108323,0.00021951449,0.00034460612,0.0005733986,0.00022628694,0.000009445993,0.00015525326,0.000110573535,0.000005693604],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005502776,0.00049845764,0.036189657,0.28326803,0.36202443,0.000014444983,0.00021501622,6.304233e-7,0.0000052998403,0.00013321465,0.0004795825,0.31662098],"study_design_scores_gemma":[0.0033792437,0.001164056,0.17367345,0.07318829,0.7212907,0.00019762566,0.0000776744,7.4875095e-7,0.000012958407,0.00014027389,0.025436176,0.0014388007],"about_ca_topic_score_codex":0.0012894417,"about_ca_topic_score_gemma":0.0010781625,"teacher_disagreement_score":0.35926628,"about_ca_system_score_codex":0.000280178,"about_ca_system_score_gemma":0.00029360346,"threshold_uncertainty_score":0.8951541},"labels":[],"label_agreement":null},{"id":"W2519236007","doi":"10.1007/s10549-016-3974-x","title":"Ten-year survival in women with primary stage IV breast cancer","year":2016,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":137,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; Women's College Hospital","funders":"","keywords":"Breast cancer; Medicine; Hazard ratio; Stage (stratigraphy); Cancer; Proportional hazards model; Gynecology; Epidemiology; Cancer registry; Internal medicine; Cause of death; Survival analysis; Oncology; Disease; Confidence interval","score_opus":0.02208895164619191,"score_gpt":0.31040092859549234,"score_spread":0.28831197694930044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2519236007","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890998,0.001969526,0.0000066080406,0.005095546,0.00006247375,0.0005057331,0.002523628,0.000020212234,0.0007164436],"genre_scores_gemma":[0.9844495,0.01064163,0.00003518682,0.00007316557,0.00032942276,0.0019395589,0.000026310297,0.00005151664,0.002453692],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99753404,0.00012494117,0.0001847953,0.0007792173,0.0004229561,0.0009540291],"domain_scores_gemma":[0.9989837,0.00004653589,0.000053513555,0.00041167284,0.00021005534,0.00029456793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020452306,0.00033637034,0.0003432075,0.00013138918,0.00017757466,0.000041314473,0.00015690886,0.00009806543,0.00023726663],"category_scores_gemma":[0.0000045292677,0.00019103517,0.000038973023,0.00024233636,0.0004235184,0.00001918316,0.00018213551,0.000093137176,0.000012946382],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01210398,0.00072856585,0.7929793,0.000045318742,0.0007255406,0.00007840911,0.00023972834,0.0000048739453,0.007868247,0.00007364409,0.00034718792,0.18480518],"study_design_scores_gemma":[0.0074064815,0.00075034285,0.9847269,0.00016415541,0.000019211067,0.0000606832,0.0003684668,3.8053375e-7,0.0018723741,0.000033642165,0.004319225,0.00027816073],"about_ca_topic_score_codex":0.0062490646,"about_ca_topic_score_gemma":0.0067447107,"teacher_disagreement_score":0.19174755,"about_ca_system_score_codex":0.0012210082,"about_ca_system_score_gemma":0.0005902576,"threshold_uncertainty_score":0.94467574},"labels":[],"label_agreement":null},{"id":"W2522392425","doi":"10.1007/s10549-016-3979-5","title":"Inhibition of EGFR, HER2, and HER3 signaling with AZD8931 in combination with anastrozole as an anticancer approach: Phase II randomized study in women with endocrine-therapy-naïve advanced breast cancer","year":2016,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Jewish General Hospital","funders":"National Institute for Health and Care Research; AstraZeneca; Pfizer","keywords":"Anastrozole; Medicine; Internal medicine; Tolerability; Placebo; Breast cancer; Rash; Combination therapy; Adverse effect; Oncology; Gastroenterology; Cancer; Aromatase; Pathology","score_opus":0.041784829547201,"score_gpt":0.392317485535919,"score_spread":0.35053265598871797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2522392425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913511,0.0008755698,0.000032152268,0.0019438837,0.000009961879,0.005429579,0.00019677509,0.000027292264,0.00013364456],"genre_scores_gemma":[0.98918796,0.0032016423,0.0001957707,0.00003576218,0.00006127053,0.0070607373,0.000017565038,0.00006920378,0.00017011775],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9959387,0.00054644136,0.00044608137,0.00089971005,0.0012114187,0.00095762557],"domain_scores_gemma":[0.9982258,0.0001891149,0.00014376477,0.00039796758,0.0005587842,0.00048457473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010131681,0.0004039329,0.0010479206,0.0006475464,0.00016431135,0.000053172225,0.0000972306,0.00006368788,0.00020007309],"category_scores_gemma":[0.0000135562,0.00021268816,0.000029016372,0.0009602336,0.0008478596,0.0004045105,0.000061047576,0.00030452767,6.823905e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.52341926,0.010690017,0.14061189,0.00016087464,0.0005326819,0.00034537626,0.0043974114,0.000051876676,0.005624927,0.000039864135,0.0000037014336,0.3141221],"study_design_scores_gemma":[0.7670376,0.04728293,0.16472915,0.0027726793,0.000093352784,0.00039901398,0.007818547,0.00018783218,0.009069453,0.00010581562,0.000050207997,0.00045344263],"about_ca_topic_score_codex":0.019437807,"about_ca_topic_score_gemma":0.0066485987,"teacher_disagreement_score":0.31366867,"about_ca_system_score_codex":0.001784132,"about_ca_system_score_gemma":0.0012011682,"threshold_uncertainty_score":0.98709184},"labels":[],"label_agreement":null},{"id":"W2531975516","doi":"10.1007/s10549-016-4029-z","title":"Can we prevent BRCA1-associated breast cancer by RANKL inhibition?","year":2016,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Public Health Ontario; Women's College Hospital","funders":"","keywords":"RANKL; Denosumab; Breast cancer; Medicine; Cancer research; Osteoprotegerin; Carcinogenesis; Cancer; Oncology; Internal medicine; Population; Osteoporosis; Receptor; Activator (genetics)","score_opus":0.07244517315629172,"score_gpt":0.41097463733749984,"score_spread":0.3385294641812081,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2531975516","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015168497,0.9654858,4.4849375e-7,0.0077106897,0.00031217415,0.0038364916,0.020662673,0.000082374616,0.00039246626],"genre_scores_gemma":[0.0057854736,0.97293013,0.0000058544083,0.000052892854,0.00070876325,0.007384055,0.0004717977,0.00018084874,0.012480191],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99474066,0.00047771534,0.0007138723,0.0013268373,0.0013206315,0.0014202684],"domain_scores_gemma":[0.9972055,0.00025501926,0.00028806258,0.0006845693,0.0005681597,0.000998666],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00038419853,0.0009183576,0.0022147733,0.00041746526,0.00033596667,0.000102524486,0.00020917541,0.00054055307,0.003702746],"category_scores_gemma":[0.000024988454,0.00056464557,0.00047674743,0.00071054744,0.00049480086,0.00006476195,0.00021254037,0.0006660935,0.00008796411],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040491778,0.0010135525,0.00055935816,0.003322817,0.0021511607,0.00011531227,0.000084258485,8.281675e-8,0.000020914968,0.000009639426,0.016098404,0.9762196],"study_design_scores_gemma":[0.0053858277,0.0013673701,0.0011505074,0.054229185,0.0016061427,0.0009782773,0.000031831612,0.000001195014,0.000095183656,0.00014827256,0.9342213,0.0007848747],"about_ca_topic_score_codex":0.009104461,"about_ca_topic_score_gemma":0.0031956688,"teacher_disagreement_score":0.9754347,"about_ca_system_score_codex":0.009196918,"about_ca_system_score_gemma":0.004368354,"threshold_uncertainty_score":0.9996805},"labels":[],"label_agreement":null},{"id":"W2533671240","doi":"10.1007/s10549-016-4028-0","title":"Optimal primary febrile neutropenia prophylaxis for patients receiving docetaxel–cyclophosphamide chemotherapy for breast cancer: a systematic review","year":2016,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Public Health; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Febrile neutropenia; Docetaxel; Internal medicine; Pegfilgrastim; Neutropenia; Cyclophosphamide; Breast cancer; Randomized controlled trial; Chemotherapy; Surgery; Oncology; Cancer","score_opus":0.04772956691183437,"score_gpt":0.3922678859825366,"score_spread":0.3445383190707022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2533671240","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012205491,0.9564824,0.0000105935715,0.0012870528,0.0002722492,0.03203145,0.009590808,0.00007030085,0.00013310128],"genre_scores_gemma":[0.000096033364,0.91165406,0.00012829622,0.00016912658,0.0007697962,0.082157284,0.00032759173,0.0002196603,0.0044781608],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99537635,0.0002704996,0.0011265146,0.0012916629,0.00072261237,0.0012123563],"domain_scores_gemma":[0.9962515,0.0005151273,0.0005535029,0.0008746715,0.001182685,0.00062247954],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005833325,0.0009126931,0.0043605207,0.00032156616,0.0005445766,0.0001428152,0.0003042153,0.00026901622,0.00035447162],"category_scores_gemma":[0.000047810663,0.00052612735,0.0009780356,0.000584847,0.00021551175,0.00017486165,0.00010686068,0.00034698003,0.000032455013],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070869655,0.0005076417,0.00013782961,0.43687317,0.0013459214,0.0000073104843,0.000012795186,5.8906206e-8,0.000001225254,0.000010487004,0.0013672921,0.55902755],"study_design_scores_gemma":[0.0063906405,0.0027248783,0.00087291456,0.61926955,0.003888901,0.0004531817,0.000005044476,6.297925e-7,0.000005228089,0.0000096273225,0.3658118,0.0005676281],"about_ca_topic_score_codex":0.0006767865,"about_ca_topic_score_gemma":0.00010779559,"teacher_disagreement_score":0.55845994,"about_ca_system_score_codex":0.0041901786,"about_ca_system_score_gemma":0.002726817,"threshold_uncertainty_score":0.999719},"labels":[],"label_agreement":null},{"id":"W2542607693","doi":"10.1007/s10549-016-4015-5","title":"The impact of nodal micrometastasis on mortality among women with early-stage breast cancer","year":2016,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto; Women's College Hospital","funders":"","keywords":"Micrometastasis; Stage (stratigraphy); Breast cancer; Medicine; Oncology; Cancer; Internal medicine; NODAL; Gynecology; Biology","score_opus":0.0319408832722315,"score_gpt":0.35977956595953253,"score_spread":0.32783868268730104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2542607693","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99242777,0.00097486447,0.0000027167014,0.0009539065,0.000029127143,0.00045185492,0.004999412,0.000010027363,0.00015034621],"genre_scores_gemma":[0.9922722,0.005505679,0.000006099639,0.000008983133,0.00016642528,0.0011687116,0.000012489927,0.000036400805,0.00082299794],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99791574,0.00013173187,0.00019225119,0.00056946196,0.0003975569,0.00079324906],"domain_scores_gemma":[0.9986925,0.000076474535,0.00010471506,0.0005535458,0.00030150707,0.00027122072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002152302,0.000327789,0.000303429,0.000075872005,0.00035850616,0.000049668823,0.00018552522,0.00007050498,0.00013182712],"category_scores_gemma":[0.0000064125065,0.00014009878,0.00010346542,0.00020308571,0.0009183109,0.0000138239475,0.00012762738,0.00007835735,0.0000044081867],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006914376,0.00050892396,0.9043901,0.000013527467,0.003057644,0.000016645225,0.00018871049,0.000011455835,0.009194205,0.000023763556,0.00024129599,0.075439356],"study_design_scores_gemma":[0.0028161283,0.0017838615,0.98300767,0.00008756148,0.000042054435,0.000028089069,0.00013179031,5.295411e-7,0.011579231,0.000022790946,0.00032989736,0.0001704101],"about_ca_topic_score_codex":0.0336414,"about_ca_topic_score_gemma":0.0056179906,"teacher_disagreement_score":0.07861756,"about_ca_system_score_codex":0.00076777546,"about_ca_system_score_gemma":0.00041075604,"threshold_uncertainty_score":0.97279364},"labels":[],"label_agreement":null},{"id":"W2544044666","doi":"10.1007/s10549-016-4018-2","title":"Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3","year":2016,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; McGill University and Génome Québec Innovation Centre; McMaster University; Juravinski Hospital; Hôpital du Saint-Sacrement; Juravinski Cancer Centre; University of Toronto; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; McGill University; Université Laval; Centre hospitalier universitaire de Québec","funders":"Jonsson Comprehensive Cancer Center; National Center for Advancing Translational Sciences; European Regional Development Fund; lékařská fakulta Univerzity Karlovy; University of California, San Francisco; National Institutes of Health; Kerry Group Kuok Foundation; Freistaat Sachsen; National Cancer Institute; Liga Portuguesa Contra o Cancro; Fox Chase Cancer Center; Ministero dello Sviluppo Economico; Medical Research Council; Uppsala Universitet; Institut National Du Cancer; Deutsche Krebshilfe; Sahlgrenska Universitetssjukhuset; Università degli Studi di Firenze; Ovarian Cancer Research Fund; Landspítali Háskólasjúkrahús; Hungarian Scientific Research Fund; National Health and Medical Research Council; Fundación Cellex; Fisher Center for Alzheimer's Research Foundation; Jewish General Hospital; Lunds Universitet; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Ministero della Salute; Generalitat de Catalunya; American Cancer Society; Fonds Wetenschappelijk Onderzoek; Cancer Center, University of Kansas; Cancerfonden; Cancer Association of South Africa; National Breast Cancer Foundation; European Commission; National Institute for Health and Care Research; KWF Kankerbestrijding; Cancer Research UK; Government of Canada; Fondation du cancer du sein du Québec; Memorial Sloan-Kettering Cancer Center; NRG Oncology; Israel Cancer Association; Institut Català de la Salut; University of Pennsylvania; Ministère du Développement Économique, de l’Innovation et de l’Exportation; Associazione Italiana per la Ricerca sul Cancro; Genome Canada; Clalit Health Services; Deutsches Krebsforschungszentrum; Breast Cancer Research Foundation; McGill University; Univerzita Karlova v Praze; NIH Office of the Director; Ministério da Ciência, Tecnologia e Inovação; Dr. Ralph and Marian Falk Medical Research Trust; Kansas Bioscience Authority; Georgetown University; Susan G. Komen for the Cure; Canadian Institutes of Health Research; General Secretariat for Research and Technology; Beth Israel Deaconess Medical Center; Instituto de Salud Carlos III; Ohio State University; Cancer Australia; Fondation ARC pour la Recherche sur le Cancer; Istituto Oncologico Veneto; Royal Marsden NHS Foundation Trust; European Social Fund; University of Chicago; Lietuvos Mokslo Taryba","keywords":"Breast cancer; Allele; Locus (genetics); Genetics; Oncology; Biology; Cancer; Medicine; Cancer research; Gene","score_opus":0.015748540519999445,"score_gpt":0.30108115978313227,"score_spread":0.2853326192631328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2544044666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99003893,0.0025375588,0.00025854268,0.00049441686,0.00008700926,0.00056093733,0.006006191,0.000004691798,0.000011750179],"genre_scores_gemma":[0.9858998,0.012912087,0.00006460503,0.000003858196,0.00015410534,0.00056383427,0.000041788004,0.000032293883,0.00032763192],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977658,0.00028061416,0.00045434726,0.0005920349,0.000531092,0.0003761093],"domain_scores_gemma":[0.9983599,0.000069620204,0.0004944093,0.0003496642,0.0005887918,0.0001376178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030152925,0.00022625863,0.00032737362,0.00018555026,0.00013903726,0.000021843112,0.0001258115,0.00017247531,0.00013021973],"category_scores_gemma":[0.000024476987,0.00016056155,0.000061116196,0.000249999,0.00028010868,0.00002902747,0.00010460375,0.00009841518,5.093383e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020032027,0.00022075076,0.54135454,0.00007850483,0.0006339277,0.0000031505826,0.00056812674,0.0005939328,0.3859519,0.000002954157,0.000107374304,0.06848167],"study_design_scores_gemma":[0.004008234,0.00022091964,0.87782085,0.00025315856,0.00015804416,0.000034189652,0.00015480984,0.00016033974,0.11694772,0.00004408683,0.000033409477,0.00016424415],"about_ca_topic_score_codex":0.013945178,"about_ca_topic_score_gemma":0.011001353,"teacher_disagreement_score":0.33646634,"about_ca_system_score_codex":0.0010057287,"about_ca_system_score_gemma":0.0005423855,"threshold_uncertainty_score":0.99262106},"labels":[],"label_agreement":null},{"id":"W2545442682","doi":"10.1007/s10549-016-4038-y","title":"Revisiting breast cancer patients who previously tested negative for BRCA mutations using a 12-gene panel","year":2016,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Lawrence College; Public Health Ontario; Women's College Hospital; University of Toronto","funders":"Canadian Cancer Society; Canadian Institutes of Health Research; National Comprehensive Cancer Network","keywords":"Breast cancer; CHEK2; PALB2; Genetic testing; Family history; Medicine; BRCA mutation; Mutation; Genetics; Cancer; Genetic counseling; Oncology; BRCA2 Protein; Germline mutation; Male breast cancer; Gene; Internal medicine; Biology","score_opus":0.07089785526257396,"score_gpt":0.3705309631384166,"score_spread":0.29963310787584263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2545442682","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892581,0.0016219583,0.00034612027,0.0020412805,0.000089489804,0.0014106712,0.0051437193,0.000015783984,0.000072869465],"genre_scores_gemma":[0.993547,0.0020623056,0.00067053916,0.000058770856,0.00061573373,0.0019150968,0.00013391094,0.000053864005,0.0009427295],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99812293,0.00011254575,0.0002475987,0.00063811935,0.00026918188,0.0006096289],"domain_scores_gemma":[0.99846065,0.000103032886,0.00010872355,0.00029250007,0.0008191468,0.00021595495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017359559,0.00023721444,0.00021908453,0.00010618488,0.0004256052,0.00006774292,0.00013161126,0.00010129375,0.00006938664],"category_scores_gemma":[0.000056614484,0.00016767648,0.000082548126,0.00018999164,0.00024346585,0.000020782181,0.000099806944,0.000058701084,0.0000030512545],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018518283,0.00058766,0.22887652,0.00012811755,0.0011017043,0.0000074786694,0.0006535146,0.00012502124,0.12812361,0.00005527849,0.0013938072,0.63709545],"study_design_scores_gemma":[0.020529876,0.0025632028,0.7433585,0.0015773688,0.00043002292,0.00024875312,0.00052634504,0.0006012695,0.21809739,0.000636305,0.010079873,0.0013511175],"about_ca_topic_score_codex":0.0020414006,"about_ca_topic_score_gemma":0.0009136092,"teacher_disagreement_score":0.63574433,"about_ca_system_score_codex":0.00096095126,"about_ca_system_score_gemma":0.0008792537,"threshold_uncertainty_score":0.6837649},"labels":[],"label_agreement":null},{"id":"W2561642944","doi":"10.1007/s10549-016-4080-9","title":"Survival with metastatic breast cancer based on initial presentation, de novo versus relapsed","year":2016,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":189,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Metastatic breast cancer; Internal medicine; Breast cancer; Cancer; Oncology; Cohort; Gynecology; Gastroenterology","score_opus":0.05852073882272807,"score_gpt":0.38370038208199975,"score_spread":0.3251796432592717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561642944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9792718,0.0009076754,0.00020271719,0.013794851,0.00021595045,0.0008225262,0.003838483,0.000038778526,0.0009072171],"genre_scores_gemma":[0.9959952,0.0013072704,0.00012568751,0.00007884841,0.00040982245,0.0014889208,0.00007382881,0.00004969586,0.00047067646],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977959,0.00020797171,0.00016146661,0.00065842416,0.0004890008,0.0006872596],"domain_scores_gemma":[0.99878323,0.00017133301,0.000060025755,0.0003785132,0.000324618,0.0002823049],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016158159,0.00031901491,0.0002549377,0.000115634815,0.00028978524,0.000049290502,0.00012993987,0.00006745499,0.00020659753],"category_scores_gemma":[0.000017215818,0.00018570371,0.00006509931,0.00020127854,0.00040320886,0.00001496088,0.00006533061,0.00007954308,0.000012198144],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14797017,0.0041908617,0.470979,0.00013000665,0.005706315,0.0004646374,0.00044298056,0.00040201654,0.016922595,0.0005517029,0.0026795615,0.34956014],"study_design_scores_gemma":[0.065885074,0.0069246967,0.87903494,0.0005169208,0.00046941853,0.00030874214,0.0004971021,0.00005330262,0.04028418,0.0001314513,0.0049579483,0.0009362561],"about_ca_topic_score_codex":0.003935684,"about_ca_topic_score_gemma":0.0055812052,"teacher_disagreement_score":0.4080559,"about_ca_system_score_codex":0.00061241386,"about_ca_system_score_gemma":0.0008098525,"threshold_uncertainty_score":0.7572777},"labels":[],"label_agreement":null},{"id":"W2576591218","doi":"10.1007/s10549-017-4114-y","title":"Response to “Do metastasis-free interval less or more than 24 months for recurrent metastatic breast cancer and primary surgery for de novo metastatic breast cancer matter for survival?”","year":2017,"lang":"en","type":"letter","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Metastatic breast cancer; Medicine; Breast cancer; Oncology; Metastasis; Cancer; Internal medicine","score_opus":0.09692937252843159,"score_gpt":0.3927217579376347,"score_spread":0.2957923854092031,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2576591218","genre_codex":"commentary","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10555163,0.019733856,0.00044531637,0.567833,0.0011696103,0.00946683,0.2957381,0.00004719601,0.000014476619],"genre_scores_gemma":[0.25607023,0.06334156,0.012769254,0.097769715,0.023495814,0.4902234,0.02025247,0.0035353003,0.03254225],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99294096,0.00055792765,0.000836026,0.002438554,0.0008442448,0.0023822987],"domain_scores_gemma":[0.9944883,0.0014440691,0.0005004919,0.0016025153,0.0012985487,0.00066606136],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.001444688,0.0014748239,0.0021361355,0.00054226624,0.0010431333,0.0004968891,0.0008178749,0.00041308004,0.000102800965],"category_scores_gemma":[0.00015336616,0.0010950894,0.00074228167,0.00023031048,0.0007210164,0.00006117234,0.0006946492,0.00046568952,0.0000033025522],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12562424,0.0011778966,0.017517118,0.0039390037,0.014693253,0.00027992655,0.00059401017,0.000014882555,0.000603074,0.000007296873,0.6773943,0.15815501],"study_design_scores_gemma":[0.04200066,0.0056816675,0.26663342,0.005820416,0.009899432,0.004116954,0.0016495632,0.00006475621,0.003165178,0.0005711904,0.655118,0.005278811],"about_ca_topic_score_codex":0.0084263645,"about_ca_topic_score_gemma":0.012130577,"teacher_disagreement_score":0.48075658,"about_ca_system_score_codex":0.0018924532,"about_ca_system_score_gemma":0.0029327797,"threshold_uncertainty_score":0.9998001},"labels":[],"label_agreement":null},{"id":"W2583563217","doi":"10.1007/s10549-017-4128-5","title":"A comparison of serum miRNAs influencing metastatic growth of EMT6 vs 4THM tumor cells in wild-type and CD200R1KO mice","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Toronto Rehabilitation Institute; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"microRNA; Metastatic breast cancer; Biology; Cancer research; Breast cancer; Internal medicine; Mammary gland; Metastasis; Breast tumor; Oncology; Cancer; Endocrinology; Medicine; Gene; Genetics","score_opus":0.046467036384413705,"score_gpt":0.3886256419724195,"score_spread":0.3421586055880058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2583563217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947901,0.0043898053,0.0000018875002,0.00018082006,0.00001998714,0.00027989643,0.00026064407,0.0000017581311,0.00007512861],"genre_scores_gemma":[0.9988193,0.00078873005,0.00017845804,0.000008100958,0.000027808042,0.000034559795,0.000011169151,0.000013592281,0.00011827683],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99894637,0.00009159496,0.00021281798,0.00029033722,0.0001897773,0.0002690778],"domain_scores_gemma":[0.99916774,0.000025379954,0.0001248228,0.000338254,0.00019975913,0.00014406374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019205271,0.00012725985,0.00025180832,0.000074563875,0.00010535761,0.000028793025,0.00015683746,0.000037489885,0.000012075068],"category_scores_gemma":[0.00003280981,0.00010803368,0.00003143058,0.000076070304,0.0003436573,0.00001035232,0.00016078295,0.000071321636,9.326474e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011716684,0.0006003056,0.47302982,0.00025480954,0.00018042947,0.000044839835,0.00032002683,0.0000105553345,0.51446146,0.000041129562,0.000057922694,0.009827048],"study_design_scores_gemma":[0.001839317,0.0008589336,0.30016127,0.00012066339,0.000041564846,0.000023047762,0.00023329926,0.000088684035,0.6962983,0.00013346647,0.00009094081,0.00011053013],"about_ca_topic_score_codex":0.0048481473,"about_ca_topic_score_gemma":0.0014377773,"teacher_disagreement_score":0.18183683,"about_ca_system_score_codex":0.000047825306,"about_ca_system_score_gemma":0.00022130577,"threshold_uncertainty_score":0.73289806},"labels":[],"label_agreement":null},{"id":"W2587392492","doi":"10.1007/s10549-017-4145-4","title":"The BIG 2.04 MRC/EORTC SUPREMO Trial: pathology quality assurance of a large phase 3 randomised international clinical trial of postmastectomy radiotherapy in intermediate-risk breast cancer","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"Medical Research Council; KWF Kankerbestrijding; Cancer Australia; European Organisation for Research and Treatment of Cancer; HSBC Bank USA","keywords":"Lymphovascular invasion; Medicine; Breast cancer; Radiation therapy; Mastectomy; Cancer; Pathology; Internal medicine; Oncology; Metastasis","score_opus":0.07847980045363512,"score_gpt":0.47858866135636563,"score_spread":0.4001088609027305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587392492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98735976,0.0035286043,0.000016166829,0.002620171,0.0009094086,0.0017723001,0.0036809323,0.0000061658193,0.00010649025],"genre_scores_gemma":[0.9500278,0.047397107,0.000024311523,0.000018862636,0.0009428557,0.00138412,0.000054752236,0.000026970016,0.00012319154],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9965856,0.0009059871,0.000865547,0.0006558547,0.00043988766,0.00054712436],"domain_scores_gemma":[0.9974748,0.00045889834,0.0006590568,0.0008351333,0.00042232202,0.00014978333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002059885,0.00029160766,0.00074389327,0.00010341754,0.00035738648,0.00006001841,0.0005079175,0.00017753392,0.000040056362],"category_scores_gemma":[0.0003004272,0.0001891166,0.000282383,0.000091670656,0.0010885788,0.000016982118,0.00023476036,0.00021694168,7.5459087e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.66911465,0.00263874,0.12650777,0.00001836343,0.0011818795,0.000015602349,0.0001397595,0.0000019321883,0.0009548884,0.000021716349,0.00010939007,0.19929534],"study_design_scores_gemma":[0.5944791,0.0027468824,0.3993011,0.00007328755,0.00006013469,0.0000192362,0.00010750932,0.000014987547,0.0016754025,0.00004723881,0.0013313213,0.00014379187],"about_ca_topic_score_codex":0.0073132203,"about_ca_topic_score_gemma":0.016937073,"teacher_disagreement_score":0.27279335,"about_ca_system_score_codex":0.00021163658,"about_ca_system_score_gemma":0.0006966689,"threshold_uncertainty_score":0.99929714},"labels":[],"label_agreement":null},{"id":"W2587651410","doi":"10.1007/s10549-017-4150-7","title":"Diffuse optical tomography changes correlate with residual cancer burden after neoadjuvant chemotherapy in breast cancer patients","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Optical Imaging and Spectroscopy Techniques","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; Natural Sciences and Engineering Research Council of Canada; Directorate for Education and Human Resources; Susan G. Komen for the Cure","keywords":"Medicine; Breast cancer; Internal medicine; Chemotherapy; Cancer; Hemoglobin; Oncology; Gastroenterology; Urology; Nuclear medicine","score_opus":0.022829970206299843,"score_gpt":0.3664419296927874,"score_spread":0.34361195948648754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587651410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9552698,0.001643697,0.0000017047952,0.041099224,0.0000561974,0.00092132937,0.00047742913,0.000059778034,0.00047084084],"genre_scores_gemma":[0.9839282,0.0123323025,0.00018848122,0.00019537337,0.00034893464,0.0020359436,0.000015154638,0.00005466814,0.0009009343],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99766487,0.00004556431,0.0001845221,0.00062659953,0.0006252101,0.0008532365],"domain_scores_gemma":[0.9986196,0.00003760939,0.00006434606,0.00052846206,0.00029745765,0.0004525355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013961854,0.00032179028,0.00047428824,0.00025904924,0.0002858123,0.00019403789,0.00015397987,0.00011449893,0.00027532247],"category_scores_gemma":[0.000006307651,0.00020368637,0.000051891275,0.00017371244,0.0007059506,0.00014536871,0.00009053494,0.00038202116,0.0000042693036],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008518591,0.001406097,0.85676825,0.00006135429,0.00027608007,0.00027534802,0.00040634116,4.897644e-7,0.00052883936,0.000037494676,0.0003183579,0.13140276],"study_design_scores_gemma":[0.008217335,0.0014598975,0.98633546,0.0010686343,0.00008609112,0.000059184615,0.0000533131,0.000048855938,0.0018696821,0.00005280745,0.00051883777,0.0002299176],"about_ca_topic_score_codex":0.030504238,"about_ca_topic_score_gemma":0.006479334,"teacher_disagreement_score":0.13117284,"about_ca_system_score_codex":0.0006278147,"about_ca_system_score_gemma":0.00026768143,"threshold_uncertainty_score":0.97595173},"labels":[],"label_agreement":null},{"id":"W2588836981","doi":"10.1007/s10549-017-4148-1","title":"A high frequency of PALB2 mutations in Jamaican patients with breast cancer","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Women's College Hospital; Toronto Rehabilitation Institute; Sinai Health System; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; University of Toronto; Ontario Institute for Cancer Research","funders":"Susan G. Komen for the Cure","keywords":"PALB2; Breast cancer; Medicine; Oncology; Internal medicine; Cancer; Mutation; Genetics; Biology; Germline mutation; Gene","score_opus":0.023947965615280474,"score_gpt":0.34202613060381004,"score_spread":0.3180781649885296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588836981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99509794,0.00058448245,0.000005386388,0.0015942443,0.000052369716,0.00042777695,0.0020155415,0.0000033658664,0.00021888253],"genre_scores_gemma":[0.9977414,0.0008249853,0.00020070863,0.000015289586,0.00011516925,0.00076527207,0.00010770174,0.000021509702,0.00020794135],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988232,0.000050584866,0.00015523125,0.00038384594,0.0002582105,0.00032891732],"domain_scores_gemma":[0.99889165,0.000013329002,0.00009725007,0.00048397627,0.00039536823,0.000118451935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008930419,0.00014631984,0.00016483307,0.00009678843,0.00025881178,0.00005055057,0.00018458338,0.00006804217,0.00010152646],"category_scores_gemma":[0.000010725002,0.00011020779,0.000029047374,0.00010511064,0.00043553574,0.000014581125,0.00008137527,0.00007986935,0.0000016925997],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005112688,0.00042672045,0.9384501,0.000020415438,0.00019917636,0.0000066758366,0.00012616972,0.000060003647,0.002784772,0.00011490167,0.000099051584,0.057200722],"study_design_scores_gemma":[0.0029841294,0.00033788008,0.9909941,0.00007562032,0.000020945894,0.000008968126,0.00006420295,0.0000040600025,0.005065593,0.00015448693,0.00016966234,0.00012034976],"about_ca_topic_score_codex":0.029001042,"about_ca_topic_score_gemma":0.026404446,"teacher_disagreement_score":0.057080373,"about_ca_system_score_codex":0.0003324342,"about_ca_system_score_gemma":0.0006748496,"threshold_uncertainty_score":0.99136114},"labels":[],"label_agreement":null},{"id":"W2592675053","doi":"10.1007/s10549-017-4167-y","title":"A single-institution experience of salvage therapy for patients with early and locally advanced breast cancer who progress during neoadjuvant chemotherapy","year":2017,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; Chemotherapy; Oncology; Lymphovascular invasion; Internal medicine; Cancer; Stage (stratigraphy); Retrospective cohort study; Neoadjuvant therapy; Radiation therapy; Surgery; Metastasis","score_opus":0.05151731546310423,"score_gpt":0.3885889089770704,"score_spread":0.33707159351396615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592675053","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21176225,0.7826169,0.00000427143,0.00012403092,0.000054580505,0.002819153,0.0025936002,0.00001187726,0.000013329243],"genre_scores_gemma":[0.121391766,0.87200767,0.00008087409,0.000006274493,0.0002027423,0.005983309,0.00013548374,0.0000778488,0.000114038194],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9975317,0.00007664749,0.00034501156,0.0010095566,0.0003813548,0.00065574446],"domain_scores_gemma":[0.99832094,0.000029719682,0.0003581783,0.00057630404,0.0005057269,0.00020915987],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00008099448,0.0006277416,0.0011228891,0.00013005671,0.0005055536,0.00010324754,0.00024272724,0.00020272743,0.000007729654],"category_scores_gemma":[0.0000054921534,0.00040623202,0.00016587494,0.00012427174,0.0009797049,0.000031606818,0.00013312699,0.00011688941,3.401522e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004520575,0.0008001266,0.019525994,0.0013498001,0.0012046098,0.000007088784,0.0002363658,4.3309544e-7,0.000047409765,0.000006467069,0.0000075740336,0.97229356],"study_design_scores_gemma":[0.040032342,0.010378554,0.6136361,0.030614085,0.0008274709,0.00027301192,0.00015538832,0.000002144149,0.0021483896,0.000018545166,0.29982737,0.002086638],"about_ca_topic_score_codex":0.0010944378,"about_ca_topic_score_gemma":0.00043622463,"teacher_disagreement_score":0.9702069,"about_ca_system_score_codex":0.0003874995,"about_ca_system_score_gemma":0.0005535692,"threshold_uncertainty_score":0.99983895},"labels":[],"label_agreement":null},{"id":"W2595590050","doi":"10.1007/s10549-017-4194-8","title":"Ovarian suppression in combination endocrine adjuvant therapy in premenopausal women with early breast cancer","year":2017,"lang":"en","type":"letter","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"ArcelorMittal Dofasco","keywords":"Medicine; Breast cancer; Endocrine system; Oncology; Adjuvant; Internal medicine; Cancer; Gynecology; Hormone","score_opus":0.020016887309978786,"score_gpt":0.3200418893353596,"score_spread":0.3000250020253808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2595590050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9420578,0.004441765,4.3070492e-7,0.0514562,0.000089471614,0.0012034875,0.0005590835,0.000008973373,0.00018281874],"genre_scores_gemma":[0.97745186,0.01597535,0.000007726931,0.0010457396,0.0007325344,0.0024150007,0.0004321197,0.00007211497,0.0018675716],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99748915,0.00025468037,0.00020180778,0.0007464955,0.00042375238,0.00088410923],"domain_scores_gemma":[0.9990976,0.000021760123,0.00010389431,0.0004817209,0.00014401971,0.0001510005],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019315864,0.00038484271,0.00038931545,0.00023803404,0.00017063374,0.00011397837,0.00023747567,0.00043131656,0.00006616467],"category_scores_gemma":[0.000003174971,0.00025833864,0.000033212396,0.00012429095,0.00021193876,0.000016441603,0.000109907895,0.0007722109,0.0000034055306],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.039580986,0.0038216738,0.3095473,0.00046087633,0.0026733722,0.007823374,0.0014545141,0.00004640191,0.0879701,0.000019571517,0.0644205,0.4821813],"study_design_scores_gemma":[0.026724314,0.011696945,0.87809056,0.001408157,0.000049081187,0.0007246574,0.00006544471,0.000022930095,0.01583834,0.00011235037,0.06425439,0.0010128099],"about_ca_topic_score_codex":0.0144754825,"about_ca_topic_score_gemma":0.0011940757,"teacher_disagreement_score":0.56854326,"about_ca_system_score_codex":0.00056077767,"about_ca_system_score_gemma":0.0005350505,"threshold_uncertainty_score":0.9999869},"labels":[],"label_agreement":null},{"id":"W2597614090","doi":"10.1007/s10549-017-4203-y","title":"Cardiac safety, efficacy, and correlation of serial serum HER2-extracellular domain shed antigen measurement with the outcome of the combined trastuzumab plus CMF in women with HER2-positive metastatic breast cancer: results from the EORTC 10995 phase II study","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"National Cancer Institute; F. Hoffmann-La Roche","keywords":"Trastuzumab; Medicine; Internal medicine; Breast cancer; Metastatic breast cancer; Chemotherapy; Cardiotoxicity; Oncology; Cancer; Gastroenterology; Surgery","score_opus":0.061904357849037736,"score_gpt":0.37300700441964424,"score_spread":0.3111026465706065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2597614090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97448665,0.001323886,0.000010640893,0.013748475,0.00007528381,0.0064035943,0.0038469397,0.0000098811,0.000094641466],"genre_scores_gemma":[0.9977784,0.0008122228,0.000022080587,0.000019637899,0.00011156074,0.0010135848,0.000025743066,0.00004732155,0.00016945049],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99470204,0.0010558867,0.0006019093,0.0006908923,0.0022130487,0.00073623034],"domain_scores_gemma":[0.99705243,0.00039852894,0.00036571673,0.0012456386,0.00065727433,0.00028038296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028559961,0.0003819182,0.00090120744,0.00010567721,0.0010128231,0.00011252613,0.00043885718,0.00006737573,0.00006423207],"category_scores_gemma":[0.00005976595,0.00016967813,0.00007099701,0.0003953804,0.0013099051,0.000120421224,0.00028328894,0.000499143,8.052223e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.23651262,0.0075672716,0.6077786,0.00016872108,0.0057713846,0.00023215197,0.0360448,0.00042672775,0.0021809272,0.000050498547,0.00015445302,0.10311184],"study_design_scores_gemma":[0.049885515,0.00992065,0.931064,0.0007753874,0.00032779688,0.000036013374,0.006872399,0.00012396571,0.000696531,0.000024348565,0.000104931794,0.00016846029],"about_ca_topic_score_codex":0.09710294,"about_ca_topic_score_gemma":0.03426282,"teacher_disagreement_score":0.3232854,"about_ca_system_score_codex":0.0021174802,"about_ca_system_score_gemma":0.0017690208,"threshold_uncertainty_score":0.98335934},"labels":[],"label_agreement":null},{"id":"W2601984009","doi":"10.1007/s10549-017-4223-7","title":"Prolactin/androgen-inducible carboxypeptidase-D increases with nitrotyrosine and Ki67 for breast cancer progression in vivo, and upregulates progression markers VEGF-C and Runx2 in vitro","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Canadian Cancer Society; Breast Cancer Society of Canada; Cure Brain Cancer Foundation; Cancer Research Institute","keywords":"Biology; Cancer research; Androgen receptor; Endocrinology; Internal medicine; Nitrotyrosine; Cancer; Nitric oxide synthase; Nitric oxide; Medicine; Prostate cancer","score_opus":0.0353913259735797,"score_gpt":0.3632009935615901,"score_spread":0.3278096675880104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2601984009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853309,0.008747873,2.9490727e-7,0.0024614308,0.000019652685,0.0028329727,0.0005197189,0.000023532619,0.000063628715],"genre_scores_gemma":[0.99244535,0.004927919,0.00018041421,0.000020432282,0.00011080609,0.002120844,0.000029004721,0.000048373753,0.00011682759],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977303,0.00008149297,0.00026602717,0.00078006607,0.0004013358,0.00074074557],"domain_scores_gemma":[0.9987214,0.00009138895,0.00012462569,0.00034608855,0.00018749955,0.0005289589],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037016312,0.0003641125,0.0005532967,0.00033161757,0.0004959187,0.00020411817,0.00007773729,0.00014992025,0.000019386005],"category_scores_gemma":[0.000029678073,0.00023413845,0.000031294105,0.00018037616,0.0005820506,0.00036058176,0.00014227547,0.00024157534,2.3118464e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030591682,0.00062982825,0.7728697,0.00034787954,0.00012700581,0.000108524124,0.00024869546,1.5663616e-7,0.013082018,0.0000066800985,0.00003917369,0.18194865],"study_design_scores_gemma":[0.012883496,0.0019833797,0.9547836,0.0018232445,0.00009379211,0.0004091559,0.00028156943,0.00021103033,0.027071547,0.00004744959,0.00016456356,0.00024715235],"about_ca_topic_score_codex":0.01153549,"about_ca_topic_score_gemma":0.0023248356,"teacher_disagreement_score":0.18191391,"about_ca_system_score_codex":0.00033560893,"about_ca_system_score_gemma":0.00040085986,"threshold_uncertainty_score":0.9950468},"labels":[],"label_agreement":null},{"id":"W2604242421","doi":"10.1007/s10549-017-4226-4","title":"Which women decide to take tamoxifen?","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Tamoxifen; Breast cancer; Lumpectomy; Medicine; Mastectomy; Oncology; Cancer; Internal medicine; Estrogen receptor; Gynecology; Lymph node; Obstetrics","score_opus":0.04730701913211405,"score_gpt":0.38222266416889894,"score_spread":0.3349156450367849,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604242421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888593,0.00092183356,0.000008867426,0.0069192997,0.00010299091,0.00044338228,0.0004105962,0.0000140643615,0.0023196847],"genre_scores_gemma":[0.9936948,0.0018572094,0.00011367303,0.000096873315,0.00051389914,0.0015916185,0.000027108228,0.000031954383,0.0020728984],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981064,0.000051597046,0.00012999304,0.00065253646,0.00029627618,0.0007631873],"domain_scores_gemma":[0.99834216,0.000020503596,0.00004921289,0.0008416349,0.00029899593,0.00044751883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001897177,0.0002413506,0.00022885257,0.00007696951,0.00096397055,0.00018437704,0.00028771002,0.00007810553,0.000087070905],"category_scores_gemma":[0.00004297653,0.00018695235,0.000042791373,0.000089086585,0.00021312493,0.000010435007,0.00039827466,0.000073458585,0.000048985214],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058669867,0.0013004687,0.49446684,0.000043846412,0.0019206016,0.00008157105,0.001476518,0.000017737095,0.022188617,0.00036510176,0.008482421,0.46378928],"study_design_scores_gemma":[0.002634419,0.0010742415,0.93971634,0.00004602658,0.000022606027,0.00006536639,0.0003218958,0.000001657368,0.012390728,0.00022451012,0.043237675,0.00026453717],"about_ca_topic_score_codex":0.004241067,"about_ca_topic_score_gemma":0.009601594,"teacher_disagreement_score":0.46352476,"about_ca_system_score_codex":0.00037718235,"about_ca_system_score_gemma":0.00024959032,"threshold_uncertainty_score":0.7623696},"labels":[],"label_agreement":null},{"id":"W2606387632","doi":"10.1007/s10549-017-4228-2","title":"Ablative Therapies in Metastatic Breast Cancer: A Systematic Review","year":2017,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Ontario Clinical Oncology Group; Juravinski Cancer Centre","funders":"Hamilton Health Sciences","keywords":"Medicine; Breast cancer; Metastatic breast cancer; Metastasectomy; Oncology; Disease; Population; Internal medicine; Cancer; Clinical trial; Observational study; Meta-analysis; Cohort; Metastasis","score_opus":0.15737470404306564,"score_gpt":0.4706398704527674,"score_spread":0.31326516640970176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606387632","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003329329,0.98934996,5.764736e-7,0.0009391695,0.00009020274,0.004761525,0.004662916,0.000015407099,0.00014697529],"genre_scores_gemma":[0.00053361105,0.978633,0.000016320742,0.000049342972,0.00026009636,0.019102909,0.00027866394,0.000105332045,0.0010207539],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9957081,0.00083371793,0.0007816336,0.0012120822,0.00053715537,0.0009273212],"domain_scores_gemma":[0.9975465,0.00015528996,0.0005187324,0.0011903025,0.00032666567,0.00026253285],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00060140115,0.0009345876,0.0035434475,0.00028645384,0.0004251524,0.00014027605,0.00051788497,0.00019671925,0.00008684258],"category_scores_gemma":[0.00004615214,0.0005903082,0.00046934604,0.00032041036,0.0004902846,0.00001848404,0.00032978764,0.0003082711,0.000028041806],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017470564,0.00053954014,0.0002895338,0.40793306,0.006358279,0.000119241566,0.00013266852,2.2264845e-7,9.736253e-7,0.00003164424,0.0004912022,0.58392894],"study_design_scores_gemma":[0.0023941877,0.00047663687,0.0013576346,0.79953146,0.005284011,0.001231768,0.00015193573,7.356599e-7,0.0000049121873,0.000058442023,0.18846147,0.0010467988],"about_ca_topic_score_codex":0.0063720415,"about_ca_topic_score_gemma":0.0046041016,"teacher_disagreement_score":0.5828821,"about_ca_system_score_codex":0.0010809565,"about_ca_system_score_gemma":0.0013923674,"threshold_uncertainty_score":0.9996548},"labels":[],"label_agreement":null},{"id":"W2606736232","doi":"10.1007/s10549-010-0979-8","title":"Erratum to: Recording of hormone therapy and breast density in breast screening programs: summary and recommendations of the International Cancer Screening Network","year":2010,"lang":"en","type":"erratum","venue":"Breast Cancer Research and Treatment","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario","funders":"","keywords":"Breast cancer; Medicine; Breast density; Oncology; Gynecology; Cancer; Breast cancer screening; Hormone therapy; Internal medicine; Obstetrics; Mammography","score_opus":0.07088839722031119,"score_gpt":0.36910111948721835,"score_spread":0.29821272226690715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606736232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86269253,0.04924963,0.000036083045,0.07038981,0.0045976946,0.005432164,0.00581395,0.000056489283,0.001731651],"genre_scores_gemma":[0.83391625,0.15111734,0.0009979077,0.00018576827,0.0027033985,0.0010435906,0.00054624997,0.00013365326,0.009355846],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99761176,0.00011310707,0.00045392223,0.00062574656,0.00063542725,0.00056005403],"domain_scores_gemma":[0.99849683,0.00010195161,0.00023873056,0.00037283104,0.00046204246,0.0003275856],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005007758,0.0003597784,0.0007127847,0.0003377993,0.00025403075,0.000086320426,0.00018524946,0.00027548484,0.000050496044],"category_scores_gemma":[0.000012847319,0.00024771408,0.00010978223,0.0005585998,0.00040493364,0.00011282002,0.0003198486,0.0010404128,1.7331158e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026133591,0.00026272648,0.33774975,0.00006854262,0.00058724213,0.000011486042,0.00034768687,0.0000032808762,0.00023074128,0.000019657762,0.058056265,0.60004926],"study_design_scores_gemma":[0.003477852,0.00053642824,0.9508064,0.0035282217,0.0001167412,0.000366367,0.00039069745,0.00016081403,0.00004393826,0.000068660804,0.040246755,0.000257128],"about_ca_topic_score_codex":0.100867055,"about_ca_topic_score_gemma":0.03750286,"teacher_disagreement_score":0.61305666,"about_ca_system_score_codex":0.00035831338,"about_ca_system_score_gemma":0.00065415265,"threshold_uncertainty_score":0.9999975},"labels":[],"label_agreement":null},{"id":"W2606772776","doi":"10.1007/s10549-016-3898-5","title":"UK Breast Cancer Research Symposium 2016: Submitted Abstracts","year":2016,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Breast cancer; Medicine; Oncology; Cancer; Gynecology; Internal medicine","score_opus":0.07096547379454653,"score_gpt":0.40906914589680904,"score_spread":0.3381036721022625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606772776","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89483213,0.008947524,0.0000160032,0.08871019,0.00027885192,0.002150591,0.0023495797,0.0001716699,0.0025434522],"genre_scores_gemma":[0.96237254,0.017007617,0.00007776119,0.00013365292,0.0013498272,0.002158217,0.000023697141,0.000115075505,0.01676162],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99427295,0.00027601566,0.00046718423,0.0011817777,0.0017420796,0.0020600033],"domain_scores_gemma":[0.99573535,0.000451243,0.00010109304,0.0009053769,0.0016079461,0.0011989969],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009005492,0.00048723785,0.00063899567,0.0006460431,0.0006257914,0.00011496027,0.0002736587,0.00021002292,0.002651949],"category_scores_gemma":[0.00002920848,0.0002890415,0.00013740256,0.0008609552,0.001307655,0.0003116082,0.00020190749,0.0005374291,0.00027963202],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0145878205,0.0015046054,0.1021234,0.00017957992,0.0012293314,0.0005836897,0.00059379655,0.000006745909,0.11483024,0.00041470362,0.00438159,0.7595645],"study_design_scores_gemma":[0.015959892,0.0017896135,0.89790684,0.002470157,0.00013364459,0.0020763364,0.0004585173,0.0000071215013,0.028648302,0.0012440719,0.048673842,0.00063165737],"about_ca_topic_score_codex":0.016449613,"about_ca_topic_score_gemma":0.0018341709,"teacher_disagreement_score":0.79578346,"about_ca_system_score_codex":0.0034106441,"about_ca_system_score_gemma":0.0019165486,"threshold_uncertainty_score":0.9999562},"labels":[],"label_agreement":null},{"id":"W2608642020","doi":"10.1007/s10549-017-4265-x","title":"Effects of metformin versus placebo on vitamin B12 metabolism in non-diabetic breast cancer patients in CCTG MA.32","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Juravinski Cancer Centre; Sunnybrook Health Science Centre; University of British Columbia; Centre hospitalier universitaire de Québec; BC Cancer Agency; Queen's University; University of Toronto; University Health Network; Children's Hospital of Eastern Ontario; Princess Margaret Cancer Centre; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"Canadian Cancer Society Research Institute; National Cancer Institute; Cancer Research UK; National Institutes of Health; Apotex; Canadian Cancer Society; Breast Cancer Research Foundation","keywords":"Metformin; Medicine; Breast cancer; Internal medicine; Vitamin B12; Placebo; Oncology; Endocrinology; Diabetes mellitus; Cancer; Pathology","score_opus":0.017662310273575572,"score_gpt":0.3250811798057714,"score_spread":0.3074188695321958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2608642020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96771103,0.030113809,4.4270496e-7,0.000101355545,0.0003718901,0.0009051215,0.0005367739,0.0000032948478,0.0002563084],"genre_scores_gemma":[0.93593884,0.062247824,0.0000135117,0.000023051905,0.00022956388,0.0012315874,0.00003937956,0.000032696254,0.0002435708],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99784535,0.00014457435,0.00026591023,0.0006094871,0.00041104385,0.00072365324],"domain_scores_gemma":[0.99888664,0.000066134235,0.00012585518,0.0005315739,0.00016482531,0.00022496283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028898922,0.0002980434,0.00046252072,0.0002182612,0.00015533857,0.000057763176,0.00030094295,0.00015799887,0.000052243806],"category_scores_gemma":[0.000042378502,0.00023856729,0.00008614956,0.00014135492,0.0002543716,0.000023023496,0.00016569893,0.00016944166,0.000006194466],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010983632,0.0022251832,0.111040115,0.0002673286,0.00044877524,0.000036561647,0.00026802983,0.000024827314,0.010455367,0.00006668187,0.0004702903,0.8637132],"study_design_scores_gemma":[0.02119522,0.0008087902,0.87207913,0.00025675923,0.000060425664,0.0000020585167,0.000043267813,0.000019270292,0.10148918,0.00004000507,0.003725957,0.00027990818],"about_ca_topic_score_codex":0.0108344825,"about_ca_topic_score_gemma":0.0072371815,"teacher_disagreement_score":0.8634333,"about_ca_system_score_codex":0.00025541172,"about_ca_system_score_gemma":0.000279001,"threshold_uncertainty_score":0.99575245},"labels":[],"label_agreement":null},{"id":"W2610118912","doi":"10.1007/s10549-017-4263-z","title":"Metabolic factors, anthropometric measures, diet, and physical activity in long-term breast cancer survivors: change from diagnosis and comparison to non-breast cancer controls","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; BC Cancer Agency; Statistics Canada; University of Toronto; Mount Sinai Hospital","funders":"University of Toronto; Breast Cancer Research Foundation","keywords":"Medicine; Breast cancer; Anthropometry; Waist; Interquartile range; Internal medicine; Diabetes mellitus; Cancer; Metabolic equivalent; Odds ratio; Body mass index; Physical therapy; Physical activity; Endocrinology","score_opus":0.14414349442341914,"score_gpt":0.43791641691025573,"score_spread":0.2937729224868366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2610118912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9622733,0.017638618,0.0000039560355,0.0073005087,0.00019555376,0.0021090475,0.01043177,0.000028015478,0.000019240983],"genre_scores_gemma":[0.9356358,0.060234036,0.0000040463688,0.00004183295,0.0009678956,0.0029549936,0.00003900193,0.00006133057,0.000061053805],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99657,0.00014406367,0.00027368683,0.0011123179,0.00085755513,0.001042373],"domain_scores_gemma":[0.9975505,0.0002429822,0.00016921051,0.0006564717,0.00028054437,0.0011002944],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022324423,0.00057662197,0.0013970864,0.0005236874,0.00064291613,0.0003547274,0.0002015265,0.00015958188,0.0002118211],"category_scores_gemma":[0.000022950837,0.0004126557,0.000119520635,0.0004769292,0.00062366016,0.00043652885,0.00027593246,0.0004490808,0.000003642458],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031760286,0.0013522453,0.6445098,0.00006552529,0.0004571505,0.00004711128,0.00095256086,7.4205605e-7,0.00036368385,0.0000026745956,0.00005249544,0.34901997],"study_design_scores_gemma":[0.006202596,0.00075407175,0.9898768,0.0006291073,0.00029659603,0.00002537431,0.00017050089,0.00010708368,0.0010514917,0.0000069189427,0.00049791933,0.0003815127],"about_ca_topic_score_codex":0.7549676,"about_ca_topic_score_gemma":0.3295909,"teacher_disagreement_score":0.42537665,"about_ca_system_score_codex":0.0009828737,"about_ca_system_score_gemma":0.00033496268,"threshold_uncertainty_score":0.9998325},"labels":[],"label_agreement":null},{"id":"W2611609325","doi":"10.1007/s10549-017-4269-6","title":"The role of quantitative estrogen receptor status in predicting tumor response at surgery in breast cancer patients treated with neoadjuvant chemotherapy","year":2017,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; Institute of Health Services and Policy Research","funders":"","keywords":"Breast cancer; Chemotherapy; Medicine; Oncology; Estrogen receptor; Internal medicine; Estrogen; Cancer; Neoadjuvant therapy; Mammary gland; Gynecology","score_opus":0.053567593266640776,"score_gpt":0.3815715253022727,"score_spread":0.3280039320356319,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2611609325","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.34167144,0.65270233,2.2553143e-8,0.00015819831,0.000033600987,0.0011760193,0.00423076,0.0000057759166,0.00002184257],"genre_scores_gemma":[0.0627844,0.9332487,0.000011457217,0.0000046760138,0.00008641284,0.003299139,0.00033356572,0.00008928198,0.00014236904],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99625987,0.00070409005,0.0006078758,0.00094912515,0.00046740868,0.0010116582],"domain_scores_gemma":[0.9977938,0.00048605815,0.000512503,0.00065479777,0.0003417693,0.0002110701],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005561833,0.0006314514,0.001373903,0.00028505753,0.00041080653,0.000064043896,0.00026287706,0.00017894496,0.000021137526],"category_scores_gemma":[0.000053961572,0.00036981778,0.00021011198,0.00034042235,0.00063402,0.000016116957,0.00021621723,0.00022853006,0.0000028393895],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013534194,0.00052451494,0.45789808,0.00027426978,0.0009547999,0.000021805792,0.00014613636,0.0000011444116,0.00002995467,0.000002391815,0.00005638387,0.5265563],"study_design_scores_gemma":[0.0078076255,0.001967463,0.6640227,0.013284841,0.0003632352,0.0001265086,0.0004815241,0.000004548568,0.00075553014,0.000008247976,0.31029546,0.0008823435],"about_ca_topic_score_codex":0.021081321,"about_ca_topic_score_gemma":0.01151464,"teacher_disagreement_score":0.525674,"about_ca_system_score_codex":0.0017747363,"about_ca_system_score_gemma":0.0017738373,"threshold_uncertainty_score":0.99987537},"labels":[],"label_agreement":null},{"id":"W2612229014","doi":"10.1007/s10549-017-4287-4","title":"Limited influence of germline genetic variation on all-cause mortality in women with early onset breast cancer: evidence from gene-based tests, single-marker regression, and whole-genome prediction","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Genetic Associations and Epidemiology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"National Cancer Institute; National Institutes of Health","keywords":"Breast cancer; Biology; Germline; Genome-wide association study; Exome; Germline mutation; Oncology; Genetic association; Genetics; Genetic variation; Cancer; Single-nucleotide polymorphism; Gene; Internal medicine; Exome sequencing; Medicine; Mutation; Genotype","score_opus":0.05873789789022375,"score_gpt":0.352359507779468,"score_spread":0.29362160988924424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2612229014","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945845,0.0012873297,0.000021379561,0.001289249,0.000019334264,0.0004009132,0.002388043,0.0000052722107,0.0000039959423],"genre_scores_gemma":[0.994806,0.0042786985,0.00018469275,0.00004603633,0.000090238114,0.00043038113,0.00011357628,0.000016234288,0.00003416409],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99830204,0.00025016634,0.00026731403,0.00055195845,0.00024600537,0.00038252663],"domain_scores_gemma":[0.9986815,0.00009792052,0.00022235302,0.0005393236,0.0002783154,0.00018062169],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037342758,0.00019150555,0.00025422778,0.000089840956,0.00021028673,0.00005492028,0.0001422061,0.00015231685,0.000013014932],"category_scores_gemma":[0.00009257263,0.00014169967,0.000021464954,0.00008633783,0.00026765108,0.000018658739,0.00008022987,0.00010943878,7.4582783e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019446509,0.0002735701,0.9145145,0.000015282232,0.0003249187,0.000009841699,0.0001468339,0.0009876061,0.0742525,3.703359e-7,0.000012298208,0.0075176256],"study_design_scores_gemma":[0.0016202355,0.0012786896,0.9951909,0.0002306862,0.000057558525,0.000010675484,0.00002231347,0.00023039844,0.0011646058,0.000035634872,0.000036471443,0.00012179819],"about_ca_topic_score_codex":0.018520655,"about_ca_topic_score_gemma":0.004172174,"teacher_disagreement_score":0.08067643,"about_ca_system_score_codex":0.00027971718,"about_ca_system_score_gemma":0.0002976321,"threshold_uncertainty_score":0.9880151},"labels":[],"label_agreement":null},{"id":"W2612557208","doi":"10.1007/s10549-017-4273-x","title":"Impact of serum HER2, TIMP-1, and CAIX on outcome for HER2+ metastatic breast cancer patients: CCTG MA.31 (lapatinib vs. trastuzumab)","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Queen's University","funders":"Canadian Cancer Society Research Institute; GlaxoSmithKline; Pfizer","keywords":"Lapatinib; Trastuzumab; Medicine; Oncology; Breast cancer; Internal medicine; Cancer; Metastatic breast cancer","score_opus":0.13082130753244084,"score_gpt":0.49038875891903344,"score_spread":0.35956745138659263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2612557208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9771132,0.0009900434,0.0000029661214,0.005688808,0.00012274958,0.0033206146,0.012241968,0.000028810948,0.0004908456],"genre_scores_gemma":[0.99292517,0.0022388003,0.00009078224,0.000059972048,0.00025945838,0.0020131853,0.0000698765,0.00009522765,0.0022475568],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959041,0.00015463494,0.00054808875,0.0008816894,0.0012169629,0.0012945306],"domain_scores_gemma":[0.9966037,0.00030647928,0.00023711134,0.0009499071,0.00094747334,0.00095529767],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006234116,0.00049654726,0.0010051955,0.00035021306,0.0006793649,0.00020806988,0.00030643705,0.00012655741,0.00077959953],"category_scores_gemma":[0.00012081105,0.00033392673,0.0002537186,0.00021401451,0.0007319544,0.00022833695,0.00018061939,0.00039376208,0.000015506886],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069033005,0.0020431718,0.7488776,0.0005606088,0.0012088203,0.000062201805,0.00036831046,0.000005065493,0.00010618162,0.000052701744,0.0017200916,0.23809196],"study_design_scores_gemma":[0.012672938,0.00886801,0.97554386,0.0006319213,0.00022265088,0.000096882985,0.000109722416,0.00013799842,0.0005071795,0.00010669514,0.0008365754,0.00026554603],"about_ca_topic_score_codex":0.04879302,"about_ca_topic_score_gemma":0.0039859354,"teacher_disagreement_score":0.23782642,"about_ca_system_score_codex":0.0023186873,"about_ca_system_score_gemma":0.0015804555,"threshold_uncertainty_score":0.99991125},"labels":[],"label_agreement":null},{"id":"W2613080729","doi":"10.1007/s10549-017-4282-9","title":"Risk of death from cardiovascular disease following breast cancer: a systematic review","year":2017,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":217,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Population; Disease; Cause of death; Cancer; Internal medicine; Cohort study; Cochrane Library; Oncology; Meta-analysis; Environmental health","score_opus":0.12971090185966094,"score_gpt":0.42632055778601124,"score_spread":0.2966096559263503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2613080729","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003615369,0.984658,0.0000029700175,0.0002145134,0.000098352655,0.0084112985,0.006139449,0.000028583217,0.00008526389],"genre_scores_gemma":[0.0024438866,0.9900057,0.000012711708,0.000018510005,0.00045751073,0.0063638487,0.00029638753,0.000086172484,0.00031531398],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99590904,0.00071884575,0.0007267121,0.00085582386,0.0012558074,0.00053379533],"domain_scores_gemma":[0.99653655,0.00021155132,0.00045232684,0.0018252191,0.00030923897,0.0006651239],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009483996,0.0005906494,0.005298988,0.00021356666,0.00032316198,0.00007460256,0.00024884322,0.00020761273,0.00007182876],"category_scores_gemma":[0.00008868633,0.00037884607,0.0027813262,0.0002453337,0.00014484923,0.000100342986,0.000092172675,0.00042311102,0.000013621997],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000105039486,0.00017301737,0.00026531555,0.4275341,0.019979969,0.00021875632,0.000028657178,2.2013992e-7,0.0000011156264,0.0000042312813,0.00003588396,0.5516537],"study_design_scores_gemma":[0.0020120528,0.000126555,0.001027845,0.89952797,0.057179913,0.00026671146,0.000014494671,0.0000026041128,0.000011802705,0.000027297636,0.039464183,0.00033859667],"about_ca_topic_score_codex":0.019239536,"about_ca_topic_score_gemma":0.00013181007,"teacher_disagreement_score":0.55131507,"about_ca_system_score_codex":0.001537717,"about_ca_system_score_gemma":0.002049746,"threshold_uncertainty_score":0.99986637},"labels":[],"label_agreement":null},{"id":"W2615476028","doi":"10.1007/s10549-017-4299-0","title":"Effect of age on breast cancer screening using tomosynthesis in combination with digital mammography","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Digital Radiography and Breast Imaging","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"National Cancer Institute; Hologic","keywords":"Tomosynthesis; Mammography; Digital mammography; Medicine; Digital Breast Tomosynthesis; Breast cancer; Cancer detection; Breast cancer screening; Radiology; Cancer; Nuclear medicine; Internal medicine","score_opus":0.03833765043007683,"score_gpt":0.36297614639031234,"score_spread":0.32463849596023553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2615476028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960625,0.00027945565,0.000008341453,0.0009707654,0.00001996158,0.0006264708,0.00042816685,0.000016470161,0.0015878504],"genre_scores_gemma":[0.9994501,0.0001877998,0.000031905067,0.000007917814,0.000058736492,0.0001488193,0.000014383897,0.000025229356,0.000075098134],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99849474,0.000054343098,0.00015407897,0.00035591907,0.00050914526,0.00043175305],"domain_scores_gemma":[0.9991065,0.00012883234,0.00008799569,0.0003418204,0.00012406547,0.000210784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023220388,0.00021351012,0.00038328423,0.0005156883,0.00024946808,0.00023202531,0.00010207763,0.00004412969,0.0000205718],"category_scores_gemma":[0.0000119337055,0.00013814974,0.00009751437,0.0003132318,0.00045880774,0.00039782672,0.000045236236,0.00014169473,6.500493e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048202975,0.00043045214,0.51044065,0.00008385336,0.00021064265,0.00019433812,0.00004183927,0.000008615931,0.00014845566,0.000028843364,0.0000038363587,0.4835882],"study_design_scores_gemma":[0.0064557265,0.0027857842,0.98468405,0.0023439447,0.00009765958,0.0003792917,0.000058617403,0.00018881673,0.0027853113,0.00003734463,0.00003737889,0.00014604625],"about_ca_topic_score_codex":0.0073354044,"about_ca_topic_score_gemma":0.00035461274,"teacher_disagreement_score":0.48344216,"about_ca_system_score_codex":0.00020430567,"about_ca_system_score_gemma":0.00010159154,"threshold_uncertainty_score":0.99927485},"labels":[],"label_agreement":null},{"id":"W2615995330","doi":"10.1007/s10549-017-4302-9","title":"The Canadian National Breast Screening Studies are compromised and their results are unreliable. They should not factor into decisions about breast cancer screening","year":2017,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Breast cancer; Medicine; Cancer; Breast cancer screening; Oncology; Gynecology; Breast screening; Obstetrics; Internal medicine; Mammography","score_opus":0.5872976110480123,"score_gpt":0.5285825469658729,"score_spread":0.058715064082139334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2615995330","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005735429,0.9589029,0.000004015479,0.0132486,0.0002423973,0.0025155542,0.024123503,0.000052106483,0.0003373659],"genre_scores_gemma":[0.05288466,0.9425246,0.00010685369,0.00017407001,0.0012001105,0.0017021475,0.00024342645,0.00010822551,0.0010559158],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99367917,0.0003878617,0.00094032724,0.0014792503,0.001888524,0.0016248465],"domain_scores_gemma":[0.9927196,0.0015748636,0.0007227052,0.0010141301,0.002414748,0.0015539501],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0014830447,0.001070636,0.0023881274,0.00061512913,0.005535565,0.0009212906,0.0006668838,0.0004538907,0.000048397404],"category_scores_gemma":[0.0004307451,0.00058820704,0.0004285034,0.00045161616,0.0010913248,0.00030099257,0.00046298534,0.0012784321,0.000011487678],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017412654,0.00007241636,0.0043190964,0.00079590763,0.002596903,0.00020652072,0.00042617726,0.000007508413,5.60436e-7,0.00004910042,0.0025204,0.98726416],"study_design_scores_gemma":[0.0053400174,0.00039300235,0.15088941,0.089828715,0.00088468794,0.0026411796,0.002429693,0.00010296258,0.000002472686,0.00015344362,0.7463451,0.0009893057],"about_ca_topic_score_codex":0.4418066,"about_ca_topic_score_gemma":0.74516255,"teacher_disagreement_score":0.98627484,"about_ca_system_score_codex":0.004162068,"about_ca_system_score_gemma":0.005278885,"threshold_uncertainty_score":0.9996608},"labels":[],"label_agreement":null},{"id":"W2619353077","doi":"10.1007/s10549-017-4290-9","title":"Predictors of distress in female breast cancer survivors: a systematic review","year":2017,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Cancer survivorship and care","field":"Medicine","cited_by":231,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McGill University; McGill University Health Centre","funders":"Canadian Institutes of Health Research","keywords":"Breast cancer; Distress; Medicine; Oncology; Cancer; Internal medicine; Gynecology; Clinical psychology","score_opus":0.13724437385951666,"score_gpt":0.44862203048864835,"score_spread":0.3113776566291317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2619353077","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00025227002,0.9841658,1.4781565e-7,0.0004128882,0.00025449897,0.006162424,0.0083659375,0.00002395103,0.00036208576],"genre_scores_gemma":[0.0024590602,0.98545647,0.000001037949,0.000015520955,0.00034110906,0.009270753,0.00026440618,0.00008943062,0.0021022137],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9955591,0.0005868191,0.001108952,0.00087785465,0.0010653633,0.0008019254],"domain_scores_gemma":[0.9967946,0.00025208603,0.0005727173,0.0013963595,0.0004672105,0.0005170164],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00084146624,0.0006845629,0.0050852355,0.00046460316,0.00015607229,0.000072757175,0.00039763201,0.00027544328,0.000291718],"category_scores_gemma":[0.000052460833,0.0004282888,0.0006022914,0.00059783366,0.0003963981,0.00010176879,0.00018274879,0.0005217184,0.000013943752],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013137513,0.00036306365,0.003452669,0.69244003,0.0010377833,0.00016205705,0.00013349007,3.1783454e-8,5.696032e-8,0.000011643723,0.000099361925,0.30216843],"study_design_scores_gemma":[0.000985936,0.00028369785,0.002070858,0.92137516,0.003597412,0.0005553762,0.000091827635,6.472963e-7,6.2846254e-7,0.0000027395367,0.070713654,0.00032205653],"about_ca_topic_score_codex":0.098542966,"about_ca_topic_score_gemma":0.069647364,"teacher_disagreement_score":0.30184639,"about_ca_system_score_codex":0.0018996076,"about_ca_system_score_gemma":0.0019821369,"threshold_uncertainty_score":0.9998169},"labels":[],"label_agreement":null},{"id":"W2621449981","doi":"10.1007/s10549-017-4333-2","title":"The prognostic effect of estrogen receptor status differs for younger versus older breast cancer patients","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Breast cancer; Medicine; Oncology; Tamoxifen; Estrogen receptor; Internal medicine; Cancer; Hazard ratio; Proportional hazards model; Gynecology; Confidence interval","score_opus":0.025642079047637253,"score_gpt":0.3612508241880705,"score_spread":0.3356087451404332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2621449981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880377,0.00444041,0.0000013351888,0.0014464207,0.0004226125,0.0015629437,0.0040123407,0.000008158912,0.00006809629],"genre_scores_gemma":[0.9890841,0.0062888144,0.000015467398,0.0000072657112,0.00039305544,0.003793468,0.00014490225,0.000040405976,0.00023251651],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99809796,0.00010435694,0.00018179812,0.0005255096,0.00033489513,0.0007554987],"domain_scores_gemma":[0.9984709,0.0002033406,0.00014398295,0.0005575724,0.00041334378,0.00021087438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016413206,0.00029992432,0.00029126334,0.00003947746,0.0011378751,0.000110360605,0.00024867395,0.0000889907,0.000020745483],"category_scores_gemma":[0.00006936351,0.00017628052,0.00012954946,0.000050992905,0.0006260671,0.000016265252,0.00020201797,0.000072745745,0.00000275379],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014528777,0.00039081555,0.83661354,0.000064016014,0.0015272595,0.0000013893388,0.00007544323,0.0000013473657,0.0011765535,0.00002693703,0.0010806628,0.1445133],"study_design_scores_gemma":[0.011648358,0.002563325,0.97069955,0.000093738105,0.00019481342,0.0000044764024,0.000051846266,0.0000032204573,0.011128474,0.000010882377,0.003409875,0.00019146476],"about_ca_topic_score_codex":0.0041554244,"about_ca_topic_score_gemma":0.00095857703,"teacher_disagreement_score":0.14432183,"about_ca_system_score_codex":0.00031385644,"about_ca_system_score_gemma":0.00023823018,"threshold_uncertainty_score":0.87517303},"labels":[],"label_agreement":null},{"id":"W2622584394","doi":"10.1007/s10549-017-4323-4","title":"Lifetime moderate-to-vigorous physical activity and ER/PR/HER-defined post-menopausal breast cancer risk","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Physical Activity and Health","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Université de Montréal; University of British Columbia; Queen's University; Centre Hospitalier de l’Université de Montréal","funders":"Institute of Population and Public Health; Canadian Institutes of Health Research; Terry Fox Foundation","keywords":"Breast cancer; Medicine; Demography; Metabolic equivalent; Logistic regression; Estrogen receptor; Internal medicine; Odds ratio; Cancer; Oncology; Gynecology; Gerontology; Physical activity; Physical therapy","score_opus":0.0662484269751112,"score_gpt":0.41045525824711826,"score_spread":0.3442068312720071,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2622584394","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9629076,0.00027727764,0.000004545893,0.032921027,0.00005237858,0.0009874137,0.0023421675,0.000045614015,0.0004619837],"genre_scores_gemma":[0.9953066,0.0021538823,0.00003050601,0.00013973148,0.0009077234,0.0005491194,0.000013184819,0.000041912674,0.0008573118],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9974611,0.00014231954,0.0001288153,0.00076431106,0.00060906337,0.0008943875],"domain_scores_gemma":[0.9976754,0.00015355492,0.00009565044,0.00060126156,0.00030882924,0.001165271],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.00019417921,0.00033440464,0.00069347414,0.00011158647,0.001318972,0.0002192401,0.00013412895,0.00009827041,0.00009650869],"category_scores_gemma":[0.000029987057,0.00023932841,0.0000620056,0.00012008,0.00043218266,0.00039055772,0.00022314527,0.0004994282,0.000047818703],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024435634,0.009582282,0.045960974,0.00024636244,0.00092642114,0.00022702203,0.0009054231,0.000014757864,0.022926712,0.00041279773,0.00038683528,0.8939748],"study_design_scores_gemma":[0.0047021396,0.0038391494,0.9863391,0.00021936893,0.0001629196,0.00015420117,0.000041153413,0.0008428084,0.0026298852,0.00044944344,0.00036864937,0.00025121614],"about_ca_topic_score_codex":0.12776373,"about_ca_topic_score_gemma":0.005330618,"teacher_disagreement_score":0.94037807,"about_ca_system_score_codex":0.0007029302,"about_ca_system_score_gemma":0.00076951954,"threshold_uncertainty_score":0.99998116},"labels":[],"label_agreement":null},{"id":"W2624904204","doi":"10.1007/s10549-017-4332-3","title":"Preferences for breast cancer risk reduction among BRCA1/BRCA2 mutation carriers: a discrete-choice experiment","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"Medical Research Council; University of Toronto; Cancer Australia; National Breast Cancer Foundation; National Institute for Health and Care Research; National Health and Medical Research Council; Amgen","keywords":"Breast cancer; BRCA mutation; Medicine; Fertility; Oncology; Gynecology; Cancer; Genetic counseling; Internal medicine; Demography; Obstetrics; Environmental health; Population; Genetics; Biology","score_opus":0.04841910130758634,"score_gpt":0.39464503095536685,"score_spread":0.34622592964778054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2624904204","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905061,0.003272027,0.000099899305,0.0015873907,0.00030262576,0.0011655039,0.0028531877,0.000015064182,0.00019819695],"genre_scores_gemma":[0.9885212,0.0042156535,0.00018287379,0.000010053216,0.001009172,0.004860092,0.0001353628,0.00003645721,0.0010291339],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9981885,0.00010631216,0.00019416181,0.00072454195,0.00030110116,0.0004853627],"domain_scores_gemma":[0.99856436,0.00003125027,0.0001777471,0.00059769495,0.0004065931,0.00022237681],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023674939,0.00023635112,0.00018738398,0.000079757156,0.0011674246,0.00026271967,0.00023576494,0.00013173328,0.00008356138],"category_scores_gemma":[0.000041917203,0.00019340472,0.000085452084,0.00006609155,0.0005102001,0.000039765266,0.00011467065,0.00010646625,0.0000021463638],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003862753,0.00057725504,0.25251108,0.00011899522,0.001988557,0.0000071104137,0.0019189791,0.00064242445,0.046362128,0.0000888669,0.004566917,0.6873549],"study_design_scores_gemma":[0.005493528,0.0013098416,0.84066564,0.00016349439,0.00018290945,0.00009214623,0.001615811,0.00027176944,0.1429164,0.0005676745,0.0061911545,0.00052961917],"about_ca_topic_score_codex":0.023871722,"about_ca_topic_score_gemma":0.009056498,"teacher_disagreement_score":0.6868253,"about_ca_system_score_codex":0.00061844627,"about_ca_system_score_gemma":0.00058672286,"threshold_uncertainty_score":0.9826284},"labels":[],"label_agreement":null},{"id":"W2626019450","doi":"10.1007/s10549-017-4329-y","title":"Development of a Ki-67-based clinical trial assay for neoadjuvant endocrine therapy response monitoring in breast cancer","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health; Novartis Pharmaceuticals Corporation; Foundation for Barnes-Jewish Hospital; University of British Columbia; Breast Cancer Research Foundation; Avon Foundation for Women","keywords":"Medicine; Breast cancer; Concordance; Internal medicine; Neoadjuvant therapy; Clinical trial; Oncology; Triage; Cancer; Clinical endpoint","score_opus":0.17084832900656038,"score_gpt":0.4824769193406639,"score_spread":0.3116285903341035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2626019450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919185,0.0026226554,0.000017161958,0.0030089437,0.00027804647,0.0013448407,0.00077203504,0.000008636552,0.000029163373],"genre_scores_gemma":[0.9898393,0.004665955,0.00075103436,0.000020764548,0.0006565709,0.0038043584,0.000033596516,0.000038493286,0.00018992658],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9975758,0.00025487592,0.0004876262,0.0006980395,0.0003446094,0.00063903676],"domain_scores_gemma":[0.9984585,0.00019527161,0.00020267336,0.00061161665,0.00032995257,0.00020200263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010432655,0.00030408334,0.00047194085,0.00012693809,0.00049225375,0.00006716806,0.00027682533,0.00011885683,0.000021812282],"category_scores_gemma":[0.00007008546,0.00023005596,0.00014694702,0.00007547908,0.00036937438,0.000013370564,0.00016132258,0.00011844492,0.0000012386757],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2817962,0.0016581572,0.31230187,0.000029377572,0.0006400976,0.00002026066,0.00016371635,0.000007923209,0.010059863,0.000006687144,0.000101792044,0.39321408],"study_design_scores_gemma":[0.07748778,0.0013805312,0.8690835,0.00019405791,0.000030464926,0.000013772858,0.00012841201,0.000012325019,0.045236334,0.00001535433,0.0061791916,0.00023822574],"about_ca_topic_score_codex":0.0030577783,"about_ca_topic_score_gemma":0.00202786,"teacher_disagreement_score":0.55678165,"about_ca_system_score_codex":0.00038688327,"about_ca_system_score_gemma":0.0013599208,"threshold_uncertainty_score":0.938141},"labels":[],"label_agreement":null},{"id":"W2732269941","doi":"10.1007/s10549-017-4356-8","title":"Prevalence and spectrum of germline rare variants in BRCA1/2 and PALB2 among breast cancer cases in Sarawak, Malaysia","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Institutes of Health","keywords":"PALB2; Breast cancer; Germline mutation; Germline; Genetics; Population; Biology; Oncology; Cancer; Mutation; Medicine; Cancer research; Gene","score_opus":0.03240576977175894,"score_gpt":0.3555621382868467,"score_spread":0.3231563685150877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2732269941","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98854834,0.008656708,0.0000013078871,0.0012946798,0.00003564678,0.00041148582,0.0009537511,0.0000023981634,0.00009569414],"genre_scores_gemma":[0.9776688,0.021499515,0.0000341247,0.0000109193925,0.00011447485,0.0003060717,0.000014358129,0.000017115532,0.00033461663],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986885,0.000077312216,0.00018809269,0.0005115705,0.00016807055,0.00036641464],"domain_scores_gemma":[0.999285,0.000028855717,0.00008194632,0.00038945713,0.00008536661,0.00012941907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019976721,0.00016833749,0.00021126347,0.00012134569,0.00015145766,0.00006865527,0.00013546465,0.000094658935,0.000063535714],"category_scores_gemma":[0.000021201482,0.00014404354,0.000022238253,0.00008682091,0.000521302,0.000021896103,0.00019480565,0.00010237648,4.0791429e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005378885,0.00015482966,0.96434605,0.00011292379,0.00007762472,0.00007925335,0.0001362035,0.000027579717,0.004437276,0.000020326077,0.00004444395,0.030025577],"study_design_scores_gemma":[0.0019819525,0.0002398592,0.99115056,0.00023980517,0.000015625967,0.0002006641,0.00006750758,0.00010072791,0.0057203895,0.00008445972,0.000066627275,0.00013182993],"about_ca_topic_score_codex":0.021984106,"about_ca_topic_score_gemma":0.027174508,"teacher_disagreement_score":0.029893747,"about_ca_system_score_codex":0.00019631175,"about_ca_system_score_gemma":0.00032295487,"threshold_uncertainty_score":0.99057704},"labels":[],"label_agreement":null},{"id":"W2734965735","doi":"10.1007/s10549-017-4376-4","title":"Executive functioning impairment in women treated with chemotherapy for breast cancer: a systematic review","year":2017,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; St. Joseph’s Healthcare Hamilton; University of Toronto; York University","funders":"Canadian Institutes of Health Research","keywords":"PsycINFO; Executive dysfunction; Checklist; MEDLINE; Breast cancer; Meta-analysis; Clinical psychology; Neuropsychology; Systematic review; Medicine; Cognition; Executive functions; Psychology; Cancer; Psychiatry; Internal medicine; Cognitive psychology","score_opus":0.09627293851627458,"score_gpt":0.4325062621053616,"score_spread":0.336233323589087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2734965735","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015906233,0.9714575,0.0000016071236,0.0019776975,0.000058902242,0.02333551,0.0027589737,0.000056962446,0.00019381434],"genre_scores_gemma":[0.00028975608,0.9065188,0.000008977382,0.000114358176,0.00025322416,0.08860577,0.00010851526,0.00013442515,0.003966151],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9956267,0.0003044177,0.0008661671,0.001143039,0.00075010385,0.0013095915],"domain_scores_gemma":[0.9971214,0.00031341633,0.0005911225,0.00073568075,0.0007529503,0.0004854577],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007843736,0.00094509084,0.005018852,0.0005876503,0.00053680775,0.000118790726,0.00018847652,0.00021249555,0.00018648426],"category_scores_gemma":[0.00003683673,0.00055373774,0.00039153287,0.0006359301,0.00037982984,0.00012765195,0.00008928744,0.00047888423,0.000012436385],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028029368,0.00074313366,0.00039020352,0.4639868,0.00578811,0.00011303497,0.00021232039,1.2528857e-7,9.6172336e-8,0.0000030645413,0.0005488545,0.5254113],"study_design_scores_gemma":[0.00919485,0.0036422024,0.0019535206,0.9178415,0.0053423867,0.0012696114,0.00027563007,0.0000031313964,8.8879216e-7,0.0000059603994,0.059934348,0.000535985],"about_ca_topic_score_codex":0.003396319,"about_ca_topic_score_gemma":0.0006752362,"teacher_disagreement_score":0.5248753,"about_ca_system_score_codex":0.0105472095,"about_ca_system_score_gemma":0.002277638,"threshold_uncertainty_score":0.9996914},"labels":[],"label_agreement":null},{"id":"W2740248158","doi":"10.1007/s10549-017-4436-9","title":"Trends in adjuvant therapies after breast-conserving surgery for hormone receptor-positive ductal carcinoma in situ: findings from the National Cancer Database, 2004–2013","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Breast Cancer Research Foundation","keywords":"Ductal carcinoma; Medicine; Breast cancer; Adjuvant; Oncology; Cancer; Internal medicine; Breast-conserving surgery; Mastectomy; Gynecology","score_opus":0.04945624269678677,"score_gpt":0.3457972961242214,"score_spread":0.2963410534274346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740248158","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9546487,0.02108228,0.00000147192,0.013538768,0.000101501726,0.0004470244,0.010127433,0.0000053221493,0.000047533296],"genre_scores_gemma":[0.98884594,0.006605415,0.000044152584,0.000107254804,0.00051571964,0.0029719363,0.0006759672,0.000032525782,0.00020105694],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980282,0.00011684709,0.00022771014,0.0006925951,0.00033055118,0.00060409453],"domain_scores_gemma":[0.99898624,0.00020541267,0.00008239621,0.00037794895,0.00023799924,0.00010997669],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031163578,0.00030043192,0.00032626803,0.00016478327,0.00047524975,0.00013096047,0.00022998743,0.0000977653,0.0000667937],"category_scores_gemma":[0.000026344625,0.00020983898,0.00010626423,0.00013384446,0.00038137997,0.000042227875,0.00023076432,0.00012788005,0.0000020546033],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052497154,0.00035504345,0.9426322,0.000010459249,0.0004840026,0.000028867644,0.0006086675,0.0000037478408,0.008938693,0.000010727805,0.0055912025,0.036086705],"study_design_scores_gemma":[0.0028248325,0.000116264506,0.9922081,0.00013595918,0.000028635382,0.000027617183,0.00023275346,0.000009770746,0.0031932073,0.00005724545,0.0009534949,0.00021207276],"about_ca_topic_score_codex":0.06837786,"about_ca_topic_score_gemma":0.09870924,"teacher_disagreement_score":0.049575977,"about_ca_system_score_codex":0.0005349465,"about_ca_system_score_gemma":0.00034543886,"threshold_uncertainty_score":0.9378259},"labels":[],"label_agreement":null},{"id":"W2743331008","doi":"10.1007/s10549-017-4408-0","title":"Breast cancer in Africa: prevalence, treatment options, herbal medicines, and socioeconomic determinants","year":2017,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":70,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"Canadian Institutes of Health Research; Canadian Cancer Society; Coordenação de Aperfeiçoamento de Pessoal de Nível Superior; Saskatchewan Health Research Foundation","keywords":"Breast cancer; Medicine; Incidence (geometry); Cancer; Socioeconomic status; Developing country; Demography; Population; Environmental health; Economic growth; Internal medicine","score_opus":0.0984079523897632,"score_gpt":0.4330157599921215,"score_spread":0.3346078076023583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2743331008","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0065023075,0.9864907,3.67398e-7,0.00042455006,0.00017195882,0.0014758642,0.0047703027,0.000008602256,0.00015534466],"genre_scores_gemma":[0.007024228,0.9832179,0.000026222951,0.000006656024,0.0006969529,0.005134692,0.00012150483,0.00006894114,0.0037029318],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972474,0.00023235871,0.00045681887,0.0011074949,0.00022386003,0.000732079],"domain_scores_gemma":[0.99859655,0.000053589793,0.0002258308,0.00071166275,0.00012446457,0.0002878846],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030852738,0.00056637765,0.0010259781,0.00025479085,0.00036906023,0.00012527201,0.0002885978,0.00036113238,0.00015494655],"category_scores_gemma":[0.00000665243,0.0004138205,0.00016979405,0.00010028129,0.0005803627,0.000016170738,0.0002063965,0.00019495709,0.000014597556],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012650361,0.00022333444,0.0037772718,0.0013480851,0.000494564,0.0000386277,0.000087437,0.0000015870875,0.0000072737325,0.00000601114,0.00046949476,0.9934198],"study_design_scores_gemma":[0.0027785357,0.0008371462,0.013926689,0.0048203836,0.00063491974,0.0010681166,0.000085123065,0.000010521818,0.00002981907,0.00004049707,0.97512484,0.00064339914],"about_ca_topic_score_codex":0.00277329,"about_ca_topic_score_gemma":0.0060133594,"teacher_disagreement_score":0.9927764,"about_ca_system_score_codex":0.002288176,"about_ca_system_score_gemma":0.002619205,"threshold_uncertainty_score":0.9998314},"labels":[],"label_agreement":null},{"id":"W2744491752","doi":"10.1007/s10549-017-4449-4","title":"Does obesity modify the relationship between physical activity and breast cancer risk?","year":2017,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Physical Activity and Health","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; Canadian Centre for Applied Research in Cancer Control; University of British Columbia; BC Cancer Agency; McMaster University","funders":"Canadian Institutes of Health Research; Killam Trusts; Michael Smith Health Research BC","keywords":"Breast cancer; Overweight; Medicine; Body mass index; Obesity; Cancer; Internal medicine; Cohort study; Relative risk; Risk factor; Oncology; Gynecology; Obstetrics; Confidence interval","score_opus":0.36800044545572513,"score_gpt":0.5267949990426872,"score_spread":0.1587945535869621,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2744491752","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.27025938,0.7118653,0.0000011489425,0.0068627456,0.00007382362,0.0027672558,0.00794212,0.000041426145,0.00018680377],"genre_scores_gemma":[0.37689716,0.62045825,0.0000016975786,0.0000039304646,0.0012483706,0.0007211144,0.000029075163,0.000027023398,0.0006133683],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9972091,0.0005758928,0.0001906053,0.00074960274,0.0005994194,0.0006753814],"domain_scores_gemma":[0.9966609,0.0016274322,0.00024565426,0.0007258236,0.00013564671,0.0006045253],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.00040857206,0.00045180603,0.0017567892,0.00012179304,0.0015507858,0.0001460209,0.00017984574,0.0002275846,0.000025599573],"category_scores_gemma":[0.000052379477,0.00019013697,0.00027286002,0.00019649562,0.0007571418,0.00018021492,0.00020092784,0.0014251517,0.000019669216],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022343178,0.001115827,0.082215495,0.003415848,0.00055454986,0.000015278118,0.00009950874,3.4877342e-8,2.1503905e-7,0.000143945,0.000060710063,0.91215515],"study_design_scores_gemma":[0.000996863,0.00037914666,0.92384547,0.005317737,0.0014517063,0.0000727661,0.000012090664,0.000007602004,0.0000022485767,0.0009061262,0.06678298,0.0002252693],"about_ca_topic_score_codex":0.035909586,"about_ca_topic_score_gemma":0.0018614314,"teacher_disagreement_score":0.9119299,"about_ca_system_score_codex":0.0010628335,"about_ca_system_score_gemma":0.001492434,"threshold_uncertainty_score":0.99974906},"labels":[],"label_agreement":null},{"id":"W2746993714","doi":"10.1007/s10549-017-4469-0","title":"Panel sequencing of 264 candidate susceptibility genes and segregation analysis in a cohort of non-BRCA1, non-BRCA2 breast cancer families","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sinai Health System; Lunenfeld-Tanenbaum Research Institute","funders":"National Cancer Institute; National Medical Research Council; Cancer Council NSW; National Health and Medical Research Council; National Institutes of Health","keywords":"Breast cancer; Candidate gene; Germline mutation; Genetics; Penetrance; Cancer; Biology; Germline; Gene; Oncology; Mutation; Medicine; Phenotype","score_opus":0.039064350741587255,"score_gpt":0.36094979512906256,"score_spread":0.3218854443874753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2746993714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99580014,0.0018426727,0.000027728678,0.00037517044,0.000034641336,0.00046177336,0.0013475186,0.0000024282988,0.000107900974],"genre_scores_gemma":[0.99047875,0.008749435,0.00012263807,0.000006465177,0.00006936756,0.00032762162,0.00007669671,0.000015043841,0.00015398522],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984994,0.00007509972,0.00028565846,0.00054562057,0.00027057654,0.00032362767],"domain_scores_gemma":[0.9986722,0.000023532893,0.00017452304,0.00061915076,0.00039746315,0.00011315604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003796488,0.00018306101,0.0003631087,0.00022253834,0.0002139163,0.000046361834,0.00016980864,0.000106579784,0.00003667685],"category_scores_gemma":[0.000015031516,0.00015344782,0.000074573596,0.00024555167,0.0005791776,0.00001973024,0.00015450708,0.00007696675,3.205433e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004115409,0.00009570904,0.83883464,0.00008295891,0.00076088886,0.0000039870156,0.0003110681,0.00034505845,0.10570025,0.000004125214,0.000015079264,0.05343471],"study_design_scores_gemma":[0.0011579489,0.00017840712,0.9145302,0.000057665824,0.0001662312,0.000011580444,0.00037237976,0.0006646613,0.08267365,0.000035237023,0.00002696381,0.00012507406],"about_ca_topic_score_codex":0.11481577,"about_ca_topic_score_gemma":0.09770011,"teacher_disagreement_score":0.075695574,"about_ca_system_score_codex":0.00048567727,"about_ca_system_score_gemma":0.0008264445,"threshold_uncertainty_score":0.91876453},"labels":[],"label_agreement":null},{"id":"W2752234866","doi":"10.1007/s10549-017-4465-4","title":"Reply to Kopans","year":2017,"lang":"en","type":"letter","venue":"Breast Cancer Research and Treatment","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Medicine; Breast cancer; Gynecology; Internal medicine; Cancer","score_opus":0.2284374600326951,"score_gpt":0.4607737602601215,"score_spread":0.2323363002274264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2752234866","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0088055255,0.0026470113,0.0000019894978,0.9781198,0.00016138426,0.0011463702,0.0006947239,0.000044221313,0.008378974],"genre_scores_gemma":[0.054149453,0.004950433,0.00028440013,0.8095022,0.016662296,0.0025704484,0.00041598442,0.00015741102,0.111307405],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99690366,0.00006535461,0.00020222791,0.00081477745,0.0010575107,0.000956499],"domain_scores_gemma":[0.9979437,0.00006723156,0.00006614233,0.0009994275,0.00043188166,0.0004916148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002453642,0.00033127205,0.00057167344,0.00027119208,0.0004519379,0.00020057107,0.00022950083,0.00026794078,0.0003796273],"category_scores_gemma":[0.000037934275,0.00023834723,0.00012383242,0.00014424493,0.0002253239,0.00007854436,0.00014618093,0.0009402087,0.0001912848],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072026526,0.00005396862,0.005524394,0.000090407724,0.00027907183,0.005123353,0.00009276699,2.2263741e-7,0.000019809206,0.000007886362,0.9137767,0.07431117],"study_design_scores_gemma":[0.0011377102,0.0015619685,0.022537753,0.0009545009,0.0001130007,0.0010711376,0.000034119115,0.0000014384962,0.00010037281,0.00007608323,0.97221154,0.0002003662],"about_ca_topic_score_codex":0.04532814,"about_ca_topic_score_gemma":0.00060976885,"teacher_disagreement_score":0.16861762,"about_ca_system_score_codex":0.001293089,"about_ca_system_score_gemma":0.000987328,"threshold_uncertainty_score":0.9719518},"labels":[],"label_agreement":null},{"id":"W2756272086","doi":"10.1007/s10549-017-4476-1","title":"The expected benefit of preventive mastectomy on breast cancer incidence and mortality in BRCA mutation carriers, by age at mastectomy","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":67,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Women's College Hospital","funders":"","keywords":"Mastectomy; Prophylactic Mastectomy; Breast cancer; Medicine; Incidence (geometry); BRCA mutation; Oncology; Cancer; Internal medicine; Gynecology","score_opus":0.02942241028155653,"score_gpt":0.3634506063564046,"score_spread":0.33402819607484807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2756272086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927099,0.0043280213,0.000002963256,0.0007985379,0.000058297454,0.0005883769,0.0012637604,0.0000039851766,0.00024616672],"genre_scores_gemma":[0.99354225,0.004494674,0.000015088734,0.000011405116,0.000081072845,0.0007292129,0.000050931903,0.000018707848,0.001056625],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99854726,0.00010490729,0.00019208409,0.0004893398,0.00031290867,0.00035350808],"domain_scores_gemma":[0.99899274,0.000044399058,0.00013557992,0.0005147512,0.00019293516,0.00011959222],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002255515,0.00017820537,0.00018113526,0.000056528144,0.0005188337,0.00008716327,0.00019917857,0.000089382,0.000036598794],"category_scores_gemma":[0.00002229777,0.00012932731,0.00003950819,0.00009117274,0.00057147205,0.00001682235,0.00020336559,0.00010110499,8.948301e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031670434,0.00034040463,0.74031305,0.00007975535,0.00076823455,0.000060405644,0.0009709306,0.000097334756,0.06372049,0.00010166749,0.00074964896,0.18963103],"study_design_scores_gemma":[0.0021725711,0.00034744595,0.94075114,0.00010684575,0.00002720489,0.000040169514,0.00027812665,0.000027970194,0.055158745,0.00016120372,0.0007828439,0.00014571876],"about_ca_topic_score_codex":0.013505533,"about_ca_topic_score_gemma":0.038711555,"teacher_disagreement_score":0.2004381,"about_ca_system_score_codex":0.0005878186,"about_ca_system_score_gemma":0.0002687755,"threshold_uncertainty_score":0.9930636},"labels":[],"label_agreement":null},{"id":"W2760883434","doi":"10.1007/s10549-017-4538-4","title":"A randomized phase II study of weekly paclitaxel with or without pelareorep in patients with metastatic breast cancer: final analysis of Canadian Cancer Trials Group IND.213.","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":101,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Juravinski Cancer Centre; Queen's University; Ottawa Hospital; Jewish General Hospital; BC Cancer Agency","funders":"Canadian Cancer Society Research Institute; Oncolytics Biotech","keywords":"Medicine; Metastatic breast cancer; Clinical endpoint; Paclitaxel; Breast cancer; Internal medicine; Randomized controlled trial; Cancer; Interim analysis; Chemotherapy; Phases of clinical research; Oncology; Gastroenterology; Surgery; Urology","score_opus":0.0964503014945268,"score_gpt":0.42715013033816457,"score_spread":0.3306998288436378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2760883434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99074286,0.0010117815,0.0000033513372,0.00046976106,0.000016442473,0.0031869137,0.0045387875,0.000002862482,0.000027254253],"genre_scores_gemma":[0.9950293,0.0019402907,0.00003557875,0.0000118440275,0.000047093876,0.0024880238,0.00015148314,0.00003717097,0.00025926172],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9962131,0.0010072365,0.00057405775,0.0006994283,0.00080889015,0.0006972889],"domain_scores_gemma":[0.9974696,0.00010277988,0.00042825873,0.00084214885,0.0007252961,0.0004319212],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017319786,0.00034467407,0.0015815718,0.0011135484,0.00040169814,0.000073248404,0.0003596481,0.0000764671,0.00025517028],"category_scores_gemma":[0.00006631948,0.00019767444,0.00014767861,0.0008830367,0.0006507547,0.000024406672,0.00010970669,0.00016016133,2.587678e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5937243,0.0040028584,0.35444254,0.0000397804,0.010352316,0.000030774285,0.00066504517,0.00011141965,0.0006789776,0.0000031790607,0.000021042299,0.035927784],"study_design_scores_gemma":[0.5950891,0.053125564,0.34372786,0.00026097702,0.0027318462,0.000008235401,0.0010836194,0.00019073123,0.0032625592,0.000009330448,0.00006393173,0.00044628442],"about_ca_topic_score_codex":0.66980106,"about_ca_topic_score_gemma":0.948748,"teacher_disagreement_score":0.2789469,"about_ca_system_score_codex":0.00034672715,"about_ca_system_score_gemma":0.0021284595,"threshold_uncertainty_score":0.806093},"labels":[],"label_agreement":null},{"id":"W2765513317","doi":"10.1007/s10549-017-4525-9","title":"Serum selenium levels predict survival after breast cancer","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Selenium in Biological Systems","field":"Nursing","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Women's College Hospital; University of Toronto","funders":"","keywords":"Breast cancer; Oncology; Selenium; Medicine; Internal medicine; Mammary gland; Cancer; Biology; Physiology; Gynecology; Chemistry","score_opus":0.10826515416267685,"score_gpt":0.39631910144367455,"score_spread":0.2880539472809977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765513317","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9755655,0.0020434158,0.0000012074403,0.01407715,0.0012022939,0.0009587733,0.0047394037,0.000095498144,0.001316758],"genre_scores_gemma":[0.9947668,0.0005872797,0.00001533814,0.000056409706,0.0017275653,0.0014186618,0.000011092263,0.00004750874,0.0013693979],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99664754,0.00030857412,0.0002834088,0.000832493,0.0007282195,0.0011997555],"domain_scores_gemma":[0.99805355,0.00014062796,0.000119939104,0.0008236022,0.0003370605,0.00052521494],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00047585426,0.00036518704,0.0004585419,0.00010527226,0.0010677375,0.00046624595,0.00043845078,0.00020808664,0.0012286473],"category_scores_gemma":[0.000020336951,0.00024346706,0.00010793268,0.00013010098,0.00058655237,0.0002832022,0.00024046323,0.00030655583,0.00008868302],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003641483,0.000384081,0.8864265,0.00006891782,0.00028320853,0.000042773412,0.00021270257,0.0000029653434,0.0017377426,0.000045454362,0.00065140106,0.10650275],"study_design_scores_gemma":[0.0022043737,0.00041336246,0.98958737,0.00020150947,0.00004477963,0.0001410164,0.0001017961,0.00003734392,0.0020313624,0.00012687198,0.0048431302,0.00026706533],"about_ca_topic_score_codex":0.03644371,"about_ca_topic_score_gemma":0.006897667,"teacher_disagreement_score":0.10623568,"about_ca_system_score_codex":0.0011019272,"about_ca_system_score_gemma":0.00016190398,"threshold_uncertainty_score":0.9996844},"labels":[],"label_agreement":null},{"id":"W2765692744","doi":"10.1007/s10549-017-4523-y","title":"Ribociclib with letrozole vs letrozole alone in elderly patients with hormone receptor-positive, HER2-negative breast cancer in the randomized MONALEESA-2 trial","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa; Occupational Cancer Research Centre","funders":"Novartis Institutes for BioMedical Research; Astex Pharmaceuticals; Novartis Pharmaceuticals Corporation","keywords":"Letrozole; Medicine; Breast cancer; Hazard ratio; Discontinuation; Internal medicine; Placebo; Metastatic breast cancer; Clinical endpoint; Population; Nausea; Oncology; Cancer; Surgery; Randomized controlled trial; Tamoxifen; Confidence interval","score_opus":0.02442456894890639,"score_gpt":0.33779852049377096,"score_spread":0.3133739515448646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765692744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97781515,0.0017454729,0.000011739339,0.01317404,0.000058843416,0.005613049,0.0011104251,0.00002578348,0.00044546818],"genre_scores_gemma":[0.99110836,0.0022877785,0.00016281969,0.00011732995,0.00033138948,0.0053844466,0.00006526524,0.00006995089,0.00047268308],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9959686,0.0005324702,0.00042824034,0.0008109722,0.0012487998,0.0010109306],"domain_scores_gemma":[0.99771863,0.0004314923,0.0002696999,0.00075107865,0.0005240965,0.00030502523],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006893151,0.00051209214,0.0011781619,0.00030483078,0.0005719981,0.00019364765,0.000326626,0.00011531783,0.00017663796],"category_scores_gemma":[0.00003834832,0.00027311788,0.00011037821,0.00043432624,0.0014745956,0.00047349767,0.00008684689,0.00060115213,0.0000085216825],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.78852683,0.0019244672,0.12041657,0.000030095962,0.00068005355,0.00014002006,0.0013477139,0.000021187716,0.000055690096,0.00004768188,0.000050661612,0.08675903],"study_design_scores_gemma":[0.45775914,0.0031941012,0.53737205,0.0005170451,0.000087398155,0.00005627532,0.00037930653,0.000014476672,0.0001583034,0.00007414258,0.00017652732,0.00021124503],"about_ca_topic_score_codex":0.056619767,"about_ca_topic_score_gemma":0.021735895,"teacher_disagreement_score":0.41695547,"about_ca_system_score_codex":0.0014364925,"about_ca_system_score_gemma":0.0006818007,"threshold_uncertainty_score":0.9999721},"labels":[],"label_agreement":null},{"id":"W2767515019","doi":"10.1007/s10549-017-4561-5","title":"Patient-reported factors associated with adherence to adjuvant endocrine therapy after breast cancer: an integrative review","year":2017,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":126,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; University of British Columbia; University of British Columbia Hospital","funders":"University of British Columbia","keywords":"Breast cancer; Medicine; Oncology; Adjuvant; Endocrine system; Cancer; Internal medicine; Adjuvant therapy; Gynecology; Hormone","score_opus":0.3054605754013411,"score_gpt":0.5019105560680036,"score_spread":0.19644998066666253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767515019","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0043994677,0.98643905,9.9624e-7,0.0009697135,0.00008860034,0.0055458234,0.002238606,0.000053271353,0.0002644904],"genre_scores_gemma":[0.004877894,0.977496,0.000011181361,0.00020705714,0.00015532247,0.012991491,0.0005545612,0.000075093514,0.0036313739],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958673,0.0003687668,0.0006893828,0.0011492411,0.0010951983,0.0008300786],"domain_scores_gemma":[0.99594414,0.000120538156,0.0005721572,0.0011935384,0.0010354248,0.0011342057],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00025056078,0.00078892964,0.0025015727,0.00025165538,0.00030067516,0.00010895731,0.00030514426,0.0001499747,0.0027373875],"category_scores_gemma":[0.00006223601,0.00040400124,0.00024140258,0.00055964704,0.0003364616,0.00017051355,0.00009008804,0.00059745775,0.00006992698],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055293465,0.0007703126,0.0052620065,0.0023528193,0.0013642332,0.00028941373,0.00014254576,1.587565e-8,6.540066e-7,0.0000027679841,0.0010961841,0.9881661],"study_design_scores_gemma":[0.0026852116,0.005985091,0.04615635,0.29778478,0.0012712072,0.0006119749,0.00012302405,0.0000010119151,0.000009631094,0.000008229041,0.64467126,0.0006921923],"about_ca_topic_score_codex":0.006504721,"about_ca_topic_score_gemma":0.0015740953,"teacher_disagreement_score":0.9874739,"about_ca_system_score_codex":0.0013052037,"about_ca_system_score_gemma":0.0032885324,"threshold_uncertainty_score":0.9998412},"labels":[],"label_agreement":null},{"id":"W2767885640","doi":"10.1007/s10549-017-4554-4","title":"The effect of an aerobic exercise bout 24 h prior to each doxorubicin treatment for breast cancer on markers of cardiotoxicity and treatment symptoms: a RCT","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":113,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; BC Cancer Agency; University of British Columbia, Okanagan Campus; University of British Columbia; University of Alberta","funders":"BC Cancer Agency","keywords":"Medicine; Cardiotoxicity; Breast cancer; Internal medicine; Doxorubicin; Anthracycline; Subclinical infection; Cancer; Cardiology; Chemotherapy; Physical therapy","score_opus":0.036156392980862886,"score_gpt":0.3785445484125434,"score_spread":0.34238815543168055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767885640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98920494,0.0017113291,0.0000030467747,0.002171384,0.00009248884,0.0055284984,0.0011266973,0.00001976765,0.0001418673],"genre_scores_gemma":[0.988166,0.0070198528,0.000039741153,0.000017459832,0.0002417234,0.0036689034,0.000028032104,0.000046707213,0.00077157863],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997739,0.00017989642,0.00031003077,0.00064729474,0.0005090033,0.0006147551],"domain_scores_gemma":[0.99789006,0.00030807534,0.00015888926,0.000909981,0.00022824814,0.0005047398],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004886827,0.00041706453,0.0009214154,0.000167971,0.00077149086,0.00010107194,0.00014282715,0.00013122949,0.000020267613],"category_scores_gemma":[0.000021702312,0.00023474333,0.0002697681,0.000117857664,0.0004437848,0.000104420564,0.000045045996,0.00010028312,0.000001176732],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03659524,0.000719933,0.019750966,0.00016632653,0.0016556991,0.000020466116,0.00073845166,0.00001621559,0.04110285,0.000020318763,0.000041744697,0.89917177],"study_design_scores_gemma":[0.020625973,0.028977415,0.3133937,0.0010306924,0.0007382072,0.00011624957,0.00025531003,0.00010531989,0.633777,0.000020227175,0.00071751024,0.00024239079],"about_ca_topic_score_codex":0.014722206,"about_ca_topic_score_gemma":0.0034684606,"teacher_disagreement_score":0.8989294,"about_ca_system_score_codex":0.0017500042,"about_ca_system_score_gemma":0.00038385452,"threshold_uncertainty_score":0.9918389},"labels":[],"label_agreement":null},{"id":"W2767899580","doi":"10.1007/s10549-017-4572-2","title":"Impact of microinvasion on breast cancer mortality in women with ductal carcinoma in situ","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":85,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Women's College Hospital; University of Toronto","funders":"","keywords":"Ductal carcinoma; Breast cancer; Medicine; Oncology; Cancer; Lobular carcinoma; Carcinoma in situ; Mammary gland; Internal medicine; Radiation therapy; Mammography; Epidemiology; Carcinoma; Invasive lobular carcinoma; Gynecology; Pathology; Invasive ductal carcinoma","score_opus":0.04364264707845005,"score_gpt":0.37516147601582717,"score_spread":0.3315188289373771,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767899580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964885,0.0009890442,1.4026593e-7,0.00077975064,0.000025761126,0.00042791266,0.0010151519,0.0000035190806,0.00027018835],"genre_scores_gemma":[0.99678683,0.0023176773,0.000006333393,0.00001037069,0.00011768756,0.00065511256,0.00002375405,0.000024527228,0.000057699996],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982671,0.00007790754,0.00018118134,0.0005801095,0.00027094514,0.0006227652],"domain_scores_gemma":[0.9989917,0.000017114367,0.00009679564,0.00058516324,0.000137907,0.00017126702],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015474421,0.0002726408,0.0003477905,0.00014010213,0.00018777426,0.00004269433,0.00017835807,0.000082950326,0.000036169935],"category_scores_gemma":[0.000006343665,0.00018314438,0.000055901037,0.000113753435,0.0004026571,0.000016391808,0.00014973512,0.00011414485,0.0000014733034],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00809251,0.00094496226,0.9521517,0.000026479738,0.00037936232,0.00009964623,0.000306403,0.000032425065,0.018637965,0.000005984212,0.000046993307,0.019275527],"study_design_scores_gemma":[0.0048752204,0.0013551412,0.9842786,0.00015493497,0.000015515321,0.00007680761,0.00013967844,0.0000020540929,0.008901497,0.000022435688,0.000016271018,0.00016180381],"about_ca_topic_score_codex":0.08345548,"about_ca_topic_score_gemma":0.048488203,"teacher_disagreement_score":0.034967277,"about_ca_system_score_codex":0.0010609953,"about_ca_system_score_gemma":0.00054156117,"threshold_uncertainty_score":0.9688744},"labels":[],"label_agreement":null},{"id":"W2768603319","doi":"10.1007/s10549-017-4583-z","title":"Nestin expression in breast cancer: association with prognosis and subtype on 3641 cases with long-term follow-up","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; BC Cancer Agency; University of British Columbia Hospital; University of British Columbia","funders":"National Cancer Institute; BC Cancer Agency; National Institutes of Health","keywords":"Nestin; Breast cancer; Immunohistochemistry; Tissue microarray; Oncology; Medicine; Internal medicine; Estrogen receptor; Proportional hazards model; Pathology; Cancer; Biology; Stem cell; Neural stem cell","score_opus":0.03799049350481668,"score_gpt":0.3441108099052847,"score_spread":0.306120316400468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2768603319","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99345905,0.0018246647,0.0000010452165,0.003358492,0.000044223612,0.0006032009,0.00056951906,0.000011876288,0.00012790467],"genre_scores_gemma":[0.992005,0.005902675,0.000026813377,0.000028017215,0.00019547211,0.0012339677,0.000063069325,0.00003438726,0.0005106367],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982207,0.000081110506,0.00012603028,0.0006653898,0.0003746824,0.00053209125],"domain_scores_gemma":[0.99903274,0.00005038429,0.00013529582,0.00037540155,0.00022430622,0.00018188717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012596292,0.00029519183,0.00027627876,0.000086274835,0.0005917175,0.00015652298,0.00012033997,0.000103955244,0.000020105777],"category_scores_gemma":[0.00001454009,0.00018881436,0.000029649435,0.000087418004,0.00024269514,0.000025689491,0.0001239568,0.000115863186,0.0000018402495],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064709974,0.0004068727,0.95297384,0.000031995616,0.00027114616,0.00012993059,0.00010520461,0.0000038018027,0.0012498391,0.000006132687,0.00017797686,0.03817229],"study_design_scores_gemma":[0.0056674746,0.0012274041,0.98114115,0.00047386545,0.00006703729,0.00018376809,0.000064467655,0.0000014994793,0.010860297,0.000005500179,0.00009785806,0.00020969342],"about_ca_topic_score_codex":0.012190016,"about_ca_topic_score_gemma":0.03373661,"teacher_disagreement_score":0.037962597,"about_ca_system_score_codex":0.00047893895,"about_ca_system_score_gemma":0.00026563954,"threshold_uncertainty_score":0.9943879},"labels":[],"label_agreement":null},{"id":"W2768885575","doi":"10.1007/s10549-017-4543-7","title":"Evaluation of applying IHC4 as a prognostic model in the translational study of Intergroup Exemestane Study (IES): PathIES","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"Imperial Experimental Cancer Medicine Centre; National Institute for Health and Care Research; Pfizer UK; NIHR Imperial Biomedical Research Centre; Cancer Research UK; Imperial College London; Pfizer","keywords":"Exemestane; Medicine; Internal medicine; Oncology; Proportional hazards model; Tamoxifen; Hazard ratio; Breast cancer; Gynecology; Quartile; Adjuvant; Progesterone receptor; Population; Estrogen receptor; Cancer; Confidence interval","score_opus":0.09266416976186627,"score_gpt":0.42405101686941277,"score_spread":0.3313868471075465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2768885575","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961985,0.001329779,0.000004528836,0.0000931966,0.000011766924,0.0021266702,0.000019130553,0.0000011235404,0.00021533605],"genre_scores_gemma":[0.9984707,0.00022849825,0.0000070616006,0.0000011086488,0.000021486694,0.0012318626,0.00000990484,0.000006332449,0.000023009407],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986594,0.00029651495,0.00014050453,0.00019982463,0.0005653499,0.00013840587],"domain_scores_gemma":[0.9993857,0.000028090686,0.000060187936,0.0002694434,0.00022610283,0.000030450221],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010644904,0.00008604352,0.00011971199,0.00005367607,0.00015721151,0.000024742993,0.00013379354,0.00003944325,0.0000032199678],"category_scores_gemma":[0.000034033645,0.000052629144,0.000025704481,0.00005033624,0.00011031123,0.0000062666845,0.00004626993,0.000071300296,2.6243535e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034641833,0.01538828,0.67418534,0.00006194366,0.0013820125,0.00004038027,0.015925024,0.0019949807,0.03618728,0.00015358381,0.000013641924,0.25120333],"study_design_scores_gemma":[0.014744128,0.014746327,0.9399442,0.00013354051,0.00041832172,0.000031183972,0.015169639,0.007006665,0.006850296,0.0007662984,0.000007737805,0.00018166286],"about_ca_topic_score_codex":0.0015648509,"about_ca_topic_score_gemma":0.0014578563,"teacher_disagreement_score":0.26575884,"about_ca_system_score_codex":0.000028950672,"about_ca_system_score_gemma":0.00020161638,"threshold_uncertainty_score":0.23655969},"labels":[],"label_agreement":null},{"id":"W2769260727","doi":"10.1007/s10549-017-4586-9","title":"Willingness of breast cancer patients to undergo biopsy and breast cancer clinicians’ practices around seeking biopsy at the time of breast cancer relapse","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Biopsy; Breast biopsy; Cancer; Clinical trial; Oncology; Internal medicine; Mammography","score_opus":0.12405423251317997,"score_gpt":0.4387113813448564,"score_spread":0.3146571488316764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2769260727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9574848,0.005568979,0.0000033148283,0.026082998,0.00030615588,0.0014205999,0.008744143,0.000028453764,0.00036056945],"genre_scores_gemma":[0.98628986,0.010355798,0.000046314526,0.00024458428,0.0007155431,0.00072371186,0.000037202688,0.000076468445,0.0015105219],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952181,0.00021908586,0.00077184325,0.0011237964,0.0015173424,0.0011498382],"domain_scores_gemma":[0.9951334,0.00029567262,0.0011111847,0.0010781981,0.0016199347,0.00076159753],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008035659,0.00057972677,0.0010237413,0.00023707913,0.0012206779,0.00025687754,0.00051065226,0.00022858559,0.000771077],"category_scores_gemma":[0.000070436414,0.00038647224,0.00018775872,0.00053203496,0.0012235135,0.00062509003,0.00053767493,0.00044202205,0.000016245944],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0097235525,0.00066932465,0.89713204,0.0003046038,0.0010665014,0.00007570136,0.00086668285,0.000051232335,0.0028263018,0.00003372268,0.0008062007,0.08644411],"study_design_scores_gemma":[0.0047894064,0.00058849505,0.9875332,0.0029067523,0.0005536452,0.0009582758,0.00086476153,0.00019051653,0.00046046576,0.000045694385,0.00072488276,0.0003838706],"about_ca_topic_score_codex":0.26956114,"about_ca_topic_score_gemma":0.02632765,"teacher_disagreement_score":0.24323349,"about_ca_system_score_codex":0.0017469408,"about_ca_system_score_gemma":0.0014681143,"threshold_uncertainty_score":0.99985874},"labels":[],"label_agreement":null},{"id":"W2769385365","doi":"10.1007/s10549-017-4575-z","title":"Abundant tumor infiltrating lymphocytes after primary systemic chemotherapy predicts poor prognosis in estrogen receptor-positive/HER2-negative breast cancers","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministry of Education, Culture, Sports, Science and Technology; Alberta Innovates - Health Solutions; Japanese Breast Cancer Society","keywords":"Tumor-infiltrating lymphocytes; Estrogen receptor; Medicine; Oncology; Internal medicine; Breast cancer; Chemotherapy; Triple-negative breast cancer; Pathological; Estrogen; Cancer; Immunotherapy","score_opus":0.024877519237589796,"score_gpt":0.3231705649301975,"score_spread":0.29829304569260773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2769385365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883888,0.0035043606,9.73608e-7,0.0035045582,0.00010801108,0.0027381182,0.0009771826,0.000043925273,0.00073410384],"genre_scores_gemma":[0.9910225,0.0044369265,0.0001427348,0.0001890732,0.00034519276,0.0033120562,0.000041630916,0.000059912738,0.00044993075],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972539,0.00014692008,0.0003969245,0.00071783556,0.0006433186,0.0008411004],"domain_scores_gemma":[0.99862593,0.00011104298,0.00019381611,0.00043854688,0.00027793925,0.0003526911],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00041222587,0.00039074023,0.000583006,0.00022645349,0.0005111765,0.00024693052,0.00020048351,0.0001109551,0.0002820861],"category_scores_gemma":[0.000016890897,0.00029193627,0.00013583316,0.00023013787,0.0007035373,0.00028393284,0.00007853529,0.00023591526,0.000010412683],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03682909,0.0007552106,0.7344731,0.00038783174,0.0012051512,0.000439922,0.0016228134,0.0000018504256,0.01345578,0.000010684994,0.00026882155,0.21054973],"study_design_scores_gemma":[0.014485603,0.0016411564,0.9563091,0.0028238152,0.00006820571,0.001458432,0.00059252774,0.000049361846,0.021946702,0.000014167758,0.00030784303,0.0003030987],"about_ca_topic_score_codex":0.057467975,"about_ca_topic_score_gemma":0.0028194264,"teacher_disagreement_score":0.22183597,"about_ca_system_score_codex":0.005253383,"about_ca_system_score_gemma":0.0019504819,"threshold_uncertainty_score":0.99995327},"labels":[],"label_agreement":null},{"id":"W2770320042","doi":"10.1007/s10549-017-4580-2","title":"Impact of multi-gene mutational profiling on clinical trial outcomes in metastatic breast cancer","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"University of Toronto; Ontario Ministry of Health and Long-Term Care; Princess Margaret Cancer Foundation; Cancer Care Ontario","keywords":"Breast cancer; Metastatic breast cancer; Oncology; Medicine; Profiling (computer programming); Clinical trial; Internal medicine; Gene; Cancer; Bioinformatics; Biology; Genetics; Computer science","score_opus":0.17038149954369378,"score_gpt":0.5107144739087063,"score_spread":0.34033297436501253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2770320042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99496365,0.00060908345,0.0000055225323,0.000510217,0.00013271274,0.00066433236,0.0030729866,0.0000020508223,0.00003942932],"genre_scores_gemma":[0.995852,0.0030445019,0.00017198507,0.00001680812,0.00026735695,0.000399003,0.000078189274,0.000018394054,0.00015175494],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99865735,0.00007918353,0.0003075605,0.00040343066,0.0002186391,0.0003338121],"domain_scores_gemma":[0.9990168,0.00009775887,0.00013757258,0.0003892799,0.00018620459,0.00017238296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033796972,0.00016766856,0.0003120737,0.00008178776,0.00016082592,0.000062063875,0.00016145686,0.00007049351,0.00003913662],"category_scores_gemma":[0.000093486524,0.00011975265,0.00015387152,0.00004214739,0.00024282915,0.0000070105707,0.000101997124,0.00010513502,0.0000021721635],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027156113,0.00241948,0.907799,0.000015055156,0.000732635,0.000033957782,0.000033285985,0.00030658796,0.004149177,0.00006001949,0.000065678774,0.057228982],"study_design_scores_gemma":[0.032817155,0.0026110744,0.96080387,0.00003299506,0.00003140772,0.000016104956,0.000019025834,0.00010416063,0.0033407276,0.000051936397,0.0000433968,0.00012812002],"about_ca_topic_score_codex":0.011217143,"about_ca_topic_score_gemma":0.0039006928,"teacher_disagreement_score":0.057100862,"about_ca_system_score_codex":0.0002098242,"about_ca_system_score_gemma":0.0009141572,"threshold_uncertainty_score":0.9953672},"labels":[],"label_agreement":null},{"id":"W2773830972","doi":"10.1007/s10549-017-4602-0","title":"Assessment of the functional impact of germline BRCA1/2 variants located in non-coding regions in families with breast and/or ovarian cancer predisposition","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Health and Medical Research Council; Unicancer","keywords":"Germline; Biology; Genetics; Sanger sequencing; Gene; Coding region; Breast cancer; Promoter; Germline mutation; Ovarian cancer; Intron; Cancer research; Mutation; Cancer; Gene expression","score_opus":0.03776485083918895,"score_gpt":0.3800652218658811,"score_spread":0.34230037102669214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2773830972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99764293,0.00028555523,0.000109375746,0.00062400155,0.00003260159,0.0004333281,0.00072304654,0.0000013521601,0.00014777752],"genre_scores_gemma":[0.9974262,0.0019336282,0.00007635604,0.000004545229,0.000062096035,0.00032936607,0.000038290025,0.0000114638415,0.00011802948],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99908864,0.00006259621,0.00016074683,0.00027868283,0.00019429835,0.00021505286],"domain_scores_gemma":[0.99929816,0.000018144587,0.00010435851,0.0003321723,0.00019024934,0.000056903562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001653296,0.00011938375,0.0001615344,0.00010226924,0.00016260627,0.00002881427,0.00011098586,0.00006307688,0.00002692214],"category_scores_gemma":[0.00000802089,0.00007029427,0.000032302785,0.0001461525,0.00028952406,0.000016083522,0.00009722706,0.000087082,5.2874036e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001472012,0.00038232407,0.9535951,0.000050706185,0.00028630046,0.000006458076,0.00014503529,0.0011879338,0.026973588,0.00008989833,0.000040110113,0.015770558],"study_design_scores_gemma":[0.0026237653,0.00043027752,0.9926311,0.0002630287,0.00001986875,0.00006327011,0.00012293243,0.0005480119,0.0031905472,0.000029709685,0.0000072498747,0.000070282644],"about_ca_topic_score_codex":0.026887223,"about_ca_topic_score_gemma":0.027683528,"teacher_disagreement_score":0.03903598,"about_ca_system_score_codex":0.00042528447,"about_ca_system_score_gemma":0.0011585085,"threshold_uncertainty_score":0.9900587},"labels":[],"label_agreement":null},{"id":"W2774434691","doi":"10.1007/s10549-017-4608-7","title":"Effects of physical exercise on markers of inflammation in breast cancer patients during adjuvant chemotherapy","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer survivorship and care","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"World Cancer Research Fund; Wereld Kanker Onderzoek Fonds; Newfoundland and Labrador; KWF Kankerbestrijding; ZonMw; Pink Ribbon Foundation","keywords":"Breast cancer; Medicine; Oncology; Chemotherapy; Inflammation; Internal medicine; Adjuvant chemotherapy; Adjuvant; Cancer; Mammary gland","score_opus":0.015087650304850254,"score_gpt":0.332562159599975,"score_spread":0.3174745092951247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2774434691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974888,0.0004466497,7.864096e-8,0.00081718224,0.000055652457,0.0008185761,0.00018115978,0.0000060674865,0.0001858403],"genre_scores_gemma":[0.99624556,0.0030487035,0.0000013413749,0.000005335289,0.000121050936,0.00041139632,0.000008645905,0.000018481778,0.00013946886],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99879897,0.00004059293,0.00015814924,0.0002570492,0.00046491483,0.00028030112],"domain_scores_gemma":[0.9992122,0.00005049407,0.00010287004,0.00028966376,0.00020467184,0.00014008442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000081487364,0.00014684664,0.0003758051,0.00015714006,0.00009769325,0.000016848504,0.00008067921,0.000047351874,0.000036563502],"category_scores_gemma":[0.000006855136,0.00010761625,0.00007049375,0.000102543956,0.00017310174,0.00008354609,0.00003880975,0.00010732723,0.0000013163075],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0142852,0.0012454551,0.59363055,0.00082474167,0.00014537341,0.00002453456,0.001278611,0.000003915815,0.009660804,0.000015335543,0.000017985209,0.37886748],"study_design_scores_gemma":[0.0073059187,0.0007413674,0.90843314,0.0017952105,0.00003678599,0.0000022692223,0.000066714674,0.000028416638,0.081483446,0.000018631585,0.000016369968,0.000071753224],"about_ca_topic_score_codex":0.023030438,"about_ca_topic_score_gemma":0.002256695,"teacher_disagreement_score":0.3787957,"about_ca_system_score_codex":0.0004619329,"about_ca_system_score_gemma":0.00015729433,"threshold_uncertainty_score":0.98347527},"labels":[],"label_agreement":null},{"id":"W2774891724","doi":"10.1007/s10549-017-4605-x","title":"Predictors of survival for breast cancer patients with a BRCA1 mutation","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"Peter Gilgan Foundation","keywords":"Medicine; Breast cancer; Oophorectomy; Hazard ratio; Oncology; Internal medicine; Cancer; Cause of death; Cohort; Gynecology; Chemotherapy; Cancer registry; Survival analysis; Medical record; Ovarian cancer; Surgery; Hysterectomy; Disease","score_opus":0.02994448968060479,"score_gpt":0.3520465062761707,"score_spread":0.32210201659556587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2774891724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931584,0.0004599001,0.000054569984,0.0007889744,0.00013682425,0.00071382907,0.0045327074,0.0000046351274,0.00015016722],"genre_scores_gemma":[0.99747306,0.00054687035,0.00009499095,0.000008244226,0.000280742,0.0009785099,0.00014132042,0.000025481275,0.0004507624],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99892324,0.000034460285,0.00012564204,0.00036061194,0.00026584105,0.0002902113],"domain_scores_gemma":[0.99876994,0.00001886028,0.0001068469,0.00036294095,0.0006295304,0.00011187641],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000116125295,0.00013693316,0.0001515426,0.000052991993,0.0003437068,0.000055335808,0.0001499522,0.000066471504,0.000035384208],"category_scores_gemma":[0.000013010674,0.000101081336,0.0000404248,0.000048545156,0.00031154713,0.000012576966,0.00006600173,0.00004189622,6.2430377e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036529906,0.00071661524,0.85482866,0.00007899429,0.00090154057,0.0000025757604,0.00020183348,0.000094255265,0.0034727824,0.000056836816,0.00067904487,0.13531388],"study_design_scores_gemma":[0.0043156506,0.0010526448,0.97839266,0.00005408194,0.00005333217,0.000008261916,0.00006343051,0.000019936531,0.014406635,0.000039751845,0.0014653711,0.0001282144],"about_ca_topic_score_codex":0.002345339,"about_ca_topic_score_gemma":0.0030251849,"teacher_disagreement_score":0.13518566,"about_ca_system_score_codex":0.00021603792,"about_ca_system_score_gemma":0.00052555837,"threshold_uncertainty_score":0.41219774},"labels":[],"label_agreement":null},{"id":"W2775364783","doi":"10.1007/s10549-017-4594-9","title":"CD14+ HLA-DR−/low MDSCs are elevated in the periphery of early-stage breast cancer patients and suppress autologous T cell proliferation","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences North","funders":"Eberhard Karls Universität Tübingen; Deutsche Forschungsgemeinschaft","keywords":"CD14; Breast cancer; Medicine; Myeloid; Immune system; Cancer; Immunology; Immunotherapy; T cell; Internal medicine; Oncology; Cancer research","score_opus":0.030461658720075297,"score_gpt":0.32228209157422494,"score_spread":0.29182043285414966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2775364783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915681,0.0043400363,4.2970453e-7,0.0012803691,0.00022987182,0.0009649541,0.0013061787,0.00001323723,0.00029683355],"genre_scores_gemma":[0.99367684,0.0031829702,0.0000033286885,0.000031839536,0.000045036028,0.0007231954,0.000058639653,0.000022711843,0.0022554381],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99816823,0.0003569426,0.00027174398,0.00045069034,0.00015398287,0.000598403],"domain_scores_gemma":[0.99882627,0.000101917525,0.00020723161,0.00052631483,0.0002932014,0.000045080553],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029795463,0.00024355449,0.00035044702,0.00012119878,0.0006552281,0.00011064305,0.00034026225,0.00019753112,0.0003218752],"category_scores_gemma":[0.000015671802,0.00016126696,0.00004549605,0.00010350337,0.00079402135,0.00018556282,0.00017343523,0.00033725734,0.000011492148],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027337463,0.0012208045,0.9432483,0.00016449577,0.00024431615,0.000030416886,0.002538642,0.000010704982,0.013190299,0.000035882455,0.00074801594,0.035834394],"study_design_scores_gemma":[0.0043112407,0.0004726598,0.9683394,0.00015226883,0.00003183403,0.000034149558,0.0003649029,0.0000126935975,0.025024084,0.00002173885,0.0010750443,0.00015998443],"about_ca_topic_score_codex":0.01976957,"about_ca_topic_score_gemma":0.0035061815,"teacher_disagreement_score":0.035674408,"about_ca_system_score_codex":0.0002912044,"about_ca_system_score_gemma":0.00024595094,"threshold_uncertainty_score":0.9867579},"labels":[],"label_agreement":null},{"id":"W2775577815","doi":"10.1007/s10549-017-4604-y","title":"A multi-center pragmatic, randomized, feasibility trial comparing standard of care schedules of filgrastim administration for primary febrile neutropenia prophylaxis in early-stage breast cancer","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Grand River Hospital; Ottawa Hospital; University of Ottawa","funders":"European Society for Medical Oncology; Ottawa Hospital Research Institute","keywords":"Medicine; Filgrastim; Febrile neutropenia; Discontinuation; Randomized controlled trial; Breast cancer; Neutropenia; Randomization; Chemotherapy; Internal medicine; Clinical endpoint; Surgery; Cancer","score_opus":0.08349081564704279,"score_gpt":0.4204643519534432,"score_spread":0.3369735363064004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2775577815","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875306,0.00068606227,0.0000401303,0.000658251,0.00013625882,0.0071151187,0.0036541107,0.000011875145,0.00016758966],"genre_scores_gemma":[0.99506104,0.0006384446,0.00043852266,0.000004517359,0.00014468607,0.0034390097,0.00007396934,0.000024746301,0.000175055],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9980061,0.00018590462,0.00052650657,0.00044695314,0.00044724476,0.00038725685],"domain_scores_gemma":[0.99815434,0.00013682303,0.00029026,0.0005109188,0.0007096374,0.00019799157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048248903,0.00022317257,0.0010947619,0.00016983082,0.00028977066,0.00008613562,0.00013191525,0.00008423949,0.00007774414],"category_scores_gemma":[0.00005175135,0.00016086664,0.00020200666,0.000110443885,0.0005757218,0.00018568798,0.000083587496,0.00018690931,7.220645e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6419536,0.0015964609,0.34512475,0.0009787438,0.00027674504,0.00001072421,0.00040368194,0.000009533456,0.0006419958,0.00009289664,0.000009986552,0.00890092],"study_design_scores_gemma":[0.5173421,0.0040903706,0.4743678,0.0007326668,0.00014260228,0.000019599063,0.00021875754,0.00007184315,0.0027913172,0.0000213572,0.00007790133,0.00012372868],"about_ca_topic_score_codex":0.014403893,"about_ca_topic_score_gemma":0.019098993,"teacher_disagreement_score":0.12924303,"about_ca_system_score_codex":0.00086286484,"about_ca_system_score_gemma":0.0012771706,"threshold_uncertainty_score":0.9987999},"labels":[],"label_agreement":null},{"id":"W2777306706","doi":"10.1007/s10549-017-4613-x","title":"Interventions are needed to support patient–provider decision-making for DCIS: a scoping review","year":2017,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Calgary; University Health Network; Dalhousie University; University of Saskatchewan; Sunnybrook Health Science Centre; Health Sciences Centre","funders":"Canadian Cancer Society Research Institute","keywords":"Medicine; Psychological intervention; CINAHL; MEDLINE; Family medicine; Breast cancer; Mastectomy; Decision aids; Cochrane Library; Alternative medicine; Cancer; Nursing; Internal medicine; Pathology","score_opus":0.5766634076006307,"score_gpt":0.6166275158136431,"score_spread":0.03996410821301233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2777306706","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000022636139,0.98751813,0.000062305306,0.001380423,0.00015334872,0.009679523,0.00094533636,0.000029352072,0.00020894302],"genre_scores_gemma":[0.00012127371,0.98788124,0.0005772059,0.00041237343,0.00033114234,0.010076184,0.00010728854,0.0000621425,0.00043116097],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9966767,0.000111188034,0.0008220024,0.0008635757,0.00073089305,0.00079563685],"domain_scores_gemma":[0.99717057,0.0003784271,0.00039418493,0.00084175356,0.00064397824,0.00057108485],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000634379,0.0004604731,0.0021839994,0.00038150788,0.00059306325,0.00021259834,0.00027040232,0.00015480687,0.00032724682],"category_scores_gemma":[0.00046409582,0.00031453618,0.00086643925,0.00032251104,0.000105728104,0.00014405102,0.0002652405,0.0002883356,0.000058317946],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002827944,0.00012555697,0.000033324064,0.10489056,0.00028559507,0.00015220717,0.000034231674,9.272527e-8,2.2203654e-8,0.0000065748054,0.009515526,0.88467354],"study_design_scores_gemma":[0.00061226485,0.0013451228,0.000023328128,0.6367586,0.000815704,0.00035168524,0.00007352812,3.3304195e-7,2.926414e-7,0.000021877615,0.35982445,0.00017281616],"about_ca_topic_score_codex":0.0011693734,"about_ca_topic_score_gemma":0.0019506735,"teacher_disagreement_score":0.8845007,"about_ca_system_score_codex":0.0013466326,"about_ca_system_score_gemma":0.0020318485,"threshold_uncertainty_score":0.9999307},"labels":[],"label_agreement":null},{"id":"W2781326879","doi":"10.1007/s10549-017-4627-4","title":"Cognitive sequelae of endocrine therapy in women treated for breast cancer: a meta-analysis","year":2017,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Sunnybrook Hospital; Health Sciences Centre; Women's College Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"Department of Family and Community Medicine, University of Toronto; Canadian Federation of University Women","keywords":"Verbal memory; Breast cancer; Medicine; Cognition; Neuropsychology; Subgroup analysis; Tamoxifen; Internal medicine; Oncology; Verbal learning; Effects of sleep deprivation on cognitive performance; Adverse effect; Visual memory; Meta-analysis; Cancer; Psychology; Psychiatry","score_opus":0.4002790515465721,"score_gpt":0.528464017968056,"score_spread":0.12818496642148386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2781326879","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018482213,0.95854783,0.0000011343337,0.0010323667,0.00003738434,0.0073786858,0.030912597,0.000027632967,0.00021416595],"genre_scores_gemma":[0.01966498,0.94028723,0.0000068847794,0.000027983584,0.00019813984,0.036670018,0.00033413386,0.000095413525,0.0027152216],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9955834,0.00038218612,0.0008808351,0.0011901825,0.0007395387,0.0012238323],"domain_scores_gemma":[0.9963445,0.0007450627,0.0005645344,0.00061959424,0.0012901435,0.00043618397],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005847547,0.0008910728,0.0069701774,0.0016277038,0.00030749023,0.00006849795,0.00020458839,0.00019192477,0.001139918],"category_scores_gemma":[0.00004634846,0.0005507122,0.0017399238,0.0012845545,0.00067704066,0.000106527565,0.00013123215,0.00045193042,0.0000060375037],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004540884,0.0011751205,0.00085075153,0.0022108145,0.28693894,0.00010581298,0.00018498705,3.3009292e-7,7.161648e-7,0.0000036138526,0.000064736734,0.7039233],"study_design_scores_gemma":[0.03134548,0.013726123,0.027803456,0.014053111,0.6615875,0.00068209553,0.00076065434,0.000010715306,0.000055956833,0.00008719179,0.24842554,0.0014622113],"about_ca_topic_score_codex":0.02509219,"about_ca_topic_score_gemma":0.0054176506,"teacher_disagreement_score":0.70246106,"about_ca_system_score_codex":0.0032014465,"about_ca_system_score_gemma":0.0018842423,"threshold_uncertainty_score":0.9997732},"labels":[],"label_agreement":null},{"id":"W2785301351","doi":"10.1007/s10549-017-4644-3","title":"Is invasion a necessary step for metastases in breast cancer?","year":2018,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Public Health Ontario; Women's College Hospital; Toronto Western Hospital","funders":"","keywords":"Breast cancer; Medicine; Cancer; Oncology; Radiation therapy; Metastasis; CA15-3; Internal medicine","score_opus":0.12516604826931607,"score_gpt":0.43568833085996594,"score_spread":0.31052228259064985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2785301351","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006455403,0.97479707,0.0000056672116,0.0011142275,0.00015731175,0.002313659,0.020880414,0.000016342769,0.0000697899],"genre_scores_gemma":[0.0012062743,0.98525536,0.00010015345,0.000069974616,0.0010905146,0.010669985,0.000929303,0.00012040048,0.00055803766],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962683,0.00027399714,0.0005146742,0.0014924081,0.00040776646,0.0010428841],"domain_scores_gemma":[0.9983242,0.00013292502,0.00019927516,0.00067673635,0.00036445528,0.00030240457],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032925655,0.00080194615,0.0014408649,0.0003592261,0.0003469123,0.000097707394,0.00033156353,0.0003515541,0.00012235396],"category_scores_gemma":[0.00001246188,0.0005693522,0.00041418883,0.00046295527,0.0004261791,0.0000148241215,0.00037899413,0.00020019013,0.000016009873],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010597544,0.0006596143,0.002014281,0.0025629776,0.002048054,0.000027062486,0.00006170708,2.3633697e-7,0.0000084640105,0.000014574248,0.010448679,0.9810946],"study_design_scores_gemma":[0.003468478,0.0008065211,0.0028285389,0.00668797,0.00085757667,0.00031959388,0.00010314336,0.000002312353,0.00016118465,0.00004178853,0.9840558,0.000667052],"about_ca_topic_score_codex":0.008851543,"about_ca_topic_score_gemma":0.0068331994,"teacher_disagreement_score":0.98042756,"about_ca_system_score_codex":0.0007697989,"about_ca_system_score_gemma":0.0014728263,"threshold_uncertainty_score":0.9996758},"labels":[],"label_agreement":null},{"id":"W2785718812","doi":"10.1007/s10549-018-4703-4","title":"Reply to K. Altundag","year":2018,"lang":"lt","type":"letter","venue":"Breast Cancer Research and Treatment","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Breast cancer; Medicine; Internal medicine; Cancer","score_opus":0.08252661129058458,"score_gpt":0.4042798192367468,"score_spread":0.3217532079461622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2785718812","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03986965,0.012224306,0.0000067212836,0.92662203,0.0014443804,0.0065137753,0.00434972,0.0001280796,0.008841332],"genre_scores_gemma":[0.119425915,0.0762639,0.00017254193,0.34355918,0.06639651,0.015400164,0.0010362703,0.000740944,0.37700456],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9919094,0.00041023197,0.00068376894,0.002202553,0.0020900273,0.0027040096],"domain_scores_gemma":[0.9948809,0.0005003844,0.00016933838,0.0011198123,0.0020301675,0.0012993969],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000649909,0.0010880227,0.0014296017,0.0010281762,0.00112736,0.0002528846,0.00029516857,0.00050831906,0.0046562646],"category_scores_gemma":[0.0001167369,0.00083343434,0.00027488085,0.0010818378,0.0014496042,0.00012210337,0.0005856886,0.0015784176,0.0029522611],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052532586,0.0008184973,0.0067448705,0.00036686027,0.004259239,0.0021370596,0.0012311118,3.874973e-7,0.000059929807,0.000009481104,0.8687415,0.11037779],"study_design_scores_gemma":[0.0065925196,0.011701957,0.040142305,0.0036958738,0.0008210424,0.00068598246,0.00045849572,0.0000048385314,0.00037585475,0.000086764216,0.9347513,0.0006831115],"about_ca_topic_score_codex":0.030421773,"about_ca_topic_score_gemma":0.0015468705,"teacher_disagreement_score":0.5830628,"about_ca_system_score_codex":0.0065148086,"about_ca_system_score_gemma":0.0018875635,"threshold_uncertainty_score":0.99941164},"labels":[],"label_agreement":null},{"id":"W2786309762","doi":"10.1007/s10549-018-4694-1","title":"Physical activity during adolescence and young adulthood and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers","year":2018,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Physical Activity and Health","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Women's College Hospital; Princess Margaret Cancer Centre; McGill University; Mount Sinai Hospital; North York General Hospital; Sunnybrook Health Science Centre; University of Toronto","funders":"Canada Research Chairs; Cancer Care Ontario","keywords":"Breast cancer; Medicine; BRCA mutation; Metabolic equivalent; Odds ratio; Internal medicine; Menopause; Confidence interval; Population; Case-control study; Gynecology; Cancer; Body mass index; Oncology; Demography; Physical activity; Physical therapy; Environmental health","score_opus":0.030597456011906048,"score_gpt":0.3730417773836264,"score_spread":0.3424443213717204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2786309762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99536693,0.0005845503,0.000001539655,0.0030990306,0.000015027488,0.0005724427,0.00031396138,0.000007123821,0.000039371087],"genre_scores_gemma":[0.9942137,0.005406308,0.0000058815326,0.000010513625,0.00020129145,0.00012542434,0.0000012952282,0.000009522554,0.000026091497],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988299,0.00016689411,0.00009151664,0.00033360717,0.00026224845,0.00031582138],"domain_scores_gemma":[0.9993415,0.00011944627,0.000054142518,0.00012970441,0.00011814671,0.000237044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000182795,0.0001315956,0.00033690513,0.00007301644,0.0002570739,0.000025468376,0.000027686996,0.00004025129,0.0000071878344],"category_scores_gemma":[0.000017266368,0.000080450554,0.00002392497,0.00018010658,0.0010102933,0.00013683044,0.000059018534,0.00023615918,3.6494816e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013512211,0.0012897569,0.63535666,0.00047270546,0.00026326635,0.000027326161,0.0076763113,0.0000012592202,0.0064662863,0.00019517571,0.000005963615,0.33473307],"study_design_scores_gemma":[0.0065336046,0.00054543937,0.9870277,0.00031664167,0.000066131215,0.00013909064,0.00045579663,0.00075812853,0.0038361917,0.00025145762,0.0000024258366,0.00006741599],"about_ca_topic_score_codex":0.040176496,"about_ca_topic_score_gemma":0.007856588,"teacher_disagreement_score":0.351671,"about_ca_system_score_codex":0.00023246912,"about_ca_system_score_gemma":0.00020029595,"threshold_uncertainty_score":0.9662151},"labels":[],"label_agreement":null},{"id":"W2786320243","doi":"10.1007/s10549-018-4671-8","title":"Management and outcomes of women diagnosed with primary breast lymphoma: a multi-institution experience","year":2018,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Institution; Oncology; Lymphoma; Internal medicine; Family medicine; Gynecology; Cancer; Political science","score_opus":0.03323221631856504,"score_gpt":0.34173096650705864,"score_spread":0.3084987501884936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2786320243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99665564,0.0008936811,0.000009424127,0.00060737634,0.000028039127,0.0010314367,0.00012866623,0.000027377244,0.0006183789],"genre_scores_gemma":[0.9944782,0.0024647263,0.0005161918,0.00005977562,0.000054694756,0.0018662043,0.000014595993,0.000016642023,0.0005289417],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99827445,0.0000405928,0.00018634422,0.00047240657,0.00046779608,0.0005584143],"domain_scores_gemma":[0.9989673,0.000056497804,0.000051660678,0.00031364622,0.00020050634,0.00041037172],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012744394,0.0002298251,0.00041121792,0.00018063035,0.00022134739,0.00003785268,0.00005485292,0.00004530237,0.00006837686],"category_scores_gemma":[0.0000036749148,0.00013593685,0.00003707778,0.00023778513,0.00078583584,0.000112127644,0.00009078572,0.000031011477,0.00000800177],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019649388,0.0031123979,0.7486536,0.000094431976,0.00068627077,0.00043071885,0.002082041,1.5402996e-7,0.000054849763,0.0003399482,0.000018220053,0.24256244],"study_design_scores_gemma":[0.015735691,0.0021188736,0.97862864,0.00023878865,0.000094634335,0.0004428858,0.0012156826,0.000010925214,0.0007037943,0.000012505402,0.0006778693,0.00011969236],"about_ca_topic_score_codex":0.003494512,"about_ca_topic_score_gemma":0.00034920743,"teacher_disagreement_score":0.24244276,"about_ca_system_score_codex":0.0016993845,"about_ca_system_score_gemma":0.00023983422,"threshold_uncertainty_score":0.55433434},"labels":[],"label_agreement":null},{"id":"W2787929656","doi":"10.1007/s10549-018-4713-2","title":"Patient-reported predictors of early treatment discontinuation: treatment-related symptoms and health-related quality of life among postmenopausal women with primary breast cancer randomized to anastrozole or exemestane on NCIC Clinical Trials Group (CCTG) MA.27 (E1Z03)","year":2018,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":95,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Cancer Institute; Canadian Cancer Society Research Institute","keywords":"Anastrozole; Medicine; Exemestane; Aromatase inhibitor; Internal medicine; Breast cancer; Hazard ratio; Discontinuation; Quality of life (healthcare); Randomized controlled trial; Clinical endpoint; Oncology; Gynecology; Cancer; Physical therapy; Tamoxifen; Confidence interval","score_opus":0.05822184799215232,"score_gpt":0.3983368100951973,"score_spread":0.340114962103045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2787929656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99145585,0.0024945086,0.000003967498,0.00066915195,0.00015426714,0.004124223,0.0009992619,0.000024807818,0.00007396625],"genre_scores_gemma":[0.992671,0.004860716,0.00003974796,0.00003261687,0.00016791526,0.0013156502,0.00027289326,0.0000539091,0.00058552],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99384016,0.0021423707,0.0017751078,0.00093378645,0.0005536044,0.0007550021],"domain_scores_gemma":[0.9968863,0.000363234,0.00092244305,0.0005339412,0.00038906737,0.0009049956],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0022138397,0.00052545406,0.0019397973,0.00021623084,0.00021344937,0.00004338476,0.00010678517,0.000294319,0.000079788704],"category_scores_gemma":[0.000090759844,0.00029282345,0.00019635716,0.0003936593,0.0010682306,0.00002561492,0.00008128225,0.00015230037,0.0000021336018],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.53170824,0.0052222447,0.27796248,0.00006784652,0.012653927,0.000052459225,0.0018079701,0.000019609464,0.008064413,0.00004198161,0.00009654192,0.16230232],"study_design_scores_gemma":[0.14901386,0.09984909,0.7451853,0.00041397582,0.00048434598,0.00007857928,0.00032368398,0.000020734413,0.0041294754,0.000012428619,0.00008327063,0.000405237],"about_ca_topic_score_codex":0.011081716,"about_ca_topic_score_gemma":0.0011032954,"teacher_disagreement_score":0.46722284,"about_ca_system_score_codex":0.0006505333,"about_ca_system_score_gemma":0.0012305788,"threshold_uncertainty_score":0.9999524},"labels":[],"label_agreement":null},{"id":"W2787932235","doi":"10.1007/s10549-018-4662-9","title":"Endocrine therapy and related issues in hormone receptor-positive early breast cancer: a roundtable discussion by the breast cancer therapy expert group (BCTEG)","year":2018,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; BioTheranostics; AGE-WELL; American Society of Clinical Oncology","keywords":"Breast cancer; Medicine; Oncology; Endocrine system; Internal medicine; Cancer; Hormone receptor; Hormone; Hormone therapy; Gynecology","score_opus":0.04707387037458561,"score_gpt":0.38310566788109546,"score_spread":0.33603179750650986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2787932235","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013686939,0.9656956,6.586999e-7,0.007849381,0.00020868475,0.0026500472,0.00981462,0.000034071953,0.00006000638],"genre_scores_gemma":[0.008296346,0.9764093,0.000011764595,0.00007466696,0.0010650766,0.008973652,0.0007835587,0.00018498363,0.0042006294],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9946764,0.0007826824,0.00065798394,0.001827417,0.00066067814,0.0013948118],"domain_scores_gemma":[0.9980264,0.00010552686,0.00030059798,0.0008266434,0.00035597157,0.0003848887],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00035079694,0.0012364166,0.0015929004,0.00023090576,0.00077449414,0.0003550206,0.00046840138,0.00043511664,0.000207276],"category_scores_gemma":[0.000004892748,0.000625803,0.00031628666,0.0006799848,0.0008969738,0.00007681305,0.0003913666,0.00051664544,0.0000100024345],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032184662,0.0007634107,0.003864569,0.00018487385,0.0031293186,0.000030269834,0.0006583688,2.315571e-7,0.0003938839,0.000013822625,0.0090009635,0.9787418],"study_design_scores_gemma":[0.009602867,0.0021315524,0.044775106,0.00631878,0.0003284435,0.0013082264,0.00040987172,0.0000018203781,0.0003526553,0.000055554203,0.9332752,0.0014399249],"about_ca_topic_score_codex":0.11360405,"about_ca_topic_score_gemma":0.0058734976,"teacher_disagreement_score":0.9773019,"about_ca_system_score_codex":0.001659263,"about_ca_system_score_gemma":0.0006493392,"threshold_uncertainty_score":0.9996193},"labels":[],"label_agreement":null},{"id":"W2788624573","doi":"10.1007/s10549-018-4716-z","title":"A comparison of two models for breast cancer mortality for women with ductal carcinoma in situ: an SEER-based analysis","year":2018,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; Public Health Ontario; Women's College Hospital; University of Toronto","funders":"","keywords":"Ductal carcinoma; Breast cancer; Medicine; Oncology; Internal medicine; Cancer; In situ; Gynecology; Geography","score_opus":0.08642971431898802,"score_gpt":0.4298985493663145,"score_spread":0.3434688350473265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2788624573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99201894,0.0007528352,0.00049079413,0.0004403171,0.000023815306,0.001037466,0.005177193,0.000008313504,0.00005034423],"genre_scores_gemma":[0.9946431,0.000086924476,0.00034744584,0.000021082376,0.00024480012,0.0043552713,0.00021654915,0.000031904863,0.000052953816],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980065,0.00007757696,0.00025555093,0.0007172676,0.00027458437,0.0006684866],"domain_scores_gemma":[0.99862224,0.000039918992,0.00009861232,0.0004065126,0.000615907,0.0002168044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021334094,0.00027871435,0.00053712795,0.000204033,0.00020095719,0.000030191453,0.00013605566,0.00006495391,0.000023557652],"category_scores_gemma":[0.000003036437,0.00020839539,0.00008491294,0.00040628063,0.00043956214,0.000017716855,0.000052777927,0.000050873314,1.9641111e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015609807,0.0021113828,0.9539417,0.000095322415,0.003012668,0.0000039696815,0.00081386237,0.0019041033,0.007824395,0.00006650101,0.000043829874,0.014572434],"study_design_scores_gemma":[0.008821788,0.005488881,0.9546693,0.000038791895,0.00044894186,0.000010029736,0.00065505813,0.004233705,0.025100635,0.00019648264,0.000054266395,0.00028211903],"about_ca_topic_score_codex":0.016249793,"about_ca_topic_score_gemma":0.105966136,"teacher_disagreement_score":0.08971634,"about_ca_system_score_codex":0.00048199386,"about_ca_system_score_gemma":0.0005224036,"threshold_uncertainty_score":0.9903011},"labels":[],"label_agreement":null},{"id":"W2788948172","doi":"10.1007/s10549-018-4710-5","title":"Influence of control group therapy on the benefit from dose-dense chemotherapy in early breast cancer: a systemic review and meta-analysis","year":2018,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Meta-analysis; Internal medicine; Oncology; Subgroup analysis; Hazard ratio; Chemotherapy; Adjuvant; Confidence interval; Cancer; Paclitaxel","score_opus":0.0779080882642573,"score_gpt":0.3808844227708233,"score_spread":0.302976334506566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2788948172","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04418643,0.94237983,3.9244782e-7,0.001549771,0.000013291371,0.0026092958,0.0092429705,0.000008108845,0.000009919292],"genre_scores_gemma":[0.118545264,0.87485963,0.000004003382,0.00024217663,0.00013565151,0.005965601,0.00010599402,0.000059535847,0.00008214642],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99646616,0.0005951074,0.00066990504,0.0011966673,0.00048572692,0.000586415],"domain_scores_gemma":[0.9977957,0.0002766714,0.0004100014,0.000996407,0.0003438568,0.00017734978],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00049397355,0.0007837014,0.0034104309,0.0002410308,0.00018591782,0.000058827,0.00037918173,0.00021095485,0.00012406938],"category_scores_gemma":[0.00000920682,0.00040863943,0.00077809073,0.000710247,0.0005299516,0.00001092225,0.000120641074,0.00023404384,0.000005096635],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036607252,0.0018604896,0.008675418,0.006053443,0.5570975,0.0000435342,0.0003549639,0.000017420944,0.00005781119,0.000089533736,0.00038761421,0.42170155],"study_design_scores_gemma":[0.016851299,0.0073464494,0.24685188,0.020372486,0.577978,0.00053524505,0.000106422835,0.0000034925704,0.00013254816,0.00019517358,0.1265943,0.0030327197],"about_ca_topic_score_codex":0.03437645,"about_ca_topic_score_gemma":0.0049304534,"teacher_disagreement_score":0.41866884,"about_ca_system_score_codex":0.0003535845,"about_ca_system_score_gemma":0.0003107716,"threshold_uncertainty_score":0.99983656},"labels":[],"label_agreement":null},{"id":"W2790212344","doi":"10.1007/s10549-018-4739-5","title":"Reply to Hollingsworth: does breast cancer metastasize in the clinical window between the mammogram and the mass?","year":2018,"lang":"en","type":"letter","venue":"Breast Cancer Research and Treatment","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Breast cancer; Cancer; Medicine; Oncology; Pathology; Cancer research; Internal medicine","score_opus":0.19977631799197965,"score_gpt":0.465460740032841,"score_spread":0.26568442204086135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790212344","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.083918,0.005022782,0.000003979204,0.90559655,0.00019975172,0.0031944152,0.0017059625,0.000024678558,0.00033387452],"genre_scores_gemma":[0.50394136,0.022047093,0.00016645617,0.43918312,0.025974512,0.004987831,0.00019050184,0.00014033883,0.0033687686],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9940623,0.001205979,0.000699937,0.0010987545,0.0017015504,0.0012314487],"domain_scores_gemma":[0.99614245,0.0017198293,0.00018831373,0.0011633676,0.00045697516,0.00032905376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034314767,0.0005477456,0.0010718299,0.00019798444,0.00064729823,0.00040818602,0.00063054793,0.00033493678,0.00019873555],"category_scores_gemma":[0.00009967115,0.0001964007,0.00029054805,0.00072355417,0.0019437601,0.00009932814,0.00023999758,0.002266828,0.000021634061],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00613066,0.00013255289,0.4190512,0.000122051206,0.0018009404,0.0010046948,0.0010527406,0.0000013595532,0.000002038834,0.00003678143,0.3838577,0.18680727],"study_design_scores_gemma":[0.0051406603,0.0010778866,0.44049028,0.00086996873,0.0007896913,0.00052490376,0.00062394334,0.0000050299263,0.000012359629,0.00048144805,0.5497011,0.0002827578],"about_ca_topic_score_codex":0.06498717,"about_ca_topic_score_gemma":0.0067286287,"teacher_disagreement_score":0.46641344,"about_ca_system_score_codex":0.0005164961,"about_ca_system_score_gemma":0.0008187761,"threshold_uncertainty_score":0.9848366},"labels":[],"label_agreement":null},{"id":"W2790923982","doi":"10.1007/s10549-018-4747-5","title":"Thirty-day postoperative morbidity and mortality in elderly women with breast cancer: an analysis of the NSQIP database","year":2018,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Ottawa; Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Complication; Surgery; Cancer; Mortality rate; Breast surgery; Internal medicine","score_opus":0.03657854980379744,"score_gpt":0.3604312748680924,"score_spread":0.32385272506429497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790923982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99337554,0.0010030499,0.000004094381,0.0010644294,0.00002760385,0.0004137747,0.004027893,0.0000054419506,0.00007820211],"genre_scores_gemma":[0.99698085,0.0021103567,0.000020234398,0.000054592045,0.000118945434,0.0005355075,0.000074406256,0.000016363649,0.00008875515],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99812365,0.00025787286,0.00017591809,0.0006456163,0.00032466446,0.00047225374],"domain_scores_gemma":[0.99881506,0.000027775974,0.00007072085,0.0005581602,0.00033821617,0.00019003985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029643165,0.00024367451,0.0003549972,0.00013310026,0.00027889464,0.000038198807,0.00015538956,0.00006494756,0.00007699063],"category_scores_gemma":[0.0000067174187,0.00014090512,0.00004088067,0.0005866817,0.00093773496,0.000023855773,0.00019027355,0.00009746822,4.609395e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018885541,0.0005395637,0.96982175,0.0000149436855,0.0023648455,0.000009838542,0.0013766977,0.000018562801,0.0038020103,0.000035180583,0.000034158133,0.020093914],"study_design_scores_gemma":[0.0016699709,0.0010200844,0.99083006,0.000044848442,0.0002482501,0.000024524788,0.0008172006,0.000046102497,0.0050174813,0.000016585584,0.00011711747,0.00014776707],"about_ca_topic_score_codex":0.059878033,"about_ca_topic_score_gemma":0.16699488,"teacher_disagreement_score":0.107116856,"about_ca_system_score_codex":0.00032027625,"about_ca_system_score_gemma":0.00036978166,"threshold_uncertainty_score":0.94638234},"labels":[],"label_agreement":null},{"id":"W2793007601","doi":"10.1007/s10549-018-4737-7","title":"Mammographic non-dense area and breast cancer risk in postmenopausal women: a causal inference approach in a case–control study","year":2018,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Digital Radiography and Breast Imaging","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; Queen's University; Spinal Cord Injury BC; University of British Columbia","funders":"University of British Columbia Graduate School; Canadian Institutes of Health Research; Canadian Cancer Society","keywords":"Quartile; Breast cancer; Medicine; Confounding; Akaike information criterion; Odds ratio; Statistics; Logistic regression; Case-control study; Population; Cancer; Gynecology; Demography; Internal medicine; Mathematics; Confidence interval; Environmental health","score_opus":0.028258391757759727,"score_gpt":0.33953881968694916,"score_spread":0.3112804279291894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793007601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99424803,0.0012448261,0.000006261639,0.0006971254,0.000036164944,0.0020156805,0.0012859106,0.000029535451,0.00043643324],"genre_scores_gemma":[0.9964826,0.0009769724,0.000028894772,0.00005792861,0.00017565662,0.0021515628,0.00000785626,0.000035879413,0.00008265268],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99690044,0.00022739403,0.00035379163,0.0008654774,0.0005167408,0.0011361574],"domain_scores_gemma":[0.99853307,0.00015544724,0.00006928982,0.00036732666,0.00024874083,0.00062611216],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006854789,0.000392613,0.00062318577,0.0011642608,0.00023083582,0.00016418488,0.00009309886,0.00008783805,0.00008764648],"category_scores_gemma":[0.000014768993,0.00029027197,0.000050695082,0.0014466428,0.00066417584,0.00027736224,0.000093828865,0.00043054827,0.000003049838],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004937153,0.003367466,0.83376825,0.00005369114,0.00045886976,0.0035595822,0.002812086,0.000002407846,0.000060097787,0.000012248894,0.000012254602,0.15095587],"study_design_scores_gemma":[0.013094999,0.0043398314,0.9702734,0.00024183127,0.00010878194,0.007390062,0.0037314573,0.00044156887,0.0000072796074,0.000110705296,0.000013324679,0.00024678535],"about_ca_topic_score_codex":0.046910577,"about_ca_topic_score_gemma":0.016181549,"teacher_disagreement_score":0.1507091,"about_ca_system_score_codex":0.00063706987,"about_ca_system_score_gemma":0.00043851187,"threshold_uncertainty_score":0.99995494},"labels":[],"label_agreement":null},{"id":"W2793494034","doi":"10.1007/s10549-018-4693-2","title":"Refined estimates of local recurrence risks by DCIS score adjusting for clinicopathological features: a combined analysis of ECOG-ACRIN E5194 and Ontario DCIS cohort studies","year":2018,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Health Sciences Centre; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"National Cancer Institute; Canadian Cancer Society Research Institute; National Institutes of Health","keywords":"Medicine; Cohort; Proportional hazards model; Hazard ratio; Internal medicine; Breast cancer; Oncology; Cancer; Cohort study; Confidence interval","score_opus":0.13703593772350434,"score_gpt":0.4427730666125103,"score_spread":0.30573712888900595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793494034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98512226,0.012298642,0.00012064966,0.00031103307,0.000047393456,0.00058411877,0.0014640464,0.000008272373,0.000043595177],"genre_scores_gemma":[0.9918147,0.006500154,0.0006284131,0.000018592818,0.00006460754,0.00060080417,0.00022861455,0.000015350673,0.0001287924],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99819994,0.00008683671,0.00035602922,0.0006852713,0.00024323986,0.00042871045],"domain_scores_gemma":[0.9984754,0.0002358716,0.00016276503,0.0003105008,0.00068127783,0.00013418403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035715083,0.00027417747,0.0007202914,0.0001387533,0.00024663625,0.000017793525,0.00011728353,0.00011697326,0.000018680534],"category_scores_gemma":[0.00009909722,0.0001961642,0.00012983732,0.00030574494,0.0013739049,0.000008024123,0.00021926321,0.00008732292,3.35628e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056962557,0.0007157619,0.8994538,0.00011258637,0.0066136904,0.00000731529,0.0006361309,0.000008814355,0.002640059,0.000037314094,0.0010309911,0.08304724],"study_design_scores_gemma":[0.0033167384,0.0051325164,0.96406233,0.00016921783,0.0017388073,0.000022213246,0.00077370956,0.000052171075,0.024075048,0.00013116402,0.0003019123,0.00022419264],"about_ca_topic_score_codex":0.0187294,"about_ca_topic_score_gemma":0.057196345,"teacher_disagreement_score":0.082823046,"about_ca_system_score_codex":0.0002129227,"about_ca_system_score_gemma":0.00020447926,"threshold_uncertainty_score":0.98780495},"labels":[],"label_agreement":null},{"id":"W2794142549","doi":"10.1007/s10549-018-4734-x","title":"Factors influencing survival among patients with HER2-positive metastatic breast cancer treated with trastuzumab","year":2018,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Institute of Cancer Research; Ontario Institute for Cancer Research; McMaster University; Health Sciences Centre; CancerCare Manitoba; University of Toronto; Institute of Health Services and Policy Research; Western University","funders":"Canadian Cancer Society; Canadian Institutes of Health Research; Sunnybrook Research Institute","keywords":"Medicine; Hazard ratio; Internal medicine; Trastuzumab; Proportional hazards model; Breast cancer; Metastatic breast cancer; Oncology; Confidence interval; Cancer; Metastasis","score_opus":0.06202613288929283,"score_gpt":0.3763758606711169,"score_spread":0.3143497277818241,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794142549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936104,0.00030409894,0.000007436042,0.0007873375,0.00004787116,0.0022308892,0.0021519782,0.00007585572,0.00078415073],"genre_scores_gemma":[0.9971054,0.00033821023,0.000049302347,0.000036158384,0.00025514635,0.0010364515,0.00013541502,0.00011931626,0.00092458475],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99503285,0.00029704304,0.00032418908,0.0010002917,0.0019075613,0.0014380588],"domain_scores_gemma":[0.996301,0.00019322407,0.00010490901,0.000531149,0.0018266689,0.0010430275],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00028829658,0.00056887657,0.0007601818,0.00043322935,0.0005693994,0.00016249772,0.00017589098,0.00009755485,0.0010677201],"category_scores_gemma":[0.000013672825,0.00032070166,0.00007670972,0.0011230042,0.0015303069,0.0002888425,0.00009171627,0.00045843594,0.000021159984],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071015665,0.0013026696,0.9540946,0.000106306936,0.0015597026,0.00018446131,0.0013461766,0.000004973454,0.000092005925,0.000012424252,0.00012221023,0.034072928],"study_design_scores_gemma":[0.0081374375,0.007982874,0.9788064,0.0009909219,0.00028495074,0.000077923614,0.0009988254,0.000032021373,0.00217769,0.000006686305,0.00017033957,0.00033393246],"about_ca_topic_score_codex":0.08735868,"about_ca_topic_score_gemma":0.023584092,"teacher_disagreement_score":0.063774586,"about_ca_system_score_codex":0.00330787,"about_ca_system_score_gemma":0.0016837845,"threshold_uncertainty_score":0.9999245},"labels":[],"label_agreement":null},{"id":"W2798042703","doi":"10.1007/s10549-018-4769-z","title":"Health-related quality of life of postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer treated with ribociclib + letrozole: results from MONALEESA-2","year":2018,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Novartis Institutes for BioMedical Research; Astex Pharmaceuticals; Novartis Pharmaceuticals Corporation","keywords":"Letrozole; Medicine; Breast cancer; Internal medicine; Quality of life (healthcare); Placebo; Oncology; Cancer; Gynecology; Tamoxifen; Pathology","score_opus":0.04369723222632609,"score_gpt":0.35752007979006534,"score_spread":0.31382284756373924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2798042703","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96076685,0.0030071284,0.000011285446,0.0055495007,0.000036550075,0.0019632918,0.028387142,0.00008716918,0.00019106058],"genre_scores_gemma":[0.99505913,0.0018338662,0.0007865796,0.00009954956,0.0002683534,0.00082115096,0.0005018841,0.00012007847,0.0005094138],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99437726,0.0006046666,0.0012006185,0.0012101217,0.0013196543,0.0012876703],"domain_scores_gemma":[0.9945971,0.00047211102,0.00093587994,0.00067310187,0.002241488,0.001080327],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00043291118,0.0006944181,0.0018035079,0.0003537786,0.0004336368,0.00002958878,0.00021356184,0.00017501124,0.00083828444],"category_scores_gemma":[0.000051827992,0.00046917598,0.00008435336,0.0010884125,0.0022087789,0.00038264898,0.000097643715,0.00045573225,0.0000103628245],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5038301,0.0044635558,0.16225286,0.00034935764,0.008691511,0.000055557983,0.010257141,0.000022406948,0.14267428,0.000154016,0.00028012687,0.16696912],"study_design_scores_gemma":[0.034497175,0.018199015,0.9151814,0.0009948385,0.00009049653,0.00006360989,0.0015254251,0.000005507058,0.028799728,0.000086432156,0.000105933934,0.00045046763],"about_ca_topic_score_codex":0.10572122,"about_ca_topic_score_gemma":0.0041860417,"teacher_disagreement_score":0.7529285,"about_ca_system_score_codex":0.0026967924,"about_ca_system_score_gemma":0.0016536424,"threshold_uncertainty_score":0.999776},"labels":[],"label_agreement":null},{"id":"W2799587885","doi":"10.1007/s10549-018-4807-x","title":"Homologous recombination deficiency and host anti-tumor immunity in triple-negative breast cancer","year":2018,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Triple-negative breast cancer; Olaparib; PARP inhibitor; Immune system; Biomarker; Breast cancer; Immunology; Immunotherapy; Immunity; Medicine; Homologous recombination; Cancer research; Cancer; DNA repair; Biology; Internal medicine; Poly ADP ribose polymerase; DNA; Genetics","score_opus":0.1224340836293274,"score_gpt":0.4512091297398764,"score_spread":0.32877504611054903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2799587885","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017148284,0.9747795,0.0000011351888,0.0010198026,0.00022392695,0.003307514,0.0029344477,0.00004243335,0.0005429941],"genre_scores_gemma":[0.018762162,0.9761331,0.000028101902,0.000041393858,0.00032977824,0.0037939597,0.000107140615,0.000075069955,0.0007292553],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.996361,0.0006173131,0.00061889074,0.0009575995,0.0006017878,0.0008433834],"domain_scores_gemma":[0.99798405,0.00032126546,0.0002638528,0.0005191864,0.00052303146,0.00038858582],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007104853,0.0005843003,0.0016624517,0.00085011794,0.0003735636,0.00009442254,0.0001667382,0.00025921076,0.0005446033],"category_scores_gemma":[0.000035053017,0.00042389473,0.00017572111,0.0011061016,0.00087930815,0.00015497433,0.00012478505,0.0007196017,0.000029547233],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083540264,0.0012630962,0.0030713705,0.0036949776,0.00042931314,0.00023039425,0.00037538644,8.0790926e-8,0.000007982352,0.000073255826,0.0005100362,0.9895087],"study_design_scores_gemma":[0.05622864,0.011323809,0.40388694,0.14108591,0.0029405323,0.022789005,0.0011953111,0.000047302958,0.00037026018,0.0015712442,0.3549693,0.003591759],"about_ca_topic_score_codex":0.01971865,"about_ca_topic_score_gemma":0.0020289633,"teacher_disagreement_score":0.985917,"about_ca_system_score_codex":0.0038205974,"about_ca_system_score_gemma":0.0022981795,"threshold_uncertainty_score":0.9998213},"labels":[],"label_agreement":null},{"id":"W279966680","doi":"10.1007/s10549-015-3434-z","title":"Management of urogenital atrophy in breast cancer patients: a systematic review of available evidence from randomized trials","year":2015,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Menopause: Health Impacts and Treatments","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Randomized controlled trial; Breast cancer; Genitourinary system; Gynecology; Placebo; Cochrane Library; Meta-analysis; Internal medicine; Cancer; Pathology; Alternative medicine","score_opus":0.2813094219570841,"score_gpt":0.48626563074642914,"score_spread":0.20495620878934506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W279966680","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004990387,0.9700311,3.3742634e-7,0.00025880948,0.000100105506,0.02320118,0.005774295,0.000011584381,0.0001235793],"genre_scores_gemma":[0.00066979264,0.98642766,0.00007037608,0.000022947814,0.00008869061,0.011770153,0.00029745584,0.00006935579,0.00058354955],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9904994,0.003111766,0.0032306914,0.00080708065,0.0016069148,0.00074415584],"domain_scores_gemma":[0.9941844,0.0016172447,0.0016160317,0.0008899753,0.0009876011,0.00070478366],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004733022,0.0007114675,0.012662182,0.00053159904,0.00006493888,0.000030103967,0.00023122647,0.00018812393,0.0008347931],"category_scores_gemma":[0.0003263693,0.00038155183,0.00036779276,0.000852918,0.00025382565,0.00012775349,0.00015536741,0.00027482284,0.00004816094],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018819015,0.0015314575,0.0001793061,0.83351415,0.007828846,0.00017222397,0.00006246071,4.706864e-8,2.8861217e-7,0.000007813534,0.00036651935,0.1375179],"study_design_scores_gemma":[0.07528583,0.0014133606,0.00009332876,0.90037274,0.020471897,0.00006123398,0.00001600379,0.0000012450445,0.0000014446708,0.000015472255,0.0020592655,0.00020817592],"about_ca_topic_score_codex":0.021490442,"about_ca_topic_score_gemma":0.00010309905,"teacher_disagreement_score":0.13730972,"about_ca_system_score_codex":0.0026508053,"about_ca_system_score_gemma":0.0023648972,"threshold_uncertainty_score":0.9998636},"labels":[],"label_agreement":null},{"id":"W2801749275","doi":"10.1007/s10549-018-4796-9","title":"The relationship between tumour size, nodal status and distant metastases: on the origins of breast cancer","year":2018,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":190,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Lymph node; Epidemiology; Stage (stratigraphy); Cohort; Mammary gland; Cancer; Oncology; Internal medicine; Biology","score_opus":0.06188312980263837,"score_gpt":0.37469691161074037,"score_spread":0.312813781808102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2801749275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98263866,0.004623094,0.000002975212,0.008364497,0.000065872606,0.00049159396,0.0036242974,0.000007936344,0.00018108114],"genre_scores_gemma":[0.9944377,0.004223984,0.000014338587,0.00004018572,0.00047540487,0.0005126442,0.000034646106,0.000024861998,0.00023622606],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99822354,0.00020968348,0.00020138184,0.0004500678,0.00035641625,0.00055891526],"domain_scores_gemma":[0.9983916,0.00066965807,0.00008529844,0.0003964955,0.00027543545,0.0001815035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002968412,0.00024210366,0.00021810415,0.000041508436,0.0009361151,0.00006932061,0.00014542193,0.000057287223,0.000038774404],"category_scores_gemma":[0.00006392274,0.00012172384,0.00006081305,0.00020682214,0.0011693024,0.000008566877,0.00015430675,0.000121862184,0.000004446019],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022747274,0.00024092378,0.9606094,0.000022198717,0.0009955163,0.000004318985,0.00029926305,0.0000013210362,0.0012740252,0.0046303733,0.0008757124,0.02877224],"study_design_scores_gemma":[0.001372138,0.00066976727,0.98454756,0.000064563625,0.00010010392,0.000020128613,0.00040191293,0.0000017908225,0.0047103474,0.00043336535,0.0075498796,0.00012843548],"about_ca_topic_score_codex":0.0102940425,"about_ca_topic_score_gemma":0.0055182525,"teacher_disagreement_score":0.028643804,"about_ca_system_score_codex":0.00035781064,"about_ca_system_score_gemma":0.00034188118,"threshold_uncertainty_score":0.99629647},"labels":[],"label_agreement":null},{"id":"W2802195249","doi":"10.1007/s10549-018-4821-z","title":"Impact of high-deductible insurance on adjuvant hormonal therapy use in breast cancer","year":2018,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Breast cancer; Deductible; Medicine; Oncology; Hormonal therapy; Adjuvant; Internal medicine; Hormone; Cancer; Gynecology; Actuarial science; Business","score_opus":0.09645902789587696,"score_gpt":0.34924950570545865,"score_spread":0.2527904778095817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2802195249","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864943,0.0044020475,0.000003069781,0.001288743,0.00018843327,0.00044050932,0.0061654206,0.000013422643,0.0010040748],"genre_scores_gemma":[0.97647756,0.022207726,0.000023300594,0.00006418262,0.0004609998,0.00025161053,0.000011702579,0.000037934013,0.00046500578],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99804246,0.000032499353,0.0004805491,0.00061632734,0.00010247109,0.000725708],"domain_scores_gemma":[0.9989081,0.000074109084,0.00020265697,0.00038249575,0.00018912,0.00024350367],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00030614194,0.00027799202,0.0006355441,0.00048305694,0.00014740504,0.0000947383,0.00018702172,0.000112805996,0.0011732259],"category_scores_gemma":[0.000012337229,0.00023134229,0.00012524852,0.00044150907,0.0004477955,0.0004692557,0.000047759786,0.000193451,0.00008762827],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030301737,0.0007916297,0.9042406,0.0000097398515,0.00023966382,0.000008541345,0.0002876935,0.00006089485,0.0000969018,0.0062753316,0.0007715675,0.08418728],"study_design_scores_gemma":[0.0031570585,0.0015233002,0.99017984,0.00008612978,0.0000025560105,0.00001747725,0.000017424078,0.000042401392,0.00025405094,0.0033827503,0.0011119066,0.00022513563],"about_ca_topic_score_codex":0.17083396,"about_ca_topic_score_gemma":0.004560916,"teacher_disagreement_score":0.16627304,"about_ca_system_score_codex":0.0013241896,"about_ca_system_score_gemma":0.00035459897,"threshold_uncertainty_score":0.9997398},"labels":[],"label_agreement":null},{"id":"W2803463155","doi":"10.1007/s10549-018-4822-y","title":"Age at first full-term birth and breast cancer risk in BRCA1 and BRCA2 mutation carriers","year":2018,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Birth, Development, and Health","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Sunnybrook Health Science Centre; Women's College Hospital; London Health Sciences Centre; Public Health Ontario; University of Toronto","funders":"Canadian Cancer Society Research Institute","keywords":"Breast cancer; Oncology; Medicine; Mutation; Term (time); Cancer; BRCA2 Protein; Gynecology; Internal medicine; Obstetrics; Genetics; Biology; Germline mutation; Gene","score_opus":0.04077077344882113,"score_gpt":0.3663778575862307,"score_spread":0.3256070841374096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2803463155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98952746,0.0034480714,0.0000014898017,0.0050338265,0.00006966502,0.0008091341,0.0006127436,0.000024161967,0.00047345567],"genre_scores_gemma":[0.84677017,0.152143,0.000044466706,0.00009608692,0.00025062516,0.000284829,0.000027773005,0.000024178202,0.00035888297],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981206,0.00008416041,0.00022174873,0.0005634009,0.00036723207,0.0006428718],"domain_scores_gemma":[0.99890864,0.000057744473,0.00006152638,0.00019496129,0.00016415985,0.0006129608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029556215,0.00022187752,0.0003358901,0.00026001342,0.00053778104,0.000058290232,0.00004202245,0.00010271144,0.000331943],"category_scores_gemma":[0.0000077609575,0.00016471815,0.000024284029,0.00026917594,0.0005468066,0.00009446718,0.000079886835,0.00019996462,0.000009877847],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027658937,0.00018770063,0.8473585,0.0002504826,0.00019433285,0.00026727412,0.0043369117,2.5680083e-7,0.00024988627,0.00016181162,0.0003987959,0.14382814],"study_design_scores_gemma":[0.0061646276,0.00085559185,0.98979104,0.0003219481,0.0000431433,0.00074514997,0.0004420373,0.000067370784,0.00020071142,0.0002997434,0.00091673766,0.00015191479],"about_ca_topic_score_codex":0.034231417,"about_ca_topic_score_gemma":0.14193213,"teacher_disagreement_score":0.14869492,"about_ca_system_score_codex":0.0012405752,"about_ca_system_score_gemma":0.00056439824,"threshold_uncertainty_score":0.97219974},"labels":[],"label_agreement":null},{"id":"W2804249484","doi":"10.1007/s10549-018-4785-z","title":"Exploration of tumour-infiltrating lymphocytes as a predictive biomarker for adjuvant endocrine therapy in early breast cancer","year":2018,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"Cancer Research UK","keywords":"Medicine; Exemestane; Internal medicine; Oncology; Breast cancer; Hazard ratio; Tamoxifen; Cohort; Tumor-infiltrating lymphocytes; Adjuvant therapy; Univariate analysis; Cancer; Multivariate analysis; Immunotherapy; Confidence interval","score_opus":0.0863728712915903,"score_gpt":0.3953243361581453,"score_spread":0.308951464866555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804249484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98876387,0.004870135,0.00002336243,0.0032230169,0.00008839055,0.0018643257,0.0008836492,0.00002431834,0.00025894228],"genre_scores_gemma":[0.9867254,0.0102466075,0.00006938558,0.00006647253,0.00033517613,0.0021584688,0.0000337473,0.000032460735,0.00033229802],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9982474,0.00008266935,0.0003300541,0.0004249928,0.00040238074,0.0005124972],"domain_scores_gemma":[0.99886376,0.00011852986,0.00009738602,0.00021138573,0.0005472466,0.00016170433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028250722,0.00022105643,0.00037514552,0.00029011455,0.00016018505,0.000037580805,0.00007335537,0.000062563646,0.0002613303],"category_scores_gemma":[0.0000114838695,0.00015553323,0.00009426778,0.0004585237,0.0004167629,0.00024642597,0.000025089068,0.0000782155,0.0000028111044],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10123647,0.0010789057,0.1460552,0.000103540915,0.0009133138,0.000034512203,0.0025202942,0.0000018762852,0.10103056,0.00006117469,0.0002447708,0.6467194],"study_design_scores_gemma":[0.02082606,0.009202042,0.88143975,0.00078644213,0.00005340997,0.00019980919,0.00080388313,0.00030762947,0.084998526,0.00022364841,0.00096564397,0.00019318481],"about_ca_topic_score_codex":0.044843983,"about_ca_topic_score_gemma":0.0032642256,"teacher_disagreement_score":0.7353845,"about_ca_system_score_codex":0.0008721356,"about_ca_system_score_gemma":0.0008783284,"threshold_uncertainty_score":0.9615165},"labels":[],"label_agreement":null},{"id":"W2804366558","doi":"10.1007/s10549-018-4818-7","title":"Concurrent risk-reduction surgery in patients with increased lifetime risk for breast and ovarian cancer: an analysis of the National Surgical Quality Improvement Program (NSQIP) database","year":2018,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Women's College Hospital; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Breast cancer; Mastectomy; Surgery; Retrospective cohort study; Multivariate analysis; Cohort; Body mass index; Cancer; Internal medicine","score_opus":0.03586190277192471,"score_gpt":0.3881064504678801,"score_spread":0.3522445476959554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804366558","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98632795,0.00030310635,0.00001804115,0.00018452574,0.00005109838,0.0010430308,0.012060838,0.000004720749,0.0000067144547],"genre_scores_gemma":[0.9970517,0.00064618775,0.00010127757,0.00000741143,0.00020044045,0.0012807767,0.00068485,0.000012880313,0.000014432697],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99826753,0.00028987465,0.00025356057,0.0005066868,0.00040288788,0.00027946616],"domain_scores_gemma":[0.9986494,0.00006405732,0.00017500701,0.00025284092,0.0007217526,0.00013689783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006949638,0.00014994259,0.00022653934,0.00015739909,0.00024539823,0.0000359252,0.00008536983,0.00006117926,0.000032738095],"category_scores_gemma":[0.000029095898,0.00009905828,0.00006676286,0.0004374203,0.00043298205,0.000015211554,0.00007338158,0.00007694145,1.2628841e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017475886,0.000995544,0.7712409,0.00001739754,0.0009409073,1.90547e-7,0.00007131755,0.00004787113,0.00038129295,0.000014550805,0.000056965455,0.2244855],"study_design_scores_gemma":[0.0030314957,0.00090542703,0.9919545,0.000026704753,0.00023793122,0.000003116307,0.000060690512,0.00038544822,0.0027559092,0.000012293332,0.0005062179,0.00012027319],"about_ca_topic_score_codex":0.01901266,"about_ca_topic_score_gemma":0.009836107,"teacher_disagreement_score":0.22436523,"about_ca_system_score_codex":0.0003789093,"about_ca_system_score_gemma":0.00070400577,"threshold_uncertainty_score":0.9875198},"labels":[],"label_agreement":null},{"id":"W2805996619","doi":"10.1007/s10549-018-4848-1","title":"Including internal mammary lymph nodes in radiation therapy for synchronous bilateral breast cancer: an international survey of treatment technique and clinical priorities","year":2018,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Radiation therapy; Breast cancer; Population; Radiation treatment planning; Medical physics; Lymph; Inclusion (mineral); Cancer; Clinical trial; Oncology; Radiology; Internal medicine; Environmental health; Pathology; Psychology","score_opus":0.0789341864661073,"score_gpt":0.43266080211547114,"score_spread":0.35372661564936386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2805996619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99344766,0.0030995735,0.000078155696,0.00056194153,0.00014153242,0.00078555493,0.0018423836,0.000010983106,0.000032228145],"genre_scores_gemma":[0.9598517,0.037997596,0.00022174646,0.000023383953,0.00047672994,0.0011974622,0.00015447411,0.000025265914,0.000051642168],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99836344,0.00020780625,0.00032446065,0.0005848046,0.00015894228,0.00036057268],"domain_scores_gemma":[0.99907243,0.00007942428,0.00009935267,0.00024339733,0.00037636672,0.0001290071],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040878422,0.0002454934,0.00032587934,0.00016202065,0.00015892542,0.00005683782,0.0001513932,0.00011982142,0.000013519735],"category_scores_gemma":[0.0000134487545,0.0001873781,0.00006205482,0.00011036226,0.00042774784,0.000037280402,0.00012577097,0.00005196994,2.9762958e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003399672,0.0004902575,0.687477,0.0000109137145,0.00046369695,0.0000030652304,0.00014034647,0.0000012334967,0.001540084,0.00001971453,0.000008713026,0.30644533],"study_design_scores_gemma":[0.0052012596,0.0023405475,0.98438317,0.00008764777,0.000019643896,0.00006904296,0.000049722817,0.000095502495,0.007312085,0.000059114514,0.00022528904,0.00015696445],"about_ca_topic_score_codex":0.048027877,"about_ca_topic_score_gemma":0.012440223,"teacher_disagreement_score":0.30628836,"about_ca_system_score_codex":0.0006952771,"about_ca_system_score_gemma":0.00050208514,"threshold_uncertainty_score":0.9583114},"labels":[],"label_agreement":null},{"id":"W2806424511","doi":"10.1007/s10549-018-4819-6","title":"Total and out-of-pocket expenditures among women with metastatic breast cancer in low-deductible versus high-deductible health plans","year":2018,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"National Cancer Institute; Österreichische Forschungsförderungsgesellschaft","keywords":"Deductible; Medicine; Breast cancer; Confidence interval; Demography; Cancer; Internal medicine; Actuarial science; Economics","score_opus":0.06032524670866213,"score_gpt":0.3325442238534717,"score_spread":0.2722189771448096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2806424511","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98768866,0.0048770397,0.0000096426165,0.002086534,0.0004097055,0.00054824486,0.00364524,0.000015205273,0.0007197535],"genre_scores_gemma":[0.99351186,0.004932401,0.00007721747,0.000045705554,0.00038352364,0.0004736429,0.000011031693,0.000039022587,0.0005255892],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99780893,0.00003979239,0.00046581385,0.0006596003,0.000105581734,0.00092030154],"domain_scores_gemma":[0.99890774,0.00006535986,0.00024559035,0.00029609274,0.000079421516,0.00040577486],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00041941417,0.00027796716,0.0007187925,0.0004221364,0.0002251714,0.00010514041,0.00013254718,0.000067829744,0.0009399683],"category_scores_gemma":[0.000007919402,0.00024154919,0.000033371678,0.00024501822,0.0006859118,0.00044557577,0.000072461604,0.00018130291,0.000021491236],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020762512,0.0024650514,0.7500097,0.0006209235,0.0021759097,0.00007711341,0.01979302,0.0002626163,0.000074149255,0.019988583,0.0025192776,0.18125112],"study_design_scores_gemma":[0.0076091066,0.0029182404,0.98308,0.0002475575,0.000013703169,0.000040813895,0.0019463678,0.00006202203,0.000208531,0.002418916,0.0010481332,0.00040655516],"about_ca_topic_score_codex":0.07404013,"about_ca_topic_score_gemma":0.026154924,"teacher_disagreement_score":0.23307033,"about_ca_system_score_codex":0.0013004194,"about_ca_system_score_gemma":0.00045410663,"threshold_uncertainty_score":0.9999733},"labels":[],"label_agreement":null},{"id":"W2807586699","doi":"10.1007/s10549-018-4830-y","title":"Evolving surgical treatment decisions for male breast cancer: an analysis of the National Surgical Quality Improvement Program (NSQIP) database","year":2018,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Male Breast Health Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Women's College Hospital; University of Toronto; University Health Network","funders":"","keywords":"Breast cancer; Medicine; National database; Cancer; MEDLINE; Database; General surgery; Internal medicine; Computer science; Biology","score_opus":0.18354254669944817,"score_gpt":0.5222133759541183,"score_spread":0.3386708292546702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2807586699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9746518,0.0014161681,0.000006588908,0.008616171,0.00008585407,0.0033930356,0.011372102,0.000039578386,0.0004186914],"genre_scores_gemma":[0.9905416,0.0024447206,0.0003420137,0.00004311983,0.0007289008,0.0045561916,0.00025020077,0.000025931398,0.0010673145],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9961692,0.00024935868,0.00060213613,0.000815803,0.0013328722,0.00083064236],"domain_scores_gemma":[0.996145,0.00061403436,0.00016780893,0.0005738679,0.0018763449,0.0006229632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00097486906,0.0003211614,0.0007937625,0.00035026402,0.0007621053,0.000053201664,0.00016901284,0.00009075664,0.00089478557],"category_scores_gemma":[0.00005244883,0.00018107927,0.0003157296,0.001056065,0.0007286915,0.000117461,0.00017217213,0.00013423419,0.0000030948406],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008458939,0.0074010054,0.47739094,0.00014105145,0.003907781,0.00004376092,0.0004706999,0.000011629217,0.0002013384,0.00056501536,0.000499275,0.50090855],"study_design_scores_gemma":[0.008505462,0.0038825136,0.9724998,0.00020678161,0.001107254,0.0002911592,0.00032437756,0.0021385306,0.00031780315,0.000038102364,0.010494534,0.00019370492],"about_ca_topic_score_codex":0.031018749,"about_ca_topic_score_gemma":0.019310031,"teacher_disagreement_score":0.50071484,"about_ca_system_score_codex":0.0021406335,"about_ca_system_score_gemma":0.0014640256,"threshold_uncertainty_score":0.998585},"labels":[],"label_agreement":null},{"id":"W2809582497","doi":"10.1007/s10549-018-4844-5","title":"Thyroid hormone receptor beta-1 expression in early breast cancer: a validation study","year":2018,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Bone health and treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; McMaster University; Women's College Hospital; University of Toronto; Sunnybrook Hospital; Sunnybrook Health Science Centre","funders":"Canadian Association of Medical Oncologists","keywords":"Medicine; Breast cancer; Oncology; Internal medicine; Proportional hazards model; Radiation therapy; Cancer; Hormone therapy; Prospective cohort study; Hormonal therapy; Biomarker; Chemotherapy; Cohort","score_opus":0.06837218727821881,"score_gpt":0.40600795215212787,"score_spread":0.33763576487390906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809582497","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905451,0.0020130826,0.0000010186513,0.0042284587,0.00008741515,0.0023086937,0.00043295685,0.000044196262,0.00033911175],"genre_scores_gemma":[0.9933394,0.0028740955,0.00006372733,0.000043662883,0.00033552342,0.002046951,0.000050663537,0.000037041445,0.0012089171],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973886,0.00020245921,0.00031489885,0.00064332073,0.0006796278,0.0007710714],"domain_scores_gemma":[0.99854654,0.000055216213,0.00006719864,0.00038666936,0.0003451524,0.000599195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031248314,0.00026672817,0.00042283314,0.00032529133,0.00033723147,0.000058022877,0.000074848576,0.000098140474,0.00034225237],"category_scores_gemma":[0.000006241605,0.00018380632,0.000049165974,0.0005270263,0.00018180934,0.00017334183,0.00007128376,0.00022175882,0.00010316917],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008302665,0.0044030845,0.8724837,0.000031279134,0.00019813442,0.00010767606,0.0016580464,2.7212576e-7,0.002862808,0.0000072661314,0.00094787724,0.108997196],"study_design_scores_gemma":[0.012281829,0.00632924,0.976696,0.00021993298,0.0000697432,0.000089169895,0.0003382526,0.000007755014,0.003235526,0.000026531114,0.0005685198,0.00013748111],"about_ca_topic_score_codex":0.0527945,"about_ca_topic_score_gemma":0.0046699047,"teacher_disagreement_score":0.10885972,"about_ca_system_score_codex":0.0012053866,"about_ca_system_score_gemma":0.0005534399,"threshold_uncertainty_score":0.953513},"labels":[],"label_agreement":null},{"id":"W2809955198","doi":"10.1007/s10549-018-4868-x","title":"Optimal vascular access strategies for patients receiving chemotherapy for early-stage breast cancer: a systematic review","year":2018,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Central Venous Catheters and Hemodialysis","field":"Health Professions","cited_by":65,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Breast cancer; Retrospective cohort study; Prospective cohort study; Surgery; Cohort study; Cancer; Cohort; Internal medicine","score_opus":0.163793670302905,"score_gpt":0.5035038284698006,"score_spread":0.33971015816689554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809955198","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000306341,0.9597266,0.000046685876,0.00037401036,0.00023243461,0.028490936,0.010720898,0.00004926035,0.0000528408],"genre_scores_gemma":[0.000087868066,0.9321141,0.00007916343,0.00009320767,0.00073690776,0.06498754,0.0004564645,0.00015698884,0.0012877546],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9946608,0.0007822644,0.0012431183,0.0010662186,0.000632724,0.0016148806],"domain_scores_gemma":[0.9959731,0.00082527363,0.00074908487,0.000790031,0.00119282,0.00046968137],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0012971497,0.0007402218,0.0037100348,0.00028040147,0.0014847688,0.00022643984,0.000573077,0.0003720478,0.00038533454],"category_scores_gemma":[0.000039775998,0.00046955113,0.001009923,0.00046062563,0.0001590676,0.00026625348,0.00016828383,0.00040861202,0.000023812236],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024077186,0.0004936396,0.00030097706,0.81295156,0.002340062,0.000001952108,0.00049285754,2.9085587e-7,2.6312536e-8,0.000040795254,0.001923239,0.1812138],"study_design_scores_gemma":[0.0035398724,0.00093539315,0.00047383842,0.71553236,0.004719737,0.000006846726,0.00021154813,0.000017009868,1.4777035e-7,0.0000450765,0.2738546,0.00066353974],"about_ca_topic_score_codex":0.0056780847,"about_ca_topic_score_gemma":0.0013547837,"teacher_disagreement_score":0.27193138,"about_ca_system_score_codex":0.0025705248,"about_ca_system_score_gemma":0.0029275573,"threshold_uncertainty_score":0.99981517},"labels":[],"label_agreement":null},{"id":"W2810309824","doi":"10.1007/s10549-018-4865-0","title":"Patient-reported factors influencing the treatment decision-making process of older women with non-metastatic breast cancer: a systematic review of qualitative evidence","year":2018,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Cancer survivorship and care","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Ottawa; University of Toronto","funders":"","keywords":"Breast cancer; Medicine; Oncology; Qualitative research; Cancer; Metastatic breast cancer; Internal medicine; Family medicine","score_opus":0.12369454371377082,"score_gpt":0.48252609718960987,"score_spread":0.35883155347583906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810309824","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.057033412,0.932468,0.0000046030696,0.00008712791,0.00006945897,0.008926599,0.0013745198,0.000016448063,0.000019821478],"genre_scores_gemma":[0.103097945,0.88577485,0.00001453345,0.000024269617,0.00006376936,0.010862429,0.000027139498,0.00007640853,0.00005867849],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9939664,0.0009138065,0.0016588874,0.00088349805,0.0018045265,0.0007728576],"domain_scores_gemma":[0.99274516,0.0021971716,0.0015472926,0.0010933732,0.0020422204,0.0003747748],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011591291,0.00081479,0.004462723,0.00041919915,0.00022016116,0.00005079801,0.00027130236,0.00011762347,0.00021981202],"category_scores_gemma":[0.00016062474,0.00035974543,0.0004114697,0.0015732191,0.0005983394,0.0001530606,0.000079022095,0.00028516873,0.0000030278902],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008111896,0.0005720767,0.0004087017,0.6823739,0.004490892,0.000068753485,0.03637159,3.7377407e-7,2.798545e-7,0.0000014487914,0.000018278954,0.27488253],"study_design_scores_gemma":[0.0009585007,0.0036752482,0.00051461847,0.9708185,0.0063600247,0.00048109764,0.01634467,0.0000014176093,0.000007871871,0.000012313964,0.0005169186,0.0003088138],"about_ca_topic_score_codex":0.010057514,"about_ca_topic_score_gemma":0.0020888948,"teacher_disagreement_score":0.2884446,"about_ca_system_score_codex":0.003712935,"about_ca_system_score_gemma":0.004615025,"threshold_uncertainty_score":0.99988544},"labels":[],"label_agreement":null},{"id":"W2863793278","doi":"10.1007/s10549-018-4876-x","title":"CYP2D6 genotype and endoxifen plasma concentration do not predict hot flash severity during tamoxifen therapy","year":2018,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"Canadian Institutes of Health Research","keywords":"Tamoxifen; Hot flash; Genotype; Breast cancer; Oncology; Medicine; CYP2D6; Internal medicine; Flash (photography); Biology; Cancer; Genetics; Gene","score_opus":0.019587207502468767,"score_gpt":0.3069828849859282,"score_spread":0.2873956774834594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2863793278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99521214,0.0035088619,0.0000019975707,0.00024436213,0.000056471657,0.00046058986,0.00012035564,0.000013008854,0.00038223318],"genre_scores_gemma":[0.98477536,0.014076873,0.000034134504,0.000022899201,0.00043405616,0.00011962364,0.00004585845,0.000017619393,0.00047354685],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988445,0.000095654934,0.00010192586,0.00039623768,0.00018770405,0.0003739987],"domain_scores_gemma":[0.9994473,0.000015411133,0.000029160992,0.00018568264,0.00012097516,0.00020147313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011842035,0.00015676123,0.00012516878,0.000031979504,0.00028845208,0.00006650441,0.000065136075,0.0001307244,0.00003303941],"category_scores_gemma":[0.000006413494,0.00011581495,0.000031538355,0.00007379714,0.00030499237,0.000009023195,0.000069517795,0.00009746558,0.000010622412],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0072347787,0.00028559656,0.040940795,0.000025999398,0.00057765335,0.00004082712,0.00045084523,0.0000025553254,0.8530751,0.00004714409,0.00040735237,0.09691139],"study_design_scores_gemma":[0.004362434,0.0026462048,0.17770645,0.0000342571,0.000020742507,0.00018472786,0.000036329177,0.00007369988,0.8110281,0.000031029795,0.0036911876,0.00018481117],"about_ca_topic_score_codex":0.00031057236,"about_ca_topic_score_gemma":0.00010031845,"teacher_disagreement_score":0.13676566,"about_ca_system_score_codex":0.00007335841,"about_ca_system_score_gemma":0.00013685512,"threshold_uncertainty_score":0.47227967},"labels":[],"label_agreement":null},{"id":"W2883340386","doi":"10.1007/s10549-018-05096-6","title":"Clinical implications of germline mutations in breast cancer genes: RECQL","year":2019,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"European Research Council; European Commission","keywords":"Breast cancer; Genetics; Cancer; Mutation; Germline mutation; Biology; Exome sequencing; Oncology; Gene; Medicine; Internal medicine","score_opus":0.16168826995760566,"score_gpt":0.5062160668540483,"score_spread":0.34452779689644264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883340386","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020992293,0.9871644,0.000009010208,0.001143705,0.00017166931,0.0014863971,0.0077497116,0.0000071914465,0.00016869037],"genre_scores_gemma":[0.0030457533,0.99089473,0.00013325142,0.000022009388,0.00054199406,0.003450098,0.0008573131,0.00006795191,0.00098689],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99722004,0.0003452121,0.0007982406,0.00089843693,0.00025309518,0.00048495055],"domain_scores_gemma":[0.9981702,0.00013906298,0.00026133284,0.0007963602,0.00044218494,0.00019084963],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00040518332,0.0003577225,0.0009671862,0.0003006561,0.00010705476,0.000032389253,0.00030666144,0.00038380563,0.00014340889],"category_scores_gemma":[0.000015516182,0.00028533992,0.0003019081,0.0005682212,0.0003879205,0.000007286954,0.00018373123,0.0002829711,0.000017874243],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008545927,0.0004189714,0.0063398005,0.0011160265,0.00058817933,0.0000032605808,0.00001995179,0.000017646042,0.000042673055,0.000053462652,0.0007839411,0.9905306],"study_design_scores_gemma":[0.0015642812,0.000372842,0.019021865,0.0027099128,0.0005030152,0.00021355224,0.00004252445,0.000006361379,0.000048670976,0.00008752854,0.97499216,0.00043728392],"about_ca_topic_score_codex":0.0019986834,"about_ca_topic_score_gemma":0.0022396054,"teacher_disagreement_score":0.99009335,"about_ca_system_score_codex":0.00077428017,"about_ca_system_score_gemma":0.004125629,"threshold_uncertainty_score":0.9999599},"labels":[],"label_agreement":null},{"id":"W2883344686","doi":"10.1007/s10549-018-4888-6","title":"PARP3 inhibitors ME0328 and olaparib potentiate vinorelbine sensitization in breast cancer cell lines","year":2018,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Cancer Research Society","keywords":"Vinorelbine; Olaparib; Cancer research; Vinca alkaloid; Pharmacology; Biology; Poly ADP ribose polymerase; Medicine; Internal medicine; Chemotherapy; Biochemistry; Cisplatin; Polymerase","score_opus":0.04040380798639745,"score_gpt":0.36810005989460676,"score_spread":0.3276962519082093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883344686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97604454,0.005715622,0.0000074160344,0.015901629,0.00017011887,0.0008145767,0.00047339595,0.00004188586,0.0008308176],"genre_scores_gemma":[0.97662866,0.019956747,0.000062750594,0.00021837796,0.0011523517,0.00041492656,0.00005291291,0.000043021908,0.0014702328],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979113,0.00011760704,0.00030070686,0.0005877139,0.00047421374,0.0006084638],"domain_scores_gemma":[0.9987341,0.000062033345,0.000071077055,0.00026339546,0.00048761725,0.00038173606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024016903,0.0002667528,0.00036445138,0.0002474554,0.00023796612,0.00006849631,0.000048073434,0.00011867403,0.00061180507],"category_scores_gemma":[0.0000050143926,0.00020778972,0.000045844525,0.0004568993,0.000455275,0.0001843145,0.00006301627,0.0001799799,0.000019445059],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010138508,0.0021207898,0.70044607,0.00038418322,0.00050981535,0.00029490225,0.0020629123,0.000022608207,0.069416575,0.00025476076,0.0043914826,0.2099574],"study_design_scores_gemma":[0.020715015,0.0018794772,0.90056604,0.0014232154,0.00015472443,0.00094681606,0.000503214,0.00088502286,0.06797198,0.00058857293,0.0038181236,0.00054776866],"about_ca_topic_score_codex":0.022633228,"about_ca_topic_score_gemma":0.007749038,"teacher_disagreement_score":0.20940964,"about_ca_system_score_codex":0.0010205355,"about_ca_system_score_gemma":0.00038492164,"threshold_uncertainty_score":0.98387516},"labels":[],"label_agreement":null},{"id":"W2883564325","doi":"10.1007/s10549-018-4894-8","title":"Sexual health in long-term breast cancer survivors","year":2018,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer survivorship and care","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Université de Sherbrooke; Statistics Canada; Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Hôpital Charles-Le Moyne","funders":"Breast Cancer Research Foundation","keywords":"Medicine; Breast cancer; Sexual function; Cohort; Gynecology; Sexual dysfunction; Internal medicine; Cancer","score_opus":0.06725634669818031,"score_gpt":0.41034779090215595,"score_spread":0.34309144420397564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883564325","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96987516,0.0063607483,0.0000041160715,0.020963078,0.00029504427,0.00088502315,0.0010052943,0.000047197973,0.0005643548],"genre_scores_gemma":[0.98884904,0.0063946154,0.0000064313826,0.00038486393,0.0010456139,0.00056444824,0.000061873245,0.000042910222,0.002650209],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997375,0.00015934707,0.00027032234,0.0006509951,0.0005585324,0.0009857801],"domain_scores_gemma":[0.99849653,0.000053414024,0.00005103437,0.0004002644,0.00033402938,0.00066472974],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00038217093,0.00026604586,0.00046773592,0.00031823193,0.0002450367,0.000061039,0.0001041149,0.00009231943,0.0012136584],"category_scores_gemma":[0.0000037123275,0.00020173265,0.0000542013,0.00064694096,0.0004227994,0.000102306076,0.00008380776,0.00026422227,0.00003786776],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017544826,0.0004602481,0.61613744,0.00011983593,0.000121062396,0.00008319384,0.0011888455,2.9524384e-7,0.00006809865,0.000036170786,0.0005195446,0.37951076],"study_design_scores_gemma":[0.0031218082,0.0015342293,0.99158144,0.00039830458,0.0000234141,0.0003383692,0.0005131784,0.00001281712,0.00015537268,0.0000256172,0.0021214648,0.00017397648],"about_ca_topic_score_codex":0.35806373,"about_ca_topic_score_gemma":0.6606867,"teacher_disagreement_score":0.37933677,"about_ca_system_score_codex":0.0018972605,"about_ca_system_score_gemma":0.0013943808,"threshold_uncertainty_score":0.99969935},"labels":[],"label_agreement":null},{"id":"W2884906288","doi":"10.1007/s10549-018-4893-9","title":"Population-based validation of the National Cancer Comprehensive Network recommendations for breast cancer staging","year":2018,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Breast cancer; Metastasis; Oncology; Internal medicine; Stage (stratigraphy); Cancer; Population; Metastatic breast cancer; Cohort; Lung cancer; Epidemiology; Radiology","score_opus":0.08121781632641087,"score_gpt":0.4060211035996797,"score_spread":0.3248032872732688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884906288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.956118,0.002226993,0.00012502719,0.027517674,0.00050962064,0.0014918311,0.011879504,0.000019196548,0.00011216106],"genre_scores_gemma":[0.9952119,0.00086360663,0.000229689,0.00023850526,0.0012179486,0.00176103,0.0002571335,0.000026298832,0.00019387879],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985667,0.000107976484,0.00020875061,0.00040920847,0.00032583036,0.0003815191],"domain_scores_gemma":[0.998263,0.000090395915,0.00012571346,0.0001966041,0.0012411602,0.00008309714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013339886,0.0001905449,0.00019141183,0.00006326117,0.0006490323,0.000032891832,0.00012266039,0.00006489078,0.00013068542],"category_scores_gemma":[0.000010727142,0.00013541506,0.00008715521,0.00026110583,0.00025466646,0.000012061691,0.000084370804,0.000056755776,9.60525e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002326269,0.0005181703,0.89501226,0.00008593671,0.0013467859,3.3601282e-7,0.00023220261,0.0022109097,0.005292915,0.0003856461,0.012555567,0.080032974],"study_design_scores_gemma":[0.0027650588,0.00023662238,0.9707349,0.00020824444,0.00009808512,0.000007765095,0.00009075413,0.00021366788,0.01630599,0.00037385893,0.008764402,0.00020066819],"about_ca_topic_score_codex":0.009220712,"about_ca_topic_score_gemma":0.0040201824,"teacher_disagreement_score":0.07983231,"about_ca_system_score_codex":0.00046855462,"about_ca_system_score_gemma":0.0005275275,"threshold_uncertainty_score":0.997377},"labels":[],"label_agreement":null},{"id":"W2885849072","doi":"10.1007/s10549-018-4910-z","title":"Letrozole concentration is associated with CYP2A6 variation but not with arthralgia in patients with breast cancer","year":2018,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; University of Toronto; Centre for Addiction and Mental Health; Western University","funders":"Canadian Institutes of Health Research; Cancer Care Ontario; AstraZeneca; Canada Research Chairs; Amgen","keywords":"Letrozole; Breast cancer; Medicine; Oncology; Internal medicine; Cancer; Gynecology; Tamoxifen","score_opus":0.010075620685404409,"score_gpt":0.274370671019837,"score_spread":0.26429505033443257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885849072","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981124,0.00023058332,0.00001211364,0.00052066974,0.000020359825,0.0005768897,0.0003998168,0.0000091487755,0.000118032825],"genre_scores_gemma":[0.99876577,0.00033674022,0.000016491229,0.000057257865,0.00010632426,0.00021943278,0.00019188557,0.000024352596,0.00028176626],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986436,0.00008842641,0.00010708961,0.00040723826,0.00033226225,0.00042142282],"domain_scores_gemma":[0.9992341,0.000011329719,0.0000637089,0.0001696457,0.00037667959,0.00014454729],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008378361,0.00019143628,0.00016038674,0.000051636605,0.00017161899,0.000049858863,0.000055983095,0.00011296709,0.000044074823],"category_scores_gemma":[0.0000026144512,0.00011225756,0.000017146866,0.00020747351,0.0002284263,0.000017878216,0.000023218217,0.000111354755,0.000003459545],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013221832,0.0009749986,0.95815694,0.0000145083395,0.0008268682,0.000023867633,0.00032038984,0.00003720067,0.014313729,0.000023813189,0.00015544685,0.011930384],"study_design_scores_gemma":[0.0076435897,0.0046917545,0.9499271,0.0001556814,0.000045869845,0.000019848201,0.00002980675,0.00006112727,0.037173577,0.00000335126,0.000065994136,0.00018231441],"about_ca_topic_score_codex":0.002495326,"about_ca_topic_score_gemma":0.002535421,"teacher_disagreement_score":0.022859849,"about_ca_system_score_codex":0.00025103244,"about_ca_system_score_gemma":0.00028968157,"threshold_uncertainty_score":0.45777306},"labels":[],"label_agreement":null},{"id":"W2888497980","doi":"10.1007/s10549-018-4905-9","title":"NRF1 motif sequence-enriched genes involved in ER/PR −ve HER2 +ve breast cancer signaling pathways","year":2018,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"University of Pittsburgh; U.S. Department of Veterans Affairs","keywords":"NRF1; Biology; Breast cancer; Cancer research; Transcription factor; Estrogen receptor; Estrogen receptor alpha; Signal transduction; Cancer; Cell biology; Gene; Genetics","score_opus":0.04675702966355498,"score_gpt":0.33773324802767757,"score_spread":0.2909762183641226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888497980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861158,0.011919007,0.000007248537,0.00063461537,0.0001090824,0.0005503394,0.00036909882,0.000019983758,0.00027481103],"genre_scores_gemma":[0.98706317,0.011116909,0.00005853576,0.00005672152,0.0006938249,0.00047433327,0.00010058929,0.000041984782,0.00039391548],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99776363,0.00019539025,0.0002272594,0.00070396217,0.00031997147,0.0007897975],"domain_scores_gemma":[0.99896044,0.0000287702,0.00005909248,0.0003385423,0.00028923556,0.00032390247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027970993,0.00030201903,0.0002697398,0.00014087613,0.0002902056,0.00007251686,0.00017695887,0.00024706125,0.00011212302],"category_scores_gemma":[0.000008205548,0.00022869091,0.000085230335,0.00032574616,0.00038786465,0.000014127556,0.00013997455,0.0002103711,0.000022606855],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016203336,0.00053960533,0.059214633,0.00004819893,0.00050116726,0.00014405014,0.00047685514,0.00005595144,0.825102,0.000064483844,0.00045390657,0.111778826],"study_design_scores_gemma":[0.010207956,0.00487604,0.10279649,0.0005356591,0.00015219269,0.00050092814,0.0015375831,0.00075945084,0.8732163,0.000564348,0.0035790408,0.0012740559],"about_ca_topic_score_codex":0.006766727,"about_ca_topic_score_gemma":0.0024873707,"teacher_disagreement_score":0.110504776,"about_ca_system_score_codex":0.0003740264,"about_ca_system_score_gemma":0.00058162917,"threshold_uncertainty_score":0.9998473},"labels":[],"label_agreement":null},{"id":"W2888692682","doi":"10.1007/s10549-018-4916-6","title":"Histopathologic characteristics of background parenchymal enhancement (BPE) on breast MRI","year":2018,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"MRI in cancer diagnosis","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto","funders":"National Cancer Institute; Susan G. Komen; Memorial Sloan-Kettering Cancer Center; Kettering Fund; Susan G. Komen for the Cure","keywords":"Breast cancer; Medicine; Parenchyma; Mastectomy; CD34; Breast MRI; Mammary gland; Pathology; Cancer; Internal medicine; Mammography; Biology; Stem cell","score_opus":0.10610930457847485,"score_gpt":0.4052452293432783,"score_spread":0.29913592476480344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888692682","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877505,0.0006710741,0.00002067479,0.006545066,0.00020732706,0.00079828204,0.000682694,0.000026686486,0.0032977457],"genre_scores_gemma":[0.99049485,0.0060069594,0.0001907799,0.00013900638,0.0007005899,0.0005633967,0.00004794823,0.000025896697,0.0018305848],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99783915,0.00009030279,0.00030528032,0.0005369409,0.0006524394,0.000575883],"domain_scores_gemma":[0.9984599,0.000112260306,0.00009666202,0.0004926123,0.0005026776,0.00033589714],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002829144,0.00023698859,0.0004450243,0.00019881027,0.00017636245,0.000028426919,0.000104828076,0.00008611226,0.0019652832],"category_scores_gemma":[0.000007711224,0.0001715543,0.00007156999,0.0002586691,0.000664965,0.00005211521,0.00007797479,0.00016556645,0.00010680871],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009075846,0.0057000606,0.41616526,0.00034452157,0.0005251338,0.0003937101,0.0007746965,4.0780657e-7,0.00710018,0.0011229345,0.010434366,0.5483629],"study_design_scores_gemma":[0.003558211,0.009863042,0.9538053,0.00065476407,0.00011978103,0.00044834526,0.000145689,0.00002067337,0.014349497,0.00011044068,0.01670936,0.00021484184],"about_ca_topic_score_codex":0.0020399236,"about_ca_topic_score_gemma":0.00021744108,"teacher_disagreement_score":0.54814804,"about_ca_system_score_codex":0.0012181383,"about_ca_system_score_gemma":0.00038518105,"threshold_uncertainty_score":0.9989471},"labels":[],"label_agreement":null},{"id":"W2889150873","doi":"10.1007/s10549-018-4935-3","title":"Time to death in breast cancer patients as an indicator of treatment response","year":2018,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer survivorship and care","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Medicine; Breast cancer; Mortality rate; Cancer; Cause of death; Oncology; Survival analysis; Demography; Internal medicine; Disease","score_opus":0.03766983046768887,"score_gpt":0.3809153141268445,"score_spread":0.34324548365915564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889150873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931467,0.00040781347,1.7161501e-7,0.0031729545,0.00006457825,0.0011180948,0.0015150476,0.000023207866,0.0005514382],"genre_scores_gemma":[0.9955304,0.00055335247,0.0000125019615,0.00014429334,0.00025424815,0.00094326795,0.000046257697,0.000037938764,0.0024776915],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99775773,0.00022312958,0.0002628077,0.00059573946,0.00054200407,0.00061861024],"domain_scores_gemma":[0.9983073,0.000077401244,0.00005270747,0.00042842573,0.00040213668,0.00073202257],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00028190683,0.0002584945,0.00044066366,0.00048524849,0.00012459437,0.000027667962,0.00010528593,0.00009440693,0.0022968897],"category_scores_gemma":[0.000010847629,0.00018611313,0.00006751783,0.0005167682,0.000255616,0.00009355592,0.00006402064,0.00009991453,0.00016771897],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.052088104,0.0033149929,0.7632132,0.000042013693,0.00031555747,0.0000790917,0.0048934473,0.0000012281422,0.0015094007,0.000023106635,0.00040770657,0.17411216],"study_design_scores_gemma":[0.0057899687,0.012978295,0.9710164,0.00027456612,0.000064670996,0.00005406256,0.000299354,0.000013469823,0.0033411984,0.000022553188,0.0059713786,0.00017408862],"about_ca_topic_score_codex":0.074995145,"about_ca_topic_score_gemma":0.014156828,"teacher_disagreement_score":0.2078032,"about_ca_system_score_codex":0.0027738695,"about_ca_system_score_gemma":0.0013454714,"threshold_uncertainty_score":0.99861515},"labels":[],"label_agreement":null},{"id":"W2890985908","doi":"10.1007/s10549-018-4936-2","title":"Prognosis in patients diagnosed with loco-regional failure of breast cancer: 34 years longitudinal data from the Stockholm–Gotland cancer registry","year":2018,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Cancer registry; Relative survival; Poisson regression; Internal medicine; Cancer; Proportional hazards model; Survival analysis; Population; Oncology","score_opus":0.05373934337948826,"score_gpt":0.34467687838201944,"score_spread":0.29093753500253117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890985908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98032653,0.0037434476,0.0000020948385,0.0036876088,0.000057870868,0.0008037928,0.011343755,0.000008580938,0.000026320271],"genre_scores_gemma":[0.99313116,0.004036291,0.00005276227,0.00005404059,0.0006495683,0.0012628346,0.0007060352,0.000038251637,0.00006906664],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976153,0.000117975935,0.00023440825,0.000912969,0.0005472839,0.0005720909],"domain_scores_gemma":[0.9984388,0.00006208888,0.00013542053,0.000781568,0.00042097757,0.00016116381],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001297368,0.00031726065,0.00033306473,0.00006933284,0.00022874911,0.000052736734,0.0004612334,0.00011005361,0.00012821546],"category_scores_gemma":[0.00000962209,0.00020010023,0.00004673869,0.00030796247,0.000940711,0.00002556214,0.0003887247,0.00014798755,0.0000037937107],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036186804,0.00078160333,0.96414584,0.00001817783,0.0008891538,0.000019029098,0.0002192976,0.0000058444466,0.0001981352,0.0000042411357,0.006007225,0.024092756],"study_design_scores_gemma":[0.005207144,0.00067881873,0.9898407,0.00029557347,0.000110192785,0.00001920414,0.0002392217,0.0000067853653,0.00064265693,0.000009977767,0.002744353,0.0002053696],"about_ca_topic_score_codex":0.10740951,"about_ca_topic_score_gemma":0.18105543,"teacher_disagreement_score":0.07364593,"about_ca_system_score_codex":0.00033124344,"about_ca_system_score_gemma":0.00061422633,"threshold_uncertainty_score":0.89853436},"labels":[],"label_agreement":null},{"id":"W2891657378","doi":"10.1007/s10549-018-4965-x","title":"Epigenetic modulation of FOXM1-gene interacting network by BET inhibitors in breast cancer","year":2018,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Instituto de Salud Carlos III; Centro de Investigación Biomédica en Red de Cáncer; Diputación de Albacete; Ministerio de Economía y Competitividad; CRIS Cancer Foundation; Fundación Científica Asociación Española Contra el Cáncer","keywords":"FOXM1; Breast cancer; Gene knockdown; Cancer research; Gene signature; Biology; Cancer; Epigenetics; Transcription factor; Bromodomain; Gene expression; Oncology; Medicine; Gene; Genetics","score_opus":0.024728913126468365,"score_gpt":0.3411579607309338,"score_spread":0.31642904760446544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891657378","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99548215,0.002559939,0.00003312943,0.0010177155,0.00013095756,0.00035974995,0.0002546547,0.0000054849,0.00015621791],"genre_scores_gemma":[0.99643654,0.002069026,0.00007605006,0.000028804958,0.0007425256,0.0002136536,0.00010234376,0.000018491684,0.00031259493],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987523,0.000097658965,0.00022645951,0.0003560756,0.00020387601,0.00036365222],"domain_scores_gemma":[0.99939144,0.000016026877,0.00007551693,0.00019065858,0.00020561452,0.000120728815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019371249,0.0001418968,0.0001514023,0.000078302364,0.00011384411,0.000025771858,0.00008108389,0.000087630346,0.000095573836],"category_scores_gemma":[0.000009155495,0.000119913566,0.00003741422,0.00022542464,0.00017855904,0.000011336878,0.00008359888,0.00007439096,0.0000029782177],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011197402,0.0003700513,0.23780052,0.000026747193,0.00015026536,0.0000030464307,0.00015402836,0.0001318481,0.5518099,0.000018861949,0.00522316,0.2031918],"study_design_scores_gemma":[0.0024032623,0.0010119433,0.21261021,0.00026157533,0.000016271286,0.00003039571,0.000108945926,0.00046674273,0.7749224,0.000101458834,0.0077828844,0.00028394093],"about_ca_topic_score_codex":0.004657591,"about_ca_topic_score_gemma":0.0015639229,"teacher_disagreement_score":0.22311243,"about_ca_system_score_codex":0.00014802975,"about_ca_system_score_gemma":0.00015065217,"threshold_uncertainty_score":0.70409155},"labels":[],"label_agreement":null},{"id":"W2892343964","doi":"10.1007/s10549-018-4967-8","title":"Optimal duration of adjuvant trastuzumab in treatment of early breast cancer: a meta-analysis of randomized controlled trials","year":2018,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Trastuzumab; Medicine; Internal medicine; Breast cancer; Hazard ratio; Oncology; Meta-analysis; Odds ratio; Randomized controlled trial; Population; Adjuvant; Confidence interval; Cancer","score_opus":0.3371883552928294,"score_gpt":0.5253974729976785,"score_spread":0.18820911770484905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892343964","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006324172,0.9655148,0.0000061707296,0.00049234496,0.000061634004,0.016249418,0.01120094,0.0000128022675,0.00013774486],"genre_scores_gemma":[0.03130458,0.9458209,0.00009867232,0.000002399081,0.00022677208,0.021304637,0.0002757797,0.00008280121,0.00088345096],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9839476,0.006126837,0.005427561,0.0011735,0.0023658138,0.0009587349],"domain_scores_gemma":[0.98899645,0.005061752,0.0024905792,0.0010896054,0.0018538071,0.00050778943],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.008968138,0.0009944969,0.042458296,0.0037264174,0.00008687896,0.00005019928,0.0002953974,0.00043024987,0.0025645392],"category_scores_gemma":[0.00042486348,0.000504301,0.010227982,0.0027956946,0.00124817,0.00009135427,0.00008714177,0.00033234,0.0000046092873],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1915562,0.002906701,0.00028396436,0.004384237,0.45838907,0.00006919823,0.0005725269,0.0000168163,0.00001380037,0.000037980422,0.000035610086,0.34173387],"study_design_scores_gemma":[0.28391412,0.005957509,0.00084186584,0.0051180176,0.69854987,0.00009712546,0.00011854141,0.00017649781,0.00016047838,0.00001452282,0.0046403115,0.00041117906],"about_ca_topic_score_codex":0.058873937,"about_ca_topic_score_gemma":0.0040567336,"teacher_disagreement_score":0.34132272,"about_ca_system_score_codex":0.0032033725,"about_ca_system_score_gemma":0.0063697016,"threshold_uncertainty_score":0.99974084},"labels":[],"label_agreement":null},{"id":"W2896012636","doi":"10.1007/s10549-018-5002-9","title":"Predictors of time to death after distant recurrence in breast cancer patients","year":2018,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Proportional hazards model; Cancer; Hazard ratio; Cohort; Radiation therapy; Univariate analysis; Oncology; Internal medicine; Multivariate analysis; Hormonal therapy; Stage (stratigraphy); Cause of death; Disease; Confidence interval","score_opus":0.017519121006749273,"score_gpt":0.3208581104632067,"score_spread":0.30333898945645743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896012636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937229,0.0012917473,0.0000018889759,0.0009905073,0.000094296134,0.0005548427,0.0030661197,0.000007299539,0.0002703884],"genre_scores_gemma":[0.99643147,0.0016118241,0.0000271346,0.000045068427,0.00029978406,0.0011338025,0.000059141013,0.000025563399,0.00036620584],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99820775,0.00007929106,0.00022248761,0.0006037751,0.00033503296,0.0005516624],"domain_scores_gemma":[0.99897784,0.000019295569,0.000048962775,0.00030756078,0.00041205494,0.00023431545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010796577,0.00024559846,0.0002612265,0.00013692681,0.00010439019,0.00002115974,0.0001352847,0.00007483938,0.0002655694],"category_scores_gemma":[0.0000091089405,0.00018622025,0.000050035174,0.0002813186,0.00030401468,0.000010422035,0.00020580667,0.000063825806,0.000029486011],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00392941,0.0008242317,0.96408445,0.000020945618,0.00025338738,0.0000068330455,0.00029295898,0.000001978627,0.0013270658,0.0000052703167,0.00090312195,0.028350363],"study_design_scores_gemma":[0.0018460243,0.0010483812,0.98919684,0.00017706108,0.000028420429,0.00000936964,0.000029913437,0.000003025673,0.0050853896,0.000018956236,0.0023850289,0.00017159112],"about_ca_topic_score_codex":0.005327234,"about_ca_topic_score_gemma":0.0031132328,"teacher_disagreement_score":0.028178772,"about_ca_system_score_codex":0.00037968138,"about_ca_system_score_gemma":0.00023370731,"threshold_uncertainty_score":0.805322},"labels":[],"label_agreement":null},{"id":"W2896462385","doi":"10.1007/s10549-018-4991-8","title":"Enhanced recovery after surgery (ERAS) pathways in breast reconstruction: systematic review and meta-analysis of the literature","year":2018,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Enhanced Recovery After Surgery","field":"Medicine","cited_by":205,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Breast reconstruction; Mastectomy; Meta-analysis; MEDLINE; Breast surgery; Breast cancer; Mammaplasty; Subgroup analysis; Systematic review; Surgery; Incidence (geometry); Internal medicine; Cancer","score_opus":0.09536515579857086,"score_gpt":0.3654907485094829,"score_spread":0.270125592710912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896462385","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000639433,0.9920994,7.6910584e-7,0.0004365078,0.00011526171,0.0037300943,0.0029051302,0.00001369263,0.000059721424],"genre_scores_gemma":[0.0013010679,0.9911606,0.000015051819,0.00009631678,0.00009886792,0.0060151415,0.00010122787,0.000051648305,0.0011600979],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99495333,0.0013793176,0.0014543871,0.00097608153,0.0006715174,0.00056539086],"domain_scores_gemma":[0.99631834,0.0010364521,0.00060889445,0.0012502649,0.0005231106,0.00026293698],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014843133,0.00067076826,0.009066833,0.0012278539,0.00009926576,0.000086231,0.00015016367,0.00031780792,0.00046656007],"category_scores_gemma":[0.000097259865,0.00032796076,0.0026921956,0.0032990512,0.00035305225,0.00017134871,0.00014645614,0.0005238342,0.0000073766964],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029993674,0.00027927605,0.00017428883,0.77408504,0.14898609,0.000119364966,0.000093519186,7.56583e-8,9.0548275e-7,0.0000031399345,0.000105498875,0.07585287],"study_design_scores_gemma":[0.00028582584,0.00014713116,0.001073171,0.41456226,0.5792434,0.002646147,0.000018540406,4.934938e-7,0.0000093085955,0.000019444347,0.0016075212,0.00038670862],"about_ca_topic_score_codex":0.0002182252,"about_ca_topic_score_gemma":0.00038924164,"teacher_disagreement_score":0.43025738,"about_ca_system_score_codex":0.00069989497,"about_ca_system_score_gemma":0.00090403,"threshold_uncertainty_score":0.99991727},"labels":[],"label_agreement":null},{"id":"W2897172238","doi":"10.1007/s10549-018-4993-6","title":"Improving the competency of medical students in clinical breast examination through a standardized simulation and multimedia-based curriculum","year":2018,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Lesions and Carcinomas","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Objective structured clinical examination; Curriculum; Test (biology); Palpation; Medicine; Physical examination; Medical education; Educational measurement; Breast cancer; Medical physics; Psychology; Radiology; Internal medicine; Pedagogy","score_opus":0.06987901911549708,"score_gpt":0.45856791453094914,"score_spread":0.38868889541545204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897172238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99543446,0.00061781995,0.000155,0.0027955945,0.00005267925,0.0007836058,0.00008786499,0.00001137866,0.00006156908],"genre_scores_gemma":[0.99904555,0.0003158419,0.00017764748,0.000055373886,0.00024050756,0.00011168361,0.000016400003,0.000012537804,0.00002445036],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972761,0.00034403763,0.00037173895,0.00033900593,0.0013694542,0.0002996313],"domain_scores_gemma":[0.9987011,0.0003492611,0.00007708782,0.00023223126,0.00042024153,0.00022009351],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018152677,0.00013401979,0.00031924984,0.00011352068,0.00015482414,0.000038751077,0.00011773851,0.00011151898,0.00014706576],"category_scores_gemma":[0.00008673719,0.000076784854,0.000051865147,0.00028751598,0.0007243398,0.00007139693,0.00011399131,0.00022004057,0.0000022641195],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001013265,0.0012865638,0.58796,0.00005020041,0.0000693236,0.000035616693,0.00037302123,0.00000289505,0.000068013265,0.00006152162,0.000013923631,0.40906566],"study_design_scores_gemma":[0.0093599325,0.0011379361,0.96100414,0.00031241935,0.000049074253,0.00008030458,0.00041861768,0.027394839,0.00007375038,0.000028558929,0.00007608176,0.000064365406],"about_ca_topic_score_codex":0.0069391653,"about_ca_topic_score_gemma":0.0012362868,"teacher_disagreement_score":0.40900132,"about_ca_system_score_codex":0.00021155698,"about_ca_system_score_gemma":0.0005792849,"threshold_uncertainty_score":0.9996737},"labels":[],"label_agreement":null},{"id":"W2899955386","doi":"10.1007/s10549-018-5027-0","title":"CYP2D6 as a treatment decision aid for ER-positive non-metastatic breast cancer patients: a systematic review with accompanying clinical practice guidelines","year":2018,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Research (Canada); BC Cancer Agency; BC Children's Hospital; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Tamoxifen; Breast cancer; CYP2D6; Medicine; Oncology; Genotyping; Context (archaeology); Metastatic breast cancer; Critical appraisal; Internal medicine; Gynecology; Cancer; Bioinformatics; Biology; Genotype; Alternative medicine; Pathology; Genetics","score_opus":0.39078011189290024,"score_gpt":0.6369050860232861,"score_spread":0.24612497413038587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899955386","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003798334,0.9692634,0.00002276379,0.0012774806,0.0007647542,0.016993819,0.011081604,0.00004119819,0.00017514595],"genre_scores_gemma":[0.00009324255,0.9719182,0.001110639,0.0012213582,0.0012496805,0.02321386,0.00039929207,0.0001696684,0.00062405854],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9910571,0.0025582353,0.0024105245,0.0016256577,0.0009494981,0.0013990075],"domain_scores_gemma":[0.9881032,0.004632352,0.0013039783,0.00072619994,0.004075187,0.0011591007],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0029803133,0.0013009722,0.004551587,0.00039656236,0.000830141,0.00017467908,0.00055995904,0.0004163379,0.0003688925],"category_scores_gemma":[0.00050657435,0.0007497869,0.0008258704,0.0007472731,0.00052052416,0.00024782078,0.00023873473,0.0007791903,0.00016951219],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028288749,0.004164464,0.00006237664,0.10988603,0.009240626,0.00015096924,0.00014354115,0.0000025060488,3.420029e-7,0.000016307318,0.003845455,0.8696585],"study_design_scores_gemma":[0.010554494,0.0024467467,0.00003923966,0.19215964,0.032513395,0.0010382477,0.00007657879,0.00008030343,0.000008334856,0.00003796461,0.76026595,0.00077909476],"about_ca_topic_score_codex":0.0011615364,"about_ca_topic_score_gemma":0.00019276077,"teacher_disagreement_score":0.86887944,"about_ca_system_score_codex":0.001658145,"about_ca_system_score_gemma":0.0030966655,"threshold_uncertainty_score":0.9999742},"labels":[],"label_agreement":null},{"id":"W2903202196","doi":"10.1007/s10549-020-05903-z","title":"Prognostic associations of plasma hepcidin in women with early breast cancer","year":2020,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Health Sciences Centre; Mount Sinai Hospital; Western University; Sunnybrook Health Science Centre","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","keywords":"Hepcidin; Breast cancer; Medicine; Internal medicine; Oncology; Cancer; Physiology; Anemia","score_opus":0.0473389381710566,"score_gpt":0.3413579946223462,"score_spread":0.29401905645128956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2903202196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98705137,0.0010272791,0.0000010637984,0.010035184,0.000012706792,0.00069148897,0.00079022005,0.000015708423,0.0003749698],"genre_scores_gemma":[0.99762076,0.0012345394,0.0000280871,0.00009430792,0.00009269252,0.00071226497,0.000013664345,0.000018908315,0.00018475695],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986141,0.000060682614,0.00016058286,0.0002780216,0.00042673975,0.000459895],"domain_scores_gemma":[0.99926215,0.000058540074,0.0000435025,0.00011380169,0.00017502155,0.00034700797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000106354324,0.00013469021,0.0003146105,0.00012103346,0.000069853304,0.000020345073,0.000050463685,0.000046138193,0.00025147264],"category_scores_gemma":[0.000016188369,0.000092040544,0.00002294154,0.0004896807,0.00013991688,0.00007425136,0.000028321812,0.00013857218,0.0000072885464],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043102433,0.0006328376,0.93213314,0.000107950735,0.00014170876,0.00005254236,0.0029370177,0.0000127736275,0.00039046738,0.00009848166,0.00014315067,0.05903971],"study_design_scores_gemma":[0.0057933154,0.0009958701,0.9917081,0.00011109518,0.000049922066,0.000019512432,0.00075609994,0.000025361787,0.00024805652,0.000024401363,0.00018577371,0.00008247873],"about_ca_topic_score_codex":0.01394069,"about_ca_topic_score_gemma":0.001979813,"teacher_disagreement_score":0.059574995,"about_ca_system_score_codex":0.0003706636,"about_ca_system_score_gemma":0.0006377707,"threshold_uncertainty_score":0.99262553},"labels":[],"label_agreement":null},{"id":"W2903357954","doi":"10.1007/s10549-018-5045-y","title":"A clinically structured and partnered approach to genetic testing in Trinidadian women with breast cancer and their families","year":2018,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Women's College Hospital; University of Toronto","funders":"Susan G. Komen","keywords":"Genetic testing; Genetic counseling; Medicine; Breast cancer; Cancer; Cancer prevention; Breast cancer screening; Family medicine; Gerontology; Demography; Gynecology; Mammography; Internal medicine; Genetics; Biology","score_opus":0.047793708537703226,"score_gpt":0.3512920786672355,"score_spread":0.3034983701295323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2903357954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99664557,0.0013915929,0.000021382371,0.00064206804,0.000020477524,0.00057294517,0.00040197582,0.000007440831,0.00029656023],"genre_scores_gemma":[0.9955175,0.0013226253,0.001410243,0.000098055614,0.00028137653,0.0011897712,0.000011271726,0.000027238671,0.00014193231],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99845386,0.000080152386,0.00018044475,0.0006397408,0.0001394654,0.0005063341],"domain_scores_gemma":[0.99915135,0.000037860897,0.000037338144,0.00025242483,0.00021280066,0.00030821576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001860587,0.0002048119,0.00021039855,0.000118247954,0.00017578661,0.000079876176,0.000093658215,0.00008635261,0.0000128603215],"category_scores_gemma":[0.00001633343,0.00013986912,0.0000116726615,0.00028829265,0.0004786478,0.000007057441,0.00012114172,0.00009152651,6.601674e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029079209,0.00019763908,0.34634057,0.000044271845,0.00026865714,0.0000070425967,0.002505721,0.0000670556,0.012080755,0.0000117043965,0.000105575054,0.63546306],"study_design_scores_gemma":[0.0027725564,0.0019485538,0.98980564,0.00006229125,0.000012795936,0.00020955387,0.0014099679,0.00014005741,0.0019869448,0.000092725226,0.0013243346,0.00023457636],"about_ca_topic_score_codex":0.0026684606,"about_ca_topic_score_gemma":0.005459291,"teacher_disagreement_score":0.64346504,"about_ca_system_score_codex":0.0002433484,"about_ca_system_score_gemma":0.0005408163,"threshold_uncertainty_score":0.5703697},"labels":[],"label_agreement":null},{"id":"W2903454478","doi":"10.1007/s10549-018-05077-9","title":"Yield of surveillance magnetic resonance imaging after bilateral mastectomy and reconstruction: a retrospective cohort study","year":2018,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Implant and Reconstruction","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Medicine; Breast MRI; Magnetic resonance imaging; Breast cancer; Mastectomy; Breast reconstruction; Retrospective cohort study; Cohort; Confidence interval; Radiology; Cohort study; Mammography; Cancer; Surgery; Internal medicine","score_opus":0.022257788119429436,"score_gpt":0.30915928009649474,"score_spread":0.2869014919770653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2903454478","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942665,0.0036358791,0.0000010084112,0.00041055767,0.00014157586,0.00092742936,0.00012693614,0.000020274581,0.00046981886],"genre_scores_gemma":[0.99833405,0.00050383987,0.00008151958,0.0000054694005,0.00031692054,0.00023425373,0.000002536937,0.000013716148,0.0005077162],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99871004,0.00006973264,0.00019464605,0.00042224888,0.00029002118,0.0003132974],"domain_scores_gemma":[0.99919695,0.00003927017,0.00004248162,0.00020281602,0.0003631195,0.00015534593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023975776,0.00015068875,0.00032705514,0.00017780135,0.00014024097,0.00003157157,0.000029306979,0.00004214666,0.00033467085],"category_scores_gemma":[0.000005827255,0.000106344596,0.000030059573,0.00024383195,0.0006557732,0.00008675709,0.000043477106,0.0001291229,0.000004154858],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016605166,0.00012791314,0.67003,0.000014491183,0.000053120075,0.000041442545,0.00016949633,5.2272915e-9,0.00012037565,0.0000044160033,0.0000136069275,0.32776463],"study_design_scores_gemma":[0.0023344478,0.0016035446,0.97871566,0.0001858203,0.000039582723,0.01625208,0.00028061532,0.00002316966,0.00036702282,0.000057456105,0.000050233608,0.00009034449],"about_ca_topic_score_codex":0.003116081,"about_ca_topic_score_gemma":0.0012777586,"teacher_disagreement_score":0.3276743,"about_ca_system_score_codex":0.00021032826,"about_ca_system_score_gemma":0.000113478185,"threshold_uncertainty_score":0.47106034},"labels":[],"label_agreement":null},{"id":"W2904225298","doi":"10.1007/s10549-018-05095-7","title":"The mammography screening detection of ductal carcinoma in situ and invasive breast cancer according to women’s characteristics: is it the same?","year":2018,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Saint-François d'Assise; Université Laval; Institut National de Santé Publique du Québec","funders":"","keywords":"Ductal carcinoma; Medicine; Mammography; Breast cancer; Odds ratio; Internal medicine; Oncology; Cancer; Gynecology; Logistic regression; Carcinoma in situ; Biopsy; Radiology","score_opus":0.08524520396557766,"score_gpt":0.377005096543775,"score_spread":0.29175989257819734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2904225298","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98725224,0.0014917927,0.000007057796,0.010160902,0.00006693248,0.0006706985,0.0002171009,0.000007907608,0.00012538557],"genre_scores_gemma":[0.9960357,0.0024155634,0.000018520432,0.00035816178,0.00041021075,0.00065327884,0.0000026080918,0.000015983282,0.000089950256],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99818474,0.000088634035,0.00024284516,0.00037885303,0.00048525893,0.0006196501],"domain_scores_gemma":[0.9988255,0.00016216093,0.00007243521,0.00026414977,0.0003989255,0.0002768601],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046559036,0.00018186412,0.0002815868,0.00020220254,0.0004996782,0.00009427445,0.00011682276,0.000053759682,0.000062278494],"category_scores_gemma":[0.00003150653,0.00010426781,0.00004874109,0.0005723127,0.00046955288,0.00011325921,0.00012902974,0.00019740322,0.0000030782728],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042357473,0.000058261754,0.7326879,0.000038697297,0.00019076993,0.000053507563,0.004286766,5.193743e-7,0.008563808,0.000016392692,0.00012503366,0.24974261],"study_design_scores_gemma":[0.0012770052,0.0010536528,0.97736984,0.00038344145,0.000040405066,0.00036155822,0.0130116,0.000031482,0.0059265285,0.000040978346,0.00040015197,0.0001033772],"about_ca_topic_score_codex":0.03389408,"about_ca_topic_score_gemma":0.021760665,"teacher_disagreement_score":0.24963923,"about_ca_system_score_codex":0.0006138035,"about_ca_system_score_gemma":0.00028191847,"threshold_uncertainty_score":0.99608964},"labels":[],"label_agreement":null},{"id":"W2906970298","doi":"10.1007/s10549-018-05122-7","title":"Three-dimensional tumor visualization of invasive breast carcinomas using whole-mount serial section histopathology: implications for tumor size assessment","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"The Scarborough Hospital; Sunnybrook Hospital; University of Toronto; Institute for Work & Health; Sunnybrook Health Science Centre","funders":"","keywords":"Undersampling; Lumpectomy; Histology; Nuclear medicine; Mathematics; Volume (thermodynamics); Medicine; Breast cancer; Histopathology; Cancer; Pathology; Mastectomy; Physics; Internal medicine","score_opus":0.039636163633089666,"score_gpt":0.365979890636119,"score_spread":0.3263437270030294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906970298","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99433553,0.0007132752,0.00020486719,0.0009377424,0.00022738062,0.0012980388,0.0022392727,0.000012765129,0.000031149775],"genre_scores_gemma":[0.9974953,0.00006221843,0.0006328592,0.00004265923,0.0004200958,0.0009065729,0.00033195587,0.00003800106,0.00007035195],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99839145,0.00008159695,0.00026229868,0.000626278,0.00022126634,0.0004170856],"domain_scores_gemma":[0.99868876,0.000095526695,0.00015140153,0.0003332857,0.00060793804,0.0001230618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017922712,0.00024751763,0.0003139884,0.000100243065,0.00029456845,0.0000276681,0.00009487203,0.00007737584,0.000030133098],"category_scores_gemma":[0.000017245478,0.00021047673,0.00009890672,0.00016813871,0.00020932592,0.000017007009,0.00013030338,0.00006293033,0.0000019682002],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00236623,0.00082591095,0.4750522,0.00010643408,0.00036773944,0.0000053472313,0.00007585954,0.00021485031,0.5178924,0.0006618367,0.00025528143,0.002175885],"study_design_scores_gemma":[0.004062042,0.0012538219,0.9783565,0.00007712068,0.0001125922,0.0004254463,0.00008855455,0.00013596463,0.01448992,0.00030016943,0.00047878752,0.00021910612],"about_ca_topic_score_codex":0.0037846009,"about_ca_topic_score_gemma":0.0024557859,"teacher_disagreement_score":0.50340253,"about_ca_system_score_codex":0.00087857345,"about_ca_system_score_gemma":0.00082824385,"threshold_uncertainty_score":0.8582992},"labels":[],"label_agreement":null},{"id":"W2907101057","doi":"10.1007/s10549-018-05114-7","title":"The clinical utility of baseline cardiac assessments prior to adjuvant anthracycline chemotherapy in breast cancer: a systematic review and meta-analysis","year":2019,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Capital District Health Authority; Dalhousie University","funders":"","keywords":"Medicine; Ejection fraction; Anthracycline; Breast cancer; Internal medicine; Chemotherapy; Stage (stratigraphy); Cardiology; Clinical trial; Oncology; Cancer; Heart failure","score_opus":0.2477288008254014,"score_gpt":0.5368365337611267,"score_spread":0.28910773293572534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907101057","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00037536013,0.98123354,0.0000047972917,0.0046147066,0.000042017673,0.010428939,0.0032630137,0.000011501295,0.0000261185],"genre_scores_gemma":[0.003952013,0.99089366,0.0000355097,0.00022744882,0.00010802421,0.0040266453,0.00012350455,0.00004892841,0.0005842698],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9940774,0.001834406,0.0016980562,0.0009592222,0.00089589716,0.00053503504],"domain_scores_gemma":[0.9962759,0.0011164793,0.0005223339,0.0011610306,0.0005073522,0.0004168939],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0048373966,0.00056434755,0.009897906,0.00034439767,0.00013305296,0.000055089997,0.00020075543,0.00021075485,0.00019723445],"category_scores_gemma":[0.000073681746,0.00028682442,0.0018438612,0.0013225636,0.00024678351,0.0000603766,0.00009699079,0.0005175096,0.0000049865234],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044980517,0.00079767284,0.0006530681,0.28811106,0.15010536,0.000013710405,0.00003484865,1.6339695e-7,0.0000030159765,0.000004424112,0.0001655784,0.55966127],"study_design_scores_gemma":[0.0031455734,0.0011360804,0.0070354985,0.08713071,0.87163734,0.00015215173,0.00008196394,0.000031824216,0.000026596192,0.000008204783,0.029064601,0.0005494599],"about_ca_topic_score_codex":0.0030373007,"about_ca_topic_score_gemma":0.0006830461,"teacher_disagreement_score":0.721532,"about_ca_system_score_codex":0.0006149905,"about_ca_system_score_gemma":0.001331049,"threshold_uncertainty_score":0.9999584},"labels":[],"label_agreement":null},{"id":"W2907218362","doi":"10.1007/s10549-018-05109-4","title":"Is microductectomy still necessary to diagnose breast cancer: a 10-year study on the effectiveness of duct excision and galactography","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Lesions and Carcinomas","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Providence Health Care; University of British Columbia; Vancouver Coastal Health","funders":"","keywords":"Medicine; Nipple discharge; Breast cancer; Malignancy; Mammography; Breast disease; Radiological weapon; Radiology; Incidence (geometry); Retrospective cohort study; Cancer; Surgery; Internal medicine","score_opus":0.038271335045331145,"score_gpt":0.3573218608961007,"score_spread":0.31905052585076954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907218362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899994,0.0016963097,3.774942e-7,0.00456514,0.0000546282,0.002894715,0.00054760155,0.000015844827,0.00022598381],"genre_scores_gemma":[0.9976777,0.0010296422,0.0000056268527,0.00006376386,0.000119842225,0.0007821409,0.000007097422,0.00003217841,0.00028201906],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99771094,0.00039522478,0.00018567123,0.0006699849,0.00059563573,0.00044254193],"domain_scores_gemma":[0.99817467,0.0004804279,0.00004460467,0.0006084876,0.00035578373,0.00033601114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006859399,0.0002611614,0.00045983063,0.00031955412,0.00014822949,0.000046029196,0.00011411821,0.000058243022,0.0007161228],"category_scores_gemma":[0.000014564406,0.00014623371,0.000088199886,0.0006675007,0.00017397151,0.00006087981,0.00013618325,0.00019716499,0.000025037521],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012343514,0.0021958991,0.9391372,0.00016890903,0.00044712608,0.000049250266,0.000680655,0.0000011507585,0.008318848,0.000047731617,0.0005772819,0.036032386],"study_design_scores_gemma":[0.0048188292,0.0035655093,0.98538923,0.00069578696,0.00009666658,0.00013056309,0.0009780846,0.0000026831744,0.0036747134,0.000033326913,0.00048377193,0.00013085542],"about_ca_topic_score_codex":0.009668486,"about_ca_topic_score_gemma":0.00020013248,"teacher_disagreement_score":0.046251964,"about_ca_system_score_codex":0.00023133072,"about_ca_system_score_gemma":0.00022695542,"threshold_uncertainty_score":0.9969262},"labels":[],"label_agreement":null},{"id":"W2907259814","doi":"10.1007/s10549-018-05118-3","title":"Folic acid supplement use and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a case–control study","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Princess Margaret Cancer Centre; University of Toronto; University Health Network; St. Michael's Hospital; Western University; Women's College Hospital","funders":"Division of Cancer Epidemiology and Genetics, National Cancer Institute","keywords":"Breast cancer; Medicine; Oncology; Mutation; Case-control study; Folic acid; Internal medicine; Genetics; Cancer; Gynecology; Biology; Gene","score_opus":0.04052469990405163,"score_gpt":0.37870936921740056,"score_spread":0.33818466931334895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907259814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885306,0.0035537104,9.941107e-7,0.0023082031,0.000031814914,0.0032512776,0.0022810118,0.00001631395,0.000026119951],"genre_scores_gemma":[0.9936431,0.0047120894,0.00001641061,0.0000377239,0.00010792681,0.0009635866,0.000021395947,0.000032353866,0.0004654279],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973692,0.00030442854,0.000262455,0.0007008738,0.00061617914,0.0007468593],"domain_scores_gemma":[0.99866587,0.00017595477,0.0000470627,0.00032988063,0.00026914704,0.00051210495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058239937,0.000262467,0.00045140693,0.0004342713,0.00022615367,0.00018116782,0.00005134992,0.00008230447,0.00046431788],"category_scores_gemma":[0.000020410504,0.00018860576,0.000039678598,0.00037179247,0.0001752825,0.00027041047,0.00009622213,0.0003243156,0.000009311946],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029314929,0.00079563615,0.8611918,0.000083508276,0.00073049543,0.0023760032,0.0021888206,0.0000036300441,0.000478848,0.000009729087,0.00007434058,0.12913565],"study_design_scores_gemma":[0.020003594,0.002997295,0.9691311,0.00013218194,0.00018029795,0.0030377717,0.0034734411,0.0004772794,0.00016640808,0.000018956065,0.00021565761,0.00016598437],"about_ca_topic_score_codex":0.15505135,"about_ca_topic_score_gemma":0.055301715,"teacher_disagreement_score":0.12896967,"about_ca_system_score_codex":0.00079816196,"about_ca_system_score_gemma":0.00039867384,"threshold_uncertainty_score":0.9619366},"labels":[],"label_agreement":null},{"id":"W2907731420","doi":"10.1007/s10549-018-05076-w","title":"Age-specific risks of incident, contralateral and ipsilateral breast cancer among 1776 Polish BRCA1 mutation carriers","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto; Women's College Hospital","funders":"Canada Research Chairs","keywords":"Breast cancer; Medicine; BRCA mutation; Cumulative incidence; Cancer; Incidence (geometry); Oncology; Internal medicine; Gynecology; Germline mutation; Obstetrics; Cohort; Mutation; Genetics; Biology","score_opus":0.04213065313632332,"score_gpt":0.3592300690624636,"score_spread":0.31709941592614027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907731420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937787,0.0035118228,0.000005221731,0.000502201,0.0001539332,0.0005979984,0.0012271451,0.000008724369,0.00021427563],"genre_scores_gemma":[0.99413675,0.0042638257,0.00003959295,0.000031517942,0.00024099369,0.00030111984,0.0001344614,0.000031063566,0.0008206446],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99839944,0.00009967616,0.00022789628,0.0005317741,0.00028551064,0.0004557035],"domain_scores_gemma":[0.99911803,0.000019980218,0.00008769564,0.00029147454,0.0002698856,0.00021291329],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015177291,0.00020916143,0.00024066413,0.000120397366,0.00013222604,0.00008305987,0.000111219895,0.0001302517,0.00019870221],"category_scores_gemma":[0.0000034759005,0.00017782713,0.000059444672,0.00015273993,0.00040332222,0.000023883522,0.00009596308,0.000117615986,0.000003230728],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013926944,0.00015236085,0.8769876,0.00006734008,0.000558158,0.000035949553,0.00096245087,0.00025640082,0.05477032,0.00007167893,0.00070896244,0.064036086],"study_design_scores_gemma":[0.0028564564,0.00038209962,0.9742225,0.000068582565,0.000032032272,0.00011494977,0.0002485852,0.00005691572,0.020349503,0.00008762476,0.001381015,0.00019975335],"about_ca_topic_score_codex":0.015727004,"about_ca_topic_score_gemma":0.0031126179,"teacher_disagreement_score":0.09723489,"about_ca_system_score_codex":0.00038409242,"about_ca_system_score_gemma":0.00031279426,"threshold_uncertainty_score":0.9908274},"labels":[],"label_agreement":null},{"id":"W2908699784","doi":"10.1007/s10549-018-05125-4","title":"Palbociclib plus letrozole as first-line therapy in estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer with extended follow-up","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":442,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of Alberta","funders":"Pfizer","keywords":"Palbociclib; Letrozole; Medicine; Breast cancer; Oncology; Internal medicine; Placebo; Metastatic breast cancer; Hazard ratio; Estrogen receptor; Population; Cancer; Gynecology; Tamoxifen; Confidence interval; Pathology","score_opus":0.03527075155297768,"score_gpt":0.3551255762284284,"score_spread":0.3198548246754507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908699784","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98144835,0.0040642996,0.000011958097,0.0083081005,0.00017972138,0.0035166403,0.0019718858,0.00011405681,0.00038499915],"genre_scores_gemma":[0.98547214,0.0070766956,0.00031836214,0.00023810772,0.0004247411,0.0026889471,0.00016927175,0.00016938821,0.0034423366],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99522376,0.00025440805,0.00051854574,0.001367177,0.0011167526,0.001519341],"domain_scores_gemma":[0.99732214,0.00027738616,0.00021367564,0.0006325006,0.0008238278,0.00073049305],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021749518,0.0007823654,0.0011380122,0.0004373759,0.00040341698,0.00008786599,0.0002521074,0.00019013009,0.0037290913],"category_scores_gemma":[0.000017549419,0.00055768644,0.00018130582,0.00086625334,0.00057100673,0.0005514957,0.00011066775,0.00064006733,0.00010342498],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09151347,0.002199138,0.37040186,0.00024331635,0.0023963968,0.00024878985,0.0040440946,0.000115409064,0.023884797,0.0005213197,0.000109807086,0.50432163],"study_design_scores_gemma":[0.081153944,0.010766721,0.8512605,0.0019123148,0.000101726735,0.000565167,0.0018589289,0.000052552423,0.047950212,0.0005147713,0.0027218508,0.0011413149],"about_ca_topic_score_codex":0.017501121,"about_ca_topic_score_gemma":0.0032049255,"teacher_disagreement_score":0.5031803,"about_ca_system_score_codex":0.0037282386,"about_ca_system_score_gemma":0.0012068853,"threshold_uncertainty_score":0.99968743},"labels":[],"label_agreement":null},{"id":"W2908879255","doi":"10.1007/s10549-019-05132-z","title":"National consensus recommendations on patient-centered care for ductal carcinoma in situ","year":2019,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Cancer survivorship and care","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Foothills Medical Centre; University of Calgary; Saskatoon City Hospital; Sunnybrook Health Science Centre; University of Saskatchewan; Dalhousie University; University Health Network; Toronto General Hospital; Health Sciences Centre","funders":"Canadian Cancer Society","keywords":"Ductal carcinoma; Breast cancer; Medicine; In situ; Carcinoma in situ; MEDLINE; Oncology; Internal medicine; Cancer; Political science; Geography","score_opus":0.19371757187776198,"score_gpt":0.450230148961514,"score_spread":0.25651257708375197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908879255","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002706845,0.982508,1.382605e-7,0.001349777,0.00036350606,0.0039027578,0.0071236915,0.00001479783,0.0020304825],"genre_scores_gemma":[0.04715245,0.946032,0.000014025093,0.00004079089,0.00030145736,0.0033652198,0.0023647784,0.00005272953,0.0006765889],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99796677,0.00014596978,0.00033629805,0.00060507987,0.00048185012,0.00046404212],"domain_scores_gemma":[0.99863005,0.00032265726,0.00008606943,0.00026598715,0.00048460736,0.00021060708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011566028,0.00032188525,0.0009234995,0.00048352778,0.00013067352,0.000040647636,0.00006835499,0.00016063388,0.00009938257],"category_scores_gemma":[0.000019761907,0.00023875438,0.00025547363,0.0002896824,0.00008158217,0.00002174074,0.000046225978,0.0002824165,0.000024547364],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076780573,0.00037993398,0.0004228561,0.0053271963,0.00025824847,0.0000546745,0.00055665226,2.494588e-7,4.3246584e-7,0.00013056152,0.0017870757,0.9903143],"study_design_scores_gemma":[0.0032619701,0.001673893,0.0006090022,0.007691101,0.00023776258,0.00018869646,0.00076647074,0.000002009789,0.0000055345786,0.000017031238,0.985334,0.00021253408],"about_ca_topic_score_codex":0.002802925,"about_ca_topic_score_gemma":0.010057246,"teacher_disagreement_score":0.99010175,"about_ca_system_score_codex":0.0031824873,"about_ca_system_score_gemma":0.0022866533,"threshold_uncertainty_score":0.97361207},"labels":[],"label_agreement":null},{"id":"W2910153650","doi":"10.1007/s10549-019-05129-8","title":"Tumor microenvironmental plasmacytoid dendritic cells contribute to breast cancer lymph node metastasis via CXCR4/SDF-1 axis","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Cairo University","keywords":"Breast cancer; SKBR3; CXCR4; Lymph; Cancer research; Lymph node; Chemokine; Metastasis; Medicine; Pathology; Biology; Cancer; Immunology; Internal medicine; Immune system","score_opus":0.015983957341125968,"score_gpt":0.28810471208207317,"score_spread":0.2721207547409472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910153650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97005856,0.018493785,0.0000134572,0.002558335,0.00051251735,0.001221642,0.0070133572,0.000047370195,0.00008098659],"genre_scores_gemma":[0.98469067,0.0055408143,0.000030484707,0.00034812075,0.00006777883,0.0008548481,0.000127435,0.00006266777,0.008277175],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99677736,0.00048462534,0.0003765561,0.0008021277,0.00019032769,0.0013690372],"domain_scores_gemma":[0.9988085,0.00025006456,0.000085104046,0.0005535248,0.00012905174,0.00017373913],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00031088604,0.00046999136,0.0006415067,0.00030065648,0.000535712,0.000087768625,0.0003241953,0.00015020386,0.006873408],"category_scores_gemma":[0.0000049424766,0.0003713096,0.00017607174,0.00028302186,0.00043388212,0.00017202353,0.00021235865,0.00028979545,0.0019056888],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011620321,0.001068732,0.025175933,0.000049776085,0.0019280892,0.00007540078,0.0004049053,0.000023230928,0.8830669,0.000024069435,0.001069917,0.07549271],"study_design_scores_gemma":[0.013130343,0.0011941744,0.21266928,0.00027177602,0.00016955807,0.0019814724,0.0006056853,0.0000074049403,0.7159194,0.000020681458,0.0533477,0.00068252295],"about_ca_topic_score_codex":0.012791632,"about_ca_topic_score_gemma":0.00029083755,"teacher_disagreement_score":0.18749335,"about_ca_system_score_codex":0.001226784,"about_ca_system_score_gemma":0.00033400318,"threshold_uncertainty_score":0.9998739},"labels":[],"label_agreement":null},{"id":"W2912504528","doi":"10.1007/s10549-019-05158-3","title":"Exemestane may be less detrimental than letrozole to bone health in women homozygous for the UGT2B17*2 gene deletion","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Research Resources; National Institute of General Medical Sciences; Pfizer Canada; National Institutes of Health; Fashion Footwear Association of New York; U.S. Department of Defense","keywords":"Exemestane; Letrozole; Medicine; Aromatase inhibitor; Breast cancer; Internal medicine; Bone mineral; Oncology; Aromatase; Bone remodeling; Osteoporosis; Pharmacogenetics; Endocrinology; Cancer; Genotype; Biology","score_opus":0.025507966692360117,"score_gpt":0.3456521872000151,"score_spread":0.320144220507655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912504528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98462355,0.0091562625,0.000027156626,0.0044216365,0.000056749494,0.0014839324,0.00018012579,0.000005559187,0.000045047032],"genre_scores_gemma":[0.99257916,0.004895934,0.000058879366,0.00019670487,0.000104594925,0.0009556566,0.00008720993,0.000021007807,0.0011008474],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987174,0.000081194295,0.00012536594,0.00034785087,0.00016011985,0.000568032],"domain_scores_gemma":[0.9994529,0.000031708954,0.000027704433,0.00022944591,0.00005325156,0.00020501275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033388025,0.00013539112,0.00016082483,0.00008285628,0.0001586338,0.000033608085,0.000089932095,0.00007259408,0.000010563264],"category_scores_gemma":[0.0000039919946,0.000088865265,0.00004284303,0.00015483433,0.000057536505,0.0000039697734,0.00007334774,0.00008674176,0.000006716815],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01211057,0.0015945492,0.022592714,0.00011195233,0.0007152687,0.000060474445,0.0010997829,0.0002388373,0.44098708,0.00021210345,0.0029809747,0.5172957],"study_design_scores_gemma":[0.039203946,0.050373465,0.20225999,0.00042826333,0.00008572445,0.0013344658,0.0062768757,0.0005625002,0.56254476,0.00022145096,0.13508913,0.001619441],"about_ca_topic_score_codex":0.0020263472,"about_ca_topic_score_gemma":0.0005490313,"teacher_disagreement_score":0.51567626,"about_ca_system_score_codex":0.00040119453,"about_ca_system_score_gemma":0.00023937388,"threshold_uncertainty_score":0.36238202},"labels":[],"label_agreement":null},{"id":"W2914478693","doi":"10.1007/s10549-019-05162-7","title":"Oophorectomy and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Sunnybrook Health Science Centre; McGill University; Public Health Ontario; Women's College Hospital; University of Toronto","funders":"National Cancer Institute; Canadian Cancer Society Research Institute","keywords":"Medicine; Breast cancer; Oophorectomy; Hazard ratio; Mastectomy; BRCA mutation; Cancer; Gynecology; Oncology; Proportional hazards model; Internal medicine; Prospective cohort study; Confidence interval; Obstetrics; Surgery; Hysterectomy","score_opus":0.012904818122163144,"score_gpt":0.31161599075858554,"score_spread":0.2987111726364224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914478693","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915621,0.0060373726,0.000004214702,0.00035694736,0.0000743701,0.0005203015,0.001318162,0.0000056646522,0.000120861085],"genre_scores_gemma":[0.98640066,0.012688391,0.00004737391,0.000014757174,0.000113821945,0.0002583288,0.00004866432,0.000022133885,0.00040586616],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987663,0.00009901672,0.00015568723,0.00046294596,0.00019372848,0.0003223],"domain_scores_gemma":[0.99929774,0.0000280909,0.000072127346,0.00020971055,0.00021546152,0.0001768946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015940749,0.00016781056,0.00019797683,0.00008496662,0.0001239064,0.000046761885,0.0000606288,0.00010034301,0.00009035626],"category_scores_gemma":[0.000006013915,0.0001365993,0.00003496598,0.00011504197,0.00037973508,0.000014259307,0.00007115336,0.00009335966,0.0000011759244],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007753517,0.000063744505,0.9041708,0.000049957613,0.0006023148,0.000005522303,0.0004977532,0.00006699724,0.018533733,0.000020217034,0.00013191192,0.07508171],"study_design_scores_gemma":[0.002935744,0.00045217428,0.97547734,0.00005545261,0.00006977432,0.00010486347,0.00027821763,0.00014602164,0.019581813,0.00006571555,0.00067250617,0.0001603958],"about_ca_topic_score_codex":0.013457029,"about_ca_topic_score_gemma":0.0030628091,"teacher_disagreement_score":0.07492132,"about_ca_system_score_codex":0.00019279795,"about_ca_system_score_gemma":0.00029440067,"threshold_uncertainty_score":0.99311244},"labels":[],"label_agreement":null},{"id":"W2922459755","doi":"10.1007/s10549-019-05196-x","title":"Patient-reported symptoms following mastectomy alone or lumpectomy plus radiation for early stage breast cancer: a cohort study","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Manitoba; Institute for Clinical Evaluative Sciences; University of Calgary; Cancer Care Ontario; McMaster University; University of Toronto; Sunnybrook Health Science Centre","funders":"Cancer Care Ontario","keywords":"Lumpectomy; Medicine; Breast cancer; Mastectomy; Stage (stratigraphy); Cohort; Cancer; Radiation therapy; Oncology; Cohort study; Internal medicine; Surgery","score_opus":0.023678309724773004,"score_gpt":0.33610667710801256,"score_spread":0.31242836738323954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2922459755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99024683,0.0019837986,0.000011321035,0.0005382654,0.0002709196,0.0052128704,0.0015898267,0.000043669144,0.00010248533],"genre_scores_gemma":[0.98841846,0.001073593,0.000034678756,0.000040426927,0.0003176922,0.0078377295,0.00020401753,0.000080466605,0.0019929355],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967645,0.00015057558,0.0004038531,0.0011570872,0.0006384093,0.0008856169],"domain_scores_gemma":[0.9984988,0.000076953576,0.00016816935,0.00060807983,0.00036310693,0.0002849149],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002704175,0.0004613336,0.0005874272,0.00017172137,0.00040951755,0.00012041411,0.0001541707,0.00012751218,0.00014453642],"category_scores_gemma":[0.000015147518,0.0003410389,0.00017658615,0.00033023956,0.000111280664,0.00003241681,0.00017826108,0.00011880263,0.000010859006],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064523867,0.0009549943,0.9466648,0.00004420005,0.0040174536,0.00006120847,0.00053292414,0.000033913555,0.0015337928,0.0000046715536,0.00018579476,0.03951383],"study_design_scores_gemma":[0.014867915,0.0030871087,0.9763909,0.00008431199,0.00030145142,0.0000771341,0.00080896076,0.000034802404,0.00192322,0.00000581638,0.0020275605,0.0003908205],"about_ca_topic_score_codex":0.01919664,"about_ca_topic_score_gemma":0.0041966825,"teacher_disagreement_score":0.03912301,"about_ca_system_score_codex":0.0009921952,"about_ca_system_score_gemma":0.00071600627,"threshold_uncertainty_score":0.99990416},"labels":[],"label_agreement":null},{"id":"W2929837227","doi":"10.1007/s10549-019-05209-9","title":"Toxicity and clinical outcomes of partial breast irradiation compared to whole breast irradiation for early-stage breast cancer: a systematic review and meta-analysis","year":2019,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Odds ratio; Brachytherapy; Oncology; Internal medicine; Radiation therapy; Subgroup analysis; Confidence interval; Cosmesis; Randomized controlled trial; Cancer; Surgery","score_opus":0.19039169083806035,"score_gpt":0.4726006323750448,"score_spread":0.28220894153698445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2929837227","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019561294,0.93922395,0.00001729016,0.0019132429,0.000061499435,0.0069506415,0.04985345,0.000016060814,0.00000775187],"genre_scores_gemma":[0.029740062,0.96118164,0.000056156136,0.00010926005,0.00017650677,0.0071712276,0.0009175961,0.00007973402,0.0005678343],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99500626,0.0007808768,0.001402235,0.0015168245,0.00056236977,0.0007314228],"domain_scores_gemma":[0.9967816,0.00036009916,0.0007981589,0.0009303567,0.00060968555,0.0005201405],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00092269393,0.0008990457,0.0066043786,0.0003559921,0.00027381364,0.00012442147,0.0002765718,0.00028813884,0.000055307097],"category_scores_gemma":[0.00004250453,0.00059727475,0.0013656188,0.000600303,0.00030452796,0.000031162574,0.00028980794,0.00019725903,0.0000066343923],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015408341,0.0025357136,0.044737414,0.3246135,0.53365,0.00001209287,0.00018725591,0.000015682399,0.00000654147,0.00006203468,0.00062053464,0.09201836],"study_design_scores_gemma":[0.0041020373,0.001428956,0.22308517,0.010965042,0.7499466,0.00040941403,0.0000848048,0.00002700363,0.0000045614825,0.0000087149465,0.008630169,0.0013075403],"about_ca_topic_score_codex":0.006490446,"about_ca_topic_score_gemma":0.0031127394,"teacher_disagreement_score":0.3136485,"about_ca_system_score_codex":0.00043776087,"about_ca_system_score_gemma":0.0005519728,"threshold_uncertainty_score":0.99964786},"labels":[],"label_agreement":null},{"id":"W2930733551","doi":"10.1007/s10549-019-05215-x","title":"Body mass index impacts infection rates in immediate autogenous breast reconstruction","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Implant and Reconstruction","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University","funders":"","keywords":"Medicine; Breast reconstruction; Reconstructive surgery; Breast cancer; Body mass index; Surgery; Retrospective cohort study; Cancer; Risk factor; Internal medicine","score_opus":0.028081160597550007,"score_gpt":0.3366055308780903,"score_spread":0.3085243702805403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2930733551","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965036,0.00043701427,0.0000036116994,0.000860944,0.0004266253,0.0009389021,0.00013610163,0.000048848455,0.0006443795],"genre_scores_gemma":[0.9970246,0.001792957,0.000024219682,0.000008590561,0.00036829835,0.00014965844,0.00005447793,0.00002448918,0.0005527284],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99826854,0.00009864947,0.00024991727,0.00041566085,0.0003195104,0.0006477084],"domain_scores_gemma":[0.9991797,0.00005014638,0.00006570549,0.00020093027,0.00016777363,0.00033570384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002368517,0.0002134964,0.0003433646,0.0005421547,0.00012696702,0.00006062687,0.00003399871,0.00015908424,0.00040414534],"category_scores_gemma":[0.0000033157328,0.00015723436,0.00006310631,0.00043848113,0.00015037977,0.00022720099,0.000024315823,0.000302888,0.00007582514],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001465975,0.00017909503,0.6661105,0.000059091075,0.00011541466,0.000037672984,0.00006932624,0.000004897825,0.0026721365,0.000021277912,0.000012302925,0.3292523],"study_design_scores_gemma":[0.004593577,0.00057675247,0.94358,0.00030104117,0.00003194984,0.049054295,0.00014112378,0.00032174774,0.0010026521,0.00018965233,0.00006915107,0.00013806237],"about_ca_topic_score_codex":0.016861929,"about_ca_topic_score_gemma":0.0017909195,"teacher_disagreement_score":0.32911426,"about_ca_system_score_codex":0.0010321357,"about_ca_system_score_gemma":0.000500894,"threshold_uncertainty_score":0.9896849},"labels":[],"label_agreement":null},{"id":"W2944306293","doi":"10.1007/s10549-019-05265-1","title":"De-escalation of bone-modifying agents in patients with bone metastases from breast cancer: a systematic review and meta-analysis","year":2019,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Bone health and treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Public Health; University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Denosumab; Breast cancer; Meta-analysis; Randomized controlled trial; Zoledronic acid; Relative risk; Confidence interval; Internal medicine; Oncology; Dosing; Clinical trial; Cancer; Surgery; Osteoporosis","score_opus":0.216998523895043,"score_gpt":0.46197718058548987,"score_spread":0.24497865669044686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944306293","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015835685,0.9784284,0.0000011291227,0.00033802303,0.000010264091,0.007943532,0.011668997,0.000011553643,0.000014523075],"genre_scores_gemma":[0.0150475865,0.97864324,0.000058302856,0.00006142,0.000013618425,0.004663281,0.0011466214,0.00005665394,0.0003092956],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99571097,0.00072169414,0.0011534682,0.00085551006,0.00090143544,0.0006569327],"domain_scores_gemma":[0.9974754,0.0002761783,0.00066880917,0.00069741753,0.00036038124,0.0005218539],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00056548853,0.0006336125,0.008690031,0.000793737,0.000103187915,0.000046129015,0.00007943128,0.00014317401,0.00029742072],"category_scores_gemma":[0.000017591243,0.0003431977,0.0006409352,0.0011819982,0.00011595606,0.00011275208,0.00007363879,0.00029031117,0.0000080399],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006804187,0.0019633665,0.030080868,0.67774516,0.19866519,0.0001061301,0.00006441159,0.0000010121375,2.6319228e-8,0.0000048898087,0.00003200711,0.09065654],"study_design_scores_gemma":[0.0036791547,0.00089244876,0.039427165,0.092034474,0.8628785,0.00009636206,0.000012424221,0.000008180942,1.8806514e-7,0.0000046177583,0.0006738673,0.00029261239],"about_ca_topic_score_codex":0.038633157,"about_ca_topic_score_gemma":0.0024937957,"teacher_disagreement_score":0.6642133,"about_ca_system_score_codex":0.0013677012,"about_ca_system_score_gemma":0.0010092687,"threshold_uncertainty_score":0.999902},"labels":[],"label_agreement":null},{"id":"W2944649909","doi":"10.1007/s10549-019-05266-0","title":"Patterns of adjuvant care and outcomes of elderly women with stage I breast cancer after breast-conserving surgery: a population-based analysis","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Sunnybrook Hospital; McMaster University","funders":"","keywords":"Medicine; Breast cancer; Breast-conserving surgery; Internal medicine; Adjuvant; Population; Radiation therapy; Proportional hazards model; Stage (stratigraphy); Oncology; Cohort; Adjuvant therapy; Gynecology; Cancer; Cohort study; Mastectomy","score_opus":0.01329237496388253,"score_gpt":0.2997558694760951,"score_spread":0.2864634945122126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944649909","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98758984,0.0029689567,0.0000058959877,0.00048100835,0.000023308032,0.00044980113,0.008460974,0.000007846908,0.0000123655545],"genre_scores_gemma":[0.99781144,0.0010141749,0.0000321358,0.0000266375,0.000036687292,0.0007313955,0.00019173212,0.000032497457,0.00012332058],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99810994,0.00010603765,0.00028141314,0.0006007863,0.00039810652,0.0005037318],"domain_scores_gemma":[0.99870896,0.000088236564,0.00015442858,0.0004487321,0.0004112022,0.00018840947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012181288,0.00031564606,0.0006997038,0.00027943013,0.00009260251,0.000028836574,0.00009109236,0.000072227245,0.00020261719],"category_scores_gemma":[0.0000029962916,0.00021919215,0.000110267036,0.00032845908,0.00012702144,0.000015383379,0.00009684983,0.00006590455,6.9140106e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037186164,0.00028818913,0.9632433,0.00025524801,0.0031679324,0.0000097448665,0.00037139468,0.00008424564,0.0004338472,0.0000023990947,0.000003537487,0.02842152],"study_design_scores_gemma":[0.0020125376,0.0007425891,0.9947005,0.00015922538,0.00030957474,0.000017908753,0.0009554822,0.000011640485,0.0008555492,0.0000023060436,0.000027213537,0.00020550264],"about_ca_topic_score_codex":0.055434346,"about_ca_topic_score_gemma":0.023711706,"teacher_disagreement_score":0.03172264,"about_ca_system_score_codex":0.0002963736,"about_ca_system_score_gemma":0.00036120805,"threshold_uncertainty_score":0.994103},"labels":[],"label_agreement":null},{"id":"W2946432848","doi":"10.1007/s10549-019-05274-0","title":"Creating a pragmatic trials program for breast cancer patients: Rethinking Clinical Trials (REaCT)","year":2019,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Grand River Hospital; University of Alberta; Queen's University; Ottawa Hospital; University of Ottawa","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Cancer Care Ontario","keywords":"Clinical trial; Breast cancer; Medicine; Psychological intervention; Randomized controlled trial; Health care; Accrual; Informed consent; Family medicine; Systematic review; MEDLINE; Cancer; Alternative medicine; Nursing; Surgery; Internal medicine; Pathology","score_opus":0.8370010017280224,"score_gpt":0.729580852097827,"score_spread":0.10742014963019542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946432848","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026249685,0.9453939,0.0000059888685,0.0033440546,0.0007142651,0.038886346,0.010594058,0.00013875587,0.00066013087],"genre_scores_gemma":[0.00021082978,0.9564287,0.00085693866,0.0000906251,0.0037037104,0.03341364,0.0008669927,0.0002750547,0.0041535096],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.97419876,0.011043169,0.006622831,0.0024891584,0.0035452757,0.002100824],"domain_scores_gemma":[0.84291357,0.1480376,0.0023273418,0.0015197468,0.0036809137,0.0015208265],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["metaresearch","research_integrity"],"category_scores_codex":[0.09036142,0.0011283554,0.011918979,0.0007447302,0.00061318517,0.00051277224,0.0006369911,0.00220905,0.00082903745],"category_scores_gemma":[0.060654186,0.0006592608,0.003118129,0.0009338045,0.00095263944,0.00017784821,0.00050887093,0.004778459,0.000082785875],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034685517,0.0031884543,0.0015145426,0.042416792,0.0054207887,0.000042599102,0.00013642982,9.640611e-8,3.0589663e-7,0.00042987955,0.00090587843,0.9424757],"study_design_scores_gemma":[0.028338417,0.012916875,0.0022705302,0.20034717,0.013719337,0.00026473383,0.00014282973,0.000062190185,0.0000024812693,0.00350536,0.73723537,0.0011947061],"about_ca_topic_score_codex":0.0027310252,"about_ca_topic_score_gemma":0.0008903725,"teacher_disagreement_score":0.94128096,"about_ca_system_score_codex":0.0033374976,"about_ca_system_score_gemma":0.014824787,"threshold_uncertainty_score":0.99958587},"labels":[],"label_agreement":null},{"id":"W2947977538","doi":"10.1007/s10549-019-05273-1","title":"Is immediate breast reconstruction safe in women over 70? An analysis of the National Surgical Quality Improvement Program (NSQIP) database","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Implant and Reconstruction","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Toronto General Hospital; University of Toronto; University Health Network; Women's College Hospital; Public Health Ontario","funders":"","keywords":"Medicine; Breast reconstruction; Breast cancer; Surgery; Implant; Complication; Quality of life (healthcare); Mortality rate; Database; Cancer; Internal medicine","score_opus":0.05492312856655687,"score_gpt":0.40438682442081175,"score_spread":0.34946369585425485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947977538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956706,0.00009229964,2.676926e-7,0.000993223,0.00010728351,0.0009836995,0.0019025593,0.000013115106,0.00023693519],"genre_scores_gemma":[0.99876386,0.0002747477,0.00003149856,0.000022101072,0.00013340604,0.0003226732,0.00013743681,0.000009806068,0.0003044748],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99786454,0.00016318356,0.00036638454,0.00043797196,0.0007503212,0.00041760638],"domain_scores_gemma":[0.9990346,0.000065999215,0.00011331865,0.00027525268,0.00027399327,0.00023687798],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00067398377,0.00015941268,0.00040739824,0.0004232185,0.00009043148,0.00003036333,0.00007506174,0.000085170584,0.001008232],"category_scores_gemma":[0.0000034617476,0.00009681117,0.00011517225,0.00086748315,0.00023907407,0.00017072844,0.000060011513,0.0001952002,0.00000504185],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023085277,0.0008145277,0.4717728,0.000046816498,0.00070630206,0.000004642793,0.00022842792,0.0000039741153,0.0006535657,0.00006896867,0.000009576974,0.5233819],"study_design_scores_gemma":[0.004625502,0.00048685493,0.990997,0.00010082623,0.00013025357,0.0017670866,0.0004904074,0.0006089437,0.0004831173,0.00006092462,0.00014608276,0.000102955026],"about_ca_topic_score_codex":0.0076505835,"about_ca_topic_score_gemma":0.0013087499,"teacher_disagreement_score":0.52327895,"about_ca_system_score_codex":0.0010213893,"about_ca_system_score_gemma":0.0004439028,"threshold_uncertainty_score":0.999905},"labels":[],"label_agreement":null},{"id":"W2949402590","doi":"10.1007/s10549-019-05315-8","title":"Quality of DCIS information on the internet: a content analysis","year":2019,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Health Literacy and Information Accessibility","field":"Health Professions","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Toronto General Hospital; Health Sciences Centre; University Health Network","funders":"Ontario Ministry of Health and Long-Term Care","keywords":"Ductal carcinoma; The Internet; Confusion; Quality (philosophy); Anxiety; Medicine; Breast cancer; Information quality; Psychology; Cancer; Internal medicine; Computer science; World Wide Web; Information system; Political science; Psychiatry","score_opus":0.603513367508862,"score_gpt":0.6307397905054555,"score_spread":0.027226422996593502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949402590","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0041637206,0.9757348,0.000051348,0.0011206064,0.00025563774,0.007381614,0.00491424,0.000030557545,0.006347504],"genre_scores_gemma":[0.0040477724,0.99119616,0.000010526297,0.00025053936,0.000073238516,0.0024026851,0.00039335067,0.000009131555,0.0016166244],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99432164,0.0022184257,0.0021054666,0.00024330242,0.00062316976,0.0004879977],"domain_scores_gemma":[0.99509776,0.0021525421,0.0011182971,0.0006919845,0.0007521088,0.00018731738],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0038241183,0.00024958915,0.0013609203,0.0005342213,0.00037708052,0.00004290057,0.00025850182,0.00018716214,0.0014278863],"category_scores_gemma":[0.00015784026,0.00011563551,0.00028755993,0.0008923427,0.00012644884,0.00037905833,0.00014115014,0.0007225706,0.0004095075],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026500225,0.00013505512,0.006516373,0.012436811,0.00086530234,1.40196e-7,0.0011919388,2.3551641e-7,5.580084e-9,0.002542366,0.0006377872,0.975409],"study_design_scores_gemma":[0.00054892444,0.00036436855,0.021808442,0.004844351,0.00028986318,6.509859e-7,0.0004966504,0.00005459808,1.4571737e-7,0.00002802078,0.97144824,0.000115733],"about_ca_topic_score_codex":0.014199959,"about_ca_topic_score_gemma":0.0007525109,"teacher_disagreement_score":0.9752933,"about_ca_system_score_codex":0.0010148691,"about_ca_system_score_gemma":0.0014304171,"threshold_uncertainty_score":0.99948496},"labels":[],"label_agreement":null},{"id":"W2954087664","doi":"10.1007/s10549-019-05334-5","title":"A generalizable relationship between mortality and time-to-death among breast cancer patients can be explained by tumour dormancy","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Women's College Hospital; University of Toronto","funders":"","keywords":"Breast cancer; Decile; Medicine; Dormancy; Internal medicine; Oncology; Cancer; Mortality rate; Cohort; Biology","score_opus":0.04724710897080818,"score_gpt":0.33784452264436976,"score_spread":0.29059741367356157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954087664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885661,0.0012719077,0.0000019096774,0.0023648168,0.000044622233,0.00097068475,0.0064686406,0.000022075725,0.0002892265],"genre_scores_gemma":[0.99457765,0.000736337,0.0000251399,0.000089811954,0.00024309188,0.0009856776,0.00072644214,0.000049703627,0.0025661234],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99767447,0.00013191698,0.00024105998,0.00083104026,0.00041648527,0.0007050326],"domain_scores_gemma":[0.99880874,0.0000521678,0.00007569061,0.0003653728,0.00024951049,0.0004484931],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015551983,0.0003640264,0.0003594279,0.00011575099,0.00034150472,0.00008054857,0.00013562199,0.00012527508,0.00016696747],"category_scores_gemma":[0.000010473737,0.00029481942,0.00006112316,0.00022648838,0.00016351255,0.000023477867,0.000228392,0.000117870186,0.000024487055],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036232301,0.0002648633,0.99262893,0.00003215837,0.00044002762,0.0000031895859,0.00018038014,0.000009330062,0.0011153863,0.000013067791,0.0027768959,0.002173456],"study_design_scores_gemma":[0.0028115045,0.00048158263,0.9932405,0.00006901658,0.00008693502,0.000009258543,0.000057166708,0.000008220864,0.0019097838,0.000032426662,0.0010024647,0.0002911768],"about_ca_topic_score_codex":0.023798767,"about_ca_topic_score_gemma":0.0024487767,"teacher_disagreement_score":0.02134999,"about_ca_system_score_codex":0.0004304159,"about_ca_system_score_gemma":0.0002088389,"threshold_uncertainty_score":0.9999504},"labels":[],"label_agreement":null},{"id":"W2954586745","doi":"10.1007/s10549-019-05331-8","title":"Role of docosahexaenoic acid in enhancement of docetaxel action in patient-derived breast cancer xenografts","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Fatty Acid Research and Health","field":"Nursing","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"Docetaxel; Survivin; Docosahexaenoic acid; Breast cancer; Apoptosis; Medicine; Internal medicine; Chemotherapy; Triple-negative breast cancer; Endocrinology; Cancer; Oncology; Cancer research; Biology; Polyunsaturated fatty acid; Fatty acid; Biochemistry","score_opus":0.04029556302212165,"score_gpt":0.3720375746306889,"score_spread":0.33174201160856726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954586745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907818,0.004652417,7.675941e-7,0.0022884107,0.00012097687,0.0015369763,0.00040123845,0.000009437429,0.00020802164],"genre_scores_gemma":[0.9939741,0.0052051116,0.00004809752,0.00001913603,0.00006222532,0.00061011687,0.000022527498,0.000023358392,0.00003532662],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971362,0.00026782867,0.00045613438,0.0004710886,0.0007604859,0.00090827676],"domain_scores_gemma":[0.9989689,0.000081293125,0.0001268306,0.0003187117,0.00025219994,0.00025207354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003536079,0.00021203446,0.000466377,0.00061761,0.00008017196,0.00002556132,0.00014399184,0.000097999895,0.0005939589],"category_scores_gemma":[0.000007816787,0.00017127763,0.00006266983,0.00069933315,0.00019289315,0.00021469759,0.000085046246,0.00030602101,0.00001541928],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071437946,0.001628497,0.18070012,0.00033446308,0.00007079672,0.00000907194,0.0015967557,0.000031814627,0.4690587,0.000026062247,0.000036393514,0.33936352],"study_design_scores_gemma":[0.004861003,0.0019325968,0.49280167,0.0006552132,0.000008966381,0.000017809418,0.0012901145,0.00013334406,0.49775717,0.00013890857,0.00025993117,0.00014328212],"about_ca_topic_score_codex":0.083344825,"about_ca_topic_score_gemma":0.034831714,"teacher_disagreement_score":0.33922026,"about_ca_system_score_codex":0.0014086055,"about_ca_system_score_gemma":0.000425573,"threshold_uncertainty_score":0.9827801},"labels":[],"label_agreement":null},{"id":"W2961291484","doi":"10.1007/s10549-019-05354-1","title":"Breast pain and cancer: should we continue to work-up isolated breast pain?","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Lesions and Carcinomas","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Breast cancer; Asymptomatic; Mammography; Breast pain; Retrospective cohort study; Malignancy; Incidence (geometry); Work-up; Breast ultrasound; Medical record; Obstetrics; Cancer; Gynecology; Radiology; Internal medicine","score_opus":0.05108060971157251,"score_gpt":0.34582697931785,"score_spread":0.2947463696062775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2961291484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9414778,0.008706376,0.000031998246,0.045716092,0.00015999109,0.0022630144,0.0010313072,0.000099485755,0.0005139368],"genre_scores_gemma":[0.985832,0.0025218416,0.00004786769,0.0005042538,0.00038608556,0.0007689348,0.00005223094,0.00007488641,0.00981192],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9964989,0.00040528184,0.0003311195,0.00093739224,0.00069894124,0.0011283866],"domain_scores_gemma":[0.99744046,0.00023866002,0.0000616953,0.0005950911,0.00043831073,0.0012257985],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011031781,0.0004491959,0.0006826832,0.0003452048,0.00029428175,0.00015114543,0.00014302033,0.00019494646,0.0012843506],"category_scores_gemma":[0.000012826892,0.00032375296,0.000115914656,0.0007705437,0.00022462953,0.000120351484,0.00017091226,0.0004051728,0.00009262587],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042771227,0.00046857708,0.28313038,0.00012407378,0.00032390427,0.00012207993,0.00043533824,0.0000026275757,0.0008197941,0.000066027686,0.003469349,0.70676076],"study_design_scores_gemma":[0.0075476402,0.002492881,0.9608569,0.0017106417,0.00015602847,0.0027063123,0.0010046847,0.00029470568,0.00010839717,0.000051435047,0.022580953,0.00048942195],"about_ca_topic_score_codex":0.012647844,"about_ca_topic_score_gemma":0.0012300124,"teacher_disagreement_score":0.7062713,"about_ca_system_score_codex":0.0007130965,"about_ca_system_score_gemma":0.0005510298,"threshold_uncertainty_score":0.99992144},"labels":[],"label_agreement":null},{"id":"W2963140894","doi":"10.1007/s10549-019-05364-z","title":"Multiple foci of microinvasion is associated with an increased risk of invasive local recurrence in women with ductal carcinoma in situ treated with breast-conserving surgery","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; McMaster University; University of Toronto; Sunnybrook Hospital; Sunnybrook Health Science Centre","funders":"Canadian Cancer Society Research Institute; Ontario Ministry of Health and Long-Term Care; Cancer Care Ontario","keywords":"Medicine; Ductal carcinoma; Breast cancer; Breast-conserving surgery; Proportional hazards model; Oncology; Cohort; Population; Internal medicine; Radiation therapy; Hazard ratio; Mastectomy; Cancer; Radiology; Confidence interval","score_opus":0.019382227856688704,"score_gpt":0.2630816724768086,"score_spread":0.2436994446201199,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2963140894","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973841,0.00075233134,0.0000016375002,0.00008875186,0.0000067488904,0.000723275,0.0010006271,0.00000635649,0.000036174766],"genre_scores_gemma":[0.99856347,0.0007835235,0.00004078326,0.000011723671,0.000016433487,0.00036755172,0.00016517018,0.00003544743,0.000015920043],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99774665,0.0003107789,0.00028506876,0.0006901356,0.00035808465,0.00060929795],"domain_scores_gemma":[0.9985997,0.00023780736,0.00020335725,0.00039393478,0.00038653094,0.0001786391],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002898206,0.00033010083,0.00060083164,0.00026212787,0.00007187175,0.000015431988,0.0001193444,0.00010876747,0.000017704695],"category_scores_gemma":[0.000023171864,0.00021944496,0.000038600487,0.0005650093,0.00045015404,0.000028527435,0.00008343975,0.00013816966,6.834118e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02501948,0.0012345937,0.95257884,0.00007281591,0.0005801778,0.000098401855,0.0007370852,0.00004085323,0.013680771,7.5752666e-7,0.000008019925,0.0059482018],"study_design_scores_gemma":[0.007992496,0.0032235805,0.91917294,0.0006517227,0.000047059326,0.00014368874,0.0015322629,0.000020829715,0.066988416,0.000005450962,0.0000019217284,0.00021965994],"about_ca_topic_score_codex":0.061263014,"about_ca_topic_score_gemma":0.08011795,"teacher_disagreement_score":0.05330764,"about_ca_system_score_codex":0.0005584801,"about_ca_system_score_gemma":0.0009134097,"threshold_uncertainty_score":0.94498813},"labels":[],"label_agreement":null},{"id":"W2963266806","doi":"10.1007/s10549-019-05367-w","title":"Risk of malignancy in papillary neoplasms of the breast","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Lesions and Carcinomas","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia; Providence Health Care","funders":"University of British Columbia; Providence Health Care","keywords":"Atypia; Malignancy; Medicine; Breast cancer; Concordance; Biopsy; Nuclear atypia; Radiology; Pathology; Cancer; Oncology; Internal medicine; Immunohistochemistry","score_opus":0.024399315459459836,"score_gpt":0.3116737059987765,"score_spread":0.28727439053931664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2963266806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944676,0.0020909645,2.5095994e-7,0.001170348,0.000038475588,0.0006301227,0.0003580247,0.0000042488355,0.0012399573],"genre_scores_gemma":[0.9971161,0.001729472,0.000017840823,0.000011266609,0.000035676552,0.000066036126,0.0000045100173,0.000012763675,0.0010063213],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987812,0.00011131905,0.00020294206,0.00022813964,0.00038607648,0.00029032046],"domain_scores_gemma":[0.9991876,0.00006978143,0.00006170104,0.00040498606,0.00015909855,0.00011687105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021582042,0.00011395094,0.00029508455,0.00012877103,0.00004656326,0.0000054305046,0.0000806992,0.000057310503,0.0002986595],"category_scores_gemma":[0.000005250427,0.00006223161,0.00008670877,0.00037766417,0.00017680589,0.000033145472,0.00007980199,0.00014837254,0.000008864515],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087144086,0.0005034831,0.9388505,0.000097773576,0.00010312287,0.00001625452,0.00016890366,0.0000037181564,0.002532311,0.000248383,0.000048161368,0.056555938],"study_design_scores_gemma":[0.0027723794,0.0005013797,0.99281275,0.00044564044,0.00004046195,0.00037795716,0.00024406635,0.000028115926,0.0024631177,0.00011371184,0.00015029416,0.000050116374],"about_ca_topic_score_codex":0.010569398,"about_ca_topic_score_gemma":0.00065198075,"teacher_disagreement_score":0.05650582,"about_ca_system_score_codex":0.00015938212,"about_ca_system_score_gemma":0.00035994855,"threshold_uncertainty_score":0.9960193},"labels":[],"label_agreement":null},{"id":"W2963846945","doi":"10.1007/s10549-019-05363-0","title":"National trends of synchronous bilateral breast cancer incidence in the United States","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Breast cancer; Incidence (geometry); Mastectomy; Stage (stratigraphy); Cancer; Epidemiology; Oncology; Mammography; Internal medicine; Gynecology","score_opus":0.02719226620367043,"score_gpt":0.3522937252626555,"score_spread":0.3251014590589851,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2963846945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920134,0.0019730097,9.037113e-7,0.0039939126,0.00004667385,0.00028556236,0.0013998528,0.0000053196404,0.0002813458],"genre_scores_gemma":[0.99418145,0.0044739726,0.000012538418,0.00010896228,0.00013483186,0.0004975132,0.00024531252,0.000016161746,0.00032925766],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998429,0.00013227758,0.00018453908,0.00040383698,0.000444578,0.00040579573],"domain_scores_gemma":[0.9992633,0.000061799,0.000058095655,0.00024281118,0.00030298287,0.000071026996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022032595,0.00019717452,0.00020486431,0.00023508986,0.000106940905,0.000031026666,0.0001770492,0.000064044194,0.00015882438],"category_scores_gemma":[0.000004111492,0.00012357633,0.00005370211,0.0005017705,0.00024591337,0.000011226077,0.00010220362,0.000093927716,0.000005659298],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023970015,0.0010414962,0.93848044,0.00006227079,0.0006475059,0.000022931883,0.0012964121,0.0008356506,0.0032655345,0.00022518823,0.0011380819,0.050587498],"study_design_scores_gemma":[0.0023684725,0.0004680778,0.9929035,0.00008881632,0.00002254117,0.00013135337,0.00043855511,0.0001025789,0.0014249386,0.00010427936,0.0017952675,0.00015165943],"about_ca_topic_score_codex":0.028063089,"about_ca_topic_score_gemma":0.0060040755,"teacher_disagreement_score":0.054423034,"about_ca_system_score_codex":0.0003167599,"about_ca_system_score_gemma":0.00030980844,"threshold_uncertainty_score":0.9784091},"labels":[],"label_agreement":null},{"id":"W2964384918","doi":"10.1007/s10549-019-05381-y","title":"A randomized, double-blind, window of opportunity trial evaluating the effects of chloroquine in breast cancer patients","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Autophagy in Disease and Therapy","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation; University of Ottawa; McMaster University; Health Sciences North; Ottawa Hospital","funders":"Canadian Cancer Society","keywords":"Chloroquine; Placebo; Medicine; Breast cancer; Adverse effect; Randomized controlled trial; Internal medicine; Oncology; Toxicity; Clinical trial; Cancer; Pharmacology; Surgery; Pathology; Malaria","score_opus":0.0904509321332827,"score_gpt":0.43191195704074076,"score_spread":0.34146102490745806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964384918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989574,0.0025072505,1.9138555e-7,0.0009388852,0.000141093,0.006446743,0.00017006687,0.0000071538448,0.00021458477],"genre_scores_gemma":[0.9944117,0.0030043432,0.0000032018413,0.00004208457,0.00014199865,0.0019381179,0.000030661457,0.000019682595,0.00040818437],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99778724,0.0003574503,0.00040719294,0.00029549442,0.00078229595,0.00037033763],"domain_scores_gemma":[0.9983309,0.0005449486,0.00016873702,0.0003403826,0.0003880107,0.00022705873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088427885,0.00018833461,0.00076077314,0.00018549284,0.000066488596,0.00001232296,0.000103657905,0.00006953024,0.00048093344],"category_scores_gemma":[0.000044151508,0.00010280313,0.00015780845,0.00032284853,0.0002986304,0.00006994848,0.000057279507,0.00017765534,0.0000034954571],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.89929396,0.0022674564,0.05528811,0.000282484,0.0006993585,0.000012333512,0.00044477315,0.000003582481,0.00071169063,0.00006327712,0.000016546932,0.04091641],"study_design_scores_gemma":[0.87331516,0.0036350254,0.118649654,0.0006158945,0.00020384078,0.000008867927,0.00006541246,0.000070676084,0.0032517163,0.000096659955,0.000008744615,0.00007837482],"about_ca_topic_score_codex":0.010977313,"about_ca_topic_score_gemma":0.00017958954,"teacher_disagreement_score":0.06336154,"about_ca_system_score_codex":0.0002748775,"about_ca_system_score_gemma":0.0009445342,"threshold_uncertainty_score":0.9956087},"labels":[],"label_agreement":null},{"id":"W2964461993","doi":"10.1007/s10549-019-05388-5","title":"A multicentre, randomized pilot trial comparing vascular access strategies for early stage breast cancer patients receiving non-trastuzumab containing chemotherapy","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Central Venous Catheters and Hemodialysis","field":"Health Professions","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Ottawa; Ottawa Hospital","funders":"","keywords":"Trastuzumab; Medicine; Breast cancer; Oncology; Stage (stratigraphy); Chemotherapy; Internal medicine; Randomized controlled trial; Cancer; Gynecology","score_opus":0.10393096685917173,"score_gpt":0.4431091563680435,"score_spread":0.33917818950887174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964461993","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862942,0.00035866335,0.0000864039,0.0005121686,0.00040783265,0.011154506,0.0006539376,0.000048764632,0.00048350537],"genre_scores_gemma":[0.9903466,0.0025789293,0.000042680735,0.000086719694,0.00046335848,0.005594053,0.00007564537,0.00006776015,0.0007442296],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9961607,0.0005479116,0.00062352413,0.0007022164,0.00060062896,0.0013650294],"domain_scores_gemma":[0.9975576,0.00086297997,0.00027037563,0.00034540956,0.00059004006,0.0003736044],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010114679,0.00037119485,0.0012007237,0.00021477116,0.0010280977,0.00025099426,0.0002594277,0.0001258973,0.00073088065],"category_scores_gemma":[0.000017725306,0.00026770702,0.0002700708,0.0002449915,0.00014237622,0.00041700405,0.00012640806,0.000384166,0.000020564852],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6382851,0.0016700331,0.3308341,0.00031819218,0.0014500275,0.0000028674801,0.007572542,0.00006847202,0.00007912496,0.00012635298,0.000092587106,0.01950057],"study_design_scores_gemma":[0.71624196,0.0016930158,0.27678457,0.00057116366,0.00018138613,6.1857685e-7,0.0022017204,0.0015119305,0.000024793435,0.000092585564,0.00037502177,0.00032122814],"about_ca_topic_score_codex":0.06541116,"about_ca_topic_score_gemma":0.008677165,"teacher_disagreement_score":0.07795684,"about_ca_system_score_codex":0.0014983022,"about_ca_system_score_gemma":0.0010979928,"threshold_uncertainty_score":0.9999775},"labels":[],"label_agreement":null},{"id":"W2964765340","doi":"10.1007/s10549-019-05377-8","title":"The time-varying effect of radiotherapy after breast-conserving surgery for DCIS","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Concordia University; McGill University; Sunnybrook Hospital; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Canadian Cancer Society Research Institute; Ontario Ministry of Health and Long-Term Care; Cancer Care Ontario","keywords":"Medicine; Hazard ratio; Proportional hazards model; Breast cancer; Population; Internal medicine; Cohort; Cohort study; Radiation therapy; Oncology; Gynecology; Confidence interval; Cancer; Environmental health","score_opus":0.014665862742417204,"score_gpt":0.3185867611986557,"score_spread":0.3039208984562385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964765340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.981077,0.015578216,0.000008347358,0.0016974823,0.0000968705,0.00096972554,0.00047302153,0.000008944609,0.00009035415],"genre_scores_gemma":[0.99291426,0.004407129,0.00003729371,0.000030725976,0.0002316518,0.0015278823,0.000041640476,0.000035605914,0.0007737954],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99855703,0.00014837887,0.00017489467,0.00041263312,0.00021368318,0.000493401],"domain_scores_gemma":[0.99874145,0.0005545355,0.000060215672,0.0003826579,0.00016398168,0.00009714947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000409366,0.00022179993,0.00031794765,0.00006307131,0.00023510773,0.000043334774,0.00011137739,0.000069457536,0.000054201937],"category_scores_gemma":[0.000013638677,0.00013140621,0.00016042835,0.00011171953,0.00020655642,0.0000072457224,0.000081985134,0.000050545485,0.0000068530503],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023502935,0.00027058952,0.5846198,0.00020230739,0.0022795843,0.0000085543015,0.00015110029,0.00001163116,0.029216334,0.000018791765,0.0017020853,0.35801625],"study_design_scores_gemma":[0.014704662,0.0050789244,0.81567997,0.0005703077,0.00027512183,0.000488813,0.00014101552,0.00018238308,0.13724333,0.00012822865,0.02466902,0.0008382308],"about_ca_topic_score_codex":0.0008513261,"about_ca_topic_score_gemma":0.00016093768,"teacher_disagreement_score":0.35717803,"about_ca_system_score_codex":0.00014686835,"about_ca_system_score_gemma":0.00016751906,"threshold_uncertainty_score":0.5358589},"labels":[],"label_agreement":null},{"id":"W2964957864","doi":"10.1007/s10549-019-05360-3","title":"A phase Ib, open-label, dose-escalation study of the safety and pharmacology of taselisib (GDC-0032) in combination with either docetaxel or paclitaxel in patients with HER2-negative, locally advanced, or metastatic breast cancer","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Cancer Institute; Genentech; F. Hoffmann-La Roche","keywords":"Docetaxel; Taxane; Paclitaxel; Medicine; Adverse effect; Breast cancer; Lung cancer; Cancer; Metastatic breast cancer; Internal medicine; Pharmacology; Oncology","score_opus":0.05230859694138998,"score_gpt":0.42508213895852676,"score_spread":0.37277354201713675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964957864","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990178,0.0003028487,0.0000012165821,0.0012775089,0.000045991805,0.0073808357,0.00073591166,0.00000557294,0.000072119685],"genre_scores_gemma":[0.99700975,0.0008404979,0.00006562465,0.000054543485,0.000015529104,0.0012413812,0.000031727297,0.000029348676,0.00071158475],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99783814,0.00037907038,0.00040261413,0.0004930917,0.0004957397,0.0003913418],"domain_scores_gemma":[0.9987727,0.00024124402,0.00021409657,0.00022477226,0.00040126828,0.00014592263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027423684,0.00027058387,0.0006786644,0.0002485738,0.00008411631,0.000018429362,0.00012299135,0.000046977093,0.00068730256],"category_scores_gemma":[0.000006360733,0.0001323493,0.000017069036,0.0008617664,0.0002933123,0.0002308701,0.0000986076,0.00020320095,9.006104e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.219169,0.03827156,0.67707586,0.00020565414,0.0009870072,0.000049333772,0.0015928068,0.00008040616,0.00035372376,0.000011539013,0.000037733265,0.062165357],"study_design_scores_gemma":[0.22915903,0.0318078,0.73648715,0.00045245435,0.00032747228,0.000025636757,0.00088496157,0.00016780748,0.00048685735,0.000010723949,0.00006227568,0.0001278562],"about_ca_topic_score_codex":0.017099768,"about_ca_topic_score_gemma":0.035592634,"teacher_disagreement_score":0.0620375,"about_ca_system_score_codex":0.00069336494,"about_ca_system_score_gemma":0.00079288735,"threshold_uncertainty_score":0.98944545},"labels":[],"label_agreement":null},{"id":"W2966937023","doi":"10.1007/s10549-019-05392-9","title":"Randomized window of opportunity trial evaluating high-dose vitamin D in breast cancer patients","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; University of Toronto; McMaster University; Ottawa Hospital","funders":"Canadian Cancer Society","keywords":"Medicine; Breast cancer; Vitamin D and neurology; Placebo; Cholecalciferol; Internal medicine; Randomized controlled trial; Vitamin; Gastroenterology; vitamin D deficiency; Prospective cohort study; Cancer; Adverse effect; Surgery; Pathology","score_opus":0.09183233463186527,"score_gpt":0.42480420447560946,"score_spread":0.33297186984374416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2966937023","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890092,0.00085583207,1.9508855e-7,0.0031462633,0.00014920483,0.0057552564,0.00064341165,0.000015861333,0.0004247593],"genre_scores_gemma":[0.9918322,0.0038119662,0.00003119955,0.000026848447,0.00018392006,0.0024519726,0.000055124292,0.00003188207,0.0015749028],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9958245,0.00076019147,0.00054891955,0.00055897783,0.0015082441,0.0007991274],"domain_scores_gemma":[0.9974098,0.00069889415,0.0001414936,0.00038742262,0.0008999859,0.00046236694],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019194785,0.00028301863,0.0012012953,0.0004661364,0.00013221247,0.000030177385,0.00012378753,0.00009747963,0.0009301691],"category_scores_gemma":[0.00026772887,0.00018417924,0.00014954199,0.00050684833,0.0005185377,0.00012772116,0.00020087768,0.0003415237,0.000016259117],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6527686,0.0028960716,0.26116878,0.0002644285,0.0007683254,0.00004347061,0.00048969086,0.000005210421,0.00076090253,0.00003863603,0.00016678285,0.08062908],"study_design_scores_gemma":[0.5331519,0.002202631,0.4633782,0.00045319155,0.00007969506,0.000010749264,0.00018515601,0.00008122865,0.00028808456,0.00005288351,0.000015143123,0.00010112409],"about_ca_topic_score_codex":0.025949636,"about_ca_topic_score_gemma":0.00089159224,"teacher_disagreement_score":0.2022094,"about_ca_system_score_codex":0.0011367833,"about_ca_system_score_gemma":0.001401973,"threshold_uncertainty_score":0.99998313},"labels":[],"label_agreement":null},{"id":"W2967410501","doi":"10.1007/s10549-019-05395-6","title":"Phase II randomized controlled trial of hypnosis versus progressive muscle relaxation for body image after breast or gynecologic cancer","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Pain Management and Placebo Effect","field":"Neuroscience","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Breast Cancer Research Foundation","keywords":"Breast cancer; Hypnosis; Gynecologic cancer; Medicine; Randomized controlled trial; Relaxation (psychology); Mammary gland; Cancer; Muscle relaxation; Gynecology; Oncology; Internal medicine; Ovarian cancer; Pathology; Alternative medicine","score_opus":0.05073080516788391,"score_gpt":0.3935759177609779,"score_spread":0.34284511259309397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2967410501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97680366,0.00042159503,0.000023431541,0.0011474257,0.00041281653,0.019850295,0.0006439402,0.000034306267,0.0006624998],"genre_scores_gemma":[0.9641591,0.0011027906,0.000034373825,0.000028978959,0.00017581052,0.031888902,0.000016376342,0.00002099381,0.002572684],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9965429,0.0014705904,0.00036227636,0.0005750548,0.0005034175,0.00054581865],"domain_scores_gemma":[0.9929727,0.006192098,0.00024474075,0.00025703516,0.00019246702,0.00014100902],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0021544038,0.0002504393,0.0009114591,0.00021464589,0.00025135712,0.00008731997,0.00014728238,0.00007591089,0.0011980796],"category_scores_gemma":[0.0007196628,0.00014393704,0.00026031065,0.0002753844,0.00029603616,0.00020955695,0.000083982544,0.00010346135,0.000014277824],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.943777,0.0022777927,0.00012978003,0.00007225061,0.00030405686,0.00002479184,0.00012458896,0.0000038441553,0.005408566,0.00011168112,0.00014890266,0.047616705],"study_design_scores_gemma":[0.9854695,0.0075042173,0.00040689495,0.000083263854,0.00024767572,0.0000033794956,0.000042941632,0.001970421,0.003640019,0.00007325169,0.00039979015,0.00015861403],"about_ca_topic_score_codex":0.0004132566,"about_ca_topic_score_gemma":0.000106152824,"teacher_disagreement_score":0.047458094,"about_ca_system_score_codex":0.00030534368,"about_ca_system_score_gemma":0.00031112635,"threshold_uncertainty_score":0.999715},"labels":[],"label_agreement":null},{"id":"W2967636994","doi":"10.1007/s10549-019-05391-w","title":"Allelic modification of breast cancer risk in women with an NBN mutation","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Women's College Hospital; University of Toronto","funders":"Narodowe Centrum Nauki","keywords":"Missense mutation; Breast cancer; Genotype; Allele; Penetrance; Genetics; Genotyping; Prostate cancer; Mutation; Biology; Cancer; Oncology; Internal medicine; Medicine; Gene; Phenotype","score_opus":0.02532644674796673,"score_gpt":0.3453704890080137,"score_spread":0.32004404226004696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2967636994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974151,0.0009384599,0.000020570289,0.00045092936,0.00002564992,0.00050543627,0.00052525796,0.0000048201164,0.00011373603],"genre_scores_gemma":[0.99548995,0.0029520595,0.00011589567,0.000016607268,0.000082856146,0.0009984319,0.000069183785,0.000020456308,0.00025458104],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9988257,0.000106319145,0.00014254407,0.00040130384,0.00022557106,0.00029855914],"domain_scores_gemma":[0.999264,0.00001307428,0.00006938001,0.00031119146,0.00023690132,0.000105428],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001911964,0.0001229412,0.00013724114,0.000113724214,0.000059082246,0.000021554835,0.00009145148,0.00006808039,0.000116299656],"category_scores_gemma":[0.0000027035308,0.000095955984,0.000015576874,0.00021049754,0.000118719174,0.000014406074,0.000029924158,0.00007376262,0.00000408932],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011193484,0.0011631056,0.3715244,0.00009738157,0.0005408045,0.000009023189,0.0023313186,0.0065489206,0.0962908,0.000101326885,0.00011243172,0.510087],"study_design_scores_gemma":[0.0034317349,0.0015982651,0.9793404,0.000054448174,0.000016093589,0.00004283632,0.00092830654,0.00038222322,0.013340287,0.00014183273,0.0005578694,0.00016569914],"about_ca_topic_score_codex":0.007904973,"about_ca_topic_score_gemma":0.0042200414,"teacher_disagreement_score":0.60781604,"about_ca_system_score_codex":0.0005368626,"about_ca_system_score_gemma":0.0005204542,"threshold_uncertainty_score":0.99870145},"labels":[],"label_agreement":null},{"id":"W2969401789","doi":"10.1007/s10549-019-05411-9","title":"Germline pathogenic variants in BRCA1, BRCA2, PALB2 and RAD51C in breast cancer women from Argentina","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto; Women's College Hospital","funders":"","keywords":"PALB2; Breast cancer; Germline mutation; Medicine; Oncology; Cancer; Internal medicine; Cancer research; Mutation; Genetics; Biology; Gene","score_opus":0.020517722369330416,"score_gpt":0.32335858894469005,"score_spread":0.30284086657535964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2969401789","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9849672,0.010911529,0.000002222255,0.0016368837,0.00011600521,0.0005920759,0.0016532228,0.000006365617,0.000114496375],"genre_scores_gemma":[0.98271084,0.015163127,0.00006509818,0.00008207881,0.00022727091,0.0009275678,0.00011843161,0.000034383764,0.0006712307],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99790764,0.00014087325,0.00024659798,0.0007816632,0.00025048244,0.0006727194],"domain_scores_gemma":[0.99923104,0.000031022548,0.000051251638,0.0003789176,0.00010151769,0.00020622593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024668445,0.00023305452,0.0002753558,0.00017194664,0.0000740999,0.00005699427,0.00014020101,0.00014273282,0.0005650987],"category_scores_gemma":[0.0000053565404,0.00020441497,0.000036225203,0.00029024648,0.00015999503,0.000014672245,0.00017000892,0.00015644555,0.000014365311],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015852352,0.00053046265,0.7956277,0.00004381426,0.00029799616,0.000060710365,0.0007511567,0.000083552186,0.08742871,0.000030301653,0.00026659443,0.113293774],"study_design_scores_gemma":[0.0048930626,0.00023898791,0.98833364,0.000093229886,0.00001293949,0.000061327264,0.00033960375,0.000112100744,0.0027744342,0.00024134052,0.002651461,0.0002478597],"about_ca_topic_score_codex":0.010658404,"about_ca_topic_score_gemma":0.0075824605,"teacher_disagreement_score":0.19270596,"about_ca_system_score_codex":0.0008240871,"about_ca_system_score_gemma":0.0006124754,"threshold_uncertainty_score":0.9959297},"labels":[],"label_agreement":null},{"id":"W2969950347","doi":"10.1007/s10549-019-05398-3","title":"Pathologic complete response and outcomes by intrinsic subtypes in NSABP B-41, a randomized neoadjuvant trial of chemotherapy with trastuzumab, lapatinib, or the combination","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"National Cancer Institute; Georgetown University; GlaxoSmithKline; Breast Cancer Research Foundation","keywords":"Trastuzumab; Lapatinib; Medicine; Oncology; Internal medicine; Breast cancer; Chemotherapy; Estrogen receptor; Proportional hazards model; Neoadjuvant therapy; Cancer","score_opus":0.05395772915114432,"score_gpt":0.38805740147013806,"score_spread":0.33409967231899373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2969950347","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97920024,0.0009162889,0.0000018474417,0.014301891,0.00003253419,0.005258513,0.0001497249,0.000014242615,0.00012473868],"genre_scores_gemma":[0.9938593,0.003272301,0.00004468132,0.000105745705,0.00002943857,0.0012797274,0.00001560567,0.000025930736,0.0013672556],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.997028,0.0009998176,0.00035252125,0.00040851336,0.0007610387,0.0004501231],"domain_scores_gemma":[0.9973345,0.0018522118,0.00009202467,0.00035307347,0.00021271434,0.00015551779],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022206528,0.00021179594,0.0008719998,0.00023441139,0.00009265019,0.000044836353,0.00010696852,0.00007581419,0.00022505858],"category_scores_gemma":[0.0001408543,0.00008840888,0.000063020394,0.00039477795,0.0006992248,0.00005326151,0.000048811136,0.00027441492,0.000005159356],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.85436326,0.0009699459,0.05395409,0.000065409215,0.00020843635,0.000069090376,0.0012181002,6.9509184e-7,0.0006536144,0.000047522622,0.000108586086,0.088341266],"study_design_scores_gemma":[0.71410155,0.01157973,0.2714373,0.00024216533,0.000041183695,0.000095609605,0.0006569552,0.00008677786,0.0006894336,0.00010867378,0.0008400882,0.00012053054],"about_ca_topic_score_codex":0.00478689,"about_ca_topic_score_gemma":0.0008850228,"teacher_disagreement_score":0.2174832,"about_ca_system_score_codex":0.00045308057,"about_ca_system_score_gemma":0.00065330503,"threshold_uncertainty_score":0.72363776},"labels":[],"label_agreement":null},{"id":"W2970279264","doi":"10.1007/s10549-019-05415-5","title":"Inherited variants in XRCC2 and the risk of breast cancer","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Women's College Hospital; University of Toronto","funders":"Pomorski Uniwersytet Medyczny W Szczecinie; Narodowym Centrum Nauki; Narodowe Centrum Nauki","keywords":"Breast cancer; Mutation; Cancer; Internal medicine; Medicine; Oncology; Genetics; Biology; Gene","score_opus":0.016981846986388757,"score_gpt":0.3111979705399772,"score_spread":0.29421612355358845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2970279264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994749,0.0032126573,0.0000022631145,0.0007375225,0.00003741339,0.00053136225,0.00048328107,0.0000034735679,0.00024302477],"genre_scores_gemma":[0.9890838,0.009886171,0.000026872274,0.000022537775,0.00005849419,0.0002422535,0.000011621158,0.000014149179,0.00065408065],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989188,0.00018446954,0.0001257869,0.00031769896,0.00017595009,0.00027730517],"domain_scores_gemma":[0.9994742,0.000032089567,0.000044797325,0.00026863843,0.000096689095,0.000083563755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033071186,0.000118101525,0.00017816442,0.000055381846,0.000055721554,0.000020697998,0.00009014702,0.00007009459,0.000089261055],"category_scores_gemma":[0.000007946055,0.00007166638,0.000035650864,0.0001324689,0.00019649573,0.000004752273,0.00011952552,0.00008683381,0.0000028049692],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009085782,0.00062057696,0.67375076,0.00009358947,0.00084755174,0.000019970294,0.0005331566,0.000045677283,0.18050471,0.0008647829,0.00019676817,0.1334367],"study_design_scores_gemma":[0.01003742,0.0006171422,0.963909,0.00010682049,0.000041861946,0.000105573556,0.00026317002,0.0002808327,0.023095386,0.00048735258,0.00088572095,0.00016975636],"about_ca_topic_score_codex":0.017338226,"about_ca_topic_score_gemma":0.0030438136,"teacher_disagreement_score":0.2901582,"about_ca_system_score_codex":0.000062146224,"about_ca_system_score_gemma":0.00015219093,"threshold_uncertainty_score":0.9892054},"labels":[],"label_agreement":null},{"id":"W2970913246","doi":"10.1007/s10549-019-05407-5","title":"The microbiome and breast cancer: a review","year":2019,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":137,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia, Okanagan Campus; Kelowna General Hospital","funders":"","keywords":"Microbiome; Breast cancer; Dysbiosis; Human microbiome; Biology; Human Microbiome Project; Cancer; Medicine; Physiology; Bioinformatics; Genetics","score_opus":0.08622918266623122,"score_gpt":0.44636865157781275,"score_spread":0.36013946891158155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2970913246","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001133637,0.99231595,1.4483744e-7,0.002258625,0.000109328925,0.0019240993,0.0031882534,0.0000064041205,0.00008383213],"genre_scores_gemma":[0.000037172325,0.9941056,0.0000055100195,0.00011902777,0.00037004446,0.0010455078,0.00028330446,0.000054131568,0.003979753],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99771523,0.00027615874,0.00033905706,0.00076558656,0.00017313665,0.0007308182],"domain_scores_gemma":[0.998771,0.000053296164,0.00013818668,0.00058974617,0.00017633446,0.00027144072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038425287,0.0004280155,0.00089749537,0.000076373115,0.00043029914,0.0001079043,0.00024903,0.00022602077,0.000055709614],"category_scores_gemma":[0.0000046922128,0.00023670714,0.00019555674,0.0002093294,0.00031600808,0.000003787563,0.00026726504,0.00025780985,0.000032189437],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000061989194,0.000069175585,0.000047570335,0.014172343,0.00042228444,0.0000059055797,0.0000063307484,8.2737355e-9,0.00012625846,0.00001748227,0.0087629035,0.97630775],"study_design_scores_gemma":[0.00042524454,0.00024120219,0.0002579839,0.014195876,0.00029382523,0.0008885319,0.0000064417645,7.911565e-8,0.0000070989618,0.0000029202108,0.98345447,0.00022632873],"about_ca_topic_score_codex":0.0017889584,"about_ca_topic_score_gemma":0.0007552624,"teacher_disagreement_score":0.97608143,"about_ca_system_score_codex":0.00029099477,"about_ca_system_score_gemma":0.0015431884,"threshold_uncertainty_score":0.9652637},"labels":[],"label_agreement":null},{"id":"W2972111131","doi":"10.1007/s10549-019-05418-2","title":"Analysis of incidence, mortality trends, and geographic distribution of breast cancer patients in Canada","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; McGill University","funders":"Fonds de Recherche du Québec - Santé; Social Sciences and Humanities Research Council of Canada; Canadian Dermatology Foundation","keywords":"Breast cancer; Incidence (geometry); Demography; Medicine; Distribution (mathematics); Oncology; Cancer; Gynecology; Internal medicine","score_opus":0.048751547616142914,"score_gpt":0.3703935749754942,"score_spread":0.32164202735935127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972111131","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99440295,0.0013357418,3.5513395e-7,0.00036777,0.000024017962,0.00027333037,0.0035065555,0.0000027909987,0.00008649224],"genre_scores_gemma":[0.99734086,0.0023321856,0.0000023331515,0.000014932454,0.000014787392,0.00007334081,0.00017868933,0.00000544807,0.000037442493],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99827516,0.000058097627,0.00029713113,0.00032589294,0.00070180465,0.00034188907],"domain_scores_gemma":[0.99906,0.00004556523,0.00009907135,0.00021320971,0.0003793124,0.00020284086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018702017,0.00013401355,0.0005022851,0.00037011545,0.00004084663,0.000008703306,0.00005872411,0.000042603748,0.00020560595],"category_scores_gemma":[0.000006203977,0.000101818936,0.00006532117,0.001556406,0.00013575525,0.0000887532,0.00004949819,0.00010394358,2.1121559e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075240014,0.00018007956,0.96259534,0.000061091276,0.0007423652,0.000012463489,0.00004882681,0.00004907435,0.000038569564,0.000023756733,0.00002512039,0.035470884],"study_design_scores_gemma":[0.0016763319,0.00029634297,0.99680436,0.00021785017,0.00036443988,0.000006800983,0.00014034788,0.00029221995,0.000095514304,0.000009903871,0.000021285594,0.00007462074],"about_ca_topic_score_codex":0.99070114,"about_ca_topic_score_gemma":0.9641628,"teacher_disagreement_score":0.035396263,"about_ca_system_score_codex":0.0010832092,"about_ca_system_score_gemma":0.0010128192,"threshold_uncertainty_score":0.41520557},"labels":[],"label_agreement":null},{"id":"W2972898528","doi":"10.1007/s10549-019-05438-y","title":"Mismatch repair protein loss in breast cancer: clinicopathological associations in a large British Columbia cohort","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia Hospital; Vancouver General Hospital; Centre for Advancing Health Outcomes; University of British Columbia","funders":"Canadian Cancer Society","keywords":"Medicine; Breast cancer; Oncology; MSH2; Internal medicine; MSH6; Tamoxifen; Cancer; Tissue microarray; Estrogen receptor; Lynch syndrome; Colorectal cancer; DNA mismatch repair","score_opus":0.034466873272750886,"score_gpt":0.36252316291309694,"score_spread":0.32805628964034605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972898528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903135,0.001474934,1.9819917e-7,0.0024311533,0.000101850914,0.003288073,0.0017767221,0.00005455602,0.0005590165],"genre_scores_gemma":[0.98968077,0.002516296,0.000065523585,0.00010220477,0.0001271946,0.003344241,0.000053073796,0.000033065407,0.004077644],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969964,0.00024660307,0.00042243005,0.0007682953,0.0006672405,0.00089902856],"domain_scores_gemma":[0.99892896,0.00010736638,0.000070017806,0.00033385545,0.00026702977,0.00029274664],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00082486594,0.00017928987,0.00058985705,0.00013205857,0.00011695628,0.00010269704,0.00010316187,0.00021508306,0.0022463738],"category_scores_gemma":[0.00003585662,0.00019760388,0.000103320854,0.0006149314,0.00016477893,0.00007023678,0.00011376503,0.0004783989,0.00003332114],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000635585,0.0014819935,0.98294765,0.00007655847,0.00008201795,0.0005358211,0.00015839086,0.000003399511,0.00022445305,0.000005757898,0.00060896785,0.013239388],"study_design_scores_gemma":[0.0060226717,0.00072579115,0.9911743,0.0005613835,0.000025771162,0.0003184621,0.00013017897,0.00007464059,0.000038917187,0.00010354887,0.000653753,0.00017060274],"about_ca_topic_score_codex":0.23006056,"about_ca_topic_score_gemma":0.3772826,"teacher_disagreement_score":0.14722203,"about_ca_system_score_codex":0.002801479,"about_ca_system_score_gemma":0.0009927258,"threshold_uncertainty_score":0.9986657},"labels":[],"label_agreement":null},{"id":"W2978375464","doi":"10.1007/s10549-019-05430-6","title":"Factors associated with endocrine therapy adherence among post-menopausal women treated for early-stage breast cancer in Ontario, Canada","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; CancerCare Manitoba; Canadian Centre for Applied Research in Cancer Control; University of Toronto; London Health Sciences Centre; Sunnybrook Health Science Centre; Western University","funders":"Academic Medical Organization of Southwestern Ontario","keywords":"Medicine; Breast cancer; Internal medicine; Endocrine system; Odds ratio; Population; Adjuvant therapy; Oncology; Cancer; Proportional hazards model; Survivorship curve; Hormone","score_opus":0.0807307166114365,"score_gpt":0.34417616123083683,"score_spread":0.26344544461940034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2978375464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99511105,0.0002555839,3.9407868e-7,0.0009645928,0.000049191298,0.00209247,0.0011461606,0.00002386012,0.0003567127],"genre_scores_gemma":[0.9656215,0.0002727975,0.0000026366151,0.000090104855,0.00003382023,0.0024265687,0.0001368964,0.00002974233,0.031385966],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99770725,0.00006423474,0.00023222381,0.0005323387,0.00061038986,0.00085358456],"domain_scores_gemma":[0.9985719,0.00012710909,0.00009318234,0.00029355742,0.0004370499,0.00047721347],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013257701,0.00028521512,0.0004674242,0.00013273534,0.000120255405,0.000042384545,0.000119706914,0.00006094227,0.0060713673],"category_scores_gemma":[0.000008255292,0.00018133144,0.000023128057,0.0003397553,0.00013283324,0.000118824915,0.000023774042,0.00025971807,0.0000072175612],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026587173,0.00043852776,0.98711085,0.000026828482,0.00039325294,0.00004757585,0.00055535673,0.000004738319,0.000650322,0.000009324608,0.00015668754,0.007947811],"study_design_scores_gemma":[0.007990743,0.0031917507,0.9863117,0.0003531783,0.000019442306,0.000009712043,0.0006063205,0.000024614203,0.0005304652,0.0000063244674,0.0007755667,0.00018020709],"about_ca_topic_score_codex":0.9847915,"about_ca_topic_score_gemma":0.98561305,"teacher_disagreement_score":0.031029254,"about_ca_system_score_codex":0.004366323,"about_ca_system_score_gemma":0.0041326676,"threshold_uncertainty_score":0.99945575},"labels":[],"label_agreement":null},{"id":"W2980686905","doi":"10.1007/s10549-019-05465-9","title":"The Jacki Jacket after mastectomy with reconstruction: a randomized pilot study","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Implant and Reconstruction","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"DAISY Foundation","keywords":"Medicine; Randomized controlled trial; Physical therapy; Mastectomy; Quality of life (healthcare); Breast cancer; McGill Pain Questionnaire; Surgery; Visual analogue scale; Cancer; Internal medicine","score_opus":0.03609315086142572,"score_gpt":0.3220452240224757,"score_spread":0.28595207316105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980686905","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925882,0.0010550807,0.0000015799417,0.0015951978,0.00019056497,0.003255311,0.00003589616,0.000031109284,0.0012470505],"genre_scores_gemma":[0.9936901,0.0005816145,0.00004634032,0.000008402288,0.00023566553,0.0015038276,0.000004923052,0.000019426323,0.0039097085],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99839824,0.00022440265,0.00019869462,0.00035556624,0.00041311546,0.00040995606],"domain_scores_gemma":[0.9990052,0.00021270197,0.00004880923,0.00029963173,0.00023114149,0.00020251755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046585733,0.00018520933,0.00042788,0.0001257879,0.000265424,0.000095130636,0.00004827461,0.000031517488,0.0004443616],"category_scores_gemma":[0.0000032520575,0.000081530285,0.0000517076,0.00022102497,0.00046437234,0.00008807241,0.000031681997,0.00020315385,0.00006464166],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3402228,0.0006005531,0.19682197,0.000025102068,0.0008738578,0.00007343228,0.00018276107,2.4051232e-7,0.000024962728,0.000043904016,0.00003305266,0.46109733],"study_design_scores_gemma":[0.4825457,0.016433943,0.40166566,0.00052519905,0.00048714344,0.09272771,0.003793006,0.00007734148,0.00024032497,0.00023207488,0.00092991645,0.00034196838],"about_ca_topic_score_codex":0.0015481662,"about_ca_topic_score_gemma":0.0012627179,"teacher_disagreement_score":0.46075538,"about_ca_system_score_codex":0.00022019068,"about_ca_system_score_gemma":0.0002703579,"threshold_uncertainty_score":0.4865448},"labels":[],"label_agreement":null},{"id":"W2981183343","doi":"10.1007/s10549-019-05468-6","title":"Emotional distress and psychosocial needs in patients with breast cancer in British Columbia: younger versus older adults","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer survivorship and care","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; Ottawa Hospital; Spinal Cord Injury BC; University of British Columbia","funders":"BC Cancer Foundation","keywords":"Psychosocial; Breast cancer; Distress; Medicine; Emotional distress; Gerontology; Clinical psychology; Psychiatry; Psychology; Cancer; Anxiety; Internal medicine","score_opus":0.012040421385709715,"score_gpt":0.29484959030170554,"score_spread":0.28280916891599583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981183343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939836,0.0011886695,7.313426e-8,0.001154623,0.00021245534,0.0010489289,0.0021321613,0.000011502877,0.00026794808],"genre_scores_gemma":[0.9972489,0.0010930724,0.0000020015698,0.000033927423,0.00016223051,0.00046889167,0.00011976577,0.00002615995,0.00084508635],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982746,0.000056763514,0.00015976002,0.00044462996,0.0005683725,0.00049587426],"domain_scores_gemma":[0.9992889,0.000038903756,0.000031396823,0.00015894863,0.00023737483,0.000244445],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00008135828,0.00014548913,0.0003038625,0.0001334007,0.00008433605,0.00012183014,0.00004988343,0.0000895068,0.0010886653],"category_scores_gemma":[0.0000021415901,0.00015308171,0.000031945987,0.0004507831,0.00015602526,0.00014901275,0.000040481955,0.00021747762,0.000003990359],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006801325,0.00074474385,0.84467465,0.000095810734,0.00009935563,0.000040610063,0.00065083086,7.833966e-7,0.0000011073333,0.0000041015564,0.0001547112,0.14673194],"study_design_scores_gemma":[0.026350023,0.0007265127,0.9702978,0.0012283241,0.000023691418,0.000030449582,0.0010173715,0.00000676191,0.0000010039643,0.000005966942,0.00016555782,0.00014653149],"about_ca_topic_score_codex":0.42819896,"about_ca_topic_score_gemma":0.7844289,"teacher_disagreement_score":0.35622993,"about_ca_system_score_codex":0.00091218576,"about_ca_system_score_gemma":0.00029058338,"threshold_uncertainty_score":0.99982446},"labels":[],"label_agreement":null},{"id":"W2981583476","doi":"10.1007/s10549-019-05472-w","title":"Untapped “-omics”: the microbial metagenome, estrobolome, and their influence on the development of breast cancer and response to treatment","year":2019,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Sunnybrook Hospital; McMaster University","funders":"","keywords":"Breast cancer; Dysbiosis; Microbiome; Metagenomics; Cancer; Estrogen receptor; Bioinformatics; Biology; Carcinogenesis; Medicine; Computational biology; Internal medicine; Gene; Genetics","score_opus":0.0811881164033844,"score_gpt":0.39412676695489257,"score_spread":0.31293865055150816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981583476","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.39751384,0.59691626,7.518409e-7,0.0011078201,0.000035913956,0.0020102512,0.0023961402,0.0000035403607,0.000015514433],"genre_scores_gemma":[0.032396883,0.9652532,0.000042256317,0.000088776134,0.00010954573,0.0011063135,0.00008583143,0.000047312307,0.00086990756],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997646,0.00043978312,0.0004116885,0.0007571179,0.00015966115,0.00058575114],"domain_scores_gemma":[0.99866617,0.0002098012,0.00015990456,0.00057888095,0.00014374647,0.00024149245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005257378,0.0005237086,0.00083281874,0.00015106291,0.0004251172,0.0000823059,0.0002534269,0.00019045157,0.00002724482],"category_scores_gemma":[0.0000101554815,0.00023928907,0.00012518077,0.00020837475,0.00033899944,0.000004765946,0.0002813582,0.00018958797,0.00000829409],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002421791,0.00027846982,0.0002531661,0.0008122476,0.0012940225,0.0000036587196,0.0008839676,0.0000029551338,0.019880587,0.000030424319,0.00014210845,0.9739966],"study_design_scores_gemma":[0.0015104649,0.001675543,0.015096926,0.001861112,0.00027256558,0.00024403674,0.00027938272,5.6616716e-7,0.002545656,0.0000044914964,0.9760872,0.00042204311],"about_ca_topic_score_codex":0.0012713277,"about_ca_topic_score_gemma":0.0013837214,"teacher_disagreement_score":0.9759451,"about_ca_system_score_codex":0.0005259429,"about_ca_system_score_gemma":0.0022919904,"threshold_uncertainty_score":0.9757925},"labels":[],"label_agreement":null},{"id":"W2984443212","doi":"10.1007/s10549-019-05481-9","title":"Flat epithelial atypia: are we being too aggressive?","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Lesions and Carcinomas","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Misericordia Community Hospital; Covenant Health; University of Alberta","funders":"","keywords":"Medicine; Biopsy; Atypia; Radiology; Lobular carcinoma; Breast cancer; Radiological weapon; Mammography; Ductal carcinoma; Cancer; Pathology; Internal medicine","score_opus":0.05218872426763596,"score_gpt":0.35330258818213955,"score_spread":0.30111386391450357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984443212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9806886,0.0042912676,0.0000011634826,0.011166751,0.0001077388,0.00068245246,0.00021071814,0.00003477383,0.0028165733],"genre_scores_gemma":[0.9855705,0.0038426635,0.000035521756,0.00007774891,0.00037625566,0.00017422292,0.000026339865,0.00002811841,0.009868612],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99836147,0.000060850016,0.00014253947,0.00042593523,0.00045683308,0.00055235694],"domain_scores_gemma":[0.9989727,0.000060336606,0.000055349457,0.0003563636,0.00016999997,0.00038524042],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013229788,0.00018614555,0.0003184214,0.00015532608,0.00019423042,0.000047434525,0.00006726084,0.00008728288,0.00100228],"category_scores_gemma":[0.0000053509084,0.00012335631,0.000069452864,0.00019790289,0.00013015045,0.00007246984,0.000083870626,0.00021254612,0.00024454863],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039563994,0.00072910514,0.4992125,0.0002135151,0.00049885927,0.0012180093,0.00050784386,0.0000022305614,0.008191456,0.0011711329,0.0027712123,0.48152772],"study_design_scores_gemma":[0.0060523874,0.0012751205,0.9563181,0.0007375119,0.000086752596,0.0011982548,0.0005192232,0.00006185839,0.0026074776,0.00030456192,0.030638156,0.00020064486],"about_ca_topic_score_codex":0.0014641623,"about_ca_topic_score_gemma":0.00014372834,"teacher_disagreement_score":0.4813271,"about_ca_system_score_codex":0.00039749005,"about_ca_system_score_gemma":0.00028899888,"threshold_uncertainty_score":0.99991095},"labels":[],"label_agreement":null},{"id":"W2990021777","doi":"10.1007/s10549-019-05499-z","title":"Results of a phase I, non-randomized study evaluating a Magnetic Occult Lesion Localization Instrument (MOLLI) for excision of non-palpable breast lesions","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; Sunnybrook Health Science Centre","funders":"Canadian Cancer Society Research Institute; Sunnybrook Research Institute","keywords":"Medicine; Lesion; Radiology; Occult; Lumpectomy; Mammography; Breast cancer; Radiological weapon; Nuclear medicine; Mastectomy; Surgery; Pathology; Cancer","score_opus":0.06490335096028299,"score_gpt":0.42001249533936846,"score_spread":0.3551091443790855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990021777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99259704,0.0010058188,0.0002719497,0.00023277118,0.00006882458,0.00443291,0.0012622919,0.0000063175485,0.000122094],"genre_scores_gemma":[0.9962438,0.0011117896,0.00040922136,0.0000073878455,0.00008568722,0.0015381237,0.00024697933,0.000030043931,0.00032696623],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99758893,0.0002281909,0.00056829175,0.00066533376,0.0005299256,0.00041932127],"domain_scores_gemma":[0.99826735,0.00017519783,0.00022845047,0.00047263934,0.00072168274,0.00013469407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008500034,0.00028342655,0.00065425347,0.00017105867,0.00020107324,0.000022178423,0.00013494962,0.000092034374,0.000030406984],"category_scores_gemma":[0.000054425396,0.00020383293,0.0001557714,0.0002677816,0.00026375323,0.000013628935,0.00017175186,0.00005885188,0.000002675601],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.45301476,0.012243539,0.023805905,0.0003897166,0.0017556848,0.0000076176743,0.0026540463,0.0006627154,0.14220649,0.000028966624,0.00041303365,0.36281753],"study_design_scores_gemma":[0.80363417,0.037303995,0.06616274,0.0010187686,0.0007639802,0.00007327562,0.004787904,0.007918692,0.07726478,0.0001670635,0.0002727805,0.0006318178],"about_ca_topic_score_codex":0.004576431,"about_ca_topic_score_gemma":0.00044666824,"teacher_disagreement_score":0.36218572,"about_ca_system_score_codex":0.0001843589,"about_ca_system_score_gemma":0.00034506366,"threshold_uncertainty_score":0.83120656},"labels":[],"label_agreement":null},{"id":"W2999894408","doi":"10.1007/s10549-020-05530-8","title":"RE: Mismatch repair protein loss in breast cancer: clinicopathological associations in a large British Columbia cohort","year":2020,"lang":"en","type":"letter","venue":"Breast Cancer Research and Treatment","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Breast cancer; Cohort; Oncology; Medicine; Cohort study; Internal medicine; Cancer","score_opus":0.05282480570235285,"score_gpt":0.36307017271636677,"score_spread":0.3102453670140139,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999894408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5887179,0.0026515436,2.2503998e-7,0.3933923,0.00016607293,0.004527364,0.010121923,0.00010442143,0.00031825947],"genre_scores_gemma":[0.8984572,0.013141632,0.0001516965,0.056275103,0.0031816582,0.018782565,0.0012487532,0.00021104052,0.008550303],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99406713,0.00063625834,0.00081407797,0.0015843402,0.0013727333,0.0015254706],"domain_scores_gemma":[0.9982105,0.00023312314,0.00018446633,0.0005364952,0.0004233956,0.00041204956],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007187749,0.00044040836,0.001369685,0.0002265567,0.00022840056,0.00022899803,0.00023380863,0.00092919695,0.0021041217],"category_scores_gemma":[0.00009913638,0.0005039947,0.00025140005,0.0009671787,0.0003892373,0.00006634752,0.0002405671,0.002848873,0.000025335643],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004856182,0.00072689785,0.7421078,0.00027174345,0.00020578784,0.011333629,0.00014908484,5.9156685e-7,0.000013337594,3.5835978e-7,0.23859449,0.006110664],"study_design_scores_gemma":[0.0052825087,0.0009119298,0.9481869,0.0015810507,0.0001176391,0.0005014081,0.00008272999,0.000028009912,0.000008591927,0.00012201689,0.04277684,0.0004004246],"about_ca_topic_score_codex":0.2647867,"about_ca_topic_score_gemma":0.412468,"teacher_disagreement_score":0.3371172,"about_ca_system_score_codex":0.005787938,"about_ca_system_score_gemma":0.0023888364,"threshold_uncertainty_score":0.9997412},"labels":[],"label_agreement":null},{"id":"W3008249523","doi":"10.1007/s10549-020-05549-x","title":"Adherence trajectories of adjuvant endocrine therapy in the five years after its initiation among women with non-metastatic breast cancer: a cohort study using administrative databases","year":2020,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Michel-Sarrazin; Hôpital du Saint-Sacrement; Université Laval","funders":"Institut National Du Cancer; Université Laval","keywords":"Medicine; Breast cancer; Cohort; Cohort study; Internal medicine; Demography; Cancer; Discontinuation; Hormone therapy; Oncology; Database","score_opus":0.18284200853259894,"score_gpt":0.43526260606799394,"score_spread":0.25242059753539503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3008249523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957039,0.0006385536,0.000006204349,0.000811865,0.000010968676,0.0022019912,0.0005756516,0.0000070885117,0.000043791566],"genre_scores_gemma":[0.9947838,0.0014218882,0.00003103407,0.0000979665,0.00006477278,0.0035122675,0.00001996659,0.000011569653,0.000056729543],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983604,0.0001649078,0.00022074836,0.00034653553,0.000605053,0.00030234535],"domain_scores_gemma":[0.99918425,0.00009441431,0.0000905833,0.00020405871,0.0002398286,0.0001868756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018628115,0.00015746123,0.00033688877,0.00007561638,0.000063971405,0.000025532321,0.00009403228,0.000012415802,0.0005778935],"category_scores_gemma":[0.000012024098,0.00009212387,0.000018097058,0.00051726936,0.00021516807,0.00014715997,0.000023845887,0.00015539872,0.0000043917908],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005172431,0.0010379208,0.96710825,0.00006709398,0.00027959165,0.0003007048,0.010832381,0.000004934674,0.00019494744,0.000004566316,0.000024592102,0.014972577],"study_design_scores_gemma":[0.0037946096,0.0037286335,0.97895557,0.00029602344,0.000051314753,0.00006162056,0.0126265185,0.00013060027,0.00025143198,0.000003696073,0.000018090517,0.000081877704],"about_ca_topic_score_codex":0.008919788,"about_ca_topic_score_gemma":0.0015177353,"teacher_disagreement_score":0.0148907,"about_ca_system_score_codex":0.00021506466,"about_ca_system_score_gemma":0.0007925419,"threshold_uncertainty_score":0.9976799},"labels":[],"label_agreement":null},{"id":"W3014809226","doi":"10.1007/s10549-020-05614-5","title":"Comparison of outcomes in a population-based cohort of metastatic breast cancer patients receiving anti-HER2 therapy with clinical trial outcomes","year":2020,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; Institute for Clinical Evaluative Sciences; Sunnybrook Hospital; Canadian Centre for Applied Research in Cancer Control; Health Sciences Centre; Sunnybrook Health Science Centre; St. Michael's Hospital; Ontario Institute for Cancer Research; University of Toronto","funders":"Ontario Ministry of Health and Long-Term Care; Ontario Institute for Cancer Research","keywords":"Pertuzumab; Medicine; Trastuzumab; Cohort; Internal medicine; Metastatic breast cancer; Population; Breast cancer; Trastuzumab emtansine; Oncology; Randomized controlled trial; Cohort study; Cancer","score_opus":0.23654628794184537,"score_gpt":0.5262910221048149,"score_spread":0.28974473416296953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014809226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894399,0.00049296126,0.0000033767287,0.006042637,0.00006589036,0.0032066985,0.0006861306,0.000018152614,0.000044270815],"genre_scores_gemma":[0.99787825,0.0008733249,0.0001403824,0.00009867099,0.00007770619,0.00077678834,0.00006477954,0.00004562715,0.000044439417],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958377,0.00048928004,0.0009849294,0.0005993797,0.0015182723,0.00057045417],"domain_scores_gemma":[0.9976381,0.00070000696,0.00025339605,0.00036361217,0.0005907527,0.0004541534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072675035,0.0002892644,0.0015753609,0.00028638373,0.00007876298,0.00002738102,0.00016337188,0.00008705129,0.0003391065],"category_scores_gemma":[0.00012362708,0.00018027265,0.00016612995,0.0006997158,0.00032297548,0.00008173849,0.000053161122,0.00038332614,0.0000024673184],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.042126257,0.0047186036,0.9048035,0.00018991577,0.0008422684,0.000018573746,0.0002920482,0.0000491038,0.000023881157,0.0000051171955,0.00005707064,0.046873674],"study_design_scores_gemma":[0.06546339,0.005598538,0.9276864,0.0003432572,0.00009338939,0.000002104573,0.00010712795,0.00029362366,0.00023090822,0.000005191551,0.00004415414,0.00013193044],"about_ca_topic_score_codex":0.035562612,"about_ca_topic_score_gemma":0.0039383937,"teacher_disagreement_score":0.046741743,"about_ca_system_score_codex":0.00059279613,"about_ca_system_score_gemma":0.0013642071,"threshold_uncertainty_score":0.97085965},"labels":[],"label_agreement":null},{"id":"W3015333700","doi":"10.1007/s10549-020-05622-5","title":"Treatment-induced symptoms, depression and age as predictors of sexual problems in premenopausal women with early breast cancer receiving adjuvant endocrine therapy","year":2020,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer survivorship and care","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Canadian Partnership Against Cancer; University of Calgary","funders":"Ipsen Biopharmaceuticals; Pfizer","keywords":"Medicine; Depression (economics); Breast cancer; Sexual dysfunction; Quality of life (healthcare); Sexual function; Randomized controlled trial; Internal medicine; Gynecology; Pediatrics; Cancer","score_opus":0.0437331674938029,"score_gpt":0.32902405227964704,"score_spread":0.28529088478584413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3015333700","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99157816,0.004346983,5.385634e-7,0.0017657551,0.00004303849,0.0016019758,0.00045434543,0.000043864027,0.00016533969],"genre_scores_gemma":[0.9904376,0.007037042,0.000005188998,0.000045887584,0.00023962393,0.0018591435,0.000028021634,0.00005352047,0.000293971],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974812,0.00013704244,0.00028691223,0.0007291752,0.0006333474,0.00073231116],"domain_scores_gemma":[0.99874014,0.00006945062,0.00008340592,0.00027024158,0.0001760761,0.0006606693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011584296,0.00035658176,0.00063156977,0.00017932079,0.00011438183,0.000053701915,0.00008372546,0.00007969478,0.00018532434],"category_scores_gemma":[0.0000051823977,0.00022522821,0.000024459812,0.00045589823,0.00018678677,0.00014954337,0.000068016416,0.00021959768,0.0000014931771],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0106634265,0.00058715366,0.73224765,0.00017682777,0.0005626018,0.00024962646,0.010056936,0.000005856281,0.016038574,0.0000033075335,0.000009543311,0.2293985],"study_design_scores_gemma":[0.012681455,0.016092988,0.9647087,0.00051420165,0.00008501799,0.00023656705,0.0012972881,0.000021768978,0.0038192254,0.0000093151175,0.0003198529,0.00021365711],"about_ca_topic_score_codex":0.08976458,"about_ca_topic_score_gemma":0.014670754,"teacher_disagreement_score":0.23246102,"about_ca_system_score_codex":0.0009846329,"about_ca_system_score_gemma":0.00065408705,"threshold_uncertainty_score":0.918454},"labels":[],"label_agreement":null},{"id":"W3022018269","doi":"10.1007/s10549-020-05664-9","title":"The impact of ductal carcinoma in situ on health services utilization","year":2020,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Sunnybrook Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"Canadian Cancer Society Research Institute","keywords":"Medicine; Ductal carcinoma; Breast cancer; Anxiety; Depression (economics); Population; Comorbidity; Mammography; Cohort; Internal medicine; Cancer; Psychiatry","score_opus":0.23515660022977386,"score_gpt":0.478777041920667,"score_spread":0.24362044169089314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3022018269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9849835,0.0040897173,5.5239417e-7,0.009921756,0.000008447386,0.00039441275,0.000055796456,0.000006157318,0.0005396331],"genre_scores_gemma":[0.9971543,0.0025619986,0.000004123911,0.000117315176,0.00008006512,0.000044397675,0.000013963491,0.000006045005,0.000017783217],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990483,0.00005962408,0.00012965384,0.00017670791,0.0003069486,0.00027874904],"domain_scores_gemma":[0.99948925,0.000042187854,0.000033684057,0.00010998596,0.000102724494,0.0002221429],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013794427,0.00008172402,0.00016580753,0.000048119964,0.000107802305,0.00001897045,0.000048305697,0.000020653819,0.000025043097],"category_scores_gemma":[0.000006036417,0.00004435515,0.00003572061,0.0003104792,0.00006806938,0.000041744916,0.000023731985,0.00008821098,0.0000030939725],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068622623,0.00024411948,0.8137814,0.000119750985,0.00011121088,0.00011597107,0.0022304042,0.00007817527,0.0006837968,0.00020015759,0.00045703317,0.17511575],"study_design_scores_gemma":[0.0015906193,0.004078221,0.99159366,0.0001882826,0.000005282785,0.000041520092,0.0011490922,0.00036947193,0.0007989527,0.000041227566,0.00011021051,0.000033439967],"about_ca_topic_score_codex":0.040126197,"about_ca_topic_score_gemma":0.0038637314,"teacher_disagreement_score":0.17781231,"about_ca_system_score_codex":0.00050865184,"about_ca_system_score_gemma":0.00053367397,"threshold_uncertainty_score":0.9662657},"labels":[],"label_agreement":null},{"id":"W3025381089","doi":"10.1007/s10549-020-05651-0","title":"Association between the polymorphisms in MMP-2 and MMP-9 with adiposity and mammographic features","year":2020,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Canadian Breast Cancer Research Alliance","keywords":"Matrix metalloproteinase; Mammography; Medicine; MAMMOGRAPHIC DENSITY; Breast cancer; Internal medicine; Oncology; Association (psychology); Endocrinology; Cancer; Psychology","score_opus":0.021955365832821424,"score_gpt":0.2822758636719979,"score_spread":0.2603204978391765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3025381089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859659,0.0061594336,0.0000048542383,0.0073602456,0.0000062701656,0.00033126672,0.000102369726,0.000004308124,0.000065349304],"genre_scores_gemma":[0.99710673,0.002324188,0.000020873034,0.000119496195,0.00017003268,0.000108324864,0.00002483579,0.000008509354,0.000116996875],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991977,0.00008346588,0.000062487634,0.00027087957,0.00015717138,0.00022827393],"domain_scores_gemma":[0.9996852,0.000018529456,0.000024879824,0.000089866044,0.000040456096,0.00014104474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001350271,0.0001009195,0.00010365986,0.000031092346,0.00014231385,0.000050403094,0.00004522999,0.00007085225,0.000004411269],"category_scores_gemma":[0.000007387043,0.00006082626,0.000015014926,0.000096459684,0.00008384115,0.000005957776,0.000065384214,0.00010164986,4.4579852e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009574393,0.00008627764,0.9112186,0.000021410377,0.00044326682,0.000020633428,0.0002893756,6.523353e-7,0.05382945,0.00012485479,0.0005374658,0.032470614],"study_design_scores_gemma":[0.0020479548,0.0019137061,0.8806405,0.000039567287,0.00006082437,0.000029250692,0.00007008063,0.0000057925295,0.11313452,0.00024919308,0.0016613582,0.000147242],"about_ca_topic_score_codex":0.0015899884,"about_ca_topic_score_gemma":0.0009028449,"teacher_disagreement_score":0.059305064,"about_ca_system_score_codex":0.0000377843,"about_ca_system_score_gemma":0.00005653008,"threshold_uncertainty_score":0.24804229},"labels":[],"label_agreement":null},{"id":"W3027207030","doi":"10.1007/s10549-020-05691-6","title":"Radiation and/or endocrine therapy? Recurrence and survival outcomes in women over 70 with early breast cancer after breast-conserving surgery","year":2020,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Dalhousie University","funders":"","keywords":"Medicine; Breast cancer; Radiation therapy; Adjuvant therapy; Population; Adjuvant; Oncology; Endocrine system; Internal medicine; Surgery; Cancer; Hormone","score_opus":0.035435332082713884,"score_gpt":0.32430379538192367,"score_spread":0.2888684632992098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027207030","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98092216,0.0086483,0.0000015730732,0.00860555,0.00004369351,0.00048231156,0.0012652224,0.0000150930355,0.00001611069],"genre_scores_gemma":[0.9680644,0.029823335,0.000014286145,0.00023747972,0.00020518854,0.0015145254,0.000025772171,0.00003674919,0.00007823951],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99789983,0.00015112823,0.00021377011,0.0007585574,0.0003069044,0.00066980586],"domain_scores_gemma":[0.9991359,0.000114451585,0.00006458946,0.00021426454,0.00012732414,0.0003434771],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014758047,0.0003584994,0.00045700654,0.00011072029,0.00015640119,0.000092735805,0.00007964625,0.000070175716,0.00009040901],"category_scores_gemma":[0.0000105644995,0.00023691081,0.00004093063,0.00025520174,0.00028033747,0.000036354195,0.0001528237,0.0001257413,0.0000012821048],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01033147,0.00020169574,0.8315681,0.000042345255,0.00044554146,0.00006715156,0.0006448952,0.0000014614963,0.0002797904,0.0000033530357,0.000047380632,0.15636678],"study_design_scores_gemma":[0.0039810725,0.00050554593,0.99384207,0.000106413994,0.000023364093,0.00015609551,0.0002986534,0.0000075485204,0.00035977954,0.000010693884,0.00045119956,0.00025755318],"about_ca_topic_score_codex":0.012706007,"about_ca_topic_score_gemma":0.004535461,"teacher_disagreement_score":0.16227394,"about_ca_system_score_codex":0.00024265276,"about_ca_system_score_gemma":0.00033022955,"threshold_uncertainty_score":0.99386847},"labels":[],"label_agreement":null},{"id":"W3027898627","doi":"10.1007/s10549-020-05665-8","title":"Does oncoplastic surgery increase immediate (30-day) postoperative complications? An analysis of the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) database","year":2020,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Princess Margaret Cancer Centre; Toronto General Hospital; University of Toronto; University Health Network; Women's College Hospital","funders":"","keywords":"Lumpectomy; Medicine; Surgery; Complication; Breast cancer; Breast surgery; Logistic regression; Mastectomy; General surgery; Cancer; Internal medicine","score_opus":0.05566617204129754,"score_gpt":0.3923488447333212,"score_spread":0.3366826726920237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027898627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97503537,0.00025458419,0.0000074909312,0.005269165,0.000024904926,0.00063909014,0.01873316,0.000008997331,0.000027242279],"genre_scores_gemma":[0.99737436,0.00087567855,0.000041625834,0.0000947851,0.00006220319,0.0007274785,0.0007905407,0.000013754179,0.000019564257],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977555,0.00044211486,0.00038524382,0.00054575776,0.0005525787,0.00031878473],"domain_scores_gemma":[0.9981294,0.0003465698,0.0002237524,0.00036113657,0.0006820896,0.00025702573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003830359,0.00021281502,0.00051437446,0.000121258956,0.00021692454,0.000015138066,0.00015767352,0.000035991827,0.000031907104],"category_scores_gemma":[0.00009177498,0.00011774482,0.0001739777,0.0008343372,0.00080375193,0.000012219364,0.00021139135,0.00007720919,7.0673195e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030100134,0.003473822,0.9427318,0.0000579084,0.005276432,0.000015886948,0.00031325727,0.00009350276,0.01123109,0.0003558051,0.00039450583,0.033045992],"study_design_scores_gemma":[0.001200701,0.00075666286,0.9834417,0.000022829945,0.00028814806,0.000004152635,0.0005392663,0.0001101477,0.012459154,0.000013158867,0.0010115477,0.00015254258],"about_ca_topic_score_codex":0.0101654865,"about_ca_topic_score_gemma":0.00530668,"teacher_disagreement_score":0.0407099,"about_ca_system_score_codex":0.00019359765,"about_ca_system_score_gemma":0.00068857265,"threshold_uncertainty_score":0.9964259},"labels":[],"label_agreement":null},{"id":"W3030098331","doi":"10.1007/s10549-020-05715-1","title":"Evolution in the risk of adverse events of adjuvant endocrine therapy in postmenopausal women with early-stage breast cancer","year":2020,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Tamoxifen; Breast cancer; Adverse effect; Internal medicine; Oncology; Odds ratio; Adjuvant therapy; Discontinuation; Cancer; Aromatase inhibitor; Gynecology; Surgery","score_opus":0.022330431814402137,"score_gpt":0.34323868389577206,"score_spread":0.3209082520813699,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3030098331","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4163158,0.5813879,2.4109463e-7,0.000039971645,0.000012475504,0.00097655284,0.0012465493,0.0000016104924,0.000018903747],"genre_scores_gemma":[0.34093294,0.6580997,0.0000034425755,0.0000023037542,0.00004906841,0.00079070433,0.000055833523,0.00002100076,0.00004496768],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9979236,0.00054907106,0.0003154634,0.00043563292,0.00032809487,0.00044810536],"domain_scores_gemma":[0.9992583,0.000042669522,0.0001918498,0.00029985333,0.00008987631,0.000117475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026619836,0.0003097097,0.0007173342,0.00015929808,0.00004750802,0.000004235725,0.00020014487,0.00014955232,0.000020465899],"category_scores_gemma":[0.000004601401,0.00016265541,0.00009182817,0.00042099608,0.00016673992,0.0000061613387,0.00007402716,0.00031898258,0.0000013145997],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066968496,0.0015003682,0.069813006,0.001648942,0.0020191495,0.0002122824,0.000527007,0.000037815,0.00070081843,0.000024256082,0.000013108017,0.9168064],"study_design_scores_gemma":[0.02493132,0.03628974,0.8321278,0.014371312,0.00095633266,0.0009849728,0.0012084938,0.000020678413,0.001353313,0.00006235849,0.086206146,0.0014875382],"about_ca_topic_score_codex":0.011944496,"about_ca_topic_score_gemma":0.00076593243,"teacher_disagreement_score":0.91531885,"about_ca_system_score_codex":0.0003712905,"about_ca_system_score_gemma":0.00080588274,"threshold_uncertainty_score":0.99463505},"labels":[],"label_agreement":null},{"id":"W3030638475","doi":"10.1007/s10549-020-05708-0","title":"Utilization patterns and temporal trends of internal mammary nodal irradiation at a tertiary cancer center","year":2020,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Breast cancer; Mastectomy; Radiation therapy; Internal medicine; Odds ratio; Lymphovascular invasion; Cohort; Logistic regression; Surgery; Cancer; Metastasis","score_opus":0.05093524076706331,"score_gpt":0.3447732734640082,"score_spread":0.2938380326969449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3030638475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893725,0.004121716,0.000061265724,0.0048149126,0.000045336892,0.00019217707,0.001266646,0.00001019513,0.000115280665],"genre_scores_gemma":[0.9927009,0.0062185773,0.00003219106,0.00015811276,0.0002198052,0.00022084937,0.00021699369,0.000018142802,0.00021444898],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989017,0.00006272729,0.00015669326,0.00042192938,0.00019477548,0.00026214172],"domain_scores_gemma":[0.99951833,0.000010310203,0.00005915457,0.00013909534,0.000096937685,0.0001761829],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000043299413,0.00017412142,0.00017480298,0.000070203976,0.00010839326,0.000023560264,0.000072187315,0.000059778715,0.00006980082],"category_scores_gemma":[0.0000034446232,0.00013753721,0.000046168076,0.00010495541,0.00011999184,0.000013445197,0.0002031912,0.00004969595,0.0000010057487],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010734887,0.00016908073,0.85838765,0.000044907454,0.00033568803,0.000010525688,0.00033487356,0.0000026423845,0.0029146357,0.0000111760855,0.0005090672,0.13620624],"study_design_scores_gemma":[0.0027547313,0.0005263049,0.9821727,0.000055309756,0.000034873476,0.00004103937,0.00006983793,0.000075104974,0.011316271,0.000008994414,0.002815854,0.00012897044],"about_ca_topic_score_codex":0.004218875,"about_ca_topic_score_gemma":0.0025178082,"teacher_disagreement_score":0.13607727,"about_ca_system_score_codex":0.0001407032,"about_ca_system_score_gemma":0.00007793309,"threshold_uncertainty_score":0.63777053},"labels":[],"label_agreement":null},{"id":"W3036114328","doi":"10.1007/s10549-020-05745-9","title":"Correction to: Mismatch repair protein loss in breast cancer: clinicopathological associations in a large British Columbia cohort","year":2020,"lang":"en","type":"erratum","venue":"Breast Cancer Research and Treatment","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia Hospital; Vancouver General Hospital; Centre for Advancing Health Outcomes; University of British Columbia","funders":"Breast Cancer Research Foundation","keywords":"Statement (logic); Breast cancer; Medicine; Cohort; Cohort study; Oncology; Internal medicine; Cancer; Family medicine; Political science; Law","score_opus":0.038754213873156834,"score_gpt":0.3650358402279431,"score_spread":0.3262816263547863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036114328","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9528729,0.0055744876,0.0000012711045,0.0110842185,0.007442185,0.0093802195,0.010431866,0.00020112876,0.003011757],"genre_scores_gemma":[0.817397,0.017607272,0.00009215141,0.00047216847,0.0024066526,0.017304048,0.0010248305,0.00016130222,0.14353456],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9948984,0.00045168304,0.000742728,0.0014935952,0.0011807313,0.0012329118],"domain_scores_gemma":[0.9980395,0.00014872105,0.0001610302,0.00042425067,0.00053380174,0.0006926972],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008124376,0.00040187791,0.0012549979,0.0002773922,0.00023594829,0.00021950384,0.00018385082,0.0006781826,0.0013558884],"category_scores_gemma":[0.00020477273,0.00047554105,0.0002116415,0.0013052424,0.00020362981,0.00006121365,0.00023440717,0.0020379755,0.000029090117],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008072,0.001092915,0.65133876,0.00014840835,0.00014191434,0.0012191943,0.00019160933,0.0000024310334,0.000016955151,4.817067e-7,0.32915634,0.01588377],"study_design_scores_gemma":[0.0035338402,0.0014369083,0.96092266,0.0027362565,0.00009499077,0.0004740512,0.00012535806,0.000121136836,0.0000067829865,0.00003218963,0.03016141,0.0003544361],"about_ca_topic_score_codex":0.39539143,"about_ca_topic_score_gemma":0.7431856,"teacher_disagreement_score":0.34779415,"about_ca_system_score_codex":0.007659201,"about_ca_system_score_gemma":0.003567672,"threshold_uncertainty_score":0.9997696},"labels":[],"label_agreement":null},{"id":"W3038504329","doi":"10.1007/s10549-020-05777-1","title":"Genetic and clinical predictors of arthralgia during letrozole or anastrozole therapy in breast cancer patients","year":2020,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"Canadian Institutes of Health Research; Breast Cancer Society of Canada; Cancer Care Ontario","keywords":"Letrozole; Anastrozole; Medicine; Breast cancer; Internal medicine; Exemestane; Oncology; Prospective cohort study; Discontinuation; Aromatase inhibitor; Single-nucleotide polymorphism; Cancer; Tamoxifen; Genotype","score_opus":0.026032971647157902,"score_gpt":0.3378087130746484,"score_spread":0.3117757414274905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3038504329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99470824,0.0038944315,6.0508074e-7,0.0006512432,0.000035414283,0.00040803172,0.00028084472,0.0000052783294,0.000015885666],"genre_scores_gemma":[0.9665851,0.033028442,0.00001558745,0.00003074018,0.00015995589,0.000096432894,0.000020104926,0.000018369601,0.00004526463],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987594,0.00012040573,0.00022496315,0.00038769344,0.00017912591,0.000328401],"domain_scores_gemma":[0.9994514,0.0000164817,0.00004919537,0.00012538402,0.00008569355,0.00027187538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007323366,0.00015344711,0.0002129245,0.000051317234,0.00006940632,0.00001670404,0.000074192336,0.00011429895,0.00003198337],"category_scores_gemma":[0.000006139513,0.00010453123,0.00004897224,0.00014506171,0.0002000291,0.000006349456,0.000085859974,0.00013333063,0.0000011507026],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003833679,0.00042336446,0.9482319,0.000029903815,0.000251711,0.000018569965,0.0000802164,0.000013941394,0.013774792,8.232636e-7,0.00009654917,0.03324459],"study_design_scores_gemma":[0.0051282705,0.0024815234,0.9814261,0.00005146034,0.00001486771,0.000017462266,0.000036306294,0.00003652138,0.010539027,0.0000014290089,0.00016730887,0.000099721634],"about_ca_topic_score_codex":0.00083681854,"about_ca_topic_score_gemma":0.00018839007,"teacher_disagreement_score":0.03319424,"about_ca_system_score_codex":0.000045057528,"about_ca_system_score_gemma":0.0001664655,"threshold_uncertainty_score":0.42626598},"labels":[],"label_agreement":null},{"id":"W3042061226","doi":"10.1007/s10549-020-05781-5","title":"Patient-reported acute fatigue in elderly breast cancer patients treated with and without regional nodal radiation","year":2020,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer survivorship and care","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Breast cancer; Cohort; Prospective cohort study; Radiation therapy; Logistic regression; Internal medicine; Cancer; Cohort study; Univariate analysis; Physical therapy; Multivariate analysis","score_opus":0.04985522990995125,"score_gpt":0.3404472129029514,"score_spread":0.29059198299300015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3042061226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98904485,0.001113611,0.000002125472,0.007984728,0.000030295145,0.0010356734,0.00061320316,0.000035739107,0.00013976237],"genre_scores_gemma":[0.99634683,0.0022396804,0.000010852409,0.00023901025,0.00013396816,0.00066252676,0.00019995419,0.000035044977,0.00013214254],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979961,0.00008095867,0.00024593552,0.0005872719,0.00062388263,0.00046583024],"domain_scores_gemma":[0.9988351,0.000027043265,0.00008158133,0.00016743752,0.00034772145,0.00054113846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005717529,0.00025854804,0.00037614102,0.00016415947,0.00013183504,0.000055184202,0.000040776824,0.000083197236,0.00011665892],"category_scores_gemma":[0.000004347234,0.0001801695,0.00003952671,0.0005049022,0.00017455625,0.00014639755,0.000033855256,0.00020663618,0.0000020055468],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007534461,0.00036322558,0.8182129,0.000047505186,0.00040350898,0.000104767474,0.0015607995,0.000002904195,0.00010475465,0.000006837828,0.00019438703,0.17146394],"study_design_scores_gemma":[0.009996147,0.0031229267,0.9845048,0.00027141615,0.0001615801,0.00017418616,0.00034119704,0.00010786305,0.00029539427,0.0000055398395,0.0008254607,0.00019346185],"about_ca_topic_score_codex":0.038076207,"about_ca_topic_score_gemma":0.010657981,"teacher_disagreement_score":0.17127047,"about_ca_system_score_codex":0.0005866122,"about_ca_system_score_gemma":0.00045070713,"threshold_uncertainty_score":0.9683293},"labels":[],"label_agreement":null},{"id":"W3044249165","doi":"10.1007/s10549-020-05795-z","title":"Differential expression and prognostic relevance of autophagy-related markers ATG4B, GABARAP, and LC3B in breast cancer","year":2020,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Autophagy in Disease and Therapy","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; University of British Columbia; University of British Columbia Hospital; Canada's Michael Smith Genome Sciences Centre","funders":"Canadian Institutes of Health Research","keywords":"Breast cancer; Tissue microarray; Oncology; Immunohistochemistry; Internal medicine; Clinical significance; Autophagy; Cancer; Proportional hazards model; Medicine; Biology; Biomarker; Genetics; Apoptosis","score_opus":0.030517490483007243,"score_gpt":0.3410157086576971,"score_spread":0.31049821817468987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3044249165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9817226,0.012860689,0.0000020516798,0.004116434,0.000029177423,0.0008307911,0.0003388521,0.000025310557,0.000074112104],"genre_scores_gemma":[0.9794145,0.019909583,0.00002562609,0.00006184992,0.00008494602,0.00029740564,0.000018588662,0.000025173304,0.00016231475],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984434,0.000095476964,0.0002420342,0.00047438304,0.0003546736,0.0003900055],"domain_scores_gemma":[0.99912447,0.00010504738,0.000056393576,0.00015288824,0.00009614377,0.0004650694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000071950206,0.00021048138,0.00038958006,0.00011839795,0.00009725415,0.000024603667,0.000050416103,0.000088509136,0.00043133437],"category_scores_gemma":[0.000014023032,0.00015056005,0.000042188818,0.00025186047,0.0003212437,0.00008820767,0.00007354856,0.00019483035,0.0000018276044],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014562747,0.0011050948,0.697817,0.0006232727,0.0005814923,0.00043171475,0.0015819191,0.0000054356824,0.04345562,0.000097843316,0.00026586908,0.23947197],"study_design_scores_gemma":[0.00819656,0.00079286454,0.98206145,0.0008112366,0.00008819479,0.00010817433,0.00015005209,0.00068860105,0.0067427857,0.00012776005,0.000096685944,0.0001356453],"about_ca_topic_score_codex":0.0014303112,"about_ca_topic_score_gemma":0.00006857244,"teacher_disagreement_score":0.28424442,"about_ca_system_score_codex":0.00013665068,"about_ca_system_score_gemma":0.00022700257,"threshold_uncertainty_score":0.6139661},"labels":[],"label_agreement":null},{"id":"W3044842013","doi":"10.1007/s10549-020-05812-1","title":"Variation in the UGT2B17 genotype, exemestane metabolism and menopause-related toxicities in the CCTG MAP.3 trial","year":2020,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Menopause: Health Impacts and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Cancer Society; Queen's University; Université de Montréal","funders":"National Institute of Environmental Health Sciences; National Cancer Institute; Foundation for the National Institutes of Health","keywords":"Exemestane; Internal medicine; Placebo; Medicine; Joint pain; Relative risk; Menopause; Confounding; Hot flash; Breast cancer; Endocrinology; Oncology; Confidence interval; Cancer; Aromatase","score_opus":0.09674133608062481,"score_gpt":0.39016974227250945,"score_spread":0.29342840619188465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3044842013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94499636,0.007970562,8.86456e-7,0.043549635,0.000053694264,0.0027978155,0.00009600643,0.000013663981,0.0005213906],"genre_scores_gemma":[0.99397904,0.0041695083,0.000024282375,0.0006788224,0.00020547087,0.0006963948,0.000030756382,0.000016621783,0.00019911063],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99787223,0.00044247997,0.00029852384,0.00033136248,0.0005519655,0.0005034373],"domain_scores_gemma":[0.9991862,0.00023313765,0.00005222,0.00023041913,0.00006256937,0.0002354339],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007341985,0.00019004785,0.000330192,0.00013415549,0.00020447874,0.000087579436,0.0000927826,0.00007296486,0.00010132275],"category_scores_gemma":[0.000040832987,0.000091572234,0.000010923112,0.00043666066,0.00011806188,0.00009433858,0.000031911353,0.00027551834,0.000011026976],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3902596,0.01363275,0.037791096,0.0013871813,0.0031047482,0.0052474155,0.20561656,0.000026914935,0.00925135,0.022139069,0.0036638358,0.30787948],"study_design_scores_gemma":[0.1529157,0.015907379,0.8177185,0.00018895061,0.00033908305,0.00028089085,0.0020755948,0.00013348226,0.00008281862,0.0019858277,0.008148632,0.00022310909],"about_ca_topic_score_codex":0.009317587,"about_ca_topic_score_gemma":0.0011775191,"teacher_disagreement_score":0.77992743,"about_ca_system_score_codex":0.00023340792,"about_ca_system_score_gemma":0.00032161694,"threshold_uncertainty_score":0.99727947},"labels":[],"label_agreement":null},{"id":"W3048905405","doi":"10.1007/s10549-020-05782-4","title":"Treatment effect of palbociclib plus endocrine therapy by prognostic and intrinsic subtype and biomarker analysis in patients with bone-only disease: a joint analysis of PALOMA-2 and PALOMA-3 clinical trials","year":2020,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Pfizer","keywords":"Palbociclib; Internal medicine; Oncology; Medicine; Breast cancer; Hazard ratio; Progression-free survival; Placebo; Population; Biomarker; Cancer; Gastroenterology; Metastatic breast cancer; Confidence interval; Biology; Chemotherapy; Pathology","score_opus":0.09056274542627094,"score_gpt":0.4249490110503013,"score_spread":0.3343862656240304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048905405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97313476,0.022314733,0.000011404952,0.0012672576,0.000007958247,0.0021776615,0.0010670881,0.000014521315,0.0000046451405],"genre_scores_gemma":[0.98605734,0.013207334,0.000052144802,0.000028104767,0.000032527303,0.00037748477,0.00019879329,0.000028022652,0.000018270033],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99666184,0.0008094228,0.00078742846,0.00078338454,0.00053255365,0.00042534614],"domain_scores_gemma":[0.99748963,0.0010081826,0.00030196004,0.00030935832,0.0002120646,0.00067877385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006324627,0.00039148878,0.0023186367,0.0006288255,0.00007142277,0.000031810643,0.000044556364,0.00006763188,0.00004277963],"category_scores_gemma":[0.00014757928,0.00022142616,0.00022735339,0.0016232994,0.0006301384,0.00008500758,0.00006223249,0.0001253166,2.1082464e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03829015,0.0006537075,0.6438346,0.00009864701,0.010480312,0.000058327572,0.00023008333,0.0000027361662,0.00012237777,0.0000042091033,0.0000022280888,0.30622262],"study_design_scores_gemma":[0.03252613,0.010078354,0.9503384,0.00011428293,0.0060072197,0.000009304191,0.00006642728,0.00035586057,0.0002611518,0.000008992843,0.00007521734,0.00015865183],"about_ca_topic_score_codex":0.0020155276,"about_ca_topic_score_gemma":0.000539209,"teacher_disagreement_score":0.3065038,"about_ca_system_score_codex":0.00023380537,"about_ca_system_score_gemma":0.00027974052,"threshold_uncertainty_score":0.9029497},"labels":[],"label_agreement":null},{"id":"W3057932598","doi":"10.1007/s10549-020-05872-3","title":"Association of RAD51C germline mutations with breast cancer among Bahamians","year":2020,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Women's College Hospital; University of Toronto","funders":"Canadian Cancer Society Research Institute","keywords":"Breast cancer; Germline; Germline mutation; Oncology; Genetics; Medicine; Internal medicine; Mutation; Biology; Cancer; Cancer research; Gene","score_opus":0.025600441470279317,"score_gpt":0.33046631461336157,"score_spread":0.3048658731430822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3057932598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98378134,0.0009897758,0.00009602138,0.012383277,0.000037152804,0.00042719627,0.0019963384,0.000012381567,0.0002764977],"genre_scores_gemma":[0.99612075,0.0017412143,0.00019107941,0.00008536677,0.00033521448,0.00048372088,0.00013359023,0.000026836382,0.00088224764],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987515,0.000077368895,0.00016092304,0.00037647388,0.00032572256,0.00030796186],"domain_scores_gemma":[0.9990693,0.000026697147,0.00009171043,0.00017452582,0.0004541283,0.00018369358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010476303,0.00014452162,0.00016513358,0.00005543625,0.00013945226,0.00003121674,0.00009329984,0.00008534789,0.00016509819],"category_scores_gemma":[0.0000125181,0.00011334558,0.000043694803,0.00028335128,0.00018357637,0.000010825033,0.000049687096,0.00009338095,0.000003129489],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020304692,0.0005297417,0.83152074,0.00010935995,0.0020310963,0.000021077154,0.0014300488,0.0014773803,0.094081156,0.000063778854,0.004622047,0.06208313],"study_design_scores_gemma":[0.004715447,0.0013369386,0.90543365,0.00009385367,0.00018594718,0.00005389982,0.00053340226,0.0003401922,0.07812412,0.000041520114,0.008793664,0.0003473696],"about_ca_topic_score_codex":0.0023558915,"about_ca_topic_score_gemma":0.0038801685,"teacher_disagreement_score":0.073912926,"about_ca_system_score_codex":0.00042782837,"about_ca_system_score_gemma":0.0006373639,"threshold_uncertainty_score":0.46220988},"labels":[],"label_agreement":null},{"id":"W3080238326","doi":"10.1007/s10549-020-05895-w","title":"Screening women at high risk for breast cancer: one program fits all?","year":2020,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Breast cancer; Medicine; Mammography; Hazard ratio; Cohort; Incidence (geometry); Radiation therapy; Internal medicine; Gynecology; Cohort study; Breast cancer screening; Oncology; Cancer; Obstetrics; Confidence interval","score_opus":0.06363138168320369,"score_gpt":0.3704795236405841,"score_spread":0.3068481419573804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3080238326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97375345,0.0034961782,0.00012438686,0.013798169,0.00006460217,0.0015967741,0.0070587834,0.000040920855,0.000066705594],"genre_scores_gemma":[0.9820004,0.006681788,0.0014437019,0.00024985254,0.00092485856,0.0074794823,0.0002504752,0.000054234824,0.00091518497],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99804616,0.00007894404,0.00017468193,0.0006963836,0.0002930087,0.0007108413],"domain_scores_gemma":[0.9989439,0.000030163053,0.00006908102,0.00026749322,0.0002536209,0.00043572971],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016030391,0.00021837017,0.00021820179,0.00004911097,0.0003428304,0.000073108065,0.00016549874,0.00011022424,0.0002235877],"category_scores_gemma":[0.000013138591,0.0001873212,0.000070019676,0.00018518938,0.00018032886,0.000008335956,0.00019210266,0.000108310895,0.000006725849],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004185779,0.0003885318,0.01929486,0.00007775521,0.0012276815,0.0000067419505,0.00047290523,0.0002300893,0.0114011895,0.000024992623,0.005218446,0.957471],"study_design_scores_gemma":[0.021354226,0.011804834,0.3937127,0.00019171947,0.00037353582,0.00016749253,0.00092121516,0.0011623048,0.09812964,0.00034443004,0.47039577,0.0014421494],"about_ca_topic_score_codex":0.0020162375,"about_ca_topic_score_gemma":0.0012733784,"teacher_disagreement_score":0.9560289,"about_ca_system_score_codex":0.0007313009,"about_ca_system_score_gemma":0.00041764876,"threshold_uncertainty_score":0.7638737},"labels":[],"label_agreement":null},{"id":"W3080892362","doi":"10.1007/s10549-020-05824-x","title":"Exercise training affects hemodynamics not cardiac function during anthracycline-based chemotherapy","year":2020,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; BC Cancer Agency; University of British Columbia; University of Alberta","funders":"BC Cancer Agency; American College of Sports Medicine","keywords":"Medicine; Anthracycline; Hemodynamics; Ejection fraction; Cardiac function curve; Cardiotoxicity; Internal medicine; Cardiology; Aerobic exercise; Cardiac output; Chemotherapy; Hematocrit; Vascular resistance; Breast cancer; Cancer; Heart failure","score_opus":0.06899440469397268,"score_gpt":0.3441263598031645,"score_spread":0.27513195510919186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3080892362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98649836,0.0007948029,0.00007196123,0.011172026,0.00006120913,0.0010004138,0.00010486646,0.00009061148,0.00020577687],"genre_scores_gemma":[0.99569374,0.0027319784,0.0000987356,0.0003937596,0.00055538554,0.00027655793,0.0000637501,0.0000430145,0.0001431024],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99850994,0.00005591055,0.00013420075,0.0004407341,0.00044233215,0.0004168754],"domain_scores_gemma":[0.99918914,0.00005402491,0.000037110316,0.00019076579,0.00011402625,0.00041495476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014501513,0.0002014781,0.00039086273,0.0001037234,0.00022547379,0.00004813733,0.00003980064,0.00010017984,0.00007422119],"category_scores_gemma":[0.000008972591,0.00016916,0.00014129198,0.00029899125,0.00011559503,0.0000857944,0.000014471017,0.00021048459,0.000007427161],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0074815513,0.00031042247,0.004653499,0.00024517011,0.00037877745,0.000054227872,0.0012349825,0.000054328142,0.58141303,0.0000266148,0.00007328261,0.40407407],"study_design_scores_gemma":[0.0155239375,0.0019795527,0.17195572,0.0006047937,0.0001959672,0.00004659694,0.00077697414,0.0022175899,0.8049546,0.000035578745,0.0013802714,0.00032841976],"about_ca_topic_score_codex":0.00025515075,"about_ca_topic_score_gemma":0.000023008848,"teacher_disagreement_score":0.40374568,"about_ca_system_score_codex":0.0004345154,"about_ca_system_score_gemma":0.0003063307,"threshold_uncertainty_score":0.68981445},"labels":[],"label_agreement":null},{"id":"W3083495364","doi":"10.1007/s10549-020-05893-y","title":"Lobular neoplasia occult on conventional imaging and diagnosed on MRI-guided biopsy: can we estimate upgrade on surgical pathology?","year":2020,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"MRI in cancer diagnosis","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Sinai Health System; Women's College Hospital; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Malignancy; Biopsy; Lesion; Radiology; Surgical pathology; Occult; Breast MRI; Cohort; Breast cancer; Pathology; Cancer; Mammography; Internal medicine","score_opus":0.07666782838208683,"score_gpt":0.3949243611034412,"score_spread":0.31825653272135435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083495364","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7708869,0.0015740211,0.00000232008,0.22505756,0.000086116816,0.0009392789,0.0007693993,0.000065491135,0.0006188976],"genre_scores_gemma":[0.98748815,0.009770544,0.000101810845,0.0011570714,0.0004018322,0.00074830785,0.0001091087,0.000043481625,0.00017970164],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974663,0.00015791428,0.0002377728,0.0008216101,0.0006949367,0.0006214178],"domain_scores_gemma":[0.9983637,0.0004112418,0.000053848715,0.00027376827,0.0001249366,0.000772517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017799294,0.00031326554,0.00043470974,0.00018850408,0.00023397719,0.000068878995,0.00008080576,0.00008446997,0.00040119936],"category_scores_gemma":[0.000035276702,0.00023186851,0.00008741768,0.00026421703,0.00035851946,0.000039121976,0.00006185809,0.00034001903,0.000059125785],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014483488,0.0037622417,0.7256731,0.0004465571,0.0009112503,0.034632877,0.0012399529,0.00014432333,0.0006630621,0.0037634012,0.05571543,0.15856431],"study_design_scores_gemma":[0.046285436,0.013116444,0.8577386,0.002802088,0.00038521583,0.0047591995,0.0005218617,0.001766298,0.00859947,0.00072394055,0.062375043,0.00092636194],"about_ca_topic_score_codex":0.001252031,"about_ca_topic_score_gemma":0.000100517806,"teacher_disagreement_score":0.22390048,"about_ca_system_score_codex":0.0006398486,"about_ca_system_score_gemma":0.0003125729,"threshold_uncertainty_score":0.9455324},"labels":[],"label_agreement":null},{"id":"W3086503545","doi":"10.1007/s10549-020-05887-w","title":"Anthracycline-induced cardiotoxicity in patients with early-stage breast cancer: the Canadian Cancer Trials Group (CCTG) MA.21 experience","year":2020,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; Queen's University; McMaster University; Health Sciences Centre; Saint John Regional Hospital; Thunder Bay Regional Health Sciences Centre; University of Ottawa","funders":"Division of Cancer Epidemiology and Genetics, National Cancer Institute; Canadian Cancer Society Research Institute; Canadian Institutes of Health Research","keywords":"Epirubicin; Medicine; Anthracycline; Cardiotoxicity; Breast cancer; Internal medicine; Cyclophosphamide; Ejection fraction; Dexrazoxane; Myocardial infarction; Chemotherapy; Cancer; Gastroenterology; Heart failure; Cardiology","score_opus":0.10018511868532987,"score_gpt":0.38330665242018985,"score_spread":0.28312153373486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3086503545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.977863,0.00080201076,0.000003268731,0.01653409,0.00009104526,0.0027296308,0.0017763479,0.00003240903,0.00016820428],"genre_scores_gemma":[0.99463046,0.002138044,0.000017031685,0.000594858,0.00059728214,0.0018022143,0.000052838546,0.00004954106,0.00011773035],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966453,0.00036511518,0.00041211347,0.00073836715,0.00095428224,0.0008848602],"domain_scores_gemma":[0.99803793,0.00012605281,0.00012278567,0.00039932292,0.00035111574,0.00096277986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052906084,0.0003614792,0.0008101447,0.00018785486,0.0005001094,0.00012393344,0.00016398585,0.00016500406,0.00031405524],"category_scores_gemma":[0.000038575075,0.00022295727,0.00014353613,0.00076317874,0.0003128801,0.0002054962,0.00004797196,0.000490329,0.0000053247477],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006953767,0.0004359853,0.8630637,0.000084111765,0.00073183625,0.0001373534,0.004441217,0.000030353609,0.007907109,0.000045678415,0.00014145169,0.11602743],"study_design_scores_gemma":[0.0096989125,0.0008631169,0.9692816,0.0003079595,0.00009678822,0.000023134373,0.0005957279,0.00005346169,0.01725292,0.0000065320705,0.0015576042,0.00026223663],"about_ca_topic_score_codex":0.65981686,"about_ca_topic_score_gemma":0.49449962,"teacher_disagreement_score":0.16531725,"about_ca_system_score_codex":0.0024428582,"about_ca_system_score_gemma":0.0017210708,"threshold_uncertainty_score":0.90919334},"labels":[],"label_agreement":null},{"id":"W3090280703","doi":"10.1007/s10549-020-05894-x","title":"Impact of wait time from neoadjuvant chemotherapy to surgery in breast cancer: Does time to surgery affect patient outcomes?","year":2020,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Mastectomy; Surgery; Chemotherapy; Breast-conserving surgery; Neoadjuvant therapy; Confidence interval; Breast surgery; Cancer; Internal medicine","score_opus":0.02509337863301482,"score_gpt":0.32978626020928975,"score_spread":0.30469288157627494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3090280703","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9724417,0.0012720458,0.0000017250742,0.018893862,0.00005156738,0.0008511931,0.0064346907,0.00002015698,0.00003310982],"genre_scores_gemma":[0.9962864,0.0017448263,0.000032536034,0.00048704457,0.00023979747,0.0008150529,0.00019451712,0.00006217616,0.00013765944],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99726325,0.0001780243,0.00040263816,0.0008994008,0.00044951023,0.0008071555],"domain_scores_gemma":[0.99838895,0.00024256198,0.00010036807,0.00041847816,0.00021584106,0.00063378416],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016856637,0.0004627408,0.0009010384,0.00021915877,0.000104964005,0.000043883323,0.0001574451,0.000111976915,0.00080760475],"category_scores_gemma":[0.000032468415,0.00030293028,0.00031366033,0.00048414932,0.00011948514,0.0000144822025,0.00021140491,0.000100383295,0.00008181686],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060711824,0.0007527883,0.80350757,0.000022909067,0.0013218271,0.000046663612,0.0004818343,0.0000757374,0.021850983,3.281771e-7,0.010138147,0.15573004],"study_design_scores_gemma":[0.0014956495,0.00069561374,0.9839902,0.00016910411,0.0000368532,0.000013424089,0.000045741428,0.000013627977,0.012101708,0.0000062195227,0.0010959852,0.00033586763],"about_ca_topic_score_codex":0.031011961,"about_ca_topic_score_gemma":0.0011350614,"teacher_disagreement_score":0.18048264,"about_ca_system_score_codex":0.00064306037,"about_ca_system_score_gemma":0.0006149409,"threshold_uncertainty_score":0.9999423},"labels":[],"label_agreement":null},{"id":"W3093031070","doi":"10.1007/s10549-020-05960-4","title":"A population-based comparison of treatment patterns, resource utilization, and costs by cancer stage for Ontario patients with hormone receptor-positive/HER2-negative breast cancer","year":2020,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Roche (Canada); University of Toronto; Sunnybrook Health Science Centre; Mount Sinai Hospital","funders":"F. Hoffmann-La Roche","keywords":"Medicine; Breast cancer; Lumpectomy; Population; Cancer; Cohort; Internal medicine; Stage (stratigraphy); Cancer registry; Health care; Oncology; Gynecology; Mastectomy; Environmental health","score_opus":0.05523799174352821,"score_gpt":0.3646883773413735,"score_spread":0.30945038559784527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093031070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97030056,0.003371958,0.00016404425,0.004537173,0.000022595344,0.0031428442,0.018402893,0.000038299528,0.000019649362],"genre_scores_gemma":[0.9945652,0.0010658118,0.00023241877,0.00017356046,0.000113774026,0.0022750949,0.0011285843,0.00007488145,0.00037070806],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976145,0.00011208339,0.00037417252,0.00075472385,0.00058101787,0.0005634792],"domain_scores_gemma":[0.9980905,0.00018593999,0.00022850244,0.0002378949,0.00072336267,0.0005338113],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00006829327,0.00043105843,0.0007491619,0.00012108755,0.00028862292,0.00004626133,0.00007696471,0.00009368711,0.0002961806],"category_scores_gemma":[0.000008156402,0.00030940564,0.000067635505,0.0003105329,0.00025048124,0.00014709895,0.00003408635,0.00015652087,7.480776e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02116931,0.0009788965,0.79873073,0.00011738545,0.0007367827,0.0000025726708,0.0021039033,0.00010965962,0.00019145284,0.0000099429835,0.00019753736,0.17565185],"study_design_scores_gemma":[0.019675862,0.0060832966,0.96507,0.00061965873,0.00023177337,0.000003474991,0.0006864874,0.00029127678,0.0029241194,0.000004030538,0.004116623,0.00029338934],"about_ca_topic_score_codex":0.3321175,"about_ca_topic_score_gemma":0.101124205,"teacher_disagreement_score":0.23099329,"about_ca_system_score_codex":0.004668796,"about_ca_system_score_gemma":0.0009085428,"threshold_uncertainty_score":0.9999358},"labels":[],"label_agreement":null},{"id":"W3093782821","doi":"10.1007/s10549-020-05976-w","title":"A population-based comparison of treatment, resource utilization, and costs by cancer stage for Ontario patients with HER2-positive breast cancer","year":2020,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Roche (Canada); University of Toronto; Sunnybrook Health Science Centre; Mount Sinai Hospital","funders":"F. Hoffmann-La Roche","keywords":"Medicine; Lumpectomy; Breast cancer; Trastuzumab; Stage (stratigraphy); Population; Internal medicine; Cancer; Oncology; Cancer registry; Health care; Gynecology; Mastectomy; Environmental health","score_opus":0.10140654018881648,"score_gpt":0.41887150982277555,"score_spread":0.3174649696339591,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093782821","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9719744,0.0030939498,0.000033483026,0.0069977553,0.000023120101,0.0038043587,0.013907712,0.000032455282,0.00013279087],"genre_scores_gemma":[0.9943779,0.0008337584,0.00008405651,0.00016387875,0.00011222411,0.0023789424,0.000968012,0.00006934037,0.001011888],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972763,0.00014005051,0.00035734475,0.0007579986,0.0007953461,0.0006729287],"domain_scores_gemma":[0.9978002,0.00020946046,0.00014161879,0.00026987956,0.00084835483,0.000730527],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012202547,0.0003536604,0.00068318995,0.00015536645,0.00030815857,0.00006928559,0.00009312221,0.00010579575,0.00051070977],"category_scores_gemma":[0.000014693021,0.0002522041,0.000066313165,0.00044155077,0.00028941073,0.000098295015,0.000043768083,0.0001952122,0.000001264846],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011225669,0.0011493519,0.87900263,0.00021661888,0.0005167203,0.0000063463717,0.001321559,0.000069972586,0.000088357505,0.00001663808,0.0014527504,0.1049334],"study_design_scores_gemma":[0.015136072,0.0075263954,0.95882446,0.0007134931,0.00022848946,0.000004520067,0.0003532287,0.0009875726,0.001964573,0.0000029757582,0.013996995,0.00026125307],"about_ca_topic_score_codex":0.44794068,"about_ca_topic_score_gemma":0.19313402,"teacher_disagreement_score":0.25480664,"about_ca_system_score_codex":0.005269216,"about_ca_system_score_gemma":0.0022114955,"threshold_uncertainty_score":0.999993},"labels":[],"label_agreement":null},{"id":"W3095266796","doi":"10.1007/s10549-020-06008-3","title":"COVID-19 and breast cancer at a Regional Breast Centre: our flexible approach during the pandemic","year":2020,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Providence Health Care; St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Breast cancer; Pandemic; Breast surgery; Cancer; General surgery; Coronavirus disease 2019 (COVID-19); Surgery; Internal medicine; Disease; Infectious disease (medical specialty)","score_opus":0.22772182194845397,"score_gpt":0.4578214901620437,"score_spread":0.23009966821358974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095266796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.62046117,0.006765692,0.000006147265,0.36954257,0.000036788184,0.0014027201,0.0015471389,0.000107573156,0.0001301987],"genre_scores_gemma":[0.97898084,0.012917635,0.000017089304,0.0045628133,0.0009130088,0.0003877392,0.00005160189,0.00004323317,0.0021260546],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99707085,0.00016796235,0.00025339003,0.00076673063,0.000779633,0.0009614388],"domain_scores_gemma":[0.99661857,0.0001303825,0.00007029248,0.0003339793,0.00020767002,0.0026391072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028286016,0.00032250935,0.00043802816,0.00013468761,0.00084289256,0.000085587395,0.00012528316,0.00011867683,0.0003334702],"category_scores_gemma":[0.00003889509,0.000197727,0.00009076006,0.00046681074,0.0002702226,0.000103700084,0.00020842745,0.0003969845,0.000016914328],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012263002,0.0004926434,0.9139368,0.0015132597,0.00053394097,0.00022757829,0.0038033377,0.000026152287,0.00084122707,0.00011464286,0.008503242,0.05774416],"study_design_scores_gemma":[0.00834823,0.00037944774,0.9621021,0.00021435822,0.000121433295,0.005493089,0.0016603009,0.00021863585,0.00006263555,0.00004368767,0.021109138,0.00024694673],"about_ca_topic_score_codex":0.032921903,"about_ca_topic_score_gemma":0.0040253713,"teacher_disagreement_score":0.36497974,"about_ca_system_score_codex":0.003109262,"about_ca_system_score_gemma":0.002967225,"threshold_uncertainty_score":0.97351795},"labels":[],"label_agreement":null},{"id":"W3095303989","doi":"10.1007/s10549-020-05989-5","title":"Response to neoadjuvant chemotherapy and the 21-gene Breast Recurrence Score test in young women with estrogen receptor-positive early breast cancer","year":2020,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Breast cancer; Medicine; Internal medicine; Estrogen receptor; Oncology; Chemotherapy; Cancer; Logistic regression; Stage (stratigraphy); Estrogen; Cohort; Pathological; Prospective cohort study; Gynecology; Gastroenterology; Biology","score_opus":0.017519189565547936,"score_gpt":0.2950526082072244,"score_spread":0.27753341864167647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095303989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9500155,0.003015055,0.0000055935147,0.042254377,0.000032270218,0.0012212698,0.0033938591,0.000017577895,0.000044511427],"genre_scores_gemma":[0.9910218,0.0053453273,0.00007689425,0.0004345074,0.0002925069,0.0025948728,0.00003926268,0.000056448196,0.00013836131],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99716777,0.00028407286,0.00024239797,0.0010025215,0.00042807922,0.0008751688],"domain_scores_gemma":[0.99859166,0.000131483,0.00007719929,0.00036707544,0.0002985786,0.00053401],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003519479,0.00044773135,0.00045419278,0.00009593535,0.00033765248,0.00012360679,0.00023122395,0.000097615106,0.000051601128],"category_scores_gemma":[0.000024665182,0.00028193905,0.000049599283,0.00052243756,0.00070237025,0.000022784114,0.00022870493,0.00019750537,0.000007853942],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15294287,0.00062067667,0.68754566,0.00003442575,0.0010335575,0.00006719215,0.007832907,0.000023690682,0.034487158,0.000027691638,0.00038715152,0.11499701],"study_design_scores_gemma":[0.011521112,0.0022170274,0.9756765,0.00020862128,0.000039927956,0.0004437129,0.0008872738,0.000008676853,0.008107249,0.000016127067,0.00050606753,0.00036775216],"about_ca_topic_score_codex":0.010233722,"about_ca_topic_score_gemma":0.002171256,"teacher_disagreement_score":0.28813076,"about_ca_system_score_codex":0.0005933853,"about_ca_system_score_gemma":0.0005040779,"threshold_uncertainty_score":0.9999633},"labels":[],"label_agreement":null},{"id":"W3095982111","doi":"10.1007/s10549-020-05965-z","title":"Canada follows the US in the rise of bilateral mastectomies for unilateral breast cancer: a 23-year population cohort study","year":2020,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Clinical Evaluative Sciences; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Breast cancer; Mastectomy; Cancer registry; Cohort; Population; Cancer; Odds ratio; Retrospective cohort study; Surgery; Internal medicine","score_opus":0.028412639469136563,"score_gpt":0.32066533674966496,"score_spread":0.2922526972805284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095982111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9846365,0.0012229646,0.000001227665,0.0102268625,0.000046451198,0.0019390521,0.0018896475,0.0000046014366,0.000032725515],"genre_scores_gemma":[0.9967043,0.0006081258,0.000008058624,0.00012290636,0.00021135123,0.0021624018,0.00008067859,0.00002108844,0.000081128586],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983333,0.000230297,0.00022690388,0.0004376025,0.0003663853,0.0004055386],"domain_scores_gemma":[0.9993448,0.00005944957,0.00006865532,0.00027981715,0.0001545652,0.000092678776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024757878,0.00022041055,0.00027482686,0.000039105016,0.0002529419,0.000040786104,0.0002050723,0.000044228585,0.000015650658],"category_scores_gemma":[0.000009675856,0.00012063104,0.000064975255,0.00023079166,0.0001572364,0.000008860706,0.000101219564,0.000088757304,3.8642077e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022420976,0.00027484036,0.98959756,0.00002551496,0.0005283719,0.000011417058,0.0005493442,0.00010387429,0.00024392198,0.000022230884,0.0006611848,0.0057396684],"study_design_scores_gemma":[0.0030301665,0.0005149995,0.9935104,0.00002314222,0.00008790318,0.000023012657,0.00082613784,0.000046366855,0.0003062109,0.000017664868,0.0014961206,0.00011782213],"about_ca_topic_score_codex":0.7607466,"about_ca_topic_score_gemma":0.76488674,"teacher_disagreement_score":0.012067793,"about_ca_system_score_codex":0.00029842797,"about_ca_system_score_gemma":0.0004834613,"threshold_uncertainty_score":0.4919191},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":true,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":true,"confidence":"high"}],"label_agreement":"agree"},{"id":"W3096017934","doi":"10.1007/s10549-020-06009-2","title":"A scoping review characterizing \"Choosing Wisely®\" recommendations for breast cancer management","year":2020,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Healthcare cost, quality, practices","field":"Health Professions","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Public Health; Ottawa Regional Cancer Foundation; University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Psychological intervention; Breast cancer; MEDLINE; Modalities; Family medicine; Systematic review; Mammography; Inclusion (mineral); Data extraction; Health care; Cancer; Nursing; Psychology; Internal medicine; Political science","score_opus":0.8474534319292549,"score_gpt":0.6897045344676153,"score_spread":0.15774889746163967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096017934","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000003071395,0.8754756,0.000013172368,0.09518198,0.0005559832,0.020152066,0.008213408,0.00010873713,0.00029599847],"genre_scores_gemma":[0.000005241549,0.9367168,0.00031487216,0.0023923686,0.0015100071,0.05742968,0.00055814505,0.00017030361,0.000902575],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.990263,0.003977207,0.0017906006,0.0014550596,0.0007436092,0.0017705358],"domain_scores_gemma":[0.9941813,0.0022160665,0.0010541811,0.000763039,0.00080140895,0.0009840172],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0029915792,0.000769491,0.0026983302,0.00041386753,0.0024499868,0.00013229085,0.00042700255,0.00033912473,0.0013726833],"category_scores_gemma":[0.00013030035,0.0005951594,0.00037070847,0.0009749607,0.00014449212,0.00040990752,0.000497739,0.0014687849,0.00019473565],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0000947057,0.00012607944,0.00006627892,0.28782597,0.0005793499,0.000023482271,0.00019280627,7.8364035e-9,1.00763806e-7,0.00015816942,0.0030713608,0.7078617],"study_design_scores_gemma":[0.00055771944,0.00008132111,0.00013404418,0.43100563,0.0006460747,0.000034622233,0.00015916869,9.846625e-7,6.544603e-8,0.000018643736,0.56709504,0.0002667117],"about_ca_topic_score_codex":0.0053971307,"about_ca_topic_score_gemma":0.0020613598,"teacher_disagreement_score":0.707595,"about_ca_system_score_codex":0.0050003193,"about_ca_system_score_gemma":0.0057824855,"threshold_uncertainty_score":0.9998538},"labels":[],"label_agreement":null},{"id":"W3096577467","doi":"10.1007/s10549-020-06003-8","title":"International variation in breast cancer incidence and mortality in young women","year":2020,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":132,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; Ontario Institute for Cancer Research","funders":"","keywords":"Breast cancer; Medicine; Incidence (geometry); Cancer; Demography; Mortality rate; Gynecology; Oncology; Internal medicine","score_opus":0.11200113058241642,"score_gpt":0.4217091629548931,"score_spread":0.3097080323724767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096577467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9829785,0.00068325695,0.000004816879,0.015115596,0.0000434893,0.00037281352,0.00020017478,0.000012853324,0.00058847276],"genre_scores_gemma":[0.9946456,0.0043333373,0.000032560543,0.00024477803,0.00021614929,0.00045123312,0.000009576437,0.000009122284,0.000057658584],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984369,0.000060463022,0.00020354954,0.00040684023,0.00049810065,0.0003941376],"domain_scores_gemma":[0.9993817,0.000031827407,0.00003514727,0.000104121245,0.00014085059,0.00030634252],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029849852,0.00012847668,0.00023624586,0.0001366109,0.000056803703,0.000054566302,0.00007194763,0.000053186013,0.0003183911],"category_scores_gemma":[0.000019889923,0.00010586654,0.000018515595,0.00038049126,0.000096984826,0.00022292908,0.00008265071,0.00019352786,0.0000035838502],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014659315,0.00011141632,0.9654266,0.0000338175,0.000070636874,0.00016165467,0.0023510419,0.000021539418,0.00067092315,0.00007639671,0.000037272286,0.029572738],"study_design_scores_gemma":[0.0023702383,0.00021331871,0.99518704,0.00020598105,0.000010940275,0.00011696774,0.0005713748,0.0009467599,0.000043380733,0.00011847039,0.00013133425,0.00008417232],"about_ca_topic_score_codex":0.08110373,"about_ca_topic_score_gemma":0.01256121,"teacher_disagreement_score":0.06854252,"about_ca_system_score_codex":0.0015393323,"about_ca_system_score_gemma":0.0003529417,"threshold_uncertainty_score":0.9250153},"labels":[],"label_agreement":null},{"id":"W3101982531","doi":"10.1007/s10549-020-05992-w","title":"The relationship between the predicted risk of death and psychosocial functioning among women with early-stage breast cancer","year":2020,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer survivorship and care","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Health Sciences Centre; Sunnybrook Health Science Centre; Women's College Hospital; University of Toronto","funders":"","keywords":"Breast cancer; Medicine; Anxiety; Psychosocial; Distress; Cancer; Stage (stratigraphy); Quality of life (healthcare); Internal medicine; Obstetrics; Clinical psychology; Psychiatry","score_opus":0.06081328957557633,"score_gpt":0.3407832175920043,"score_spread":0.27996992801642795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3101982531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876406,0.0013607627,0.000011877557,0.008745827,0.00003816532,0.0006698721,0.0012585693,0.00002568693,0.00024859328],"genre_scores_gemma":[0.99646395,0.0017874675,0.0000033096983,0.00003295272,0.0004840986,0.0006823909,0.000012934693,0.000023511626,0.00050935114],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984054,0.00018267315,0.00017250403,0.00031279377,0.0005219125,0.00040470337],"domain_scores_gemma":[0.99869007,0.00043305167,0.000089105284,0.00021189678,0.00022766386,0.00034823132],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029956963,0.00015835425,0.00023443642,0.000046724388,0.0007419067,0.00008039236,0.00007762474,0.00006094233,0.000077989775],"category_scores_gemma":[0.000025261013,0.000078585,0.00003680333,0.0004098227,0.00047731347,0.000079667385,0.000046542267,0.00034883805,0.000001003455],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034902566,0.000036818878,0.96436477,0.00004335521,0.0005017329,0.000005738274,0.004895478,0.000003341864,0.0000041900307,0.00007931326,0.000089430956,0.026485568],"study_design_scores_gemma":[0.002185544,0.00088865473,0.9930677,0.00012135864,0.00015810892,0.000010753191,0.0025885906,0.00001765991,0.000016220874,0.0000651601,0.0008053548,0.00007494183],"about_ca_topic_score_codex":0.03846838,"about_ca_topic_score_gemma":0.00943027,"teacher_disagreement_score":0.029038109,"about_ca_system_score_codex":0.00033993993,"about_ca_system_score_gemma":0.00033893547,"threshold_uncertainty_score":0.96793455},"labels":[],"label_agreement":null},{"id":"W3106369591","doi":"10.1007/s10549-020-06012-7","title":"Time to surgery among women treated with neoadjuvant systemic therapy and upfront surgery for breast cancer","year":2020,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; McGill University Health Centre","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Breast cancer; Mastectomy; Breast-conserving surgery; Proportional hazards model; Cancer; Neoadjuvant therapy; Surgery; Chemotherapy; Internal medicine; Oncology","score_opus":0.04016864036281586,"score_gpt":0.29565337636344946,"score_spread":0.2554847360006336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3106369591","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9829048,0.007033238,0.000008543853,0.0058669723,0.000028802755,0.0012795879,0.0028144359,0.00003716106,0.000026481797],"genre_scores_gemma":[0.98523194,0.008263714,0.000020685642,0.00022461347,0.00045441106,0.005072699,0.000121042176,0.000075260155,0.00053566013],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99741215,0.000116963965,0.00025673682,0.0009584447,0.00029992638,0.0009557761],"domain_scores_gemma":[0.99843997,0.00015384916,0.000081845064,0.00029088074,0.00032616663,0.0007072937],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023426773,0.00042913327,0.0006419314,0.00012470437,0.00030866687,0.000085169566,0.00009709451,0.00010347006,0.00012181369],"category_scores_gemma":[0.000013599883,0.00029454904,0.000097735254,0.0002730503,0.00030261307,0.000017567569,0.000098111326,0.00007389529,0.000009743638],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021049751,0.00048726433,0.6244552,0.00018136416,0.0028459334,0.00007280029,0.0009973012,0.000041765365,0.007233901,0.0000032597964,0.008339743,0.33429173],"study_design_scores_gemma":[0.005101945,0.0018810116,0.9775213,0.00043528844,0.00011095271,0.00033687093,0.0007286177,0.000056372908,0.006154993,0.0000059548097,0.006909776,0.00075694063],"about_ca_topic_score_codex":0.0030212759,"about_ca_topic_score_gemma":0.0004838779,"teacher_disagreement_score":0.3530661,"about_ca_system_score_codex":0.0004399478,"about_ca_system_score_gemma":0.00048500046,"threshold_uncertainty_score":0.99995065},"labels":[],"label_agreement":null},{"id":"W3110381708","doi":"10.1007/s10549-020-06027-0","title":"Tumor phenotype and concordance in synchronous bilateral breast cancer in young women","year":2020,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital","funders":"","keywords":"Breast cancer; Medicine; Concordance; Internal medicine; Cancer; Oncology; Cohort; Incidence (geometry); Prospective cohort study; Mastectomy; Male breast cancer; Disease; Gynecology","score_opus":0.02084120853245856,"score_gpt":0.3133351964906339,"score_spread":0.2924939879581753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110381708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98676443,0.0069639944,0.0000014713859,0.004760067,0.00004945884,0.00047653166,0.00083309546,0.000012071479,0.00013887716],"genre_scores_gemma":[0.9914318,0.00676218,0.000021948346,0.0001664177,0.00027646354,0.0011937812,0.000022126651,0.00003208328,0.00009325289],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99802,0.00009519652,0.00021438856,0.0007306287,0.00020589166,0.0007339232],"domain_scores_gemma":[0.9993668,0.00002212584,0.000043499866,0.00018604119,0.00008938327,0.0002921024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011253064,0.00028374404,0.00034350276,0.00009324107,0.00011598478,0.000050819395,0.000110389745,0.00006668948,0.00008325467],"category_scores_gemma":[0.0000075495454,0.00023232844,0.00002981407,0.00028284598,0.00027878466,0.000016443855,0.00018673005,0.00014166445,0.000004791355],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035381387,0.0003348279,0.9269415,0.000070512026,0.00022262729,0.00013002194,0.0016495709,0.00003999381,0.0052074986,0.000026453423,0.0000847604,0.06175405],"study_design_scores_gemma":[0.0044353697,0.0005482624,0.99255294,0.000094036965,0.000012464145,0.00012023432,0.0005264781,0.00006177043,0.0009527305,0.000044966986,0.0004123566,0.00023839645],"about_ca_topic_score_codex":0.017169321,"about_ca_topic_score_gemma":0.015206589,"teacher_disagreement_score":0.06561139,"about_ca_system_score_codex":0.0006420056,"about_ca_system_score_gemma":0.00032150082,"threshold_uncertainty_score":0.9893754},"labels":[],"label_agreement":null},{"id":"W3118628217","doi":"10.1007/s10549-020-06037-y","title":"N-myristoyltransferase proteins in breast cancer: prognostic relevance and validation as a new drug target","year":2021,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Protein Kinase Regulation and GTPase Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Alberta Health Services","funders":"Alberta Cancer Foundation","keywords":"Breast cancer; Immunohistochemistry; Cancer; Cancer research; Biology; Apoptosis; In vivo; Pathology; Internal medicine; Oncology; Medicine; Immunology; Biochemistry","score_opus":0.02081469150852863,"score_gpt":0.3168684897439837,"score_spread":0.2960537982354551,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3118628217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9758946,0.0144611085,0.00010002254,0.008360941,0.000026720098,0.0007736311,0.0002854656,0.000011261774,0.000086283144],"genre_scores_gemma":[0.98869926,0.008717242,0.00034642813,0.00007477734,0.00019947844,0.00059669063,0.00013400288,0.000020994037,0.0012111025],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986088,0.000132405,0.00015970532,0.000510783,0.00023691765,0.00035137008],"domain_scores_gemma":[0.9992927,0.000020923486,0.000027853375,0.00018733651,0.00017162263,0.0002995839],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015529562,0.0001645396,0.00015848929,0.000073449795,0.00014590185,0.00007088572,0.000051149673,0.00007120246,0.00011635877],"category_scores_gemma":[0.00003260995,0.00014544648,0.000033645203,0.00021572964,0.00009876953,0.000013200888,0.00005171969,0.00010290441,0.0000030146646],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027638592,0.0010655095,0.14958507,0.0002619476,0.00029440946,0.00039515216,0.0006010679,0.000330329,0.5363649,0.000579393,0.0009190744,0.30683926],"study_design_scores_gemma":[0.0070669134,0.0005739817,0.12861495,0.0006665534,0.000050271632,0.00070214993,0.00023960124,0.00020074041,0.8456252,0.0019369132,0.013751783,0.00057092623],"about_ca_topic_score_codex":0.005275506,"about_ca_topic_score_gemma":0.0018560034,"teacher_disagreement_score":0.30926028,"about_ca_system_score_codex":0.00013428238,"about_ca_system_score_gemma":0.0010447275,"threshold_uncertainty_score":0.7975022},"labels":[],"label_agreement":null},{"id":"W3119592225","doi":"10.1007/s10549-020-06030-5","title":"A clinical calculator to predict disease outcomes in women with triple-negative breast cancer","year":2021,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; National Center for Research Resources; Breast Cancer Research Foundation","keywords":"Medicine; Triple-negative breast cancer; Breast cancer; Internal medicine; Oncology; Anthracycline; Nomogram; Cancer; Mastectomy","score_opus":0.09590931085154607,"score_gpt":0.4649260142349547,"score_spread":0.36901670338340864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3119592225","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.026138285,0.95344895,5.530639e-7,0.002078101,0.00016388754,0.0068843598,0.0111618135,0.000056881472,0.000067172434],"genre_scores_gemma":[0.0036349965,0.9693818,0.00006985508,0.00013646492,0.00046175538,0.024779491,0.0001163279,0.00013527895,0.0012840322],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99409854,0.0008181242,0.0009600121,0.0015616202,0.0012146839,0.0013470323],"domain_scores_gemma":[0.9951138,0.0004850842,0.00018936675,0.0008908821,0.00049949175,0.002821401],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00072928227,0.0008294368,0.0031570024,0.0006681571,0.00018252751,0.00011508802,0.00023793272,0.0002819748,0.00075218844],"category_scores_gemma":[0.00011584925,0.0005061451,0.00044563494,0.001110761,0.00051652046,0.000099176934,0.00028453005,0.0006640706,0.000031279036],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0068770126,0.0017328426,0.2516122,0.0042442004,0.0036535664,0.002429974,0.00011520364,2.7563436e-7,3.398886e-8,0.0000074730256,0.0005978434,0.72872937],"study_design_scores_gemma":[0.009806347,0.001258917,0.7502824,0.048974097,0.002303615,0.00029764656,0.00021108602,0.000006342322,5.0953025e-7,0.00001176084,0.18609709,0.0007501952],"about_ca_topic_score_codex":0.0025238984,"about_ca_topic_score_gemma":0.0010652483,"teacher_disagreement_score":0.7279792,"about_ca_system_score_codex":0.005150414,"about_ca_system_score_gemma":0.008476821,"threshold_uncertainty_score":0.999739},"labels":[],"label_agreement":null},{"id":"W3120002718","doi":"10.1007/s10549-020-06057-8","title":"Association between radiologists’ and facilities’ characteristics and mammography screening detection of ductal carcinoma in situ","year":2021,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Digital Radiography and Breast Imaging","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Saint-François d'Assise; Université Laval; Institut National de Santé Publique du Québec","funders":"","keywords":"Medicine; Ductal carcinoma; Confidence interval; Mammography; Odds ratio; Breast cancer; Logistic regression; Radiology; Cancer detection; Cohort; Oncology; Internal medicine; Cancer","score_opus":0.040079363152228945,"score_gpt":0.31295954963310496,"score_spread":0.27288018648087603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120002718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99603397,0.0023739177,0.00001370065,0.00078702014,0.000015178345,0.00018781258,0.0003330984,0.000009202125,0.000246095],"genre_scores_gemma":[0.99825585,0.001396375,0.000045347617,0.0000060113125,0.0000735863,0.00003587336,0.000047137924,0.0000067565343,0.00013304599],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99904174,0.00006743395,0.00015899978,0.0002487246,0.00021674606,0.00026633518],"domain_scores_gemma":[0.9994696,0.000119259596,0.00004287382,0.00008433121,0.00014100611,0.00014295777],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001951503,0.0001046066,0.00026776455,0.00025042688,0.00007373677,0.00004528047,0.00001557383,0.000055268913,0.0000064581586],"category_scores_gemma":[0.00002802908,0.00008877791,0.000039793216,0.00031561352,0.00016403983,0.000102781836,0.000034016062,0.00012387804,1.57255e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023370858,0.00007429945,0.7925407,0.00007722622,0.00017446384,0.000093739836,0.00018492813,4.142248e-8,0.0029289906,0.000010141875,0.0000030457488,0.20367868],"study_design_scores_gemma":[0.0015765504,0.00038763817,0.99306697,0.000105255924,0.000054819426,0.00035650923,0.0005378147,0.000011358994,0.003665898,0.00007109763,0.00010114383,0.00006496158],"about_ca_topic_score_codex":0.0016028245,"about_ca_topic_score_gemma":0.00027042336,"teacher_disagreement_score":0.20361371,"about_ca_system_score_codex":0.00014129111,"about_ca_system_score_gemma":0.000068659756,"threshold_uncertainty_score":0.3620258},"labels":[],"label_agreement":null},{"id":"W3120020809","doi":"10.1007/s10549-020-06048-9","title":"HER2 fluorescent in situ hybridization signal degradation: a 10-year retrospective study","year":2021,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"In situ hybridization; In situ; Fluorescence in situ hybridization; Breast cancer; Degradation (telecommunications); Fluorescence; Medicine; Retrospective cohort study; Biology; Pathology; Internal medicine; Chemistry; Genetics; Cancer; Computer science; Telecommunications; Chromosome; Optics; Physics; Gene expression","score_opus":0.07400740665816091,"score_gpt":0.40829915614598367,"score_spread":0.33429174948782275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120020809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98999786,0.0014747265,0.000008609196,0.004281667,0.00004546966,0.0016787157,0.00010654892,0.00003323192,0.0023731904],"genre_scores_gemma":[0.9930002,0.0015200699,0.00008848068,0.00002649239,0.00026039284,0.0008095185,0.000077772274,0.000034091878,0.0041829995],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99683535,0.00033828276,0.00026154588,0.00070824707,0.0012238226,0.00063276093],"domain_scores_gemma":[0.9982937,0.00006722946,0.000031261792,0.00039302587,0.00084245903,0.00037233782],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00052675285,0.00019341228,0.00035843527,0.0002899193,0.00018352237,0.00010785897,0.00007932281,0.00006249532,0.0020205562],"category_scores_gemma":[0.00006061605,0.00015955449,0.000051723433,0.0010651334,0.0001466649,0.00009853039,0.00011721493,0.000327401,0.00006675186],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002508927,0.004851598,0.9155902,0.000083808765,0.00030414102,0.0022175156,0.0009301374,0.0000067649385,0.0035771993,0.00017679657,0.0015138215,0.06823907],"study_design_scores_gemma":[0.0075458065,0.0028253545,0.9739504,0.0002573404,0.00004094418,0.00018163497,0.0020017368,0.00006171588,0.011344448,0.0001061763,0.0015274285,0.00015702963],"about_ca_topic_score_codex":0.004414155,"about_ca_topic_score_gemma":0.00844033,"teacher_disagreement_score":0.06808204,"about_ca_system_score_codex":0.003122182,"about_ca_system_score_gemma":0.0016520488,"threshold_uncertainty_score":0.9988917},"labels":[],"label_agreement":null},{"id":"W3120827443","doi":"10.1007/s10549-020-06072-9","title":"Breast cancer risk after age 60 among BRCA1 and BRCA2 mutation carriers","year":2021,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Public Health Ontario; Women's College Hospital; University Health Network; University of Toronto; McGill University; Sunnybrook Health Science Centre","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research","keywords":"Breast cancer; Medicine; Oncology; Cancer; Mutation; BRCA2 Protein; Gynecology; Internal medicine; Biology; Germline mutation; Genetics; Gene","score_opus":0.018107810407866416,"score_gpt":0.32715585689404486,"score_spread":0.30904804648617845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120827443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9824526,0.0133978315,0.0000234743,0.0011470877,0.000115916984,0.00032567268,0.0023047952,0.000011861029,0.00022076706],"genre_scores_gemma":[0.9834691,0.013235295,0.00011839755,0.00006319465,0.00038279372,0.0010561267,0.00015955178,0.000036965917,0.0014785654],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9982225,0.0001634356,0.00016595877,0.00069745217,0.0002854747,0.00046520357],"domain_scores_gemma":[0.99896264,0.000023489441,0.000051964314,0.0003459818,0.0003377158,0.0002781956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015490109,0.00021641847,0.00018076913,0.00008016996,0.00027556324,0.00012795551,0.00007628598,0.00013141353,0.00025666016],"category_scores_gemma":[0.000012188855,0.000190472,0.000059631893,0.00021849402,0.0004026944,0.000015491696,0.00013099967,0.00014338357,0.000004142602],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018895497,0.0004326195,0.4559764,0.00011415098,0.0017822495,0.0016882875,0.0017072384,0.00023055686,0.01983954,0.00004004692,0.0028747295,0.51342463],"study_design_scores_gemma":[0.0022171233,0.0002290019,0.9719065,0.000067628454,0.00010095418,0.00046201044,0.0005984461,0.000056909827,0.01842513,0.00015973405,0.005490217,0.00028636717],"about_ca_topic_score_codex":0.006786267,"about_ca_topic_score_gemma":0.014892313,"teacher_disagreement_score":0.5159301,"about_ca_system_score_codex":0.0004611562,"about_ca_system_score_gemma":0.0007102382,"threshold_uncertainty_score":0.9998276},"labels":[],"label_agreement":null},{"id":"W3121812824","doi":"10.1007/s10549-020-06086-3","title":"Can we rely on surgical clips placed during oncoplastic breast surgery to accurately delineate the tumor bed for targeted breast radiotherapy?","year":2021,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa; Carleton University","funders":"Ministry of National Guard Health Affairs","keywords":"CLIPS; Medicine; Oncoplastic Surgery; Quadrant (abdomen); Breast surgery; Breast cancer; Breast-conserving surgery; Radiology; Surgical margin; Surgery; Mastectomy; Nuclear medicine; Resection; Cancer; Internal medicine","score_opus":0.05650922758596673,"score_gpt":0.35612650057162554,"score_spread":0.2996172729856588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3121812824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9592281,0.0049263374,0.000010734055,0.029609052,0.00020755411,0.0010227638,0.00492071,0.000035968806,0.000038809092],"genre_scores_gemma":[0.9904491,0.004776975,0.000085615924,0.0002070751,0.0010871736,0.002102812,0.00036129923,0.00008993025,0.00084002723],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9966858,0.00029072363,0.000374455,0.0010923393,0.0004732528,0.0010834096],"domain_scores_gemma":[0.99785924,0.0004344225,0.000091170565,0.00060337223,0.000542011,0.00046980663],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00029093798,0.0005019537,0.0005427792,0.00014272373,0.0007819813,0.00014301437,0.00019569232,0.00011846002,0.00008553393],"category_scores_gemma":[0.00004809665,0.00033916082,0.00023826088,0.00043119598,0.00023594171,0.000011306761,0.0001704396,0.0001779251,0.00000986835],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1804718,0.0085802525,0.18769433,0.00078877225,0.01430588,0.0037245934,0.00230142,0.0015775766,0.14611563,0.00046952776,0.024580695,0.42938954],"study_design_scores_gemma":[0.034421764,0.0036212408,0.6732234,0.0013478053,0.0005425426,0.020652477,0.0020679983,0.00018192196,0.21155934,0.0001936059,0.049587313,0.0026006026],"about_ca_topic_score_codex":0.0014126982,"about_ca_topic_score_gemma":0.002792091,"teacher_disagreement_score":0.48552907,"about_ca_system_score_codex":0.0006406977,"about_ca_system_score_gemma":0.0009222685,"threshold_uncertainty_score":0.99990606},"labels":[],"label_agreement":null},{"id":"W3125432354","doi":"10.1007/s10549-020-06051-0","title":"Factors associated with waiting time to breast cancer diagnosis among symptomatic breast cancer patients: a population-based study from Ontario, Canada","year":2021,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Cancer Care Ontario; University of Toronto; Queen's University","funders":"","keywords":"Medicine; Breast cancer; Interquartile range; Cancer; Population; Disease; Breast disease; Internal medicine; Pediatrics","score_opus":0.06717089342758882,"score_gpt":0.33530551983035356,"score_spread":0.26813462640276475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3125432354","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868477,0.00033498398,4.3327665e-7,0.0029194725,0.00007831466,0.0014889585,0.008217983,0.0000494396,0.00006274134],"genre_scores_gemma":[0.9954691,0.000029173221,0.000007762396,0.00029063804,0.00015899756,0.0026851667,0.0006635885,0.000058687026,0.0006368767],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957919,0.00020717586,0.00042844404,0.00090624485,0.001693169,0.0009730377],"domain_scores_gemma":[0.99703854,0.00029862326,0.00015605692,0.00039160525,0.0012137984,0.00090135785],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015170153,0.00047589382,0.0007568772,0.00016290894,0.0005241908,0.00016750643,0.00014332806,0.00009355273,0.006097534],"category_scores_gemma":[0.000041983578,0.00034421196,0.000086891494,0.00083206536,0.000067174056,0.00020200577,0.000091876005,0.00030930672,0.0000052223686],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00073321257,0.0012255339,0.9844237,0.00002443643,0.0012237964,0.00020411133,0.0006451092,0.00024212863,0.00000957316,5.0359137e-7,0.00094068155,0.010327197],"study_design_scores_gemma":[0.004705357,0.0005924026,0.9908198,0.0018915407,0.00043387737,0.000007879589,0.00084597734,0.00021649398,0.00008704987,0.0000024173044,0.000051553427,0.0003456341],"about_ca_topic_score_codex":0.9967075,"about_ca_topic_score_gemma":0.99745077,"teacher_disagreement_score":0.009981562,"about_ca_system_score_codex":0.012774497,"about_ca_system_score_gemma":0.005688933,"threshold_uncertainty_score":0.9999479},"labels":[],"label_agreement":null},{"id":"W3125885873","doi":"10.1007/s10549-020-06093-4","title":"Analysis of tumor nuclear features using artificial intelligence to predict response to neoadjuvant chemotherapy in high-risk breast cancer patients","year":2021,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; Health Sciences Centre; Sunnybrook Health Science Centre; Artificial Intelligence in Medicine (Canada); York University; University of Toronto","funders":"Social Sciences and Humanities Research Council of Canada; Natural Sciences and Engineering Research Council of Canada; Terry Fox Research Institute","keywords":"Breast cancer; Medicine; Pathological; Univariate analysis; Logistic regression; Oncology; Cancer; Multivariate analysis; Stage (stratigraphy); Chemotherapy; Internal medicine; Radiology; Biology","score_opus":0.024580081631910885,"score_gpt":0.3407335780916868,"score_spread":0.3161534964597759,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3125885873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920882,0.0008619473,0.000027946095,0.002406373,0.00006668729,0.0004927009,0.004038991,0.000008169663,0.000008957339],"genre_scores_gemma":[0.9977582,0.0012979748,0.00027179226,0.00014275557,0.00012977718,0.00025549217,0.00006761164,0.000036288755,0.000040073137],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976391,0.0002641511,0.00031802797,0.0007920172,0.00042478114,0.00056192087],"domain_scores_gemma":[0.99864334,0.000056969875,0.00008241953,0.0004187619,0.0005087132,0.0002898013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002328001,0.00028077635,0.00047382314,0.00041250212,0.00018077572,0.000049200993,0.00015367374,0.00007909119,0.000115914976],"category_scores_gemma":[0.00004242602,0.00023581971,0.00012169218,0.0013408292,0.00014073569,0.000009801646,0.00021714612,0.00010727813,0.0000026288444],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03275767,0.0025468627,0.701844,0.000028162793,0.00392731,0.00007700715,0.0012318416,0.0036684764,0.02704372,0.00006470371,0.00013654535,0.22667372],"study_design_scores_gemma":[0.00089979783,0.00073922455,0.9686318,0.0000989615,0.00025199374,0.000016085161,0.0004167771,0.0000745052,0.028425485,0.0000400807,0.00019144571,0.00021383831],"about_ca_topic_score_codex":0.02256536,"about_ca_topic_score_gemma":0.014794621,"teacher_disagreement_score":0.26678783,"about_ca_system_score_codex":0.00058272213,"about_ca_system_score_gemma":0.00038727483,"threshold_uncertainty_score":0.98394346},"labels":[],"label_agreement":null},{"id":"W3130005770","doi":"10.1007/s10549-021-06109-7","title":"The efficacy and safety of enzalutamide with trastuzumab in patients with HER2+ and androgen receptor-positive metastatic or locally advanced breast cancer","year":2021,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Astellas Foundation for Research on Metabolic Disorders; Astellas Pharma; National Institute for Health and Care Research; Pfizer","keywords":"Trastuzumab; Medicine; Enzalutamide; Internal medicine; Oncology; Metastatic breast cancer; Breast cancer; Response Evaluation Criteria in Solid Tumors; Regimen; Adverse effect; Androgen receptor; Cancer; Clinical endpoint; Progressive disease; Phases of clinical research; Prostate cancer; Clinical trial; Chemotherapy","score_opus":0.027840409809214116,"score_gpt":0.35712052906739994,"score_spread":0.32928011925818584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130005770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98721343,0.0061754603,0.0000058248143,0.0033896107,0.000017202208,0.0019643807,0.0010969995,0.000011141923,0.00012596867],"genre_scores_gemma":[0.985625,0.012826823,0.00023953705,0.000039095255,0.000038668302,0.0006612039,0.000041940653,0.000048390655,0.00047933447],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99709123,0.0002903076,0.00030696412,0.00064644916,0.0009459227,0.0007191133],"domain_scores_gemma":[0.99785167,0.00051704916,0.00007376044,0.00033919798,0.00077185663,0.00044644537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003523798,0.0002887108,0.00055153307,0.00013864803,0.00027504517,0.00007112079,0.00008369813,0.0000526826,0.00015557311],"category_scores_gemma":[0.00003438877,0.00014829377,0.00002628795,0.000683034,0.00085604296,0.0001187713,0.00010273802,0.00031474035,0.0000011749505],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07005524,0.0012163144,0.42422447,0.00026842582,0.0009932894,0.00027964596,0.0008816873,0.000022848939,0.00022437677,0.000049507198,0.000040974588,0.50174326],"study_design_scores_gemma":[0.026031628,0.0058088796,0.9616592,0.0019277566,0.00013589463,0.0003500019,0.00108957,0.000027688146,0.0020845835,0.000016442973,0.0006649951,0.00020334421],"about_ca_topic_score_codex":0.0046853004,"about_ca_topic_score_gemma":0.012773007,"teacher_disagreement_score":0.53743476,"about_ca_system_score_codex":0.0009829615,"about_ca_system_score_gemma":0.002115119,"threshold_uncertainty_score":0.7127638},"labels":[],"label_agreement":null},{"id":"W3132043293","doi":"10.1007/s10549-021-06110-0","title":"Impact of sequence order of anthracyclines and taxanes in neoadjuvant chemotherapy on pathologic complete response rate in HER2-negative breast cancer patients","year":2021,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Breast cancer; Medicine; Internal medicine; Oncology; Clinical endpoint; Chemotherapy; Cancer; Neoadjuvant therapy; Cohort; Triple-negative breast cancer; Clinical trial","score_opus":0.04926383731731095,"score_gpt":0.3944026748608143,"score_spread":0.3451388375435034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3132043293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937932,0.0017074626,5.153969e-7,0.0011802033,0.000022585193,0.00040288497,0.002869918,0.0000030573108,0.00002017707],"genre_scores_gemma":[0.9883278,0.011170662,0.000044240413,0.000033471253,0.000032714062,0.0002687803,0.000058053873,0.000019649915,0.00004460942],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981099,0.00047027078,0.00028177866,0.00054171315,0.00020462126,0.0003917487],"domain_scores_gemma":[0.99893785,0.00014984535,0.00011608437,0.00024313308,0.0004588637,0.00009421003],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026220822,0.00025815787,0.00043188257,0.00014432735,0.000065210304,0.000013642328,0.00007762826,0.00008507111,0.000040483792],"category_scores_gemma":[0.00006342315,0.00018487734,0.00006079114,0.00038044582,0.00045136324,0.00001128777,0.00009682788,0.00009539129,4.577681e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017229786,0.0015997888,0.90845567,0.000039425133,0.0002699886,0.00008469347,0.0005079081,0.000089374145,0.041577406,0.0000063343805,0.000020000873,0.030119654],"study_design_scores_gemma":[0.005963392,0.0013976666,0.97337997,0.00023726515,0.000012266861,0.00003711065,0.00019204378,0.000013972925,0.018551694,0.000052527146,0.000019300724,0.0001428139],"about_ca_topic_score_codex":0.022271942,"about_ca_topic_score_gemma":0.008593168,"teacher_disagreement_score":0.06492431,"about_ca_system_score_codex":0.00029984763,"about_ca_system_score_gemma":0.00044754733,"threshold_uncertainty_score":0.9842388},"labels":[],"label_agreement":null},{"id":"W31325071","doi":"10.1007/s10549-019-05364-z","title":"REMOTE SENSING (LIDAR) FOR MANAGEMENT OF HIGHWAY ASSETS FOR SAFETY","year":2003,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Traffic and Road Safety","field":"Engineering","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Cancer Society Research Institute","keywords":"Lidar; Sight; Intersection (aeronautics); Crash; Identification (biology); Transport engineering; Computer science; Engineering; Remote sensing; Geography","score_opus":0.04031553278173334,"score_gpt":0.3242415377514173,"score_spread":0.28392600496968395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W31325071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.61817324,0.019540342,0.29804465,0.003819162,0.0017772113,0.015426702,0.007283256,0.0008775528,0.035057876],"genre_scores_gemma":[0.9839146,0.0022934845,0.01281883,0.0000033230904,0.00005696663,0.00005379632,0.000027754437,0.000033620545,0.00079760555],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99907726,0.000021700658,0.00015530153,0.0001990125,0.00015338589,0.00039336702],"domain_scores_gemma":[0.9995341,0.00009100972,0.000015009748,0.00015968081,0.0000913216,0.000108918306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021835061,0.00012709964,0.00017932322,0.00006867618,0.00014348223,0.0000158516,0.000042069358,0.000043639484,0.000014738212],"category_scores_gemma":[0.0000022986287,0.00010025577,0.000060655093,0.00010913745,0.000048600807,0.00003261868,0.000011442754,0.000044255034,0.0000019726276],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005550398,0.00008144735,0.00014999279,0.00047636134,0.0006041306,0.000011326525,0.00012483676,0.0012205555,0.00020507704,0.0044157454,0.0007654951,0.99139],"study_design_scores_gemma":[0.038046915,0.002962999,0.10594192,0.0018402942,0.0006000831,0.00022658012,0.001661311,0.0490865,0.033945195,0.00698037,0.75703996,0.0016678649],"about_ca_topic_score_codex":0.00011492227,"about_ca_topic_score_gemma":0.00009807189,"teacher_disagreement_score":0.98972213,"about_ca_system_score_codex":0.00026959492,"about_ca_system_score_gemma":0.000041300806,"threshold_uncertainty_score":0.40883115},"labels":[],"label_agreement":null},{"id":"W3134342541","doi":"10.1007/s10549-021-06103-z","title":"Baseline characteristics and first-line treatment patterns in patients with HER2-positive metastatic breast cancer in the SystHERs registry","year":2021,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"F. Hoffmann-La Roche","keywords":"Medicine; Metastatic breast cancer; Internal medicine; Taxane; Pertuzumab; Breast cancer; Cancer registry; Trastuzumab; Oncology; Cancer; Odds ratio; Chemotherapy","score_opus":0.04727928516653658,"score_gpt":0.3718786086865928,"score_spread":0.3245993235200562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134342541","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97561085,0.0018796679,0.000005728521,0.015693152,0.000034487013,0.0017974495,0.004879815,0.000012304522,0.00008655314],"genre_scores_gemma":[0.9858718,0.011274884,0.000031432694,0.00015185424,0.00014639445,0.0017055272,0.00028020644,0.0000483127,0.0004895841],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967164,0.00047603066,0.00035103253,0.00072556984,0.0009178544,0.0008131331],"domain_scores_gemma":[0.9982446,0.00032296192,0.00007130226,0.00051651255,0.00048799563,0.00035663997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000489883,0.0003521319,0.00058688584,0.00023271047,0.00017740678,0.0001259228,0.00011084138,0.000071680835,0.00036141064],"category_scores_gemma":[0.000028561408,0.00020482179,0.000050439878,0.0006311141,0.00028411354,0.000093819996,0.00007232016,0.00036362294,0.000004785323],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032750592,0.0028622753,0.8505214,0.00026602633,0.00033940596,0.0016408368,0.0011426755,0.000010429062,0.000012000903,0.000013098798,0.00005121278,0.13986558],"study_design_scores_gemma":[0.009834651,0.0021707485,0.9841205,0.0015078589,0.00011835417,0.00034407584,0.0008544751,0.00014126932,0.00012163387,0.000010512609,0.00059253443,0.00018341359],"about_ca_topic_score_codex":0.03896036,"about_ca_topic_score_gemma":0.042125035,"teacher_disagreement_score":0.13968216,"about_ca_system_score_codex":0.0023860873,"about_ca_system_score_gemma":0.0011008242,"threshold_uncertainty_score":0.97535366},"labels":[],"label_agreement":null},{"id":"W3137776366","doi":"10.1007/s10549-021-06164-0","title":"Tumor levels of the mediators of ErbB2-driven anoikis resistance correlate with breast cancer relapse in patients receiving trastuzumab-based therapies","year":2021,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Moncton Hospital; Saint John Regional Hospital; Nova Scotia Health Authority; Dalhousie University","funders":"Canadian Institutes of Health Research; Beatrice Hunter Cancer Research Institute","keywords":"Trastuzumab; Anoikis; Medicine; Breast cancer; Oncology; Cancer; Immunohistochemistry; Internal medicine; Epidermal growth factor receptor; Apoptosis; Cancer research; Cancer cell; Biology","score_opus":0.03670378781311591,"score_gpt":0.34039308619681263,"score_spread":0.30368929838369674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3137776366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887654,0.003494589,0.000001993046,0.004522374,0.00008738801,0.0011256147,0.0016670334,0.000013295803,0.0003223012],"genre_scores_gemma":[0.99667007,0.0016629397,0.00012303944,0.00004728124,0.000062976826,0.0005220176,0.000014024465,0.000053940563,0.0008437037],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963172,0.0004065947,0.00045685048,0.0005832966,0.0015306844,0.00070537446],"domain_scores_gemma":[0.9975556,0.0002833954,0.00016744038,0.00058334984,0.001128412,0.00028176667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040154258,0.00027556843,0.0006156927,0.00025621676,0.00015571341,0.000026891146,0.00019821068,0.00008935712,0.000511373],"category_scores_gemma":[0.000060409726,0.00016789441,0.00010327462,0.0013101238,0.00074906874,0.00008973179,0.00009969778,0.00044831834,0.0000018080443],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005343011,0.0012693215,0.954791,0.000451166,0.00036196865,0.0001188614,0.0012229662,0.000041542975,0.0012012656,0.000034570938,0.00020456107,0.034959726],"study_design_scores_gemma":[0.008158197,0.0007061875,0.97961974,0.0028980235,0.000063553074,0.000029102106,0.00047782267,0.000039764407,0.007510968,0.000031844385,0.0003196034,0.0001451888],"about_ca_topic_score_codex":0.0050727287,"about_ca_topic_score_gemma":0.017626602,"teacher_disagreement_score":0.03481454,"about_ca_system_score_codex":0.0015747778,"about_ca_system_score_gemma":0.0036069397,"threshold_uncertainty_score":0.9836058},"labels":[],"label_agreement":null},{"id":"W3138930066","doi":"10.1007/s10549-021-06147-1","title":"Adjuvant bisphosphonate use in patients with early stage breast cancer: a physician survey","year":2021,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Bone health and treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre; Ottawa Hospital; Ottawa Regional Cancer Foundation; University of Ottawa","funders":"","keywords":"Medicine; Adjuvant; Breast cancer; Bisphosphonate; Clinical trial; Internal medicine; Regimen; Oncology; Cancer; Family medicine; Adjuvant therapy; Osteoporosis","score_opus":0.0582924583654317,"score_gpt":0.359033206134235,"score_spread":0.30074074776880333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3138930066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910978,0.0012454041,3.917289e-7,0.0012611378,0.00005557887,0.0010784682,0.0051435437,0.000026087075,0.00009158544],"genre_scores_gemma":[0.9934942,0.0024149867,0.000034193647,0.00018050845,0.000028585182,0.0005920949,0.00036505057,0.000050644085,0.0028397199],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971677,0.00020542684,0.00025917927,0.00069492403,0.0007246198,0.000948124],"domain_scores_gemma":[0.9980362,0.000102843915,0.00006408013,0.00041805138,0.0006918245,0.0006870136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016372211,0.0003074935,0.0005473937,0.0001775976,0.00019764135,0.00008594724,0.000054430933,0.00008051901,0.00018429552],"category_scores_gemma":[0.000009074261,0.00020983291,0.000050639963,0.0007755444,0.00015682298,0.00020550705,0.000061941544,0.00026725157,0.000021909394],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008309121,0.0028115117,0.8931011,0.00006029562,0.00033494135,0.00054671534,0.00014279156,0.0000023334453,0.000008029425,0.000013908527,0.00007722865,0.094592005],"study_design_scores_gemma":[0.015061975,0.0012805524,0.98227394,0.00039703262,0.000053091437,0.000029298002,0.000044720335,0.0000100973875,0.00018299729,0.0000071639515,0.0004899013,0.00016926137],"about_ca_topic_score_codex":0.34621817,"about_ca_topic_score_gemma":0.15598777,"teacher_disagreement_score":0.19023041,"about_ca_system_score_codex":0.0012389482,"about_ca_system_score_gemma":0.0014978589,"threshold_uncertainty_score":0.85941327},"labels":[],"label_agreement":null},{"id":"W3139520813","doi":"10.1007/s10549-021-06172-0","title":"A qualitative study to evaluate physician attitudes regarding omission of surgery among exceptional responders to neoadjuvant systemic therapy for breast cancer (NRG-CC006)","year":2021,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"National Cancer Institute","keywords":"Medicine; Breast cancer; Lumpectomy; Surgical oncology; Oncology; Mastectomy; Specialty; Neoadjuvant therapy; Clinical trial; Qualitative research; Family medicine; Multidisciplinary approach; Internal medicine; Systemic therapy; Cancer","score_opus":0.11859033199687266,"score_gpt":0.4610899640249085,"score_spread":0.3424996320280358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3139520813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893358,0.0038187401,0.000047683225,0.0024462023,0.00011143959,0.0017248512,0.0024778787,0.000012814933,0.000024614088],"genre_scores_gemma":[0.9934306,0.0018258538,0.00009080292,0.00009593961,0.00036078345,0.0036052272,0.00010291899,0.000048224316,0.0004396455],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996988,0.00053421466,0.0003473202,0.00090856943,0.00058207,0.0006398039],"domain_scores_gemma":[0.9978133,0.0002269655,0.00010521037,0.00040606305,0.0011240388,0.00032443536],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007366876,0.0003382803,0.00056162773,0.00019629429,0.0003422652,0.000054786968,0.0001258413,0.00006406023,0.00004536014],"category_scores_gemma":[0.00004248313,0.00026091046,0.00017986727,0.0004083842,0.00014759749,0.000016629076,0.0001747425,0.00007177155,0.0000031041882],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.047110334,0.007032027,0.4585643,0.00035117878,0.007924074,0.000078115234,0.032891195,0.0005698013,0.16286175,0.000061049745,0.005171747,0.27738443],"study_design_scores_gemma":[0.0064988956,0.0017363889,0.9405175,0.00085876026,0.00013230092,0.000053083182,0.027168589,0.000008116939,0.022136722,0.00005679459,0.00037872535,0.00045413832],"about_ca_topic_score_codex":0.0033788853,"about_ca_topic_score_gemma":0.0027125683,"teacher_disagreement_score":0.48195317,"about_ca_system_score_codex":0.0005988169,"about_ca_system_score_gemma":0.00088424556,"threshold_uncertainty_score":0.9999843},"labels":[],"label_agreement":null},{"id":"W3147084398","doi":"10.1007/s10549-021-06205-8","title":"Exercise and health-related fitness predictors of chemotherapy completion in breast cancer patients: pooled analysis of two multicenter trials","year":2021,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer survivorship and care","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia; Alberta Health Services; University of Alberta","funders":"Canada Research Chairs; Alberta Innovates; Canadian Breast Cancer Research Alliance; Alberta Innovates - Health Solutions; Alberta Cancer Foundation","keywords":"Medicine; Breast cancer; Internal medicine; Logistic regression; Chemotherapy; Physical therapy; Aerobic exercise; Physical fitness; Chemotherapy regimen; Cancer; Regimen; Oncology","score_opus":0.059163771315368534,"score_gpt":0.3996673073864689,"score_spread":0.34050353607110034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3147084398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9835889,0.0097249225,0.0000019286335,0.0036637255,0.00008371208,0.00083187217,0.002070961,0.0000083099385,0.000025686222],"genre_scores_gemma":[0.98028886,0.018970735,0.000008638863,0.00004940661,0.00004020724,0.0002589327,0.00025809728,0.00001652627,0.00010856397],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978872,0.00028742125,0.000622195,0.0003854214,0.0004932321,0.0003245517],"domain_scores_gemma":[0.9986293,0.00011055483,0.00019113686,0.00022758624,0.0006074196,0.00023400852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059359515,0.00017010185,0.0011476559,0.00044492775,0.00005519614,0.00001513901,0.000041845535,0.0000631583,0.00056152954],"category_scores_gemma":[0.000011270018,0.00012802857,0.00014719233,0.0011296617,0.0001640567,0.000055855096,0.000036339166,0.00011375526,2.83757e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031028548,0.0014025836,0.8839971,0.00023119767,0.0023353358,0.000009877684,0.0019411439,0.000021427235,0.00038610963,0.0000132806845,0.00005428221,0.106504835],"study_design_scores_gemma":[0.013497398,0.00032005584,0.9823851,0.00092649384,0.00082471105,0.000005474603,0.0004847885,0.00022638302,0.0011851231,0.00001110836,0.00004954955,0.000083817446],"about_ca_topic_score_codex":0.098843716,"about_ca_topic_score_gemma":0.03304097,"teacher_disagreement_score":0.106421016,"about_ca_system_score_codex":0.00057873223,"about_ca_system_score_gemma":0.0004402306,"threshold_uncertainty_score":0.9846035},"labels":[],"label_agreement":null},{"id":"W3148244480","doi":"10.1007/s10549-021-06187-7","title":"DUCHESS: an evaluation of the ductal carcinoma in situ score for decisions on radiotherapy in patients with low/intermediate-risk DCIS","year":2021,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency; University of Alberta; University of Toronto; Western University; Royal Victoria Regional Health Centre; University of Ottawa; Health Sciences Centre; Ottawa Hospital; University of Calgary; Thunder Bay Regional Health Sciences Centre; Princess Margaret Cancer Centre; McMaster University; Sunnybrook Hospital; Trillium Health Centre; Juravinski Cancer Centre; Sunnybrook Health Science Centre","funders":"Genomic Health","keywords":"Medicine; Ductal carcinoma; Breast cancer; Internal medicine; Oncology; Radiation therapy; Cohort; Cohort study; Cancer; Prospective cohort study; Breast-conserving surgery; Gynecology; Mastectomy","score_opus":0.04307461667470092,"score_gpt":0.35062697621047917,"score_spread":0.30755235953577825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3148244480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969461,0.0014283025,0.000002704927,0.000265406,0.000044031436,0.0008354318,0.00044965892,0.0000014821087,0.00002688555],"genre_scores_gemma":[0.9982794,0.00067479,0.000043525757,0.0000155961,0.00006841505,0.000760603,0.00012546034,0.000016628494,0.000015584916],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998591,0.00021713333,0.00014123342,0.0004074914,0.00038067007,0.00026249123],"domain_scores_gemma":[0.99911493,0.000055437813,0.00004959263,0.0003276023,0.0003894538,0.000062981795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002237822,0.00014200177,0.00017092867,0.000075278316,0.00009617474,0.000015010153,0.00008440456,0.00005138362,0.000010088709],"category_scores_gemma":[0.00004109797,0.00008700888,0.00004312947,0.00019311697,0.00013763105,0.0000074703626,0.000045660778,0.00006313033,2.0750127e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030973032,0.0013397987,0.9284737,0.000007913991,0.00014188336,0.0000034564277,0.00032956255,0.00013962407,0.0012696858,0.000007065455,0.000023321865,0.06516669],"study_design_scores_gemma":[0.009152135,0.0011971651,0.9692815,0.00010253551,0.000032491294,0.000003667797,0.00019648897,0.000030196885,0.019843576,0.000059750982,0.00002126268,0.00007922831],"about_ca_topic_score_codex":0.0011666409,"about_ca_topic_score_gemma":0.019937666,"teacher_disagreement_score":0.06508746,"about_ca_system_score_codex":0.00039617758,"about_ca_system_score_gemma":0.00049165025,"threshold_uncertainty_score":0.9979459},"labels":[],"label_agreement":null},{"id":"W3161702437","doi":"10.1007/s10549-021-06238-z","title":"Sarcopenia and serum biomarkers of oxidative stress after a 6-month physical activity intervention in women with metastatic breast cancer: results from the ABLE feasibility trial","year":2021,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"Ministère de l'Education Nationale, de l'Enseignement Superieur et de la Recherche; Ligue Contre le Cancer; Agence Nationale de la Recherche","keywords":"Sarcopenia; Medicine; Breast cancer; Oxidative stress; Internal medicine; Glutathione peroxidase; Cancer; Gastroenterology; Oncology; Superoxide dismutase","score_opus":0.08671372881445939,"score_gpt":0.42580158216155845,"score_spread":0.33908785334709907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3161702437","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98325086,0.0010674419,0.0000021168319,0.009217763,0.000023234403,0.0012849671,0.0051119043,0.0000067541314,0.000034961166],"genre_scores_gemma":[0.9978553,0.0009418239,0.000060889884,0.00003104795,0.00008044013,0.00089599,0.000032045366,0.000010786843,0.00009164999],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99823785,0.00041994313,0.00019624777,0.00042888196,0.00036198576,0.00035507104],"domain_scores_gemma":[0.99899673,0.00025874923,0.000076570366,0.0002442064,0.00020751255,0.00021620706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041824888,0.00014082485,0.00038511225,0.00007070404,0.00009827302,0.000037912607,0.00003956139,0.000027944603,0.00012759013],"category_scores_gemma":[0.000019664547,0.00008341248,0.000037363872,0.00031844416,0.00025341794,0.00011151507,0.00006124149,0.00018844445,6.0393444e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6044853,0.006177429,0.14882073,0.00036387786,0.0007603099,0.00018452849,0.0033521967,0.000001736066,0.00068583275,0.000011715684,0.00004636002,0.23511001],"study_design_scores_gemma":[0.074799344,0.0014496266,0.9180097,0.0011755354,0.00006887964,0.000027177957,0.0021095197,0.00008104296,0.0020124372,0.0001612545,0.000031619744,0.00007386371],"about_ca_topic_score_codex":0.034388825,"about_ca_topic_score_gemma":0.019551786,"teacher_disagreement_score":0.769189,"about_ca_system_score_codex":0.0008195157,"about_ca_system_score_gemma":0.0005076733,"threshold_uncertainty_score":0.9983388},"labels":[],"label_agreement":null},{"id":"W3163142692","doi":"10.1007/s10549-021-06295-4","title":"NEK5 activity regulates the mesenchymal and migratory phenotype in breast cancer cells","year":2021,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; National Institutes of Health; Ministero dello Sviluppo Economico; Ontario Ministry of Economic Development and Innovation; Novartis Pharma; Tulane University; Wellcome Trust; European Federation of Pharmaceutical Industries and Associations; Merck KGaA; Genome Canada","keywords":"Cancer research; Kinome; Metastasis; Metastatic breast cancer; Biology; Cell migration; Cell growth; Breast cancer; Cancer; Cancer cell; Gene knockdown; Cell; Cell biology; Kinase; Cell culture","score_opus":0.01839222892442476,"score_gpt":0.30797924123849457,"score_spread":0.2895870123140698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3163142692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98639953,0.009648907,0.000001925375,0.003201136,0.000047623795,0.00021841924,0.0003789102,0.0000037605732,0.00009980286],"genre_scores_gemma":[0.9780961,0.020542137,0.000015734737,0.0000775451,0.00017619132,0.0001715066,0.000022412394,0.000015437334,0.00088291935],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9988496,0.00013221228,0.00009177252,0.00041576015,0.00014265355,0.0003680316],"domain_scores_gemma":[0.9994402,0.000024062907,0.000024249786,0.00026462777,0.0001244458,0.00012242184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013087089,0.00015016129,0.00014287459,0.000036839716,0.00016189786,0.000058232967,0.00007683418,0.0000902134,0.00005211311],"category_scores_gemma":[0.000003074863,0.00010237275,0.000037487313,0.0001391071,0.0002005699,0.000007057637,0.00014342171,0.00011875337,0.0000017754638],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047926806,0.00034234612,0.06414545,0.000031991665,0.0001885782,0.000037552993,0.00016464732,0.000016917797,0.84620523,0.000049121398,0.000914614,0.087424256],"study_design_scores_gemma":[0.0017277354,0.00018928183,0.53092396,0.00006916266,0.000034472236,0.000154156,0.00027951496,0.00010550576,0.458524,0.00007954188,0.007675747,0.00023695974],"about_ca_topic_score_codex":0.005755799,"about_ca_topic_score_gemma":0.012268831,"teacher_disagreement_score":0.4667785,"about_ca_system_score_codex":0.00010422783,"about_ca_system_score_gemma":0.0003754059,"threshold_uncertainty_score":0.8701084},"labels":[],"label_agreement":null},{"id":"W3165029584","doi":"10.1007/s10549-021-06255-y","title":"Combinatorial targeting of microRNA-26b and microRNA-101 exerts a synergistic inhibition on cyclooxygenase-2 in brain metastatic triple-negative breast cancer cells","year":2021,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Terry Fox Foundation; Al Jalila Foundation","keywords":"Extravasation; Cancer research; Triple-negative breast cancer; Downregulation and upregulation; microRNA; Breast cancer; Metastasis; Matrix metalloproteinase; Cancer; Biology; Medicine; Chemistry; Immunology; Internal medicine; Gene","score_opus":0.025213571495030618,"score_gpt":0.3292433093995798,"score_spread":0.3040297379045492,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165029584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99347144,0.002144198,0.000002015436,0.002158346,0.00025494353,0.0010222414,0.0008070673,0.000014348114,0.00012537588],"genre_scores_gemma":[0.99679613,0.0020674684,0.000053506363,0.00007787571,0.0002782335,0.0004362814,0.00006381299,0.00003724869,0.00018945165],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975551,0.00039909667,0.00038971275,0.0005539903,0.00050520716,0.00059690786],"domain_scores_gemma":[0.9984555,0.0005033266,0.00011778182,0.00020874584,0.0003463104,0.00036830426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051332114,0.00029345212,0.0006219733,0.00029703832,0.00015494929,0.000039668426,0.000040247174,0.00009222028,0.00017035603],"category_scores_gemma":[0.00008967688,0.00023060807,0.00007983627,0.00045578164,0.00026465405,0.0000820129,0.000059903912,0.000289559,0.000005524231],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01571616,0.004238395,0.028956953,0.0020424267,0.0010868373,0.005413233,0.003689192,0.00003059712,0.87639165,0.0007575871,0.0030912177,0.05858578],"study_design_scores_gemma":[0.029803267,0.0019015817,0.11950887,0.0030013584,0.00024840407,0.0004162334,0.0009826992,0.0001611223,0.8423465,0.0007129099,0.00046567217,0.0004514127],"about_ca_topic_score_codex":0.006262999,"about_ca_topic_score_gemma":0.0012626317,"teacher_disagreement_score":0.09055191,"about_ca_system_score_codex":0.00071305485,"about_ca_system_score_gemma":0.00077347807,"threshold_uncertainty_score":0.9467823},"labels":[],"label_agreement":null},{"id":"W3174437576","doi":"10.1007/s10549-021-06186-8","title":"Developing patient-centred strategies to optimize the management of vasomotor symptoms in breast cancer patients: a survey of health care providers","year":2021,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Menopause: Health Impacts and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; McMaster University; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Psychological intervention; Breast cancer; Family medicine; Health care; Affect (linguistics); Quality of life (healthcare); MEDLINE; Cancer; Nursing; Internal medicine; Psychology","score_opus":0.0883453615668979,"score_gpt":0.3982776545365396,"score_spread":0.30993229296964175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3174437576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97738576,0.012452929,0.000003388765,0.0052993475,0.00007567776,0.0028980875,0.0017811352,0.000010037264,0.00009366497],"genre_scores_gemma":[0.99283534,0.005720682,0.0002969559,0.0001458804,0.000014945566,0.00072981196,0.0001711975,0.000025834222,0.000059332575],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99732035,0.00031579955,0.00053979375,0.00044783013,0.00066799566,0.0007082442],"domain_scores_gemma":[0.99823266,0.000077825825,0.00015154295,0.00035304567,0.00083549565,0.00034943142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017790607,0.00023532906,0.0005449557,0.00017620868,0.00016298417,0.000041308587,0.00008658716,0.00004546804,0.000070561655],"category_scores_gemma":[0.000006330289,0.0001464551,0.000021454318,0.0006737603,0.00010679537,0.0000948507,0.0001135272,0.00010718228,0.0000016087973],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005957335,0.0028339399,0.58976245,0.0032483074,0.001918166,0.00012555254,0.011459453,0.00007778916,0.000046819103,0.00017486236,0.0001266987,0.38426864],"study_design_scores_gemma":[0.008867331,0.0025609748,0.97881454,0.0022358017,0.00007218784,0.00001666748,0.0069404836,0.0000069178896,0.00022429675,0.000011309279,0.00013822354,0.00011126403],"about_ca_topic_score_codex":0.08901575,"about_ca_topic_score_gemma":0.00894538,"teacher_disagreement_score":0.38905212,"about_ca_system_score_codex":0.0019510466,"about_ca_system_score_gemma":0.0026858437,"threshold_uncertainty_score":0.9170506},"labels":[],"label_agreement":null},{"id":"W3175806398","doi":"10.1007/s10549-021-06300-w","title":"Psychological consequences of MRI-based screening among women with strong family histories of breast cancer","year":2021,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Toronto General Hospital; University of Toronto; Health Sciences North; Public Health Ontario; NOSM University; St. Michael's Hospital","funders":"Cancer Care Ontario","keywords":"Worry; Breast cancer; Anxiety; Medicine; Breast cancer screening; Family history; Clinical psychology; Cancer; Internal medicine; Mammography; Oncology; Psychiatry","score_opus":0.050517180601116034,"score_gpt":0.3636759045878075,"score_spread":0.3131587239866915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3175806398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99352294,0.0037687249,0.00018166576,0.0010478415,0.0000414397,0.00019839744,0.0009995225,0.000005463905,0.0002339876],"genre_scores_gemma":[0.99734855,0.0010159378,0.000717168,0.000026378004,0.000078408186,0.0004882158,0.00004039049,0.000016192298,0.00026875484],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99861354,0.00010998669,0.00018424401,0.00042967347,0.00031319453,0.0003493891],"domain_scores_gemma":[0.9989045,0.000029060811,0.000087626795,0.0002885685,0.0005559382,0.00013428832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013815599,0.00015154095,0.00022976522,0.00006536228,0.00010536426,0.000019271047,0.00010838099,0.000081680686,0.00014402067],"category_scores_gemma":[0.000006655606,0.000112998685,0.000038367936,0.00023694405,0.001071001,0.000007428617,0.000051800253,0.00008180119,1.9794844e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005927496,0.00096972357,0.5693249,0.00014733672,0.0011582051,0.00007537708,0.0005909746,0.0016842805,0.33412427,0.00020771248,0.00060855947,0.085181184],"study_design_scores_gemma":[0.0034781005,0.001967552,0.7841233,0.00017348051,0.000053810196,0.00009743989,0.002161299,0.000029952489,0.20580475,0.000051674444,0.0017945914,0.00026404415],"about_ca_topic_score_codex":0.002219184,"about_ca_topic_score_gemma":0.0013754802,"teacher_disagreement_score":0.2147984,"about_ca_system_score_codex":0.0003282449,"about_ca_system_score_gemma":0.0010334793,"threshold_uncertainty_score":0.46079525},"labels":[],"label_agreement":null},{"id":"W3176168168","doi":"10.1007/s10549-021-06293-6","title":"COVID-19 vaccination and breast cancer surgery timing","year":2021,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Lymphadenopathy Diagnosis and Analysis","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Breast cancer; Vaccination; Axillary Lymphadenopathy; Coronavirus disease 2019 (COVID-19); Sentinel lymph node; Infectious disease (medical specialty); Axillary lymph nodes; Disease; General surgery; Biopsy; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Surgery; Oncology; Internal medicine; Cancer; Pathology; Outbreak","score_opus":0.21160634276509327,"score_gpt":0.4834449782410773,"score_spread":0.271838635475984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3176168168","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00045110067,0.9924641,0.0000015166707,0.0046255584,0.000055851902,0.0008194729,0.0014752159,0.00002897757,0.000078152494],"genre_scores_gemma":[0.0010044593,0.9944041,0.000007983485,0.00011658258,0.0006173711,0.0019083598,0.00042834057,0.000061279796,0.0014515345],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971119,0.00031699054,0.0004492512,0.00088670314,0.0006266401,0.000608512],"domain_scores_gemma":[0.9973732,0.00062082603,0.00015842587,0.00036711525,0.00032440436,0.001156023],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004952475,0.00044988174,0.0019976075,0.0004946931,0.0003587076,0.00017078227,0.000070730646,0.00021498099,0.002388903],"category_scores_gemma":[0.00007727043,0.00030229858,0.0003856576,0.00080317724,0.00010370624,0.00009168545,0.00012129158,0.00022074909,0.000010612832],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005680687,0.00041227057,0.006736559,0.008501358,0.001311741,0.0005484758,0.000068391615,3.50525e-7,3.6904808e-7,0.000013724454,0.002219369,0.9801306],"study_design_scores_gemma":[0.0016402362,0.000108288674,0.009723316,0.016363228,0.0036791887,0.0031739566,0.0001428937,0.000015895434,0.0000026225728,0.000011724381,0.964699,0.00043970154],"about_ca_topic_score_codex":0.012494354,"about_ca_topic_score_gemma":0.0007684934,"teacher_disagreement_score":0.9796909,"about_ca_system_score_codex":0.003178919,"about_ca_system_score_gemma":0.0055157435,"threshold_uncertainty_score":0.9999429},"labels":[],"label_agreement":null},{"id":"W3184056556","doi":"10.1007/s10549-021-06327-z","title":"Clinical outcomes and prognostic biomarkers among pregnant, post-partum and nulliparous women with breast cancer: a prospective cohort study","year":2021,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; McMaster University; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Proportional hazards model; Breast cancer; Prospective cohort study; Internal medicine; Pregnancy; Oncology; Gynecology; Cancer; Cohort; Survival analysis; Obstetrics","score_opus":0.03443636033829581,"score_gpt":0.38313934093316504,"score_spread":0.34870298059486926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3184056556","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904135,0.00330088,5.447421e-7,0.0018703713,0.000059993148,0.0034749645,0.00070611,0.00004090908,0.0001327572],"genre_scores_gemma":[0.9883031,0.007513101,0.000019863457,0.000044933786,0.00012484934,0.0031791672,0.0000196302,0.000042420797,0.00075288006],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99719715,0.00017277493,0.00031641294,0.0009883045,0.00059847516,0.00072685734],"domain_scores_gemma":[0.9980207,0.00020082125,0.00007908261,0.00034645028,0.00053717755,0.00081575697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035795127,0.00033859894,0.00076819153,0.00013545703,0.00029589218,0.00014416552,0.000052159503,0.000084267966,0.00014248806],"category_scores_gemma":[0.000030277553,0.00020905507,0.00005118781,0.00034126718,0.00073352136,0.00013316063,0.00012872522,0.00027985396,0.0000017009196],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048183156,0.0019837467,0.90086013,0.00008391669,0.0029525245,0.000711289,0.0011726181,2.3563526e-7,0.000011126938,0.0000051960487,0.000040596737,0.08736032],"study_design_scores_gemma":[0.008882622,0.0045793126,0.9817423,0.00039185263,0.00039539632,0.0006047629,0.0030460695,0.000011040339,0.0000150832,0.000014401222,0.00010015151,0.00021698956],"about_ca_topic_score_codex":0.027379923,"about_ca_topic_score_gemma":0.01842396,"teacher_disagreement_score":0.08714333,"about_ca_system_score_codex":0.00073426886,"about_ca_system_score_gemma":0.000995291,"threshold_uncertainty_score":0.9994872},"labels":[],"label_agreement":null},{"id":"W3186180211","doi":"10.1007/s10549-021-06393-3","title":"Population-based analysis of non-operative management and treatment patterns in older women with estrogen receptor-positive breast cancer","year":2021,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Jewish General Hospital; McGill University","funders":"Fonds de Recherche du Québec - Santé","keywords":"Medicine; Breast cancer; Mastectomy; Breast-conserving surgery; Axillary Lymph Node Dissection; Population; Sentinel lymph node; Radiation therapy; Stage (stratigraphy); Cohort; Surgery; Gynecology; Cancer; General surgery; Internal medicine","score_opus":0.01394940512214276,"score_gpt":0.3234483958171334,"score_spread":0.30949899069499065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3186180211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930167,0.0016823778,0.000021571605,0.00093638594,0.000017983913,0.0006119146,0.0036441477,0.000005735896,0.00006318288],"genre_scores_gemma":[0.99126816,0.0054351594,0.00014060062,0.000040215873,0.00005926299,0.0021517563,0.00061501405,0.000027442662,0.00026238267],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99804586,0.00013659747,0.0002257362,0.0007776327,0.00029731067,0.0005168356],"domain_scores_gemma":[0.9991071,0.000038078328,0.000073972704,0.0003219294,0.00026848057,0.00019041038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008086843,0.0003316026,0.0005075128,0.00026608826,0.00016423214,0.000044262804,0.000064788605,0.000072726565,0.00015458956],"category_scores_gemma":[0.000001392192,0.00024099798,0.00007143736,0.0006216398,0.00014929124,0.000013032133,0.000087600114,0.00005763225,7.153745e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002197166,0.0010497589,0.9330499,0.000035828278,0.0068273977,0.00006307784,0.00075115915,0.00043759693,0.00074413815,0.000017703813,0.000011015887,0.05481527],"study_design_scores_gemma":[0.004703959,0.0006804327,0.98626703,0.00014243727,0.00045925367,0.0000160701,0.0011678471,0.00006226521,0.0062366514,0.0000035354146,0.0000494341,0.00021105679],"about_ca_topic_score_codex":0.02272972,"about_ca_topic_score_gemma":0.022420397,"teacher_disagreement_score":0.05460421,"about_ca_system_score_codex":0.0010541781,"about_ca_system_score_gemma":0.00027931927,"threshold_uncertainty_score":0.9954179},"labels":[],"label_agreement":null},{"id":"W3193376311","doi":"10.1007/s10549-021-06344-y","title":"Patient and provider determinants of breast cancer screening among Ontario women aged 40–49: a population-based retrospective cohort study","year":2021,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Clinical Evaluative Sciences; Princess Margaret Cancer Centre; Public Health Ontario; Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Retrospective cohort study; Mammography; Cohort; Breast cancer screening; Logistic regression; Breast cancer; Population; Cancer screening; Cohort study; Gynecology; Family medicine; Demography; Cancer; Obstetrics; Internal medicine; Environmental health","score_opus":0.06119979431892037,"score_gpt":0.3720282873998819,"score_spread":0.31082849308096155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3193376311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969827,0.00068661885,0.000002567649,0.0002930107,0.000039857645,0.0015783124,0.0003093291,0.000018725283,0.000088901834],"genre_scores_gemma":[0.9978837,0.00013582867,0.00007710066,0.000049736533,0.0000736358,0.0012250618,0.000027041828,0.000024458319,0.0005034867],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99725264,0.00014697415,0.0003510259,0.0006777358,0.0009690751,0.00060252903],"domain_scores_gemma":[0.9984106,0.000062695515,0.00012357593,0.00032703034,0.00065583247,0.00042028842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033245006,0.00024918033,0.0006121809,0.0001552127,0.0002960411,0.00007158865,0.000052588533,0.00007098282,0.0003929522],"category_scores_gemma":[0.00002560005,0.0001952559,0.000061911545,0.00038007158,0.00016320824,0.00016105063,0.00009330114,0.00024345543,7.812476e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002661312,0.00063676934,0.95717037,0.000056083416,0.00040624052,0.00040306675,0.0022601117,0.000019490572,0.00007120944,0.0000014035705,0.000022699405,0.03629122],"study_design_scores_gemma":[0.003851387,0.0016041675,0.99080175,0.00059217185,0.00013814268,0.00012250066,0.0022937483,0.00009486108,0.00030552986,0.000016368975,0.000019112424,0.0001602338],"about_ca_topic_score_codex":0.54219496,"about_ca_topic_score_gemma":0.4252721,"teacher_disagreement_score":0.116922826,"about_ca_system_score_codex":0.0030888806,"about_ca_system_score_gemma":0.0012082674,"threshold_uncertainty_score":0.8077315},"labels":[],"label_agreement":null},{"id":"W3196278183","doi":"10.1007/s10549-021-06334-0","title":"Full population results from the core phase of CompLEEment-1, a phase 3b study of ribociclib plus letrozole as first-line therapy for advanced breast cancer in an expanded population","year":2021,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Novartis Pharmaceuticals Corporation","keywords":"Medicine; Tolerability; Letrozole; Internal medicine; Breast cancer; Adverse effect; Neutropenia; Metastatic breast cancer; Population; Oncology; Progression-free survival; Hazard ratio; Cancer; Confidence interval; Chemotherapy; Tamoxifen","score_opus":0.1592860876520025,"score_gpt":0.48420631349289217,"score_spread":0.32492022584088964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3196278183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9834991,0.0038192857,0.000039564773,0.001982508,0.00008175538,0.0032345324,0.0073152,0.000022285238,0.000005766582],"genre_scores_gemma":[0.9948252,0.0015552489,0.00017007338,0.000049275313,0.00027220475,0.0014736558,0.0015436109,0.000046286477,0.00006445213],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99732417,0.00018753976,0.00067551824,0.0006151013,0.00069027557,0.00050742435],"domain_scores_gemma":[0.9979581,0.00030384294,0.00028690894,0.00058762875,0.0006449293,0.0002185461],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003107692,0.00029806857,0.00069186697,0.00016884474,0.00021978648,0.000025064031,0.00012121109,0.00007132734,0.00015330814],"category_scores_gemma":[0.00003344581,0.00020905456,0.00009190722,0.00054248946,0.00012862934,0.00026137556,0.00005074725,0.00016224757,4.125823e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19674814,0.016157044,0.19203506,0.00007896033,0.00073856633,0.000034746823,0.006042198,0.0009871738,0.014641053,0.00004556293,0.00001584264,0.5724757],"study_design_scores_gemma":[0.19737636,0.013101398,0.77412325,0.00064715696,0.00016592731,0.000063300446,0.00688328,0.0015841911,0.0050903684,0.00046785353,0.000222849,0.00027406254],"about_ca_topic_score_codex":0.046969295,"about_ca_topic_score_gemma":0.038366277,"teacher_disagreement_score":0.5820882,"about_ca_system_score_codex":0.0009750114,"about_ca_system_score_gemma":0.00034171896,"threshold_uncertainty_score":0.97918105},"labels":[],"label_agreement":null},{"id":"W3197500711","doi":"10.1007/s10549-021-06366-6","title":"Immediate breast reconstruction in locally advanced breast cancer: is it safe?","year":2021,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Breast Implant and Reconstruction","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Providence Health Care; University of British Columbia","funders":"","keywords":"Medicine; Breast cancer; Mastectomy; Adjuvant therapy; Oncology; Internal medicine; Cancer; Adjuvant; Breast reconstruction; Surgery","score_opus":0.07638653743108041,"score_gpt":0.40612122213854723,"score_spread":0.3297346847074668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3197500711","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0030683377,0.98236865,0.000001478568,0.0038265362,0.0008043195,0.0023513502,0.006957612,0.00004398969,0.00057769887],"genre_scores_gemma":[0.0009798425,0.9923246,0.000079663754,0.000038257404,0.0012517237,0.0018833362,0.0005192592,0.00011379246,0.0028095145],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99502313,0.0003646235,0.0010218121,0.0014551461,0.00082252565,0.0013127812],"domain_scores_gemma":[0.99749124,0.000167073,0.00031966966,0.0006281555,0.0005831109,0.00081077183],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00039077378,0.00090257125,0.0027418488,0.0009897549,0.00029625255,0.00013301925,0.00018241917,0.00063987746,0.0025465835],"category_scores_gemma":[0.0000055266,0.000658223,0.00050817226,0.0012950987,0.0005207183,0.0002519636,0.00014428874,0.001125284,0.000101938334],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00095384946,0.00044886427,0.0018701841,0.0038517814,0.0010191527,0.00050421944,0.00009831597,5.8820564e-7,0.0000028138838,0.000019774512,0.0005403511,0.9906901],"study_design_scores_gemma":[0.009640503,0.0005215918,0.008902244,0.09206447,0.0016766075,0.6454719,0.00064706354,0.000022717237,0.000015313186,0.000047072102,0.23981437,0.0011761738],"about_ca_topic_score_codex":0.00747594,"about_ca_topic_score_gemma":0.0029763475,"teacher_disagreement_score":0.98951393,"about_ca_system_score_codex":0.0033147517,"about_ca_system_score_gemma":0.0045004524,"threshold_uncertainty_score":0.9995869},"labels":[],"label_agreement":null},{"id":"W3198753429","doi":"10.1007/s10549-021-06372-8","title":"The characteristics associated with upgrade on surgical pathology of conventional imaging occult DCIS diagnosed by MRI","year":2021,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"MRI in cancer diagnosis","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Sinai Health System; Women's College Hospital; University of Toronto; University Health Network","funders":"","keywords":"Occult; Medicine; Breast MRI; Breast cancer; Radiology; Surgical pathology; Magnetic resonance imaging; Breast imaging; Pathology; Mammary gland; Mammography; Cancer; Internal medicine","score_opus":0.03626721805103881,"score_gpt":0.36208222450832,"score_spread":0.3258150064572812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3198753429","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9572928,0.0038923966,0.0000037743398,0.03607259,0.00007672653,0.00049236574,0.0016329332,0.000018643595,0.000517762],"genre_scores_gemma":[0.98056436,0.017431589,0.000014575324,0.00009377165,0.00010555075,0.00048324277,0.00027234695,0.000019226538,0.0010153273],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99832004,0.00019644211,0.00019490872,0.0003305514,0.00055781077,0.00040021553],"domain_scores_gemma":[0.998147,0.00090455747,0.0000724027,0.00023432406,0.00045018687,0.00019151524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025624095,0.00014005539,0.0002962093,0.000051246003,0.00020390068,0.000035582194,0.000056374152,0.000048924954,0.00026681344],"category_scores_gemma":[0.00005086618,0.000082714345,0.000060771406,0.00023101734,0.00042373542,0.000024915476,0.000038403534,0.0001873365,0.000004762708],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003102099,0.0030219466,0.89996284,0.000052813568,0.00091506104,0.004746309,0.00018808225,0.0000013370471,0.0005726631,0.00068658666,0.020171598,0.06657864],"study_design_scores_gemma":[0.009844741,0.0014918072,0.9474686,0.0005756616,0.00013548107,0.0006241374,0.00024350962,0.00004820674,0.005299081,0.00007400817,0.034048364,0.00014643751],"about_ca_topic_score_codex":0.0004372118,"about_ca_topic_score_gemma":0.0002780768,"teacher_disagreement_score":0.0664322,"about_ca_system_score_codex":0.0005042506,"about_ca_system_score_gemma":0.00048011314,"threshold_uncertainty_score":0.33729932},"labels":[],"label_agreement":null},{"id":"W3200570903","doi":"10.1007/s10549-021-06377-3","title":"Impact of the menstrual cycle on commercial prognostic gene signatures in oestrogen receptor-positive primary breast cancer","year":2021,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa; University of Toronto","funders":"Breast Cancer Research Foundation","keywords":"Menstrual cycle; Oestrogen receptor; Breast cancer; Medicine; Internal medicine; Progesterone receptor; Estrogen; Endocrinology; Estrogen receptor; Oncology; Gynecology; Cancer; Physiology; Hormone","score_opus":0.019410505661243596,"score_gpt":0.3389526644688165,"score_spread":0.3195421588075729,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3200570903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882788,0.0043753204,4.5214838e-7,0.0018858215,0.00008149193,0.0005188384,0.004624847,0.000005783011,0.00022861674],"genre_scores_gemma":[0.9960507,0.0027790742,0.00002547173,0.000064700085,0.0002766308,0.00051405083,0.00014190817,0.000029310091,0.000118146505],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981094,0.000244972,0.00019689009,0.00054960896,0.00037060987,0.0005284928],"domain_scores_gemma":[0.9990597,0.000066436296,0.000071096736,0.00035392347,0.00030901373,0.0001398478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009603097,0.00028250433,0.00031242653,0.00006830597,0.0002070027,0.000028796872,0.00014886534,0.000116125135,0.000094729614],"category_scores_gemma":[0.000013164269,0.00018030853,0.00015893472,0.00030441664,0.00034107757,0.000008218842,0.00022696472,0.00017274996,0.000001911767],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035939564,0.0017430598,0.8920847,0.000028870425,0.0014257055,0.000043101736,0.00032491662,0.00030667687,0.041583702,0.00004229712,0.0006439709,0.05817902],"study_design_scores_gemma":[0.0024906779,0.00055678614,0.9538571,0.0001455118,0.000050576706,0.00006842273,0.00008440895,0.0000031294978,0.042501997,0.000023223502,0.00006716493,0.0001509653],"about_ca_topic_score_codex":0.0071404055,"about_ca_topic_score_gemma":0.0034574904,"teacher_disagreement_score":0.061772414,"about_ca_system_score_codex":0.0007656504,"about_ca_system_score_gemma":0.0010172755,"threshold_uncertainty_score":0.9994711},"labels":[],"label_agreement":null},{"id":"W3202734983","doi":"10.1007/s10549-021-06405-2","title":"Novel classes of immunotherapy for breast cancer","year":2021,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Breast cancer; Immunotherapy; Tumor microenvironment; Medicine; Immune checkpoint; Cancer; Oncology; Immune system; Disease; Cancer immunotherapy; Immunology; Cancer research; Internal medicine","score_opus":0.1567430733818638,"score_gpt":0.46845098389637924,"score_spread":0.3117079105145154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3202734983","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013548462,0.98387027,0.000011577862,0.001148836,0.00019316858,0.0027541735,0.011763044,0.000021953721,0.00010151681],"genre_scores_gemma":[0.00012668347,0.9918082,0.0001387445,0.000044872377,0.0005672707,0.0043069264,0.00026118194,0.00011214342,0.0026339744],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972903,0.00010377703,0.0006251628,0.00073272444,0.00055054383,0.00069750816],"domain_scores_gemma":[0.99800164,0.00029607542,0.00024049432,0.00057550304,0.0006468536,0.00023941172],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032531325,0.0005355843,0.0021917014,0.00035851772,0.0001863391,0.00006377291,0.00016599474,0.00029275945,0.00089949806],"category_scores_gemma":[0.0000065825343,0.00035152398,0.0007944862,0.00063536526,0.00038960512,0.00005974653,0.000058150243,0.00027290094,0.0000023576727],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029215997,0.0010163557,0.00012041409,0.0076398514,0.0048899767,0.000020050833,0.000060283634,7.6258075e-8,0.00021509935,0.000054030606,0.0008682235,0.98219407],"study_design_scores_gemma":[0.006253392,0.0009517823,0.001386731,0.028929815,0.0009084475,0.0010993949,0.000071534974,0.0000014087324,0.00009174524,0.000007030905,0.95998347,0.00031523287],"about_ca_topic_score_codex":0.007618297,"about_ca_topic_score_gemma":0.00065633113,"teacher_disagreement_score":0.9818788,"about_ca_system_score_codex":0.0015302988,"about_ca_system_score_gemma":0.004117055,"threshold_uncertainty_score":0.99989367},"labels":[],"label_agreement":null},{"id":"W3206145754","doi":"10.1007/s10549-021-06414-1","title":"Comparison of upper extremity lymphedema after sentinel lymph node biopsy and axillary lymph node dissection: patient-reported outcomes in 3044 patients","year":2021,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Lymphatic System and Diseases","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Lymphedema; Axillary Lymph Node Dissection; Biopsy; Lymph node; Radiology; Axilla; Dissection (medical); Breast cancer; Sentinel lymph node; Lymph; Axillary Dissection; Surgery; Cancer; Internal medicine; Pathology","score_opus":0.04340044689382134,"score_gpt":0.36583052213939504,"score_spread":0.3224300752455737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3206145754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99135256,0.0066634845,0.0000024620635,0.00077983836,0.00011273774,0.00041286985,0.00019608295,0.000019568079,0.00046042068],"genre_scores_gemma":[0.99838847,0.00047124233,0.00006266007,0.00006222916,0.00005490434,0.00032583665,0.00009708777,0.000023101302,0.0005144587],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99775434,0.00014885963,0.00051821204,0.0005103398,0.0006277101,0.00044054544],"domain_scores_gemma":[0.99861944,0.00012318879,0.00010492364,0.0003545713,0.00041101014,0.00038685446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010335863,0.00024378611,0.0006177623,0.00017659774,0.00010979918,0.000041505456,0.000036449037,0.00009310683,0.0002356594],"category_scores_gemma":[0.000062206134,0.00017707299,0.000101653,0.00033672297,0.00019121869,0.000101575504,0.000102475045,0.000018670453,0.000005222915],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012575961,0.003526705,0.9747255,0.00031259411,0.00032208662,0.00041348606,0.00043576307,0.0000015711212,0.00021848812,0.000009656378,0.000024318073,0.018752258],"study_design_scores_gemma":[0.008034125,0.000067762936,0.9890119,0.00051977515,0.00012904163,0.00036426785,0.00084592233,0.00009180204,0.00073484116,0.000021007752,0.000037154135,0.00014244128],"about_ca_topic_score_codex":0.0030880289,"about_ca_topic_score_gemma":0.000065572574,"teacher_disagreement_score":0.018609818,"about_ca_system_score_codex":0.0006220938,"about_ca_system_score_gemma":0.0005176344,"threshold_uncertainty_score":0.7220827},"labels":[],"label_agreement":null},{"id":"W3210722715","doi":"10.1007/s10549-021-06431-0","title":"Breast cancer immune microenvironment: from pre-clinical models to clinical therapies","year":2021,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Tumor microenvironment; Immune system; Breast cancer; Cancer research; Cancer; Immunology; Medicine; Biology; Internal medicine","score_opus":0.22796645007064711,"score_gpt":0.4921559509684505,"score_spread":0.26418950089780335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3210722715","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004262292,0.98232555,0.0000059476642,0.0029768902,0.0005321368,0.0029665446,0.0067949025,0.000043544816,0.00009216518],"genre_scores_gemma":[0.0007078356,0.98937184,0.00013169629,0.0002202191,0.0020604134,0.002697716,0.00051359617,0.00015359516,0.0041430807],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99377656,0.00096416863,0.0016363839,0.0017198077,0.0008711805,0.0010318905],"domain_scores_gemma":[0.9967073,0.00061761646,0.0002912825,0.001245835,0.0002184795,0.00091944647],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009937485,0.0008353527,0.003545497,0.00025613123,0.00027596916,0.00016415813,0.00034750038,0.00060296315,0.0027558382],"category_scores_gemma":[0.0000086440705,0.00055385527,0.0013599587,0.00051426346,0.00071178086,0.000103987906,0.00032425605,0.0009780864,0.000075064105],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042733406,0.0017903295,0.0017448,0.000823593,0.007982025,0.00019612735,0.00019254086,4.95138e-7,0.000005420153,0.0000066080215,0.0019859779,0.98099875],"study_design_scores_gemma":[0.0055900984,0.0013002421,0.027325395,0.021409769,0.0018060212,0.0005422579,0.00010681546,0.000005954612,0.000005349634,0.000029151388,0.9412989,0.00058005453],"about_ca_topic_score_codex":0.023380933,"about_ca_topic_score_gemma":0.0012911463,"teacher_disagreement_score":0.9804187,"about_ca_system_score_codex":0.0017321183,"about_ca_system_score_gemma":0.0025163412,"threshold_uncertainty_score":0.9996913},"labels":[],"label_agreement":null},{"id":"W3215701750","doi":"10.1007/s10549-021-06450-x","title":"Ipatasertib plus paclitaxel for PIK3CA/AKT1/PTEN-altered hormone receptor-positive HER2-negative advanced breast cancer: primary results from cohort B of the IPATunity130 randomized phase 3 trial","year":2021,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":88,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"Genentech; F. Hoffmann-La Roche","keywords":"Medicine; Breast cancer; Internal medicine; Hazard ratio; Placebo; Paclitaxel; Taxane; Oncology; Clinical endpoint; Chemotherapy; Cancer; Gastroenterology; Randomized controlled trial; Confidence interval; Pathology","score_opus":0.03520119051657982,"score_gpt":0.3610917612727934,"score_spread":0.3258905707562136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215701750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9119057,0.007861085,0.00009715852,0.0023193553,0.0004340307,0.003984825,0.07321628,0.000015307998,0.00016627171],"genre_scores_gemma":[0.9791358,0.010840936,0.00038694296,0.00012781516,0.0010299023,0.0043245656,0.0031967626,0.00006372807,0.00089355215],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9961389,0.0008817526,0.00063901936,0.001040319,0.0006165639,0.0006834579],"domain_scores_gemma":[0.99681693,0.00064021186,0.0003326371,0.0007921637,0.001115234,0.00030279616],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00074968685,0.0004131853,0.00089470414,0.000067422785,0.00036494463,0.000067018176,0.00030688616,0.00021141264,0.00007738845],"category_scores_gemma":[0.00028461937,0.00029119733,0.00035092334,0.0002992684,0.00073177926,0.000022971835,0.00024761664,0.00024854223,0.000001690314],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.79272276,0.0010192482,0.00021147814,0.00003452076,0.0019909034,0.000010924171,0.00031824593,0.000049055852,0.1693142,0.000016471302,0.002249087,0.032063078],"study_design_scores_gemma":[0.6440489,0.0019398048,0.0039240434,0.0003008515,0.00033541126,0.000021483698,0.0002498379,0.00008087111,0.34650376,0.00020464756,0.0020096188,0.00038071137],"about_ca_topic_score_codex":0.01240168,"about_ca_topic_score_gemma":0.001720148,"teacher_disagreement_score":0.17718956,"about_ca_system_score_codex":0.00079261337,"about_ca_system_score_gemma":0.0021788757,"threshold_uncertainty_score":0.99995404},"labels":[],"label_agreement":null},{"id":"W3216654828","doi":"10.1007/s10549-021-06457-4","title":"Impact of rapid genetic testing for BRCA1 and BRCA2 at time of breast cancer diagnosis on psychosocial functioning","year":2021,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Health Sciences Centre; Sunnybrook Health Science Centre; Women's College Hospital; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Breast cancer; Psychosocial; Genetic testing; Medicine; BRCA2 Protein; Oncology; Cancer; Internal medicine; Clinical psychology; Biology; Genetics; Psychiatry; Mutation; Gene; Germline mutation","score_opus":0.04670255303637044,"score_gpt":0.3774977584194234,"score_spread":0.33079520538305296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216654828","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98938644,0.0069996337,0.000010632585,0.0005568843,0.00005309416,0.00034704682,0.0025310025,0.000004036828,0.00011121629],"genre_scores_gemma":[0.99441165,0.0035224312,0.0003000742,0.000018458208,0.0003016864,0.0010140345,0.00006969699,0.000026772284,0.0003352184],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988282,0.00006844993,0.00018299425,0.00042824156,0.000189901,0.0003022504],"domain_scores_gemma":[0.99895537,0.00010460119,0.000083072366,0.00021758424,0.0005210038,0.00011834633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010742778,0.000152509,0.0002083433,0.000067728135,0.00018302,0.000021857526,0.000058237783,0.000083509316,0.00026280817],"category_scores_gemma":[0.00003216399,0.00012904579,0.0000904231,0.00019791434,0.00018933274,0.0000047955637,0.00007510564,0.000049881328,0.0000010389695],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016949002,0.00047624164,0.44915944,0.00008702981,0.0009971285,0.000004598177,0.000191045,0.0002875054,0.15879308,0.0000058379824,0.0027136568,0.38558954],"study_design_scores_gemma":[0.002615799,0.0020426845,0.9249076,0.00012892994,0.00007504706,0.00008982221,0.000053129606,0.00008431332,0.06911531,0.000045936413,0.0006888065,0.0001525972],"about_ca_topic_score_codex":0.0015246053,"about_ca_topic_score_gemma":0.00043691028,"teacher_disagreement_score":0.47574818,"about_ca_system_score_codex":0.00044515386,"about_ca_system_score_gemma":0.00071910874,"threshold_uncertainty_score":0.52623343},"labels":[],"label_agreement":null},{"id":"W3216668262","doi":"10.1007/s10549-021-06448-5","title":"Predicting the clinical outcomes and benefit from letrozole after 5 years of treatment with aromatase inhibitors for early breast cancer: analysis from CCTG MA.17R","year":2021,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Nomogram; Letrozole; Medicine; Oncology; Internal medicine; Breast cancer; Placebo; Aromatase; Aromatase inhibitor; Concordance; Cancer; Pathology","score_opus":0.02995413333652299,"score_gpt":0.3482789496093993,"score_spread":0.31832481627287634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216668262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9648833,0.009597685,0.000008920069,0.0016450348,0.00006304645,0.00051926466,0.023263367,0.000009974093,0.000009385531],"genre_scores_gemma":[0.9895725,0.0075197294,0.0001969919,0.00004439404,0.00039063365,0.0014525132,0.00060328434,0.00003456284,0.00018536286],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99795383,0.00010341977,0.0003455819,0.0008461832,0.0002940166,0.00045698034],"domain_scores_gemma":[0.99858904,0.00026907364,0.00012673273,0.00054133433,0.00025487284,0.00021893281],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011963809,0.00032060148,0.0005872526,0.0000804224,0.00021691716,0.000076682765,0.000107128195,0.00011491753,0.0000545019],"category_scores_gemma":[0.0000090165895,0.00019981206,0.00024283586,0.00026394863,0.0004032324,0.000014848764,0.0001648898,0.00008602897,0.000001018366],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029425258,0.0004956355,0.92014897,0.000009019927,0.009226507,0.000030765415,0.00031100918,0.000013858833,0.00027701203,0.000004432637,0.000039076378,0.06650118],"study_design_scores_gemma":[0.004752079,0.0009155434,0.98914057,0.000066474,0.001549863,0.00001398891,0.0004373916,0.000017834196,0.0022845322,0.00005956274,0.00057994237,0.00018224686],"about_ca_topic_score_codex":0.07196543,"about_ca_topic_score_gemma":0.04393195,"teacher_disagreement_score":0.06899156,"about_ca_system_score_codex":0.00024297365,"about_ca_system_score_gemma":0.0003110115,"threshold_uncertainty_score":0.9735138},"labels":[],"label_agreement":null},{"id":"W4205172350","doi":"10.1007/s10549-021-06473-4","title":"Yield of flow cytometry in addition to cytology for lymph node sampling in patients with incidental axillary adenopathy without a concurrent diagnosis of primary breast malignancy","year":2022,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Lymphadenopathy Diagnosis and Analysis","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Radiology; Malignancy; Axillary Lymphadenopathy; Fine-needle aspiration; Cytology; Lymphoma; Breast cancer; Axillary lymph nodes; Lymph node; Biopsy; Pathology; Internal medicine; Cancer","score_opus":0.04177114855228701,"score_gpt":0.33346702272891,"score_spread":0.29169587417662296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205172350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927867,0.0012081844,0.000019466002,0.00041723295,0.00003006997,0.0012797292,0.0042371796,0.000006177321,0.000015256888],"genre_scores_gemma":[0.99530697,0.00052551506,0.00016767556,0.000057118246,0.00003814558,0.0034634122,0.0004053625,0.000025112982,0.000010676583],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979777,0.000105204585,0.00041238253,0.00044704153,0.00063317595,0.00042450358],"domain_scores_gemma":[0.99904233,0.00022471134,0.000115040304,0.00020564412,0.00023091542,0.00018133469],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027502564,0.00018505471,0.0006586613,0.0008245889,0.00009469883,0.0000101559035,0.00009387966,0.000048360518,0.00016403937],"category_scores_gemma":[0.00002655229,0.00014696698,0.000078700476,0.00087943743,0.000099728495,0.000070197195,0.00013880797,0.00009705309,6.2577254e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038603232,0.0037440099,0.9130282,0.00020217082,0.00016402706,0.000044761968,0.00043084752,0.00008707866,0.00019373042,0.000013860398,0.000024149684,0.07820685],"study_design_scores_gemma":[0.009247537,0.0027451043,0.9855878,0.0008109451,0.00010130066,0.00006499953,0.00053729466,0.000066535205,0.000677182,0.000010545658,0.00002626027,0.00012449303],"about_ca_topic_score_codex":0.0037894172,"about_ca_topic_score_gemma":0.000546684,"teacher_disagreement_score":0.07808236,"about_ca_system_score_codex":0.0015613101,"about_ca_system_score_gemma":0.0004161431,"threshold_uncertainty_score":0.599314},"labels":[],"label_agreement":null},{"id":"W4205694647","doi":"10.1007/s10549-021-06434-x","title":"Inflammatory breast cancer defined: proposed common diagnostic criteria to guide treatment and research","year":2022,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Cancer Center, University of Kansas; York University; Susan G. Komen; Erasmus Universiteit Rotterdam; Breast Cancer Research Foundation","keywords":"Medicine; Inflammatory breast cancer; Breast cancer; Clinical trial; Categorization; Cancer; Medical physics; Intensive care medicine; Pathology; Internal medicine; Artificial intelligence","score_opus":0.1107589988330923,"score_gpt":0.45493256197461124,"score_spread":0.3441735631415189,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205694647","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008535963,0.97555006,4.7382107e-7,0.0018732473,0.00022795728,0.004376471,0.009045288,0.000043010496,0.00034750687],"genre_scores_gemma":[0.003780124,0.97228235,0.000041657244,0.000048162954,0.0010490529,0.020000085,0.00077504665,0.00020468843,0.0018188275],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9932867,0.0012566308,0.0007228369,0.0020928173,0.00093543064,0.0017055607],"domain_scores_gemma":[0.99660325,0.0007457043,0.0001710603,0.0011757076,0.00042577786,0.00087850913],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.00076112483,0.0011303351,0.00175948,0.00066509104,0.0013565978,0.00026191786,0.00047832882,0.00034682578,0.00053565437],"category_scores_gemma":[0.000084251544,0.00082978944,0.0003145431,0.0007559089,0.0007212101,0.000018830242,0.0013236122,0.0004907691,0.000038628645],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008353778,0.0009515808,0.0045341034,0.0016407802,0.0022123107,0.0002162246,0.0002994028,0.0000016465553,0.000041519328,0.000047426063,0.0049821897,0.98423743],"study_design_scores_gemma":[0.0021285855,0.002094444,0.0063755224,0.0022917355,0.00060775783,0.00075988047,0.00022285164,6.732139e-7,0.00007219847,0.000030988147,0.98470074,0.0007146357],"about_ca_topic_score_codex":0.018889327,"about_ca_topic_score_gemma":0.008389665,"teacher_disagreement_score":0.9835228,"about_ca_system_score_codex":0.0040037283,"about_ca_system_score_gemma":0.0026156942,"threshold_uncertainty_score":0.9999435},"labels":[],"label_agreement":null},{"id":"W4205726578","doi":"10.1007/s10549-021-06452-9","title":"Comprehensive immunohistochemical analysis of RET, BCAR1, and BCAR3 expression in patients with Luminal A and B breast cancer subtypes","year":2022,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Conselho Nacional de Desenvolvimento Científico e Tecnológico; Fundação de Amparo à Pesquisa do Estado de São Paulo","keywords":"Breast cancer; Immunohistochemistry; Cancer; Endocrine system; Gene expression; Gene expression profiling","score_opus":0.01572996857839717,"score_gpt":0.30611876618415435,"score_spread":0.2903887976057572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205726578","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889789,0.008431724,7.635831e-7,0.000366095,0.000018744688,0.00035107616,0.0018261832,0.0000040196137,0.000022473274],"genre_scores_gemma":[0.99674606,0.0022642354,0.000030305391,0.000019089257,0.00003483511,0.0006435085,0.00019193074,0.000017139915,0.00005286749],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985126,0.000115159055,0.00016596934,0.00054663594,0.00033362303,0.00032599096],"domain_scores_gemma":[0.9993643,0.00003308952,0.00007088768,0.00022422163,0.00019124491,0.00011623075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000068589194,0.00020803402,0.00036014777,0.00021021934,0.00023745216,0.000015833137,0.000074531716,0.00004684457,0.00004703848],"category_scores_gemma":[0.0000022571894,0.00015794241,0.000043842167,0.0003835029,0.00039035856,0.000008777646,0.00031142583,0.000109868044,9.069443e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061638285,0.0005268496,0.9742722,0.00003062115,0.0012969731,0.0000086665095,0.00035840596,0.00002730012,0.007734027,0.0000047934445,0.000078277,0.009498038],"study_design_scores_gemma":[0.003545696,0.00066713523,0.9927475,0.00004132009,0.00024815885,0.000021812153,0.00041201428,0.00001136934,0.0018460361,0.000006148995,0.00030477528,0.00014802271],"about_ca_topic_score_codex":0.0060892785,"about_ca_topic_score_gemma":0.00093393924,"teacher_disagreement_score":0.018475292,"about_ca_system_score_codex":0.0002705221,"about_ca_system_score_gemma":0.00012666247,"threshold_uncertainty_score":0.92052084},"labels":[],"label_agreement":null},{"id":"W4206303014","doi":"10.1007/s10549-021-06374-6","title":"Correction to: Full population results from the core phase of CompLEEment-1, a phase 3b study of ribociclib plus letrozole as first-line therapy for advanced breast cancer in an expanded population","year":2021,"lang":"en","type":"erratum","venue":"Breast Cancer Research and Treatment","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Letrozole; Breast cancer; Medicine; Oncology; Population; Cancer; Phase (matter); Internal medicine; Gynecology; Tamoxifen","score_opus":0.12615718773354898,"score_gpt":0.4729401635544931,"score_spread":0.3467829758209441,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206303014","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9659561,0.0065233577,0.000048063164,0.0015697195,0.0023151692,0.0072440486,0.016285688,0.000036370187,0.000021490376],"genre_scores_gemma":[0.9794485,0.0039138957,0.00009231493,0.000062783576,0.001416226,0.00379897,0.009319671,0.00011239448,0.0018352313],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9957611,0.0002819847,0.0010502915,0.001055687,0.0011356225,0.0007153434],"domain_scores_gemma":[0.9967254,0.00040926793,0.00060702674,0.0008653607,0.0010464151,0.0003465608],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004280546,0.0005862531,0.0013341745,0.00043264532,0.00030694364,0.000047019003,0.00021024243,0.000203257,0.00017494579],"category_scores_gemma":[0.000075709744,0.00042873374,0.00016667007,0.00085475214,0.00013389345,0.00026108266,0.00008374065,0.0005084349,6.3022924e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2418059,0.017305933,0.03574658,0.00020560889,0.0014310221,0.00003461191,0.0071594976,0.0013620041,0.0024281696,0.000007277837,0.0033670426,0.68914634],"study_design_scores_gemma":[0.24203098,0.039548825,0.68886817,0.005913395,0.00064807653,0.0001252143,0.011111314,0.0037425957,0.0011632867,0.00019454634,0.005728579,0.0009250274],"about_ca_topic_score_codex":0.13336775,"about_ca_topic_score_gemma":0.1221976,"teacher_disagreement_score":0.68822134,"about_ca_system_score_codex":0.0026039174,"about_ca_system_score_gemma":0.0007908949,"threshold_uncertainty_score":0.9998164},"labels":[],"label_agreement":null},{"id":"W4210606558","doi":"10.1007/s10549-021-06475-2","title":"Behavioral and health outcomes from the NRG Oncology/NSABP B-36 trial comparing two different adjuvant therapy regimens for early-stage node-negative breast cancer","year":2022,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Université Laval; McGill University Health Centre; University of Calgary; Centre Hospitalier de l’Université de Montréal","funders":"National Cancer Institute","keywords":"Medicine; Epirubicin; Internal medicine; Breast cancer; Amenorrhea; Quality of life (healthcare); Randomization; Cancer; Oncology; Randomized controlled trial; Pregnancy","score_opus":0.1691916945966959,"score_gpt":0.45006740860172334,"score_spread":0.2808757140050274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210606558","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9633224,0.0072879433,0.0000068427644,0.01668696,0.000248788,0.0024131166,0.00998418,0.000019659909,0.000030081563],"genre_scores_gemma":[0.98434067,0.0060477667,0.00004776054,0.00035039443,0.00046017638,0.008136404,0.00025366008,0.00004891493,0.0003142634],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99728966,0.00038231918,0.0003011516,0.00083807134,0.00042838976,0.00076040183],"domain_scores_gemma":[0.9988361,0.00017755936,0.00016529184,0.00042643034,0.00014393641,0.00025069114],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.00031485024,0.0004045513,0.000619434,0.00006276992,0.0014054939,0.000079969665,0.00022648326,0.00006161494,0.00011362557],"category_scores_gemma":[0.000004001559,0.00025446204,0.00014934046,0.00011526326,0.0003962232,0.000011597829,0.0004152278,0.00023510722,7.913859e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09382544,0.0028496794,0.6988147,0.000016028946,0.0023578326,0.000018746008,0.0028163295,0.000036701214,0.0005103574,0.00006476452,0.001915453,0.196774],"study_design_scores_gemma":[0.069020584,0.0037214987,0.91964984,0.000031532367,0.00010147703,0.000028230557,0.001619297,0.00002076145,0.0006612216,0.0000896896,0.004766987,0.00028887417],"about_ca_topic_score_codex":0.10979163,"about_ca_topic_score_gemma":0.027284393,"teacher_disagreement_score":0.22083518,"about_ca_system_score_codex":0.0011170887,"about_ca_system_score_gemma":0.00054446055,"threshold_uncertainty_score":0.99999076},"labels":[],"label_agreement":null},{"id":"W4210785085","doi":"10.1007/s10549-021-06488-x","title":"Long-term outcomes of women with large DCIS lesions treated with breast-conserving therapy","year":2022,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; Princess Margaret Cancer Centre; Public Health Ontario; University of Toronto","funders":"Canadian Cancer Society Research Institute; Institute for Clinical Evaluative Sciences","keywords":"Medicine; Breast cancer; Internal medicine; Breast-conserving surgery; Proportional hazards model; Radiation therapy; Cohort; Hazard ratio; Oncology; Gynecology; Cancer; Mastectomy; Confidence interval","score_opus":0.03550043262724635,"score_gpt":0.33460816473508936,"score_spread":0.299107732107843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210785085","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941142,0.0023831797,0.0000063752877,0.001147079,0.000015950483,0.00060893677,0.0016003929,0.000019134286,0.00010471448],"genre_scores_gemma":[0.9948899,0.0018209475,0.000032487485,0.00006565793,0.000051435483,0.0024104526,0.00013764732,0.000047398007,0.0005440746],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978438,0.00016095565,0.00016861595,0.0005773812,0.00046499455,0.000784275],"domain_scores_gemma":[0.9989713,0.000044879078,0.00008415049,0.00045743267,0.00021649462,0.0002257644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000183984,0.00031011095,0.00038518384,0.00013446198,0.00061493146,0.00002916165,0.00017635243,0.000042735992,0.00026542245],"category_scores_gemma":[0.0000024177186,0.00019192888,0.00005429361,0.00031331874,0.00027021422,0.000010009848,0.00023461846,0.000114434355,0.0000013524553],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008454074,0.0015181743,0.95342946,0.000017636426,0.0019608238,0.00007253248,0.00049330003,0.000013561512,0.0016518446,0.000024919691,0.00005914994,0.032304544],"study_design_scores_gemma":[0.0071707503,0.0034304701,0.9842516,0.000030917585,0.000047981102,0.00037807578,0.00087579334,0.0000011894274,0.0030489063,0.0000086712125,0.0005430506,0.00021259283],"about_ca_topic_score_codex":0.0034406492,"about_ca_topic_score_gemma":0.0019285078,"teacher_disagreement_score":0.032091953,"about_ca_system_score_codex":0.0005554683,"about_ca_system_score_gemma":0.00039009217,"threshold_uncertainty_score":0.7826633},"labels":[],"label_agreement":null},{"id":"W4210879173","doi":"10.1007/s10549-021-06449-4","title":"Afatinib alone and in combination with vinorelbine or paclitaxel, in patients with HER2-positive breast cancer who failed or progressed on prior trastuzumab and/or lapatinib (LUX-Breast 2): an open-label, multicenter, phase II trial","year":2022,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"Boehringer Ingelheim","keywords":"Vinorelbine; Medicine; Afatinib; Lapatinib; Internal medicine; Oncology; Trastuzumab; Breast cancer; Metastatic breast cancer; Clinical endpoint; Rash; Cancer; Chemotherapy; Clinical trial; Gefitinib; Epidermal growth factor receptor","score_opus":0.07544896408578985,"score_gpt":0.4259875661619342,"score_spread":0.3505386020761443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210879173","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9784501,0.0003255498,6.6405283e-7,0.004528202,0.000045267036,0.012199453,0.0043751,0.00003280372,0.000042858588],"genre_scores_gemma":[0.9850956,0.0008186143,0.00015789844,0.00009188103,0.00010316008,0.012509964,0.00041490005,0.00010628701,0.0007016923],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9944965,0.0008063531,0.000555648,0.0013355934,0.001689428,0.0011164246],"domain_scores_gemma":[0.9977595,0.00029861368,0.0001810177,0.00048749056,0.00053385657,0.000739524],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008165706,0.00054024346,0.00097148126,0.0006115262,0.0006881583,0.0002381771,0.00026638957,0.00010487625,0.0008624666],"category_scores_gemma":[0.00004147729,0.00031547615,0.000020521153,0.0012456459,0.00052625657,0.00043987783,0.0003918608,0.00074124226,0.0000012456393],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5948973,0.034524046,0.11547418,0.00015816648,0.00026698122,0.0005636121,0.0015868059,0.000003036363,0.000037125166,0.000007821033,0.00007261014,0.25240833],"study_design_scores_gemma":[0.39809215,0.16327734,0.43476313,0.0014376374,0.00008373157,0.00019702673,0.0011266401,0.000382681,0.00011339158,0.000003992125,0.00018532347,0.00033696747],"about_ca_topic_score_codex":0.018540453,"about_ca_topic_score_gemma":0.03389572,"teacher_disagreement_score":0.31928894,"about_ca_system_score_codex":0.0028354807,"about_ca_system_score_gemma":0.0022480022,"threshold_uncertainty_score":0.9999297},"labels":[],"label_agreement":null},{"id":"W4213114563","doi":"10.1007/s10549-022-06540-4","title":"Axillary surgery and complication rates after mastectomy and reconstruction for breast cancer: an analysis of the NSQIP database","year":2022,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Breast Implant and Reconstruction","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network; University of Ottawa; McMaster University; Juravinski Hospital","funders":"","keywords":"Medicine; Axillary Lymph Node Dissection; Sentinel lymph node; Breast cancer; Surgery; Mastectomy; Breast reconstruction; Breast surgery; Lymphedema; Retrospective cohort study; Sentinel node; Cancer; Internal medicine","score_opus":0.14051576390148754,"score_gpt":0.41578646223818255,"score_spread":0.27527069833669504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213114563","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09932828,0.8825318,0.0000026746145,0.00036870784,0.0001499713,0.0018875559,0.015706617,0.000015225598,0.000009138123],"genre_scores_gemma":[0.015562047,0.9809278,0.000036244935,0.0000060440857,0.0002001556,0.0023215548,0.0008285777,0.000032045515,0.000085500964],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9980633,0.00027132625,0.0004195023,0.00061746646,0.00030071248,0.0003276946],"domain_scores_gemma":[0.99861014,0.00033867548,0.00024320674,0.00039826354,0.0001751658,0.00023457817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003943341,0.0003070479,0.0012588196,0.00068586855,0.00032991738,0.000053013726,0.00006429288,0.0001266259,0.00028622153],"category_scores_gemma":[0.000005274395,0.0001833363,0.00025771093,0.00079375354,0.00041553058,0.00013371078,0.000096683056,0.00022901237,2.5409645e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070983777,0.00011643855,0.03500434,0.0030946902,0.0020938742,0.0000056868375,0.00003373611,2.0061135e-7,0.0000025339327,0.000011554339,0.000020703703,0.9589064],"study_design_scores_gemma":[0.004803429,0.0007810515,0.6877208,0.016168846,0.035666384,0.12243103,0.0008740066,0.0005160609,0.000034597393,0.0000827445,0.12979616,0.0011249069],"about_ca_topic_score_codex":0.0036959886,"about_ca_topic_score_gemma":0.0012909896,"teacher_disagreement_score":0.9577815,"about_ca_system_score_codex":0.0004312317,"about_ca_system_score_gemma":0.0006517436,"threshold_uncertainty_score":0.74762374},"labels":[],"label_agreement":null},{"id":"W4214625336","doi":"10.1007/s10549-022-06522-6","title":"A Canadian national guideline on the neoadjuvant treatment of invasive breast cancer, including patient assessment, systemic therapy, and local management principles","year":2022,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; McGill University; Sunnybrook Health Science Centre; Jewish General Hospital; BC Cancer Agency; University of Manitoba; Health Sciences Centre; McMaster University; London Health Sciences Centre; Hamilton Health Sciences; University of Toronto; Western University","funders":"Terry Fox Research Institute","keywords":"Guideline; Systemic therapy; Breast cancer; Medicine; Cancer; Neoadjuvant therapy; Oncology; Internal medicine; Pathology","score_opus":0.15927295947853704,"score_gpt":0.4140007529831589,"score_spread":0.2547277935046219,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214625336","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0038713962,0.98007274,0.000001635093,0.0015376771,0.00013713221,0.0032065676,0.010475953,0.000011649028,0.0006852682],"genre_scores_gemma":[0.03862247,0.95040756,0.000030400031,0.000074106705,0.00024984858,0.009574706,0.00071941584,0.00007728576,0.00024423166],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962505,0.0004744008,0.0006571687,0.0010643703,0.00080897304,0.00074455864],"domain_scores_gemma":[0.99825746,0.00021642444,0.00033545244,0.0005493929,0.00030504243,0.0003362067],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033322023,0.0007439547,0.0010524964,0.0003893358,0.00081956445,0.00007230801,0.00027839091,0.00015689163,0.00019068253],"category_scores_gemma":[0.000007549207,0.0004448242,0.0002642295,0.00035084772,0.0003529775,0.000008799789,0.0003739356,0.00018459719,0.000002444349],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032675837,0.00063272414,0.0007730884,0.0006270381,0.0041637183,0.00006939712,0.00016637634,0.00003820734,0.000004934114,0.0004776291,0.00061511697,0.992105],"study_design_scores_gemma":[0.0026632925,0.0022882156,0.0023363142,0.0031374556,0.0005502888,0.00071187573,0.0010069539,0.00001251446,0.000045235967,0.00003859624,0.98665166,0.00055761996],"about_ca_topic_score_codex":0.110148154,"about_ca_topic_score_gemma":0.0575374,"teacher_disagreement_score":0.9915474,"about_ca_system_score_codex":0.0062093115,"about_ca_system_score_gemma":0.003443459,"threshold_uncertainty_score":0.9998003},"labels":[],"label_agreement":null},{"id":"W4220773470","doi":"10.1007/s10549-022-06569-5","title":"Targeting HIF1-alpha/miR-326/ITGA5 axis potentiates chemotherapy response in triple-negative breast cancer","year":2022,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":61,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill Genome Centre","funders":"National Cancer Institute; National Institutes of Health; Higher Education Commision, Pakistan; National Institute of General Medical Sciences; Türkiye Bilimsel ve Teknolojik Araştırma Kurumu; Fonds de Recherche du Québec - Santé; Marie Curie; European Commission; Susan G. Komen; American Cancer Society","keywords":"Triple-negative breast cancer; Breast cancer; Chemotherapy; Medicine; Oncology; Cancer; Alpha (finance); Internal medicine; Cancer research; Surgery","score_opus":0.020928638804907113,"score_gpt":0.3278867694548976,"score_spread":0.30695813064999045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220773470","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.970698,0.021037748,0.0000069912676,0.004352487,0.00042208566,0.0008960675,0.0024568632,0.000018765533,0.000111019326],"genre_scores_gemma":[0.97557616,0.017283112,0.000056702745,0.00020797846,0.00096797134,0.0020965016,0.00012773309,0.000059165173,0.0036246898],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.997049,0.00052165723,0.00028673722,0.00080580584,0.00049755804,0.0008392767],"domain_scores_gemma":[0.9990524,0.0000591426,0.00008931766,0.00034983247,0.00018955041,0.00025974546],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00072155334,0.00031168378,0.0003454604,0.00023146925,0.00051066227,0.00006718325,0.00023447014,0.000094079995,0.0008344393],"category_scores_gemma":[0.000023936404,0.00027446335,0.00011830395,0.00045427278,0.0002208719,0.00001591817,0.00023764325,0.00027659436,0.000004357008],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09366824,0.003090079,0.04306204,0.000090161404,0.0015164816,0.00013578069,0.0031063037,0.00095918396,0.5230226,0.000084757696,0.024726937,0.30653745],"study_design_scores_gemma":[0.02824173,0.0036590367,0.5971399,0.00012984242,0.000108167274,0.0005434221,0.003928993,0.00032145437,0.060307033,0.00038932226,0.30384126,0.0013898533],"about_ca_topic_score_codex":0.014018398,"about_ca_topic_score_gemma":0.0016820513,"teacher_disagreement_score":0.55407786,"about_ca_system_score_codex":0.0006089981,"about_ca_system_score_gemma":0.00080458465,"threshold_uncertainty_score":0.99997073},"labels":[],"label_agreement":null},{"id":"W4220779215","doi":"10.1007/s10549-022-06528-0","title":"Post-diagnostic beta blocker use and breast cancer-specific mortality: a population-based cohort study","year":2022,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Queen's University; University of Auckland; Auckland Medical Research Foundation","keywords":"Medicine; Breast cancer; Hazard ratio; Proportional hazards model; Cancer; Internal medicine; Population; Cohort; Oncology; Cohort study; Cause of death; Gynecology; Confidence interval; Disease; Environmental health","score_opus":0.05542429143326465,"score_gpt":0.35472745772879666,"score_spread":0.299303166295532,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220779215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9827238,0.0074391095,4.8281606e-7,0.0046509984,0.00011159736,0.002868985,0.00213217,0.00005305352,0.000019839854],"genre_scores_gemma":[0.99036956,0.004119236,0.000008206094,0.00013149057,0.0003289918,0.003906179,0.00021329623,0.00005620696,0.00086683495],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967049,0.00041329287,0.0003362761,0.0007891408,0.0010958157,0.0006606196],"domain_scores_gemma":[0.99800044,0.00053376245,0.000082400154,0.00059992564,0.0003455289,0.00043792842],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004510965,0.00033057132,0.00057338295,0.00035534985,0.0008341569,0.00016024277,0.00010788288,0.000052673404,0.0010726611],"category_scores_gemma":[0.000027895841,0.0002721956,0.000099801226,0.0004689961,0.00021754885,0.00013272613,0.00012109604,0.0003204894,0.000004900862],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005325039,0.0022789084,0.9563729,0.000047885253,0.00062449335,0.00049540517,0.000359412,0.00003815549,0.00008672936,0.000013618199,0.00041872013,0.033938743],"study_design_scores_gemma":[0.005578181,0.0019309564,0.9869503,0.000106694744,0.00031902565,0.00062939414,0.0008387386,0.000083299594,0.000038938208,0.0000061714095,0.0032835307,0.00023478847],"about_ca_topic_score_codex":0.15955047,"about_ca_topic_score_gemma":0.0075537045,"teacher_disagreement_score":0.15199678,"about_ca_system_score_codex":0.0014803387,"about_ca_system_score_gemma":0.0008634747,"threshold_uncertainty_score":0.999973},"labels":[],"label_agreement":null},{"id":"W4220931859","doi":"10.1007/s10549-021-06417-y","title":"Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer: the NSABP B-36 trial (NRG Oncology)","year":2022,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval; Hôpital du Saint-Sacrement; Centre Hospitalier de l’Université de Montréal","funders":"National Cancer Institute; National Institutes of Health","keywords":"Epirubicin; Medicine; Breast cancer; Internal medicine; Placebo; Cyclophosphamide; Clinical endpoint; Chemotherapy; Oncology; Cancer; Surgery; Clinical trial; Gastroenterology; Pathology","score_opus":0.086597028550857,"score_gpt":0.3949531656894934,"score_spread":0.3083561371386364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220931859","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891154,0.0014246543,8.445798e-7,0.003149001,0.00008353102,0.003500592,0.00224953,0.000010552307,0.00046587086],"genre_scores_gemma":[0.9933416,0.0022477745,0.00003330851,0.00004073937,0.00021908946,0.0038589966,0.000020676938,0.000031182208,0.00020659955],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9964893,0.0007236467,0.0007348137,0.00051342114,0.00086626684,0.0006725901],"domain_scores_gemma":[0.9977963,0.0008224432,0.00032073664,0.0004325698,0.00037470317,0.00025322833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001145408,0.00028724,0.0012551757,0.00041732963,0.00027809048,0.00001940745,0.000232903,0.000064523825,0.00016464137],"category_scores_gemma":[0.00006996888,0.00018493405,0.00011612919,0.000789358,0.0006262469,0.00008367257,0.0001788056,0.00036249132,7.9123936e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8675064,0.004516812,0.0018386212,0.00007364594,0.0006921391,0.000110277666,0.008595607,0.0003392293,0.0008528459,0.000017037231,0.00016094511,0.11529647],"study_design_scores_gemma":[0.8159369,0.04326845,0.11048959,0.0010268178,0.0002590096,0.00029238622,0.021039033,0.0001459343,0.0056579686,0.000035341323,0.0015620303,0.000286519],"about_ca_topic_score_codex":0.093226045,"about_ca_topic_score_gemma":0.00893788,"teacher_disagreement_score":0.11500995,"about_ca_system_score_codex":0.0019412709,"about_ca_system_score_gemma":0.002898637,"threshold_uncertainty_score":0.91281223},"labels":[],"label_agreement":null},{"id":"W4224326647","doi":"10.1007/s10549-022-06576-6","title":"Risk factors for psychological morbidity and the protective role of coping self-efficacy in young women with breast cancer early in diagnosis: a national multicentre cohort study","year":2022,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Family Support in Illness","field":"Social Sciences","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Health Sciences Centre; Sunnybrook Health Science Centre; St. Michael's Hospital; University of Calgary; Alberta Health Services; Women's College Hospital; University Health Network; University of Toronto; Princess Margaret Cancer Centre","funders":"Canadian Cancer Society Research Institute","keywords":"Medicine; Anxiety; Breast cancer; Depression (economics); Cohort; Internal medicine; Cohort study; Coping (psychology); Population; History of depression; Gynecology; Cancer; Psychiatry","score_opus":0.045863586708318645,"score_gpt":0.38334073635902455,"score_spread":0.3374771496507059,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224326647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924758,0.00020720919,3.0851342e-7,0.0007204022,0.00002905176,0.005599164,0.0008723421,0.0000117557865,0.00008395632],"genre_scores_gemma":[0.97309124,0.00044940438,0.000006241364,0.00000563668,0.000035364465,0.026381135,0.0000029137477,0.00000914215,0.000018928306],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99734783,0.00084081874,0.00017042118,0.0003986813,0.00079897366,0.00044327503],"domain_scores_gemma":[0.9989309,0.0005917257,0.000082717335,0.00009981325,0.0001902306,0.00010461835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015306472,0.000121651996,0.000251409,0.00012688062,0.0006728567,0.0000514872,0.00014426876,0.000032983924,0.00008338496],"category_scores_gemma":[0.00006079379,0.00007551408,0.00002110667,0.00048985,0.0003922531,0.00010650861,0.00008743449,0.00022850992,1.4605749e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002617712,0.0029996268,0.9239877,0.0000057433062,0.00016396686,0.0000051917586,0.06549674,0.00009072738,8.615883e-7,0.000085074986,0.000006571392,0.0045400653],"study_design_scores_gemma":[0.005874368,0.0005327844,0.93838567,0.000019692516,0.00001661929,0.0000024476947,0.05479722,0.000047742215,0.000003236566,0.00020528861,0.000034590277,0.0000803174],"about_ca_topic_score_codex":0.37952775,"about_ca_topic_score_gemma":0.13416962,"teacher_disagreement_score":0.24535812,"about_ca_system_score_codex":0.0019833082,"about_ca_system_score_gemma":0.0004112316,"threshold_uncertainty_score":0.8816295},"labels":[],"label_agreement":null},{"id":"W4225397966","doi":"10.1007/s10549-022-06613-4","title":"Correction to: Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer: the NSABP B-36 trial (NRG Oncology)","year":2022,"lang":"en","type":"erratum","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval; Hôpital du Saint-Sacrement; Centre Hospitalier de l’Université de Montréal","funders":"National Cancer Institute","keywords":"Breast cancer; Medicine; Oncology; Adjuvant; Internal medicine; Gynecology; Cancer","score_opus":0.04118652091838295,"score_gpt":0.36754859889728836,"score_spread":0.32636207797890543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225397966","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98740804,0.0018300746,0.0000018899151,0.0005895981,0.0014832898,0.0034520505,0.0034925693,0.000006042476,0.0017364213],"genre_scores_gemma":[0.98841816,0.005414032,0.00002289691,0.000020801908,0.00050542183,0.0032027315,0.00023500332,0.00004483326,0.0021361106],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99689215,0.00063544785,0.0006047289,0.00070618326,0.0005497254,0.0006117811],"domain_scores_gemma":[0.99837554,0.00023723833,0.0003671703,0.00040016114,0.00037093152,0.0002489889],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007173516,0.0003782021,0.0010019674,0.0002962928,0.00020992896,0.000023709083,0.00028889705,0.000271317,0.00003819093],"category_scores_gemma":[0.00007610077,0.00024760902,0.00012684384,0.00053743867,0.00034189588,0.000009646892,0.00028464143,0.00061468617,7.3201034e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.92058814,0.0026312803,0.00015284802,0.00007149477,0.0014670088,0.000043709868,0.0018146645,0.00068040093,0.0046045384,0.0000034829402,0.014455802,0.05348662],"study_design_scores_gemma":[0.8021071,0.11367618,0.011761941,0.0026268954,0.0005633315,0.00020310143,0.006972052,0.00022052927,0.048506547,0.000026348162,0.012354828,0.0009811465],"about_ca_topic_score_codex":0.038745794,"about_ca_topic_score_gemma":0.009841076,"teacher_disagreement_score":0.118481055,"about_ca_system_score_codex":0.000917908,"about_ca_system_score_gemma":0.0023888666,"threshold_uncertainty_score":0.9999976},"labels":[],"label_agreement":null},{"id":"W4239318063","doi":"10.1007/s10549-006-9165-4","title":"Erratum to: The latest is the greatest? Results of a structured lecture about aromatase inhibitor use for breast cancer","year":2006,"lang":"en","type":"erratum","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Aromatase; Aromatase inhibitor; Breast cancer; Medicine; Oncology; Gynecology; Internal medicine; Cancer","score_opus":0.018807523383586596,"score_gpt":0.31490275768883597,"score_spread":0.29609523430524937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239318063","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3402545,0.16913852,0.000016878717,0.0692504,0.009929099,0.016281882,0.3930987,0.00008951443,0.0019404917],"genre_scores_gemma":[0.7997647,0.04213499,0.000090616384,0.00066926493,0.009833549,0.0053407275,0.011018619,0.0003426687,0.13080485],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99721,0.0001961459,0.0003788168,0.0009029479,0.0004923133,0.0008197359],"domain_scores_gemma":[0.9979887,0.00010282329,0.00019969388,0.0009170313,0.00052845484,0.0002632841],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026321952,0.00055897626,0.00046366244,0.00011769901,0.0005230105,0.00018568088,0.00040741853,0.0006703072,0.000017974351],"category_scores_gemma":[0.00003742733,0.00027976412,0.00025067842,0.00033641624,0.00039046377,0.000008995024,0.00020116962,0.000601482,0.0000032629712],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041762623,0.00019842162,0.0003441669,0.000108990105,0.0010052214,0.00002060985,0.00017040412,0.000085495296,0.0048175035,0.0000059734994,0.9723104,0.016756553],"study_design_scores_gemma":[0.0058885776,0.002943821,0.035618167,0.0009795541,0.00056085497,0.00037780503,0.00006612042,0.00006771846,0.025812274,0.00013403007,0.92676693,0.00078414415],"about_ca_topic_score_codex":0.012838831,"about_ca_topic_score_gemma":0.0069601503,"teacher_disagreement_score":0.4595102,"about_ca_system_score_codex":0.00021210636,"about_ca_system_score_gemma":0.0009978521,"threshold_uncertainty_score":0.9999654},"labels":[],"label_agreement":null},{"id":"W4241563663","doi":"10.1007/s10549-008-0208-x","title":"Cognitive impairments associated with breast cancer treatments: results from a longitudinal study","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Breast cancer; Medicine; Oncology; Cognition; Cancer; Longitudinal study; Internal medicine; Psychiatry; Pathology","score_opus":0.10710883099612725,"score_gpt":0.39662519745529545,"score_spread":0.28951636645916823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241563663","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9785744,0.0014998575,0.000001953764,0.0025005462,0.00008640361,0.0038317158,0.012813112,0.00012468189,0.00056734635],"genre_scores_gemma":[0.9879345,0.0045676646,0.000013164243,0.000072897565,0.00034635817,0.003310099,0.00040311477,0.00007684691,0.0032753234],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954559,0.00027103478,0.00045569887,0.0012966936,0.0013827609,0.0011378727],"domain_scores_gemma":[0.99704945,0.0004543795,0.00018015355,0.00036727756,0.0012976298,0.00065108534],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023948107,0.00061799405,0.0008681778,0.00034416554,0.00096317055,0.000060840437,0.000096965756,0.0001187018,0.00045714327],"category_scores_gemma":[0.00005858586,0.00041184048,0.00012091175,0.00085981627,0.0007611225,0.0002297197,0.00013737023,0.00039933115,0.000041344058],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03635899,0.01204082,0.9084509,0.000011173162,0.011752503,0.0031849926,0.0031383669,0.0000028693953,0.000030075675,7.1849587e-7,0.00066522264,0.024363387],"study_design_scores_gemma":[0.053217344,0.00984368,0.9307526,0.0011001811,0.0013961521,0.0007327065,0.0024343412,0.000017294036,0.00011544567,0.0000118621765,0.00003819908,0.0003402435],"about_ca_topic_score_codex":0.060669065,"about_ca_topic_score_gemma":0.011262326,"teacher_disagreement_score":0.04940674,"about_ca_system_score_codex":0.0033201114,"about_ca_system_score_gemma":0.001024208,"threshold_uncertainty_score":0.99983335},"labels":[],"label_agreement":null},{"id":"W4242719372","doi":"10.1023/b:brea.0000018384.64326.dd","title":"Mitogenic Properties of Insulin-Like Growth Factors I and II, Insulin-like Growth Factor Binding Protein-3 and Epidermal Growth Factor on Human Breast Stromal Cells in Primary Culture","year":2004,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Stromal cell; Epidermal growth factor; Growth factor; Endocrinology; Growth factor receptor inhibitor; Internal medicine; Cancer research; Insulin-like growth factor; Biology; Cell growth; Insulin-like growth factor-binding protein; Medicine; Receptor; Biochemistry","score_opus":0.05255183529351035,"score_gpt":0.2998606397421739,"score_spread":0.24730880444866357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242719372","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99162596,0.0029395523,0.000001266839,0.00092626776,0.00011114777,0.0027420544,0.0014368559,0.00008231358,0.00013455763],"genre_scores_gemma":[0.995033,0.0036982973,0.00008279504,0.00007403802,0.00019880805,0.00035617198,0.00012859983,0.000110719644,0.00031751735],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9949406,0.00024587038,0.00089127664,0.0013180802,0.0012121259,0.00139205],"domain_scores_gemma":[0.99767244,0.000093261566,0.00024863653,0.00043627268,0.00054819835,0.0010011812],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002671133,0.0009533677,0.0013053297,0.0009852077,0.00067578326,0.00013323403,0.00024036715,0.00042207635,0.000042118558],"category_scores_gemma":[0.000045803434,0.0006497767,0.00019783873,0.000768478,0.0008657336,0.0005544742,0.00033366392,0.0009186409,0.000006271984],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005179717,0.00389445,0.5067416,0.0014351715,0.0008653927,0.00029195865,0.00644864,6.420779e-7,0.47034365,0.0003975235,0.00006950604,0.00433178],"study_design_scores_gemma":[0.012459836,0.0063417833,0.7710434,0.0012353922,0.0001192869,0.0002554098,0.00076419755,0.0000030808624,0.20691332,0.00016079612,0.000053854375,0.0006496026],"about_ca_topic_score_codex":0.009809181,"about_ca_topic_score_gemma":0.00040165073,"teacher_disagreement_score":0.26430184,"about_ca_system_score_codex":0.001346661,"about_ca_system_score_gemma":0.0007077899,"threshold_uncertainty_score":0.99959534},"labels":[],"label_agreement":null},{"id":"W4250267835","doi":"10.1007/s10549-011-1797-3","title":"Erratum to: Role of Src in breast cancer cell migration and invasion in a breast cell/bone-derived cell microenvironment","year":2011,"lang":"en","type":"erratum","venue":"Breast Cancer Research and Treatment","topic":"Bone health and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Breast cancer; Cell; Cancer research; Medicine; Cell migration; Proto-oncogene tyrosine-protein kinase Src; Oncology; Biology; Internal medicine; Cancer; Receptor; Genetics","score_opus":0.030188439443543873,"score_gpt":0.30998261863591203,"score_spread":0.27979417919236815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4250267835","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9309747,0.04912696,3.255531e-7,0.004489821,0.0007047714,0.0043885633,0.003582711,0.000028337125,0.006703798],"genre_scores_gemma":[0.8644039,0.11391141,0.00008422603,0.00017027878,0.0002480921,0.0020332804,0.000538216,0.00012580378,0.018484797],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955299,0.00024989888,0.0007839564,0.0013133149,0.0008246462,0.0012983223],"domain_scores_gemma":[0.99779385,0.000055064054,0.0002633425,0.0006405863,0.00018568356,0.0010614574],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030247803,0.000753232,0.0012446962,0.0006154978,0.00016424006,0.000046026333,0.00014442146,0.00055698,0.00032253523],"category_scores_gemma":[0.0000025482716,0.0006089992,0.00012557195,0.00047726207,0.00024005097,0.00015153438,0.00020968306,0.00083964964,0.00002801493],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020311423,0.019394703,0.74780494,0.00457559,0.00045642984,0.0011906851,0.0062721684,0.000008238777,0.03842545,0.000006839511,0.07078907,0.09076449],"study_design_scores_gemma":[0.014836954,0.0023430628,0.9591795,0.0031444044,0.00028705786,0.0003868566,0.0010716089,0.00004547757,0.008537727,0.00007659633,0.009442457,0.00064825703],"about_ca_topic_score_codex":0.26519483,"about_ca_topic_score_gemma":0.08802357,"teacher_disagreement_score":0.21137463,"about_ca_system_score_codex":0.0029919096,"about_ca_system_score_gemma":0.0017382079,"threshold_uncertainty_score":0.9996361},"labels":[],"label_agreement":null},{"id":"W4253346138","doi":"10.1007/s10549-012-2178-2","title":"Erratum to: 25-Hydroxy vitamin-D, obesity, and associated variables as predictors of breast cancer risk and tamoxifen benefit in NSABP-P1","year":2012,"lang":"en","type":"erratum","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Breast cancer; Tamoxifen; Medicine; Obesity; Oncology; Internal medicine; Cancer; Gynecology; Endocrinology","score_opus":0.010041688378690187,"score_gpt":0.2882597292784426,"score_spread":0.27821804089975244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253346138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9518856,0.040026728,3.8438992e-7,0.00031139297,0.0008562422,0.0011477175,0.0043015853,0.000012704295,0.0014576812],"genre_scores_gemma":[0.87290406,0.1103667,0.000010067492,0.000020940628,0.0007232403,0.00059489225,0.00048302108,0.00007662669,0.014820458],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971746,0.00024198051,0.00034127195,0.00086587766,0.00046670274,0.0009095394],"domain_scores_gemma":[0.99854654,0.00005767518,0.0001810589,0.0003738989,0.00022321868,0.0006175887],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00043738037,0.00052505056,0.0006689636,0.00028286292,0.0002206521,0.00007007153,0.00018134895,0.0009349289,0.000042132448],"category_scores_gemma":[0.000032810225,0.00041889734,0.00008852551,0.00032454144,0.00032939573,0.000016085609,0.00038832737,0.0006589542,0.000002966399],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022757037,0.0022336172,0.88662994,0.00051555055,0.0041828565,0.00010693403,0.0007532323,0.00003109848,0.011157567,0.00007277579,0.059104152,0.032936558],"study_design_scores_gemma":[0.0044103377,0.0025204855,0.9723578,0.0012438584,0.00052557245,0.00019885864,0.000113739356,0.000038679555,0.003156072,0.00016240138,0.014494713,0.00077748066],"about_ca_topic_score_codex":0.025131082,"about_ca_topic_score_gemma":0.005816159,"teacher_disagreement_score":0.08572785,"about_ca_system_score_codex":0.00034207987,"about_ca_system_score_gemma":0.0006112856,"threshold_uncertainty_score":0.9998263},"labels":[],"label_agreement":null},{"id":"W4281399319","doi":"10.1007/s10549-022-06626-z","title":"Breast reconstruction and quality of life five years after cancer diagnosis: VICAN French National cohort","year":2022,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Implant and Reconstruction","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Fonds de Recherche du Québec - Santé; Ligue Contre le Cancer","keywords":"Medicine; Breast cancer; Cohort; Quality of life (healthcare); Mastectomy; Socioeconomic status; Breast reconstruction; Mental health; Cohort study; Cancer; Gerontology; Demography; Internal medicine; Psychiatry; Population; Environmental health","score_opus":0.05271845942973064,"score_gpt":0.3620642759755856,"score_spread":0.30934581654585497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281399319","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99144375,0.0026054224,4.7484326e-7,0.001436254,0.00015232747,0.00051137496,0.003653772,0.000015679201,0.00018095746],"genre_scores_gemma":[0.9935053,0.0018745397,0.000036139405,0.00002586538,0.00023688561,0.0038354618,0.000053633717,0.000012765042,0.00041939563],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983615,0.00014972742,0.00025082863,0.00034799808,0.00062387367,0.00026602254],"domain_scores_gemma":[0.9992022,0.00007698624,0.00008456267,0.000114713876,0.00026974536,0.0002517794],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00034747532,0.00012853544,0.00030114234,0.00022261449,0.00020122444,0.00001985769,0.000037232603,0.00005025873,0.0016740258],"category_scores_gemma":[0.000004677509,0.0001069247,0.00005334186,0.00024876292,0.0003261578,0.000080463826,0.00007090819,0.0001964166,0.0000017536886],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011579255,0.00020442538,0.6627692,0.000043342854,0.00030140026,0.000008037308,0.00018577011,0.0000021643132,0.000031183186,0.000048833914,0.00019313852,0.3350546],"study_design_scores_gemma":[0.0023393328,0.00023298242,0.98934805,0.00008099761,0.000059063288,0.0069593606,0.0004205499,0.000020888807,0.000054265016,0.000111433714,0.00027532154,0.00009774405],"about_ca_topic_score_codex":0.029245079,"about_ca_topic_score_gemma":0.0020507376,"teacher_disagreement_score":0.33495685,"about_ca_system_score_codex":0.00060967554,"about_ca_system_score_gemma":0.00068044505,"threshold_uncertainty_score":0.99923855},"labels":[],"label_agreement":null},{"id":"W4281620344","doi":"10.1007/s10549-022-06631-2","title":"Excision of breast fibroepithelial lesions: when is it still necessary?—A 10-year review of a regional centre","year":2022,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Breast Lesions and Carcinomas","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Providence Health Care; University of British Columbia","funders":"","keywords":"Medicine; Fibroadenoma; Pathological; Logistic regression; Lesion; Biopsy; Phyllodes tumor; Radiology; Surgical excision; Breast cancer; Cancer; Surgery; Internal medicine","score_opus":0.19095347585918995,"score_gpt":0.42800892669145346,"score_spread":0.2370554508322635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281620344","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001451017,0.98574185,4.3837522e-7,0.004814776,0.000048858692,0.0023096676,0.006246486,0.000014706974,0.00067811355],"genre_scores_gemma":[0.00012924647,0.99276173,0.000080037666,0.00010387019,0.00022603139,0.00059950777,0.0006716594,0.0000787875,0.0053491304],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953983,0.0005227415,0.000979765,0.00086198247,0.0016107714,0.00062648597],"domain_scores_gemma":[0.9971277,0.00036223503,0.0004448461,0.00096486165,0.0005740658,0.00052626507],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00062225567,0.0005587733,0.0025379232,0.0005034278,0.00017622554,0.000018693278,0.00030898364,0.00021065767,0.024158219],"category_scores_gemma":[0.000035063356,0.0003664501,0.0007987906,0.00075712526,0.0003678633,0.00007247469,0.00036583346,0.0004935073,0.00004633745],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077394955,0.00095771236,0.00007920801,0.05986766,0.0006304734,0.00010501823,0.00014931842,2.6120931e-8,0.0000016319855,0.000054121116,0.034862775,0.9025181],"study_design_scores_gemma":[0.0015773254,0.00082670886,0.0008151988,0.13491035,0.001141178,0.0015969527,0.00018021073,9.052454e-7,0.0000017342195,0.000054797452,0.8586752,0.00021945717],"about_ca_topic_score_codex":0.0024400011,"about_ca_topic_score_gemma":0.000040336166,"teacher_disagreement_score":0.9022986,"about_ca_system_score_codex":0.00079598493,"about_ca_system_score_gemma":0.0027193788,"threshold_uncertainty_score":0.99987876},"labels":[],"label_agreement":null},{"id":"W4282931672","doi":"10.1007/s10549-022-06640-1","title":"Clinical utility of MRI in the neoadjuvant management of early-stage breast cancer","year":2022,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; BC Cancer Agency; University of Waterloo","funders":"","keywords":"Medicine; Breast cancer; Breast MRI; Stage (stratigraphy); Neoadjuvant therapy; Radiology; Magnetic resonance imaging; Prospective cohort study; Cancer; Mammography; Internal medicine","score_opus":0.06731858544311073,"score_gpt":0.4083742778777368,"score_spread":0.3410556924346261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282931672","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883335,0.004142742,0.000003830544,0.0029871163,0.00008595936,0.0007422741,0.0030920184,0.0000044664876,0.0006080706],"genre_scores_gemma":[0.9857913,0.012365837,0.00003791577,0.000046481564,0.00008652204,0.0013057154,0.000045134704,0.00001645374,0.00030463256],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977397,0.00040245178,0.0003762392,0.0005196712,0.00053857896,0.00042337461],"domain_scores_gemma":[0.99909914,0.000056779612,0.00011501258,0.00051407213,0.0001294901,0.00008551612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007172658,0.00019401134,0.00032330037,0.0000816422,0.00020907169,0.000011601866,0.0002919086,0.000048220627,0.00023181281],"category_scores_gemma":[0.000002082173,0.00013312038,0.00012307073,0.00031429718,0.0004344427,0.000005774029,0.000445929,0.00016911462,8.510478e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037278414,0.0022679232,0.88383764,0.00009657321,0.0010038749,0.00004969042,0.00048655766,0.000046720626,0.00020136443,0.00024522463,0.0009999212,0.10703667],"study_design_scores_gemma":[0.0027784165,0.0007119453,0.9889549,0.000047979483,0.000060153183,0.00002924102,0.0015124127,0.000012277692,0.00042546412,0.000055786702,0.0053016124,0.000109815424],"about_ca_topic_score_codex":0.015006708,"about_ca_topic_score_gemma":0.0019887015,"teacher_disagreement_score":0.10692686,"about_ca_system_score_codex":0.00014641898,"about_ca_system_score_gemma":0.00020903302,"threshold_uncertainty_score":0.9915525},"labels":[],"label_agreement":null},{"id":"W4283265318","doi":"10.1007/s10549-022-06646-9","title":"Long-term survival in elderly women receiving chemotherapy for non-metastatic breast cancer: a population-based analysis","year":2022,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Princess Margaret Cancer Centre; Public Health Ontario; University of Toronto","funders":"","keywords":"Medicine; Hazard ratio; Breast cancer; Internal medicine; Chemotherapy; Cohort; Proportional hazards model; Population; Cancer; Oncology; Mastectomy; Survival analysis; Cohort study; Confidence interval; Gynecology","score_opus":0.02704962814871996,"score_gpt":0.3511521609248528,"score_spread":0.3241025327761328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283265318","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99194896,0.0012711546,0.000067800145,0.0024150733,0.00007717823,0.00093768997,0.0032515759,0.000013401388,0.000017175213],"genre_scores_gemma":[0.98864603,0.0011285279,0.00007368864,0.00008003616,0.00015976353,0.009004142,0.0005869402,0.000046205703,0.0002746461],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975693,0.00018269019,0.0002688793,0.00077691657,0.0004157786,0.0007864417],"domain_scores_gemma":[0.99909276,0.00009684343,0.00009519782,0.0003656658,0.00016087548,0.00018864073],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00037273066,0.0003036437,0.00046530453,0.00036865813,0.0005225607,0.000060387723,0.00017692326,0.000040120343,0.00030941828],"category_scores_gemma":[0.000006440438,0.00027114243,0.00013747255,0.000804634,0.00009504263,0.000010703728,0.00010709659,0.00011577815,7.329719e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038847812,0.0010632522,0.9110877,0.000049109596,0.0021536374,0.000015536923,0.0002783357,0.00095085474,0.00062840205,0.000004963015,0.00004549838,0.07983791],"study_design_scores_gemma":[0.0057427026,0.0012020356,0.99168944,0.000027758,0.0001594159,0.000016968015,0.00029344988,0.00016544313,0.00026994405,0.000033188593,0.00014638285,0.0002532551],"about_ca_topic_score_codex":0.018627556,"about_ca_topic_score_gemma":0.021894965,"teacher_disagreement_score":0.08060174,"about_ca_system_score_codex":0.0016125565,"about_ca_system_score_gemma":0.0004598703,"threshold_uncertainty_score":0.9999741},"labels":[],"label_agreement":null},{"id":"W4283787414","doi":"10.1007/s10549-022-06656-7","title":"Adherence to the 2020 American Cancer Society Guideline for Cancer Prevention and risk of breast cancer for women at increased familial and genetic risk in the Breast Cancer Family Registry: an evaluation of the weight, physical activity, and alcohol consumption recommendations","year":2022,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"National Center for Advancing Translational Sciences; National Cancer Institute","keywords":"Breast cancer; Medicine; Family history; Cancer; Internal medicine; Hazard ratio; Oncology; Guideline; Gynecology; Cancer prevention; Body mass index; Obstetrics; Confidence interval; Pathology","score_opus":0.06836903123576685,"score_gpt":0.42360988495206436,"score_spread":0.35524085371629754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283787414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9629225,0.0035545465,0.000050864946,0.0054524066,0.00008374411,0.002662776,0.02526707,0.0000033700742,0.0000027347312],"genre_scores_gemma":[0.9535358,0.027206205,0.00014275595,0.0000977884,0.00028662884,0.018541502,0.000092068134,0.000025014511,0.00007223913],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9975789,0.00071012403,0.00027140524,0.0006118625,0.00047347686,0.0003542139],"domain_scores_gemma":[0.9985545,0.00012903915,0.00033514152,0.0003801006,0.0004895083,0.00011168497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009966197,0.00021685574,0.0002647288,0.00004124839,0.00069741195,0.00003826164,0.00020793048,0.000053085383,0.000042535234],"category_scores_gemma":[0.00002306073,0.00014044582,0.00007880071,0.00030040232,0.00048826146,0.000021726493,0.00024007673,0.00015591156,4.529776e-8],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002613498,0.00047824736,0.32801437,0.00008680712,0.00070210634,1.7710704e-7,0.0024106398,0.0022472658,0.029596735,0.000005297593,0.0037300468,0.6301148],"study_design_scores_gemma":[0.0037424222,0.0008217116,0.9805336,0.0000633554,0.00043452866,0.00002186622,0.0017355587,0.0080206115,0.002000452,0.00016435189,0.002268183,0.00019335993],"about_ca_topic_score_codex":0.06983969,"about_ca_topic_score_gemma":0.07163717,"teacher_disagreement_score":0.6525192,"about_ca_system_score_codex":0.0010331303,"about_ca_system_score_gemma":0.0010958989,"threshold_uncertainty_score":0.945303},"labels":[],"label_agreement":null},{"id":"W4288902525","doi":"10.1007/s10549-022-06650-z","title":"Risk of recurrence and pregnancy outcomes in young women with breast cancer who do and do not undergo fertility preservation","year":2022,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Reproductive Biology and Fertility","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Pacific Centre for Reproductive Medicine; Sunnybrook Health Science Centre; Credit Valley Hospital; William Osler Health System; Trillium Health Centre; University of British Columbia; University of Calgary","funders":"","keywords":"Medicine; Fertility preservation; Breast cancer; Pregnancy; Fertility; Gynecology; Odds ratio; Clinical endpoint; Internal medicine; Proportional hazards model; Obstetrics; Cancer; Oncology; Population; Randomized controlled trial","score_opus":0.04964507820425152,"score_gpt":0.3550865978342504,"score_spread":0.3054415196299989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4288902525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99009377,0.005991156,0.0000013321791,0.0019001057,0.000024685025,0.00095720356,0.0009380854,0.000008363943,0.000085286825],"genre_scores_gemma":[0.99447006,0.0041332846,0.000013810736,0.000008580689,0.000014551201,0.0010103113,0.000009048685,0.000008827496,0.00033150925],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99823856,0.00029878365,0.0001914702,0.00059914973,0.00032545163,0.00034656294],"domain_scores_gemma":[0.99917096,0.000102357095,0.00007224982,0.00031453467,0.00018629317,0.0001536062],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005207192,0.00015438917,0.00036283297,0.000113705086,0.00022848234,0.000017750026,0.00005515656,0.00004360389,0.00012783842],"category_scores_gemma":[0.00003443288,0.00010009408,0.00001715142,0.0002527845,0.0004307886,0.0001354041,0.00013665367,0.00025608356,1.6456296e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015726004,0.00055407046,0.9066856,0.00011269052,0.00022500732,0.000010379295,0.0018476935,0.0000030478914,0.00011830978,0.000026528885,0.0000044398466,0.07468625],"study_design_scores_gemma":[0.0029672554,0.0012504259,0.9940887,0.000197507,0.000036368438,0.000039445695,0.00073045347,0.000021161617,0.00013203669,0.0004306485,0.000022958819,0.00008304152],"about_ca_topic_score_codex":0.014361371,"about_ca_topic_score_gemma":0.0027323698,"teacher_disagreement_score":0.08740312,"about_ca_system_score_codex":0.0005847045,"about_ca_system_score_gemma":0.00028498485,"threshold_uncertainty_score":0.9922021},"labels":[],"label_agreement":null},{"id":"W4288941108","doi":"10.1007/s10549-022-06674-5","title":"Cancer-specific mortality in breast cancer patients with hypothyroidism: a UK population-based study","year":2022,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Thyroid Disorders and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Queen's University Belfast; Queen's University; Cancer Research UK","keywords":"Medicine; Breast cancer; Hazard ratio; Internal medicine; Cancer; Oncology; Proportional hazards model; Cohort; Cohort study; Population; Cancer registry; Epidemiology; Epidemiology of cancer; Gynecology; Confidence interval","score_opus":0.044264744456994944,"score_gpt":0.3504026034994008,"score_spread":0.3061378590424058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4288941108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98867464,0.0030719182,3.9358127e-7,0.0020066933,0.00007509787,0.0028355955,0.0032204778,0.00003410012,0.00008111061],"genre_scores_gemma":[0.9914781,0.0005531682,0.000009503964,0.00007196616,0.000075173746,0.0071961666,0.00028187537,0.000050912604,0.0002831575],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967867,0.00020251366,0.00030618132,0.0007999002,0.0011989315,0.0007057691],"domain_scores_gemma":[0.9988515,0.000054816326,0.00008812007,0.00043575137,0.00021932577,0.00035051527],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001737557,0.00033862685,0.000493829,0.0003493083,0.0005543016,0.000054963017,0.000112696594,0.000040257386,0.0013520512],"category_scores_gemma":[0.0000019908698,0.00024428358,0.00006703803,0.00082340656,0.00008850833,0.00008221462,0.00009244411,0.00028318705,0.000003955606],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053407503,0.010760076,0.9655108,0.000020282447,0.0004930696,0.00019909782,0.0003771508,0.00024276742,0.0000110204255,0.0000136303415,0.00020278852,0.016828604],"study_design_scores_gemma":[0.021359056,0.002234135,0.9751209,0.000061001814,0.00012845111,0.000012883416,0.0006304356,0.000038025868,0.000009279478,0.000031638654,0.00016323505,0.000210983],"about_ca_topic_score_codex":0.1691263,"about_ca_topic_score_gemma":0.033505276,"teacher_disagreement_score":0.13562103,"about_ca_system_score_codex":0.0030960327,"about_ca_system_score_gemma":0.00071752956,"threshold_uncertainty_score":0.99956083},"labels":[],"label_agreement":null},{"id":"W4293331767","doi":"10.1007/s10549-022-06715-z","title":"Stabilization of c-Myc by the atypical cell cycle regulator, Spy1, decreases efficacy of breast cancer treatments","year":2022,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Protein Kinase Regulation and GTPase Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Regional Hospital; Western University; University of Windsor","funders":"Canadian Institutes of Health Research","keywords":"Tamoxifen; Breast cancer; Cancer research; Biology; Cancer; Medicine; Internal medicine","score_opus":0.02243779155938513,"score_gpt":0.3203811366636735,"score_spread":0.2979433451042884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293331767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99020153,0.007002894,0.00001586736,0.00051409734,0.000024275681,0.0005760252,0.0015924881,0.0000052806718,0.00006753114],"genre_scores_gemma":[0.99748975,0.0012301012,0.000023292901,0.0000164409,0.000064033484,0.00045180094,0.00020476835,0.000018432935,0.00050137175],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986133,0.00021666088,0.0002033344,0.000323122,0.0003844023,0.00025917252],"domain_scores_gemma":[0.999291,0.000036679798,0.00009834921,0.00029576558,0.00015473652,0.00012344179],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001757785,0.00014093303,0.00016988257,0.000054442287,0.00027538466,0.000013247961,0.0001236338,0.000044960285,0.00038677675],"category_scores_gemma":[0.0000068700456,0.000098952856,0.00007748124,0.00020603147,0.00021875575,0.0000054729658,0.00013435732,0.00006283027,5.2688046e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009234403,0.0045388285,0.05194311,0.00011014457,0.0006821937,0.000009080897,0.00031204984,0.0023744486,0.78981555,0.00026148648,0.0018644745,0.13885422],"study_design_scores_gemma":[0.0070157824,0.0017587806,0.18481022,0.00006856133,0.00013689438,0.000083892104,0.00036001718,0.00029580755,0.7991487,0.00017503799,0.005878221,0.00026813117],"about_ca_topic_score_codex":0.002583969,"about_ca_topic_score_gemma":0.0001272248,"teacher_disagreement_score":0.13858609,"about_ca_system_score_codex":0.00016634718,"about_ca_system_score_gemma":0.00029502332,"threshold_uncertainty_score":0.42349344},"labels":[],"label_agreement":null},{"id":"W4296129100","doi":"10.1007/s10549-022-06744-8","title":"Impact of body mass index on survival in women receiving chemotherapy for early breast cancer","year":2022,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Epirubicin; Internal medicine; Anthracycline; Body mass index; Breast cancer; Cohort; Overweight; Underweight; Retrospective cohort study; Docetaxel; Population; Cyclophosphamide; Cancer; Oncology; Chemotherapy","score_opus":0.0460481916780641,"score_gpt":0.40230897390144643,"score_spread":0.3562607822233823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296129100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938518,0.00045800072,0.0000021366845,0.0018270658,0.000078155914,0.0010925668,0.002528385,0.000013652934,0.00014822968],"genre_scores_gemma":[0.99480975,0.0018020825,0.0000050950384,0.00003497922,0.00018077278,0.002472391,0.000018747496,0.0000416336,0.00063457293],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99805623,0.00008362736,0.00021686968,0.0004049446,0.0005636184,0.0006746978],"domain_scores_gemma":[0.9991648,0.00010695374,0.00006583992,0.00024913086,0.00013647658,0.00027680706],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00036407163,0.00019942834,0.0004437082,0.00032390855,0.00016572312,0.000025081488,0.00008910209,0.000046295936,0.0013119977],"category_scores_gemma":[0.0000045726724,0.00014753405,0.00011990953,0.00043779894,0.00009754829,0.000053824526,0.000041663392,0.00024940062,7.9869386e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022024268,0.00089382,0.8314461,0.000042780975,0.0004252319,0.000020826805,0.0009095822,0.00008088033,0.0010529631,0.00001423486,0.00019060532,0.14289868],"study_design_scores_gemma":[0.009082396,0.004039676,0.9852829,0.000102710175,0.000014722878,0.000023903991,0.0003965818,0.00010097035,0.00014521024,0.00007857321,0.00061079406,0.00012155406],"about_ca_topic_score_codex":0.08692177,"about_ca_topic_score_gemma":0.0013073081,"teacher_disagreement_score":0.15383679,"about_ca_system_score_codex":0.0046602553,"about_ca_system_score_gemma":0.0008969811,"threshold_uncertainty_score":0.99960095},"labels":[],"label_agreement":null},{"id":"W4309889494","doi":"10.1007/s10549-022-06812-z","title":"Estimating the incidence of breast cancer recurrence using administrative data","year":2022,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre; Cancer Care Ontario; Western University","funders":"","keywords":"Medicine; Breast cancer; Incidence (geometry); Metastasis; Cancer; Internal medicine; Stage (stratigraphy); Oncology; Cancer registry; Distant metastasis; Primary tumor; Comorbidity","score_opus":0.16635457659894268,"score_gpt":0.4470585430517837,"score_spread":0.280703966452841,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309889494","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97750574,0.008645647,0.000044121683,0.002964562,0.00016412722,0.00058301643,0.010000912,0.000008636487,0.00008326243],"genre_scores_gemma":[0.99717396,0.001184047,0.00036496256,0.000038117432,0.00027536997,0.00072313746,0.00013765902,0.000020449093,0.00008227355],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998001,0.00023723648,0.00021121198,0.0006453104,0.00047903194,0.00042620063],"domain_scores_gemma":[0.9987457,0.00007715653,0.00012812144,0.00071975397,0.00022400646,0.000105256775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003677042,0.00020884261,0.00021646167,0.000055078468,0.00087349693,0.000035252462,0.00049242406,0.000032157004,0.00012919628],"category_scores_gemma":[0.000019602961,0.00014497493,0.000041608982,0.00030596042,0.00050143705,0.000016333322,0.0011825616,0.00015764764,7.1153477e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0065031634,0.0023965435,0.5700422,0.00017275516,0.0032055415,0.00010583722,0.0027784791,0.0039551514,0.024429966,0.00029788422,0.0038236848,0.38228878],"study_design_scores_gemma":[0.0065376773,0.0027835881,0.9523216,0.0005105361,0.0005361804,0.0033099311,0.0060056457,0.008004478,0.013602356,0.0005153077,0.0047502327,0.0011224891],"about_ca_topic_score_codex":0.016950466,"about_ca_topic_score_gemma":0.0024035003,"teacher_disagreement_score":0.38227937,"about_ca_system_score_codex":0.00032899476,"about_ca_system_score_gemma":0.00088603585,"threshold_uncertainty_score":0.9895958},"labels":[],"label_agreement":null},{"id":"W4309924041","doi":"10.1007/s10549-022-06792-0","title":"Circadian rhythm disrupting behaviours and cancer outcomes in breast cancer survivors: a systematic review","year":2022,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Circadian rhythm and melatonin","field":"Neuroscience","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"University of Queensland","keywords":"Breast cancer; Circadian rhythm; Medicine; Cancer; Oncology; Internal medicine; Confounding; Cohort study; Cohort","score_opus":0.12611101170459846,"score_gpt":0.4197784252101648,"score_spread":0.29366741350556635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309924041","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002153146,0.98209167,8.398614e-8,0.0014231582,0.00027887351,0.0060635433,0.007837808,0.00005368575,0.000098046025],"genre_scores_gemma":[0.0011840909,0.9744831,0.000001681961,0.00015765378,0.0001671757,0.022410454,0.00004324484,0.00014336339,0.001409251],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99312586,0.0014736211,0.0010898018,0.0017000008,0.0011081011,0.001502591],"domain_scores_gemma":[0.99694645,0.00096514693,0.00044905822,0.00079438067,0.000080060294,0.0007649189],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009464998,0.00092749926,0.0036109665,0.0007323397,0.0006187913,0.0002520142,0.0004013687,0.00021516962,0.0009225833],"category_scores_gemma":[0.000099295416,0.0006627722,0.0003998349,0.001414951,0.00037055905,0.00023925996,0.00036072344,0.0009825648,0.000019773059],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003197458,0.0003811989,0.005439887,0.3548982,0.00026356615,0.0010333309,0.0003580985,5.7769853e-7,8.7462115e-7,0.00032390835,0.00005676846,0.6372116],"study_design_scores_gemma":[0.0021624467,0.00026544562,0.0062907697,0.8026305,0.0031496552,0.008143596,0.00021390394,0.000011451318,0.000006867343,0.00002157577,0.17514881,0.0019550193],"about_ca_topic_score_codex":0.05545268,"about_ca_topic_score_gemma":0.013429488,"teacher_disagreement_score":0.6352566,"about_ca_system_score_codex":0.0032150717,"about_ca_system_score_gemma":0.0016343306,"threshold_uncertainty_score":0.9999907},"labels":[],"label_agreement":null},{"id":"W4313545061","doi":"10.1007/s10549-022-06854-3","title":"A rare but persistent cause of decreased function secondary to adjuvant radiation therapy in women with breast cancer","year":2023,"lang":"en","type":"letter","venue":"Breast Cancer Research and Treatment","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of British Columbia Hospital","funders":"","keywords":"Breast cancer; Medicine; Radiation therapy; Adjuvant radiotherapy; Oncology; Cancer; Internal medicine; Adjuvant; Adjuvant therapy","score_opus":0.0508902963238128,"score_gpt":0.3322693203768117,"score_spread":0.2813790240529989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313545061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7297047,0.008053356,4.466919e-7,0.25282463,0.00014922139,0.003130021,0.006013937,0.000049749575,0.00007398096],"genre_scores_gemma":[0.8890519,0.054421075,0.000012911261,0.02773497,0.0021462261,0.022334656,0.0010173318,0.00024376914,0.0030371507],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9963193,0.00016097797,0.00041838744,0.0010032306,0.001069382,0.0010287568],"domain_scores_gemma":[0.99815106,0.0001596784,0.00014658086,0.0005609982,0.00046915017,0.00051251694],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021066637,0.0005586222,0.0010149117,0.00089757936,0.00014434477,0.000067390516,0.0001063501,0.0003004594,0.00094393786],"category_scores_gemma":[0.0000052073397,0.00037809898,0.000162315,0.00080852635,0.00016998655,0.000095450814,0.000056535788,0.0006650895,0.000020877556],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.035965614,0.0020581498,0.14564511,0.0007744787,0.0057858275,0.002741429,0.0019816787,0.000052163567,0.00012991566,0.0000023833406,0.123657025,0.6812062],"study_design_scores_gemma":[0.016440118,0.009581468,0.9270788,0.0022299713,0.00041603533,0.00033298336,0.0005979717,0.00001023559,0.00022840161,0.0000124753415,0.042646635,0.000424919],"about_ca_topic_score_codex":0.060793497,"about_ca_topic_score_gemma":0.007300484,"teacher_disagreement_score":0.7814337,"about_ca_system_score_codex":0.00601459,"about_ca_system_score_gemma":0.0023377417,"threshold_uncertainty_score":0.99996936},"labels":[],"label_agreement":null},{"id":"W4319293765","doi":"10.1007/s10549-023-06861-y","title":"False-positive incidental lesions detected on contrast-enhanced breast MRI: clinical and imaging features","year":2023,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"MRI in cancer diagnosis","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; Princess Margaret Cancer Centre; University of Toronto; University Health Network; Health Sciences Centre; Sinai Health System; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Radiology; Breast cancer; Breast MRI; Breast imaging; Univariate analysis; Mammography; Biopsy; Magnetic resonance imaging; Histopathology; Retrospective cohort study; Logistic regression; Lesion; Cancer; Pathology; Internal medicine; Multivariate analysis","score_opus":0.06323039931296562,"score_gpt":0.4349031769445479,"score_spread":0.37167277763158224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319293765","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97237855,0.0014496658,0.0000056634217,0.023105046,0.00014140409,0.0012062102,0.0009970231,0.00014241046,0.0005740363],"genre_scores_gemma":[0.9844003,0.013313566,0.00004442649,0.00020638898,0.0004215785,0.00075132115,0.000075595475,0.000045353136,0.00074147753],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99743396,0.00021886155,0.00028159286,0.0007434044,0.00061440613,0.0007077817],"domain_scores_gemma":[0.99794734,0.0007639599,0.000051844494,0.00031340282,0.00028995206,0.0006335087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004031324,0.00026881942,0.00043497613,0.00032360427,0.00037703762,0.00009448124,0.000081156315,0.00010142924,0.0001388663],"category_scores_gemma":[0.0000440907,0.00020065648,0.0000972288,0.0004775022,0.00058373774,0.00009026341,0.00012646531,0.00041002023,0.00006024296],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004466597,0.00083086145,0.39888075,0.00005435102,0.00054153823,0.000723713,0.0004293746,0.000002991109,0.0020222554,0.00013507043,0.008319554,0.58359295],"study_design_scores_gemma":[0.0058145933,0.0010026947,0.9864061,0.0006086173,0.00010222886,0.00059335725,0.0004450889,0.000069663765,0.0043374114,0.00013162245,0.00032208452,0.00016653968],"about_ca_topic_score_codex":0.0042382367,"about_ca_topic_score_gemma":0.0016334299,"teacher_disagreement_score":0.58752537,"about_ca_system_score_codex":0.0005251985,"about_ca_system_score_gemma":0.0003352993,"threshold_uncertainty_score":0.81825334},"labels":[],"label_agreement":null},{"id":"W4321168145","doi":"10.1007/s10549-022-06848-1","title":"Screening behaviours, demographics, and stage at diagnosis in the publicly funded Ontario Breast Screening Program","year":2023,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Public Health Ontario; University of Toronto","funders":"Canadian Institutes of Health Research; Cancer Care Ontario","keywords":"Medicine; Odds ratio; Confidence interval; Breast cancer; Breast cancer screening; Stage (stratigraphy); Demography; Logistic regression; Mammography; Cancer screening; Gynecology; Cancer; Internal medicine; Obstetrics","score_opus":0.2476520295429569,"score_gpt":0.43885493192785907,"score_spread":0.19120290238490217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321168145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863836,0.0017224574,0.0000042013717,0.009469465,0.000026293403,0.0015763043,0.0003337642,0.00010242842,0.00038147645],"genre_scores_gemma":[0.99397993,0.0019820044,0.00031820222,0.0001466481,0.00012599232,0.0019838419,0.00017175848,0.000029752355,0.0012618823],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99687654,0.00015453745,0.0002686725,0.0006560335,0.0009980741,0.0010461329],"domain_scores_gemma":[0.99873865,0.00020227424,0.0000579233,0.00037726643,0.0001766254,0.00044725367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089928124,0.00027545026,0.0003538574,0.00046271912,0.000612264,0.00026896523,0.00016630995,0.000110501795,0.00018384414],"category_scores_gemma":[0.000018721808,0.00018512618,0.00009391921,0.0012924059,0.00037740124,0.00023364455,0.00022042677,0.00045075818,0.000005556858],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007415826,0.00021911922,0.7429562,0.000020015068,0.000108169246,0.0004578515,0.0006449676,0.0000039161278,0.0000057482275,0.00007710303,0.00073636096,0.25402898],"study_design_scores_gemma":[0.0027870971,0.0010436137,0.9874656,0.0003579424,0.000075812924,0.00059583766,0.001819418,0.00009170485,0.000024893423,0.000034526976,0.005537548,0.00016595553],"about_ca_topic_score_codex":0.44543478,"about_ca_topic_score_gemma":0.63647807,"teacher_disagreement_score":0.253863,"about_ca_system_score_codex":0.00065707415,"about_ca_system_score_gemma":0.00025458072,"threshold_uncertainty_score":0.7549226},"labels":[],"label_agreement":null},{"id":"W4321436546","doi":"10.1007/s10549-023-06872-9","title":"Concordance of immunohistochemistry for predictive and prognostic factors in breast cancer between biopsy and surgical excision: a single-centre experience and review of the literature","year":2023,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"Università degli Studi di Pavia","keywords":"Concordance; Medicine; Biopsy; Breast cancer; Context (archaeology); Progesterone receptor; Immunohistochemistry; Cancer; Oestrogen receptor; Gynecology; Oncology; Internal medicine; Estrogen receptor","score_opus":0.06707423783327625,"score_gpt":0.4024659828294986,"score_spread":0.3353917449962223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321436546","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10353741,0.886545,2.4793354e-7,0.0002641917,0.000032361193,0.0017821742,0.0078279385,0.0000043516884,0.0000063303733],"genre_scores_gemma":[0.04872554,0.9492475,0.000010048234,0.000003557644,0.00011367729,0.0015958826,0.00017667159,0.000034626344,0.00009251679],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.998017,0.00015197441,0.00045251704,0.0007429495,0.00026029412,0.0003752529],"domain_scores_gemma":[0.9987469,0.00027330648,0.0002527954,0.0003175412,0.00026939597,0.00014008771],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016102484,0.0004292742,0.001158137,0.00007799484,0.00013178386,0.000026912841,0.00014776878,0.00020772972,0.0000047796802],"category_scores_gemma":[0.000047289603,0.00025635443,0.00014130371,0.00037136246,0.00082503806,0.000010179484,0.00033227672,0.00016419071,5.111259e-8],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001124264,0.00054577703,0.1951648,0.10465359,0.0022421998,0.000040484007,0.001321622,1.5153387e-7,0.00026010897,0.000012739545,0.00018187793,0.6944524],"study_design_scores_gemma":[0.009178169,0.0017738693,0.30222479,0.6141675,0.0028611196,0.0013513898,0.0011478981,0.0000023494158,0.001168501,0.00007600855,0.0644972,0.0015512112],"about_ca_topic_score_codex":0.0006058111,"about_ca_topic_score_gemma":0.000068342546,"teacher_disagreement_score":0.6929012,"about_ca_system_score_codex":0.00022632816,"about_ca_system_score_gemma":0.00040050567,"threshold_uncertainty_score":0.99998885},"labels":[],"label_agreement":null},{"id":"W4323036952","doi":"10.1007/s10549-023-06886-3","title":"Discordance between PAM50 intrinsic subtyping and immunohistochemistry in South African women with breast cancer","year":2023,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Division of Cancer Epidemiology and Genetics, National Cancer Institute; South African Medical Research Council; Medical Research Council; National Cancer Institute; National Institutes of Health; Canada Excellence Research Chairs, Government of Canada; National Research Foundation","keywords":"Subtyping; Concordance; Immunohistochemistry; Breast cancer; Oncology; Medicine; Internal medicine; Cancer; Population; Pathology","score_opus":0.02673833638178889,"score_gpt":0.3236112366129637,"score_spread":0.2968729002311748,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323036952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928666,0.00345361,0.0000022278302,0.0018298656,0.000027378414,0.00041476957,0.0012676441,0.000031143554,0.00010676399],"genre_scores_gemma":[0.9923761,0.0048167678,0.000019030143,0.000020301386,0.00029361056,0.0019523752,0.00008463963,0.000046764148,0.00039039837],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977361,0.000070953625,0.00019704492,0.00079692336,0.00029320008,0.000905786],"domain_scores_gemma":[0.9991532,0.000042872627,0.0000651444,0.0003512485,0.00012608926,0.00026145478],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018182643,0.00033537103,0.00036286924,0.00016202747,0.0002885013,0.00006476597,0.00013799782,0.00008795581,0.000026008156],"category_scores_gemma":[0.000006793101,0.00025231126,0.00003076354,0.00055160455,0.00049495796,0.000015677235,0.00025095796,0.00016137326,0.000004841479],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033697442,0.00017608865,0.8739503,0.000092865674,0.00068155886,0.00007121571,0.0020395124,0.00001450773,0.007143756,0.000013176649,0.00009456135,0.11235269],"study_design_scores_gemma":[0.002911914,0.00035773925,0.9917679,0.00016840492,0.000032727447,0.000065800494,0.0019875772,0.0000028589066,0.0019808658,0.00004891876,0.0003867708,0.00028855263],"about_ca_topic_score_codex":0.0046175886,"about_ca_topic_score_gemma":0.0011138322,"teacher_disagreement_score":0.11781754,"about_ca_system_score_codex":0.00066683145,"about_ca_system_score_gemma":0.000346307,"threshold_uncertainty_score":0.9999929},"labels":[],"label_agreement":null},{"id":"W4323348174","doi":"10.1007/s10549-023-06892-5","title":"BRCA1 and BRCA2 germline mutation analysis from a cohort of 1267 patients at high risk for breast cancer in Brazil","year":2023,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Air (Canada)","funders":"","keywords":"Breast cancer; Germline mutation; Genetic counseling; Germline; Genetic testing; Cancer; Family history; Mutation; Medicine; Oncology; Cohort; Genetics; Biology; Internal medicine; Gene","score_opus":0.01796588506055182,"score_gpt":0.34764649523449487,"score_spread":0.32968061017394307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323348174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9798837,0.0014187308,0.000026099242,0.00065775454,0.000049712555,0.00064981915,0.017295294,0.000007804934,0.000011122467],"genre_scores_gemma":[0.98979586,0.0072049485,0.00008810025,0.00001859733,0.00011877856,0.0011344262,0.0013550417,0.00002332409,0.0002609037],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985082,0.00009010558,0.00023868284,0.0005666249,0.00026110176,0.00033525293],"domain_scores_gemma":[0.999147,0.00006966722,0.000095748816,0.0002568404,0.00031319095,0.00011756151],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020916195,0.00016009511,0.00026208127,0.00027092994,0.0001431763,0.000024647323,0.00008042826,0.00012569822,0.00008992225],"category_scores_gemma":[0.00001722921,0.00013887143,0.00007200576,0.0006183119,0.00016230778,0.000008780502,0.00011008692,0.0000719176,0.0000019895315],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011134353,0.0001727694,0.8976743,0.000022539201,0.0014206367,0.000003436297,0.00016268018,0.0007756435,0.0029500865,0.0000046988625,0.0003436586,0.0953561],"study_design_scores_gemma":[0.0031478463,0.00026261338,0.98842627,0.000022744229,0.0002511987,0.000002701214,0.00005749918,0.00061628205,0.0066658505,0.00012943403,0.00029166296,0.00012587481],"about_ca_topic_score_codex":0.027390705,"about_ca_topic_score_gemma":0.037198152,"teacher_disagreement_score":0.09523023,"about_ca_system_score_codex":0.00047677907,"about_ca_system_score_gemma":0.00022947926,"threshold_uncertainty_score":0.98037046},"labels":[],"label_agreement":null},{"id":"W4327681995","doi":"10.1007/s10549-022-06815-w","title":"Post-diagnostic statin use and breast cancer-specific mortality: a population-based cohort study","year":2023,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Queen's University; Auckland District Health Board; Auckland Medical Research Foundation; Aarhus Universitet; Kaiser Permanente","keywords":"Breast cancer; Medicine; Oncology; Cohort; Internal medicine; Cohort study; Population; Statin; Cancer; Environmental health","score_opus":0.04986996933219678,"score_gpt":0.36258505612737263,"score_spread":0.31271508679517585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4327681995","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909834,0.0025616444,0.0000034344753,0.0007738413,0.0005578172,0.0013497717,0.0037246915,0.00003206061,0.000013291501],"genre_scores_gemma":[0.9835572,0.011425236,0.000012321764,0.0000594869,0.0021291191,0.0016492076,0.0005412097,0.000039962844,0.0005862364],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99790716,0.0001740539,0.00021870411,0.00071896653,0.00043024437,0.00055089605],"domain_scores_gemma":[0.99879366,0.00012385451,0.000051247524,0.00040511062,0.00031291574,0.00031323492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030165017,0.00024776516,0.00028290978,0.0001623382,0.00029862887,0.00015556614,0.00009365616,0.000078553385,0.00008038001],"category_scores_gemma":[0.000035252706,0.00020583362,0.000055107175,0.00030293263,0.00014021432,0.000016265998,0.000096448544,0.0001007241,0.00000698656],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005199699,0.00040179997,0.96466553,0.00002334324,0.00031055845,0.000006308263,0.000110185436,0.000061410436,0.0025274123,0.000019356876,0.0028380838,0.028516049],"study_design_scores_gemma":[0.0022268714,0.0004759115,0.98607427,0.000033338732,0.0000693017,0.000020005167,0.0002589851,0.000035415127,0.00020182745,0.000016396682,0.010384374,0.00020331267],"about_ca_topic_score_codex":0.06666944,"about_ca_topic_score_gemma":0.019938035,"teacher_disagreement_score":0.04673141,"about_ca_system_score_codex":0.0001674871,"about_ca_system_score_gemma":0.00036277217,"threshold_uncertainty_score":0.99794555},"labels":[],"label_agreement":null},{"id":"W4353015178","doi":"10.1007/s10549-023-06881-8","title":"Long-term outcomes of dual vs single HER2-directed neoadjuvant therapy in NSABP B-41","year":2023,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; Jewish General Hospital; McGill University; Centre Hospitalier de l’Université de Montréal","funders":"National Cancer Institute; NSABP Foundation; GlaxoSmithKline; U.S. Department of Health and Human Services","keywords":"Medicine; Lapatinib; Breast cancer; Trastuzumab; Internal medicine; Neoadjuvant therapy; Randomized controlled trial; Gastroenterology; Surgery; Confidence interval; Cohort; Cancer","score_opus":0.16420894382315235,"score_gpt":0.45441019810179134,"score_spread":0.29020125427863896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4353015178","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98783237,0.0022001623,3.8379252e-7,0.0076785935,0.00008415565,0.0013147453,0.00022263508,0.000110380315,0.0005565744],"genre_scores_gemma":[0.9854151,0.01014767,0.000026548212,0.0000450824,0.00013932427,0.0007276037,0.00005584425,0.000054148073,0.0033886775],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967818,0.00020494036,0.0003555197,0.0005480066,0.0011272578,0.000982444],"domain_scores_gemma":[0.9984452,0.0002888886,0.0000467349,0.00048515337,0.00032919343,0.00040482348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005620773,0.00024934649,0.00061627803,0.0006727233,0.00010941481,0.000045557324,0.00012970324,0.00011103277,0.00064191857],"category_scores_gemma":[0.000049913513,0.0001749979,0.00010101963,0.0012713254,0.00037659385,0.00006771732,0.00011912549,0.00030873797,0.00006606032],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002484524,0.0012604343,0.73143923,0.00010423357,0.00026828083,0.00078887003,0.00047137597,0.0000025720994,0.0030743445,0.000016284772,0.0006482175,0.25944164],"study_design_scores_gemma":[0.0065864,0.0030634047,0.98129433,0.00034649827,0.000014514296,0.000069405505,0.00013119949,0.00003808749,0.0074476143,0.00005321812,0.0008231488,0.00013217724],"about_ca_topic_score_codex":0.011946781,"about_ca_topic_score_gemma":0.004539076,"teacher_disagreement_score":0.25930947,"about_ca_system_score_codex":0.0009918112,"about_ca_system_score_gemma":0.0007513623,"threshold_uncertainty_score":0.9946328},"labels":[],"label_agreement":null},{"id":"W4362505745","doi":"10.1007/s10549-023-06893-4","title":"Bridging pre-surgical endocrine therapy for breast cancer during the COVID-19 pandemic: outcomes from the B-MaP-C study","year":2023,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University Hospitals Coventry and Warwickshire NHS Trust; Barts Health NHS Trust; North Bristol NHS Trust; Newcastle upon Tyne Hospitals NHS Foundation Trust; Queen's University; University of Sussex; University of Oxford; University College London; Imperial College Healthcare NHS Trust; Imperial College London; University of Warwick; Queen's University Belfast; University of Cambridge; National Institute for Health and Care Research; Royal Marsden NHS Foundation Trust; University Hospitals Plymouth NHS Trust; Middlesex University; National and Kapodistrian University of Athens; Cambridge University Hospitals; University Hospitals of Leicester NHS Trust; University Hospital Southampton NHS Foundation Trust","keywords":"Medicine; Pandemic; Endocrine system; Breast cancer; Coronavirus disease 2019 (COVID-19); Internal medicine; Retrospective cohort study; Gynecology; Cancer; Hormone; Disease","score_opus":0.26262097849269356,"score_gpt":0.5264756326044315,"score_spread":0.263854654111738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362505745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8049776,0.002968142,0.0000031543452,0.1860619,0.00011099088,0.0035833227,0.0021687867,0.00011574903,0.000010373056],"genre_scores_gemma":[0.98223966,0.009756596,0.0000023952955,0.0013463816,0.001055273,0.0037650943,0.000043343178,0.000044205335,0.0017470388],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99710655,0.0002728736,0.00029172815,0.0005938309,0.0007655712,0.0009694673],"domain_scores_gemma":[0.99675304,0.0017628674,0.00006222376,0.00055716344,0.00019909542,0.0006656282],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074278266,0.00028892406,0.00046001608,0.0001334069,0.0011374938,0.00011785248,0.00020147076,0.000055034943,0.0003875557],"category_scores_gemma":[0.000076354256,0.00013223066,0.00014518545,0.00043886993,0.00021691684,0.00007090868,0.00013878632,0.00032991086,0.000011888793],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061448473,0.00046180116,0.83922803,0.00008048129,0.0006912462,0.00022338062,0.0025371527,0.000018478073,0.000059855432,0.000010525162,0.0012035703,0.14934061],"study_design_scores_gemma":[0.013233584,0.0006818234,0.9633194,0.00007999091,0.000077289114,0.00024728416,0.0010852764,0.00007964621,0.00002818496,0.000073841904,0.020967454,0.00012620236],"about_ca_topic_score_codex":0.13508838,"about_ca_topic_score_gemma":0.01744901,"teacher_disagreement_score":0.18471552,"about_ca_system_score_codex":0.0015084441,"about_ca_system_score_gemma":0.0014961861,"threshold_uncertainty_score":0.97369576},"labels":[],"label_agreement":null},{"id":"W4362506944","doi":"10.1007/s10549-023-06921-3","title":"Tumour Infiltrating Lymphocytes (TILs) and immune composition in breast cancer patients from Kenya: Spatial distributions and associations with risk factors and tumour characteristics","year":2023,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Division of Cancer Epidemiology and Genetics, National Cancer Institute; National Cancer Institute; Medical Research Council; UK Research and Innovation; University of Cape Town; Irving Medical Center, Columbia University; National Commission for Science, Technology and Innovation","keywords":"Tumor-infiltrating lymphocytes; Breast cancer; Oncology; FOXP3; Immunohistochemistry; CD68; CD3; Medicine; Stroma; Internal medicine; CD20; CD8; Pathology; Cancer; Immune system; Immunology","score_opus":0.02312506720409118,"score_gpt":0.3095471636068535,"score_spread":0.28642209640276234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362506944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98381567,0.00102898,0.0000036080648,0.0011803751,0.00003681953,0.0005440495,0.013353312,0.000027488764,0.000009683388],"genre_scores_gemma":[0.9891947,0.009375889,0.000012706208,0.000011628155,0.000084251966,0.00019898909,0.0010880346,0.000018367267,0.000015431553],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986873,0.000093034294,0.00023319772,0.00034260625,0.00028261836,0.0003612332],"domain_scores_gemma":[0.9992855,0.0001776115,0.00010359244,0.00009345587,0.00015709376,0.00018272326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013815827,0.00020172063,0.0003225179,0.00015675965,0.0004170413,0.00010916722,0.000028443694,0.00006555138,0.00003363239],"category_scores_gemma":[0.000012442716,0.00014382445,0.000026001213,0.0003065919,0.00022928421,0.00011602458,0.000048114154,0.00015512828,7.468116e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017389634,0.0002596406,0.9633056,0.000025882537,0.0002871306,0.000017113996,0.00062066584,5.075101e-7,0.0041274866,0.0000049426308,0.000018136017,0.029593952],"study_design_scores_gemma":[0.0061818985,0.0004449648,0.99097633,0.0003379272,0.00010322263,0.000025947023,0.00034565298,0.00022120311,0.0011859093,0.00002183377,0.00001830881,0.00013679061],"about_ca_topic_score_codex":0.115047075,"about_ca_topic_score_gemma":0.0064308974,"teacher_disagreement_score":0.10861617,"about_ca_system_score_codex":0.00074133987,"about_ca_system_score_gemma":0.00022707345,"threshold_uncertainty_score":0.8908459},"labels":[],"label_agreement":null},{"id":"W4365458321","doi":"10.1007/s10549-023-06935-x","title":"Associations between health-related fitness and quality of life in newly diagnosed breast cancer patients","year":2023,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer survivorship and care","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Athabasca University; Alberta Health Services; University of Calgary; University of Alberta","funders":"Canadian Institutes of Health Research; Alberta Innovates; Canada Research Chairs; National Institutes of Health; Alberta Cancer Foundation","keywords":"Breast cancer; Medicine; Oncology; Quality of life (healthcare); Internal medicine; Cancer; Demography","score_opus":0.1071937572969787,"score_gpt":0.4185788330390001,"score_spread":0.3113850757420214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365458321","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98018056,0.0020779727,2.7093787e-7,0.010124679,0.0000787875,0.0007581325,0.0066638035,0.000033143773,0.00008266285],"genre_scores_gemma":[0.9939502,0.004779623,0.0000017874003,0.000057616588,0.00009798582,0.00038410106,0.0003756988,0.00002099026,0.00033198093],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978326,0.0002505828,0.0004710644,0.00036785874,0.0005678589,0.00051003625],"domain_scores_gemma":[0.9986314,0.00030952855,0.00012793705,0.0001848338,0.0003072905,0.00043898844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056251587,0.000157241,0.0006038698,0.0002817154,0.00014960325,0.000022337881,0.0000533935,0.00009253544,0.00010083918],"category_scores_gemma":[0.000046996716,0.00012796682,0.000056037774,0.00092383916,0.00014700429,0.00007101393,0.00006588882,0.00018752934,0.0000046156783],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004256919,0.00033545113,0.9177699,0.0001285559,0.0002025348,0.0000067583,0.001611923,0.0000027289536,0.000008875999,0.00004097041,0.0003122175,0.0791544],"study_design_scores_gemma":[0.0062621376,0.00033116477,0.9924303,0.0002563145,0.000025253703,0.0000012998303,0.0004066659,0.000008374145,0.00001615812,0.000067062276,0.00010003693,0.00009521125],"about_ca_topic_score_codex":0.37860504,"about_ca_topic_score_gemma":0.10596032,"teacher_disagreement_score":0.27264473,"about_ca_system_score_codex":0.00091732317,"about_ca_system_score_gemma":0.0008278371,"threshold_uncertainty_score":0.9103536},"labels":[],"label_agreement":null},{"id":"W4366550209","doi":"10.1007/s10549-023-06938-8","title":"Patient reported symptom burden amongst immigrant and Canadian long-term resident women undergoing breast cancer surgery","year":2023,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hamilton Health Sciences; St. Joseph’s Healthcare Hamilton; McMaster University; Juravinski Hospital; Juravinski Cancer Centre","funders":"Hamilton Health Sciences Foundation; McMaster University; Hamilton Health Sciences","keywords":"Medicine; Breast cancer; Immigration; Demography; Population; Retrospective cohort study; Cohort; Cohort study; Cancer; Gerontology; Internal medicine","score_opus":0.08878312569479602,"score_gpt":0.3666106292993172,"score_spread":0.2778275036045212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366550209","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98414207,0.0039405944,4.5377806e-7,0.010158988,0.00013354402,0.00083449174,0.00046431148,0.000086783446,0.0002387649],"genre_scores_gemma":[0.9804437,0.016449338,0.000004130664,0.00015198933,0.0003503357,0.0010071056,0.00008370891,0.000046788595,0.0014628666],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962385,0.00010607701,0.00043215087,0.00078354904,0.00092159223,0.0015181168],"domain_scores_gemma":[0.9972788,0.0002060467,0.0001030751,0.0004263335,0.0003863419,0.0015993972],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005389059,0.00033011986,0.0005488978,0.0006571864,0.00056238205,0.00017554393,0.00008070791,0.000121075274,0.00039685637],"category_scores_gemma":[0.000037068825,0.00026098537,0.000092438124,0.000878337,0.00026910688,0.00018411237,0.00011575426,0.00025156548,0.00002357554],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001141417,0.000055247954,0.8644885,0.00013881378,0.0005474309,0.0037503769,0.0019548307,0.000012323472,0.00013865568,0.000013549946,0.0021786704,0.12558024],"study_design_scores_gemma":[0.0014383596,0.00035668176,0.9921727,0.0012236831,0.00008372832,0.0014122259,0.002223885,0.000036019548,0.000099310455,0.000043289274,0.00066421164,0.00024586864],"about_ca_topic_score_codex":0.78656024,"about_ca_topic_score_gemma":0.51680744,"teacher_disagreement_score":0.26975283,"about_ca_system_score_codex":0.0036721288,"about_ca_system_score_gemma":0.0030066052,"threshold_uncertainty_score":0.99998426},"labels":[],"label_agreement":null},{"id":"W4375955601","doi":"10.1007/s10549-023-06922-2","title":"Metformin, placebo, and endocrine therapy discontinuation among participants in a randomized double-blind trial of metformin vs placebo in hormone receptor-positive early-stage breast cancer (CCTG MA32)","year":2023,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Juravinski Cancer Centre; BC Cancer Agency; Université Laval; University of British Columbia; McMaster University; Queen's University","funders":"Canadian Cancer Society Research Institute; Division of Cancer Prevention, National Cancer Institute","keywords":"Metformin; Discontinuation; Placebo; Medicine; Breast cancer; Internal medicine; Oncology; Endocrine system; Endocrinology; Randomized controlled trial; Hormone; Cancer; Insulin; Alternative medicine","score_opus":0.06600611439713074,"score_gpt":0.37733847469914567,"score_spread":0.31133236030201494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4375955601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9530328,0.042636693,0.0000020521336,0.00017604601,0.00008236859,0.0032941676,0.00069557066,0.000009355505,0.00007093828],"genre_scores_gemma":[0.7660883,0.2283535,0.0000098743585,0.000008263201,0.00017099544,0.0046624057,0.00012523474,0.000026838843,0.00055457046],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99729955,0.0004121381,0.0005079046,0.00059504504,0.00040471452,0.00078061613],"domain_scores_gemma":[0.9990591,0.00014357943,0.000154274,0.00025964575,0.00016147553,0.00022192269],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013444464,0.00030092095,0.000786824,0.00034521637,0.00009189622,0.00006234351,0.00012226304,0.00012880602,0.00008370519],"category_scores_gemma":[0.000032534408,0.00022250293,0.000111497706,0.00048545207,0.00038475086,0.00004363391,0.00010726565,0.00015765238,0.000002292158],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.83880156,0.00044870612,0.009824151,0.000023784842,0.00045232565,0.000016697026,0.00072448514,0.000024607469,0.0046572173,0.0000438658,0.00007032703,0.14491227],"study_design_scores_gemma":[0.89438266,0.0012508571,0.0475259,0.00014246898,0.000072361225,0.0000056354997,0.00045333823,0.00015006281,0.054633353,0.00005792977,0.0010085333,0.00031691586],"about_ca_topic_score_codex":0.020533526,"about_ca_topic_score_gemma":0.010430037,"teacher_disagreement_score":0.18694448,"about_ca_system_score_codex":0.00016136744,"about_ca_system_score_gemma":0.00031215986,"threshold_uncertainty_score":0.9859888},"labels":[],"label_agreement":null},{"id":"W4380870903","doi":"10.1007/s10549-023-06989-x","title":"Impact of non-adherence to endocrine therapy on recurrence risk in older women with stage I breast cancer after breast-conserving surgery","year":2023,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; Health Sciences Centre; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; Princess Margaret Cancer Centre; Public Health Ontario; University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Internal medicine; Proportional hazards model; Cohort; Population; Mastectomy; Stage (stratigraphy); Breast-conserving surgery; Oncology; Gynecology; Cancer; Cancer registry; Surgery","score_opus":0.07992184348475317,"score_gpt":0.4203156468875517,"score_spread":0.3403938034027985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380870903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994839,0.00048398194,0.0000033898855,0.0020167022,0.00003918769,0.0011426137,0.0013354127,0.000030444207,0.00010923029],"genre_scores_gemma":[0.98544073,0.008583285,0.000015643729,0.00008976335,0.000095799514,0.0039768326,0.000018720053,0.00002925765,0.0017499436],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974163,0.00012481937,0.00030634983,0.000597976,0.0006931787,0.00086136855],"domain_scores_gemma":[0.99824125,0.00023446397,0.00010292364,0.0005020037,0.00033548038,0.00058385887],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00041071436,0.00028011145,0.0005154263,0.00050005177,0.000090309295,0.000034746296,0.00013107929,0.00004768921,0.0027159678],"category_scores_gemma":[0.000016046872,0.00017690312,0.000066888846,0.001432165,0.00017722425,0.00010306922,0.000055796463,0.00026424308,0.0001360367],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009045437,0.0005774805,0.7254533,0.00007360711,0.00017216304,0.00015685968,0.000748578,0.0000197942,0.0002601345,0.0000012326981,0.0006359427,0.26285544],"study_design_scores_gemma":[0.003071275,0.0018927307,0.9924747,0.0015576858,0.000010334923,0.00011818955,0.00029734834,0.000070828755,0.0002223173,0.000012908102,0.000110196524,0.00016148755],"about_ca_topic_score_codex":0.0329884,"about_ca_topic_score_gemma":0.0013398342,"teacher_disagreement_score":0.26702136,"about_ca_system_score_codex":0.0008238655,"about_ca_system_score_gemma":0.0013617815,"threshold_uncertainty_score":0.9981957},"labels":[],"label_agreement":null},{"id":"W4383873232","doi":"10.1007/s10549-023-06991-3","title":"Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation","year":2023,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Juravinski Cancer Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; Public Health Ontario; McMaster University; Women's College Hospital; University of Toronto","funders":"Canadian Institutes of Health Research; Peter Gilgan Foundation; Canada Research Chairs; Canadian Cancer Society","keywords":"Breast cancer; Tamoxifen; Medicine; Oncology; Internal medicine; Gynecology; BRCA2 Protein; Antiestrogen; Mutation; Cancer; Germline mutation; Biology; Genetics; Gene","score_opus":0.022312505655089604,"score_gpt":0.33842634788156073,"score_spread":0.3161138422264711,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383873232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937049,0.0017603637,0.000005996303,0.002971216,0.000024032941,0.0005338639,0.0009031286,0.0000074281693,0.00008906679],"genre_scores_gemma":[0.98322827,0.014148092,0.000026872292,0.000029365212,0.00009906231,0.0017286404,0.000019604566,0.000019830819,0.0007002685],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99877995,0.00015670188,0.00014287798,0.0003428642,0.00022865113,0.00034896864],"domain_scores_gemma":[0.99939865,0.00007060047,0.00005837323,0.00022586535,0.0001554349,0.00009110688],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039126756,0.00013064171,0.000168886,0.000113796355,0.0001321369,0.00003216307,0.00008873122,0.000056696404,0.00006720109],"category_scores_gemma":[0.000014425636,0.000071528775,0.000018997689,0.0004574357,0.00047098385,0.000007467189,0.0000813047,0.00008575592,0.000001883632],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.045153268,0.00044608113,0.16537887,0.00017070957,0.0018750313,0.0000896638,0.0073621296,0.0021586656,0.011739101,0.00011970308,0.0014739017,0.7640329],"study_design_scores_gemma":[0.0114052035,0.0009956161,0.9764541,0.00011891999,0.00005587616,0.00019283319,0.0017811527,0.0003517446,0.0066530914,0.0004417446,0.0013466086,0.00020310933],"about_ca_topic_score_codex":0.006925988,"about_ca_topic_score_gemma":0.007646892,"teacher_disagreement_score":0.8110752,"about_ca_system_score_codex":0.00027863623,"about_ca_system_score_gemma":0.00058338937,"threshold_uncertainty_score":0.99968696},"labels":[],"label_agreement":null},{"id":"W4386208836","doi":"10.1007/s10549-023-07057-0","title":"Ultrasound and clinicopathological characteristics-based model for prediction of pathologic response to neoadjuvant chemotherapy in HER2-positive breast cancer: a case–control study","year":2023,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Artificial Intelligence in Medicine (Canada)","funders":"","keywords":"Medicine; Breast cancer; Oncology; Stage (stratigraphy); Receiver operating characteristic; Internal medicine; Univariate analysis; Chemotherapy; Cancer; Trastuzumab; Multivariate analysis; Area under the curve; Biology","score_opus":0.047356041254190774,"score_gpt":0.3775125068555172,"score_spread":0.3301564656013264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386208836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9718968,0.00045523443,0.0001137959,0.0020989424,0.000038762082,0.0020954534,0.023277404,0.000021024864,0.0000025805714],"genre_scores_gemma":[0.9942501,0.0014019591,0.00007408553,0.00009535374,0.00011191228,0.003875815,0.00009253345,0.00003081158,0.000067425404],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979059,0.00031466765,0.00031500153,0.00074308075,0.00020851083,0.0005128204],"domain_scores_gemma":[0.99896467,0.00024907498,0.00007745333,0.00026698402,0.0002638399,0.00017795493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007597376,0.00027449045,0.00043522683,0.00019450298,0.00020230771,0.00003008401,0.000081456885,0.00011773655,0.000008341758],"category_scores_gemma":[0.000055415152,0.00021006221,0.00006843622,0.00026771633,0.00022688342,0.000007928212,0.000067378736,0.00009052729,8.81928e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.053575527,0.002313904,0.8541877,0.000045918012,0.00031228832,0.000639672,0.0013511521,0.00048202477,0.020431198,0.0000044580474,0.00009603318,0.06656012],"study_design_scores_gemma":[0.009573104,0.0039252057,0.9833058,0.00007187839,0.000071102506,0.0004973536,0.0005339041,0.0011862495,0.0006382511,0.000026161884,0.000015528607,0.00015542157],"about_ca_topic_score_codex":0.0009320392,"about_ca_topic_score_gemma":0.0016193376,"teacher_disagreement_score":0.12911813,"about_ca_system_score_codex":0.00024459086,"about_ca_system_score_gemma":0.00025829644,"threshold_uncertainty_score":0.8566088},"labels":[],"label_agreement":null},{"id":"W4386572692","doi":"10.1007/s10549-023-07123-7","title":"Retraction Note: Glypican-3 regulates migration, adhesion and actin cytoskeleton organization in mammary tumor cells through Wnt signaling modulation","year":2023,"lang":"en","type":"retraction","venue":"Breast Cancer Research and Treatment","topic":"Proteoglycans and glycosaminoglycans research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":true,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Wnt signaling pathway; Cell biology; Actin cytoskeleton; Cytoskeleton; Actin; Signal transduction; Adhesion; Biology; Chemistry; Cell; Biochemistry","score_opus":0.03334789904950621,"score_gpt":0.3421459720676849,"score_spread":0.3087980730181787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386572692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902652,0.0041303555,0.0002013201,0.0022089244,0.0004996309,0.0018913397,0.00064512703,0.00005376265,0.00010437454],"genre_scores_gemma":[0.9087713,0.081415586,0.00022839692,0.000020538308,0.0010550693,0.0004674504,0.0032003631,0.00011634608,0.0047249566],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971462,0.00028012486,0.00036986126,0.0009766258,0.0006461273,0.00058109476],"domain_scores_gemma":[0.99868274,0.00008065676,0.00015871697,0.00036098016,0.000544837,0.00017206391],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004629628,0.0003680357,0.00034787183,0.0003893188,0.00034133342,0.00020311054,0.00013729576,0.00044760763,0.000034274304],"category_scores_gemma":[0.00008434996,0.00033083966,0.000051623494,0.00082387833,0.00012905135,0.000056357047,0.00015106612,0.000559344,0.000010285236],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016488722,0.0005748808,0.0045580375,0.00069424533,0.00027992955,0.00020410701,0.00026713466,0.00025757434,0.7569338,0.000046847894,0.008175814,0.22635873],"study_design_scores_gemma":[0.0036075113,0.002395807,0.064396605,0.0011035784,0.00008627999,0.00038599846,0.00028327602,0.0012777221,0.86944777,0.00045118554,0.055529602,0.0010346579],"about_ca_topic_score_codex":0.013231855,"about_ca_topic_score_gemma":0.0049768775,"teacher_disagreement_score":0.22532406,"about_ca_system_score_codex":0.00073973724,"about_ca_system_score_gemma":0.00076915574,"threshold_uncertainty_score":0.99991435},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"editorial","about_ca_system":false,"about_ca_topic":false,"confidence":"high"},{"model":"gpt","categories":["research_integrity"],"domain":null,"study_design":"not_applicable","genre":"editorial","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"split"},{"id":"W4388492584","doi":"10.1007/s10549-023-07159-9","title":"The impact of erythropoiesis-stimulating agents administration concomitantly with adjuvant anti-HER2 treatments on the outcomes of patients with early breast cancer: a sub-analysis of the ALTTO study","year":2023,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kelowna General Hospital","funders":"National Cancer Institute; Genentech; National Institutes of Health; Ipsen; European Society for Medical Oncology; Servier; Max-Planck-Gesellschaft; F. Hoffmann-La Roche; Novartis; Pfizer; Les Laboratories Pierre Fabre; AstraZeneca; Eli Lilly and Company; Canadian Cancer Society; GlaxoSmithKline; Seagen; Gilead Sciences; Daiichi Sankyo Europe; U.S. Department of Defense","keywords":"Medicine; Breast cancer; Erythropoiesis; Adjuvant; Oncology; Cancer; Internal medicine; Anemia","score_opus":0.05064984620022655,"score_gpt":0.39014992459173925,"score_spread":0.3395000783915127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388492584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99337846,0.00013241245,2.2274014e-7,0.002164854,0.000020845644,0.0023625323,0.0018575323,0.000014452251,0.00006866068],"genre_scores_gemma":[0.9987062,0.0005161932,0.000005002125,0.000007945981,0.000018102324,0.0004226422,0.000049446462,0.000030939987,0.00024349023],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99716485,0.00028106922,0.00045293383,0.0004068227,0.0012234022,0.00047093508],"domain_scores_gemma":[0.99769425,0.00053750176,0.0003472491,0.0006992347,0.00056333264,0.00015843687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030575128,0.00034122102,0.00080602436,0.00020864584,0.00046691173,0.000036616195,0.00016932935,0.00004723517,0.00006923881],"category_scores_gemma":[0.000019146075,0.000116076626,0.0002725383,0.0014732829,0.0006219307,0.000054245826,0.00006764554,0.00014290852,0.0000016038636],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044127135,0.0036236974,0.96627164,0.000023698902,0.017014235,0.00002503605,0.001185388,0.00024683453,0.00006689177,0.000014671063,0.000046747427,0.0070684305],"study_design_scores_gemma":[0.0067271455,0.009233425,0.9785801,0.00022528984,0.0026071656,0.000005925533,0.0017824547,0.00014147512,0.0005930706,0.0000047048425,0.0000019750917,0.000097223565],"about_ca_topic_score_codex":0.021812323,"about_ca_topic_score_gemma":0.0040721935,"teacher_disagreement_score":0.01774013,"about_ca_system_score_codex":0.00059733173,"about_ca_system_score_gemma":0.0006027471,"threshold_uncertainty_score":0.9847015},"labels":[],"label_agreement":null},{"id":"W4389978835","doi":"10.1007/s10549-023-07165-x","title":"Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY","year":2023,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"AstraZeneca","keywords":"Medicine; Olaparib; Metastatic breast cancer; Internal medicine; Oncology; BRCA mutation; Breast cancer; Taxane; Population; Eribulin; Cancer","score_opus":0.11391323041243315,"score_gpt":0.4893376363452184,"score_spread":0.37542440593278525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389978835","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939097,0.0006884287,0.000004505818,0.0018199001,0.000033193017,0.0010975836,0.0022386962,0.000017875536,0.00019009208],"genre_scores_gemma":[0.9871716,0.011721749,0.000053894924,0.000019082188,0.000042374464,0.00075909967,0.000056230052,0.000023099346,0.00015290073],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99687165,0.0008018298,0.00070830947,0.0005789159,0.00054219225,0.0004970972],"domain_scores_gemma":[0.99761856,0.0013795818,0.00016936635,0.0002730584,0.00032549285,0.0002339394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017104138,0.00022424685,0.0011115728,0.0014437016,0.0000634563,0.000013387426,0.00007212773,0.00006777907,0.00023646424],"category_scores_gemma":[0.00004238491,0.00017678543,0.00014268377,0.0040268893,0.00055099715,0.00008377523,0.000067229696,0.00029129573,0.0000019361373],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013142256,0.00088273874,0.89627385,0.0003054835,0.0024722617,0.00016932804,0.0007865353,0.00041889743,0.00043394917,0.00008806298,0.000027945365,0.08499871],"study_design_scores_gemma":[0.012639526,0.00059396744,0.9822053,0.0011522871,0.00043165957,0.000025549743,0.0003763402,0.0010507643,0.0011348131,0.0002434824,0.000026275035,0.00012005994],"about_ca_topic_score_codex":0.074859165,"about_ca_topic_score_gemma":0.04813588,"teacher_disagreement_score":0.08593145,"about_ca_system_score_codex":0.0010129927,"about_ca_system_score_gemma":0.0007754746,"threshold_uncertainty_score":0.96923316},"labels":[],"label_agreement":null},{"id":"W4390061897","doi":"10.1007/s10549-023-07185-7","title":"Survival, treatment patterns, and costs of HER2+ metastatic breast cancer patients in Ontario between 2005 to 2020","year":2023,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"AstraZeneca (Canada); Canadian Breast Cancer Network; Sunnybrook Hospital; Mount Sinai Hospital; Sunnybrook Health Science Centre","funders":"AstraZeneca Canada","keywords":"Medicine; Metastatic breast cancer; Trastuzumab; Breast cancer; Pertuzumab; Stage (stratigraphy); Internal medicine; Cohort; Cancer; Population; Oncology; Retrospective cohort study; Gynecology","score_opus":0.07276757750080395,"score_gpt":0.38936530344920967,"score_spread":0.31659772594840574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390061897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98968536,0.0008142581,0.0000033327613,0.004357342,0.000075557524,0.0017208931,0.0032481859,0.00003738156,0.000057714795],"genre_scores_gemma":[0.9922502,0.004453866,0.000058116944,0.00004300918,0.00013163587,0.0013180973,0.0001826527,0.00005779041,0.0015046563],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99714714,0.00013928527,0.00040224363,0.0006978453,0.00069327425,0.00092019065],"domain_scores_gemma":[0.99847835,0.00018273074,0.000081984086,0.00034320328,0.00025602416,0.0006577041],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023827984,0.00038092624,0.0007973017,0.00044191335,0.00011965569,0.000035327368,0.00009450962,0.00006434898,0.00038877563],"category_scores_gemma":[0.0000074524046,0.00028404142,0.00007153296,0.0006195471,0.00017268598,0.00013107821,0.0001146642,0.00018568666,0.000019763993],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017341849,0.00063116156,0.7192997,0.000058298807,0.00051206397,0.00007708566,0.00090032694,0.000014741825,0.00006763003,0.000007526382,0.00005171093,0.2766456],"study_design_scores_gemma":[0.008512472,0.0016994751,0.98633915,0.00064140564,0.00012466106,0.00003361107,0.00045163385,0.000008421916,0.00038744925,0.0000357893,0.0015585686,0.00020734698],"about_ca_topic_score_codex":0.564486,"about_ca_topic_score_gemma":0.6606788,"teacher_disagreement_score":0.27643827,"about_ca_system_score_codex":0.00453064,"about_ca_system_score_gemma":0.00079970376,"threshold_uncertainty_score":0.9999612},"labels":[],"label_agreement":null},{"id":"W4390775580","doi":"10.1007/s10549-023-07232-3","title":"The COVID-19 pandemic and its effects on follow-up of patients with early breast cancer: A patient survey","year":2024,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; London Health Sciences Centre; Ottawa Hospital; Ottawa Regional Cancer Foundation; University of Ottawa","funders":"","keywords":"Medicine; Breast cancer; Pandemic; Coronavirus disease 2019 (COVID-19); Cancer; Family medicine; Emergency medicine; Internal medicine; Disease","score_opus":0.10611443924969254,"score_gpt":0.4342361523645151,"score_spread":0.3281217131148226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390775580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9791201,0.009028935,8.8782053e-7,0.007829766,0.0001258778,0.0017159819,0.0021188287,0.000037892954,0.000021763413],"genre_scores_gemma":[0.99128497,0.007405692,0.00000113472,0.00033417938,0.00009629974,0.0005132882,0.000040792103,0.000032395095,0.00029123103],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99763787,0.00027547346,0.00021060636,0.0004762142,0.0008004524,0.00059937383],"domain_scores_gemma":[0.9971483,0.0012830375,0.000049087328,0.00025846693,0.00038547206,0.0008756668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000456016,0.00023663412,0.00034870405,0.00019403637,0.00033869746,0.00008076613,0.00006326251,0.00007568155,0.000034884844],"category_scores_gemma":[0.00009939555,0.00012166168,0.000047800528,0.0004230016,0.00017468598,0.000069926224,0.00005595667,0.000254465,0.0000052126425],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010890339,0.00022014602,0.74156624,0.0006385739,0.00034468615,0.00006490473,0.0007875599,0.0000010390738,0.000023343577,0.00005502387,0.0003771866,0.24503097],"study_design_scores_gemma":[0.0055056564,0.0053198584,0.98495466,0.0007362048,0.00007830826,0.00005903734,0.000036944228,0.000019603012,0.00008959344,0.000030589774,0.0030573325,0.00011220118],"about_ca_topic_score_codex":0.05445001,"about_ca_topic_score_gemma":0.017901238,"teacher_disagreement_score":0.24491878,"about_ca_system_score_codex":0.0014333931,"about_ca_system_score_gemma":0.0022070748,"threshold_uncertainty_score":0.99893105},"labels":[],"label_agreement":null},{"id":"W4391480168","doi":"10.1007/s10549-023-07239-w","title":"MRI-visualized T2 hyperintense breast lesions: identifying clinical and imaging factors linked to malignant biopsy outcomes","year":2024,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"MRI in cancer diagnosis","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University of Ottawa","funders":"","keywords":"Medicine; Malignancy; Breast MRI; Radiology; Biopsy; Breast cancer; Magnetic resonance imaging; Breast imaging; Lesion; Univariate analysis; Retrospective cohort study; Multivariate analysis; Pathology; Cancer; Mammography; Internal medicine","score_opus":0.19089160779728015,"score_gpt":0.5105697599208137,"score_spread":0.3196781521235335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391480168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9507903,0.008260919,0.000043303287,0.03838049,0.0004307193,0.0012513332,0.00057210133,0.00014970647,0.00012117127],"genre_scores_gemma":[0.98011446,0.016739951,0.00035180847,0.00022460983,0.0003353842,0.00066835986,0.00002837514,0.0000707503,0.001466303],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969936,0.00016482094,0.00047828193,0.00097536936,0.00064142735,0.00074652705],"domain_scores_gemma":[0.99773955,0.0005919273,0.000035100362,0.00042593313,0.00026026892,0.0009472246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061937387,0.00034450536,0.0006417555,0.000480259,0.0002583372,0.0003099997,0.000104975574,0.000093684175,0.00040692068],"category_scores_gemma":[0.00005222257,0.00022585792,0.00017710825,0.0004691633,0.00038026954,0.00015163333,0.00022577053,0.00032794225,0.000064771964],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007783649,0.00041201647,0.8355272,0.00021834605,0.00058813073,0.0009375589,0.00060948764,3.8668585e-7,0.0007083624,0.00017038797,0.002159389,0.15789036],"study_design_scores_gemma":[0.0028380642,0.00043950052,0.9838001,0.0016493825,0.00021741929,0.0013055797,0.0009930049,0.00013721117,0.00028191158,0.00012267788,0.007964263,0.00025088515],"about_ca_topic_score_codex":0.0073981597,"about_ca_topic_score_gemma":0.00032245836,"teacher_disagreement_score":0.15763949,"about_ca_system_score_codex":0.0005852759,"about_ca_system_score_gemma":0.00044753889,"threshold_uncertainty_score":0.99921167},"labels":[],"label_agreement":null},{"id":"W4391997837","doi":"10.1007/s10549-024-07251-8","title":"Preoperative factors that predict pathologic nodal involvement in early-stage HER2+ breast cancer: selecting cT1cN0 patients for treatment with neoadjuvant chemotherapy versus upfront surgery","year":2024,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University; McGill University Health Centre","funders":"Fonds de Recherche du Québec - Santé","keywords":"Breast cancer; Medicine; Chemotherapy; Stage (stratigraphy); Oncology; Neoadjuvant therapy; Internal medicine; Breast surgery; Cancer","score_opus":0.05618413191922758,"score_gpt":0.33686742953934634,"score_spread":0.2806832976201188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391997837","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98490167,0.0065645813,0.000013396529,0.0009254793,0.0002523356,0.0020376912,0.005200142,0.00005054039,0.000054151504],"genre_scores_gemma":[0.977669,0.015926495,0.00005010039,0.000024912233,0.00026965834,0.00496238,0.00059955294,0.000086347616,0.00041152467],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968415,0.00014988154,0.00029996442,0.0012489647,0.0004408944,0.0010187782],"domain_scores_gemma":[0.9988778,0.00019253079,0.00008201186,0.00034263037,0.0002540966,0.00025088846],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019652028,0.0006222934,0.0005687862,0.00021861437,0.00036973378,0.00016286626,0.00012457136,0.00014939495,0.00004278243],"category_scores_gemma":[0.0000069279963,0.0004003309,0.00016634974,0.00030513597,0.00025178483,0.000039456805,0.0000893705,0.00011992164,0.000002158246],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008662522,0.0012818871,0.9074164,0.00009212784,0.0017159664,0.00005427805,0.0017252539,0.00003340792,0.00022998975,0.0000091454895,0.00032033882,0.078458704],"study_design_scores_gemma":[0.011083214,0.00634999,0.964221,0.00039107734,0.00015701773,0.00002705687,0.0013125563,0.00006243798,0.011984113,0.00001112416,0.0038361705,0.000564235],"about_ca_topic_score_codex":0.024143051,"about_ca_topic_score_gemma":0.022944976,"teacher_disagreement_score":0.07789447,"about_ca_system_score_codex":0.00202409,"about_ca_system_score_gemma":0.00076972554,"threshold_uncertainty_score":0.99984485},"labels":[],"label_agreement":null},{"id":"W4392238907","doi":"10.1007/s10549-024-07243-8","title":"Pro-vegetarian dietary pattern and risk of breast cancer: a case–control study","year":2024,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Agriculture Sustainability and Environmental Impact","field":"Environmental Science","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Odds ratio; Logistic regression; Confidence interval; Breast cancer; Demography; Incidence (geometry); Case-control study; Cancer; Gynecology; Population; Internal medicine; Environmental health","score_opus":0.01992499096631311,"score_gpt":0.31156479607504056,"score_spread":0.29163980510872745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392238907","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924349,0.0024881451,0.0000054402026,0.0016624824,0.000035281926,0.0012829338,0.0019407739,0.000023917417,0.00012612788],"genre_scores_gemma":[0.9968603,0.0022240174,0.000006944671,0.00001197584,0.00008183985,0.00047218794,0.0000037273549,0.000016302203,0.0003226634],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99810797,0.00022929229,0.00018947473,0.0005777981,0.00040791597,0.00048757315],"domain_scores_gemma":[0.9993263,0.0000940284,0.000034320015,0.00022241069,0.000013910976,0.0003090128],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00036874626,0.00023065407,0.0002496423,0.000054773674,0.00030260268,0.000084081854,0.000085259824,0.000054862394,0.0010839846],"category_scores_gemma":[0.0000036323179,0.00014033738,0.00005759495,0.00023584999,0.00048006352,0.0002457911,0.00016857708,0.00020749842,0.000017484415],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018396688,0.00062400097,0.6275565,0.000044977107,0.00035133818,0.0006953892,0.0016458894,0.00007392931,0.00009474468,0.0000014552887,0.00007201464,0.3686558],"study_design_scores_gemma":[0.0010734682,0.00097122655,0.99379474,0.0000481714,0.00019749001,0.001035416,0.0021013264,0.00031846346,0.000030136898,0.000098172066,0.00018578811,0.00014562526],"about_ca_topic_score_codex":0.16008003,"about_ca_topic_score_gemma":0.029693542,"teacher_disagreement_score":0.36851016,"about_ca_system_score_codex":0.00091247796,"about_ca_system_score_gemma":0.000045853023,"threshold_uncertainty_score":0.9998292},"labels":[],"label_agreement":null},{"id":"W4392386270","doi":"10.1007/s10549-024-07258-1","title":"Primary MALT lymphoma of the breast: pathological and radiological characteristics","year":2024,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Toronto General Hospital; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Lymphoma; Radiology; Radiological weapon; Breast cancer; Biopsy; Radiation therapy; Etiology; Pathology; Pathological; MALT lymphoma; Mammography; Cancer; Internal medicine","score_opus":0.048446132025886365,"score_gpt":0.3457668137984467,"score_spread":0.2973206817725603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392386270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9815593,0.010164186,7.828699e-7,0.006441871,0.000073973046,0.00055438903,0.00061182387,0.00002941008,0.0005642641],"genre_scores_gemma":[0.9894453,0.009407645,0.00003966673,0.000089616646,0.00017042375,0.00029870126,0.000027998372,0.000012808739,0.0005078267],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99863863,0.000101806676,0.00018959928,0.00039409104,0.00033357783,0.00034228386],"domain_scores_gemma":[0.99924994,0.00018005095,0.000025511297,0.00023496019,0.0000863664,0.00022320461],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017570447,0.00017658924,0.00034678448,0.00005854589,0.0001370505,0.000053144413,0.000056960664,0.000090592,0.00010972893],"category_scores_gemma":[0.000010237551,0.000080879334,0.00009158888,0.00018664883,0.00049226545,0.000037221598,0.00012257475,0.00008520696,0.0000082284605],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071943115,0.0010662498,0.4493011,0.00014585101,0.00027459257,0.00075169187,0.0001262315,5.022389e-8,0.000568963,0.0012542991,0.00029873516,0.5454928],"study_design_scores_gemma":[0.0019162921,0.0009576593,0.98852557,0.0003006246,0.000119323304,0.0053164978,0.000037342485,0.000024051998,0.00031731278,0.00017760684,0.0022365826,0.00007111292],"about_ca_topic_score_codex":0.00037309632,"about_ca_topic_score_gemma":0.000011682264,"teacher_disagreement_score":0.5454217,"about_ca_system_score_codex":0.00050391356,"about_ca_system_score_gemma":0.00032110547,"threshold_uncertainty_score":0.32981637},"labels":[],"label_agreement":null},{"id":"W4392911941","doi":"10.1007/s10549-024-07269-y","title":"The distribution of breast density in women aged 18 years and older","year":2024,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Digital Radiography and Breast Imaging","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"University of Western Australia; Cancer Australia; National Breast Cancer Foundation; Australian Government","keywords":"Breast cancer; Body mass index; Medicine; Mammography; Breast density; Breast imaging; Demography; MAMMOGRAPHIC DENSITY; Gynecology; Obstetrics; Internal medicine; Cancer","score_opus":0.02432985901848697,"score_gpt":0.33759799427778664,"score_spread":0.31326813525929964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392911941","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99314165,0.0039843847,0.0000029796013,0.0020571304,0.000026144593,0.00027371768,0.00026943677,0.000015049306,0.00022951848],"genre_scores_gemma":[0.9975447,0.0019218578,0.0000029506718,0.000008889328,0.00004814093,0.00009954892,0.000017348311,0.000007808014,0.00034873243],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9990962,0.000038763304,0.00010785005,0.00020701955,0.00023063475,0.00031948937],"domain_scores_gemma":[0.99956733,0.00009740392,0.00001057263,0.000117247444,0.000054735072,0.00015273299],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027404792,0.00008478611,0.00014076059,0.00011018068,0.00008001126,0.00009088997,0.000029791418,0.000025269332,0.000019856077],"category_scores_gemma":[0.0000054301872,0.00005190409,0.000033744753,0.00037374187,0.00030520986,0.00008692007,0.000036203364,0.00011726819,0.0000017651813],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010360401,0.00023860886,0.11716045,0.00009412732,0.00018098863,0.0002060499,0.0004954225,2.1096942e-7,0.00022103965,0.00036889888,0.0002980584,0.8797001],"study_design_scores_gemma":[0.0010251715,0.00021517712,0.9960128,0.00033596376,0.000016895045,0.00063238956,0.00034192944,0.000034596884,0.0001071181,0.0003954321,0.00083737867,0.000045156183],"about_ca_topic_score_codex":0.0015622592,"about_ca_topic_score_gemma":0.0001604364,"teacher_disagreement_score":0.87965494,"about_ca_system_score_codex":0.00026964405,"about_ca_system_score_gemma":0.00013385338,"threshold_uncertainty_score":0.23616791},"labels":[],"label_agreement":null},{"id":"W4392959472","doi":"10.1007/s10549-024-07277-y","title":"Trends in socioeconomic inequalities in breast cancer mortality in Canada: 1992–2019","year":2024,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia, Okanagan Campus; University of British Columbia; Dalhousie University","funders":"University of British Columbia; Canada Research Chairs; Beatrice Hunter Cancer Research Institute","keywords":"Breast cancer; Socioeconomic status; Demography; Mortality rate; National Death Index; Census; Medicine; Population; Cancer; Gerontology; Environmental health; Confidence interval; Hazard ratio; Internal medicine; Sociology","score_opus":0.1493425231834533,"score_gpt":0.4288807224006364,"score_spread":0.2795381992171831,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392959472","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9728861,0.011753173,1.437528e-7,0.012917767,0.000093386305,0.00030129746,0.001238732,0.000015203943,0.0007942062],"genre_scores_gemma":[0.99345976,0.0050584073,0.0000042051934,0.00015203252,0.00017495132,0.00051697897,0.00005165524,0.000020767933,0.0005612245],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997781,0.000103611164,0.00037298293,0.0005384599,0.00043622582,0.0007677215],"domain_scores_gemma":[0.99939257,0.00008118608,0.00002507015,0.00020906911,0.000048368256,0.00024373361],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042427707,0.00021854056,0.00045298928,0.0005717397,0.000048849015,0.00005814084,0.00008701136,0.00007209774,0.00078958436],"category_scores_gemma":[0.000003173757,0.00017702678,0.000053094747,0.0006098801,0.000114393944,0.00017789355,0.00005652975,0.00036838625,0.000007756434],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055713876,0.00009559266,0.8751808,0.00008671218,0.00009209088,0.0009030614,0.0005328908,0.00006701245,0.000027100625,0.00020607887,0.0011577435,0.121093765],"study_design_scores_gemma":[0.0018607054,0.00011144047,0.9944456,0.0007440254,0.000018983945,0.00011128813,0.0011767672,0.0004224492,0.00004030051,0.00013876097,0.0007784489,0.00015121044],"about_ca_topic_score_codex":0.9979452,"about_ca_topic_score_gemma":0.9978807,"teacher_disagreement_score":0.120942555,"about_ca_system_score_codex":0.011548385,"about_ca_system_score_gemma":0.0047026733,"threshold_uncertainty_score":0.9922461},"labels":[],"label_agreement":null},{"id":"W4395079708","doi":"10.1007/s10549-024-07306-w","title":"Disentangling the relationships of body mass index and circulating sex hormone concentrations in mammographic density using Mendelian randomization","year":2024,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Digital Radiography and Breast Imaging","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; University of British Columbia; University of Toronto; University Health Network; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; BC Cancer Agency","funders":"Division of Cancer Epidemiology and Genetics, National Cancer Institute; National Cancer Institute","keywords":"Mendelian randomization; Sex hormone-binding globulin; Body mass index; Internal medicine; Breast cancer; Endocrinology; Hormone; Testosterone (patch); Phenotype; Medicine; Oncology; Biology; Cancer; Genetics; Androgen; Genotype; Gene","score_opus":0.05773142106971615,"score_gpt":0.34818569564940993,"score_spread":0.2904542745796938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395079708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99206126,0.0050287824,0.00028849897,0.0017567956,0.000020215217,0.00056876475,0.00005177139,0.000018504594,0.00020541257],"genre_scores_gemma":[0.9988226,0.0009581783,0.00005519517,0.000007461825,0.000051738658,0.00005011793,0.000019206338,0.000010921386,0.00002452296],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990186,0.00010303422,0.00019089904,0.00021819513,0.00024794333,0.00022129009],"domain_scores_gemma":[0.99948615,0.00019712772,0.00002640903,0.000105086765,0.00008026907,0.00010494332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036753237,0.000098673336,0.00017043824,0.000327271,0.0002095371,0.00010200166,0.000023163266,0.00003362067,0.000004350381],"category_scores_gemma":[0.000016937365,0.00006531178,0.000046655507,0.00076820614,0.00029555676,0.00016716261,0.00001794679,0.00017113105,1.8242687e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049801054,0.00009575162,0.97186,0.00006152671,0.00019020343,0.000054978886,0.00042920953,0.00009018623,0.001902952,0.00096522825,0.000004312335,0.02384762],"study_design_scores_gemma":[0.006148811,0.00017411682,0.8875095,0.00081287307,0.00019596868,0.0005739412,0.0024253747,0.099360004,0.0006560448,0.0019760316,0.000032420467,0.00013491744],"about_ca_topic_score_codex":0.0010693985,"about_ca_topic_score_gemma":0.0002251321,"teacher_disagreement_score":0.099269815,"about_ca_system_score_codex":0.00014289167,"about_ca_system_score_gemma":0.0001370014,"threshold_uncertainty_score":0.26633373},"labels":[],"label_agreement":null},{"id":"W4395467322","doi":"10.1007/s10549-024-07302-0","title":"Perspectives on shorter durations of anti-HER2 therapy in early-stage HER2-positive breast cancer: a patient survey","year":2024,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; McMaster University; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Breast cancer; Pertuzumab; Trastuzumab; Internal medicine; myalgia; Clinical trial; Cancer; Adverse effect; Oncology; Physical therapy","score_opus":0.07811656565937058,"score_gpt":0.42488924505717257,"score_spread":0.346772679397802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395467322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9765925,0.0095761465,0.000001954212,0.006158615,0.000085586515,0.0017697302,0.005010601,0.0000375239,0.00076736964],"genre_scores_gemma":[0.9571372,0.040367916,0.0000114976465,0.000034545574,0.00016941056,0.0012260616,0.000057925703,0.000059158174,0.00093627855],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965701,0.00045334123,0.0003441296,0.0008080531,0.0010677829,0.00075657456],"domain_scores_gemma":[0.99821943,0.0003344312,0.00003873932,0.00041762754,0.00062530057,0.00036445912],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005581811,0.00030158146,0.000491889,0.0006237532,0.00015066174,0.00012433162,0.0001188392,0.00011020594,0.00096528634],"category_scores_gemma":[0.000018575754,0.00021465255,0.00011034502,0.0010614534,0.00046119065,0.00013523627,0.00006728698,0.00050537946,0.000025999787],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006696391,0.003359399,0.7145289,0.00020690744,0.001070448,0.0007664175,0.013583132,0.00002742045,0.0013577132,0.00043856495,0.0011525758,0.2568121],"study_design_scores_gemma":[0.001998015,0.003315362,0.9879938,0.0010555842,0.000019943165,0.0000802239,0.0017621071,0.00012213938,0.0025332554,0.000023735265,0.0009183445,0.00017749463],"about_ca_topic_score_codex":0.16580914,"about_ca_topic_score_gemma":0.017651182,"teacher_disagreement_score":0.27346486,"about_ca_system_score_codex":0.002189425,"about_ca_system_score_gemma":0.0015399131,"threshold_uncertainty_score":0.99994797},"labels":[],"label_agreement":null},{"id":"W4395690084","doi":"10.1007/s10549-024-07282-1","title":"Neoadjuvant chemotherapy for triple-negative and Her2 +ve breast cancer: striving for the standard of care","year":2024,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Canadian Cancer Society; Institute for Clinical Evaluative Sciences; Sunnybrook Research Institute","keywords":"Medicine; Breast cancer; Internal medicine; Trastuzumab; Oncology; Stage (stratigraphy); Triple-negative breast cancer; Population; Cancer; Cohort; Neoadjuvant therapy; Odds ratio; Logistic regression; Chemotherapy; Disease; Retrospective cohort study; Mastectomy","score_opus":0.026347154271018396,"score_gpt":0.36780957367120914,"score_spread":0.34146241940019073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395690084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6374628,0.27031714,0.00072574534,0.031093134,0.0005413366,0.0070243236,0.052643765,0.00005644336,0.00013528638],"genre_scores_gemma":[0.96474326,0.030728724,0.00018868493,0.000036490015,0.0004935081,0.0033635355,0.00007234712,0.000046029112,0.00032745156],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9985549,0.0000418668,0.00017764725,0.0005597163,0.00021896545,0.00044692637],"domain_scores_gemma":[0.9989526,0.0002382157,0.000046910776,0.00023406818,0.0004171406,0.00011102671],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016244035,0.0002558281,0.00031379185,0.000067741035,0.00035922107,0.000077475364,0.00010590487,0.000077865494,0.000020280093],"category_scores_gemma":[0.000012670677,0.00015783218,0.00012303588,0.000140746,0.00035205993,0.000010607813,0.00007740906,0.00006984396,2.3516564e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011807807,0.0001607775,0.009887811,0.0005065872,0.0028493276,0.0000048370807,0.0024265766,0.000019347497,0.00311718,0.0003669782,0.0025905967,0.96626216],"study_design_scores_gemma":[0.059392735,0.021760205,0.3834666,0.0032462275,0.0021101506,0.00052160723,0.02676092,0.00085628015,0.29596817,0.0028662062,0.20086023,0.0021906644],"about_ca_topic_score_codex":0.0026436325,"about_ca_topic_score_gemma":0.0034605176,"teacher_disagreement_score":0.9640715,"about_ca_system_score_codex":0.00031465196,"about_ca_system_score_gemma":0.00046855933,"threshold_uncertainty_score":0.64362097},"labels":[],"label_agreement":null},{"id":"W4397290537","doi":"10.1007/s10549-024-07360-4","title":"Development and application of a weighted change score to evaluate interventions for vasomotor symptoms in patients with breast cancer using regression trees: a cohort study","year":2024,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Menopause: Health Impacts and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Children's Hospital of Eastern Ontario; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Psychological intervention; Discontinuation; Physical therapy; Quality of life (healthcare); Breast cancer; Prospective cohort study; Cohort; Observational study; Internal medicine; Cancer","score_opus":0.1518513345406456,"score_gpt":0.466677174049842,"score_spread":0.3148258395091964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4397290537","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98750645,0.001958252,0.000032412085,0.00053885515,0.0000341609,0.009340639,0.00056727254,0.000017441283,0.000004502082],"genre_scores_gemma":[0.9901383,0.00023833824,0.00031061957,0.000014199773,0.00005558023,0.009060126,0.00007738144,0.000031760766,0.00007368766],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99824125,0.000060957278,0.00030956868,0.0005028712,0.00048514717,0.0004002005],"domain_scores_gemma":[0.9990325,0.000040742572,0.000059495163,0.00019842514,0.0003062003,0.00036262444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031136294,0.00020759851,0.00038514024,0.00043417193,0.00015497791,0.00003644696,0.000037480557,0.000042124793,0.00002920538],"category_scores_gemma":[0.0000038603043,0.000121492405,0.00001566322,0.00043879292,0.000052588795,0.0001027421,0.000046430927,0.00007749451,0.0000012687491],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037281935,0.0020780177,0.7302517,0.0006145104,0.0005828887,0.0000129261425,0.0012465067,7.901837e-7,0.00006595918,0.0000069536277,0.000006192441,0.26140532],"study_design_scores_gemma":[0.009737461,0.005771215,0.97848487,0.004928327,0.00030992719,0.00001650474,0.000112986265,0.00038601327,0.00006048236,0.000008159906,0.00008420667,0.00009984034],"about_ca_topic_score_codex":0.009098456,"about_ca_topic_score_gemma":0.0052434695,"teacher_disagreement_score":0.26130548,"about_ca_system_score_codex":0.0013241696,"about_ca_system_score_gemma":0.00045744533,"threshold_uncertainty_score":0.99750006},"labels":[],"label_agreement":null},{"id":"W4399481017","doi":"10.1007/s10549-024-07400-z","title":"Second primary non-breast cancers in young breast cancer survivors","year":2024,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Susan G. Komen; Breast Cancer Research Foundation","keywords":"Medicine; Breast cancer; Cumulative incidence; Internal medicine; Incidence (geometry); Population; Hazard ratio; Gynecology; Oncology; Proportional hazards model; Confidence interval; Obstetrics; Cancer; Cohort","score_opus":0.033906846359865156,"score_gpt":0.35156391040752355,"score_spread":0.31765706404765837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399481017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9561425,0.016525844,0.0000033051685,0.00731811,0.00065313326,0.0015037819,0.0054578753,0.00011094023,0.01228451],"genre_scores_gemma":[0.9731999,0.01586064,0.000028535233,0.00026978258,0.000810152,0.0014248005,0.00017434219,0.00009613939,0.00813569],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99630547,0.00011605981,0.0004414194,0.0011040168,0.00079609477,0.001236942],"domain_scores_gemma":[0.99840164,0.00013786071,0.00004615495,0.00047255313,0.00023162487,0.00071015],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00043561318,0.0004864192,0.0007113791,0.0006810475,0.00023124125,0.00018722545,0.0001677854,0.00017768973,0.005282803],"category_scores_gemma":[0.0000030258245,0.0003766397,0.00016739171,0.0009606714,0.0004021304,0.00038585506,0.00011695452,0.00066009926,0.000054691915],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005494212,0.0005794346,0.45477283,0.0014820986,0.001291694,0.0016352459,0.0019894643,0.000044509103,0.003615524,0.000105296764,0.0056199837,0.5233697],"study_design_scores_gemma":[0.0049932227,0.00047289513,0.9760759,0.0012582765,0.00011573645,0.0023847877,0.00047592292,0.0007159605,0.0003731025,0.00004720433,0.012643498,0.00044347942],"about_ca_topic_score_codex":0.13911642,"about_ca_topic_score_gemma":0.14853929,"teacher_disagreement_score":0.5229262,"about_ca_system_score_codex":0.0075115645,"about_ca_system_score_gemma":0.0044597583,"threshold_uncertainty_score":0.9998686},"labels":[],"label_agreement":null},{"id":"W4399692189","doi":"10.1007/s10549-024-07372-0","title":"UM171 suppresses breast cancer progression by inducing KLF2","year":2024,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Mechanisms and Therapy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Guizhou Medical University; National Natural Science Foundation of China","keywords":"Cancer research; Cell growth; Cancer; Breast cancer; Biology; Apoptosis; Cell cycle; Metastasis; Immunology; Cell culture; Medicine; Internal medicine","score_opus":0.05165709184154351,"score_gpt":0.4276487107807912,"score_spread":0.3759916189392477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399692189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8648875,0.09761559,0.000026794994,0.03131831,0.00050738256,0.0016181674,0.002877313,0.00022939802,0.0009195841],"genre_scores_gemma":[0.9693871,0.023962896,0.00005668827,0.00010139362,0.00079591986,0.0013880347,0.000064204934,0.00006405687,0.004179679],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99782014,0.000056381832,0.00018511145,0.0006448223,0.00062896777,0.00066459994],"domain_scores_gemma":[0.9990125,0.000061223895,0.000024728564,0.00027923431,0.00018242812,0.00043989113],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001911698,0.000260638,0.00032070663,0.00020567767,0.00025164706,0.00019869358,0.00007670119,0.000103953345,0.0020801907],"category_scores_gemma":[0.0000024446247,0.00016989204,0.00008258703,0.000421843,0.00015357502,0.0001568164,0.00006366245,0.00029019578,0.000025894993],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001791036,0.0005951656,0.005547378,0.000295262,0.0005857037,0.0003003934,0.0005315137,0.0000011317843,0.03772301,0.00045932952,0.012464011,0.9397061],"study_design_scores_gemma":[0.020837842,0.008228623,0.16849849,0.0143213365,0.0008318587,0.005095955,0.0015842245,0.0010668116,0.21023701,0.0027564317,0.5648017,0.0017397273],"about_ca_topic_score_codex":0.010620688,"about_ca_topic_score_gemma":0.00062150176,"teacher_disagreement_score":0.93796635,"about_ca_system_score_codex":0.0008694823,"about_ca_system_score_gemma":0.00063488557,"threshold_uncertainty_score":0.99883205},"labels":[],"label_agreement":null},{"id":"W4401179317","doi":"10.1007/s10549-024-07443-2","title":"A randomised trial comparing 6-monthly adjuvant zoledronate with a single one-time dose in patients with early breast cancer","year":2024,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Bone health and treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"William Osler Health System; Markham Stouffville Hospital; McMaster University; Queen's University; Ottawa Hospital; University of Ottawa","funders":"Ottawa Hospital Research Institute","keywords":"Medicine; Discontinuation; Bisphosphonate; Breast cancer; Zoledronic acid; Internal medicine; Randomized controlled trial; Adjuvant; Oncology; Cancer; Surgery; Osteoporosis","score_opus":0.047448031603157685,"score_gpt":0.34270979006183816,"score_spread":0.29526175845868047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401179317","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897842,0.0025067069,6.6506334e-7,0.0019462754,0.000062773026,0.0043400587,0.00056446536,0.00007554474,0.00071933493],"genre_scores_gemma":[0.9959486,0.00028084824,0.000046543853,0.000034959918,0.00012495455,0.0024912183,0.000101023776,0.00006647441,0.0009053912],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9970412,0.00013020907,0.00033724468,0.0007099713,0.00084281346,0.00093852537],"domain_scores_gemma":[0.9986405,0.000107203436,0.000055795004,0.00029112922,0.00022872355,0.00067666825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020967616,0.0003619041,0.00076072564,0.0003754138,0.00018256075,0.00013441924,0.00006523891,0.00008477659,0.0001875377],"category_scores_gemma":[0.0000037599218,0.00021494595,0.00006876154,0.0005637265,0.00019851018,0.00019457587,0.000040905034,0.00031949283,0.00003701759],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5628972,0.004275108,0.34950268,0.00017028202,0.00097471883,0.0004918859,0.0004442718,0.000010241616,0.000019552579,0.000009759784,0.00004862931,0.081155665],"study_design_scores_gemma":[0.33610314,0.0063765217,0.65516293,0.0015412638,0.00022237506,0.000043956596,0.00001923025,0.00016800253,0.00003361603,0.0000108533295,0.00015174266,0.00016637731],"about_ca_topic_score_codex":0.03299603,"about_ca_topic_score_gemma":0.0075295437,"teacher_disagreement_score":0.30566025,"about_ca_system_score_codex":0.0016747478,"about_ca_system_score_gemma":0.0011620475,"threshold_uncertainty_score":0.9734433},"labels":[],"label_agreement":null},{"id":"W4401386337","doi":"10.1007/s10549-024-07435-2","title":"Barrier films or dressings for the prevention of acute radiation dermatitis in breast cancer: a systematic review and network meta-analysis","year":2024,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Effects of Radiation Exposure","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Calgary; McGill University; Sunnybrook Health Science Centre; McGill University Health Centre; Princess Margaret Cancer Centre; London Health Sciences Centre; University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Meta-analysis; Randomized controlled trial; Internal medicine; Dermatology; Cancer","score_opus":0.10543895501969264,"score_gpt":0.4542095488019307,"score_spread":0.34877059378223807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401386337","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000006374141,0.98303676,0.000011168521,0.0035244245,0.00003448981,0.009891637,0.0034752886,0.000013262524,0.0000065809268],"genre_scores_gemma":[0.00032142477,0.9775864,0.00005473664,0.000082560626,0.000103815335,0.020073302,0.00023960353,0.000044708977,0.0014934648],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99712634,0.0006144807,0.0008695762,0.00050625147,0.00050489197,0.00037846694],"domain_scores_gemma":[0.99786717,0.00079776015,0.0004320249,0.0004654322,0.00025585585,0.00018176605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001105294,0.0003978742,0.004485457,0.00042756263,0.00013728844,0.000091092596,0.000118608004,0.00012742606,0.0002646489],"category_scores_gemma":[0.00004303581,0.00017959898,0.0009585365,0.0014281363,0.00011289921,0.000097823555,0.000051031635,0.00024323068,0.0000027605167],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009265593,0.00011059066,0.00005462004,0.66407686,0.21535206,0.000028438755,0.00007466552,0.0000047324297,1.1007057e-7,0.000023973684,0.0026569536,0.11752432],"study_design_scores_gemma":[0.00069823215,0.0004199106,0.00036150706,0.13127446,0.85844237,0.00040100428,0.000014758495,0.00016175464,3.9760968e-7,0.000017657636,0.008043449,0.00016448746],"about_ca_topic_score_codex":0.001387011,"about_ca_topic_score_gemma":0.0009790027,"teacher_disagreement_score":0.6430903,"about_ca_system_score_codex":0.0005387273,"about_ca_system_score_gemma":0.00091407663,"threshold_uncertainty_score":0.73238343},"labels":[],"label_agreement":null},{"id":"W4402228524","doi":"10.1007/s10549-024-07448-x","title":"Microcalcifications in benign breast biopsies: association with lesion type and risk","year":2024,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Lesions and Carcinomas","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; National Institutes of Health","keywords":"Medicine; Breast cancer; Association (psychology); Breast disease; Lesion; Mammary gland; Internal medicine; Pathology; Oncology; Dermatology; Cancer; Psychology","score_opus":0.05213125450565592,"score_gpt":0.36288581112328766,"score_spread":0.31075455661763174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402228524","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986725,0.0066050766,0.0000055150254,0.0055959006,0.00002619739,0.00039709307,0.00026967956,0.000033088265,0.00034246338],"genre_scores_gemma":[0.9889787,0.009061463,0.00006955688,0.000011176153,0.00009905742,0.00013981464,0.00003777026,0.000018129134,0.0015843201],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99888915,0.00006925281,0.00011626426,0.00034903424,0.00027304117,0.00030328272],"domain_scores_gemma":[0.9993374,0.00009971458,0.000020466172,0.0001516357,0.00020661864,0.00018417877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025278566,0.00012211039,0.0001653113,0.00024292927,0.00015428831,0.000084829335,0.000026131718,0.000074003845,0.0000766536],"category_scores_gemma":[0.000008077712,0.000077828554,0.000019795978,0.00063232874,0.00009106779,0.00007374106,0.000025535433,0.00020343135,0.000019426525],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093632424,0.00035744152,0.81338024,0.000084541156,0.00017705128,0.00011926663,0.00045434575,0.0000016189337,0.0017396889,0.00026148043,0.0004409474,0.18204707],"study_design_scores_gemma":[0.0012872701,0.0005454464,0.994217,0.00034291038,0.00008882715,0.00062253454,0.0004090556,0.00014002765,0.00024448696,0.00006515275,0.0019564503,0.00008083074],"about_ca_topic_score_codex":0.0068556354,"about_ca_topic_score_gemma":0.0014161151,"teacher_disagreement_score":0.18196623,"about_ca_system_score_codex":0.00072336814,"about_ca_system_score_gemma":0.0003799339,"threshold_uncertainty_score":0.9997578},"labels":[],"label_agreement":null},{"id":"W4403616501","doi":"10.1007/s10549-024-07519-z","title":"CYP2D6 activity in patients with metastatic breast cancer treated with single agent tamoxifen: results from ECOG-ACRIN E3108","year":2024,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Foundation; Spinal Cord Injury BC; BC Cancer Agency","funders":"Genomic Health; Foundation Medicine; Veracyte; Genentech; Max-Planck-Gesellschaft; Eisai; Puma Biotechnology; Natera; National Institutes of Health; ECOG-ACRIN Cancer Research Group; BeiGene; Susan G. Komen; Sanofi Genzyme; Pfizer; Incyte; American College of Radiology Imaging Network; National Cancer Institute; Gilead Sciences; Sanofi; Johns Hopkins University; Susan G. Komen for the Cure; Celgene; AstraZeneca; Eli Lilly and Company","keywords":"Tamoxifen; Medicine; Breast cancer; Oncology; Metastatic breast cancer; Cancer; Internal medicine; Mammary gland; Antiestrogen","score_opus":0.14977172718728982,"score_gpt":0.44882049944701197,"score_spread":0.29904877225972215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403616501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9763126,0.0037608538,0.0000039082875,0.0021881508,0.00023805711,0.0012137276,0.015736612,0.00006894165,0.00047716746],"genre_scores_gemma":[0.9942164,0.0035381757,0.000047927217,0.00011098178,0.000240081,0.0008711555,0.00020769623,0.00006650764,0.0007011084],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99659514,0.0005882905,0.0003199127,0.0009611764,0.0005475856,0.0009879116],"domain_scores_gemma":[0.99843216,0.00034562798,0.0000814338,0.00029100524,0.00024310146,0.00060666166],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00037792602,0.00047036196,0.00049629423,0.0003305022,0.00026739432,0.00014165508,0.00017997509,0.00012567545,0.0008389897],"category_scores_gemma":[0.0000055406645,0.00030773706,0.00006391678,0.00071535533,0.00037152108,0.00021697523,0.000099088094,0.0006395176,0.000039467595],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04750128,0.0077691693,0.24696071,0.00013776663,0.003764497,0.0012487354,0.0020920597,0.0009658319,0.0075541413,0.000047729965,0.0011278965,0.6808302],"study_design_scores_gemma":[0.029624904,0.0017979385,0.91394794,0.00040764292,0.0008722944,0.000061668674,0.00013898098,0.0019871022,0.027182968,0.00012609965,0.023063876,0.0007885666],"about_ca_topic_score_codex":0.015038956,"about_ca_topic_score_gemma":0.005232987,"teacher_disagreement_score":0.6800416,"about_ca_system_score_codex":0.0009016942,"about_ca_system_score_gemma":0.0005187974,"threshold_uncertainty_score":0.9999375},"labels":[],"label_agreement":null},{"id":"W4404355148","doi":"10.1007/s10549-024-07547-9","title":"Impact of the COVID-19 pandemic on breast cancer surgeries in a Canadian population","year":2024,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Mount Sinai Hospital; Health Sciences Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; Toronto General Hospital; University Health Network; University of Toronto","funders":"Canadian Institutes of Health Research; Ontario Ministry of Health and Long-Term Care","keywords":"Coronavirus disease 2019 (COVID-19); Pandemic; Breast cancer; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Medicine; Population; Cancer; Coronavirus Infections; Virology; Internal medicine; Environmental health; Disease; Infectious disease (medical specialty); Outbreak","score_opus":0.1903884993582467,"score_gpt":0.519642351783939,"score_spread":0.32925385242569233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404355148","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9505548,0.0024622066,1.5647376e-7,0.044269294,0.0001002139,0.0007118607,0.0018017477,0.00002060107,0.00007915664],"genre_scores_gemma":[0.9957515,0.0030312634,6.144546e-7,0.00036684272,0.00015081072,0.00020920913,0.000028481307,0.000018789078,0.00044246146],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984092,0.00011740003,0.00018493153,0.00029510338,0.00038108713,0.0006122849],"domain_scores_gemma":[0.9984818,0.00020816272,0.000024172461,0.00023380165,0.00009746649,0.00095457427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003662158,0.00015103366,0.00025657544,0.0004801573,0.00015624291,0.000040175877,0.00005233704,0.00007918166,0.00041283906],"category_scores_gemma":[0.00005819399,0.00008388635,0.00009574869,0.0006575073,0.0001218354,0.00006193452,0.000020293899,0.00023079941,0.0000039353904],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0010460919,0.00009652335,0.9166779,0.00022255912,0.00011347722,0.00009451791,0.0006079972,0.00003773213,0.00004601903,0.00010196385,0.00080685114,0.08014841],"study_design_scores_gemma":[0.0009294705,0.00038822368,0.9946639,0.00051520596,0.000023309243,0.0002706364,0.000048401034,0.000071489834,0.000008313452,0.0001231628,0.002891145,0.00006672946],"about_ca_topic_score_codex":0.9908657,"about_ca_topic_score_gemma":0.96299547,"teacher_disagreement_score":0.08008167,"about_ca_system_score_codex":0.010982266,"about_ca_system_score_gemma":0.012162292,"threshold_uncertainty_score":0.9934378},"labels":[],"label_agreement":null},{"id":"W4405096693","doi":"10.1007/s10549-024-07557-7","title":"Inference of genetic ancestry from a multi-gene cancer panel in Colombian women with cancer","year":2024,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Race, Genetics, and Society","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McGill University","funders":"National Cancer Institute; Instituto Nacional de Cancerología; Georgia Institute of Technology","keywords":"Genetic genealogy; Ancestry-informative marker; Cancer; Population; 1000 Genomes Project; Cohort; Inference; Breast cancer; Genetics; Health equity; Genetic testing; Biology; Demography; Medicine; Gene; Allele frequency; Genotype; Internal medicine; Public health; Single-nucleotide polymorphism; Environmental health; Pathology; Computer science","score_opus":0.06512567454030706,"score_gpt":0.37076375651974197,"score_spread":0.30563808197943493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405096693","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96161115,0.036275245,0.000026906702,0.0003294471,0.00007407925,0.00035119551,0.0012894478,0.0000080498,0.000034465418],"genre_scores_gemma":[0.9432899,0.05426486,0.0002598617,0.000029512326,0.00019925063,0.0012036548,0.00003638172,0.00002682154,0.0006898139],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984182,0.00007068889,0.00018457371,0.00058643706,0.00024036923,0.00049970765],"domain_scores_gemma":[0.9993388,0.000028791961,0.000035110257,0.00026809625,0.00013599143,0.00019318555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010419102,0.00019527435,0.00023301759,0.00006183003,0.000080778154,0.000051198243,0.00013173831,0.00012333645,0.00010880493],"category_scores_gemma":[0.000004872465,0.00014861903,0.000035639623,0.00021683975,0.00033283234,0.0000065828913,0.00007830877,0.00012856683,0.0000017353622],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001348539,0.0006073747,0.6553536,0.00017085043,0.0009083444,0.00008498754,0.003469357,0.000653605,0.1702366,0.000009090017,0.00022067442,0.16693698],"study_design_scores_gemma":[0.0028822373,0.0012869264,0.93133116,0.0003453111,0.00004287742,0.000012105027,0.0010351624,0.00049507146,0.059045985,0.000079063175,0.003116603,0.00032750223],"about_ca_topic_score_codex":0.031150091,"about_ca_topic_score_gemma":0.025838867,"teacher_disagreement_score":0.27597755,"about_ca_system_score_codex":0.00031116928,"about_ca_system_score_gemma":0.0010108412,"threshold_uncertainty_score":0.99193704},"labels":[],"label_agreement":null},{"id":"W4405774694","doi":"10.1007/s10549-024-07578-2","title":"Steatotic liver disease in metastatic breast cancer treated with endocrine therapy and CDK4/6 inhibitor","year":2024,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; Health Sciences North; University Health Network; University of Toronto; Regional Municipality of Durham; Princess Margaret Cancer Centre; Queen's University","funders":"","keywords":"Medicine; Breast cancer; Internal medicine; Oncology; Proportional hazards model; Cancer; Population; Hormonal therapy; Metastatic breast cancer","score_opus":0.05660394675775749,"score_gpt":0.3702484980170477,"score_spread":0.3136445512592902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405774694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9073315,0.083430275,0.00000660854,0.006478311,0.000043418306,0.0015302288,0.0010200054,0.00010109038,0.000058512916],"genre_scores_gemma":[0.96716356,0.02890796,0.000089254834,0.00008521225,0.00026045844,0.001919279,0.000036261783,0.000087789005,0.0014501975],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9974081,0.000125941,0.0002460409,0.00083301635,0.00058908924,0.00079779234],"domain_scores_gemma":[0.99861634,0.00014252147,0.000032651904,0.00032564474,0.00019891789,0.000683918],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001342883,0.00042693017,0.0005166913,0.0004709333,0.00014857548,0.00013159508,0.000067754445,0.00003797389,0.0005606464],"category_scores_gemma":[0.000003868516,0.00026387532,0.00006199751,0.00073305884,0.0004942182,0.00028160147,0.000052226384,0.00029583016,0.000011940769],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018493244,0.0011672182,0.29040882,0.00055851846,0.001270542,0.0049827327,0.0007891967,0.000031523403,0.0009771592,0.00026349677,0.000056922956,0.68100065],"study_design_scores_gemma":[0.013432325,0.0018036806,0.9722588,0.0025742804,0.00027367196,0.0022091593,0.00032649885,0.00073843746,0.0010655778,0.00022351356,0.004648705,0.0004453414],"about_ca_topic_score_codex":0.012434334,"about_ca_topic_score_gemma":0.001957623,"teacher_disagreement_score":0.68184996,"about_ca_system_score_codex":0.0011020766,"about_ca_system_score_gemma":0.00079831283,"threshold_uncertainty_score":0.99998134},"labels":[],"label_agreement":null},{"id":"W4406778471","doi":"10.1007/s10549-024-07580-8","title":"A Canadian real-world, multi-center, prospective, observational study assessing the treatment duration, the treatment sequence, and the overall survival for patients treated with endocrine therapy ± targeted therapy in HR + HER2-negative advanced breast cancer","year":2025,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; Novartis (Canada); Kingston Health Sciences Centre; McGill University Health Centre; Jewish General Hospital; Ottawa Hospital; Saskatchewan Cancer Agency; Ottawa Regional Cancer Foundation; Windsor Regional Hospital; Western University; Grand River Hospital; Centre hospitalier universitaire de Québec","funders":"Novartis Pharmaceuticals Canada","keywords":"Medicine; Observational study; Oncology; Targeted therapy; Survival analysis; Internal medicine; Prospective cohort study; Endocrine system; Cancer; Hormone","score_opus":0.08490122213785031,"score_gpt":0.4171629806915637,"score_spread":0.3322617585537134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406778471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96610373,0.0023938345,0.0000073533365,0.015440306,0.0000932547,0.014291837,0.0015332215,0.000042701467,0.00009377361],"genre_scores_gemma":[0.95485324,0.019991059,0.00010693063,0.00023198679,0.00013962697,0.022624794,0.00016375187,0.00006367232,0.0018249502],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99648744,0.0005747041,0.00049266464,0.00092671847,0.0005833772,0.00093510683],"domain_scores_gemma":[0.99722356,0.0007771224,0.0001835978,0.0005832365,0.0009763938,0.0002560744],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033834734,0.00066014647,0.0007546847,0.0003330201,0.0012998533,0.00023446724,0.00019529143,0.000059102647,0.000047207614],"category_scores_gemma":[0.000016151766,0.000278032,0.000121233155,0.0010204907,0.00076257566,0.00029155315,0.000027433747,0.00023222173,6.150283e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020574294,0.0060974085,0.8079804,0.000012224087,0.0020514978,0.000024908708,0.0035604776,0.00006744872,0.000048986567,0.00020674206,0.000010148993,0.15936543],"study_design_scores_gemma":[0.09159211,0.0041411095,0.89909506,0.00018497498,0.0001242882,0.000020782692,0.0018909486,0.00033067606,0.00028444204,0.00019044333,0.0019171963,0.00022799562],"about_ca_topic_score_codex":0.50685304,"about_ca_topic_score_gemma":0.6543381,"teacher_disagreement_score":0.15913744,"about_ca_system_score_codex":0.006997347,"about_ca_system_score_gemma":0.0020479034,"threshold_uncertainty_score":0.99996716},"labels":[],"label_agreement":null},{"id":"W4407114667","doi":"10.1007/s10549-025-07612-x","title":"The association between cirrhosis and outcomes among female patients undergoing surgery for breast cancer in Ontario: a population-based study","year":2025,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Kingston Health Sciences Centre; Kingston General Hospital; Queen's University","funders":"","keywords":"Breast cancer; Medicine; Surgery; Population; Oncology; Cirrhosis; Internal medicine; Breast surgery; Cancer; Gynecology; General surgery; Environmental health","score_opus":0.039574581809844335,"score_gpt":0.35374269347030013,"score_spread":0.3141681116604558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407114667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963544,0.00015711655,0.0000021360072,0.00137104,0.000046123765,0.0015016638,0.0005372567,0.000010231806,0.00002000326],"genre_scores_gemma":[0.99814874,0.00019662628,0.0000025835798,0.000023131997,0.00002527339,0.0010818326,0.00011533254,0.000008942225,0.00039754272],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99888116,0.000090880974,0.0001920371,0.00025068407,0.00030253484,0.0002827215],"domain_scores_gemma":[0.9982955,0.0012818343,0.000050953124,0.00010168749,0.00017156782,0.00009848055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002756211,0.00011482506,0.00023586022,0.00017552951,0.00032013815,0.00006804142,0.00002589909,0.000041909545,0.000015635946],"category_scores_gemma":[0.000013612176,0.00007607997,0.000049532882,0.00017437253,0.000023468798,0.00008328475,0.0000116633455,0.00008174711,3.1246145e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008200418,0.0004192942,0.9793411,0.00008156477,0.000831411,0.0000032506782,0.00030303432,0.0000043642476,2.7532465e-7,0.0000071812988,0.0000086952605,0.01817982],"study_design_scores_gemma":[0.00500744,0.00017296724,0.99377656,0.00027609273,0.0004120405,1.5187896e-7,0.0002203801,0.000015472433,0.000005500599,0.000048402402,0.00000464174,0.00006032444],"about_ca_topic_score_codex":0.3462087,"about_ca_topic_score_gemma":0.7806319,"teacher_disagreement_score":0.4344232,"about_ca_system_score_codex":0.0018407105,"about_ca_system_score_gemma":0.0007474882,"threshold_uncertainty_score":0.65814495},"labels":[],"label_agreement":null},{"id":"W4407851919","doi":"10.1007/s10549-025-07646-1","title":"Genetic counseling referral rates and genetic testing outcomes in women with young breast cancer: a 20-year Canadian review","year":2025,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Sinai Health System; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Breast cancer; Genetic counseling; Referral; Genetic testing; Medicine; Family medicine; Demography; Oncology; Gynecology; Cancer; Obstetrics; Internal medicine; Biology; Genetics","score_opus":0.029604664406602043,"score_gpt":0.34764455930972676,"score_spread":0.31803989490312473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407851919","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94148815,0.05322693,0.000003927171,0.003833115,0.000045354536,0.00068450544,0.00047813216,0.000007586691,0.00023233073],"genre_scores_gemma":[0.9406116,0.056359477,0.00039181518,0.0003401867,0.00008158908,0.001590572,0.000017252796,0.000026655824,0.0005808544],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982744,0.00009736928,0.00021404652,0.0005642888,0.00019362597,0.00065630005],"domain_scores_gemma":[0.99910295,0.000032364194,0.000040270872,0.00028816145,0.00027337836,0.00026289886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017357925,0.00022562224,0.0002745762,0.00018523245,0.00022429891,0.00007517654,0.00012321131,0.000077355544,0.000046486504],"category_scores_gemma":[0.000017317429,0.00017722936,0.000019019406,0.00042018987,0.00018872961,0.000007707356,0.00006187827,0.00012513365,0.0000015868796],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003587081,0.00007787199,0.8824454,0.0002625415,0.0003003802,0.000050854258,0.0001802049,0.00012701935,0.0016628994,0.000005872727,0.0005911449,0.11393713],"study_design_scores_gemma":[0.001713638,0.0003220457,0.9930897,0.000984227,0.00004773361,0.00019783375,0.00028224118,0.000058077567,0.00024201072,0.00004965096,0.0027791145,0.0002337234],"about_ca_topic_score_codex":0.12767309,"about_ca_topic_score_gemma":0.32783008,"teacher_disagreement_score":0.200157,"about_ca_system_score_codex":0.0011237292,"about_ca_system_score_gemma":0.002325809,"threshold_uncertainty_score":0.8781358},"labels":[],"label_agreement":null},{"id":"W4408083539","doi":"10.1007/s10549-025-07661-2","title":"Oncotype DX recurrence score in node-positive patients in the post-RxPONDER era: a single-institution experience","year":2025,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"Medicine; Breast cancer; Oncology; Node (physics); Internal medicine; Gynecology; Cancer","score_opus":0.03492032706353536,"score_gpt":0.3531760292277033,"score_spread":0.31825570216416793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408083539","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99444777,0.002051349,0.0000072787943,0.0018178789,0.00007886619,0.00062909693,0.00012960925,0.0000045620795,0.00083356176],"genre_scores_gemma":[0.9973788,0.0013630711,0.000026322925,0.00017575387,0.000043437816,0.0008616286,0.000090182395,0.0000069112934,0.000053883316],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99858266,0.00015421175,0.00015799259,0.00047953377,0.00022997962,0.00039560776],"domain_scores_gemma":[0.9994199,0.00004555585,0.000028989754,0.0002476366,0.00020727607,0.00005060386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012565388,0.00018088151,0.00015448037,0.00014109687,0.00018996437,0.000053552405,0.00014718674,0.00007130776,0.0000068406503],"category_scores_gemma":[0.000031512907,0.00012244642,0.000034205703,0.00040835372,0.0002919192,0.000017652676,0.00011199336,0.00012402459,0.00000223224],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001865557,0.0017241102,0.9102742,0.000019153686,0.00009390129,0.00002752769,0.0024601268,0.000012300833,0.0017173225,0.00015790107,0.00008811776,0.081559755],"study_design_scores_gemma":[0.0022943008,0.00054040697,0.99235207,0.0001911363,0.000010634638,0.000009595797,0.00096143846,0.000004537379,0.0031836901,0.000039935843,0.00030431655,0.0001079267],"about_ca_topic_score_codex":0.0105097005,"about_ca_topic_score_gemma":0.017672276,"teacher_disagreement_score":0.08207786,"about_ca_system_score_codex":0.0004966152,"about_ca_system_score_gemma":0.00029546968,"threshold_uncertainty_score":0.9960794},"labels":[],"label_agreement":null},{"id":"W4408371064","doi":"10.1007/s10549-025-07654-1","title":"Evaluating PREDICT and developing outcome prediction models in early-onset breast cancer using data from Alberta, Canada","year":2025,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Proportional hazards model; Breast cancer; Lasso (programming language); Cohort; Receiver operating characteristic; Cohort study; Predictive modelling; Regression analysis; Survival analysis; Demography; Mortality rate; Statistics; Cancer; Internal medicine; Mathematics","score_opus":0.1511304431035496,"score_gpt":0.4253393452398174,"score_spread":0.2742089021362678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408371064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9831206,0.005539152,0.00005542696,0.0020960618,0.00013364792,0.00051908655,0.008463996,0.0000082509905,0.000063783664],"genre_scores_gemma":[0.9954836,0.0029746,0.00026090932,0.000086273,0.0001671332,0.0003935956,0.0004241024,0.000023821964,0.00018600529],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977588,0.00014249168,0.0003056779,0.00090360653,0.00034696495,0.00054247276],"domain_scores_gemma":[0.99903136,0.00009838407,0.000057100464,0.00050116226,0.00017321797,0.00013875992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022173433,0.00028218701,0.00030630265,0.00011612345,0.00032698942,0.00006748847,0.00019842619,0.00009861262,0.000016560865],"category_scores_gemma":[0.000021253254,0.00023981114,0.000022388504,0.00024085424,0.00015394503,0.000033903416,0.00053115474,0.00012831215,3.2654722e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078399363,0.00009420241,0.97284627,0.000035599413,0.0005942708,0.0000110363635,0.00011794955,0.00036313754,0.0003371516,0.000012754713,0.00026162856,0.024542017],"study_design_scores_gemma":[0.0027858305,0.00007816409,0.989537,0.00031739863,0.000110345274,0.000036334975,0.0001948427,0.005953432,0.00042019694,0.00014941957,0.00021898378,0.00019807009],"about_ca_topic_score_codex":0.955856,"about_ca_topic_score_gemma":0.925517,"teacher_disagreement_score":0.030339038,"about_ca_system_score_codex":0.0011405062,"about_ca_system_score_gemma":0.002178927,"threshold_uncertainty_score":0.9779214},"labels":[],"label_agreement":null},{"id":"W4408921873","doi":"10.1007/s10549-025-07653-2","title":"Impact of adding palbociclib on treatment adherence to ongoing adjuvant endocrine treatment in the global randomized PALLAS randomized trial in patients with early breast cancer","year":2025,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Centre hospitalier de l'Université Laval; Centre hospitalier universitaire de Québec","funders":"","keywords":"Palbociclib; Medicine; Randomized controlled trial; Breast cancer; Adjuvant; Internal medicine; Cancer; Pill; Gynecology; Oncology; Metastatic breast cancer; Pharmacology","score_opus":0.03299598826769643,"score_gpt":0.40508378264795325,"score_spread":0.3720877943802568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408921873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9813661,0.001668338,0.0000084290605,0.0018918416,0.00009009245,0.013358366,0.0012098517,0.000028282157,0.00037869444],"genre_scores_gemma":[0.98446804,0.0019247732,0.00008136338,0.00006271956,0.00013276604,0.012946372,0.000051252016,0.000036710844,0.00029599635],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9953957,0.0009438562,0.00082636223,0.0008830991,0.0008916935,0.0010592785],"domain_scores_gemma":[0.9972871,0.0012055889,0.00020830991,0.00062239513,0.00034619487,0.00033044367],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00062851986,0.00070544385,0.0024920518,0.000572995,0.00015805417,0.000075899865,0.0001946665,0.00009058476,0.00015313775],"category_scores_gemma":[0.00006656095,0.00032988968,0.00045435986,0.0012601955,0.0004939092,0.00012941309,0.000057350797,0.00021148498,0.0000044506314],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.63557494,0.0032336551,0.2009373,0.000024635647,0.0014998721,0.00006223447,0.0009801368,0.00015583218,0.000009096873,0.00012701847,0.0000037936888,0.15739149],"study_design_scores_gemma":[0.649128,0.009217805,0.33992332,0.0009264195,0.0002608104,0.00001655012,0.00014154192,0.000026178763,0.00005705356,0.00010850692,0.000030624782,0.00016315369],"about_ca_topic_score_codex":0.11157919,"about_ca_topic_score_gemma":0.012950789,"teacher_disagreement_score":0.15722834,"about_ca_system_score_codex":0.008475923,"about_ca_system_score_gemma":0.0015845388,"threshold_uncertainty_score":0.9999153},"labels":[],"label_agreement":null},{"id":"W4409118679","doi":"10.1007/s10549-025-07636-3","title":"Risk-guided cardioprotection with carvedilol in patients with breast cancer (CCT guide): a phase 1 randomized clinical trial","year":2025,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"National Institutes of Health; National Heart, Lung, and Blood Institute; Genome Canada; American Heart Association","keywords":"Medicine; Randomized controlled trial; Breast cancer; Carvedilol; Tolerability; Cardiotoxicity; Adverse effect; Internal medicine; Oncology; Cancer; Heart failure; Chemotherapy","score_opus":0.05147466225907994,"score_gpt":0.43220684244028484,"score_spread":0.3807321801812049,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409118679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99004954,0.00040070264,0.00010076264,0.001762771,0.00012521597,0.0066011082,0.00035626438,0.000038999573,0.0005646446],"genre_scores_gemma":[0.9933385,0.0018970018,0.00006147558,0.00007236711,0.00040372155,0.003420509,0.000058416175,0.00002823528,0.0007197429],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9970755,0.00066634826,0.0005147584,0.00062470353,0.00065539597,0.00046328298],"domain_scores_gemma":[0.9984376,0.00024013748,0.00013190726,0.0003543942,0.00057927886,0.00025669107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014047677,0.0002726475,0.0010017855,0.00031536503,0.00020038865,0.000056706314,0.000058536043,0.00015136106,0.00006736622],"category_scores_gemma":[0.00006789058,0.00016406032,0.00018425532,0.00058540277,0.0003863333,0.000111058995,0.000025748652,0.00041551108,0.0000018071755],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6934194,0.0016911842,0.10012848,0.00004247033,0.001525526,0.00002855287,0.00010891975,0.000011897871,0.00007471944,0.000011851878,0.00018594268,0.20277107],"study_design_scores_gemma":[0.8494673,0.00304574,0.14427876,0.0005758014,0.00047006115,0.000046124176,0.00007508896,0.000073362484,0.001327338,0.000033691147,0.0004477973,0.00015893998],"about_ca_topic_score_codex":0.028133854,"about_ca_topic_score_gemma":0.0029715556,"teacher_disagreement_score":0.20261212,"about_ca_system_score_codex":0.0012538916,"about_ca_system_score_gemma":0.0012265313,"threshold_uncertainty_score":0.9783379},"labels":[],"label_agreement":null},{"id":"W4409867429","doi":"10.1007/s10549-025-07699-2","title":"Association of statin use on survival outcomes of patients with early-stage HER2-positive breast cancer in the APHINITY trial","year":2025,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Charles-Le Moyne; Université de Sherbrooke","funders":"Deutsches Krebsforschungszentrum; Genentech; F. Hoffmann-La Roche","keywords":"Medicine; Internal medicine; Statin; Breast cancer; Oncology; Pertuzumab; Taxane; Proportional hazards model; Trastuzumab; Population; Cancer","score_opus":0.022854513502231732,"score_gpt":0.33885003644746725,"score_spread":0.31599552294523553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409867429","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930993,0.00019524433,0.0000023845882,0.0006461339,0.00033430217,0.0007492943,0.004850582,0.000001763267,0.00012101252],"genre_scores_gemma":[0.99656665,0.0016412004,0.000005072745,0.000033573862,0.00029072163,0.00026523773,0.00007556834,0.000008540535,0.0011134265],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986494,0.0002851425,0.00018310292,0.000249093,0.00038605195,0.00024719862],"domain_scores_gemma":[0.9992113,0.00013133524,0.00010175312,0.0002026882,0.00030636595,0.00004653336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031427603,0.00013066528,0.0002533152,0.000086450345,0.000066979745,0.000023952745,0.00009192601,0.000067508605,0.000017928556],"category_scores_gemma":[0.000027823262,0.000078871446,0.00005429846,0.0001884341,0.00010508577,0.000008966625,0.000037538648,0.00009465161,2.0640941e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028874336,0.0011272295,0.9568772,0.00001988777,0.00045352054,2.1489758e-7,0.0002975099,0.000014581101,0.0002068014,0.000107381275,0.00052607805,0.011495265],"study_design_scores_gemma":[0.016607001,0.00086046505,0.9792071,0.00004186031,0.00003988197,1.3272202e-7,0.00012747463,9.0403347e-7,0.0008194903,0.000011572114,0.0022175754,0.000066558976],"about_ca_topic_score_codex":0.035827342,"about_ca_topic_score_gemma":0.0230711,"teacher_disagreement_score":0.02232989,"about_ca_system_score_codex":0.00017265748,"about_ca_system_score_gemma":0.00031266717,"threshold_uncertainty_score":0.9947553},"labels":[],"label_agreement":null},{"id":"W4410101946","doi":"10.1007/s10549-025-07700-y","title":"Chronic skin toxicities in breast cancer survivors: a systematic review and meta-analysis of radiotherapy techniques","year":2025,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Effects of Radiation Exposure","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Ottawa; The Scarborough Hospital; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"University of Toronto; Princess Margaret Cancer Foundation","keywords":"Meta-analysis; Breast cancer; Medicine; Radiation therapy; Oncology; Internal medicine; Cancer","score_opus":0.07128226325003369,"score_gpt":0.4472514647824135,"score_spread":0.37596920153237984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410101946","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000014575151,0.9875398,0.0000015640258,0.002127887,0.00001028017,0.0073331287,0.0028959503,0.000026107533,0.000050707353],"genre_scores_gemma":[0.00013459758,0.9888857,0.000029394867,0.00007617164,0.00006629331,0.00910212,0.000099819285,0.000041132847,0.0015647532],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9963084,0.0010252042,0.00095096097,0.0006640686,0.000607618,0.00044376365],"domain_scores_gemma":[0.997696,0.0007211381,0.00036305905,0.0007065737,0.0003142322,0.0001990258],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011107711,0.000552463,0.008747947,0.001667124,0.00006589494,0.0000430868,0.00016299427,0.00020594835,0.0004637239],"category_scores_gemma":[0.000031628668,0.00032133944,0.001058627,0.002107578,0.00021663313,0.000072761155,0.00005768266,0.00030841873,8.388556e-7],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035170946,0.00017080968,0.000103894636,0.7519632,0.14014119,0.00002747908,0.00005395126,4.7964795e-7,4.256676e-7,0.000039818166,0.00009087329,0.107372686],"study_design_scores_gemma":[0.0007038034,0.0005272503,0.0003342287,0.24045737,0.7465547,0.00019520592,0.000022605653,0.000006935655,0.0000062948743,0.000005450117,0.01084894,0.00033725396],"about_ca_topic_score_codex":0.016486473,"about_ca_topic_score_gemma":0.0072094155,"teacher_disagreement_score":0.6064135,"about_ca_system_score_codex":0.002103979,"about_ca_system_score_gemma":0.0015664401,"threshold_uncertainty_score":0.9999239},"labels":[],"label_agreement":null},{"id":"W4411561109","doi":"10.1007/s10549-025-07749-9","title":"Adjunctive statistical standardization of quantitated adjuvant HER2 and ultra-low HER2 in Canadian Cancer Trials Group MA.27 trial of exemestane versus anastrozole","year":2025,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Essar Steel Algoma (Canada); North York General Hospital; London Health Sciences Centre; Queen's University; McMaster University; University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute; Canadian Cancer Society Research Institute; AstraZeneca; Government of Ontario; Strong; Pfizer","keywords":"Anastrozole; Exemestane; Medicine; Oncology; Breast cancer; Internal medicine; Adjuvant; Clinical trial; Cancer; Gynecology; Aromatase inhibitor; Tamoxifen","score_opus":0.09989953334003839,"score_gpt":0.47022284479665905,"score_spread":0.3703233114566207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411561109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97438115,0.0068805325,0.00017003286,0.0035704689,0.0004302089,0.0048934384,0.008373651,0.000018191313,0.0012823249],"genre_scores_gemma":[0.98879355,0.0098586865,0.00017064811,0.000015884943,0.0000889527,0.0006269316,0.00015964538,0.000025990536,0.000259716],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99649435,0.00064014655,0.00068570924,0.00052665995,0.0008578376,0.00079530897],"domain_scores_gemma":[0.99759245,0.0007857892,0.000111792135,0.00029902754,0.0006259957,0.0005849535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018018996,0.0002361056,0.0010291246,0.0007635333,0.00010039354,0.000035971876,0.00009278359,0.0001335418,0.00037212542],"category_scores_gemma":[0.00047458496,0.00018517158,0.00006906729,0.0009315801,0.0005576176,0.000079575446,0.0000375017,0.00027942366,0.0000010152584],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4926398,0.0020295978,0.108450554,0.0012670413,0.0018325812,0.00037436708,0.00088968995,0.000078408586,0.0039841593,0.004559271,0.0019958713,0.38189864],"study_design_scores_gemma":[0.4310031,0.026769826,0.49999264,0.005034996,0.0007595302,0.00003533555,0.003099961,0.0010030824,0.01969645,0.0007204969,0.011233549,0.0006510337],"about_ca_topic_score_codex":0.6990206,"about_ca_topic_score_gemma":0.64475524,"teacher_disagreement_score":0.39154208,"about_ca_system_score_codex":0.002568036,"about_ca_system_score_gemma":0.0057145385,"threshold_uncertainty_score":0.99992216},"labels":[],"label_agreement":null},{"id":"W4412011848","doi":"10.1007/s10549-025-07754-y","title":"Adherence to breast screening guidelines and breast cancer mortality: a population cohort study","year":2025,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Public Health Ontario; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Breast cancer; Medicine; Oncology; Cohort study; Cohort; Gynecology; Population; Breast cancer screening; Obstetrics; Internal medicine; Cancer; Mammography; Environmental health","score_opus":0.2660464963754245,"score_gpt":0.5116750774621833,"score_spread":0.24562858108675883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412011848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858679,0.00247785,0.00004959225,0.0082917465,0.000086560205,0.0022550724,0.00057289883,0.00005851209,0.00033982916],"genre_scores_gemma":[0.9951986,0.0011954062,0.00020900763,0.00038577188,0.0002983786,0.0013859605,0.00003306963,0.000021802176,0.0012720174],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99710107,0.000109881235,0.00042416263,0.00083498994,0.00088080805,0.0006490646],"domain_scores_gemma":[0.9980709,0.000054471544,0.00006132122,0.000414732,0.0008826653,0.0005158969],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062751025,0.00030411748,0.00054051453,0.0003203676,0.00041722946,0.0001542862,0.00011526011,0.000079617,0.00018750381],"category_scores_gemma":[0.000030669147,0.00023239302,0.00006138849,0.0008008578,0.00012241978,0.00018934032,0.00018891868,0.0002026396,0.000005455268],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012989397,0.00022717114,0.7389598,0.000040666317,0.00045918135,0.00007021165,0.00012870673,0.000021563383,0.00006995592,0.000050749786,0.00064312184,0.25802994],"study_design_scores_gemma":[0.0024672714,0.0008020963,0.9934516,0.00095895573,0.0002800153,0.00031466573,0.0009455845,0.00021942865,0.00002817899,0.00006971491,0.00028273812,0.0001797327],"about_ca_topic_score_codex":0.2673131,"about_ca_topic_score_gemma":0.029060373,"teacher_disagreement_score":0.2578502,"about_ca_system_score_codex":0.00071582623,"about_ca_system_score_gemma":0.00044396785,"threshold_uncertainty_score":0.98865676},"labels":[],"label_agreement":null},{"id":"W4412481961","doi":"10.1007/s10549-025-07779-3","title":"Repeat lumpectomy and external beam radiation therapy for ipsilateral breast cancer recurrence: a systematic review","year":2025,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Health Sciences Centre; Occupational Cancer Research Centre; McGill University; University of Calgary; McGill University Health Centre; Sunnybrook Health Science Centre; McMaster University","funders":"","keywords":"Lumpectomy; Breast cancer; Medicine; Radiation therapy; Mastectomy; External beam radiation; Oncology; Cancer; Radiology; Internal medicine","score_opus":0.04896347226366435,"score_gpt":0.41483092270608424,"score_spread":0.36586745044241986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412481961","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019885524,0.98625493,0.000004883095,0.0005457882,0.00016563362,0.006787142,0.0059986473,0.000019337444,0.000024788744],"genre_scores_gemma":[0.0002936739,0.9712648,0.000025255446,0.00009042602,0.00051915273,0.026234081,0.00057300826,0.000062735046,0.00093689165],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99673504,0.00034203794,0.00063822174,0.0012119692,0.00036850656,0.00070422684],"domain_scores_gemma":[0.998286,0.0001673213,0.00030506897,0.00062574353,0.00037529072,0.00024056583],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00038914953,0.00075258536,0.002030807,0.00020559286,0.00039055164,0.00012609064,0.0002460115,0.00025162255,0.000030878695],"category_scores_gemma":[0.000032587825,0.0004982925,0.00039317575,0.0003062939,0.00022020558,0.000015431511,0.00017688928,0.00018729929,0.0000026634552],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000360812,0.000235498,0.00039563334,0.2932814,0.0021281035,0.000009551821,0.000036136862,1.0028957e-7,0.0000062471995,0.000012316775,0.0010442967,0.7024899],"study_design_scores_gemma":[0.006107433,0.0013180411,0.0030982182,0.8406335,0.005614561,0.0014832913,0.000039353352,0.000002772346,0.000093364826,0.00006599596,0.14014389,0.0013995491],"about_ca_topic_score_codex":0.001345614,"about_ca_topic_score_gemma":0.00019654546,"teacher_disagreement_score":0.70109034,"about_ca_system_score_codex":0.00065178936,"about_ca_system_score_gemma":0.0010606333,"threshold_uncertainty_score":0.99974686},"labels":[],"label_agreement":null},{"id":"W4412989408","doi":"10.1007/s10549-025-07793-5","title":"Do regularly scheduled visits result in earlier detection of curable breast cancer recurrences?","year":2025,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Ontario Clinical Oncology Group; Ottawa Hospital","funders":"","keywords":"Breast cancer; Medicine; Oncology; Cancer; Internal medicine; Gynecology","score_opus":0.026368319646930566,"score_gpt":0.3602977742559081,"score_spread":0.3339294546089775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412989408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97723794,0.018018141,0.000017254817,0.0026501657,0.00015309741,0.0005967895,0.0007816441,0.000012972778,0.000532021],"genre_scores_gemma":[0.98484266,0.013175285,0.000041407795,0.000024264185,0.00014368982,0.00094758865,0.000032528882,0.000019278123,0.0007732909],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99795,0.00016131988,0.0002985433,0.0007125171,0.00031820618,0.0005593674],"domain_scores_gemma":[0.9989109,0.00004162078,0.00008478751,0.00040766422,0.0004308753,0.0001241525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026813045,0.00026991498,0.00034152452,0.0002302665,0.0002094048,0.000052615138,0.00015922629,0.00014887446,0.000046461788],"category_scores_gemma":[0.0000184883,0.0002179846,0.00007826296,0.0006472856,0.0002654752,0.000020118703,0.0001594473,0.0001527114,0.0000033042484],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007377802,0.0012347084,0.4284119,0.00016805471,0.0011084087,0.000020539981,0.00030992125,0.000055782853,0.0606505,0.00030928405,0.0005122125,0.4998409],"study_design_scores_gemma":[0.0053489762,0.00048737775,0.91349226,0.00058569503,0.00007497705,0.000042211985,0.0003515689,0.000022999333,0.07656111,0.0004233248,0.002348655,0.00026086494],"about_ca_topic_score_codex":0.013305549,"about_ca_topic_score_gemma":0.010377382,"teacher_disagreement_score":0.49958003,"about_ca_system_score_codex":0.00045384633,"about_ca_system_score_gemma":0.0004972997,"threshold_uncertainty_score":0.9932649},"labels":[],"label_agreement":null},{"id":"W4413111991","doi":"10.1007/s10549-025-07778-4","title":"Omission of anthracyclines from neoadjuvant chemotherapy for breast cancer: a population-based analysis","year":2025,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; Public Health Ontario; Health Sciences Centre; Occupational Cancer Research Centre; Hamilton Health Sciences; University of Toronto; London Health Sciences Centre; Institute for Clinical Evaluative Sciences; Western University","funders":"","keywords":"Anthracycline; Breast cancer; Medicine; Hazard ratio; Internal medicine; Oncology; Cumulative incidence; Regimen; Population; Cohort; Proportional hazards model; Neoadjuvant therapy; Cancer; Chemotherapy; Surgery; Confidence interval","score_opus":0.02439180170157113,"score_gpt":0.3856760448875486,"score_spread":0.36128424318597746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413111991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97693366,0.006314444,0.00029149596,0.0076574725,0.00008101234,0.0006829472,0.007980427,0.000014744963,0.000043824894],"genre_scores_gemma":[0.9932185,0.004346349,0.00035788788,0.00009036811,0.00019968489,0.0009211336,0.0005805349,0.000020475849,0.00026509826],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985227,0.0000630491,0.00025799894,0.00058681046,0.00021295353,0.00035649247],"domain_scores_gemma":[0.9989732,0.000098706325,0.00009426397,0.00036285637,0.00035835092,0.00011260857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000100298974,0.00024341073,0.00043274034,0.0002308865,0.00024182236,0.000028444296,0.00012040052,0.000086718035,0.00008027626],"category_scores_gemma":[0.000009854275,0.00018288534,0.00017373447,0.00046806032,0.00014609467,0.0000065297827,0.000053204127,0.00004641142,3.7751633e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060129296,0.0008736597,0.7683198,0.000049907525,0.004017671,0.0000015817523,0.00006002884,0.0002574927,0.00957829,0.000044364588,0.00037595758,0.21040833],"study_design_scores_gemma":[0.0047372016,0.00032860928,0.9732345,0.0001228644,0.00049964717,0.0000014537139,0.00008201028,0.00033839248,0.019434776,0.00020402331,0.00085720094,0.00015934258],"about_ca_topic_score_codex":0.04077956,"about_ca_topic_score_gemma":0.008644322,"teacher_disagreement_score":0.21024899,"about_ca_system_score_codex":0.00023693082,"about_ca_system_score_gemma":0.00035251307,"threshold_uncertainty_score":0.96560794},"labels":[],"label_agreement":null},{"id":"W4413414196","doi":"10.1007/s10549-025-07797-1","title":"Patient perceptions around the use of clinico-pathologic and genomic tools in the management of early breast cancer","year":2025,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation; Agricultural Research Institute of Ontario; Ottawa Public Health; McMaster University; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Breast cancer; Nomogram; Internal medicine; Chemotherapy; Oncology; Disease; Cancer","score_opus":0.09172001293806188,"score_gpt":0.3809760193351547,"score_spread":0.2892560063970928,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413414196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99020845,0.005069404,0.0000048193065,0.0028094947,0.00003759583,0.00076562073,0.0009774513,0.00000283653,0.00012434319],"genre_scores_gemma":[0.9762456,0.02244821,0.00006126791,0.000083714345,0.00004067656,0.00095508073,0.000019941044,0.000008751868,0.00013676666],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987239,0.00017982532,0.00024534317,0.0003626079,0.00019415632,0.00029412663],"domain_scores_gemma":[0.9992891,0.00009225772,0.00006842439,0.0003839145,0.0001264708,0.000039838735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001839441,0.00016996966,0.00020937124,0.00007837125,0.0001876014,0.000046863726,0.0001381736,0.000057152873,0.000014275753],"category_scores_gemma":[0.0000036158012,0.00009323838,0.00006268107,0.00021915915,0.0005123207,0.000010911621,0.00021940502,0.00008864302,6.4724765e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020553516,0.0010380847,0.63304394,0.00011786705,0.0012137074,0.00003257896,0.0014098488,0.00008480093,0.0022580593,0.0005873292,0.0004062418,0.35775217],"study_design_scores_gemma":[0.0012526136,0.0003626339,0.9949079,0.0001263096,0.00010273202,0.00003902584,0.0016666397,0.000004985469,0.00025211257,0.000094814604,0.0011137635,0.000076457975],"about_ca_topic_score_codex":0.0065525905,"about_ca_topic_score_gemma":0.0018874609,"teacher_disagreement_score":0.36186397,"about_ca_system_score_codex":0.00013104209,"about_ca_system_score_gemma":0.00011424762,"threshold_uncertainty_score":0.99056},"labels":[],"label_agreement":null},{"id":"W4413940286","doi":"10.1007/s10549-025-07801-8","title":"Natural language processing for local, regional, and distant breast cancer relapse identification in pathology reports","year":2025,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"AI in cancer detection","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Breast cancer; Medicine; Cancer; Cohort; Oncology; Receiver operating characteristic; Pathology; Internal medicine","score_opus":0.02888630840797602,"score_gpt":0.37336620953311966,"score_spread":0.34447990112514365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413940286","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8146558,0.085874476,0.04486317,0.049801577,0.0010661689,0.0031405762,0.00024494974,0.00021258922,0.00014070257],"genre_scores_gemma":[0.9956962,0.0017586027,0.00030269742,0.00005560739,0.000067123845,0.0014992496,0.000009326052,0.000009633352,0.0006015516],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9983839,0.00007735576,0.00024381284,0.00068290456,0.00023888798,0.00037316966],"domain_scores_gemma":[0.9992224,0.0000769029,0.00008356457,0.0003152281,0.0002182913,0.000083640145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032704708,0.00013969862,0.00017391425,0.00025624107,0.00027904293,0.00018061417,0.00013175445,0.00006387587,0.0000038057715],"category_scores_gemma":[0.000009384667,0.0001132704,0.000026646312,0.0005304238,0.00022313018,0.00032546525,0.00010690193,0.00014259211,4.2025337e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034952653,0.00014068712,0.007058659,0.00012475913,0.0000356228,0.00016322402,0.0008905894,0.00002599173,0.0013145658,0.0007049667,0.00041195107,0.9887795],"study_design_scores_gemma":[0.0063465796,0.00063867075,0.8919528,0.0017412561,0.00008141629,0.0042733666,0.0021626852,0.06631862,0.0060170447,0.013967288,0.0056731044,0.00082714035],"about_ca_topic_score_codex":0.004499455,"about_ca_topic_score_gemma":0.0048897984,"teacher_disagreement_score":0.9879523,"about_ca_system_score_codex":0.0010293322,"about_ca_system_score_gemma":0.00045818524,"threshold_uncertainty_score":0.680186},"labels":[],"label_agreement":null},{"id":"W4416729538","doi":"10.1007/s10549-025-07861-w","title":"High PARP1 expression is associated with proliferative tumor biology in breast cancer","year":2025,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Institutes of Health","keywords":"Breast cancer; PARP1; Biomarker; Gene expression; Human breast; Cancer; Gene","score_opus":0.04612059288081777,"score_gpt":0.4055971153934276,"score_spread":0.3594765225126098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416729538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9690681,0.002220378,0.000009139959,0.025154421,0.00007453059,0.0013003427,0.0015553781,0.00004512419,0.0005725625],"genre_scores_gemma":[0.99179494,0.0022944964,0.000042378397,0.00068939733,0.00013573913,0.003364402,0.000060650542,0.000022770837,0.0015952064],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980944,0.00019747364,0.0002314395,0.0005657072,0.0003215805,0.0005894234],"domain_scores_gemma":[0.9989766,0.00012144652,0.000063882406,0.000248992,0.00038496562,0.00020413543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019768714,0.00023992514,0.00045817913,0.0003307532,0.00018634628,0.00003425126,0.0000703256,0.000096626696,0.0007006899],"category_scores_gemma":[0.0000084913145,0.00015440819,0.00003977526,0.0006689814,0.0003315136,0.00008143404,0.00004498426,0.00027629655,0.0000057345933],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014884499,0.0020450258,0.92577666,0.000091965034,0.00092415925,0.00025837042,0.0009203241,0.000013039476,0.012938053,0.0006223394,0.0049758204,0.036549754],"study_design_scores_gemma":[0.023603426,0.0015185733,0.91339034,0.0036279422,0.000082617196,0.00015439081,0.00031745774,0.00006292205,0.05382404,0.0011806075,0.0019466955,0.000290975],"about_ca_topic_score_codex":0.009243015,"about_ca_topic_score_gemma":0.0018441046,"teacher_disagreement_score":0.04088599,"about_ca_system_score_codex":0.0019685254,"about_ca_system_score_gemma":0.001200669,"threshold_uncertainty_score":0.9973545},"labels":[],"label_agreement":null},{"id":"W4416892868","doi":"10.1007/s10549-025-07869-2","title":"Using the cancer aging and research group- breast cancer (CARG-BC) predictive model in older adults (OA) with early breast cancer: an external validation study","year":2025,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; McMaster University; Princess Margaret Cancer Centre","funders":"","keywords":"Breast cancer; Cancer; Breast disease; Mammary gland; Predictive value of tests","score_opus":0.04606726158027532,"score_gpt":0.39365635795542,"score_spread":0.3475890963751447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416892868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9836496,0.00847961,0.00013023059,0.002956878,0.00008973527,0.0023391277,0.0022764683,0.000023920531,0.00005440012],"genre_scores_gemma":[0.98554593,0.00815543,0.0000663637,0.000054856027,0.00043598146,0.0054218224,0.000040889594,0.00006784426,0.00021086464],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954285,0.0005717519,0.00035431143,0.0015540865,0.0009138115,0.0011775068],"domain_scores_gemma":[0.99797314,0.00007616814,0.000108491564,0.0006517656,0.00089148915,0.00029895102],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00068326615,0.0005309409,0.00046870415,0.0003774464,0.0010321114,0.00027291998,0.00035830255,0.00015171757,0.00003981054],"category_scores_gemma":[0.000005777032,0.0003586379,0.00006226103,0.0008104948,0.0007192386,0.00009232622,0.00047447305,0.00045615662,6.205575e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008087777,0.0015988812,0.9054232,0.000084019586,0.0010489388,0.000038420585,0.0031166952,0.0017263517,0.001817184,0.00003665868,0.000056741555,0.07696513],"study_design_scores_gemma":[0.007772243,0.0007110735,0.9822209,0.0009955053,0.00020386498,0.0000953986,0.0035359862,0.0027540578,0.0012664476,0.00007611375,0.00001883175,0.00034959486],"about_ca_topic_score_codex":0.25326025,"about_ca_topic_score_gemma":0.09126615,"teacher_disagreement_score":0.16199411,"about_ca_system_score_codex":0.0015260191,"about_ca_system_score_gemma":0.0010873657,"threshold_uncertainty_score":0.9998866},"labels":[],"label_agreement":null},{"id":"W4417319238","doi":"10.1007/s10549-025-07867-4","title":"Lymphovenous bypass for the treatment of secondary lymphedema: A meta-analysis of prospective outcomes","year":2025,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Lymphatic System and Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Cellulitis; Prospective cohort study; Complication; Breast cancer; Lymphedema; Cordotomy","score_opus":0.11163789376098228,"score_gpt":0.4299068761238484,"score_spread":0.31826898236286616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417319238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8191537,0.15383522,0.0001229539,0.008874401,0.000109909124,0.008386295,0.006243887,0.00003656061,0.003237016],"genre_scores_gemma":[0.99022925,0.0016814136,0.00004276524,0.000040876206,0.000025993852,0.0034826535,0.000028510576,0.000009944341,0.0044585825],"study_design_codex":"meta_analysis","study_design_gemma":"observational","domain_scores_codex":[0.99864703,0.000074801144,0.0003276191,0.00032252533,0.00035222172,0.00027577134],"domain_scores_gemma":[0.99805224,0.0008629823,0.00009235908,0.0004427294,0.0004272912,0.00012238177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017673774,0.00018924409,0.001265279,0.00033093255,0.0001475915,0.000017319899,0.00006881139,0.000041939984,0.00021439117],"category_scores_gemma":[0.000022057257,0.00008540861,0.0009122837,0.00063082995,0.00022307015,0.000027986931,0.000020784071,0.0000055584223,8.219106e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038182356,0.0060280715,0.32524437,0.00030415328,0.6088541,0.000018649524,0.0011409956,0.000019074534,0.000094335635,0.0016937554,0.00018015482,0.052604124],"study_design_scores_gemma":[0.010820283,0.002601779,0.73503995,0.000031241274,0.24590439,0.00001247282,0.0012677052,0.00013673905,0.0029476995,0.0003493835,0.0007964866,0.000091872265],"about_ca_topic_score_codex":0.0088912295,"about_ca_topic_score_gemma":0.00096333807,"teacher_disagreement_score":0.40979558,"about_ca_system_score_codex":0.0007529485,"about_ca_system_score_gemma":0.0010817182,"threshold_uncertainty_score":0.9977087},"labels":[],"label_agreement":null},{"id":"W569551381","doi":"10.1007/s10549-015-3455-7","title":"Comparative adherence to oral hormonal agents in older women with breast cancer","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Cancer Research Institute","keywords":"Exemestane; Medicine; Anastrozole; Letrozole; Tamoxifen; Internal medicine; Breast cancer; Proportional hazards model; Aromatase inhibitor; Oncology; Gynecology; Cancer","score_opus":0.27117940472053265,"score_gpt":0.47032884602175706,"score_spread":0.19914944130122442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W569551381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99088717,0.00060957076,0.00000979036,0.005711546,0.000031553205,0.0010066936,0.00017555902,0.00001807546,0.0015500294],"genre_scores_gemma":[0.99056894,0.00032968252,0.000093019196,0.00030489743,0.000100081634,0.0028817724,0.000013802753,0.000012206146,0.0056955847],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980873,0.000072033086,0.00016355977,0.00041985817,0.0006827757,0.0005744574],"domain_scores_gemma":[0.9983328,0.000024928844,0.000035370824,0.00022658722,0.00040362682,0.0009767143],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020307083,0.00017719652,0.00034567277,0.00015347479,0.00007284396,0.000036962763,0.000100027144,0.00004006001,0.0015421842],"category_scores_gemma":[0.000004371947,0.00011463309,0.000014466175,0.00053887774,0.00017754779,0.000099387995,0.000047948422,0.00016870865,0.0002342219],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013441064,0.002153267,0.7700294,0.00006619495,0.00036501762,0.00029109558,0.0072955694,0.000031936237,0.00024646995,0.000091377166,0.020066675,0.18592188],"study_design_scores_gemma":[0.0060202163,0.0023385712,0.9858173,0.00040497497,0.00001449853,0.00016799512,0.0020470733,0.000083096245,0.00013225469,0.000055059973,0.002781788,0.00013713403],"about_ca_topic_score_codex":0.009081722,"about_ca_topic_score_gemma":0.0019502694,"teacher_disagreement_score":0.21578789,"about_ca_system_score_codex":0.0012221375,"about_ca_system_score_gemma":0.001249897,"threshold_uncertainty_score":0.9993705},"labels":[],"label_agreement":null},{"id":"W634017482","doi":"10.1007/s10549-015-3441-0","title":"Adjuvant taxane-based chemotherapy for early stage breast cancer: a real-world comparison of chemotherapy regimens in Ontario","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"Government of Ontario; Institute for Clinical Evaluative Sciences; Genomic Health; Amgen","keywords":"Medicine; Internal medicine; Docetaxel; Epirubicin; Cyclophosphamide; Taxane; Breast cancer; Regimen; Chemotherapy; Fluorouracil; Oncology; Anthracycline; Cancer; Gynecology","score_opus":0.0761319468049118,"score_gpt":0.3889712350003227,"score_spread":0.3128392881954109,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W634017482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912914,0.0020731022,0.000020143261,0.0034529793,0.00007896279,0.0013156164,0.0014557205,0.000016902399,0.00029517556],"genre_scores_gemma":[0.9936688,0.0015728939,0.00028255224,0.00008447299,0.00017901162,0.0018132852,0.00014359572,0.000060772305,0.0021946442],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976383,0.00009612098,0.00037349298,0.000731291,0.0004262875,0.00073454063],"domain_scores_gemma":[0.9985606,0.000051516025,0.00016848047,0.0004716185,0.00044124364,0.00030654905],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026839913,0.0003871821,0.0006257096,0.0002184359,0.00013196946,0.000038476028,0.00019061407,0.0001230348,0.00007653582],"category_scores_gemma":[0.000004870519,0.00031625733,0.00012364093,0.0002844854,0.00032674646,0.000013502155,0.000062623,0.00014525016,0.00000156228],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012138752,0.0015112192,0.94939363,0.000048238217,0.00054918573,0.000008300889,0.001159226,0.000104987215,0.0021198785,0.00004592502,0.0011624274,0.031758226],"study_design_scores_gemma":[0.018206023,0.0018311634,0.9417655,0.00016271163,0.000049644565,0.000009480947,0.00042043623,0.000050465223,0.027142994,0.00004775964,0.00997382,0.00034001732],"about_ca_topic_score_codex":0.50375575,"about_ca_topic_score_gemma":0.6800702,"teacher_disagreement_score":0.17631446,"about_ca_system_score_codex":0.0014924835,"about_ca_system_score_gemma":0.0016358213,"threshold_uncertainty_score":0.99992895},"labels":[],"label_agreement":null},{"id":"W802625524","doi":"10.1007/s10549-015-3466-4","title":"Phase II randomized clinical trial evaluating neoadjuvant chemotherapy regimens with weekly paclitaxel or eribulin followed by doxorubicin and cyclophosphamide in women with locally advanced HER2-negative breast cancer: NSABP Foundation Study FB-9","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Eisai; NSABP Foundation","keywords":"Medicine; Eribulin; Breast cancer; Anthracycline; Cyclophosphamide; Taxane; Capecitabine; Chemotherapy; Internal medicine; Neoadjuvant therapy; Oncology; Epirubicin; Surgery; Randomized controlled trial; Cancer; Metastatic breast cancer; Colorectal cancer","score_opus":0.05531339928623241,"score_gpt":0.4301154364575364,"score_spread":0.374802037171304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W802625524","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988354,0.001829634,0.000038883878,0.003670913,0.00008073263,0.0055185636,0.00043691718,0.000025220885,0.000045092853],"genre_scores_gemma":[0.9851516,0.005138415,0.00038193748,0.00011297685,0.00025014408,0.008303143,0.00007422649,0.000071356815,0.00051623536],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99548995,0.0009857928,0.00065498706,0.0012554167,0.00073798024,0.00087585975],"domain_scores_gemma":[0.99788105,0.00030898515,0.00029010494,0.00044635538,0.0005610957,0.0005123749],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019248773,0.0005775721,0.001169563,0.00011185004,0.0003727405,0.00009690688,0.00015389257,0.00013442535,0.000042521755],"category_scores_gemma":[0.00010502125,0.00034779048,0.000067691726,0.00039176145,0.00080927537,0.000043514217,0.00014851923,0.0002330938,0.0000014612457],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7751371,0.005625871,0.009290509,0.000013649303,0.0015786261,0.000052873434,0.0018572445,0.000026383808,0.00037940635,0.0000019639406,0.00016250456,0.20587385],"study_design_scores_gemma":[0.91013455,0.06433109,0.017901408,0.00024201725,0.00020095606,0.000076212295,0.005379036,0.00007255521,0.0007986825,0.000047610185,0.0003469768,0.00046888491],"about_ca_topic_score_codex":0.011680926,"about_ca_topic_score_gemma":0.011347901,"teacher_disagreement_score":0.20540495,"about_ca_system_score_codex":0.0009395737,"about_ca_system_score_gemma":0.0015145929,"threshold_uncertainty_score":0.9998974},"labels":[],"label_agreement":null},{"id":"W817271235","doi":"10.1007/s10549-015-3489-x","title":"Lifetime physical activity and risk of breast cancer in pre-and post-menopausal women","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Physical Activity and Health","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Breast cancer; Medicine; Logistic regression; Cancer; Internal medicine; Demography; Oncology; Case-control study; Gynecology; Obstetrics","score_opus":0.05370282482651702,"score_gpt":0.40417262393421166,"score_spread":0.35046979910769466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W817271235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99393886,0.0005887339,3.2771698e-7,0.003762146,0.000012645219,0.00053029385,0.0010320806,0.000010761516,0.0001241547],"genre_scores_gemma":[0.9959674,0.0032723844,0.000007091798,0.000015650574,0.00019396182,0.0002853999,0.0000036619317,0.000013843985,0.00024063412],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99854344,0.00014847128,0.0000998557,0.0003524749,0.0003797013,0.0004760738],"domain_scores_gemma":[0.99880713,0.00013692152,0.000046950772,0.00015569136,0.00016017581,0.0006931465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025025767,0.0001571764,0.00047349976,0.00010912675,0.00008230893,0.000019028266,0.00003385765,0.000052865067,0.00002421142],"category_scores_gemma":[0.000015257604,0.000109555156,0.00001594011,0.0001877743,0.00032563944,0.0001383096,0.00008572006,0.00027261613,0.0000021121496],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021007415,0.009165683,0.35465813,0.0003765636,0.0006186284,0.000056914454,0.0070272866,0.000006101919,0.021591082,0.00016102819,0.00005644053,0.58527476],"study_design_scores_gemma":[0.004133526,0.0040648724,0.98969436,0.00013481831,0.000054017124,0.000064381406,0.00017477412,0.00020061905,0.0010092496,0.00031788243,0.000062620566,0.000088870336],"about_ca_topic_score_codex":0.074512966,"about_ca_topic_score_gemma":0.0026543303,"teacher_disagreement_score":0.63503623,"about_ca_system_score_codex":0.00066657434,"about_ca_system_score_gemma":0.00066374766,"threshold_uncertainty_score":0.9316499},"labels":[],"label_agreement":null},{"id":"W979723212","doi":"10.1007/s10549-015-3498-9","title":"Tumor RNA disruption predicts survival benefit from breast cancer chemotherapy","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Queen's University; Canada Research Chairs; Sunnybrook Health Science Centre; Northeast Cancer Centre; University of Waterloo; University of Toronto; Laurentian University","funders":"Ontario Institute for Cancer Research","keywords":"Breast cancer; RNA; Chemotherapy; Oncology; Medicine; Internal medicine; Cancer; Biomarker; Cancer research; Biology; Gene","score_opus":0.04191813074431651,"score_gpt":0.36476469360936137,"score_spread":0.3228465628650449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W979723212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98967206,0.0024894846,0.00021039206,0.003669687,0.00006128808,0.00050232693,0.0029642356,0.00003021054,0.0004002901],"genre_scores_gemma":[0.9921792,0.004706355,0.00018895486,0.00013544201,0.0005507631,0.0010565053,0.0004968956,0.000029779485,0.0006561094],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.998701,0.000059734317,0.00013510628,0.0005125307,0.00022046057,0.00037118734],"domain_scores_gemma":[0.9990648,0.00000925097,0.000044433637,0.0003537812,0.00022514978,0.00030257626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014070129,0.00018545095,0.00016364043,0.000043718832,0.00013896072,0.000042124084,0.00014437782,0.000112137255,0.00009194484],"category_scores_gemma":[0.000003304317,0.00014405353,0.00005352779,0.00011155881,0.00018034285,0.0000056986246,0.000094511684,0.00009008907,0.000007263904],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035867938,0.0014480393,0.1398578,0.000021399268,0.0008997839,0.0000369421,0.00020385755,0.000033573906,0.39225742,0.0010020181,0.0073701423,0.45328224],"study_design_scores_gemma":[0.008934939,0.0023344734,0.6726294,0.00014165962,0.000115572,0.0002392089,0.00031158913,0.00023320148,0.19101372,0.0031592438,0.11995902,0.0009279426],"about_ca_topic_score_codex":0.008531114,"about_ca_topic_score_gemma":0.0015161462,"teacher_disagreement_score":0.53277165,"about_ca_system_score_codex":0.00015551398,"about_ca_system_score_gemma":0.00022082232,"threshold_uncertainty_score":0.99807113},"labels":[],"label_agreement":null},{"id":"W989188527","doi":"10.1007/s10549-015-3517-x","title":"Localized experimental bone metastasis drives osteolysis and sensory hypersensitivity at distant non-tumor-bearing sites","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Bone health and treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Shriners Hospitals for Children - Canada; McGill University","funders":"","keywords":"Medicine; Osteolysis; Pathology; Osteoclast; Bone metastasis; Metastasis; Cancer; Internal medicine; Receptor; Surgery","score_opus":0.10685390839493877,"score_gpt":0.3950519717475849,"score_spread":0.2881980633526461,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W989188527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882032,0.008423817,0.000002273797,0.0015706237,0.000037197988,0.0008091272,0.0002348591,0.00003810574,0.00068074116],"genre_scores_gemma":[0.9968617,0.0009302958,0.00026679432,0.00007591605,0.00006623215,0.00028381677,0.000059344737,0.000032569355,0.001423339],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99780893,0.00014293725,0.00021942734,0.000586086,0.00056633976,0.00067629677],"domain_scores_gemma":[0.9981521,0.00009556104,0.000050815044,0.0003001287,0.00016647072,0.001234923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025761398,0.0002812034,0.00055608386,0.00018163974,0.00035945798,0.000051366245,0.000025716558,0.000056981182,0.00006371957],"category_scores_gemma":[0.000015244496,0.00019938241,0.00007554039,0.00017854953,0.00037667356,0.00010439343,0.00014031974,0.00013328518,0.000038073817],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029491706,0.0059926845,0.7221398,0.00036003473,0.00282289,0.008476742,0.0062260823,0.00000528416,0.060443085,0.00011672374,0.00072344026,0.16320157],"study_design_scores_gemma":[0.08146301,0.013412895,0.6412437,0.00068449246,0.0014051105,0.011044522,0.012666297,0.0014347432,0.22578825,0.0001833023,0.009377687,0.0012960004],"about_ca_topic_score_codex":0.010800594,"about_ca_topic_score_gemma":0.0014821171,"teacher_disagreement_score":0.16534516,"about_ca_system_score_codex":0.0012374984,"about_ca_system_score_gemma":0.00029154602,"threshold_uncertainty_score":0.99578655},"labels":[],"label_agreement":null}]}